Citrus Sinensis ID: 018489
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 355 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.785 | 0.715 | 0.364 | 3e-55 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.822 | 0.318 | 0.328 | 7e-49 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.808 | 0.349 | 0.370 | 1e-45 | |
| Q54RB7 | 527 | Dual specificity protein | no | no | 0.726 | 0.489 | 0.360 | 1e-43 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.718 | 0.153 | 0.330 | 4e-43 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.757 | 0.111 | 0.321 | 1e-42 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | no | 0.738 | 0.225 | 0.343 | 9e-42 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.723 | 0.199 | 0.351 | 2e-41 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.752 | 0.386 | 0.344 | 3e-41 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.771 | 0.541 | 0.339 | 9e-41 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 216 bits (549), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 109/299 (36%), Positives = 168/299 (56%), Gaps = 20/299 (6%)
Query: 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALR 98
K +R++W + S+L I + A G ++RG+Y VAVK++ T A+ L
Sbjct: 73 KGEREEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAK---LE 129
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F EVA+ +L HPN+ +FI A + C++ EY+ G L+
Sbjct: 130 QQFKSEVALLSRLFHPNIVQFIAACKKPP----------------VYCIITEYMSQGNLR 173
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
YL K L+ + V++LALD++RG+ YLHSQ ++HRD+K+ N+LL+ VK+ADFG
Sbjct: 174 MYLNKKEPYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGT 233
Query: 219 ARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278
+ +E + + G GT +MAPE++ PY RK DVYSFGI LWE+ +P+ ++
Sbjct: 234 SCLE-TQCREAKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 292
Query: 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGM 337
+ AV +N RP +P C +LA+++KRCW NP KRP+ +V++LE D G+
Sbjct: 293 QAAFAVAEKNERPPLPASCQPALAHLIKRCWSENPSKRPDFSNIVAVLEKYDECVKEGL 351
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (494), Expect = 7e-49, Method: Compositional matrix adjust.
Identities = 107/326 (32%), Positives = 178/326 (54%), Gaps = 34/326 (10%)
Query: 4 SKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTF 63
S Q N+ NIL + + + ++ D EI S+L I S + GTF
Sbjct: 624 SPNQYNNQGNILKNSGSVVEPPSQQ----------QQYFSDIEISFSELKISSKLGEGTF 673
Query: 64 GTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123
G V++GL+ G VA+K + E+ + E F +E+ + +L HPN+ + A
Sbjct: 674 GVVYKGLWRGSSVAIKQIKINEDVNNQVLE------EFRKELTILSRLRHPNIVLLMAAC 727
Query: 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR 183
P N+C + EYLPGG+L L +++ K+ ++ +LA+ +A+
Sbjct: 728 TA---------------PPNLC-FITEYLPGGSLYDAL-HSKKIKMNMQLYKKLAIQIAQ 770
Query: 184 GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEV 243
G++YLH ++HRD+K+ N+LLD++ VKI DFG+++++ S +MT G+ +M+PE+
Sbjct: 771 GMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLK-SKSTEMTKSIGSPIWMSPEL 829
Query: 244 LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLAN 303
L G Y K DVY+FGI LWE+ ++PY L ++ AV ++LRP IP P L++
Sbjct: 830 LMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSH 889
Query: 304 VMKRCWDANPDKRPEMDEVVSMLEAI 329
+++ CW +P KRP E++++L I
Sbjct: 890 LIQACWHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 184 bits (466), Expect = 1e-45, Method: Compositional matrix adjust.
Identities = 117/316 (37%), Positives = 174/316 (55%), Gaps = 29/316 (9%)
Query: 19 AAAASANATATPI-GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVA 77
AA +A + P+ +A+ L D +I L IK I G+FGTVHR + G DVA
Sbjct: 517 AAPMNAPPISQPVPNRANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVA 576
Query: 78 VKLLDWGEEGHRTEAEIAALR-SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENG 136
VK+L E + A R + F +EVA+ +L HPN+ F+GA
Sbjct: 577 VKIL--------MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA-------------- 614
Query: 137 QVAMPSNICCVVVEYLPGGALKTYLIKN-RRRKLAFKVVVQLALDLARGLSYLHSQK--I 193
V P N+ +V EYL G+L L K+ R +L + + +A D+A+G++YLH++ I
Sbjct: 615 -VTQPPNLS-IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 672
Query: 194 VHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKC 253
VHRD+K+ N+L+DK TVK+ DFG++R++AS GT +MAPEVL P N K
Sbjct: 673 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 732
Query: 254 DVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANP 313
DVYSFG+ LWE+ P+ +L+ ++V +AV + R EIPR +A +++ CW P
Sbjct: 733 DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEP 792
Query: 314 DKRPEMDEVVSMLEAI 329
KRP ++ +L +
Sbjct: 793 WKRPSFATIMDLLRPL 808
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54RB7|SHKA_DICDI Dual specificity protein kinase shkA OS=Dictyostelium discoideum GN=shkA PE=2 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (448), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 105/291 (36%), Positives = 164/291 (56%), Gaps = 33/291 (11%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
EI +++ +S++ G+FGTV++G DVAVK++ + +T + F +EV
Sbjct: 39 EISETEITTESILGDGSFGTVYKGRCRLKDVAVKVM-LKQVDQKTLTD-------FRKEV 90
Query: 106 AVWHKLDHPNVTKFIGA-TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
A+ K+ HPN+ F+GA T +L I TE L G L++ L+ +
Sbjct: 91 AIMSKIFHPNIVLFLGACTSTPGKLMICTE-----------------LMKGNLESLLL-D 132
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDKNRTVKIADFGVARVE 222
KL +++A D A G+ +LHS +HRD+KT N+L+D N TVK+ DFG+++++
Sbjct: 133 PMVKLPLITRMRMAKDAALGVLWLHSSNPVFIHRDLKTSNLLVDANLTVKVCDFGLSQIK 192
Query: 223 ASNPNDMTGETGTLG---YMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL-SFS 278
N G+ G G +MAPEVL G +N K DVYSFG+ LW+I+ +P+ +F
Sbjct: 193 QRGENLKDGQDGAKGTPLWMAPEVLQGRLFNEKADVYSFGLVLWQIFTRQELFPEFDNFF 252
Query: 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
+ +A+ + LRP IP CP SL ++++CWD NP+ RP + +VS LE I
Sbjct: 253 KFVAAICEKQLRPSIPDDCPKSLKELIQKCWDPNPEVRPSFEGIVSELEEI 303
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 176 bits (445), Expect = 4e-43, Method: Compositional matrix adjust.
Identities = 94/284 (33%), Positives = 159/284 (55%), Gaps = 29/284 (10%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
W I ++ + I G++G V+RG + DVA+K + E + +R +E
Sbjct: 1392 WVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKF---IKQKIDENHLLGIR----EE 1444
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+A KL HPN+ +GA++ + C+V EY+ G L+ + +
Sbjct: 1445 IAFLKKLHHPNIITMVGASLKKPNI----------------CIVTEYMAKGNLRDAM-RT 1487
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDKNRTVKIADFGVARVE 222
KL + +++ +++A+G+SYLHS I+HRD+K N+L+D+N VKIADFG AR++
Sbjct: 1488 CTPKLEWHQKIKILVNIAKGISYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIK 1547
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
N + GT + APE++ + Y+ K DV+SFGI +WE+ C P+ +F ++T
Sbjct: 1548 EENA--IMTRCGTPCWTAPEIIRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITM 1605
Query: 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
++ +++RP+IP+ CP A +M++CW A KRP MD+V+ +L
Sbjct: 1606 DIL-EDVRPKIPQDCPEEFAKLMRKCWHAKSTKRPTMDDVIIVL 1648
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 1e-42, Method: Composition-based stats.
Identities = 98/305 (32%), Positives = 163/305 (53%), Gaps = 36/305 (11%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
R ++EI+ ++L I +G FG V RG + DVA+K++ +R + + + F
Sbjct: 2105 RSEYEIDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKII------YRDQFKTKSSLVMF 2158
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
EV + KL HPNV +F+GA E H C+V E++ GG+L+ +L
Sbjct: 2159 QNEVGILSKLRHPNVVQFLGACTAGGEDH--------------HCIVTEWMGGGSLRQFL 2204
Query: 162 IKN-RRRKLAFKVVVQLALDLARGLSYLH--SQKIVHRDVKTENMLLD-----KNRTV-- 211
+ + + ++LALD+A+G++YLH + I+HRD+ + N+LLD KN V
Sbjct: 2205 TDHFNLLEQNPHIRLKLALDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSS 2264
Query: 212 ------KIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
KI+DFG++R++ + MT G + YMAPEV G+ + K DVYS+G+ L+E+
Sbjct: 2265 RQDIKCKISDFGLSRLKMEQASQMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFEL 2324
Query: 266 YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
D P D+ ++ ++ RP IP S ++ +CWD+NPD RP +++
Sbjct: 2325 LTSDEPQQDMKPMKMAHLAAYESYRPPIPLTTSSKWKEILTQCWDSNPDSRPTFKQIIVH 2384
Query: 326 LEAID 330
L+ ++
Sbjct: 2385 LKEME 2389
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (432), Expect = 9e-42, Method: Compositional matrix adjust.
Identities = 104/303 (34%), Positives = 157/303 (51%), Gaps = 41/303 (13%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRT-EAEIAALRSAF 101
Q EIE ++L IK VI G F VHRG YDG +VA+K+ H+T E ++ +R
Sbjct: 133 QPHEIEYNELDIKEVIGSGGFCKVHRGYYDGEEVAIKI------AHQTGEDDMQRMRDNV 186
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
QE ++ L H N+ G + + C+V+EY GG+L L
Sbjct: 187 LQEAKLFWALKHENIAALRGVCLNTK-----------------LCLVMEYARGGSLNRIL 229
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQ---KIVHRDVKTENMLLD--------KNRT 210
K+ V+V A+ +ARG++YLH++ I+HRD+K+ N+L+ + +T
Sbjct: 230 AG----KIPPDVLVNWAIQIARGMNYLHNEAPMSIIHRDLKSSNVLIYEAIEGNHLQQKT 285
Query: 211 VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM 270
+KI DFG+AR E N M+ GT +M PEV++ + Y++ DV+S+G+ LWE+ +
Sbjct: 286 LKITDFGLAR-EMYNTQRMSA-AGTYAWMPPEVISVSTYSKFSDVWSYGVLLWELITGET 343
Query: 271 PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330
PY V V L IP+ CP + +MK CW +P KRP E++ LE+I
Sbjct: 344 PYKGFDPLSVAYGVAVNTLTLPIPKTCPETWGALMKSCWQTDPHKRPGFKEILKQLESIA 403
Query: 331 TSK 333
SK
Sbjct: 404 CSK 406
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (430), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 102/290 (35%), Positives = 157/290 (54%), Gaps = 33/290 (11%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
+WE+ S++ I + I RG +G V RG + G +VAVK+L + L S +
Sbjct: 843 EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKML-------FNDNVNLKLISDLRK 895
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
EV + KL HPN+ F+GA S C+V EYL G+L L+
Sbjct: 896 EVDLLCKLRHPNIVLFMGACTEPSS----------------PCIVTEYLSRGSLANILL- 938
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ ++ + + +QL D ARG++YLHS+ I+HRD+KT+N+L+D + VK+ADFG+A V
Sbjct: 939 DESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATV 998
Query: 222 EASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
++ +T GT G++APEVL Y K DVYS+ I LWE+ +PY + +
Sbjct: 999 KSH----TFAKTMCGTTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQ 1054
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
V ++ R P +P CP A +M RCW+ +P RP E++ ++E +
Sbjct: 1055 VVRSIDRGERLP-MPAWCPPKYAALMNRCWETDPTHRPSFPEILPIMEGM 1103
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (428), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 102/296 (34%), Positives = 161/296 (54%), Gaps = 29/296 (9%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
+I+ ++ I I +G FG V+ G + G VAVK L H I F +E+
Sbjct: 385 DIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKL----PAHNINENIL---KEFHREI 437
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ L HPNV +F+G+ + S ++ C+ EY+P G+L + ++ N
Sbjct: 438 NLMKNLRHPNVIQFLGSCLISPDI----------------CICTEYMPRGSLYS-ILHNE 480
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ K+++ +V ++ +D A+G+ YLH I+HRD+K+ N+L+D+N VK+ADFG++ +E
Sbjct: 481 KIKISWSLVKRMMIDAAKGIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQ 540
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
MT GT + +PEVL Y K DVYSFGI LWE PY + +V A
Sbjct: 541 QGAT-MTA-CGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFA 598
Query: 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIP 339
V R+ +RP P+ P ++K C + NP +RP M++ + +LE+I+T KG IP
Sbjct: 599 VGREGMRPPTPKYGPPKYIQLLKDCLNENPSQRPTMEQCLEILESIET-KGFDDIP 653
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 167 bits (424), Expect = 9e-41, Method: Compositional matrix adjust.
Identities = 103/303 (33%), Positives = 163/303 (53%), Gaps = 29/303 (9%)
Query: 32 GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTE 91
G S++ +++ EI P ++ + +I G+FG V++G VAVKLL H+
Sbjct: 4 GLGSSYPEERSGPPEIRPEEINFEELIGTGSFGKVYKGRCRQKAVAVKLL------HKQN 57
Query: 92 AEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY 151
+ A L SAF +EV + K+ HPN+ F+GA +P C +V E
Sbjct: 58 FDAATL-SAFRKEVHLMSKIYHPNICLFMGAC---------------TIPGR-CVIVTEL 100
Query: 152 LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDKNR 209
+P G L+T L+ +++ +L + +++A D A G+++LH VHRD+K+ N+L+D+N
Sbjct: 101 VPKGNLET-LLHDQKIQLPLYLRMRMARDAALGINWLHESNPVFVHRDIKSSNLLVDENM 159
Query: 210 TVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
VKI DFG++ ++ + D + GT YMAPEV+ +N DVYSFGI LWEI
Sbjct: 160 RVKICDFGLSALKQKHKMLKDQSSAKGTPLYMAPEVMMFKEFNESSDVYSFGIVLWEILT 219
Query: 268 CDMPYP-DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
P+ + AV ++ RP IP C SL ++++CWD P RP E++S L
Sbjct: 220 RKEPFSHHRELEKFREAVCVKHERPPIPNDCLDSLRRLIEKCWDKEPISRPSFKEIISAL 279
Query: 327 EAI 329
+ +
Sbjct: 280 DHV 282
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 355 | ||||||
| 449440684 | 379 | PREDICTED: serine/threonine-protein kina | 0.977 | 0.915 | 0.856 | 0.0 | |
| 356508671 | 386 | PREDICTED: serine/threonine-protein kina | 0.994 | 0.914 | 0.841 | 1e-180 | |
| 356516684 | 386 | PREDICTED: serine/threonine-protein kina | 0.994 | 0.914 | 0.841 | 1e-180 | |
| 225457064 | 381 | PREDICTED: serine/threonine-protein kina | 0.983 | 0.916 | 0.839 | 1e-179 | |
| 147768303 | 381 | hypothetical protein VITISV_010542 [Viti | 0.983 | 0.916 | 0.836 | 1e-179 | |
| 297733801 | 349 | unnamed protein product [Vitis vinifera] | 0.983 | 1.0 | 0.839 | 1e-179 | |
| 356562746 | 392 | PREDICTED: serine/threonine-protein kina | 0.966 | 0.875 | 0.854 | 1e-179 | |
| 356513267 | 391 | PREDICTED: dual specificity protein kina | 0.997 | 0.905 | 0.833 | 1e-179 | |
| 449446652 | 385 | PREDICTED: serine/threonine-protein kina | 0.884 | 0.815 | 0.926 | 1e-178 | |
| 255540709 | 393 | protein kinase atmrk1, putative [Ricinus | 1.0 | 0.903 | 0.833 | 1e-178 |
| >gi|449440684|ref|XP_004138114.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449477402|ref|XP_004155013.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 639 bits (1647), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 304/355 (85%), Positives = 321/355 (90%), Gaps = 8/355 (2%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
MEK+KK+ N +T+A A + +T K RQ+WEI+PSKL+IKSVIAR
Sbjct: 33 MEKNKKKDEDTGNSFLTSAPIARSRSTKVA--------AKDRQEWEIDPSKLIIKSVIAR 84
Query: 61 GTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120
GTFGTVHRG+YDG DVAVKLLDWGEEGHRTEAEIA+LR+AF QEVAVWHKL+HPNVTKFI
Sbjct: 85 GTFGTVHRGVYDGLDVAVKLLDWGEEGHRTEAEIASLRAAFKQEVAVWHKLEHPNVTKFI 144
Query: 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180
GATMGS+EL IQTENG + MPSNICCVVVEYL GGALK+YLIKNRRRKLAFKVVVQLALD
Sbjct: 145 GATMGSAELQIQTENGLIGMPSNICCVVVEYLAGGALKSYLIKNRRRKLAFKVVVQLALD 204
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
LARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMA
Sbjct: 205 LARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMA 264
Query: 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS 300
PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS
Sbjct: 265 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS 324
Query: 301 LANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIPGDQPQGCLCFRKHRGP 355
LANVMKRCWDA PDKRPEMDEVVSMLEAIDTSKGGGMIP DQ QGCLCFRK+RGP
Sbjct: 325 LANVMKRCWDATPDKRPEMDEVVSMLEAIDTSKGGGMIPVDQAQGCLCFRKYRGP 379
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508671|ref|XP_003523078.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 638 bits (1645), Expect = e-180, Method: Compositional matrix adjust.
Identities = 298/354 (84%), Positives = 322/354 (90%), Gaps = 1/354 (0%)
Query: 2 EKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARG 61
+K + SD + ++ A A+ + A+ F KKQRQ+WEI+PS L+IKSVIARG
Sbjct: 34 QKEEDDAGSDHSRHSSSFATATKFKSVAGSAGATTF-KKQRQEWEIDPSNLIIKSVIARG 92
Query: 62 TFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121
TFGTVHRG+YDG DVAVK+LDWGEEGHRTEAEIAALRSAFTQEVAVWHKL+HPNVTKFIG
Sbjct: 93 TFGTVHRGIYDGQDVAVKMLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLEHPNVTKFIG 152
Query: 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDL 181
ATMGSSEL IQT+NG ++MPSNICCVVVEYL GG LK++LIKNRRRKLAFKVV+QLALDL
Sbjct: 153 ATMGSSELQIQTDNGLISMPSNICCVVVEYLAGGTLKSFLIKNRRRKLAFKVVIQLALDL 212
Query: 182 ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAP 241
ARGLSYLHSQK+VHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMAP
Sbjct: 213 ARGLSYLHSQKVVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMAP 272
Query: 242 EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSL 301
EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE+TSAVVRQNLRPEIPRCCPSSL
Sbjct: 273 EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEITSAVVRQNLRPEIPRCCPSSL 332
Query: 302 ANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIPGDQPQGCLCFRKHRGP 355
ANVMKRCWDANPDKRPEMDEVV+M+EAIDTSKGGGMIP DQ QGC CFRKHRGP
Sbjct: 333 ANVMKRCWDANPDKRPEMDEVVAMIEAIDTSKGGGMIPVDQQQGCFCFRKHRGP 386
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516684|ref|XP_003527023.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 637 bits (1644), Expect = e-180, Method: Compositional matrix adjust.
Identities = 298/354 (84%), Positives = 322/354 (90%), Gaps = 1/354 (0%)
Query: 2 EKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARG 61
+K + SD + ++ A A+ + A+ F KKQRQ+WEI+PS L+IKSVIARG
Sbjct: 34 QKEEDDAGSDHSRHSSSFATATKFKSVAGSAGATTF-KKQRQEWEIDPSNLIIKSVIARG 92
Query: 62 TFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121
TFGTVHRG+YDG DVAVK+LDWGEEGHRTEAEIAALRSAFTQEVAVWH+L+HPNVTKFIG
Sbjct: 93 TFGTVHRGIYDGQDVAVKMLDWGEEGHRTEAEIAALRSAFTQEVAVWHRLEHPNVTKFIG 152
Query: 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDL 181
ATMGSSEL IQT+NG ++MPSNICCVVVEYL GG LK++LIKNRRRKLAFKVVVQLALDL
Sbjct: 153 ATMGSSELQIQTDNGLISMPSNICCVVVEYLAGGTLKSFLIKNRRRKLAFKVVVQLALDL 212
Query: 182 ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAP 241
ARGLSYLHSQK+VHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMAP
Sbjct: 213 ARGLSYLHSQKVVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMAP 272
Query: 242 EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSL 301
EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE+TSAVVRQNLRPEIPRCCPSSL
Sbjct: 273 EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEITSAVVRQNLRPEIPRCCPSSL 332
Query: 302 ANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIPGDQPQGCLCFRKHRGP 355
ANVMKRCWDANPDKRPEMDEVV+M+EAIDTSKGGGMIP DQ QGC CFRKHRGP
Sbjct: 333 ANVMKRCWDANPDKRPEMDEVVAMIEAIDTSKGGGMIPVDQQQGCFCFRKHRGP 386
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225457064|ref|XP_002283021.1| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 634 bits (1635), Expect = e-179, Method: Compositional matrix adjust.
Identities = 298/355 (83%), Positives = 326/355 (91%), Gaps = 6/355 (1%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
M+K+KK+ + +++AAA+ A ++ RQDWEI+PSKL+IK+VIAR
Sbjct: 33 MDKNKKKEDD------SSSAAAAIPTLAPSTTASTTAPTTARQDWEIDPSKLIIKTVIAR 86
Query: 61 GTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120
GTFGTVHRG+YDG DVAVKLLDWGEEGHRTEAEIA+LR+AFTQEVAVWHKLDHPNVTKFI
Sbjct: 87 GTFGTVHRGVYDGQDVAVKLLDWGEEGHRTEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 146
Query: 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180
GATMGS+EL+IQTENG + MPSNICCVVVEYLPGGALK+YLIKNRRRKLAFKVV+QLALD
Sbjct: 147 GATMGSAELNIQTENGHIGMPSNICCVVVEYLPGGALKSYLIKNRRRKLAFKVVIQLALD 206
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
LARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMA
Sbjct: 207 LARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMA 266
Query: 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS 300
PEVLNG+PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP+S
Sbjct: 267 PEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPNS 326
Query: 301 LANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIPGDQPQGCLCFRKHRGP 355
LANVMKRCWDANPDKRPEMDEVV+M+EAIDTS+GGGM+P DQPQGC CFRK+RGP
Sbjct: 327 LANVMKRCWDANPDKRPEMDEVVAMIEAIDTSRGGGMLPVDQPQGCFCFRKYRGP 381
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147768303|emb|CAN64754.1| hypothetical protein VITISV_010542 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 634 bits (1634), Expect = e-179, Method: Compositional matrix adjust.
Identities = 297/355 (83%), Positives = 326/355 (91%), Gaps = 6/355 (1%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
M+K+KK+ + +++AAA+ A ++ RQDWEI+PSKL+IK+VJAR
Sbjct: 33 MDKNKKKEDD------SSSAAAAIPTLAPSTTASTTAPTTARQDWEIDPSKLIIKTVJAR 86
Query: 61 GTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120
GTFGTVHRG+YDG DVAVKLLDWGEEGHRTEAEIA+LR+AFTQEVAVWHKLDHPNVTKFI
Sbjct: 87 GTFGTVHRGVYDGQDVAVKLLDWGEEGHRTEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 146
Query: 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180
GATMGS+EL+IQTENG + MPSNICCVVVEYLPGGALK+YLIKNRRRKLAFKVV+QLALD
Sbjct: 147 GATMGSAELNIQTENGHIGMPSNICCVVVEYLPGGALKSYLIKNRRRKLAFKVVIQLALD 206
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
LARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMA
Sbjct: 207 LARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMA 266
Query: 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS 300
PEVLNG+PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP+S
Sbjct: 267 PEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPNS 326
Query: 301 LANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIPGDQPQGCLCFRKHRGP 355
LANVMKRCWDANPDKRPEMDEVV+M+EAIDTS+GGGM+P DQPQGC CFRK+RGP
Sbjct: 327 LANVMKRCWDANPDKRPEMDEVVAMIEAIDTSRGGGMLPVDQPQGCFCFRKYRGP 381
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297733801|emb|CBI15048.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 634 bits (1634), Expect = e-179, Method: Compositional matrix adjust.
Identities = 298/355 (83%), Positives = 326/355 (91%), Gaps = 6/355 (1%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
M+K+KK+ + +++AAA+ A ++ RQDWEI+PSKL+IK+VIAR
Sbjct: 1 MDKNKKKEDD------SSSAAAAIPTLAPSTTASTTAPTTARQDWEIDPSKLIIKTVIAR 54
Query: 61 GTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120
GTFGTVHRG+YDG DVAVKLLDWGEEGHRTEAEIA+LR+AFTQEVAVWHKLDHPNVTKFI
Sbjct: 55 GTFGTVHRGVYDGQDVAVKLLDWGEEGHRTEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 114
Query: 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180
GATMGS+EL+IQTENG + MPSNICCVVVEYLPGGALK+YLIKNRRRKLAFKVV+QLALD
Sbjct: 115 GATMGSAELNIQTENGHIGMPSNICCVVVEYLPGGALKSYLIKNRRRKLAFKVVIQLALD 174
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
LARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMA
Sbjct: 175 LARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMA 234
Query: 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS 300
PEVLNG+PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP+S
Sbjct: 235 PEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPNS 294
Query: 301 LANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIPGDQPQGCLCFRKHRGP 355
LANVMKRCWDANPDKRPEMDEVV+M+EAIDTS+GGGM+P DQPQGC CFRK+RGP
Sbjct: 295 LANVMKRCWDANPDKRPEMDEVVAMIEAIDTSRGGGMLPVDQPQGCFCFRKYRGP 349
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356562746|ref|XP_003549630.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1633), Expect = e-179, Method: Compositional matrix adjust.
Identities = 294/344 (85%), Positives = 317/344 (92%), Gaps = 1/344 (0%)
Query: 12 DNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY 71
D++ T+A A+ + A+ + NF KK++QDWEI+PSKL+IK+VIARGTFGTVHRG+Y
Sbjct: 50 DHVHTTSATASPKFSHASSAARVINF-KKKKQDWEIDPSKLIIKTVIARGTFGTVHRGVY 108
Query: 72 DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131
D DVAVKLLDWGEEG RTEAEIA+LR+AFTQEVAVWHKLDHPNVTKFIGATMGSSEL I
Sbjct: 109 DTQDVAVKLLDWGEEGQRTEAEIASLRAAFTQEVAVWHKLDHPNVTKFIGATMGSSELQI 168
Query: 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ 191
QT+NG + MPSN+CCVVVEYL GG LK YLIKNRRRKLA KVV+QLALDLARGLSYLHSQ
Sbjct: 169 QTDNGLIGMPSNVCCVVVEYLAGGNLKQYLIKNRRRKLALKVVIQLALDLARGLSYLHSQ 228
Query: 192 KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNR 251
KIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNR
Sbjct: 229 KIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNR 288
Query: 252 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 311
KCDVYSFGICLWEIYCCDMPYPDLSFSE+TSAVVRQNLRPE+PRCCPSSLANVMK+CWDA
Sbjct: 289 KCDVYSFGICLWEIYCCDMPYPDLSFSEITSAVVRQNLRPEVPRCCPSSLANVMKKCWDA 348
Query: 312 NPDKRPEMDEVVSMLEAIDTSKGGGMIPGDQPQGCLCFRKHRGP 355
+PDKRPEMDEVVSMLEAIDTSKGGGMIP DQ QGC CFRKHRGP
Sbjct: 349 SPDKRPEMDEVVSMLEAIDTSKGGGMIPHDQQQGCFCFRKHRGP 392
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513267|ref|XP_003525335.1| PREDICTED: dual specificity protein kinase zakA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1632), Expect = e-179, Method: Compositional matrix adjust.
Identities = 300/360 (83%), Positives = 321/360 (89%), Gaps = 6/360 (1%)
Query: 1 MEKSKKQRNSDDNILV-----TTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIK 55
+EK K+ +D V TT+A AS + NF KK++QDWEI+PSKL+IK
Sbjct: 33 IEKKKRSEGEEDADHVHLHVHTTSATASPKFSHASSAARVNF-KKKKQDWEIDPSKLIIK 91
Query: 56 SVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+VIARGTFGTVHRG+YD DVAVKLLDWGEEG RTEAEIA+LR+AFTQEVAVWHKLDHPN
Sbjct: 92 TVIARGTFGTVHRGVYDTQDVAVKLLDWGEEGQRTEAEIASLRAAFTQEVAVWHKLDHPN 151
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
VTKFIGATMGSSEL IQT+NG + MPSN+CCVVVEYL GG LK YLIKNRRRKLAFKVV+
Sbjct: 152 VTKFIGATMGSSELQIQTDNGLIGMPSNVCCVVVEYLAGGNLKQYLIKNRRRKLAFKVVI 211
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
QLALDLARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGT
Sbjct: 212 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGT 271
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR 295
LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE+TSAVVRQNLRPE+PR
Sbjct: 272 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEITSAVVRQNLRPEVPR 331
Query: 296 CCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIPGDQPQGCLCFRKHRGP 355
CCPSSLANVMK+CWDA+PDKRPEMDEVVSMLEAIDTSKGGGMIP DQ QGC CFRKHRGP
Sbjct: 332 CCPSSLANVMKKCWDASPDKRPEMDEVVSMLEAIDTSKGGGMIPLDQQQGCFCFRKHRGP 391
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446652|ref|XP_004141085.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1625), Expect = e-178, Method: Compositional matrix adjust.
Identities = 291/314 (92%), Positives = 307/314 (97%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
RQ+WEI+PSKL+IK+VIARGTFGTVHRG+YDG DVAVKLLDWGEEGHR+EAEIA+LR+AF
Sbjct: 72 RQEWEIDPSKLIIKAVIARGTFGTVHRGVYDGQDVAVKLLDWGEEGHRSEAEIASLRAAF 131
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
TQEVAVWHKLDHPNVTKFIGAT+GSS+LHIQTENGQ+ MPSNICCVVVEY PGGALK+YL
Sbjct: 132 TQEVAVWHKLDHPNVTKFIGATIGSSDLHIQTENGQIGMPSNICCVVVEYCPGGALKSYL 191
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
IKNRR+KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARV
Sbjct: 192 IKNRRKKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARV 251
Query: 222 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281
EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT
Sbjct: 252 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 311
Query: 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIPGD 341
SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV+MLEAIDTSKGGGMIP D
Sbjct: 312 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVTMLEAIDTSKGGGMIPLD 371
Query: 342 QPQGCLCFRKHRGP 355
Q QGC CFR++RGP
Sbjct: 372 QSQGCFCFRRYRGP 385
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255540709|ref|XP_002511419.1| protein kinase atmrk1, putative [Ricinus communis] gi|223550534|gb|EEF52021.1| protein kinase atmrk1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1624), Expect = e-178, Method: Compositional matrix adjust.
Identities = 301/361 (83%), Positives = 322/361 (89%), Gaps = 6/361 (1%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKK------QRQDWEIEPSKLVI 54
M+K+K+ N +N++ A SA+ +A + F K RQ+WEI+PSKL+I
Sbjct: 33 MDKNKRADNHHNNLIARPPLAFSADDSAISATTTATFTKTTTALKKDRQEWEIDPSKLII 92
Query: 55 KSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
K+VIARGTFGTVHRG+YDG DVAVKLLDWGEEGHRTEAEIA LR+AFTQEV VWHKLDHP
Sbjct: 93 KTVIARGTFGTVHRGIYDGQDVAVKLLDWGEEGHRTEAEIATLRAAFTQEVVVWHKLDHP 152
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
NVTKFIGATMGSSEL IQTENG + MPSNICCV+VEYLPGGALK+YLIKNRR+KLAFKVV
Sbjct: 153 NVTKFIGATMGSSELQIQTENGYIGMPSNICCVIVEYLPGGALKSYLIKNRRKKLAFKVV 212
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
V+LALDLARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETG
Sbjct: 213 VELALDLARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETG 272
Query: 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 294
TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP
Sbjct: 273 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 332
Query: 295 RCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIPGDQPQGCLCFRKHRG 354
RCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID SKGGGMIP DQ GCLCFR+ RG
Sbjct: 333 RCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDISKGGGMIPADQQGGCLCFRRVRG 392
Query: 355 P 355
P
Sbjct: 393 P 393
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 355 | ||||||
| TAIR|locus:2084193 | 411 | AT3G01490 [Arabidopsis thalian | 0.904 | 0.781 | 0.878 | 2e-159 | |
| TAIR|locus:2170106 | 385 | AT5G50000 [Arabidopsis thalian | 0.994 | 0.916 | 0.802 | 1.3e-157 | |
| TAIR|locus:2094329 | 378 | AT3G22750 [Arabidopsis thalian | 0.881 | 0.828 | 0.731 | 6.2e-133 | |
| TAIR|locus:2130230 | 364 | AT4G14780 [Arabidopsis thalian | 0.890 | 0.868 | 0.696 | 8.7e-127 | |
| TAIR|locus:2077244 | 391 | ATMRK1 [Arabidopsis thaliana ( | 0.881 | 0.800 | 0.713 | 7e-125 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.526 | 0.453 | 0.441 | 2.6e-59 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.526 | 0.454 | 0.441 | 3.8e-58 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.507 | 0.329 | 0.435 | 2.9e-54 | |
| TAIR|locus:2102802 | 475 | AT3G46930 [Arabidopsis thalian | 0.507 | 0.378 | 0.434 | 1.6e-51 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.507 | 0.315 | 0.397 | 3.3e-51 |
| TAIR|locus:2084193 AT3G01490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1553 (551.7 bits), Expect = 2.0e-159, P = 2.0e-159
Identities = 282/321 (87%), Positives = 309/321 (96%)
Query: 35 SNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEI 94
S ++K R++WEI+PSKL+IKSVIARGTFGTVHRG+YDG DVAVKLLDWGEEGHR++AEI
Sbjct: 91 STEVEKSRREWEIDPSKLIIKSVIARGTFGTVHRGIYDGQDVAVKLLDWGEEGHRSDAEI 150
Query: 95 AALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG 154
A+LR+AFTQEVAVWHKLDHPNVTKFIGA MG+SE+ IQTENGQ+ MPSN+CCVVVEY PG
Sbjct: 151 ASLRAAFTQEVAVWHKLDHPNVTKFIGAAMGTSEMSIQTENGQMGMPSNVCCVVVEYCPG 210
Query: 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
GALK++LIK RRRKLAFKVV+QL+LDLARGLSYLHSQKIVHRDVKTENMLLDK+RT+KIA
Sbjct: 211 GALKSFLIKTRRRKLAFKVVIQLSLDLARGLSYLHSQKIVHRDVKTENMLLDKSRTLKIA 270
Query: 215 DFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274
DFGVAR+EASNPNDMTGETGTLGYMAPEVLNG+PYNRKCDVYSFGICLWEIYCCDMPYPD
Sbjct: 271 DFGVARLEASNPNDMTGETGTLGYMAPEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPD 330
Query: 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334
LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANP+KRPEM+EVV+MLEAIDTSKG
Sbjct: 331 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPEKRPEMEEVVAMLEAIDTSKG 390
Query: 335 GGMIPGDQPQGCLCFRKHRGP 355
GGMIP DQ QGC CFR+HRGP
Sbjct: 391 GGMIPPDQQQGCFCFRRHRGP 411
|
|
| TAIR|locus:2170106 AT5G50000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1536 (545.8 bits), Expect = 1.3e-157, P = 1.3e-157
Identities = 285/355 (80%), Positives = 312/355 (87%)
Query: 1 MEKSKKQRNSDDNILVXXXXXXXXXXXXXPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
+EK+KK+ D + G +KQR +WEI+PSKL+IK+V+AR
Sbjct: 33 LEKNKKKDEEDTTAVAIGGSASSSPVTLNGGGFVGK--RKQRLEWEIDPSKLIIKTVLAR 90
Query: 61 GTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120
GTFGTVHRG+YDG DVAVKLLDWGEEGHR+EAEI +LR+ F QEVAVWHKLDHPNVTKFI
Sbjct: 91 GTFGTVHRGIYDGQDVAVKLLDWGEEGHRSEAEIVSLRADFAQEVAVWHKLDHPNVTKFI 150
Query: 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180
GATMG+S L +QTE+G +AMP+NICCVVVEYLPGGALK+YLIKNRRRKL FK+VVQLALD
Sbjct: 151 GATMGASGLQLQTESGPLAMPNNICCVVVEYLPGGALKSYLIKNRRRKLTFKIVVQLALD 210
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
LARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMA
Sbjct: 211 LARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMA 270
Query: 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS 300
PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL+FSEVTSAVVRQNLRP+IPRCCPS+
Sbjct: 271 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLTFSEVTSAVVRQNLRPDIPRCCPSA 330
Query: 301 LANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIPGDQPQGCLCFRKHRGP 355
LA VMKRCWDANPDKRPEMDEVV MLE+IDT+KGGGMIP DQ QGCLCFR+ RGP
Sbjct: 331 LAAVMKRCWDANPDKRPEMDEVVPMLESIDTTKGGGMIPNDQQQGCLCFRRKRGP 385
|
|
| TAIR|locus:2094329 AT3G22750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1303 (463.7 bits), Expect = 6.2e-133, P = 6.2e-133
Identities = 234/320 (73%), Positives = 281/320 (87%)
Query: 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRS 99
K +++WEIE +KL +++VIARG +G V++G+YDG DVAVK+LDWGE+G+ T AE +ALR+
Sbjct: 62 KPKEEWEIELAKLEMRNVIARGAYGIVYKGIYDGQDVAVKVLDWGEDGYATTAETSALRA 121
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHI----QTENGQVAMPSNICCVVVEYLPGG 155
+F QEVAVWHKLDHPNVT+F+GA+MG++ L I +TEN ++P CCVVVEY+PGG
Sbjct: 122 SFRQEVAVWHKLDHPNVTRFVGASMGTANLKIPSSAETEN---SLPQRACCVVVEYIPGG 178
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
LK YL +NRR+KLAFKVVVQLALDL+RGLSYLHS++IVHRDVKTENMLLD R +KIAD
Sbjct: 179 TLKQYLFRNRRKKLAFKVVVQLALDLSRGLSYLHSERIVHRDVKTENMLLDYQRNLKIAD 238
Query: 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
FGVARVEA NP DMTGETGTLGYMAPEVL+G PYNR+CDVYSFGICLWEIYCCDMPYPDL
Sbjct: 239 FGVARVEAQNPKDMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGICLWEIYCCDMPYPDL 298
Query: 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335
SF++V+SAVVRQNLRP+IPRCCP++LA +MKRCW+ANP+KRPEM+EVVS+LEA+DT+KGG
Sbjct: 299 SFADVSSAVVRQNLRPDIPRCCPTALATIMKRCWEANPEKRPEMEEVVSLLEAVDTTKGG 358
Query: 336 GMIPGDQPQGCLCFRKHRGP 355
GMIP DQ GC CF RGP
Sbjct: 359 GMIPEDQRPGCFCFVSGRGP 378
|
|
| TAIR|locus:2130230 AT4G14780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1245 (443.3 bits), Expect = 8.7e-127, P = 8.7e-127
Identities = 220/316 (69%), Positives = 268/316 (84%)
Query: 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRS 99
K +++WEI+ +KL +VIARGT+GTV++G+YDG DVAVK+LDW ++G+ T A+ A R+
Sbjct: 49 KAKEEWEIDLAKLETSNVIARGTYGTVYKGIYDGQDVAVKVLDWEDDGNETTAKTATNRA 108
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F QEV VWHKL+HPNVTKF+GA+MG++ L+I++ + + ++P CCVVVEYLPGG LK
Sbjct: 109 LFRQEVTVWHKLNHPNVTKFVGASMGTTNLNIRSADSKGSLPQQACCVVVEYLPGGTLKQ 168
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+LI+++ +KLAFK V++LALDLARGLSYLHS+KIVHRDVKTENMLLD + +KIADFGVA
Sbjct: 169 HLIRHKSKKLAFKAVIKLALDLARGLSYLHSEKIVHRDVKTENMLLDAQKNLKIADFGVA 228
Query: 220 RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
RVEA NP DMTGETGTLGYMAPEV++G PYNR+CDVYSFGICLWEIYCCDMPYPDLSF +
Sbjct: 229 RVEALNPKDMTGETGTLGYMAPEVIDGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFVD 288
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIP 339
V+SAVV NLRPEIPRCCP++LA +MK CWD NP KRPEM EVV MLE +DTSKGGGMIP
Sbjct: 289 VSSAVVLHNLRPEIPRCCPTALAGIMKTCWDGNPQKRPEMKEVVKMLEGVDTSKGGGMIP 348
Query: 340 GDQPQGCLCFRKHRGP 355
DQ +GC CF RGP
Sbjct: 349 EDQSRGCFCFAPARGP 364
|
|
| TAIR|locus:2077244 ATMRK1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1227 (437.0 bits), Expect = 7.0e-125, P = 7.0e-125
Identities = 227/318 (71%), Positives = 263/318 (82%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT 102
Q+WEI+ SKL +K V+A GT+GTV+RG+Y G +VAVK+LDWGE+G+ T AE ALR++F
Sbjct: 74 QEWEIDLSKLDMKHVLAHGTYGTVYRGVYAGQEVAVKVLDWGEDGYATPAETTALRASFE 133
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN-----GQVAMPSNICCVVVEYLPGGAL 157
QEVAVW KLDHPNVTKFIGA+MG+S+L I G A P+ CCVVVEY+ GG L
Sbjct: 134 QEVAVWQKLDHPNVTKFIGASMGTSDLRIPPAGDTGGRGNGAHPARACCVVVEYVAGGTL 193
Query: 158 KTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
K +LIK R KL K V+QLALDLARGLSYLHS+ IVHRDVK+ENMLL N+T+KIADFG
Sbjct: 194 KKFLIKKYRAKLPIKDVIQLALDLARGLSYLHSKAIVHRDVKSENMLLQPNKTLKIADFG 253
Query: 218 VARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
VARVEA NP DMTGETGTLGYMAPEVL G PYNRKCDVYSFG+CLWEIYCCDMPY D SF
Sbjct: 254 VARVEAQNPQDMTGETGTLGYMAPEVLEGKPYNRKCDVYSFGVCLWEIYCCDMPYADCSF 313
Query: 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGM 337
+E++ AVV +NLRPEIP+CCP ++AN+MKRCWD NPD+RPEM+EVV +LEAIDTSKGGGM
Sbjct: 314 AEISHAVVHRNLRPEIPKCCPHAVANIMKRCWDPNPDRRPEMEEVVKLLEAIDTSKGGGM 373
Query: 338 IPGDQPQGCLCFRKHRGP 355
I DQ QGCLCF K RGP
Sbjct: 374 IAPDQFQGCLCFFKPRGP 391
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 469 (170.2 bits), Expect = 2.6e-59, Sum P(2) = 2.6e-59
Identities = 83/188 (44%), Positives = 128/188 (68%)
Query: 144 ICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
+ C+V EY GG+++ +L K + R + K+ V ALD+ARG++Y+H + +HRD+K++N+
Sbjct: 204 VWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVARGMAYVHERNFIHRDLKSDNL 263
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
L+ +R++KIADFGVAR+E MT ETGT +MAPE++ PY +K DVYSFGI LW
Sbjct: 264 LISADRSIKIADFGVARIEVQTEG-MTPETGTYRWMAPEMIQHRPYTQKVDVYSFGIVLW 322
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
E+ +P+ +++ + AVV + +RP +P C L +M RCWDA+P+ RP E+V
Sbjct: 323 ELITGLLPFQNMTAVQAAFAVVNRGVRPTVPADCLPVLGEIMTRCWDADPEVRPCFAEIV 382
Query: 324 SMLEAIDT 331
++LEA +T
Sbjct: 383 NLLEAAET 390
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 469 (170.2 bits), Expect = 3.8e-58, Sum P(2) = 3.8e-58
Identities = 83/188 (44%), Positives = 130/188 (69%)
Query: 144 ICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
+ C+V EY GG+++ +L + + R + K+ V+ ALD+ARG++Y+H + +HRD+K++N+
Sbjct: 203 VWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGRNFIHRDLKSDNL 262
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
L+ ++++KIADFGVAR+E MT ETGT +MAPE++ YN+K DVYSFGI LW
Sbjct: 263 LISADKSIKIADFGVARIEVQTEG-MTPETGTYRWMAPEMIQHRAYNQKVDVYSFGIVLW 321
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
E+ +P+ +++ + AVV + +RP +P C L+++M RCWDANP+ RP EVV
Sbjct: 322 ELITGLLPFQNMTAVQAAFAVVNRGVRPTVPNDCLPVLSDIMTRCWDANPEVRPCFVEVV 381
Query: 324 SMLEAIDT 331
+LEA +T
Sbjct: 382 KLLEAAET 389
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 430 (156.4 bits), Expect = 2.9e-54, Sum P(2) = 2.9e-54
Identities = 81/186 (43%), Positives = 128/186 (68%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKV--VVQLALDLARGLSYLHSQKIVHRDVKTENM 203
C+V E++ G++ +L K +K AFK+ ++++ALD+A+G+SYLH I+HRD+KT N+
Sbjct: 357 CIVTEFMARGSIYDFLHK---QKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANL 413
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
L+D++ VK+ADFGVARV+ + MT ETGT +MAPEV+ PYN K DV+S+ I LW
Sbjct: 414 LMDEHGLVKVADFGVARVQIES-GVMTAETGTYRWMAPEVIEHKPYNHKADVFSYAIVLW 472
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
E+ D+PY L+ + VV++ LRP+IP+ + +++RCW +P++RP +E++
Sbjct: 473 ELLTGDIPYAFLTPLQAAVGVVQKGLRPKIPKKTHPKVKGLLERCWHQDPEQRPLFEEII 532
Query: 324 SMLEAI 329
ML+ I
Sbjct: 533 EMLQQI 538
|
|
| TAIR|locus:2102802 AT3G46930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 443 (161.0 bits), Expect = 1.6e-51, Sum P(2) = 1.6e-51
Identities = 80/184 (43%), Positives = 128/184 (69%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C++ EY+P G+L++YL K ++ L + ++ LD+A+G+ Y+HS++IVH+D+K EN+L+
Sbjct: 235 CIITEYVPRGSLRSYLHKLEQKSLPLEQLIDFGLDIAKGMEYIHSREIVHQDLKPENVLI 294
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
D + +KIADFG+A E D+ G+ GT +MAPEVL P+ RKCDVYSFG+ LWE
Sbjct: 295 DNDFHLKIADFGIACEEEYC--DVLGDNIGTYRWMAPEVLKRIPHGRKCDVYSFGLLLWE 352
Query: 265 IYCCDMPYPDLSFSE-VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
+ +PY ++ F+E + AV+ + +RP IP CP+++ +++RCW + DKRPE ++V
Sbjct: 353 MVAGALPYEEMKFAEQIAYAVIYKKIRPVIPTDCPAAMKELIERCWSSQTDKRPEFWQIV 412
Query: 324 SMLE 327
+LE
Sbjct: 413 KVLE 416
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 401 (146.2 bits), Expect = 3.3e-51, Sum P(2) = 3.3e-51
Identities = 74/186 (39%), Positives = 123/186 (66%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKV--VVQLALDLARGLSYLHSQKIVHRDVKTENM 203
C+V E++ G++ +L K+ K FK+ ++++ALD+++G++YLH I+HRD+KT N+
Sbjct: 363 CIVTEFMTRGSIYDFLHKH---KGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANL 419
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
L+D++ VK+ADFGVARV+ + MT ETGT +MAPEV+ PY+ + DV+S+ I LW
Sbjct: 420 LMDEHEVVKVADFGVARVQTES-GVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLW 478
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
E+ ++PY L+ + VV++ LRP+IP+ L ++++CW +P RP E++
Sbjct: 479 ELLTGELPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNFAEII 538
Query: 324 SMLEAI 329
ML +
Sbjct: 539 EMLNQL 544
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 355 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-80 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-78 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-78 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-77 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-68 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-62 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-61 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-53 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-52 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-49 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-46 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-46 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-46 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-45 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-45 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-44 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-44 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-43 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-43 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-42 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-42 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-41 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-41 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-40 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-40 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-40 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-39 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-38 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-38 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-38 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-38 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-38 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-37 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-37 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-37 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-37 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-37 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-36 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-36 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-36 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-36 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-36 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-36 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-35 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-35 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-35 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-34 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-34 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-34 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-34 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-34 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-33 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-33 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-33 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-33 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-33 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-33 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-33 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-33 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-33 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-32 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-32 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-32 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-32 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-31 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-31 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-31 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-31 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-31 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-31 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-31 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-30 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-30 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-30 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-30 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-30 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-29 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-29 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-29 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-29 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-29 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-29 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-29 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-27 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-27 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-27 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-27 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-26 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-26 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-26 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-26 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-26 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-26 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-26 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-26 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-26 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-25 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-25 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-25 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-25 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-24 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-24 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-24 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-24 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-24 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-23 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-23 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-23 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-23 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-23 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-22 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-22 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-22 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-22 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-22 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-21 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-21 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-21 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-20 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-19 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-18 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-18 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-17 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-14 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-14 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-14 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-13 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-10 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-08 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 4e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 7e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 6e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 7e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 7e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 244 bits (626), Expect = 5e-80
Identities = 95/284 (33%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 52 LVIKSVIARGTFGTVHRGLYDGH------DVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
L + + G FG V++G G VAVK L EG E R F +E
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEE-----REEFLEEA 52
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
++ KL HPN+ + +G L +V EY+PGG L +L +
Sbjct: 53 SIMKKLSHPNIVRLLGVCTQGEPL----------------YIVTEYMPGGDLLDFL-RKH 95
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
KL K ++Q+AL +A+G+ YL S+ VHRD+ N L+ +N VKI+DFG++R +
Sbjct: 96 GEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED 155
Query: 226 PNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTS 282
G L +MAPE L + K DV+SFG+ LWEI+ + PYP +S EV
Sbjct: 156 DYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-L 214
Query: 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
++ R P CP L +M +CW +P+ RP E+V L
Sbjct: 215 ELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 240 bits (616), Expect = 2e-78
Identities = 97/286 (33%), Positives = 136/286 (47%), Gaps = 40/286 (13%)
Query: 57 VIARGTFGTVHRGLYDG-----HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ G FG V++G G +VAVK L E E R F +E V KL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEE-----RKDFLKEARVMKKL 53
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------ 165
HPNV + +G L +V+EY+ GG L YL K+R
Sbjct: 54 GHPNVVRLLGVCTEEEPL----------------YLVLEYMEGGDLLDYLRKSRPVFPSP 97
Query: 166 -RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ L+ K ++ A+ +A+G+ YL S+K VHRD+ N L+ ++ VKI+DFG++R
Sbjct: 98 EKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157
Query: 225 NPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281
+ G L +MAPE L + K DV+SFG+ LWEI+ PYP LS EV
Sbjct: 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV- 216
Query: 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
+R+ R P CP L +M CW +P+ RP E+V LE
Sbjct: 217 LEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 240 bits (615), Expect = 2e-78
Identities = 94/283 (33%), Positives = 143/283 (50%), Gaps = 33/283 (11%)
Query: 52 LVIKSVIARGTFGTVHRGLYDGH------DVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
L + + G FG V++G G +VAVK L + +A F +E
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-------KEDASEQQ-IEEFLREA 52
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ KLDHPN+ K +G L +V+EY+PGG L YL KNR
Sbjct: 53 RIMRKLDHPNIVKLLGVCTEEEPL----------------MIVMEYMPGGDLLDYLRKNR 96
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
++L+ ++ AL +ARG+ YL S+ +HRD+ N L+ +N VKI+DFG++R +
Sbjct: 97 PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156
Query: 226 P-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSA 283
+ G + +MAPE L + K DV+SFG+ LWEI+ + PYP +S +EV
Sbjct: 157 DYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVL-E 215
Query: 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
+++ R P CP L +M +CW +P+ RP E+V +L
Sbjct: 216 YLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 237 bits (608), Expect = 2e-77
Identities = 93/283 (32%), Positives = 139/283 (49%), Gaps = 34/283 (12%)
Query: 52 LVIKSVIARGTFGTVHRGLYDGH------DVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
L + + G FG V++G G +VAVK L +E +I +E
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK----EDASEQQIEEFL----REA 52
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ KLDHPNV K +G L +V+EY+ GG L +YL +
Sbjct: 53 RIMRKLDHPNVVKLLGVCTEEEPL----------------YIVMEYMEGGDLLSYL-RKN 95
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
R KL+ ++ AL +ARG+ YL S+ +HRD+ N L+ +N VKI+DFG++R +
Sbjct: 96 RPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 155
Query: 226 P-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSA 283
G + +MAPE L + K DV+SFG+ LWEI+ + PYP +S EV
Sbjct: 156 DYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL-E 214
Query: 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
++ R P CP L ++M +CW +P+ RP E+V +L
Sbjct: 215 YLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 213 bits (546), Expect = 4e-68
Identities = 77/273 (28%), Positives = 122/273 (44%), Gaps = 31/273 (11%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G+FG V+ G VA+K++ + +I R +E+ + KL
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIK--------KKKIKKDRERILREIKILKKL 54
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ + +L++ V+EY GG L L K R L+
Sbjct: 55 KHPNIVRLYDVFEDEDKLYL----------------VMEYCEGGDLFDLLKKRGR--LSE 96
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
+ L YLHS+ IVHRD+K EN+LLD++ VK+ADFG+AR + +T
Sbjct: 97 DEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLAR-QLDPGEKLTT 155
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 291
GT YMAPEVL G Y + D++S G+ L+E+ P+P + + P
Sbjct: 156 FVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP 215
Query: 292 EIPRC--CPSSLANVMKRCWDANPDKRPEMDEV 322
P +++++ +P+KR +E
Sbjct: 216 FPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 5e-62
Identities = 79/273 (28%), Positives = 130/273 (47%), Gaps = 62/273 (22%)
Query: 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ G FGTV+ G VA+K++ + + ++L +E+ + KL+HPN
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK--------KEDSSSLLEELLREIEILKKLNHPN 52
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ K G + EN +V+EY GG+LK +K KL+ ++
Sbjct: 53 IVKLYGV--------FEDENH--------LYLVMEYCEGGSLKDL-LKENEGKLSEDEIL 95
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDK-NRTVKIADFGVARVEASNPNDMTGETG 234
++ L + GL YLHS I+HRD+K EN+LLD N VK+ADFG++++ S+ + + G
Sbjct: 96 RILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155
Query: 235 TLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293
T YMAPEVL G Y+ K D++S G+ L+E+
Sbjct: 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------- 187
Query: 294 PRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
L +++++ +P+KRP E++ L
Sbjct: 188 -----PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 4e-61
Identities = 88/281 (31%), Positives = 140/281 (49%), Gaps = 35/281 (12%)
Query: 52 LVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
+ + G+FGTV++ G VAVK+L + +E + +E+ +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKIL-------KKRSEKSKKDQTARREIRILR 53
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
+L HPN+ + I A L++ V+EY GG L YL + L
Sbjct: 54 RLSHPNIVRLIDAFEDKDHLYL----------------VMEYCEGGDLFDYLSRGGP--L 95
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM 229
+ ++AL + RGL YLHS I+HRD+K EN+LLD+N VKIADFG+A+ + + +
Sbjct: 96 SEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL 155
Query: 230 TGETGTLGYMAPEVLN-GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288
T GT YMAPEVL GN Y K DV+S G+ L+E+ P+ + + ++R+
Sbjct: 156 TTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQ-LQLIRRI 214
Query: 289 LRPEIP------RCCPSSLANVMKRCWDANPDKRPEMDEVV 323
L P + +++K+C + +P KRP +E++
Sbjct: 215 LGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-53
Identities = 83/270 (30%), Positives = 132/270 (48%), Gaps = 28/270 (10%)
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
++ RG+FG+V+ L G +AVK + E +E E+ AL +E+ + L HP
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSV---ELSGDSEEELEALE----REIRILSSLQHP 59
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N+ ++ G SE + N + +EY+ GG+L + L+K + KL V+
Sbjct: 60 NIVRYYG-----SERDEEK---------NTLNIFLEYVSGGSL-SSLLK-KFGKLPEPVI 103
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET- 233
+ + GL+YLHS IVHRD+K N+L+D + VK+ADFG A+ +
Sbjct: 104 RKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV 163
Query: 234 -GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL-SFSEVTSAVVRQNLRP 291
GT +MAPEV+ G Y R D++S G + E+ P+ +L + + P
Sbjct: 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPP 223
Query: 292 EIPRCCPSSLANVMKRCWDANPDKRPEMDE 321
EIP + +++C +P KRP DE
Sbjct: 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 5e-52
Identities = 93/288 (32%), Positives = 138/288 (47%), Gaps = 35/288 (12%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
W I +L + + I +G FG V G Y G VAVK L + T A+ AF E
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCL----KDDSTAAQ------AFLAE 50
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+V L HPN+ + +G + + L+I V EY+ G+L YL
Sbjct: 51 ASVMTTLRHPNLVQLLGVVLQGNPLYI----------------VTEYMAKGSLVDYLRSR 94
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
R + + ALD+ G+ YL + VHRD+ N+L+ ++ K++DFG+A+ +
Sbjct: 95 GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154
Query: 225 NPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVT 281
++G L + APE L ++ K DV+SFGI LWEIY +PYP + +V
Sbjct: 155 GQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
Query: 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
V + R E P CP + VMK CW+ +P KRP ++ L I
Sbjct: 210 PHVEK-GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 4e-49
Identities = 88/275 (32%), Positives = 138/275 (50%), Gaps = 30/275 (10%)
Query: 58 IARGTFGTVHRG-LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
I +G FG V++G L +VAVK L+ F QE + + DHPN+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTC--------RSTLPPDLKRKFLQEAEILKQYDHPNI 54
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQ 176
K IG + ++I V+E +PGG+L T+L K + R L K ++Q
Sbjct: 55 VKLIGVCVQKQPIYI----------------VMELVPGGSLLTFLRKKKNR-LTVKKLLQ 97
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL 236
++LD A G+ YL S+ +HRD+ N L+ +N +KI+DFG++R E ++ +
Sbjct: 98 MSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157
Query: 237 --GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEI 293
+ APE LN Y + DV+S+GI LWE + D PYP +S + T + R
Sbjct: 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-TRERIESGYRMPA 216
Query: 294 PRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328
P+ CP + +M +CW +P+ RP E+ + L+
Sbjct: 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 9e-49
Identities = 87/285 (30%), Positives = 141/285 (49%), Gaps = 35/285 (12%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
I+PS+L + G FG VH G + G DVA+K++ EG +E + F +E
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMI---REGAMSEDD-------FIEEA 50
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
V KL HPN+ + G + T+ + +V EY+ G L YL + R
Sbjct: 51 KVMMKLSHPNLVQLYG---------VCTKQRPI-------FIVTEYMANGCLLNYL-RER 93
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+ KL + ++ + D+ + YL S +HRD+ N L+ ++ VK++DFG+AR
Sbjct: 94 KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD- 152
Query: 226 PNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 281
+ T GT + + PEV + + ++ K DV+SFG+ +WE++ MPY S SEV
Sbjct: 153 -DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211
Query: 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
+ V R P+ P+ + +M CW P+ RP +++S L
Sbjct: 212 ES-VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-47
Identities = 80/273 (29%), Positives = 132/273 (48%), Gaps = 42/273 (15%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I I +G FG V++ + G +VA+K++ ++ + + E+ + K
Sbjct: 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIK-----LESKEK----KEKIINEIQILKKC 54
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ K+ G+ + EL I V+E+ GG+LK L+K+ + L
Sbjct: 55 KHPNIVKYYGSYLKKDELWI----------------VMEFCSGGSLKD-LLKSTNQTLTE 97
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-RVEASNPNDMT 230
+ + +L +GL YLHS I+HRD+K N+LL + VK+ DFG++ ++ + +
Sbjct: 98 SQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA--VVRQN 288
GT +MAPEV+NG PY+ K D++S GI E+ PY +L A + N
Sbjct: 158 --VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKIATN 212
Query: 289 LRPEIPRCCPS----SLANVMKRCWDANPDKRP 317
P + P + +K+C NP+KRP
Sbjct: 213 GPPGLR--NPEKWSDEFKDFLKKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-46
Identities = 84/286 (29%), Positives = 136/286 (47%), Gaps = 42/286 (14%)
Query: 51 KLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108
K I I +G+FG V+ R DG +K +D + +E E EV +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS---NMSEKEREDAL----NEVKIL 53
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK 168
KL+HPN+ K+ + +L I V+EY GG L IK ++++
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCI----------------VMEYADGGDLS-QKIKKQKKE 96
Query: 169 LAF-------KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
VQL L L YLHS+KI+HRD+K +N+ L N VK+ DFG+++V
Sbjct: 97 GKPFPEEQILDWFVQLCL----ALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV 152
Query: 222 EASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
S+ D+ +T GT Y++PE+ PYN K D++S G L+E+ P+ + E
Sbjct: 153 -LSSTVDL-AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE 210
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
+ +++ P IP S L N++ +P++RP + +++
Sbjct: 211 LALKILKGQYPP-IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-46
Identities = 91/304 (29%), Positives = 145/304 (47%), Gaps = 47/304 (15%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAAL 97
WE+ K+ + + +G+FG V+ GL G VA+K ++ E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN--------ENASMRE 52
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
R F E +V + + +V + +G GQ + VV+E + G L
Sbjct: 53 RIEFLNEASVMKEFNCHHVVRLLGVV----------STGQPTL------VVMELMAKGDL 96
Query: 158 KTYLIKNRRRKLAFKVVV---------QLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
K+YL ++RR + + Q+A ++A G++YL ++K VHRD+ N ++ ++
Sbjct: 97 KSYL-RSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED 155
Query: 209 RTVKIADFGVAR-VEASNPNDMTGETGTLG--YMAPEVLNGNPYNRKCDVYSFGICLWEI 265
TVKI DFG+ R + ++ G+ G L +MAPE L + K DV+SFG+ LWE+
Sbjct: 156 LTVKIGDFGMTRDIYETDYYRKGGK-GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
Query: 266 YC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
+ PY LS EV V+ ++P CP L +M+ CW NP RP E+VS
Sbjct: 215 ATLAEQPYQGLSNEEVLKFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273
Query: 325 MLEA 328
L+
Sbjct: 274 SLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 3e-46
Identities = 85/281 (30%), Positives = 132/281 (46%), Gaps = 37/281 (13%)
Query: 58 IARGTFGTVHRGLY---DGH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
+ G FG+V +G+Y G +VAVK L + IAA + F +E +V +LD
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTL--------KQEHIAAGKKEFLREASVMAQLD 54
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
HP + + IG G +V+E P G L YL K R ++
Sbjct: 55 HPCIVRLIGVCKGEP-----------------LMLVMELAPLGPLLKYLKKRR--EIPVS 95
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+ +LA +A G++YL S+ VHRD+ N+LL KI+DFG++R + +
Sbjct: 96 DLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155
Query: 233 TG---TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQN 288
T L + APE +N ++ K DV+S+G+ LWE + PY ++ +EV A++
Sbjct: 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESG 214
Query: 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
R P CP + ++M CW P+ RP E+ S
Sbjct: 215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-45
Identities = 89/284 (31%), Positives = 142/284 (50%), Gaps = 33/284 (11%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
W + KL + +I G FG V +G Y G VAVK + + ++ A AF +E
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNI---------KCDVTA--QAFLEE 49
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
AV KL H N+ + +G + + L+I V+E + G L +L
Sbjct: 50 TAVMTKLHHKNLVRLLGVILHNG-LYI----------------VMELMSKGNLVNFLRTR 92
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
R ++ ++Q +LD+A G+ YL S+K+VHRD+ N+L+ ++ K++DFG+ARV
Sbjct: 93 GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV--- 149
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVTSA 283
+ + + APE L ++ K DV+S+G+ LWE++ PYP +S EV
Sbjct: 150 GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC 209
Query: 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
V + R E P CP+ + +M CW+ P KRP ++ LE
Sbjct: 210 -VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 9e-45
Identities = 91/290 (31%), Positives = 137/290 (47%), Gaps = 34/290 (11%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI L ++ + G FG V G ++G VAVK L + G + AF Q
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL---KPGTMSPE-------AFLQ 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E + KL H + + ++I V EY+ G+L +L
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYI----------------VTEYMSKGSLLDFLKS 94
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+KL +V +A +A G++YL S+ +HRD+ N+L+ +N KIADFG+AR+
Sbjct: 95 GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154
Query: 224 SNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279
++ T G + + APE N + K DV+SFGI L EI +PYP ++ E
Sbjct: 155 D--DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE 212
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
V V R R P CP L ++M +CWD +P++RP + + S LE
Sbjct: 213 VLEQVER-GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-44
Identities = 86/294 (29%), Positives = 143/294 (48%), Gaps = 45/294 (15%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD--VAVKLLDWGEEGHRTEAEIAALRSAFT 102
WE+E + + +K + G +G V+ G++ + VAVK L E+ E F
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEE--------FL 50
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+E AV ++ HPN+ + +G +I + E++ G L YL
Sbjct: 51 KEAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLR 94
Query: 163 KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
+ R+++ V++ +A ++ + YL + +HRD+ N L+ +N VK+ADFG++R+
Sbjct: 95 ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL- 153
Query: 223 ASNPNDMTGETGT--------LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYP 273
MTG+T T + + APE L N ++ K DV++FG+ LWEI M PYP
Sbjct: 154 ------MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207
Query: 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
+ S+V ++ + R E P CP + +M+ CW NP RP E+ E
Sbjct: 208 GIDLSQVYE-LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-44
Identities = 84/297 (28%), Positives = 141/297 (47%), Gaps = 50/297 (16%)
Query: 58 IARGTFGTVHRGLYD------GHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ G FG V YD G VAVK L+ GEE HR++ F +E+ +
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---------FEREIEILRT 62
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
LDH N+ K+ G + + G +++EYLP G+L+ YL ++R +
Sbjct: 63 LDHENIVKYKG---------VCEKPGG-----RSLRLIMEYLPSGSLRDYLQRHRDQINL 108
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
K ++ + + +G+ YL SQ+ +HRD+ N+L++ VKI+DFG+A+V + +
Sbjct: 109 -KRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY 167
Query: 231 ----GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI--YCCDMPYPDLSFSEVTSAV 284
GE+ Y APE L + ++ DV+SFG+ L+E+ Y P F +
Sbjct: 168 VKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA 226
Query: 285 VRQNL------------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
Q + R P CP + ++MK CW+A P RP +++ +++ +
Sbjct: 227 QGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 80/278 (28%), Positives = 127/278 (45%), Gaps = 34/278 (12%)
Query: 58 IARGTFGTVHRGLYD---GH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
+ G+FG V RG + G VAVK L +++ +++ + F +E A+ H LD
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-------KSD-KLSDIMDDFLKEAAIMHSLD 54
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
H N+ + G + M +V E P G+L L K+
Sbjct: 55 HENLIRLYGVVLTHP-----------LM------MVTELAPLGSLLDRLRKDALGHFLIS 97
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+ A+ +A G+ YL S++ +HRD+ N+LL + VKI DFG+ R N + E
Sbjct: 98 TLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157
Query: 233 TGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQN 288
+ APE L ++ DV+ FG+ LWE++ + P+ LS S++ + ++
Sbjct: 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG 217
Query: 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
R E P CP + NVM +CW NP RP + L
Sbjct: 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-43
Identities = 89/312 (28%), Positives = 143/312 (45%), Gaps = 54/312 (17%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAAL 97
WE+ +L + + G FG V + G D VAVK+L + TE +++ L
Sbjct: 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML----KDDATEKDLSDL 62
Query: 98 RSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
S E+ + + H N+ +G L+ VVVEY G
Sbjct: 63 VS----EMEMMKMIGKHKNIINLLGVCTQEGPLY----------------VVVEYAAHGN 102
Query: 157 LKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202
L+ +L R L K +V A +ARG+ +L S+K +HRD+ N
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN 162
Query: 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGT----LGYMAPEVLNGNPYNRKCDVYSF 258
+L+ ++ +KIADFG+AR + D +T + +MAPE L Y + DV+SF
Sbjct: 163 VLVTEDHVMKIADFGLAR--DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 220
Query: 259 GICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
G+ LWEI+ PYP + E+ ++++ R E P+ C L ++M+ CW P +RP
Sbjct: 221 GVLLWEIFTLGGSPYPGIPVEELF-KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRP 279
Query: 318 EMDEVVSMLEAI 329
++V L+ +
Sbjct: 280 TFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 3e-42
Identities = 86/293 (29%), Positives = 141/293 (48%), Gaps = 36/293 (12%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAALRS 99
+EI+ + + I G FG V++G+Y + VAVK + ++R
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-------KNCTS-PSVRE 52
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F QE + + DHP++ K IG + TEN P I V+E P G L++
Sbjct: 53 KFLQEAYIMRQFDHPHIVKLIG---------VITEN-----PVWI---VMELAPLGELRS 95
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
YL N+ L ++ + L+ L+YL S++ VHRD+ N+L+ VK+ DFG++
Sbjct: 96 YLQVNKYS-LDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
Query: 220 RVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLS 276
R + + G L +MAPE +N + DV+ FG+C+WEI + P+ +
Sbjct: 155 RY-LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213
Query: 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
++V + R +P CP +L ++M +CW +P KRP E+ + L I
Sbjct: 214 NNDVIG-RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 3e-42
Identities = 88/275 (32%), Positives = 139/275 (50%), Gaps = 29/275 (10%)
Query: 57 VIARGTFGTVHRG-LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
++ +G FG V +G L D VAVK E L+ F E + + DHPN
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTC--------KEDLPQELKIKFLSEARILKQYDHPN 53
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ K IG ++I V+E +PGG ++L + ++ +L K +V
Sbjct: 54 IVKLIGVCTQRQPIYI----------------VMELVPGGDFLSFL-RKKKDELKTKQLV 96
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG-ETG 234
+ ALD A G++YL S+ +HRD+ N L+ +N +KI+DFG++R E +G +
Sbjct: 97 KFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156
Query: 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEI 293
+ + APE LN Y+ + DV+S+GI LWE + + PYP ++ + V + R
Sbjct: 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYRMSC 215
Query: 294 PRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328
P+ CP + VM+RCWD P+ RP+ E+ L A
Sbjct: 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 1e-41
Identities = 90/283 (31%), Positives = 134/283 (47%), Gaps = 35/283 (12%)
Query: 57 VIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
VI +G FG V+ G D AVK L+ + E F +E +
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ--------FLKEGIIMKDF 53
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPNV +G + S + VV+ Y+ G L+ + I++
Sbjct: 54 SHPNVLSLLGICLPSEGSPL---------------VVLPYMKHGDLRNF-IRSETHNPTV 97
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR----VEASNPN 227
K ++ L +A+G+ YL S+K VHRD+ N +LD++ TVK+ADFG+AR E + +
Sbjct: 98 KDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVR 286
+ TG + +MA E L + K DV+SFG+ LWE+ PYPD+ ++T ++
Sbjct: 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL- 216
Query: 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
Q R P CP L VM CW P+ RP E+VS +E I
Sbjct: 217 QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 6e-41
Identities = 85/276 (30%), Positives = 137/276 (49%), Gaps = 35/276 (12%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHD-VAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
I PS+L + I G FG V G + VA+K + EG +E + F +E
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSEED-------FIEEA 50
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
V KL HP + + G + TE + C+V E++ G L YL + +
Sbjct: 51 QVMMKLSHPKLVQLYG---------VCTERSPI-------CLVFEFMEHGCLSDYL-RAQ 93
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
R K + + ++ + LD+ G++YL S ++HRD+ N L+ +N+ VK++DFG+ R
Sbjct: 94 RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD- 152
Query: 226 PNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281
+ T TGT + + +PEV + + Y+ K DV+SFG+ +WE++ PY + S SEV
Sbjct: 153 -DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211
Query: 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
+ R PR S+ +M+ CW P+ RP
Sbjct: 212 ET-INAGFRLYKPRLASQSVYELMQHCWKERPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 9e-41
Identities = 82/272 (30%), Positives = 130/272 (47%), Gaps = 34/272 (12%)
Query: 51 KLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108
+ +I RG FG V++GL G VA+K + + + AL+S QE+ +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQIS------LEKIKEEALKS-IMQEIDLL 53
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR- 167
L HPN+ K+IG+ S L+I ++EY G+L+ +IK
Sbjct: 54 KNLKHPNIVKYIGSIETSDSLYI----------------ILEYAENGSLRQ-IIKKFGPF 96
Query: 168 --KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
L V Q+ +GL+YLH Q ++HRD+K N+L K+ VK+ADFGVA
Sbjct: 97 PESLVAVYVYQVL----QGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285
D GT +MAPEV+ + + D++S G + E+ + PY DL+ +V
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212
Query: 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
Q+ P +P L + + +C+ +P+ RP
Sbjct: 213 -QDDHPPLPEGISPELKDFLMQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 87/288 (30%), Positives = 129/288 (44%), Gaps = 34/288 (11%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI+ + + + + G FG V GL++ VAVK L G F
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG----------TMDPKDFLA 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E + KL HP + + ++I V E + G+L YL
Sbjct: 51 EAQIMKKLRHPKLIQLYAVCTLEEPIYI----------------VTELMKYGSLLEYLQG 94
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
R L ++ +A +A G++YL +Q +HRD+ N+L+ +N K+ADFG+ARV
Sbjct: 95 GAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK 154
Query: 224 SNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279
+ G + + APE N ++ K DV+SFGI L EI MPYP ++ +E
Sbjct: 155 E--DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
V V Q R P CP L ++M CW +PD RP + + LE
Sbjct: 213 VLQQ-VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 5e-40
Identities = 90/288 (31%), Positives = 140/288 (48%), Gaps = 35/288 (12%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
W + +L + I +G FG V G Y G+ VAVK + + A+ AF E
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-----NDATAQ------AFLAE 49
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+V +L H N+ + +G I E G + +V EY+ G+L YL
Sbjct: 50 ASVMTQLRHSNLVQLLGV--------IVEEKGGLY-------IVTEYMAKGSLVDYLRSR 94
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
R L +++ +LD+ + YL + VHRD+ N+L+ ++ K++DFG+ + EAS
Sbjct: 95 GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EAS 153
Query: 225 NPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVT 281
+ D TG L + APE L ++ K DV+SFGI LWEIY +PYP + +V
Sbjct: 154 STQD----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
Query: 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
V + + + P CP + +VMK+CW + RP ++ LE I
Sbjct: 210 PR-VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 5e-40
Identities = 85/291 (29%), Positives = 136/291 (46%), Gaps = 32/291 (10%)
Query: 52 LVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGH-RTEAEIAALRSAFTQEV 105
L + ++ G FG+V G D VAVK + + H +E E F E
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL--DIHTYSEIE------EFLSEA 52
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
A DHPNV K IG +S L ++ P V++ ++ G L ++L+ +R
Sbjct: 53 ACMKDFDHPNVMKLIGVCFEASSL------QKIPKP----MVILPFMKHGDLHSFLLYSR 102
Query: 166 RRKLAFKVVVQ----LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
L K+ +Q +D+A G+ YL ++ +HRD+ N +L ++ TV +ADFG+++
Sbjct: 103 LGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162
Query: 222 EASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFS 278
S G + ++A E L Y K DV++FG+ +WEI PYP +
Sbjct: 163 IYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222
Query: 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
E+ +R R + P C L ++M CW A+P RP ++ +LE I
Sbjct: 223 EIYD-YLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 7e-39
Identities = 80/286 (27%), Positives = 136/286 (47%), Gaps = 35/286 (12%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
I+P L + G FG V G + G +DVA+K++ +EG +E E F +E
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDE-------FIEEA 50
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
V KL H + + G ++I V EY+ G L YL +
Sbjct: 51 KVMMKLSHEKLVQLYGVCTKQRPIYI----------------VTEYMSNGCLLNYL-REH 93
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
++ ++++ D+ G++YL S++ +HRD+ N L+D VK++DFG++R
Sbjct: 94 GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD- 152
Query: 226 PNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 281
++ T G+ + + PEVL + ++ K DV++FG+ +WE+Y MPY + SE
Sbjct: 153 -DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211
Query: 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
V Q LR P + +M CW ++RP +++S +E
Sbjct: 212 EKVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 90/293 (30%), Positives = 134/293 (45%), Gaps = 48/293 (16%)
Query: 58 IARGTFGTVHRG-----LYDGHD---VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
+ G FG V+ G L G VAVK L G T+ E + F +E +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQE----KKEFLKEAHLMS 54
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK- 168
+HPN+ K +G + + +I ++E + GG L +YL R +
Sbjct: 55 NFNHPNIVKLLGVCLLNEPQYI----------------IMELMEGGDLLSYLRDARVERF 98
Query: 169 ----LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL-----DKNRTVKIADFGVA 219
L K ++ + LD+A+G YL +HRD+ N L+ D +R VKI DFG+A
Sbjct: 99 GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158
Query: 220 R-VEASNPNDMTGETGTLG--YMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDL 275
R + S+ GE G L +MAPE L + + DV+SFG+ +WEI PYP L
Sbjct: 159 RDIYKSDYYRKEGE-GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217
Query: 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328
+ EV V R + P CP + +M CW +P +RP D + +L+
Sbjct: 218 NNQEVL-QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-38
Identities = 85/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I RG FG V G D VAVK E L++ F QE + + HPN
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC--------RETLPPDLKAKFLQEARILKQYSHPN 54
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ + IG ++I V+E + GG T+L + +L K ++
Sbjct: 55 IVRLIGVCTQKQPIYI----------------VMELVQGGDFLTFL-RTEGPRLKVKELI 97
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG--ET 233
Q+ + A G+ YL S+ +HRD+ N L+ + +KI+DFG++R E TG +
Sbjct: 98 QMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPE 292
+ + APE LN Y+ + DV+SFGI LWE + +PY +LS ++ T + Q +R
Sbjct: 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS-NQQTREAIEQGVRLP 216
Query: 293 IPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328
P CP ++ +M+RCW+ +P +RP V L++
Sbjct: 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-38
Identities = 75/279 (26%), Positives = 147/279 (52%), Gaps = 31/279 (11%)
Query: 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
++I G+FG+V+ G+ G +AVK ++ ++ ++ A +E+A+ +L H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
N+ +++G+++ + L+I +EY+PGG++ L N +
Sbjct: 66 ENIVQYLGSSLDADHLNI----------------FLEYVPGGSVAALL--NNYGAFEETL 107
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-RVEASNPNDMTGE 232
V + +GL+YLH++ I+HRD+K N+L+D +KI+DFG++ ++EA++ + T
Sbjct: 108 VRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167
Query: 233 T-----GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR- 286
G++ +MAPEV+ Y RK D++S G + E+ P+PD + A+ +
Sbjct: 168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT---QLQAIFKI 224
Query: 287 -QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
+N PEIP S + +++ ++ + +KRP E++
Sbjct: 225 GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 5e-38
Identities = 88/301 (29%), Positives = 132/301 (43%), Gaps = 43/301 (14%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAALR 98
E+ + + + G FG V+ GLY G D VAVK L E+
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--------PESCSEQDE 53
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
S F E + K +H N+ + IG V+ +++E + GG LK
Sbjct: 54 SDFLMEALIMSKFNHQNIVRLIG----------------VSFERLPRFILLELMAGGDLK 97
Query: 159 TYLIKNRRR-----KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD---KNRT 210
++L +NR R L K ++ A D+A+G YL +HRD+ N LL R
Sbjct: 98 SFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV 157
Query: 211 VKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268
KIADFG+AR + ++ G + +M PE + K DV+SFG+ LWEI+
Sbjct: 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217
Query: 269 D-MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
MPYP + EV V R + P+ CP + +M CW P+ RP ++ ++
Sbjct: 218 GYMPYPGRTNQEVMEFVTGGG-RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
Query: 328 A 328
Sbjct: 277 Y 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 6e-38
Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 32/270 (11%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + I +G+FG V + + D A+K +D + R E A+ E V KL
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREE--AID-----EARVLAKL 56
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
D + ++ + + +L +V+EY G L L R R L
Sbjct: 57 DSSYIIRYYESFLDKGKL----------------NIVMEYAENGDLHKLLKMQRGRPLPE 100
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
V + + + GL++LHS+KI+HRD+K+ N+ LD VKI D GVA++ + N N
Sbjct: 101 DQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR- 290
GT Y++PE+ PYN K DV++ G+ L+E CC +P + ++ A++ + +R
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE--CCTGKHPFDANNQG--ALILKIIRG 216
Query: 291 --PEIPRCCPSSLANVMKRCWDANPDKRPE 318
P + + LA ++ +C + +RP+
Sbjct: 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 90/311 (28%), Positives = 141/311 (45%), Gaps = 58/311 (18%)
Query: 48 EPSKLVIKSVIARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
E L + +G FG+V YD G VAVK L H LR F
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH--------LRD-F 52
Query: 102 TQEVAVWHKLDHPNVTKFIGA--TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
+E+ + L H N+ K+ G + G L + V+EYLP G+L+
Sbjct: 53 EREIEILKSLQHDNIVKYKGVCYSAGRRNLRL----------------VMEYLPYGSLRD 96
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
YL K+R R L + ++ A + +G+ YL S++ VHRD+ T N+L++ VKI DFG+
Sbjct: 97 YLQKHRER-LDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155
Query: 220 RVEASNPNDMT----GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI--YC------ 267
+V + GE+ Y APE L + ++ DV+SFG+ L+E+ Y
Sbjct: 156 KVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214
Query: 268 ---------CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 318
D + + + +++ N R P CP+ + +MK CW+ +P +RP
Sbjct: 215 PAEFMRMMGNDKQGQMIVYHLIE--LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPS 272
Query: 319 MDEVVSMLEAI 329
E+ +EAI
Sbjct: 273 FSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 87/290 (30%), Positives = 135/290 (46%), Gaps = 34/290 (11%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
I+PS + I+ VI G FG V RG DVA+K L G ++ + R F
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS----SDKQ----RLDF 52
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E ++ + DHPN+ + G S + I + EY+ G+L +L
Sbjct: 53 LTEASIMGQFDHPNIIRLEGVVTKSRPVMI----------------ITEYMENGSLDKFL 96
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ K +V + +A G+ YL VHRD+ N+L++ N K++DFG++R
Sbjct: 97 -RENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155
Query: 222 -EASNPNDMT-GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFS 278
E S T G + + APE + + DV+SFGI +WE+ + PY D+S
Sbjct: 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215
Query: 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328
+V A V R P CPS+L +M CW + ++RP ++VS L+
Sbjct: 216 DVIKA-VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 34/279 (12%)
Query: 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
S L V+ +G+ G V++ + G A+K + R +E+
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI--------HVDGDEEFRKQLLRELKT 52
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
+ P V K GA + G++ +V+EY+ GG+L L+K +
Sbjct: 53 LRSCESPYVVKCYGAFY---------KEGEI-------SIVLEYMDGGSLAD-LLK-KVG 94
Query: 168 KLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARV-EASN 225
K+ V+ +A + +GL YLH++ I+HRD+K N+L++ VKIADFG+++V E +
Sbjct: 95 KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL---SFSEVTS 282
T GT+ YM+PE + G Y+ D++S G+ L E P+ SF E+
Sbjct: 155 DQCNTFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ 213
Query: 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE 321
A+ + + C +P KRP E
Sbjct: 214 AICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 83/294 (28%), Positives = 134/294 (45%), Gaps = 35/294 (11%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAAL 97
WE + L + G FG V G VAVK+L H +E E
Sbjct: 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK--PTAHSSERE---- 83
Query: 98 RSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
A E+ + L +H N+ +GA + + TE CC G
Sbjct: 84 --ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE---------YCCY-------GD 125
Query: 157 LKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADF 216
L +L + R L + ++ + +A+G+++L S+ +HRD+ N+LL + VKI DF
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF 185
Query: 217 GVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYP 273
G+AR ++ N + L +MAPE + Y + DV+S+GI LWEI+ PYP
Sbjct: 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP 245
Query: 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
+ ++++ R P P+ + ++MK CWDA+P KRP ++V ++
Sbjct: 246 GMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 82/285 (28%), Positives = 139/285 (48%), Gaps = 30/285 (10%)
Query: 57 VIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
++ +G FG+V D VAVK+L + + ++ F +E A +
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKML-------KADIFSSSDIEEFLREAACMKEF 58
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK--- 168
DHPNV K IG ++ S G++ +P V++ ++ G L T+L+ +R +
Sbjct: 59 DHPNVIKLIGVSLRSRA------KGRLPIP----MVILPFMKHGDLHTFLLMSRIGEEPF 108
Query: 169 -LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
L + +V+ +D+A G+ YL S+ +HRD+ N +L++N TV +ADFG+++ S
Sbjct: 109 TLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY 168
Query: 228 DMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV 284
G L ++A E L N Y DV++FG+ +WEI PY + SE+ + +
Sbjct: 169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228
Query: 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
++ N R + P C + +M +CW P RP + LE I
Sbjct: 229 IKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-37
Identities = 82/278 (29%), Positives = 129/278 (46%), Gaps = 40/278 (14%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWG----EEGHRTEAEIAALRSAFTQEVAV 107
+ + +G++G+V++ L D A+K +D G +E EI L S
Sbjct: 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILAS-------- 55
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
++HPN+ + A + N C+V+EY P G L + K +++
Sbjct: 56 ---VNHPNIISYKEAFL----------------DGNKLCIVMEYAPFGDLSKAISKRKKK 96
Query: 168 KLAFK--VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+ + ++ + L RGL LH QKI+HRD+K+ N+LL N VKI D G+++V N
Sbjct: 97 RKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156
Query: 226 PNDMT-GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284
M + GT YMAPEV G PY+ K D++S G L+E+ P+ S ++ V
Sbjct: 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
Query: 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
R P IP L N ++ P RP D++
Sbjct: 214 QRGKY-PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 9e-37
Identities = 84/288 (29%), Positives = 138/288 (47%), Gaps = 35/288 (12%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WE+ L + + G FG V G Y+GH VA+K L ++G + AF
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL---KQGSMSP-------EAFLA 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E + +L HP + + + A + ++I + EY+ G+L +L
Sbjct: 51 EANLMKQLQHPRLVR-LYAVVTQEPIYI----------------ITEYMENGSLVDFLKT 93
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
KL ++ +A +A G++++ + +HRD++ N+L+ + KIADFG+AR+
Sbjct: 94 PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL-- 151
Query: 224 SNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSE 279
N+ T G + + APE +N + K DV+SFGI L EI +PYP ++ E
Sbjct: 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
V + R R P CP L +M+ CW P++RP + + S+LE
Sbjct: 212 VIQNLER-GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 5e-36
Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 48/295 (16%)
Query: 54 IKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I + G+FG V+ D VA+K+L + + F +E+ + L+H
Sbjct: 4 ILRKLGEGSFGEVYLA-RDRKLVALKVL------AKKLESKSKEVERFLREIQILASLNH 56
Query: 114 P-NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF- 171
P N+ K Q E +V+EY+ GG+L+ L+K RK
Sbjct: 57 PPNIVKLYD--------FFQDEGS--------LYLVMEYVDGGSLE-DLLKKIGRKGPLS 99
Query: 172 -KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT-VKIADFGVARV------EA 223
+ + + L YLHS+ I+HRD+K EN+LLD++ VK+ DFG+A++ +
Sbjct: 100 ESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159
Query: 224 SNPNDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPDLS---- 276
S P + GT GYMAPEVL G + D++S GI L+E+ P+
Sbjct: 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA 219
Query: 277 -------FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
E+ + + L P P + ++++K+ +P R +S
Sbjct: 220 TSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 5e-36
Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 40/287 (13%)
Query: 57 VIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
+ RG FG V G + V VK L ++ + L+S F +E+ ++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDEN--------LQSEFRRELDMFR 63
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK- 168
KL H NV + +G +E H +++EY G LK +L + +
Sbjct: 64 KLSHKNVVRLLGLCR-EAEPH---------------YMILEYTDLGDLKQFLRATKSKDE 107
Query: 169 ------LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-V 221
L+ K V L +A G+ +L + + VHRD+ N L+ R VK++ +++ V
Sbjct: 108 KLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDV 167
Query: 222 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEV 280
S + L ++APE + + ++ K DV+SFG+ +WE++ ++P+ LS EV
Sbjct: 168 YNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227
Query: 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
+ + L +P CPS L +M RCW NP RP E+VS L
Sbjct: 228 LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-36
Identities = 77/283 (27%), Positives = 122/283 (43%), Gaps = 47/283 (16%)
Query: 50 SKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
+ I +G+FG V++ + VA+K++D E E EI + QE+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDI----QQEIQF 52
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
+ P +TK+ G+ + S+L I ++EY GG+ L +
Sbjct: 53 LSQCRSPYITKYYGSFLKGSKLWI----------------IMEYCGGGSCLDLL---KPG 93
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
KL + + ++ GL YLH + +HRD+K N+LL + VK+ADFGV+ S +
Sbjct: 94 KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
GT +MAPEV+ + Y+ K D++S GI E+ + P DL V
Sbjct: 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF----- 208
Query: 288 NLRPEIPRCCPSSLANVM---------KRCWDANPDKRPEMDE 321
IP+ P SL C + +P +RP E
Sbjct: 209 ----LIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 8e-36
Identities = 81/283 (28%), Positives = 129/283 (45%), Gaps = 31/283 (10%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
I PS+L + G FG VH G + VA+K ++ EG +E + F +E
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEED-------FIEEA 50
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
V KL HP + + G L+I V E++ G L YL + R
Sbjct: 51 KVMMKLSHPKLVQLYGVCTQQKPLYI----------------VTEFMENGCLLNYL-RQR 93
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VEAS 224
+ KL+ +++ + D+ G+ YL +HRD+ N L+ VK++DFG+ R V
Sbjct: 94 QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283
+G + + PEV N + Y+ K DV+SFG+ +WE++ MP+ S EV
Sbjct: 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM 213
Query: 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
+ R R P+ ++ VM CW P+ RP E++ +
Sbjct: 214 ISRGF-RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-36
Identities = 76/278 (27%), Positives = 129/278 (46%), Gaps = 41/278 (14%)
Query: 58 IARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
+ +G FG V+ YD G ++AVK + + + T+ E+ AL E+ + L H
Sbjct: 10 LGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALE----CEIQLLKNLQHE 64
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY------LIKNRRRK 168
+ ++ G ++ + + +EY+PGG++K L + RK
Sbjct: 65 RIVQYYGC---------LRDDETL-------SIFMEYMPGGSVKDQLKAYGALTETVTRK 108
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-RVEA--SN 225
+++ G+ YLHS IVHRD+K N+L D VK+ DFG + R++ S+
Sbjct: 109 YTRQIL--------EGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285
M TGT +M+PEV++G Y RK DV+S G + E+ P+ + +
Sbjct: 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 220
Query: 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
Q P++P N ++R + N KRP +E++
Sbjct: 221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-36
Identities = 71/288 (24%), Positives = 127/288 (44%), Gaps = 30/288 (10%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WE + ++ + G FG V GL+ VA+K+L + + + F +
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD---------FQK 51
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
EV +L H ++ ++I + E + G+L +L
Sbjct: 52 EVQALKRLRHKHLISLFAVCSVGEPVYI----------------ITELMEKGSLLAFLRS 95
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ L ++ +A +A G++YL Q +HRD+ N+L+ ++ K+ADFG+AR+
Sbjct: 96 PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL-I 154
Query: 224 SNPNDMTGETGT-LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281
++ + + APE + ++ K DV+SFGI L+E++ +PYP ++ EV
Sbjct: 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214
Query: 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
+ R P CP + +M CW A P+ RP + L+ I
Sbjct: 215 DQITA-GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 9e-36
Identities = 75/237 (31%), Positives = 113/237 (47%), Gaps = 36/237 (15%)
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
A +E+ + +L+HP++ + +GAT S ++ VE++ GG++
Sbjct: 49 ALRKEIRLMARLNHPHIIRMLGATCEDSHFNL----------------FVEWMAGGSVSH 92
Query: 160 YLIKNRRRKLAFK--VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN-RTVKIADF 216
L K AFK V++ L RGLSYLH +I+HRDVK N+L+D + ++IADF
Sbjct: 93 LLSKYG----AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADF 148
Query: 217 GVARVEASNPNDMTGE-------TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269
G A A+ TG GT+ +MAPEVL G Y R CDV+S G + E+
Sbjct: 149 GAAARLAA---KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
Query: 270 MPYPDLSFS---EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
P+ S + + P IP L +V RC + P+ RP E++
Sbjct: 206 PPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 78/282 (27%), Positives = 129/282 (45%), Gaps = 41/282 (14%)
Query: 54 IKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ I +G+FGTV R DG + K +D+G + TE E + EV + +L
Sbjct: 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG---NMTEKE----KQQLVSEVNILREL 56
Query: 112 DHPNVTKFIG--ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR-- 167
HPN+ ++ + L+I V+EY GG L LI+ ++
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYI----------------VMEYCEGGDLAQ-LIQKCKKER 99
Query: 168 -KLAFKVVVQLALDLARGLSYLH-----SQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ + + ++ L L H ++HRD+K N+ LD N VK+ DFG+A++
Sbjct: 100 KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159
Query: 222 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM--PYPDLSFSE 279
+ + GT YM+PE LN Y+ K D++S G ++E+ C + P+ + +
Sbjct: 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL--CALSPPFTARNQLQ 217
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE 321
+ S + R IP S L V+K + +PDKRP +E
Sbjct: 218 LASKIKEGKFRR-IPYRYSSELNEVIKSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 5e-35
Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 40/274 (14%)
Query: 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I G G V++ G +VA+K + ++ + E+ + H
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN----------KELIINEILIMKDCKH 74
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
PN+ + + + EL VV+EY+ GG+L T +I ++
Sbjct: 75 PNIVDYYDSYLVGDELW----------------VVMEYMDGGSL-TDIITQNFVRMNEPQ 117
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA---RVEASNPNDMT 230
+ + ++ +GL YLHSQ ++HRD+K++N+LL K+ +VK+ADFG A E S N +
Sbjct: 118 IAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV- 176
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS-AVVRQNL 289
GT +MAPEV+ Y K D++S GI E+ + PY L + + ++
Sbjct: 177 --VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY--LREPPLRALFLITTKG 232
Query: 290 RPEI--PRCCPSSLANVMKRCWDANPDKRPEMDE 321
P + P + + +C +P+KRP +E
Sbjct: 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-35
Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 28/268 (10%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ G+FG+V+ G L DG AVK + ++G + + L QE+A+ KL HPN
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE----QEIALLSKLQHPN 63
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ +++G L + +E +PGG+L L ++ + V+
Sbjct: 64 IVQYLGTEREEDNL----------------YIFLELVPGGSLAKLL---KKYGSFPEPVI 104
Query: 176 QL-ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+L + GL YLH + VHRD+K N+L+D N VK+ADFG+A+ + G
Sbjct: 105 RLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF-SFAKSFKG 163
Query: 235 TLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293
+ +MAPEV+ Y D++S G + E+ P+ L + R P I
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPI 223
Query: 294 PRCCPSSLANVMKRCWDANPDKRPEMDE 321
P + + +C +P RP E
Sbjct: 224 PDHLSDEAKDFILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 9e-35
Identities = 87/304 (28%), Positives = 132/304 (43%), Gaps = 63/304 (20%)
Query: 58 IARGTFGTVHR----GLYDGHD---VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
I +G FG V + GL VAVK+L E A +++ F +E A+ +
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML--------KEEASADMQADFQREAALMAE 64
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN------ 164
DHPN+ K +G V C++ EY+ G L +L
Sbjct: 65 FDHPNIVKLLG----------------VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQC 108
Query: 165 --------------RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
L+ + +A +A G++YL +K VHRD+ T N L+ +N
Sbjct: 109 SLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV 168
Query: 211 VKIADFGVARVEAS------NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
VKIADFG++R S + ND + +M PE + N Y + DV+++G+ LWE
Sbjct: 169 VKIADFGLSRNIYSADYYKASENDAI----PIRWMPPESIFYNRYTTESDVWAYGVVLWE 224
Query: 265 IYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
I+ M PY ++ EV V N+ P CP L N+M+ CW P RP +
Sbjct: 225 IFSYGMQPYYGMAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283
Query: 324 SMLE 327
+L+
Sbjct: 284 RILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 86/305 (28%), Positives = 129/305 (42%), Gaps = 47/305 (15%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRG-LY------DGHDVAVKLLDWGEEGHRTEAEIAALR 98
++ +V+K + G FG V G Y D VAVK L E R
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL--------KETASNDAR 52
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F +E + H N+ KF G TE M V EY+ G L
Sbjct: 53 KDFEREAELLTNFQHENIVKFYGVC---------TEGDPPIM-------VFEYMEHGDLN 96
Query: 159 TYL------------IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+L + +L ++Q+A+ +A G+ YL SQ VHRD+ T N L+
Sbjct: 97 KFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG 156
Query: 207 KNRTVKIADFGVARVEASNPNDMTGETGTLG--YMAPEVLNGNPYNRKCDVYSFGICLWE 264
+ VKI DFG++R + G L +M PE + + + DV+SFG+ LWE
Sbjct: 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWE 216
Query: 265 IYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
I+ P+ LS EV + Q + PR CPS + ++M CW +P +R + ++
Sbjct: 217 IFTYGKQPWYGLSNEEV-IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275
Query: 324 SMLEA 328
L+
Sbjct: 276 ERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 93/315 (29%), Positives = 149/315 (47%), Gaps = 56/315 (17%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTEAEI 94
WE +LV+ + G FG V R G D VAVK+L + + T+ ++
Sbjct: 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML----KDNATDKDL 61
Query: 95 AALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLP 153
A L S E+ + + H N+ +G + T+ G + V+VEY
Sbjct: 62 ADLIS----EMELMKLIGKHKNIINLLG---------VCTQEGPLY-------VIVEYAA 101
Query: 154 GGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
G L+ +L R +L+FK +V A +ARG+ YL S++ +HRD+
Sbjct: 102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA 161
Query: 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT----LGYMAPEVLNGNPYNRKCDV 255
N+L+ ++ +KIADFG+AR + D +T + +MAPE L Y + DV
Sbjct: 162 ARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219
Query: 256 YSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPD 314
+SFGI +WEI+ PYP + E+ ++R+ R + P C L +M+ CW A P
Sbjct: 220 WSFGILMWEIFTLGGSPYPGIPVEELFK-LLREGHRMDKPSNCTHELYMLMRECWHAVPT 278
Query: 315 KRPEMDEVVSMLEAI 329
+RP ++V L+ +
Sbjct: 279 QRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 83/288 (28%), Positives = 134/288 (46%), Gaps = 34/288 (11%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI + + + G FG V G Y+ VAVK L G + AF +
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ----------AFLE 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E + L H + + ++I + EY+ G+L +L
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYI----------------ITEYMAKGSLLDFLKS 94
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ K+ ++ + +A G++Y+ + +HRD++ N+L+ ++ KIADFG+ARV
Sbjct: 95 DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARV-- 152
Query: 224 SNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSE 279
N+ T G + + APE +N + K DV+SFGI L+EI +PYP +S S+
Sbjct: 153 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
V SA+ R P CP L ++MK CW ++RP D + S+L+
Sbjct: 213 VMSALQRGYRMPR-MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 28/217 (12%)
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E + +++HP + K LH QTE +V+EY PGG L ++L
Sbjct: 43 ERNILSRINHPFIVK----------LHYAFQTEEK--------LYLVLEYAPGGELFSHL 84
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
++ + + + A ++ L YLHS I++RD+K EN+LLD + +K+ DFG+A+
Sbjct: 85 --SKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKE 142
Query: 222 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281
+S + GT Y+APEVL G Y + D +S G+ L+E+ P+ ++E
Sbjct: 143 LSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF----YAEDR 198
Query: 282 SAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKR 316
+ + L+ P +++ +P KR
Sbjct: 199 KEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 88/293 (30%), Positives = 141/293 (48%), Gaps = 39/293 (13%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
I+ S + I+ VI G FG V RG VA+K L G TE + R F
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----YTEKQ----RRDF 52
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E ++ + DHPN+ G S + I TE ++ GAL ++L
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE----------------FMENGALDSFL 96
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+N + ++V L +A G+ YL VHRD+ N+L++ N K++DFG++R
Sbjct: 97 RQNDGQFTVIQLVGMLR-GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155
Query: 222 EASNPNDMTGETGTLG------YMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPD 274
+ +D T T +LG + APE + + DV+S+GI +WE+ + PY D
Sbjct: 156 LEDDTSDPT-YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214
Query: 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
+S +V +A + Q+ R P CP++L +M CW + + RP+ ++VS L+
Sbjct: 215 MSNQDVINA-IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 35/268 (13%)
Query: 58 IARGTFGTVHRGLYD----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
+ G FGTV +G+Y VAVK+L + + AL+ +E V +LD+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-------KNDNNDPALKDELLREANVMQQLDN 55
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P + + IG S + +V+E G L +L KN+ + K
Sbjct: 56 PYIVRMIGICEAESWM-----------------LVMELAELGPLNKFLQKNKH--VTEKN 96
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
+ +L ++ G+ YL VHRD+ N+LL KI+DFG+++ ++ N +T
Sbjct: 97 ITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156
Query: 234 G---TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNL 289
+ + APE +N ++ K DV+SFG+ +WE + PY + +EVT ++
Sbjct: 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QMIESGE 215
Query: 290 RPEIPRCCPSSLANVMKRCWDANPDKRP 317
R E P+ CP + ++MK CW D+RP
Sbjct: 216 RMECPQRCPPEMYDLMKLCWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 1e-33
Identities = 85/294 (28%), Positives = 141/294 (47%), Gaps = 39/294 (13%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRG---LYDGHD--VAVKLLDWGEEGHRTEAEIAALRSAF 101
I+ S + I+ VI G FG V G L + VA+K L G TE + R F
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG----YTEKQ----RRDF 52
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E ++ + DHPN+ G S + I V EY+ G+L +L
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSKPVMI----------------VTEYMENGSLDAFL 96
Query: 162 IKNRRRKLAFKVV--VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
K+ + F V+ V + +A G+ YL VHRD+ N+L++ N K++DFG++
Sbjct: 97 RKHDGQ---FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153
Query: 220 RVEASNPNDMTGETG---TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDL 275
RV +P G + + APE + + DV+S+GI +WE+ + PY ++
Sbjct: 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213
Query: 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
S +V A + + R P CP++L +M CW + ++RP+ +++VS+L+ +
Sbjct: 214 SNQDVIKA-IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 84/309 (27%), Positives = 138/309 (44%), Gaps = 57/309 (18%)
Query: 51 KLVIKSVIARGTFGTVHR-------GLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
LV+ + G FG V + G VAVK+L + +E+ L S F
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFN- 55
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
+ +++HP+V K GA L + +VEY G+L+++L +
Sbjct: 56 ---LLKQVNHPHVIKLYGACSQDGPLLL----------------IVEYAKYGSLRSFLRE 96
Query: 164 NRR----------------------RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201
+R+ R L ++ A ++RG+ YL K+VHRD+
Sbjct: 97 SRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156
Query: 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFG 259
N+L+ + R +KI+DFG++R + + G + +MA E L + Y + DV+SFG
Sbjct: 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFG 216
Query: 260 ICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 318
+ LWEI PYP ++ + + +++ R E P C + N+M CW PDKRP
Sbjct: 217 VLLWEIVTLGGNPYPGIAPERLFN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPT 275
Query: 319 MDEVVSMLE 327
++ LE
Sbjct: 276 FADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 75/271 (27%), Positives = 127/271 (46%), Gaps = 28/271 (10%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
V+ RG FG VH R D V +K + E R A E V L HP
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIP-------VEQMTKDERLAAQNECQVLKLLSHP 59
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N+ ++ + L I V+EY PGG L Y+ K L +
Sbjct: 60 NIIEYYENFLEDKALMI----------------VMEYAPGGTLAEYIQKRCNSLLDEDTI 103
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV-KIADFGVARVEASNPNDMTGET 233
+ + + L ++H++ I+HRD+KT+N+LLDK++ V KI DFG++++ +S T
Sbjct: 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VV 162
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293
GT Y++PE+ G PYN+K D+++ G L+E+ + + + ++ P
Sbjct: 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS 222
Query: 294 PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
R P L ++ + +P KRP++ ++++
Sbjct: 223 DRYSP-DLRQLILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 84/289 (29%), Positives = 135/289 (46%), Gaps = 29/289 (10%)
Query: 52 LVIKSVIARGTFGTVHRGLYDGHD----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
L + + G FG+V G + D VAVK + R+E E F E
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEME------DFLSEAVC 53
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-- 165
+ DHPNV + IG + + E PS + V++ ++ G L ++L+ +R
Sbjct: 54 MKEFDHPNVMRLIGVCLQTVE--------SEGYPSPV--VILPFMKHGDLHSFLLYSRLG 103
Query: 166 --RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ L +++V+ D+A G+ YL S+ +HRD+ N +L++N V +ADFG+++
Sbjct: 104 DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY 163
Query: 224 SNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280
+ G + ++A E L Y K DV+SFG+ +WEI PYP + SE+
Sbjct: 164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223
Query: 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
+RQ R + P C L ++M CW NP RP + + LE
Sbjct: 224 YD-YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 70/284 (24%), Positives = 132/284 (46%), Gaps = 36/284 (12%)
Query: 50 SKLVIKSVIARGTFGTVHRGLY--DGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
++L V+ G FGTV++G++ +G VA+K+L E
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--------EETSPKANKEILD 58
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E V +DHP+V + +G + S ++ + +P G L Y+ +
Sbjct: 59 EAYVMASVDHPHVVRLLGICLSSQ-----------------VQLITQLMPLGCLLDYV-R 100
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
N + + + ++ + +A+G+SYL +++VHRD+ N+L+ + VKI DFG+A++
Sbjct: 101 NHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160
Query: 224 SNPNDMTGETGT--LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEV 280
+ + E G + +MA E + Y K DV+S+G+ +WE+ PY + E+
Sbjct: 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220
Query: 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
+ + R P C + V+ +CW + + RP E+++
Sbjct: 221 PDLLEK-GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 85/293 (29%), Positives = 136/293 (46%), Gaps = 35/293 (11%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLYD--GHD---VAVKLLDWGEEGHRTEAEIAALRSA 100
EI PS + + VI G FG V RG+ G VA+K L G TE + R
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG----YTEKQ----RQD 52
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
F E ++ + H N+ + G I + EY+ GAL Y
Sbjct: 53 FLSEASIMGQFSHHNIIRLEGVVTKFKPAMI----------------ITEYMENGALDKY 96
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L + ++++V L +A G+ YL VHRD+ N+L++ N K++DFG++R
Sbjct: 97 LRDHDGEFSSYQLVGMLR-GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155
Query: 221 VEASNPNDMTGETG---TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLS 276
V +P +G + + APE + + DV+SFGI +WE+ + PY D+S
Sbjct: 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215
Query: 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
EV A + R P CPS++ +M +CW + +RP ++V++L+ +
Sbjct: 216 NHEVMKA-INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 90/317 (28%), Positives = 138/317 (43%), Gaps = 64/317 (20%)
Query: 37 FLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRT 90
+LKK R V+ G FG V YD G VAVK L
Sbjct: 5 YLKKIR--------------VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ-- 48
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
S + +E+ + L H N+ K+ G +Q +++E
Sbjct: 49 ------NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ--------------LIME 88
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
Y+P G+L+ YL K+ KL ++ A + G++YLHSQ +HRD+ N+LLD +R
Sbjct: 89 YVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL 145
Query: 211 VKIADFGVAR-VEASNPNDMTGETGT--LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
VKI DFG+A+ V + E G + + A E L N ++ DV+SFG+ L+E+
Sbjct: 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
Query: 268 -CDMPY--PDLSFSEVTS------AVVR------QNLRPEIPRCCPSSLANVMKRCWDAN 312
CD P F E+ VVR + +R P+ CP + +MK CW+
Sbjct: 206 HCD-SKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETE 264
Query: 313 PDKRPEMDEVVSMLEAI 329
RP ++ +L+ +
Sbjct: 265 AKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 87/272 (31%), Positives = 122/272 (44%), Gaps = 38/272 (13%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GTFG V+ L G +AVK + + +T EIA E+ V L HPN
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA-------DEMKVLELLKHPN 60
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ K+ G + +++I +EY GG L+ L R L V+
Sbjct: 61 LVKYYGVEVHREKVYI----------------FMEYCSGGTLEELL--EHGRILDEHVIR 102
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE--- 232
L L GL+YLHS IVHRD+K N+ LD N +K+ DFG A V+ N GE
Sbjct: 103 VYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCA-VKLKNNTTTMGEEVQ 161
Query: 233 --TGTLGYMAPEVLNGNP---YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
GT YMAPEV+ G + R D++S G + E+ P+ +L V
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA 221
Query: 288 NLRPEIPRCCPSSLA--NVMKRCWDANPDKRP 317
+P IP S + + RC +++P KRP
Sbjct: 222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 76/292 (26%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 61 GTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
G FG V++G VA+K L + AE ++ F QE + L H
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTL-------KENAEPK-VQQEFRQEAELMSDLQH 67
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-------- 165
PN+ +G C++ EYL G L +L++N
Sbjct: 68 PNIVCLLGVCTKEQPT----------------CMLFEYLAHGDLHEFLVRNSPHSDVGAE 111
Query: 166 ------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+ L + +A+ +A G+ YL S VHRD+ N L+ + TVKI+DFG++
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 220 R-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLS 276
R + +++ + ++ + +M PE + + + D++SFG+ LWEI+ + PY S
Sbjct: 172 RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231
Query: 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328
EV + + L P P CP+ + +M CW+ P +RP ++ + L +
Sbjct: 232 NQEVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-32
Identities = 93/314 (29%), Positives = 141/314 (44%), Gaps = 52/314 (16%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTEAEIA 95
WE KL + + G FG V G D VAVK+L + TE +++
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML----KDDATEKDLS 65
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
L S + H N+ +GA L+ V+VEY G
Sbjct: 66 DLVSEMEMMKMIGK---HKNIINLLGACTQDGPLY----------------VIVEYASKG 106
Query: 156 ALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201
L+ YL R ++ FK +V +ARG+ YL SQK +HRD+
Sbjct: 107 NLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166
Query: 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETG---TLGYMAPEVLNGNPYNRKCDVYSF 258
N+L+ +N +KIADFG+AR + +N + T + +MAPE L Y + DV+SF
Sbjct: 167 NVLVTENNVMKIADFGLAR-DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225
Query: 259 GICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
G+ +WEI+ PYP + E+ ++++ R + P C + L +M+ CW A P RP
Sbjct: 226 GVLMWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRP 284
Query: 318 EMDEVVSMLEAIDT 331
++V L+ I T
Sbjct: 285 TFKQLVEDLDRILT 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 85/286 (29%), Positives = 132/286 (46%), Gaps = 31/286 (10%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI L + + G FG V G ++G+ VAVK L G +F +
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----------PESFLE 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E + KL H + + A + ++I V EY+ G+L +L
Sbjct: 51 EAQIMKKLRHDKLVQLY-AVVSEEPIYI----------------VTEYMSKGSLLDFLKD 93
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VE 222
R L +V +A +A G++Y+ +HRD+++ N+L+ KIADFG+AR +E
Sbjct: 94 GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE 153
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281
+ G + + APE + K DV+SFGI L E+ +PYP ++ EV
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213
Query: 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
V R R P+ CP SL +M +CW +P++RP + + S LE
Sbjct: 214 EQVER-GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 57/280 (20%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G++G+V++ ++ G VA+K++ E+ EI+ L+ +
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILK-----------QC 55
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA- 170
D P + K+ G+ +++L I V+EY G++ ++K + L
Sbjct: 56 DSPYIVKYYGSYFKNTDLWI----------------VMEYCGAGSVSD-IMKITNKTLTE 98
Query: 171 --FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228
++ L +GL YLHS K +HRD+K N+LL++ K+ADFGV+ + ++
Sbjct: 99 EEIAAILYQTL---KGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSG-QLTDTMA 154
Query: 229 MTGET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
GT +MAPEV+ YN K D++S GI E+ PY D+
Sbjct: 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM---- 210
Query: 288 NLRPEIPRCCPSSLAN----------VMKRCWDANPDKRP 317
IP P +L++ +K+C +P++RP
Sbjct: 211 -----IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 87/286 (30%), Positives = 132/286 (46%), Gaps = 31/286 (10%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI L + + +G FG V G ++G VA+K L G + AF Q
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG----------TMMPEAFLQ 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E + KL H + A + ++I V E++ G+L +L +
Sbjct: 51 EAQIMKKLRHDKLVPLY-AVVSEEPIYI----------------VTEFMGKGSLLDFLKE 93
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VE 222
+ L +V +A +A G++Y+ +HRD++ N+L+ N KIADFG+AR +E
Sbjct: 94 GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIE 153
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281
+ G + + APE + K DV+SFGI L E+ +PYP + EV
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL 213
Query: 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
V R R P+ CP SL +MK CW +PD+RP + + S LE
Sbjct: 214 EQVER-GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 7e-32
Identities = 73/270 (27%), Positives = 125/270 (46%), Gaps = 35/270 (12%)
Query: 61 GTFGTVHRGLYDGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
G FG V +G+Y DVA+K+L E ++R +E + H+LD+P +
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLKNENE--------KSVRDEMMREAEIMHQLDNPYI 57
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQ 176
+ IG + + +V+E GG L +L ++ ++ VV+
Sbjct: 58 VRMIGVCEAEALM-----------------LVMEMASGGPLNKFLS-GKKDEITVSNVVE 99
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG-- 234
L ++ G+ YL + VHRD+ N+LL KI+DFG+++ ++ + +
Sbjct: 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159
Query: 235 -TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPE 292
L + APE +N ++ + DV+S+GI +WE + PY + EV S + Q R +
Sbjct: 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-FIEQGKRLD 218
Query: 293 IPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
P CP + +MK CW + RP +V
Sbjct: 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 1e-31
Identities = 86/297 (28%), Positives = 144/297 (48%), Gaps = 35/297 (11%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRS--AFT 102
WE+ K+ + + +G+FG V+ G+ G VK +T E A++R F
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKG---VVKDEPETRVAIKTVNEAASMRERIEFL 57
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
E +V + + +V + +G GQ + V++E + G LK+YL
Sbjct: 58 NEASVMKEFNCHHVVRLLGVV----------SQGQPTL------VIMELMTRGDLKSYL- 100
Query: 163 KNRRRKL---------AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213
++ R ++ + K ++Q+A ++A G++YL++ K VHRD+ N ++ ++ TVKI
Sbjct: 101 RSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160
Query: 214 ADFGVARVEASNPNDMTGETGTLG--YMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDM 270
DFG+ R G G L +M+PE L + DV+SFG+ LWEI +
Sbjct: 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 220
Query: 271 PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
PY +S +V V+ L + P CP L +M+ CW NP RP E++S ++
Sbjct: 221 PYQGMSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 92/311 (29%), Positives = 141/311 (45%), Gaps = 50/311 (16%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTEAEIA 95
WE+ +LV+ + G FG V G D VAVK+L + TE +++
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML----KSDATEKDLS 68
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
L S + H N+ +GA L+ V+VEY G
Sbjct: 69 DLISEMEMMKMIG---KHKNIINLLGACTQDGPLY----------------VIVEYASKG 109
Query: 156 ALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201
L+ YL R +L+FK +V A +ARG+ YL S+K +HRD+
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169
Query: 202 NMLLDKNRTVKIADFGVAR--VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFG 259
N+L+ ++ +KIADFG+AR T + +MAPE L Y + DV+SFG
Sbjct: 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 229
Query: 260 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 318
+ LWEI+ PYP + E+ ++++ R + P C + L +M+ CW A P +RP
Sbjct: 230 VLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT 288
Query: 319 MDEVVSMLEAI 329
++V L+ I
Sbjct: 289 FKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 37/214 (17%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKL--LDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
+ GT+G V++ G VA+K LD EEG ALR E+++ +L H
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG----IPSTALR-----EISLLKELKH 57
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
PN+ K L + ++ + V EY LK YL R L+ +
Sbjct: 58 PNIVKL---------LDVIHTERKLYL-------VFEYCDMD-LKKYL-DKRPGPLSPNL 99
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
+ + L RGL+Y HS +I+HRD+K +N+L++++ +K+ADFG+AR T E
Sbjct: 100 IKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
TL Y APE+L G YS + +W + C
Sbjct: 160 VTLWYRAPEILLG------SKHYSTAVDIWSVGC 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 1e-31
Identities = 90/300 (30%), Positives = 141/300 (47%), Gaps = 41/300 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHR----TEAEIAALRS- 99
WE+ K+ + + +G+FG V+ G D+ +K GE R T E A+LR
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGN--ARDI-IK----GEAETRVAVKTVNESASLRER 53
Query: 100 -AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F E +V +V + +G GQ + VV+E + G LK
Sbjct: 54 IEFLNEASVMKGFTCHHVVRLLGVV----------SKGQPTL------VVMELMAHGDLK 97
Query: 159 TYLIKNR--------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
+YL R R + ++Q+A ++A G++YL+++K VHRD+ N ++ + T
Sbjct: 98 SYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT 157
Query: 211 VKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC- 267
VKI DFG+ R G G L +MAPE L + D++SFG+ LWEI
Sbjct: 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSL 217
Query: 268 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
+ PY LS +V V+ + P CP + ++M+ CW NP RP E+V++L+
Sbjct: 218 AEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 83/295 (28%), Positives = 139/295 (47%), Gaps = 46/295 (15%)
Query: 58 IARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ G FG V YD G VAVK L G+ IA L+ +E+ + L
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN----HIADLK----KEIEILRNL 63
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
H N+ K+ G I TE+G + +++E+LP G+LK YL +N+ K+
Sbjct: 64 YHENIVKYKG---------ICTEDGGNGIK-----LIMEFLPSGSLKEYLPRNKN-KINL 108
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
K ++ A+ + +G+ YL S++ VHRD+ N+L++ VKI DFG+ + ++ T
Sbjct: 109 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 168
Query: 232 E---TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF---------S 278
+ + + APE L + + DV+SFG+ L+E+ CD ++
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG 228
Query: 279 EVTSA----VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
++T V+ + R P CP + +M++CW+ P KR ++ EAI
Sbjct: 229 QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 85/288 (29%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI L ++ + G FG V Y+ H VAVK + G AF
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----------VEAFLA 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E V L H + K + A + ++I + E++ G+L +L
Sbjct: 51 EANVMKTLQHDKLVK-LHAVVTKEPIYI----------------ITEFMAKGSLLDFLKS 93
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ K ++ + +A G++++ + +HRD++ N+L+ + KIADFG+ARV
Sbjct: 94 DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-- 151
Query: 224 SNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSE 279
N+ T G + + APE +N + K DV+SFGI L EI +PYP +S E
Sbjct: 152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
V A+ R R P CP L N+M RCW P++RP + + S+L+
Sbjct: 212 VIRALER-GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-31
Identities = 95/310 (30%), Positives = 139/310 (44%), Gaps = 58/310 (18%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGH--DVAVKLLD--WGEEGHRTEAEIAALR 98
WE + + VI G FG V R + DG + A+K+L E HR
Sbjct: 1 WE----DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-------- 48
Query: 99 SAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
F E+ V KL HPN+ +GA L+I +EY P G L
Sbjct: 49 --FAGELEVLCKLGHHPNIINLLGACENRGYLYI----------------AIEYAPYGNL 90
Query: 158 KTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
+L K+R L + ++Q A D+A G+ YL ++ +HRD+ N+
Sbjct: 91 LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNV 150
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
L+ +N KIADFG++R E G + +MA E LN + Y K DV+SFG+ LW
Sbjct: 151 LVGENLASKIADFGLSRGEEVYVKKTMGRL-PVRWMAIESLNYSVYTTKSDVWSFGVLLW 209
Query: 264 EIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
EI PY ++ +E+ + Q R E PR C + +M++CW P +RP ++
Sbjct: 210 EIVSLGGTPYCGMTCAELYEK-LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
Query: 323 V----SMLEA 328
MLEA
Sbjct: 269 SVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 4e-31
Identities = 92/314 (29%), Positives = 143/314 (45%), Gaps = 52/314 (16%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTEAEIA 95
WE+ ++L + + G FG V G D VAVK+L + T+ +++
Sbjct: 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML----KDDATDKDLS 62
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
L S + H N+ +GA L+ V+VEY G
Sbjct: 63 DLVSEMEMMKMIG---KHKNIINLLGACTQDGPLY----------------VLVEYASKG 103
Query: 156 ALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201
L+ YL R +L FK +V A +ARG+ YL SQK +HRD+
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163
Query: 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETG---TLGYMAPEVLNGNPYNRKCDVYSF 258
N+L+ ++ +KIADFG+AR + N + T + +MAPE L Y + DV+SF
Sbjct: 164 NVLVTEDNVMKIADFGLAR-DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 259 GICLWEIYCCD-MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
G+ LWEI+ PYP + E+ ++++ R + P C L +M+ CW A P +RP
Sbjct: 223 GVLLWEIFTLGGSPYPGIPVEELFK-LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRP 281
Query: 318 EMDEVVSMLEAIDT 331
++V L+ + T
Sbjct: 282 TFKQLVEDLDRVLT 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 76/285 (26%), Positives = 138/285 (48%), Gaps = 41/285 (14%)
Query: 57 VIARGTFGTVHRGL--YDGHDVAVKLLDWGE-EGHRTEAEIAALRSAFTQEVAVWHKLDH 113
+I +GT+G V+ L G +AVK ++ R ++ + A E+ LDH
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK- 172
N+ +++G E + + +EY+PGG++ + L R F+
Sbjct: 68 LNIVQYLGF-----------ETTE-----EYLSIFLEYVPGGSIGSCL----RTYGRFEE 107
Query: 173 -VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA---SNPND 228
+V + GL+YLHS+ I+HRD+K +N+L+D + KI+DFG+++ N +
Sbjct: 108 QLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167
Query: 229 MTGETGTLGYMAPEVLN--GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
M+ + G++ +MAPEV++ Y+ K D++S G + E++ P+ D E +A+ +
Sbjct: 168 MSMQ-GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE---EAIAAMFK 223
Query: 287 ---QNLRPEIPRCCPSSL----ANVMKRCWDANPDKRPEMDEVVS 324
+ P IP +L + + C+ NPD RP E++
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-30
Identities = 86/286 (30%), Positives = 132/286 (46%), Gaps = 31/286 (10%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI L ++ + +G FG V G ++G VA+K L G AF Q
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQ 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E V KL H + + A + ++I V EY+ G+L +L
Sbjct: 51 EAQVMKKLRHEKLVQLY-AVVSEEPIYI----------------VTEYMSKGSLLDFLKG 93
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VE 222
+ L +V +A +A G++Y+ VHRD++ N+L+ +N K+ADFG+AR +E
Sbjct: 94 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281
+ G + + APE + K DV+SFGI L E+ +PYP + EV
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 213
Query: 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
V R R P CP SL ++M +CW P++RP + + + LE
Sbjct: 214 DQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 80/297 (26%), Positives = 137/297 (46%), Gaps = 43/297 (14%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
I ++ + ++ GTFG + G+ +V VK + + H +E ++ L
Sbjct: 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV----KDHASEIQVTLL--- 55
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
QE + + L H N+ LH+ E+G+ V+ Y+ G LK +
Sbjct: 56 -LQESCLLYGLSHQNI---------LPILHVCIEDGEPPF------VLYPYMNWGNLKLF 99
Query: 161 LIKNR------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
L + R + L+ + +V +A+ +A G+SYLH + ++H+D+ N ++D+ VKI
Sbjct: 100 LQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159
Query: 215 DFGVARVEASNPNDM----TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-D 269
D ++R P D E + +MA E L Y+ DV+SFG+ LWE+
Sbjct: 160 DNALSR--DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217
Query: 270 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
PY ++ E+ A ++ R P CP L VM CW +P++RP ++V L
Sbjct: 218 TPYVEIDPFEMA-AYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 64/274 (23%), Positives = 129/274 (47%), Gaps = 44/274 (16%)
Query: 66 VHRGLYDGHDVAVKLLDWGEEGHR-----TEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120
+++G+++ +V ++ +GH+ TE EI LR ++D N+ K
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLR-----------RIDSNNILKIY 84
Query: 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180
G + +P +++EY G L+ L K + L+FK + +A+D
Sbjct: 85 GFIIDIV----------DDLPRLS--LILEYCTRGYLREVLDKEK--DLSFKTKLDMAID 130
Query: 181 LARGLSYLH-SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP----NDMTGETGT 235
+GL L+ ++++ + + L+ +N +KI G+ ++ +S P N M
Sbjct: 131 CCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----- 185
Query: 236 LGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293
Y + ++LN + Y K D+YS G+ LWEI+ +P+ +L+ E+ ++ +N ++
Sbjct: 186 --YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL 243
Query: 294 PRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
P CP + +++ C + KRP + E++ L
Sbjct: 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 43/266 (16%)
Query: 76 VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135
VAVK+L R +A A R F +EV + +L PN+ + +G
Sbjct: 49 VAVKVL-------RPDASDNA-REDFLKEVKILSRLSDPNIARLLGVCTVD--------- 91
Query: 136 GQVAMPSNICCVVVEYLPGGALKTYL---------IKNRRRKLAFKVVVQLALDLARGLS 186
C+++EY+ G L +L + + L+F ++ +A +A G+
Sbjct: 92 -------PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMR 144
Query: 187 YLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VEASNPNDMTGETGT-LGYMAPEVL 244
YL S VHRD+ T N L+ KN T+KIADFG++R + +S+ + G + +MA E +
Sbjct: 145 YLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV 204
Query: 245 NGNPYNRKCDVYSFGICLWEIY--CCDMPYPDLSFSEV---TSAVVRQNLRPEI---PRC 296
+ K DV++FG+ LWEI C + PY L+ +V R + R P
Sbjct: 205 LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPN 264
Query: 297 CPSSLANVMKRCWDANPDKRPEMDEV 322
CP + +M CW + + RP E+
Sbjct: 265 CPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 9e-30
Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 34/276 (12%)
Query: 57 VIARGTFG--TVHRGLYDGHDVAVKLLDWGE--EGHRTEAEIAALRSAFTQEVAVWHKLD 112
V+ +G FG T++R D V K ++ E R +A E+ + L
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA---------LNEIVILSLLQ 57
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF- 171
HPN+ + M + L I+ +EY GG L Y R++ F
Sbjct: 58 HPNIIAYYNHFMDDNTLLIE----------------MEYANGGTL--YDKIVRQKGQLFE 99
Query: 172 -KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
++V+ + +SY+H I+HRD+KT N+ L K +K+ DFG++++ S +
Sbjct: 100 EEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 290
GT YM+PE+ G YN K D+++ G L+E+ + + + +V+ N
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT 219
Query: 291 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
P + S L +++ +P+KRP DEV+
Sbjct: 220 PVVSVYS-SELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-29
Identities = 74/270 (27%), Positives = 126/270 (46%), Gaps = 27/270 (10%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
V+ +G++G V R DG +K L+ R R A QE + +L HP
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRE-------RKAAEQEAQLLSQLKHP 59
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N+ + + G E+G + +V+ + GG L L + + + L V
Sbjct: 60 NIVAYRESWEG--------EDGLLY-------IVMGFCEGGDLYHKLKEQKGKLLPENQV 104
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE-T 233
V+ + +A L YLH + I+HRD+KT+N+ L + +K+ D G+ARV N DM
Sbjct: 105 VEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDMASTLI 163
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293
GT YM+PE+ + PYN K DV++ G C++E+ + + + ++ L P +
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPM 222
Query: 294 PRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
P+ L ++ P+KRP + ++
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-29
Identities = 77/280 (27%), Positives = 129/280 (46%), Gaps = 32/280 (11%)
Query: 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGH-RTEAEIAALRSAFT----QEV 105
+ +++ + +G+FGTV+ V K E E + L T QE
Sbjct: 1 RYILQQRLGKGSFGTVYL-------VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEA 53
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL--KTYLIK 163
+ KLDHP + KF + + C++ EY G L K +K
Sbjct: 54 QLLSKLDHPAIVKFHASFLERDAF----------------CIITEYCEGRDLDCKLEELK 97
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ + L+ V + + L G+ Y+H ++I+HRD+K +N+ L KN +KI DFGV+R+
Sbjct: 98 HTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLM 156
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
+ + T TGT YM+PE L Y+ K D++S G L+E+ C + +F V
Sbjct: 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR 216
Query: 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
+V + P +P L ++M+ + +P RP E++
Sbjct: 217 IV-EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 75/229 (32%), Positives = 115/229 (50%), Gaps = 32/229 (13%)
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+E+ + P + K+ GA + S I +AM EY GG+L +
Sbjct: 48 RELEINKSCKSPYIVKYYGAFLDESSSSIG-----IAM---------EYCEGGSLDSIYK 93
Query: 163 KNRRR--KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
K ++R ++ KV+ ++A + +GLSYLHS+KI+HRD+K N+LL + VK+ DFGV+
Sbjct: 94 KVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG 153
Query: 221 VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP-----DL 275
E N T TGT YMAPE + G PY+ DV+S G+ L E+ P+P L
Sbjct: 154 -ELVNSLAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL 211
Query: 276 SFSEVTSAVVRQNLRPEIPRCCPS-------SLANVMKRCWDANPDKRP 317
E+ S +V PE+ P + +K+C + +P +RP
Sbjct: 212 GPIELLSYIVNMPN-PELKD-EPGNGIKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 89/324 (27%), Positives = 141/324 (43%), Gaps = 73/324 (22%)
Query: 46 EIEPSKLVIKSVIARGTFGTVH----RGLYDGHD--------------VAVKLLDWGEEG 87
E +L K + G FG VH G+ D VAVK+L
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML------ 54
Query: 88 HRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
R +A A R+ F +E+ + +L PN+ + + + S L C+
Sbjct: 55 -REDANKNA-RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL----------------CM 96
Query: 148 VVEYLPGGALKTYLIKNR---------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198
+ EY+ G L +L ++ +++ ++ +A +A G+ YL S VHRD+
Sbjct: 97 ITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL 156
Query: 199 KTENMLLDKNRTVKIADFGVARVEASNPNDMTGE--------TGTLGYMAPEVLNGNPYN 250
T N L+ KN T+KIADFG++R N +G+ + +M+ E + +
Sbjct: 157 ATRNCLVGKNYTIKIADFGMSR------NLYSGDYYRIQGRAVLPIRWMSWESILLGKFT 210
Query: 251 RKCDVYSFGICLWEI--YCCDMPYPDLSFSEV---TSAVVR-QNLRPEIPR--CCPSSLA 302
DV++FG+ LWEI C + PY LS +V T R Q + +P+ CP SL
Sbjct: 211 TASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLY 270
Query: 303 NVMKRCWDANPDKRPEMDEVVSML 326
+M CW N +RP E+ + L
Sbjct: 271 KLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 98/351 (27%), Positives = 151/351 (43%), Gaps = 76/351 (21%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHR----GLYDGHD---VAVKLLDWGEEGHRTEAEIAAL 97
WE ++L + G FG V GL+ VAVK+L H TE
Sbjct: 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLK--PSAHLTE------ 81
Query: 98 RSAFTQEVAVWHKL-DHPNVTKFIGA-TMGSSELHI------------------------ 131
R A E+ V L +H N+ +GA T+G L I
Sbjct: 82 REALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPK 141
Query: 132 QTENGQVAMPSNI-------CCVVVEYLPGGALKTYLI--KNRRRKLAF-------KVVV 175
++ + A+ N+ C + EY+ +Y++ K +R+ V
Sbjct: 142 HEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTS 201
Query: 176 ------QLALDL----------ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+LALD A+G+S+L S+ +HRD+ N+LL R KI DFG+A
Sbjct: 202 EILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA 261
Query: 220 RVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLS 276
R ++ N + L +MAPE + Y + DV+S+GI LWEI+ PYP +
Sbjct: 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321
Query: 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
++++ R P C PS + ++MK CWDA+P KRP ++V ++E
Sbjct: 322 VDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 83/292 (28%), Positives = 132/292 (45%), Gaps = 50/292 (17%)
Query: 57 VIARGTFGTVHRGLY--DG--HDVAVKLLD--WGEEGHRTEAEIAALRSAFTQEVAVWHK 110
VI G FG V + DG D A+K + ++ HR F E+ V K
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD----------FAGELEVLCK 51
Query: 111 L-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---- 165
L HPN+ +GA L++ +EY P G L +L K+R
Sbjct: 52 LGHHPNIINLLGACEHRGYLYL----------------AIEYAPHGNLLDFLRKSRVLET 95
Query: 166 ----------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
L+ + ++ A D+ARG+ YL ++ +HRD+ N+L+ +N KIAD
Sbjct: 96 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155
Query: 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPD 274
FG++R + G + +MA E LN + Y DV+S+G+ LWEI PY
Sbjct: 156 FGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214
Query: 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
++ +E+ + Q R E P C + ++M++CW P +RP +++ L
Sbjct: 215 MTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 71/279 (25%), Positives = 136/279 (48%), Gaps = 41/279 (14%)
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH- 113
+I RG +G V+RG + G VA+K+++ + +++ ++ +EVA+ +L
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQ----REVALLSQLRQS 59
Query: 114 --PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
PN+TK+ G+ + L +++EY GG+++T + + +A
Sbjct: 60 QPPNITKYYGSYLKGPRL----------------WIIMEYAEGGSVRTLM---KAGPIAE 100
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
K + + ++ L Y+H ++HRD+K N+L+ VK+ DFGVA + N + +
Sbjct: 101 KYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160
Query: 232 ETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 290
GT +MAPEV G Y+ K D++S GI ++E+ + PY D+ + + +
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--K 218
Query: 291 PEIPRCCPSSLANVMKR----CWDANPDKRPEMDEVVSM 325
P PR + + +++ C D P +R +E++
Sbjct: 219 P--PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-29
Identities = 84/313 (26%), Positives = 139/313 (44%), Gaps = 60/313 (19%)
Query: 46 EIEPSKLVIKSVIARGTFGTVH----RGL----------YDGHD--VAVKLLDWGEEGHR 89
E +L +K + G FG VH GL +DG VAVK+L R
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-------R 53
Query: 90 TEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV 149
+ A R+ F +E+ + +L +PN+ + +G + L C++
Sbjct: 54 ADVTKTA-RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL----------------CMIT 96
Query: 150 EYLPGGALKTYL----------IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
EY+ G L +L N ++ ++ +A+ +A G+ YL S VHRD+
Sbjct: 97 EYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156
Query: 200 TENMLLDKNRTVKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYS 257
T N L+ + T+KIADFG++R + + + + G + +MA E + + DV++
Sbjct: 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216
Query: 258 FGICLWEIY--CCDMPYPDLSFSEV---TSAVVRQNLRP---EIPRCCPSSLANVMKRCW 309
FG+ LWE++ C + PY LS +V T R R CPS + +M RCW
Sbjct: 217 FGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCW 276
Query: 310 DANPDKRPEMDEV 322
+ RP +++
Sbjct: 277 SRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 1e-28
Identities = 80/280 (28%), Positives = 135/280 (48%), Gaps = 33/280 (11%)
Query: 48 EPSKLVIK-SVIARGTFGTVHRGLYDGHD---VAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
+P +L K I +G+FG V++G+ D VA+K++D E E EI ++ Q
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEE----AEDEIEDIQ----Q 51
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E+ V + D P +T++ G+ + ++L I ++EYL GG+ L
Sbjct: 52 EITVLSQCDSPYITRYYGSYLKGTKLWI----------------IMEYLGGGSALDLL-- 93
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ L + + ++ +GL YLHS++ +HRD+K N+LL + VK+ADFGVA
Sbjct: 94 -KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
GT +MAPEV+ + Y+ K D++S GI E+ + P DL V
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-F 211
Query: 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
++ +N P + ++ C + +P RP E++
Sbjct: 212 LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-28
Identities = 68/293 (23%), Positives = 113/293 (38%), Gaps = 61/293 (20%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLD----WGEEGHRTEAEIAALRSAFTQEVAV 107
+I G+F TV + A+K+LD E + + E V
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE---KKVKYV-------KIEKEV 54
Query: 108 WHKLD-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR 166
+L+ HP + K L+ V+EY P G L Y+ +
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYF----------------VLEYAPNGELLQYI--RKY 96
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP 226
L K A ++ L YLHS+ I+HRD+K EN+LLDK+ +KI DFG A+V +P
Sbjct: 97 GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL--DP 154
Query: 227 NDMTGET----------------------GTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
N GT Y++PE+LN P + D+++ G +++
Sbjct: 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQ 214
Query: 265 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
+ P+ + ++ L P P +++++ +P R
Sbjct: 215 MLTGKPPFRGSNEYLTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 79/281 (28%), Positives = 123/281 (43%), Gaps = 57/281 (20%)
Query: 56 SVIARGTFGTV----HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ G G V HR G +AVK + E A++ +E+ + HK
Sbjct: 7 GELGAGNSGVVSKVLHRP--TGKIMAVKTI------RLEINE--AIQKQILRELDILHKC 56
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR---- 167
+ P + F GA NG + +IC +EY+ GG+L L + + R
Sbjct: 57 NSPYIVGFYGAFY---------NNGDI----SIC---MEYMDGGSLDKILKEVQGRIPER 100
Query: 168 ---KLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
K+A V+ +GL+YLH + KI+HRDVK N+L++ +K+ DFGV+
Sbjct: 101 ILGKIAVAVL--------KGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152
Query: 224 SNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP-----DLSF 277
N + GT YMAPE + GN Y+ K D++S G+ L E+ PYP
Sbjct: 153 ---NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209
Query: 278 SEVTSAVVRQNLRPEIPR-CCPSSLANVMKRCWDANPDKRP 317
E+ +V + P +P + + C +P +RP
Sbjct: 210 FELLQYIVNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-28
Identities = 75/278 (26%), Positives = 135/278 (48%), Gaps = 30/278 (10%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I+ I +G F V++ L DG VA+K + E A R +E+ + +L
Sbjct: 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQI------FEMMDAKARQDCLKEIDLLKQL 59
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN---RRRK 168
DHPNV K++ + + ++EL+I V+E G L +IK+ ++R
Sbjct: 60 DHPNVIKYLASFIENNELNI----------------VLELADAGDLSR-MIKHFKKQKRL 102
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228
+ + + + + L L ++HS++I+HRD+K N+ + VK+ D G+ R +S
Sbjct: 103 IPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMP-YPD-LSFSEVTSAVVR 286
GT YM+PE ++ N YN K D++S G L+E+ P Y D ++ + + +
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222
Query: 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
+ P L +++ RC + +P+KRP++ V+
Sbjct: 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 78/280 (27%), Positives = 127/280 (45%), Gaps = 42/280 (15%)
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
VI G V+ + + VA+K +D + + + LR +EV + +HP
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELR----KEVQAMSQCNHP 59
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF--K 172
NV K+ + + EL + V+ YL GG+L ++K+ +
Sbjct: 60 NVVKYYTSFVVGDELWL----------------VMPYLSGGSL-LDIMKSSYPRGGLDEA 102
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
++ + ++ +GL YLHS +HRD+K N+LL ++ +VKIADFGV+ A D T +
Sbjct: 103 IIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD-GGDRTRK 161
Query: 233 T-----GTLGYMAPEVLN-GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
GT +MAPEV+ + Y+ K D++SFGI E+ PY +V +
Sbjct: 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL- 220
Query: 287 QNLRPEIPRC-----CPSSLANVMKRCWDANPDKRPEMDE 321
QN P + S ++ C +P KRP +E
Sbjct: 221 QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-27
Identities = 81/279 (29%), Positives = 136/279 (48%), Gaps = 31/279 (11%)
Query: 48 EPSKLVIK-SVIARGTFGTVHRGLYDGHD--VAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
+P +L K I +G+FG V +G+ + VA+K++D E E EI ++ QE
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----AEDEIEDIQ----QE 52
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+ V + D P VTK+ G+ + ++L I ++EYL GG+ L
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKDTKLWI----------------IMEYLGGGSALDLLEPG 96
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ +++ ++ +GL YLHS+K +HRD+K N+LL ++ VK+ADFGVA
Sbjct: 97 PLDETQIATILR---EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284
GT +MAPEV+ + Y+ K D++S GI E+ + P+ +L +V +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
Query: 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
+ N P + L ++ C + P RP E++
Sbjct: 214 PKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 48/279 (17%)
Query: 54 IKSVIARGTFGTVH--RGLYDGHDVAVKL--LDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
+ I GT+G V+ R + G VA+K+ L+ G++ + EI+ L+
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC--------- 57
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--- 166
HPN+ + G+ + +L I V+EY GG+L+ R
Sbjct: 58 --RHPNIVAYFGSYLRRDKLWI----------------VMEYCGGGSLQDIYQVTRGPLS 99
Query: 167 -RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
++A+ V + L +GL+YLH +HRD+K N+LL ++ VK+ADFGV+ +
Sbjct: 100 ELQIAY--VCRETL---KGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154
Query: 226 PNDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
GT +MAPEV Y+ KCD+++ GI E+ P DL
Sbjct: 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF 214
Query: 283 AVVRQNLRP----EIPRCCPSSLANVMKRCWDANPDKRP 317
+ + N P + + P + +K+C +P KRP
Sbjct: 215 LISKSNFPPPKLKDKEKWSP-VFHDFIKKCLTKDPKKRP 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 61/241 (25%)
Query: 54 IKSVIARGTFGTVHRGLYDGHD--VAVKLLDWGE------EGHRTEAEIAALRSAFTQEV 105
+ G+FG V + G A+K+L + H E L+S
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-VLNEKRILQS------ 57
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ HP + G+ S L++ V+EY+PGG L ++L K+
Sbjct: 58 -----IRHPFLVNLYGSFQDDSNLYL----------------VMEYVPGGELFSHLRKSG 96
Query: 166 R------RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
R R A +VV LAL+ YLHS IV+RD+K EN+LLD + +KI DFG A
Sbjct: 97 RFPEPVARFYAAQVV--LALE------YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFA 148
Query: 220 RVEASNPNDMTGET----GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
+ T GT Y+APE++ Y + D ++ GI ++E+ P+ D
Sbjct: 149 KRVKGR-------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201
Query: 276 S 276
+
Sbjct: 202 N 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-27
Identities = 71/276 (25%), Positives = 137/276 (49%), Gaps = 36/276 (13%)
Query: 57 VIARGTFGTVHRGLY--DGHD----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V+ G FGTV++GL+ +G VA+K L EA E V
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--------REATSPKANKEILDEAYVMAS 65
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+D+P+V + +G + S+ +Q ++ + +P G L Y+ +++ +
Sbjct: 66 VDNPHVCRLLGICLTST---VQ--------------LITQLMPFGCLLDYVREHKDN-IG 107
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ ++ + +A+G++YL +++VHRD+ N+L+ + VKI DFG+A++ ++ +
Sbjct: 108 SQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167
Query: 231 GETGT--LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQ 287
E G + +MA E + Y + DV+S+G+ +WE+ PY + SE++S + +
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 227
Query: 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
P+ P C + +M +CW + D RP+ E++
Sbjct: 228 ERLPQ-PPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-27
Identities = 83/278 (29%), Positives = 136/278 (48%), Gaps = 48/278 (17%)
Query: 55 KSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
+ V+ +GT+G V+ R L +A+K E R + L +E+A+ L
Sbjct: 13 RVVLGKGTYGIVYAARDLSTQVRIAIK-----EIPERDSRYVQPLH----EEIALHSYLK 63
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL------IKNRR 166
H N+ +++G+ +ENG + +E +PGG+L L +K+
Sbjct: 64 HRNIVQYLGSD---------SENGFFK-------IFMEQVPGGSLSALLRSKWGPLKDNE 107
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK-NRTVKIADFGVA-RVEAS 224
+ + F + GL YLH +IVHRD+K +N+L++ + VKI+DFG + R+
Sbjct: 108 QTIIF-----YTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162
Query: 225 NPNDMTGETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
NP T TGTL YMAPEV++ P Y D++S G + E+ P+ +L E +
Sbjct: 163 NPCTETF-TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL--GEPQA 219
Query: 283 AVVRQNL---RPEIPRCCPSSLANVMKRCWDANPDKRP 317
A+ + + PEIP + N + RC++ +PDKR
Sbjct: 220 AMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRA 257
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 7e-27
Identities = 82/295 (27%), Positives = 137/295 (46%), Gaps = 57/295 (19%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ VI GT+G V++ + G VA+K++D +E + E LR
Sbjct: 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILR----------KY 59
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---R 167
+HPN+ F GA + + + Q+ + V+E GG++ T L+K R +
Sbjct: 60 SNHPNIATFYGAFIKKNP---PGNDDQLWL-------VMELCGGGSV-TDLVKGLRKKGK 108
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
+L + + + + RGL+YLH K++HRD+K +N+LL KN VK+ DFGV+ + +
Sbjct: 109 RLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTL 167
Query: 228 DMTGE-TGTLGYMAPEVL--NGNP---YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281
GT +MAPEV+ + P Y+ + DV+S GI E+ P D+
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM------ 221
Query: 282 SAVVRQNLRP--EIPRCCPSSLA----------NVMKRCWDANPDKRPEMDEVVS 324
+R +IPR P +L + + C N ++RP M+E++
Sbjct: 222 -----HPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-27
Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 8/172 (4%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQL-ALDLARGLSYLHSQKIVHRDVKTENMLLD 206
VV+ L GG L+ +L + + V+ ++ L YLHS+ I+HRD+K +N+LLD
Sbjct: 78 VVDLLLGGDLRYHLSQKVKFSEE---QVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD 134
Query: 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+ V I DF +A + T +GT GYMAPEVL Y+ D +S G+ +E
Sbjct: 135 EQGHVHITDFNIATKVTPDTL-TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL 193
Query: 267 CCDMPYPDLSFSEVTSAVVRQNL--RPEIPRCCPSSLANVMKRCWDANPDKR 316
PY S + + + P + + + + + +P KR
Sbjct: 194 RGKRPYRGHS-RTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-27
Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 56/281 (19%)
Query: 61 GTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSA----------FTQEVAVWHK 110
G FG V++ H+ AA + F E+ + +
Sbjct: 16 GAFGKVYKAQ-----------------HKETGLFAAAKIIQIESEEELEDFMVEIDILSE 58
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RK 168
HPN+ A ++L I ++E+ GGAL + +++ R +
Sbjct: 59 CKHPNIVGLYEAYFYENKLWI----------------LIEFCDGGALDSIMLELERGLTE 102
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228
+ V + L+ L++LHS K++HRD+K N+LL + VK+ADFGV+ S
Sbjct: 103 PQIRYVCRQMLE---ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159
Query: 229 MTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
GT +MAPEV+ NPY+ K D++S GI L E+ + P+ +L+ V
Sbjct: 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK 219
Query: 284 VVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEV 322
+++ P + P SS + +K C +PD RP E+
Sbjct: 220 ILKSE-PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 29/216 (13%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD- 112
I G +GTV++ L G VA+K + EEG ++ LR E+A+ +L+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG----IPLSTLR-----EIALLKQLES 57
Query: 113 --HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
HPN+ + + G +T+ +V E++ L TYL K + L
Sbjct: 58 FEHPNIVRLLDVCHGP-----RTDRELKLT------LVFEHVDQD-LATYLSKCPKPGLP 105
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ + L L RG+ +LHS +IVHRD+K +N+L+ + VKIADFG+AR+ S +T
Sbjct: 106 PETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI-YSFEMALT 164
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
TL Y APEVL + Y D++S G E++
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 51/186 (27%), Positives = 91/186 (48%), Gaps = 22/186 (11%)
Query: 146 CVVVEYLPGGALKTYL--IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
+V+EYLPGG L + L + + +A + ++ L L YLHS I+HRD+K +N+
Sbjct: 69 YLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVL----ALEYLHSNGIIHRDLKPDNI 124
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGET--------GTLGYMAPEVLNGNPYNRKCDV 255
L+D N +K+ DFG+++V + GT Y+APEV+ G +++ D
Sbjct: 125 LIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDW 184
Query: 256 YSFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 311
+S G L+E P+ P+ F + + + PE ++ +++ +
Sbjct: 185 WSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE---WPEDVEVSDEAI-DLISKLLVP 240
Query: 312 NPDKRP 317
+P+KR
Sbjct: 241 DPEKRL 246
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 88/352 (25%), Positives = 136/352 (38%), Gaps = 92/352 (26%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAAL 97
WE +L + V+ G FG V G D VAVK+L G T +E AL
Sbjct: 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----TASEHKAL 57
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
S + H +H NV +GA P+ V+VE+ G L
Sbjct: 58 MSELKILI---HIGNHLNVVNLLGA---------------CTKPNGPLMVIVEFCKYGNL 99
Query: 158 KTYLIKNR-----------RRKLAFKVVVQLA---------------------------- 178
+L R +++ F+ +V+ +
Sbjct: 100 SNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159
Query: 179 ---------------------LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
+ARG+ +L S+K +HRD+ N+LL +N VKI DFG
Sbjct: 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 219
Query: 218 VARVEASNPNDMTGETG--TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPD 274
+AR +P+ + + L +MAPE + Y + DV+SFG+ LWEI+ PYP
Sbjct: 220 LARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279
Query: 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
+ +E ++ R P + +M CW +P +RP +V +L
Sbjct: 280 VQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 79/292 (27%), Positives = 129/292 (44%), Gaps = 53/292 (18%)
Query: 63 FGTVHRG-LY-DGHD----VAVKLL-DWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
FG +++G LY G D VA+K L D E F QE ++ +L HPN
Sbjct: 18 FGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE---------FQQEASLMAELHHPN 68
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---------- 165
+ +G T+ V C++ EYL G L +LI
Sbjct: 69 IVCLLGVV---------TQEQPV-------CMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 166 -----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
+ L + +A+ +A G+ YL S VH+D+ N+L+ + VKI+D G++R
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 221 VEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLS 276
E + + + +L +M PE + ++ D++SFG+ LWEI+ + PY S
Sbjct: 173 -EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231
Query: 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328
EV V ++ L P CP + ++M CW P +RP ++ + L +
Sbjct: 232 NQEVIEMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 87/307 (28%), Positives = 135/307 (43%), Gaps = 50/307 (16%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRTEAEIAALRS 99
I+ +V+K + G FG V D VAVK L + +AA R
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--------KDPTLAA-RK 52
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F +E + L H ++ KF G L +V EY+ G L
Sbjct: 53 DFQREAELLTNLQHEHIVKFYGVCGDGDPL----------------IMVFEYMKHGDLNK 96
Query: 160 YL--------------IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
+L + + +L ++ +A +A G+ YL SQ VHRD+ T N L+
Sbjct: 97 FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156
Query: 206 DKNRTVKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
N VKI DFG++R V +++ + G T + +M PE + + + DV+SFG+ LW
Sbjct: 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 216
Query: 264 EIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
EI+ P+ LS +EV + Q E PR CP + ++M CW P +R + E+
Sbjct: 217 EIFTYGKQPWFQLSNTEVIECIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275
Query: 323 VSMLEAI 329
+L A+
Sbjct: 276 YKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 85/305 (27%), Positives = 139/305 (45%), Gaps = 54/305 (17%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTV--HRGLYDG--HDVAVKLL-DWG-EEGHRTEAEIAAL 97
+W + + + VI G FG V R DG D A+K + ++ ++ HR
Sbjct: 5 EW----NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------- 53
Query: 98 RSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
F E+ V KL HPN+ +GA L++ +EY P G
Sbjct: 54 ---FAGELEVLCKLGHHPNIINLLGACEHRGYLYL----------------AIEYAPHGN 94
Query: 157 LKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202
L +L K+R L+ + ++ A D+ARG+ YL ++ +HRD+ N
Sbjct: 95 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 154
Query: 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
+L+ +N KIADFG++R + G + +MA E LN + Y DV+S+G+ L
Sbjct: 155 ILVGENYVAKIADFGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLL 213
Query: 263 WEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE 321
WEI PY ++ +E+ + Q R E P C + ++M++CW P +RP +
Sbjct: 214 WEIVSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 272
Query: 322 VVSML 326
++ L
Sbjct: 273 ILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 82/279 (29%), Positives = 133/279 (47%), Gaps = 31/279 (11%)
Query: 48 EPSKLVIK-SVIARGTFGTVHRGLYDGHD--VAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
+P +L K I +G+FG V +G+ + VA+K++D E E EI ++ QE
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQ----QE 52
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+ V + D P VTK+ G+ + ++L I ++EYL GG+ L
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKGTKLWI----------------IMEYLGGGSALDLLRAG 96
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ F++ L ++ +GL YLHS+K +HRD+K N+LL + VK+ADFGVA
Sbjct: 97 PFDE--FQIATMLK-EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284
GT +MAPEV+ + Y+ K D++S GI E+ + P D+ V +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
Query: 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
+ N P + + C + +P RP E++
Sbjct: 214 PKNN-PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 53/152 (34%), Positives = 82/152 (53%), Gaps = 3/152 (1%)
Query: 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL- 236
+ +ARG+ +L S+K +HRD+ N+LL +N VKI DFG+AR +P+ + L
Sbjct: 179 SFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 237 -GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIP 294
+MAPE + Y + DV+SFG+ LWEI+ PYP + E +++ R P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP 298
Query: 295 RCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
+ ++M CW NP+ RP E+V +L
Sbjct: 299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 41/216 (18%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVK--LLDWGEEGHRTEA--EIAALRSAFTQEVAVWHKL 111
I GT+G V+ R G VA+K L + EG A EI L+ +L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLK-----------EL 55
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
+HPN+ K + +L++ E M +++ LIK+R+R L
Sbjct: 56 NHPNIIKLLDVFRHKGDLYLVFE----FMDTDLY--------------KLIKDRQRGLPE 97
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
++ L +GL++ HS I+HRD+K EN+L++ +K+ADFG+AR S T
Sbjct: 98 SLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
T Y APE+L G YS + +W + C
Sbjct: 158 YVVTRWYRAPELLLG------DKGYSTPVDIWSVGC 187
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 35/217 (16%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GT+G V++ G VA+K + E + I A+R E+ + KL HPN
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIR-----EIKLLQKLRHPN 59
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLP----GGALKTYLIKNRRRKLAF 171
+ + E+ G + M V EY+ G L+ + K
Sbjct: 60 IVRLK-------EIVTSKGKGSIYM-------VFEYMDHDLTG------LLDSPEVKFTE 99
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VEASNPNDMT 230
+ L GL YLHS I+HRD+K N+L++ + +K+ADFG+AR N D T
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159
Query: 231 GETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIY 266
TL Y PE+L G Y + D++S G L E++
Sbjct: 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 84/322 (26%), Positives = 137/322 (42%), Gaps = 69/322 (21%)
Query: 50 SKLVIKSVIARGTFGTVHR----------------GLYDGHD--VAVKLLDWGEEGHRTE 91
L+ K + G FG VH + G VAVK+L R +
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-------RPD 57
Query: 92 AEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY 151
A A R+ F +EV + +L PN+ + +G + L C++ EY
Sbjct: 58 ANKNA-RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL----------------CMITEY 100
Query: 152 LPGGALKTYLIKNRRRK-----------------LAFKVVVQLALDLARGLSYLHSQKIV 194
+ G L +L + +++ ++ +AL +A G+ YL S V
Sbjct: 101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160
Query: 195 HRDVKTENMLLDKNRTVKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRK 252
HRD+ T N L+ +N T+KIADFG++R + A + + G + +MA E + +
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220
Query: 253 CDVYSFGICLWEIY--CCDMPYPDLSFSEV---TSAVVRQNLRPEI---PRCCPSSLANV 304
DV++FG+ LWEI C + PY +L+ +V R R P CP L +
Sbjct: 221 SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYEL 280
Query: 305 MKRCWDANPDKRPEMDEVVSML 326
M +CW + +RP ++ + L
Sbjct: 281 MLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 6e-26
Identities = 69/277 (24%), Positives = 134/277 (48%), Gaps = 36/277 (12%)
Query: 57 VIARGTFGTVHRGLY--DGHDV----AVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V+ G FGTV++G++ +G V A+K+L+ G + E F E +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVE-------FMDEALIMAS 65
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+DHP++ + +G + + IQ +V + +P G L Y + + +
Sbjct: 66 MDHPHLVRLLGVCLSPT---IQ--------------LVTQLMPHGCLLDY-VHEHKDNIG 107
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
++++ + +A+G+ YL +++VHRD+ N+L+ VKI DFG+AR+ + +
Sbjct: 108 SQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
Query: 231 GETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQ 287
+ G + +MA E ++ + + DV+S+G+ +WE+ PY + E+ + +
Sbjct: 168 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG 227
Query: 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
P+ P C + VM +CW + D RP+ E+ +
Sbjct: 228 ERLPQ-PPICTIDVYMVMVKCWMIDADSRPKFKELAA 263
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 57/178 (32%), Positives = 95/178 (53%), Gaps = 4/178 (2%)
Query: 153 PGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212
P + LI N L++ +V + +A G+ +L S+ VHRD+ N+L+ + + VK
Sbjct: 221 PERTRRDTLI-NESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVK 279
Query: 213 IADFGVARVEASNPNDMT-GETG-TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-D 269
I DFG+AR + N ++ G T L +MAPE + N Y DV+SFGI LWEI+
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339
Query: 270 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
PYP+L +E +++ R P + +M++CW+ + RP+ ++V ++
Sbjct: 340 TPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-26
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 25/202 (12%)
Query: 61 GTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118
GT+ V++ G VA+K + + G R EA+ +A +E+ + +L HPN+
Sbjct: 11 GTYAVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTAL-REIKLLQELKHPNIIG 66
Query: 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLA 178
+ S +++ V E++ K +IK++ L +
Sbjct: 67 LLDVFGHKSNINL----------------VFEFMETDLEK--VIKDKSIVLTPADIKSYM 108
Query: 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGY 238
L RGL YLHS I+HRD+K N+L+ + +K+ADFG+AR S MT + T Y
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168
Query: 239 MAPEVLNG-NPYNRKCDVYSFG 259
APE+L G Y D++S G
Sbjct: 169 RAPELLFGARHYGVGVDMWSVG 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVK------LLDWGEEGHRTEAEIAALRSAF 101
+ I+ I RG F V+R DG VA+K L+D A R+
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD------------AKARADC 49
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+E+ + +L+HPNV K+ + + +EL+I V+E G L +
Sbjct: 50 IKEIDLLKQLNHPNVIKYYASFIEDNELNI----------------VLELADAGDLSRMI 93
Query: 162 --IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
K ++R + K V + + L L ++HS++++HRD+K N+ + VK+ D G+
Sbjct: 94 KHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153
Query: 220 RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMP-YPDLSFS 278
R +S GT YM+PE ++ N YN K D++S G L+E+ P Y D
Sbjct: 154 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 279 EVTSAVVRQNLRPEIPRCCPSS-LANVMKRCWDANPDKRPEMDEVVSM 325
+ Q P +P S L ++ C + +P+KRP++ V +
Sbjct: 214 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 71/299 (23%)
Query: 50 SKLVIKSVIARGTFGTV----HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
S+L + I G GTV HR G A+K++ E +R +E+
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRP--TGRLYALKVIYGNHED--------TVRRQICREI 123
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ ++HPNV K ++ NG++ V++E++ GG+L+ I +
Sbjct: 124 EILRDVNHPNVVK-------CHDMFDH--NGEIQ-------VLLEFMDGGSLEGTHIADE 167
Query: 166 RRKLAFKVVVQLALDLAR----GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ LA D+AR G++YLH + IVHRD+K N+L++ + VKIADFGV+R+
Sbjct: 168 Q---------FLA-DVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217
Query: 222 EASNPNDMTGETGTLGYMAPEV----LNGNPYNRKC-DVYSFGICLWEIYCCDMPYPDLS 276
A + GT+ YM+PE LN Y+ D++S G+ + E Y P+
Sbjct: 218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF---- 273
Query: 277 FSEVTSAVVRQ------------NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
V RQ + PE P + + C P KR +++
Sbjct: 274 ------GVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 75/280 (26%), Positives = 128/280 (45%), Gaps = 40/280 (14%)
Query: 53 VIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+IK I G+FG ++ + D +K +D + E E A +EV + K
Sbjct: 4 IIK-KIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKE------ASKKEVILLAK 55
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ HPN+ F + + L I V+EY GG L + NR+R +
Sbjct: 56 MKHPNIVTFFASFQENGRLFI----------------VMEYCDGGDLMKRI--NRQRGVL 97
Query: 171 FKV------VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV-KIADFGVARVEA 223
F VQ++L GL ++H +KI+HRD+K++N+ L KN V K+ DFG+AR
Sbjct: 98 FSEDQILSWFVQISL----GLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
+ GT Y++PE+ PYN K D++S G L+E+ P+ + ++
Sbjct: 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213
Query: 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
+ + P P L +++ + + +P RP + ++
Sbjct: 214 ICQGYFAPISPN-FSRDLRSLISQLFKVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 84/275 (30%), Positives = 120/275 (43%), Gaps = 50/275 (18%)
Query: 56 SVIARGTFGTV-------HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRS---AFTQEV 105
+V+ RG FG V LY A+K L G+ R E E +L F E
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELY-----AIKALKKGDIIARDEVE--SLMCEKRIF--ET 55
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN- 164
A + HP + QTE+ C V+EY GG L ++ +
Sbjct: 56 A--NSERHPFLVNLFAC--------FQTEDH--------VCFVMEYAAGGDLMMHIHTDV 97
Query: 165 --RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
R + + V L GL YLH KIV+RD+K +N+LLD VKIADFG+ + E
Sbjct: 98 FSEPRAVFYAACVVL------GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-E 150
Query: 223 ASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281
D T GT ++APEVL Y R D + G+ ++E+ + P+P EV
Sbjct: 151 GMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210
Query: 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
++V N PR ++M+R NP++R
Sbjct: 211 DSIV--NDEVRYPRFLSREAISIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 77/290 (26%), Positives = 138/290 (47%), Gaps = 42/290 (14%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHD----VAVKLL-DWGEEGHRTEAEIAALRS 99
++ ++L ++ G FGTVH+G++ +G VA+K + D G +T EI
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEI----- 56
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
T + LDH + + +G G+S +Q +V + P G+L
Sbjct: 57 --TDHMLAMGSLDHAYIVRLLGICPGAS---LQ--------------LVTQLSPLGSLLD 97
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+ ++ R L + ++ + +A+G+ YL ++VHR++ N+LL + V+IADFGVA
Sbjct: 98 H-VRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156
Query: 220 RVEASNPND---MTGETGT-LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPD 274
+ P+D E T + +MA E + Y + DV+S+G+ +WE+ PY
Sbjct: 157 --DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214
Query: 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
+ EV ++ + R P+ C + VM +CW + + RP E+ +
Sbjct: 215 MRPHEVPD-LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 73/277 (26%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 57 VIARGTFGTVHRGLYD-GHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
V+ +G +GTV+ GL + G +AVK LD E E L+ +EV + L H
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV-LAAEKEYEKLQ----EEVDLLKSLKH 61
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
N+ +++G + N + +E++PGG++ + L NR L V
Sbjct: 62 VNIVQYLGT----------------CLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPV 103
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR------VEASNPN 227
+ + G++YLH+ +VHRD+K N++L N +K+ DFG AR + ++ N
Sbjct: 104 FCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS-FSEVTSAVVR 286
+ GT +MAPEV+N + Y RK D++S G ++E+ P + + +
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223
Query: 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
+ L P +P ++ + + C + +RP +++
Sbjct: 224 RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 72/278 (25%), Positives = 117/278 (42%), Gaps = 59/278 (21%)
Query: 58 IARGTFGTVHRGLYDGHDV--AVKLL------DWGEEGH-RTEAEIAALRSAFTQEVAVW 108
+ G FG V + A+K + + G++ H +E EI +E
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEI-------LEEC--- 50
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK 168
+HP + K T + +I +++EY GG L T L R R
Sbjct: 51 ---NHPFIVKLY-RTF-KDKKYIY--------------MLMEYCLGGELWTIL---RDR- 87
Query: 169 LAFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
AR YLH++ I++RD+K EN+LLD N VK+ DFG A+
Sbjct: 88 ------GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAK 141
Query: 221 VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY--PDLSFS 278
S T GT Y+APE++ Y+ D +S GI L+E+ P+ D
Sbjct: 142 KLKSGQKTWT-FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200
Query: 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
E+ + +++ N + E P + +++K+ NP++R
Sbjct: 201 EIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-24
Identities = 76/263 (28%), Positives = 126/263 (47%), Gaps = 30/263 (11%)
Query: 57 VIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT-QEVAVWHKLDH 113
++ +GTFG V R G A+K+L + E IA A T E V H
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKIL-------KKEVIIAKDEVAHTLTESRVLKNTRH 54
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P +T S + QT++ C V+EY+ GG L +L +R R +
Sbjct: 55 PFLT--------SLKYSFQTKDR--------LCFVMEYVNGGELFFHL--SRERVFSEDR 96
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
++ L YLHS KIV+RD+K EN++LDK+ +KI DFG+ + ++ M
Sbjct: 97 TRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC 156
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293
GT Y+APEVL N Y R D + G+ ++E+ C +P+ + ++ ++ ++++
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK--F 214
Query: 294 PRCCPSSLANVMKRCWDANPDKR 316
PR + +++ +P+KR
Sbjct: 215 PRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 84/313 (26%), Positives = 138/313 (44%), Gaps = 60/313 (19%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTE 91
+R+D +V+K + G FG V L + H+ VAVK L E R +
Sbjct: 3 KRRD-------IVLKWELGEGAFGKVF--LAECHNLLPEQDKMLVAVKALKEASESARQD 53
Query: 92 AEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY 151
F +E + L H ++ +F G + TE + M V EY
Sbjct: 54 ---------FQREAELLTVLQHQHIVRFYG---------VCTEGRPLLM-------VFEY 88
Query: 152 LPGGALKTYLIKNRRR-------------KLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198
+ G L +L + +L ++ +A +A G+ YL S VHRD+
Sbjct: 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDL 148
Query: 199 KTENMLLDKNRTVKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVY 256
T N L+ + VKI DFG++R + +++ + G T + +M PE + + + D++
Sbjct: 149 ATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIW 208
Query: 257 SFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 315
SFG+ LWEI+ P+ LS +E + Q E PR CP + +M+ CW P +
Sbjct: 209 SFGVVLWEIFTYGKQPWYQLSNTEAIECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQ 267
Query: 316 RPEMDEVVSMLEA 328
R + ++ S L+A
Sbjct: 268 RMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 73/265 (27%), Positives = 119/265 (44%), Gaps = 27/265 (10%)
Query: 49 PSKLVIKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
P + ++ RG FG V+ YD G ++AVK + + + T E+ AL E+
Sbjct: 1 PVNWRLGKLLGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALEC----EI 55
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ L H + ++ G E + + VEY+PGG++K L
Sbjct: 56 QLLKNLRHDRIVQYYGCLRDPEEKKLS--------------IFVEYMPGGSIKDQL--KA 99
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
L V + + +G+SYLHS IVHRD+K N+L D VK+ DFG ++ +
Sbjct: 100 YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159
Query: 226 PNDMTG---ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
TG TGT +M+PEV++G Y RK DV+S + E+ P+ +
Sbjct: 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF 219
Query: 283 AVVRQNLRPEIPRCCPSSLANVMKR 307
+ Q +P +P + + +K+
Sbjct: 220 KIATQPTKPMLPDGVSDACRDFLKQ 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 75/281 (26%), Positives = 125/281 (44%), Gaps = 28/281 (9%)
Query: 49 PSKLVIKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
P+ + ++ +G FG V+ YD G ++AVK + + E T E+ AL E+
Sbjct: 1 PTNWRLGKLLGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALEC----EI 55
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ L H + ++ G E + + +E++PGG++K L
Sbjct: 56 QLLKNLLHERIVQYYGCLRDPMERTLS--------------IFMEHMPGGSIKDQL--KS 99
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS- 224
L V + + G+SYLHS IVHRD+K N+L D VK+ DFG ++ +
Sbjct: 100 YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159
Query: 225 --NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
+ M TGT +M+PEV++G Y RK D++S G + E+ P+ +
Sbjct: 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF 219
Query: 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
+ Q P +P + +KR + RP DE++
Sbjct: 220 KIATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 49/171 (28%), Positives = 86/171 (50%), Gaps = 4/171 (2%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V+EY+ GG L ++ ++ R A ++ GL +LH + I++RD+K +N+LL
Sbjct: 72 FFVMEYVNGGDLMFHIQRSGRFDEP--RARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
D +KIADFG+ + + GT Y+APE+L+ PY D ++ G+ L+E+
Sbjct: 130 DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEM 189
Query: 266 YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
P+ E+ +++ +R PR +++K NP+KR
Sbjct: 190 LAGQSPFEGDDEDELFQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-24
Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
+L HPN+ ++ + + L+I V++ + G L + + +K
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYI----------------VMDLIEGAPLGEHFNSLKEKKQ 108
Query: 170 AF------KVVVQLALDLARGLSYLHSQK-IVHRDVKTENMLLDKNRTVKIADFGVARVE 222
F + VQ+ L L YLH +K IVHRD+ N++L ++ V I DFG+A+
Sbjct: 109 RFTEERIWNIFVQMVL----ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-- 162
Query: 223 ASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281
P +T GT+ Y PE++ PY K DV++FG L+++ P+ + +
Sbjct: 163 QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA 222
Query: 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
+ +V P + +V+ C + + RP++ +V +M+
Sbjct: 223 TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 4e-24
Identities = 74/274 (27%), Positives = 122/274 (44%), Gaps = 28/274 (10%)
Query: 57 VIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
++ +G FG V+ YD G ++A K + + E T E++AL E+ + L H
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALEC----EIQLLKNLQH 63
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
+ ++ G +E + + +EY+PGG++K L L V
Sbjct: 64 ERIVQYYGCLRDRAEKTLT--------------IFMEYMPGGSVKDQL--KAYGALTESV 107
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS---NPNDMT 230
+ + G+SYLHS IVHRD+K N+L D VK+ DFG ++ + + +
Sbjct: 108 TRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR 167
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 290
TGT +M+PEV++G Y RK DV+S G + E+ P+ + + Q
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 227
Query: 291 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
P++P S A C RP +E++
Sbjct: 228 PQLPSHI-SEHARDFLGCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 3/164 (1%)
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
++ L + ++ + +A+G+ +L S+K +HRD+ N+LL +N VKI DFG+AR +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 226 PNDMTGETG--TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTS 282
P+ + L +MAPE + Y + DV+SFG+ LWEI+ PYP + E
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292
Query: 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
+++ R P + M CW P +RP E+V L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 53/181 (29%), Positives = 90/181 (49%), Gaps = 3/181 (1%)
Query: 152 LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211
+K L + L ++ +ARG+ +L S+ VHRD+ N+LL + + V
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIV 276
Query: 212 KIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC- 268
KI DFG+AR + N ++ + L +MAPE + N Y DV+S+GI LWEI+
Sbjct: 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG 336
Query: 269 DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328
PYP + ++ R P + ++M +CW++ P+KRP + ++E+
Sbjct: 337 GTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396
Query: 329 I 329
+
Sbjct: 397 L 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 8e-24
Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 28/279 (10%)
Query: 50 SKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
+ I+ I RG F V+R L D VA+K + E A R +E+ +
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKV------QIFEMMDAKARQDCVKEIDL 55
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL--IKNR 165
+L+HPNV K++ + + +EL+I V+E G L + K +
Sbjct: 56 LKQLNHPNVIKYLDSFIEDNELNI----------------VLELADAGDLSQMIKYFKKQ 99
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+R + + V + + L + ++HS++++HRD+K N+ + VK+ D G+ R +S
Sbjct: 100 KRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMP-YPDLSFSEVTSAV 284
GT YM+PE ++ N YN K D++S G L+E+ P Y D
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK 219
Query: 285 VRQNLRPEIPRCCPSS-LANVMKRCWDANPDKRPEMDEV 322
+ Q P +P S L ++ C +PD+RP++ V
Sbjct: 220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-23
Identities = 75/263 (28%), Positives = 117/263 (44%), Gaps = 30/263 (11%)
Query: 57 VIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT-QEVAVWHKLDH 113
++ +GTFG V R G A+K+L R E IA A T E V H
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRH 54
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P +T A L C V+EY GG L +L +R R +
Sbjct: 55 PFLTALKYAFQTHDRL----------------CFVMEYANGGELFFHL--SRERVFTEER 96
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
++ L YLHS+ +V+RD+K EN++LDK+ +KI DFG+ + S+ M
Sbjct: 97 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293
GT Y+APEVL N Y R D + G+ ++E+ C +P+ + + ++ + +R
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--F 214
Query: 294 PRCCPSSLANVMKRCWDANPDKR 316
PR +++ +P +R
Sbjct: 215 PRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-23
Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 29/232 (12%)
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
R +EVAV + HPN+ ++ + + L+I V++Y GG L
Sbjct: 43 REESRKEVAVLSNMKHPNIVQYQESFEENGNLYI----------------VMDYCEGGDL 86
Query: 158 KTYLIKNRRRKLAFKV------VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211
Y N +R + F VQ+ L L ++H +KI+HRD+K++N+ L K+ T+
Sbjct: 87 --YKKINAQRGVLFPEDQILDWFVQICL----ALKHVHDRKILHRDIKSQNIFLTKDGTI 140
Query: 212 KIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMP 271
K+ DFG+ARV S GT Y++PE+ PYN K D+++ G L+E+
Sbjct: 141 KLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200
Query: 272 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
+ + + ++R + P + L N++ + + NP RP ++ ++
Sbjct: 201 FEAGNMKNLVLKIIRGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-23
Identities = 72/277 (25%), Positives = 133/277 (48%), Gaps = 36/277 (12%)
Query: 57 VIARGTFGTVHRGLY--DGHD----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V+ G FGTV++G++ DG + VA+K+L E +A L A+ V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVL---RENTSPKANKEILDEAY-----VMAG 65
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ P V + +G + S+ +Q +V + +P G L Y+ +N+ R +
Sbjct: 66 VGSPYVCRLLGICLTST---VQ--------------LVTQLMPYGCLLDYVRENKDR-IG 107
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ ++ + +A+G+SYL ++VHRD+ N+L+ VKI DFG+AR+ + +
Sbjct: 108 SQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167
Query: 231 GETGT--LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQ 287
+ G + +MA E + + + DV+S+G+ +WE+ PY + E+ + +
Sbjct: 168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG 227
Query: 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
P+ P C + +M +CW + + RP E+V
Sbjct: 228 ERLPQ-PPICTIDVYMIMVKCWMIDSECRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 70/223 (31%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 57 VIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT-QEVAVWHKLDH 113
++ +GTFG V R G A+K+L + E IA A T E V H
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKIL-------KKEVIIAKDEVAHTLTESRVLQNTRH 54
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----RRKL 169
P +T + + QT + C V+EY GG L +L + R R
Sbjct: 55 PFLT--------ALKYSFQTHDR--------LCFVMEYANGGELFFHLSRERVFSEDRAR 98
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM 229
+ + AL YLHS +V+RD+K EN++LDK+ +KI DFG+ + S+ M
Sbjct: 99 FYGAEIVSALG------YLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 230 TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
GT Y+APEVL N Y R D + G+ ++E+ C +P+
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-23
Identities = 77/289 (26%), Positives = 129/289 (44%), Gaps = 35/289 (12%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRG---LYDGHD--VAVKLLDWGEEGHRTEAEIAALRSA 100
E++ + I+ ++ G FG + RG L + VA+ L G R
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--------DKQRRG 52
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
F E + DH N+ + G V N +V EY+ GAL ++
Sbjct: 53 FLAEALTLGQFDHSNIVRLEG----------------VITRGNTMMIVTEYMSNGALDSF 96
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L K+ + +A +++ L LA G+ YL VH+ + +L++ + KI+ F +
Sbjct: 97 LRKHEGQLVAGQLMGMLP-GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155
Query: 221 VEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 277
+ S M+G++ L + APE + + ++ DV+SFGI +WE+ + PY D+S
Sbjct: 156 EDKSEAIYTTMSGKSPVL-WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214
Query: 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
+V AV R PR CP+ L +M CW +RP ++ S+L
Sbjct: 215 QDVIKAV-EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-23
Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 17/222 (7%)
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+E + K+ HPN+ F + L+I V+EY GG L +
Sbjct: 47 KEAVLLAKMKHPNIVAFKESFEADGHLYI----------------VMEYCDGGDLMQKIK 90
Query: 163 KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
R + ++Q + + G+ ++H ++++HRD+K++N+ L +N VK+ DFG AR+
Sbjct: 91 LQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
S GT Y+ PE+ PYN K D++S G L+E+ P+ S+ +
Sbjct: 151 TSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210
Query: 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
V + + +P +P L +++K+ + NP RP ++S
Sbjct: 211 KVCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 4e-23
Identities = 85/302 (28%), Positives = 136/302 (45%), Gaps = 47/302 (15%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRG----LYDGHD---VAVKLLDWGEEGHRTEAEIAALRS 99
I+ +V+K + G FG V L D VAVK L + R +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD-------- 53
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F +E + L H ++ KF G V + + +V EY+ G L
Sbjct: 54 -FHREAELLTNLQHEHIVKFYG----------------VCVEGDPLIMVFEYMKHGDLNK 96
Query: 160 YLIK-----------NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
+L NR +L ++ +A +A G+ YL SQ VHRD+ T N L+ +N
Sbjct: 97 FLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156
Query: 209 RTVKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
VKI DFG++R V +++ + G T + +M PE + + + DV+S G+ LWEI+
Sbjct: 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216
Query: 267 CC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
P+ LS +EV + + + + PR CP + ++M CW P R + E+ S+
Sbjct: 217 TYGKQPWYQLSNNEVIECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSL 275
Query: 326 LE 327
L+
Sbjct: 276 LQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-23
Identities = 74/243 (30%), Positives = 123/243 (50%), Gaps = 34/243 (13%)
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
F QEV + +L+HPNV + +G + S +V+E+ P G LK Y
Sbjct: 42 FLQEVQPYRELNHPNVLQCLGQCIESIPY----------------LLVLEFCPLGDLKNY 85
Query: 161 LIKNR--RRKLAFKVVVQ-LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
L NR ++A K V+Q +A ++A GL +LH +H D+ N L + +VKI D+G
Sbjct: 86 LRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYG 145
Query: 218 VARVEASNPNDMTGETGT--LGYMAPEVLNGNPYN-------RKCDVYSFGICLWEIY-C 267
+A + +T + L ++APE++ + +K +++S G+ +WE++
Sbjct: 146 LALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205
Query: 268 CDMPYPDLSFSEVTSAVVR-QNL---RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
D PYPDLS +V VVR Q++ +P++ VM+ CW +P+ RP +EV
Sbjct: 206 ADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVH 264
Query: 324 SML 326
+L
Sbjct: 265 ELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 12/175 (6%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
+V+EYL GG + LIK L Q ++ G+ LH + I+HRD+K EN+L+
Sbjct: 73 YLVMEYLNGGDCAS-LIK-TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
D+ +K+ DFG++R N + GT Y+APE + G ++ D +S G ++E
Sbjct: 131 DQTGHLKLTDFGLSRNGLENKKFV----GTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186
Query: 266 YCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
P+ PD F + S + N E+ C +++ R +P KR
Sbjct: 187 LFGYPPFHAETPDAVFDNILSRRI--NWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 1e-22
Identities = 50/129 (38%), Positives = 68/129 (52%), Gaps = 12/129 (9%)
Query: 157 LKTYLIKNRRR---KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213
L TYL K R A + Q+ GL YLH+Q+I+HRDVKTEN+ ++ V I
Sbjct: 143 LYTYLTKRSRPLPIDQALIIEKQIL----EGLRYLHAQRIIHRDVKTENIFINDVDQVCI 198
Query: 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
D G A+ P + G GT+ APEVL + YN K D++S GI L+E+ + YP
Sbjct: 199 GDLGAAQFPVVAPAFL-GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM----LAYP 253
Query: 274 DLSFSEVTS 282
F + S
Sbjct: 254 STIFEDPPS 262
|
Length = 357 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-22
Identities = 48/157 (30%), Positives = 85/157 (54%), Gaps = 3/157 (1%)
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
+++ + +A+G+ +L S+ +HRDV N+LL R KI DFG+AR ++ N +
Sbjct: 214 LLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273
Query: 234 GTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLR 290
L +MAPE + Y + DV+S+GI LWEI+ PYP + + +V++ +
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333
Query: 291 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
P P + ++MK CW+ P +RP ++ +++
Sbjct: 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 3e-22
Identities = 78/281 (27%), Positives = 125/281 (44%), Gaps = 47/281 (16%)
Query: 55 KSVIARGTFGTVHRGLY--DGHDVAVKL--LDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ ++ G GTV++ + +AVK+ LD E L+ E+ + +K
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE----------LQKQIMSELEILYK 55
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
D P + F GA + + I TE ++ GG+L Y RK+
Sbjct: 56 CDSPYIIGFYGAFFVENRISICTE----------------FMDGGSLDVY------RKIP 93
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
V+ ++A+ + +GL+YL S KI+HRDVK NML++ VK+ DFGV+ + N T
Sbjct: 94 EHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST-QLVNSIAKT 152
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 290
GT YMAPE ++G Y DV+S GI E+ PYP + S + Q L+
Sbjct: 153 -YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI-QKNQGSLMPLQLLQ 210
Query: 291 PEIPRCCP--------SSLANVMKRCWDANPDKRPEMDEVV 323
+ P + + +C P +RP + ++
Sbjct: 211 CIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-22
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 40/216 (18%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIA--ALRSAFTQEVAVWHKLDH 113
I G G V + G VA+K + R E I ALR E+ H
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPNQALR-----EIKALQACQH 58
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV-EYLPGGALKTYLIKNRRRKLAFK 172
P V K + P V+V EY+P + ++++ R L
Sbjct: 59 PYVVKLLDVF-----------------PHGSGFVLVMEYMPSDL--SEVLRDEERPLPEA 99
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN-PNDMTG 231
V L +G++Y+H+ I+HRD+K N+L+ + +KIADFG+AR+ + P +
Sbjct: 100 QVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+ T Y APE+L G RK Y G+ LW + C
Sbjct: 160 QVATRWYRAPELLYG---ARK---YDPGVDLWAVGC 189
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-22
Identities = 56/173 (32%), Positives = 93/173 (53%), Gaps = 4/173 (2%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EYL GG L ++ + R A A ++ GL +LH + I++RD+K +N+LLDK
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEARARF--YAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+ +KIADFG+ + + + GT Y+APE+L G YN D +SFG+ L+E+
Sbjct: 132 DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI 191
Query: 268 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD 320
P+ E+ +++ N RP PR + + + ++ +P KR +D
Sbjct: 192 GQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDPTKRLGVD 242
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 56 SVIARGTFGTVH--RGLYDGHDVAVKLL---DWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V+ G +G V R G VA+K + E+ +T ALR EV V +
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT-----ALR-----EVKVLRQ 56
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
L H N+ A L++ V EY+ L+ L++ L
Sbjct: 57 LRHENIVNLKEAFRRKGRLYL----------------VFEYVERTLLE--LLEASPGGLP 98
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN-DM 229
V L + ++Y HS I+HRD+K EN+L+ ++ +K+ DFG AR + P +
Sbjct: 99 PDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158
Query: 230 TGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
T T Y APE+L G+ Y + DV++ G + E+
Sbjct: 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 6e-22
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 32/212 (15%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GT+G V+ R G VA+K + R + E + S +E+++ +L+HPN
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPN 60
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ K + I TEN +V E+L LK ++ + + ++
Sbjct: 61 IVKLLDV--------IHTENKLY--------LVFEFL-HQDLKKFMDASPLSGIPLPLIK 103
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
L +GL++ HS +++HRD+K +N+L++ +K+ADFG+AR T E T
Sbjct: 104 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 163
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
L Y APE+L G C YS + +W + C
Sbjct: 164 LWYRAPEILLG------CKYYSTAVDIWSLGC 189
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 8e-22
Identities = 75/307 (24%), Positives = 133/307 (43%), Gaps = 49/307 (15%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALR 98
EI S + + FG V++G G VA+K L + +AE LR
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-------KDKAEGP-LR 52
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F E + +L HPN+ +G + T+ ++M + Y L
Sbjct: 53 EEFKHEAMMRSRLQHPNIVCLLG---------VVTKEQPLSM-------IFSYCSHSDLH 96
Query: 159 TYLI--------------KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
+L+ K + L V + +A G+ +L S +VH+D+ T N+L
Sbjct: 97 EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156
Query: 205 LDKNRTVKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYSFGICL 262
+ VKI+D G+ R V A++ + G + + +M+PE + ++ D++S+G+ L
Sbjct: 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVL 216
Query: 263 WEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE 321
WE++ + PY S +V + + + P P CP+ + +M CW+ P +RP +
Sbjct: 217 WEVFSYGLQPYCGYSNQDVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKD 275
Query: 322 VVSMLEA 328
+ S L
Sbjct: 276 IHSRLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 9e-22
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 58 IARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I G+ G V G VAVK +D ++ R EV + HPN
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR---------ELLFNEVVIMRDYQHPN 77
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ + + + EL VV+E+L GGAL + R + V
Sbjct: 78 IVEMYSSYLVGDEL----------------WVVMEFLEGGALTDIVTHTRMNEEQIATVC 121
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG-VARVEASNPNDMTGETG 234
L + LS+LH+Q ++HRD+K++++LL + VK++DFG A+V P + G
Sbjct: 122 LAVL---KALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-LVG 177
Query: 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
T +MAPEV++ PY + D++S GI + E+ + PY
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-21
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 32/212 (15%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GT+G V+ R G VA+K + R E E + S +E+++ +L+HPN
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ + + ++L++ V E+L LK Y+ + L ++
Sbjct: 60 IVRLLDVVHSENKLYL----------------VFEFLDLD-LKKYMDSSPLTGLDPPLIK 102
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
L +G++Y HS +++HRD+K +N+L+D+ +K+ADFG+AR T E T
Sbjct: 103 SYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT 162
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
L Y APE+L G+ YS + +W I C
Sbjct: 163 LWYRAPEILLGSRQ------YSTPVDIWSIGC 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 4e-21
Identities = 84/283 (29%), Positives = 129/283 (45%), Gaps = 36/283 (12%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I I +GT+G V + L +G AVK+LD H + EI A E + L
Sbjct: 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILD---PIHDIDEEIEA-------EYNILKAL 71
Query: 112 -DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK---NRRR 167
DHPNV KF G +NG + +V+E GG++ T L+K R
Sbjct: 72 SDHPNVVKFYGMYYKKD-----VKNG------DQLWLVLELCNGGSV-TDLVKGFLKRGE 119
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
++ ++ + + GL +LH K +HRDVK N+LL VK+ DFGV+ S
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179
Query: 228 DMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
GT +MAPEV+ + Y+ +CDV+S GI E+ D P DL
Sbjct: 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF 239
Query: 283 AVVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
+ R N P + P + + +++C + +KRP + +++
Sbjct: 240 KIPR-NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 5e-21
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 30/207 (14%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GT+G V+R G VA+K L E + I +LR E+ + KL HPN
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLR-----EINILLKLQHPN 65
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCV--VVEYLPGGALKTYLIKNRRRKLAFKV 173
+ + ++ +V + SN+ + V+EY+ LK+ L++ ++
Sbjct: 66 I------------VTVK----EVVVGSNLDKIYMVMEYVEH-DLKS-LMETMKQPFLQSE 107
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
V L L L G+++LH I+HRD+KT N+LL+ +KI DFG+AR S T
Sbjct: 108 VKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLV 167
Query: 234 GTLGYMAPEVLNGNP-YNRKCDVYSFG 259
TL Y APE+L G Y+ D++S G
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-21
Identities = 73/264 (27%), Positives = 121/264 (45%), Gaps = 31/264 (11%)
Query: 57 VIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT-QEVAVWHKLDH 113
++ +GTFG V + G A+K+L + E +A A T E V H
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKIL-------KKEVIVAKDEVAHTLTENRVLQNSRH 54
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P F+ A S + H + C V+EY GG L +L +R R +
Sbjct: 55 P----FLTALKYSFQTH------------DRLCFVMEYANGGELFFHL--SRERVFSEDR 96
Query: 174 VVQLALDLARGLSYLHSQK-IVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
++ L YLHS+K +V+RD+K EN++LDK+ +KI DFG+ + + M
Sbjct: 97 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 292
GT Y+APEVL N Y R D + G+ ++E+ C +P+ + ++ ++ + +R
Sbjct: 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-- 214
Query: 293 IPRCCPSSLANVMKRCWDANPDKR 316
PR +++ +P +R
Sbjct: 215 FPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 8e-21
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 37/214 (17%)
Query: 61 GTFGTVHRGL--YDGHDVAVKL--LDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
GT+ TV++G G VA+K LD EEG A+R E+++ +L H N+
Sbjct: 11 GTYATVYKGRNRTTGEIVALKEIHLD-AEEG----TPSTAIR-----EISLMKELKHENI 60
Query: 117 TKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYL-IKNRRRKLAFKV 173
+ LH I TEN + +V EY+ LK Y+ R L
Sbjct: 61 VR----------LHDVIHTENKLM--------LVFEYMDKD-LKKYMDTHGVRGALDPNT 101
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
V L +G+++ H +++HRD+K +N+L++K +K+ADFG+AR N + E
Sbjct: 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEV 161
Query: 234 GTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIY 266
TL Y AP+VL G+ Y+ D++S G + E+
Sbjct: 162 VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 72/234 (30%), Positives = 104/234 (44%), Gaps = 40/234 (17%)
Query: 48 EPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQ 103
E SK + I +GTFG V R VA+K L++ +EG I ALR
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF----PITALR----- 60
Query: 104 EVAVWHKLDHPNVTKFI-----GATMGSSELHIQTENGQVAMPSNICCVVVEY-LPGGAL 157
E+ + L H NV I AT + G + C E+ L G
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRY------KGSFYLVFEFC----EHDLAG--- 107
Query: 158 KTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
L+ N+ K + ++ L GL Y+H KI+HRD+K N+L+ K+ +K+ADFG
Sbjct: 108 ---LLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164
Query: 218 VARV----EASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIY 266
+AR + S PN T TL Y PE+L G Y D++ G + E++
Sbjct: 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-20
Identities = 81/266 (30%), Positives = 120/266 (45%), Gaps = 42/266 (15%)
Query: 54 IKSVIARGTFGTVHR--GLYDGHDVAVKLLD-WGEEGHRTEAEIAALRSAFTQEVAVWHK 110
I I +GT+G V++ DG AVK+LD + EAE L+S
Sbjct: 26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL---------- 75
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN---RRR 167
+HPNV KF G + +L GQ+ + V+E GG++ T L+K +
Sbjct: 76 PNHPNVVKFYGMFYKADKL----VGGQLWL-------VLELCNGGSV-TELVKGLLICGQ 123
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
+L ++ + GL +LH+ +I+HRDVK N+LL VK+ DFGV+ S
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 228 DMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
GT +MAPEV+ Y+ +CDV+S GI E+ D P D+ +
Sbjct: 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF 243
Query: 283 AVVRQNLRPEIPRCCPSSLANVMKRC 308
+IPR P +L + K C
Sbjct: 244 ---------KIPRNPPPTLLHPEKWC 260
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-20
Identities = 82/312 (26%), Positives = 123/312 (39%), Gaps = 89/312 (28%)
Query: 53 VIKSVIARGTFGTVHRGLY--DGHDVAVK-----LLDWGEEGHRTEAEIAALRSAFTQEV 105
VIK + GTFG+V+ G VA+K W E LR EV
Sbjct: 3 VIKQ-LGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--------EECMNLR-----EV 48
Query: 106 AVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
KL +HPN+ K + EL+ V EY+ G + L+K+
Sbjct: 49 KSLRKLNEHPNIVKLKEVFRENDELYF----------------VFEYMEGNLYQ--LMKD 90
Query: 165 RRRKL-----AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
R+ K ++ Q+ GL+++H HRD+K EN+L+ VKIADFG+A
Sbjct: 91 RKGKPFSESVIRSIIYQILQ----GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLA 146
Query: 220 R-VEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIY----------- 266
R + + P T T Y APE+L + Y+ D+++ G + E+Y
Sbjct: 147 REIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE 204
Query: 267 -------CCDMPYPDLS-FSEVTSAVVRQNLRPEIPRCCPSSL-----------ANVMKR 307
C + P + E + R P+ P+SL +++K
Sbjct: 205 IDQLYKICSVLGTPTKQDWPEGYKLASKLGFR--FPQFAPTSLHQLIPNASPEAIDLIKD 262
Query: 308 C--WDANPDKRP 317
WD P KRP
Sbjct: 263 MLRWD--PKKRP 272
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 51/169 (30%), Positives = 95/169 (56%), Gaps = 4/169 (2%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+E+L GG L + I+++ R ++ A ++ GL +LHS+ I++RD+K +N++LD+
Sbjct: 74 VMEFLNGGDL-MFHIQDKGRFDLYRATF-YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+ +KIADFG+ + N + GT Y+APE+L G Y D +SFG+ L+E+
Sbjct: 132 DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191
Query: 268 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
P+ E+ + +R + P PR +++++ ++ +P +R
Sbjct: 192 GQSPFHGDDEDELFES-IRVD-TPHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 33/225 (14%)
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E+ + +HP + K +GA +L I ++E+ PGGA+ +++
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDGKLWI----------------MIEFCPGGAVDAIMLE 102
Query: 164 NRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
R + +V+ + L+ L YLHS KI+HRD+K N+LL + +K+ADFGV+
Sbjct: 103 LDRGLTEPQIQVICRQMLE---ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159
Query: 222 EASNPNDMTGETGTLGYMAPEV-----LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
GT +MAPEV + PY+ K D++S GI L E+ + P+ +L+
Sbjct: 160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219
Query: 277 FSEVTSAVVRQNLRPEIPRCCPSSLA----NVMKRCWDANPDKRP 317
V + + P + PS + + +K D +P+ RP
Sbjct: 220 PMRVLLKIAKSE-PPTLS--QPSKWSMEFRDFLKTALDKHPETRP 261
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-20
Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 1/148 (0%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C+V+ + GG LK ++ R L + V+ + + G+ +LHS IV+RD+K EN+LL
Sbjct: 69 CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL 128
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
D +++D G+A VE + +T GT GYMAPE+L PY+ D ++ G ++E+
Sbjct: 129 DDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEM 187
Query: 266 YCCDMPYPDLSFSEVTSAVVRQNLRPEI 293
P+ D + R+ L E+
Sbjct: 188 VAGRTPFKDHKEKVAKEELKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-20
Identities = 68/266 (25%), Positives = 124/266 (46%), Gaps = 39/266 (14%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I +G GTV+ + G +VA+K ++ ++ + E+ V + HPN
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---------ELIINEILVMRENKHPN 77
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ ++ + + EL VV+EYL GG+L + + + V
Sbjct: 78 IVNYLDSYLVGDELW----------------VVMEYLAGGSLTDVVTETCMDEGQIAAVC 121
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
+ L + L +LHS +++HRD+K++N+LL + +VK+ DFG + + GT
Sbjct: 122 RECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA-VVRQNLRPEIP 294
+MAPEV+ Y K D++S GI E+ + PY L+ + + + ++ N PE+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRALYLIATNGTPELQ 236
Query: 295 RCCPSSLANVMK----RCWDANPDKR 316
P L+ + + RC + + +KR
Sbjct: 237 N--PEKLSAIFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 50/175 (28%), Positives = 74/175 (42%), Gaps = 44/175 (25%)
Query: 148 VVEYLPGGALKTYLIKNR--RRKLA-FKVV-VQLALDLARGLSYLHSQKIVHRDVKTENM 203
V+EY+PGG L LI+ + A F + + LALD +H +HRD+K +N+
Sbjct: 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD------SVHKLGFIHRDIKPDNI 132
Query: 204 LLDKNRTVKIADFGVA------------RVEASNPNDMTGET-----------------G 234
L+D + +K+ADFG+ ++ N G
Sbjct: 133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVG 192
Query: 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 289
T Y+APEVL G PY +CD +S G+ L+E M Y F T +
Sbjct: 193 TPDYIAPEVLRGTPYGLECDWWSLGVILYE-----MLYGFPPFYSDTLQETYNKI 242
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GT+G V++G G VA+K + R E+E + S +E+++ +L HPN
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-------RLESEEEGVPSTAIREISLLKELQHPN 60
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ M S L++ + E+L LK YL + + +V
Sbjct: 61 IVCLQDVLMQESRLYL----------------IFEFLSMD-LKKYLDSLPKGQYMDAELV 103
Query: 176 QLAL-DLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ L + +G+ + HS++++HRD+K +N+L+D +K+ADFG+AR T E
Sbjct: 104 KSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV 163
Query: 235 TLGYMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
TL Y APEVL G+P Y+ D++S G E+
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 5e-20
Identities = 55/175 (31%), Positives = 90/175 (51%), Gaps = 16/175 (9%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EYL GG L ++ + L A ++ GL +LHS+ IV+RD+K +N+LLD
Sbjct: 74 VMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKGIVYRDLKLDNILLDT 131
Query: 208 NRTVKIADFGVARVEASNPNDMTGET------GTLGYMAPEVLNGNPYNRKCDVYSFGIC 261
+ +KIADFG+ + +M G+ GT Y+APE+L G YN D +SFG+
Sbjct: 132 DGHIKIADFGMCK------ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVL 185
Query: 262 LWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
L+E+ P+ E+ ++ N P PR +++ + + P++R
Sbjct: 186 LYEMLIGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 6e-20
Identities = 58/184 (31%), Positives = 96/184 (52%), Gaps = 24/184 (13%)
Query: 93 EI-AALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY 151
EI A+R+ +E+ V H+ + P + F GA E+ +IC +E+
Sbjct: 37 EIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI-------------SIC---MEH 80
Query: 152 LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRT 210
+ GG+L L K R + ++ ++++ + RGL+YL + KI+HRDVK N+L++
Sbjct: 81 MDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE 138
Query: 211 VKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269
+K+ DFGV+ ++ S N GT YM+PE L G Y + D++S G+ L E+
Sbjct: 139 IKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
Query: 270 MPYP 273
P P
Sbjct: 196 YPIP 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 8e-20
Identities = 68/217 (31%), Positives = 94/217 (43%), Gaps = 41/217 (18%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAE-----IAALRSAFTQEVAVWHK 110
I GT+G V+R G VA+K + R + E I++LR E+ +
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV-------RMDNERDGIPISSLR-----EITLLLN 62
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
L HPN+ + +G I +V+EY L+ N +
Sbjct: 63 LRHPNIVELKEVVVGKHLDSI--------------FLVMEYCEQDLAS--LLDNMPTPFS 106
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
V L L L RGL YLH I+HRD+K N+LL +KIADFG+AR MT
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+ TL Y APE+L G C Y+ I +W + C
Sbjct: 167 PKVVTLWYRAPELLLG------CTTYTTAIDMWAVGC 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 73/267 (27%), Positives = 121/267 (45%), Gaps = 40/267 (14%)
Query: 61 GTFGTVHRGLYDGHDV--AVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118
G FG V++ V A K++D ++E E+ + E+ + DHPN+ K
Sbjct: 16 GAFGKVYKAQNKETGVLAAAKVID-----TKSEEEL----EDYMVEIDILASCDHPNIVK 66
Query: 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKLAFKVVVQ 176
+ A + L I ++E+ GGA+ +++ R + +VV +
Sbjct: 67 LLDAFYYENNLWI----------------LIEFCAGGAVDAVMLELERPLTEPQIRVVCK 110
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL 236
L+ L+YLH KI+HRD+K N+L + +K+ADFGV+ GT
Sbjct: 111 QTLE---ALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 167
Query: 237 GYMAPEVL-----NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 291
+MAPEV+ PY+ K DV+S GI L E+ + P+ +L+ V + + P
Sbjct: 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PP 226
Query: 292 EI--PRCCPSSLANVMKRCWDANPDKR 316
+ P S + +K+C + N D R
Sbjct: 227 TLAQPSRWSSEFKDFLKKCLEKNVDAR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 77/288 (26%), Positives = 136/288 (47%), Gaps = 36/288 (12%)
Query: 51 KLVIKSVIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108
K I V+ G GTV + + DG AVK++D EG +EA+ ++ EV
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDM--EGM-SEADKNRAQA----EVCCL 85
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV--VVEYLPGGALKTYLIKNRR 166
D ++ K H P N+ + V++Y G L+ IK+R
Sbjct: 86 LNCDFFSIVK----------CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQE-IKSRA 134
Query: 167 R-KLAFK------VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+ F+ + +Q+ L + ++HS+ ++HRD+K+ N+LL N VK+ DFG +
Sbjct: 135 KTNRTFREHEAGLLFIQVLL----AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190
Query: 220 RVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
++ A+ +D G T GT Y+APE+ PY++K D++S G+ L+E+ P+ +
Sbjct: 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250
Query: 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
EV + P P P + ++ ++P +RP ++++M
Sbjct: 251 EEVMHKTLAGRYDPLPPSISP-EMQEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 67/239 (28%), Positives = 110/239 (46%), Gaps = 35/239 (14%)
Query: 58 IARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I G+ G V R + G VAVK++D ++ R EV + H N
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---------ELLFNEVVIMRDYQHQN 79
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
V + + + EL V++E+L GGAL + + R + V
Sbjct: 80 VVEMYKSYLVGEEL----------------WVLMEFLQGGALTDIVSQTRLNEEQIATVC 123
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
+ L + L YLHSQ ++HRD+K++++LL + VK++DFG + + GT
Sbjct: 124 ESVL---QALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT 180
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 294
+MAPEV++ PY + D++S GI + E+ + PY FS+ +++ LR P
Sbjct: 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY----FSDSPVQAMKR-LRDSPP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 54/172 (31%), Positives = 89/172 (51%), Gaps = 10/172 (5%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFK--VVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V+EY+ GG L Y I+ + FK V A ++A GL +LHS+ I++RD+K +N++L
Sbjct: 79 VMEYVNGGDL-MYHIQQVGK---FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
D +KIADFG+ + E T GT Y+APE++ PY + D ++FG+ L+E
Sbjct: 135 DAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 193
Query: 265 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
+ P+ E+ +++ N P+ ++ K +P KR
Sbjct: 194 MLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 53/178 (29%), Positives = 97/178 (54%), Gaps = 13/178 (7%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+V+EY+ GG L ++ R+RKL + A ++ L++LH + I++RD+K +N+LLD
Sbjct: 73 LVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 207 KNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+ +K+ D+G+ + E P D T GT Y+APE+L G Y D ++ G+ ++E+
Sbjct: 131 ADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189
Query: 266 YCCDMPY------PDLSFSEVTSAVVRQNLRP-EIPRCCPSSLANVMKRCWDANPDKR 316
P+ PD++ + V+ + +P IPR ++V+K + +P +R
Sbjct: 190 MAGRSPFDIITDNPDMNTEDYLFQVILE--KPIRIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-19
Identities = 81/279 (29%), Positives = 125/279 (44%), Gaps = 43/279 (15%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ GT+G V+ R L+ G AVK++ E G S QE+ + + H N
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDF--------SLIQQEIFMVKECKHCN 67
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK-TYLIKNRRRKLAFKVV 174
+ + G+ + +L I +EY GG+L+ Y + +L V
Sbjct: 68 IVAYFGSYLSREKLWI----------------CMEYCGGGSLQDIYHVTGPLSELQIAYV 111
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ L +GL+YLHS+ +HRD+K N+LL N VK+ADFGVA + G
Sbjct: 112 CRETL---QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIG 168
Query: 235 TLGYMAPEVL----NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 290
T +MAPEV NG YN+ CD+++ GI E+ P DL + + N +
Sbjct: 169 TPYWMAPEVAAVEKNGG-YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ 227
Query: 291 PEIPRC-----CPSSLANVMKRCWDANPDKRPEMDEVVS 324
P P+ S+ N +K NP KRP + +++
Sbjct: 228 P--PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 5e-19
Identities = 53/178 (29%), Positives = 94/178 (52%), Gaps = 13/178 (7%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EY+ GG L ++ R+RKL + + +++ L+YLH + I++RD+K +N+LLD
Sbjct: 74 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131
Query: 208 NRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+K+ D+G+ + E P D T GT Y+APE+L G Y D ++ G+ ++E+
Sbjct: 132 EGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 267 CCDMPY--------PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
P+ PD + + V+ + + IPR A+V+K + +P +R
Sbjct: 191 AGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 5e-19
Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 35/225 (15%)
Query: 71 YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130
+ G VAVK +D ++ R EV + H NV + + EL
Sbjct: 45 HTGKQVAVKKMDLRKQQRR---------ELLFNEVVIMRDYHHENVVDMYNSYLVGDEL- 94
Query: 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS 190
VV+E+L GGAL + R + + + + L + R LSYLH+
Sbjct: 95 ---------------WVVMEFLEGGALTDIVTHTRMNE---EQIATVCLSVLRALSYLHN 136
Query: 191 QKIVHRDVKTENMLLDKNRTVKIADFG-VARVEASNPNDMTGETGTLGYMAPEVLNGNPY 249
Q ++HRD+K++++LL + +K++DFG A+V P + GT +MAPEV++ PY
Sbjct: 137 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS-LVGTPYWMAPEVISRLPY 195
Query: 250 NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 294
+ D++S GI + E+ + PY F+E +R+ +R +P
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPY----FNEPPLQAMRR-IRDNLP 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 6e-19
Identities = 68/256 (26%), Positives = 112/256 (43%), Gaps = 51/256 (19%)
Query: 31 IGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTV----HRGLYDGHDVAVKLLDWGEE 86
+ A F K W++ S + + G+FG V H+G G A+K L
Sbjct: 1 MKAAYMFTKPDTSSWKL--SDFEMGETLGTGSFGRVRIAKHKG--TGEYYAIKCL----- 51
Query: 87 GHRTEAEIAALRSA--FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNI 144
+ EI ++ QE ++ +L HP + + + + ++
Sbjct: 52 ---KKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF------------- 95
Query: 145 CCVVVEYLPGGALKTYLIK-----NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
++E++ GG L T+L K N K +V LA + YLHS+ I++RD+K
Sbjct: 96 ---LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV-LAFE------YLHSKDIIYRDLK 145
Query: 200 TENMLLDKNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258
EN+LLD VK+ DFG A +V P+ GT Y+APEV+ + + D ++
Sbjct: 146 PENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTM 201
Query: 259 GICLWEIYCCDMPYPD 274
G+ L+E P+ D
Sbjct: 202 GVLLYEFIAGYPPFFD 217
|
Length = 329 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 70/226 (30%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 61 GTFGTVHRGLY--DGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
GTFG V++ G VA+K L+ ++G I ALR E+ + KL HPNV
Sbjct: 19 GTFGEVYKARQIKTGRVVALKKILMHNEKDG----FPITALR-----EIKILKKLKHPNV 69
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY----LPGGALKTYLIKNRRRKLAFK 172
I + + + + G V M V Y L G L++N KL
Sbjct: 70 VPLIDMAVERPDKS-KRKRGSVYM-------VTPYMDHDLSG------LLENPSVKLTES 115
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV-EASNPNDMTG 231
+ L L G++YLH I+HRD+K N+L+D +KIADFG+AR + PN G
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 232 ETG----------TLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIY 266
G T Y PE+L G Y D++ G E++
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-19
Identities = 72/249 (28%), Positives = 113/249 (45%), Gaps = 45/249 (18%)
Query: 56 SVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV----AVWH 109
+ GTFG VH R H A+K++ E+ L+ Q V V
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAI--------PEVIRLKQ--EQHVHNEKRVLK 56
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
++ HP + + L++ ++EY+PGG L +YL +N R
Sbjct: 57 EVSHPFIIRLFWTEHDQRFLYM----------------LMEYVPGGELFSYL-RNSGR-- 97
Query: 170 AFKVVVQL--ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
F L A ++ L YLHS++IV+RD+K EN+LLDK +K+ DFG A+
Sbjct: 98 -FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK----KLR 152
Query: 228 DMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
D T GT Y+APEV+ +N+ D ++ GI ++E+ P+ D + + ++
Sbjct: 153 DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212
Query: 287 QNLRPEIPR 295
L E PR
Sbjct: 213 GKL--EFPR 219
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-19
Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 15/193 (7%)
Query: 93 EIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC------- 145
E+ A + T ++ KLD + K G M +E I +V+ +
Sbjct: 8 EVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE---KVSSRFIVSLAYAFET 64
Query: 146 ----CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201
C+V+ + GG LK ++ + A + GL +LH ++IV+RD+K E
Sbjct: 65 KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPE 124
Query: 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGIC 261
N+LLD + V+I+D G+A VE + G GT GYMAPEVL G Y+ D ++ G
Sbjct: 125 NVLLDDHGNVRISDLGLA-VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCT 183
Query: 262 LWEIYCCDMPYPD 274
L+E+ P+
Sbjct: 184 LYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 8e-19
Identities = 67/271 (24%), Positives = 126/271 (46%), Gaps = 35/271 (12%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I +G GTV+ + G +VA+K ++ ++ + E+ V + +PN
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---------ELIINEILVMRENKNPN 77
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ ++ + + EL VV+EYL GG+L + + + V
Sbjct: 78 IVNYLDSYLVGDEL----------------WVVMEYLAGGSLTDVVTETCMDEGQIAAVC 121
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
+ L + L +LHS +++HRD+K++N+LL + +VK+ DFG + + GT
Sbjct: 122 RECL---QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA-VVRQNLRPEI- 293
+MAPEV+ Y K D++S GI E+ + PY L+ + + + ++ N PE+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRALYLIATNGTPELQ 236
Query: 294 -PRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
P + + + RC + + D+R E++
Sbjct: 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 69/214 (32%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---D 112
I G +GTV+ R + GH VA+K + R + L + +EVA+ +L D
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-------RVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
HPN+ + + +S +T+ +V E++ L+TYL K L +
Sbjct: 61 HPNIVRLMDVC-ATSRTDRETK----------VTLVFEHVDQD-LRTYLDKVPPPGLPAE 108
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+ L RGL +LH+ IVHRD+K EN+L+ VK+ADFG+AR+ S +T
Sbjct: 109 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPV 167
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
TL Y APEVL + Y D++S G E++
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 70/235 (29%), Positives = 104/235 (44%), Gaps = 44/235 (18%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDW----GEEGHRTEAEI 94
+ WE+ P + S + G +G V G VA+K L RT E+
Sbjct: 7 NKTVWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYREL 65
Query: 95 AALRSAFTQEVAVWHKLDHPNVTKFIGA----TMGSSELHIQTENGQVAMPSNICCVVVE 150
L+ H +DH NV IG T SS Q V + V
Sbjct: 66 RLLK----------H-MDHENV---IGLLDVFTPASSLEDFQ----DVYL--------VT 99
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
+L G L + + +KL+ + L + RGL Y+HS I+HRD+K N+ ++++
Sbjct: 100 HLMGADLNNIV---KCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 156
Query: 211 VKIADFGVARVEASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWE 264
+KI DFG+AR ++MTG T Y APE+ LN YN+ D++S G + E
Sbjct: 157 LKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-18
Identities = 61/193 (31%), Positives = 101/193 (52%), Gaps = 18/193 (9%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLA---FKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
+V+E+ P G LK YL R+ +L + ++A ++A GL +LH +H D+ N
Sbjct: 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNC 131
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETG--TLGYMAPEVLN---GN----PYNRKCD 254
LL + TVKI D+G++ + +T + L ++APE+++ GN ++ +
Sbjct: 132 LLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191
Query: 255 VYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVR-QNLRPEIPRC-CPSS--LANVMKRCW 309
V+S G+ +WE++ PY LS +V + VR Q L+ PR P S VM+ CW
Sbjct: 192 VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW 251
Query: 310 DANPDKRPEMDEV 322
P++RP +EV
Sbjct: 252 -LQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-18
Identities = 67/271 (24%), Positives = 126/271 (46%), Gaps = 35/271 (12%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I +G GTV+ + G +VA++ ++ ++ + E+ V + +PN
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---------ELIINEILVMRENKNPN 78
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ ++ + + EL VV+EYL GG+L + + + V
Sbjct: 79 IVNYLDSYLVGDEL----------------WVVMEYLAGGSLTDVVTETCMDEGQIAAVC 122
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
+ L + L +LHS +++HRD+K++N+LL + +VK+ DFG + + GT
Sbjct: 123 RECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA-VVRQNLRPEI- 293
+MAPEV+ Y K D++S GI E+ + PY L+ + + + ++ N PE+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQ 237
Query: 294 -PRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
P + + + RC D + +KR E++
Sbjct: 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 3e-18
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKL--LDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I GT+GTV + VA+K LD +EG + +ALR E+ + +L H
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS----SALR-----EICLLKELKH 58
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
N+ + +L + V EY LK Y + + ++
Sbjct: 59 KNIVRLYDVLHSDKKLTL----------------VFEYCDQD-LKKYF-DSCNGDIDPEI 100
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
V L +GL++ HS ++HRD+K +N+L++KN +K+ADFG+AR + E
Sbjct: 101 VKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV 160
Query: 234 GTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
TL Y P+VL G Y+ D++S G E+
Sbjct: 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-18
Identities = 63/250 (25%), Positives = 114/250 (45%), Gaps = 32/250 (12%)
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
++R +E+ + H+ P + F GA EN NIC + +E++ G
Sbjct: 45 SVRKQILRELQIMHECRSPYIVSFYGA--------FLNEN-------NIC-MCMEFMDCG 88
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENMLLDKNRTVKIA 214
+L I + + +++ ++A+ + GL+YL++ +I+HRD+K N+L++ +K+
Sbjct: 89 SLDR--IYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLC 146
Query: 215 DFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY-- 272
DFGV+ E N T GT YM+PE + G Y K DV+S GI + E+ P+
Sbjct: 147 DFGVSG-ELINSIADTF-VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204
Query: 273 -PDLSFSEVTSAVVRQNLR-------PEIPRCC-PSSLANVMKRCWDANPDKRPEMDEVV 323
+ + L+ P +P P L + + C +P +RP ++
Sbjct: 205 SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264
Query: 324 SMLEAIDTSK 333
+M I +
Sbjct: 265 AMPPFIQALR 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-18
Identities = 74/279 (26%), Positives = 121/279 (43%), Gaps = 45/279 (16%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKL--LDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I GT+G V+ R + G A+K+ L+ GE+ + EI ++ H
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-----------KH 65
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK-TYLIKNRRRKLAFK 172
N+ + G+ + +L I +E+ GG+L+ Y + +
Sbjct: 66 SNIVAYFGSYLRRDKLWIC----------------MEFCGGGSLQDIYHVTGPLSESQIA 109
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
V + L +GL YLHS+ +HRD+K N+LL N VK+ADFGV+ +
Sbjct: 110 YVSRETL---QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166
Query: 233 TGTLGYMAPEVL---NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 289
GT +MAPEV YN+ CD+++ GI E+ P DL + + N
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226
Query: 290 RPEIPRC-----CPSSLANVMKRCWDANPDKRPEMDEVV 323
+P P+ +S + +K NP KRP ++++
Sbjct: 227 QP--PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 4e-18
Identities = 68/271 (25%), Positives = 125/271 (46%), Gaps = 35/271 (12%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I +G GTV + G +VA+K ++ ++ + E+ V +L +PN
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---------ELIINEILVMKELKNPN 77
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ F+ + + EL VV+EYL GG+L + + + V
Sbjct: 78 IVNFLDSFLVGDELF----------------VVMEYLAGGSLTDVVTETCMDEAQIAAVC 121
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
+ L + L +LH+ +++HRD+K++N+LL + +VK+ DFG + + GT
Sbjct: 122 RECL---QALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA-VVRQNLRPEI- 293
+MAPEV+ Y K D++S GI E+ + PY L+ + + + ++ N PE+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRALYLIATNGTPELQ 236
Query: 294 -PRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
P + + RC + + +KR E++
Sbjct: 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-18
Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 31/212 (14%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I GT+G V+ R G VA+K L+ EEG ALR E+++ L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG----IPPTALR-----EISLLQMLSE 59
Query: 114 -PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---RKL 169
+ + + H++ +NG+ ++ +V EYL LK ++ N R R L
Sbjct: 60 SIYIVRLLDVE------HVEEKNGKPSL-----YLVFEYLDSD-LKKFMDSNGRGPGRPL 107
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV-KIADFGVARVEASNPND 228
K + L +G+++ H ++HRD+K +N+L+DK + + KIAD G+ R +
Sbjct: 108 PAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 229 MTGETGTLGYMAPEVLNGNP-YNRKCDVYSFG 259
T E TL Y APEVL G+ Y+ D++S G
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVG 199
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 5e-18
Identities = 54/180 (30%), Positives = 97/180 (53%), Gaps = 23/180 (12%)
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
A+R+ +E+ V H+ + P + F GA E+ +IC +E++ GG
Sbjct: 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI-------------SIC---MEHMDGG 88
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIA 214
+L L + +R + +++ ++++ + RGL+YL + +I+HRDVK N+L++ +K+
Sbjct: 89 SLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLC 146
Query: 215 DFGVA-RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
DFGV+ ++ S N G T YM+PE L G Y+ + D++S G+ L E+ P P
Sbjct: 147 DFGVSGQLIDSMANSFVG---TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-18
Identities = 42/120 (35%), Positives = 66/120 (55%), Gaps = 1/120 (0%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C+V+ + GG LK ++ + V A ++ GL LH ++IV+RD+K EN+LL
Sbjct: 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL 135
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
D ++I+D G+A VE + G GT+GYMAPEV+ Y D + G ++E+
Sbjct: 136 DDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 6e-18
Identities = 70/257 (27%), Positives = 118/257 (45%), Gaps = 39/257 (15%)
Query: 73 GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQ 132
G VAVK +D ++ R EV + H NV + + + EL
Sbjct: 45 GKLVAVKKMDLRKQQRR---------ELLFNEVVIMRDYQHENVVEMYNSYLVGDEL--- 92
Query: 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK 192
VV+E+L GGAL + R + + + + L + + LS LH+Q
Sbjct: 93 -------------WVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLKALSVLHAQG 136
Query: 193 IVHRDVKTENMLLDKNRTVKIADFG-VARVEASNPNDMTGETGTLGYMAPEVLNGNPYNR 251
++HRD+K++++LL + VK++DFG A+V P + GT +MAPE+++ PY
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS-LVGTPYWMAPELISRLPYGP 195
Query: 252 KCDVYSFGICLWEIYCCDMPY---PDLSFSEVTSAVVRQNLRPEIPRC--CPSSLANVMK 306
+ D++S GI + E+ + PY P L ++R NL P++ SL +
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRDNLPPKLKNLHKVSPSLKGFLD 251
Query: 307 RCWDANPDKRPEMDEVV 323
R +P +R E++
Sbjct: 252 RLLVRDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-18
Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 71/296 (23%)
Query: 60 RGTFGTVHRGLY----------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
+GTF +++G+ G +V+V L G + + A F + ++
Sbjct: 5 QGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA--------FFETASLMS 56
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR-K 168
+L H ++ K G + NI +V EY+ G L +L + +
Sbjct: 57 QLSHKHLVKLYGVCVR---------------DENI--MVEEYVKFGPLDVFLHREKNNVS 99
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT-------VKIADFGVA-- 219
L +K+ V A LA L YL +K+VH +V +N+L+ + +K++D G+
Sbjct: 100 LHWKLDV--AKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157
Query: 220 ------RVEASNPNDMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYC-CDM 270
RVE P ++APE + D +SFG L EI +
Sbjct: 158 VLSREERVERI-P-----------WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205
Query: 271 PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
P LS SE Q+ P +P C LAN++ +CW +P KRP ++ L
Sbjct: 206 PLSTLSSSEKERFYQDQHRLP-MPDCAE--LANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 38/272 (13%)
Query: 58 IARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
+ +G +G+V++ L+ V + + + R E + + E+ + HK P +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-----RLELDESKFNQ-IIMELDILHKAVSPYIV 62
Query: 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL-KTYLIKNRRRKLAFKVVVQ 176
F GA G V M C+ EY+ G+L K Y + V+ +
Sbjct: 63 DFYGAF---------FIEGAVYM-----CM--EYMDAGSLDKLYAGGVATEGIPEDVLRR 106
Query: 177 LALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVA-RVEASNPNDMTGETG 234
+ + +GL +L + I+HRDVK N+L++ N VK+ DFGV+ + AS G
Sbjct: 107 ITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT---NIG 163
Query: 235 TLGYMAPE-VLNGNP-----YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV---TSAVV 285
YMAPE + +G P Y + DV+S G+ + E+ PYP +++ + SA+V
Sbjct: 164 CQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV 223
Query: 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
+ P +P + + +C + P++RP
Sbjct: 224 DGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 68/228 (29%), Positives = 114/228 (50%), Gaps = 35/228 (15%)
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH- 113
V+ GT+G V++G + G A+K++D E+ E EI E+ + K H
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED---EEEEI-------KLEINMLKKYSHH 72
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFK 172
N+ + GA + S + Q+ + V+E+ G++ T L+KN + L
Sbjct: 73 RNIATYYGAFIKKSP---PGHDDQLWL-------VMEFCGAGSV-TDLVKNTKGNALKED 121
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+ + ++ RGL++LH+ K++HRD+K +N+LL +N VK+ DFGV+
Sbjct: 122 WIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 181
Query: 233 TGTLGYMAPEVL--NGNP---YNRKCDVYSFGICLWEIY-----CCDM 270
GT +MAPEV+ + NP Y+ + D++S GI E+ CDM
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 68/244 (27%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 57 VIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTE-AEIAALRSAFTQEVAVWHKLDH 113
VI +G+FG V + DG AVK+L + E I A R+ + + H
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK------H 55
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P + + + +L+ V++Y+ GG L +L R R
Sbjct: 56 PFLVGLHYSFQTAEKLYF----------------VLDYVNGGELFFHL--QRERCFLEPR 97
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE- 232
A ++A + YLHS I++RD+K EN+LLD V + DFG+ + E P + T
Sbjct: 98 ARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTF 156
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 292
GT Y+APEVL PY+R D + G L+E+ P+ S++ ++ + L +
Sbjct: 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL--Q 214
Query: 293 IPRC 296
+P
Sbjct: 215 LPGG 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 53/204 (25%)
Query: 149 VEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
+E P G L ++R RK F+++ RG+ + HS I+HRD+K EN+L+ ++
Sbjct: 90 LEKYPNG-----LDESRVRKYLFQIL--------RGIEFCHSHNIIHRDIKPENILVSQS 136
Query: 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLW---- 263
VK+ DFG AR A+ T T Y APE+L G+ Y R D+++ G CL
Sbjct: 137 GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVG-CLVTEML 195
Query: 264 ------------------------------EIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293
EI+ + + + EV + L
Sbjct: 196 TGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI---EPLEKRF 252
Query: 294 PRCCPSSLANVMKRCWDANPDKRP 317
P+ L ++ K+C +PD RP
Sbjct: 253 PKLSGLVL-DLAKQCLRIDPDDRP 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 41/224 (18%)
Query: 58 IARGTFGTVHRGL--YDGHDVA---VKLLDWGEEGHRTEAEIAALRSAFT--QEVAVWHK 110
+ GT+G V + G VA VK+++ + + + FT +E+ + ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ H N+ MG +++++ + +V++ + K + +R+ +L
Sbjct: 77 IKHENI-------MGLVDVYVEGD---------FINLVMDIMASDLKK---VVDRKIRLT 117
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP---- 226
V + L + GL+ LH +HRD+ N+ ++ KIADFG+AR P
Sbjct: 118 ESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 227 ----------NDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFG 259
+MT + TL Y APE+L G Y+ D++S G
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221
|
Length = 335 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 54/180 (30%), Positives = 96/180 (53%), Gaps = 23/180 (12%)
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
A+R+ +E+ V H+ + P + F GA E+ +IC +E++ GG
Sbjct: 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI-------------SIC---MEHMDGG 88
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIA 214
+L L K ++ +++ ++++ + +GL+YL + KI+HRDVK N+L++ +K+
Sbjct: 89 SLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 146
Query: 215 DFGVA-RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
DFGV+ ++ S N G T YM+PE L G Y+ + D++S G+ L E+ P P
Sbjct: 147 DFGVSGQLIDSMANSFVG---TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 57/179 (31%), Positives = 93/179 (51%), Gaps = 22/179 (12%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFK---VVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
+++++L GG L T L K ++ F V LA +LA L +LHS I++RD+K EN+
Sbjct: 75 LILDFLRGGDLFTRLSK----EVMFTEEDVKFYLA-ELALALDHLHSLGIIYRDLKPENI 129
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
LLD+ +K+ DFG+++ + GT+ YMAPEV+N + + D +SFG+ ++
Sbjct: 130 LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMF 189
Query: 264 EIYCCDMPYPDLSFSEVTSAVVR------QNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
E+ +P+ E + +++ Q L PE S L + KR NP R
Sbjct: 190 EMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPE----AQSLLRALFKR----NPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 38/79 (48%), Positives = 51/79 (64%), Gaps = 2/79 (2%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAP 241
RGL YLHS I+HRD+K N+L++ N +KI DFG+ARVE + + MT E T Y AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 242 EVLNGNP-YNRKCDVYSFG 259
E+L G+ Y D++S G
Sbjct: 174 EILMGSRHYTSAVDIWSVG 192
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-17
Identities = 67/228 (29%), Positives = 112/228 (49%), Gaps = 35/228 (15%)
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLD-WGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
++ GT+G V++G + G A+K++D G+E + EI L+ H
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS----------HH 62
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFK 172
N+ + GA + + + + +V+E+ G++ T LIKN + L +
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQ----------LWLVMEFCGAGSV-TDLIKNTKGNTLKEE 111
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+ + ++ RGLS+LH K++HRD+K +N+LL +N VK+ DFGV+
Sbjct: 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 171
Query: 233 TGTLGYMAPEVL--NGNP---YNRKCDVYSFGICLWEIY-----CCDM 270
GT +MAPEV+ + NP Y+ K D++S GI E+ CDM
Sbjct: 172 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 54/151 (35%), Positives = 79/151 (52%), Gaps = 15/151 (9%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLAL-DLARGLSYLHSQKIVHRDVKTENMLL 205
+V+EY PGG L + L NR + + Q L +L + +H VHRD+K EN+L+
Sbjct: 78 LVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135
Query: 206 DKNRTVKIADFG-VARVEASNPNDMTGETGTLGYMAPEVL---NGNP---YNRKCDVYSF 258
D+ +K+ADFG AR+ A+ + GT Y+APEVL NG+ Y +CD +S
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195
Query: 259 GICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 289
G+ +E+ P F E TSA N+
Sbjct: 196 GVIAYEMIYGRSP-----FHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 48/163 (29%), Positives = 84/163 (51%), Gaps = 15/163 (9%)
Query: 173 VVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM-- 229
++ ++A+ + + L YLHS+ ++HRDVK N+L+++N VK+ DFG++ + +
Sbjct: 104 ILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS---GYLVDSVAK 160
Query: 230 TGETGTLGYMAPEVLN--GNP--YNRKCDVYSFGICLWEIYCCDMPYPDLS--FSEVTSA 283
T + G YMAPE +N N Y+ K DV+S GI + E+ PY F ++
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV 220
Query: 284 VVRQNLRPEIPRCCPS-SLANVMKRCWDANPDKRPEMDEVVSM 325
V + P++P S + + +C N +RP E++
Sbjct: 221 V--EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 3e-17
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 53/225 (23%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVK--------LLDWGEEGHRTEAEIAALRSAFTQ 103
+ I G +G V + G VA+K L+D R EI LR
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLID----AKRILREIKLLRH---- 55
Query: 104 EVAVWHKLDHPNVTKFI-----GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
L H N+ + + ++++I TE M +++
Sbjct: 56 -------LRHENIIGLLDILRPPSPEDFNDVYIVTE----LMETDLH------------- 91
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
+IK+ + L + + RGL YLHS ++HRD+K N+L++ N +KI DFG+
Sbjct: 92 -KVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL 149
Query: 219 ARV---EASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFG 259
AR + +T T Y APE+ L+ + Y + D++S G
Sbjct: 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG 194
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 52/141 (36%), Positives = 75/141 (53%), Gaps = 16/141 (11%)
Query: 147 VVVEYLPGGALKT----YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202
+V+EY+PGG L Y I + + VV LALD +HS +HRDVK +N
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVV-LALDA------IHSMGFIHRDVKPDN 172
Query: 203 MLLDKNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVLNG----NPYNRKCDVYS 257
MLLDK+ +K+ADFG +++A+ GT Y++PEVL Y R+CD +S
Sbjct: 173 MLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 258 FGICLWEIYCCDMPYPDLSFS 278
G+ L+E+ D P+ S
Sbjct: 233 VGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-17
Identities = 50/169 (29%), Positives = 86/169 (50%), Gaps = 4/169 (2%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EY+ GG L + + R K V A ++A GL +LHS+ I++RD+K +N++LD
Sbjct: 79 VMEYVNGGDLMYQIQQVGRFKEPHAVF--YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+KIADFG+ + + GT Y+APE++ PY + D ++FG+ L+E+
Sbjct: 137 EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
Query: 268 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
P+ E+ +++ N+ P+ + K +P KR
Sbjct: 197 GQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-17
Identities = 60/242 (24%), Positives = 109/242 (45%), Gaps = 33/242 (13%)
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
F Q+ + L HPN+ + +G + A+P +V EY G LK+Y
Sbjct: 42 FLQQGDPYRILQHPNILQCLGQCVE-------------AIPY---LLVFEYCELGDLKSY 85
Query: 161 LIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
L + RR ++ ++A ++A G++++H +H D+ N L + TVK+ D+G+
Sbjct: 86 LSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
Query: 219 ARVEASNPNDMTGET--GTLGYMAPEV-------LNGNPYNRKCDVYSFGICLWEIY-CC 268
T + L ++APE+ L + +V++ G+ LWE++
Sbjct: 146 GPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205
Query: 269 DMPYPDLSFSEVTSAVVRQN----LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
PY LS EV + V++ +P++ V++ CW +P+KR +EV
Sbjct: 206 AQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264
Query: 325 ML 326
+L
Sbjct: 265 LL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 70/256 (27%), Positives = 114/256 (44%), Gaps = 29/256 (11%)
Query: 57 VIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAE-IAALRSAFTQEVAVWHKLDH 113
VI +G+FG V + DG AVK+L +R E + I A R+ + V H
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV------KH 55
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P + + + +L+ V++++ GG L +L R R
Sbjct: 56 PFLVGLHYSFQTTEKLYF----------------VLDFVNGGELFFHL--QRERSFPEPR 97
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
A ++A L YLHS IV+RD+K EN+LLD V + DFG+ + + + T
Sbjct: 98 ARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ--NLRP 291
GT Y+APEV+ PY+ D + G L+E+ P+ +E+ ++ + LRP
Sbjct: 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRP 217
Query: 292 EIPRCCPSSLANVMKR 307
S L ++++
Sbjct: 218 GASLTAWSILEELLEK 233
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 5e-17
Identities = 34/89 (38%), Positives = 55/89 (61%)
Query: 184 GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEV 243
GL +LH ++I++RD+K EN+LLD + V+I+D G+A + G GT G+MAPE+
Sbjct: 109 GLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL 168
Query: 244 LNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
L G Y+ D ++ G+ L+E+ P+
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 50/183 (27%), Positives = 91/183 (49%), Gaps = 23/183 (12%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+E++ GG L ++ R+RKL + + +++ L++LH + I++RD+K +N+LLD
Sbjct: 74 VIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131
Query: 208 NRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+K+ D+G+ + E P D T GT Y+APE+L G Y D ++ G+ ++E+
Sbjct: 132 EGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 267 CCDMPY-------------PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANP 313
P+ D F + +R IPR ++V+K + +P
Sbjct: 191 AGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------IPRSLSVKASSVLKGFLNKDP 244
Query: 314 DKR 316
+R
Sbjct: 245 KER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 7e-17
Identities = 42/126 (33%), Positives = 60/126 (47%), Gaps = 21/126 (16%)
Query: 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTE 201
EY+PGG +T L L+ D AR + LH +HRD+K E
Sbjct: 81 EYVPGGDFRTLLNNLG----------VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPE 130
Query: 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGIC 261
N L+D + +K+ DFG+++ + N + G YMAPEVL G Y+ D +S G
Sbjct: 131 NFLIDASGHIKLTDFGLSKGIVTYANSVVGSP---DYMAPEVLRGKGYDFTVDYWSLGCM 187
Query: 262 LWEIYC 267
L+E C
Sbjct: 188 LYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 8e-17
Identities = 35/89 (39%), Positives = 53/89 (59%), Gaps = 5/89 (5%)
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND----MTGETGTL 236
L RGL Y+HS ++HRD+K N+L++++ ++I DFG+AR +S+P + MT T
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 237 GYMAPEVLNGNP-YNRKCDVYSFGICLWE 264
Y APE+L P Y D++S G E
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAE 204
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 8e-17
Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 41/275 (14%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I G+FG V+ R + VA+K + + G++ + +I +EV +L HP
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-------IKEVRFLQQLRHP 75
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N ++ G + +V+EY G A + +++ ++ L +
Sbjct: 76 NTIEYKGCYLREH----------------TAWLVMEYCLGSA--SDILEVHKKPLQEVEI 117
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ +GL+YLHS + +HRD+K N+LL + TVK+ADFG A + S N G
Sbjct: 118 AAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL-VSPANSF---VG 173
Query: 235 TLGYMAPEV---LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV--VRQNL 289
T +MAPEV ++ Y+ K DV+S GI E+ P +++ SA+ + QN
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQND 230
Query: 290 RPEIPRCCPS-SLANVMKRCWDANPDKRPEMDEVV 323
P + S N + C P RP +E++
Sbjct: 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-17
Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 6/163 (3%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V++Y+ GG L +L R R A ++A L YLHS IV+RD+K EN+LLD
Sbjct: 74 VLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS 131
Query: 208 NRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+ + DFG+ + E N T GT Y+APEVL+ PY+R D + G L+E+
Sbjct: 132 QGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
Query: 267 CCDMPYPDLSFSEVTSAVVRQ--NLRPEIPRCCPSSLANVMKR 307
P+ + +E+ ++ + L+P I L ++++
Sbjct: 191 YGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK 233
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 9e-17
Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 92 AEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI-QTENGQVAM-------PSN 143
E+ A + T ++ +L+ + K G +M +E I + N Q + +
Sbjct: 14 GEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD 73
Query: 144 ICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
C+V+ + GG LK ++ + + A ++ GL LH + V+RD+K EN+
Sbjct: 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENI 133
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
LLD ++I+D G+A V+ + G GT+GYMAPEVLN Y D + G ++
Sbjct: 134 LLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIY 192
Query: 264 EIYCCDMPY 272
E+ P+
Sbjct: 193 EMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 42/218 (19%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHP 114
I GTF V + G A+K + ++ ++ ++ LR E+ +L HP
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM---KKHFKSLEQVNNLR-----EIQALRRLSPHP 58
Query: 115 NVTKFIGATMGSSELHIQTENGQVA-----MPSNICCVVVEYLPGGALKTY-LIKNRRRK 168
N+ + I E+ + G++A M N+ Y LIK R+R
Sbjct: 59 NILRLI-------EVLFDRKTGRLALVFELMDMNL---------------YELIKGRKRP 96
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228
L K V L + L ++H I HRD+K EN+L+ + +K+ADFG R S P
Sbjct: 97 LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP-P 154
Query: 229 MTGETGTLGYMAPE-VLNGNPYNRKCDVYSFGICLWEI 265
T T Y APE +L Y K D+++ G +EI
Sbjct: 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEI 192
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 47/177 (26%), Positives = 93/177 (52%), Gaps = 11/177 (6%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
++++Y+ GG L T+L + + +V V +A ++ L +LH I++RD+K EN+LLD
Sbjct: 82 LILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLHQLGIIYRDIKLENILLD 139
Query: 207 KNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNP--YNRKCDVYSFGICLW 263
V + DFG+++ + + GT+ YMAPEV+ G +++ D +S G+ +
Sbjct: 140 SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199
Query: 264 EIYCCDMPYP----DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
E+ P+ S SE++ +++ P P+ + + +++ + +P KR
Sbjct: 200 ELLTGASPFTVDGEQNSQSEISRRILKSK--PPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 72/257 (28%), Positives = 112/257 (43%), Gaps = 31/257 (12%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAE-IAALRSAFTQEVAVWHKLDH 113
VI +G+FG V + DG AVK+L + E + I A R+ + V H
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK------H 55
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P + LH + V++Y+ GG L +L R R
Sbjct: 56 PFLVG----------LHYSFQTADKLY------FVLDYVNGGELFFHL--QRERSFPEPR 97
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE- 232
A ++A L YLHS I++RD+K EN+LLD V + DFG+ + E + T
Sbjct: 98 ARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTF 156
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ--NLR 290
GT Y+APEVL PY+R D + G L+E+ P+ +E+ ++ + L+
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK 216
Query: 291 PEIPRCCPSSLANVMKR 307
P I L ++++
Sbjct: 217 PNISVSARHLLEGLLQK 233
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 9/189 (4%)
Query: 92 AEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI-QTENGQVAMP-------SN 143
E+ A + T ++ KL+ + K G +M +E I + N + + +
Sbjct: 14 GEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD 73
Query: 144 ICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
C+V+ + GG LK ++ V A ++ GL LH ++IV+RD+K EN+
Sbjct: 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
LLD + ++I+D G+A V + G GT+GYMAPEV+ Y D ++ G L+
Sbjct: 134 LLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLY 192
Query: 264 EIYCCDMPY 272
E+ P+
Sbjct: 193 EMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 37/86 (43%), Positives = 51/86 (59%), Gaps = 1/86 (1%)
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
L RGL Y+HS ++HRD+K N+LL+ N +KI DFG+AR + + MT T Y A
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRA 176
Query: 241 PEV-LNGNPYNRKCDVYSFGICLWEI 265
PE+ LN + Y DV+S G E+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 71/231 (30%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 53 VIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V+K VI RG FG V R A+KLL E R+++ F +E +
Sbjct: 47 VVK-VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF------FWEERDIMAF 99
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL----KTYLIKNRR 166
+ P V + A L++ V+EY+PGG L Y + +
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYM----------------VMEYMPGGDLVNLMSNYDVPEKW 143
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-RVEASN 225
K + V LALD +HS ++HRDVK +NMLLDK+ +K+ADFG +++ +
Sbjct: 144 AKF-YTAEVVLALDA------IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196
Query: 226 PNDMTGETGTLGYMAPEVLNGNP----YNRKCDVYSFGICLWEIYCCDMPY 272
GT Y++PEVL Y R+CD +S G+ L+E+ D P+
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 48/171 (28%), Positives = 89/171 (52%), Gaps = 8/171 (4%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EY+ GG L ++ + K V A +++ GL +LH + I++RD+K +N++LD
Sbjct: 79 VMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136
Query: 208 NRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+KIADFG+ + + +T T GT Y+APE++ PY + D +++G+ L+E+
Sbjct: 137 EGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 194
Query: 266 YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
P+ E+ +++ N+ P+ ++ K +P KR
Sbjct: 195 LAGQPPFDGEDEDELFQSIMEHNV--SYPKSLSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 74/256 (28%), Positives = 110/256 (42%), Gaps = 50/256 (19%)
Query: 36 NFLKKQR------QDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEG 87
NFL + + +D ++ + VI RG FG V R A+KLL E
Sbjct: 23 NFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 82
Query: 88 HRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
R+++ F +E + + P V + A L++
Sbjct: 83 KRSDSAF------FWEERDIMAFANSPWVVQLFYAFQDDRYLYM---------------- 120
Query: 148 VVEYLPGGAL----KTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
V+EY+PGG L Y + + + + V LALD +HS +HRDVK +NM
Sbjct: 121 VMEYMPGGDLVNLMSNYDVPEKWARF-YTAEVVLALD------AIHSMGFIHRDVKPDNM 173
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMT---GETGTLGYMAPEVLNGNP----YNRKCDVY 256
LLDK+ +K+ADFG N M GT Y++PEVL Y R+CD +
Sbjct: 174 LLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 257 SFGICLWEIYCCDMPY 272
S G+ L+E+ D P+
Sbjct: 232 SVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 29/211 (13%)
Query: 58 IARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
+ GT+ TV +G + V L + E H A A+R EV++ L H N+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLE-HEEGAPCTAIR-----EVSLLKNLKHANIV 66
Query: 118 KFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
LH I TE +V EYL LK YL N ++ V
Sbjct: 67 T----------LHDIIHTERC--------LTLVFEYLDSD-LKQYL-DNCGNLMSMHNVK 106
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
L RGLSY H +KI+HRD+K +N+L+++ +K+ADFG+AR ++ + E T
Sbjct: 107 IFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVT 166
Query: 236 LGYMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
L Y P+VL G+ Y+ D++ G L+E+
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEM 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 9e-16
Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 42/283 (14%)
Query: 58 IARGTFGTVHRGLYD--GHDVAVK---LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
I RG FGTV++ L+ G +AVK +E R ++ + + D
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS----------SD 61
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI--KNRRRKLA 170
P + KF GA + C + +E + K Y + + +
Sbjct: 62 CPYIVKFYGALFREGD----------------CWICMELMDISLDKFYKYVYEVLKSVIP 105
Query: 171 FKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM 229
+++ ++A+ + L+YL + KI+HRDVK N+LLD+N +K+ DFG++ + +
Sbjct: 106 EEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG-QLVDSIAK 164
Query: 230 TGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPDL-SFSEVTSAVV 285
T + G YMAPE ++ + Y+ + DV+S GI L+E+ PYP S + + VV
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224
Query: 286 RQN---LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
+ + L R S N + C + KRP+ E++
Sbjct: 225 KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 31/225 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRT-EAEIAALRSAF 101
WE+ P + + G +G+V + G VA+K L R ++EI A R A+
Sbjct: 11 WEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL------SRPFQSEIFAKR-AY 62
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+E+ + + H NV + + + ++ + MP ++T L
Sbjct: 63 -RELTLLKHMQHENVIGLLDVFTSAVSGD-EFQDFYLVMPY--------------MQTDL 106
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
K L+ V L + GL Y+HS I+HRD+K N+ ++++ +KI DFG+AR
Sbjct: 107 QKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR- 165
Query: 222 EASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEI 265
+MTG T Y APEV LN YN+ D++S G + E+
Sbjct: 166 --HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 45/179 (25%), Positives = 75/179 (41%), Gaps = 49/179 (27%)
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-----VEASNPNDMTGETGT 235
L + L Y+HS ++HRD+K N+LL+ + VK+ADFG+AR E +T T
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC---------------------------C 268
Y APE+L G+ Y+ G+ +W + C
Sbjct: 176 RWYRAPEILLGSTR------YTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229
Query: 269 DMPYP-DLS--FSEVTSAVV-------RQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
P D+ S + ++ R+ L +P+ +L +++K+ NP+KR
Sbjct: 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDAL-DLLKKLLVFNPNKRL 287
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 73/301 (24%), Positives = 118/301 (39%), Gaps = 68/301 (22%)
Query: 54 IKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTE-AEIAALRSAFTQEVAVWH 109
I +I +G G V+ YD VA+K + R + +E L+ F +E +
Sbjct: 6 IIRLIGKGGMGEVYLA-YDPVCSRRVALKKI-------REDLSENPLLKKRFLREAKIAA 57
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQV--AMPSNICCVVVEYLPGGALKTYLIKNRRR 167
L HP + I ++ V MP Y+ G LK+ L+K+ +
Sbjct: 58 DLIHPGIVPVYS---------ICSDGDPVYYTMP---------YIEGYTLKS-LLKSVWQ 98
Query: 168 K------LAFKVVVQLALDL----ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
K LA K V L + + Y+HS+ ++HRD+K +N+LL V I D+G
Sbjct: 99 KESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158
Query: 218 VAR-----------VEASNPNDMTGE-------TGTLGYMAPEVLNGNPYNRKCDVYSFG 259
A ++ N GT YMAPE L G P + D+Y+ G
Sbjct: 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALG 218
Query: 260 ICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP----RCCPSSLANVMKRCWDANPDK 315
+ L+++ PY ++ R + I R P L+ + + +P +
Sbjct: 219 VILYQMLTLSFPYRRKKGRKI---SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAE 275
Query: 316 R 316
R
Sbjct: 276 R 276
|
Length = 932 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 4/90 (4%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV---EASNPNDMTGETGTLGYM 239
RGL Y+HS ++HRD+K N+LL+ N +KI DFG+AR+ E + +T T Y
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 240 APEV-LNGNPYNRKCDVYSFGICLWEIYCC 268
APE+ LN Y + D++S G L E+
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 76/275 (27%), Positives = 124/275 (45%), Gaps = 41/275 (14%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I G+FG V+ R + VA+K + + G++ + +I +EV ++ HP
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-------IKEVKFLQRIKHP 85
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N ++ G + + +V+EY G A + L++ ++ L +
Sbjct: 86 NSIEYKGCYL----------------REHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEI 127
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ +GL+YLHS ++HRD+K N+LL + VK+ADFG A + AS N G
Sbjct: 128 AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASI-ASPANSF---VG 183
Query: 235 TLGYMAPEV---LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV--VRQNL 289
T +MAPEV ++ Y+ K DV+S GI E+ P L SA+ + QN
Sbjct: 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL---AERKPPLFNMNAMSALYHIAQNE 240
Query: 290 RPEIPRCCPSS-LANVMKRCWDANPDKRPEMDEVV 323
P + S N + C P RP +E++
Sbjct: 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 42/127 (33%), Positives = 68/127 (53%), Gaps = 1/127 (0%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C+V+ + GG LK ++ + + A +L GL L ++IV+RD+K EN+LL
Sbjct: 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL 135
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
D ++I+D G+A V+ + G GT+GYMAPEV+N Y D + G ++E+
Sbjct: 136 DDRGHIRISDLGLA-VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEM 194
Query: 266 YCCDMPY 272
P+
Sbjct: 195 IQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 35/84 (41%), Positives = 52/84 (61%), Gaps = 4/84 (4%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPE 242
RGL Y+HS +VHRD+K N+L+++N +KI DFG+AR++ MTG T Y APE
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MTGYVSTRYYRAPE 175
Query: 243 V-LNGNPYNRKCDVYSFGICLWEI 265
+ L Y+ + D++S G E+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 38/218 (17%)
Query: 58 IARGTFGTVHRG----LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I RGT+G V++ DG + A+K G++ T +A R E+A+ +L H
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGISQSACR-----EIALLRELKH 61
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY----LPGGALKTYLIKNRRRKL 169
NV + E+ ++ + V + + +Y L + + + +R +
Sbjct: 62 ENVVSLV-------EVFLEHADKSVYL-------LFDYAEHDL--WQIIKFHRQAKRVSI 105
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEASN 225
+V L + G+ YLHS ++HRD+K N+L+ + VKI D G+AR+ +
Sbjct: 106 PPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 226 PNDMTGETG---TLGYMAPEVLNG-NPYNRKCDVYSFG 259
+ T+ Y APE+L G Y + D+++ G
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 20/175 (11%)
Query: 95 AALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG 154
A R E + ++HP++ + G + C++ LP
Sbjct: 124 AGQRGGTATEAHILRAINHPSIIQLKGTFTYNK----------------FTCLI---LPR 164
Query: 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
Y +R +A ++ + + R + YLH +I+HRD+K EN+ ++ V +
Sbjct: 165 YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLG 224
Query: 215 DFGVARVEAS-NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268
DFG A N N G GT+ APE+L +PY D++S GI L+E+ C
Sbjct: 225 DFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 75/272 (27%), Positives = 119/272 (43%), Gaps = 41/272 (15%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I G+FG V+ R + + VA+K + + G++ + +I +EV KL HP
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-------IKEVRFLQKLRHP 75
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N ++ G + + +V+EY G A + L++ ++ L +
Sbjct: 76 NTIQYRGCYL----------------REHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEI 117
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ +GL+YLHS ++HRDVK N+LL + VK+ DFG A + A G
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVG 173
Query: 235 TLGYMAPEV---LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV--VRQNL 289
T +MAPEV ++ Y+ K DV+S GI E+ P L SA+ + QN
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL---AERKPPLFNMNAMSALYHIAQNE 230
Query: 290 RPEIPRCCPS-SLANVMKRCWDANPDKRPEMD 320
P + S N + C P RP +
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 29/211 (13%)
Query: 58 IARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
+ GT+ TV++G D V L + E H A A+R EV++ L H N+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLE-HEEGAPCTAIR-----EVSLLKDLKHANIV 67
Query: 118 KFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
LH I TE +V EYL LK YL + + V
Sbjct: 68 T----------LHDIIHTEKS--------LTLVFEYLDKD-LKQYL-DDCGNSINMHNVK 107
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
L RGL+Y H +K++HRD+K +N+L+++ +K+ADFG+AR ++ + E T
Sbjct: 108 LFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVT 167
Query: 236 LGYMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
L Y P++L G+ Y+ + D++ G +E+
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 58 IARGTFGTVH--RGLYDGHD-VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-- 112
I G +G V R L +G VA+K + R + + + +EVAV L+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 113 -HPNVTK-FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
HPNV + F T+ ++ + +V E++ L TYL K +
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLT------------LVFEHVDQD-LTTYLDKVPEPGVP 108
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ + + L RGL +LHS ++VHRD+K +N+L+ + +K+ADFG+AR+ S +T
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALT 167
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
TL Y APEVL + Y D++S G E++
Sbjct: 168 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GT+G V++ +A+K + R E E + S +E+++ ++ H N
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-------RLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ + L++ V EYL LK ++ + +++
Sbjct: 63 IVRLQDVVHSEKRLYL----------------VFEYLDLD-LKKHMDSSPDFAKNPRLIK 105
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR-TVKIADFGVARVEASNPNDMTGETG 234
+ RG++Y HS +++HRD+K +N+L+D+ +K+ADFG+AR T E
Sbjct: 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV 165
Query: 235 TLGYMAPEVLNGN-PYNRKCDVYSFG 259
TL Y APE+L G+ Y+ D++S G
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVG 191
|
Length = 294 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 13/185 (7%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKV--VVQLALDLARGLSYLHSQKIVHRDVKTENML 204
+++EY GG L + + + L F+ V L + L +HS+K++HRD+K+ N+
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201
Query: 205 LDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
L +K+ DFG ++ + + + + GT Y+APE+ Y++K D++S G+ L
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 263 WEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWD----ANPDKRPE 318
+E+ P+ S E+ V+ P P +++ MK D NP RP
Sbjct: 262 YELLTLHRPFKGPSQREIMQQVLYGKYDP-----FPCPVSSGMKALLDPLLSKNPALRPT 316
Query: 319 MDEVV 323
+++
Sbjct: 317 TQQLL 321
|
Length = 478 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 35/214 (16%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I G+FG V+ + VAVK + + G++ + +I +EV +L HP
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDI-------IKEVKFLQQLKHP 81
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N ++ G + + +V+EY G A + L++ ++ L +
Sbjct: 82 NTIEYKGCYL----------------KEHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEI 123
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ +GL+YLHS ++HRD+K N+LL + VK+ADFG A +S N G
Sbjct: 124 AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK-SSPANSF---VG 179
Query: 235 TLGYMAPEV---LNGNPYNRKCDVYSFGICLWEI 265
T +MAPEV ++ Y+ K DV+S GI E+
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 49/147 (33%), Positives = 73/147 (49%), Gaps = 14/147 (9%)
Query: 185 LSYL-HSQKIVHRDVKTENMLLDKNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPE 242
L YL ++HRDVK N+LLD + VK+ DFG++ R+ S T G YMAPE
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPE 184
Query: 243 VL---NGNP-YNRKCDVYSFGICLWEIYCCDMPYP--DLSFSEVTSAVVRQNLRPEIPRC 296
+ + NP Y+ + DV+S GI L E+ PY F EV + ++++ P +P
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTKILQEEP-PSLPPN 242
Query: 297 CPSS--LANVMKRCWDANPDKRPEMDE 321
S + + C + KRP+ E
Sbjct: 243 EGFSPDFCSFVDLCLTKDHRKRPKYRE 269
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 47/178 (26%), Positives = 95/178 (53%), Gaps = 13/178 (7%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLAL-DLARGLSYLHSQKIVHRDVKTENMLL 205
++++Y+ GG L T+L + R K + VQ+ ++ L +LH I++RD+K EN+LL
Sbjct: 82 LILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL 138
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNP--YNRKCDVYSFGICL 262
D N V + DFG+++ + + GT+ YMAP+++ G +++ D +S G+ +
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLM 198
Query: 263 WEIYCCDMPYP----DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
+E+ P+ S +E++ +++ P P+ + ++++R +P KR
Sbjct: 199 YELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 40/198 (20%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRD 197
C+V+EY+ GG T L+KN + L +D+AR L YLH+ IVHRD
Sbjct: 77 CMVMEYVEGGDCAT-LLKN---------IGALPVDMARMYFAETVLALEYLHNYGIVHRD 126
Query: 198 VKTENMLLDKNRTVKIADFGVARVEASN------PNDMTGET---------GTLGYMAPE 242
+K +N+L+ +K+ DFG++++ + + +T GT Y+APE
Sbjct: 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 243 VLNGNPYNRKCDVYSFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCP 298
V+ Y + D ++ GI L+E +P+ P+ F +V S + PE P
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI---EWPEGDEALP 243
Query: 299 SSLANVMKRCWDANPDKR 316
+ +++ R NP +R
Sbjct: 244 ADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 41/125 (32%), Positives = 68/125 (54%), Gaps = 2/125 (1%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+E++ GG L ++ K+RR A A ++ L +LH + I++RD+K +N+LLD
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEARARF--YAAEITSALMFLHDKGIIYRDLKLDNVLLDH 131
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
K+ADFG+ + N + GT Y+APE+L Y D ++ G+ L+E+ C
Sbjct: 132 EGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191
Query: 268 CDMPY 272
P+
Sbjct: 192 GHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 66/248 (26%), Positives = 109/248 (43%), Gaps = 23/248 (9%)
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
ALR E+ + +LDH N+ K + +G S TE+ N +V EY+
Sbjct: 49 ALR-----EIKIIRRLDHDNIVK-VYEVLGPSG-SDLTEDVGSLTELNSVYIVQEYMETD 101
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV-KIA 214
L L + L+ + L RGL Y+HS ++HRD+K N+ ++ V KI
Sbjct: 102 -LANVLEQGP---LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157
Query: 215 DFGVARV---EASNPNDMTGETGTLGYMAPE-VLNGNPYNRKCDVYSFGICLWEIYCCDM 270
DFG+AR+ S+ ++ T Y +P +L+ N Y + D+++ G E+
Sbjct: 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
Query: 271 PYP---DLSFSEV---TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD-EVV 323
+ +L ++ + VVR+ R E+ PS + N D P ++ E +
Sbjct: 218 LFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEAL 277
Query: 324 SMLEAIDT 331
LE I T
Sbjct: 278 DFLEQILT 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 36/177 (20%)
Query: 104 EVAVWHKL--DHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKT 159
E V H+L D+PN FI +L+ + T G V ++++Y+ G L
Sbjct: 58 EPMV-HQLMKDNPN---FI-------KLYYSVTTLKGHV--------LIMDYIKDGDLFD 98
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT-VKIADFGV 218
L+K KL+ V ++ L L+ LH I+H D+K EN+L D+ + + + D+G+
Sbjct: 99 -LLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL 156
Query: 219 ARVEASNPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
++ + + GTL Y +PE + G+ Y+ D ++ G+ +E+ P+
Sbjct: 157 CKIIGT-------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 40/121 (33%), Positives = 70/121 (57%), Gaps = 6/121 (4%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLAL-DLARGLSYLHSQKIVHRDVKTENMLL 205
+++EYL GG L +L R + + L +++ L +LH Q I++RD+K EN+LL
Sbjct: 77 LILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL 133
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
D VK+ DFG+ + E+ + +T GT+ YMAPE+L + + + D +S G +++
Sbjct: 134 DAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYD 192
Query: 265 I 265
+
Sbjct: 193 M 193
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 46/123 (37%), Positives = 66/123 (53%), Gaps = 7/123 (5%)
Query: 145 CCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
C V+ +Y L TYL R R L V +A L + Y+H + I+HRD+KTEN+L
Sbjct: 236 CLVLPKY--RSDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVL 292
Query: 205 LDKNRTVKIADFGVA---RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGIC 261
++ + + DFG A R S P G GT+ APEVL G+PY D++S G+
Sbjct: 293 VNGPEDICLGDFGAACFARGSWSTPFHY-GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLV 351
Query: 262 LWE 264
++E
Sbjct: 352 IFE 354
|
Length = 461 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 44/130 (33%), Positives = 70/130 (53%), Gaps = 9/130 (6%)
Query: 147 VVVEYLPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
+V +Y+ GG L +L K R A + +L L L +LH IV+RD+K EN+L
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL----ALEHLHKYDIVYRDLKPENIL 128
Query: 205 LDKNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEV-LNGNPYNRKCDVYSFGICL 262
LD + + DFG+++ ++ N T GT Y+APEV L+ Y + D +S G+ +
Sbjct: 129 LDATGHIALCDFGLSKANLTD-NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187
Query: 263 WEIYCCDMPY 272
+E+ C P+
Sbjct: 188 FEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 50/174 (28%), Positives = 88/174 (50%), Gaps = 15/174 (8%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+V+E++ GG T+L +N+R V A + YL S IV+RD+K EN+LLD
Sbjct: 108 LVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD 165
Query: 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
K+ +K+ DFG A+V + + GT Y+APE+L + + D ++ GI ++EI
Sbjct: 166 KDGFIKMTDFGFAKVVDTRTYTL---CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
Query: 267 CCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
P+ P L + ++ ++ P+ ++ ++MK+ + KR
Sbjct: 223 VGCPPFYANEPLLIYQKILEGIIY------FPKFLDNNCKHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 41/218 (18%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
+ G++ TV++G+ +G VA+K++ EEG A+R E ++ L H
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIR-----EASLLKGLKHA 63
Query: 115 NVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYL---PGGALKTYLIKNRRRKL 169
N+ LH I T+ + + + +Y+ PGG L Y + R
Sbjct: 64 NIVL----------LHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG-LHPYNV----RLF 108
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM 229
F+ L RGL+Y+H Q I+HRD+K +N+L+ +K+ADFG+AR ++
Sbjct: 109 MFQ--------LLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160
Query: 230 TGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIY 266
+ E TL Y P+VL G Y+ D++ G E+
Sbjct: 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 42/112 (37%), Positives = 65/112 (58%), Gaps = 6/112 (5%)
Query: 157 LKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADF 216
L TY+ +R L + + + L L+YLH + I+HRDVKTEN+ LD+ + DF
Sbjct: 172 LFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDF 229
Query: 217 GVA-RVEAS--NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
G A +++A P G +GTL +PE+L +PY K D++S G+ L+E+
Sbjct: 230 GAACKLDAHPDTPQCY-GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 70/263 (26%), Positives = 115/263 (43%), Gaps = 47/263 (17%)
Query: 73 GHDVAVKLL--DWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130
GH+VA+KLL D EE H+ R+ F +E A+ +L HPN+ +
Sbjct: 3 GHEVAIKLLRTDAPEEEHQ--------RARFRRETALCARLYHPNIVALL---------- 44
Query: 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS 190
++G+ P + V EY+PG L+ L + L +L L + L+ H+
Sbjct: 45 ---DSGEA--PPGLLFAVFEYVPGRTLREVLAADG--ALPAGETGRLMLQVLDALACAHN 97
Query: 191 QKIVHRDVKTENMLL---DKNRTVKIADFGVAR----VEASNPNDMTGETGTLG---YMA 240
Q IVHRD+K +N+++ K+ DFG+ V ++ +T T LG Y A
Sbjct: 98 QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCA 157
Query: 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS 300
PE L G P D+Y++G+ E C + + ++ Q L P + P
Sbjct: 158 PEQLRGEPVTPNSDLYAWGLIFLE---CLTGQRVVQ-GASVAEILYQQLSP-VDVSLPPW 212
Query: 301 -----LANVMKRCWDANPDKRPE 318
L V+++ + +P +R
Sbjct: 213 IAGHPLGQVLRKALNKDPRQRAA 235
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 58 IARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
+ GT+ TV +G + V L + E H A A+R EV++ L H N+
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLE-HEEGAPCTAIR-----EVSLLKDLKHANIV 67
Query: 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQL 177
LH + +V EYL LK Y+ + ++ V
Sbjct: 68 T----------LH------DIVHTDKSLTLVFEYLDKD-LKQYM-DDCGNIMSMHNVKIF 109
Query: 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLG 237
+ RGL+Y H +K++HRD+K +N+L+++ +K+ADFG+AR ++ + E TL
Sbjct: 110 LYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLW 169
Query: 238 YMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
Y P+VL G+ Y+ + D++ G +E+
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-14
Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 42/274 (15%)
Query: 58 IARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
+ +GTF + +G+ +V D+GE H+TE + L + H N +
Sbjct: 3 LGQGTFTKIFKGIR--REVG----DYGE-LHKTEVLLKVLDKS------------HRNYS 43
Query: 118 K--FIGATMGS--SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
+ F A+M S S H+ G V + + +V EY+ G+L TYL KN+ +
Sbjct: 44 ESFFEAASMMSQLSHKHLVLNYG-VCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISW 101
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLL-----DKNRT---VKIADFGVARVEASN 225
+++A LA L +L + + H +V +N+LL K +K++D G++
Sbjct: 102 KLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVL 159
Query: 226 PNDMTGETGTLGYMAPEVL-NGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283
P ++ E + ++ PE + N + D +SFG LWEI+ D P LS +
Sbjct: 160 PKEILLE--RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP---LSALDSQKK 214
Query: 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
+ R ++P + LAN++ +C D PD RP
Sbjct: 215 LQFYEDRHQLPAPKWTELANLINQCMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 37/96 (38%), Positives = 52/96 (54%), Gaps = 11/96 (11%)
Query: 174 VVQLALDLAR----------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
V+Q+ LD R G+ +LHS I+HRD+K N+++ + T+KI DFG+AR A
Sbjct: 110 VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-A 168
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFG 259
MT T Y APEV+ G Y D++S G
Sbjct: 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 41/124 (33%), Positives = 63/124 (50%), Gaps = 11/124 (8%)
Query: 174 VVQLALDLAR----------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
V+Q+ LD R G+ +LHS I+HRD+K N+++ + T+KI DFG+AR A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-A 176
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
MT T Y APEV+ G Y D++S G + E+ + +P + +
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 284 VVRQ 287
V+ Q
Sbjct: 237 VIEQ 240
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 39/100 (39%), Positives = 59/100 (59%), Gaps = 4/100 (4%)
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP 226
+KL V L + RGL Y+HS I+HRD+K N+ ++++ +KI DFG+AR
Sbjct: 115 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 171
Query: 227 NDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEI 265
++MTG T Y APE+ LN YN+ D++S G + E+
Sbjct: 172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 23/166 (13%)
Query: 143 NICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIV 194
N +V++Y GG L T L K R L D+AR + +H V
Sbjct: 74 NYLYLVMDYYVGGDLLTLLSKFEDR---------LPEDMARFYIAEMVLAIHSIHQLHYV 124
Query: 195 HRDVKTENMLLDKNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVLNG-----NP 248
HRD+K +N+LLD N +++ADFG ++ + GT Y++PE+L
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK 184
Query: 249 YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 294
Y +CD +S G+C++E+ + P+ S E ++ R + P
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 41/144 (28%), Positives = 77/144 (53%), Gaps = 2/144 (1%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+V+ ++ GG L +L + R L+ L A L LH +++RD+K EN+LLD
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA--LENLHKFNVIYRDLKPENILLD 127
Query: 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+ + DFG+ ++ + + GT Y+APE+L G+ Y + D ++ G+ L+E+
Sbjct: 128 YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187
Query: 267 CCDMPYPDLSFSEVTSAVVRQNLR 290
P+ D + +E+ ++++ LR
Sbjct: 188 TGLPPFYDENVNEMYRKILQEPLR 211
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 61 GTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118
G++ TV++G G VA+K + R E E A +A +E ++ L H N+
Sbjct: 16 GSYATVYKGRSKLTGQLVALKEI-------RLEHEEGAPFTAI-REASLLKDLKHANIVT 67
Query: 119 FIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQ 176
LH I T+ +V EYL LK Y+ + L+ V
Sbjct: 68 ----------LHDIIHTKKTLT--------LVFEYLDTD-LKQYM-DDCGGGLSMHNVRL 107
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL 236
L RGL+Y H ++++HRD+K +N+L+ + +K+ADFG+AR ++ + E TL
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTL 167
Query: 237 GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
Y P+VL G+ YS + +W + C
Sbjct: 168 WYRPPDVLLGS------TEYSTSLDMWGVGC 192
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 40/129 (31%), Positives = 66/129 (51%), Gaps = 10/129 (7%)
Query: 148 VVEYLPGGALKTYLIKNRR----RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
V+EY+ GG L + ++R+ R + V LAL +LH +++RD+K +N+
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL------MFLHRHGVIYRDLKLDNI 127
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
LLD K+ADFG+ + N T GT Y+APE+L Y D ++ G+ ++
Sbjct: 128 LLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMY 187
Query: 264 EIYCCDMPY 272
E+ P+
Sbjct: 188 EMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 70/280 (25%), Positives = 113/280 (40%), Gaps = 67/280 (23%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTE-AEIAALRSAFTQEVAVWHKLDH 113
VI RG FG V + GH A+K+L + + + I A R + ++W
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW----- 62
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
V K + L++ ++E+LPGG + T L+K + L +
Sbjct: 63 --VVKMFYSFQDKLNLYL----------------IMEFLPGGDMMTLLMK--KDTLTEEE 102
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-------RVE---- 222
+ + +H +HRD+K +N+LLD VK++DFG+ R E
Sbjct: 103 TQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRN 162
Query: 223 --ASNPNDMT---------GET-------------GTLGYMAPEVLNGNPYNRKCDVYSF 258
S P+D T ET GT Y+APEV YN+ CD +S
Sbjct: 163 LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222
Query: 259 GICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIP 294
G+ ++E+ P+ P ++ +V + PE+P
Sbjct: 223 GVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 70/237 (29%), Positives = 101/237 (42%), Gaps = 51/237 (21%)
Query: 54 IKSVIARGTFG--TVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I VI RG FG V + G A+K+L+ E R E + F +E V
Sbjct: 5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET------ACFREERDVLVNG 58
Query: 112 DHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
D +T LH Q EN +V++Y GG L T L K R
Sbjct: 59 DRRWIT----------NLHYAFQDENNLY--------LVMDYYVGGDLLTLLSKFEDR-- 98
Query: 170 AFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-R 220
L D+AR + +H VHRD+K +N+LLDKN +++ADFG R
Sbjct: 99 -------LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLR 151
Query: 221 VEASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPY 272
+ A GT Y++PE+L Y +CD +S G+C++E+ + P+
Sbjct: 152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 36/90 (40%), Positives = 55/90 (61%), Gaps = 4/90 (4%)
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL 236
L L RGL Y+HS I+HRD+K N+ ++++ ++I DFG+AR ++MTG T
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVATR 179
Query: 237 GYMAPEV-LNGNPYNRKCDVYSFGICLWEI 265
Y APE+ LN YN+ D++S G + E+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 49/222 (22%), Positives = 86/222 (38%), Gaps = 64/222 (28%)
Query: 148 VVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V++Y+PGG + + LI+ LA + +L + +H +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTC----AIESVHKMGFIHRDIKPDNILI 134
Query: 206 DKNRTVKIADFGV------------------ARVEASNPNDMTGE--------------- 232
D++ +K+ DFG+ R ++ P++ E
Sbjct: 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKR 194
Query: 233 ----------TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
GT Y+APEVL Y + CD +S G+ L+E+ P+ + +E
Sbjct: 195 QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQL 254
Query: 283 AVV--RQNLRPEIPRCCPSSLANVMKRCWD------ANPDKR 316
V+ L IP A + + D + R
Sbjct: 255 KVINWETTLH--IPSQ-----AKLSREASDLILRLCCGAEDR 289
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR----VEASNPNDMTGETGTLGY 238
GL Y+HS ++HRD+K N+L++ + +KI DFG+AR N MT T Y
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 239 MAPEV-LNGNPYNRKCDVYSFGICLWEIY 266
APE+ L+ Y + DV+S G L E+
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 67/257 (26%), Positives = 106/257 (41%), Gaps = 47/257 (18%)
Query: 54 IKSVIARGTFGTVHRGLYDGHD--VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I VI RG FG V D A+K+L+ E R E + F +E V
Sbjct: 5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET------ACFREERDVLVNG 58
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
D+ +T A + L++ V++Y GG L T L K R
Sbjct: 59 DNQWITTLHYAFQDENNLYL----------------VMDYYVGGDLLTLLSKFEDR---- 98
Query: 172 KVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-RVE 222
L D+AR + +H VHRD+K +N+L+D N +++ADFG ++
Sbjct: 99 -----LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153
Query: 223 ASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
+ GT Y++PE+L Y +CD +S G+C++E+ + P+ S
Sbjct: 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 278 SEVTSAVVRQNLRPEIP 294
E ++ R + P
Sbjct: 214 VETYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 50 SKLVIKSVIARGTFGTVHRGLY-DGHD-VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
+K + V+ G +G V + + + + VA+K EE E + LR E+ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE--EVKETTLR-----ELKM 53
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
L N+ + A +L++ E + M ++E +P G + R
Sbjct: 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE-----LLEEMPNGVPP-----EKVR 103
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR--VEASN 225
++++ + + + H IVHRD+K EN+L+ N +K+ DFG AR E SN
Sbjct: 104 SYIYQLI--------KAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
N T T Y +PE+L G PY + D++S G L E+
Sbjct: 156 AN-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 32/207 (15%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIA--ALRSAFTQEVAVWHKLDH 113
I G++G V R G VA+K E+ + I ALR E+ + +L H
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESED----DPVIKKIALR-----EIRMLKQLKH 59
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
PN+ I +LH+ V EY L ++ R + +
Sbjct: 60 PNLVNLIEVFRRKRKLHL----------------VFEYCDHTVLNE--LEKNPRGVPEHL 101
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
+ ++ + +++ H +HRDVK EN+L+ K +K+ DFG AR+ +D T
Sbjct: 102 IKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV 161
Query: 234 GTLGYMAPEVLNGN-PYNRKCDVYSFG 259
T Y APE+L G+ Y DV++ G
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIG 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 7e-13
Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 6/174 (3%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
++++Y+ GG + T+L + R + V + ++ L +LH IV+RD+K EN+LLD
Sbjct: 82 LILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD 139
Query: 207 KNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWE 264
V + DFG+++ S + T GT+ YMAPE++ G + + D +S GI ++E
Sbjct: 140 SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFE 199
Query: 265 IYCCDMPYPDLSFSEVTSAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKR 316
+ P+ S V R+ L+ P P +++ + +P KR
Sbjct: 200 LLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 37/103 (35%), Positives = 59/103 (57%), Gaps = 4/103 (3%)
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ KL+ + L + +GL Y+H+ I+HRD+K N+ ++++ +KI DFG+AR S
Sbjct: 111 KHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170
Query: 225 NPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEIY 266
+MTG T Y APEV LN Y + D++S G + E+
Sbjct: 171 ---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 79/303 (26%), Positives = 132/303 (43%), Gaps = 70/303 (23%)
Query: 53 VIKSVIARGTFGTVH----RGLYDGHDVAVKLLDWGE-----EGHRTEAEIAALRSAFTQ 103
IK ++ +G G V +G G A+K+LD E + R E L +
Sbjct: 5 KIK-LLGKGDVGRVFLVRLKG--TGKLFALKVLDKKEMIKRNKVKRVLTEQEILAT---- 57
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
LDHP F+ T+ +S QTE C+V++Y PGG L L +
Sbjct: 58 -------LDHP----FL-PTLYAS---FQTET--------YLCLVMDYCPGGELFRLLQR 94
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADF------- 216
+ L+ +V A ++ L YLH IV+RD+K EN+LL ++ + ++DF
Sbjct: 95 QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154
Query: 217 --GVARVEA-------SNPNDMTGET-------------GTLGYMAPEVLNGNPYNRKCD 254
+A S+ N + ET GT Y+APEV++G+ + D
Sbjct: 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVD 214
Query: 255 VYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR-PEIPRCCPSSLANVMKRCWDANP 313
++ GI L+E+ P+ + E S ++++ + P P SS +++++ +P
Sbjct: 215 WWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPP-VSSSARDLIRKLLVKDP 273
Query: 314 DKR 316
KR
Sbjct: 274 SKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 3e-12
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ G++ TV++G +G VA+K++ EE A+R E ++ L H N
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIR-----EASLLKGLKHAN 64
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ L + E + C ++ PGG L + F+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDL-----CQYMDKHPGG-----LHPENVKLFLFQ--- 111
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
L RGLSY+H + I+HRD+K +N+L+ +K+ADFG+AR ++ + + E T
Sbjct: 112 -----LLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVT 166
Query: 236 LGYMAPEVLNGNPYNRKC-DVYSFGICLWEI 265
L Y P+VL G+ C D++ G E+
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 69/280 (24%), Positives = 113/280 (40%), Gaps = 67/280 (23%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTE-AEIAALRSAFTQEVAVWHKLDH 113
VI RG FG V + GH A+K+L + + + A I A R + W
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW----- 62
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
V K + L++ ++E+LPGG + T L+K + L+ +
Sbjct: 63 --VVKMFYSFQDKRNLYL----------------IMEFLPGGDMMTLLMK--KDTLSEEA 102
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-------RVE---- 222
+ + +H +HRD+K +N+LLD VK++DFG+ R E
Sbjct: 103 TQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN 162
Query: 223 --ASNPNDMT---------GET-------------GTLGYMAPEVLNGNPYNRKCDVYSF 258
+ P+D + ET GT Y+APEV YN+ CD +S
Sbjct: 163 LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222
Query: 259 GICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIP 294
G+ ++E+ P+ P ++ +V + PE+P
Sbjct: 223 GVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 65/223 (29%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 54 IKSVIARGTFGTVH--RGLYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
I I GT+G V+ R G VA+K LD +EG I A+R E+ +
Sbjct: 11 IIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGF----PITAIR-----EIKILR 61
Query: 110 KLDHPNVTKFIG-ATMGSSELHIQTENGQVAMPSNICCVVVEYLPG---GALKTYLIKNR 165
+L+H N+ T L + + G + V EY+ G L++ L+
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYL-------VFEYMDHDLMGLLESGLVHFS 114
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV-EAS 224
+ L GL+Y H + +HRD+K N+LL+ +K+ADFG+AR+ +
Sbjct: 115 EDHIK-----SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 225 NPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIY 266
T + TL Y PE+L G Y DV+S G L E++
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 41/132 (31%), Positives = 73/132 (55%), Gaps = 13/132 (9%)
Query: 146 CVVVEYLPGGALKTYLIKN---RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202
C +++ + GG L +L ++ +++ F A ++ GL ++H++ +V+RD+K N
Sbjct: 73 CFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLEHMHNRFVVYRDLKPAN 127
Query: 203 MLLDKNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVLN-GNPYNRKCDVYSFGI 260
+LLD++ V+I+D G+A P+ GT GYMAPEVL G Y+ D +S G
Sbjct: 128 ILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGTAYDSSADWFSLGC 184
Query: 261 CLWEIYCCDMPY 272
L+++ P+
Sbjct: 185 MLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 8e-12
Identities = 44/135 (32%), Positives = 67/135 (49%), Gaps = 16/135 (11%)
Query: 174 VVQLALDLAR----------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
V+Q+ LD R G+ +LHS I+HRD+K N+++ + T+KI DFG+AR A
Sbjct: 111 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-A 169
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
MT T Y APEV+ G Y D++S G + E+ + +P + + +
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229
Query: 284 VVRQNLRPEIPRCCP 298
V+ Q P CP
Sbjct: 230 VIEQLGTP-----CP 239
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 38/122 (31%), Positives = 68/122 (55%), Gaps = 7/122 (5%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
+++ + GG L +L ++ + + A ++ GL ++H++ +V+RD+K N+LL
Sbjct: 73 SFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 206 DKNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVL-NGNPYNRKCDVYSFGICLW 263
D++ V+I+D G+A P+ GT GYMAPEVL G Y+ D +S G L+
Sbjct: 131 DEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 187
Query: 264 EI 265
++
Sbjct: 188 KL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 69/270 (25%), Positives = 106/270 (39%), Gaps = 88/270 (32%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGE--EGHRTEAEIAALRSAFTQEVAVWHKLD 112
VI RG FG V + GH A+K L E E + A + A R + D
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQV-AHVRAERDILAEA-------D 59
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-------R 165
+P V K + + L++ ++EYLPGG + T L+K
Sbjct: 60 NPWVVKLYYSFQDENYLYL----------------IMEYLPGGDMMTLLMKKDTFTEEET 103
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG-------- 217
R +A + LA+D +H +HRD+K +N+LLD +K++DFG
Sbjct: 104 RFYIAETI---LAID------SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154
Query: 218 --------VARVEASNPNDMTGET----------------------GTLGYMAPEVLNGN 247
++ SN D + GT Y+APEV
Sbjct: 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT 214
Query: 248 PYNRKCDVYSFGICLWEI------YCCDMP 271
YN++CD +S G+ ++E+ +C D P
Sbjct: 215 GYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 33/82 (40%), Positives = 49/82 (59%), Gaps = 1/82 (1%)
Query: 184 GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEV 243
G+ +LHS I+HRD+K N+++ + T+KI DFG+AR +N MT T Y APEV
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM-MTPYVVTRYYRAPEV 193
Query: 244 LNGNPYNRKCDVYSFGICLWEI 265
+ G Y D++S G + E+
Sbjct: 194 ILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 21/190 (11%)
Query: 138 VAMPSNICCVVVEYLPGGALKTYLIKNRRR-KLAFKVVVQLALDLARGLSYLHSQKIVHR 196
V NI +V E++ G L L K + R +A+K+ V A LA LSYL + +VH
Sbjct: 86 VRGSENI--MVEEFVEHGPLDVCLRKEKGRVPVAWKITV--AQQLASALSYLEDKNLVHG 141
Query: 197 DVKTENMLLDKNRT-------VKIADFGVARVEASNPNDMTGETGTLGYMAPEVL-NGNP 248
+V +N+LL + +K++D GV+ S + + ++APE + GN
Sbjct: 142 NVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE----RIPWIAPECVPGGNS 197
Query: 249 YNRKCDVYSFGICLWEI-YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKR 307
+ D +SFG L EI + ++P + + SE +++ PE P C LA ++ +
Sbjct: 198 LSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPE-PSC--KELATLISQ 254
Query: 308 CWDANPDKRP 317
C P +RP
Sbjct: 255 CLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 57/233 (24%), Positives = 102/233 (43%), Gaps = 29/233 (12%)
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICC------VVVEYLPGGA 156
+E+ V K+ P+ A ++ + Q + + + +C +V E++ G
Sbjct: 31 KEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90
Query: 157 LKTYLIKNRRRK---LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT--- 210
L ++ RK L ++A LA LSYL + +VH +V T+N+LL +
Sbjct: 91 LDLFM----HRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGE 146
Query: 211 ----VKIADFGVARVEASNPNDMTGETGTLGYMAPE-VLNGNPYNRKCDVYSFGICLWEI 265
+K++D G+ S + + ++APE V + + D +SFG LWEI
Sbjct: 147 CGPFIKLSDPGIPITVLSRQECVE----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
Query: 266 -YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
Y ++P D + +E P C LA++M C + +P++RP
Sbjct: 203 CYNGEIPLKDKTLAE-KERFYEGQCMLVTPSC--KELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 19/149 (12%)
Query: 147 VVVEYLPGGALK--TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
VV+E++P K + +N L +V + L R L+Y+HS+ I HRD+K +N+L
Sbjct: 144 VVMEFIPQTVHKYMKHYARNNH-ALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLL 202
Query: 205 LDKN-RTVKIADFGVARVEASNPNDMTGETG-----TLGYMAPEVLNGNP-YNRKCDVYS 257
+D N T+K+ DFG A+ N + G+ + Y APE++ G Y D++S
Sbjct: 203 IDPNTHTLKLCDFGSAK------NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWS 256
Query: 258 FGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
G + E+ + YP S +VR
Sbjct: 257 LGCIIAEMI---LGYPIFSGQSSVDQLVR 282
|
Length = 440 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 8/90 (8%)
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN-PNDM--TGETGTLG 237
L R L Y+H+ + HRD+K +N+L + + +KI DFG+ARV ++ P + T T
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 238 YMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
Y APE L G+ +++ Y+ I +W I C
Sbjct: 172 YRAPE-LCGSFFSK----YTPAIDIWSIGC 196
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 52/217 (23%), Positives = 88/217 (40%), Gaps = 56/217 (25%)
Query: 148 VVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V++Y+PGG + + LI+ LA + +L L + +H +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL----AIESVHKMGFIHRDIKPDNILI 134
Query: 206 DKNRTVKIADFGVA------------------RVEASNPND--------------MTGE- 232
D + +K+ DFG+ R ++ P+D T E
Sbjct: 135 DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQ 194
Query: 233 --------------TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278
GT Y+APEVL Y + CD +S G+ L+E+ P+ + +
Sbjct: 195 RATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPT 254
Query: 279 EVTSAVVRQNLRPEIP---RCCPSSLANVMKRCWDAN 312
E V+ IP + P ++ + K C A
Sbjct: 255 ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE 291
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 29/77 (37%), Positives = 47/77 (61%), Gaps = 6/77 (7%)
Query: 147 VVVEYLPGGALKTYL--IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
+V+EYL GG +K+ L ++A K + ++AL L YLH I+HRD+K +NML
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVAL----ALDYLHRHGIIHRDLKPDNML 136
Query: 205 LDKNRTVKIADFGVARV 221
+ +K+ DFG+++V
Sbjct: 137 ISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 47/192 (24%)
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
QE+ +L HPN+ ++ + + SEL+ VV + G+ + L+
Sbjct: 48 QEIITSRQLQHPNILPYVTSFIVDSELY----------------VVSPLMAYGSCED-LL 90
Query: 163 KNRRRKLAFK------VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADF 216
K F + + D+ L Y+HS+ +HR VK ++LL + V ++
Sbjct: 91 KTH-----FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145
Query: 217 GVAR--VEASN----PNDMT-GETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYC 267
+ ++ +D L +++PEVL N YN K D+YS GI
Sbjct: 146 RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGIT-----A 200
Query: 268 CDM-----PYPD 274
C++ P+ D
Sbjct: 201 CELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 27/87 (31%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT--GETGTLGY 238
L + Y+H +K++HRD+K EN+ L+ + + + DFG A + + G GT+
Sbjct: 276 LLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPFEKEREAFDYGWVGTVAT 334
Query: 239 MAPEVLNGNPYNRKCDVYSFGICLWEI 265
+PE+L G+ Y D++S G+ L ++
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 58 IARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
+ RGT+G V++ DG D +E + E + + +E+A+ +L HPNV
Sbjct: 9 VGRGTYGHVYKAKRKDGKD--------EKEYALKQIEGTGISMSACREIALLRELKHPNV 60
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQ 176
+ S+ + ++ +Y ++IK R A K +Q
Sbjct: 61 IALQKVFLSHSDRKVW--------------LLFDYAEHDLW--HIIKFHRASKANKKPMQ 104
Query: 177 LALDLAR--------GLSYLHSQKIVHRDVKTENMLL-----DKNRTVKIADFGVARVEA 223
L + + G+ YLH+ ++HRD+K N+L+ ++ R VKIAD G AR+
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR-VKIADMGFARLFN 163
Query: 224 S--NP-NDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEI 265
S P D+ T Y APE+L G Y + D+++ G E+
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 49/229 (21%)
Query: 58 IARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
+ RGT+G V++ D D A+K + EG T ++A R E+A+ +L H
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EG--TGISMSACR-----EIALLRELKH 57
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
PNV + ++ + ++ +Y ++IK R A K
Sbjct: 58 PNVISLQKVFLSHADRKVW--------------LLFDYAEHDLW--HIIKFHRASKANKK 101
Query: 174 VVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLL-----DKNRTVKIADFGVAR 220
VQL + + G+ YLH+ ++HRD+K N+L+ ++ R VKIAD G AR
Sbjct: 102 PVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR-VKIADMGFAR 160
Query: 221 VEAS--NP-NDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEI 265
+ S P D+ T Y APE+L G Y + D+++ G E+
Sbjct: 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 66/181 (36%)
Query: 147 VVVEYLPGGALKTYLIKNR-------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
+++E+LPGG L T LIK R +A V LA++ L + +HRD+K
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV---LAIEAVHKLGF------IHRDIK 128
Query: 200 TENMLLDKNRTVKIADFGV---------------------ARVEASNPNDMTGET----- 233
+N+L+D+ +K++DFG+ + N N + ++
Sbjct: 129 PDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTM 188
Query: 234 ---------------------GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
GT Y+APE+ Y ++CD +S G ++E C + +
Sbjct: 189 SSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE---CLIGW 245
Query: 273 P 273
P
Sbjct: 246 P 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 9/99 (9%)
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA--------RVEA 223
K++ + D+ L Y+H I H D+K EN+++D N I D+G+A +E
Sbjct: 126 KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEY 185
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
S GTL Y + NG R+ D+ S G C+
Sbjct: 186 SK-EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCM 223
|
Length = 294 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 39/171 (22%), Positives = 72/171 (42%), Gaps = 13/171 (7%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+V+++ GG L +++ K + + V + A ++ L LH + IV RD+ N+LLD
Sbjct: 62 LVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 207 KNRTVKIADFGVAR-VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+++ F VE S + Y APEV + CD +S G L+E+
Sbjct: 120 DRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPEVGGISEETEACDWWSLGAILFEL 175
Query: 266 YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
+ E + + + IP +++++ NP +R
Sbjct: 176 LT------GKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 15/105 (14%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG----------VARVEASNPNDMTGE 232
RGL+YLH +HR++K ++L+ + V ++ A+V P
Sbjct: 112 RGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQ---FS 168
Query: 233 TGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDL 275
T L +++PE+L + YN K D+YS GI E+ +P+ D+
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+V+EY+ G LK L + R L +V + LH IVH D+ T N++L
Sbjct: 76 IVMEYIEGELLKDALEEARP-DLLREVGRLVGK--------LHKAGIVHGDLTTSNIILS 126
Query: 207 KNRTVKIADFGVARVEAS 224
R I DFG+
Sbjct: 127 GGRIYFI-DFGLGEFSDE 143
|
Length = 204 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 17/36 (47%), Positives = 22/36 (61%), Gaps = 1/36 (2%)
Query: 185 LSYLHSQKIVHRDVKTENMLLD-KNRTVKIADFGVA 219
L LHS IVHRDVK +N++ + + KI D G A
Sbjct: 268 LDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 77/320 (24%), Positives = 118/320 (36%), Gaps = 90/320 (28%)
Query: 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
S L ++VI+RG G ++G + + EI + S + E+A
Sbjct: 690 SSLKEENVISRGKKGASYKGKSIKNGM-----------QFVVKEINDVNSIPSSEIADMG 738
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK---NRR 166
KL HPN+ K IG + SE + A ++ EY+ G L L RR
Sbjct: 739 KLQHPNIVKLIG--LCRSE--------KGAY------LIHEYIEGKNLSEVLRNLSWERR 782
Query: 167 RKLAFKVVVQLALDLARGLSYLH---SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
RK+A + +A+ L +LH S +V ++ E +++D +
Sbjct: 783 RKIA--------IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK--------DEPHLRL 826
Query: 224 SNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICL------------------ 262
S P + +T Y+APE K D+Y FG+ L
Sbjct: 827 SLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886
Query: 263 ----WEIYC---C--DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANP 313
W YC C DM + D S S V QN E+ N+ C +P
Sbjct: 887 SIVEWARYCYSDCHLDM-WIDPSIRGDVS--VNQNEIVEV--------MNLALHCTATDP 935
Query: 314 DKRPEMDEVVSMLEAIDTSK 333
RP ++V+ LE+ S
Sbjct: 936 TARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 24/72 (33%), Positives = 37/72 (51%), Gaps = 7/72 (9%)
Query: 155 GALKTYLIKNRR-------RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
G L+ +++ ++ K V+ + + GL LH IVHRD+K EN+L+
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV 344
Query: 208 NRTVKIADFGVA 219
+ VKI DFG A
Sbjct: 345 DGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 22/73 (30%), Positives = 42/73 (57%), Gaps = 6/73 (8%)
Query: 148 VVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V++Y+PGG + + LI+ LA + +L + +H +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTC----AVESVHKMGFIHRDIKPDNILI 134
Query: 206 DKNRTVKIADFGV 218
D++ +K+ DFG+
Sbjct: 135 DRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 7e-05
Identities = 23/73 (31%), Positives = 38/73 (52%), Gaps = 7/73 (9%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EY+ G LK + N ++L+ ++ R + LHS I+H D+ T NM+L
Sbjct: 77 VMEYIEGEPLKDLINSNGME------ELELSREIGRLVGKLHSAGIIHGDLTTSNMIL-S 129
Query: 208 NRTVKIADFGVAR 220
+ + DFG+A
Sbjct: 130 GGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 65/298 (21%), Positives = 122/298 (40%), Gaps = 60/298 (20%)
Query: 53 VIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
VIK I G FG V H + W +R E +S EV V +L
Sbjct: 17 VIKK-IGNGRFGEV---FLVKHKRTQEFFCWKAISYRGLKERE--KSQLVIEVNVMRELK 70
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR--KLA 170
H N+ ++I + + + +++E+ G L + K + K+
Sbjct: 71 HKNIVRYIDRFLNKANQKLY--------------ILMEFCDAGDLSRNIQKCYKMFGKIE 116
Query: 171 FKVVVQLALDLARGLSYLHS-------QKIVHRDVKTENML-----------------LD 206
+V + L L+Y H+ ++++HRD+K +N+ L+
Sbjct: 117 EHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176
Query: 207 KNRTVKIADFGVAR---VEASNPNDMTGETGTLGYMAPEVL--NGNPYNRKCDVYSFGIC 261
KI DFG+++ +E+ + + GT Y +PE+L Y+ K D+++ G
Sbjct: 177 GRPIAKIGDFGLSKNIGIESMAHSCV----GTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 262 LWEIYCCDMPYPDL-SFSEVTSAVVRQNLRPEIPRCCPSSLANVM-KRCWDANPDKRP 317
++E+ P+ +FS++ S + R P++P S N++ K + + +RP
Sbjct: 233 IYELCSGKTPFHKANNFSQLISELKRG---PDLPIKGKSKELNILIKNLLNLSAKERP 287
|
Length = 1021 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 6e-04
Identities = 39/153 (25%), Positives = 58/153 (37%), Gaps = 29/153 (18%)
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VEASNPNDMTGETGT 235
+ L L LH Q K+ N+LL + +K+ + E S P+
Sbjct: 22 VCLQCLGALRELHRQA------KSGNILLTWDGLLKLDGSVAFKTPEQSRPDPY------ 69
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD-----------LSFSEVTSAV 284
+MAPEV+ G Y K D+YS GI L+E ++PY + L+
Sbjct: 70 --FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR 127
Query: 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
R NL S + M+ C P +R
Sbjct: 128 DRSNLEGVSAAR---SFEDFMRLCASRLPQRRE 157
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 7e-04
Identities = 20/74 (27%), Positives = 36/74 (48%), Gaps = 10/74 (13%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EY+ G LK +I+ +L ++ + LH IVH D+ T N+++
Sbjct: 75 VMEYIEGKPLK-DVIEEGNDELLREIGRLVGK--------LHKAGIVHGDLTTSNIIVRD 125
Query: 208 NRTVKIADFGVARV 221
++ I DFG+ +
Sbjct: 126 DKLYLI-DFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 7e-04
Identities = 21/75 (28%), Positives = 33/75 (44%), Gaps = 11/75 (14%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+V+EY+ G LK L N + ++ LH IVH D+ T N ++
Sbjct: 413 IVMEYIGGKDLKDVLEGNPEL----------VRKVGEIVAKLHKAGIVHGDLTTSNFIVR 462
Query: 207 KNRTVKIADFGVARV 221
+R I DFG+ +
Sbjct: 463 DDRLYLI-DFGLGKY 476
|
Length = 535 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 40/189 (21%), Positives = 76/189 (40%), Gaps = 31/189 (16%)
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E+ V +HPN+ + + +EL VV ++ G+ K +
Sbjct: 49 ELHVSKLFNHPNIVPYRATFIADNEL----------------WVVTSFMAYGSAKDLICT 92
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV----- 218
+ ++ + + + + L Y+H VHR VK ++L+ + V ++
Sbjct: 93 HFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 152
Query: 219 -----ARVEASNPNDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMP 271
RV P L +++PEVL N Y+ K D+YS GI E+ +P
Sbjct: 153 NHGQRLRVVHDFPKY---SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
Query: 272 YPDLSFSEV 280
+ D+ +++
Sbjct: 210 FKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 25/86 (29%), Positives = 39/86 (45%), Gaps = 5/86 (5%)
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293
GT Y+APEVL Y + CD +S G+ L+E+ P+ + E V+ I
Sbjct: 210 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHI 269
Query: 294 P---RCCPSSLANVMKRCWDANPDKR 316
P + P + ++K C P+ R
Sbjct: 270 PPQAKLSPEASDLIIKLC--RGPEDR 293
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 36/163 (22%)
Query: 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN---RRRKLAFKVVVQLALDLARGLS 186
+ Q E G ++C V+ +Y P L +++K+ R LA Q+ L
Sbjct: 199 YFQNETG------HMCIVMPKYGP--CLLDWIMKHGPFSHRHLA-----QIIFQTGVALD 245
Query: 187 YLHSQ-KIVHRDVKTENMLLDKNRT----------------VKIADFGVARVEASNPNDM 229
Y H++ ++H D+K EN+L++ + T V+I D G E +
Sbjct: 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---HSR 302
Query: 230 TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
T T Y +PEV+ G + D++S G ++E+Y + Y
Sbjct: 303 TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 355 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.56 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.52 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.29 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.27 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.24 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.07 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.99 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.96 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.94 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.85 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.81 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.63 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.58 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.52 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.32 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.27 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.21 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.15 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.1 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.08 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.99 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.96 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.94 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.88 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.87 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.84 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.76 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.76 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.59 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.55 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.44 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.38 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.34 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.33 | |
| PLN02236 | 344 | choline kinase | 97.21 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.19 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.16 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.12 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.09 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.97 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.91 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.84 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.65 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.58 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.52 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.47 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.99 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.93 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.57 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.56 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.38 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.18 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=372.14 Aligned_cols=249 Identities=27% Similarity=0.433 Sum_probs=228.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+|+..+.||+|+|+.||.+++ +|+.||+|++.+..... ...++.+.+|+++.+.|+|||||+++++|.+.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k------~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK------PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC------cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence 6799999999999999999965 89999999996543322 334667889999999999999999999999877
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. |||.|.|+.++|..+++ +.+.++|.+++.+++||+.+|.|||+.+|+|||||..|+|+++
T Consensus 92 nV----------------YivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~ 153 (592)
T KOG0575|consen 92 NV----------------YIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNE 153 (592)
T ss_pred ce----------------EEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecC
Confidence 66 55999999999999985 6788999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+.+||++|||+|.....+.......+||+.|.|||++.....+..+||||+||++|.||+|++||+..+-.+.+..+...
T Consensus 154 ~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~ 233 (592)
T KOG0575|consen 154 NMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN 233 (592)
T ss_pred cCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc
Confidence 99999999999998888878888899999999999999999999999999999999999999999999999999998887
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+. +|..++.++.+||.++|+.||.+|||+++|+.
T Consensus 234 ~Y~--~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 234 EYS--MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred Ccc--cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 664 77799999999999999999999999999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=352.29 Aligned_cols=250 Identities=30% Similarity=0.532 Sum_probs=218.1
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
.+..++.+.++.||+|..|+||++++ ++..+|+|++..... ...++.+.+|+++++..+||+||++|+.|
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~--------~~~~~Qi~rEl~il~~~~spyIV~~ygaF 146 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNID--------PALQKQILRELEILRSCQSPYIVGFYGAF 146 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCC--------HHHHHHHHHHHHHHhhCCCCCeeeEeEEE
Confidence 45556899999999999999999976 589999999943221 23456688999999999999999999999
Q ss_pred cCCcc-cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCCC
Q 018489 124 MGSSE-LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTE 201 (355)
Q Consensus 124 ~~~~~-~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~di~p~ 201 (355)
..... . .|+||||++|+|++++.. .+.+++..+.+|+.+++++|.|||+ ++|+||||||+
T Consensus 147 ~~~~~~i----------------sI~mEYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPs 208 (364)
T KOG0581|consen 147 YSNGEEI----------------SICMEYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPS 208 (364)
T ss_pred EeCCceE----------------EeehhhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHH
Confidence 98774 4 569999999999999854 3679999999999999999999995 89999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC-----C
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL-----S 276 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~-----~ 276 (355)
||||+..|+|||+|||.+...... .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||... .
T Consensus 209 NlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~ 286 (364)
T KOG0581|consen 209 NLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD 286 (364)
T ss_pred HeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC
Confidence 999999999999999999866544 556689999999999999999999999999999999999999999874 4
Q ss_pred hhHHHHHHHhcCCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 277 FSEVTSAVVRQNLRPEIPRC-CPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+.+..++.. ..+.+|.. ++++++++|..||++||.+||++.++++
T Consensus 287 ~~~Ll~~Iv~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 287 IFELLCAIVDE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHHHHHhcC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 45666666553 45566665 9999999999999999999999999987
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=358.91 Aligned_cols=273 Identities=45% Similarity=0.821 Sum_probs=243.1
Q ss_pred cccccceecCCcceeecccccccceEEEEEEECCce-eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 40 ~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
.....+.++..+..+.+.||.|+||+||+|.+.|.. ||+|++......... .+.|.+|+.++..++|||||+
T Consensus 31 ~~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-------~~~f~~E~~il~~l~HpNIV~ 103 (362)
T KOG0192|consen 31 DELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-------RKAFRREASLLSRLRHPNIVQ 103 (362)
T ss_pred ccccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-------HHHHHHHHHHHHhCCCCCeee
Confidence 455678888899999999999999999999999998 999999654432211 567999999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC-ccccC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK-IVHRD 197 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-i~H~d 197 (355)
+++++..... .++|||||+++|+|.+++.......++...+..|+.||+.|+.|||+++ |+|+|
T Consensus 104 f~G~~~~~~~---------------~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrD 168 (362)
T KOG0192|consen 104 FYGACTSPPG---------------SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRD 168 (362)
T ss_pred EEEEEcCCCC---------------ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecc
Confidence 9999876542 2478999999999999997655778999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC-cEEEeeccccccccCCCCCCCCCCCcccccCCcccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 018489 198 VKTENMLLDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN--GNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (355)
Q Consensus 198 i~p~Nili~~~~-~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~~lltg~~p~~~ 274 (355)
|||+|||++.++ ++||+|||+++.............||..|||||++. ...++.++||||+|+++|+|+||+.||..
T Consensus 169 LK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~ 248 (362)
T KOG0192|consen 169 LKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED 248 (362)
T ss_pred cChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC
Confidence 999999999997 999999999986665434444478999999999999 56999999999999999999999999999
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
....+....+.....++.++..+++.+..++..||+.||..||++.+|+..|+.+...-.
T Consensus 249 ~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 249 LAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 988888888888999999999999999999999999999999999999999999977544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-52 Score=341.92 Aligned_cols=258 Identities=26% Similarity=0.448 Sum_probs=220.1
Q ss_pred CcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+|+|++.||+|.||.||++. .+|..+|.|.++.+.. .+..++.+..|+.+|++|+|||||++++.....+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-------d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-------DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED 91 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-------cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc
Confidence 589999999999999999995 5899999999864433 2344677889999999999999999998433322
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHS--QK--IVHRDVKTE 201 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~--~~--i~H~di~p~ 201 (355)
.-. ++||||||.+|+|...++.. ..+.+++..+|+++.|++.||.++|. .+ |.||||||.
T Consensus 92 ~ev--------------lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPa 157 (375)
T KOG0591|consen 92 NEV--------------LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPA 157 (375)
T ss_pred chh--------------hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcch
Confidence 221 25699999999999999743 35669999999999999999999999 45 999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
|||++.+|.|||+|||+++.......-....+||+.||+||.+.+.+|++++||||+||++|+|+.-..||.+.+..+..
T Consensus 158 NIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~ 237 (375)
T KOG0591|consen 158 NIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLC 237 (375)
T ss_pred heEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHH
Confidence 99999999999999999998877766667789999999999999999999999999999999999999999999888877
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
.++......+.....+|.++..||..|+..||+.||+.-.++..+.+
T Consensus 238 ~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 238 KKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 77777655443336789999999999999999999986555554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=345.82 Aligned_cols=247 Identities=28% Similarity=0.454 Sum_probs=219.6
Q ss_pred eecCCcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
.+..++|++++.||+|+||.||.++ ++++.+|+|++++.......+ .+...+|..+|..++||.||+++..|
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e------~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKE------VRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhh------HHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 4567899999999999999999994 578999999997655443322 23467899999999999999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
++.+..| +|+||+.||.|...+ ++.+.+++..+..++.+|+.||.|||++||+||||||+||
T Consensus 95 Qt~~kLy----------------lVld~~~GGeLf~hL--~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENI 156 (357)
T KOG0598|consen 95 QTEEKLY----------------LVLDYLNGGELFYHL--QREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENI 156 (357)
T ss_pred ccCCeEE----------------EEEeccCCccHHHHH--HhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHe
Confidence 9888775 599999999999999 4567899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
|++.+|+++|+|||++.............+||+.|||||++.+.+|+.++|.||||+++|+|++|..||.+.+.......
T Consensus 157 LLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~ 236 (357)
T KOG0598|consen 157 LLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK 236 (357)
T ss_pred eecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH
Confidence 99999999999999998666655566668999999999999999999999999999999999999999999999999988
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 317 (355)
+.... ....+..++.+.+++|+++|+.||++|.
T Consensus 237 I~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 237 ILKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HhcCc-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 88766 2345566899999999999999999996
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-51 Score=352.52 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=214.4
Q ss_pred cCCcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..+.|.+.+.||+|+||.|-+|. .++..||||++++........ ..+. ...+.+|+++|++++|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~-~~~~-~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR-AIAK-TRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc-cccc-hhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 45778999999999999999994 479999999997665544332 1111 1226799999999999999999999998
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
++.. ||||||++||.|.+.+- .++-+.+...+.++.||+.|+.|||+.||+||||||+|||+
T Consensus 248 ~ds~----------------YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl 309 (475)
T KOG0615|consen 248 PDSS----------------YMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILL 309 (475)
T ss_pred CCce----------------EEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEe
Confidence 8877 45999999999999994 45668899999999999999999999999999999999999
Q ss_pred cCC---CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCC---CCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 206 DKN---RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY---NRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 206 ~~~---~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
+.+ ..+|++|||+|.... ...-....+||+.|.|||++.+... ..+.|+|||||++|-+++|.+||.+..-..
T Consensus 310 ~~~~e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 310 SNDAEDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred ccCCcceEEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 866 789999999998765 3444556899999999999987643 347799999999999999999998876555
Q ss_pred -HHHHHHhcCCC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 280 -VTSAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 280 -~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....+.+..+. +..+..++++..+||.+||..||++|||++|+|+
T Consensus 389 sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 389 SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 45555555443 3456778999999999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=347.75 Aligned_cols=253 Identities=25% Similarity=0.426 Sum_probs=220.0
Q ss_pred eecCCcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeee
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGA 122 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~ 122 (355)
....+||.+++.||+|+|++|++|+ .++..|||||+.+..... +.-.+.+..|-.+|.+| +||+|++++-.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik------e~KvkYV~~Ek~~l~~L~~hPgivkLy~T 142 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK------EKKVKYVTREKEALTQLSGHPGIVKLYFT 142 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh------hcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence 4467899999999999999999995 478999999995433211 11124467888999999 99999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
|++...+|+ |+||+++|+|.++|++. +.|++...+.++.+|+.||.|||++|||||||||+|
T Consensus 143 FQD~~sLYF----------------vLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPEN 204 (604)
T KOG0592|consen 143 FQDEESLYF----------------VLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPEN 204 (604)
T ss_pred eecccceEE----------------EEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence 998777754 99999999999999654 779999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCC-----------C--CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCC
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPN-----------D--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~-----------~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~ 269 (355)
||++.+++++|+|||.|........ . ...++||..|.+||++..+..++++|+|+|||++|+|+.|.
T Consensus 205 ILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~ 284 (604)
T KOG0592|consen 205 ILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQ 284 (604)
T ss_pred eeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCC
Confidence 9999999999999999986443211 1 14478999999999999999999999999999999999999
Q ss_pred CCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 270 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 270 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+||.+.++-...+.++...+ .++..+++.+.+||+++|..||.+|+++++|..
T Consensus 285 PPFra~NeyliFqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 285 PPFRAANEYLIFQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred CCCccccHHHHHHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 99999998888888877554 588899999999999999999999999988876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=327.86 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=214.6
Q ss_pred CcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|+.+..+|+|+||+||+++ ++|+.||||.|..++ +....++...+|+++|++++|+|+|.++++|....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-------dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-------DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-------ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence 689999999999999999994 589999999995333 33456777889999999999999999999998877
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
..+ +|+|||+..-|.+ +.. ...+++...+.+++.|++.|+.|+|+++++||||||+||||+.
T Consensus 75 klh----------------LVFE~~dhTvL~e-Le~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~ 136 (396)
T KOG0593|consen 75 KLH----------------LVFEYCDHTVLHE-LER-YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ 136 (396)
T ss_pred eeE----------------EEeeecchHHHHH-HHh-ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec
Confidence 764 5999997644444 443 3456999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.|.+||||||+|+....++..++..+.|.+|.|||.+.| ..|+...|||++||++.||++|...|++.++-+++..+..
T Consensus 137 ~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 137 NGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK 216 (396)
T ss_pred CCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence 999999999999988878888888999999999999998 6799999999999999999999999999998888776655
Q ss_pred cCCCCC-----------------C------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPE-----------------I------------PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~-----------------~------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.-.... + ...++.-+.++++.||+.||.+|++.++++.
T Consensus 217 tLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 217 TLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 211100 0 1223567899999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-48 Score=333.40 Aligned_cols=249 Identities=27% Similarity=0.447 Sum_probs=213.6
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
..+|.+.+.||.|+|++||+|++ ++..||||.+.+... .....+.+..|+++|+.++|||||.++++....
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD 81 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence 47899999999999999999954 689999999965432 233455678999999999999999999999876
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++|||||.||+|.+++. ..+.+++..++.++.|++.||++||+++|+||||||.|||++
T Consensus 82 ~~i----------------~lVMEyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs 143 (429)
T KOG0595|consen 82 DFI----------------YLVMEYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLS 143 (429)
T ss_pred CeE----------------EEEEEeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEec
Confidence 655 66999999999999995 445799999999999999999999999999999999999998
Q ss_pred CC------CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 207 KN------RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 207 ~~------~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
.. -.+||.|||+|+... +.......+|++.|||||++....|+.++|+||+|+++|+|++|+.||...+..+.
T Consensus 144 ~~~~~~~~~~LKIADFGfAR~L~-~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 144 TTARNDTSPVLKIADFGFARFLQ-PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred cCCCCCCCceEEecccchhhhCC-chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 65 468999999998766 33444557899999999999999999999999999999999999999999999998
Q ss_pred HHHHHhcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 018489 281 TSAVVRQNLRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323 (355)
Q Consensus 281 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 323 (355)
...+....... .++..++..+.+++...|+.++.+|.+..+-.
T Consensus 223 ~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 223 LLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred HHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 88776654443 44556788888999999999999997665543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=329.65 Aligned_cols=257 Identities=29% Similarity=0.524 Sum_probs=214.6
Q ss_pred CCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
..++...+.||+|+||.||++... |+..|||.....+... .+.+.+|+.+|.+++|||||++++.....
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~ 86 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---------SESLEREIRILSRLNHPNIVQYYGSSSSR 86 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---------HHHHHHHHHHHHhCCCCCEEeeCCccccc
Confidence 567889999999999999999664 7999999986441110 34578999999999999999999974433
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... .++++|||+++|+|.+++....+ .+++..+..+.+|++++|.|||++|++|+||||+|||++
T Consensus 87 ~~~--------------~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~ 151 (313)
T KOG0198|consen 87 END--------------EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD 151 (313)
T ss_pred cCe--------------eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe
Confidence 321 23779999999999999976655 799999999999999999999999999999999999999
Q ss_pred C-CCcEEEeeccccccccC---CCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCC-CChhHH
Q 018489 207 K-NRTVKIADFGVARVEAS---NPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPD-LSFSEV 280 (355)
Q Consensus 207 ~-~~~v~L~Dfg~a~~~~~---~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~-~~~~~~ 280 (355)
. ++.+||.|||.+..... .........||+.|||||++..+ ...+++|||||||++.+|+||+.||.. ......
T Consensus 152 ~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~ 231 (313)
T KOG0198|consen 152 PSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA 231 (313)
T ss_pred CCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH
Confidence 9 79999999999876553 12223446799999999999953 344699999999999999999999988 455555
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
...+......+.++..++++.+++|.+|+.+||++|||+.++|+-.-..
T Consensus 232 ~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 232 LLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred HHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 6666666667789999999999999999999999999999999854443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.89 Aligned_cols=262 Identities=25% Similarity=0.515 Sum_probs=222.4
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIG 121 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~ 121 (355)
.....++|++++.||+|+||.|++|.+ +++.||+|++......... ....+.+.+|+.+++.+. ||||+++++
T Consensus 12 ~~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~----~~~~~~i~rEi~~~~~~~~HpnI~~l~e 87 (370)
T KOG0583|consen 12 LQLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS----QKLDELIKREISILRRLRSHPNIIRLLE 87 (370)
T ss_pred cccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc----cccchhhHHHHHHHHHhccCCCEeEEEE
Confidence 345668999999999999999999965 7899999977553221111 122344668999999998 999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++.....+ ++||||+.||.|.+++.. .+++.+..+..+++|++.|++|+|++||+||||||+
T Consensus 88 v~~t~~~~----------------~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~E 149 (370)
T KOG0583|consen 88 VFATPTKI----------------YIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPE 149 (370)
T ss_pred EEecCCeE----------------EEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHH
Confidence 99887775 569999999999999965 577999999999999999999999999999999999
Q ss_pred cEEEcCC-CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCC-CC-CcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 202 NMLLDKN-RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YN-RKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 202 Nili~~~-~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
||+++.+ +++||+|||++.............+|++.|+|||++.+.. |+ .++||||+|++||.|++|..||...+..
T Consensus 150 Nilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~ 229 (370)
T KOG0583|consen 150 NILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP 229 (370)
T ss_pred HEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH
Confidence 9999999 9999999999987644445566789999999999999976 76 8899999999999999999999998777
Q ss_pred HHHHHHHhcCCCCCCCCCC-cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 279 EVTSAVVRQNLRPEIPRCC-PSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
.....+..... .++..+ ++++..||.+||..||.+|+++.+|+ .-.-++.
T Consensus 230 ~l~~ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 230 NLYRKIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred HHHHHHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 77777655544 466667 99999999999999999999999999 4444443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=323.36 Aligned_cols=265 Identities=25% Similarity=0.413 Sum_probs=223.1
Q ss_pred ccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
....|.++.++|++.+.||.|..++||+|.. +++.||||++.....+. -...+.+|+..++.++||||++
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--------~ld~l~kE~~~msl~~HPNIv~ 88 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--------DLDALRKEVQTMSLIDHPNIVT 88 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--------hHHHHHHHHHHhhhcCCCCcce
Confidence 3456778889999999999999999999954 78999999996543321 1345788999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
++..|.....+++ ||.||.+|++.++++......+++..+..|++++++||.|||.+|.+||||
T Consensus 89 ~~~sFvv~~~LWv----------------VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdv 152 (516)
T KOG0582|consen 89 YHCSFVVDSELWV----------------VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDV 152 (516)
T ss_pred EEEEEEecceeEE----------------eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceeccc
Confidence 9999998877755 999999999999999888888999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCCCC----CCCCCcccccCCcccC--CCCCCCcchhHHHHHHHHHHHhCCCCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPNDM----TGETGTLGYMAPEVLN--GNPYNRKCDVYSFGICLWEIYCCDMPY 272 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~----~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~~lltg~~p~ 272 (355)
|+.||||+.+|.|+|+|||.+......+... ...+|+++|+|||++. ..+|+.++||||||++.+||.+|..||
T Consensus 153 KAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 153 KAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred ccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 9999999999999999999887655544332 4458999999999954 358999999999999999999999999
Q ss_pred CCCChhHHHHHHHhcCCC--------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHh
Q 018489 273 PDLSFSEVTSAVVRQNLR--------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAI 329 (355)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~ 329 (355)
.....-+.+-..+..... .+....++.+++++|..||++||.+|||+.++++ .++..
T Consensus 233 ~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 233 SKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred ccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 988777666555544332 1122335778999999999999999999999987 44443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=330.36 Aligned_cols=283 Identities=25% Similarity=0.358 Sum_probs=227.2
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHH-----HHHHHHHHHHHhhCCCCccce
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAAL-----RSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
....+.|++...||+|.||.|-+|.+ +++.||||++.+...........+.. .+.+.+|+.+++++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 33447999999999999999999965 68999999997555432221111111 246889999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcccc-ccHHHHHHHHHHHHHHHHHHHhCCccccC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK-LAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~-~~~~~~~~i~~qi~~al~~LH~~~i~H~d 197 (355)
++++..++..-.+ |||+|||..|.+... ..... +++.++++++++++.+|.|||.+||+|||
T Consensus 173 LiEvLDDP~s~~~--------------YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRD 235 (576)
T KOG0585|consen 173 LIEVLDDPESDKL--------------YLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRD 235 (576)
T ss_pred EEEeecCcccCce--------------EEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccc
Confidence 9999988765554 899999988877543 34455 99999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccccCC-----CCCCCCCCCcccccCCcccCCC----CCCCcchhHHHHHHHHHHHhC
Q 018489 198 VKTENMLLDKNRTVKIADFGVARVEASN-----PNDMTGETGTLGYMAPEVLNGN----PYNRKCDVYSFGICLWEIYCC 268 (355)
Q Consensus 198 i~p~Nili~~~~~v~L~Dfg~a~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~~lltg 268 (355)
|||+|+|++.+|+|||.|||.+...... ........||+.|+|||...++ ..+.+.|||++|++||+|+.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 9999999999999999999998744221 1222336799999999998763 245789999999999999999
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCCCCccee
Q 018489 269 DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIPGDQPQGCLC 348 (355)
Q Consensus 269 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~~~~~~~~~~~~ 348 (355)
..||.+....+...+++...+.......+.+.+.+||.+||.+||++|.++.+|.....-.. ........+.+.|
T Consensus 316 ~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~-----~g~~~~~s~~~~c 390 (576)
T KOG0585|consen 316 QLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR-----DGDSPQSSEPSSC 390 (576)
T ss_pred cCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc-----CCCCCccCCcccc
Confidence 99999999999999999888776666678999999999999999999999998865443222 2222345566666
Q ss_pred ee
Q 018489 349 FR 350 (355)
Q Consensus 349 ~~ 350 (355)
.+
T Consensus 391 ~~ 392 (576)
T KOG0585|consen 391 SR 392 (576)
T ss_pred ee
Confidence 44
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=333.13 Aligned_cols=266 Identities=34% Similarity=0.645 Sum_probs=234.3
Q ss_pred cccceecCCcceeecccccccceEEEEEEECCc-eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
...|++..+.+++.+.||+|.||.|+.|.+++. .||+|.++..... .+.|.+|+.++++|+|+|||+++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----------~~~f~~Ea~iMk~L~H~~lV~l~ 267 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----------PEAFLREAQIMKKLRHEKLVKLY 267 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----------hhHHHHHHHHHHhCcccCeEEEE
Confidence 777999999999999999999999999999887 9999999754322 23477999999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++...+.+ +|||||++.|+|.+++....+..+.....+.++.||+++++||+++++|||||..
T Consensus 268 gV~~~~~pi----------------yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAA 331 (468)
T KOG0197|consen 268 GVCTKQEPI----------------YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAA 331 (468)
T ss_pred EEEecCCce----------------EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhh
Confidence 999876655 6699999999999999876678899999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChh
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~ 278 (355)
.||||++++.+|++|||+|+...++.. ......-...|.|||.+..+.++.++||||||++|+||+| |+.||.+.+..
T Consensus 332 RNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ 411 (468)
T KOG0197|consen 332 RNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE 411 (468)
T ss_pred hheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence 999999999999999999994433322 2222334568999999999999999999999999999998 99999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
+.+..+.+ +.+..-|..+|+++.+++..||+.+|++|||++.+...|+++.....
T Consensus 412 ev~~~le~-GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 412 EVLELLER-GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred HHHHHHhc-cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 88876554 56667788899999999999999999999999999999999987643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=328.42 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=216.1
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
....+.|+.++.||+|+||.||+|++ +|+.||+|.++.......... -..+|+.+|++|+||||+++.+..
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~-------t~~REI~ILr~l~HpNIikL~eiv 185 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPI-------TAIREIKILRRLDHPNIIKLEEIV 185 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchH-------HHHHHHHHHHhcCCCcccceeeEE
Confidence 44567899999999999999999965 788999999988775444332 256899999999999999999987
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
..... ..+|+|+|||+. +|.-++. ...-+|++.+++-++.|++.+|.|+|++||+|||||.+||
T Consensus 186 t~~~~--------------~siYlVFeYMdh-DL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNi 249 (560)
T KOG0600|consen 186 TSKLS--------------GSIYLVFEYMDH-DLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNI 249 (560)
T ss_pred EecCC--------------ceEEEEEecccc-hhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccce
Confidence 66522 334889999965 7877774 3456799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
||+++|.+||.|||+|+++.... ...+..+.|.+|.|||++.| ..|+.+.|+||.|||+.||+.|+..|++.++.+++
T Consensus 250 Lidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl 329 (560)
T KOG0600|consen 250 LIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL 329 (560)
T ss_pred EEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence 99999999999999999765543 34777889999999999988 47999999999999999999999999999999999
Q ss_pred HHHHhcCCCC--------CC-------------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRP--------EI-------------------PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~--------~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+.+.-..+ .+ ...++....+|+..+|..||.+|.|+.++|.
T Consensus 330 ~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 330 HKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 8887722111 11 2345788999999999999999999998875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=301.72 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=217.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+|...+.||+|.||.||+|.+ +|+.||||.++..+....... ...+|+..|+.++|+||+.++++|...+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~-------talREIK~Lqel~h~nIi~LiD~F~~~~ 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINR-------TALREIKLLQELKHPNIIELIDVFPHKS 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccH-------HHHHHHHHHHHccCcchhhhhhhccCCC
Confidence 5799999999999999999976 689999999987765444332 2568999999999999999999998877
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
... ||+||++ .+|+..++. ....++...+..|+.+++++|+|||++.|+||||||.|+||+.
T Consensus 75 ~l~----------------lVfEfm~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~ 136 (318)
T KOG0659|consen 75 NLS----------------LVFEFMP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS 136 (318)
T ss_pred ceE----------------EEEEecc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC
Confidence 664 5999995 599988864 4567999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
+|.+||.|||+++............+-|..|.|||.+.| ..|+...|+||.||++.||+.+.+-|.+.++-+++..+..
T Consensus 137 ~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~ 216 (318)
T KOG0659|consen 137 DGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFR 216 (318)
T ss_pred CCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHH
Confidence 999999999999998888777777789999999999887 4799999999999999999999999999998888888877
Q ss_pred cCCCCC--------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 287 QNLRPE--------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 287 ~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
.-..+. +....+.++.+|+.+||.+||.+|+++.|+++.
T Consensus 217 ~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 217 ALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 333221 112246778999999999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=306.90 Aligned_cols=241 Identities=28% Similarity=0.451 Sum_probs=215.6
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
...++|++++.||.|+||.|.+++. ++..+|+|++.+. ........+...+|..+|+.+.||.++++++.+.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~------~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQ------KVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHH------HHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 4557899999999999999999954 6899999999543 2333445566889999999999999999999888
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
+.+.. ++||||++||.|..+++ +.+++++..++.++.||+.||+|||+++|++||+||+|||
T Consensus 115 d~~~l----------------ymvmeyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiL 176 (355)
T KOG0616|consen 115 DNSNL----------------YMVMEYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLL 176 (355)
T ss_pred cCCeE----------------EEEEeccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHee
Confidence 76665 56999999999999995 4577999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
++.+|.+|++|||+|...... ....+||+.|+|||++.+.++..++|.|+||+++|||+.|..||...+.-....++
T Consensus 177 lD~~G~iKitDFGFAK~v~~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI 253 (355)
T KOG0616|consen 177 LDQNGHIKITDFGFAKRVSGR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI 253 (355)
T ss_pred eccCCcEEEEeccceEEecCc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH
Confidence 999999999999999866533 34478999999999999999999999999999999999999999999998999999
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 316 (355)
+..... +|..++.++.+||+++|+.|-.+|
T Consensus 254 ~~~~v~--fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 254 LEGKVK--FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HhCccc--CCcccCHHHHHHHHHHHhhhhHhh
Confidence 887664 888999999999999999999999
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=315.70 Aligned_cols=280 Identities=23% Similarity=0.330 Sum_probs=231.6
Q ss_pred cccceecCCcceeecccccccceEEEEEEECC--ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG--HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
.+...+..+.|++++.||+|.-|+||++...+ ..+|+|++.+... ....-..+...|-+||+.++||.++.+
T Consensus 69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l------~~rkKl~Ra~tE~eIL~~lDHPFlPTL 142 (459)
T KOG0610|consen 69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL------ASRKKLKRAQTEREILSLLDHPFLPTL 142 (459)
T ss_pred cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH------hhhhHHHHHHHHHHHHHhcCCCccchh
Confidence 45677888999999999999999999997654 7899999954332 222233457789999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
|..|...+.. |++||||+||+|..+.+++.++.+++..++.++.+++-||+|||..|||+||||
T Consensus 143 Ya~fet~~~~----------------cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLK 206 (459)
T KOG0610|consen 143 YASFETDKYS----------------CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLK 206 (459)
T ss_pred hheeecccee----------------EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCC
Confidence 9998865544 789999999999999999999999999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccC---------------------------------C-C-------------------
Q 018489 200 TENMLLDKNRTVKIADFGVARVEAS---------------------------------N-P------------------- 226 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~---------------------------------~-~------------------- 226 (355)
|+||||-++|++.|+||.++..... . .
T Consensus 207 PENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ae 286 (459)
T KOG0610|consen 207 PENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAE 286 (459)
T ss_pred cceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcC
Confidence 9999999999999999998753111 0 0
Q ss_pred ---CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHH
Q 018489 227 ---NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLAN 303 (355)
Q Consensus 227 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 303 (355)
......+||-.|.|||++.|...+.+.|.|+||+++|||+.|..||.+.+.++.+.+++.......-...++..+++
T Consensus 287 p~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akD 366 (459)
T KOG0610|consen 287 PTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKD 366 (459)
T ss_pred CCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHH
Confidence 01123458899999999999999999999999999999999999999999999999999887776555678899999
Q ss_pred HHHHhhhcCCCCCCC----HHHHHH--HHHHhHhhcCCCCCCCCCC
Q 018489 304 VMKRCWDANPDKRPE----MDEVVS--MLEAIDTSKGGGMIPGDQP 343 (355)
Q Consensus 304 li~~~l~~~p~~Rps----~~ell~--~l~~~~~~~~~~~~~~~~~ 343 (355)
||+++|.+||.+|.. +.||.+ .++.++=..-....|++-|
T Consensus 367 LIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP 412 (459)
T KOG0610|consen 367 LIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIP 412 (459)
T ss_pred HHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCC
Confidence 999999999999998 555544 3444433334444444443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=331.91 Aligned_cols=265 Identities=30% Similarity=0.578 Sum_probs=214.8
Q ss_pred cceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCc
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 115 (355)
.|++..++|++.+.||+|+||.||+|.+ ++..||+|+++.... . ...+.+.+|+.++..+ +|||
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~l~~h~n 72 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT----A----SEHKALMSELKILIHIGNHLN 72 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc----h----HHHHHHHHHHHHHHHhccCcc
Confidence 3678889999999999999999999964 246799999853221 1 1124578899999999 8999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc------------------------------
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------------------------ 165 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------------ 165 (355)
|+++++++...+. ..+++|||+++|+|.+++....
T Consensus 73 iv~~~~~~~~~~~---------------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (338)
T cd05102 73 VVNLLGACTKPNG---------------PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRI 137 (338)
T ss_pred eeeEEeEecCCCC---------------ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccccc
Confidence 9999997754332 2367999999999999986432
Q ss_pred ------------------------------cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEee
Q 018489 166 ------------------------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (355)
Q Consensus 166 ------------------------------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~D 215 (355)
...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~D 217 (338)
T cd05102 138 EAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICD 217 (338)
T ss_pred ccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEee
Confidence 13477889999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCC
Q 018489 216 FGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPE 292 (355)
Q Consensus 216 fg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~ 292 (355)
||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+.............
T Consensus 218 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 297 (338)
T cd05102 218 FGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297 (338)
T ss_pred cccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC
Confidence 999875432211 1122345678999999998889999999999999999997 9999988665544444444444455
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 293 IPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 293 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
.+..+++++.++|.+||+.||.+|||+.++++.|+++..
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 667789999999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=329.16 Aligned_cols=252 Identities=26% Similarity=0.364 Sum_probs=213.0
Q ss_pred cCCcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeecc
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATM 124 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~ 124 (355)
..++|.+.+.||.|+||.||+|+ .+++.||||.++..-. .-++.. -.||+..|++++ ||||+++.+++.
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~---s~ee~~-----nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY---SWEECM-----NLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc---cHHHHH-----HHHHHHHHHhcCCCCcchhhHHHhh
Confidence 45799999999999999999994 5799999999864322 112222 347999999997 999999999998
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
+.+. .+++||||| ...|..+++.. ++.|+++.+..|+.||+++|+|+|++|+.|||+||+|||
T Consensus 80 d~~~---------------~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiL 142 (538)
T KOG0661|consen 80 DNDR---------------ILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENIL 142 (538)
T ss_pred ccCc---------------eEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheE
Confidence 8763 236799999 66999998765 888999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
|.....+||+|||+|+-.. ....++..+.|.+|+|||++. .+.|+.+.|+|++||+++|+.+-+..|++.++-+++.+
T Consensus 143 i~~~~~iKiaDFGLARev~-SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K 221 (538)
T KOG0661|consen 143 ISGNDVIKIADFGLAREVR-SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK 221 (538)
T ss_pred ecccceeEecccccccccc-cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH
Confidence 9999999999999998544 345567789999999999875 57899999999999999999999999999998888877
Q ss_pred HHhcCCCCC----------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 284 VVRQNLRPE----------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 284 ~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
+..--..+. +....+.++.++|..||.+||.+|||+.++++.
T Consensus 222 Ic~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 222 ICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 765222211 123368899999999999999999999999973
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=298.56 Aligned_cols=255 Identities=27% Similarity=0.452 Sum_probs=227.3
Q ss_pred cccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
...|.+ ++|.+++.||+|-||.||+|.. ++..||+|++-+. +-........+.+|+++.+.|+||||+++
T Consensus 16 ~~~~~l--~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKs------qi~~~~v~~qlrREiEIqs~L~hpnilrl 87 (281)
T KOG0580|consen 16 TKTWTL--DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS------QILKTQVEHQLRREIEIQSHLRHPNILRL 87 (281)
T ss_pred ccccch--hhccccccccCCccccEeEeeeccCCcEEEEeeeeHH------HHHHhcchhhhhheeEeecccCCccHHhh
Confidence 345555 7999999999999999999965 5678999999432 33344456778999999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
|++|.+.... |+++||.++|++...+......++++...+.++.|++.|+.|+|.++|+|||||
T Consensus 88 Y~~fhd~~ri----------------yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiK 151 (281)
T KOG0580|consen 88 YGYFHDSKRI----------------YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIK 151 (281)
T ss_pred hhheecccee----------------EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCC
Confidence 9999987776 569999999999999987778889999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
|+|+|++..+.+++.|||.+...+ .......+||..|.+||...+...+...|+|++|++.|+++.|..||...+..+
T Consensus 152 penlLlg~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e 229 (281)
T KOG0580|consen 152 PENLLLGSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE 229 (281)
T ss_pred HHHhccCCCCCeeccCCCceeecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH
Confidence 999999999999999999997554 344556789999999999999999999999999999999999999999999889
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+..+.+.... ++..++.+..++|.+||..+|.+|.+..|++.
T Consensus 230 tYkrI~k~~~~--~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 230 TYKRIRKVDLK--FPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HHHHHHHcccc--CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 99888876654 66889999999999999999999999999876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=318.85 Aligned_cols=258 Identities=22% Similarity=0.418 Sum_probs=217.1
Q ss_pred CCcceee--cccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC-
Q 018489 49 PSKLVIK--SVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG- 125 (355)
Q Consensus 49 ~~~y~i~--~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~- 125 (355)
.+++... ..||+|+++.||+|.++++.||+|.++..... ...+.+.+.+|+.++.+++||||+++++++.+
T Consensus 17 ~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 17 SDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKG------HKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred HHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccc------cHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 3344444 67899999999999999999999998654321 12234568899999999999999999998865
Q ss_pred -CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcE
Q 018489 126 -SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENM 203 (355)
Q Consensus 126 -~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~di~p~Ni 203 (355)
... ...+++|||+++|+|.+++.. ...+++...+.++.+++.+|.+||+. +++|+||+|+||
T Consensus 91 ~~~~--------------~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~ni 154 (283)
T PHA02988 91 VDDL--------------PRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSF 154 (283)
T ss_pred ccCC--------------CceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhE
Confidence 221 233789999999999999954 45689999999999999999999985 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+..
T Consensus 155 ll~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~ 231 (283)
T PHA02988 155 LVTENYKLKIICHGLEKILSSP---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY 231 (283)
T ss_pred EECCCCcEEEcccchHhhhccc---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999999999999998754322 123467889999999976 67899999999999999999999999988887777
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
..+........++..+++++.+++.+||+.||++|||+.++++.|+.++.
T Consensus 232 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 232 DLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 77766666666777789999999999999999999999999999998864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=326.45 Aligned_cols=264 Identities=25% Similarity=0.430 Sum_probs=220.0
Q ss_pred ccchhhcccccceecCCcceeecccccccceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC
Q 018489 34 ASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111 (355)
Q Consensus 34 ~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 111 (355)
+..+++..+.++ ..++|+++..||+|+||.||+| +++|+.+|+|++++........ .+.+..|-.+|...
T Consensus 127 Ete~lR~~R~r~--~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Q------v~hV~aERdiL~~~ 198 (550)
T KOG0605|consen 127 ETEYLRLRRTRL--SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQ------VEHVRAERDILAEV 198 (550)
T ss_pred HHHHHHhccccC--CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhh------HHHHHHHHHHhhhc
Confidence 444555555544 5589999999999999999999 4689999999997655433222 34467788888889
Q ss_pred CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC
Q 018489 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ 191 (355)
Q Consensus 112 ~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 191 (355)
.+|.||+++..|.+.+.+ ||||||++||++..+|. ....+++..+..++.+++.||..+|+.
T Consensus 199 ds~~vVKLyYsFQD~~~L----------------YLiMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~ 260 (550)
T KOG0605|consen 199 DSPWVVKLYYSFQDKEYL----------------YLIMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQL 260 (550)
T ss_pred CCCcEEEEEEEecCCCee----------------EEEEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHc
Confidence 999999999999887766 56999999999999994 457799999999999999999999999
Q ss_pred CccccCCCCCcEEEcCCCcEEEeeccccccccC--------------------CCCCC----------------------
Q 018489 192 KIVHRDVKTENMLLDKNRTVKIADFGVARVEAS--------------------NPNDM---------------------- 229 (355)
Q Consensus 192 ~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~--------------------~~~~~---------------------- 229 (355)
|++||||||+|+||+..|++||+|||++.-... .....
T Consensus 261 gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~n 340 (550)
T KOG0605|consen 261 GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRN 340 (550)
T ss_pred CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhh
Confidence 999999999999999999999999999852111 00000
Q ss_pred -----CCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC--CCCcHHHH
Q 018489 230 -----TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP--RCCPSSLA 302 (355)
Q Consensus 230 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~ 302 (355)
...+||+-|+|||++.+.+|+...|.||||||+||||.|.+||.+.+..+....++.+.....+| ..+++++.
T Consensus 341 rr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~ 420 (550)
T KOG0605|consen 341 RRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAK 420 (550)
T ss_pred hhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHH
Confidence 11249999999999999999999999999999999999999999999999999999887555555 44789999
Q ss_pred HHHHHhhhcCCCCCCC---HHHHHH
Q 018489 303 NVMKRCWDANPDKRPE---MDEVVS 324 (355)
Q Consensus 303 ~li~~~l~~~p~~Rps---~~ell~ 324 (355)
+||.+||. ||++|.. ++||.+
T Consensus 421 DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 421 DLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHhc-CHHHhcCcccHHHHhc
Confidence 99999998 9999975 555543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=328.10 Aligned_cols=247 Identities=27% Similarity=0.478 Sum_probs=216.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
..|.....||+|+.|.||.+.. ++..||||.+....... ++.+.+|+.+++..+|+|||.+++.|...+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---------keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---------KELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---------hhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 5788899999999999999954 67889999997655443 345789999999999999999999999887
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.+++ ||||++||+|.+.+.. ..+++.++..|++++++||.|||.+||+|+|||.+||+++.
T Consensus 344 eLWV----------------VMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~ 404 (550)
T KOG0578|consen 344 ELWV----------------VMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTM 404 (550)
T ss_pred eeEE----------------EEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEecc
Confidence 7755 9999999999999854 45999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh-
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR- 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~- 286 (355)
+|.+||+|||++.............+||+.|||||++....|+++.||||||+++.||+-|..||-..+.-..+..+-.
T Consensus 405 ~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n 484 (550)
T KOG0578|consen 405 DGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 484 (550)
T ss_pred CCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc
Confidence 9999999999998766655566678999999999999999999999999999999999999999976555444444433
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.......++.+++++++++.+||+.|+++|+++.|||+
T Consensus 485 g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 485 GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 33344566779999999999999999999999999997
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=327.75 Aligned_cols=247 Identities=33% Similarity=0.565 Sum_probs=220.1
Q ss_pred CcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|.+.+.||+|.||.||+|+ .+.+.||+|.+.+.... +.+ .+.+.+|+++++.++||||+.+++.|....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~---~k~----l~~l~~ev~i~r~lkHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN---EKE----LKNLRQEVRILRSLKHPNIVEMLESFETSA 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc---hHH----HHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence 689999999999999999994 57789999999654432 222 345789999999999999999999998877
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
++ ++|.||+.| +|..++. ..+.++++.+..++.+++.||.|||+.+|+|+|+||.||++..
T Consensus 75 ~~----------------~vVte~a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~ 135 (808)
T KOG0597|consen 75 HL----------------WVVTEYAVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEK 135 (808)
T ss_pred eE----------------EEEehhhhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecC
Confidence 66 559999976 9999994 5678999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
.|.+|++|||+|+.............||+.|||||...+..|+..+|+|||||++|+|+.|++||-..+..+....+...
T Consensus 136 ~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d 215 (808)
T KOG0597|consen 136 GGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD 215 (808)
T ss_pred CCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC
Confidence 99999999999998777666677778999999999999999999999999999999999999999998888888888775
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... .+...+..+.+++..+|.+||.+|.+..+++.
T Consensus 216 ~v~--~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 216 PVK--PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCC--CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 443 45578999999999999999999999999886
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=324.38 Aligned_cols=254 Identities=26% Similarity=0.477 Sum_probs=227.9
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|.+++++|+|+||.++++++ ++..+++|.+......... ++...+|+.+++++.|||||.+.+.|...
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-------r~~A~~E~~lis~~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-------RRSAIQEMDLLSKLLHPNIVEYKDSFEED 75 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-------hHHHHHHHHHHHhccCCCeeeeccchhcC
Confidence 47899999999999999998754 5778999999765544332 33567899999999999999999998875
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.+ .||+|+|++||++.+.+.+.++..+++..+++|+.|++.|+.|||+++|+|||||+.|||++
T Consensus 76 ~~~---------------l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt 140 (426)
T KOG0589|consen 76 GQL---------------LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT 140 (426)
T ss_pred Cce---------------EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc
Confidence 542 47899999999999999988888899999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.|+|+|||+|+............+||+.|++||++.+.+|..++|||||||++|+|++-+.+|.+.+.......+..
T Consensus 141 k~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~ 220 (426)
T KOG0589|consen 141 KDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR 220 (426)
T ss_pred ccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh
Confidence 99999999999999877665455667899999999999999999999999999999999999999999999999988887
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
.. ...++..++.+++.+|+.||+.+|+.||++.++|..
T Consensus 221 ~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 66 456788899999999999999999999999999986
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=305.40 Aligned_cols=253 Identities=28% Similarity=0.355 Sum_probs=217.2
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.+.|++++.|++|+||.||+|++ +++.||+|.++........... ..+|+.+|.+++|||||.+-++....
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIt-------sLREIniLl~~~H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPIT-------SLREINILLKARHPNIVEVKEVVVGS 147 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcch-------hHHHHHHHHhcCCCCeeeeEEEEecc
Confidence 46899999999999999999976 6789999999876654444321 45799999999999999998887655
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.-. .|||||||+. +|..++.. ..++|+..+++-++.|++.++.|||...|+||||||+|+|++
T Consensus 148 ~~d~--------------iy~VMe~~Eh-DLksl~d~-m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~ 211 (419)
T KOG0663|consen 148 NMDK--------------IYIVMEYVEH-DLKSLMET-MKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS 211 (419)
T ss_pred ccce--------------eeeeHHHHHh-hHHHHHHh-ccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec
Confidence 4333 3889999965 88888875 457899999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
+.|.+|++|||+|+-+.++....+..+.|.+|.|||++.| ..|+.+.|+||+|||+.+|+++++.|.+.++-+++..++
T Consensus 212 ~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If 291 (419)
T KOG0663|consen 212 HKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIF 291 (419)
T ss_pred cCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHH
Confidence 9999999999999988888777888899999999999987 579999999999999999999999999999988888887
Q ss_pred hcCCCCC-----------------------------CCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPE-----------------------------IPRC-CPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~-----------------------------~~~~-~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..-..+. +... +++.-.+|+..+|.+||.+|.|+.+.|+
T Consensus 292 ~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 292 KLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred HHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 7322211 1111 4578899999999999999999999886
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=328.10 Aligned_cols=248 Identities=28% Similarity=0.463 Sum_probs=219.8
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIG 121 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~ 121 (355)
..+..++|.++++||+|.||+|+++.. +++.+|||++++...-.+.+.+ ..+.|.+++... +||.++.++.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve------~~~~EkrI~~la~~HPFL~~L~~ 436 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVE------SLMCEKRIFELANRHPFLVNLFS 436 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHH------HHHHHHHHHHHhccCCeEeeccc
Confidence 356678999999999999999999954 6789999999988876555533 245677777777 6999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
+|...++. |+||||+.||++..++ ....|++..+..++..|+.||.|||++||++||||.+
T Consensus 437 ~fQT~~~l----------------~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLd 497 (694)
T KOG0694|consen 437 CFQTKEHL----------------FFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLD 497 (694)
T ss_pred ccccCCeE----------------EEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchh
Confidence 99988877 4599999999954433 5577999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
|||++.+|++||.|||++.-....+......+||+.|+|||++.+..|+.+.|.|+||+++|+||.|..||.+.++++..
T Consensus 498 NiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F 577 (694)
T KOG0694|consen 498 NLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF 577 (694)
T ss_pred heEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99999999999999999987666666777899999999999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
..++.... .+|..++.+..++++++|.++|++|..+
T Consensus 578 dsI~~d~~--~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDEV--RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCCC--CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 99987554 4788899999999999999999999754
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=317.03 Aligned_cols=246 Identities=27% Similarity=0.401 Sum_probs=208.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV------IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH------hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence 4799999999999999999976 488999999853221 11122445788999999999999999998776554
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++.. ...+++..++.++.|++.||+|||++|++|+||+|+||+++.
T Consensus 75 ~~----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~ 136 (291)
T cd05612 75 FL----------------YMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK 136 (291)
T ss_pred eE----------------EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC
Confidence 43 679999999999999854 456899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.++|+|||.+...... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+...
T Consensus 137 ~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 213 (291)
T cd05612 137 EGHIKLTDFGFAKKLRDR---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213 (291)
T ss_pred CCCEEEEecCcchhccCC---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 999999999998754322 22346889999999999988999999999999999999999999988877767666554
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVS 324 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 324 (355)
. ..++..+++.+.++|++||+.||.+||+ ++++++
T Consensus 214 ~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 214 K--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred C--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 3 3466777999999999999999999995 888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=311.79 Aligned_cols=250 Identities=26% Similarity=0.508 Sum_probs=218.6
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
...+|++.+.||+|+||.|-+|.+ .|+.||||.++++......+ .-.+.+|+++++.|+||||+.+|++|..
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqD------lvhIRREIeIMSsLNHPhII~IyEVFEN 124 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQD------LVHIRREIEIMSSLNHPHIIQIYEVFEN 124 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHH------HHHHHHHHHHHhhcCCCceeehhhhhcC
Confidence 358999999999999999999954 68999999998765433222 2237789999999999999999999998
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.+ .|||||..+|.|.+++. ..+.+++.++..+++||++|+.|+|+++++|||||.+|||+
T Consensus 125 kdKI----------------vivMEYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL 186 (668)
T KOG0611|consen 125 KDKI----------------VIVMEYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL 186 (668)
T ss_pred CceE----------------EEEEEecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee
Confidence 8877 45999999999999994 45779999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCC-CcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.++++|+.|||++-.+... .-...++|++.|.+||+++|.+|. +..|.||||++||.|+.|..||.+.+...+...+
T Consensus 187 D~N~NiKIADFGLSNly~~~-kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI 265 (668)
T KOG0611|consen 187 DQNNNIKIADFGLSNLYADK-KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI 265 (668)
T ss_pred cCCCCeeeeccchhhhhccc-cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh
Confidence 99999999999999766543 445668999999999999998774 7899999999999999999999999999888888
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
....+. ....|....-||++||-.||++|.|+.+|.+-
T Consensus 266 s~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 266 SRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred hccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 776653 23346678999999999999999999999863
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=324.65 Aligned_cols=248 Identities=29% Similarity=0.534 Sum_probs=219.3
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
+-|++++.||.|+.|.|-+|++ +|+..|||++.+...... ..-..+.+|+-+++.+.|||++.+|+++....
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~------s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSS------SQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccccccc------ccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 3588999999999999999965 899999999975532111 11233778999999999999999999998877
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
++ |+|.||++||.|.+++. ..+++++.++.++++||+.++.|+|..+|+|||+||+|++++.
T Consensus 86 ~l----------------ylvlEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~ 147 (786)
T KOG0588|consen 86 HL----------------YLVLEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV 147 (786)
T ss_pred eE----------------EEEEEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc
Confidence 76 45999999999999994 5678999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCC-CcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.+++|+.|||.|.... ++......+|++.|.+||++.|..|+ .++||||-|+|||.||+|++||++-+....+.++..
T Consensus 148 ~~nIKIADFGMAsLe~-~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~ 226 (786)
T KOG0588|consen 148 KNNIKIADFGMASLEV-PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR 226 (786)
T ss_pred ccCEeeeccceeeccc-CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence 9999999999998554 44556678999999999999998775 789999999999999999999998888888888877
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+.+ ++|.+++.++++||++||..||++|+|.+||++
T Consensus 227 G~f--~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 227 GVF--EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred Ccc--cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 655 589999999999999999999999999999998
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=318.80 Aligned_cols=249 Identities=30% Similarity=0.483 Sum_probs=215.9
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
...|...+.||+|.||.||+|.+ +++.||+|++...... .-.+.+.+|+.+|.+++++||.++|+.|..+
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--------deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--------DEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcc--------hhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 46688889999999999999965 6899999999654322 1134577899999999999999999999988
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
..+++ +|||+.||++.+.+ ..+..+.+..+..++++++.|+.|||.++.+|+|||+.||+++
T Consensus 84 ~~Lwi----------------iMey~~gGsv~~lL--~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s 145 (467)
T KOG0201|consen 84 TKLWI----------------IMEYCGGGSVLDLL--KSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS 145 (467)
T ss_pred ccHHH----------------HHHHhcCcchhhhh--ccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe
Confidence 88866 99999999999999 3455569999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.+|.|+|+|||.+.............+||+.|||||++.+..|+.++||||||++.++|++|.+||...+....+.. +.
T Consensus 146 ~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-Ip 224 (467)
T KOG0201|consen 146 ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-IP 224 (467)
T ss_pred ccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-cc
Confidence 99999999999998666655555778999999999999998999999999999999999999999988776443333 33
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....+.+...+++.+++++..||++||+.||++.++|+
T Consensus 225 k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 225 KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 34555666788999999999999999999999998886
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=292.15 Aligned_cols=269 Identities=21% Similarity=0.335 Sum_probs=216.0
Q ss_pred cccceecCCcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
+.++.++.+||+|.+.||+|+|+-||+++ .++..||+|.+..... .-.+...+|++..++++|||++++
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---------~~~e~~~rEid~~rkf~s~~vl~l 83 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---------EDIEEALREIDNHRKFNSPNVLRL 83 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---------HHHHHHHHHHHHHHhhCCcchHHH
Confidence 67788999999999999999999999985 5889999999865441 113446789999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--cccccHHHHHHHHHHHHHHHHHHHhCC--ccc
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQK--IVH 195 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H 195 (355)
+++......- .....+|+++|...|+|.+.+.... +..+++.++++|+.++++||.+||+.. +.|
T Consensus 84 ~dh~l~~~~D-----------~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH 152 (302)
T KOG2345|consen 84 VDHQLREEKD-----------GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAH 152 (302)
T ss_pred HHHHHHhhcc-----------CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccc
Confidence 9877643320 1345688999999999999987543 446999999999999999999999998 999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccccccccCC---------CCCCCCCCCcccccCCcccCC---CCCCCcchhHHHHHHHH
Q 018489 196 RDVKTENMLLDKNRTVKIADFGVARVEASN---------PNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLW 263 (355)
Q Consensus 196 ~di~p~Nili~~~~~v~L~Dfg~a~~~~~~---------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~ 263 (355)
+||||.||+++.++.++|.|||.++...-. ........+|..|.|||.++- ...+.++|||||||++|
T Consensus 153 ~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY 232 (302)
T KOG2345|consen 153 RDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY 232 (302)
T ss_pred cCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence 999999999999999999999998743221 122344568899999999974 46789999999999999
Q ss_pred HHHhCCCCCCCCChh--HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 264 EIYCCDMPYPDLSFS--EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 264 ~lltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
.|+.|..||+..-.. .....+.......+....+|..+.++|++||+.||.+||++.+++..++++.
T Consensus 233 a~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 233 AMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 999999999642111 1111222222332333448999999999999999999999999999998874
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=318.85 Aligned_cols=243 Identities=27% Similarity=0.446 Sum_probs=203.9
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~ 133 (355)
+.||+|+||.||++.+ +++.||+|+++.... ........+.+|+.++..++||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~---- 70 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI------IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRL---- 70 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEE----
Confidence 4689999999999965 688999999863221 1111223466899999999999999999888765544
Q ss_pred ccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 018489 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (355)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L 213 (355)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|
T Consensus 71 ------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl 136 (323)
T cd05571 71 ------------CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKI 136 (323)
T ss_pred ------------EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEE
Confidence 679999999999998853 467899999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC
Q 018489 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293 (355)
Q Consensus 214 ~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
+|||++..............|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.... ..+
T Consensus 137 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~--~~~ 214 (323)
T cd05571 137 TDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRF 214 (323)
T ss_pred eeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCC
Confidence 999998754333333444578999999999999999999999999999999999999998877766666555433 356
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 294 PRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 294 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
+..+++++.++|.+||+.||.+|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 778899999999999999999999 7998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=323.64 Aligned_cols=267 Identities=28% Similarity=0.525 Sum_probs=217.4
Q ss_pred cccccceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-
Q 018489 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL- 111 (355)
Q Consensus 40 ~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 111 (355)
...+.|.+..++|++.+.||+|+||.||+|.+ ++..||+|+++..... ...+.+.+|+.+++.+
T Consensus 28 ~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~il~~l~ 99 (374)
T cd05106 28 PYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--------DEREALMSELKILSHLG 99 (374)
T ss_pred cccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--------HHHHHHHHHHHHHHhhc
Confidence 34456778888999999999999999999864 2247999998643211 1134577899999999
Q ss_pred CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------------------
Q 018489 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-------------------------- 165 (355)
Q Consensus 112 ~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------------- 165 (355)
+|+||+++++.+...+.. ++||||+++|+|.+++....
T Consensus 100 ~h~nIv~~~~~~~~~~~~----------------~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (374)
T cd05106 100 QHKNIVNLLGACTHGGPV----------------LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLE 163 (374)
T ss_pred cCCceeeEeeEecCCCCe----------------EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchh
Confidence 899999999988765544 66999999999999985432
Q ss_pred ------------------------------------------cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 166 ------------------------------------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 166 ------------------------------------------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...+++..+++++.||+.||.|||++|++||||||+||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Ni 243 (374)
T cd05106 164 KKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNV 243 (374)
T ss_pred cccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheE
Confidence 12478889999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~ 280 (355)
+++.++.++|+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||........
T Consensus 244 l~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~ 323 (374)
T cd05106 244 LLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK 323 (374)
T ss_pred EEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH
Confidence 9999999999999998754322111 112234567999999988889999999999999999997 9999987765555
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
.............+...++++.++|.+||+.||.+||++.+++++|+++.
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 324 FYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 55555555555566677999999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=318.79 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=208.9
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI------LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH------hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 47899999999999999999976 578899999863221 1112245578899999999999999999988766
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. +++|||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 91 ~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~ 152 (329)
T PTZ00263 91 NRV----------------YFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD 152 (329)
T ss_pred CEE----------------EEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC
Confidence 554 669999999999999854 45689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+..
T Consensus 153 ~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 229 (329)
T PTZ00263 153 NKGHVKVTDFGFAKKVPDR---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229 (329)
T ss_pred CCCCEEEeeccCceEcCCC---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 9999999999998754332 2234688999999999998899999999999999999999999988777666666554
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 324 (355)
.. ..++..++..+.++|.+||+.||.+|++ +++++.
T Consensus 230 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 230 GR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 43 3466778999999999999999999986 677764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=320.97 Aligned_cols=267 Identities=34% Similarity=0.650 Sum_probs=225.1
Q ss_pred ccccceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
..++|++..+...+...||+|.||+||+|.|.|. ||||++....... + ..+.|++|+.+|++-+|.||+-+.
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~---~----qlqaFKnEVa~lkkTRH~NIlLFM 454 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTP---E----QLQAFKNEVAVLKKTRHENILLFM 454 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCCH---H----HHHHHHHHHHHHhhcchhhheeee
Confidence 3477999999999999999999999999999885 8999997655432 2 356799999999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
|++..+.. .||..+|+|.+|..+++.. ...|.....+.|++|+++++.|||.++|+|+|||.
T Consensus 455 G~~~~p~~-----------------AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKS 516 (678)
T KOG0193|consen 455 GACMNPPL-----------------AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKS 516 (678)
T ss_pred hhhcCCce-----------------eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccc
Confidence 99886654 4699999999999999754 46799999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeecccccccc--CCCCCCCCCCCcccccCCcccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 201 ENMLLDKNRTVKIADFGVARVEA--SNPNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~--~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
.|||+.++++|||+|||++.... ..........+...|+|||+++. .+|++.+|||++|+++|||++|.+||...
T Consensus 517 nNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~ 596 (678)
T KOG0193|consen 517 NNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ 596 (678)
T ss_pred cceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC
Confidence 99999999999999999987432 22233334567889999999874 57999999999999999999999999965
Q ss_pred ChhHHHHHHHhcCCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 276 SFSEVTSAVVRQNLRPE---IPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
..++.+..+-++.+.+. ....++.++.+|+..||.+++++||.+.+|+..|..+.-+.
T Consensus 597 ~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 597 NRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 55555555544433333 33557889999999999999999999999999888887654
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=304.95 Aligned_cols=258 Identities=31% Similarity=0.597 Sum_probs=215.5
Q ss_pred ceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
|++..++|++.+.||+|++|.||+|.. ++..|++|.+..... ..+.+.+|+.+++.++|+||+++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----------SVQAFLEEANLMKTLQHDKLVRLYAVV 70 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch----------hHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 567889999999999999999999965 567799998753221 124578899999999999999999887
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...+.. +++|||+++++|.+++.......+++..++.++.|++.+|+|||+.+++|+||+|+||
T Consensus 71 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 134 (261)
T cd05072 71 TKEEPI----------------YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANV 134 (261)
T ss_pred cCCCCc----------------EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 665544 6699999999999999766666789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~ 281 (355)
+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 135 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~ 214 (261)
T cd05072 135 LVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM 214 (261)
T ss_pred EecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH
Confidence 999999999999999975543221 1122335668999999998889999999999999999998 99999887766655
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
..+.. .........++.++.+++.+||+.+|++||++++++++|+++
T Consensus 215 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 215 SALQR-GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHc-CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 55443 333444556889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=309.03 Aligned_cols=250 Identities=25% Similarity=0.340 Sum_probs=203.9
Q ss_pred ceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
|++.+.||+|+||.||++.+ +++.||+|.+...... .......+.+|+.++..++|++|+++++.+...+..
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~ 75 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh------hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeE
Confidence 78899999999999999964 6899999998543211 111223467899999999999999999988765544
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
+++|||+++++|...+.......+++..++.++.|++.||.|||++|++|+||||+||+++.++
T Consensus 76 ----------------~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~ 139 (285)
T cd05631 76 ----------------CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG 139 (285)
T ss_pred ----------------EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC
Confidence 6799999999999888654455799999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh--c
Q 018489 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR--Q 287 (355)
Q Consensus 210 ~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~--~ 287 (355)
.++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.. .
T Consensus 140 ~~kl~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 218 (285)
T cd05631 140 HIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK 218 (285)
T ss_pred CEEEeeCCCcEEcCCC-CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh
Confidence 9999999998754322 222345689999999999999999999999999999999999999987654322222211 1
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVS 324 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 324 (355)
.....++..++.++.+||++||+.||.+||+ ++++++
T Consensus 219 ~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 219 EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 2233456678999999999999999999997 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=316.89 Aligned_cols=249 Identities=21% Similarity=0.308 Sum_probs=208.1
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||+|+++.... ........+.+|+.++..++||||+++++++...+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL------FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH------hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence 4799999999999999999976 578999999963221 11122345778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.
T Consensus 75 ~~----------------~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~ 136 (333)
T cd05600 75 YL----------------YLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA 136 (333)
T ss_pred EE----------------EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 44 679999999999999953 456899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.++|+|||.+..... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+...
T Consensus 137 ~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 213 (333)
T cd05600 137 SGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213 (333)
T ss_pred CCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc
Confidence 99999999999875433 233457899999999999989999999999999999999999999988777766655443
Q ss_pred CCCCCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 288 NLRPEIP------RCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 288 ~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
......+ ..+++++.++|.+||..+|.+||++.++++.
T Consensus 214 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 214 KETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 2221111 2458999999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=321.03 Aligned_cols=262 Identities=32% Similarity=0.577 Sum_probs=212.9
Q ss_pred cceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCc
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 115 (355)
.|.+..++|++.+.||+|+||.||+|.+ ++..||+|+++..... ...+.+.+|+.++..+ +|||
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~~Ei~il~~l~~Hpn 100 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--------TEREALMSELKVLSYLGNHIN 100 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--------HHHHHHHHHHHHHHHhcCCcc
Confidence 4556667899999999999999999863 3567999998533211 1134577899999999 8999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc------------------------------
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------------------------ 165 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------------ 165 (355)
|+++++++...+.. ++||||+++|+|.+++....
T Consensus 101 Iv~l~~~~~~~~~~----------------~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (375)
T cd05104 101 IVNLLGACTVGGPT----------------LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDS 164 (375)
T ss_pred eeeeeeeeccCCcc----------------eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchh
Confidence 99999988776655 56999999999999986432
Q ss_pred -------------------------------------------cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 166 -------------------------------------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 166 -------------------------------------------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
...+++..++.++.||+.||.|||+.|++|+||||+|
T Consensus 165 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 244 (375)
T cd05104 165 LNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARN 244 (375)
T ss_pred hhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhh
Confidence 1247888999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~ 279 (355)
|+++.++.++|+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 245 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~ 324 (375)
T cd05104 245 ILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324 (375)
T ss_pred EEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH
Confidence 99999999999999998754332211 111234567999999999899999999999999999998 899998766555
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
..............+...+.++.++|.+||+.||++||++.+|++.|++.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 325 KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 55555555555555666789999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=303.21 Aligned_cols=258 Identities=31% Similarity=0.617 Sum_probs=216.3
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
|++...+|.+.+.||+|++|.||+|.+ ++..+++|.+..... . ...+.+|+.+++.++|+||++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~------~----~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------E----VEEFLKEAAVMKEIKHPNLVQLLGV 70 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch------H----HHHHHHHHHHHHhCCCCChhheEEE
Confidence 567788999999999999999999965 578899999853211 1 2347789999999999999999998
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...+.. +++|||+++++|.+++.......+++..++.++.|++.+|++||++|++|+||+|+|
T Consensus 71 ~~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~n 134 (263)
T cd05052 71 CTREPPF----------------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 134 (263)
T ss_pred EcCCCCc----------------EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcce
Confidence 7765544 569999999999999976556678999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCC-CCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDM-TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~ 280 (355)
|+++.++.++|+|||.+.......... .....+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+.
T Consensus 135 il~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~ 214 (263)
T cd05052 135 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 214 (263)
T ss_pred EEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999987544322111 11233567999999998889999999999999999998 9999988776665
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
...+. .......+..++.++.++|.+||+.+|.+||++.++++.|+.+
T Consensus 215 ~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 215 YELLE-KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHH-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 54443 3445567778899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=306.26 Aligned_cols=259 Identities=27% Similarity=0.555 Sum_probs=217.9
Q ss_pred ceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
|+....+|++.+.||.|++|.||+|.+ .+..+++|++..... .....+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 71 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL---------LKQQDFQKEVQALKRLRHKHLISLFAVC 71 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch---------hhHHHHHHHHHHHhcCCCcchhheeeeE
Confidence 345567899999999999999999965 468899999854321 1123477899999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...+.. +++|||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 72 ~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~ni 135 (261)
T cd05148 72 SVGEPV----------------YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNI 135 (261)
T ss_pred ecCCCe----------------EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceE
Confidence 765544 6699999999999999766667799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTS 282 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~ 282 (355)
+++.++.++|+|||.+..............++..|++||.+.+..++.++|+||||+++|+|++ |+.||...+..+...
T Consensus 136 lv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~ 215 (261)
T cd05148 136 LVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD 215 (261)
T ss_pred EEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999999998765443333333445678999999988889999999999999999998 899998877766666
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
.+.. ......+..+++++.++|.+||+.||.+|||+.+|++.|+.+
T Consensus 216 ~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 216 QITA-GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHh-CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 5553 344556678899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=313.93 Aligned_cols=243 Identities=28% Similarity=0.460 Sum_probs=203.2
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~ 133 (355)
+.||+|+||.||++.+ ++..||+|+++..... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~---- 70 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL---- 70 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEE----
Confidence 4689999999999965 6889999998632211 111233466799999999999999999988765544
Q ss_pred ccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 018489 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (355)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L 213 (355)
++||||+++++|..++.. ...+++..++.++.||+.||.|||++|++|+||||+|||++.++.++|
T Consensus 71 ------------~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL 136 (323)
T cd05595 71 ------------CFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKI 136 (323)
T ss_pred ------------EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEe
Confidence 679999999999988843 457899999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC
Q 018489 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293 (355)
Q Consensus 214 ~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
+|||++..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+..... .+
T Consensus 137 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~--~~ 214 (323)
T cd05595 137 TDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--RF 214 (323)
T ss_pred cccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CC
Confidence 9999987543333333445789999999999998899999999999999999999999988877776666554433 46
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 294 PRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 294 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
+..+++++.++|.+||+.||.+|+ ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 678899999999999999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=306.71 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=201.7
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||.|+||.||+|.+ ++..||+|+++....... ...+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--------PCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc--------chhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 46899999999999999999965 578999999865432211 12356799999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ++||||+++ +|.+++... ...+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus 76 ~~~----------------~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~ 137 (288)
T cd07871 76 RCL----------------TLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN 137 (288)
T ss_pred CeE----------------EEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence 443 679999965 898887543 34588999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
.++.++|+|||.+..............++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+..+....+.
T Consensus 138 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 217 (288)
T cd07871 138 EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217 (288)
T ss_pred CCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999998755443334445577899999999876 568899999999999999999999998876655554433
Q ss_pred hcCCCC----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRP----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.....+ .....++.++.++|++||+.||.+|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 218 RLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 211000 011245788999999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=316.61 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=210.4
Q ss_pred ceecCCcceeecccccccceEEEEEEEC---CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
..+..++|++.+.||+|+||.||+|.+. +..||+|++...... .....+.+.+|+.++..++||||+++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~ 98 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII------KQKQVDHVFSERKILNYINHPFCVNLYG 98 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhCCCCCCcceEE
Confidence 4456678999999999999999999753 257999998532211 1122345778999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++...... ++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+
T Consensus 99 ~~~~~~~~----------------~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~ 160 (340)
T PTZ00426 99 SFKDESYL----------------YLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPE 160 (340)
T ss_pred EEEeCCEE----------------EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHH
Confidence 98765544 679999999999999854 456999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
|||++.++.++|+|||.+...... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.....
T Consensus 161 NILl~~~~~ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 237 (340)
T PTZ00426 161 NLLLDKDGFIKMTDFGFAKVVDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY 237 (340)
T ss_pred HEEECCCCCEEEecCCCCeecCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999999998754322 23356889999999999888999999999999999999999999988776666
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
..+.... ..++..+++.+.++|++||+.||.+|+ +++++++
T Consensus 238 ~~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 238 QKILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 6665543 346677899999999999999999995 7888876
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=301.04 Aligned_cols=257 Identities=30% Similarity=0.594 Sum_probs=214.1
Q ss_pred ceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
|++..++|++.+.||+|+||.||+|.. ++..+|+|.+...... .+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~~ 70 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----------PEAFLAEANLMKQLQHPRLVRLYAVV 70 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----------HHHHHHHHHHHHhcCCcCeeeEEEEE
Confidence 567789999999999999999999965 6788999998643321 13477899999999999999999875
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.. + ..+++|||+++++|.+++....+..+++..++.++.|++.+|+|||+.|++|+||+|+||
T Consensus 71 ~~-~----------------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni 133 (260)
T cd05067 71 TQ-E----------------PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANI 133 (260)
T ss_pred cc-C----------------CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhE
Confidence 32 2 236799999999999998766666799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~ 281 (355)
+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|++++ |+.||.+.+..+..
T Consensus 134 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 213 (260)
T cd05067 134 LVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213 (260)
T ss_pred EEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence 99999999999999987544221 11222345678999999998889999999999999999999 99999887766555
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
.... .......+...+.++.++|.+||+.+|++||+++++++.|+.+
T Consensus 214 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 214 QNLE-RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHH-cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 5443 3344456677889999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=314.24 Aligned_cols=265 Identities=32% Similarity=0.590 Sum_probs=214.7
Q ss_pred cceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCc
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 115 (355)
.|++..++|++.+.||.|+||.||+|.+ +++.||+|+++.... .. ..+.+.+|+.++.++ +|+|
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~----~~----~~~~~~~E~~~~~~l~~h~n 72 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT----AS----EYKALMTELKILIHIGHHLN 72 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC----HH----HHHHHHHHHHHHHhhccCcc
Confidence 3777788999999999999999999854 236799999853221 11 123466799999999 8999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc------------------------------
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------------------------ 165 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------------ 165 (355)
|+++++++...+. ..+++|||+++++|.+++....
T Consensus 73 iv~~~~~~~~~~~---------------~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (337)
T cd05054 73 VVNLLGACTKPGG---------------PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVS 137 (337)
T ss_pred hhheeeeEecCCC---------------CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCC
Confidence 9999997754332 2367999999999999985432
Q ss_pred -----------------------------cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeec
Q 018489 166 -----------------------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADF 216 (355)
Q Consensus 166 -----------------------------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Df 216 (355)
...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+||
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~Df 217 (337)
T cd05054 138 SSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDF 217 (337)
T ss_pred ccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEecc
Confidence 126889999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCC
Q 018489 217 GVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEI 293 (355)
Q Consensus 217 g~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
|.+........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+..............
T Consensus 218 G~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 297 (337)
T cd05054 218 GLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA 297 (337)
T ss_pred ccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC
Confidence 99975432221 1122345668999999999999999999999999999998 99999876555555445454455555
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 294 PRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 294 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
+...++++.+++.+||+.+|++||++.++++.|+.+..
T Consensus 298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 66788999999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=313.50 Aligned_cols=241 Identities=21% Similarity=0.355 Sum_probs=200.8
Q ss_pred cccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccccc
Q 018489 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (355)
Q Consensus 58 lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~ 135 (355)
||+|+||.||+|.+ ++..||+|+++..... .......+.+|+.++.+++||||+++++.+...+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------ 68 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV------SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKL------ 68 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeE------
Confidence 79999999999976 5788999998532211 111234567899999999999999999888765544
Q ss_pred ccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEee
Q 018489 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (355)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~D 215 (355)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|
T Consensus 69 ----------~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~D 136 (312)
T cd05585 69 ----------YLVLAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCD 136 (312)
T ss_pred ----------EEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEE
Confidence 669999999999999854 45699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 018489 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR 295 (355)
Q Consensus 216 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 295 (355)
||++..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+... ...++.
T Consensus 137 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~ 214 (312)
T cd05585 137 FGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPD 214 (312)
T ss_pred CcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCC
Confidence 999875433333334456899999999999999999999999999999999999999988777766666543 334667
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 018489 296 CCPSSLANVMKRCWDANPDKRPE---MDEVVS 324 (355)
Q Consensus 296 ~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 324 (355)
.+++++.++|.+||+.||.+||+ +.+++.
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 78999999999999999999985 555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=303.06 Aligned_cols=257 Identities=27% Similarity=0.525 Sum_probs=211.6
Q ss_pred ecCCcceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
++..+|++.+.||+|+||.||+|.+ .+..||+|.++.... . .....+.+|+..+.+++||||+++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~----~----~~~~~~~~e~~~l~~l~h~~iv~~~~ 73 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS----D----KQRRGFLAEALTLGQFDHSNIVRLEG 73 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC----H----HHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 5667899999999999999999964 356899999864321 1 11245788999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++...+.. ++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++|+||+|+
T Consensus 74 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~ 136 (266)
T cd05064 74 VITRGNTM----------------MIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAH 136 (266)
T ss_pred EEecCCCc----------------EEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHh
Confidence 88765544 6799999999999998643 346899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhH
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~ 279 (355)
||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+
T Consensus 137 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~ 216 (266)
T cd05064 137 KVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216 (266)
T ss_pred hEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 99999999999999998764322211 1112234568999999998889999999999999999775 999998887776
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
....+.. ......+..++..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus 217 ~~~~~~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 217 VIKAVED-GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHC-CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 6665543 334456777899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=298.68 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=210.3
Q ss_pred ccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
..+++ ..+|...+.||.|++|.|+.+.+ +|+.||||.+. ...+.....++-.+|+.+|++++|+||+.+.
T Consensus 16 ~~~~i-~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~-------~~F~~~~~akRtlRElklLr~~~HeNIi~l~ 87 (359)
T KOG0660|consen 16 ELFEI-PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL-------NPFENQIDAKRTLRELKLLRHLRHENIIGLL 87 (359)
T ss_pred eEEec-cceecccccccCcceeeEEEEEEcCCCCEeehhhhh-------hhhhchHHHHHHHHHHHHHHHhcCCCcceEE
Confidence 33444 46677789999999999999865 68999999884 1223334455677899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+.+..+..- .-+-.|+|+|+| +.+|...++ .++.+++..+..++.|++.||.|+|+.||+|||+||
T Consensus 88 di~~p~~~~-----------~f~DvYiV~elM-etDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKP 153 (359)
T KOG0660|consen 88 DIFRPPSRD-----------KFNDVYLVFELM-ETDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKP 153 (359)
T ss_pred eeccccccc-----------ccceeEEehhHH-hhHHHHHHH--cCccccHHHHHHHHHHHHHhcchhhcccccccccch
Confidence 998762211 123348899999 668998884 345599999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCC--CCCCCCCCCcccccCCcccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLN-GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~lltg~~p~~~~~~ 277 (355)
+|++++.++.+|++|||+|+..... ....+..+.|.+|.|||++. ...|+.+.||||+||++.||++|+..|.+.+.
T Consensus 154 sNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 154 SNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred hheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 9999999999999999999876542 23335677899999999875 46899999999999999999999999998876
Q ss_pred hHHHHHHHhcCCCCC-----------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 278 SEVTSAVVRQNLRPE-----------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..++..+...-..++ +....++.+.+|+.+||..||.+|+|++|+|.
T Consensus 234 v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 234 VHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 666655544222221 22456889999999999999999999999987
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=319.26 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=209.2
Q ss_pred CcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+. ++.||+|+++..... .......+.+|+.++..++|+||+++++.+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI------KRNQIAHVRAERDILADADSPWIVKLYYSFQDEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh------hccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence 47999999999999999999764 899999999643211 1122345788999999999999999998877655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.
T Consensus 75 ~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~ 136 (350)
T cd05573 75 HL----------------YLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA 136 (350)
T ss_pred eE----------------EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 44 6799999999999999643 67999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCC-----------------------------CCCCCCCCcccccCCcccCCCCCCCcchhHHH
Q 018489 208 NRTVKIADFGVARVEASNP-----------------------------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 258 (355)
++.++|+|||.+....... .......|+..|+|||.+.+..++.++|||||
T Consensus 137 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 216 (350)
T cd05573 137 DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSL 216 (350)
T ss_pred CCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEec
Confidence 9999999999987544332 12234568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHhc--CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 018489 259 GICLWEIYCCDMPYPDLSFSEVTSAVVRQ--NLRPEIPRCCPSSLANVMKRCWDANPDKRPE-MDEVVS 324 (355)
Q Consensus 259 G~il~~lltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~ell~ 324 (355)
||++|+|++|+.||...+.......+... .........+++++.++|.+||. ||.+||+ +.++++
T Consensus 217 G~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 217 GVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred chhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 99999999999999988877766666652 22222233469999999999997 9999999 999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=317.51 Aligned_cols=268 Identities=30% Similarity=0.544 Sum_probs=218.9
Q ss_pred hcccccceecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 111 (355)
-+..++|++..++|++++.||+|+||.||+|.+. +..||||++..... . ...+.+.+|+.++.++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~----~----~~~~~~~~Ei~~l~~l 97 (400)
T cd05105 26 LPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR----S----SEKQALMSELKIMTHL 97 (400)
T ss_pred CCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC----h----HHHHHHHHHHHHHHhc
Confidence 3445789999999999999999999999999752 24699999853321 1 1234588999999999
Q ss_pred C-CCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-------------------------
Q 018489 112 D-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------------------- 165 (355)
Q Consensus 112 ~-h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------- 165 (355)
. ||||+++++++...+.. ++||||+++|+|.+++..+.
T Consensus 98 ~~HpnIv~l~~~~~~~~~~----------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (400)
T cd05105 98 GPHLNIVNLLGACTKSGPI----------------YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADE 161 (400)
T ss_pred CCCCCeeeEEEEEccCCce----------------EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccc
Confidence 5 99999999998765544 67999999999999886532
Q ss_pred ---------------------------------------------------------------------cccccHHHHHH
Q 018489 166 ---------------------------------------------------------------------RRKLAFKVVVQ 176 (355)
Q Consensus 166 ---------------------------------------------------------------------~~~~~~~~~~~ 176 (355)
...+++..++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~ 241 (400)
T cd05105 162 STRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLS 241 (400)
T ss_pred cccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHH
Confidence 12477888999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcch
Q 018489 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCD 254 (355)
Q Consensus 177 i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~D 254 (355)
++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|
T Consensus 242 ~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 321 (400)
T cd05105 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSD 321 (400)
T ss_pred HHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhh
Confidence 999999999999999999999999999999999999999999875432221 122234567899999999888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 255 VYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 255 vwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
|||||+++|+|++ |..||.....................+..++..+.+++.+||+.+|++||++.+|.+.|+.+.
T Consensus 322 iwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 322 VWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 9999999999997 999998765544444445555555566778999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=311.51 Aligned_cols=246 Identities=29% Similarity=0.473 Sum_probs=202.8
Q ss_pred ceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHH---hhCCCCccceeeeeccCC
Q 018489 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW---HKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~Iv~~~~~~~~~ 126 (355)
|++.+.||+|+||.||+|.+ ++..||||+++...... ....+.+.+|.+++ +.++||||+++++++...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~ 74 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA------RDEVESLMCEKRIFETANSERHPFLVNLFACFQTE 74 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh------hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence 78899999999999999965 57899999996432111 11123355555544 566899999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++||||+++++|...+. ...+++..++.++.|++.||.|||+.|++|+||||+||+++
T Consensus 75 ~~~----------------~lv~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~ 135 (324)
T cd05589 75 DHV----------------CFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135 (324)
T ss_pred CEE----------------EEEEcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence 544 67999999999988873 35699999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+..
T Consensus 136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~ 215 (324)
T cd05589 136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN 215 (324)
T ss_pred CCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 99999999999987543333334446789999999999998899999999999999999999999998887777766655
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
... .++..+++++.++|.+||+.||.+|| ++.++++
T Consensus 216 ~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 216 DEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 433 46677899999999999999999999 5777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=299.52 Aligned_cols=255 Identities=31% Similarity=0.628 Sum_probs=213.5
Q ss_pred ceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
|.++..+|++.+.||+|++|.||++...+..+++|.++.... .+.+.+|+.+++.++|+|++++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~-----------~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLGVIV 69 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch-----------HHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 456778999999999999999999999999999999853211 234778999999999999999998754
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..+ +..+++|||+++++|.+++.......+++..++.++.|++.+|++||++|++|+||+|+||+
T Consensus 70 ~~~---------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil 134 (256)
T cd05082 70 EEK---------------GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVL 134 (256)
T ss_pred cCC---------------CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEE
Confidence 322 22367999999999999997655556899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018489 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~ 283 (355)
++.++.++|+|||.+....... .....+..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....
T Consensus 135 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~ 211 (256)
T cd05082 135 VSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 211 (256)
T ss_pred EcCCCcEEecCCccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999987443221 12234567999999998889999999999999999997 9999987776665544
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
+.. ......+..+++.+.++|.+||+.+|.+|||+.++++.|+.+
T Consensus 212 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 VEK-GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred Hhc-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 433 344556677899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=313.20 Aligned_cols=243 Identities=28% Similarity=0.457 Sum_probs=202.6
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~ 133 (355)
+.||+|+||.||++.+ ++..||+|++...... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~---- 70 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII------AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRL---- 70 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEE----
Confidence 3689999999999965 6889999999643211 111234567899999999999999999888765554
Q ss_pred ccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 018489 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (355)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L 213 (355)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||++|++|+||||+|||++.++.++|
T Consensus 71 ------------~lv~Ey~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL 136 (328)
T cd05593 71 ------------CFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKI 136 (328)
T ss_pred ------------EEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEE
Confidence 669999999999988843 457999999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC
Q 018489 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293 (355)
Q Consensus 214 ~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
+|||++..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+... ...+
T Consensus 137 ~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~~~~ 214 (328)
T cd05593 137 TDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--DIKF 214 (328)
T ss_pred ecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--CccC
Confidence 99999875433333334456899999999999988999999999999999999999999887776665554433 3356
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 294 PRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 294 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
+..+++++.++|.+||+.||.+|+ ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 778899999999999999999997 8898885
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=330.03 Aligned_cols=269 Identities=23% Similarity=0.408 Sum_probs=218.0
Q ss_pred ccccceecCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccc
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVT 117 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv 117 (355)
-.+.++|...+++|.+.|.+|||+.||+|++. +..||+|.+-..+ +...+.+.+|+.++++| +|+|||
T Consensus 28 ~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d---------e~~L~~v~~EI~~MK~L~gh~nIV 98 (738)
T KOG1989|consen 28 VGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND---------EEALNAVKREIDIMKLLSGHKNIV 98 (738)
T ss_pred CceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC---------HHHHHHHHHHHHHHHHhcCCCcee
Confidence 34789999999999999999999999999764 3799999885432 12245588999999999 699999
Q ss_pred eeeee-ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC--cc
Q 018489 118 KFIGA-TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IV 194 (355)
Q Consensus 118 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~ 194 (355)
.+++. ......- + ..--++|+||||.||.|-+++...-...|++.++++|+.++++|+++||... |+
T Consensus 99 ~yidss~~~~~~~------~----~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiI 168 (738)
T KOG1989|consen 99 SYIDSSAINRSSN------N----GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPII 168 (738)
T ss_pred eEeccccccccCC------C----ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccc
Confidence 99993 3221100 0 0012378999999999999998766677999999999999999999999998 99
Q ss_pred ccCCCCCcEEEcCCCcEEEeeccccccccCCCCCC---------CCCCCcccccCCcccC---CCCCCCcchhHHHHHHH
Q 018489 195 HRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM---------TGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICL 262 (355)
Q Consensus 195 H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~---------~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il 262 (355)
|||||-+||||+.+|+.||||||.++......... .....|+.|++||.+. +..++.++|||+|||+|
T Consensus 169 HRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclL 248 (738)
T KOG1989|consen 169 HRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLL 248 (738)
T ss_pred hhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHH
Confidence 99999999999999999999999997543322111 1123688999999874 67899999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 263 WEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 263 ~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
|-|+....||+..-. ..|+...+..+....+++.+.+||+.||+.||++||++-+++..+..+...
T Consensus 249 YkLCy~t~PFe~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 249 YKLCYFTTPFEESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred HHHHHhCCCcCcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 999999999976422 244455555555567899999999999999999999999999999988744
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=305.32 Aligned_cols=255 Identities=27% Similarity=0.367 Sum_probs=200.6
Q ss_pred CcceeecccccccceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC---CCCccceeeeec
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIGAT 123 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~ 123 (355)
.+|++.+.||+|+||.||+|.+ .+..||+|.++......... ..+.+|+.+++.+ +||||+++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~-------~~~~~e~~~l~~l~~~~hpniv~~~~~~ 73 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-------LSTIREVAVLRHLETFEHPNVVRLFDVC 73 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCch-------HHHHHHHHHHHhhcccCCCCcceEEEEE
Confidence 4799999999999999999976 35789999987544322211 1234566655554 799999999987
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...... .....+++|||+. ++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||
T Consensus 74 ~~~~~~-----------~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Ni 141 (290)
T cd07862 74 TVSRTD-----------RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 141 (290)
T ss_pred ecccCC-----------CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 532110 1233478999995 6899998765566799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
+++.++.++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....
T Consensus 142 l~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~ 220 (290)
T cd07862 142 LVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 220 (290)
T ss_pred EEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence 9999999999999998754332 223345688999999999888899999999999999999999999998877666655
Q ss_pred HHhcCCCC-------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRP-------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+......+ .+...++..+.++|.+||+.||++||++.++++
T Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 221 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 54321100 011346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=311.78 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=204.1
Q ss_pred ecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 55 KSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 55 ~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
++.||+|+||.||++.. +++.||+|+++..... ........+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-----RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH-----hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence 36799999999999864 5788999998642211 1112234467899999999999999999988765544
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
+++|||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++
T Consensus 76 ----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~ 137 (323)
T cd05584 76 ----------------YLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG 137 (323)
T ss_pred ----------------EEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC
Confidence 669999999999998853 45688999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC
Q 018489 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 289 (355)
Q Consensus 210 ~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~ 289 (355)
.++|+|||++..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+....
T Consensus 138 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~- 216 (323)
T cd05584 138 HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK- 216 (323)
T ss_pred CEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-
Confidence 9999999998644333333344568999999999999889999999999999999999999999888777666665543
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 290 RPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 290 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
..++..+++++.++|.+||+.+|++|| +++++++
T Consensus 217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 356777899999999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=305.55 Aligned_cols=257 Identities=30% Similarity=0.558 Sum_probs=212.1
Q ss_pred cCCcceeecccccccceEEEEEEECC-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
..++|++.+.||+|++|.||+|...+ ..|++|.+..... ......+.+|+.++..++||||++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--------~~~~~~~~~ei~~l~~l~h~~i~~~~ 74 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--------PKVQQEFRQEAELMSDLQHPNIVCLL 74 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--------HHHHHHHHHHHHHHHhcCCcccceEE
Confidence 44689999999999999999996532 4699998753221 12244578899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc--------------ccccHHHHHHHHHHHHHHHH
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--------------RKLAFKVVVQLALDLARGLS 186 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~ 186 (355)
+++...... +++|||+++++|.+++..... ..+++..++.++.|++.||.
T Consensus 75 ~~~~~~~~~----------------~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~ 138 (283)
T cd05048 75 GVCTKEQPT----------------CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGME 138 (283)
T ss_pred EEEcCCCce----------------EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence 988765444 669999999999999965321 45888999999999999999
Q ss_pred HHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHH
Q 018489 187 YLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264 (355)
Q Consensus 187 ~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ 264 (355)
|||++|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+
T Consensus 139 ~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~e 218 (283)
T cd05048 139 YLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218 (283)
T ss_pred HHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHH
Confidence 9999999999999999999999999999999987443221 11223456778999999988889999999999999999
Q ss_pred HHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 265 IYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 265 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
|++ |..||.+.+..+....+.. ......+..+++++.+|+.+||+.||.+||++.+|++.|+++
T Consensus 219 l~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 219 IFSYGLQPYYGFSNQEVIEMIRS-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHc-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 998 9999988877766555443 344456778899999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=309.85 Aligned_cols=251 Identities=25% Similarity=0.474 Sum_probs=204.2
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
+..++|++.+.||+|+||.||++.+ ++..+|+|++..... ......+.+|++++++++||||+++++++.
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--------HHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 4568999999999999999999976 578899999864211 123456889999999999999999999887
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENM 203 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~di~p~Ni 203 (355)
..+.. ++||||+++++|.+++.. ...+++..++.++.|++.+|.|||++ +++|+||||+||
T Consensus 74 ~~~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Ni 135 (331)
T cd06649 74 SDGEI----------------SICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 135 (331)
T ss_pred ECCEE----------------EEEeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhE
Confidence 65544 669999999999999854 35689999999999999999999986 699999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
+++.++.++|+|||.+...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....
T Consensus 136 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~ 213 (331)
T cd06649 136 LVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI 213 (331)
T ss_pred EEcCCCcEEEccCccccccccc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999998644322 22335688999999999998899999999999999999999999976554333221
Q ss_pred HHh---------------------------------------------cCCCCCC-CCCCcHHHHHHHHHhhhcCCCCCC
Q 018489 284 VVR---------------------------------------------QNLRPEI-PRCCPSSLANVMKRCWDANPDKRP 317 (355)
Q Consensus 284 ~~~---------------------------------------------~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp 317 (355)
+.. ....+.. ...+++++.+||.+||+.||++||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rp 293 (331)
T cd06649 214 FGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERA 293 (331)
T ss_pred hcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCC
Confidence 110 0111111 124688999999999999999999
Q ss_pred CHHHHHHH
Q 018489 318 EMDEVVSM 325 (355)
Q Consensus 318 s~~ell~~ 325 (355)
|+++|++-
T Consensus 294 t~~ell~h 301 (331)
T cd06649 294 DLKMLMNH 301 (331)
T ss_pred CHHHHhcC
Confidence 99999873
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=305.85 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=199.9
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||++.+ ++..||+|++....... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-------EVKETTLRELKMLRTLKQENIVELKEAFRRRG 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-------cchhhHHHHHHHHHhCCCccccchhhhEecCC
Confidence 4799999999999999999976 57889999986543221 12345678999999999999999998887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||++++++..+.. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 74 ~~----------------~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~ 135 (287)
T cd07848 74 KL----------------YLVFEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH 135 (287)
T ss_pred EE----------------EEEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 44 67999998877765442 3456999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..
T Consensus 136 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~ 215 (287)
T cd07848 136 NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQK 215 (287)
T ss_pred CCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999987543322 222335688899999999988899999999999999999999999987665443332221
Q ss_pred cCC-------------------C-C----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNL-------------------R-P----------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~-------------------~-~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... . + .....++.++.++|++||+.||++|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 216 VLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 100 0 0 011236788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.75 Aligned_cols=258 Identities=33% Similarity=0.583 Sum_probs=213.9
Q ss_pred ceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
|++..++|++.+.||+|++|.||+|.+ .+..||+|.++..... .+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----------PKDFLAEAQIMKKLRHPKLIQLYAVC 70 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----------HHHHHHHHHHHHHCCCCCccceeEEE
Confidence 567778999999999999999999975 4567999998643211 23367899999999999999999987
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...... +++|||+++++|.+++.......+++..+..++.|++.+|.+||++|++|+||+|+||
T Consensus 71 ~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 134 (261)
T cd05068 71 TLEEPI----------------YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNV 134 (261)
T ss_pred ecCCCe----------------eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceE
Confidence 655444 6699999999999999765556799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCC-CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~ 281 (355)
+++.++.++|+|||.+......... ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+.....
T Consensus 135 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 214 (261)
T cd05068 135 LVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL 214 (261)
T ss_pred EEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999998765432111 111223457999999998889999999999999999999 99999887766655
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
..+.. ......+..++..+.+++.+||+.+|.+||+++++++.|+.+
T Consensus 215 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 215 QQVDQ-GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHc-CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 55433 333445667889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=297.62 Aligned_cols=258 Identities=32% Similarity=0.562 Sum_probs=212.1
Q ss_pred ceecCCcceeecccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
|++..++|++.+.||+|++|.||+|.+. +..|++|.++.... . .+.+.+|+.+++.++|+||+++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~-------~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---S-------PEAFLQEAQVMKKLRHEKLVQLYAVV 70 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---C-------HHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 5667789999999999999999999764 35799999864221 1 13477899999999999999998875
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.. +. .+++|||+++++|.+++.......+++..++.++.|++.||++||+.|++|+||+|+||
T Consensus 71 ~~-~~----------------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Ni 133 (262)
T cd05071 71 SE-EP----------------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 133 (262)
T ss_pred CC-CC----------------cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccE
Confidence 42 21 26799999999999999765556689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCC-CCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDM-TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~ 281 (355)
+++.++.++|+|||.+.......... ....++..|+|||...+..++.++|+||||+++|+|++ |..||......+..
T Consensus 134 ll~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~ 213 (262)
T cd05071 134 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 213 (262)
T ss_pred EEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH
Confidence 99999999999999987544322211 22345667999999988889999999999999999999 88899877666655
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
..+.. ......+..++..+.++|.+||+.+|.+||++.++++.|+...
T Consensus 214 ~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 214 DQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHhc-CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 54433 2333445668899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=304.44 Aligned_cols=257 Identities=29% Similarity=0.537 Sum_probs=203.7
Q ss_pred ecCCcceeecccccccceEEEEEEEC------------------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHH
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYD------------------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 108 (355)
+..++|++.+.||+|+||.||+|.+. +..||+|++..... ...+..+.+|+.++
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l 73 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--------KNARNDFLKEVKIL 73 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--------HHHHHHHHHHHHHH
Confidence 34578999999999999999999642 33699999854321 11244588999999
Q ss_pred hhCCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-----------------cccccH
Q 018489 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-----------------RRKLAF 171 (355)
Q Consensus 109 ~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------------~~~~~~ 171 (355)
..++||||+++++++...+.. +++|||+++++|.+++.... ...+++
T Consensus 74 ~~l~h~niv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (304)
T cd05096 74 SRLKDPNIIRLLGVCVDEDPL----------------CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISY 137 (304)
T ss_pred hhcCCCCeeEEEEEEecCCce----------------EEEEecCCCCcHHHHHHhccccccccccccccccccccccccH
Confidence 999999999999988765544 67999999999999985421 124678
Q ss_pred HHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCC
Q 018489 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPY 249 (355)
Q Consensus 172 ~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 249 (355)
..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..+
T Consensus 138 ~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 217 (304)
T cd05096 138 SSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF 217 (304)
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC
Confidence 89999999999999999999999999999999999999999999999875432211 1122345678999999988889
Q ss_pred CCcchhHHHHHHHHHHHh--CCCCCCCCChhHHHHHHHh---c---CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 018489 250 NRKCDVYSFGICLWEIYC--CDMPYPDLSFSEVTSAVVR---Q---NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE 321 (355)
Q Consensus 250 ~~~~DvwslG~il~~llt--g~~p~~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e 321 (355)
+.++||||||+++|+|++ +..||...+..+....... . ......+..++..+.++|.+||+.||.+|||+.+
T Consensus 218 ~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~ 297 (304)
T cd05096 218 TTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSD 297 (304)
T ss_pred CchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 999999999999999986 5678887766554433321 1 1112234567899999999999999999999999
Q ss_pred HHHHHH
Q 018489 322 VVSMLE 327 (355)
Q Consensus 322 ll~~l~ 327 (355)
|.+.|+
T Consensus 298 i~~~l~ 303 (304)
T cd05096 298 IHAFLT 303 (304)
T ss_pred HHHHHh
Confidence 998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=296.03 Aligned_cols=255 Identities=35% Similarity=0.683 Sum_probs=215.9
Q ss_pred ceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
|.+..++|++.+.||.|++|.||+|...+..|++|.+..... ..+.+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 70 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----------AAQAFLAEASVMTTLRHPNLVQLLGVVL 70 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh----------HHHHHHHHHHHHHhcCCcceeeeEEEEc
Confidence 345678999999999999999999999999999999853321 2345788999999999999999999887
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..+.. +++|||+++++|.+++.......+++..++.++.|++.+|.|||+.|++|+||+|+||+
T Consensus 71 ~~~~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nil 134 (256)
T cd05039 71 QGNPL----------------YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVL 134 (256)
T ss_pred CCCCe----------------EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEE
Confidence 64444 67999999999999997655557999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018489 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~ 283 (355)
++.++.++|+|||.+........ ....+..|+|||.+.+..++.++|+||||+++++|++ |..||...+.......
T Consensus 135 i~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 211 (256)
T cd05039 135 VSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH 211 (256)
T ss_pred EeCCCCEEEcccccccccccccc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999999999875532211 2344567999999988888999999999999999997 9999988776665544
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
... ......+..+++++.++|.+||..+|.+||++.+++.+|+++
T Consensus 212 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 212 VEK-GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred Hhc-CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 433 334455667899999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=316.62 Aligned_cols=253 Identities=30% Similarity=0.612 Sum_probs=221.4
Q ss_pred ccceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
..|+|--+...-++-||.|+.|.||+|+..++.||||.++ +.-..+++-|++|+||||+.+.++
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~----------------elkETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVR----------------ELKETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHh----------------hhhhhhHHHHHhccCcceeeEeee
Confidence 3466666666677889999999999999999999999873 223458888999999999999998
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+... ..+|||||||..|-|...+ ..++.+.......|..+|+.++.|||.+.|||||||.-|
T Consensus 181 Ctqs----------------PcyCIiMEfCa~GqL~~VL--ka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPN 242 (904)
T KOG4721|consen 181 CTQS----------------PCYCIIMEFCAQGQLYEVL--KAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPN 242 (904)
T ss_pred ecCC----------------ceeEEeeeccccccHHHHH--hccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCc
Confidence 8753 3448999999999999999 456789999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
|||+.+..|||+|||.++....- .....+.||..|||||+++..+++.+.||||||++||+||||..||.+.+....+.
T Consensus 243 iLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw 321 (904)
T KOG4721|consen 243 ILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW 321 (904)
T ss_pred eEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE
Confidence 99999999999999999754433 56677899999999999999999999999999999999999999998876665555
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
-+-...+...+|..+|+.|.-||++||+-.|.+||++.+|+.-|+.+.
T Consensus 322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 555555666789999999999999999999999999999999887654
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=315.12 Aligned_cols=257 Identities=26% Similarity=0.371 Sum_probs=211.4
Q ss_pred ccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
..+.+..++|++.+.||+|+||.||++.+ ++..||+|++...... .......+.+|+.+++.++||||++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~il~~~~h~~iv~~~ 109 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI------KRSDSAFFWEERDIMAHANSEWIVQLH 109 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence 34566778999999999999999999965 5789999998532111 111233467899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++...+.. ++||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||
T Consensus 110 ~~~~~~~~~----------------~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp 170 (370)
T cd05596 110 YAFQDDKYL----------------YMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 170 (370)
T ss_pred EEEecCCEE----------------EEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 888765544 679999999999998843 4588999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCC----CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGN----PYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
+|||++.++.++|+|||.+........ ......|++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.
T Consensus 171 ~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 171 DNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred HHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 999999999999999999875433221 22345689999999998653 4788999999999999999999999988
Q ss_pred ChhHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 018489 276 SFSEVTSAVVRQNLRPEIPR--CCPSSLANVMKRCWDANPDK--RPEMDEVVS 324 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~--Rps~~ell~ 324 (355)
+.......+........++. .++.++.++|.+||+.+|.+ |++++++++
T Consensus 251 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 251 SLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 88777777765443334444 47999999999999999988 999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=312.99 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=204.7
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ ++..||+|+++.... ........+.+|+.++.+++|+||+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM------LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH------HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4799999999999999999965 578999999953211 11223355778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 75 ~~----------------~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~ 136 (363)
T cd05628 75 NL----------------YLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS 136 (363)
T ss_pred eE----------------EEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC
Confidence 44 669999999999999854 467999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCC-----------------------------------CCCCCCCcccccCCcccCCCCCCCc
Q 018489 208 NRTVKIADFGVARVEASNPN-----------------------------------DMTGETGTLGYMAPEVLNGNPYNRK 252 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 252 (355)
++.++|+|||++........ ......||..|+|||.+.+..++.+
T Consensus 137 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ 216 (363)
T cd05628 137 KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL 216 (363)
T ss_pred CCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc
Confidence 99999999999864321100 0123468999999999999899999
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhcCCC---CCCCHHHHHHH
Q 018489 253 CDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR--CCPSSLANVMKRCWDANPD---KRPEMDEVVSM 325 (355)
Q Consensus 253 ~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~---~Rps~~ell~~ 325 (355)
+||||||+++|+|++|+.||.+.+..+....+........++. .+++++.++|.+++. +|. .||++++|++-
T Consensus 217 ~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 217 CDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred hhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 9999999999999999999998887777777665433333443 368899999998764 444 45899999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=315.28 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=206.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||||++..... ........+.+|+.++..++||||+++++.+...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM------LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence 4799999999999999999976 588999999963211 11122345778999999999999999999887665
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+|||++.
T Consensus 75 ~~----------------~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~ 136 (364)
T cd05599 75 YL----------------YLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA 136 (364)
T ss_pred eE----------------EEEECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence 54 669999999999999854 456999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCC--------------------------------------CCCCCCCcccccCCcccCCCCC
Q 018489 208 NRTVKIADFGVARVEASNPN--------------------------------------DMTGETGTLGYMAPEVLNGNPY 249 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 249 (355)
++.++|+|||++........ ......||+.|+|||++.+..+
T Consensus 137 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (364)
T cd05599 137 KGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216 (364)
T ss_pred CCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC
Confidence 99999999998864321100 0012358999999999999889
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 018489 250 NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR--CCPSSLANVMKRCWDANPDKRPE---MDEVVS 324 (355)
Q Consensus 250 ~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 324 (355)
+.++|||||||++|+|++|..||...+..+....+........++. .+++++.++|.+||. +|.+|++ +.++++
T Consensus 217 ~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 217 NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999999999999999999999998887776666655443333333 468999999999996 9999997 888877
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=308.78 Aligned_cols=243 Identities=25% Similarity=0.366 Sum_probs=201.3
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCC-ccceeeeeccCCc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP-NVTKFIGATMGSS 127 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~Iv~~~~~~~~~~ 127 (355)
+|++.+.||+|+||.||+|.+ ++..||+|++...... .....+.+..|.+++..+.|+ +|+.+++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII------QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence 589999999999999999976 4678999998643211 011124467788999999665 5778888876655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+|||++.
T Consensus 75 ~~----------------~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 136 (324)
T cd05587 75 RL----------------YFVMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA 136 (324)
T ss_pred EE----------------EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC
Confidence 44 669999999999998853 456899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.++|+|||++..............|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.+..+....+...
T Consensus 137 ~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~ 216 (324)
T cd05587 137 EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216 (324)
T ss_pred CCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999864333333334456899999999999988999999999999999999999999988877777666553
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
...++..++.++.++|.+||+.||.+|++.
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 --NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 345677789999999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=301.10 Aligned_cols=259 Identities=30% Similarity=0.545 Sum_probs=209.8
Q ss_pred ceecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
|.+..++|++.+.||+|++|.||+|.+. +..||+|.+..... . .....+.+|+.+++.++||||+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~----~----~~~~~~~~e~~~l~~l~~~~iv 72 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS----M----RERIEFLNEASVMKEFNCHHVV 72 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC----H----HHHHHHHHHHHHHHhCCCCCee
Confidence 5677889999999999999999998653 35699998743211 1 1134477899999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------cccccHHHHHHHHHHHHHHHHHHH
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------RRKLAFKVVVQLALDLARGLSYLH 189 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~LH 189 (355)
++++++...... +++|||+++++|.+++.... ...+++..+..++.|++.+|.|||
T Consensus 73 ~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 136 (277)
T cd05062 73 RLLGVVSQGQPT----------------LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN 136 (277)
T ss_pred eEEEEEcCCCCe----------------EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 999988655544 66999999999999986432 123677889999999999999999
Q ss_pred hCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh
Q 018489 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 190 ~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt 267 (355)
+.|++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 137 ~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 216 (277)
T cd05062 137 ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216 (277)
T ss_pred HCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHc
Confidence 999999999999999999999999999998644322111 112244678999999998889999999999999999999
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 268 -CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 268 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
|..||...+........... .....+..++..+.++|.+||+.+|.+||++.++++.|++
T Consensus 217 ~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 217 LAEQPYQGMSNEQVLRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 78999887766655544433 3345667789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=298.42 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=210.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ ++..||+|.+....... ......+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD------AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC------HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence 6899999999999999999965 68999999875432211 122345778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.. ++++||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||+|+||++
T Consensus 76 ~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~ 139 (267)
T cd08228 76 EL----------------NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred eE----------------EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE
Confidence 44 5699999999999988543 23458999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh--hHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF--SEVTSA 283 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~--~~~~~~ 283 (355)
+.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||..... ......
T Consensus 140 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~ 219 (267)
T cd08228 140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK 219 (267)
T ss_pred cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH
Confidence 999999999999987654433333345678899999999888889999999999999999999999965432 233333
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
+......+.....++..+.+++.+||+.+|++||++.++++.++.+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 33323333333457889999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=303.69 Aligned_cols=263 Identities=30% Similarity=0.563 Sum_probs=216.8
Q ss_pred ccceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCC
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHP 114 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 114 (355)
..+.+..++|.+.+.||+|+||.||++.+ ++..+|+|.++.... . ...+.+.+|+.+++++ +|+
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~l~~h~ 99 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH----S----SEREALMSELKIMSHLGNHE 99 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC----h----HHHHHHHHHHHHHHhccCCC
Confidence 35778888999999999999999999864 235799998853321 1 1234578899999999 899
Q ss_pred ccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcc
Q 018489 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIV 194 (355)
Q Consensus 115 ~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~ 194 (355)
||+++++++...+.. +++|||+.+++|.+++.......+++..++.++.|++.+|.|||+++++
T Consensus 100 ~iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~iv 163 (302)
T cd05055 100 NIVNLLGACTIGGPI----------------LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCI 163 (302)
T ss_pred CcceEEEEEecCCce----------------EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 999999988765544 6799999999999999654444589999999999999999999999999
Q ss_pred ccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCC
Q 018489 195 HRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMP 271 (355)
Q Consensus 195 H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p 271 (355)
|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||+|+++|+|++ |..|
T Consensus 164 H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p 243 (302)
T cd05055 164 HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243 (302)
T ss_pred hhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999875433221 1122345678999999999889999999999999999998 9999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 272 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
|.....................+...++++.+++.+||+.+|++||++.++++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 244 YPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 9887665555555555555455666789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=304.67 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=197.1
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||+|++........ ...+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--------PFTAIREASLLKGLKHANIVLLHDIIHTK 75 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--------chhHHHHHHHHhhCCCCCcCeEEEEEecC
Confidence 47899999999999999999976 678999999864432211 12356799999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++||||+. ++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 76 ~~~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~ 137 (303)
T cd07869 76 ETL----------------TLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS 137 (303)
T ss_pred CeE----------------EEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 544 67999995 5787777543 45689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChh-HHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTSAV 284 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~-~~~~~~ 284 (355)
.++.++|+|||.+..............++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.... .....+
T Consensus 138 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 217 (303)
T cd07869 138 DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI 217 (303)
T ss_pred CCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence 9999999999998754433334444668899999999865 45788999999999999999999999875432 222222
Q ss_pred HhcCCC----------------CC-----CC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLR----------------PE-----IP---------RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~----------------~~-----~~---------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...... +. .+ ...++++.++|.+||+.||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 218 FLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 110000 00 00 123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=295.75 Aligned_cols=256 Identities=32% Similarity=0.607 Sum_probs=211.2
Q ss_pred cCCcceeecccccccceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
..++|++.+.||+|+||.||+|.+. ...|++|.++.... ......+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--------DKQRLDFLTEASIMGQFDHPNIIRLEGV 73 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--------hHHHHHHHHHHHHHHhCCCCCcceEeEE
Confidence 4578999999999999999999763 35799998853321 1123457789999999999999999998
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...+.. +++|||+++++|.+++... ...+++..++.++.|++.+|.|||+.|++|+||+|+|
T Consensus 74 ~~~~~~~----------------~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~n 136 (266)
T cd05033 74 VTKSRPV----------------MIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARN 136 (266)
T ss_pred EecCCce----------------EEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence 7655444 6799999999999998654 3468999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~ 279 (355)
|+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~ 216 (266)
T cd05033 137 ILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD 216 (266)
T ss_pred EEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH
Confidence 99999999999999999865421111 112234568999999998889999999999999999998 999998777666
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
....+.. ......+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 217 ~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 217 VIKAVED-GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 5555543 333345567899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=315.64 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=204.2
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|.+.+.||+|+||.||++.+ +++.||||++.... .......+.+.+|++++.+++||||+++++++...+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE------MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH------HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 4799999999999999999965 68899999985321 111223355788999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.
T Consensus 75 ~~----------------~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~ 136 (377)
T cd05629 75 YL----------------YLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR 136 (377)
T ss_pred ee----------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 44 669999999999999853 456899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCC-------------C----------------------------------CCCCCCCcccccC
Q 018489 208 NRTVKIADFGVARVEASNP-------------N----------------------------------DMTGETGTLGYMA 240 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~-------------~----------------------------------~~~~~~~~~~y~a 240 (355)
++.++|+|||++....... . ......|+..|+|
T Consensus 137 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 216 (377)
T cd05629 137 GGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIA 216 (377)
T ss_pred CCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccC
Confidence 9999999999985221100 0 0012358899999
Q ss_pred CcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCC--
Q 018489 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR--CCPSSLANVMKRCWDANPDKR-- 316 (355)
Q Consensus 241 PE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~R-- 316 (355)
||.+.+..++.++|||||||++|+|++|..||...+..+....+........++. .++.++.++|.+||. +|.+|
T Consensus 217 PE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~ 295 (377)
T cd05629 217 PEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG 295 (377)
T ss_pred HHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence 9999998899999999999999999999999988777666666655433333443 478999999999997 77765
Q ss_pred -CCHHHHHHH
Q 018489 317 -PEMDEVVSM 325 (355)
Q Consensus 317 -ps~~ell~~ 325 (355)
+++.+++..
T Consensus 296 r~~~~~~l~h 305 (377)
T cd05629 296 RGGAHEIKSH 305 (377)
T ss_pred CCCHHHHhcC
Confidence 599998873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=314.38 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=203.1
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
+.|++++.||+|+||.||+|.+ ++..||+|++..... ......+.+.+|+.++..++||||+++++++.+.+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~------~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 74 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV------LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD 74 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC
Confidence 4689999999999999999965 678899999864221 11222356888999999999999999999988665
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.
T Consensus 75 ~~----------------~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~ 136 (381)
T cd05626 75 NL----------------YFVMDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL 136 (381)
T ss_pred EE----------------EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC
Confidence 54 669999999999999854 456899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCC-----------------------------------------------CCCCCCCCcccccC
Q 018489 208 NRTVKIADFGVARVEASNP-----------------------------------------------NDMTGETGTLGYMA 240 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~-----------------------------------------------~~~~~~~~~~~y~a 240 (355)
++.++|+|||++....... .......||..|+|
T Consensus 137 ~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 216 (381)
T cd05626 137 DGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIA 216 (381)
T ss_pred CCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccC
Confidence 9999999999874221000 00122468999999
Q ss_pred CcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhh--hcCCCCC
Q 018489 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCW--DANPDKR 316 (355)
Q Consensus 241 PE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l--~~~p~~R 316 (355)
||.+.+..++.++|||||||++|+|++|..||...+..+....+.........+ ..+++++.++|.+|+ ..++..|
T Consensus 217 PE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R 296 (381)
T cd05626 217 PEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGR 296 (381)
T ss_pred HHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCC
Confidence 999998889999999999999999999999998877766665555433333333 357899999999955 4555569
Q ss_pred CCHHHHHH
Q 018489 317 PEMDEVVS 324 (355)
Q Consensus 317 ps~~ell~ 324 (355)
+++.+++.
T Consensus 297 ~~~~~~l~ 304 (381)
T cd05626 297 NGADDIKA 304 (381)
T ss_pred CCHHHHhc
Confidence 99999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=320.82 Aligned_cols=268 Identities=23% Similarity=0.370 Sum_probs=217.0
Q ss_pred ccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
+..+.....++|++.+.||+|+||.||+|.+ ++..||||++...... .. ....+.+|+..+..++|+||++
T Consensus 23 d~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~---~~----~~~~~~~Ei~~l~~~~h~~iv~ 95 (496)
T PTZ00283 23 DEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS---EA----DKNRAQAEVCCLLNCDFFSIVK 95 (496)
T ss_pred CcccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC---HH----HHHHHHHHHHHHhcCCCCcEEE
Confidence 3344555678999999999999999999965 6899999998654321 11 1334678999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
++..+...+.... ......++||||+++++|.+++... ....+++..++.++.|++.+|.|||+.||+||
T Consensus 96 ~~~~~~~~~~~~~--------~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHr 167 (496)
T PTZ00283 96 CHEDFAKKDPRNP--------ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHR 167 (496)
T ss_pred eecceecccccCc--------ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 8876654332110 0112357899999999999998643 23568999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeeccccccccCC--CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 018489 197 DVKTENMLLDKNRTVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (355)
Q Consensus 197 di~p~Nili~~~~~v~L~Dfg~a~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~ 274 (355)
||||+|||++.++.++|+|||++...... ........|+..|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 168 DLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 168 DIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred CCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999998754322 1222345689999999999999999999999999999999999999998
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+..+.......... ..++..+++++.+++.+||+.||.+||++.+++.
T Consensus 248 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 248 ENMEEVMHKTLAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 877776666655433 3467778999999999999999999999999986
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=295.44 Aligned_cols=254 Identities=28% Similarity=0.489 Sum_probs=211.9
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
+.|++.+.||+|++|.||.+.. ++..+++|.+....... ......+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP----ETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccch----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC
Confidence 5799999999999999999964 68999999986543221 11122345788999999999999999999987765
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++++||+++++|.+++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.
T Consensus 78 ~~----------------~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~ 139 (263)
T cd06625 78 TL----------------SIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS 139 (263)
T ss_pred eE----------------EEEEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 44 669999999999999854 356899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCC---CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
++.++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+........
T Consensus 140 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 219 (263)
T cd06625 140 AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 219 (263)
T ss_pred CCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH
Confidence 999999999998654321111 12345678899999999988999999999999999999999999887666665555
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
........++..++..+.++|.+||..+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 220 ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 55555666778889999999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=307.09 Aligned_cols=250 Identities=27% Similarity=0.436 Sum_probs=221.2
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~ 125 (355)
...|++.+.||+|.||.||+++. +|+.+|+|++.+....... ....+.+|+.+++++. ||||+.+++.|.+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~------~~~~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE------DREDVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc------cHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 46899999999999999999965 6899999999766554322 2345889999999997 9999999999998
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.... ++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.|++|+||||+|+|+
T Consensus 108 ~~~~----------------~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~ 168 (382)
T KOG0032|consen 108 PDSV----------------YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLL 168 (382)
T ss_pred CCeE----------------EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeee
Confidence 7766 5599999999999999765 39999999999999999999999999999999999999
Q ss_pred cC----CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 206 DK----NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 206 ~~----~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
.. ++.++++|||++..... .......+||+.|+|||++....|+...|+||+|+++|.|++|..||.+.+.....
T Consensus 169 ~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~ 247 (382)
T KOG0032|consen 169 ASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF 247 (382)
T ss_pred ccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH
Confidence 53 35799999999987766 55667789999999999999999999999999999999999999999999988888
Q ss_pred HHHHhcCCC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+....+. ......++..+.++|+.||..||.+|+++.++|+
T Consensus 248 ~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 248 LAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 888777653 3455678999999999999999999999999998
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=295.29 Aligned_cols=256 Identities=32% Similarity=0.575 Sum_probs=212.4
Q ss_pred ceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
|++..++|++.+.||+|++|.||+|.+ .+..+++|.++..... .+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----------PESFLEEAQIMKKLRHDKLVQLYAVV 70 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----------HHHHHHHHHHHHhcCCCceEEEEeEE
Confidence 566778999999999999999999965 4578999998643321 13478899999999999999999876
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
... . .+++|||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 71 ~~~-~----------------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Ni 133 (260)
T cd05070 71 SEE-P----------------IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANI 133 (260)
T ss_pred CCC-C----------------cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceE
Confidence 432 2 26799999999999999765556689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~ 281 (355)
+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+..
T Consensus 134 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~ 213 (260)
T cd05070 134 LVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213 (260)
T ss_pred EEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999999975443221 1122334567999999988889999999999999999999 89999887766655
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
..+.. ......+...+..+.+++.+||+.+|.+|||++++.+.|+.
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 214 EQVER-GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHc-CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 55433 34445667789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=316.60 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=204.1
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||++.+ +++.||+|++.... .......+.+.+|+.+++.++|+||+++++.+...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~------~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD------VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH------HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 4799999999999999999965 57899999985321 111222455778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 75 ~~----------------~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~ 136 (376)
T cd05598 75 NL----------------YFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 136 (376)
T ss_pred EE----------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC
Confidence 44 679999999999999854 456899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCC-------------------------------------------CCCCCCCCCcccccCCccc
Q 018489 208 NRTVKIADFGVARVEASN-------------------------------------------PNDMTGETGTLGYMAPEVL 244 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~-------------------------------------------~~~~~~~~~~~~y~aPE~~ 244 (355)
++.++|+|||++...... ........|+..|+|||++
T Consensus 137 ~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 216 (376)
T cd05598 137 DGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL 216 (376)
T ss_pred CCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH
Confidence 999999999987421100 0001124689999999999
Q ss_pred CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCC---CH
Q 018489 245 NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRP---EM 319 (355)
Q Consensus 245 ~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~ 319 (355)
.+..++.++|||||||++|+|++|+.||.+.+..+....+........++ ..+++++.++|.+|+ .+|.+|+ ++
T Consensus 217 ~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~ 295 (376)
T cd05598 217 LRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA 295 (376)
T ss_pred cCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence 99999999999999999999999999999887766665555433332332 357899999999977 5999999 88
Q ss_pred HHHHHH
Q 018489 320 DEVVSM 325 (355)
Q Consensus 320 ~ell~~ 325 (355)
.++++-
T Consensus 296 ~ell~h 301 (376)
T cd05598 296 DEIKAH 301 (376)
T ss_pred HHHhCC
Confidence 998863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=311.01 Aligned_cols=243 Identities=27% Similarity=0.446 Sum_probs=202.0
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~ 133 (355)
+.||+|+||.||++.+ ++..||+|++...... .......+.+|++++..++||||+++++.+...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~---- 70 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV------AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL---- 70 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEE----
Confidence 4689999999999965 6889999999642211 111123466799999999999999999888765544
Q ss_pred ccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEE
Q 018489 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+++++|..++.. ...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.++
T Consensus 71 ------------~lv~E~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~k 136 (325)
T cd05594 71 ------------CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK 136 (325)
T ss_pred ------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEE
Confidence 679999999999988843 4579999999999999999999997 7999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 292 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 292 (355)
|+|||.+..............|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.... ..
T Consensus 137 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~--~~ 214 (325)
T cd05594 137 ITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IR 214 (325)
T ss_pred EecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC--CC
Confidence 9999998754333333344568999999999999889999999999999999999999998877766666554433 34
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 293 IPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 293 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
++..+++++.++|.+||+.||.+|+ ++.++++
T Consensus 215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 6677899999999999999999997 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=296.25 Aligned_cols=250 Identities=25% Similarity=0.451 Sum_probs=211.0
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||.|+||.||++.+ ++..+++|.++..... ...+.+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 72 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--------SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH 72 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--------HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence 589999999999999999965 6788999998643211 113446789999999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+++++|.+++.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.+
T Consensus 73 ~----------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~ 136 (255)
T cd08219 73 L----------------YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136 (255)
T ss_pred E----------------EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC
Confidence 4 669999999999999876566678999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 288 (355)
+.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.. .
T Consensus 137 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-~ 215 (255)
T cd08219 137 GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ-G 215 (255)
T ss_pred CcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc-C
Confidence 999999999987654443333445688899999999988899999999999999999999999988776665555443 3
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 289 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
....++..++..+.++|.+||+.||.+||++.+++..
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 3334566788999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=303.14 Aligned_cols=268 Identities=33% Similarity=0.586 Sum_probs=217.1
Q ss_pred cccceecCCcceeecccccccceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL- 111 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 111 (355)
.++|++..++|.+.+.||+|+||.||++.+. ...+|+|.+..... ... ...+.+|+.++..+
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~----~~~----~~~~~~e~~~l~~l~ 81 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT----EKD----LSDLISEMEMMKMIG 81 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC----hHH----HHHHHHHHHHHHHhc
Confidence 4577888899999999999999999999652 24699999853211 111 23467799999999
Q ss_pred CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHHHH
Q 018489 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQL 177 (355)
Q Consensus 112 ~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i 177 (355)
+||||+++++++...+.. +++|||+++++|.+++.... ...+++..++.+
T Consensus 82 ~h~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 145 (307)
T cd05098 82 KHKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145 (307)
T ss_pred CCCCEeeEEEEEecCCce----------------EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHH
Confidence 899999999988765544 66999999999999996532 135889999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchh
Q 018489 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDV 255 (355)
Q Consensus 178 ~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv 255 (355)
+.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+
T Consensus 146 ~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 225 (307)
T cd05098 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225 (307)
T ss_pred HHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHH
Confidence 999999999999999999999999999999999999999998754321111 111233467999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 256 YSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 256 wslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
||||+++|+|++ |..||...+..+....+ ........+..++.++.++|.+||..+|.+||++.++++.|+.+.....
T Consensus 226 wslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 226 WSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred HHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 999999999998 88999876665544443 3344445667789999999999999999999999999999999876643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=292.95 Aligned_cols=250 Identities=29% Similarity=0.489 Sum_probs=211.1
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|.+.+.||+|++|.||+|.+ ++..|++|.+...... ......+.+|+++++.++||||+++++++...+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-------RREREEAIDEARVLAKLDSSYIIRYYESFLDKGK 73 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-------HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCE
Confidence 588999999999999999965 6889999998643322 1123457889999999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 74 ~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~ 137 (256)
T cd08529 74 L----------------NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY 137 (256)
T ss_pred E----------------EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC
Confidence 4 669999999999999977656789999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 288 (355)
+.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|+.||...+.......+...
T Consensus 138 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~- 216 (256)
T cd08529 138 DNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG- 216 (256)
T ss_pred CCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-
Confidence 9999999999875544333333456788999999999988999999999999999999999999887765555554443
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 289 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.....+..++.++.++|.+||+.+|++||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 334455578899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=307.90 Aligned_cols=238 Identities=25% Similarity=0.391 Sum_probs=197.9
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
+.||+|+||.||+|.+ +++.||+|++...... .....+.+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~--- 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL------QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL--- 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh------hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE---
Confidence 4689999999999975 5789999998632211 111123456788888776 799999999988766554
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 72 -------------~iv~Ey~~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~k 136 (320)
T cd05590 72 -------------FFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCK 136 (320)
T ss_pred -------------EEEEcCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEE
Confidence 669999999999998853 45699999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 292 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 292 (355)
|+|||++..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+.... ..
T Consensus 137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~ 214 (320)
T cd05590 137 LADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VV 214 (320)
T ss_pred EeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--CC
Confidence 9999998754333333344578999999999999889999999999999999999999999888877776665433 34
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 018489 293 IPRCCPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 293 ~~~~~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
++..++.++.++|++||+.||.+||++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 566789999999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=294.11 Aligned_cols=251 Identities=30% Similarity=0.593 Sum_probs=207.3
Q ss_pred cCCcceeecccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
+.++|++.+.||+|+||.||++.+. +..+|+|.+...... ...+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----------HHHHHHHHHHHHHCCCCCceeEEEEEccC
Confidence 4578999999999999999999764 458999987533211 23477899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. +++|||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus 72 ~~~----------------~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~ 134 (256)
T cd05114 72 KPL----------------YIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS 134 (256)
T ss_pred CCE----------------EEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc
Confidence 544 6799999999999988643 24689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~ 284 (355)
.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+..+....+
T Consensus 135 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i 214 (256)
T cd05114 135 STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214 (256)
T ss_pred CCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999998875432211 1122234567999999998889999999999999999999 89999887776666665
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
... .....+...+.++.+++.+||+.+|.+||++.++++.|
T Consensus 215 ~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 215 SRG-FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HCC-CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 443 23344556788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=294.39 Aligned_cols=256 Identities=33% Similarity=0.587 Sum_probs=210.7
Q ss_pred ceecCCcceeecccccccceEEEEEEECC-ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
|++..++|++.+.||+|++|.||++.+.+ ..+++|.+..... ..+.+.+|+.+++.++|+|++++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~ 70 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----------MPEAFLQEAQIMKKLRHDKLVPLYAVV 70 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----------cHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 45667889999999999999999997644 5799998753221 123477899999999999999998876
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.. + ..+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 71 ~~-~----------------~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Ni 133 (260)
T cd05069 71 SE-E----------------PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANI 133 (260)
T ss_pred cC-C----------------CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceE
Confidence 42 2 226799999999999999765555689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~ 281 (355)
+++.++.++|+|||.+........ ......++..|+|||...+..++.++|+||||+++|+|++ |..||.+....+..
T Consensus 134 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 213 (260)
T cd05069 134 LVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL 213 (260)
T ss_pred EEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999875433221 1122345668999999988889999999999999999999 99999887666555
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
..+. .......+...+..+.+++.+||..||.+||+++++++.|+.
T Consensus 214 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 214 EQVE-RGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHH-cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 4443 334445566789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=307.33 Aligned_cols=243 Identities=25% Similarity=0.375 Sum_probs=202.0
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSS 127 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~ 127 (355)
+|.+.+.||+|+||.||+|.+ ++..||+|+++...... ....+.+..|..++..+ .|++|+++++++...+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ------DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh------hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence 589999999999999999976 46789999986432111 11123355677777777 6889999998887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+|||++.
T Consensus 75 ~~----------------~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 136 (323)
T cd05616 75 RL----------------YFVMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136 (323)
T ss_pred EE----------------EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC
Confidence 44 669999999999998843 456899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.++|+|||.+..............|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 137 ~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~ 216 (323)
T cd05616 137 EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 216 (323)
T ss_pred CCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 99999999999875433333334457899999999999999999999999999999999999999988877777766654
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
. ..++..++.++.+++.+||+.||.+|++.
T Consensus 217 ~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 N--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred C--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 3 34667789999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=308.34 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=196.7
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||+|+||.||+|.+ ++..||||.+....... .....+.+|+.+++.++||||+++++++.....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 73 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV-------SDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 73 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc-------hhHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence 689999999999999999975 57899999985321111 112346789999999999999999988754332
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. .....++||||+ +++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+|||++.+
T Consensus 74 ~-----------~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~ 139 (338)
T cd07859 74 R-----------EFKDIYVVFELM-ESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD 139 (338)
T ss_pred C-----------CCceEEEEEecC-CCCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 1 112357899999 5689888843 4569999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 209 RTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
+.++|+|||.+........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.......
T Consensus 140 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~ 219 (338)
T cd07859 140 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 219 (338)
T ss_pred CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Confidence 9999999999875432211 1234568899999999876 5788999999999999999999999977654332221
Q ss_pred HHhc--------------------------CCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQ--------------------------NLRPE---IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~--------------------------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+... ..... ....+++.+.++|.+||+.||++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 220 ITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1110 00000 11245788999999999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=297.06 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=210.6
Q ss_pred cceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
.|.-.+++|.|+||+||+|. .+++.||||..-.+.. .-.+|+++++.+.|||||++.-+|.....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------------~knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------------YKNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------------cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 48888999999999999994 4678999998743332 13479999999999999999988875443
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
. +.-+..+||||++ .+|.+.++.. .+..++...++-++.||++||+|||+.||+||||||.|+|++
T Consensus 92 ~-----------d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD 159 (364)
T KOG0658|consen 92 S-----------DEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD 159 (364)
T ss_pred C-----------chhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc
Confidence 3 1123378999995 5999988642 356799999999999999999999999999999999999999
Q ss_pred CC-CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 207 KN-RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 207 ~~-~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
.+ |.+||||||.|.......+. ....++..|+|||.+.| ..|+.+.||||.||++.||+.|+..|.+.+..+++..+
T Consensus 160 ~~tg~LKicDFGSAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eI 238 (364)
T KOG0658|consen 160 PDTGVLKICDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEI 238 (364)
T ss_pred CCCCeEEeccCCcceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHH
Confidence 76 99999999999876554433 55778999999999987 57999999999999999999999999998888887777
Q ss_pred HhcCCCCC---------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHhHhh
Q 018489 285 VRQNLRPE---------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAIDTS 332 (355)
Q Consensus 285 ~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~~~~ 332 (355)
.+.-..+. +....++++.+++.++|.++|.+|.++.|++. .++.+...
T Consensus 239 ik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 239 IKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 66222221 33456899999999999999999999999986 56666554
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=299.04 Aligned_cols=258 Identities=32% Similarity=0.578 Sum_probs=212.6
Q ss_pred ceecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
|++..++|++.+.||+|+||.||+|.+. +..|++|.+..... . .....+.+|+.++..++|+||+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~----~----~~~~~~~~e~~~l~~~~~~~i~ 72 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS----M----RERIEFLNEASVMKEFNCHHVV 72 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC----H----HHHHHHHHHHHHHHhCCCCcee
Confidence 5677889999999999999999999653 36799999743221 1 1124477899999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------cccccHHHHHHHHHHHHHHHHHHH
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------RRKLAFKVVVQLALDLARGLSYLH 189 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~LH 189 (355)
++++++...... +++|||+++++|.+++.... ...+++..++.++.|++.||.|||
T Consensus 73 ~~~~~~~~~~~~----------------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 136 (277)
T cd05032 73 RLLGVVSTGQPT----------------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA 136 (277)
T ss_pred EEEEEEcCCCCc----------------EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999988765544 66999999999999986432 224788899999999999999999
Q ss_pred hCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh
Q 018489 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 190 ~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt 267 (355)
+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|++++
T Consensus 137 ~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 216 (277)
T cd05032 137 AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216 (277)
T ss_pred hCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhc
Confidence 99999999999999999999999999999875432211 1122345678999999988889999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 268 -CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 268 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
|..||...+......... .......+..++.++.++|.+||+.+|++|||+.++++.|+
T Consensus 217 ~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 217 LAEQPYQGLSNEEVLKFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCCCCccCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 999998877766665554 44445667778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=310.17 Aligned_cols=239 Identities=26% Similarity=0.415 Sum_probs=200.2
Q ss_pred cccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccc
Q 018489 56 SVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 130 (355)
+.||+|+||.||++.+ +++.+|+|++...... ......+.+|++++++++||||+++++++...+..
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-------VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKL- 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEE-
Confidence 5799999999998854 5789999999642211 11123467799999999999999999988765544
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~ 210 (355)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 74 ---------------~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 136 (318)
T cd05582 74 ---------------YLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH 136 (318)
T ss_pred ---------------EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc
Confidence 669999999999998843 456999999999999999999999999999999999999999999
Q ss_pred EEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC
Q 018489 211 VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 290 (355)
Q Consensus 211 v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~ 290 (355)
++|+|||.+..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+....
T Consensus 137 ~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-- 214 (318)
T cd05582 137 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-- 214 (318)
T ss_pred EEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--
Confidence 999999998755443333344578999999999998888999999999999999999999999887777666655433
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 018489 291 PEIPRCCPSSLANVMKRCWDANPDKRPEMDE 321 (355)
Q Consensus 291 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e 321 (355)
..++..+++++.++|++||+.||.+||++.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 3466778999999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=299.97 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=205.3
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
.|++.+.||+|+||.||++.+ +++.||+|++...... .......+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh------hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence 488999999999999999975 5789999998532211 11223446789999999999999999988876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++++
T Consensus 75 ~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 138 (285)
T cd05605 75 L----------------CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY 138 (285)
T ss_pred E----------------EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC
Confidence 4 679999999999988865545679999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh--
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR-- 286 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~-- 286 (355)
+.++|+|||.+...... .......++..|+|||.+.+..++.++||||+|+++|+|++|..||.+.........+..
T Consensus 139 ~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 217 (285)
T cd05605 139 GHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV 217 (285)
T ss_pred CCEEEeeCCCceecCCC-CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh
Confidence 99999999998754322 222335688999999999988899999999999999999999999987655433322211
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
......++..+++.+.++|.+||+.||.+|| +++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 218 KEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred hhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1223345667899999999999999999999 8889876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=299.91 Aligned_cols=261 Identities=31% Similarity=0.529 Sum_probs=214.3
Q ss_pred ecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
++.++|.+.+.||+|+||.||++.. ++..+++|.+.... ......+.+|+.++.+++||||+++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~ 72 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---------DNARKDFHREAELLTNLQHEHIVKF 72 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---------HHHHHHHHHHHHHHHhCCCCCcceE
Confidence 5678899999999999999999964 24568899875321 1123457889999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-----------cccccHHHHHHHHHHHHHHHHHH
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-----------RRKLAFKVVVQLALDLARGLSYL 188 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~al~~L 188 (355)
++++...+.. +++|||+++++|.+++.... ...+++..++.++.|++.||+||
T Consensus 73 ~~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l 136 (288)
T cd05093 73 YGVCVEGDPL----------------IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL 136 (288)
T ss_pred EEEEecCCcc----------------EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 9988765444 67999999999999986432 23489999999999999999999
Q ss_pred HhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHH
Q 018489 189 HSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266 (355)
Q Consensus 189 H~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll 266 (355)
|++|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 137 H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~ 216 (288)
T cd05093 137 ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216 (288)
T ss_pred HhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999999999874432211 112233467899999999888999999999999999999
Q ss_pred h-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 267 C-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 267 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
+ |..||...........+.... ....+..++.++.+++.+||+.||.+|||+.++++.|+++....
T Consensus 217 t~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 217 TYGKQPWYQLSNNEVIECITQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred hCCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 8 999998877766665554433 33455668899999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=307.03 Aligned_cols=243 Identities=24% Similarity=0.358 Sum_probs=201.9
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
+.||+|+||.||+|.+ +++.||+|++...... .....+.+..|.+++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~--- 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL------QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL--- 71 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh------hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE---
Confidence 4689999999999976 4678999998642211 111223456788888766 899999999998766554
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+++++|..++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 72 -------------~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~k 136 (321)
T cd05591 72 -------------FFVMEYVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCK 136 (321)
T ss_pred -------------EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEE
Confidence 669999999999988853 45689999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 292 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 292 (355)
|+|||.+..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+..... .
T Consensus 137 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--~ 214 (321)
T cd05591 137 LADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--L 214 (321)
T ss_pred EeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--C
Confidence 99999987544333334445689999999999998899999999999999999999999998888777776665433 3
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCC-------CHHHHHH
Q 018489 293 IPRCCPSSLANVMKRCWDANPDKRP-------EMDEVVS 324 (355)
Q Consensus 293 ~~~~~~~~l~~li~~~l~~~p~~Rp-------s~~ell~ 324 (355)
++..++.++.++|.+||+.||.+|+ ++.++++
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 5566799999999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=294.39 Aligned_cols=252 Identities=29% Similarity=0.597 Sum_probs=207.4
Q ss_pred cCCcceeecccccccceEEEEEEECC-ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
..++|++.+.||+|++|.||++.+.+ ..+|+|.+..... . ...+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---S-------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---c-------HHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 46789999999999999999997654 4599998753321 1 13377899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. +++|||+.+++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++
T Consensus 72 ~~~----------------~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~ 134 (256)
T cd05113 72 RPI----------------YIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD 134 (256)
T ss_pred CCc----------------EEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc
Confidence 544 66999999999999986533 3689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~ 284 (355)
.++.++|+|||.+........ ......++..|++||.+.+..++.++|+||||+++|+|++ |..||...+.......+
T Consensus 135 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05113 135 DQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214 (256)
T ss_pred CCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 999999999999875433221 1122335567999999998889999999999999999998 99999887766655555
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
... .....+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 215 ~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 215 SQG-LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred hcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 443 333445567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=286.19 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=215.4
Q ss_pred ecCCcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
+..+.|++.+.||+|.|+.|+++. .+|..+++|++........ --+.+.+|+++-+.|+||||+++.+.+.
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-------~~e~l~rEarIC~~LqHP~IvrL~~ti~ 80 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-------DFQKLEREARICRKLQHPNIVRLHDSIQ 80 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-------cHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence 345789999999999999999884 4789999998854333222 2345788999999999999999998877
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..... ++|+|.++|++|..-|- .+.-+++..+-.+++||++||.|+|.+||+|||+||+|++
T Consensus 81 ~~~~~----------------ylvFe~m~G~dl~~eIV--~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nll 142 (355)
T KOG0033|consen 81 EESFH----------------YLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLL 142 (355)
T ss_pred cccee----------------EEEEecccchHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhhee
Confidence 65444 66999999999976663 3366899999999999999999999999999999999999
Q ss_pred Ec---CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 205 LD---KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 205 i~---~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
+. ...-+||+|||.+.... .....-...|++.|+|||++...+|+..+|||+-|+++|-|+.|.+||.+.+.....
T Consensus 143 LASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly 221 (355)
T KOG0033|consen 143 LASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 221 (355)
T ss_pred eeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH
Confidence 94 45679999999998665 556667788999999999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+....... .....++++.++||++||..||.+|+|+.|+|+
T Consensus 222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 8888876543 345678999999999999999999999988764
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=291.60 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=217.7
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc-cceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN-VTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~ 125 (355)
...|..++.||+|+||+||+|+. +|..||+|.++.....+... ....+|+.+++.++|+| |+.+++++..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P-------~taiREisllk~L~~~~~iv~L~dv~~~ 82 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVP-------STAIREISLLKRLSHANHIVRLHDVIHT 82 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCC-------chhhHHHHHHHHhCCCcceEEEEeeeee
Confidence 46788999999999999999954 78999999998765532221 12468999999999999 9999999887
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc--ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
..... ....+++||||+ ..+|..++..... ..++...++.+++||+.||+|||++||+||||||.||
T Consensus 83 ~~~~~----------~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNl 151 (323)
T KOG0594|consen 83 SNNHR----------GIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNL 151 (323)
T ss_pred ccccc----------ccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceE
Confidence 66310 123457899999 5699999976543 4688899999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
+|+++|.+||+|||+|+...-+.......++|..|+|||++.|. .|+...|+||+||++++|++++..|.+.++.+++.
T Consensus 152 Li~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~ 231 (323)
T KOG0594|consen 152 LISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF 231 (323)
T ss_pred EECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 99999999999999999766666677888999999999999886 78999999999999999999999999999888888
Q ss_pred HHHhcCCCCC----------------C------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHh
Q 018489 283 AVVRQNLRPE----------------I------------PRCCPSSLANVMKRCWDANPDKRPEMDEVVSM--LEAI 329 (355)
Q Consensus 283 ~~~~~~~~~~----------------~------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~--l~~~ 329 (355)
.+...-..+. + ....+++..+++.+||+.+|.+|.|+..+++. +..+
T Consensus 232 ~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 232 RIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 7776333221 0 01123578999999999999999999999885 4444
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=297.97 Aligned_cols=257 Identities=30% Similarity=0.533 Sum_probs=211.0
Q ss_pred ecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
+...+|.+.+.||+|+||.||+|... +..||+|.++.... ....+.+.+|+++++.++|+||+++
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~ 73 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--------NDARKDFEREAELLTNFQHENIVKF 73 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--------HHHHHHHHHHHHHHHhcCCCCchhe
Confidence 34578999999999999999999642 46799999864322 1123567889999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc------------cccccHHHHHHHHHHHHHHHHH
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------RRKLAFKVVVQLALDLARGLSY 187 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~~~i~~qi~~al~~ 187 (355)
++++...... +++|||+++++|.+++.... ...+++..+..++.|++.++.+
T Consensus 74 ~~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~ 137 (280)
T cd05049 74 YGVCTEGDPP----------------IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVY 137 (280)
T ss_pred eeEEecCCCe----------------EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHH
Confidence 9988765444 67999999999999996432 2457899999999999999999
Q ss_pred HHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHH
Q 018489 188 LHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265 (355)
Q Consensus 188 LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l 265 (355)
||++|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|
T Consensus 138 lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~ 217 (280)
T cd05049 138 LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217 (280)
T ss_pred HhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHH
Confidence 999999999999999999999999999999987432221 111223456789999999998999999999999999999
Q ss_pred Hh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 266 YC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 266 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
++ |..||...+..+....+... .....+..++..+.+++.+||+.||.+||++.|+++.|++
T Consensus 218 ~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 218 FTYGKQPWYGLSNEEVIECITQG-RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 98 99999887776666555433 3334556789999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=294.01 Aligned_cols=258 Identities=34% Similarity=0.602 Sum_probs=214.1
Q ss_pred ceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
|++..++|++.+.||.|++|.||++.. .+..+++|.+...... .+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----------PEAFLQEAQIMKKLRHDKLVQLYAVC 70 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----------HHHHHHHHHHHhhCCCCCEeeeeeee
Confidence 567889999999999999999999965 4567999988643221 13477899999999999999999987
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...... +++|||+++++|.+++.......+++..+..++.+++.|+.|||++|++|+||+|+||
T Consensus 71 ~~~~~~----------------~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~ni 134 (261)
T cd05034 71 SEEEPI----------------YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNI 134 (261)
T ss_pred ecCCce----------------EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheE
Confidence 654443 6799999999999999765556799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~ 281 (355)
+++.++.++|+|||.+........ .......+..|+|||.+.+..++.++|+||+|+++|+|++ |+.||.+.+.....
T Consensus 135 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 214 (261)
T cd05034 135 LVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214 (261)
T ss_pred EEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999875432111 1112234567999999998889999999999999999998 99999887776666
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
..+.. ......+...+.++.+++.+||+.+|.+||+++++.+.|+.+
T Consensus 215 ~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 215 EQVER-GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HHHHc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 55543 333445566789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=307.90 Aligned_cols=249 Identities=25% Similarity=0.376 Sum_probs=200.3
Q ss_pred cceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeecc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 124 (355)
+|++.+.||+|+||.||++.. ++..||+|++..... .......+.+.+|+.++..+ +|+||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-----VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe
Confidence 589999999999999999864 578899999853221 11122334577899999999 6899999998887
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..+.. +++|||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||
T Consensus 76 ~~~~~----------------~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil 137 (332)
T cd05614 76 TEAKL----------------HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137 (332)
T ss_pred cCCEE----------------EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence 65544 669999999999999853 456999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCh----h
Q 018489 205 LDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSF----S 278 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~----~ 278 (355)
++.++.++|+|||++....... .......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||..... .
T Consensus 138 i~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 217 (332)
T cd05614 138 LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217 (332)
T ss_pred ECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH
Confidence 9999999999999987543222 222335689999999999875 478899999999999999999999965322 1
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
.....+. ...+.++..+++.+.++|.+||+.||.+|| +++++++
T Consensus 218 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 218 EVSRRIL--KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHHHh--cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 2222222 234456677899999999999999999999 7778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=295.97 Aligned_cols=259 Identities=27% Similarity=0.453 Sum_probs=211.1
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||.|++|.||++.+ ++..++||.+...... .......+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM------DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh------hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence 5799999999999999999964 7899999987543211 1122355788999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.. +++|||+++++|.+++... ....+++..++.++.|++.+|.|||+.|++|+||+|+||++
T Consensus 76 ~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili 139 (267)
T cd08229 76 EL----------------NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred eE----------------EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 44 5699999999999988642 23568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh--hHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF--SEVTSA 283 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~--~~~~~~ 283 (355)
+.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T cd08229 140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219 (267)
T ss_pred cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh
Confidence 999999999999987654443333445688899999999988899999999999999999999999965433 222233
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
+......+.....++..+.++|.+||+.+|.+|||+.+|++.++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 220 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 33222222333457889999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=312.18 Aligned_cols=259 Identities=26% Similarity=0.371 Sum_probs=211.2
Q ss_pred cccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
...+.+..++|++.+.||+|+||.||++.+ +++.+|+|++...... .....+.+.+|+.+++.++||||+++
T Consensus 35 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~i~~~~~hp~iv~~ 108 (370)
T cd05621 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI------KRSDSAFFWEERDIMAFANSPWVVQL 108 (370)
T ss_pred HHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhCCCCCEeeE
Confidence 345667778999999999999999999976 5788999998532111 11123447789999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++...+.. ++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus 109 ~~~~~~~~~~----------------~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLK 169 (370)
T cd05621 109 FCAFQDDKYL----------------YMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVK 169 (370)
T ss_pred EEEEEcCCEE----------------EEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 9988765544 669999999999998843 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCC----CCCCcchhHHHHHHHHHHHhCCCCCCC
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGN----PYNRKCDVYSFGICLWEIYCCDMPYPD 274 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~~lltg~~p~~~ 274 (355)
|+|||++.++.++|+|||.+........ ......|+..|+|||.+.+. .++.++|+||||+++|+|++|..||..
T Consensus 170 p~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 170 PDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred HHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 9999999999999999999875433221 22345689999999998764 377899999999999999999999998
Q ss_pred CChhHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 018489 275 LSFSEVTSAVVRQNLRPEIPR--CCPSSLANVMKRCWDANPDK--RPEMDEVVSM 325 (355)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~--Rps~~ell~~ 325 (355)
.+.......+........++. .++..+.++|..||..++.+ |+++.++++.
T Consensus 250 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 250 DSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 888777777766544444444 46899999999999855543 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=306.94 Aligned_cols=240 Identities=26% Similarity=0.392 Sum_probs=195.8
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~ 133 (355)
+.||+|+||.||+|.+ +++.||+|++...... ......+.+..+..+++.++||||+++++.+...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~---- 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-----KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL---- 71 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE----
Confidence 4689999999999976 6889999998642211 1111122233333456788999999999888765544
Q ss_pred ccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 018489 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (355)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L 213 (355)
++||||+++++|..++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.++|
T Consensus 72 ------------~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl 137 (323)
T cd05575 72 ------------YFVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVL 137 (323)
T ss_pred ------------EEEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEE
Confidence 669999999999998853 457999999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC
Q 018489 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293 (355)
Q Consensus 214 ~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
+|||++..............|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.... ..+
T Consensus 138 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~ 215 (323)
T cd05575 138 TDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP--LRL 215 (323)
T ss_pred eccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--CCC
Confidence 999998754333333344568999999999999899999999999999999999999999887777766665543 235
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 018489 294 PRCCPSSLANVMKRCWDANPDKRPEMD 320 (355)
Q Consensus 294 ~~~~~~~l~~li~~~l~~~p~~Rps~~ 320 (355)
+..++.++.++|.+||+.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 566799999999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=308.09 Aligned_cols=250 Identities=27% Similarity=0.448 Sum_probs=199.8
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
.....++|++.+.||+|+||.||+|.+ +++.||||++..... ......+.+|+.+++.++|+||++++++
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 140 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--------DTVRRQICREIEILRDVNHPNVVKCHDM 140 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--------HHHHHHHHHHHHHHHhCCCCCcceeeeE
Confidence 334457899999999999999999976 578999999853321 1234557899999999999999999998
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...+.. ++||||+++++|... ...++..++.++.||+.||.|||+.|++|+||||+|
T Consensus 141 ~~~~~~~----------------~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 198 (353)
T PLN00034 141 FDHNGEI----------------QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSN 198 (353)
T ss_pred eccCCeE----------------EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHH
Confidence 8765554 569999999998643 235678889999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~lltg~~p~~~~~~ 277 (355)
||++.++.++|+|||++..............|+..|+|||.+.. ...+.++||||||+++|+|++|+.||.....
T Consensus 199 Ill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 278 (353)
T PLN00034 199 LLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ 278 (353)
T ss_pred EEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999998765433333344578999999998753 2345689999999999999999999974332
Q ss_pred hHHHHH--HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 278 SEVTSA--VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 278 ~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...... ..........+..++.++.++|.+||+.||++||++.|+++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 279 GDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred ccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222211 11223334456678999999999999999999999999987
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=304.50 Aligned_cols=243 Identities=28% Similarity=0.449 Sum_probs=197.6
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
+.||+|+||.||+|.+ +++.||+|+++....... ...+.+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~--- 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED------DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL--- 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh------hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE---
Confidence 4689999999999966 567899999964321111 1122234566666554 899999999988765544
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+++++|..++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus 72 -------------~lv~e~~~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~k 136 (316)
T cd05592 72 -------------FFVMEYLNGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIK 136 (316)
T ss_pred -------------EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEE
Confidence 669999999999998854 45699999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 292 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 292 (355)
|+|||.+..............|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+.. ..+.
T Consensus 137 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~ 214 (316)
T cd05592 137 IADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPH 214 (316)
T ss_pred EccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCC
Confidence 99999987543333333445789999999999998899999999999999999999999998887776666544 3345
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 018489 293 IPRCCPSSLANVMKRCWDANPDKRPEMD-EVVS 324 (355)
Q Consensus 293 ~~~~~~~~l~~li~~~l~~~p~~Rps~~-ell~ 324 (355)
++..++.++.++|.+||+.||.+||++. ++++
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 6777899999999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=312.70 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=203.5
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++++.||+|+||.||+|.+ ++..||+|++.... .......+.+.+|+.++++++|+||+++++.+...+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~------~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~ 74 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD------VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 74 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH------hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC
Confidence 4699999999999999999965 67889999985321 112233456788999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 ~~----------------~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~ 136 (382)
T cd05625 75 NL----------------YFVMDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR 136 (382)
T ss_pred EE----------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 44 669999999999999854 356899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCC-----------------------------------------------CCCCCCCCCcccccC
Q 018489 208 NRTVKIADFGVARVEASN-----------------------------------------------PNDMTGETGTLGYMA 240 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~-----------------------------------------------~~~~~~~~~~~~y~a 240 (355)
++.++|+|||++...... ........|+..|+|
T Consensus 137 ~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 216 (382)
T cd05625 137 DGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIA 216 (382)
T ss_pred CCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCC
Confidence 999999999987421100 000112468899999
Q ss_pred CcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCC
Q 018489 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPE 318 (355)
Q Consensus 241 PE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps 318 (355)
||++.+..++.++|||||||++|+|++|+.||...+..+....+.........+ ..+++++.++|.+|+ .+|.+|++
T Consensus 217 PE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 217 PEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 999999899999999999999999999999999887766666655543333333 457899999999976 59999987
Q ss_pred ---HHHHHH
Q 018489 319 ---MDEVVS 324 (355)
Q Consensus 319 ---~~ell~ 324 (355)
++++++
T Consensus 296 ~~~~~ei~~ 304 (382)
T cd05625 296 KNGADEIKA 304 (382)
T ss_pred CCCHHHHhc
Confidence 888775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=306.10 Aligned_cols=266 Identities=30% Similarity=0.563 Sum_probs=212.8
Q ss_pred cceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCc
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 115 (355)
.|.+..++|++.+.||+|+||.||+|.+ +++.||||+++.... .. ....+.+|+.++.++ +|||
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~----~~~~~~~E~~~l~~l~~h~n 72 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----HS----EHRALMSELKILIHIGHHLN 72 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC----hH----HHHHHHHHHHHHHhccCCcc
Confidence 3677788999999999999999999963 457899999864321 11 123477899999999 7899
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc------------------------------
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------------------------ 165 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------------------ 165 (355)
|+++++++...+. ..+++|||+++++|.+++....
T Consensus 73 iv~~~~~~~~~~~---------------~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (343)
T cd05103 73 VVNLLGACTKPGG---------------PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRR 137 (343)
T ss_pred HhhhcceeecCCC---------------ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhh
Confidence 9999987754332 2367999999999999986432
Q ss_pred -----------------------------------cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc
Q 018489 166 -----------------------------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (355)
Q Consensus 166 -----------------------------------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~ 210 (355)
...+++..+..++.|++.||+|||++|++|+||||+||+++.++.
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~ 217 (343)
T cd05103 138 LDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV 217 (343)
T ss_pred ccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc
Confidence 123678888999999999999999999999999999999999999
Q ss_pred EEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhc
Q 018489 211 VKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 211 v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~ 287 (355)
++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...............
T Consensus 218 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 297 (343)
T cd05103 218 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 297 (343)
T ss_pred EEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc
Confidence 99999999875432211 1112234567999999988889999999999999999997 99999876544444444444
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
......+...++++.+++..||+.+|.+||++.+|++.|+.+.+.
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 298 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred cCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 444555666788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=309.47 Aligned_cols=267 Identities=29% Similarity=0.560 Sum_probs=219.4
Q ss_pred cccccceecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC
Q 018489 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112 (355)
Q Consensus 40 ~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 112 (355)
.....|++..++|.+.+.||+|+||.||+|.+. +..||+|+++..... ...+.+.+|+.++.++.
T Consensus 27 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~~E~~~l~~l~ 98 (401)
T cd05107 27 PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--------SEKQALMSELKIMSHLG 98 (401)
T ss_pred CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--------hHHHHHHHHHHHHHhcC
Confidence 344458999999999999999999999999753 357999999643211 11234778999999996
Q ss_pred -CCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc-------------------------
Q 018489 113 -HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR------------------------- 166 (355)
Q Consensus 113 -h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------- 166 (355)
||||+++++.+...... ++||||+++|+|.+++..+..
T Consensus 99 ~H~niv~~~~~~~~~~~~----------------~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (401)
T cd05107 99 PHLNIVNLLGACTKGGPI----------------YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLS 162 (401)
T ss_pred CCCCeEEEEEEEccCCCc----------------EEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccc
Confidence 99999999988765544 679999999999999965321
Q ss_pred -----------------------------------------------------------------------ccccHHHHH
Q 018489 167 -----------------------------------------------------------------------RKLAFKVVV 175 (355)
Q Consensus 167 -----------------------------------------------------------------------~~~~~~~~~ 175 (355)
..+++..++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 242 (401)
T cd05107 163 QRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLV 242 (401)
T ss_pred ccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHH
Confidence 236777889
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcc
Q 018489 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKC 253 (355)
Q Consensus 176 ~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~ 253 (355)
.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++
T Consensus 243 ~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 322 (401)
T cd05107 243 GFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS 322 (401)
T ss_pred HHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHh
Confidence 9999999999999999999999999999999999999999999875432211 12223467789999999988899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 254 DVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 254 DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
|+||||+++|+|++ |..||......+..............+..++.++.+++.+||..+|.+||++.+|++.|+.+.
T Consensus 323 DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 323 DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 99999999999998 899998766666555555555555667778999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=293.31 Aligned_cols=255 Identities=28% Similarity=0.550 Sum_probs=211.7
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|.+...||.|++|.||+|.+ ++..+++|.+.................+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 578889999999999999965 578999999876555444334444556678899999999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+++++|.+++.. ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus 81 ~----------------~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~ 142 (267)
T cd06628 81 L----------------NIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK 142 (267)
T ss_pred c----------------EEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC
Confidence 4 569999999999999954 3568999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCC------CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 209 RTVKIADFGVARVEASNPN------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
+.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+......
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 222 (267)
T cd06628 143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF 222 (267)
T ss_pred CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH
Confidence 9999999999875542211 1122347788999999998888999999999999999999999998776555444
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.... ...+.++..++..+.++|.+||+.||.+||++.++++
T Consensus 223 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 KIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 3333 3445566778999999999999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=293.36 Aligned_cols=251 Identities=34% Similarity=0.663 Sum_probs=211.0
Q ss_pred eecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
-+...+|++.+.||+|+||.||++..++..+++|..+... ..+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 70 (254)
T cd05083 2 LLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----------TAQAFLEETAVMTKLHHKNLVRLLGVILH 70 (254)
T ss_pred cccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc-----------hHHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence 3455789999999999999999999999999999985321 12457889999999999999999988754
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.. .+++|||+++++|.+++.......+++..++.++.|++.||.+||+.|++|+||+|+||++
T Consensus 71 ~~-----------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili 133 (254)
T cd05083 71 NG-----------------LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV 133 (254)
T ss_pred CC-----------------cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE
Confidence 32 2679999999999999976555568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~ 284 (355)
+.++.++|+|||.+...... ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 210 (254)
T cd05083 134 SEDGVAKVSDFGLARVGSMG---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV 210 (254)
T ss_pred cCCCcEEECCCccceecccc---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 99999999999998753321 122234567999999988889999999999999999997 99999887776655544
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
.. ......+..++.++.+++.+||+.+|.+||+++++++.|++
T Consensus 211 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 211 EK-GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred hC-CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 33 34445566789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.87 Aligned_cols=258 Identities=27% Similarity=0.491 Sum_probs=211.1
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|++|.||+|.. ++..|++|.++....... ...+.+.+|++++++++|+||+++++++...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA------KARQDCLKEIDLLKQLDHPNVIKYLASFIENN 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccch------hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 5899999999999999999966 689999998864332111 12345788999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.. +++|||+++++|.+++... ....+++..++.++.+++.+|.+||+.|++|+||+|+||++
T Consensus 76 ~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~ 139 (267)
T cd08224 76 EL----------------NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI 139 (267)
T ss_pred eE----------------EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE
Confidence 44 5699999999999988643 24568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh--hHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF--SEVTSA 283 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~--~~~~~~ 283 (355)
+.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......
T Consensus 140 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T cd08224 140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219 (267)
T ss_pred CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh
Confidence 999999999999987554433333445678889999999988899999999999999999999999965432 223333
Q ss_pred HHhcCCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 284 VVRQNLRPEIPR-CCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 284 ~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
+... .....+. .++..+.++|.+||..+|.+||++.+|++.|+.+.
T Consensus 220 ~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 220 IEKC-DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhcC-CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 3222 2223333 67889999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=298.29 Aligned_cols=249 Identities=35% Similarity=0.682 Sum_probs=202.5
Q ss_pred eeecccccccceEEEEEEEC------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 53 VIKSVIARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 53 ~i~~~lg~G~~~~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.+.+.||.|.||.||+|.+. +..|+||.++... ... ..+.+.+|++.+++++||||+++++++...
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~----~~~----~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~ 73 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS----SEE----EEEEFLNEIQILRKLRHPNIVKLYGFCIEN 73 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS----SHH----HHHHHHHHHHHHHTHSBTTBE-EEEEEESS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc----ccc----cceeeeeccccccccccccccccccccccc
Confidence 46789999999999999776 6789999994321 111 135578899999999999999999999855
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++|+||+++++|.+++.......+++..++.|+.|++.||.|||+++++|++|+++||+++
T Consensus 74 ~~~----------------~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~ 137 (259)
T PF07714_consen 74 EPL----------------FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD 137 (259)
T ss_dssp SSE----------------EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred ccc----------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 544 6699999999999999776567899999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCC--CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018489 207 KNRTVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~ 283 (355)
.++.+||+|||.+...... ............|+|||.+.+..++.++||||||+++|++++ |+.||...+..+....
T Consensus 138 ~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~ 217 (259)
T PF07714_consen 138 SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK 217 (259)
T ss_dssp TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999998755211 122233456778999999988889999999999999999999 7899998877776666
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
+ ........+..++..+.++|..||+.+|.+||++.+|++.|
T Consensus 218 ~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 218 L-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp H-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred c-cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 6 44455566778899999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=291.83 Aligned_cols=246 Identities=31% Similarity=0.570 Sum_probs=202.8
Q ss_pred ccccccceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccccc
Q 018489 57 VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 57 ~lg~G~~~~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
.||+|+||.||+|.+ ++..+|+|+++..... ....+.+.+|+.+++.+.||||+++++++...
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 68 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-------PALKDELLREANVMQQLDNPYIVRMIGICEAE------ 68 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-------HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC------
Confidence 689999999999864 4688999998643221 12345578899999999999999999876422
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
..+++|||+++++|.+++.. ...+++..++.++.|++.||++||++|++|+||+|+||+++.++.++
T Consensus 69 -----------~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~k 135 (257)
T cd05116 69 -----------SWMLVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAK 135 (257)
T ss_pred -----------CcEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEE
Confidence 22679999999999999853 35689999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCC---CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcC
Q 018489 213 IADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~ 288 (355)
|+|||.+......... .....++..|+|||.+....++.++|+||||+++|+|++ |..||......+....+. ..
T Consensus 136 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~ 214 (257)
T cd05116 136 ISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SG 214 (257)
T ss_pred ECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CC
Confidence 9999998754433221 112233568999999988888999999999999999998 999998877666555544 34
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 289 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
.....+..+++++.++|.+||+.||.+||++++|.+.|++.
T Consensus 215 ~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 44567778899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=304.88 Aligned_cols=251 Identities=26% Similarity=0.488 Sum_probs=202.0
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
++..++|++.+.||.|+||.||++.+ ++..+|+|++..... ......+.+|+++++.++|+||+++++++
T Consensus 1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (333)
T cd06650 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYIVGFYGAF 72 (333)
T ss_pred CcchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--------HHHHHHHHHHHHHHHHCCCCcccceeEEE
Confidence 35668999999999999999999976 578899998854321 11234578899999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCc
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTEN 202 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~di~p~N 202 (355)
...+.. ++||||+++++|.+++.. ...+++..+..++.|++.+|.|||+. +++|+||||+|
T Consensus 73 ~~~~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~N 134 (333)
T cd06650 73 YSDGEI----------------SICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 134 (333)
T ss_pred EECCEE----------------EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhh
Confidence 765544 679999999999999854 45689999999999999999999975 79999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
|+++.++.++|+|||.+...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..........
T Consensus 135 ili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 212 (333)
T cd06650 135 ILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212 (333)
T ss_pred EEEcCCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 99999999999999998644322 1223468889999999999889999999999999999999999997654432221
Q ss_pred HH-------------------------------------------HhcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCC
Q 018489 283 AV-------------------------------------------VRQNLRPEIP-RCCPSSLANVMKRCWDANPDKRPE 318 (355)
Q Consensus 283 ~~-------------------------------------------~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps 318 (355)
.. ......+..+ ..++.++.+||.+||+.||++||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt 292 (333)
T cd06650 213 MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD 292 (333)
T ss_pred HhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcC
Confidence 11 0011111111 235788999999999999999999
Q ss_pred HHHHHH
Q 018489 319 MDEVVS 324 (355)
Q Consensus 319 ~~ell~ 324 (355)
+.+++.
T Consensus 293 ~~ell~ 298 (333)
T cd06650 293 LKQLMV 298 (333)
T ss_pred HHHHhh
Confidence 999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=304.54 Aligned_cols=243 Identities=26% Similarity=0.391 Sum_probs=201.0
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
+.||+|+||.||+|.+ ++..||+|+++..... .......+.+|..++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~--- 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL------QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL--- 71 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE---
Confidence 4699999999999976 5678999999643211 111123456788888887 799999999988765544
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+++++|..++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 72 -------------~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~k 136 (318)
T cd05570 72 -------------FFVMEYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIK 136 (318)
T ss_pred -------------EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEE
Confidence 679999999999988853 45799999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 292 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 292 (355)
|+|||++..............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.... ..
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~--~~ 214 (318)
T cd05570 137 IADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE--VR 214 (318)
T ss_pred ecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC
Confidence 9999998643333333334568899999999999999999999999999999999999998887776666555433 34
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 018489 293 IPRCCPSSLANVMKRCWDANPDKRPEM-----DEVVS 324 (355)
Q Consensus 293 ~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell~ 324 (355)
++..+++++.++|.+||+.||.+||++ .++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 567789999999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.98 Aligned_cols=251 Identities=31% Similarity=0.626 Sum_probs=206.6
Q ss_pred cCCcceeecccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
...+|++.+.||+|++|.||++.+. +..+++|++...... ...+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----------HHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 3467999999999999999999764 457999998533221 12367899999999999999999987655
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. +++|||+++++|.+++.... ..+++..++.++.|++.+|++||+.|++|+||+|+||+++
T Consensus 72 ~~~----------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~ 134 (256)
T cd05059 72 RPI----------------FIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG 134 (256)
T ss_pred Cce----------------EEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC
Confidence 443 67999999999999986533 3689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCC-CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~ 284 (355)
.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+
T Consensus 135 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05059 135 EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214 (256)
T ss_pred CCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 9999999999998754322111 111223457999999998889999999999999999999 89999887766655444
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
. .......+..++.++.+++.+||..+|++||++.++++.|
T Consensus 215 ~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 215 S-AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred H-cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 3 3444556677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=314.44 Aligned_cols=261 Identities=22% Similarity=0.342 Sum_probs=202.4
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
...+|++.+.||+|+||.||+|.+ +++.||||.+.... ....+|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------------~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------------QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 456899999999999999999965 67899999884321 113469999999999999999887653
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
..... .....++++||||+++ +|.+++... ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 131 ~~~~~--------~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NI 201 (440)
T PTZ00036 131 ECFKK--------NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNL 201 (440)
T ss_pred ccccc--------CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHE
Confidence 22110 0012245789999964 777776532 346799999999999999999999999999999999999
Q ss_pred EEcCCC-cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 204 LLDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~~-~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
|++.++ .++|+|||++...... .......++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+..
T Consensus 202 Ll~~~~~~vkL~DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 280 (440)
T PTZ00036 202 LIDPNTHTLKLCDFGSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280 (440)
T ss_pred EEcCCCCceeeeccccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 998664 6999999999754332 223345778999999998764 6899999999999999999999999887665554
Q ss_pred HHHHhcCC---------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHhHh
Q 018489 282 SAVVRQNL---------------------------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAIDT 331 (355)
Q Consensus 282 ~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~~~ 331 (355)
..+..... ...++...++++.+||.+||++||.+|||+.+++. .++.+..
T Consensus 281 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 281 VRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 44432110 01133456789999999999999999999999995 5666544
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=306.70 Aligned_cols=244 Identities=25% Similarity=0.379 Sum_probs=197.2
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~ 133 (355)
+.||+|+||.||+|.+ ++..||+|++...... ........+.++..+++.++||||+++++.+...+..
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~---- 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL-----KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL---- 71 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH-----hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE----
Confidence 4699999999999976 5678999998632211 1111122233334456788999999999988766554
Q ss_pred ccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 018489 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (355)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L 213 (355)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|
T Consensus 72 ------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl 137 (325)
T cd05602 72 ------------YFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 137 (325)
T ss_pred ------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEE
Confidence 669999999999998853 456889999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC
Q 018489 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293 (355)
Q Consensus 214 ~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
+|||++..............|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..... .+
T Consensus 138 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--~~ 215 (325)
T cd05602 138 TDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--QL 215 (325)
T ss_pred ccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc--CC
Confidence 9999987543333333445789999999999999999999999999999999999999998887777666655432 35
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 294 PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 294 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...++.++.++|.+||+.||.+|+++.+.+.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 5678999999999999999999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=303.27 Aligned_cols=248 Identities=26% Similarity=0.498 Sum_probs=217.7
Q ss_pred CcceeecccccccceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.-|.+.+.||+|.|++|-+| +.+|+.||||++.+...+... ...+.+|++-++.++|||||++|++.....
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-------t~hlfqEVRCMKLVQHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-------TGHLFQEVRCMKLVQHPNIVRLYEVIDTQT 90 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-------hhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence 45888999999999999988 469999999999765544322 233667999999999999999999887666
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE-c
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL-D 206 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili-~ 206 (355)
.+ |+|+|.-++|+|.++|.+. ..++++..+.+++.||+.|+.|+|+..++||||||+||++ .
T Consensus 91 Kl----------------yLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE 153 (864)
T KOG4717|consen 91 KL----------------YLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE 153 (864)
T ss_pred eE----------------EEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee
Confidence 55 5699999999999999764 4569999999999999999999999999999999999876 4
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCC-CcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
.-|-|||+|||++-... ++......+|+..|.|||++.|..|+ ++.||||||+|||.|++|..||+..++.+.+-.++
T Consensus 154 KlGlVKLTDFGFSNkf~-PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm 232 (864)
T KOG4717|consen 154 KLGLVKLTDFGFSNKFQ-PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM 232 (864)
T ss_pred ecCceEeeeccccccCC-CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh
Confidence 67899999999996443 45556778999999999999998887 68899999999999999999999999999999998
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+. +|..++.+.++||..||..||.+|.+.++|..
T Consensus 233 DCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 87764 78889999999999999999999999999976
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=291.51 Aligned_cols=257 Identities=31% Similarity=0.583 Sum_probs=212.7
Q ss_pred ceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
|++..++|++.+.||+|+||.||++.+ .+..+++|.+..... ..+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----------SVEAFLAEANVMKTLQHDKLVKLHAVV 70 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh----------HHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 678889999999999999999999965 457799998753211 124577899999999999999999887
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.. .. .+++|||+++++|.+++.......+++..+..++.|++.||.+||+.|++|+||+|+||
T Consensus 71 ~~-~~----------------~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni 133 (260)
T cd05073 71 TK-EP----------------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 133 (260)
T ss_pred cC-CC----------------eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceE
Confidence 65 22 26799999999999999765566788999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~ 281 (355)
+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|++++ |+.||...+.....
T Consensus 134 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~ 213 (260)
T cd05073 134 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213 (260)
T ss_pred EEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999999875432211 1122334567999999998889999999999999999998 99999887665555
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
..+ ........+...+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 214 ~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 214 RAL-ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHH-hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 443 33344445567889999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=305.70 Aligned_cols=253 Identities=25% Similarity=0.319 Sum_probs=198.0
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||++.+ ++..||+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-------QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ 92 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-------hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 37899999999999999999965 5789999998643211 11123466899999999999999999987654
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.... .....+++|||+++ +|...+. ..+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 93 ~~~~----------~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~ 157 (359)
T cd07876 93 KSLE----------EFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 157 (359)
T ss_pred CCcc----------ccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence 3221 12335789999965 6666552 3488999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..........
T Consensus 158 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~ 236 (359)
T cd07876 158 SDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236 (359)
T ss_pred CCCCEEEecCCCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999998743322 223345678899999999998999999999999999999999999987665433322211
Q ss_pred cCCC--------------------C--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLR--------------------P--------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~--------------------~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.... + ......++++.++|.+||+.||.+|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 237 QLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred hcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 1000 0 011224678999999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=308.10 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=206.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|.+.+.||+|+||.||++.+ +++.||+|+++.... ......+.+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL------LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence 4799999999999999999965 688999999964221 11223455788999999999999999998877654
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++||||||+||+++.
T Consensus 75 ~~----------------~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~ 137 (330)
T cd05601 75 NL----------------YLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR 137 (330)
T ss_pred eE----------------EEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC
Confidence 44 6799999999999998653 356999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccC------CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 208 NRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLN------GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
++.++|+|||.+........ ......++..|+|||.+. +..++.++||||||+++|+|++|+.||...+....
T Consensus 138 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~ 217 (330)
T cd05601 138 TGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT 217 (330)
T ss_pred CCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH
Confidence 99999999999975543222 222346889999999986 45678899999999999999999999988877776
Q ss_pred HHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 281 TSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+........++ ..++.++.++|..||+ +|.+||+++++++
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 218 YNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 66665543333333 3478999999999997 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=296.10 Aligned_cols=245 Identities=23% Similarity=0.365 Sum_probs=196.4
Q ss_pred cccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccccc
Q 018489 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (355)
Q Consensus 58 lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~ 135 (355)
||+|+||.||++.+ +++.+|+|.+..... ......+.+..|+.+++.++|+||+++.+++......
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~------ 68 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL------KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDL------ 68 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH------hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeE------
Confidence 69999999999965 678999999853221 1111224567899999999999999999887765544
Q ss_pred ccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 018489 136 GQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (355)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L 213 (355)
+++|||+++++|...+... ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|
T Consensus 69 ----------~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l 138 (280)
T cd05608 69 ----------CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRI 138 (280)
T ss_pred ----------EEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence 6799999999999887432 3456999999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc--CCCC
Q 018489 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ--NLRP 291 (355)
Q Consensus 214 ~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~--~~~~ 291 (355)
+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|+.||............... ....
T Consensus 139 ~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 218 (280)
T cd05608 139 SDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV 218 (280)
T ss_pred eeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC
Confidence 99999875544333334457889999999999999999999999999999999999999765432222111111 1223
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 292 EIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 292 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
.++..+++.+.+++.+||+.||.+|| +++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 45567899999999999999999999 6777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=298.57 Aligned_cols=268 Identities=33% Similarity=0.578 Sum_probs=217.9
Q ss_pred ccccceecCCcceeecccccccceEEEEEEE---------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY---------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 111 (355)
+..+|++...+|.+.+.||+|+||.||+|.+ ++..+++|.+..... . ...+.+.+|+.+++.+
T Consensus 6 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~----~----~~~~~~~~E~~~l~~l 77 (304)
T cd05101 6 EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT----E----KDLSDLVSEMEMMKMI 77 (304)
T ss_pred cCCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc----h----HHHHHHHHHHHHHHhh
Confidence 3456888999999999999999999999964 234699998753211 1 1124577899999999
Q ss_pred -CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHHH
Q 018489 112 -DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQ 176 (355)
Q Consensus 112 -~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~ 176 (355)
+||||+++++++...... +++|||+++++|.+++.... ...+++..++.
T Consensus 78 ~~h~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (304)
T cd05101 78 GKHKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141 (304)
T ss_pred ccCCCchheeEEEecCCce----------------EEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHH
Confidence 899999999988765544 56999999999999996532 23578889999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcch
Q 018489 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCD 254 (355)
Q Consensus 177 i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~D 254 (355)
++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|
T Consensus 142 ~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 221 (304)
T cd05101 142 CTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 221 (304)
T ss_pred HHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhh
Confidence 9999999999999999999999999999999999999999998755432211 12233456799999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 255 VYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 255 vwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
|||||+++|+|++ |..||...+..+....+.. ......+..++.++.++|.+||+.+|.+||++.++++.|+++.+..
T Consensus 222 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 222 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 9999999999998 8899988777666655433 3344456678999999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=281.00 Aligned_cols=271 Identities=25% Similarity=0.413 Sum_probs=228.0
Q ss_pred CCcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 125 (355)
..+|.-.+.||.|..++|-++. .++..+|+|++.........+. ...+++.-.+|+.+|+++ +||+|+++.++|..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~-~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGET-PYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCcc-HHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3578888999999999999884 4788999999876555444444 667778888999999999 99999999999987
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
+... ++|+|.++.|.|.|+++ ..-.+|++...+|++|++.++.|||.++|+||||||+|||+
T Consensus 95 ~sF~----------------FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl 156 (411)
T KOG0599|consen 95 DAFV----------------FLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL 156 (411)
T ss_pred cchh----------------hhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee
Confidence 7666 45999999999999995 45679999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC------CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG------NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
+++-+++|+|||+++... ++......+||++|+|||.+.. .+|+...|.|+.|+++|.|+.|..||....---
T Consensus 157 ddn~~i~isDFGFa~~l~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml 235 (411)
T KOG0599|consen 157 DDNMNIKISDFGFACQLE-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML 235 (411)
T ss_pred ccccceEEeccceeeccC-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH
Confidence 999999999999998554 3455566899999999999863 468889999999999999999999997766666
Q ss_pred HHHHHHhcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHhHhhcCCCCCC
Q 018489 280 VTSAVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAIDTSKGGGMIP 339 (355)
Q Consensus 280 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~~~~~~~~~~~ 339 (355)
++..+..+++.. +.+.+++....+||.+||+.||.+|.|++|+|. .+..+.......+.|
T Consensus 236 MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP 299 (411)
T KOG0599|consen 236 MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP 299 (411)
T ss_pred HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence 666676665543 445678999999999999999999999999997 555555554455544
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=296.63 Aligned_cols=260 Identities=32% Similarity=0.547 Sum_probs=212.7
Q ss_pred ecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
+...+|.+.+.||+|+||.||+|.+ ++..+++|.+.... ....+.+.+|+..++.++|+||+++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~ 72 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---------LAARKDFQREAELLTNLQHEHIVKF 72 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---------HHHHHHHHHHHHHHhcCCCCCcceE
Confidence 3456899999999999999999964 23458888874221 1123457789999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHHHHHHHHHHHH
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGL 185 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al 185 (355)
++++...+.. ++||||+++++|.+++.... ...+++..++.++.|++.||
T Consensus 73 ~~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 136 (291)
T cd05094 73 YGVCGDGDPL----------------IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGM 136 (291)
T ss_pred EEEEccCCce----------------EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHH
Confidence 9988765544 67999999999999996432 23488999999999999999
Q ss_pred HHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHH
Q 018489 186 SYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263 (355)
Q Consensus 186 ~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ 263 (355)
+|||++|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|
T Consensus 137 ~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 216 (291)
T cd05094 137 VYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 216 (291)
T ss_pred HHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHH
Confidence 999999999999999999999999999999999875433221 122344577899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 264 EIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 264 ~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
+|++ |+.||...+.......+.. ......+..++..+.+++.+||+.+|.+||++.++++.|+++...
T Consensus 217 el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 217 EIFTYGKQPWFQLSNTEVIECITQ-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHhC-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 9998 9999988777665554433 333345566789999999999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=289.84 Aligned_cols=251 Identities=26% Similarity=0.503 Sum_probs=209.5
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||.|++|.||++.+ +++.+++|.+...... ....+.+.+|+.+++.++|+|++++++.+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-------RRERKAAEQEAQLLSQLKHPNIVAYRESWEGED- 72 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-------HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC-
Confidence 589999999999999999965 5788999998543221 112345778999999999999999987664322
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
+..+++|||+++++|.+++.......+++.+++.++.+++.+|.+||+.|++|+||+|+||+++.+
T Consensus 73 --------------~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~ 138 (257)
T cd08223 73 --------------GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT 138 (257)
T ss_pred --------------CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC
Confidence 234789999999999999976556679999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 288 (355)
+.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|..||...+.......+...
T Consensus 139 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~- 217 (257)
T cd08223 139 NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG- 217 (257)
T ss_pred CcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-
Confidence 9999999999876544433344456788999999999988999999999999999999999999887766655554443
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 289 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+..+..+++++.++|.+||+.+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 218 KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 334566778999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.30 Aligned_cols=256 Identities=27% Similarity=0.516 Sum_probs=208.1
Q ss_pred cCCcceeecccccccceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
..++|++.+.||+|+||.||+|.. .+..+++|.+..... . .....+.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~----~----~~~~~~~~E~~~l~~l~h~niv~~~~ 74 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN----P----QQWGEFQQEASLMAELHHPNIVCLLG 74 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC----H----HHHHHHHHHHHHHhhCCCCCeeeEEE
Confidence 447899999999999999999963 457899998853221 1 11234778999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc---------------cccccHHHHHHHHHHHHHHHH
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---------------RRKLAFKVVVQLALDLARGLS 186 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~i~~qi~~al~ 186 (355)
++...... +++|||+++++|.+++.... ...+++..+..++.|++.||.
T Consensus 75 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 138 (283)
T cd05090 75 VVTQEQPV----------------CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGME 138 (283)
T ss_pred EEecCCce----------------EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHH
Confidence 87765544 67999999999999985321 234788999999999999999
Q ss_pred HHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHH
Q 018489 187 YLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264 (355)
Q Consensus 187 ~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ 264 (355)
|||++|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+
T Consensus 139 ~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 218 (283)
T cd05090 139 YLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWE 218 (283)
T ss_pred HHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHH
Confidence 9999999999999999999999999999999987543221 11222345667999999988889999999999999999
Q ss_pred HHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 265 IYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 265 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
|++ |..||.+.........+.. ......+..+++.+.+++.+||+.||.+||++.+|++.|+.
T Consensus 219 l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 219 IFSFGLQPYYGFSNQEVIEMVRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 998 9999987766554444433 33445667789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.80 Aligned_cols=256 Identities=28% Similarity=0.488 Sum_probs=202.3
Q ss_pred Ccc-eeecccccccceEEEEEE------ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 50 SKL-VIKSVIARGTFGTVHRGL------YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 50 ~~y-~i~~~lg~G~~~~Vy~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
++| ++.+.||+|+||.||++. .++..||+|+++..... .....+.+|+++++.++||||++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--------QNTSGWKKEINILKTLYHENIVKYKGC 74 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 355 999999999999998764 25678999998643211 123457789999999999999999988
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+..... ...+++|||+++++|.+++.. ..+++..++.++.|++.+|.|||++|++|+||+|+|
T Consensus 75 ~~~~~~--------------~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~N 137 (283)
T cd05080 75 CSEQGG--------------KGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARN 137 (283)
T ss_pred EecCCC--------------ceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChhe
Confidence 754332 223789999999999999843 459999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCC---CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh-
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS- 278 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~- 278 (355)
|+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 138 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~ 217 (283)
T cd05080 138 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF 217 (283)
T ss_pred EEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh
Confidence 99999999999999998754432211 11223456799999998888999999999999999999999998643211
Q ss_pred -------------HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 279 -------------EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 279 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
...............+..++.++.+++.+||+.+|.+||+++++++.|+.+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 218 EEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0111112222233345667899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=300.00 Aligned_cols=260 Identities=25% Similarity=0.560 Sum_probs=211.5
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCc----eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
+...+|++.+.||+|+||.||+|.+ +++ .||+|+++.... ....+.+.+|+.+++.++||||++++
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~ 75 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--------PKANKEILDEAYVMASVDNPHVCRLL 75 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 4567899999999999999999965 343 389999853211 11234577899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++.... .+++++|+++|+|.+++... ...+++..++.++.||+.||+|||+.|++|+||||
T Consensus 76 g~~~~~~-----------------~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp 137 (316)
T cd05108 76 GICLTST-----------------VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAA 137 (316)
T ss_pred EEEcCCC-----------------ceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccch
Confidence 9876432 24699999999999998653 34588999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCCCC--CCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPNDM--TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
+||+++.++.++|+|||.+.......... .....+..|++||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus 138 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~ 217 (316)
T cd05108 138 RNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 217 (316)
T ss_pred hheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999999998654332211 12234567999999999889999999999999999997 9999988766
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
.+.. .+.........+..++.++.+++.+||..+|.+||++.+++..|..+....
T Consensus 218 ~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 218 SEIS-SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHH-HHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 5543 344444444556678899999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=308.35 Aligned_cols=275 Identities=36% Similarity=0.610 Sum_probs=236.6
Q ss_pred hhhcccccceecCCcceeecccccccceEEEEEEE--C-C--ce-eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhh
Q 018489 37 FLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--D-G--HD-VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110 (355)
Q Consensus 37 ~~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~-~--~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 110 (355)
.-+..++.|++.-++..+.+.||+|+||.||+|.. . + .. ||+|..+... .........+.+|.+++++
T Consensus 144 ~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~------~~~~~~~~e~m~EArvMr~ 217 (474)
T KOG0194|consen 144 KRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS------ELTKEQIKEFMKEARVMRQ 217 (474)
T ss_pred cccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc------cccHHHHHHHHHHHHHHHh
Confidence 34777888999999999999999999999999954 2 1 23 8999885311 1223445678999999999
Q ss_pred CCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh
Q 018489 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS 190 (355)
Q Consensus 111 l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 190 (355)
++|||||++||+......+ ++|||+|+||+|.+++.++.. .++..+...++.+.+.+|+|||+
T Consensus 218 l~H~NVVr~yGVa~~~~Pl----------------~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 218 LNHPNVVRFYGVAVLEEPL----------------MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS 280 (474)
T ss_pred CCCCCEEEEEEEEcCCCcc----------------EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH
Confidence 9999999999998877766 559999999999999976543 69999999999999999999999
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CC
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CD 269 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~ 269 (355)
++++||||-..|+|++.++.+|++|||+++.............-...|+|||.+....++.++||||+|+++||+.+ |.
T Consensus 281 k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~ 360 (474)
T KOG0194|consen 281 KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGA 360 (474)
T ss_pred CCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCC
Confidence 99999999999999999999999999998755422222212235678999999999999999999999999999998 88
Q ss_pred CCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 270 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 270 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
.||.+....+....+.....+...+...|.++..++.+|+..+|++||++.++.+.|+.+.....
T Consensus 361 ~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 361 EPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 99999999999988888888888889999999999999999999999999999999999976644
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=309.92 Aligned_cols=246 Identities=23% Similarity=0.405 Sum_probs=194.4
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
..+...+|++.+.||+|+||.||++.+ +++.||+|... +..+.+|++++++++||||++++++
T Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------------~~~~~~E~~il~~l~HpnIv~~~~~ 151 (391)
T PHA03212 87 AGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------------RGGTATEAHILRAINHPSIIQLKGT 151 (391)
T ss_pred cccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------------hhhhHHHHHHHHhCCCCCCCCEeEE
Confidence 345667899999999999999999976 67899999752 1235689999999999999999998
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...... ++++|++ +++|..++.. ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 152 ~~~~~~~----------------~lv~e~~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~N 212 (391)
T PHA03212 152 FTYNKFT----------------CLILPRY-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAEN 212 (391)
T ss_pred EEECCee----------------EEEEecC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHh
Confidence 8755443 6799999 4688888743 3568999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCC-CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-----
Q 018489 203 MLLDKNRTVKIADFGVARVEASN-PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS----- 276 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~----- 276 (355)
|+++.++.++|+|||.+...... ........||..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 213 Ill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~ 292 (391)
T PHA03212 213 IFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD 292 (391)
T ss_pred EEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccccc
Confidence 99999999999999998643221 222334578999999999999889999999999999999999998764321
Q ss_pred --hhHHHHHHHhc--------------------------CCCCC--C-----CCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 018489 277 --FSEVTSAVVRQ--------------------------NLRPE--I-----PRCCPSSLANVMKRCWDANPDKRPEMDE 321 (355)
Q Consensus 277 --~~~~~~~~~~~--------------------------~~~~~--~-----~~~~~~~l~~li~~~l~~~p~~Rps~~e 321 (355)
....+..+... ..... . ...++.++.+||.+||++||.+|||+.|
T Consensus 293 ~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~e 372 (391)
T PHA03212 293 CDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEA 372 (391)
T ss_pred CchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHH
Confidence 11111111110 00000 0 0124678999999999999999999999
Q ss_pred HHH
Q 018489 322 VVS 324 (355)
Q Consensus 322 ll~ 324 (355)
+++
T Consensus 373 lL~ 375 (391)
T PHA03212 373 LLD 375 (391)
T ss_pred Hhc
Confidence 986
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=317.87 Aligned_cols=250 Identities=22% Similarity=0.361 Sum_probs=207.9
Q ss_pred CCcceeecccccccceEEEEEEE--C-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--D-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
...|.+.+.||+|++|.||+|.. + +..||+|...... .. ....+.+|+.++..++||||+++++++..
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-----~~----~~~~~~~E~~~l~~l~Hpniv~~~~~~~~ 136 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-----ER----QAAYARSELHCLAACDHFGIVKHFDDFKS 136 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-----HH----HHHHHHHHHHHHHhCCCCCEeEEEEEEEE
Confidence 34599999999999999999965 3 5678888763221 11 12346789999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.+.. ++||||+++++|.+++... ...++++..+..++.|++.||.|||++||+||||||+||
T Consensus 137 ~~~~----------------~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NI 200 (478)
T PTZ00267 137 DDKL----------------LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANI 200 (478)
T ss_pred CCEE----------------EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhE
Confidence 6554 6699999999999988542 244689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
+++.++.++|+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+..
T Consensus 201 ll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~ 280 (478)
T PTZ00267 201 FLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM 280 (478)
T ss_pred EECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999975443221 223356899999999999989999999999999999999999999888777766
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+..... ...+..++.++.++|.+||+.||.+||++.+++.
T Consensus 281 ~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 281 QQVLYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 66655433 3455678999999999999999999999999875
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=308.76 Aligned_cols=258 Identities=27% Similarity=0.376 Sum_probs=208.6
Q ss_pred ccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
..+.+..++|++.+.||+|+||.||++.+ ++..+|+|++..... ......+.+.+|..+++.++||||++++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~------~~~~~~~~~~~e~~i~~~~~hp~iv~~~ 109 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM------IKRSDSAFFWEERDIMAFANSPWVVQLF 109 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh------hhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34567779999999999999999999966 578899999853211 1112234577899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+.+...... ++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||
T Consensus 110 ~~~~~~~~~----------------~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp 170 (371)
T cd05622 110 YAFQDDRYL----------------YMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 170 (371)
T ss_pred EEEEcCCEE----------------EEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 988765444 679999999999998843 4589999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCC----CCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGN----PYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
+|||++.++.++|+|||.+........ ......|++.|+|||.+.+. .++.++||||||+++|+|++|..||...
T Consensus 171 ~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred HHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 999999999999999999875543221 22345689999999998753 3788999999999999999999999988
Q ss_pred ChhHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 018489 276 SFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDK--RPEMDEVVSM 325 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~--Rps~~ell~~ 325 (355)
+.......+........++ ..++.++.++|..||..++.+ |+++.++++.
T Consensus 251 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 251 SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 8777777766544333333 358999999999999844433 6789988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=302.93 Aligned_cols=242 Identities=26% Similarity=0.423 Sum_probs=197.5
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
+.||+|+||.||+|.+ +++.||+|+++...... ....+....|..++... +||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~--- 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI------DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL--- 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh------cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE---
Confidence 4699999999999976 57899999986422110 01122345677777655 899999999988765544
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+.+++|..++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++
T Consensus 72 -------------~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~k 136 (316)
T cd05620 72 -------------FFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIK 136 (316)
T ss_pred -------------EEEECCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence 669999999999998853 45689999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 292 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 292 (355)
|+|||.+..............|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+... .+.
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~~ 214 (316)
T cd05620 137 IADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TPH 214 (316)
T ss_pred eCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC
Confidence 999999864332233334456899999999999999999999999999999999999999888776666555433 345
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 018489 293 IPRCCPSSLANVMKRCWDANPDKRPEMD-EVV 323 (355)
Q Consensus 293 ~~~~~~~~l~~li~~~l~~~p~~Rps~~-ell 323 (355)
++..++.++.++|.+||+.||.+||++. +++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 6667899999999999999999999974 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=296.14 Aligned_cols=261 Identities=31% Similarity=0.532 Sum_probs=211.3
Q ss_pred ceecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
|++..++|++.+.||+|+||.||+|..+ +..||+|.+..... . .....+.+|+.+++.++||||+
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~e~~~l~~l~~~~i~ 72 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS----L----RERIEFLNEASVMKGFTCHHVV 72 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC----H----HHHHHHHHHHHHHHhCCCCCee
Confidence 6788899999999999999999998542 34799998753221 1 1123467899999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------cccccHHHHHHHHHHHHHHHHHHH
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------RRKLAFKVVVQLALDLARGLSYLH 189 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~LH 189 (355)
++++++...... +++|||+++++|.+++.... ...++...+..++.|++.||.|||
T Consensus 73 ~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 136 (288)
T cd05061 73 RLLGVVSKGQPT----------------LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN 136 (288)
T ss_pred eEEEEEcCCCCc----------------EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999987765544 67999999999999996532 133567788999999999999999
Q ss_pred hCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh
Q 018489 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 190 ~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt 267 (355)
++|++|+||||+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 137 ~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~ 216 (288)
T cd05061 137 AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216 (288)
T ss_pred hCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHh
Confidence 999999999999999999999999999998744322111 112234667999999998889999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 268 -CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 268 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
|..||.+.+..+....+... .....+..+++.+.+++.+||+.+|.+|||+.++++.|++..
T Consensus 217 ~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 217 LAEQPYQGLSNEQVLKFVMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 78999887776655554433 333456677899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=293.55 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=206.8
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 125 (355)
.+.|++.+.||+|+||.||+|.+ +++.+|+|.+...... ...+.+|+.++..+ +|+||+++++++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----------EEEIKQEINMLKKYSHHRNIATYYGAFIK 74 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----------HHHHHHHHHHHHHhcCCCCeeeEeeEEee
Confidence 46799999999999999999965 6789999998643211 12366788999988 79999999998865
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
..... .....+++|||+.+++|.+++.......+++..++.++.|++.+|+|||+++++|+||+|+||++
T Consensus 75 ~~~~~----------~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili 144 (272)
T cd06637 75 KNPPG----------MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL 144 (272)
T ss_pred cCCCC----------CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE
Confidence 33210 12345789999999999999976555679999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
+.++.++|+|||++..............++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||........
T Consensus 145 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~ 224 (272)
T cd06637 145 TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 224 (272)
T ss_pred CCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 99999999999998755433333344568889999999863 3578899999999999999999999987665544
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
................++.++.+++.+||..+|.+||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 225 LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 44443333333344567899999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=296.63 Aligned_cols=257 Identities=31% Similarity=0.573 Sum_probs=209.5
Q ss_pred cceeecccccccceEEEEEEECC-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 51 KLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
+|++.+.||+|+||.||+|.+.. ..+++|.+..... ... ...+.+|+.+++.+.||||+++++.+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~----~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS----SSE----LRDLLSEFNLLKQVNHPHVIKLYGAC 72 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC----HHH----HHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 58899999999999999996532 4688888753221 111 24577899999999999999999987
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc----------------------cccccHHHHHHHHHHH
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----------------------RRKLAFKVVVQLALDL 181 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------------~~~~~~~~~~~i~~qi 181 (355)
...+.. +++|||+.+++|.+++.... ...+++..++.++.|+
T Consensus 73 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 73 SQDGPL----------------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred ecCCCc----------------EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 765544 66999999999999986421 1357899999999999
Q ss_pred HHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHH
Q 018489 182 ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFG 259 (355)
Q Consensus 182 ~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 259 (355)
+.+|.|||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||
T Consensus 137 ~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG 216 (290)
T cd05045 137 SRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFG 216 (290)
T ss_pred HHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHH
Confidence 9999999999999999999999999999999999999875432211 11223456689999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 260 ICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 260 ~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
+++++|++ |..||.+......... .........+..++.++.+++.+||+.+|.+||++.++++.|+++...
T Consensus 217 ~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 217 VLLWEIVTLGGNPYPGIAPERLFNL-LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHHHhcCCCCCCCCCHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 99999998 9999988776665544 334445556777899999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=302.08 Aligned_cols=243 Identities=25% Similarity=0.373 Sum_probs=200.7
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeeccCCc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSS 127 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~ 127 (355)
+|++.+.||+|+||.||+|.+ ++..||+|+++..... .....+.+..|..++..+. |++|+++++++...+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI------QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence 478899999999999999965 5789999998642211 1111234667888888885 577888888877655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 75 ~~----------------~lv~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~ 136 (323)
T cd05615 75 RL----------------YFVMEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136 (323)
T ss_pred EE----------------EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 44 669999999999998843 456999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.++|+|||.+..............|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+...
T Consensus 137 ~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~ 216 (323)
T cd05615 137 EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216 (323)
T ss_pred CCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 99999999999875433333333456899999999999988999999999999999999999999988877777766654
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
. ..++..++.++.+++.+||+.+|.+|++.
T Consensus 217 ~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 217 N--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred C--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 3 34667789999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=304.31 Aligned_cols=243 Identities=23% Similarity=0.398 Sum_probs=195.9
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
+.||+|+||.||++.+ ++..||+|+++...... ......+.+|..++..+ +||||+++++++......
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~------~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~--- 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND------DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL--- 71 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh------hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE---
Confidence 4689999999999965 57899999996432111 11234467899999888 799999999988766554
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 72 -------------~lv~e~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~k 136 (329)
T cd05588 72 -------------FFVIEFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIK 136 (329)
T ss_pred -------------EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence 669999999999988843 46799999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--------hhH-HHHH
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS--------FSE-VTSA 283 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~--------~~~-~~~~ 283 (355)
|+|||++..............|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ... ....
T Consensus 137 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~ 216 (329)
T cd05588 137 LTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV 216 (329)
T ss_pred ECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH
Confidence 9999998643333333344578999999999999999999999999999999999999996321 111 2222
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC------HHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE------MDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~ell~ 324 (355)
+.. ....++..++.++.++|.+||+.||.+|++ +.++++
T Consensus 217 ~~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 217 ILE--KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHc--CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 222 233467778999999999999999999997 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=299.94 Aligned_cols=271 Identities=31% Similarity=0.576 Sum_probs=218.4
Q ss_pred cccceecCCcceeecccccccceEEEEEEE---------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY---------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL- 111 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 111 (355)
...|.+..++|.+.+.||+|+||.||++.. ....+|+|.++.... ... ...+.+|+.+++.+
T Consensus 4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~----~~~----~~~~~~E~~~l~~l~ 75 (314)
T cd05099 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT----DKD----LADLISEMELMKLIG 75 (314)
T ss_pred cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC----hHH----HHHHHHHHHHHHhcc
Confidence 456778889999999999999999999864 235699998753221 111 23467899999999
Q ss_pred CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHHHH
Q 018489 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQL 177 (355)
Q Consensus 112 ~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i 177 (355)
+||||+++++++...... +++|||+++++|.+++.... ...+++..+..+
T Consensus 76 ~h~~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 139 (314)
T cd05099 76 KHKNIINLLGVCTQEGPL----------------YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139 (314)
T ss_pred CCCCeeeEEEEEccCCce----------------EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHH
Confidence 699999999988755443 67999999999999996532 245889999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchh
Q 018489 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDV 255 (355)
Q Consensus 178 ~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv 255 (355)
+.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+
T Consensus 140 ~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (314)
T cd05099 140 AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219 (314)
T ss_pred HHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchh
Confidence 999999999999999999999999999999999999999999754322111 111223457999999998889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 256 YSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 256 wslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
||||+++|+|++ |..||...+..+....+.. ......+..++.++.++|.+||+.+|.+||++.++++.|+++.....
T Consensus 220 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGIPVEELFKLLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 999999999999 8999988776665655443 33345566788999999999999999999999999999999987655
Q ss_pred CCC
Q 018489 335 GGM 337 (355)
Q Consensus 335 ~~~ 337 (355)
...
T Consensus 299 ~~~ 301 (314)
T cd05099 299 EEY 301 (314)
T ss_pred CCc
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=291.07 Aligned_cols=262 Identities=25% Similarity=0.481 Sum_probs=209.4
Q ss_pred cCCcceeecccccccceEEEEEEE--CCc----eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
...+|++.+.||+|+||.||+|.+ ++. .+++|.+.... . ......+..|+..+..+.||||+++++
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~----~----~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS----G----RQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc----c----hHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 457899999999999999999976 454 36677663211 1 112234677888899999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++... . .++++||+++++|.+++... ...+++..++.|+.|++.||.|||++|++|+||+|+
T Consensus 77 ~~~~~-~----------------~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~ 138 (279)
T cd05111 77 ICPGA-S----------------LQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAAR 138 (279)
T ss_pred EECCC-c----------------cEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence 76432 1 25699999999999998643 356899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChh
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~ 278 (355)
||+++.++.++|+|||.+........ ......++..|++||.+.+..++.++||||||+++|+|++ |..||.+....
T Consensus 139 nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 139 NILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred eEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999975432211 1223346678999999998889999999999999999998 99999887655
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCC
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGG 336 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~ 336 (355)
..... .........+..++.++.+++.+||..||.+||++.++++.|..+....++.
T Consensus 219 ~~~~~-~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~ 275 (279)
T cd05111 219 EVPDL-LEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY 275 (279)
T ss_pred HHHHH-HHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence 54333 3444444455667889999999999999999999999999999988765544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=297.61 Aligned_cols=257 Identities=26% Similarity=0.488 Sum_probs=210.8
Q ss_pred ecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
++..+|++.+.||+|+||.||+|.+. +..||+|+++.... ....+.+.+|+.++..++||||+++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~h~~iv~~ 73 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--------GPLREEFKHEAMMRSRLQHPNIVCL 73 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--------HHHHHHHHHHHHHHhcCCCCCcCeE
Confidence 45678999999999999999999653 46799999863321 1234567889999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--------------ccccccHHHHHHHHHHHHHHH
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--------------RRRKLAFKVVVQLALDLARGL 185 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~al 185 (355)
++++...... +++++|+.+++|.+++... ....+++..++.++.|++.||
T Consensus 74 ~~~~~~~~~~----------------~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL 137 (283)
T cd05091 74 LGVVTKEQPL----------------SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137 (283)
T ss_pred EEEEcCCCce----------------EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 9988766554 5699999999999998421 123588889999999999999
Q ss_pred HHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHH
Q 018489 186 SYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263 (355)
Q Consensus 186 ~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ 263 (355)
.|||++|++||||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|
T Consensus 138 ~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 217 (283)
T cd05091 138 EFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLW 217 (283)
T ss_pred HHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHH
Confidence 999999999999999999999999999999998874432211 112334567899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 264 EIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 264 ~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
+|++ |..||.+....+....+.... ....+..++..+.+++..||+.+|.+||++++|+..|+.
T Consensus 218 el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 218 EVFSYGLQPYCGYSNQDVIEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 9998 888998877766665554443 334567789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.69 Aligned_cols=264 Identities=31% Similarity=0.573 Sum_probs=216.3
Q ss_pred cccceecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CC
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DH 113 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 113 (355)
...|++..++|++.+.||+|++|.||++... ...+++|.+..... .. ....+.+|+.++..+ +|
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~----~~----~~~~~~~E~~~l~~l~~h 75 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT----EK----DLSDLVSEMEMMKMIGKH 75 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC----HH----HHHHHHHHHHHHHhhcCC
Confidence 3567888899999999999999999999653 25799998853211 11 123477899999999 89
Q ss_pred CccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--------------ccccccHHHHHHHHH
Q 018489 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--------------RRRKLAFKVVVQLAL 179 (355)
Q Consensus 114 ~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~~~i~~ 179 (355)
+||+++++++...+.. +++|||+++++|..++... ....+++..++.++.
T Consensus 76 ~~i~~~~~~~~~~~~~----------------~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 139 (293)
T cd05053 76 KNIINLLGVCTQEGPL----------------YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139 (293)
T ss_pred CCeeeEEEEEcCCCCe----------------EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence 9999999988765544 6699999999999998642 245689999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHH
Q 018489 180 DLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYS 257 (355)
Q Consensus 180 qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 257 (355)
|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||
T Consensus 140 qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 219 (293)
T cd05053 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219 (293)
T ss_pred HHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceee
Confidence 999999999999999999999999999999999999999875433211 112223456799999998888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 258 FGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 258 lG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
||+++|+|++ |..||......+....... ......+..++..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 220 lG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 220 FGVLLWEIFTLGGSPYPGIPVEELFKLLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred hhhHHHHHhcCCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 9999999997 9999988776665554433 3444566678899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=301.31 Aligned_cols=243 Identities=27% Similarity=0.423 Sum_probs=197.5
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
+.||+|+||.||+|.+ ++..||+|+++...... ....+....|..++... +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~--- 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM------DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL--- 71 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh------cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE---
Confidence 4689999999999976 46789999986432110 01122345577777664 999999999988766554
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus 72 -------------~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~k 136 (316)
T cd05619 72 -------------FFVMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIK 136 (316)
T ss_pred -------------EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEE
Confidence 669999999999999853 35689999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 292 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 292 (355)
|+|||.+..............|+..|+|||.+.+..++.++||||+|+++|+|++|..||...+..+....+.... +.
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--~~ 214 (316)
T cd05619 137 IADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--PC 214 (316)
T ss_pred EccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CC
Confidence 9999998743322233334568899999999999889999999999999999999999998887776666554432 34
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 018489 293 IPRCCPSSLANVMKRCWDANPDKRPEMD-EVVS 324 (355)
Q Consensus 293 ~~~~~~~~l~~li~~~l~~~p~~Rps~~-ell~ 324 (355)
++..++.++.++|.+||+.||.+||++. +++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 5566899999999999999999999996 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=294.79 Aligned_cols=254 Identities=28% Similarity=0.345 Sum_probs=197.5
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhh---CCCCccceeeeeccC
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK---LDHPNVTKFIGATMG 125 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~h~~Iv~~~~~~~~ 125 (355)
+|++.+.||+|+||.||+|.+ ++..||+|.++......... ..+.+|+.+++. ++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~-------~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~ 73 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP-------LSTVREVALLKRLEAFDHPNIVRLMDVCAT 73 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCc-------hHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence 589999999999999999965 57889999986543222111 113345555554 479999999998764
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.... .....+++|||+. ++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 74 ~~~~-----------~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili 141 (288)
T cd07863 74 SRTD-----------RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 141 (288)
T ss_pred ccCC-----------CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 3211 1233478999996 489888866555669999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
+.++.++|+|||.+...... .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...........+.
T Consensus 142 ~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~ 220 (288)
T cd07863 142 TSGGQVKLADFGLARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 220 (288)
T ss_pred CCCCCEEECccCccccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHH
Confidence 99999999999998754322 22233467889999999998889999999999999999999999998776655554443
Q ss_pred hcCCC-------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLR-------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..... ......++..+.++|.+||+.||.+|||+.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 221 DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 31100 0112346788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=295.34 Aligned_cols=262 Identities=32% Similarity=0.563 Sum_probs=211.5
Q ss_pred CcceeecccccccceEEEEEEEC--Cc--eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeecc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYD--GH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 124 (355)
++|++.+.||+|+||.||+|... +. .+++|.++.... . ...+.+.+|+.++.++ +||||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~----~----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS----E----NDHRDFAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC----H----HHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence 68999999999999999999653 33 468887752111 1 1134578899999999 7999999999887
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHHHHHHHHHHHHHHHHh
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHS 190 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~ 190 (355)
..+.. +++|||+++++|.+++.... ...+++..++.++.|++.||+|||+
T Consensus 74 ~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~ 137 (297)
T cd05089 74 NRGYL----------------YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE 137 (297)
T ss_pred cCCcc----------------eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 65544 56999999999999996432 1358899999999999999999999
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CC
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CD 269 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~ 269 (355)
+|++|+||||+||+++.++.++|+|||.+...... ........+..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 138 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~ 216 (297)
T cd05089 138 KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGG 216 (297)
T ss_pred CCcccCcCCcceEEECCCCeEEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999998633211 11111233457999999998889999999999999999997 99
Q ss_pred CCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 018489 270 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGM 337 (355)
Q Consensus 270 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~ 337 (355)
.||...+.......+.. ......+..++.++.++|.+||+.+|.+||+++++++.|+.+........
T Consensus 217 ~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 217 TPYCGMTCAELYEKLPQ-GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred CCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 99988777666555443 34445666789999999999999999999999999999999987765444
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=290.72 Aligned_cols=260 Identities=29% Similarity=0.517 Sum_probs=205.0
Q ss_pred ceeecccccccceEEEEEEECC--c--eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 52 LVIKSVIARGTFGTVHRGLYDG--H--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~~~--~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
|.+.+.||+|+||.||+|.+.. . .+|+|.++.... .... .+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~---~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC---TRSE----MEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC---CHHH----HHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 3577899999999999997643 2 589998854321 1111 345778999999999999999998765332
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhh----ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN----RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
... .....+++|||+++++|.+++... ....+++..++.++.|++.||+|||++|++|+||||+||
T Consensus 74 ~~~----------~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 143 (272)
T cd05075 74 ESE----------GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNC 143 (272)
T ss_pred ccc----------CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhe
Confidence 210 012347899999999999987532 234589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~ 280 (355)
+++.++.++|+|||.+......... .....++..|++||.+.+..++.++|+||||+++|+|++ |..||......+.
T Consensus 144 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 223 (272)
T cd05075 144 MLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223 (272)
T ss_pred EEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999998754332211 122245668999999999889999999999999999999 8999988766655
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
...+... .....+..++..+.++|.+||+.||++|||+.+|++.|+.+
T Consensus 224 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 224 YDYLRQG-NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 5554433 33345567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=290.82 Aligned_cols=256 Identities=31% Similarity=0.604 Sum_probs=209.3
Q ss_pred cCCcceeecccccccceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
...+|++.+.||+|+||.||+|.+. +..+++|.++.... . ...+.+.+|+.++.+++||||++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~----~----~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT----E----KQRRDFLSEASIMGQFDHPNIIHLEGV 73 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC----H----HHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4578999999999999999999652 33699998753221 1 123467889999999999999999998
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...+.. +++|||+++++|.+++... ...+++..++.++.|++.+|++||+.|++|+||+|+|
T Consensus 74 ~~~~~~~----------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~n 136 (267)
T cd05066 74 VTKSKPV----------------MIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 136 (267)
T ss_pred EecCCcc----------------EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhc
Confidence 8655443 6799999999999998653 3468999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCC---CCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChh
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDM---TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~ 278 (355)
|+++.++.++|+|||.+.......... ....++..|++||.+.+..++.++|+|+||+++|++++ |..||......
T Consensus 137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 137 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred EEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 999999999999999987544322111 11223457999999998889999999999999999886 99999887766
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
+....+... .....+..+++.+.+++.+||+.+|.+||++.++++.|+++
T Consensus 217 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 217 DVIKAIEEG-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 655555433 34445566789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=308.04 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=203.7
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||++.+ +++.||+|+++.... ........+.+|+.++..++|++|+++++.+....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM------LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH------hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 4799999999999999999965 678999999853211 11223455778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||++|++|.+++.. ...+++..++.++.|++.+|.|||++|++||||||+||+++.
T Consensus 75 ~~----------------~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~ 136 (360)
T cd05627 75 NL----------------YLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA 136 (360)
T ss_pred EE----------------EEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC
Confidence 44 679999999999999853 456999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCC-----------------------------------CCCCCCCCcccccCCcccCCCCCCCc
Q 018489 208 NRTVKIADFGVARVEASNP-----------------------------------NDMTGETGTLGYMAPEVLNGNPYNRK 252 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 252 (355)
++.++|+|||++....... .......|+..|+|||++.+..++.+
T Consensus 137 ~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~ 216 (360)
T cd05627 137 KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL 216 (360)
T ss_pred CCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc
Confidence 9999999999876332110 00113468999999999999999999
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 018489 253 CDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR--CCPSSLANVMKRCWDANPDKRPE---MDEVVS 324 (355)
Q Consensus 253 ~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 324 (355)
+|+|||||++|+|++|+.||...+.......+........++. .+++++.++|.+|+ .||.+|++ +.++++
T Consensus 217 ~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 217 CDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred ceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 9999999999999999999998887777766665433333333 36899999999987 59999985 566655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=288.42 Aligned_cols=261 Identities=30% Similarity=0.591 Sum_probs=212.6
Q ss_pred ceecCCcceeecccccccceEEEEEEECC-----ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDG-----HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
+++...+|.+.+.||+|++|.||+|.+.. ..+++|....... ....+.+.+|+.+++.+.||||+++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~ 72 (270)
T cd05056 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--------PSVREKFLQEAYIMRQFDHPHIVKL 72 (270)
T ss_pred CeechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--------HHHHHHHHHHHHHHHhCCCCchhce
Confidence 35677889999999999999999996532 4689998753321 1223567889999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++.... .+++|||+++++|.+++... ...+++..++.++.|++.+|.|||+.|++|+||+
T Consensus 73 ~~~~~~~~-----------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~ 134 (270)
T cd05056 73 IGVITENP-----------------VWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIA 134 (270)
T ss_pred eEEEcCCC-----------------cEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC
Confidence 98775422 25799999999999999653 3458999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCCC-CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
|+||+++.++.++|+|||.+......... .....++..|+|||.+....++.++|+||||+++|+|++ |..||...+.
T Consensus 135 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 135 ARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred hheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99999999999999999998754332111 112233467999999988889999999999999999986 9999988776
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
.+....+. .......+..++.++.++|.+|+..+|.+|||+.++++.|+.+...
T Consensus 215 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 215 NDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 66554443 3334456677899999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=294.88 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=194.5
Q ss_pred cccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccccc
Q 018489 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (355)
Q Consensus 58 lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~ 135 (355)
||+|+||.||++.. ++..||+|.+....... ......+..|+++++.++||||+++++.+......
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~------ 68 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK------KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHL------ 68 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc------chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeE------
Confidence 79999999999964 58999999985322111 11123345699999999999999999888765444
Q ss_pred ccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEee
Q 018489 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (355)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~D 215 (355)
+++|||++|++|.+++.......+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|
T Consensus 69 ----------~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~D 138 (277)
T cd05607 69 ----------CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSD 138 (277)
T ss_pred ----------EEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEee
Confidence 6799999999999888665556789999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhH----HHHHHHhcCCCC
Q 018489 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE----VTSAVVRQNLRP 291 (355)
Q Consensus 216 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~----~~~~~~~~~~~~ 291 (355)
||.+...... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .......... .
T Consensus 139 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 216 (277)
T cd05607 139 LGLAVELKDG-KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV-K 216 (277)
T ss_pred ceeeeecCCC-ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc-c
Confidence 9998754332 22233568889999999998889999999999999999999999997654322 2222222111 1
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 292 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 292 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
.....+++++.++|.+||+.||.+||++.|+++.+.
T Consensus 217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 122457899999999999999999999977664333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=296.42 Aligned_cols=262 Identities=31% Similarity=0.552 Sum_probs=209.0
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCce--eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHD--VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIG 121 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~ 121 (355)
+..++|++.+.||+|+||.||+|.+ ++.. +++|.++... . ....+.+.+|+.++.++ +|+||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~----~----~~~~~~~~~Ei~~l~~l~~h~~iv~~~~ 75 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----S----KDDHRDFAGELEVLCKLGHHPNIINLLG 75 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC----C----HHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence 4557899999999999999999975 3443 5666653211 1 11234577899999999 8999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHHHHHHHHHHHHHH
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSY 187 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~ 187 (355)
++...+.. +++|||+++++|.+++.... ...+++..++.++.|++.||+|
T Consensus 76 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~ 139 (303)
T cd05088 76 ACEHRGYL----------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 139 (303)
T ss_pred EECCCCCc----------------eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHH
Confidence 88765544 66999999999999986432 2357899999999999999999
Q ss_pred HHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh
Q 018489 188 LHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 188 LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt 267 (355)
||++|++|+||+|+||+++.++.++|+|||.+...... ........+..|+|||.+.+..++.++||||||+++|+|++
T Consensus 140 LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 218 (303)
T cd05088 140 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218 (303)
T ss_pred HHhCCccccccchheEEecCCCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHh
Confidence 99999999999999999999999999999998632211 11112234567999999988888999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 268 -CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 268 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
|..||...+..+...... .......+..++.++.++|.+||+.+|.+||++++++..|..+...+.
T Consensus 219 ~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 219 LGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred cCCCCcccCChHHHHHHHh-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 999998776665554432 333334555678999999999999999999999999999998866554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=302.92 Aligned_cols=238 Identities=24% Similarity=0.395 Sum_probs=192.0
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
+.||+|+||.||++.+ ++..||+|+++...... ......+.+|..++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~--- 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND------DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL--- 71 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc------hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE---
Confidence 4699999999999965 57889999996532211 11133466788888777 899999999988765544
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+++++|..++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 72 -------------~lv~E~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~k 136 (329)
T cd05618 72 -------------FFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 136 (329)
T ss_pred -------------EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEE
Confidence 669999999999988743 45799999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---------hhHHHHH
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS---------FSEVTSA 283 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~---------~~~~~~~ 283 (355)
|+|||++..............|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.... .......
T Consensus 137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~ 216 (329)
T cd05618 137 LTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 216 (329)
T ss_pred EeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH
Confidence 9999998754333333344578999999999999999999999999999999999999995311 1112222
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
+.. ....++..++..+.++|.+||+.||.+||++
T Consensus 217 i~~--~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 217 ILE--KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred Hhc--CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 222 2335677889999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=290.75 Aligned_cols=263 Identities=27% Similarity=0.491 Sum_probs=212.6
Q ss_pred ceecCCcceeecccccccceEEEEEEEC------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
+.+..++|++.+.||+|+||.||+|.+. +..|++|.+.... .. .....+.+|+.+++.++|+||++
T Consensus 1 ~~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~----~~----~~~~~~~~e~~~l~~l~h~ni~~ 72 (280)
T cd05043 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA----SE----IQVTLLLQESCLLYGLSHQNILP 72 (280)
T ss_pred CccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC----CH----HHHHHHHHHHHHHHhCCCCCCCe
Confidence 3577899999999999999999999753 4779999875221 11 11345778999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc------ccccHHHHHHHHHHHHHHHHHHHhCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR------RKLAFKVVVQLALDLARGLSYLHSQK 192 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~ 192 (355)
+++++..... ..+++++|+++++|.+++..... ..+++..++.++.|++.||+|||+.+
T Consensus 73 ~~~~~~~~~~---------------~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 137 (280)
T cd05043 73 ILHVCIEDGE---------------PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG 137 (280)
T ss_pred EEEEEecCCC---------------CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9998765322 22679999999999999865432 46899999999999999999999999
Q ss_pred ccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CC
Q 018489 193 IVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CD 269 (355)
Q Consensus 193 i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~ 269 (355)
++|+||+|+||+++.++.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|++++ |+
T Consensus 138 i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~ 217 (280)
T cd05043 138 VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217 (280)
T ss_pred EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCC
Confidence 99999999999999999999999999874432211 1122345667999999988889999999999999999998 99
Q ss_pred CCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 270 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 270 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
.||...+..+.... ............+++++.+++.+||..+|++|||+.++++.|+++..
T Consensus 218 ~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 218 TPYVEIDPFEMAAY-LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCcCcCCHHHHHHH-HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99987765554433 33344444555678999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=287.86 Aligned_cols=246 Identities=33% Similarity=0.610 Sum_probs=200.0
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~ 133 (355)
+.||+|+||.||+|.+ +++.+|+|.+..... ......+.+|+++++.++||||+++++++......
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---- 68 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--------PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI---- 68 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCC--------HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCe----
Confidence 4699999999999965 688999998753211 11234578899999999999999999988765444
Q ss_pred ccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEE
Q 018489 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (355)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L 213 (355)
++||||+++++|.+++... ...+++..++.++.|++.+|.|||++|++|+||+|+||+++.++.++|
T Consensus 69 ------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl 135 (252)
T cd05084 69 ------------YIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKI 135 (252)
T ss_pred ------------EEEEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEE
Confidence 6799999999999998542 346899999999999999999999999999999999999999999999
Q ss_pred eeccccccccCCCCCC--CCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCC
Q 018489 214 ADFGVARVEASNPNDM--TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLR 290 (355)
Q Consensus 214 ~Dfg~a~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~ 290 (355)
+|||.+.......... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+. ....
T Consensus 136 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~ 214 (252)
T cd05084 136 SDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVR 214 (252)
T ss_pred CccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCC
Confidence 9999987433211111 11122456999999998889999999999999999997 899998766655444433 3344
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 291 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 291 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
...+..++..+.+++.+||+.+|++||++.+++++|+
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 4566778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=297.20 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=200.6
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||+|.++....... ...+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--------PCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--------chhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 46899999999999999999965 578899999865432211 12356799999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++||||+++ +|.+++... ...+++..++.++.|++.||.|||+.|++||||+|+||+++
T Consensus 77 ~~~----------------~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~ 138 (309)
T cd07872 77 KSL----------------TLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN 138 (309)
T ss_pred CeE----------------EEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 544 679999965 888777543 34589999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
.++.++|+|||.+..............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 139 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 139 ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218 (309)
T ss_pred CCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9999999999998754443333444567889999998865 468899999999999999999999998776554443332
Q ss_pred hcCC---------------------CC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNL---------------------RP-------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~---------------------~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.... .. .....+++++.++|.+||+.||.+|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 219 RLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 2100 00 011246789999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=323.72 Aligned_cols=266 Identities=20% Similarity=0.331 Sum_probs=207.7
Q ss_pred ccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
.....+...++|++++.||.|+||.||+|.+ ++..+|+|++....... .....+..|+.++.+++||||++
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-------~~~~~~~~EI~IL~~L~HPNIVr 76 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-------REKSQLVIEVNVMRELKHKNIVR 76 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-------HHHHHHHHHHHHHHHcCCCCcCe
Confidence 3445566668999999999999999999966 56789999986433211 11345778999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--cccccHHHHHHHHHHHHHHHHHHHhC-----
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQ----- 191 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~----- 191 (355)
++++|..... ..++|||||+++++|.+++.... ...+++..++.|+.||+.||.|||+.
T Consensus 77 l~d~f~de~~--------------~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~ 142 (1021)
T PTZ00266 77 YIDRFLNKAN--------------QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPN 142 (1021)
T ss_pred EEEEEEecCC--------------CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccc
Confidence 9998764432 23378999999999999986432 35699999999999999999999984
Q ss_pred --CccccCCCCCcEEEcC-----------------CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC--CCCC
Q 018489 192 --KIVHRDVKTENMLLDK-----------------NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG--NPYN 250 (355)
Q Consensus 192 --~i~H~di~p~Nili~~-----------------~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~ 250 (355)
+|+|+||||+||||+. .+.++|+|||++...... .......+++.|+|||++.+ ..++
T Consensus 143 ~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s 221 (1021)
T PTZ00266 143 GERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYD 221 (1021)
T ss_pred cCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCC
Confidence 4999999999999964 234899999999754322 22234568999999999864 4578
Q ss_pred CcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 018489 251 RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEA 328 (355)
Q Consensus 251 ~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~ 328 (355)
.++|||||||++|+|++|..||...+....+...+...... .....+.++.+||..||+.+|.+||++.++|. .++.
T Consensus 222 ~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 222 DKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred chhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 89999999999999999999998765544443333332221 12346899999999999999999999999994 5554
Q ss_pred h
Q 018489 329 I 329 (355)
Q Consensus 329 ~ 329 (355)
+
T Consensus 301 i 301 (1021)
T PTZ00266 301 V 301 (1021)
T ss_pred c
Confidence 4
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=308.99 Aligned_cols=246 Identities=25% Similarity=0.409 Sum_probs=203.2
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-C-----Cccceee
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-H-----PNVTKFI 120 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~Iv~~~ 120 (355)
..+|.|.+.||+|+||.|.+|.+ +++.||||++++... .......|+.+|..++ | -|+|+++
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----------f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----------FLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----------HHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 34899999999999999999965 689999999964332 1223456999999995 4 3899999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
++|...+ ++|||+|.+ +.+|.++++.+.-.+++...++.++.||+++|..||+.||||+||||
T Consensus 255 d~F~fr~----------------HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKP 317 (586)
T KOG0667|consen 255 DYFYFRN----------------HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKP 317 (586)
T ss_pred ecccccc----------------ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCh
Confidence 9988644 458899999 67999999998888999999999999999999999999999999999
Q ss_pred CcEEEcC--CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 201 ENMLLDK--NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 201 ~Nili~~--~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
+|||+.. ...||++|||.|+....... ..+.+..|+|||++.|.+|+.+.|+||||||++||++|.+.|.+.++.
T Consensus 318 ENILL~~~~r~~vKVIDFGSSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 318 ENILLKDPKRSRIKVIDFGSSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred hheeeccCCcCceeEEecccccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 9999964 45799999999986654333 567788999999999999999999999999999999999999888877
Q ss_pred HHHHHHHhcCCCCC--------------------------------------------------CC-----------CCC
Q 018489 279 EVTSAVVRQNLRPE--------------------------------------------------IP-----------RCC 297 (355)
Q Consensus 279 ~~~~~~~~~~~~~~--------------------------------------------------~~-----------~~~ 297 (355)
+++..++.....++ .+ ...
T Consensus 395 DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~ 474 (586)
T KOG0667|consen 395 DQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKAD 474 (586)
T ss_pred HHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhccccc
Confidence 66665544111100 01 112
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 298 PSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 298 ~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+.++|++||.+||.+|+|+.++++
T Consensus 475 ~~~F~dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 475 DKLFIDFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred HHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 345899999999999999999999987
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=289.40 Aligned_cols=260 Identities=30% Similarity=0.538 Sum_probs=209.4
Q ss_pred ceeecccccccceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 52 LVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
|++.+.||+|+||.||+|... +..||+|.++..... .. ....+.+|+..++.++||||+++++++...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 73 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT---YS----EIEEFLSEAACMKDFDHPNVMKLIGVCFEA 73 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC---HH----HHHHHHHHHHHHHhCCCCCeeeEEeeeccC
Confidence 678899999999999999652 367999998643221 11 123477899999999999999999987654
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc----cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
.... .....+++|||+++++|..++.... ...+++..++.++.|++.||.|||+.|++|+||+|+|
T Consensus 74 ~~~~----------~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~N 143 (273)
T cd05035 74 SSLQ----------KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARN 143 (273)
T ss_pred Cccc----------cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhe
Confidence 4311 1234578999999999999885432 2468999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~ 279 (355)
|+++.++.++|+|||.+......... ......+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 144 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05035 144 CMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223 (273)
T ss_pred EEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999998754432211 111234567999999988889999999999999999999 899998877766
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
....+... .....+..++.++.++|.+||+.||.+||++.++++.|+.+
T Consensus 224 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 224 IYDYLRHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHHcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 66555443 44456777899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=287.35 Aligned_cols=251 Identities=25% Similarity=0.438 Sum_probs=211.8
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||.|+||.||.+.. ++..+++|.+....... .....+.+|+.++++++|+||+++++++...+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 73 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-------KERRDALNEIVILSLLQHPNIIAYYNHFMDDNT 73 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-------hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe
Confidence 589999999999998887754 68899999985433221 113346789999999999999999999876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+++++|.+++.......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus 74 ~----------------~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~ 137 (256)
T cd08221 74 L----------------LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137 (256)
T ss_pred E----------------EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC
Confidence 4 669999999999999976555679999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 288 (355)
+.++|+|||.+..............++..|.|||.+.+..++.++|+||||+++++|++|..||...+..+....+....
T Consensus 138 ~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~ 217 (256)
T cd08221 138 GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN 217 (256)
T ss_pred CCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999998765444333344568899999999988888999999999999999999999998877766666665544
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 289 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
.. ..+..++.++.++|.+||..+|.+||++.++++.
T Consensus 218 ~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 218 YT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 43 3446678999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=304.01 Aligned_cols=242 Identities=26% Similarity=0.389 Sum_probs=196.5
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHH-HHHhhCCCCccceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV-AVWHKLDHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
+.||+|+||.||+|.+ ++..+|+|++....... ......+..|. .+++.++||||+++++.+...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~--- 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN------RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL--- 71 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh------hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE---
Confidence 4689999999999965 68899999986432111 11112233444 456778999999999888766554
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+++++|..++. ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++
T Consensus 72 -------------~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~k 136 (325)
T cd05604 72 -------------YFVLDFVNGGELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVV 136 (325)
T ss_pred -------------EEEEcCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEE
Confidence 56999999999998884 346799999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 292 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 292 (355)
|+|||++..............|+..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+..... .
T Consensus 137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--~ 214 (325)
T cd05604 137 LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--V 214 (325)
T ss_pred EeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc--c
Confidence 99999987543333334445789999999999999899999999999999999999999998877776666655432 3
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 018489 293 IPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323 (355)
Q Consensus 293 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 323 (355)
+....+..+.++|.+||+.+|.+||++.+.+
T Consensus 215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 4456789999999999999999999876433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=293.19 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=207.0
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeec
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGAT 123 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~ 123 (355)
...++|++.+.||.|+||.||+|.+ ++..+++|++.... .. ...+..|+.++..+ +|+||+++++++
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~------~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE------DE----EEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh------HH----HHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 3457899999999999999999976 67899999985321 11 23366788888888 799999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...... ......+++|||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 83 ~~~~~~----------~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~ni 152 (282)
T cd06636 83 IKKSPP----------GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNV 152 (282)
T ss_pred hccccc----------CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 643211 0134568899999999999999766666789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
+++.++.++|+|||.+..............++..|+|||.+. ...++.++|+||||+++|+|++|..||......
T Consensus 153 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~ 232 (282)
T cd06636 153 LLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232 (282)
T ss_pred EECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence 999999999999999875443333334456888999999875 346788999999999999999999999776654
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..................++.++.++|.+||+.||.+||++.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 233 RALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 4444443333333334567899999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=291.03 Aligned_cols=260 Identities=26% Similarity=0.539 Sum_probs=210.2
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCc----eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
+...+|++.+.||+|+||.||+|.+ ++. .||+|++..... ....+.+.+|..++..+.|+||++++
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--------PKANKEILDEAYVMAGVGSPYVCRLL 75 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--------HHHHHHHHHHHHHHHhcCCCCCceEE
Confidence 4567899999999999999999965 444 489999853221 11234577899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++.... .+++++|+++|+|.+++... ...+++..++.++.|++.||+|||++|++|+||+|
T Consensus 76 ~~~~~~~-----------------~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp 137 (279)
T cd05109 76 GICLTST-----------------VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAA 137 (279)
T ss_pred EEEcCCC-----------------cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 8875422 25699999999999998643 34689999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 138 ~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 217 (279)
T cd05109 138 RNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217 (279)
T ss_pred ceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999999998755432221 112234567999999998889999999999999999998 8999987665
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
...... .........+..++.++.++|.+||+.||++||++.++++.|..+....
T Consensus 218 ~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 218 REIPDL-LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHH-HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 554443 3334444556678999999999999999999999999999998886554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=316.55 Aligned_cols=272 Identities=33% Similarity=0.564 Sum_probs=233.8
Q ss_pred hhcccccceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhh
Q 018489 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110 (355)
Q Consensus 38 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 110 (355)
........++..++.++.+.||+|+||.||+|.- +...||||.++.... ...++.|++|++++..
T Consensus 474 ~~~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--------~~~~~dF~REaeLla~ 545 (774)
T KOG1026|consen 474 LNPDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--------NQARQDFRREAELLAE 545 (774)
T ss_pred CCCccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--------HHHHHHHHHHHHHHHh
Confidence 3445555677788899999999999999999954 245699999863321 2346779999999999
Q ss_pred CCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------cc----cccHHHHHHHH
Q 018489 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------RR----KLAFKVVVQLA 178 (355)
Q Consensus 111 l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------~~----~~~~~~~~~i~ 178 (355)
++|||||+++|++...+.. |+|+|||..|+|.+++.... +. +++..+.+.|+
T Consensus 546 l~H~nIVrLlGVC~~~~P~----------------~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA 609 (774)
T KOG1026|consen 546 LQHPNIVRLLGVCREGDPL----------------CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIA 609 (774)
T ss_pred ccCCCeEEEEEEEccCCee----------------EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHH
Confidence 9999999999999987776 67999999999999996432 22 38899999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhH
Q 018489 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVY 256 (355)
Q Consensus 179 ~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 256 (355)
.||+.++.||-++.+|||||-..|+||++...|||+|||+++..-... .......-..+|||||.+.-+.|+.++|||
T Consensus 610 ~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVW 689 (774)
T KOG1026|consen 610 TQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVW 689 (774)
T ss_pred HHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhh
Confidence 999999999999999999999999999999999999999998543221 112234567899999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 257 SFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 257 slG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
|+|++|||+++ |+.||.+.++++.+..+..... ..-|+++|.++.+|+..||+.+|.+||++.||-..|++.-....
T Consensus 690 s~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 690 SFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred hhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 99999999998 9999999999999998888776 78899999999999999999999999999999999999866543
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=299.78 Aligned_cols=268 Identities=33% Similarity=0.573 Sum_probs=218.2
Q ss_pred cccceecCCcceeecccccccceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL- 111 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 111 (355)
..+|++...+|++.+.||+|+||.||+|.+. +..+++|.+..... . ...+.+.+|+.++.++
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~----~~~~~~~~E~~~l~~l~ 75 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT----D----KDLSDLVSEMEMMKMIG 75 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC----H----HHHHHHHHHHHHHHhhc
Confidence 3678999999999999999999999999642 23689998753211 1 1134577899999999
Q ss_pred CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHHHH
Q 018489 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQL 177 (355)
Q Consensus 112 ~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i 177 (355)
+||||+++++++...+.. +++|||+++++|.+++.... ...+++..+..+
T Consensus 76 ~h~~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 139 (334)
T cd05100 76 KHKNIINLLGACTQDGPL----------------YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139 (334)
T ss_pred CCCCeeeeeEEEccCCce----------------EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHH
Confidence 899999999988765544 66999999999999986532 234788899999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchh
Q 018489 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDV 255 (355)
Q Consensus 178 ~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv 255 (355)
+.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++||
T Consensus 140 ~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (334)
T cd05100 140 AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219 (334)
T ss_pred HHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhh
Confidence 999999999999999999999999999999999999999998754332111 111233467999999999889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 256 YSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 256 wslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
||||+++|+|++ |..||...+..+....+.. ......+..++.++.++|.+||+.+|.+||++.++++.|+.+....+
T Consensus 220 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 220 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 999999999998 8899988777666655443 34445566788999999999999999999999999999999986554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=301.94 Aligned_cols=239 Identities=26% Similarity=0.389 Sum_probs=194.3
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHH-HHHhhCCCCccceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV-AVWHKLDHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
+.||+|+||.||+|.+ +++.||+|++...... .......+..|. .+++.++||||+++++.+...+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~--- 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL------KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL--- 71 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH------HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE---
Confidence 4699999999999976 5789999998532211 111122233444 467888999999999888765554
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+++++|...+.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.++
T Consensus 72 -------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~k 136 (321)
T cd05603 72 -------------YFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVV 136 (321)
T ss_pred -------------EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEE
Confidence 669999999999988843 45689999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 292 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~ 292 (355)
|+|||++..............++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.... ..
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--~~ 214 (321)
T cd05603 137 LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP--LQ 214 (321)
T ss_pred EccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC--CC
Confidence 9999998743333333344568899999999999889999999999999999999999999887766666655432 34
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 018489 293 IPRCCPSSLANVMKRCWDANPDKRPEMD 320 (355)
Q Consensus 293 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ 320 (355)
++...+.++.++|.+||+.||.+|+++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 5667889999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=292.67 Aligned_cols=258 Identities=30% Similarity=0.558 Sum_probs=203.3
Q ss_pred cCCcceeecccccccceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
+..+|++.+.||+|+||.||++.. ++..|++|.+.... . ...+.+.+|+++++.++||||+++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-----~----~~~~~~~~e~~~l~~l~h~~iv~~~~ 72 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-----A----EHLRDFEREIEILKSLQHDNIVKYKG 72 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-----H----HHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence 346899999999999999999863 47789999985322 1 11345788999999999999999998
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++...+. ...+++|||+++++|.+++... ...+++..++.++.|++.||+|||++|++|+||+|+
T Consensus 73 ~~~~~~~--------------~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~ 137 (284)
T cd05081 73 VCYSAGR--------------RNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATR 137 (284)
T ss_pred EEccCCC--------------CceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHh
Confidence 7654332 2237899999999999998543 345899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCC---CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..++......
T Consensus 138 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~ 217 (284)
T cd05081 138 NILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE 217 (284)
T ss_pred hEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh
Confidence 999999999999999998755432221 11122345699999999888999999999999999999987765432211
Q ss_pred ---------------HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 279 ---------------EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 279 ---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
...............+..++.++.++|.+||+.+|++|||+.+|++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 218 FMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 011122233333345567889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=287.65 Aligned_cols=247 Identities=38% Similarity=0.686 Sum_probs=208.0
Q ss_pred cccccccceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccc
Q 018489 56 SVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 130 (355)
+.||+|+||.||+|.+. +..+++|++....... ..+.+.+|+..++.++|+||+++++++......
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~- 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--------ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPL- 71 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--------HHHHHHHHHHHHhhcCCCChheeeeeecCCCce-
Confidence 46899999999999764 7789999986433211 235578899999999999999999988764444
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhc-------cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
+++|||+++++|.+++.... ...+++..++.++.|++.||.+||++|++|+||+|+||
T Consensus 72 ---------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~ni 136 (262)
T cd00192 72 ---------------YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNC 136 (262)
T ss_pred ---------------EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceE
Confidence 67999999999999986532 36799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~ 280 (355)
+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.
T Consensus 137 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 216 (262)
T cd00192 137 LVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216 (262)
T ss_pred EECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999997655432 22333456788999999998889999999999999999999 6999998877666
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
...+.. ......+..++.++.+++.+||+.+|.+||++.++++.|+
T Consensus 217 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 217 LEYLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 665554 4445567778999999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=322.51 Aligned_cols=268 Identities=22% Similarity=0.311 Sum_probs=211.0
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||+|+++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~------~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSE------NPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccccc------CHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence 6899999999999999999976 5789999998642211 1233556889999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc---------cccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
.. +++|||++|++|.+++.... ...++...++.++.|++.||+|||++|++||||
T Consensus 76 ~l----------------yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDL 139 (932)
T PRK13184 76 PV----------------YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDL 139 (932)
T ss_pred EE----------------EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 44 66999999999999986421 234567788999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCC------------------CCCCCCCCcccccCCcccCCCCCCCcchhHHHHH
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNP------------------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 260 (355)
||+||+++.++.++|+|||.+....... .......||+.|+|||.+.+..++.++||||||+
T Consensus 140 KPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGV 219 (932)
T PRK13184 140 KPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGV 219 (932)
T ss_pred chheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHH
Confidence 9999999999999999999987541110 0111246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHhHhhcCCCCC
Q 018489 261 CLWEIYCCDMPYPDLSFSEVTSAVVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRP-EMDEVVSMLEAIDTSKGGGMI 338 (355)
Q Consensus 261 il~~lltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~ell~~l~~~~~~~~~~~~ 338 (355)
++|+|++|..||................. .......+++.+.+++.+||+.||.+|+ +++++++.|+........+..
T Consensus 220 ILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w~~ 299 (932)
T PRK13184 220 ILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWTV 299 (932)
T ss_pred HHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCccccc
Confidence 99999999999977554333222111111 1111245789999999999999999995 778888899988776555444
Q ss_pred C
Q 018489 339 P 339 (355)
Q Consensus 339 ~ 339 (355)
.
T Consensus 300 ~ 300 (932)
T PRK13184 300 K 300 (932)
T ss_pred c
Confidence 3
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=293.50 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=200.5
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
..+|++.+.||+|+||.||+|.+ ++..||+|++...... . ...+.+|+.++++++||||+++++.+...
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~------~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---D------FSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---h------HHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 36799999999999999999975 6788999998643211 1 12367899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++||||+++++|.+++.. ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++
T Consensus 79 ~~~----------------~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~ 140 (267)
T cd06646 79 EKL----------------WICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT 140 (267)
T ss_pred CEE----------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence 444 669999999999998853 45689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
.++.++|+|||.+..............++..|+|||.+. ...++.++|+||+|+++|+|++|..||...........
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~ 220 (267)
T cd06646 141 DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220 (267)
T ss_pred CCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee
Confidence 999999999999875543333333456788999999885 34577899999999999999999999965543333222
Q ss_pred HHhcCCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 284 VVRQNLRPEI---PRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 284 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
.......... ...++.++.++|++||+.+|++||++++|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 221 MSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred eecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 2222222111 23467899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=293.16 Aligned_cols=255 Identities=30% Similarity=0.529 Sum_probs=207.8
Q ss_pred ecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
++..+|.+.+.||+|+||.||++.. ++..+++|.+.... . .....+.+|+++++.++|+||+++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-----~----~~~~~~~~e~~~l~~l~h~~i~~~ 72 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-----E----SARQDFQREAELLTVLQHQHIVRF 72 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-----H----HHHHHHHHHHHHHhcCCCCCCceE
Confidence 3457899999999999999999853 35678888874321 1 123457889999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc-------------ccccHHHHHHHHHHHHHHHH
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-------------RKLAFKVVVQLALDLARGLS 186 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~i~~qi~~al~ 186 (355)
++++...+.. +++|||+++++|.+++..... ..+++..++.++.|++.||+
T Consensus 73 ~~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ 136 (280)
T cd05092 73 YGVCTEGRPL----------------LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMV 136 (280)
T ss_pred EEEEecCCce----------------EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHH
Confidence 9988765544 669999999999999864321 35889999999999999999
Q ss_pred HHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHH
Q 018489 187 YLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264 (355)
Q Consensus 187 ~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ 264 (355)
|||+.|++|+||+|+||++++++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+
T Consensus 137 ~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 216 (280)
T cd05092 137 YLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWE 216 (280)
T ss_pred HHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHH
Confidence 99999999999999999999999999999999864432211 1122234678999999998889999999999999999
Q ss_pred HHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 265 IYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 265 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
|++ |..||......+........ .....+..+++.+.++|.+||+.||.+||++++|++.|+
T Consensus 217 l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 217 IFTYGKQPWYQLSNTEAIECITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCCCCCCccCCHHHHHHHHHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 998 99999877766665555443 333456678999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.00 Aligned_cols=255 Identities=28% Similarity=0.472 Sum_probs=206.4
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
+.+|++.+.||+|+||.||++.+ ++..|++|.+.......... ...+.+.+|+.+++.+.||||+++++++...
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 76 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS----KEVNALECEIQLLKNLLHERIVQYYGCLRDP 76 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccH----HHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence 36899999999999999999965 57899999986433222111 2234578899999999999999999987654
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ..+++|||+++++|.+++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++
T Consensus 77 ~~~--------------~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~ 140 (265)
T cd06652 77 MER--------------TLSIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD 140 (265)
T ss_pred CCc--------------eEEEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence 322 23679999999999999853 34588999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCC---CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 207 KNRTVKIADFGVARVEASN---PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
.++.++|+|||.+...... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........
T Consensus 141 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 220 (265)
T cd06652 141 SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK 220 (265)
T ss_pred CCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH
Confidence 9999999999988743321 1112234578899999999888899999999999999999999999987765555555
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.......+..+..++..+.++|.+|+ .+|.+||+++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 221 IATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred HhcCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 44444445566677889999999999 59999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=302.43 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=199.8
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||++.+ ++..||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~ 95 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-------THAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 95 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-------hhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence 47899999999999999999965 57889999986432211 1123466899999999999999999887644
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.... .....++||||+++ +|...+. ..+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 96 ~~~~----------~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 160 (364)
T cd07875 96 KSLE----------EFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 160 (364)
T ss_pred cccc----------ccCeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC
Confidence 3221 12345889999954 7777663 3488899999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+..
T Consensus 161 ~~~~~kL~DfG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 239 (364)
T cd07875 161 SDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239 (364)
T ss_pred CCCcEEEEeCCCccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999754322 222345788999999999999999999999999999999999999988776555444332
Q ss_pred cCCC----------------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLR----------------------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~----------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.... .......+..+.++|.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1100 0011123567899999999999999999999988
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=288.82 Aligned_cols=255 Identities=27% Similarity=0.475 Sum_probs=207.4
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
+.+|++.+.||+|++|.||+|.+ ++..|++|.+........ .....+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (266)
T cd06651 1 PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE----TSKEVSALECEIQLLKNLQHERIVQYYGCLRDR 76 (266)
T ss_pred CCCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCch----hHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence 35799999999999999999965 688999999865443221 112234578899999999999999999987643
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.. ...++++||+++++|.+++.. ...+++..++.++.|++.+|.+||+.+++|+||+|+||+++
T Consensus 77 ~~--------------~~~~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~ 140 (266)
T cd06651 77 AE--------------KTLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD 140 (266)
T ss_pred CC--------------CEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence 22 223679999999999999853 34689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCC---CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 207 KNRTVKIADFGVARVEASN---PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
.++.++|+|||.+...... ........++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...........
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~ 220 (266)
T cd06651 141 SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK 220 (266)
T ss_pred CCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH
Confidence 9999999999998643321 1112224578889999999998899999999999999999999999988766665555
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.......+.++..+++.+.++| +||..+|++||+++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 221 IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 5555555666777888999999 677789999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=301.89 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=198.1
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||++.+ ++..||+|.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-------hHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence 37899999999999999999965 5789999998643221 11134466899999999999999999987644
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.... .....+++|||+++ +|...+. ..+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 89 ~~~~----------~~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~ 153 (355)
T cd07874 89 KSLE----------EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153 (355)
T ss_pred cccc----------ccceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC
Confidence 3221 12345789999965 6666663 3488999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+.......
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (355)
T cd07874 154 SDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_pred CCCCEEEeeCcccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999754322 223345788999999999998899999999999999999999999987664433322211
Q ss_pred cCCC----------------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLR----------------------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~----------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.... .......+.++.++|.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 1000 0011223567899999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=293.14 Aligned_cols=257 Identities=32% Similarity=0.552 Sum_probs=206.0
Q ss_pred ecCCcceeecccccccceEEEEEEECC------------------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHH
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYDG------------------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 108 (355)
+...+|++.+.||+|+||.||++.+.. ..||+|.+...... ...+.+.+|++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--------~~~~~~~~e~~~l 73 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--------NAREDFLKEVKIL 73 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--------HHHHHHHHHHHHH
Confidence 345789999999999999999986532 45899998643211 2245578899999
Q ss_pred hhCCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc---------cccccHHHHHHHHH
Q 018489 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---------RRKLAFKVVVQLAL 179 (355)
Q Consensus 109 ~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~~~i~~ 179 (355)
++++||||+++++++...+.. +++|||+++++|.+++.... ...+++..++.++.
T Consensus 74 ~~l~~~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (296)
T cd05051 74 SRLSDPNIARLLGVCTVDPPL----------------CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMAT 137 (296)
T ss_pred HhcCCCCEeEEEEEEecCCCc----------------EEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHH
Confidence 999999999999988765444 67999999999999986543 12689999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHH
Q 018489 180 DLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYS 257 (355)
Q Consensus 180 qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 257 (355)
|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||
T Consensus 138 ~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 217 (296)
T cd05051 138 QIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217 (296)
T ss_pred HHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhh
Confidence 999999999999999999999999999999999999999875432211 112234567899999998888999999999
Q ss_pred HHHHHHHHHh--CCCCCCCCChhHHHHHHHhc------CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 258 FGICLWEIYC--CDMPYPDLSFSEVTSAVVRQ------NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 258 lG~il~~llt--g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
||+++|+|++ +..||...+........... ......+..++.++.++|.+||+.||.+||++.+|++.|+
T Consensus 218 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 218 FGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 9999999998 77899877666555444332 1112234456789999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=292.65 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=202.9
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
.|++.+.||+|+||.||++.+ +++.||+|.+....... ......+.+|+.+++.++|++|+++++.+...+.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~ 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK------RKGESMALNEKQILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc------hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence 478889999999999999966 57899999885432211 1112345679999999999999999988776554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 75 ~----------------~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~ 138 (285)
T cd05630 75 L----------------CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH 138 (285)
T ss_pred E----------------EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 4 679999999999998866555679999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh---HHHHHHH
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS---EVTSAVV 285 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~---~~~~~~~ 285 (355)
+.++|+|||.+...... .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... .......
T Consensus 139 ~~~~l~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~ 217 (285)
T cd05630 139 GHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 217 (285)
T ss_pred CCEEEeeccceeecCCC-ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh
Confidence 99999999998654322 2223346889999999999988999999999999999999999999865432 1122221
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 324 (355)
. .....++..+++++.++|.+||+.||++||| +.++++
T Consensus 218 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 218 K-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred h-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1 1223355678899999999999999999999 889988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=293.00 Aligned_cols=248 Identities=33% Similarity=0.604 Sum_probs=200.4
Q ss_pred ceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 52 LVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
|++.+.||+|+||+||++... +..+|+|++...... ........+|+.++++++||||+++++++......
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 73 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-------EEEREENIREIKILRRLRHPNIVQILDVFQDDNYL 73 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-------HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-------ccccchhhhhhhccccccccccccccccccccccc
Confidence 789999999999999999774 557999999654321 11122234599999999999999999998875544
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
+++|||+.+++|.+++. ....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++
T Consensus 74 ----------------~~v~~~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~ 135 (260)
T PF00069_consen 74 ----------------YIVMEYCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG 135 (260)
T ss_dssp ----------------EEEEEEETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS
T ss_pred ----------------ccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 66999999999999996 456799999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCCCCCCCCCcccccCCcccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH---HHH
Q 018489 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS---AVV 285 (355)
Q Consensus 210 ~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~---~~~ 285 (355)
.++|+|||.+..............++..|+|||.+. +..++.++|+||||+++++|++|..||.......... ...
T Consensus 136 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~ 215 (260)
T PF00069_consen 136 EVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL 215 (260)
T ss_dssp EEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc
Confidence 999999999875433344455567889999999998 7889999999999999999999999998873322222 222
Q ss_pred hcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
........ ....+..+.++|.+||+.||++||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 216 KRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 21111111 1223489999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=290.45 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=203.7
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
.|++.+.||.|+||.||++.+ +++.+|+|.+...... .......+.+|+.+++.++|+||+.+.+.+...+.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~ 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK------KRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh------hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE
Confidence 378889999999999999966 5789999998542211 11122346789999999999999999888776554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+++++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.+
T Consensus 75 ~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~ 138 (285)
T cd05632 75 L----------------CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY 138 (285)
T ss_pred E----------------EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC
Confidence 4 679999999999988865555579999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh--
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR-- 286 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~-- 286 (355)
+.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+..
T Consensus 139 ~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~ 217 (285)
T cd05632 139 GHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV 217 (285)
T ss_pred CCEEEecCCcceecCCC-CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Confidence 99999999998654322 222345688999999999988899999999999999999999999987665443333222
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 324 (355)
......++..++.++.+++..||+.||.+||+ +.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 218 LETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred hccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11223455668899999999999999999999 677776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=286.35 Aligned_cols=247 Identities=32% Similarity=0.595 Sum_probs=205.9
Q ss_pred cccccccceEEEEEEEC---C--ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccc
Q 018489 56 SVIARGTFGTVHRGLYD---G--HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 130 (355)
+.||+|++|.||+|.+. + ..+|+|.+...... ...+.+.+|+..+++++||||+++++.+.. ..
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~-- 69 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HP-- 69 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--------HHHHHHHHHHHHHhhcCCCCccceeEEEcC-Ce--
Confidence 46899999999999753 2 35899998543321 345668899999999999999999988765 32
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~ 210 (355)
.+++|||+++++|.+++.......+++..++.++.|++.||++||++|++|+||+|+||+++.++.
T Consensus 70 --------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~ 135 (257)
T cd05040 70 --------------LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK 135 (257)
T ss_pred --------------EEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE
Confidence 267999999999999997654356899999999999999999999999999999999999999999
Q ss_pred EEEeeccccccccCCCCC---CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 018489 211 VKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 211 v~L~Dfg~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~ 286 (355)
++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..
T Consensus 136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 215 (257)
T cd05040 136 VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215 (257)
T ss_pred EEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999998765432211 112346678999999998889999999999999999998 9999988877777666665
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
.......+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 216 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 55555566678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=291.99 Aligned_cols=248 Identities=25% Similarity=0.461 Sum_probs=206.5
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
..+|++.+.||.|++|.||++.+ +++.|++|.+....... .+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 88 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---------KELIINEILVMKELKNPNIVNFLDSFLVG 88 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch---------HHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence 46799999999999999999964 68899999986432211 23467899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++++||+++++|..++.. ..+++..++.++.|++.+|++||+.|++|+||+|+||+++
T Consensus 89 ~~~----------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~ 149 (296)
T cd06655 89 DEL----------------FVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149 (296)
T ss_pred ceE----------------EEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 544 669999999999998843 4589999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~ 229 (296)
T cd06655 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229 (296)
T ss_pred CCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 99999999999887544333333345678899999999988899999999999999999999999988776555444333
Q ss_pred cC-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QN-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.. .....+..+++.+.++|.+||..+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 22 122345668899999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=291.41 Aligned_cols=259 Identities=28% Similarity=0.496 Sum_probs=203.6
Q ss_pred cCCcceeecccccccceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
+..-|++.+.||+|+||.||++.. ++..|++|.++.... ......+.+|+.+++.++||||+++.+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 73 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--------GNHIADLKKEIEILRNLYHENIVKYKG 73 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--------HHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence 345689999999999999999863 467899999853221 112345889999999999999999998
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++...+. ...+++|||+++++|.+++... ...+++..++.++.|++.+|+|||++|++|+||+|+
T Consensus 74 ~~~~~~~--------------~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~ 138 (284)
T cd05079 74 ICTEDGG--------------NGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR 138 (284)
T ss_pred EEecCCC--------------CceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchh
Confidence 8765422 2237899999999999998543 345899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS-- 276 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~-- 276 (355)
||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|+++..|+....
T Consensus 139 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~ 218 (284)
T cd05079 139 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL 218 (284)
T ss_pred eEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch
Confidence 99999999999999999875443221 1122345667999999988889999999999999999999876542210
Q ss_pred ------------hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 277 ------------FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 277 ------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
.................+..++..+.++|.+||+.+|.+||+++++++.|+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 219 FLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111122223333445667899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=300.14 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=199.0
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||.|+||.||+|.+ ++..||+|.+...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-------LIHARRTYRELRLLKHMKHENVIGLLDVFTPA 86 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-------hHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence 48899999999999999999965 6788999998532211 11223466899999999999999999887643
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.... .....+++++++ +++|.+++. ...+++..++.++.||+.||.|||+.|++|+||||+||+++
T Consensus 87 ~~~~----------~~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~ 152 (343)
T cd07878 87 TSIE----------NFNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN 152 (343)
T ss_pred cccc----------ccCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC
Confidence 3221 123457899998 789988773 35699999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
.++.++|+|||++..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.......+.
T Consensus 153 ~~~~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07878 153 EDCELRILDFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM 229 (343)
T ss_pred CCCCEEEcCCccceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 999999999999875432 2234568899999999877 568899999999999999999999998766544443332
Q ss_pred hcCCC---------------------CC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLR---------------------PE--------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~---------------------~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..... +. .....++.+.++|.+||+.||.+|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 230 EVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 21100 00 11234667899999999999999999999996
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=294.91 Aligned_cols=268 Identities=24% Similarity=0.373 Sum_probs=215.2
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+|++.+.||+|++|.||+|.+ ++..+|+|.+....... ....+.+.+|++++..++|+||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK------RNKVKRVLTEQEILATLDHPFLPTLYASFQTET 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch------HHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence 4799999999999999999966 57999999986433211 112345788999999999999999999886654
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. +++|||+.+++|.+++.......+++..++.++.|++.+|.|||+.|++|+||||+||+++.
T Consensus 75 ~~----------------~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~ 138 (316)
T cd05574 75 YL----------------CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE 138 (316)
T ss_pred EE----------------EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC
Confidence 44 67999999999999987655677999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCC-----------------------------CCCCCCCcccccCCcccCCCCCCCcchhHHH
Q 018489 208 NRTVKIADFGVARVEASNPN-----------------------------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 258 (355)
++.++|+|||.+........ ......++..|+|||.+.+..++.++|||||
T Consensus 139 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~sl 218 (316)
T cd05574 139 SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL 218 (316)
T ss_pred CCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHH
Confidence 99999999998764322110 1112357888999999999889999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHHHH--HHHHhHhh
Q 018489 259 GICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE----MDEVVS--MLEAIDTS 332 (355)
Q Consensus 259 G~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~ell~--~l~~~~~~ 332 (355)
|+++|+|++|+.||...+.......+............+++.+.++|.+||..+|++||+ +++++. .++.+.-.
T Consensus 219 G~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~ 298 (316)
T cd05574 219 GILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWA 298 (316)
T ss_pred HHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChh
Confidence 999999999999998887776666665544433333347999999999999999999999 777777 34444433
Q ss_pred cCCCCCC
Q 018489 333 KGGGMIP 339 (355)
Q Consensus 333 ~~~~~~~ 339 (355)
.-..+.+
T Consensus 299 ~~~~~~~ 305 (316)
T cd05574 299 LIRHTTP 305 (316)
T ss_pred hcccCCC
Confidence 3333333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=293.39 Aligned_cols=248 Identities=25% Similarity=0.451 Sum_probs=204.8
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
..+|++.+.||+|++|.||+|.+ ++..+++|.+....... ...+.+|+.+++.+.|+||+++++.+...
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---------~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---------KELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---------HHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 46899999999999999999965 67899999986533211 23477899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++
T Consensus 90 ~~~----------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~ 150 (296)
T cd06654 90 DEL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (296)
T ss_pred CEE----------------EEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc
Confidence 444 679999999999998843 4589999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|+.||..............
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~ 230 (296)
T cd06654 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230 (296)
T ss_pred CCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc
Confidence 99999999999987544333333345678899999999988889999999999999999999999987665444333322
Q ss_pred cC-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QN-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.. .....+..++..+.++|.+||..+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 21 122234567889999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.00 Aligned_cols=253 Identities=26% Similarity=0.479 Sum_probs=206.8
Q ss_pred cceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
+|++.+.||.|+||.||+|.. ++..+|+|.+....... .........+.+|+++++.++|+||+++++++...+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV---LAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccch---hhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeE
Confidence 588999999999999999965 68889999886433211 11122335588999999999999999999988765444
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
++++||+++++|.+++.+ ...+++..++.++.|++.+|++||+.|++|+||+|+||+++.++
T Consensus 78 ----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~ 139 (265)
T cd06631 78 ----------------SIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG 139 (265)
T ss_pred ----------------EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC
Confidence 679999999999999854 35689999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCC------CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 210 TVKIADFGVARVEASN------PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 210 ~v~L~Dfg~a~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
.++|+|||.+...... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~ 219 (265)
T cd06631 140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY 219 (265)
T ss_pred eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH
Confidence 9999999988743211 1112234578899999999988889999999999999999999999987665544433
Q ss_pred HHhc-CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQ-NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+... ...+..+..++.++.++|++||+.+|.+||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 220 IGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 3332 3344567778999999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=285.78 Aligned_cols=247 Identities=30% Similarity=0.582 Sum_probs=201.0
Q ss_pred ccccccceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccccc
Q 018489 57 VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 57 ~lg~G~~~~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
.||+|+||.||+|.+ ++..||+|++..... ....+.+.+|+.++++++|+||+++++++...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~------ 67 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--------KSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE------ 67 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--------hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC------
Confidence 389999999999865 245699999853221 12234588899999999999999999876422
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
..++||||+++++|.+++.. ....+++..+++++.|++.+|.|||++|++|+||+|+||+++.++.++
T Consensus 68 -----------~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~k 135 (257)
T cd05115 68 -----------ALMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAK 135 (257)
T ss_pred -----------CeEEEEEeCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEE
Confidence 23679999999999998854 245689999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCC---CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcC
Q 018489 213 IADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~ 288 (355)
|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|++++ |..||...........+. ..
T Consensus 136 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~ 214 (257)
T cd05115 136 ISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QG 214 (257)
T ss_pred eccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CC
Confidence 9999998754332221 111223568999999988888999999999999999996 999998877666554443 33
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 289 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
.....+..+++++.++|.+||..+|++||++.+|++.|+.+.
T Consensus 215 ~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 215 KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 445667778999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=292.15 Aligned_cols=257 Identities=31% Similarity=0.548 Sum_probs=209.5
Q ss_pred ecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
+..++|++.+.||+|+||.||+|.+ ++..+++|++..... ....+.+.+|+.++.++.||||+++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~ei~~l~~l~h~~iv~~ 73 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------ADMQADFQREAALMAEFDHPNIVKL 73 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--------HHHHHHHHHHHHHHHhcCCCchheE
Confidence 4567899999999999999999975 457899999853221 1223457889999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------------cccccHHHHHHHHH
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------------RRKLAFKVVVQLAL 179 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------------~~~~~~~~~~~i~~ 179 (355)
++++...+.. +++|||+++++|.+++.... ...+++..++.++.
T Consensus 74 ~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 137 (288)
T cd05050 74 LGVCAVGKPM----------------CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAK 137 (288)
T ss_pred EEEEcCCCcc----------------EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHH
Confidence 9988765544 66999999999999996432 13478889999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHH
Q 018489 180 DLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYS 257 (355)
Q Consensus 180 qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 257 (355)
|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ........+..|+|||.+.+..++.++||||
T Consensus 138 ~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 217 (288)
T cd05050 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWA 217 (288)
T ss_pred HHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHH
Confidence 99999999999999999999999999999999999999986433221 1122233456799999999888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 258 FGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 258 lG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
||+++|+|++ |..||.+.+..+....+.... ....+..++.++.++|.+||+.+|.+||++.|+++.|++
T Consensus 218 lG~il~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 218 YGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 9999999997 888998877766665554433 233456788999999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=303.74 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=199.6
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||+|+||.||++.+ +++.||+|.+...... ....+.+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 73 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-------LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI 73 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-------hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence 578999999999999999975 6899999988532111 1112347789999999999999999998875542
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
.. ....++||||+. ++|.+.+. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 74 ~~-----------~~~~~lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~ 139 (372)
T cd07853 74 DP-----------FEEIYVVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN 139 (372)
T ss_pred cc-----------cceEEEEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC
Confidence 10 123578999995 57887773 34679999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 209 RTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
+.++|+|||.+....... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||.+.+.......+..
T Consensus 140 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 219 (372)
T cd07853 140 CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219 (372)
T ss_pred CCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 999999999987543222 222334678899999998874 578999999999999999999999988766554443322
Q ss_pred c-----------------------CCCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 Q-----------------------NLRP-------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~-----------------------~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
. .... ......++++.++|.+||+.||.+|||+.++++
T Consensus 220 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 220 LLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 1 0000 123445889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=289.67 Aligned_cols=256 Identities=32% Similarity=0.574 Sum_probs=206.3
Q ss_pred ecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
+..++|++.+.||+|++|.||+|.+. +..|++|.+..... . .....+.+|+.+++.++|+||+++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~----~----~~~~~~~~e~~~l~~l~~~~i~~~ 74 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS----E----QDESDFLMEALIMSKFNHQNIVRL 74 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC----H----HHHHHHHHHHHHHHhCCCCCEeeE
Confidence 44578999999999999999999763 46788887743211 1 112347789999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc-----ccccHHHHHHHHHHHHHHHHHHHhCCcc
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-----RKLAFKVVVQLALDLARGLSYLHSQKIV 194 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~i~ 194 (355)
++++...+.. +++|||+++++|.+++..... ..+++..++.++.||+.+|+|||+++++
T Consensus 75 ~~~~~~~~~~----------------~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 138 (277)
T cd05036 75 IGVSFERLPR----------------FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFI 138 (277)
T ss_pred EEEEccCCCc----------------EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 9988765544 569999999999999965432 2589999999999999999999999999
Q ss_pred ccCCCCCcEEEcCCC---cEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-C
Q 018489 195 HRDVKTENMLLDKNR---TVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-C 268 (355)
Q Consensus 195 H~di~p~Nili~~~~---~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g 268 (355)
|+||+|+||+++.++ .++|+|||.+........ .......+..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 139 H~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g 218 (277)
T cd05036 139 HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLG 218 (277)
T ss_pred ecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCC
Confidence 999999999998654 599999999875432111 1112233567999999998889999999999999999997 9
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 269 DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 269 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
..||...+.......+.. ......+..++..+.+++.+||+.+|.+||++.++++.|+
T Consensus 219 ~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 219 YMPYPGRTNQEVMEFVTG-GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 999988777665554433 3444566778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=299.74 Aligned_cols=258 Identities=24% Similarity=0.323 Sum_probs=204.0
Q ss_pred ccccceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccce
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTK 118 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~ 118 (355)
....+.|.+..|+++++||.||.+.||++.. +...||+|.+.....+ .....-|.+|+.+|.+| +|.+|++
T Consensus 352 ~~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D-------~qtl~gy~nEI~lL~KLkg~~~IIq 424 (677)
T KOG0596|consen 352 ANEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD-------NQTLDGYRNEIALLNKLKGHDKIIQ 424 (677)
T ss_pred cCeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC-------HHHHHHHHHHHHHHHHhcCCceEEE
Confidence 3467899999999999999999999999965 4566777765332221 22345588999999999 7899999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++|-..++ ++|+||||- ..+|..++.+.... +....++.++.||+.|+.++|..||||.||
T Consensus 425 L~DYEv~d~----------------~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDL 486 (677)
T KOG0596|consen 425 LYDYEVTDG----------------YLYMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDL 486 (677)
T ss_pred EeeeeccCc----------------eEEEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCC
Confidence 999876544 447799997 56999999765443 333488899999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCC-----------CCCCcchhHHHHHHHHHH
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGN-----------PYNRKCDVYSFGICLWEI 265 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~il~~l 265 (355)
||.|+++ -.|.+||+|||+|.....+.. .....+||..||+||.+... ..++++||||||||||+|
T Consensus 487 KPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqM 565 (677)
T KOG0596|consen 487 KPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQM 565 (677)
T ss_pred CcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHH
Confidence 9999998 678999999999986655433 34557899999999998542 256789999999999999
Q ss_pred HhCCCCCCCCC-hhHHHHHHHhcCCCCCCCCCCc-HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 266 YCCDMPYPDLS-FSEVTSAVVRQNLRPEIPRCCP-SSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 266 ltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+.|+.||.... .-..+..+...+...+++..-+ .++.++++.||.+||.+||++.++|+
T Consensus 566 vYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 566 VYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 99999998765 3344445544444445555433 34999999999999999999999986
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=310.14 Aligned_cols=254 Identities=20% Similarity=0.310 Sum_probs=191.8
Q ss_pred cceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC------CCc
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD------HPN 115 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~ 115 (355)
++.+..++|++.+.||+|+||.||+|.+ ++..||||+++.... ....+..|+.++..+. |.+
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----------~~~~~~~e~~~l~~l~~~~~~~~~~ 192 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----------YTRDAKIEIQFMEKVRQADPADRFP 192 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----------hHHHHHHHHHHHHHHhhcCcccCcc
Confidence 3455568999999999999999999965 578899999853211 1122344555555554 455
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh-CCcc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIV 194 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~ 194 (355)
++.+++++.... .+.|+||+++ +++|.+++.+ ...+++..++.|+.||+.||.|||+ .||+
T Consensus 193 i~~i~~~~~~~~---------------~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~gIi 254 (467)
T PTZ00284 193 LMKIQRYFQNET---------------GHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLM 254 (467)
T ss_pred eeeeEEEEEcCC---------------ceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCee
Confidence 777877765432 2347899998 7789888854 3579999999999999999999998 5999
Q ss_pred ccCCCCCcEEEcCCC----------------cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHH
Q 018489 195 HRDVKTENMLLDKNR----------------TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258 (355)
Q Consensus 195 H~di~p~Nili~~~~----------------~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 258 (355)
||||||+|||++.++ .++|+|||.+.... .......++..|+|||++.+..++.++|||||
T Consensus 255 HrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 331 (467)
T PTZ00284 255 HTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSM 331 (467)
T ss_pred cCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHH
Confidence 999999999998665 49999999875332 22334578999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC-------------------------C--------------C-CCCCc
Q 018489 259 GICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP-------------------------E--------------I-PRCCP 298 (355)
Q Consensus 259 G~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~-------------------------~--------------~-~~~~~ 298 (355)
||++|+|++|+.||.+.+..+....+....... . . ....+
T Consensus 332 Gvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (467)
T PTZ00284 332 GCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRD 411 (467)
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhch
Confidence 999999999999998776544443322210000 0 0 00124
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH--HHHH
Q 018489 299 SSLANVMKRCWDANPDKRPEMDEVVS--MLEA 328 (355)
Q Consensus 299 ~~l~~li~~~l~~~p~~Rps~~ell~--~l~~ 328 (355)
+.+.+||.+||++||.+|||+.|+++ .+..
T Consensus 412 ~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 412 DLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred HHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 56889999999999999999999997 4544
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.15 Aligned_cols=252 Identities=29% Similarity=0.511 Sum_probs=209.6
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||.|++|.||++.+ ++..+++|++...... . ...+.+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT---E----KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC---H----HHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence 589999999999999999965 6788999998643321 1 113457789999999999999999987754332
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLH-----SQKIVHRDVKTE 201 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH-----~~~i~H~di~p~ 201 (355)
...+++|||+++++|.+++... ....+++..++.++.|++.+|.+|| +.+++|+||+|+
T Consensus 74 --------------~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ 139 (265)
T cd08217 74 --------------QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPA 139 (265)
T ss_pred --------------CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHH
Confidence 2337899999999999998653 2457899999999999999999999 889999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
||+++.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|..||...+.....
T Consensus 140 nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 219 (265)
T cd08217 140 NIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA 219 (265)
T ss_pred HEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH
Confidence 99999999999999999886654443234456888999999999888999999999999999999999999887755544
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+ .......++..++..+.+++.+||+.+|.+||++.+|++
T Consensus 220 ~~~-~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 220 SKI-KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHH-hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 443 334445667788999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=290.12 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=201.4
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ ++..|++|+++..... . ...+.+|+.+++.++||||+++++.+...
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~----~~~~~~e~~~~~~l~h~~ii~~~~~~~~~ 78 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-----D----FAVVQQEIIMMKDCKHSNIVAYFGSYLRR 78 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-----H----HHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence 35899999999999999999976 6789999998643211 1 12366899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. +++|||+++++|.+++.. ...+++..++.++.|++.+|.|||+.|++|+||+|+||+++
T Consensus 79 ~~~----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~ 140 (267)
T cd06645 79 DKL----------------WICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT 140 (267)
T ss_pred CEE----------------EEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 544 569999999999998853 45799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
.++.++|+|||.+..............++..|+|||.+. ...++.++|+||||+++|+|++|..||...........
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~ 220 (267)
T cd06645 141 DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220 (267)
T ss_pred CCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh
Confidence 999999999999875543333334457889999999874 44578899999999999999999999976544333333
Q ss_pred HHhcCCCCCCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEIP---RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.......+... ..++..+.++|.+||+.+|++||+++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 221 MTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred hhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 32222222211 236788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=300.01 Aligned_cols=269 Identities=32% Similarity=0.561 Sum_probs=209.8
Q ss_pred hcccccceecCCcceeecccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
.+...++.-..++|.-...||+|+||.||+|... +..||||.+....... .+.|.+|+.++.+++|||++
T Consensus 64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---------~~eF~~Ei~~ls~l~H~Nlv 134 (361)
T KOG1187|consen 64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---------EREFLNEVEILSRLRHPNLV 134 (361)
T ss_pred eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---------hhHHHHHHHHHhcCCCcCcc
Confidence 4455556666789999999999999999999654 5899999775433221 12389999999999999999
Q ss_pred eeeeeccCCcc-cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC---c
Q 018489 118 KFIGATMGSSE-LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK---I 193 (355)
Q Consensus 118 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i 193 (355)
+++||+.+.+. . +||+||+++|+|.+.+.......++|..+.+|+.++++||+|||... |
T Consensus 135 ~LlGyC~e~~~~~----------------~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~i 198 (361)
T KOG1187|consen 135 KLLGYCLEGGEHR----------------LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPI 198 (361)
T ss_pred cEEEEEecCCceE----------------EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCE
Confidence 99999987764 4 67999999999999996533328899999999999999999999864 9
Q ss_pred cccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCC-CCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 018489 194 VHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272 (355)
Q Consensus 194 ~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~ 272 (355)
+||||||+|||++.+.++||+|||+|...+......... .||.+|++||.+..+..+.++||||+|++++|++||+.+.
T Consensus 199 iHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~ 278 (361)
T KOG1187|consen 199 IHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAV 278 (361)
T ss_pred ecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCccc
Confidence 999999999999999999999999996554311111112 7899999999999888999999999999999999999877
Q ss_pred CCCC------hhHHHHHHHhcC-----CCCCCC-CCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 273 PDLS------FSEVTSAVVRQN-----LRPEIP-RCCP-----SSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 273 ~~~~------~~~~~~~~~~~~-----~~~~~~-~~~~-----~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
.... ..++....+... ..+.+. ...+ ..+..+...|++.+|.+||++.+++++|+.+...
T Consensus 279 d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 279 DQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 6432 122222222221 111222 2233 2366788899999999999999999999766544
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=286.31 Aligned_cols=256 Identities=32% Similarity=0.599 Sum_probs=208.1
Q ss_pred cCCcceeecccccccceEEEEEEEC--C---ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD--G---HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
...+|++.+.||+|+||.||+|... + ..|++|++.... . ......+..|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~----~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 73 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY----T----EKQRRDFLSEASIMGQFDHPNIIHLEGV 73 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC----C----HHHHHHHHHHHHHHHhCCCcCcceEEEE
Confidence 3467999999999999999999653 3 359999985321 1 1123558889999999999999999998
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...... +++|||+++++|.+++... ...+++..++.++.|++.||+|||++|++|+||+|+|
T Consensus 74 ~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~n 136 (269)
T cd05065 74 VTKSRPV----------------MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARN 136 (269)
T ss_pred ECCCCce----------------EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChhe
Confidence 8765544 6699999999999998653 4568999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCC--CCC---CCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPND--MTG---ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 276 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~--~~~---~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~ 276 (355)
|+++.++.++|+|||.+......... ... ...+..|+|||.+.+..++.++||||||+++|+|++ |..||...+
T Consensus 137 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 137 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred EEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 99999999999999998654322111 111 112347999999998889999999999999999886 999998877
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
.......+. .......+..++..+.+++.+||+.+|.+||++++|+..|+++
T Consensus 217 ~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 217 NQDVINAIE-QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 666555543 3344445567889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=296.65 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=202.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||++.. +++.||+|++.... .......+.+.+|..++..++|+||+++++++...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE------MLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH------HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 4799999999999999999965 57899999985321 111222345778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++... ...+++..+..++.||+.||+|||++|++||||||+|||++.
T Consensus 75 ~~----------------~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 137 (331)
T cd05597 75 NL----------------YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK 137 (331)
T ss_pred eE----------------EEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC
Confidence 44 6799999999999998542 456899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 208 NRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
++.++|+|||.+........ ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+..+..
T Consensus 138 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~ 217 (331)
T cd05597 138 NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217 (331)
T ss_pred CCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH
Confidence 99999999999865433222 2223468999999999863 45778999999999999999999999887776666
Q ss_pred HHHHhcCCCCCCC---CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 018489 282 SAVVRQNLRPEIP---RCCPSSLANVMKRCWDANPDK--RPEMDEVVSM 325 (355)
Q Consensus 282 ~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~--Rps~~ell~~ 325 (355)
..+........++ ..+++++.++|++||..++.+ |+++.++++-
T Consensus 218 ~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 218 GKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 6665443322222 347899999999998654433 7899888874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=285.92 Aligned_cols=250 Identities=26% Similarity=0.475 Sum_probs=209.9
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||+|+||.+|++.. ++..|++|.+....... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-------KEREESRKEVAVLSNMKHPNIVQYQESFEENGN 73 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-------HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCe
Confidence 689999999999999999865 67899999986432211 112357789999999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+++++|.+++.......+++..++.|+.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus 74 ~----------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~ 137 (256)
T cd08218 74 L----------------YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137 (256)
T ss_pred E----------------EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 4 679999999999999876555578999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 288 (355)
+.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|+.||...+..+....+....
T Consensus 138 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~ 217 (256)
T cd08218 138 GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS 217 (256)
T ss_pred CCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC
Confidence 99999999998755443333333457888999999998889999999999999999999999998777666665554433
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 289 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+..+..++.++.++|.+||+.+|.+||++.++++
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 34456678999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.60 Aligned_cols=256 Identities=30% Similarity=0.540 Sum_probs=210.0
Q ss_pred cCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
..++|++...||.|+||.||+|.. ....+++|.+..... ......+.+|++++++++|+||++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~ 74 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--------ENLQSEFRRELDMFRKLSHKNVVRLL 74 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--------hHHHHHHHHHHHHHHhcCCcceeeeE
Confidence 457899999999999999999974 245699998743221 12234578899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc-------ccccHHHHHHHHHHHHHHHHHHHhCCc
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-------RKLAFKVVVQLALDLARGLSYLHSQKI 193 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~i 193 (355)
+++...+.. ++||||+++++|.+++..... ..+++..+..++.|++.+|+|||+.|+
T Consensus 75 ~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i 138 (275)
T cd05046 75 GLCREAEPH----------------YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARF 138 (275)
T ss_pred EEECCCCcc----------------eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCc
Confidence 987654433 679999999999999965442 268999999999999999999999999
Q ss_pred cccCCCCCcEEEcCCCcEEEeeccccccccCC-CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCC
Q 018489 194 VHRDVKTENMLLDKNRTVKIADFGVARVEASN-PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMP 271 (355)
Q Consensus 194 ~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p 271 (355)
+|+||+|+||+++.++.++++|||.+...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 139 ~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p 218 (275)
T cd05046 139 VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218 (275)
T ss_pred ccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999988643221 112223345677999999988888899999999999999998 8899
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 272 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
|.....................+..++..+.+++.+||+.+|.+||++.+++..|.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 219 FYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 98877766666655444444556678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=290.06 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=198.6
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||.|++|.||+|.+ ++..||+|.++....... ....+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG-------VPSTAIREISLLKELQHPNIVCLQDVLMQESR 73 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC-------chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe
Confidence 589999999999999999965 588999999865432211 12346679999999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
. ++||||++ ++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 74 ~----------------~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~ 136 (285)
T cd07861 74 L----------------YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN 136 (285)
T ss_pred E----------------EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC
Confidence 4 67999996 58888875433 356899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
++.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..........
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~ 216 (285)
T cd07861 137 KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFR 216 (285)
T ss_pred CCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9999999999987544333333445678899999988764 578899999999999999999999987654433322211
Q ss_pred cC---------------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QN---------------------------LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~---------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.. ........+++++.++|.+||+.||.+|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 217 ILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 10 000112346889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=286.79 Aligned_cols=257 Identities=32% Similarity=0.612 Sum_probs=209.4
Q ss_pred ecCCcceeecccccccceEEEEEEEC--C---ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYD--G---HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
+..++|...+.||+|++|.||+|... + ..+++|....... . ...+.+.+|+.++.+++|+||+++.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~----~----~~~~~~~~e~~~l~~l~h~~i~~~~~ 73 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT----E----KQRQDFLSEASIMGQFSHHNIIRLEG 73 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC----H----HHHHHHHHHHHHHhcCCCCCeeEEEE
Confidence 45678999999999999999999653 3 3689998753221 1 11345778999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++...+.. +++|||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+
T Consensus 74 ~~~~~~~~----------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~ 136 (268)
T cd05063 74 VVTKFKPA----------------MIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAAR 136 (268)
T ss_pred EEccCCCc----------------EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchh
Confidence 88765544 5699999999999998643 356899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCC---CCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDM---TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
||+++.++.++|+|||.+.......... .....+..|+|||.+.+..++.++||||||+++|+|++ |+.||...+.
T Consensus 137 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 137 NILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred hEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 9999999999999999987543322111 11123457999999988889999999999999999997 9999988777
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
.+....+.. ......+..++.++.+++.+||+.+|.+||++.++++.|+++
T Consensus 217 ~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 217 HEVMKAIND-GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 666655543 333344556789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=284.18 Aligned_cols=247 Identities=32% Similarity=0.585 Sum_probs=201.8
Q ss_pred cccccccceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccc
Q 018489 56 SVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 130 (355)
+.||+|+||.||+|.+. +..+++|.+...... ...+.+.+|+.+++.+.|+||+++++++... .
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~-- 69 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--------AGKKEFLREASVMAQLDHPCIVRLIGVCKGE-P-- 69 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-c--
Confidence 46999999999999652 267999998543321 2234578899999999999999999876422 2
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~ 210 (355)
.+++|||+++++|.+++... ..+++..++.++.|++.+|.+||..|++|+||+|+||+++.++.
T Consensus 70 --------------~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~ 133 (257)
T cd05060 70 --------------LMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ 133 (257)
T ss_pred --------------eEEEEEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc
Confidence 26799999999999999543 47899999999999999999999999999999999999999999
Q ss_pred EEEeeccccccccCCCCCCC---CCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 018489 211 VKIADFGVARVEASNPNDMT---GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 211 v~L~Dfg~a~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~ 286 (355)
++|+|||.+........... ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.
T Consensus 134 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~- 212 (257)
T cd05060 134 AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE- 212 (257)
T ss_pred EEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-
Confidence 99999999875543322211 1123457999999998889999999999999999998 999998877665554443
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
.......+..++..+.++|.+||+.+|.+||++.++++.|+++.
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 213 SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 33344566778999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=290.22 Aligned_cols=257 Identities=29% Similarity=0.540 Sum_probs=203.4
Q ss_pred ecCCcceeecccccccceEEEEEEECC----------------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhh
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYDG----------------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 110 (355)
+..++|++.+.||+|+||.||++...+ ..||+|.++.... . .....+.+|++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~ei~~l~~ 73 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT----K----TARNDFLKEIKIMSR 73 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC----H----HHHHHHHHHHHHHHh
Confidence 345789999999999999999986532 2489998853211 1 123457889999999
Q ss_pred CCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc----------cccccHHHHHHHHHH
Q 018489 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----------RRKLAFKVVVQLALD 180 (355)
Q Consensus 111 l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~~~i~~q 180 (355)
++|+|++++++++...+.. +++|||+++++|.+++.... ...+++..++.++.|
T Consensus 74 l~h~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 137 (295)
T cd05097 74 LKNPNIIRLLGVCVSDDPL----------------CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQ 137 (295)
T ss_pred CCCCCcCeEEEEEcCCCcc----------------EEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHH
Confidence 9999999999988765544 67999999999999985431 123688899999999
Q ss_pred HHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHH
Q 018489 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258 (355)
Q Consensus 181 i~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 258 (355)
++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+|||
T Consensus 138 i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 217 (295)
T cd05097 138 IASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217 (295)
T ss_pred HHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHH
Confidence 99999999999999999999999999999999999999865432211 1122234668999999998889999999999
Q ss_pred HHHHHHHHh--CCCCCCCCChhHHHHHHHh------cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 259 GICLWEIYC--CDMPYPDLSFSEVTSAVVR------QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 259 G~il~~llt--g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
|+++|+|++ +..||...+..+....... .......+..+++.+.++|.+||+.+|.+||++++|++.|+
T Consensus 218 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 218 GVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 999999988 6678887766554443321 11112334557899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.40 Aligned_cols=247 Identities=28% Similarity=0.474 Sum_probs=206.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||.|++|.||+|.+ +++.+++|.+...... .....+.+|+.+++.++|+||+++.+++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--------DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--------hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC
Confidence 4799999999999999999965 6789999998643211 11234678999999999999999999877654
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++++||+++++|.+++.. ..+++..++.++.|++.++.+||+.+++|+||+|+||+++.
T Consensus 73 ~~----------------~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 133 (274)
T cd06609 73 KL----------------WIIMEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE 133 (274)
T ss_pred eE----------------EEEEEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 33 679999999999999853 37899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 134 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~- 212 (274)
T cd06609 134 EGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK- 212 (274)
T ss_pred CCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-
Confidence 9999999999997665443344445678889999999988899999999999999999999999987665544443333
Q ss_pred CCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRPEIPRC-CPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+.++.. ++.++.+++.+||..+|++||++.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 213 NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 333444444 7899999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=296.79 Aligned_cols=239 Identities=24% Similarity=0.385 Sum_probs=192.8
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
+.||+|+||.||+|.. ++..||+|+++.... ......+.+.+|..++.++ +||+|+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~--- 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV------HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL--- 71 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE---
Confidence 4699999999999965 578899999964321 1112234577888988888 799999999988765554
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+++++|..++.. ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++
T Consensus 72 -------------~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~k 136 (327)
T cd05617 72 -------------FLVIEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIK 136 (327)
T ss_pred -------------EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEE
Confidence 669999999999988843 45799999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC------hhHHHHHHHh
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS------FSEVTSAVVR 286 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~------~~~~~~~~~~ 286 (355)
|+|||.+..............|+..|+|||.+.+..++.++||||||+++|+|++|..||.... ..........
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 216 (327)
T cd05617 137 LTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL 216 (327)
T ss_pred EeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH
Confidence 9999998743333333344678999999999999999999999999999999999999996422 1222222222
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
.....++..++..+.++|.+||+.||.+|+++
T Consensus 217 -~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 217 -EKPIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -hCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 22334677789999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=289.29 Aligned_cols=246 Identities=25% Similarity=0.406 Sum_probs=206.7
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|++|.||++.+ +++.+|+|++..... ......+.+.+|+++++++.||||+++++++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI------VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence 4799999999999999999966 578999999853221 11223456888999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. +++|||+++++|.+++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.
T Consensus 75 ~~----------------~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~ 136 (290)
T cd05580 75 NL----------------YLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS 136 (290)
T ss_pred eE----------------EEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC
Confidence 44 669999999999999854 367999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.++|+|||.+...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+...
T Consensus 137 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 213 (290)
T cd05580 137 DGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG 213 (290)
T ss_pred CCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 999999999998755433 23346788999999998888899999999999999999999999887765555555432
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
...++..++..+.++|.+||..||.+|+ ++++++.
T Consensus 214 --~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 214 --KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 3456677899999999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.99 Aligned_cols=249 Identities=27% Similarity=0.457 Sum_probs=206.2
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||.|++|.||+|.+ ++..+++|++...... ..+.+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---------DFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---------hHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 6899999999999999999965 5788999999643321 1345778999999999999999999886655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. +++|||+++++|.+++... ...+++..++.++.|++.+|.|||+.|++|+||+|+||+++.
T Consensus 74 ~~----------------~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 136 (262)
T cd06613 74 KL----------------WIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE 136 (262)
T ss_pred EE----------------EEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC
Confidence 44 6799999999999988643 356999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC---CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+........
T Consensus 137 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~ 216 (262)
T cd06613 137 DGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI 216 (262)
T ss_pred CCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999987554433333445678889999999776 7889999999999999999999999887765555544
Q ss_pred HhcCCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRPE---IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
........ .....+.++.+++.+||..+|.+||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 217 SKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 44322221 22345788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=283.09 Aligned_cols=252 Identities=32% Similarity=0.624 Sum_probs=206.9
Q ss_pred cCCcceeecccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
...+|++.+.||.|++|.||++.+. +..+++|.+...... ...+.+|++++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----------EEDFIEEAQVMMKLSHPKLVQLYGVCTER 71 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----------HHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence 4578999999999999999999764 788999988543221 12367899999999999999999987765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... +++|||+++++|.+++... ...+++..++.++.|++.++++||+.|++|+||+|+||+++
T Consensus 72 ~~~----------------~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~ 134 (256)
T cd05112 72 SPI----------------CLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG 134 (256)
T ss_pred Cce----------------EEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc
Confidence 544 6699999999999988543 34588999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~ 284 (355)
.++.++|+|||.+........ .......+..|+|||.+.++.++.++|+||||+++|+|++ |..||...........+
T Consensus 135 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05112 135 ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI 214 (256)
T ss_pred CCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 999999999999874432211 1122334568999999998889999999999999999998 99999887766655554
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
.. ......+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 215 ~~-~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 215 NA-GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred hC-CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 33 2333445567899999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=290.43 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=200.9
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||.|+||.||+|.+ ++..||+|.++....... ...+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--------PCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--------hhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 46899999999999999999965 578899999864432211 12356799999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... +++|||++ ++|..++... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus 77 ~~~----------------~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~ 138 (301)
T cd07873 77 KSL----------------TLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN 138 (301)
T ss_pred CeE----------------EEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC
Confidence 544 67999996 5888887543 45689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
.++.++|+|||.+..............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+.
T Consensus 139 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~ 218 (301)
T cd07873 139 ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF 218 (301)
T ss_pred CCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999998754433333344567889999999865 457889999999999999999999998776655443332
Q ss_pred hcCCC--------------------C--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLR--------------------P--------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~--------------------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..... + .....+++.+.++|.+||+.||.+|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 219 RILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 21000 0 011346888999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=282.59 Aligned_cols=251 Identities=29% Similarity=0.505 Sum_probs=208.6
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|+..+.||+|++|.||+|.. ++..|++|.+......... ....+.+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTG----QEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccc----hHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence 578889999999999999966 5899999998654432221 2223457889999999999999999998766544
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++++||+++++|.+++.. ...+++..++.++.|++.+|++||+.|++|+||+|+||+++.+
T Consensus 77 ~----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~ 138 (258)
T cd06632 77 L----------------YIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN 138 (258)
T ss_pred E----------------EEEEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 4 669999999999999854 3468999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+.++|+|||.+....... ......++..|++||.+.... ++.++|+||||+++|+|++|..||...............
T Consensus 139 ~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 217 (258)
T cd06632 139 GVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS 217 (258)
T ss_pred CCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc
Confidence 999999999987544332 233456788899999988766 889999999999999999999999877655555554443
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+.++..+++.+.+++.+||+.+|.+||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 4455667778999999999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=290.02 Aligned_cols=256 Identities=30% Similarity=0.547 Sum_probs=202.0
Q ss_pred CCcceeecccccccceEEEEEEEC------------------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhh
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLYD------------------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 110 (355)
.++|++.+.||+|+||.||++.+. +..+|+|++..... ......+.+|+.+++.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~E~~~l~~ 75 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--------KNARNDFLKEIKIMSR 75 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--------HHHHHHHHHHHHHHHh
Confidence 468999999999999999988532 33589998853221 1223457889999999
Q ss_pred CCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc---------ccccHHHHHHHHHHH
Q 018489 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---------RKLAFKVVVQLALDL 181 (355)
Q Consensus 111 l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------~~~~~~~~~~i~~qi 181 (355)
++|+||+++++++...+.. +++|||+++++|.+++..... ..+++..++.++.|+
T Consensus 76 l~~~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 139 (296)
T cd05095 76 LKDPNIIRLLAVCITSDPL----------------CMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQI 139 (296)
T ss_pred CCCCCcceEEEEEecCCcc----------------EEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHH
Confidence 9999999999988765544 669999999999999865321 246788999999999
Q ss_pred HHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHH
Q 018489 182 ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFG 259 (355)
Q Consensus 182 ~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 259 (355)
+.||+|||++|++|+||||+||+++.++.++|+|||.+........ .......+..|++||...++.++.++|+||||
T Consensus 140 ~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG 219 (296)
T cd05095 140 ASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 219 (296)
T ss_pred HHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHH
Confidence 9999999999999999999999999999999999999875432211 11112345679999998888899999999999
Q ss_pred HHHHHHHh--CCCCCCCCChhHHHHHHHh---c---CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 260 ICLWEIYC--CDMPYPDLSFSEVTSAVVR---Q---NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 260 ~il~~llt--g~~p~~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
+++|+|++ |..||...+..+....... . ......+..+++.+.+++.+||+.||.+||++.+|++.|+.
T Consensus 220 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 220 VTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 99999998 7789977665554432211 1 11123345678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=287.97 Aligned_cols=259 Identities=30% Similarity=0.599 Sum_probs=207.7
Q ss_pred cCCcceeecccccccceEEEEEEEC------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
...+|++.+.||+|+||.||++..+ +..+|+|++...... ...+.+.+|+..++.+.|+||+++++
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~ei~~l~~l~~~~i~~~~~ 73 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--------QHRSDFEREIEILRTLDHENIVKYKG 73 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--------HHHHHHHHHHHHHHhCCCCChheEEe
Confidence 3467889999999999999999753 678999998643321 22355889999999999999999998
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++...+. .+.+++|||+++++|.+++... ...+++..++.++.|++.||.+||++|++|+||+|+
T Consensus 74 ~~~~~~~--------------~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ 138 (284)
T cd05038 74 VCEKPGG--------------RSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAAR 138 (284)
T ss_pred eeecCCC--------------CceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 8765332 2337899999999999999653 235999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCC---CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
||+++.++.++|+|||.+......... .....++..|++||.+.+..++.++|+||||+++++|++|..|+......
T Consensus 139 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 218 (284)
T cd05038 139 NILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE 218 (284)
T ss_pred hEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccch
Confidence 999999999999999999765422111 11223455799999998888999999999999999999999998653221
Q ss_pred --------------HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 279 --------------EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 279 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
...............+..++.++.+++.+||+.+|.+||++.+|+++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 219 FLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred hccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 122233333344445566789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=290.10 Aligned_cols=250 Identities=27% Similarity=0.460 Sum_probs=203.5
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||.|+||.||+|.+ ++..+++|.+.... . ...+.+.+|+.+++.++|+||+++++.+...
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-----~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----E----EELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-----H----HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 46799999999999999999965 57889999985322 1 1234577899999999999999999988655
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ++||||+++++|..++... ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++
T Consensus 82 ~~~----------------~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~ 144 (292)
T cd06644 82 GKL----------------WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT 144 (292)
T ss_pred CeE----------------EEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc
Confidence 443 6799999999998877543 45689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
.++.++|+|||.+..............++..|+|||.+. ...++.++|+||||+++|+|++|..||...+.....
T Consensus 145 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 224 (292)
T cd06644 145 LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 224 (292)
T ss_pred CCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH
Confidence 999999999998865433333334456788999999985 345678999999999999999999999877655544
Q ss_pred HHHHhcCC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
........ ....+..++.++.++|.+||+.+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 225 LKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 44433222 11234567889999999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=299.93 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=192.6
Q ss_pred cccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC---CCCccceeeeeccCCcccccc
Q 018489 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 58 lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
||+|+||.||+|.+ ++..||+|++...... .......+..|..++... +||||+++++.+...+..
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~--- 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV------AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL--- 71 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh------hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE---
Confidence 79999999999965 5889999998532111 011112234455666554 799999999988776655
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+++++|.+++. ....+++..++.++.||+.||+|||++|++|+||||+|||++.++.++
T Consensus 72 -------------~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~k 136 (330)
T cd05586 72 -------------YLVTDYMSGGELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIA 136 (330)
T ss_pred -------------EEEEcCCCCChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEE
Confidence 56999999999998885 346799999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 291 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~ 291 (355)
|+|||++..............|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+.......
T Consensus 137 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 216 (330)
T cd05586 137 LCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF 216 (330)
T ss_pred EecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999987543333333445789999999998764 57899999999999999999999998887777666655443321
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCC----CHHHHHH
Q 018489 292 EIPRCCPSSLANVMKRCWDANPDKRP----EMDEVVS 324 (355)
Q Consensus 292 ~~~~~~~~~l~~li~~~l~~~p~~Rp----s~~ell~ 324 (355)
....+++++.++|.+||+.||.+|| ++.++++
T Consensus 217 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 -PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1234789999999999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=284.54 Aligned_cols=259 Identities=26% Similarity=0.561 Sum_probs=211.8
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCc----eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
+...+|++.+.||+|+||.||+|.+ ++. .+++|....... ......+.+|+.++..++||||++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 75 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--------PKANKEILDEAYVMASVDHPHVVRLL 75 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4567899999999999999999964 333 588998754321 22234577899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++.. .. .+++|||+++++|.+++... ...+++..++.++.|++.||+|||+.|++|+||+|
T Consensus 76 ~~~~~-~~----------------~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p 137 (279)
T cd05057 76 GICLS-SQ----------------VQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAA 137 (279)
T ss_pred EEEec-Cc----------------eEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCc
Confidence 98764 22 26799999999999998654 34589999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCCCC--CCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPNDM--TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
+||+++.++.++|+|||.+.......... ....++..|+|||.+....++.++|+||||+++|++++ |..||...+.
T Consensus 138 ~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 138 RNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred ceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 99999999999999999987554322211 11223567999999988889999999999999999998 9999998877
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
.+....+.. ......+..++..+.+++.+||..+|.+||++.++++.|+++...
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 218 VEIPDLLEK-GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHHHhC-CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 666555543 334455666789999999999999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=292.49 Aligned_cols=248 Identities=25% Similarity=0.453 Sum_probs=204.9
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
..+|++.+.||.|++|.||++.+ ++..||+|.+....... .+.+.+|+.+++.++|+||+++++++...
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---------KELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---------HHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 37899999999999999999965 68999999986433211 23467899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++||||+++++|.+++.. ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++
T Consensus 89 ~~~----------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~ 149 (297)
T cd06656 89 DEL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149 (297)
T ss_pred CEE----------------EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 544 669999999999998843 4588999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..........
T Consensus 150 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~ 229 (297)
T cd06656 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229 (297)
T ss_pred CCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc
Confidence 99999999999987544333333345678899999999998899999999999999999999999977654433322222
Q ss_pred cC-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QN-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.. .....+..+++.+.++|.+||+.+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 122244567889999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=289.78 Aligned_cols=249 Identities=29% Similarity=0.480 Sum_probs=205.8
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||.|++|.||++.+ ++..+++|++..... ...+.+.+|+.+++.++||||+++++.+....
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE---------EELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH---------HHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence 5799999999999999999976 578999999853321 11245778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++... ...+++..++.++.|++.+|.|||+.|++|+||+|+||+++.
T Consensus 76 ~~----------------~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~ 138 (280)
T cd06611 76 KL----------------WILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL 138 (280)
T ss_pred eE----------------EEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC
Confidence 44 6699999999999988543 356999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
++.++|+|||.+..............++..|++||.+. ...++.++|+||||+++|+|++|+.||...+......
T Consensus 139 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~ 218 (280)
T cd06611 139 DGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL 218 (280)
T ss_pred CCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH
Confidence 99999999998875544333334456788999999875 3457789999999999999999999998877666555
Q ss_pred HHHhcCC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+..... ....+..++.++.++|.+||+.+|.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 219 KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 5443322 12234567899999999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=288.49 Aligned_cols=248 Identities=28% Similarity=0.447 Sum_probs=202.8
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
-|++.+.||.|+||.||++.+ ++..+++|.+.... . ...+.+.+|+++++.++||||+++++++...+.
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-----~----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 76 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-----E----EELEDYMVEIDILASCDHPNIVKLLDAFYYENN 76 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-----H----HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE
Confidence 368899999999999999976 46778999884322 1 113457789999999999999999998876544
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+++++|..++.. ...++++..++.++.|++.+|.|||+.|++|+||+|+||+++.+
T Consensus 77 ~----------------~~v~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~ 139 (282)
T cd06643 77 L----------------WILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD 139 (282)
T ss_pred E----------------EEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC
Confidence 4 679999999999988754 34579999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
+.++|+|||.+..............++..|+|||.+. +..++.++|+||+|+++|+|++|..||...+..+....
T Consensus 140 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 219 (282)
T cd06643 140 GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219 (282)
T ss_pred CCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH
Confidence 9999999999875543333334456888999999984 34577899999999999999999999988776665555
Q ss_pred HHhcCC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...... ....+..++.++.++|.+||+.+|.+||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 220 IAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 544322 22345567899999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=295.18 Aligned_cols=255 Identities=21% Similarity=0.380 Sum_probs=196.3
Q ss_pred eeecccccc--cceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 53 VIKSVIARG--TFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 53 ~i~~~lg~G--~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+++++||+| +|++||++.+ +++.||+|.+...... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~ 73 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-------NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 73 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-------HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCE
Confidence 357889999 6789999854 6899999998543211 1123457789999999999999999999876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.+
T Consensus 74 ~----------------~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~ 137 (327)
T cd08227 74 L----------------WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 137 (327)
T ss_pred E----------------EEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC
Confidence 4 669999999999999976555669999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCC-------CCCCCCCcccccCCcccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 209 RTVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
+.+++.||+.......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......
T Consensus 138 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 217 (327)
T cd08227 138 GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217 (327)
T ss_pred CcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 9999999986542221111 0112345678999999976 458899999999999999999999997655433
Q ss_pred HHHHHHhcCCC--------------------------------------------CCCCCCCcHHHHHHHHHhhhcCCCC
Q 018489 280 VTSAVVRQNLR--------------------------------------------PEIPRCCPSSLANVMKRCWDANPDK 315 (355)
Q Consensus 280 ~~~~~~~~~~~--------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~ 315 (355)
........... ......+++++.++|.+||+.||++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 297 (327)
T cd08227 218 MLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDA 297 (327)
T ss_pred HHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchh
Confidence 33222211100 0011235678999999999999999
Q ss_pred CCCHHHHHH--HHHHhH
Q 018489 316 RPEMDEVVS--MLEAID 330 (355)
Q Consensus 316 Rps~~ell~--~l~~~~ 330 (355)
|||++++++ .++.+.
T Consensus 298 Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 298 RPSASTLLNHSFFKQIK 314 (327)
T ss_pred cCCHHHHhcChhhhhcc
Confidence 999999987 455443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=295.71 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=202.7
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||++.+ ++..||+|++.... .........+.+|..++..++|++|+++++++...+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE------MLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH------HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 4799999999999999999965 57889999985321 111122344778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||++|++|.+++... ...+++..+..++.|++.||.|||++||+|+||||+||+++.
T Consensus 75 ~~----------------~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~ 137 (331)
T cd05624 75 YL----------------YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM 137 (331)
T ss_pred EE----------------EEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC
Confidence 44 6699999999999999643 356899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 208 NRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
++.++|+|||.+........ ......|+..|+|||.+.+ +.++.++|+||||+++|+|++|+.||...+..+..
T Consensus 138 ~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~ 217 (331)
T cd05624 138 NGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217 (331)
T ss_pred CCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH
Confidence 99999999999875443222 1223468999999999875 45788999999999999999999999888777766
Q ss_pred HHHHhcCCCCCCC---CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 018489 282 SAVVRQNLRPEIP---RCCPSSLANVMKRCWDANPDK--RPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~--Rps~~ell~ 324 (355)
..+........++ ..++.++.++|.+||..++.+ |++++++++
T Consensus 218 ~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 218 GKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 6665544333333 346899999999999866544 457888775
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=278.86 Aligned_cols=246 Identities=34% Similarity=0.647 Sum_probs=201.0
Q ss_pred cccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccccccc
Q 018489 56 SVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTE 134 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~ 134 (355)
+.||+|+||.||+|.. ++..+|+|+++.... ......+.+|+++++.++||||+++++++...+..
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----- 67 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--------QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPI----- 67 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC--------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCcc-----
Confidence 3689999999999964 567899998753321 11234578899999999999999999988765544
Q ss_pred cccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEe
Q 018489 135 NGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214 (355)
Q Consensus 135 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~ 214 (355)
+++|||+++++|.+++... ...+++..++.++.|++.+|.++|+.|++|+||+|+||+++.++.++|+
T Consensus 68 -----------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~ 135 (250)
T cd05085 68 -----------YIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKIS 135 (250)
T ss_pred -----------EEEEECCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEEC
Confidence 6799999999999988543 3458999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCCCCC-CCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCC
Q 018489 215 DFGVARVEASNPNDM-TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPE 292 (355)
Q Consensus 215 Dfg~a~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~ 292 (355)
|||.+.......... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||...........+. ......
T Consensus 136 d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~ 214 (250)
T cd05085 136 DFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMS 214 (250)
T ss_pred CCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 999986433221111 11233567999999998889999999999999999998 999998876665555443 344445
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 293 IPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 293 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
.+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 66678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=294.40 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=204.0
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||++.. ++..+|+|++.... .........+.+|..++..++|++|+++++.+...+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE------MLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH------HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 4799999999999999999966 46789999984311 111222345778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++... ...+++..++.++.||+.||.|||+.|++||||||+||+++.
T Consensus 75 ~~----------------~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~ 137 (332)
T cd05623 75 NL----------------YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 137 (332)
T ss_pred EE----------------EEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC
Confidence 44 6699999999999999643 346899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 208 NRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
++.++|+|||.+........ ......|+..|+|||.+. ...++.++||||||+++|+|++|+.||...+..+..
T Consensus 138 ~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~ 217 (332)
T cd05623 138 NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217 (332)
T ss_pred CCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999864432222 222356899999999986 345788999999999999999999999988877777
Q ss_pred HHHHhcCCCCCCC---CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 018489 282 SAVVRQNLRPEIP---RCCPSSLANVMKRCWDANPDK--RPEMDEVVSM 325 (355)
Q Consensus 282 ~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~--Rps~~ell~~ 325 (355)
..+........++ ..+++++.++|++||..++.+ |+++.++++-
T Consensus 218 ~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 218 GKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 7766554333333 357899999999999665444 6889988875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=281.13 Aligned_cols=249 Identities=28% Similarity=0.508 Sum_probs=207.3
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||+|++|.||++.. ++..+++|.+....... .....+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-------DERLAAQNECQVLKLLSHPNIIEYYENFLEDKA 73 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-------HHHHHHHHHHHHHhhCCCCchhheeeeEecCCE
Confidence 589999999999999999855 68889999986443211 113457889999999999999999988765444
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++||||+++++|.+++.......+++..++.++.+++.+|.+||++|++|+||+|+||+++.+
T Consensus 74 ~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 137 (256)
T cd08220 74 L----------------MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137 (256)
T ss_pred E----------------EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 3 679999999999999976555668999999999999999999999999999999999999855
Q ss_pred C-cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 209 R-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 209 ~-~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+ .++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||...+.......+...
T Consensus 138 ~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08220 138 KMVVKIGDFGISKILSSKS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG 216 (256)
T ss_pred CCEEEEccCCCceecCCCc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc
Confidence 4 57999999987554332 223356788999999999888899999999999999999999999887766655555443
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
. ...++..++.++.+++.+||+.+|.+|||+.+++.
T Consensus 217 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 217 T-FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred C-CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 2 33456678999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=281.22 Aligned_cols=250 Identities=36% Similarity=0.692 Sum_probs=206.5
Q ss_pred ceeecccccccceEEEEEEECC------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 52 LVIKSVIARGTFGTVHRGLYDG------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
+++.+.||.|+||.||++.+.. ..+|+|.+....... ..+.+.+|+.++..++|+||+++++++..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--------QIEEFLREARIMRKLDHPNIVKLLGVCTE 72 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--------HHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 4678899999999999997654 789999985432210 23457889999999999999999998877
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. +++|||+++++|.+++.......+++..++.++.|++.+|++||+.|++|+||+|+||++
T Consensus 73 ~~~~----------------~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~ 136 (258)
T smart00219 73 EEPL----------------MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 136 (258)
T ss_pred CCee----------------EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE
Confidence 6544 669999999999999965444339999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCC-CCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMT-GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~ 283 (355)
+.++.++|+|||.+........... ...++..|+|||.+.+..++.++|+|+||+++++|++ |..||...+.......
T Consensus 137 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~ 216 (258)
T smart00219 137 GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY 216 (258)
T ss_pred ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999875543311111 2236678999999988889999999999999999998 8899988777666665
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
..... ....+..++.++.+++.+||+.+|.+|||+.++++.|
T Consensus 217 ~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 LKKGY-RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HhcCC-CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 55443 3445566899999999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=285.45 Aligned_cols=261 Identities=28% Similarity=0.444 Sum_probs=204.2
Q ss_pred cceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFI 120 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~ 120 (355)
.+....++|++.+.||+|+||.||++.+ +++.+++|++..... ....+.+|+.+++.+ +||||++++
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----------~~~~~~~e~~~l~~l~~h~~i~~~~ 81 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----------IDEEIEAEYNILKALSDHPNVVKFY 81 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----------hHHHHHHHHHHHHHHhcCCCeeeee
Confidence 3444568999999999999999999965 678999998743211 013366789999999 799999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++...... ..+..+++|||+++++|.+++... ....+++..++.++.|++.+|.|||+.+++|+||
T Consensus 82 ~~~~~~~~~-----------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 150 (286)
T cd06638 82 GMYYKKDVK-----------NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDV 150 (286)
T ss_pred eeeeecccC-----------CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Confidence 987432110 123457899999999999987532 3456899999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYP 273 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~lltg~~p~~ 273 (355)
+|+||+++.++.++|+|||.+..............++..|+|||.+.. ..++.++|+||+|+++|+|++|+.||.
T Consensus 151 kp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~ 230 (286)
T cd06638 151 KGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230 (286)
T ss_pred CHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence 999999999999999999998755433333344568899999998853 457889999999999999999999998
Q ss_pred CCChhHHHHHHHhcC-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 274 DLSFSEVTSAVVRQN-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 274 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
............... .....+..++..+.++|.+||+.||++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 231 DLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 765544433322221 1112344567899999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=285.96 Aligned_cols=244 Identities=28% Similarity=0.506 Sum_probs=196.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|++|.||+|.+ ++..||+|++..... ....+.+.+|+.++.+++||||+++++++...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--------VELQKQIMSELEILYKCDSPYIIGFYGAFFVEN 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC
Confidence 4788999999999999999975 678899999864321 112345788999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. +++|||+++++|..+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 73 ~~----------------~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~ 130 (279)
T cd06619 73 RI----------------SICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT 130 (279)
T ss_pred EE----------------EEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC
Confidence 44 569999999999654 24788899999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh-------HH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-------EV 280 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~-------~~ 280 (355)
++.++|+|||.+...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ..
T Consensus 131 ~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 208 (279)
T cd06619 131 RGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL 208 (279)
T ss_pred CCCEEEeeCCcceecccc--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH
Confidence 999999999998754322 223357888999999999988999999999999999999999999653221 11
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
...+.............++++.++|.+||+.+|++||+++++++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 209 LQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111111111234478899999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=280.16 Aligned_cols=255 Identities=27% Similarity=0.477 Sum_probs=208.9
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
+.+|++.+.||+|++|.||++.+ ++..+++|.+......... ......+.+|+.++++++|+||+++++++...
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 76 (264)
T cd06653 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQET----SKEVNALECEIQLLKNLRHDRIVQYYGCLRDP 76 (264)
T ss_pred CCceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchh----hHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence 36899999999999999999965 6889999987543221111 12234688999999999999999999987654
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.. +..++++||+++++|.+++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++
T Consensus 77 ~~--------------~~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~ 140 (264)
T cd06653 77 EE--------------KKLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD 140 (264)
T ss_pred CC--------------CEEEEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 32 223679999999999999853 34589999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCC---CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 207 KNRTVKIADFGVARVEASN---PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
.++.++|+|||.+...... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 220 (264)
T cd06653 141 SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK 220 (264)
T ss_pred CCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH
Confidence 9999999999998754321 1112234578899999999988889999999999999999999999988766666665
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.......+.++..+++++.++|.+||+ +|..||++.+++.
T Consensus 221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 555555667788899999999999998 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=280.07 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=220.1
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
.+-.++|.++++||+|+||.|.+++. +++.+|+|++++...-... +.+ .-..|-++|+..+||.+..+...|
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd--EVA----HTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD--EVA----HTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehH--Hhh----hhhhHHHHHHhccCcHHHHhhhhh
Confidence 44457999999999999999999954 7899999999765443222 111 234688999999999999887777
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...+.+ |+||||..||.|.-.+ .+.+.+++.....+...|+.||.|||+++|++||||.+|+
T Consensus 238 Qt~drl----------------CFVMeyanGGeLf~HL--srer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENL 299 (516)
T KOG0690|consen 238 QTQDRL----------------CFVMEYANGGELFFHL--SRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENL 299 (516)
T ss_pred ccCceE----------------EEEEEEccCceEeeeh--hhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhh
Confidence 765554 8899999999998877 4567799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
+++.+|++|+.|||++.-.-..+......+||+.|+|||++..+.|+.+.|.|.+|+++|+|++|++||...+.+.....
T Consensus 300 lLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL 379 (516)
T KOG0690|consen 300 LLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL 379 (516)
T ss_pred eeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH
Confidence 99999999999999998777777777789999999999999999999999999999999999999999999988888887
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC--CHHHHHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP--EMDEVVSMLE 327 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp--s~~ell~~l~ 327 (355)
+...... +|..++++...|+..+|.+||.+|. ..+++.+...
T Consensus 380 Il~ed~k--FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 380 ILMEDLK--FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HHhhhcc--CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 7776554 8899999999999999999999996 4555555444
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=280.50 Aligned_cols=249 Identities=32% Similarity=0.531 Sum_probs=203.6
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||+|++|.||++.. ++..+++|+++..... ....+.+.+|+.+++.++|+||+++++.+...+.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-------PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK 73 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-------hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE
Confidence 689999999999999999965 6789999998754432 2234558899999999999999999998765544
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++++||+++++|.+++.. ...+++..++.++.+++.+|.+||+.|++|+||+|+||+++.+
T Consensus 74 ~----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~ 135 (264)
T cd06626 74 V----------------YIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN 135 (264)
T ss_pred E----------------EEEEecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 4 669999999999999853 3458999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCC----CCCCcccccCCcccCCCC---CCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 209 RTVKIADFGVARVEASNPNDMT----GETGTLGYMAPEVLNGNP---YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
+.++|+|||.+........... ...++..|+|||.+.+.. ++.++|||++|++++++++|..||.........
T Consensus 136 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~ 215 (264)
T cd06626 136 GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI 215 (264)
T ss_pred CCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH
Confidence 9999999999876544332221 245778999999998765 889999999999999999999999776443333
Q ss_pred HHHHhcCCCCCCCCC--CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRPEIPRC--CPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.........+.++.. ++..+.++|.+||+.+|.+||++.+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 216 MFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 333333333444444 4899999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=285.94 Aligned_cols=248 Identities=29% Similarity=0.488 Sum_probs=206.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
..|+..+.||.|+||.||+|.+ ++..||+|++..... ......+.+|+.+++++.|+||+++++++....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT 75 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 5688999999999999999976 578999999863221 111345788999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++. ..++++..+..++.|++.+|.+||+.+++|+||+|+||+++.
T Consensus 76 ~~----------------~lv~e~~~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~ 136 (277)
T cd06640 76 KL----------------WIIMEYLGGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE 136 (277)
T ss_pred EE----------------EEEEecCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC
Confidence 44 67999999999999884 346899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+ ..
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~ 215 (277)
T cd06640 137 QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PK 215 (277)
T ss_pred CCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hc
Confidence 99999999999875543332333346778899999999888999999999999999999999999876655444332 23
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
...+.+...++..+.++|.+||+.+|.+||++.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 33445566678999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=286.90 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=195.8
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||.|++|.||+|.+ +|+.+++|.++....... ....+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~-------~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-------VPSSALREICLLKELKHKNIVRLYDVLHSDKK 73 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc-------CccchhHHHHHHHhcCCCCeeeHHHHhccCCc
Confidence 589999999999999999976 688999999865432211 11235679999999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++++||++ ++|.+++... ...+++..++.++.||++||.|||++|++|+||+|+||+++.+
T Consensus 74 ~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~ 135 (284)
T cd07839 74 L----------------TLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135 (284)
T ss_pred e----------------EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC
Confidence 4 66999996 5788777543 4569999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCC-CCCChhHHHHHHHh
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPY-PDLSFSEVTSAVVR 286 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~-~~~~~~~~~~~~~~ 286 (355)
+.++|+|||.+..............++..|+|||.+.+. .++.++||||||+++|+|++|..|+ .+.+..+....+..
T Consensus 136 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 215 (284)
T cd07839 136 GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 215 (284)
T ss_pred CcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHH
Confidence 999999999987544333333445678899999998764 4688999999999999999998885 44443333332221
Q ss_pred cCC------------------CC---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNL------------------RP---------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... .. .....+++++.++|.+||+.||.+|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 216 LLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 100 00 112346789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=284.12 Aligned_cols=256 Identities=29% Similarity=0.448 Sum_probs=206.0
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 125 (355)
.++|++.+.||.|++|.||+|.+ ++..+++|++..... ..+.+.+|+.+++.+ .|+||+++++++..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----------EEEEIKEEYNILRKYSNHPNIATFYGAFIK 74 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----------hHHHHHHHHHHHHHhcCCCChheEEEEEEe
Confidence 47899999999999999999976 568899999864321 123477899999999 79999999998876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.... ......+++|||+++++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 75 ~~~~----------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni 144 (275)
T cd06608 75 KNPP----------GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNI 144 (275)
T ss_pred cCCC----------CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence 4431 01334578999999999999986543 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++||||||+++|+|++|..||......
T Consensus 145 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 224 (275)
T cd06608 145 LLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224 (275)
T ss_pred EEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH
Confidence 9999999999999998755443333444568889999998754 34678899999999999999999999876555
Q ss_pred HHHHHHHhcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 279 EVTSAVVRQNLRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 279 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.....+....... ..+..++.++.++|.+||..||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 225 RALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 5444443322211 122336789999999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=284.90 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=200.8
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|++|.||+|.+ ++..|++|++........ ..+.+.+|+.++++++|+||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV-------IKKIALREIRMLKQLKHPNLVNLIEVFRRKR 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc-------ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC
Confidence 4799999999999999999976 578999999864332111 1234678999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. +++|||+++++|..++. ....+++..++.++.|++.+|.|||+.|++|+||+|+||+++.
T Consensus 74 ~~----------------~~v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~ 135 (286)
T cd07847 74 KL----------------HLVFEYCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK 135 (286)
T ss_pred EE----------------EEEEeccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC
Confidence 44 56999999988887763 3456999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+..
T Consensus 136 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (286)
T cd07847 136 QGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK 215 (286)
T ss_pred CCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999999999765544333344567788999999876 4578899999999999999999999987765544433322
Q ss_pred cCC--------------------CCC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNL--------------------RPE---------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~--------------------~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... .+. ....++..+.++|.+||+.+|++||++.+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 216 TLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 100 000 01245788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=286.61 Aligned_cols=247 Identities=29% Similarity=0.492 Sum_probs=204.8
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
..|++.+.||.|++|.||+|.+ ++..||+|.+..... ....+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--------EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--------hHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 4688889999999999999965 578899999853321 112356789999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++. ...+++..++.++.|++.++.|||++|++|+||+|+||+++.
T Consensus 76 ~~----------------~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~ 136 (277)
T cd06642 76 KL----------------WIIMEYLGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE 136 (277)
T ss_pred ce----------------EEEEEccCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC
Confidence 44 67999999999999883 356899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||........... ...
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~ 215 (277)
T cd06642 137 QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-IPK 215 (277)
T ss_pred CCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-hhc
Confidence 9999999999987554333233334578889999999998899999999999999999999999976554443333 223
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+.+...++.++.++|.+||+.+|++||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 216 NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 3344455667899999999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=282.28 Aligned_cols=253 Identities=30% Similarity=0.540 Sum_probs=205.3
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||+|++|.||++.+ +++.+++|++....... .......+.+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS---SEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCc---hhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe
Confidence 488899999999999999965 78899999986433221 1222345668899999999999999999998876655
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+++++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.+
T Consensus 78 ~----------------~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~ 139 (268)
T cd06630 78 F----------------NLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139 (268)
T ss_pred E----------------EEEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 4 569999999999999854 3568999999999999999999999999999999999999876
Q ss_pred C-cEEEeeccccccccCCCCC----CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH--
Q 018489 209 R-TVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT-- 281 (355)
Q Consensus 209 ~-~v~L~Dfg~a~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~-- 281 (355)
+ .++|+|||.+......... .....++..|+|||.+.+..++.++|+|+||+++++|++|..||.........
T Consensus 140 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 219 (268)
T cd06630 140 GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL 219 (268)
T ss_pred CCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH
Confidence 5 5999999998755432111 12245778999999998888899999999999999999999999754432222
Q ss_pred -HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 -SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.........+.++..+++++.+++.+||+.+|.+||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 220 IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 2222334455667778999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=279.62 Aligned_cols=251 Identities=34% Similarity=0.580 Sum_probs=197.0
Q ss_pred cccccccceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccc
Q 018489 56 SVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 130 (355)
+.||+|+||.||+|.+. +..+|+|.+..... . ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~----~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 70 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD----L----EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG-- 70 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC----H----HHHHHHHHHHHHHccCCCCCcceEEEEeecCCC--
Confidence 46899999999999642 35699998742211 1 113457789999999999999999986653222
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~ 210 (355)
..+++|||+.+++|.+++... ....++..+..++.|++.||.|||+.+++|+||+|+||+++.++.
T Consensus 71 -------------~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~ 136 (262)
T cd05058 71 -------------SPLVVLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT 136 (262)
T ss_pred -------------CcEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc
Confidence 236799999999999998643 334677888999999999999999999999999999999999999
Q ss_pred EEEeeccccccccCCC----CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhC-CCCCCCCChhHHHHHHH
Q 018489 211 VKIADFGVARVEASNP----NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 211 v~L~Dfg~a~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg-~~p~~~~~~~~~~~~~~ 285 (355)
++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++| ..||...+.........
T Consensus 137 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~ 216 (262)
T cd05058 137 VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL 216 (262)
T ss_pred EEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 9999999987433211 111223456689999999888899999999999999999995 66777666555444433
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
. ......+..+++.+.+++.+||+.+|++||++.++++.|+++..
T Consensus 217 ~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 217 Q-GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred c-CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 3 33344556678999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=281.99 Aligned_cols=249 Identities=32% Similarity=0.569 Sum_probs=198.8
Q ss_pred cccccccceEEEEEEEC--Cc--eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCcccc
Q 018489 56 SVIARGTFGTVHRGLYD--GH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~ 130 (355)
+.||+|+||.||+|.+. +. .+++|.++.... . ...+.+.+|+.++.++ +||||+++++++...+..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~----~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~- 71 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS----K----DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL- 71 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC----H----HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCc-
Confidence 46899999999999763 33 468887752211 1 1123477899999999 899999999988765443
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+.|++|+
T Consensus 72 ---------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~ 136 (270)
T cd05047 72 ---------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 136 (270)
T ss_pred ---------------eEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 67999999999999986532 1347899999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 018489 197 DVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (355)
Q Consensus 197 di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~ 275 (355)
||+|+||+++.++.++|+|||++...... ........+..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 137 dikp~nili~~~~~~kl~dfgl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 137 DLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred ccccceEEEcCCCeEEECCCCCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 99999999999999999999998532211 11111233567999999988889999999999999999997 99999877
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
+..+....+.. ......+..++.++.+++.+||+.+|.+||++.+++..|+.+.
T Consensus 216 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 216 TCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CHHHHHHHHhC-CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 66665554433 3344456667899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=283.57 Aligned_cols=256 Identities=28% Similarity=0.410 Sum_probs=204.0
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeecc
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 124 (355)
..++|.+.+.||+|+||.||++.. +++.+++|++..... ....+.+|+.++..+ +|||++++++++.
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----------~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----------VDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----------HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 457899999999999999999965 678999999853211 123356788889888 8999999999886
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
..+.. .....+++|||+++++|.+++... ....+++..++.++.|++.+|++||+.|++|+||+|+|
T Consensus 90 ~~~~~-----------~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~n 158 (291)
T cd06639 90 KADKL-----------VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNN 158 (291)
T ss_pred ecccc-----------CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 54321 123457899999999999988542 34578999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-----PYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~lltg~~p~~~~~~ 277 (355)
|+++.++.++|+|||.+..............++..|+|||.+... .++.++|+||||+++|+|++|+.||.....
T Consensus 159 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 159 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred EEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 999999999999999987554333333345678899999998643 367899999999999999999999987765
Q ss_pred hHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 278 SEVTSAVVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 278 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
......+..... ....+...+..+.++|.+||+.+|++||++.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 239 VKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 554444333211 11224456788999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=281.88 Aligned_cols=260 Identities=22% Similarity=0.467 Sum_probs=209.6
Q ss_pred cceeecccccccceEEEEEEEC---CceeEEEEeecCCCCCccH-HHHHHHHHHHHHHHHHHhh-CCCCccceeeeeccC
Q 018489 51 KLVIKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTE-AEIAALRSAFTQEVAVWHK-LDHPNVTKFIGATMG 125 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~~---~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~ 125 (355)
.|++.+.||+|+||.||+|.+. +..+++|.+.......... .........+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4889999999999999999764 5789999886443322110 1112223446678887765 699999999998876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCc
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTEN 202 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~di~p~N 202 (355)
.+.. +++|||+++++|.+++... ....+++..++.++.|++.+|.+||+ .|++|+||+|+|
T Consensus 81 ~~~~----------------~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~n 144 (269)
T cd08528 81 NDRL----------------YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNN 144 (269)
T ss_pred CCeE----------------EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHH
Confidence 5544 6799999999999988542 34568999999999999999999996 689999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
|+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||..........
T Consensus 145 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~ 223 (269)
T cd08528 145 IMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT 223 (269)
T ss_pred EEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH
Confidence 999999999999999997544332 3344567889999999998889999999999999999999999998776666555
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
.+......+.....+++++.++|.+||+.||++||++.|+..+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 555544443334467899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=283.97 Aligned_cols=250 Identities=25% Similarity=0.420 Sum_probs=200.8
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||.|++|.||+|.+ ++..|+||.+........ ....+.+|++++++++||||+++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-------VPSTAIREISLLKELNHPNIVKLLDVIHTENK 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc-------cchHHHHHHHHHHhcCCCCCcchhhhcccCCc
Confidence 488999999999999999976 678999998864332111 12347789999999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+. ++|..++.......+++..++.++.|++.||+|||+.|++|+||+|+||+++.+
T Consensus 74 ~----------------~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~ 136 (284)
T cd07860 74 L----------------YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 136 (284)
T ss_pred E----------------EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 4 66999995 689888876556779999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+.++|+|||.+..............++..|+|||.+.+.. ++.++|+||||+++|+|+||+.||...+...........
T Consensus 137 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 216 (284)
T cd07860 137 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 216 (284)
T ss_pred CCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 9999999999875543333334445678899999887644 588999999999999999999999876655444333321
Q ss_pred CCCC---------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRP---------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+ .....+++++.++|.+||+.||.+||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 217 LGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 1110 012346788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=296.40 Aligned_cols=245 Identities=27% Similarity=0.428 Sum_probs=193.8
Q ss_pred cCCcceeecccccccceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
...+|++.+.||.|+||.||++.. ++..|++|.+.... ...+|+.+++.++||||+++++++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------------~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------------TPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------------cHHHHHHHHHhcCCCCccceeeeE
Confidence 345799999999999999999864 34679999874321 145799999999999999999887
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...... |++||++. ++|.+++ .....+++..++.|+.|++.||.|||++||+||||||+||
T Consensus 156 ~~~~~~----------------~lv~e~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Ni 216 (392)
T PHA03207 156 RWKSTV----------------CMVMPKYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENI 216 (392)
T ss_pred eeCCEE----------------EEEehhcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 654433 67999994 6888888 3446799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh---
Q 018489 204 LLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS--- 278 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~--- 278 (355)
|++.++.++|+|||++....... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+....
T Consensus 217 ll~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~ 296 (392)
T PHA03207 217 FLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296 (392)
T ss_pred EEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH
Confidence 99999999999999987544322 1223457899999999999989999999999999999999999999664321
Q ss_pred HHHHHHHhc-------------------------CCCC--CCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 279 EVTSAVVRQ-------------------------NLRP--EIP-----RCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 279 ~~~~~~~~~-------------------------~~~~--~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
..+..+... ...+ ..+ ...+.++.++|++||..||++||++.+++..
T Consensus 297 ~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111111110 0000 001 2346789999999999999999999999873
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.82 Aligned_cols=256 Identities=22% Similarity=0.331 Sum_probs=207.2
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||++.+ ++..|++|.+..... ........+.+|+++++.++||||+++++.+...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL------ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh------hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence 4799999999999999999965 568899998853221 11223345778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. +++|||++|++|.+++.. ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.
T Consensus 75 ~~----------------~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~ 136 (305)
T cd05609 75 HL----------------CMVMEYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS 136 (305)
T ss_pred EE----------------EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC
Confidence 44 669999999999999954 356899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCC---------------CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 018489 208 NRTVKIADFGVARVEASNPN---------------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~ 272 (355)
++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf 216 (305)
T cd05609 137 MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216 (305)
T ss_pred CCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999998763211100 011234677899999998888999999999999999999999999
Q ss_pred CCCChhHHHHHHHhcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 273 PDLSFSEVTSAVVRQNLRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
.+.+..+............ .....+++++.++|.+||+.+|++||+..++++.|+.-
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 217 FGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred CCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 8877776666655543322 22335789999999999999999999977777776664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=277.21 Aligned_cols=246 Identities=34% Similarity=0.664 Sum_probs=201.0
Q ss_pred cccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccccccc
Q 018489 56 SVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTE 134 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~ 134 (355)
+.||.|++|.||++.+. +..|++|.+...... .....+.+|+.+++++.|+||+++++++......
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----- 67 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPI----- 67 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCe-----
Confidence 46899999999999664 899999988543321 1234578899999999999999999987765544
Q ss_pred cccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEe
Q 018489 135 NGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214 (355)
Q Consensus 135 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~ 214 (355)
+++|||+++++|.+++... ...+++..++.++.+++.+|.+||++|++|+||+|+||+++.++.++|+
T Consensus 68 -----------~~v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~ 135 (251)
T cd05041 68 -----------YIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKIS 135 (251)
T ss_pred -----------EEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEe
Confidence 6699999999999998643 3468899999999999999999999999999999999999999999999
Q ss_pred eccccccccCCCCCC--CCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC
Q 018489 215 DFGVARVEASNPNDM--TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRP 291 (355)
Q Consensus 215 Dfg~a~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~ 291 (355)
|||.+.......... .....+..|+|||.+.++.++.++|+||||+++|+|++ |..||...........+. .....
T Consensus 136 d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~ 214 (251)
T cd05041 136 DFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRM 214 (251)
T ss_pred eccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCC
Confidence 999987543221111 11223457999999988889999999999999999999 889998776655444443 23344
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 292 EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 292 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
..+...+.++.+++.+||..+|.+||++.++++.|+
T Consensus 215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 456678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=279.99 Aligned_cols=247 Identities=26% Similarity=0.469 Sum_probs=204.9
Q ss_pred CcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||.|++|.||++.+. +..+++|.+.... . .+.+.+|+.+++.++|+||+++++.+....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-------D----LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-------H----HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 68999999999999999999763 6889999984321 1 356889999999999999999999887654
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++++||+++++|.+++.. ....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.
T Consensus 72 ~~----------------~l~~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~ 134 (256)
T cd06612 72 DL----------------WIVMEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE 134 (256)
T ss_pred cE----------------EEEEecCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC
Confidence 44 679999999999999854 3457899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.++|+|||.+..............++..|+|||.+.+..++.++||||+|+++|+|++|+.||...+.......+...
T Consensus 135 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~ 214 (256)
T cd06612 135 EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK 214 (256)
T ss_pred CCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC
Confidence 99999999999876544333333455788999999999988999999999999999999999999876655444333221
Q ss_pred C-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 N-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
. .....+..++.++.++|.+||+.||.+||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 215 PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1 111233456789999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=287.69 Aligned_cols=248 Identities=27% Similarity=0.505 Sum_probs=199.0
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||++.+ ++..+++|.+..... ......+.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--------PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 4799999999999999999976 578899998853211 122345778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEc
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENMLLD 206 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~di~p~Nili~ 206 (355)
.. +++|||+++++|.+++.. ...+++..+..++.|++.+|.|||+ .+++|+||+|+||+++
T Consensus 73 ~~----------------~lv~ey~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~ 134 (308)
T cd06615 73 EI----------------SICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134 (308)
T ss_pred EE----------------EEEeeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe
Confidence 44 679999999999999854 3668999999999999999999997 5999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..........
T Consensus 135 ~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 212 (308)
T cd06615 135 SRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212 (308)
T ss_pred cCCcEEEccCCCccccccc--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcC
Confidence 9999999999988644322 12335678899999999888899999999999999999999999975543322211110
Q ss_pred -----------------------------------cCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 287 -----------------------------------QNLRPEIP-RCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 287 -----------------------------------~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
....+..+ ..++.++.++|.+||..+|++||++.++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111111 2367889999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=278.87 Aligned_cols=248 Identities=29% Similarity=0.532 Sum_probs=208.0
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||.|++|.||+|.+ ++..|++|.+...... ...+.+.+|+..+..++|+||+++++++....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--------EFRKQLLRELKTLRSCESPYVVKCYGAFYKEG 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC
Confidence 4689999999999999999966 4889999998643321 22455888999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEc
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENMLLD 206 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~di~p~Nili~ 206 (355)
.. +++|||+++++|.+++... ..+++..++.++.|++.++.+||+ .|++|+||+|+||+++
T Consensus 73 ~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~ 134 (264)
T cd06623 73 EI----------------SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134 (264)
T ss_pred eE----------------EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC
Confidence 44 6699999999999999543 679999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---hhHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS---FSEVTSA 283 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~---~~~~~~~ 283 (355)
.++.++|+|||.+..............++..|+|||.+.+..++.++|+|+||+++|+|++|..||.... ..+....
T Consensus 135 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 214 (264)
T cd06623 135 SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA 214 (264)
T ss_pred CCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH
Confidence 9999999999998765443333334567889999999998889999999999999999999999997764 3333333
Q ss_pred HHhcCCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEIPRC-CPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+. .......+.. ++..+.++|.+||..+|.+||++.++++
T Consensus 215 ~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 215 IC-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred Hh-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 33 3334445555 8899999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=274.87 Aligned_cols=248 Identities=23% Similarity=0.403 Sum_probs=203.9
Q ss_pred Ccceee-cccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccC
Q 018489 50 SKLVIK-SVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (355)
Q Consensus 50 ~~y~i~-~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 125 (355)
++|.|- ++||-|-.|.|..+. .+++.+|+|++... ....+|+++--.. .|||||.++++|..
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 667664 579999999999884 57999999998532 2255788776555 89999999999875
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.-.. ...+.+|||.++||.|...+.......|++.++..|++||..|+.|||+.+|.||||||+|+|+
T Consensus 127 s~~~------------rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLy 194 (400)
T KOG0604|consen 127 SYQG------------RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLY 194 (400)
T ss_pred hccC------------ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheee
Confidence 4332 4566899999999999999988878889999999999999999999999999999999999999
Q ss_pred cC---CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh----h
Q 018489 206 DK---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF----S 278 (355)
Q Consensus 206 ~~---~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~----~ 278 (355)
.. +..+||+|||+|..... .......+.|+.|.|||++....|+...|+||+|+++|-|++|+.||..... .
T Consensus 195 t~t~~na~lKLtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp 273 (400)
T KOG0604|consen 195 TTTSPNAPLKLTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273 (400)
T ss_pred ecCCCCcceEecccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh
Confidence 64 45799999999975443 4455667889999999999999999999999999999999999999976543 2
Q ss_pred HHHHHHHhcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 279 EVTSAVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 279 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.....+....+.. +.+..+|+...++|+.+|..+|.+|.|+.+++.
T Consensus 274 gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 274 GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 3334444443332 223457999999999999999999999998875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=285.70 Aligned_cols=254 Identities=28% Similarity=0.371 Sum_probs=202.1
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||.|++|.||+|.+ +++.||+|.++........ ...+.+|+.++++++|+||+++++++..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI-------PISSLREITLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC-------cchhhHHHHHHHhCCCCCCcceEEEEec
Confidence 357899999999999999999966 5889999998654322111 1124569999999999999999998764
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
... +..++||||+. ++|.+++... ...+++..++.++.|++.+|.|||+.|++|+||+|+||++
T Consensus 78 ~~~--------------~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 141 (309)
T cd07845 78 KHL--------------DSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL 141 (309)
T ss_pred CCC--------------CeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 332 22378999995 5888888643 3569999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.++.++|+|||.+..............++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+
T Consensus 142 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~ 221 (309)
T cd07845 142 TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221 (309)
T ss_pred CCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999765543333333455778999999876 46789999999999999999999999888776666555
Q ss_pred HhcCCCC-----------------CC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRP-----------------EI-----------PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~-----------------~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
......+ .. ....++++.++|.+||+.||++|||+.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 222 IQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred HHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 4421100 00 1124788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=280.31 Aligned_cols=256 Identities=27% Similarity=0.502 Sum_probs=203.8
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCC-ccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGH-RTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
+|.+.+.||.|++|.||+|.. ++..+|+|.++...... ..........+.+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588999999999999999954 68899999886432211 112223334566888999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.
T Consensus 82 ~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~ 143 (272)
T cd06629 82 YL----------------SIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA 143 (272)
T ss_pred ce----------------EEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC
Confidence 44 5699999999999998543 57899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCC--CCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 208 NRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
++.++|+|||.+....... .......++..|+|||.+.... ++.++|+||||++++++++|..||...+.......
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 223 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223 (272)
T ss_pred CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH
Confidence 9999999999987543221 1122345778899999987654 78999999999999999999999976555444433
Q ss_pred HHhcCCCCCC----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEI----PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.........+ ...++.++.++|.+||+.+|.+||+++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 3322222222 2346899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=285.84 Aligned_cols=252 Identities=25% Similarity=0.509 Sum_probs=203.8
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
+..++|++.+.||+|++|.||++.+ ++..+++|++..... ....+.+.+|+++++.++||||+++++++.
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 73 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--------SSVRKQILRELQIMHECRSPYIVSFYGAFL 73 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--------chHHHHHHHHHHHHHHcCCCCcceEeeeEe
Confidence 4557899999999999999999976 488999998864321 122455788999999999999999999887
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENM 203 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~di~p~Ni 203 (355)
..... ++||||+++++|.+++.. .+.+++..+..++.+++.+|.|||+ .+++|+||+|+||
T Consensus 74 ~~~~~----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~ni 135 (284)
T cd06620 74 NENNI----------------CMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNI 135 (284)
T ss_pred cCCEE----------------EEEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHE
Confidence 65444 679999999999998854 3568999999999999999999997 5999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh-----
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS----- 278 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~----- 278 (355)
+++.++.++|+|||.+....... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||......
T Consensus 136 l~~~~~~~~l~d~gl~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~ 213 (284)
T cd06620 136 LVNSRGQIKLCDFGVSGELINSI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213 (284)
T ss_pred EECCCCcEEEccCCcccchhhhc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh
Confidence 99999999999999876432221 12346788999999998888999999999999999999999999865432
Q ss_pred ------HHHHHHHhcCCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 279 ------EVTSAVVRQNLRPEIPR-CCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 279 ------~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
+....+.... .+.++. .++.++.++|.+||+.||.+||++.++++...
T Consensus 214 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 214 DPMGILDLLQQIVQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred hhhHHHHHHHHHhhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 2222222221 222222 37889999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=281.25 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=203.8
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||.|+||.||+|.+ ++..|++|++....... ....+.+.+|++++++++||||+++++.+.....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 74 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE------KGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN 74 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc------hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence 589999999999999999976 48999999996432211 1223568889999999999999999988876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++++||+.+++|.+++... ..+++..++.|+.|++++|.|||+.|++|+||+|+||+++.+
T Consensus 75 ~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 136 (258)
T cd05578 75 M----------------YLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ 136 (258)
T ss_pred E----------------EEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC
Confidence 4 6699999999999998543 579999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh--hHHHHHHHh
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF--SEVTSAVVR 286 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~--~~~~~~~~~ 286 (355)
+.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+. .........
T Consensus 137 ~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 215 (258)
T cd05578 137 GHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE 215 (258)
T ss_pred CCEEEeecccccccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc
Confidence 999999999987554332 23345678899999999988899999999999999999999999987664 222222222
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH--HHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM--DEVV 323 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~--~ell 323 (355)
. .....+...+..+.++|.+||+.||.+||+. .+++
T Consensus 216 ~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 216 T-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred c-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1 4445667789999999999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.89 Aligned_cols=250 Identities=25% Similarity=0.470 Sum_probs=206.8
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|.+.+.||.|++|.||++.. ++..+++|.+........ ..+.+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~ 73 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-------EKEASKKEVILLAKMKHPNIVTFFASFQENGR 73 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch-------hhHHHHHHHHHHHhCCCCChhhhhheeccCCe
Confidence 588999999999999999966 578899999865322111 12346789999999999999999998776554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++++||+++++|.+++.......+++..++.++.|++.+|.|||+.+++|+||+|+||+++.+
T Consensus 74 ~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~ 137 (257)
T cd08225 74 L----------------FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN 137 (257)
T ss_pred E----------------EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC
Confidence 4 679999999999999976555568999999999999999999999999999999999999887
Q ss_pred Cc-EEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 209 RT-VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 209 ~~-v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+. ++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++++|++|..||...+...........
T Consensus 138 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 217 (257)
T cd08225 138 GMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG 217 (257)
T ss_pred CCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence 64 69999999876544333333346788999999998888999999999999999999999999877766655544433
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
........++.++.++|.+||..+|++||++.++++
T Consensus 218 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 218 -YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 233445567899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=277.19 Aligned_cols=250 Identities=30% Similarity=0.539 Sum_probs=211.5
Q ss_pred cceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|.+.+.||.|++|.||++.+. +..+++|.+...... ......+.+|+++++.++|+|++++.+.+.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 73 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-------EKEREDALNEVKILKKLNHPNIIKYYESFEEKGK 73 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-------hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCE
Confidence 5899999999999999999775 889999998644322 1223447789999999999999999998876544
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
. ++++||+++++|.+++.... ...+++..++.++.+++.+|.+||+.|++|+||+|+||+++
T Consensus 74 ~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~ 137 (258)
T cd08215 74 L----------------CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137 (258)
T ss_pred E----------------EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc
Confidence 3 67999999999999986543 46799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+..............++..|+|||.+.+..++.++|+|++|+++++|++|..||...+..........
T Consensus 138 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 217 (258)
T cd08215 138 SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217 (258)
T ss_pred CCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc
Confidence 99999999999987655443333445678899999999888899999999999999999999999988776665555544
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
. ....++..++..+.+++.+||..+|.+||++.++++
T Consensus 218 ~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 218 G-QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 3 344566678999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=284.55 Aligned_cols=259 Identities=25% Similarity=0.592 Sum_probs=207.1
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCc----eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
+..++|++.+.||+|+||.||+|.+ ++. .+|+|.+..... ......+.+|+.+++.++||||++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~h~niv~~~ 75 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--------PKANVEFMDEALIMASMDHPHLVRLL 75 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 3457899999999999999999965 444 468887743221 11123477899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++.... . +++++|+++|+|.+++... ...+++..++.++.|++.+|.|||++|++|+||+|
T Consensus 76 ~~~~~~~-~----------------~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp 137 (303)
T cd05110 76 GVCLSPT-I----------------QLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAA 137 (303)
T ss_pred EEEcCCC-c----------------eeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeecccccc
Confidence 9875432 1 4699999999999998543 34589999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
+||+++.++.++|+|||.+......... .....++..|++||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus 138 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~ 217 (303)
T cd05110 138 RNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217 (303)
T ss_pred ceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999754432221 122334668999999998889999999999999999997 8999987655
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
..... ..........+..++..+.+++..||..+|++||++.++++.|..+...
T Consensus 218 ~~~~~-~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 218 REIPD-LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHH-HHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 44433 3333444445566789999999999999999999999999999998544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=281.77 Aligned_cols=249 Identities=26% Similarity=0.369 Sum_probs=201.1
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||.|++|.||+|.+ ++..|++|++........ ....+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG-------IPNQALREIKALQACQHPYVVKLLDVFPHGSG 73 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccch-------hhHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 589999999999999999975 678999999875443211 12457789999999999999999998876544
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++||||+ +++|.+++... ...+++..++.++.|++.+|.|||+.|++|+||+|+||+++.+
T Consensus 74 ~----------------~~v~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~ 135 (286)
T cd07832 74 F----------------VLVMEYM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD 135 (286)
T ss_pred e----------------EEEeccc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC
Confidence 4 6699999 99999988643 3669999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 209 RTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
+.++|+|||.+....... .......++..|+|||.+.+. .++.++||||+|+++|+|++|..||.+.........+..
T Consensus 136 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~ 215 (286)
T cd07832 136 GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR 215 (286)
T ss_pred CcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHH
Confidence 999999999987554332 123345678899999998654 468999999999999999999888877665544443332
Q ss_pred cCCCC----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRP----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....+ ......+..+.++|.+||+.+|++||+++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 216 TLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11100 011345789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=279.10 Aligned_cols=250 Identities=28% Similarity=0.468 Sum_probs=204.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||.|++|.||+|.. ++..+++|++....... ....+.+|+..++.++|+||+++++.+....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--------SVDELRKEVQAMSQCNHPNVVKYYTSFVVGD 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--------HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC
Confidence 4799999999999999999965 67889999985433211 1345788999999999999999998876554
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.. +++||++++++|.+++..... ..+++..++.++.|++.||++||+.|++|+||+|+||+++
T Consensus 73 ~~----------------~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~ 136 (267)
T cd06610 73 EL----------------WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG 136 (267)
T ss_pred EE----------------EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc
Confidence 44 669999999999999965433 5689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCC----CCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 207 KNRTVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
+++.++|+|||.+......... .....++..|++||.+... .++.++|+||||+++++|++|+.||...+.....
T Consensus 137 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~ 216 (267)
T cd06610 137 EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL 216 (267)
T ss_pred CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH
Confidence 9999999999998755443222 1234578899999998776 7889999999999999999999999877665555
Q ss_pred HHHHhcCCCCCCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRPEIP-----RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
......... .+. ..++..+.+++.+||..||++||++.+|++
T Consensus 217 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 217 MLTLQNDPP-SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHhcCCCC-CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 444443211 111 256889999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=279.25 Aligned_cols=260 Identities=30% Similarity=0.540 Sum_probs=204.4
Q ss_pred ceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 52 LVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
|++.+.||+|+||.||+|.+ ++..+|||++...... .. ..+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~---~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 73 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS---SS----DIEEFLREAACMKEFDHPNVIKLIGVSLRS 73 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC---hH----HHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 67889999999999999964 3578999998543221 11 124477899999999999999999987654
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc----cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
..... ....+++++|+.+++|.+++.... ...+++..++.++.|++.+|+|||++|++|+||+|+|
T Consensus 74 ~~~~~----------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~n 143 (273)
T cd05074 74 RAKGR----------LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARN 143 (273)
T ss_pred CCCCc----------ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhh
Confidence 32110 112367899999999998874322 2247889999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~ 279 (355)
|+++.++.++|+|||.+........ ......++..|++||.+....++.++||||||+++|+|++ |..||...+...
T Consensus 144 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05074 144 CMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223 (273)
T ss_pred EEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH
Confidence 9999999999999999875432211 1122334568999999998888999999999999999999 899998776655
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
....+... .....+...+..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 224 ~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 224 IYNYLIKG-NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 55444433 22334456789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=284.24 Aligned_cols=252 Identities=26% Similarity=0.359 Sum_probs=201.0
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||.|++|.||+|.+ +++.|++|.++....... .......+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA----KDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc----cchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE
Confidence 588999999999999999976 578999999975443211 11223456789999999999999999998876444
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++||||+ +++|.+++.... ..+++..++.++.|+++||.|||++|++|+||+|+||+++.+
T Consensus 77 ~----------------~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~ 138 (298)
T cd07841 77 I----------------NLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD 138 (298)
T ss_pred E----------------EEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC
Confidence 3 6799999 889999985432 369999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+.++|+|||.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+........
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~ 218 (298)
T cd07841 139 GVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA 218 (298)
T ss_pred CCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHH
Confidence 99999999999765544333344456778999998865 46789999999999999999998888776654444333221
Q ss_pred CCCC--------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRP--------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+ ......+..+.++|.+||+.+|.+||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 219 LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 1000 012345788999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=281.17 Aligned_cols=248 Identities=31% Similarity=0.598 Sum_probs=198.9
Q ss_pred cccccccceEEEEEEECC--------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 56 SVIARGTFGTVHRGLYDG--------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
+.||+|++|.||+|.+.. ..+++|.+...... .....+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--------QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE 72 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch--------hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC
Confidence 368999999999996532 56999987532211 11234778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-----cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
.. +++|||+++++|.+++.... ...+++..++.++.|++.+|.|||+.+++|+||+|+|
T Consensus 73 ~~----------------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~n 136 (269)
T cd05044 73 PQ----------------YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARN 136 (269)
T ss_pred Ce----------------EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChhe
Confidence 43 67999999999999996532 2347889999999999999999999999999999999
Q ss_pred EEEcCCC-----cEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 018489 203 MLLDKNR-----TVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPD 274 (355)
Q Consensus 203 ili~~~~-----~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~ 274 (355)
|+++.++ .++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 137 il~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 137 CLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred EEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 9999877 89999999986443221 11122345678999999998889999999999999999998 9999987
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
.+..+....+ ........+..++..+.++|.+||..+|.+||+++++++.|++
T Consensus 217 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 217 LNNQEVLQHV-TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cCHHHHHHHH-hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 7665544443 3333445566789999999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=285.64 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=183.7
Q ss_pred ecccccccceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccc
Q 018489 55 KSVIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 55 ~~~lg~G~~~~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 130 (355)
.+.||+|+||.||+|.+ ++..+|+|.+..... ...+.+|+.++++++||||+++++.+.....
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 72 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----------SMSACREIALLRELKHPNVISLQKVFLSHAD-- 72 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCC--
Confidence 45799999999999974 357899999853321 1225679999999999999999988754332
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhc-------cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...+++|||+. ++|.+++.... ...+++..++.++.||+.||.|||+.|++|+||||+||
T Consensus 73 ------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Ni 139 (317)
T cd07868 73 ------------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANI 139 (317)
T ss_pred ------------cEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHE
Confidence 23478999994 58888775321 23589999999999999999999999999999999999
Q ss_pred EE----cCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 204 LL----DKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 204 li----~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
|+ +.++.++|+|||.+........ ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...
T Consensus 140 l~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 140 LVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred EEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99 4567899999999975543221 2234567899999999877 45889999999999999999999999643
Q ss_pred Chh---------HHHHHHHhcCC-----------------------CC-------------CCCCCCcHHHHHHHHHhhh
Q 018489 276 SFS---------EVTSAVVRQNL-----------------------RP-------------EIPRCCPSSLANVMKRCWD 310 (355)
Q Consensus 276 ~~~---------~~~~~~~~~~~-----------------------~~-------------~~~~~~~~~l~~li~~~l~ 310 (355)
... .....+..... .. ......+.++.++|++||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 299 (317)
T cd07868 220 QEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 299 (317)
T ss_pred cccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhc
Confidence 321 11111111000 00 0011235678999999999
Q ss_pred cCCCCCCCHHHHHH
Q 018489 311 ANPDKRPEMDEVVS 324 (355)
Q Consensus 311 ~~p~~Rps~~ell~ 324 (355)
.||.+|||++|+++
T Consensus 300 ~dP~~R~t~~e~l~ 313 (317)
T cd07868 300 MDPIKRITSEQAMQ 313 (317)
T ss_pred cCcccCCCHHHHhc
Confidence 99999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=278.59 Aligned_cols=242 Identities=25% Similarity=0.369 Sum_probs=201.5
Q ss_pred cccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccccc
Q 018489 58 IARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (355)
Q Consensus 58 lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~ 135 (355)
||.|++|.||++.+. +..+++|++....... ....+.+.+|+.+++.++||||+++++.+......
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------ 68 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE------TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYI------ 68 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh------hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCcc------
Confidence 699999999999875 8999999986432211 12235688999999999999999999987765544
Q ss_pred ccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEee
Q 018489 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (355)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~D 215 (355)
+++|||+++++|.+++.. ...+++..+..++.|++.+|++||+.|++|+||+|+||+++.++.++|+|
T Consensus 69 ----------~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~d 136 (262)
T cd05572 69 ----------YMLMEYCLGGELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVD 136 (262)
T ss_pred ----------EEEEecCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEee
Confidence 669999999999999954 35689999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--hhHHHHHHHhcCCCCCC
Q 018489 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS--FSEVTSAVVRQNLRPEI 293 (355)
Q Consensus 216 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~--~~~~~~~~~~~~~~~~~ 293 (355)
||.+....... ......++..|++||.+.+..++.++|+|++|+++|+|++|..||.... .......+.........
T Consensus 137 f~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 215 (262)
T cd05572 137 FGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF 215 (262)
T ss_pred CCcccccCccc-ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCC
Confidence 99987554332 2233467888999999988889999999999999999999999998766 44555555544455566
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 018489 294 PRCCPSSLANVMKRCWDANPDKRPE-----MDEVVS 324 (355)
Q Consensus 294 ~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 324 (355)
+...++++.++|.+||+.+|.+||+ +.|+++
T Consensus 216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 7777899999999999999999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=268.40 Aligned_cols=255 Identities=25% Similarity=0.444 Sum_probs=205.2
Q ss_pred cccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccce
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTK 118 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~ 118 (355)
.+++..+.++.++++.||.|+.|.|+++.. +|...|||-+...... ++ .+++...+.+.... .+|+||+
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk---ee-----~kRILmDldvv~~s~dcpyIV~ 155 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK---EE-----NKRILMDLDVVLKSHDCPYIVQ 155 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH---HH-----HHHHHHhhhHHhhccCCCeeee
Confidence 555666777888999999999999999965 5689999998654321 11 24455677776666 5999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC-CccccC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRD 197 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~d 197 (355)
.+++|..+....+ .||.| +..++.++. ...+++++..+-++...++.||.||..+ ||+|||
T Consensus 156 c~GyFi~n~dV~I----------------cMelM-s~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH~viHRD 217 (391)
T KOG0983|consen 156 CFGYFITNTDVFI----------------CMELM-STCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 217 (391)
T ss_pred eeeEEeeCchHHH----------------HHHHH-HHHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecc
Confidence 9999999888876 67777 334555554 3456799999999999999999999865 899999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC---CCCCcchhHHHHHHHHHHHhCCCCCCC
Q 018489 198 VKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPD 274 (355)
Q Consensus 198 i~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~~lltg~~p~~~ 274 (355)
+||+|||++..|++||||||++.+..+. .......|.+.|||||.+... .|+.++||||||+++++|.||..||.+
T Consensus 218 vKPSNILlDe~GniKlCDFGIsGrlvdS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 218 VKPSNILLDERGNIKLCDFGISGRLVDS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred cCccceEEccCCCEEeecccccceeecc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 9999999999999999999999865433 444556788999999999764 688999999999999999999999988
Q ss_pred CC-hhHHHHHHHhcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 275 LS-FSEVTSAVVRQNLRPEIPR--CCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 275 ~~-~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+ +.+.+-.+.. ...+.++. .+++.+++++..||++|+.+||.+.++++
T Consensus 297 c~tdFe~ltkvln-~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 297 CKTDFEVLTKVLN-EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCccHHHHHHHHh-cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 54 4455555555 44454443 37999999999999999999999998875
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=283.30 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=199.9
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|++|.||+|.+ ++..||+|.+....... ...+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-------MVKKIAMREIRMLKQLRHENLVNLIEVFRRKK 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-------hhhHHHHHHHHHHHhcCCcchhhHHHhcccCC
Confidence 4799999999999999999976 57899999985433211 12345778999999999999999999887555
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. +++|||+++++|..+.. ....+++..++.++.|++.+|+|||+.|++|+||+|+||+++.
T Consensus 74 ~~----------------~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~ 135 (286)
T cd07846 74 RL----------------YLVFEFVDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135 (286)
T ss_pred eE----------------EEEEecCCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 44 67999999988888764 2345899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
++.++|+|||.+..............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+..
T Consensus 136 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~ 215 (286)
T cd07846 136 SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK 215 (286)
T ss_pred CCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 999999999998765444444444567889999999875 3467899999999999999999999976654333322221
Q ss_pred cCC--------------------CCC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNL--------------------RPE---------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~--------------------~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... .+. ....++..+.+++.+||+.+|++||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 216 CLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 000 12356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=280.77 Aligned_cols=247 Identities=30% Similarity=0.499 Sum_probs=205.5
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
+-|++.+.||.|+||.||+|.+ ++..+|+|.+..... ....+.+.+|+.++..++||||+++++++....
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--------hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 3477889999999999999965 578999998753221 112345788999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++. ...+++..+..++.+++.++.+||+.|++|+||+|+||+++.
T Consensus 76 ~~----------------~lv~e~~~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~ 136 (277)
T cd06641 76 KL----------------WIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 136 (277)
T ss_pred eE----------------EEEEEeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC
Confidence 44 66999999999999884 346899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+ ..
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~ 215 (277)
T cd06641 137 HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-PK 215 (277)
T ss_pred CCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-hc
Confidence 99999999999865443332333346788899999998888899999999999999999999999876655444443 33
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+.+...++.++.++|.+||+.+|.+||++.+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 216 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 3444566678999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=280.26 Aligned_cols=247 Identities=29% Similarity=0.547 Sum_probs=201.3
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||.|++|.||++.+ ++..+++|.+...... ...+.+.+|+.+++.+.||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--------AIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--------HHHHHHHHHHHHHHHCCCCchhhhheeeecCC
Confidence 4688999999999999999976 4788999998643221 22345778999999999999999999877654
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEc
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENMLLD 206 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~di~p~Nili~ 206 (355)
.. ++++||+++++|.+++.... ..+++..++.++.|++.+|.+||+ .|++|+||+|+||+++
T Consensus 73 ~~----------------~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~ 135 (265)
T cd06605 73 DI----------------SICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135 (265)
T ss_pred EE----------------EEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC
Confidence 43 67999999999999986432 678999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-----hhHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS-----FSEVT 281 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~-----~~~~~ 281 (355)
.++.++|+|||.+......... ...++..|+|||.+.+..++.++|+||||+++|+|++|..||.... .....
T Consensus 136 ~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 213 (265)
T cd06605 136 SRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL 213 (265)
T ss_pred CCCCEEEeecccchhhHHHHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH
Confidence 9999999999998654322111 1567788999999999899999999999999999999999997642 22222
Q ss_pred HHHHhcCCCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRPEIPRC-CPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..... ...+..+.. ++.++.++|.+||..+|.+||++.+++.
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 214 QYIVN-EPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHhc-CCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 22222 222333333 7899999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=282.02 Aligned_cols=249 Identities=24% Similarity=0.477 Sum_probs=200.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||++.+ ++..||+|.+.... ... ....+.+|+.++++++|+||+++++.+...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DES----KFNQIIMELDILHKAVSPYIVDFYGAFFIEG 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc----CHH----HHHHHHHHHHHHHhcCCCcHHhhhhheecCC
Confidence 4799999999999999999976 58999999885321 111 1244778999999999999999999877654
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEE
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENMLL 205 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~di~p~Nili 205 (355)
.. +++|||+++++|..++.... ...+++..+..++.|++.+|.|||+ .|++|+||+|+||++
T Consensus 73 ~~----------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~ 136 (286)
T cd06622 73 AV----------------YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV 136 (286)
T ss_pred eE----------------EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE
Confidence 44 66999999999998885421 2368999999999999999999996 599999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC------CCCCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN------PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
+.++.++|+|||.+...... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.......
T Consensus 137 ~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 214 (286)
T cd06622 137 NGNGQVKLCDFGVSGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214 (286)
T ss_pred CCCCCEEEeecCCcccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence 99999999999998654322 22234577789999998654 34789999999999999999999997655444
Q ss_pred HHHHHH--hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 280 VTSAVV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 280 ~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...... .......++..++.++.++|.+||+.+|.+||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 215 IFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 333221 122334566668999999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=280.51 Aligned_cols=246 Identities=28% Similarity=0.523 Sum_probs=200.5
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC---CCccceeeeeccC
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD---HPNVTKFIGATMG 125 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~ 125 (355)
.|++.+.||.|+||.||+|.+ ++..+++|.+....... . .+.+.+|+.+++.+. |||++++++++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~----~----~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~ 73 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD----D----VSDIQREVALLSQLRQSQPPNITKYYGSYLK 73 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch----h----HHHHHHHHHHHHHhccCCCCCeeeEeeeeee
Confidence 588899999999999999975 67899999986432211 1 234667888888886 9999999998775
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.... +++|||+++++|.+++.. ..+++..++.++.|++.+|.+||+.|++|+||+|+||++
T Consensus 74 ~~~~----------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i 134 (277)
T cd06917 74 GPRL----------------WIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134 (277)
T ss_pred CCEE----------------EEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE
Confidence 5444 679999999999998843 378999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 214 (277)
T cd06917 135 TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214 (277)
T ss_pred cCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc
Confidence 99999999999998766544444444568889999998875 45788999999999999999999999876554443322
Q ss_pred HhcCCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRPEIPR-CCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... ..+.++. .++.++.+++.+||+.||.+||++.++++
T Consensus 215 ~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 215 PKS-KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ccC-CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 222 2233333 37889999999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=277.23 Aligned_cols=247 Identities=28% Similarity=0.467 Sum_probs=190.7
Q ss_pred cccccccceEEEEEEEC----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccc
Q 018489 56 SVIARGTFGTVHRGLYD----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~ 131 (355)
+.||+|+||.||+|.+. +..+++|.++.... .. ....+.+|+.++++++||||+++++++......
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~----~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-- 70 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS----VQ----EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPY-- 70 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC----hH----HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCc--
Confidence 36899999999999653 35689998753321 11 123477899999999999999999987765444
Q ss_pred ccccccccCCCCceEEEEEecCCCCHHHHHHhhc---cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
++||||+++++|.+++.... ....++..++.++.|++.||+|||+.|++|+||||+||+++.+
T Consensus 71 --------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~ 136 (269)
T cd05087 71 --------------LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD 136 (269)
T ss_pred --------------EEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC
Confidence 66999999999999986532 2346778888999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCC-------CCCCcchhHHHHHHHHHHHh-CCCCCCCCChh
Q 018489 209 RTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGN-------PYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~il~~llt-g~~p~~~~~~~ 278 (355)
+.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|+|++ |..||......
T Consensus 137 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 216 (269)
T cd05087 137 LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE 216 (269)
T ss_pred CcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH
Confidence 9999999999864432211 12234567789999998642 35789999999999999996 99999877665
Q ss_pred HHHHHHHhcC-C---CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 279 EVTSAVVRQN-L---RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 279 ~~~~~~~~~~-~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
+......... . .+.+....++.+.+++..|+ .+|++|||+++|+..|.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 217 QVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 5443332221 1 12233356788999999998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=278.01 Aligned_cols=250 Identities=31% Similarity=0.498 Sum_probs=199.2
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|.+.+.||.|++|.||++.+ ++..+|+|.+...... .....+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--------DLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--------HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 4789999999999999999976 6789999998643211 22345778999999999999999999876543
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
. +..+++|||+++++|.+++... ....+++..++.++.|++.+|.|||+.|++|+||+|+||++
T Consensus 73 ~--------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~ 138 (287)
T cd06621 73 S--------------SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL 138 (287)
T ss_pred C--------------CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 2 2337899999999999987542 34568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-----hhHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS-----FSEV 280 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~-----~~~~ 280 (355)
+.++.++|+|||.+....... .....++..|++||.+.+..++.++|+|+||+++|+|++|..||.... ..+.
T Consensus 139 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (287)
T cd06621 139 TRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL 216 (287)
T ss_pred ecCCeEEEeeccccccccccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH
Confidence 999999999999986443221 123456778999999998889999999999999999999999997652 1222
Q ss_pred HHHHHhcCCCCCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 281 TSAVVRQNLRPEIP------RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+.. ...+.+. ...++++.++|.+||+.+|.+|||+.|+++
T Consensus 217 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 217 LSYIVN-MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHHhc-CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 222222 1111111 224678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=309.91 Aligned_cols=262 Identities=37% Similarity=0.658 Sum_probs=222.3
Q ss_pred ecCCcceeecccccccceEEEEEEE---CC----ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY---DG----HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~---~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
+........+.||+|.||.||.|.. .+ ..||+|.++.... .. -...|.+|..+++.++||||+++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~----~~----~~~~Fl~Ea~~m~~f~HpNiv~l 760 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS----EQ----EVSDFLKEALLMSKFDHPNIVSL 760 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC----HH----HHHHHHHHHHHHhcCCCcceeeE
Confidence 4467778889999999999999954 23 2388888754321 11 13558899999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-----cccccHHHHHHHHHHHHHHHHHHHhCCcc
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-----RRKLAFKVVVQLALDLARGLSYLHSQKIV 194 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~i~ 194 (355)
+|+..+.... +|++|||+||+|..+|++.+ ...++....+.++.||++++.||+++++|
T Consensus 761 iGv~l~~~~~----------------~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fv 824 (1025)
T KOG1095|consen 761 IGVCLDSGPP----------------LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFV 824 (1025)
T ss_pred EEeecCCCCc----------------EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCc
Confidence 9999886655 45999999999999997642 45689999999999999999999999999
Q ss_pred ccCCCCCcEEEcCCCcEEEeeccccccc-cCCCCCCCCC-CCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCC
Q 018489 195 HRDVKTENMLLDKNRTVKIADFGVARVE-ASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMP 271 (355)
Q Consensus 195 H~di~p~Nili~~~~~v~L~Dfg~a~~~-~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p 271 (355)
||||...|+|++....||++|||+|+.. .......... .....|||||.+..+.++.++||||||+++||++| |..|
T Consensus 825 HRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P 904 (1025)
T KOG1095|consen 825 HRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP 904 (1025)
T ss_pred CcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC
Confidence 9999999999999999999999999832 2222222222 34568999999999999999999999999999998 9999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 272 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
|.+.+..+.+....... +.+.|..+|+.+.+++..||+.+|++||++..|++.+..+....
T Consensus 905 Y~~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 905 YPSRSNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred CCCcchHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 99999999998777777 77889999999999999999999999999999999999886554
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=273.92 Aligned_cols=251 Identities=31% Similarity=0.540 Sum_probs=208.1
Q ss_pred cceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|.+.+.||+|++|.||+|.+. +..+++|++...... ....+.+.+|+.++++++|+||+++++.+....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-------EEELEALEREIRILSSLQHPNIVRYYGSERDEE- 72 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC-
Confidence 5888999999999999999764 889999998654322 223456788999999999999999999887652
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
....++++||+++++|.+++... ..+++..++.++.|++.+|+|||+.|++|+||+|+||+++.+
T Consensus 73 -------------~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~ 137 (260)
T cd06606 73 -------------KNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD 137 (260)
T ss_pred -------------CCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC
Confidence 12236799999999999998643 379999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHHH
Q 018489 209 RTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS-FSEVTSAVV 285 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~-~~~~~~~~~ 285 (355)
+.++|+|||.+........ ......++..|++||.+.+..++.++|+||||+++++|++|..||.... .........
T Consensus 138 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 217 (260)
T cd06606 138 GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG 217 (260)
T ss_pred CCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc
Confidence 9999999999876554432 1344567889999999998889999999999999999999999998766 222223333
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.......++...+..+.++|.+||+.+|.+||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 223445667778999999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=284.21 Aligned_cols=245 Identities=28% Similarity=0.437 Sum_probs=200.1
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
.|.....||.|+||.||++.. ++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+.
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---------QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---------HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 344557799999999999965 68899999874321 1123457889999999999999999998776554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+++++|.+++. ...+++..++.++.|++.+|.|||++|++|+||+|+||+++.+
T Consensus 94 ~----------------~lv~e~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~ 154 (292)
T cd06658 94 L----------------WVVMEFLEGGALTDIVT---HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD 154 (292)
T ss_pred E----------------EEEEeCCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC
Confidence 4 66999999999999873 3468999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 288 (355)
+.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.......+...
T Consensus 155 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~- 233 (292)
T cd06658 155 GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN- 233 (292)
T ss_pred CCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-
Confidence 9999999999865443333333456788999999998888999999999999999999999999877665544443322
Q ss_pred CCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 289 LRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 289 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.... ....++..+.+++.+||..||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 234 LPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred CCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 2222 22346889999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=279.91 Aligned_cols=249 Identities=27% Similarity=0.490 Sum_probs=206.4
Q ss_pred CCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.+.|++.+.||+|++|.||++.+. +..+++|++..... ..+.+.+|+.+++.++|+||+++++.+...
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----------NKELIINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----------hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 467899999999999999999774 88999999864332 234477899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++++||+++++|.+++.... ..+++..++.++.|++.+|++||+.|++|+||+|+||+++
T Consensus 88 ~~~----------------~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~ 150 (286)
T cd06614 88 DEL----------------WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS 150 (286)
T ss_pred CEE----------------EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc
Confidence 544 66999999999999996543 3799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+..............++..|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 151 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~ 230 (286)
T cd06614 151 KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT 230 (286)
T ss_pred CCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 99999999999886544333233334577889999999988899999999999999999999999987766554444433
Q ss_pred cCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..... .....++.++.++|.+||+.+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 231 KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred cCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 32222 122337899999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=279.98 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=198.9
Q ss_pred ceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
|++.+.||.|++|.||+|.+ ++..|++|++........ ....+.+|+.+++.++|||++++++++...+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~ 73 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG-------VPSTAIREISLLKELNHPNIVRLLDVVHSENKL 73 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc-------chhHHHHHHHHHHhcCCCCccCHhheeccCCeE
Confidence 67889999999999999965 689999999865432211 123366799999999999999999988765444
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
+++|||++ ++|.+++.......+++..++.++.|++.+|.|||+.+++|+||+|+||+++.++
T Consensus 74 ----------------~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~ 136 (283)
T cd07835 74 ----------------YLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG 136 (283)
T ss_pred ----------------EEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC
Confidence 67999994 6899988655445799999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 018489 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 210 ~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 288 (355)
.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+....
T Consensus 137 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (283)
T cd07835 137 ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL 216 (283)
T ss_pred cEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999987544333333334567889999988664 56889999999999999999999998766544433332211
Q ss_pred C---------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 289 L---------------------------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 289 ~---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
. .......++.++.++|.+||+.+|.+||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 00123456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=295.73 Aligned_cols=243 Identities=25% Similarity=0.379 Sum_probs=189.8
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
...|.+.+.||+|+||.||++.+ ++..||||.... ..+.+|++++++++|+||+++++++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 56899999999999999999976 467899996421 1245799999999999999999987655
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. +++|+++. ++|..++... ...+++..++.|+.|++.+|.|||++||+|+||||+|||++
T Consensus 233 ~~~----------------~lv~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~ 294 (461)
T PHA03211 233 GLT----------------CLVLPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN 294 (461)
T ss_pred CEE----------------EEEEEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC
Confidence 443 67999994 6888887542 34699999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--------
Q 018489 207 KNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS-------- 276 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~-------- 276 (355)
.++.++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..++....
T Consensus 295 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~ 374 (461)
T PHA03211 295 GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPY 374 (461)
T ss_pred CCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCc
Confidence 999999999999875432211 1223468999999999999999999999999999999999876542211
Q ss_pred hhHHHHHHHhcCCC-CCCC-------------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 277 FSEVTSAVVRQNLR-PEIP-------------------------------RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 277 ~~~~~~~~~~~~~~-~~~~-------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.......+...... ..++ ...+..+.+||.+||+.||.+|||+.|+|+
T Consensus 375 ~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 375 DAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 11222222111110 0000 124568999999999999999999999986
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=279.96 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=194.6
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||.|++|.||+|.+ +++.|++|.+......... ..+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~--------~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP--------FTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCc--------hhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 36899999999999999999965 5789999998654322111 1245799999999999999999988755
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++||||+.+ +|.+++... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus 76 ~~~----------------~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~ 137 (291)
T cd07844 76 KTL----------------TLVFEYLDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS 137 (291)
T ss_pred CeE----------------EEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc
Confidence 444 679999975 899888643 34689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC-hhHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLS-FSEVTSAV 284 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~-~~~~~~~~ 284 (355)
.++.++|+|||.+..............++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.... ..+....+
T Consensus 138 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~ 217 (291)
T cd07844 138 ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217 (291)
T ss_pred CCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence 9999999999998754332233333456788999999876 457889999999999999999999997654 22222221
Q ss_pred HhcCCC-------------------------C---CCCCCCc--HHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLR-------------------------P---EIPRCCP--SSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~-------------------------~---~~~~~~~--~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...... . .....++ ..+.++|.+||+.+|.+||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 110000 0 0001223 78899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=277.37 Aligned_cols=254 Identities=28% Similarity=0.485 Sum_probs=200.4
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
++.+.+.......||+|+||.||+|.+ ++..|++|.+..... . ..+.+.+|+.+++.++|+||++++++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-----~----~~~~~~~e~~~l~~l~h~~iv~~~~~ 73 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-----R----YVQPLHEEIALHSYLKHRNIVQYLGS 73 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-----H----HHHHHHHHHHHHHhcCCCCeeeeeee
Confidence 344555555667899999999999965 567899998753221 1 12457889999999999999999998
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccc--cHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL--AFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~--~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+...+.. ++++||+++++|.+++.... ..+ ++..+..++.|++.||+|||++|++|+||+|
T Consensus 74 ~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p 136 (268)
T cd06624 74 DSENGFF----------------KIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKG 136 (268)
T ss_pred eccCCEE----------------EEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence 8765544 66999999999999986432 334 7888999999999999999999999999999
Q ss_pred CcEEEcC-CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 018489 201 ENMLLDK-NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (355)
Q Consensus 201 ~Nili~~-~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~lltg~~p~~~~~~ 277 (355)
+||+++. ++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.....
T Consensus 137 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~ 216 (268)
T cd06624 137 DNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216 (268)
T ss_pred HHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence 9999976 6799999999987554333333344678899999998664 378899999999999999999999976433
Q ss_pred hH-HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 278 SE-VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 278 ~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.. ...........+.++..+++++.+++.+||+.+|.+||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 217 PQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 22 222222223344567778999999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=281.03 Aligned_cols=252 Identities=29% Similarity=0.397 Sum_probs=200.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||.|++|.||+|.+ ++..+++|.++...... .....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 77 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-------GFPITSLREINILLKLQHPNIVTVKEVVVGSN 77 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-------cchhhHHHHHHHHHhcCCCCEEEEEEEEEecC
Confidence 5799999999999999999976 47889999986543221 11233567999999999999999999876542
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
. +..+++|||+. ++|.+++... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 78 ~--------------~~~~lv~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~ 141 (293)
T cd07843 78 L--------------DKIYMVMEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN 141 (293)
T ss_pred C--------------CcEEEEehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC
Confidence 1 23478999996 4898888543 346999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
++.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+..
T Consensus 142 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (293)
T cd07843 142 RGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK 221 (293)
T ss_pred CCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999999987655443333445678889999998764 468899999999999999999999987765544433322
Q ss_pred cC-----------------------------CCCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QN-----------------------------LRPEIPRC-CPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~-----------------------------~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.. ....++.. +++.+.++|.+||+.+|++|||+.|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 10 01112222 5888999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=283.72 Aligned_cols=249 Identities=25% Similarity=0.448 Sum_probs=203.3
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|.+.+.||+|+||.||++.+ ++..|++|.+...... ..+.+.+|+.+++.++||||+++++.+...
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~ 88 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---------KKELIINEILVMRENKHPNIVNYLDSYLVG 88 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---------HHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence 47899999999999999999964 6788999998532211 124477899999999999999999987765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++|+||+++++|.+++.. ..+++..+..++.|++.+|.+||++|++|+||+|+||+++
T Consensus 89 ~~~----------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~ 149 (293)
T cd06647 89 DEL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 149 (293)
T ss_pred CcE----------------EEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc
Confidence 544 669999999999999843 4588999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+..............++..|++||.+.+..++.++|+||||+++|++++|+.||...+..........
T Consensus 150 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~ 229 (293)
T cd06647 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229 (293)
T ss_pred CCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc
Confidence 99999999999886554433333445678889999999888889999999999999999999999987655443332222
Q ss_pred cC-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 287 QN-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 287 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
.. .....+..++..+.++|.+||..+|++||++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 1112334567899999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=283.26 Aligned_cols=246 Identities=27% Similarity=0.427 Sum_probs=201.0
Q ss_pred ceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
|.....||.|+||.||++.+ ++..|++|.+...... ..+.+.+|+.++..++||||+++++++...+..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---------RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---------hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 44566899999999999965 6889999998543221 123467899999999999999999988765544
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
+++|||+++++|..++. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++
T Consensus 94 ----------------~iv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~ 154 (297)
T cd06659 94 ----------------WVLMEFLQGGALTDIVS---QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG 154 (297)
T ss_pred ----------------EEEEecCCCCCHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC
Confidence 66999999999998773 35689999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC
Q 018489 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 289 (355)
Q Consensus 210 ~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~ 289 (355)
.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..+....+.....
T Consensus 155 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 234 (297)
T cd06659 155 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP 234 (297)
T ss_pred cEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC
Confidence 99999999986544333333445688899999999988899999999999999999999999987665555544332211
Q ss_pred -CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 290 -RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 290 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
.......++..+.++|.+||+.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 235 PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 112334578899999999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=279.08 Aligned_cols=244 Identities=27% Similarity=0.394 Sum_probs=196.0
Q ss_pred cccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccccc
Q 018489 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (355)
Q Consensus 58 lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~ 135 (355)
||+|+||.||++.+ +++.|++|++...... .....+.+.+|+.+++.++||||+++++.+...+..
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~------ 68 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK------KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDL------ 68 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh------hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeE------
Confidence 68999999999964 5889999998643211 112234466899999999999999999888765544
Q ss_pred ccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEee
Q 018489 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (355)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~D 215 (355)
|+||||+++++|.+++.......+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|
T Consensus 69 ----------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~d 138 (277)
T cd05577 69 ----------CLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISD 138 (277)
T ss_pred ----------EEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcc
Confidence 6799999999999998765555799999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh--cCCCCCC
Q 018489 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR--QNLRPEI 293 (355)
Q Consensus 216 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~--~~~~~~~ 293 (355)
||.+..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...........+.. .......
T Consensus 139 fg~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 217 (277)
T cd05577 139 LGLAVELKG-GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY 217 (277)
T ss_pred Ccchhhhcc-CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccC
Confidence 998875432 2223345677889999999888899999999999999999999999977544211111111 1223345
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 294 PRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 294 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
+..+++.+.++|.+||+.+|.+|| ++.+++.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 566799999999999999999999 7777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=287.57 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=200.8
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
..+|++.+.||+|+||.||+|.+ ++..||+|.+...... . .....+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN---V----THAKRAYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC---h----hHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence 47899999999999999999965 6889999998532211 1 1123356799999999999999999987644
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.... .....++||||+. ++|.+.+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 88 ~~~~----------~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~ 152 (353)
T cd07850 88 KSLE----------EFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 152 (353)
T ss_pred CCcc----------ccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence 3210 1234588999995 588887742 289999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+..
T Consensus 153 ~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 231 (353)
T cd07850 153 SDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231 (353)
T ss_pred CCCCEEEccCccceeCCCC-CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999754432 222334578899999999998999999999999999999999999987664443333221
Q ss_pred cCCCC-----------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH-
Q 018489 287 QNLRP-----------------------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS- 324 (355)
Q Consensus 287 ~~~~~-----------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~- 324 (355)
....+ ......++.+.++|.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10000 001134667899999999999999999999996
Q ss_pred -HHHHhHh
Q 018489 325 -MLEAIDT 331 (355)
Q Consensus 325 -~l~~~~~ 331 (355)
.++.-..
T Consensus 312 ~~~~~~~~ 319 (353)
T cd07850 312 PYINVWYD 319 (353)
T ss_pred hhHhhccC
Confidence 4444333
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=271.95 Aligned_cols=248 Identities=30% Similarity=0.530 Sum_probs=208.8
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||+|++|.||++.+ ++..|++|.+...... ......+.+|++++++++|+|++++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS 73 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Confidence 588999999999999999965 5788999999654321 1224568899999999999999999998765443
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus 74 ~----------------~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~ 135 (254)
T cd06627 74 L----------------YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD 135 (254)
T ss_pred E----------------EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC
Confidence 3 6799999999999998543 679999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 288 (355)
+.++|+|||.+..............++..|+|||...+..++.++|+|++|+++++|++|..||...+.......... .
T Consensus 136 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~ 214 (254)
T cd06627 136 GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-D 214 (254)
T ss_pred CCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-c
Confidence 999999999998665544433445678899999999888789999999999999999999999987765544444432 3
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 289 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....++..++..+.++|.+||..+|++||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 334566778999999999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=289.72 Aligned_cols=244 Identities=26% Similarity=0.419 Sum_probs=188.6
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
+...+|++.+.||+|+||.||+|.+ ++..||+|+..... ...|+.+++.++|+||+++++++.
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------------~~~E~~~l~~l~h~~iv~~~~~~~ 127 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------------TLIEAMLLQNVNHPSVIRMKDTLV 127 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------------cHHHHHHHHhCCCCCCcChhheEE
Confidence 3456799999999999999999977 45789999853211 235889999999999999999887
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..... ++||+++. ++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+||+
T Consensus 128 ~~~~~----------------~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nil 189 (357)
T PHA03209 128 SGAIT----------------CMVLPHYS-SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIF 189 (357)
T ss_pred eCCee----------------EEEEEccC-CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence 65444 67999994 588887754 3457999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCC-CCCChh-----
Q 018489 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY-PDLSFS----- 278 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~-~~~~~~----- 278 (355)
++.++.++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|+++..++ ......
T Consensus 190 l~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~ 268 (357)
T PHA03209 190 INDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268 (357)
T ss_pred ECCCCCEEEecCccccccccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHH
Confidence 999999999999998743322 2223456889999999999988999999999999999999865443 322110
Q ss_pred ----HHHHHHHhc-CC-CCCC------------------------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 018489 279 ----EVTSAVVRQ-NL-RPEI------------------------------PRCCPSSLANVMKRCWDANPDKRPEMDEV 322 (355)
Q Consensus 279 ----~~~~~~~~~-~~-~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~el 322 (355)
..+..+... .. ...+ ...++.++.++|.+||+.||.+|||+.|+
T Consensus 269 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~ 348 (357)
T PHA03209 269 KSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEI 348 (357)
T ss_pred HHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHH
Confidence 111111110 00 0000 11346678889999999999999999999
Q ss_pred HH
Q 018489 323 VS 324 (355)
Q Consensus 323 l~ 324 (355)
++
T Consensus 349 l~ 350 (357)
T PHA03209 349 LN 350 (357)
T ss_pred hc
Confidence 86
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=279.71 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=200.0
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|++|.||+|.+ +++.|++|.++..... ......+.+|+++++.+.|+||+++++++...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-------EDVKKTALREVKVLRQLRHENIVNLKEAFRRKG 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-------ccchhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence 4799999999999999999966 5789999998543221 122355788999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. +++|||++++.+..+.. ....+++..++.++.|++.+|.|||+.|++|+||+|+||+++.
T Consensus 74 ~~----------------~iv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~ 135 (288)
T cd07833 74 RL----------------YLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE 135 (288)
T ss_pred EE----------------EEEEecCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC
Confidence 44 66999998866665553 3456899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+......
T Consensus 136 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 215 (288)
T cd07833 136 SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ 215 (288)
T ss_pred CCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999876544332 33345678889999999887 88999999999999999999999998765544333222
Q ss_pred hcC----------------CC--------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQN----------------LR--------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~----------------~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... .. ..++..++.++.++|++||..+|++||+++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 216 KCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 100 00 0122335889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=279.22 Aligned_cols=267 Identities=19% Similarity=0.268 Sum_probs=192.1
Q ss_pred ceecCCcceeecccccccceEEEEEEEC-----CceeEEEEeecCCCCCccHHHH--HHHHHHHHHHHHHHhhCCCCccc
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEI--AALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
.++...+|++.+.||+|+||.||+|.+. +..+++|+..........+... .........+...+..+.|+||+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 4566689999999999999999999764 3467777654333221111100 00111223344556677999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccC
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~d 197 (355)
+++++........ .+.+++++++ ..++.+.+.. ....++..++.|+.|++.+|.|||+++++|||
T Consensus 87 ~~~~~~~~~~~~~------------~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrD 151 (294)
T PHA02882 87 KYYGCGSFKRCRM------------YYRFILLEKL-VENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGD 151 (294)
T ss_pred cEEEeeeEecCCc------------eEEEEEEehh-ccCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9998655433211 1236788887 4467766643 23467888999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccccCCC-------CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCC
Q 018489 198 VKTENMLLDKNRTVKIADFGVARVEASNP-------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM 270 (355)
Q Consensus 198 i~p~Nili~~~~~v~L~Dfg~a~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~ 270 (355)
|||+||+++.++.++|+|||++....... .......||..|+|||.+.+..++.++||||||+++|+|++|+.
T Consensus 152 iKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~ 231 (294)
T PHA02882 152 IKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKL 231 (294)
T ss_pred CCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999987543221 11122468999999999999999999999999999999999999
Q ss_pred CCCCCChhH-HHHH----HHhc-CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 271 PYPDLSFSE-VTSA----VVRQ-NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 271 p~~~~~~~~-~~~~----~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
||....... .... .... ..........++++.+++..|++.+|++||++++|++.|
T Consensus 232 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 232 PWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 998763322 1111 0010 011112345689999999999999999999999999876
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=271.64 Aligned_cols=246 Identities=31% Similarity=0.570 Sum_probs=204.1
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|.+.+.||.|++|.||++.+ ++..+++|++..... ...+.+.+|+.+++.++|+|++++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 588999999999999999977 478899999864332 123457889999999999999999998876544
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++++||+++++|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus 72 ~----------------~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~ 134 (253)
T cd05122 72 L----------------WIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD 134 (253)
T ss_pred E----------------EEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC
Confidence 4 66999999999999985432 578999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 288 (355)
+.++|+|||.+........ .....++..|++||.+.+..++.++|+||||+++|+|++|..||...+.......... .
T Consensus 135 ~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~ 212 (253)
T cd05122 135 GEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-N 212 (253)
T ss_pred CeEEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-c
Confidence 9999999999875543322 3345678899999999988889999999999999999999999987755544444433 2
Q ss_pred CCCCCCCC--CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 289 LRPEIPRC--CPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 289 ~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.....+.. ++..+.++|.+||+.||.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 213 GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22223322 3889999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=286.22 Aligned_cols=278 Identities=23% Similarity=0.345 Sum_probs=212.4
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|++|.||+|.+ ++..||+|.+..... ......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--------QTFCQRTLREIKILRRFKHENIIGILDIIRPP 75 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--------chhHHHHHHHHHHHHhCCCCCcCchhheeecc
Confidence 37899999999999999999965 688999999853211 11234467899999999999999999876543
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... .....++++||+. ++|...+ ....+++..++.++.|++.||.+||+.|++|+||+|+||+++
T Consensus 76 ~~~-----------~~~~~~lv~e~~~-~~l~~~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~ 140 (336)
T cd07849 76 SFE-----------SFNDVYIVQELME-TDLYKLI---KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 140 (336)
T ss_pred ccc-----------ccceEEEEehhcc-cCHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC
Confidence 321 1234578999995 4787776 345799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
.++.++|+|||.+........ ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+......
T Consensus 141 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~ 220 (336)
T cd07849 141 TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN 220 (336)
T ss_pred CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999875433211 1123467888999998754 568899999999999999999999997765433322
Q ss_pred HHHhcCC------------------------CCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHhHh
Q 018489 283 AVVRQNL------------------------RPE-----IPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM--LEAIDT 331 (355)
Q Consensus 283 ~~~~~~~------------------------~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~--l~~~~~ 331 (355)
.+..... ... .....++++.++|.+||+.+|++||++.++++. ++....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 221 LILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 2211000 000 112357889999999999999999999999995 777776
Q ss_pred hcCCCCCCCCCCCcceee
Q 018489 332 SKGGGMIPGDQPQGCLCF 349 (355)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~ 349 (355)
.......+.+.|.+.+..
T Consensus 301 ~~~~~~~~~~~~~~~~~~ 318 (336)
T cd07849 301 PSDEPVAEEPFPFDFELF 318 (336)
T ss_pred CCCcccCCCCCChhhccc
Confidence 666666666777665543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=278.85 Aligned_cols=245 Identities=27% Similarity=0.458 Sum_probs=201.7
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|...+.||.|++|.||++.+ ++..+++|.+..... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---------QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---------hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 456677999999999999965 578899998853221 112346789999999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++++||+++++|.+++.. ..+++..++.++.|++.+|++||+.|++|+||+|+||+++.+
T Consensus 91 ~----------------~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~ 151 (285)
T cd06648 91 L----------------WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD 151 (285)
T ss_pred E----------------EEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC
Confidence 4 669999999999998854 568999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 288 (355)
+.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+...
T Consensus 152 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~- 230 (285)
T cd06648 152 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN- 230 (285)
T ss_pred CcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-
Confidence 9999999998765443333334456888999999999888999999999999999999999999876665555544433
Q ss_pred CCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 289 LRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 289 ~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..... +..++..+.++|.+||+.+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 22222 2337889999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=273.23 Aligned_cols=248 Identities=31% Similarity=0.556 Sum_probs=206.9
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||.|++|.||++.+ ++..+++|.+...... ......+.+|+.+++.++|+||+++.+++.....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-------QKEREDAVNEIRILASVNHPNIISYKEAFLDGNK 73 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-------HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCE
Confidence 589999999999999999965 6788999998643321 1113346679999999999999999988876544
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
. +++|||+++++|.+++.... ...+++..++.++.|++.||++||+.|++|+||+|+||+++
T Consensus 74 ~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~ 137 (256)
T cd08530 74 L----------------CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV 137 (256)
T ss_pred E----------------EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe
Confidence 4 66999999999999986522 35689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+...... ......++..|++||.+.+..++.++|+||||+++++|++|+.||...+.......+..
T Consensus 138 ~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (256)
T cd08530 138 ANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215 (256)
T ss_pred cCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 9999999999998765543 22234578899999999998899999999999999999999999988876655554433
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+..+..++.++.+++.+||+.+|++||++.++++
T Consensus 216 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 216 -GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 3334455678899999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=278.76 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=199.1
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||.|++|.||+|.+ +++.|++|.+....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-------GVPSTAIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-------cchHHHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 5799999999999999999965 57889999986443211 11234678999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||++ ++|.+++.......+++..++.++.||+.||+|||++|++|+||+|+||+++.
T Consensus 75 ~~----------------~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~ 137 (294)
T PLN00009 75 RL----------------YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR 137 (294)
T ss_pred eE----------------EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC
Confidence 44 67999995 58888876554555788999999999999999999999999999999999985
Q ss_pred -CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 208 -NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 208 -~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
++.++|+|||.+..............++..|+|||.+.+. .++.++||||+|+++|+|++|..||...+..+......
T Consensus 138 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~ 217 (294)
T PLN00009 138 RTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF 217 (294)
T ss_pred CCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5679999999997544333333445677899999988764 57889999999999999999999998766555444432
Q ss_pred hcCCCC---------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRP---------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.....+ .....+++++.++|.+||+.+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 218 RILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred HHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 210000 012346788999999999999999999999986
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=274.07 Aligned_cols=238 Identities=24% Similarity=0.419 Sum_probs=186.7
Q ss_pred cccccccceEEEEEEEC--------------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 56 SVIARGTFGTVHRGLYD--------------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
+.||+|+||.||+|... ...+++|++.... ......+.+|+.++..++||||+++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---------~~~~~~~~~~~~~l~~l~hp~iv~~~~ 71 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---------RDISLAFFETASMMRQVSHKHIVLLYG 71 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---------hhHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 46899999999999632 2358888864321 122345778999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++...... +++|||+++++|..++.. ....+++..++.++.|++.||+|||++|++|+||+|+
T Consensus 72 ~~~~~~~~----------------~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 134 (262)
T cd05077 72 VCVRDVEN----------------IMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTK 134 (262)
T ss_pred EEecCCCC----------------EEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcc
Confidence 88765444 569999999999888753 3456899999999999999999999999999999999
Q ss_pred cEEEcCCCc-------EEEeeccccccccCCCCCCCCCCCcccccCCcccC-CCCCCCcchhHHHHHHHHHHH-hCCCCC
Q 018489 202 NMLLDKNRT-------VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-GNPYNRKCDVYSFGICLWEIY-CCDMPY 272 (355)
Q Consensus 202 Nili~~~~~-------v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~ll-tg~~p~ 272 (355)
||+++.++. ++++|||.+...... ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||
T Consensus 135 Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 210 (262)
T cd05077 135 NILLAREGIDGECGPFIKLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210 (262)
T ss_pred cEEEecCCccCCCCceeEeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999986664 899999988644322 2245677899999887 467889999999999999997 588898
Q ss_pred CCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 273 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
......+... ...... ......++++.++|.+||+.||.+||++.+|++.|
T Consensus 211 ~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 211 KDKTLAEKER-FYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCcchhHHHH-HHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 7655443322 112111 22334568899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=277.22 Aligned_cols=249 Identities=26% Similarity=0.418 Sum_probs=199.6
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||.|++|.||+|.+ ++..||+|.++....... .+.+.+|+.++++++|+||+++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT--------PSTAIREISLMKELKHENIVRLHDVIHTENK 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc--------hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc
Confidence 589999999999999999976 588999999875433211 1235679999999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
. +++|||+++ +|.+++.... ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.
T Consensus 73 ~----------------~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~ 135 (284)
T cd07836 73 L----------------MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK 135 (284)
T ss_pred E----------------EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC
Confidence 4 669999975 8888875432 246899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
++.++|+|||.+..............++..|++||.+.+ ..++.++|+|+||+++|+|++|+.||.+.+..+....+..
T Consensus 136 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 215 (284)
T cd07836 136 RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215 (284)
T ss_pred CCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 999999999998754433333344556788999998866 4578899999999999999999999988776655444332
Q ss_pred cCCC----------------CC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLR----------------PE-----------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~----------------~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.... .. +...++..+.++|.+||+.||.+||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 216 IMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1100 00 11245788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=273.21 Aligned_cols=247 Identities=32% Similarity=0.550 Sum_probs=190.8
Q ss_pred cccccccceEEEEEEE-C---CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccc
Q 018489 56 SVIARGTFGTVHRGLY-D---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~ 131 (355)
+.||+|+||.||+|.. . ...+++|.+.... . ......+.+|+..++.++|+||+++++.+......
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~----~----~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~-- 70 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA----T----PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPY-- 70 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC----C----hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCce--
Confidence 3689999999999954 2 3457777664221 1 11124477899999999999999999988765544
Q ss_pred ccccccccCCCCceEEEEEecCCCCHHHHHHhhcc---ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
+++|||+++++|.+++..... ...++..++.++.||+.||+|||+.|++|+||||+||+++.+
T Consensus 71 --------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~ 136 (269)
T cd05042 71 --------------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD 136 (269)
T ss_pred --------------EEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC
Confidence 669999999999999965432 235678889999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCC-------CCCCCcchhHHHHHHHHHHHh-CCCCCCCCChh
Q 018489 209 RTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNG-------NPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~ 278 (355)
+.++|+|||.+........ ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||......
T Consensus 137 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~ 216 (269)
T cd05042 137 LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE 216 (269)
T ss_pred CcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence 9999999999864332211 1122345667999998743 356789999999999999999 78899877766
Q ss_pred HHHHHHHhcCC----CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 279 EVTSAVVRQNL----RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 279 ~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
+.......... .+..+..++..+.+++..|+ .||.+||++++|++.|.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 217 QVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 65555444322 12334567889999999998 69999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=284.05 Aligned_cols=267 Identities=24% Similarity=0.330 Sum_probs=206.5
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+|++.+.||+|++|.||++.+ ++..||||.+........ ....+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 77 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-------DAKRTLREIKLLRHLDHENVIAIKDIMPPPH 77 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccc-------hhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence 6899999999999999999965 688999999864321111 1223567999999999999999998776433
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. .....++++||+. ++|.+++.. ...+++..++.++.|++.||.|||+++++|+||+|+||+++.
T Consensus 78 ~~-----------~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~ 143 (337)
T cd07858 78 RE-----------AFNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA 143 (337)
T ss_pred cc-----------ccCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 11 0123588999995 689888853 457999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+..
T Consensus 144 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 223 (337)
T cd07858 144 NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE 223 (337)
T ss_pred CCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Confidence 999999999998765433333334567889999998765 4688999999999999999999999976554332221111
Q ss_pred cC------------------------C--C---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHhHhhcCC
Q 018489 287 QN------------------------L--R---PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM--LEAIDTSKGG 335 (355)
Q Consensus 287 ~~------------------------~--~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~--l~~~~~~~~~ 335 (355)
.. . . ......+++++.++|.+||+.+|++||++.++++- +..+......
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 224 LLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred HhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 00 0 0 01124578899999999999999999999999985 8777666554
Q ss_pred CC
Q 018489 336 GM 337 (355)
Q Consensus 336 ~~ 337 (355)
..
T Consensus 304 ~~ 305 (337)
T cd07858 304 PV 305 (337)
T ss_pred cc
Confidence 44
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=289.71 Aligned_cols=253 Identities=30% Similarity=0.499 Sum_probs=219.6
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
-......|.+...||+|.|+.|.++.+ ++..||||++.+...+. ..++.+.+|++++..++|||||+++.+
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-------~~~~k~~rev~imk~l~HPnIvkl~~v 123 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-------SKRQKLGREVDIMKSLNHPNIVKLFSV 123 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-------HHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 334457899999999999999999954 79999999996544322 223447899999999999999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
......+ ++||||..+|.+++++.+ ...+.+..+..++.|+++|++|||+++|+|||||++|
T Consensus 124 ~~t~~~l----------------ylV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eN 185 (596)
T KOG0586|consen 124 IETEATL----------------YLVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAEN 185 (596)
T ss_pred eeeccee----------------EEEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhh
Confidence 8876666 559999999999999954 4567779999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
||++.+-+++|+|||++.... .......++|++.|.|||++.+..+ ++..|+|++|+++|.|+.|.+||.+.+..+..
T Consensus 186 ilL~~~mnikIaDfgfS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr 264 (596)
T KOG0586|consen 186 ILLDENMNIKIADFGFSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR 264 (596)
T ss_pred cccccccceeeeccccceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc
Confidence 999999999999999998776 4455667899999999999999765 48899999999999999999999998888877
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
...+...++ ++..++.+..++|+++|-.+|.+|++.+++.+-
T Consensus 265 ~rvl~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 265 PRVLRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred chheeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 777777666 555668899999999999999999999999874
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=277.57 Aligned_cols=249 Identities=28% Similarity=0.453 Sum_probs=205.7
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeeccCC
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGS 126 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~ 126 (355)
++|.+.+.||.|++|.||++.+ ++..|++|++...... .....+.+.+|..+++++. |+||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 74 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI------KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE 74 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc------chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence 4799999999999999999966 6899999998543221 1111245778999999998 99999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. +++|||+++++|.+++.. ...+++..++.|+.|++.+|.+||+.|++|+||+|+||+++
T Consensus 75 ~~~----------------~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~ 136 (280)
T cd05581 75 ENL----------------YFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136 (280)
T ss_pred ceE----------------EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 544 669999999999999954 34799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCC--------------------CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPN--------------------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~--------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll 266 (355)
.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++++
T Consensus 137 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~ 216 (280)
T cd05581 137 KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML 216 (280)
T ss_pred CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHH
Confidence 999999999999875443221 122335678899999998888899999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH----HHHHH
Q 018489 267 CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM----DEVVS 324 (355)
Q Consensus 267 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~ell~ 324 (355)
+|..||...+.......... ....++..+++.+.++|.+||+.+|.+||++ .++++
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 217 TGKPPFRGSNEYLTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred hCCCCCCCccHHHHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 99999988776555544443 3335667789999999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=277.90 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=198.8
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCC
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGS 126 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~ 126 (355)
++|++.+.||+|+||.||+|.+ ++..||+|.++....... ....+.+|+.+++.+ +|+||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 73 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG-------IPPTALREISLLQMLSESIYIVRLLDVEHVE 73 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC-------CchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence 4799999999999999999975 578999999864332111 123467799999999 569999999887654
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc---cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
+.. +....+++|||+++ +|.+++.... ...+++..++.++.||+.||.|||++|++|+||+|+||
T Consensus 74 ~~~-----------~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~ni 141 (295)
T cd07837 74 EKN-----------GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNL 141 (295)
T ss_pred CCC-----------CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHE
Confidence 431 11224789999975 7888876433 24689999999999999999999999999999999999
Q ss_pred EEcC-CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 204 LLDK-NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~-~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
+++. ++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.....
T Consensus 142 l~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~ 221 (295)
T cd07837 142 LVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL 221 (295)
T ss_pred EEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 9998 899999999998754433333334456788999998865 45789999999999999999999999876655444
Q ss_pred HHHHhcCCCC--------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRP--------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+......+ .....++.++.++|.+||..||.+||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 222 LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 3332211000 011346888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=273.27 Aligned_cols=236 Identities=26% Similarity=0.457 Sum_probs=188.1
Q ss_pred cccccccceEEEEEEECCc------------eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 56 SVIARGTFGTVHRGLYDGH------------DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~~~------------~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
+.||+|+||.||+|.+.+. .+++|++...... ...+.+|+.+++.++||||+++++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----------SLAFFETASLMSQLSHKHLVKLYGVC 70 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----------HHHHHHHHHHHHcCCCcchhheeeEE
Confidence 4689999999999976432 3777876432210 34578899999999999999999987
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.. ... +++|||+++++|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||
T Consensus 71 ~~-~~~----------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Ni 132 (259)
T cd05037 71 VR-DEN----------------IMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNI 132 (259)
T ss_pred ec-CCc----------------EEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceE
Confidence 65 333 57999999999999986542 2689999999999999999999999999999999999
Q ss_pred EEcCCC-------cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC--CCCCcchhHHHHHHHHHHHh-CCCCCC
Q 018489 204 LLDKNR-------TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYC-CDMPYP 273 (355)
Q Consensus 204 li~~~~-------~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~llt-g~~p~~ 273 (355)
+++.++ .++|+|||.+..... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.
T Consensus 133 ll~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~ 208 (259)
T cd05037 133 LVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208 (259)
T ss_pred EEecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcc
Confidence 999887 799999999875433 2223456789999999876 78899999999999999999 588887
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
..+.......... . ...+......+.++|.+||..+|.+||++.++++.|
T Consensus 209 ~~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 209 TLSSSEKERFYQD-Q--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred cCCchhHHHHHhc-C--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 7654333332221 1 122233347999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=288.14 Aligned_cols=269 Identities=29% Similarity=0.592 Sum_probs=227.0
Q ss_pred chhhcccccceecCCcceeecccccccceEEEEEEEC----C--ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHh
Q 018489 36 NFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD----G--HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109 (355)
Q Consensus 36 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~----~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 109 (355)
.+-.+.-.++++.-++....+.||.|.||.||.|..+ | -.||||..+.+..... ++.|..|.-+++
T Consensus 375 ty~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--------tekflqEa~iMr 446 (974)
T KOG4257|consen 375 TYSTPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--------TEKFLQEASIMR 446 (974)
T ss_pred cccCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--------HHHHHHHHHHHH
Confidence 3445556678888888899999999999999999763 2 3499999876544322 456899999999
Q ss_pred hCCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHH
Q 018489 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH 189 (355)
Q Consensus 110 ~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 189 (355)
.++||||++++|++.+.. ..||||.++-|.|..++..+ ...++......++.||..||+|||
T Consensus 447 nfdHphIikLIGv~~e~P-----------------~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLe 508 (974)
T KOG4257|consen 447 NFDHPHIIKLIGVCVEQP-----------------MWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLE 508 (974)
T ss_pred hCCCcchhheeeeeeccc-----------------eeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHH
Confidence 999999999999986433 36799999999999999765 345889999999999999999999
Q ss_pred hCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCC-CCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-
Q 018489 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT-GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC- 267 (355)
Q Consensus 190 ~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt- 267 (355)
+++++||||-..|||+.....|||+|||+++...+...... .....+-|||||.++-..++.++|||.||+++|+++.
T Consensus 509 SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~l 588 (974)
T KOG4257|consen 509 SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSL 588 (974)
T ss_pred hhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999997665433222 2335668999999999999999999999999999876
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 268 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 268 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
|..||.+..+.+.+..+.. +.+.+.|+++|+.+..|..+||.++|.+||.+.+|...|..+..
T Consensus 589 GvkPfqgvkNsDVI~~iEn-GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 589 GVKPFQGVKNSDVIGHIEN-GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cCCccccccccceEEEecC-CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 9999999887776655443 55667899999999999999999999999999999998888765
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=296.49 Aligned_cols=242 Identities=29% Similarity=0.503 Sum_probs=204.7
Q ss_pred ccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccccccc
Q 018489 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTE 134 (355)
Q Consensus 57 ~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~ 134 (355)
+||+|+||+||.|++ +...+|||-+...+. .+ .+.+.+|+.+-++++|.|||++.|.+..++.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-----r~----~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~----- 647 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-----RE----VQPLHEEIALHSTLRHKNIVRYLGSVSENGFF----- 647 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc-----hh----hccHHHHHHHHHHHhhHhHHHHhhccCCCCeE-----
Confidence 699999999999976 556688887742221 11 34578899999999999999999998776655
Q ss_pred cccccCCCCceEEEEEecCCCCHHHHHHhhccccc--cHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-CCCcE
Q 018489 135 NGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL--AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD-KNRTV 211 (355)
Q Consensus 135 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~--~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~-~~~~v 211 (355)
-|.||.++||+|.+++... =+++ .++++-.+.+||+++|.|||+..|+|||||-+||+|+ ..|-+
T Consensus 648 -----------kIFMEqVPGGSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvl 715 (1226)
T KOG4279|consen 648 -----------KIFMEQVPGGSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVL 715 (1226)
T ss_pred -----------EEEeecCCCCcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceE
Confidence 4599999999999999653 3445 7899999999999999999999999999999999996 57889
Q ss_pred EEeeccccccccCCCCCCCCCCCcccccCCcccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhcC
Q 018489 212 KIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDL-SFSEVTSAVVRQN 288 (355)
Q Consensus 212 ~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~lltg~~p~~~~-~~~~~~~~~~~~~ 288 (355)
|++|||.+.....-++....+.||..|||||++..+ +|+.++|||||||++.+|.||++||-.. +.......+-.-+
T Consensus 716 KISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK 795 (1226)
T KOG4279|consen 716 KISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK 795 (1226)
T ss_pred EecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee
Confidence 999999999887777777778999999999999754 6889999999999999999999999654 3334444444445
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 289 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+++|..++.+.+++|.+|+.++|.+||++.++|.
T Consensus 796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 567889999999999999999999999999999986
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=276.29 Aligned_cols=238 Identities=25% Similarity=0.439 Sum_probs=188.8
Q ss_pred cccccccceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 56 SVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
+.||.|+||.||+|.+. ...+++|.+.... ....+.+.+|+.+++.+.||||+++++++...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~ 71 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---------RNYSESFFEAASMMSQLSHKHLVLNYGVCVCG 71 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---------HHHHHHHHHHHHHHHhCCCCChhheeeEEEeC
Confidence 46999999999999653 2348888763211 22334577899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ++||||+++++|..++... ...+++..++.++.||+.+|+|||++|++|+||||+||+++
T Consensus 72 ~~~----------------~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~ 134 (258)
T cd05078 72 DES----------------IMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLI 134 (258)
T ss_pred CCc----------------EEEEecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEe
Confidence 544 5699999999999998643 34689999999999999999999999999999999999998
Q ss_pred CCCc--------EEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCC-CCCCCCC
Q 018489 207 KNRT--------VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCD-MPYPDLS 276 (355)
Q Consensus 207 ~~~~--------v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~-~p~~~~~ 276 (355)
.++. ++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|. .||...+
T Consensus 135 ~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~ 210 (258)
T cd05078 135 REEDRKTGNPPFIKLSDPGISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210 (258)
T ss_pred cccccccCCCceEEecccccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc
Confidence 7765 699999988643321 22356778999999986 45789999999999999999984 6666655
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
....... .. ....++...+.++.++|.+||+.+|.+|||+++|++.|
T Consensus 211 ~~~~~~~-~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 211 SQKKLQF-YE--DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHH-HH--ccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 4443322 22 22345566678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=274.83 Aligned_cols=237 Identities=25% Similarity=0.401 Sum_probs=186.3
Q ss_pred ccccccceEEEEEEEC--------------------------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhh
Q 018489 57 VIARGTFGTVHRGLYD--------------------------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110 (355)
Q Consensus 57 ~lg~G~~~~Vy~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 110 (355)
.||+|+||.||+|... ...|++|++... .......+.+|+.+++.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---------~~~~~~~~~~~~~~~~~ 72 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---------HRDIALAFFETASLMSQ 72 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---------HHHHHHHHHHHHHHHhc
Confidence 6999999999998531 134888887421 12233457789999999
Q ss_pred CCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh
Q 018489 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS 190 (355)
Q Consensus 111 l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 190 (355)
++||||+++++++...... ++||||+++++|..++... ...+++..+..++.|++.||+|||+
T Consensus 73 l~h~niv~~~~~~~~~~~~----------------~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~ 135 (274)
T cd05076 73 VSHIHLAFVHGVCVRGSEN----------------IMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED 135 (274)
T ss_pred CCCCCeeeEEEEEEeCCce----------------EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc
Confidence 9999999999988765544 6699999999999888543 4568999999999999999999999
Q ss_pred CCccccCCCCCcEEEcCCC-------cEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHH
Q 018489 191 QKIVHRDVKTENMLLDKNR-------TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICL 262 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~-------~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il 262 (355)
+|++|+||||+||+++..+ .++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++
T Consensus 136 ~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l 211 (274)
T cd05076 136 KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTL 211 (274)
T ss_pred CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHH
Confidence 9999999999999997543 4899999987533221 22346778999998865 5688999999999999
Q ss_pred HHHH-hCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 263 WEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 263 ~~ll-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
|+|+ +|..||......+.... .... ...+...++.+.++|.+||+.+|.+||++.++++.|
T Consensus 212 ~el~~~g~~p~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 212 LEICFDGEVPLKERTPSEKERF-YEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHhCCCCCccccChHHHHHH-HHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 9985 69999987655443322 2221 223444567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=289.33 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=203.5
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
..|.-++.||.|+||.||-|.+ +.+.||||.+...-.... ..+ ..+..|+.+|++++|||++.+.++|....
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~-----EKW-qDIlKEVrFL~~l~HPntieYkgCyLre~ 99 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-----EKW-QDILKEVRFLRQLRHPNTIEYKGCYLREH 99 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccH-----HHH-HHHHHHHHHHHhccCCCcccccceeeccc
Confidence 4577889999999999999965 688999999976544322 222 34667999999999999999999999877
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
..++ ||||| -|+-.|++.- ..+++-+..+..|+.+.+.+|+|||+.+.||||||..|||+++
T Consensus 100 TaWL----------------VMEYC-lGSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse 161 (948)
T KOG0577|consen 100 TAWL----------------VMEYC-LGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSE 161 (948)
T ss_pred hHHH----------------HHHHH-hccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecC
Confidence 6655 99999 5688888764 3567999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
.|.|||.|||.+.... ....++||+.|||||++. .+.|+-++||||||++..+|.-.++|+-..+.-..+.-+
T Consensus 162 ~g~VKLaDFGSAsi~~----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI 237 (948)
T KOG0577|consen 162 PGLVKLADFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 237 (948)
T ss_pred CCeeeeccccchhhcC----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH
Confidence 9999999999987553 234579999999999986 467999999999999999999999997665554444443
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
-............++.+++++..||++-|.+|||.+++++
T Consensus 238 AQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 238 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 3332222234557999999999999999999999988775
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=271.13 Aligned_cols=247 Identities=26% Similarity=0.502 Sum_probs=190.2
Q ss_pred cccccccceEEEEEEE-CC---ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccc
Q 018489 56 SVIARGTFGTVHRGLY-DG---HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~ 131 (355)
+.||+|+||.||++.. ++ ..+++|.+..... ....+.+.+|+.+++.++||||+++++.+......
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~-- 70 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--------SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPY-- 70 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--------hHHHHHHHHHHHHHhccCCcchhheEEEecCCCcc--
Confidence 3699999999999954 33 3455666543211 11134578899999999999999999988765444
Q ss_pred ccccccccCCCCceEEEEEecCCCCHHHHHHhhc--cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
+++|||+++++|.+++.... ....++..++.++.|++.||.|||+.+++|+||+|+||+++.++
T Consensus 71 --------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~ 136 (268)
T cd05086 71 --------------LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL 136 (268)
T ss_pred --------------EEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc
Confidence 67999999999999986532 23467778899999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCC--CCCCCCCCcccccCCcccCC-------CCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhH
Q 018489 210 TVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNG-------NPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (355)
Q Consensus 210 ~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~ 279 (355)
.++|+|||.+....... .......++..|+|||.+.. ..++.++||||||+++|+|++ |..||...+..+
T Consensus 137 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 216 (268)
T cd05086 137 TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE 216 (268)
T ss_pred cEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999875322211 11223456788999998753 235788999999999999997 577998777666
Q ss_pred HHHHHHhcC----CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 280 VTSAVVRQN----LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 280 ~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
......... ..+.+...+++.+.+++..|| .+|++||++++|++.|.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 217 VLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 555544332 223445567889999999999 78999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=318.66 Aligned_cols=250 Identities=29% Similarity=0.446 Sum_probs=214.2
Q ss_pred CcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
-+++-...||.|.||.||.|. ++|+..|+|-++..+.. ....+.+.+|+.++..++|||+|++|++=.+.+
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-------cccCcchHHHHHHHHhccCccccccCceeecHH
Confidence 357788899999999999994 58999999987644432 222345778999999999999999999888877
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
..++ .||||++|+|.+.+. .++..++.....+..|++.+++|||+.|||||||||.||+++.
T Consensus 1308 kv~I----------------FMEyC~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~ 1369 (1509)
T KOG4645|consen 1308 KVYI----------------FMEYCEGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDF 1369 (1509)
T ss_pred HHHH----------------HHHHhccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeec
Confidence 7766 999999999999984 4566888888899999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCC----CCCCCCcccccCCcccCCC---CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 208 NRTVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~----~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
+|-+|++|||.|.....+... .....||+.|||||++.+. +-..++|||||||++.||+||+.||...+.+-.
T Consensus 1370 ~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a 1449 (1509)
T KOG4645|consen 1370 NGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA 1449 (1509)
T ss_pred CCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH
Confidence 999999999999866544322 2345799999999999864 456799999999999999999999998877766
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+=.-+-.+..+.+|..++.+-.++|..||..||..|+++.||++
T Consensus 1450 IMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1450 IMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 66667778888999999999999999999999999999987765
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=276.23 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=192.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+|++.+.||+|+||.||+|.+ ++..|++|++........ ...+.+|+.+++.++|+||+++++++...+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 76 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV--------PFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC--------cHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence 6899999999999999999965 688999999865432211 123567999999999999999999887554
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. +++|||+. ++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 77 ~~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~ 138 (291)
T cd07870 77 TL----------------TFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY 138 (291)
T ss_pred eE----------------EEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC
Confidence 43 67999995 6777666432 345788889999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTSAVV 285 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~-~~~~~~~ 285 (355)
++.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.. +......
T Consensus 139 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 218 (291)
T cd07870 139 LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218 (291)
T ss_pred CCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHH
Confidence 9999999999987544333333445578899999998764 5788999999999999999999999765432 1111111
Q ss_pred hc----------------CCCCC-----CC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQ----------------NLRPE-----IP---------RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~----------------~~~~~-----~~---------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.. ..... .+ ...+.++.+++.+||..||.+|||+.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 219 TVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 10 00000 00 112578999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=281.91 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=182.0
Q ss_pred cccccccceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccc
Q 018489 56 SVIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~ 131 (355)
..||+|+||.||+|.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 72 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----------SMSACREIALLRELKHPNVIALQKVFLSHSD--- 72 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCC---
Confidence 5799999999999975 346799998853221 1235689999999999999999998754332
Q ss_pred ccccccccCCCCceEEEEEecCCCCHHHHHHhh-------ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-------RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-------~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
...+++|||+. ++|.+++... ....+++..++.++.|++.||.|||+.|++|+||||+||+
T Consensus 73 -----------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil 140 (317)
T cd07867 73 -----------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANIL 140 (317)
T ss_pred -----------CeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEE
Confidence 23378999995 5787776432 1235889999999999999999999999999999999999
Q ss_pred E----cCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 018489 205 L----DKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (355)
Q Consensus 205 i----~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~ 276 (355)
+ +.++.++|+|||.+........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus 141 ~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 141 VMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred EccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 9 5667999999999975443221 2233467889999999876 457899999999999999999999996432
Q ss_pred hh---------HHHHHHHhc-C----------------------C-------------CCCCCCCCcHHHHHHHHHhhhc
Q 018489 277 FS---------EVTSAVVRQ-N----------------------L-------------RPEIPRCCPSSLANVMKRCWDA 311 (355)
Q Consensus 277 ~~---------~~~~~~~~~-~----------------------~-------------~~~~~~~~~~~l~~li~~~l~~ 311 (355)
.. .....+... . . ........+..+.++|.+||+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 300 (317)
T cd07867 221 EDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTM 300 (317)
T ss_pred ccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhcc
Confidence 21 111110000 0 0 0000112356788999999999
Q ss_pred CCCCCCCHHHHHH
Q 018489 312 NPDKRPEMDEVVS 324 (355)
Q Consensus 312 ~p~~Rps~~ell~ 324 (355)
||.+|||+.|+++
T Consensus 301 dP~~R~t~~e~l~ 313 (317)
T cd07867 301 DPTKRITSEQALQ 313 (317)
T ss_pred CcccccCHHHHhc
Confidence 9999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=298.72 Aligned_cols=259 Identities=18% Similarity=0.278 Sum_probs=184.8
Q ss_pred CCcceeecccccccceEEEEEEEC---CceeEEEEeecCCCCCc--------cHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHR--------TEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~~---~~~vavK~~~~~~~~~~--------~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
.++|++.+.||+|+||.||++... +...+.|.+........ ...........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 478999999999999999998542 22233332111100000 0001112345578999999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc---cccccHHHHHHHHHHHHHHHHHHHhCCcc
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---RRKLAFKVVVQLALDLARGLSYLHSQKIV 194 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~i~ 194 (355)
++++++...+.. +++++++ +++|.+++.... ........++.|+.||+.||.|||++||+
T Consensus 227 ~l~~~~~~~~~~----------------~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIi 289 (501)
T PHA03210 227 KIEEILRSEANT----------------YMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLI 289 (501)
T ss_pred cEeEEEEECCee----------------EEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 999998766554 5699998 457777664321 22344667889999999999999999999
Q ss_pred ccCCCCCcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCC-CC
Q 018489 195 HRDVKTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PY 272 (355)
Q Consensus 195 H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~-p~ 272 (355)
||||||+|||++.++.++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|.. ||
T Consensus 290 HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred cCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 999999999999999999999999975543322 2234578999999999999999999999999999999999875 44
Q ss_pred CCCC--hhHHHHHHHhcCC---------------------CCCC---------CCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 018489 273 PDLS--FSEVTSAVVRQNL---------------------RPEI---------PRCCPSSLANVMKRCWDANPDKRPEMD 320 (355)
Q Consensus 273 ~~~~--~~~~~~~~~~~~~---------------------~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~ 320 (355)
.... ....+..+..... .... ...++.++.++|.+||++||.+|||+.
T Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~ 449 (501)
T PHA03210 370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAA 449 (501)
T ss_pred cCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHH
Confidence 3221 1111111111000 0000 012466788899999999999999999
Q ss_pred HHHH
Q 018489 321 EVVS 324 (355)
Q Consensus 321 ell~ 324 (355)
|++.
T Consensus 450 elL~ 453 (501)
T PHA03210 450 ELLA 453 (501)
T ss_pred HHhh
Confidence 9986
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=271.61 Aligned_cols=252 Identities=29% Similarity=0.505 Sum_probs=201.8
Q ss_pred cceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|.+.+.||+|++|.||++.+. +..+++|+++..........+ ...+.+|+.+++.++||||+++++++.....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE----TVQANQEAQLLSKLDHPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcch----HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc
Confidence 6899999999999999999764 455677776533221111111 1225568899999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
. +++|||+++++|.+++... ....+++..++.++.|++.+|.+||+.|++|+||+|+||+++
T Consensus 77 ~----------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~ 140 (260)
T cd08222 77 F----------------CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK 140 (260)
T ss_pred e----------------EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee
Confidence 4 6799999999999988642 345799999999999999999999999999999999999997
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
. +.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++++|++|..||...+..........
T Consensus 141 ~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~ 219 (260)
T cd08222 141 N-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219 (260)
T ss_pred c-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence 4 679999999987654443333445678899999999888888999999999999999999999987665554444433
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+..+..++.++.++|.+||+.+|++||++.++++
T Consensus 220 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 -GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 3344556678899999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=275.19 Aligned_cols=248 Identities=25% Similarity=0.481 Sum_probs=192.5
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHH-HhhCCCCccceeeeeccCC
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV-WHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~Iv~~~~~~~~~ 126 (355)
++|++.+.||+|+||.||++.+ +++.||+|.++..... ... ..+..|+.. ++.++||||+++++++...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~-----~~~~~e~~~~~~~~~~~~iv~~~~~~~~~ 72 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS---QEQ-----KRLLMDLDISMRSVDCPYTVTFYGALFRE 72 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc---HHH-----HHHHHHHHHHHHHcCCCCeeeeeEEEecC
Confidence 4799999999999999999976 5899999998643221 111 123335444 5666999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcE
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENM 203 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~di~p~Ni 203 (355)
+.. +++|||++ ++|.+++... ....+++..++.++.|++.+|.|||++ +++|+||+|+||
T Consensus 73 ~~~----------------~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~ni 135 (283)
T cd06617 73 GDV----------------WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNV 135 (283)
T ss_pred CcE----------------EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHE
Confidence 544 66999995 6888877543 235689999999999999999999997 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-h
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF-S 278 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~~lltg~~p~~~~~~-~ 278 (355)
+++.++.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||..... .
T Consensus 136 l~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 214 (283)
T cd06617 136 LINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF 214 (283)
T ss_pred EECCCCCEEEeecccccccccc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH
Confidence 9999999999999998754322 12223457788999998865 3468899999999999999999999975332 2
Q ss_pred HHHHHHHhcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 279 EVTSAVVRQNLRPEIP-RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+........ ....++ ..++.++.++|.+||..+|.+||++.++++
T Consensus 215 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 215 QQLKQVVEE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHhc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 333333322 222332 457899999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=272.69 Aligned_cols=245 Identities=25% Similarity=0.398 Sum_probs=198.9
Q ss_pred cccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccccc
Q 018489 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (355)
Q Consensus 58 lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~ 135 (355)
||.|++|.||++.+ ++..+++|++..... ......+.+.+|+++++.++|+||+++++.+......
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~------ 68 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM------IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNL------ 68 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh------hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEE------
Confidence 68999999999976 489999999854322 1123345688899999999999999998877654444
Q ss_pred ccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEee
Q 018489 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (355)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~D 215 (355)
+++|||+++++|.+++... ..+++..++.++.|++.+|++||+.|++|+||+|+||+++.++.++|+|
T Consensus 69 ----------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~d 136 (265)
T cd05579 69 ----------YLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTD 136 (265)
T ss_pred ----------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEe
Confidence 6799999999999998543 4789999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCC--------CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 216 FGVARVEASNPN--------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 216 fg~a~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
||.+........ ......++..|++||...+..++.++|+||||+++|+|++|..||......+........
T Consensus 137 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (265)
T cd05579 137 FGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG 216 (265)
T ss_pred cccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 999875443311 223345778899999998888899999999999999999999999888777766665543
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
..........+..+.+++.+||+.+|.+||++.++.+.|
T Consensus 217 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 217 KIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 333222222489999999999999999999995554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=270.12 Aligned_cols=243 Identities=24% Similarity=0.381 Sum_probs=192.2
Q ss_pred cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHH-HhhCCCCccceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV-WHKLDHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
+.||.|++|.||+|.+ +++.||+|+++..... ..... ..+..|..+ ....+|+|++++++++...+..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-----~~~~~-~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~--- 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-----AKNQV-TNVKAERAIMMIQGESPYVAKLYYSFQSKDYL--- 72 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-----HHHHH-HHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE---
Confidence 5689999999999976 6789999998533211 11111 123344443 4455999999999998765544
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++
T Consensus 73 -------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~ 137 (260)
T cd05611 73 -------------YLVMEYLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLK 137 (260)
T ss_pred -------------EEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEE
Confidence 569999999999999854 35689999999999999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC--C
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL--R 290 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~--~ 290 (355)
|+|||.+..... .....++..|++||.+.+..++.++||||+|+++|+|++|..||...+.......+..... .
T Consensus 138 l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 213 (260)
T cd05611 138 LTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP 213 (260)
T ss_pred Eeecccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 999998864332 2234577889999999888889999999999999999999999988777666555544332 2
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 291 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 291 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
......+++++.++|.+||+.+|++||++..+.+.|
T Consensus 214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 233446789999999999999999999775554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=281.34 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=198.3
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||.|++|.||+|.+ ++..|++|.+....... .....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 77 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-------TLAKRTLRELKILRHFKHDNIIAIRDILRPPG 77 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc-------cchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence 7899999999999999999964 68999999986432211 11334667999999999999999988775433
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
. .....++||||+. ++|.+++. ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.
T Consensus 78 ~------------~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~ 142 (334)
T cd07855 78 A------------DFKDVYVVMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE 142 (334)
T ss_pred C------------CCceEEEEEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 1 1234578999995 68988884 3456999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCC----CCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 208 NRTVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
++.++|+|||.+......... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+......
T Consensus 143 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~ 222 (334)
T cd07855 143 DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222 (334)
T ss_pred CCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH
Confidence 999999999998754332211 123467889999999865 467899999999999999999999997765433332
Q ss_pred HHHhc------------------------CCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQ------------------------NLRPE-----IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~------------------------~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+... ..... +....++++.++|++||+.+|.+||++.+++.
T Consensus 223 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 223 LILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 22111 00001 12346889999999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=276.79 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=199.7
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+|++.+.||+|++|.||+|.. ++..|++|.+....... ....+.+.+|+.+++.++||||+++.+++...+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS------NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc------HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence 5699999999999999999965 68899999985433211 111344778999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+. +++.+++... ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.
T Consensus 89 ~~----------------~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~ 150 (307)
T cd06607 89 TA----------------WLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE 150 (307)
T ss_pred eE----------------EEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC
Confidence 44 56999996 5777776432 356899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
++.++|+|||.+...... ....++..|+|||.+. ...++.++||||+|+++|+|++|..||...+.......+
T Consensus 151 ~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~ 226 (307)
T cd06607 151 PGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226 (307)
T ss_pred CCCEEEeecCcceecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH
Confidence 999999999998654322 2345778899999874 356888999999999999999999999877665554444
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
............++..+.++|.+||+.+|.+||++.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 227 AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred hcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 33222222234468899999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=291.13 Aligned_cols=248 Identities=28% Similarity=0.472 Sum_probs=207.6
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
-|.|++.||.|+||.||+|+. ++-..|-|++... ..++ .+.+.-|+++|..+.||+|+++++.|...+.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-----seEE----LEDylVEIeILa~CdHP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-----SEEE----LEDYLVEIEILAECDHPVIVKLLSAYYFENK 103 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-----chhH----HhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence 357899999999999999954 4555677776322 1222 3457789999999999999999998877666
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
+ .|+.|||.||-...++.. -++.+.+.++..++.|++.||.|||+.+|+|||||..|||++-+
T Consensus 104 L----------------wiliEFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld 166 (1187)
T KOG0579|consen 104 L----------------WILIEFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD 166 (1187)
T ss_pred e----------------EEEEeecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec
Confidence 6 459999999999888765 36789999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
|.++|.|||.+............++||+.|||||+.. ..+|++++||||||++|.+|..+.+|....+.-..+..
T Consensus 167 GdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK 246 (1187)
T KOG0579|consen 167 GDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 246 (1187)
T ss_pred CcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH
Confidence 9999999999876555555566789999999999864 46899999999999999999999999988777666666
Q ss_pred HHhcC-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQN-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+-+.. .....|...+.++.++++.||.+||..||++.+|++
T Consensus 247 iaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 247 IAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 54433 333456667899999999999999999999998875
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=275.61 Aligned_cols=244 Identities=26% Similarity=0.402 Sum_probs=199.1
Q ss_pred eeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccc
Q 018489 53 VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 53 ~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 130 (355)
.....||+|++|.||++.. ++..||+|.+..... .....+.+|+.+++.++|+||+++++.+...+..
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~- 92 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL- 92 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch---------hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE-
Confidence 3346799999999999965 688999998743221 1234578899999999999999999988765544
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~ 210 (355)
+++|||+++++|.+++. ...+++..++.++.|++.+|+|||+.|++|+||+|+||+++.++.
T Consensus 93 ---------------~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~ 154 (292)
T cd06657 93 ---------------WVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR 154 (292)
T ss_pred ---------------EEEEecCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC
Confidence 66999999999998773 346899999999999999999999999999999999999999999
Q ss_pred EEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC-
Q 018489 211 VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL- 289 (355)
Q Consensus 211 v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~- 289 (355)
++|+|||.+..............++..|++||.+.+..++.++|+||+|+++|+|++|..||...+.......+.....
T Consensus 155 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 234 (292)
T cd06657 155 VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP 234 (292)
T ss_pred EEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc
Confidence 9999999886554333333445678899999999888889999999999999999999999987665554444322211
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 290 RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 290 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.......++..+.+++.+||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 235 KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11123457889999999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=279.96 Aligned_cols=259 Identities=25% Similarity=0.342 Sum_probs=213.8
Q ss_pred hcccccceecCCcceeecccccccceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcc
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I 116 (355)
+.+...+.+..+.|+..++||+|+||.||-+ ..+|+.+|+|.+.+... ..........+|-.+|.+++.+.|
T Consensus 174 WK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi------Kkr~ge~maLnEk~iL~kV~s~Fi 247 (591)
T KOG0986|consen 174 WKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI------KKRKGETMALNEKQILEKVSSPFI 247 (591)
T ss_pred HHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH------HHhhhhHHhhHHHHHHHHhccCcE
Confidence 4444557888999999999999999999977 56899999998843322 122223446689999999999999
Q ss_pred ceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
|.+-..|...+.+ |+|+..|+||+|.-.|-...+..|++..+..++.+|+.+|.+||+.+||+|
T Consensus 248 VslaYAfeTkd~L----------------ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYR 311 (591)
T KOG0986|consen 248 VSLAYAFETKDAL----------------CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYR 311 (591)
T ss_pred EEEeeeecCCCce----------------EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeec
Confidence 9998777766655 889999999999988866666789999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 018489 197 DVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (355)
Q Consensus 197 di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~ 276 (355)
|+||+|||+++.|++.|+|+|+|.... .+......+||.+|||||+++...|+.+.|.|+|||++|+|+.|+.||....
T Consensus 312 DLKPeNILLDd~GhvRISDLGLAvei~-~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 312 DLKPENILLDDHGHVRISDLGLAVEIP-EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred cCChhheeeccCCCeEeeccceEEecC-CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 999999999999999999999997554 3444555699999999999999999999999999999999999999997654
Q ss_pred hhHHHHHHHhc--CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 018489 277 FSEVTSAVVRQ--NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD 320 (355)
Q Consensus 277 ~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 320 (355)
.......+.+. .-...+++.+|+++.++.+.+|++||.+|....
T Consensus 391 eKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 391 EKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 43333222221 223356788999999999999999999997543
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=276.94 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=193.0
Q ss_pred cceeecccccccceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 51 KLVIKSVIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
+|++.+.||+|++|.||+|.+ ++..||+|.+........ ...+.+.+|+.++..++||||+++++++...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT------GISQSACREIALLRELKHENVVSLVEVFLEH 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccccc------CccHHHHHHHHHHHhcCCCCccceEEEEeCC
Confidence 589999999999999999976 568999999975331111 1123366799999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc---cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.. ...++||||+++ +|.+++.... ...+++..++.++.|++.+|.|||+++++|+||+|+||
T Consensus 75 ~~--------------~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Ni 139 (316)
T cd07842 75 AD--------------KSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANI 139 (316)
T ss_pred CC--------------ceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence 22 223789999964 7777765332 23689999999999999999999999999999999999
Q ss_pred EEcC----CCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 204 LLDK----NRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 204 li~~----~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
+++. ++.++|+|||.+........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus 140 l~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 140 LVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred EEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9999 99999999999875443222 1223456788999998876 45789999999999999999999999765
Q ss_pred ChhH---------HHHHHHh------------------------cCCCCCCC-----------CCCcHHHHHHHHHhhhc
Q 018489 276 SFSE---------VTSAVVR------------------------QNLRPEIP-----------RCCPSSLANVMKRCWDA 311 (355)
Q Consensus 276 ~~~~---------~~~~~~~------------------------~~~~~~~~-----------~~~~~~l~~li~~~l~~ 311 (355)
.... ....+.. ......++ ...+..+.++|.+||+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 299 (316)
T cd07842 220 EAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299 (316)
T ss_pred cccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcC
Confidence 4322 0000000 00001111 14567899999999999
Q ss_pred CCCCCCCHHHHHH
Q 018489 312 NPDKRPEMDEVVS 324 (355)
Q Consensus 312 ~p~~Rps~~ell~ 324 (355)
||.+|||+.+++.
T Consensus 300 ~P~~Rps~~eil~ 312 (316)
T cd07842 300 DPTKRITAEEALE 312 (316)
T ss_pred CcccCcCHHHHhc
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=275.18 Aligned_cols=246 Identities=27% Similarity=0.468 Sum_probs=206.9
Q ss_pred CcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
+-|.+++.||+|+||.||++. .+|..+|||.+..... .+.+..|+-++++++.+++|++|+.|+...
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-----------LQEIIKEISIMQQC~S~yVVKYYGSYFK~s 101 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-----------LQEIIKEISIMQQCKSKYVVKYYGSYFKHS 101 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-----------HHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence 357899999999999999994 5799999998853321 233667999999999999999999998877
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.++ ||||||..|+..+.+.- +++++++.++..+++..+++|+|||...-+|||||..|||++.
T Consensus 102 DLW----------------IVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT 164 (502)
T KOG0574|consen 102 DLW----------------IVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT 164 (502)
T ss_pred ceE----------------eehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc
Confidence 774 49999999999998864 5778999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+|.+||.|||.+....+.-.....-.||+.|+|||++..-.|+.++||||||++..+|.-|+.||.+...-..+..+ ..
T Consensus 165 ~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-PT 243 (502)
T KOG0574|consen 165 DGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-PT 243 (502)
T ss_pred cchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-cC
Confidence 99999999999976555444455568999999999999989999999999999999999999999876553333222 11
Q ss_pred CCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+..+.+ |+..+.++.++|++||-++|++|.|+.++++
T Consensus 244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 222222 3446889999999999999999999988875
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=275.51 Aligned_cols=250 Identities=28% Similarity=0.476 Sum_probs=193.4
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~ 125 (355)
.++|+..+.||+|+||.||++.+ ++..+|+|.+...... .....+.+|+.++.++. |+||+++++++..
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~ 74 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence 35788889999999999999976 5789999998543221 12345778999999995 9999999998776
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHH---hhccccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCCC
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI---KNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTE 201 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~di~p~ 201 (355)
.... +++|||+. .++.++.. ......+++..+..++.+++.||+|||+. |++|+||+|+
T Consensus 75 ~~~~----------------~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~ 137 (288)
T cd06616 75 EGDC----------------WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPS 137 (288)
T ss_pred CCcE----------------EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHH
Confidence 5444 56999985 46655432 23346799999999999999999999975 9999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC---CCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
||+++.++.++|+|||.+...... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......
T Consensus 138 Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 216 (288)
T cd06616 138 NILLDRNGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV 216 (288)
T ss_pred HEEEccCCcEEEeecchhHHhccC-CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH
Confidence 999999999999999998644322 122334578889999998776 6889999999999999999999999765421
Q ss_pred -HHHHHHHhcC---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 279 -EVTSAVVRQN---LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 279 -~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+......... ........++.++.++|.+||+.+|.+||++++|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 217 FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122211111 111122347899999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=277.92 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=195.7
Q ss_pred ceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccc
Q 018489 52 LVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~ 131 (355)
|.+.+.+|.|+++.||++..++..||+|++....... ...+.+.+|+.+++.++|+||+++++++...+..
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~-- 74 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK-------EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSEL-- 74 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccch-------hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeE--
Confidence 5566777777888888888899999999986542211 1134578899999999999999999988765544
Q ss_pred ccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcE
Q 018489 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211 (355)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v 211 (355)
+++|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+
T Consensus 75 --------------~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~ 140 (314)
T cd08216 75 --------------YVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKV 140 (314)
T ss_pred --------------EEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCce
Confidence 669999999999999976656679999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCC-------CCCCCCCcccccCCcccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 212 KIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 212 ~L~Dfg~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
+|+||+.+........ ......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||..........
T Consensus 141 kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~ 220 (314)
T cd08216 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (314)
T ss_pred EEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999998764332111 1122346678999999876 357889999999999999999999998765443332
Q ss_pred HHHhcCCC--------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNLR--------------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~~--------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
........ ......++.++.+++.+||+.||++|||++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 221 EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred HHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 22211100 0011223567899999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=274.48 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=203.9
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
..|...+.||+|+||.||++.+ ++..+++|.+....... . .....+.+|+.+++.++|||++++++++....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~--~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS--N----EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH 98 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc--h----HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 3478899999999999999975 67899999986443221 1 11244778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. +++|||+.| +|.+.+.. ....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.
T Consensus 99 ~~----------------~lv~e~~~g-~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~ 160 (317)
T cd06635 99 TA----------------WLVMEYCLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 160 (317)
T ss_pred eE----------------EEEEeCCCC-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC
Confidence 44 569999965 77776643 3456899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
++.++|+|||.+..... .....++..|+|||.+. .+.++.++|+||+|+++|+|++|..||...+.......+
T Consensus 161 ~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 236 (317)
T cd06635 161 PGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236 (317)
T ss_pred CCCEEEecCCCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 99999999998864332 22345778899999974 456889999999999999999999999887666666666
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
............+++.+.++|.+||+.+|.+||++.++++.+-.
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 55544444455678899999999999999999999999975443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=271.14 Aligned_cols=241 Identities=26% Similarity=0.388 Sum_probs=187.8
Q ss_pred ccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHH---HHHhhCCCCccceeeeeccCCccccc
Q 018489 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV---AVWHKLDHPNVTKFIGATMGSSELHI 131 (355)
Q Consensus 57 ~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~Iv~~~~~~~~~~~~~~ 131 (355)
.||+|+||.||++.+ ++..+|+|.+........... ..+.+|. .++....||||+.+++.+...+..
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~-- 72 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE------TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKL-- 72 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH------HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeE--
Confidence 489999999999965 578999999865433211111 1122233 344445899999999888765544
Q ss_pred ccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcE
Q 018489 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211 (355)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v 211 (355)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus 73 --------------~lv~e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~ 136 (279)
T cd05633 73 --------------CFILDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHV 136 (279)
T ss_pred --------------EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCE
Confidence 569999999999998853 3569999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCCCCCCCCCcccccCCcccC-CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh--HHHHHHHhcC
Q 018489 212 KIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS--EVTSAVVRQN 288 (355)
Q Consensus 212 ~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~--~~~~~~~~~~ 288 (355)
+|+|||.+...... ......++..|+|||.+. +..++.++|+||+|+++|+|++|..||...... ..... ....
T Consensus 137 ~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~ 213 (279)
T cd05633 137 RISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLT 213 (279)
T ss_pred EEccCCcceecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-Hhhc
Confidence 99999998644322 222346889999999986 456789999999999999999999999754322 11111 1222
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 289 LRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 289 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
....++..+++++.++|.+||+.||.+|| ++.++++
T Consensus 214 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 214 VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 34456777899999999999999999999 5988887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=278.28 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=204.1
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|++|.||++.+ ++..||+|.+...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS-------ELFAKRAYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc-------hHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence 367899999999999999999965 6889999998532211 1223457789999999999999999998865
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
...... ....++||+|+ +++|.+++. ...+++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 86 ~~~~~~----------~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill 151 (343)
T cd07880 86 DLSLDR----------FHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV 151 (343)
T ss_pred Cccccc----------cceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 443210 12347899999 779988874 3568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.++.++|+|||.+...... .....++..|++||.+.+ ..++.++|+||||+++|+|++|..||...+.......+
T Consensus 152 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07880 152 NEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228 (343)
T ss_pred cCCCCEEEeecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998754322 223456788999999876 45788999999999999999999999876654443332
Q ss_pred HhcCCC-----------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHhHhh
Q 018489 285 VRQNLR-----------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAIDTS 332 (355)
Q Consensus 285 ~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~~~~ 332 (355)
...... ......+++.+.++|.+||+.||.+||++.+++. .++.....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 229 MKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred HHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 221110 0122456788999999999999999999999994 56555443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=272.47 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=200.1
Q ss_pred ceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
|++.+.||.|++|.||++.. +++.+++|.+....... .....+.+|+.+++.++|+||+++++++...+..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 73 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-------GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDL 73 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-------hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCE
Confidence 67889999999999999965 68899999986433221 1234577899999999999999999988765444
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
++++||+++ +|.+++... ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++
T Consensus 74 ----------------~~v~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~ 135 (283)
T cd05118 74 ----------------YLVFEFMDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG 135 (283)
T ss_pred ----------------EEEEeccCC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC
Confidence 669999965 888877543 35799999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 018489 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 210 ~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 288 (355)
.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+....
T Consensus 136 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~ 215 (283)
T cd05118 136 VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTL 215 (283)
T ss_pred cEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 99999999987665443333445677889999998876 78999999999999999999999998777655444432211
Q ss_pred CCC----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 289 LRP----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 289 ~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+ .....++.++.++|.+||+.||.+||++.+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 216 GTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 112346789999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=265.74 Aligned_cols=238 Identities=27% Similarity=0.406 Sum_probs=198.7
Q ss_pred cccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccccc
Q 018489 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (355)
Q Consensus 58 lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~ 135 (355)
||.|++|.||++.+ +++.+++|++....... ......+.+|+.+++.++|+||+++++.+......
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------ 68 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK------RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL------ 68 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc------hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCee------
Confidence 68999999999976 47899999986443211 11234577899999999999999999887655444
Q ss_pred ccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEee
Q 018489 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (355)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~D 215 (355)
+++|||+++++|.+++.. ...+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|
T Consensus 69 ----------~~v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d 136 (250)
T cd05123 69 ----------YLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTD 136 (250)
T ss_pred ----------EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEee
Confidence 679999999999999854 34689999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCC
Q 018489 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR 295 (355)
Q Consensus 216 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 295 (355)
||.+..............++..|++||.+.+..++.++|+|+||+++|++++|..||...+.......+.. ....++.
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~ 214 (250)
T cd05123 137 FGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPE 214 (250)
T ss_pred cCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCC
Confidence 99987654433334445678899999999988889999999999999999999999988776555555544 3345777
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHH
Q 018489 296 CCPSSLANVMKRCWDANPDKRPEMDE 321 (355)
Q Consensus 296 ~~~~~l~~li~~~l~~~p~~Rps~~e 321 (355)
..+..+.++|.+||..||++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 78999999999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=278.74 Aligned_cols=255 Identities=22% Similarity=0.377 Sum_probs=195.6
Q ss_pred ecccccc--cceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccc
Q 018489 55 KSVIARG--TFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 55 ~~~lg~G--~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 130 (355)
...||.| +||.||++.+ +++.||+|++...... . ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~---~----~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~- 74 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT---E----EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL- 74 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC---H----HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce-
Confidence 3456776 8899999976 7899999998643221 1 1235678899999999999999999998765544
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~ 210 (355)
+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.
T Consensus 75 ---------------~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~ 139 (328)
T cd08226 75 ---------------WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL 139 (328)
T ss_pred ---------------EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc
Confidence 66999999999999987655567999999999999999999999999999999999999999999
Q ss_pred EEEeeccccccccCCCCC-------CCCCCCcccccCCcccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 211 VKIADFGVARVEASNPND-------MTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 211 v~L~Dfg~a~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
++++||+.+......... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.........
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 219 (328)
T cd08226 140 VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219 (328)
T ss_pred EEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH
Confidence 999999765422211110 0111245679999998763 4789999999999999999999999876554443
Q ss_pred HHHHhcCC---------------------------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 018489 282 SAVVRQNL---------------------------------------------RPEIPRCCPSSLANVMKRCWDANPDKR 316 (355)
Q Consensus 282 ~~~~~~~~---------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R 316 (355)
........ .......+++.+.++|++||+.||++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 299 (328)
T cd08226 220 LQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKR 299 (328)
T ss_pred HHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccC
Confidence 33222110 011122356789999999999999999
Q ss_pred CCHHHHHH--HHHHhHhh
Q 018489 317 PEMDEVVS--MLEAIDTS 332 (355)
Q Consensus 317 ps~~ell~--~l~~~~~~ 332 (355)
||+.++++ .+..+...
T Consensus 300 pta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 300 PSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred CCHHHHhhCHHHHHHHHh
Confidence 99999986 55555443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=278.92 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=200.6
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 125 (355)
.++|++.+.||+|++|.||+|.+ ++..+++|.+....... . ....+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~---~----~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~ 78 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA---T----DAQRTFREIMFLQELGDHPNIVKLLNVIKA 78 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc---h----hhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence 36899999999999999999976 57899999885321111 1 123366799999999 99999999998765
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. ..++||||+. ++|..++.. ..+++..++.++.||+.+|.|||++|++|+||+|+||++
T Consensus 79 ~~~~--------------~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill 140 (337)
T cd07852 79 ENDK--------------DIYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL 140 (337)
T ss_pred CCCc--------------eEEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 4322 2378999996 589888743 278899999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCC-----CCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 206 DKNRTVKIADFGVARVEASNP-----NDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~-----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
+.++.++|+|||.+....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.....
T Consensus 141 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~ 220 (337)
T cd07852 141 NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220 (337)
T ss_pred cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 999999999999987544322 12223457889999998765 457889999999999999999999998765444
Q ss_pred HHHHHHhcCCC-----------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHH
Q 018489 280 VTSAVVRQNLR-----------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM--LEA 328 (355)
Q Consensus 280 ~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~--l~~ 328 (355)
....+...... ......++.++.++|.+||+.+|.+|||+.++++. +..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 33322221100 01123368899999999999999999999999973 555
Q ss_pred hHhh
Q 018489 329 IDTS 332 (355)
Q Consensus 329 ~~~~ 332 (355)
+.+.
T Consensus 301 ~~~~ 304 (337)
T cd07852 301 FHNP 304 (337)
T ss_pred hccC
Confidence 5443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=292.14 Aligned_cols=264 Identities=30% Similarity=0.585 Sum_probs=229.3
Q ss_pred eecCCcceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
+++.+...|.++||.|.||.|++|.. ....||||.++..-. +..+..|..|.-++.++.||||+++.
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--------ekqrrdFL~EAsIMGQFdHPNIIrLE 696 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--------EKQRRDFLSEASIMGQFDHPNIIRLE 696 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--------HHHHhhhhhhhhhcccCCCCcEEEEE
Confidence 67788999999999999999999953 245699999964322 23467799999999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
++....... .||.|||++|+|+.+++.+. +.|+..++..+++.|+.++.||-+.|+|||||..
T Consensus 697 GVVTks~Pv----------------MIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAA 759 (996)
T KOG0196|consen 697 GVVTKSKPV----------------MIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAA 759 (996)
T ss_pred EEEecCcee----------------EEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhh
Confidence 998776655 56999999999999998765 4599999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCCCCCCCC---CcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 276 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~---~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~ 276 (355)
.|||++.+...|+.|||+++...++........ -..+|.|||.+....++.++||||+|+++||.++ |..||-+.+
T Consensus 760 RNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 760 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred hheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence 999999999999999999997765543222222 2468999999999999999999999999999876 999999999
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCC
Q 018489 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335 (355)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 335 (355)
+.+.++.+.. +++.+-|.++|..|.+|+..||++|-.+||.+.+|+..|+++..+...
T Consensus 840 NQdVIkaIe~-gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 840 NQDVIKAIEQ-GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred hHHHHHHHHh-ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 9999888765 566677888999999999999999999999999999999999765533
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=272.42 Aligned_cols=259 Identities=25% Similarity=0.445 Sum_probs=200.2
Q ss_pred hcccccceecCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCc
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 115 (355)
......+.+..++|++.+.||.|++|.||+|.+. +..||||.++...... ....+..|+.++... .|+|
T Consensus 4 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--------~~~~~~~e~~~~~~~~~~~~ 75 (296)
T cd06618 4 TIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--------ENKRILMDLDVVLKSHDCPY 75 (296)
T ss_pred eecceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--------HHHHHHHHHHHHHhccCCCc
Confidence 3445566777899999999999999999999775 8999999986432211 122344566656666 6999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh-CCcc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIV 194 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~ 194 (355)
|+++++++...... +++|||+. ++|.+++... ...+++..+..++.|++.+|+|||+ .|++
T Consensus 76 i~~~~~~~~~~~~~----------------~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~ 137 (296)
T cd06618 76 IVKCYGYFITDSDV----------------FICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVI 137 (296)
T ss_pred hHhhheeeecCCeE----------------EEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEe
Confidence 99999988765544 66999984 5777776543 3478999999999999999999997 5999
Q ss_pred ccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCC----CCCcchhHHHHHHHHHHHhCCC
Q 018489 195 HRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP----YNRKCDVYSFGICLWEIYCCDM 270 (355)
Q Consensus 195 H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~~lltg~~ 270 (355)
|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.
T Consensus 138 H~dl~p~nill~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (296)
T cd06618 138 HRDVKPSNILLDASGNVKLCDFGISGRLVDS-KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF 216 (296)
T ss_pred cCCCcHHHEEEcCCCCEEECccccchhccCC-CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999998654322 2223345677899999987653 7889999999999999999999
Q ss_pred CCCCCCh-hHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 271 PYPDLSF-SEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 271 p~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
||..... .+......... ....+ ..++.++.++|.+||+.||.+||++++++..
T Consensus 217 p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 217 PYKNCKTEFEVLTKILQEE-PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCcchhHHHHHHHHhcCC-CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9976433 23333333322 12222 2468899999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=276.80 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=208.1
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|++.+.||.|++|.||+|.+ ++..+++|.+...... ....+.+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-------LIDAKRILREIKLLRHLRHENIIGLLDILRPPSP 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-------chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc
Confidence 689999999999999999976 4789999998643211 1123457789999999999999999998876541
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ..+..+++|+|+. ++|.+++.. ...+++..++.++.|++.+|++||+.|++|+||+|+||+++.+
T Consensus 74 ~-----------~~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~ 139 (330)
T cd07834 74 E-----------DFNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN 139 (330)
T ss_pred c-----------cccceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 1 1123478999996 588888843 3479999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCC---CCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 209 RTVKIADFGVARVEASNP---NDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.++|+|||.+....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+..+....+
T Consensus 140 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i 219 (330)
T cd07834 140 CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI 219 (330)
T ss_pred CCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence 999999999998655433 123345678889999999887 7899999999999999999999999887765555444
Q ss_pred HhcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHhHhh
Q 018489 285 VRQNLRP-----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAIDTS 332 (355)
Q Consensus 285 ~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~~~~ 332 (355)
......+ .....++.++.++|.+||+.+|.+||++.+++. .++.+..-
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 220 VEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred HHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 3321110 012336788999999999999999999999998 47766554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=273.46 Aligned_cols=264 Identities=24% Similarity=0.342 Sum_probs=202.9
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
++..++|++.+.||+|++|.||+|.+ +++.|++|.++........ ...+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~-------~~~~~~e~~~~~~l~h~~i~~~~~~~ 75 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGF-------PITAIREIKILRQLNHRNIVNLKEIV 75 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCc-------hHHHHHHHHHHHhCCCCCeeeeehee
Confidence 34557899999999999999999976 5789999998754322111 12356799999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
....... ....+....++++||+++ ++...+... ...+++..++.++.|++.||+|||+.|++|+||+|+||
T Consensus 76 ~~~~~~~------~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~ni 147 (302)
T cd07864 76 TDKQDAL------DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNI 147 (302)
T ss_pred cCcchhh------hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 7654111 011123356899999976 777766433 44689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
+++.++.++|+|||.+........ ......++..|+|||.+.+ ..++.++||||||+++++|++|+.||...+.....
T Consensus 148 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~ 227 (302)
T cd07864 148 LLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL 227 (302)
T ss_pred EECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999999999875543322 2222345778999998865 35788999999999999999999999876655544
Q ss_pred HHHHhcCCCC----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRP----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+......+ .....++..+.++|..||+.+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 228 ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 4433311100 012246889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=269.25 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=191.1
Q ss_pred ceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCcc
Q 018489 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSE 128 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~ 128 (355)
|++.+.||+|++|.||+|.+ ++..+|+|.++....... . ....+|+..+.++ +|+||+++++++.+...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~---~-----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 72 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE---Q-----VNNLREIQALRRLSPHPNILRLIEVLFDRKT 72 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch---h-----hhHHHHHHHHhhcCCCCCccceEEEEecCCC
Confidence 67899999999999999965 678999999864322111 1 1133688888888 59999999998876521
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
+..++||||++ ++|.+.+... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 73 --------------~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~- 135 (282)
T cd07831 73 --------------GRLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD- 135 (282)
T ss_pred --------------CcEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-
Confidence 22377999996 5787777542 356899999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+.++|+|||.+...... .......++..|+|||.+.. ..++.++|+||||+++|+|++|..||...+..+....+...
T Consensus 136 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~ 214 (282)
T cd07831 136 DILKLADFGSCRGIYSK-PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV 214 (282)
T ss_pred CCeEEEecccccccccC-CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHH
Confidence 99999999998754332 22233457889999997654 55788999999999999999999999876654433333211
Q ss_pred C----------------CCCCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 N----------------LRPEI-----------PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~----------------~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
. ....+ ...++.++.++|.+||+.+|++||+++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 215 LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0 00001 1245789999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=271.96 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=199.1
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
.|...+.||+|++|.||+|.+ ++..|++|.+........ ...+.+.+|+.+++.++|||++++++++.....
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN------EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT 95 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCch------HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 377778899999999999965 688999999865432211 112346789999999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|||+. ++|.+++.. ....+++..++.++.|++.+|.|||+.|++|+||+|+||+++.+
T Consensus 96 ~----------------~lv~e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~ 157 (313)
T cd06633 96 A----------------WLVMEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 157 (313)
T ss_pred E----------------EEEEecCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC
Confidence 4 56999995 577777653 34568999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
+.++|+|||.+.... ......++..|+|||.+. ...++.++|+||||+++|+|++|..||...+.........
T Consensus 158 ~~~kL~dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 233 (313)
T cd06633 158 GQVKLADFGSASKSS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 233 (313)
T ss_pred CCEEEeecCCCcccC----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999999999886332 122356788999999984 3567889999999999999999999998776655555554
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...........++..+.+++.+||+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 234 QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 443333344557889999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=270.67 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=197.3
Q ss_pred cceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeecc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 124 (355)
+|++.+.||.|+||.||++.+ ++..||+|++..... .......+.+.+|+.+++++ +|+||+++++.+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-----VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-----hhcchHHHHHHHHHHHHHhcccCCChhceeeEee
Confidence 488999999999999999865 678999999853221 11122345577899999999 6899999998877
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..... ++||||+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+
T Consensus 76 ~~~~~----------------~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 137 (290)
T cd05613 76 TDTKL----------------HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137 (290)
T ss_pred cCCeE----------------EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 65443 669999999999999854 456899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCh----
Q 018489 205 LDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDLSF---- 277 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~lltg~~p~~~~~~---- 277 (355)
++.++.++|+|||.+....... .......++..|+|||.+.+. .++.++||||+|+++|+|++|..||.....
T Consensus 138 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 217 (290)
T cd05613 138 LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217 (290)
T ss_pred ECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH
Confidence 9999999999999987543221 122234578899999998753 467899999999999999999999964322
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
......... ....++..+++.+.+++.+||+.||.+|| ++.+++.
T Consensus 218 ~~~~~~~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 218 AEISRRILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHHhhc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 222222211 23345667899999999999999999997 7777766
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=285.17 Aligned_cols=247 Identities=26% Similarity=0.497 Sum_probs=201.3
Q ss_pred eeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccc
Q 018489 53 VIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 53 ~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 130 (355)
++...||+|+|-+||+|.++ |..||=--++..+.. ....-.++|..|+++|+.|+||||+++|+++.+.....
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~-----q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVT-----QSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhh-----cChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 56778999999999999764 444443322211111 11222467999999999999999999999998776643
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEc-C
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLD-K 207 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~di~p~Nili~-~ 207 (355)
+ .+|+|.+..|+|..|+++. +.++...+..|++||+++|.|||++. |+|||||-+||||+ +
T Consensus 118 i--------------n~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~ 181 (632)
T KOG0584|consen 118 I--------------NFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN 181 (632)
T ss_pred e--------------eeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC
Confidence 3 6799999999999999654 66899999999999999999999995 99999999999996 5
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~-~~~~~~~~ 286 (355)
.|.|||+|+|+|.......... -+||+.|||||++. ..|+...||||||+++++|+|+..||..-... +.++++..
T Consensus 182 ~G~VKIGDLGLAtl~r~s~aks--vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S 258 (632)
T KOG0584|consen 182 LGEVKIGDLGLATLLRKSHAKS--VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS 258 (632)
T ss_pred cCceeecchhHHHHhhccccce--eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc
Confidence 7999999999998765433322 58999999999998 55899999999999999999999999876554 44555555
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+.....+...-.++++++|.+||.. ..+|+|+.|+|.
T Consensus 259 GiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 259 GIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 5555566677789999999999998 899999999986
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=271.18 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=202.0
Q ss_pred cceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeecc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 124 (355)
+|++.+.||+|++|.||++.+ +++.|++|+++.... .......+.+.+|+.++.++ +||||+++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-----~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-----VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-----HhhhhHHHHHHHHHHHHHhccCCcchhhhheeee
Confidence 488999999999999999864 467899999863221 11222345577899999999 6999999998876
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..... ++||||+++++|.+++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+
T Consensus 76 ~~~~~----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil 137 (288)
T cd05583 76 TDTKL----------------HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137 (288)
T ss_pred cCCEE----------------EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 55443 679999999999998843 356899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCh----
Q 018489 205 LDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMPYPDLSF---- 277 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~lltg~~p~~~~~~---- 277 (355)
++.++.++|+|||.+........ ......++..|++||.+.+.. .+.++|+||||+++|+|++|..||.....
T Consensus 138 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 217 (288)
T cd05583 138 LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217 (288)
T ss_pred ECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH
Confidence 99999999999999875433221 122245788999999987654 78899999999999999999999964322
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
.+...... ......+..++.++.++|.+||+.||++|||+.++...|+...
T Consensus 218 ~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 218 SEISRRIL--KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred HHHHHHHH--ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 22222222 2233556678899999999999999999999988887777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=276.15 Aligned_cols=256 Identities=22% Similarity=0.345 Sum_probs=197.4
Q ss_pred Ccce-eecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHH-----HHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 50 SKLV-IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEI-----AALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 50 ~~y~-i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
++|. +.+.||.|++|.||+|.+ +++.||+|.++............ ......+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 5665 557899999999999965 58899999986543321110000 001123678999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++...+.. +++|||+. ++|.+++. ....+++..+..++.|++.||.+||+.|++|+||+|+
T Consensus 88 ~~~~~~~~----------------~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~ 148 (335)
T PTZ00024 88 VYVEGDFI----------------NLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPA 148 (335)
T ss_pred EEecCCcE----------------EEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHH
Confidence 88755443 67999996 58988884 3456899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccC--------------CCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHH
Q 018489 202 NMLLDKNRTVKIADFGVARVEAS--------------NPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIY 266 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~--------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll 266 (355)
||+++.++.++|+|||.+..... .........++..|+|||.+.+. .++.++|+||||+++|+|+
T Consensus 149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~ 228 (335)
T PTZ00024 149 NIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228 (335)
T ss_pred HeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999875441 11122223467789999998764 4688999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHHhcCCCC--------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 018489 267 CCDMPYPDLSFSEVTSAVVRQNLRP--------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMD 320 (355)
Q Consensus 267 tg~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 320 (355)
+|..||...+..+....+......+ ......++.+.++|.+||+.+|.+||+++
T Consensus 229 tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 308 (335)
T PTZ00024 229 TGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308 (335)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence 9999998877666554443311100 01134578899999999999999999999
Q ss_pred HHHH
Q 018489 321 EVVS 324 (355)
Q Consensus 321 ell~ 324 (355)
+++.
T Consensus 309 ~~l~ 312 (335)
T PTZ00024 309 EALK 312 (335)
T ss_pred HHhc
Confidence 9986
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=267.93 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=189.4
Q ss_pred ccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccccccc
Q 018489 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTE 134 (355)
Q Consensus 57 ~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~ 134 (355)
.||+|+||.||++.+ +++.||+|.+........... .........+..++...||+|+.+++.+...+..
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~----- 72 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL----- 72 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH---HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEE-----
Confidence 489999999999865 578999999865432211111 1111112233455556899999999888766554
Q ss_pred cccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEe
Q 018489 135 NGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214 (355)
Q Consensus 135 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~ 214 (355)
++||||++|++|.+++.. ...+++..++.|+.|++.+|.|||+.+++|+||+|+||+++.++.++|+
T Consensus 73 -----------~~v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~ 139 (278)
T cd05606 73 -----------SFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 139 (278)
T ss_pred -----------EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEc
Confidence 569999999999988853 4569999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH-HHHhcCCCCC
Q 018489 215 DFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS-AVVRQNLRPE 292 (355)
Q Consensus 215 Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~-~~~~~~~~~~ 292 (355)
|||.+...... ......++..|+|||.+.++ .++.++|+||+|+++|+|++|+.||.......... ..........
T Consensus 140 dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 217 (278)
T cd05606 140 DLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 217 (278)
T ss_pred cCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC
Confidence 99998644322 22334688999999998754 68899999999999999999999997653221111 1112223345
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 293 IPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 293 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
++..++.++.++|.+||..+|.+|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 6667899999999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=268.08 Aligned_cols=239 Identities=22% Similarity=0.357 Sum_probs=188.8
Q ss_pred Ccceeeccc--ccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeecc
Q 018489 50 SKLVIKSVI--ARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (355)
Q Consensus 50 ~~y~i~~~l--g~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 124 (355)
++|.+.+.+ |.|+||.||++.. ++..+++|++....... .|+.....+ +||||+++++.+.
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------------~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------------IEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------------hhHHHHHHhhcCCCEEEEEEEEe
Confidence 567777776 9999999999964 67889999986432110 022222222 7999999999987
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..+.. ++||||+++++|.+++... ..+++..++.++.|++++|.+||+.|++|+||+|+||+
T Consensus 80 ~~~~~----------------~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 141 (267)
T PHA03390 80 TLKGH----------------VLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL 141 (267)
T ss_pred cCCee----------------EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence 76544 6799999999999998543 47999999999999999999999999999999999999
Q ss_pred EcCCC-cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 205 LDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 205 i~~~~-~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
++.++ .++|+|||.+...... ....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...........
T Consensus 142 ~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~ 217 (267)
T PHA03390 142 YDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217 (267)
T ss_pred EeCCCCeEEEecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH
Confidence 99988 9999999998754322 224578899999999988899999999999999999999999975543322111
Q ss_pred -H-HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 018489 284 -V-VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-MDEVVS 324 (355)
Q Consensus 284 -~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~ell~ 324 (355)
. .........+..+++.+.++|.+||+.+|.+||+ ++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 218 SLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1 1112222445568999999999999999999995 688874
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=271.04 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=197.4
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|++|.||+|.+ ++..||+|.+......... ...+.+|+.++++++||||+++++++..
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF-------PITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCc-------hhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 456899999999999999999976 6889999998644322111 1234579999999999999999998765
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
..... .......+++|||+. ++|.+++.. ....+++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 83 ~~~~~--------~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~ 152 (310)
T cd07865 83 KATPY--------NRYKGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI 152 (310)
T ss_pred ccccc--------cCCCceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 44321 112345588999995 588877743 33468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCC----CCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 206 DKNRTVKIADFGVARVEASNPN----DMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
+.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+....
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~ 232 (310)
T cd07865 153 TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232 (310)
T ss_pred CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999875433221 11234567789999988664 468899999999999999999999987665433
Q ss_pred HHHHHhcC--CCC---------------CC-------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 281 TSAVVRQN--LRP---------------EI-------------PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~~--~~~---------------~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+.... ... .+ +...+..+.++|.+||..||.+|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 233 LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 32222110 000 00 1123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=275.61 Aligned_cols=261 Identities=22% Similarity=0.287 Sum_probs=198.2
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
..+|++.+.||.|+||.||+|.+ ++..|++|.+...... ..+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---------~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---------SVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---------hHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 47999999999999999999965 5789999998644321 124467899999999999999999887654
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
..... ..-.........+++|||++ ++|.+++. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus 75 ~~~~~--~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~ 148 (342)
T cd07854 75 GSDLT--EDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN 148 (342)
T ss_pred ccccc--cccccccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc
Confidence 32211 00011223345689999996 58888773 34689999999999999999999999999999999999997
Q ss_pred C-CCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 207 K-NRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 207 ~-~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
. ++.++|+|||.+........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.....
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4 56789999999875432211 1122356788999998654 56788999999999999999999999876654444
Q ss_pred HHHHhcC-----------------------CCC-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQN-----------------------LRP-----EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~-----------------------~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....... ... .....++.++.++|.+||+.||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 3332211 000 012346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=275.48 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=197.0
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|.+.+.||+|+||.||++.+ ++..||+|.+...... ....+.+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-------IIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-------hHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 348899999999999999999964 6889999998542211 1112346789999999999999999988754
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
..... ..+..+++++++ +++|.+++. ...+++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 88 ~~~~~----------~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll 153 (345)
T cd07877 88 ARSLE----------EFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 153 (345)
T ss_pred ccccc----------ccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE
Confidence 33211 122346788887 789988773 3468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.++.++|+|||.+..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+
T Consensus 154 ~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 154 NEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230 (345)
T ss_pred cCCCCEEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999874432 2233467888999998866 56788999999999999999999999776554443332
Q ss_pred HhcCCC------------------------C-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLR------------------------P-----EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~------------------------~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...... + ......++++.++|.+||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 221100 0 011235788999999999999999999999886
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=276.81 Aligned_cols=269 Identities=29% Similarity=0.580 Sum_probs=233.7
Q ss_pred hhcccccceecCCcceeecccccccceEEEEEEECC--ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc
Q 018489 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG--HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115 (355)
Q Consensus 38 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 115 (355)
+......|+++-.+......||-|.||.||.|.|+. -.||||.++.+. .-.+.|..|..+++.++|||
T Consensus 255 vSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----------MeveEFLkEAAvMKeikHpN 324 (1157)
T KOG4278|consen 255 VSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----------MEVEEFLKEAAVMKEIKHPN 324 (1157)
T ss_pred ecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----------hhHHHHHHHHHHHHhhcCcc
Confidence 466668899999999999999999999999998864 679999885322 11345888999999999999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H 195 (355)
+|++++++.....+| ||.|||..|.|.+++.......++...++.++.||.+|+.||..+++||
T Consensus 325 LVqLLGVCT~EpPFY----------------IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIH 388 (1157)
T KOG4278|consen 325 LVQLLGVCTHEPPFY----------------IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIH 388 (1157)
T ss_pred HHHHhhhhccCCCeE----------------EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhh
Confidence 999999998877774 5999999999999999888888999999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 018489 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYP 273 (355)
Q Consensus 196 ~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~ 273 (355)
|||-..|+|+.++..||+.|||++++...+.. ....-.-.+-|.|||.+.-+.++.++|||+||++||++.| |-.||.
T Consensus 389 RDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP 468 (1157)
T KOG4278|consen 389 RDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP 468 (1157)
T ss_pred hhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999999997654332 2222334568999999999999999999999999999988 889999
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
+.+..+.+.. +..+++-+-+..|++...+|++.||+++|.+||++.||-+.++.+.++.
T Consensus 469 GidlSqVY~L-LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 469 GIDLSQVYGL-LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred CccHHHHHHH-HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 9888776654 4556777788999999999999999999999999999999999887654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=271.33 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=199.3
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
..|...+.||+|++|.||+|.+ ++..+++|.+....... . ...+.+.+|+.+++.++|+|++++++++....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 88 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS--N----EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC--h----HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence 4588889999999999999976 57889999886432211 1 11234668999999999999999999887654
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+. ++|.+.+.. ....+++..++.++.|++.+|.|||+.+++|+||+|+||+++.
T Consensus 89 ~~----------------~lv~e~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~ 150 (308)
T cd06634 89 TA----------------WLVMEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 150 (308)
T ss_pred ee----------------EEEEEccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC
Confidence 44 56999996 578777643 2456899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
++.++|+|||.+...... ....++..|+|||.+. ...++.++||||||+++|+|++|..||...+.......+
T Consensus 151 ~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 226 (308)
T cd06634 151 PGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226 (308)
T ss_pred CCcEEECCcccceeecCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH
Confidence 999999999998754322 2345778899999974 345788999999999999999999999776655544444
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
............++..+.++|.+||+.+|.+||++.++++.-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred hhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 443333333456789999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=268.08 Aligned_cols=253 Identities=28% Similarity=0.365 Sum_probs=197.6
Q ss_pred ceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC---CCCccceeeeeccCC
Q 018489 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIGATMGS 126 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~~ 126 (355)
|++.+.||+|++|.||+|.+ ++..+|+|.++....... ....+.+|+.++.++ +|+||+++++++...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 73 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-------IPLSTLREIALLKQLESFEHPNIVRLLDVCHGP 73 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch-------hhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence 67899999999999999976 478999999964432111 112344566666555 699999999998765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. .....+++|||+. ++|.+++.......+++..++.++.|++.||.+||+.|++|+||+|+||+++
T Consensus 74 ~~~-----------~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~ 141 (287)
T cd07838 74 RTD-----------RELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT 141 (287)
T ss_pred cCC-----------CCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc
Confidence 531 0122478999996 4898888665455699999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+..
T Consensus 142 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~ 220 (287)
T cd07838 142 SDGQVKIADFGLARIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD 220 (287)
T ss_pred cCCCEEEeccCcceeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHH
Confidence 99999999999987553322 22233567889999999988899999999999999999999999988776666555543
Q ss_pred cCCCC-------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRP-------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..... .....+++.+.++|.+||+.||.+||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 21100 001134577899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=271.61 Aligned_cols=259 Identities=25% Similarity=0.342 Sum_probs=197.3
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||.|++|.||+|.+ ++..+++|.+......... ...+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF-------PITALREIKILKKLKHPNVVPLIDMAVER 79 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc-------chhHHHHHHHHHhcCCCCccchhhheecc
Confidence 47899999999999999999976 5788999998654322111 12256799999999999999999877654
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.... .......+++|+|+.+ +|...+.. ....+++..++.++.|+++||.|||++|++|+||+|+||+++
T Consensus 80 ~~~~--------~~~~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~ 149 (311)
T cd07866 80 PDKS--------KRKRGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID 149 (311)
T ss_pred cccc--------cccCceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 3221 1123456889999954 67766643 345799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCC-----------CCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCC
Q 018489 207 KNRTVKIADFGVARVEASNPND-----------MTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPD 274 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~ 274 (355)
.++.++|+|||.+......... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+
T Consensus 150 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 150 NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 9999999999998754322111 1223457789999988654 578899999999999999999999987
Q ss_pred CChhHHHHHHHhcCCCC---------------------CC-------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 275 LSFSEVTSAVVRQNLRP---------------------EI-------PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 275 ~~~~~~~~~~~~~~~~~---------------------~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+.......+....... .. ....++.+.++|.+||+.||.+|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 230 KSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 76654444333211000 00 0223467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=302.28 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=216.1
Q ss_pred ccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
....+..+||.|+++||+|+||.|.+++. +++.||+|++.+-......+ ..-|..|-.++..-+.+=|+.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~------tA~F~EERDimv~~ns~Wiv~Lh 141 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAE------TACFREERDIMVFGNSEWIVQLH 141 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchh------HHHHHHHhHHHHcCCcHHHHHHH
Confidence 34567789999999999999999999965 68899999985422111111 12366777788777889999998
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
..|.+...+ |+||||++||+|..++.+.. ++++..++.++..|+-||..||+.|+|||||||
T Consensus 142 yAFQD~~~L----------------YlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKP 203 (1317)
T KOG0612|consen 142 YAFQDERYL----------------YLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKP 203 (1317)
T ss_pred HHhcCccce----------------EEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCc
Confidence 887765555 66999999999999996543 799999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~lltg~~p~~~ 274 (355)
+|||++..|+++|.|||.+-....++ -.....+|||-|.+||++.. +.|+...|.||+|+++|+|+.|..||..
T Consensus 204 DNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 204 DNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred ceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 99999999999999999987666444 34556789999999999862 5688999999999999999999999999
Q ss_pred CChhHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 018489 275 LSFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPE---MDEVVS 324 (355)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 324 (355)
.+..+.+..+........+| ..+|.++.+||.+++ -+|+.|.. ++++..
T Consensus 284 dslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 284 DSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred HHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 99999999999887666677 458999999999999 67888887 877765
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=274.34 Aligned_cols=262 Identities=23% Similarity=0.390 Sum_probs=201.6
Q ss_pred cceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
.|++ ..+|.+.+.||+|++|.||+|.+ +++.||+|.+....... .....+.+|+.+++.++||||+++++
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~ 81 (342)
T cd07879 10 VWEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-------IFAKRAYRELTLLKHMQHENVIGLLD 81 (342)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-------cchhHHHHHHHHHHhcCCCCccchhh
Confidence 3555 36899999999999999999975 68999999986432111 11234678999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++....... .....+++++|+. .+|..+. ...+++..++.++.|++.||+|||+.|++|+||+|+
T Consensus 82 ~~~~~~~~~----------~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~ 146 (342)
T cd07879 82 VFTSAVSGD----------EFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPG 146 (342)
T ss_pred eecccccCC----------CCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 876543221 1123478999995 4676654 346899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
||+++.++.++|+|||.+..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+....
T Consensus 147 NIll~~~~~~kL~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~ 223 (342)
T cd07879 147 NLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 223 (342)
T ss_pred HEEECCCCCEEEeeCCCCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999874432 2233456788999999876 4578899999999999999999999987665444
Q ss_pred HHHHHhcCC---------------------CC--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHh
Q 018489 281 TSAVVRQNL---------------------RP--------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAI 329 (355)
Q Consensus 281 ~~~~~~~~~---------------------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~ 329 (355)
...+..... .+ ......++.+.++|.+||+.||.+||++.+++. .++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 224 LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 433222100 00 001235778999999999999999999999995 47766
Q ss_pred Hh
Q 018489 330 DT 331 (355)
Q Consensus 330 ~~ 331 (355)
..
T Consensus 304 ~~ 305 (342)
T cd07879 304 RD 305 (342)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=265.89 Aligned_cols=248 Identities=28% Similarity=0.428 Sum_probs=198.7
Q ss_pred ceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
|++.+.||+|++|.||+|.. +++.+++|++........ ..+.+.+|+.+++.++|+||+++++++...+..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 73 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG-------IPSTALREISLLKELKHPNIVKLLDVIHTERKL 73 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccccc-------ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCce
Confidence 67788999999999999965 579999999975432111 123356799999999999999999988765444
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
+++|||++ ++|.+++.... ..+++..++.++.|++.+|++||+.|++|+||+|+||+++.++
T Consensus 74 ----------------~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~ 135 (282)
T cd07829 74 ----------------YLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG 135 (282)
T ss_pred ----------------EEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC
Confidence 66999996 58999986532 4699999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 018489 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 210 ~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 288 (355)
.++|+|||.+...............+..|+|||.+.+. .++.++|+|+||+++++|++|..||...+..+....+....
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 215 (282)
T cd07829 136 VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQIL 215 (282)
T ss_pred CEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHh
Confidence 99999999987655443344445567789999998776 78899999999999999999999998776554443332210
Q ss_pred C----------------CC-----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 289 L----------------RP-----------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 289 ~----------------~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
. .. ......+..+.++|.+||..+|.+||++.+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred CCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 00 011234778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=271.75 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=193.1
Q ss_pred cceeecccccccceEEEEEEEC----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccC
Q 018489 51 KLVIKSVIARGTFGTVHRGLYD----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 125 (355)
+|++.+.||+|+||.||++.+. +..||+|.+...... ....+.+.+|+.+++++ +||||+++++....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-------KILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-------chhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 5889999999999999999764 568999998532211 11234467899999999 69999999886532
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
... .....+++++|+. ++|.+++. ....+++..++.++.|++.||.|||+.|++|+||+|+|||+
T Consensus 74 ~~~------------~~~~~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili 138 (332)
T cd07857 74 FPG------------NFNELYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138 (332)
T ss_pred ccc------------cCCcEEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE
Confidence 211 1123467999984 68988884 35679999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCC----CCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 206 DKNRTVKIADFGVARVEASNPN----DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
+.++.++|+|||.+........ ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+....
T Consensus 139 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~ 218 (332)
T cd07857 139 NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ 218 (332)
T ss_pred cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH
Confidence 9999999999999875432211 1223467889999998765 4688999999999999999999999987654433
Q ss_pred HHHHHhcC--------------------------CCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 281 TSAVVRQN--------------------------LRP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~~--------------------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+.... ... ......+..+.+++.+||+.||.+|||+.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 219 LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 32222110 000 112335788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=266.12 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=197.1
Q ss_pred ceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
|++.+.||.|++|.||+|.+ +++.+++|.+....... .....+.+|+.+++.++|+|++++++++....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE-------GFPITAIREIKLLQKLRHPNIVRLKEIVTSKG-- 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc-------cchHHHHHHHHHHHhccCCCeeeheeeEecCC--
Confidence 67899999999999999976 46899999997543111 11234678999999999999999999887552
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
....+++|||+++ +|.+++... ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++
T Consensus 72 ------------~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~ 137 (287)
T cd07840 72 ------------KGSIYMVFEYMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG 137 (287)
T ss_pred ------------CCcEEEEeccccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC
Confidence 1234779999964 888887543 25799999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCC-CCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 210 TVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 210 ~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
.++|+|||.+........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+...
T Consensus 138 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~ 217 (287)
T cd07840 138 VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL 217 (287)
T ss_pred CEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999999875543321 2233456778999998765 45789999999999999999999999877665544444331
Q ss_pred CCCC-----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRP-----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+ .+...++..+.++|.+||+.+|.+||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 218 CGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1100 011123788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=296.63 Aligned_cols=262 Identities=29% Similarity=0.449 Sum_probs=194.2
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|+.++.||+|+||.||+++. +|..||||.+.... .........+|+..|.+|+|||||+++..+.+..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--------SDKLYSKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 6789999999999999999954 89999999985322 2233456788999999999999999987554322
Q ss_pred ccccccc--------------------------------------------------------------------cc---
Q 018489 128 ELHIQTE--------------------------------------------------------------------NG--- 136 (355)
Q Consensus 128 ~~~~~~~--------------------------------------------------------------------~~--- 136 (355)
...-..+ ++
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 1100000 00
Q ss_pred ------------------------cccCCC--------CceEEEEEecCCCCHHHHHHhhccccc-cHHHHHHHHHHHHH
Q 018489 137 ------------------------QVAMPS--------NICCVVVEYLPGGALKTYLIKNRRRKL-AFKVVVQLALDLAR 183 (355)
Q Consensus 137 ------------------------~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~~~-~~~~~~~i~~qi~~ 183 (355)
+-...+ .++||-||||+..+|.+++..+ ... .....|+++++|++
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N--~~~~~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN--HFNSQRDEAWRLFREILE 708 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc--ccchhhHHHHHHHHHHHH
Confidence 000011 4688999999998888888543 222 47889999999999
Q ss_pred HHHHHHhCCccccCCCCCcEEEcCCCcEEEeecccccccc------------------CCCCCCCCCCCcccccCCcccC
Q 018489 184 GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA------------------SNPNDMTGETGTLGYMAPEVLN 245 (355)
Q Consensus 184 al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~------------------~~~~~~~~~~~~~~y~aPE~~~ 245 (355)
||+|+|+.|++||||||.|||++.++.|||+|||+|+... .+....+..+||..|.|||++.
T Consensus 709 GLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 709 GLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 9999999999999999999999999999999999998611 0112345568999999999998
Q ss_pred CC---CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH-HHHHHhcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 018489 246 GN---PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV-TSAVVRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 246 ~~---~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
+. .|+.++|+||||++++||+ .||+..-+... +..+.+.....+ +...--+.-..+|++||+.||.+|||+
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA 865 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA 865 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence 64 4999999999999999998 56765433332 233322222211 122223456789999999999999999
Q ss_pred HHHHH
Q 018489 320 DEVVS 324 (355)
Q Consensus 320 ~ell~ 324 (355)
.|+|+
T Consensus 866 ~eLL~ 870 (1351)
T KOG1035|consen 866 TELLN 870 (1351)
T ss_pred HHHhh
Confidence 99985
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=275.56 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=198.8
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|++|.||+|.+ ++..||+|++...... ......+.+|+.+++.++|+||+++.+++...
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-------AIHAKRTYRELRLLKHMDHENVIGLLDVFTPA 86 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-------hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence 57899999999999999999976 5788999988532111 11123466799999999999999999877654
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+... .....++|+||+ +++|.+++. ...+++..++.++.|++.+|++||+.|++|+||+|+||+++
T Consensus 87 ~~~~----------~~~~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~ 152 (343)
T cd07851 87 SSLE----------DFQDVYLVTHLM-GADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN 152 (343)
T ss_pred cccc----------ccccEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 4310 112357899999 679999884 35699999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.
T Consensus 153 ~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~ 229 (343)
T cd07851 153 EDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM 229 (343)
T ss_pred CCCCEEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9999999999998754322 233456788999999865 367889999999999999999999998766555444433
Q ss_pred hcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRP-----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.....+ ......++.+.++|.+||+.+|.+|||+.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 230 NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 311100 011235889999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=269.80 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=194.4
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||.|+||.||++.+ ++..||+|.+....... ...+.+.+|+.+++.++||||+++.+++..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 80 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-------VLAKRTYRELKLLKHLRHENIISLSDIFIS 80 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-------chhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence 457899999999999999999964 67889999885432111 112446689999999999999999998754
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.. ..+++++||+ +++|..++. ..++++..+..++.|++++|.+||+.|++|+||+|+||++
T Consensus 81 ~~---------------~~~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili 141 (328)
T cd07856 81 PL---------------EDIYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI 141 (328)
T ss_pred CC---------------CcEEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE
Confidence 32 2236799998 668988773 3468889999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.++.++|+|||.+..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+
T Consensus 142 ~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~ 218 (328)
T cd07856 142 NENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218 (328)
T ss_pred CCCCCEEeCccccccccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999874322 2233456788999998766 56889999999999999999999999776543222111
Q ss_pred Hhc------------------------CCCC-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 285 VRQ------------------------NLRP-----EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 285 ~~~------------------------~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
... .... .....+++++.++|.+||+.+|++||++.+++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 219 TDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 110 0000 1113467899999999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=280.91 Aligned_cols=254 Identities=28% Similarity=0.540 Sum_probs=217.9
Q ss_pred ecCCcceeecccccccceEEEEEEECC-----ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYDG-----HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
|-.++.++.++||+|.||+|++|.|+. -.||||.++...... ....|.+|+.++..|+|+|++++|+
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--------~mddflrEas~M~~L~H~hliRLyG 178 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--------IMDDFLREASHMLKLQHPHLIRLYG 178 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--------hHHHHHHHHHHHHhccCcceeEEee
Confidence 345678889999999999999998853 459999997555432 3456999999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
+..+ ... .+|||.++.|+|.+.+.+.....|-...+..++.||+.|+.||.++++|||||-..
T Consensus 179 vVl~-qp~----------------mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAAR 241 (1039)
T KOG0199|consen 179 VVLD-QPA----------------MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAAR 241 (1039)
T ss_pred eecc-chh----------------hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 9876 322 45999999999999998756677999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCC---CCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDM---TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
|+++-....|||+|||+.+-.......+ ........|+|||.++...++.++|||++|+++|||++ |..||.+...
T Consensus 242 NlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 242 NLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred hheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 9999999999999999998554332222 11234668999999999999999999999999999998 7899999999
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
.+.++.+. .+.+..-+..++..+.++++.||..+|.+||++..|.+.+
T Consensus 322 ~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 322 IQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 88888877 5666677889999999999999999999999999997543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=264.43 Aligned_cols=247 Identities=26% Similarity=0.373 Sum_probs=194.5
Q ss_pred ceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeeccCCcc
Q 018489 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSE 128 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~ 128 (355)
|++.+.||.|++|.||+|.. +++.|+||.+...... .. .....+|+..+..+. |+||+++++++...+.
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 72 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WE-----ECMNLREVKSLRKLNEHPNIVKLKEVFRENDE 72 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hh-----HHHHHHHHHHHHhccCCCCchhHHHHhhcCCc
Confidence 67889999999999999976 5788999988543221 01 112346888999998 9999999998876544
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++||||+ +++|.+.+.......+++..++.++.|++.+|.|||++|++|+||+|+||+++.+
T Consensus 73 ~----------------~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~ 135 (283)
T cd07830 73 L----------------YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP 135 (283)
T ss_pred E----------------EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence 4 6799999 7899988866554578999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...+..+........
T Consensus 136 ~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~ 214 (283)
T cd07830 136 EVVKIADFGLAREIRSR-PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSV 214 (283)
T ss_pred CCEEEeecccceeccCC-CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHh
Confidence 99999999998754432 22334567888999998754 45789999999999999999999999776554443332211
Q ss_pred CCC----------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLR----------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... .......+..+.++|++||+.+|++||++.|++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 215 LGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000 0011123678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=279.77 Aligned_cols=237 Identities=24% Similarity=0.419 Sum_probs=196.0
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 125 (355)
...|.+...+|.|+|+.|-.+.+ ++...++|++.....+ ..+|+.++... +||||+++.+.+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------------~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------------NQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc-------------cccccchhhhhcCCCcceeecceecC
Confidence 46888999999999999988854 6888999999765222 22355444444 89999999999988
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
....+ +|||.+.|+.+.+.+... ..++ ..+..|+.+|+.|+.|||++|++||||||+|||+
T Consensus 388 ~~~~~----------------~v~e~l~g~ell~ri~~~--~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~ 448 (612)
T KOG0603|consen 388 GKEIY----------------LVMELLDGGELLRRIRSK--PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILL 448 (612)
T ss_pred Cceee----------------eeehhccccHHHHHHHhc--chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheee
Confidence 77764 599999999988887543 3344 7788899999999999999999999999999999
Q ss_pred -cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh-HHHHH
Q 018489 206 -DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTSA 283 (355)
Q Consensus 206 -~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~-~~~~~ 283 (355)
+..++++|+|||.+...... ....+-|..|.|||+.....|++++|+||||++||+||+|+.||...... +....
T Consensus 449 ~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~ 525 (612)
T KOG0603|consen 449 DGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR 525 (612)
T ss_pred cCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh
Confidence 69999999999999755433 34456788999999999999999999999999999999999999876655 33333
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+ ..+.+...+|+++++||.+||+.||.+|+++.+++.
T Consensus 526 i----~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 I----QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred h----cCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 2 334455789999999999999999999999999976
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=272.63 Aligned_cols=260 Identities=31% Similarity=0.571 Sum_probs=216.8
Q ss_pred eecCCcceeecccccccceEEEEEEECC-ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
++--+...+++.||+|-||.|.++...+ ..||+|.++-... ...+..|.+|+++|.+++||||+.+++++.
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~--------~~~r~~F~kEIkiLsqLkhPNIveLvGVC~ 605 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT--------KNARNDFLKEIKILSRLKHPNIVELLGVCV 605 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc--------hhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence 3345677899999999999999997665 9999999964332 223677999999999999999999999998
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
.++.+ |+++||++.|+|..++..+...........+|+.||+.+++||.+.+++||||.+.|+|
T Consensus 606 ~DePi----------------cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcL 669 (807)
T KOG1094|consen 606 QDDPL----------------CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCL 669 (807)
T ss_pred cCCch----------------HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhcccccccee
Confidence 77766 67999999999999997664444566777789999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHH--hCCCCCCCCChhHH
Q 018489 205 LDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY--CCDMPYPDLSFSEV 280 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll--tg~~p~~~~~~~~~ 280 (355)
++.++++|++|||.++...+.. ......+....|+|||.+.-+.++.++|+|++|+++||++ +...||...++++.
T Consensus 670 v~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v 749 (807)
T KOG1094|consen 670 VDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV 749 (807)
T ss_pred ecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH
Confidence 9999999999999998543322 2223345678999999999999999999999999999975 57899999888777
Q ss_pred HHHHHh---cC---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 281 TSAVVR---QN---LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 281 ~~~~~~---~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
...... .. .....|..++.++.+++..||..+-.+||+++++-..|++.
T Consensus 750 ven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 750 VENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 665433 11 22345778999999999999999999999999999888764
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=266.16 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=214.7
Q ss_pred cceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFI 120 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~ 120 (355)
.-.+...+|.++.+||+|+||.|.++.. +.+.+|||+++++..-...+.+.. +.|-++|... +-|.++++.
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvect------m~EKrvLAL~~kppFL~qlH 416 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECT------MVEKRVLALPGKPPFLVQLH 416 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccce------ehhhhheecCCCCchHHHHH
Confidence 3367778999999999999999999965 457799999987654333332221 2355666666 567889999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
.+|..-+.+|+ ||||+.||+|-..|. .-+.+.+..+..++.+|+-+|-+||++||++||||.
T Consensus 417 ScFQTmDRLyF----------------VMEyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKL 478 (683)
T KOG0696|consen 417 SCFQTMDRLYF----------------VMEYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKL 478 (683)
T ss_pred HHhhhhhheee----------------EEEEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccc
Confidence 99988887755 999999999998884 446799999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
+|||++.+|++||.|||.+.-...........+||+.|+|||++.-.+|+.++|.|++|++||+|+.|..||.+.++++.
T Consensus 479 DNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el 558 (683)
T KOG0696|consen 479 DNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 558 (683)
T ss_pred cceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 99999999999999999997555555566678999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
...+...+. .+|..+|.+..++++..|.+.|.+|...
T Consensus 559 F~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 559 FQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred HHHHHHccC--cCcccccHHHHHHHHHHhhcCCccccCC
Confidence 999887654 5889999999999999999999999643
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=277.36 Aligned_cols=248 Identities=22% Similarity=0.317 Sum_probs=219.7
Q ss_pred eecCCcceeecccccccceEEEEEEECCce--eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHD--VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
.+..++++++..||-|+||.|-++...++. +|+|++++.+....... +.+..|-+++...+.|.||++|..|
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQq------eHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQ------EHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHH------HHHHhHHHHHHhcCchHHHHHHHHh
Confidence 455678999999999999999999776555 89999987665433332 3466788999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.+.... |++||-|-||.|+..+. .++.|++.+...++.-+++|+.|||++||++|||||+|+
T Consensus 490 rd~kyv----------------YmLmEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENl 551 (732)
T KOG0614|consen 490 RDSKYV----------------YMLMEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENL 551 (732)
T ss_pred ccchhh----------------hhhHHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhe
Confidence 876666 45999999999999994 557799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
+++.+|.+||.|||+|......... ..++||+.|.|||++..+..+.++|.|+||+++|+|++|.+||.+.+.-..++.
T Consensus 552 lLd~~Gy~KLVDFGFAKki~~g~KT-wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ 630 (732)
T KOG0614|consen 552 LLDNRGYLKLVDFGFAKKIGSGRKT-WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL 630 (732)
T ss_pred eeccCCceEEeehhhHHHhccCCce-eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 9999999999999999877655444 447999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 318 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 318 (355)
+++.--...+|..++....+||+++...+|.+|..
T Consensus 631 ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 631 ILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 99988888899999999999999999999999975
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=235.06 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=208.3
Q ss_pred cceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|.-.+.||+|+||+||+++ .+++.||+|.++.++.+..-.. ...+|+-+++.++|.||++++++...+..
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvps-------salreicllkelkhknivrl~dvlhsdkk 75 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPS-------SALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcH-------HHHHHHHHHHHhhhcceeehhhhhccCce
Confidence 56677899999999999994 5789999999987776655442 25689999999999999999999887666
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
.. +|+||| ...|..+.... ++.++...+..++.|++.+|.++|++++.|||+||.|.+|+.+
T Consensus 76 lt----------------lvfe~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n 137 (292)
T KOG0662|consen 76 LT----------------LVFEFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN 137 (292)
T ss_pred eE----------------EeHHHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC
Confidence 64 499999 56888888654 5679999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHh
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~ 286 (355)
|+++|.|||+++...-+.......+.|..|.+|.++.|. -|+.+.|+||.||++.++.. |.+.|++.+-.+++..+..
T Consensus 138 gelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~ 217 (292)
T KOG0662|consen 138 GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_pred CcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence 999999999998777666677778889999999999874 58889999999999999987 7888899888888887766
Q ss_pred cCCCCC---------C---------C---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPE---------I---------P---------RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~---------~---------~---------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.-..+. + + ..++..-++++.++|.-+|.+|++++++++
T Consensus 218 ~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 218 LLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred HhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 322111 0 1 111233578999999999999999998875
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=278.35 Aligned_cols=263 Identities=27% Similarity=0.420 Sum_probs=202.2
Q ss_pred cceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
-+..-+.||+|+||.||+++ .+|+.||||.++.... ..-+++..+|++++++++|+|||+++++=.....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--------~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--------LRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--------cchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 34566789999999999996 4799999999964331 1224568899999999999999999886544332
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD- 206 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~- 206 (355)
+. ......++||||.||+|...+.+.. ..++++...+.++.++..||.|||++||+||||||.||++-
T Consensus 86 -~~---------~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~ 155 (732)
T KOG4250|consen 86 -GL---------VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQI 155 (732)
T ss_pred -Cc---------ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEee
Confidence 11 2445578999999999999996533 45799999999999999999999999999999999999984
Q ss_pred -CCCc--EEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChh----
Q 018489 207 -KNRT--VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS---- 278 (355)
Q Consensus 207 -~~~~--v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~---- 278 (355)
.+|+ -||+|||.|+-..++ ......+||..|.+||.+.. +.|+...|.||+|+++|++.||..||-.....
T Consensus 156 Gedgq~IyKLtDfG~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~ 234 (732)
T KOG4250|consen 156 GEDGQSIYKLTDFGAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK 234 (732)
T ss_pred cCCCceEEeeecccccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc
Confidence 3343 699999999855444 46777899999999999984 78999999999999999999999999654322
Q ss_pred HHHHHHHhcCC-------------------CCCCCCCCcH----HHHHHHHHhhhcCCCCCC--CHHHHHHHHHHhHhh
Q 018489 279 EVTSAVVRQNL-------------------RPEIPRCCPS----SLANVMKRCWDANPDKRP--EMDEVVSMLEAIDTS 332 (355)
Q Consensus 279 ~~~~~~~~~~~-------------------~~~~~~~~~~----~l~~li~~~l~~~p~~Rp--s~~ell~~l~~~~~~ 332 (355)
+....+..... ..+++..++. .+-.++..+|..+|++|. ...+....+.++...
T Consensus 235 ~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 235 EIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred hhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 23322222111 1112222232 356788899999999999 777777777776543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=260.34 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=196.7
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCC--Cc----cceee
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH--PN----VTKFI 120 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~----Iv~~~ 120 (355)
..+|.|+..+|+|+||.|..+.+ ++..||||+++ ....++++.+-|+++|+++.+ |+ ++.+.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik----------~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK----------NVDKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHH----------HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 68999999999999999999855 47889999984 455667778889999999932 32 55565
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
++|.. .++.|||+|.+ |.|+.+++..+.-.+++...+..|+.|+++++++||+.+++|.||||
T Consensus 158 ~wFdy----------------rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKP 220 (415)
T KOG0671|consen 158 DWFDY----------------RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKP 220 (415)
T ss_pred hhhhc----------------cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCCh
Confidence 55554 34558999999 77999999888888899999999999999999999999999999999
Q ss_pred CcEEEcC--------------------CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHH
Q 018489 201 ENMLLDK--------------------NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260 (355)
Q Consensus 201 ~Nili~~--------------------~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 260 (355)
+||++.. ...++++|||.|+..... ....+.|..|.|||++.+=+|+...||||+||
T Consensus 221 ENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGC 297 (415)
T KOG0671|consen 221 ENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGC 297 (415)
T ss_pred heEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeee
Confidence 9999832 335899999999865533 24467889999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHhcCC-------------------CCCCC-------------------------CC
Q 018489 261 CLWEIYCCDMPYPDLSFSEVTSAVVRQNL-------------------RPEIP-------------------------RC 296 (355)
Q Consensus 261 il~~lltg~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~-------------------------~~ 296 (355)
||+|+++|...|+..++.+.+.....-.. ..+.+ +.
T Consensus 298 IL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~ 377 (415)
T KOG0671|consen 298 ILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDL 377 (415)
T ss_pred EEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcH
Confidence 99999999999987765443221111000 00000 11
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 297 CPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 297 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+|.+||++||.+||.+|+|+.|+|.
T Consensus 378 e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 378 EHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHhHHHHHHHHHHccCccccccHHHHhc
Confidence 1245899999999999999999999986
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=254.31 Aligned_cols=241 Identities=23% Similarity=0.443 Sum_probs=195.7
Q ss_pred ecccccccceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCccccc
Q 018489 55 KSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHI 131 (355)
Q Consensus 55 ~~~lg~G~~~~Vy~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~~ 131 (355)
.+.||+|+++.|-.+ ..++..||||++.+... ..+.++.+|++++.+. .|+||++++++|.++..+|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---------HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY- 152 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---------HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY- 152 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc---------hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE-
Confidence 468999999999877 45899999999965432 2256688999999999 8999999999999888875
Q ss_pred ccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC--
Q 018489 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR-- 209 (355)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~-- 209 (355)
+|||.+.||+|...|. ....|++.++.++.++|+.||.+||.+||.|||+||+|||.....
T Consensus 153 ---------------LVfEKm~GGplLshI~--~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 153 ---------------LVFEKMRGGPLLSHIQ--KRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKV 215 (463)
T ss_pred ---------------EEEecccCchHHHHHH--HhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCc
Confidence 4999999999999984 457799999999999999999999999999999999999997554
Q ss_pred -cEEEeecccccccc-------CCCCCCCCCCCcccccCCcccC---C--CCCCCcchhHHHHHHHHHHHhCCCCCCCC-
Q 018489 210 -TVKIADFGVARVEA-------SNPNDMTGETGTLGYMAPEVLN---G--NPYNRKCDVYSFGICLWEIYCCDMPYPDL- 275 (355)
Q Consensus 210 -~v~L~Dfg~a~~~~-------~~~~~~~~~~~~~~y~aPE~~~---~--~~~~~~~DvwslG~il~~lltg~~p~~~~- 275 (355)
-|||+||.+..-.. ...+.....+|+..|||||+.. + ..|+.+.|+||||+++|-||+|+.||.+.
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 48999998865221 1233445567999999999864 2 36889999999999999999999999753
Q ss_pred ------Ch--------hHHHHHHHhcCCCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 276 ------SF--------SEVTSAVVRQNLRPEIP----RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 276 ------~~--------~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+. ......+....+ ++| ..+|.+..++|+.+|..++.+|.++.+++.
T Consensus 296 g~dCGWdrGe~Cr~CQ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 296 GADCGWDRGEVCRVCQNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCcCCccCCCccHHHHHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11 222333333333 333 347999999999999999999999988876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=266.35 Aligned_cols=262 Identities=21% Similarity=0.389 Sum_probs=208.9
Q ss_pred cceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
+.....++|.++.+||+|+|+.||+|-+ ..+.||+|+-.... ...++..+.+-+...+|.++-+.|.||.||++|+
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK--~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNK--NWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhcc--chhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 3455668999999999999999999954 67889999975433 2445555666677889999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVK 199 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~di~ 199 (355)
+|.-+. ..+|-|+|||+|.+|.-+++. .+-+++.++..|+.||+.||.||.+.. |+|-|||
T Consensus 535 yfslDt---------------dsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLK 597 (775)
T KOG1151|consen 535 YFSLDT---------------DSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLK 597 (775)
T ss_pred eeeecc---------------ccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccC
Confidence 986433 234789999999999998854 466999999999999999999999874 9999999
Q ss_pred CCcEEEc---CCCcEEEeeccccccccCCCCCC-------CCCCCcccccCCcccCC----CCCCCcchhHHHHHHHHHH
Q 018489 200 TENMLLD---KNRTVKIADFGVARVEASNPNDM-------TGETGTLGYMAPEVLNG----NPYNRKCDVYSFGICLWEI 265 (355)
Q Consensus 200 p~Nili~---~~~~v~L~Dfg~a~~~~~~~~~~-------~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~~l 265 (355)
|.|||+- .-|.+|++|||++.......... ....||.+|++||.+.- ...+.+.||||+|+++|.+
T Consensus 598 PgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQC 677 (775)
T KOG1151|consen 598 PGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQC 677 (775)
T ss_pred CccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhh
Confidence 9999994 45789999999999776554432 22468999999999853 3567899999999999999
Q ss_pred HhCCCCCCCCChhHHHH---HHHhcC-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 266 YCCDMPYPDLSFSEVTS---AVVRQN-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 266 ltg~~p~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+.|+.||+.......+. .++... ...+.-..++.+..++|++||++.-++|.++.++..
T Consensus 678 lYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 678 LYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 99999998754332221 112211 111223457899999999999999999999998875
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=253.42 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=195.3
Q ss_pred CcceeecccccccceEEEEEEEC------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
..|++.+.||+|+||.||+|..+ ...+|||.++-........ ....+|+.+++.++|||++.+..+|
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-------~SAcREiaL~REl~h~nvi~Lv~Vf 96 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-------MSACREIALLRELKHPNVISLVKVF 96 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-------HHHHHHHHHHHHhcCCcchhHHHHH
Confidence 57999999999999999999432 2369999987554433322 2256799999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc---cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
...+ ..+.+++||.+. +|..+|+..+ .+.++...++.|++||+.++.|||+.=|+||||||
T Consensus 97 l~~d---------------~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKP 160 (438)
T KOG0666|consen 97 LSHD---------------KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKP 160 (438)
T ss_pred hccC---------------ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCc
Confidence 7642 223679999966 8888886543 35689999999999999999999999999999999
Q ss_pred CcEEEcCC----CcEEEeeccccccccCCCCCC---CCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCC
Q 018489 201 ENMLLDKN----RTVKIADFGVARVEASNPNDM---TGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPY 272 (355)
Q Consensus 201 ~Nili~~~----~~v~L~Dfg~a~~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~ 272 (355)
.||++..+ |.||++|||+++...++-... ..-+.|..|.|||.+.| ..|+.+.|+|++||++.||++..+.|
T Consensus 161 aNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF 240 (438)
T KOG0666|consen 161 ANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF 240 (438)
T ss_pred ceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence 99999877 899999999999776553332 33457899999999988 47999999999999999999998877
Q ss_pred CCCCh---------hHHHHHHHhcCCCCC-----------------------C------------CCCCcHHHHHHHHHh
Q 018489 273 PDLSF---------SEVTSAVVRQNLRPE-----------------------I------------PRCCPSSLANVMKRC 308 (355)
Q Consensus 273 ~~~~~---------~~~~~~~~~~~~~~~-----------------------~------------~~~~~~~l~~li~~~ 308 (355)
.+... .+++..++..-..+. . ...-++...+|+.+|
T Consensus 241 ~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~kl 320 (438)
T KOG0666|consen 241 KGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKL 320 (438)
T ss_pred cchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHH
Confidence 54321 122222222111100 0 111255688999999
Q ss_pred hhcCCCCCCCHHHHHH
Q 018489 309 WDANPDKRPEMDEVVS 324 (355)
Q Consensus 309 l~~~p~~Rps~~ell~ 324 (355)
|++||.+|.|++++++
T Consensus 321 L~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 321 LTYDPIKRITAEQALE 336 (438)
T ss_pred hccCchhhccHHHHhc
Confidence 9999999999999876
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=271.89 Aligned_cols=246 Identities=28% Similarity=0.451 Sum_probs=202.0
Q ss_pred cee--ecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 52 LVI--KSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 52 y~i--~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
|+| .+.||.|.||+||-|+ .+|+.||||++.+.....+.+ ..+.+|+.+|+.+.||+||.+.-.|...+
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-------sqlR~EVaILq~l~HPGiV~le~M~ET~e 636 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-------SQLRNEVAILQNLHHPGIVNLECMFETPE 636 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchH-------HHHHHHHHHHHhcCCCCeeEEEEeecCCc
Confidence 444 3689999999999885 579999999997766554443 34789999999999999999999998888
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD- 206 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~- 206 (355)
..++ |||.+.| +..+.|.....+.+++.....++.||+.||+|||-+||+|.||||+|||+.
T Consensus 637 rvFV----------------VMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas 699 (888)
T KOG4236|consen 637 RVFV----------------VMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLAS 699 (888)
T ss_pred eEEE----------------Eehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeecc
Confidence 8755 9999955 555555555677899999999999999999999999999999999999995
Q ss_pred --CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 207 --KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 207 --~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+--++||||||+|+......-. ..-+||+.|+|||+++.+.|..+-|+||.|+++|--++|..||+. .++....+
T Consensus 700 ~~~FPQvKlCDFGfARiIgEksFR-rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQI 776 (888)
T KOG4236|consen 700 ASPFPQVKLCDFGFARIIGEKSFR-RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQI 776 (888)
T ss_pred CCCCCceeeccccceeecchhhhh-hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHh
Confidence 3458999999999976644322 335799999999999999999999999999999999999999954 23333333
Q ss_pred HhcCC--CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNL--RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....+ .+.-+.+++++..+||..+|+..-++|.+.++.++
T Consensus 777 QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 777 QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 33322 23344678999999999999999999999987664
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=286.14 Aligned_cols=148 Identities=27% Similarity=0.426 Sum_probs=126.8
Q ss_pred CCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+. ++.||||+++...... ......+.+|+.++..++||||+++++.+...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~------~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN------KNMVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC------HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 368999999999999999999775 8999999996433211 12234577899999999999999999887655
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ++||||+.+++|.+++.. ...+++..++.|+.||+.||.|||.+||+|+||||+|||++
T Consensus 77 ~~~----------------~lVmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~ 138 (669)
T cd05610 77 NNV----------------YLVMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS 138 (669)
T ss_pred CEE----------------EEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc
Confidence 444 679999999999999854 35689999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccc
Q 018489 207 KNRTVKIADFGVAR 220 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~ 220 (355)
.++.++|+|||++.
T Consensus 139 ~~g~vkL~DFGls~ 152 (669)
T cd05610 139 NEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCEEEEeCCCCc
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=253.11 Aligned_cols=218 Identities=21% Similarity=0.255 Sum_probs=175.1
Q ss_pred ccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccccccccccc
Q 018489 61 GTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQV 138 (355)
Q Consensus 61 G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~ 138 (355)
|.++.||++.+ +++.+|+|.++.... +.+|...+....||||+++++++...+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~--------- 60 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------------YSRERLTIIPHCVPNMVCLHKYIVSEDSV--------- 60 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------------hhhHHHHHHhcCCCceeehhhheecCCeE---------
Confidence 89999999976 688999999864321 22344444556799999999988765544
Q ss_pred cCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccc
Q 018489 139 AMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218 (355)
Q Consensus 139 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~ 218 (355)
+++|||+++++|.+++... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++++|||.
T Consensus 61 -------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~ 131 (237)
T cd05576 61 -------FLVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSR 131 (237)
T ss_pred -------EEEEecCCCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccc
Confidence 6799999999999998543 4599999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCc
Q 018489 219 ARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCP 298 (355)
Q Consensus 219 a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (355)
+...... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..|+...... ........++..++
T Consensus 132 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~ 202 (237)
T cd05576 132 WSEVEDS---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVS 202 (237)
T ss_pred hhccccc---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCC
Confidence 7544322 22234567799999998888899999999999999999999887543211 11112223556688
Q ss_pred HHHHHHHHHhhhcCCCCCCCH
Q 018489 299 SSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 299 ~~l~~li~~~l~~~p~~Rps~ 319 (355)
+.+.++|.+||+.||.+||++
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCC
Confidence 999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=248.30 Aligned_cols=263 Identities=24% Similarity=0.348 Sum_probs=207.7
Q ss_pred ceecCCcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
+..+.+.|+-...||+|.||.||+|+ .+++.||+|..-..+....... ...+|+.+|..++|+|++.+++.
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpi-------talreikiL~~lkHenv~nliEi 84 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPI-------TALREIKILQLLKHENVVNLIEI 84 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcH-------HHHHHHHHHHHhcchhHHHHHHH
Confidence 34567889999999999999999985 4678899987755444333332 24579999999999999999988
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+......... +..++++||++|+. +|.-++. +....++...+.+++.+++.+|.|+|+..|+|||+|+.|
T Consensus 85 c~tk~Tp~~r--------~r~t~ylVf~~ceh-DLaGlLs-n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaN 154 (376)
T KOG0669|consen 85 CRTKATPTNR--------DRATFYLVFDFCEH-DLAGLLS-NRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAAN 154 (376)
T ss_pred HhhccCCccc--------ccceeeeeHHHhhh-hHHHHhc-CccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhh
Confidence 8654433220 24567899999965 7777663 345679999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecccccccc----CCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 018489 203 MLLDKNRTVKIADFGVARVEA----SNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~----~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~ 277 (355)
++|+.+|.++|.|||+++... ...+.+++.+.|..|.+||.+.| ..++.+.|+|..||++.+|+++.+.+++.++
T Consensus 155 vLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 155 VLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred EEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 999999999999999996432 22344566778999999999887 5789999999999999999999999999888
Q ss_pred hHHHHHHHh--cCCCCCCC-------------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 278 SEVTSAVVR--QNLRPEIP-------------------------------RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 278 ~~~~~~~~~--~~~~~~~~-------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+..+.. .....+.. ..-+++..+|+.++|..||.+|+++++++.
T Consensus 235 qqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 235 QQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred HHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 777765533 11111111 111457889999999999999999988775
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=249.49 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=207.2
Q ss_pred hhhcccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CC
Q 018489 37 FLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DH 113 (355)
Q Consensus 37 ~~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 113 (355)
+.+.....+++..++.+-++.||.|+||+|++..+ .|...|||.++.... +.+ -+++..|.+...+. ++
T Consensus 51 ~~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~ke----q~rll~e~d~~mks~~c 122 (361)
T KOG1006|consen 51 KLPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKE----QKRLLMEHDTVMKSSNC 122 (361)
T ss_pred ecCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHH----HHHHHHHHHHHHhhcCC
Confidence 45666777899999999999999999999998855 689999999975443 111 23466677766665 89
Q ss_pred CccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHH---hhccccccHHHHHHHHHHHHHHHHHHHh
Q 018489 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI---KNRRRKLAFKVVVQLALDLARGLSYLHS 190 (355)
Q Consensus 114 ~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~~i~~qi~~al~~LH~ 190 (355)
||||++|+..+..... .|.||.| .-||..+.+ ......+++..+..|..-.+.||.||..
T Consensus 123 p~IVkfyGa~F~EGdc----------------WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~ 185 (361)
T KOG1006|consen 123 PNIVKFYGALFSEGDC----------------WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE 185 (361)
T ss_pred cHHHHHhhhhhcCCce----------------eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH
Confidence 9999999988766655 5589988 557766553 2345679999999999999999999986
Q ss_pred C-CccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC--CCCCCcchhHHHHHHHHHHHh
Q 018489 191 Q-KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 191 ~-~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~llt 267 (355)
. .|+|||+||+|||++..|.+||||||++..... ....+...|...|+|||.+.. .+|+.++||||||+++||+.|
T Consensus 186 ~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAt 264 (361)
T KOG1006|consen 186 ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVAT 264 (361)
T ss_pred HhhhhhccCChhheEEecCCCEeeecccchHhHHH-HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeec
Confidence 5 899999999999999999999999999864432 233344577889999999975 468999999999999999999
Q ss_pred CCCCCCCCCh-hHHHHHHHhcCCCCC-CC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 268 CDMPYPDLSF-SEVTSAVVRQNLRPE-IP---RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 268 g~~p~~~~~~-~~~~~~~~~~~~~~~-~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
|+.|+...+. .+++..++....... .+ ..++..+..+|..||.+|-..||.+.++++
T Consensus 265 G~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 265 GNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 9999988755 334444444333222 22 236899999999999999999999999886
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=249.21 Aligned_cols=257 Identities=22% Similarity=0.364 Sum_probs=213.4
Q ss_pred chhhcccccceecCCcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-C
Q 018489 36 NFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-D 112 (355)
Q Consensus 36 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 112 (355)
......+..|.+...+|.++.+||+|+|+.|.++. .+...+|+|++++.-.+...+. .-+..|-.+..+. +
T Consensus 236 ~~m~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedi------dwvqtek~vfe~asn 309 (593)
T KOG0695|consen 236 DGMDGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDI------DWVQTEKHVFEQASN 309 (593)
T ss_pred hhccccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccc------hhHHhhHHHHHhccC
Confidence 34455667788999999999999999999999884 4678899999975543332221 2244566666666 8
Q ss_pred CCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC
Q 018489 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK 192 (355)
Q Consensus 113 h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ 192 (355)
||.+|.+..+|.....++ +|.||++||+|--.+ ++.++++++.+..+...|..||.|||++|
T Consensus 310 ~pflvglhscfqtesrlf----------------fvieyv~ggdlmfhm--qrqrklpeeharfys~ei~lal~flh~rg 371 (593)
T KOG0695|consen 310 NPFLVGLHSCFQTESRLF----------------FVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEICLALNFLHERG 371 (593)
T ss_pred CCeEEehhhhhcccceEE----------------EEEEEecCcceeeeh--hhhhcCcHHHhhhhhHHHHHHHHHHhhcC
Confidence 999999999999887774 499999999997666 45678999999999999999999999999
Q ss_pred ccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 018489 193 IVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272 (355)
Q Consensus 193 i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~ 272 (355)
|++||||.+|++++..|++||+|+|.+.-...++......+||+.|.|||+++|..|..+.|.|+||+++++|+.|+.||
T Consensus 372 iiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspf 451 (593)
T KOG0695|consen 372 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 451 (593)
T ss_pred eeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCc
Confidence 99999999999999999999999999987666777777899999999999999999999999999999999999999999
Q ss_pred CC--------CChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 018489 273 PD--------LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 318 (355)
Q Consensus 273 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 318 (355)
.- +++....+.++... ..+|..++.....+++..|++||.+|..
T Consensus 452 divgm~n~d~ntedylfqvilekq--iriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 452 DIVGMDNPDMNTEDYLFQVILEKQ--IRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ceecCCCcccchhHHHHHHHhhhc--ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 52 22233333344333 3478888999999999999999999963
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=271.33 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=213.9
Q ss_pred CCcceeecccccccceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 125 (355)
...|+|.+.||.|.+|.||++ +++++..|+|+....... ++ ....|.++++.. .|||++.++++|..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---de-------EiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EE-------EIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cH-------HHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 467889999999999999988 568999999998644432 22 245688888888 79999999999876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. ..+.+.+|||||.|||..|+++...+..+.|..+..|++.++.++.+||...++|||||-.|||+
T Consensus 88 ~~~~-----------~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL 156 (953)
T KOG0587|consen 88 KDPG-----------NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL 156 (953)
T ss_pred ecCC-----------CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE
Confidence 5542 24556899999999999999988778899999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
+.++.|||+|||.+.............+||+.|||||++.. ..|+.++|+||||++..+|.-|.+|+-+...-..
T Consensus 157 T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra 236 (953)
T KOG0587|consen 157 TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA 236 (953)
T ss_pred eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh
Confidence 99999999999999877776667777899999999999864 3678899999999999999999999987766555
Q ss_pred HHHHHhcCCCCCC-CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 281 TSAVVRQNLRPEI-PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+..+-+....... +...+.++.++|..||.+|.++||+..++++
T Consensus 237 LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 5544332222112 4556889999999999999999999988764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=251.35 Aligned_cols=256 Identities=36% Similarity=0.623 Sum_probs=207.8
Q ss_pred CcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC--CCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL--DHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~Iv~~~~~~~~~~ 127 (355)
.+.++.+.||+|.||.||+|.|.|+.||||+|...++ +.+.+|.++++.. +|+||+.+++.-..+.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE------------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE------------RSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccch------------hhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 5678899999999999999999999999999964432 3367788888876 9999999998765544
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC--------CccccCCC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ--------KIVHRDVK 199 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--------~i~H~di~ 199 (355)
.. ...++||.+|-+.|||.|++.. ..++....++++..++.+|++||.. .|.|||||
T Consensus 279 gs------------~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK 343 (513)
T KOG2052|consen 279 GS------------WTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK 343 (513)
T ss_pred Cc------------eEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence 33 2345899999999999999943 6799999999999999999999963 49999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCC----CCCCCCCCcccccCCcccCCC----CC--CCcchhHHHHHHHHHHHh--
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNP----NDMTGETGTLGYMAPEVLNGN----PY--NRKCDVYSFGICLWEIYC-- 267 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~----~~~~~~~~~~~y~aPE~~~~~----~~--~~~~DvwslG~il~~llt-- 267 (355)
..||||..+|...+.|+|+|....... ...+..+||.+|||||++... .+ -..+||||||.++||+..
T Consensus 344 SKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc 423 (513)
T KOG2052|consen 344 SKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRC 423 (513)
T ss_pred cccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999997654432 223446899999999998753 11 146899999999999864
Q ss_pred ---C-----CCCCC-----CCChhHHHHHHHhcCCCCCCCCCC--c---HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 268 ---C-----DMPYP-----DLSFSEVTSAVVRQNLRPEIPRCC--P---SSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 268 ---g-----~~p~~-----~~~~~~~~~~~~~~~~~~~~~~~~--~---~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
| .+||. +.+.+++.+.+....+++.++... . ..+.++++.||..||.-|.|+-.|.+.|.++
T Consensus 424 ~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 424 ESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred hcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 2 56774 345667666666677777776543 2 3477889999999999999999999999998
Q ss_pred Hhh
Q 018489 330 DTS 332 (355)
Q Consensus 330 ~~~ 332 (355)
..+
T Consensus 504 ~~~ 506 (513)
T KOG2052|consen 504 SNS 506 (513)
T ss_pred hcC
Confidence 754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=233.60 Aligned_cols=245 Identities=19% Similarity=0.341 Sum_probs=195.7
Q ss_pred cCCcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeecc
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 124 (355)
..++|++.+.+|+|.+|.||.|. .+++.++||+++.- -++.+.+|+.+|..+ +||||+++++...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------------kkkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------------KKKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------------HHHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 46899999999999999999995 68899999999521 145688999999999 5999999999888
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
++... +..+++||+++.+...+. ..++...+..++.+++.||.|+|+.||.|||+||.|++
T Consensus 104 Dp~Sk--------------tpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvm 164 (338)
T KOG0668|consen 104 DPESK--------------TPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVM 164 (338)
T ss_pred Ccccc--------------CchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceee
Confidence 76543 336799999887776554 45888999999999999999999999999999999999
Q ss_pred EcC-CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCC-CCChhHHH
Q 018489 205 LDK-NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYP-DLSFSEVT 281 (355)
Q Consensus 205 i~~-~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~-~~~~~~~~ 281 (355)
|+. ...++|+|||+|.+... +......+.+..|..||.+.. ..|+.+-|+|||||++..|+..+-||- +.++.+++
T Consensus 165 Idh~~rkLrlIDWGLAEFYHp-~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQL 243 (338)
T KOG0668|consen 165 IDHELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 243 (338)
T ss_pred echhhceeeeeecchHhhcCC-CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHH
Confidence 985 46799999999986653 344555667778999999876 578999999999999999999999984 33332222
Q ss_pred HHHHh---------------cCCCCC--------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVR---------------QNLRPE--------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~---------------~~~~~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
-.+-+ ..+.+. ...-.++++.+++.++|..|..+|+|+.|++.
T Consensus 244 VkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 244 VKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 22111 000000 11123689999999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=242.09 Aligned_cols=236 Identities=31% Similarity=0.503 Sum_probs=191.7
Q ss_pred cceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccccccccc
Q 018489 62 TFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVA 139 (355)
Q Consensus 62 ~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~ 139 (355)
+||.||+|.+. ++.+++|++........ .+.+.+|++.++.++|+||+++++.+......
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~---------- 62 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--------RERILREISILKKLKHPNIVRLYDVFEDEDKL---------- 62 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEE----------
Confidence 57899999764 68999999864433211 35688899999999999999999987765443
Q ss_pred CCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeecccc
Q 018489 140 MPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219 (355)
Q Consensus 140 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a 219 (355)
++++||+++++|.+++... ..+++..++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 63 ------~l~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~ 134 (244)
T smart00220 63 ------YLVMEYCDGGDLFDLLKKR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLA 134 (244)
T ss_pred ------EEEEeCCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccce
Confidence 6799999999999998543 33899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC-CChhHHHHHHHhcCCCCCCCCC-C
Q 018489 220 RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD-LSFSEVTSAVVRQNLRPEIPRC-C 297 (355)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~-~ 297 (355)
....... ......++..|++||.+.+..++.++|+|++|++++++++|..||.. .+.................... +
T Consensus 135 ~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (244)
T smart00220 135 RQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKI 213 (244)
T ss_pred eeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccC
Confidence 7654432 33445678889999999888889999999999999999999999987 3444433333332222222222 7
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 298 PSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 298 ~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+.++.+++.+||..+|.+||++.++++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhh
Confidence 899999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=290.74 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=188.1
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
.|...+.||+|+||.||+|.+ ++..||+|.+...... ...|+..+++++||||+++++++...+.
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------------PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------------cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 456677899999999999974 6889999988532210 1235788899999999999999876654
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCcEEE
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH---SQKIVHRDVKTENMLL 205 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~di~p~Nili 205 (355)
. ++||||+++++|.+++. .+++..+.+|+.|++.||+||| +.+++||||||+||++
T Consensus 758 ~----------------~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~ 816 (968)
T PLN00113 758 A----------------YLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816 (968)
T ss_pred C----------------EEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE
Confidence 4 56999999999999983 3889999999999999999999 6699999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-----hHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF-----SEV 280 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~-----~~~ 280 (355)
+.++..++. |+....... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... .+.
T Consensus 817 ~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~ 891 (968)
T PLN00113 817 DGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891 (968)
T ss_pred CCCCceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHH
Confidence 988887765 554432211 1223678899999999999999999999999999999999999853211 111
Q ss_pred HHHHHhc-----CCCCCC------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCC
Q 018489 281 TSAVVRQ-----NLRPEI------PRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335 (355)
Q Consensus 281 ~~~~~~~-----~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 335 (355)
....... ...+.+ ......++.+++.+||+.||++||++.++++.|+++....+.
T Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~ 957 (968)
T PLN00113 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957 (968)
T ss_pred HHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence 1110000 001111 111234578899999999999999999999999999765543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=269.67 Aligned_cols=266 Identities=34% Similarity=0.610 Sum_probs=223.1
Q ss_pred hcccccceecCCcceeecccccccceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHh
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 109 (355)
+... .|++..++..+.+.||+|.||.|++|.-. ...||||.++..... ...+.+..|+.+++
T Consensus 286 ~~~~-~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--------~~~~~~~~El~~m~ 356 (609)
T KOG0200|consen 286 PEDP-KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--------SEKKDLMSELNVLK 356 (609)
T ss_pred CcCC-ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--------HHHHHHHHHHHHHH
Confidence 4444 89999999999999999999999998531 356999998644332 22456889999999
Q ss_pred hC-CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc------------c--ccccHHHH
Q 018489 110 KL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------R--RKLAFKVV 174 (355)
Q Consensus 110 ~l-~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~--~~~~~~~~ 174 (355)
.+ .|+||+.+++.+...... ++|+||+..|+|.++++..+ . ..++....
T Consensus 357 ~~g~H~niv~llG~~t~~~~~----------------~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dL 420 (609)
T KOG0200|consen 357 ELGKHPNIVNLLGACTQDGPL----------------YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDL 420 (609)
T ss_pred HhcCCcchhhheeeeccCCce----------------EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHH
Confidence 99 799999999988774444 56999999999999997654 0 13889999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCC-CCCC--CcccccCCcccCCCCCCC
Q 018489 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM-TGET--GTLGYMAPEVLNGNPYNR 251 (355)
Q Consensus 175 ~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~-~~~~--~~~~y~aPE~~~~~~~~~ 251 (355)
+.++.||+.+++||++++++||||-..|||++.+..++++|||+++......... .... -...|||||.+....|+.
T Consensus 421 lsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~ 500 (609)
T KOG0200|consen 421 LSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTS 500 (609)
T ss_pred HHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccc
Confidence 9999999999999999999999999999999999999999999998544332221 1112 345699999999999999
Q ss_pred cchhHHHHHHHHHHHh-CCCCCCCCC-hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 252 KCDVYSFGICLWEIYC-CDMPYPDLS-FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 252 ~~DvwslG~il~~llt-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
++||||+|+++||+++ |..||.+.. ..+. ...+..+.+...|..+++++.++++.||+.+|++||++.++.+.++..
T Consensus 501 kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 501 KSDVWSFGILLWEIFTLGGTPYPGIPPTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cchhhHHHHHHHHHhhCCCCCCCCCCcHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 9999999999999998 889999866 4444 557788888889999999999999999999999999999999999996
Q ss_pred H
Q 018489 330 D 330 (355)
Q Consensus 330 ~ 330 (355)
.
T Consensus 580 l 580 (609)
T KOG0200|consen 580 L 580 (609)
T ss_pred H
Confidence 4
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=249.44 Aligned_cols=259 Identities=32% Similarity=0.563 Sum_probs=207.6
Q ss_pred CCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC--CCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL--DHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~Iv~~~~~~~~~ 126 (355)
....++.++||+|.||.||+|+.+++.||||+|...+ ++.|.+|-++++.. +|+||+++++.-...
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~------------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~ 276 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE------------KQSFQNEKNIYSLPGMKHENILQFIGAEKRG 276 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCHHH------------HHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence 4567788999999999999999999999999995221 34577777777765 899999998876544
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC---------CccccC
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ---------KIVHRD 197 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---------~i~H~d 197 (355)
... .--+.||++|-+.|+|.++++ ...++|....+|+..|+++|+|||+. .|+|||
T Consensus 277 t~~------------~~eywLVt~fh~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRD 341 (534)
T KOG3653|consen 277 TAD------------RMEYWLVTEFHPKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRD 341 (534)
T ss_pred Ccc------------ccceeEEeeeccCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccc
Confidence 411 112367999999999999994 45799999999999999999999963 599999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccccCC--CCCCCCCCCcccccCCcccCCCC-CC-----CcchhHHHHHHHHHHHhC-
Q 018489 198 VKTENMLLDKNRTVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLNGNP-YN-----RKCDVYSFGICLWEIYCC- 268 (355)
Q Consensus 198 i~p~Nili~~~~~v~L~Dfg~a~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~DvwslG~il~~lltg- 268 (355)
||..||||.+|++..|+|||+|...... .......+||.+|||||++.+.. +. .+.||||+|.++|||++.
T Consensus 342 lkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 342 LKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred ccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 9999999999999999999999866532 22334478999999999998742 22 468999999999999863
Q ss_pred -----------CCCCC-----CCChhHHHHHHHhcCCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 269 -----------DMPYP-----DLSFSEVTSAVVRQNLRPEIPRC-----CPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 269 -----------~~p~~-----~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
.+||+ ..+.+++....+..+.++.++.. ....+++.+..||+.|++-|.|+.=+-+.+.
T Consensus 422 ~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~ 501 (534)
T KOG3653|consen 422 TDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA 501 (534)
T ss_pred ccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence 23443 34556777777777888777644 2566999999999999999999999988888
Q ss_pred HhHhhcC
Q 018489 328 AIDTSKG 334 (355)
Q Consensus 328 ~~~~~~~ 334 (355)
.+.....
T Consensus 502 ~l~~~~~ 508 (534)
T KOG3653|consen 502 ELMMLWE 508 (534)
T ss_pred HHhccCC
Confidence 8876553
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=248.26 Aligned_cols=136 Identities=24% Similarity=0.392 Sum_probs=117.0
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-----C---Ccc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-----H---PNV 116 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~I 116 (355)
+...+|.+.+.||.|.|++||++-+ ..+.||+|+.+ ..+.+.+....|+++|+++. | .+|
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK----------SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK----------SAQHYTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEe----------hhhHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 3458999999999999999999976 46789999985 23445666789999999982 2 379
Q ss_pred ceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC-Cccc
Q 018489 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVH 195 (355)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H 195 (355)
|++++.|..... ...++|+|+|++ |..|..+|.+...+.++...+++|++||+.+|.|||.+ ||+|
T Consensus 145 V~LlD~FkhsGp------------NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIH 211 (590)
T KOG1290|consen 145 VQLLDHFKHSGP------------NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIH 211 (590)
T ss_pred eeeeccceecCC------------CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 999998865443 356789999999 88999999988889999999999999999999999976 9999
Q ss_pred cCCCCCcEEE
Q 018489 196 RDVKTENMLL 205 (355)
Q Consensus 196 ~di~p~Nili 205 (355)
.||||+|||+
T Consensus 212 TDlKPENvLl 221 (590)
T KOG1290|consen 212 TDLKPENVLL 221 (590)
T ss_pred cCCCcceeee
Confidence 9999999998
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=260.64 Aligned_cols=260 Identities=28% Similarity=0.531 Sum_probs=218.0
Q ss_pred cCCcceeecccccccceEEEEEEE--C----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--D----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
.....+-.++||.|+||+||+|.| + +.+||+|++....... ....+.+|+.++..++|||++++++
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~--------~s~e~LdeAl~masldHpnl~RLLg 765 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK--------ASIELLDEALRMASLDHPNLLRLLG 765 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch--------hhHHHHHHHHHHhcCCCchHHHHhh
Confidence 334456677899999999999976 3 4579999986433221 1234788999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
+...+. . .||++|+++|+|.++++.+ +..+.....+.|+.||++++.|||.++++||||-..
T Consensus 766 vc~~s~-~----------------qlvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaR 827 (1177)
T KOG1025|consen 766 VCMLST-L----------------QLVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAAR 827 (1177)
T ss_pred hcccch-H----------------HHHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhh
Confidence 988765 2 3599999999999999864 456888999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCC--CcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChh
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~ 278 (355)
|||+.....+++.|||+++............. ..+.|+|-|.+.-..++.++||||+|+++||++| |..|+.+...+
T Consensus 828 NVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~ 907 (1177)
T KOG1025|consen 828 NVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE 907 (1177)
T ss_pred heeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence 99999999999999999997766554443332 3567899999999999999999999999999998 99999998877
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
+.-+.+.. ..+...|..++.++..++.+||..|+..||++.++...+.++.....
T Consensus 908 eI~dlle~-geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 908 EIPDLLEK-GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred HhhHHHhc-cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 76655544 45578889999999999999999999999999999999988765443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=221.51 Aligned_cols=235 Identities=26% Similarity=0.425 Sum_probs=184.6
Q ss_pred CCCCCccccchhhcccccceecCCcceeecccccccceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHH
Q 018489 27 TATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104 (355)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E 104 (355)
+++...+.--+.....+.+++..++..-+..||+|++|.|-+. ..+|...|+|.++..-. . ...+++.+|
T Consensus 23 tpp~~Ld~~a~i~I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~----q~q~r~L~d 94 (282)
T KOG0984|consen 23 TPPRNLDSRALIYIGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----S----QEQKRLLMD 94 (282)
T ss_pred CCCcccCCCceEEEecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----h----HHHHHHHHh
Confidence 3333334444445555569999999999999999999987554 56899999999864332 1 112346678
Q ss_pred HHHHhhC-CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHh--hccccccHHHHHHHHHHH
Q 018489 105 VAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK--NRRRKLAFKVVVQLALDL 181 (355)
Q Consensus 105 ~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~qi 181 (355)
+.+..+. .||.+|.+|+.+.+....++ .||.+ ..||..+..+ ..+..+++..+-+|+..+
T Consensus 95 ldi~~r~~~CPf~V~FyGa~~regdvwI----------------cME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Sv 157 (282)
T KOG0984|consen 95 LDIIMRTVDCPFTVHFYGALFREGDVWI----------------CMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSV 157 (282)
T ss_pred hhhhccCCCCCeEEEeehhhhccccEEE----------------eHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHH
Confidence 8877766 89999999998887776654 89988 5688877653 356789999999999999
Q ss_pred HHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC----CCCCCcchhH
Q 018489 182 ARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG----NPYNRKCDVY 256 (355)
Q Consensus 182 ~~al~~LH~~-~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dvw 256 (355)
+.||.|||++ .++|||+||+||||+.+|+||+||||.+....+. ...+...|...|+|||.++. ..|+.++|||
T Consensus 158 v~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS-iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvW 236 (282)
T KOG0984|consen 158 VHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS-IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVW 236 (282)
T ss_pred HHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh-hHHHHhcCCCccCChhhcCcccCcccceeehhhh
Confidence 9999999987 8999999999999999999999999999765433 22233567788999999875 3789999999
Q ss_pred HHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhc
Q 018489 257 SFGICLWEIYCCDMPYPDL-SFSEVTSAVVRQ 287 (355)
Q Consensus 257 slG~il~~lltg~~p~~~~-~~~~~~~~~~~~ 287 (355)
|||+++.||.+++.||... +..+++..++..
T Consensus 237 SLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 237 SLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 9999999999999999764 556666666553
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=255.71 Aligned_cols=247 Identities=22% Similarity=0.342 Sum_probs=199.2
Q ss_pred eecCCcceeecccccccceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
.++++-|..++.||-|+||.|.++ .++...||+|.+++.+..... ....++.|-.||.....+-||++|..|
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rn------QvaHVKAERDILAEADn~WVVrLyySF 698 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRN------QVAHVKAERDILAEADNEWVVRLYYSF 698 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhh------hhhhhhhhhhhHhhcCCcceEEEEEEe
Confidence 567788999999999999999998 467888999998654332211 123466788899999999999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.+.+.+| +||+|++||++-.++.+ -+-|.+..++.++.++..|+.+.|+.|+|||||||+||
T Consensus 699 QDkdnLY----------------FVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNI 760 (1034)
T KOG0608|consen 699 QDKDNLY----------------FVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 760 (1034)
T ss_pred ccCCceE----------------EEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccce
Confidence 8877764 49999999999999854 36799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecccccc---------ccCCCC---------------------------------CCCCCCCcccccCC
Q 018489 204 LLDKNRTVKIADFGVARV---------EASNPN---------------------------------DMTGETGTLGYMAP 241 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~---------~~~~~~---------------------------------~~~~~~~~~~y~aP 241 (355)
||+.+|++||+|||+++- +..... .....+||..|+||
T Consensus 761 LIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiap 840 (1034)
T KOG0608|consen 761 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAP 840 (1034)
T ss_pred EEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccCh
Confidence 999999999999999751 110000 00112489999999
Q ss_pred cccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCC--CCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 018489 242 EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL--RPEIPRCCPSSLANVMKRCWDANPDKRP 317 (355)
Q Consensus 242 E~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp 317 (355)
|++....++...|.|+.|++||+|+.|..||-..+..+....++.+.. ......+++.+..++|.++. .+++.|.
T Consensus 841 evl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 841 EVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred HHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 999999999999999999999999999999987776665555544433 33445678999999998766 4566775
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=252.64 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=200.9
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCC------Cccc
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH------PNVT 117 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~Iv 117 (355)
++..++|.+....|+|-||+|.+|.+ .+..||||+++....- .+.=..|+++|++|+. -|++
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----------~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----------HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----------hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 67889999999999999999999976 4779999999754322 1223469999999943 3677
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh-ccccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-RRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
.++..|.. .+++|+|||-+ ...|.+++++. .+-++....+..++.|++-||..|...||+|.
T Consensus 498 rl~r~F~h----------------knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHa 560 (752)
T KOG0670|consen 498 RLFRHFKH----------------KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHA 560 (752)
T ss_pred HHHHHhhh----------------cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeec
Confidence 77766654 56669999998 67999999764 34568899999999999999999999999999
Q ss_pred CCCCCcEEEcCC-CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 197 DVKTENMLLDKN-RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 197 di~p~Nili~~~-~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
||||+|||+++. ..+||||||.|..... +..+.+..+..|.|||++.|-+|++..|+||+||+||+|.||+..|++.
T Consensus 561 DIKPDNiLVNE~k~iLKLCDfGSA~~~~e--neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 561 DIKPDNILVNESKNILKLCDFGSASFASE--NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred ccCccceEeccCcceeeeccCcccccccc--ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 999999999865 5689999999975443 3344456677899999999999999999999999999999999999998
Q ss_pred ChhHHHHHHHhcCCCCC-------------------------------------------------------CCCC---C
Q 018489 276 SFSEVTSAVVRQNLRPE-------------------------------------------------------IPRC---C 297 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~~-------------------------------------------------------~~~~---~ 297 (355)
++..++..........+ ++.. .
T Consensus 639 TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~ 718 (752)
T KOG0670|consen 639 TNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKI 718 (752)
T ss_pred CcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHH
Confidence 88777765544221111 0111 1
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 298 PSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 298 ~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
-.+|.+|+.+||..||++|.++.++|.
T Consensus 719 ~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 719 VQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 245889999999999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=259.99 Aligned_cols=255 Identities=16% Similarity=0.167 Sum_probs=166.9
Q ss_pred ceecCCcceeecccccccceEEEEEEE--C----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--D----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
.....++|++.+.||+|+||.||+|.+ + +..||+|.+..... .+ ....+ .+....+.++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e------~~~~e--~l~~~~~~~~~~ 193 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VE------IWMNE--RVRRACPNSCAD 193 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hH------HHHHH--HHHhhchhhHHH
Confidence 445678999999999999999999976 3 67899998742211 00 01111 111222223332
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc------------------ccccHHHHHHHHHH
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR------------------RKLAFKVVVQLALD 180 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------~~~~~~~~~~i~~q 180 (355)
++..+..... .......++|+||+.+++|.+++..... .......+..++.|
T Consensus 194 ~~~~~~~~~~----------~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~q 263 (566)
T PLN03225 194 FVYGFLEPVS----------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQ 263 (566)
T ss_pred HHHhhhcccc----------cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHH
Confidence 2222211100 1123445789999999999998854311 01123456789999
Q ss_pred HHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEeeccccccccCC-CCCCCCCCCcccccCCcccCCC-----------
Q 018489 181 LARGLSYLHSQKIVHRDVKTENMLLDK-NRTVKIADFGVARVEASN-PNDMTGETGTLGYMAPEVLNGN----------- 247 (355)
Q Consensus 181 i~~al~~LH~~~i~H~di~p~Nili~~-~~~v~L~Dfg~a~~~~~~-~~~~~~~~~~~~y~aPE~~~~~----------- 247 (355)
++.+|.|||++||+||||||+|||++. ++.++|+|||++...... ........+++.|+|||.+...
T Consensus 264 ll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~ 343 (566)
T PLN03225 264 ILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV 343 (566)
T ss_pred HHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccc
Confidence 999999999999999999999999985 589999999999744322 2223345788999999976432
Q ss_pred -----------CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh--------------cCCCC------CCCCC
Q 018489 248 -----------PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR--------------QNLRP------EIPRC 296 (355)
Q Consensus 248 -----------~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~--------------~~~~~------~~~~~ 296 (355)
.++.++||||+||++|+|+++..++... .......+. ..... ...+.
T Consensus 344 ~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 421 (566)
T PLN03225 344 ATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDL 421 (566)
T ss_pred cccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccc
Confidence 1334569999999999999987665421 111111111 00000 01111
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 297 CPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 297 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+....+||.+||+.||.+|||+.++++
T Consensus 422 ~~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 422 DGGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred cchHHHHHHHHHccCCcccCCCHHHHhC
Confidence 2344668999999999999999999987
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=251.53 Aligned_cols=270 Identities=19% Similarity=0.241 Sum_probs=182.8
Q ss_pred ecCCcceeecccccccceEEEEEEE------------------CCceeEEEEeecCCCCCccHHH-----HHHHHHHHHH
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY------------------DGHDVAVKLLDWGEEGHRTEAE-----IAALRSAFTQ 103 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~~~-----~~~~~~~~~~ 103 (355)
...++|.+.+.||+|+||.||+|.. .+..||||.+.........+.. .....+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3578999999999999999999853 3457999998543221100000 0001223445
Q ss_pred HHHHHhhCCCCcc-----ceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-------------
Q 018489 104 EVAVWHKLDHPNV-----TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------- 165 (355)
Q Consensus 104 E~~~l~~l~h~~I-----v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------- 165 (355)
|+.++.+++|.++ +++++++..... .-.+.....++||||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~--------~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~ 293 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTA--------DGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMA 293 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccc--------cccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhc
Confidence 6777777766544 455555432210 01112345689999999999999885321
Q ss_pred ---------cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCc
Q 018489 166 ---------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGT 235 (355)
Q Consensus 166 ---------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~ 235 (355)
...+++..++.++.|++.+|.|||+.+++|+||||+||+++.++.++|+|||.+........ ......++
T Consensus 294 g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~t 373 (507)
T PLN03224 294 GKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLD 373 (507)
T ss_pred CCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCC
Confidence 11245678899999999999999999999999999999999999999999999864432211 11122347
Q ss_pred ccccCCcccCCCC--------------------C--CCcchhHHHHHHHHHHHhCCC-CCCCCChhH-----------HH
Q 018489 236 LGYMAPEVLNGNP--------------------Y--NRKCDVYSFGICLWEIYCCDM-PYPDLSFSE-----------VT 281 (355)
Q Consensus 236 ~~y~aPE~~~~~~--------------------~--~~~~DvwslG~il~~lltg~~-p~~~~~~~~-----------~~ 281 (355)
+.|+|||.+.... + ....|+||+|+++|+|++|.+ ||....... .+
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~ 453 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW 453 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH
Confidence 8999999875421 1 124699999999999999986 765321111 01
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCC---CCCCCHHHHHH
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANP---DKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~ell~ 324 (355)
................++...+++.+||..+| .+|+|+.|+|+
T Consensus 454 r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 454 RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11111222333445678999999999999866 68999999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=235.22 Aligned_cols=273 Identities=25% Similarity=0.444 Sum_probs=222.0
Q ss_pred hhcccccceecCCcceeecccccccceEEEEEEECC-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhh
Q 018489 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110 (355)
Q Consensus 38 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 110 (355)
++...+++++...|++...++-+|+||.||.|.+.. +.|.+|.++.. .. +.....+..|.-++..
T Consensus 272 ~~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~------AS--~iQv~~~L~es~lly~ 343 (563)
T KOG1024|consen 272 FNRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH------AS--QIQVNLLLQESMLLYG 343 (563)
T ss_pred HhhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc------cc--HHHHHHHHHHHHHHhc
Confidence 345566788889999999999999999999996532 33556655311 11 1122347788888889
Q ss_pred CCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc------cccccHHHHHHHHHHHHHH
Q 018489 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------RRKLAFKVVVQLALDLARG 184 (355)
Q Consensus 111 l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~~~i~~qi~~a 184 (355)
+.|||+.++.++..+.... .+.++.+..-|.|..++...+ .+.++..+...++.|+..|
T Consensus 344 ~sH~nll~V~~V~ie~~~~---------------P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~a 408 (563)
T KOG1024|consen 344 ASHPNLLSVLGVSIEDYAT---------------PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMA 408 (563)
T ss_pred CcCCCccceeEEEeeccCc---------------ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHH
Confidence 9999999999887754433 356889998899999997332 3457888889999999999
Q ss_pred HHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCC--CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHH
Q 018489 185 LSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262 (355)
Q Consensus 185 l~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il 262 (355)
+.|||++|++|.||-..|.+|++..+|||+|=.+++..... .....+.-....||+||.+....|+.++|+||||+++
T Consensus 409 m~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVll 488 (563)
T KOG1024|consen 409 MEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLL 488 (563)
T ss_pred HHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHH
Confidence 99999999999999999999999999999999998854322 2233334456789999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 263 WEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 263 ~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
|||+| |+.|+-..+..++...+. .+.+...|.++|+++..++.-||...|++||+++++..-|.++....+
T Consensus 489 WELmtlg~~PyaeIDPfEm~~ylk-dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 489 WELMTLGKLPYAEIDPFEMEHYLK-DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred HHHHhcCCCCccccCHHHHHHHHh-ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 99998 899999999888776554 456778899999999999999999999999999999999998876544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=233.89 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=198.3
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+.+--+.||.|+||.||.+.+ +|+.|++|.+.. -.......+.+-+|+.+|+.++|.|++...+......
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-------vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph 125 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-------VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPAN 125 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcch-------HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCC
Confidence 3455567899999999999976 689999998742 1222233456778999999999999999988776554
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.-++ .-+|.+.|.+ ..+|..+| ...++++...++-++.||+.+|.|||+.||.||||||.|++++.
T Consensus 126 ~dfF-----------qEiYV~TELm-QSDLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS 191 (449)
T KOG0664|consen 126 PSFF-----------QELYVLTELM-QSDLHKII--VSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS 191 (449)
T ss_pred chHH-----------HHHHHHHHHH-Hhhhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc
Confidence 3322 1124477777 55888877 45678999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
+..+|+||||+++...... ...+..+.|..|.|||++.|. .|+.+.||||.||++.||+..+..|+..+.-+.+..+.
T Consensus 192 NCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt 271 (449)
T KOG0664|consen 192 NCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII 271 (449)
T ss_pred CceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH
Confidence 9999999999998755432 333445678899999999874 68999999999999999999999998877766666555
Q ss_pred hcCCCCC------------------------C--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 286 RQNLRPE------------------------I--------PRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 286 ~~~~~~~------------------------~--------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
..-..+. + +..-..+...++..+|.+||++|.+..+.+.-
T Consensus 272 dLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 272 DLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 4222221 1 11223467789999999999999999887754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=259.62 Aligned_cols=245 Identities=25% Similarity=0.427 Sum_probs=187.3
Q ss_pred CCcceeecccccccceE-EEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGT-VHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~ 126 (355)
..-|.-.+.+|.|+.|+ ||+|...++.||||.+-. ..-....+|+..|+.. .||||+++++.-.+
T Consensus 508 k~~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~------------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d- 574 (903)
T KOG1027|consen 508 KLFFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLE------------EFFDFAQREIQLLQESDEHPNVIRYYCSEQD- 574 (903)
T ss_pred eeeeccHHHcccCCCCcEEEEEeeCCceehHHHHhh------------HhHHHHHHHHHHHHhccCCCceEEEEeeccC-
Confidence 34455667889999986 799999999999998721 1123467899999999 89999999876554
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
+++.||..|.| ..+|.+++... ..........+.++.|++++|++||+.+|+||||||.|||
T Consensus 575 ---------------~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNIL 638 (903)
T KOG1027|consen 575 ---------------RQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNIL 638 (903)
T ss_pred ---------------CceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEE
Confidence 34457799999 56999999753 1111222456788999999999999999999999999999
Q ss_pred EcC---C--CcEEEeeccccccccCCCCC---CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhC-CCCCCCC
Q 018489 205 LDK---N--RTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDL 275 (355)
Q Consensus 205 i~~---~--~~v~L~Dfg~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg-~~p~~~~ 275 (355)
|+. + ..++|.|||++......... .....||.+|+|||++....-+.++|||||||++|+.++| .+||+..
T Consensus 639 I~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 639 ISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred EEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 975 2 47899999999876544322 3446799999999999988888899999999999999985 8999875
Q ss_pred ChhHHHHHHHhcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 276 SFSEVTSAVVRQNLRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
-..+.. ++...... .+......+..+||.+|++++|..||++.++|.
T Consensus 719 ~~R~~N--Il~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 719 LERQAN--ILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred HHhhhh--hhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 443322 22222211 122222238999999999999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=228.34 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=200.1
Q ss_pred cCCcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
...||.-+..+|.|.. .|..+- ..+.+|++|.....-.. . .. .++..+|...+..++|+||++++.+|.-
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~-----~~-akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-Q-----TH-AKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-C-----cc-chhhhhhhhhhhhhcccceeeeeeccCc
Confidence 3578999999999999 666663 46899999988654221 1 11 2345689999999999999999998875
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
....-. ..-.++|||++ ..+|...+. -.++-..+..|+.|++.++.|||+.||+||||||+||++
T Consensus 87 ~~~l~~----------~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv 151 (369)
T KOG0665|consen 87 QKTLEE----------FQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV 151 (369)
T ss_pred cccHHH----------HHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee
Confidence 443322 12236799999 568888874 347778999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
..++.+|++|||++...... -..+..+.+..|.|||++.+..+...+||||+||++.+|++|...|.+.+.-+++.++.
T Consensus 152 ~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~ 230 (369)
T KOG0665|consen 152 NSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKII 230 (369)
T ss_pred cchhheeeccchhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHH
Confidence 99999999999999866544 44556788899999999999889999999999999999999999998877655555444
Q ss_pred hcCCCCC-----------------------------CC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPE-----------------------------IP-----------RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~-----------------------------~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..-..+. ++ ......+++++.+||-.||++|.+++++|+
T Consensus 231 ~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 231 EQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 4221111 11 112356889999999999999999999987
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=217.75 Aligned_cols=210 Identities=37% Similarity=0.675 Sum_probs=179.9
Q ss_pred cccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccccc
Q 018489 58 IARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (355)
Q Consensus 58 lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~ 135 (355)
||.|.+|.||++... +..+++|++....... ..+.+.+|+..++.+.|++|+++++++......
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~------ 66 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--------LLEELLREIEILKKLNHPNIVKLYGVFEDENHL------ 66 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeE------
Confidence 689999999999876 8999999996443321 245688999999999999999999988765444
Q ss_pred ccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-CCcEEEe
Q 018489 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK-NRTVKIA 214 (355)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~-~~~v~L~ 214 (355)
++++|++.+++|.+++.... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+
T Consensus 67 ----------~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~ 135 (215)
T cd00180 67 ----------YLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLA 135 (215)
T ss_pred ----------EEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEe
Confidence 66999999899999985432 46899999999999999999999999999999999999999 8999999
Q ss_pred eccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCC
Q 018489 215 DFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEI 293 (355)
Q Consensus 215 Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
||+.+..............+...|++||.+... .++.+.|+|++|++++++
T Consensus 136 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------- 187 (215)
T cd00180 136 DFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------- 187 (215)
T ss_pred cCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------
Confidence 999997655433223345677889999999887 788999999999999998
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 294 PRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 294 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 689999999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=217.33 Aligned_cols=261 Identities=18% Similarity=0.307 Sum_probs=214.8
Q ss_pred ceecCCcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIG 121 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~ 121 (355)
..+-+-.|++++.||+|.||.+|.|. .++++||||.-...... ..+..|.+.++.| ..++|..+|-
T Consensus 23 ~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-----------PQLrdEYr~YKlL~g~~GIP~vYY 91 (449)
T KOG1165|consen 23 VLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-----------PQLRDEYRTYKLLGGTEGIPQVYY 91 (449)
T ss_pred ceEecccceeccccccCcceeeecccccccCceEEEEeccccCCc-----------chHHHHHHHHHHHcCCCCCCceee
Confidence 34556789999999999999999994 58999999997543332 2366788888888 7799999988
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
+..++.+- .+|||.+ |.+|+|++.- .++.|+.++++.++.||+.-++++|++.+|.|||||+
T Consensus 92 FGqeG~~N----------------iLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPd 153 (449)
T KOG1165|consen 92 FGQEGKYN----------------ILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPD 153 (449)
T ss_pred eccccchh----------------hhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCcc
Confidence 77766555 3599999 9999998865 4778999999999999999999999999999999999
Q ss_pred cEEEcCC-----CcEEEeeccccccccCCC-------CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCC
Q 018489 202 NMLLDKN-----RTVKIADFGVARVEASNP-------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269 (355)
Q Consensus 202 Nili~~~-----~~v~L~Dfg~a~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~ 269 (355)
|+||... ..+.++|||.|..+.++. .......||..||+...+.|..-+.+.|+.+||.++++.|.|.
T Consensus 154 NFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGs 233 (449)
T KOG1165|consen 154 NFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 233 (449)
T ss_pred ceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCC
Confidence 9999754 358999999998654432 2234457999999999999999999999999999999999999
Q ss_pred CCCCCCC---hhHHHHHHHhcCCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 270 MPYPDLS---FSEVTSAVVRQNLRP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 270 ~p~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
+||++.. ..+...++-...... .+...+|.++...++..-..+..+-|+++-+...+.++....+
T Consensus 234 LPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 234 LPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred CccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 9998764 344444443333222 3557789999999999999999999999999999999887654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=213.67 Aligned_cols=253 Identities=19% Similarity=0.296 Sum_probs=186.7
Q ss_pred cccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCcc
Q 018489 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNV 116 (355)
Q Consensus 40 ~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~I 116 (355)
.....+++. +.|.|.+.||+|.||.+-++.+ +++.+++|.+...-. ..+.|.+|...--.| .|.||
T Consensus 15 ~el~kv~l~-d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----------t~~dF~rEfhY~~~Ls~H~hI 83 (378)
T KOG1345|consen 15 EELKKVDLE-DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----------TQADFVREFHYSFFLSPHQHI 83 (378)
T ss_pred ccccccchh-hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----------hHHHHHHHhccceeeccchhh
Confidence 333444443 7799999999999999999976 467899999853221 123477888766666 68999
Q ss_pred ceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
+.-|+.......+| ++++||++.|+|..-+ ...++.+....+++.|+++||.|+|+++++||
T Consensus 84 i~tY~vaFqt~d~Y---------------vF~qE~aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHsknlVHR 145 (378)
T KOG1345|consen 84 IDTYEVAFQTSDAY---------------VFVQEFAPRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHSKNLVHR 145 (378)
T ss_pred hHHHHHHhhcCceE---------------EEeeccCccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhccchhhc
Confidence 99888765544433 5799999999999887 34568999999999999999999999999999
Q ss_pred CCCCCcEEEc--CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-----CCCCcchhHHHHHHHHHHHhCC
Q 018489 197 DVKTENMLLD--KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-----PYNRKCDVYSFGICLWEIYCCD 269 (355)
Q Consensus 197 di~p~Nili~--~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~lltg~ 269 (355)
|||.+||||- +...|||||||.++....... ..-.+..|.+||..... ...+.+|+|+||+++|.++||+
T Consensus 146 dlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~ 222 (378)
T KOG1345|consen 146 DLKAENILIFDADFYRVKLCDFGLTRKVGTTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGK 222 (378)
T ss_pred ccccceEEEecCCccEEEeeecccccccCceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCC
Confidence 9999999994 456899999999875432211 12234568999986432 3467899999999999999999
Q ss_pred CCCCCCCh---hHHHHHHHhcCCCCCCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 270 MPYPDLSF---SEVTSAVVRQNLRPEIP---RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 270 ~p~~~~~~---~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.||+.... .-..............| ..+++.+..+.++-|..++++|=-..+..+
T Consensus 223 ~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 223 FPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred CcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 99984321 11112222222333333 446889999999999999999944333333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=239.12 Aligned_cols=248 Identities=28% Similarity=0.439 Sum_probs=210.2
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+|.....+|.|++|.||++++ +++..|+|+++......- +-..+|+.+++..+||||+.+++.+...+
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~---------~~iqqei~~~~dc~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF---------SGIQQEIGMLRDCRHPNIVAYFGSYLRRD 85 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc---------cccccceeeeecCCCcChHHHHhhhhhhc
Confidence 6899999999999999999965 789999999987654432 23668999999999999999999999888
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
..++ .||||.||+|.+.. ...+++++.++...++..+++++|||+.|=+|||||-.||++++
T Consensus 86 klwi----------------cMEycgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd 147 (829)
T KOG0576|consen 86 KLWI----------------CMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTD 147 (829)
T ss_pred CcEE----------------EEEecCCCccccee--eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecc
Confidence 8755 99999999999987 56788999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
.|.++|.|||.+..............||+.|+|||+-. .+.|....|||++|++..++--...|.........+...
T Consensus 148 ~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm 227 (829)
T KOG0576|consen 148 EGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM 227 (829)
T ss_pred cCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh
Confidence 99999999999876665555566689999999999863 356889999999999999998777777666655555555
Q ss_pred HhcCCCCCCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRPEIP---RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
-+..+.+.-. ...++.+.++++.+|..+|.+||+++.+|.
T Consensus 228 TkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 228 TKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 5555544322 235889999999999999999999987764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=218.45 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=203.2
Q ss_pred cceeecccccccceEEEEEEECC---ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC----CCccceeeeec
Q 018489 51 KLVIKSVIARGTFGTVHRGLYDG---HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD----HPNVTKFIGAT 123 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~~Iv~~~~~~ 123 (355)
+|++.+.||+|+||.||.+.+.. ..+|+|+.......... .+..|..++..+. .+++..+++.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---------~l~~E~~vl~~l~~~~~~~~~~~~~~~G 89 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---------VLKIEIQVLKKLEKKNGPSHFPKLLDHG 89 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---------cchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence 89999999999999999998754 46999998654332211 1456777777775 36888888877
Q ss_pred c-CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 124 M-GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 124 ~-~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
. .. .+.++||+.+ |.+|.++......+.++..+++.|+.|++.+|.++|+.|++||||||+|
T Consensus 90 ~~~~----------------~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N 152 (322)
T KOG1164|consen 90 RSTE----------------DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPEN 152 (322)
T ss_pred cCCC----------------ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHH
Confidence 4 32 2336799999 8999998866666889999999999999999999999999999999999
Q ss_pred EEEcCC-----CcEEEeeccccc--cccCCC------C-C-CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh
Q 018489 203 MLLDKN-----RTVKIADFGVAR--VEASNP------N-D-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 203 ili~~~-----~~v~L~Dfg~a~--~~~~~~------~-~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt 267 (355)
+++... ..+.|.|||+++ ...... . . .....||..|+++..+.+...+++.|+|||++++.+++.
T Consensus 153 ~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~ 232 (322)
T KOG1164|consen 153 FVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLK 232 (322)
T ss_pred eeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhc
Confidence 999755 469999999998 321111 1 1 233569999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHh---cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCC
Q 018489 268 CDMPYPDLSFSEVTSAVVR---QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335 (355)
Q Consensus 268 g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 335 (355)
|.+||.............. ...........+.++..+...+-..+...+|++..+...++......+.
T Consensus 233 g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~ 303 (322)
T KOG1164|consen 233 GSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGS 303 (322)
T ss_pred CCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCC
Confidence 9999977654332322222 1111113345678899999999999999999999999999999887633
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=201.63 Aligned_cols=257 Identities=20% Similarity=0.323 Sum_probs=205.8
Q ss_pred ecCCcceeecccccccceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeec
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGAT 123 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~ 123 (355)
+...+|++++.||.|+||.+|+|. ..|+.||||+-+....... +.-|..++..++ ..+|..+..++
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpq-----------L~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQ-----------LLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcc-----------hhHHHHHHHHhccCCCCchhhhhc
Confidence 456899999999999999999995 4899999999865544322 456888888884 46666665554
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.+... -.+||+.+ |.+|++++... .+.++..+++-++-||+.-++|+|.++++||||||+|+
T Consensus 81 ~e~~y----------------nvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNF 142 (341)
T KOG1163|consen 81 TEKDY----------------NVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNF 142 (341)
T ss_pred ccccc----------------ceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccce
Confidence 44333 36799999 99999998754 56799999999999999999999999999999999999
Q ss_pred EEc---CCCcEEEeeccccccccCC-------CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 018489 204 LLD---KNRTVKIADFGVARVEASN-------PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (355)
Q Consensus 204 li~---~~~~v~L~Dfg~a~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~ 273 (355)
+.. ...++.|+|||+|...-+. .....+..||..|.+...+.+...+.+.|+.|+|+++.++..|.+||+
T Consensus 143 LMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 143 LMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred eeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 986 3457999999999865432 223355679999999999998888999999999999999999999999
Q ss_pred CCChh---HHHHHHHhcCCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 274 DLSFS---EVTSAVVRQNLRP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 274 ~~~~~---~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
+.... +....+....... .+...+|.++.-.+..|-..-.++-|++.-|.+.+..+...
T Consensus 223 glka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 223 GLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred ccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 86543 3333333333222 35678899999999999999999999999998888877644
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=207.07 Aligned_cols=205 Identities=35% Similarity=0.538 Sum_probs=168.6
Q ss_pred ceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 52 LVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
|.+.+.||.|+++.||++... +..+++|.+...... ...+.+.+|+..+..++|+|++++++++......
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--------KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPL 72 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--------HHHHHHHHHHHHHHhCCCCChhhheeeeecCCce
Confidence 567889999999999999764 689999999654322 1245678899999999999999999987765444
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
++++|++++++|.+++..... .+++..++.++.+++.++.+||+.+++|+||+|+||+++.++
T Consensus 73 ----------------~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~ 135 (225)
T smart00221 73 ----------------YLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG 135 (225)
T ss_pred ----------------EEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 669999999999999864322 189999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCC-CCCCCCCCcccccCCccc-CCCCCCCcchhHHHHHHHHHHHhCCCCCCC-CChhHHH
Q 018489 210 TVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVL-NGNPYNRKCDVYSFGICLWEIYCCDMPYPD-LSFSEVT 281 (355)
Q Consensus 210 ~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~lltg~~p~~~-~~~~~~~ 281 (355)
.++|+|||.+....... .......++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .+.....
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~ 210 (225)
T smart00221 136 LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLL 210 (225)
T ss_pred CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHH
Confidence 99999999987654432 122334667789999998 666778899999999999999999999977 4444333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=218.81 Aligned_cols=251 Identities=22% Similarity=0.375 Sum_probs=190.9
Q ss_pred cccceecCCcceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCc
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 115 (355)
.+.+......|.+++.||+|+|++||++.+ .++.||+|.+..... -.++.+|+++|..+ .+.|
T Consensus 28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----------p~ri~~El~~L~~~gG~~n 96 (418)
T KOG1167|consen 28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----------PSRILNELEMLYRLGGSDN 96 (418)
T ss_pred HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----------chHHHHHHHHHHHhccchh
Confidence 344444557899999999999999999843 568899998853322 12377899999999 7899
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H 195 (355)
|+++.+++...+.. ++|+||++.....++. ..++...+..+++.++.||.++|.+||+|
T Consensus 97 i~~~~~~~rnnd~v----------------~ivlp~~~H~~f~~l~-----~~l~~~~i~~Yl~~ll~Al~~~h~~GIvH 155 (418)
T KOG1167|consen 97 IIKLNGCFRNNDQV----------------AIVLPYFEHDRFRDLY-----RSLSLAEIRWYLRNLLKALAHLHKNGIVH 155 (418)
T ss_pred hhcchhhhccCCee----------------EEEecccCccCHHHHH-----hcCCHHHHHHHHHHHHHHhhhhhccCccc
Confidence 99999999887776 5699999999988887 34778899999999999999999999999
Q ss_pred cCCCCCcEEEc-CCCcEEEeeccccccccC-C------C-------------------------------------CCCC
Q 018489 196 RDVKTENMLLD-KNRTVKIADFGVARVEAS-N------P-------------------------------------NDMT 230 (355)
Q Consensus 196 ~di~p~Nili~-~~~~v~L~Dfg~a~~~~~-~------~-------------------------------------~~~~ 230 (355)
|||||+||+.+ ..+.-.|+|||+|..... . . ....
T Consensus 156 RDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~a 235 (418)
T KOG1167|consen 156 RDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERA 235 (418)
T ss_pred cCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceec
Confidence 99999999997 467889999999872100 0 0 0001
Q ss_pred CCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-hHHHH--------------------------
Q 018489 231 GETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF-SEVTS-------------------------- 282 (355)
Q Consensus 231 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~-~~~~~-------------------------- 282 (355)
+..||++|.|||++.. +..+.+.||||.|++++.++++..||-...+ ...+.
T Consensus 236 nrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~k 315 (418)
T KOG1167|consen 236 NRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQK 315 (418)
T ss_pred ccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecc
Confidence 2248999999999865 5678899999999999999999999842110 00000
Q ss_pred -------HHH----hc--------C---CCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 -------AVV----RQ--------N---LRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 -------~~~----~~--------~---~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... .. . ... ...+..+..+.+++.+||..||.+|.+++++|+
T Consensus 316 sn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 316 SNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000 00 0 000 111234668999999999999999999999986
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=226.54 Aligned_cols=205 Identities=26% Similarity=0.369 Sum_probs=164.9
Q ss_pred cCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC---CCccceeeee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD---HPNVTKFIGA 122 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~ 122 (355)
...+|...+.+|.|+||.|.+|.++ ...|+||.+.+.......=..-.. .=.+.-|+.+|..++ |+||++++++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrk-LGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRK-LGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccc-cCccchhHHHHHHhhhcCccchhhhhhe
Confidence 4567899999999999999999764 567999988543321100000000 001456899999996 9999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEE-ecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVE-YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e-~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
|.+.+.+|+ +|| +-+|-+|.++|.. ...+++.++..|++|++.++++||+.||+|||||-+
T Consensus 638 FEddd~yyl----------------~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikde 699 (772)
T KOG1152|consen 638 FEDDDYYYL----------------ETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDE 699 (772)
T ss_pred eecCCeeEE----------------EecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccccCceecccccc
Confidence 998887755 776 3456689999954 466999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCC-CCcchhHHHHHHHHHHHhCCCCCC
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYP 273 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~lltg~~p~~ 273 (355)
|+.++..|-++|+|||.+....+ ......+||..|.|||++.|..| ....|||+||+++|.++....||.
T Consensus 700 nvivd~~g~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 700 NVIVDSNGFVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cEEEecCCeEEEeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999999999999975543 34456789999999999999765 467899999999999988888874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=195.08 Aligned_cols=164 Identities=24% Similarity=0.358 Sum_probs=130.4
Q ss_pred CCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCC
Q 018489 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234 (355)
Q Consensus 155 ~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~ 234 (355)
|+|.+++... +..+++..++.|+.|++.||.|||+.+ ||+||+++.++.+++ ||.+....... ..+
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g 66 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRV 66 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCC
Confidence 6899988643 456999999999999999999999999 999999999999999 99887544321 257
Q ss_pred cccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh-HHHHHHHhcCCCC-----CCCCCCcH--HHHHHHH
Q 018489 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTSAVVRQNLRP-----EIPRCCPS--SLANVMK 306 (355)
Q Consensus 235 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~--~l~~li~ 306 (355)
+..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+....... ..+..++. ++.++|.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 89999999999999999999999999999999999999765432 2222222211111 01122333 6999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 307 RCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 307 ~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
+||+.+|.+||++.++++.+..+...
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHHHH
Confidence 99999999999999999988877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=237.01 Aligned_cols=200 Identities=22% Similarity=0.265 Sum_probs=138.9
Q ss_pred CCC-CccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHH
Q 018489 111 LDH-PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH 189 (355)
Q Consensus 111 l~h-~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 189 (355)
+.| +||..+++++.....-.. .....+.+|||+ +++|.+++... ...+++..++.++.||+.||.|||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGL---------DDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred hhHHHHHHHhhcccCCcccccc---------ccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH
Confidence 345 577777777532221000 112335688888 66999999642 456999999999999999999999
Q ss_pred hCCccccCCCCCcEEEcCCCcE-------------------EEeeccccccccCCC----------------CCCCCCCC
Q 018489 190 SQKIVHRDVKTENMLLDKNRTV-------------------KIADFGVARVEASNP----------------NDMTGETG 234 (355)
Q Consensus 190 ~~~i~H~di~p~Nili~~~~~v-------------------~L~Dfg~a~~~~~~~----------------~~~~~~~~ 234 (355)
++||+||||||+||||+..+.+ +++|||.++...... .......+
T Consensus 98 ~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 177 (793)
T PLN00181 98 SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME 177 (793)
T ss_pred hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence 9999999999999999665544 455555554211000 00011346
Q ss_pred cccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCC
Q 018489 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPD 314 (355)
Q Consensus 235 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 314 (355)
|+.|+|||.+.+..++.++|||||||++|+|++|..|+.... .....+......+.. ....+...+++.+||+.+|.
T Consensus 178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~ 254 (793)
T PLN00181 178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPS 254 (793)
T ss_pred CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChh
Confidence 788999999999999999999999999999999988875322 111122111111111 11245677899999999999
Q ss_pred CCCCHHHHHH
Q 018489 315 KRPEMDEVVS 324 (355)
Q Consensus 315 ~Rps~~ell~ 324 (355)
+||++.++++
T Consensus 255 ~Rps~~eil~ 264 (793)
T PLN00181 255 CRPSMSELLQ 264 (793)
T ss_pred hCcChHHHhh
Confidence 9999999986
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=194.49 Aligned_cols=251 Identities=21% Similarity=0.273 Sum_probs=153.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCC----------Cccc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH----------PNVT 117 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~~Iv 117 (355)
..+...+.||.|+++.||.+.+ +++.+|+|++........ .+ .+.+.+|.-....+.+ -.++
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~--~~----~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l 85 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASA--NE----YEQLKEEQLAITLFPGVKNPKEAYRHLRFL 85 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHT--TH----HHHHHHHHHGGGGSTT--SHHHHHHHH-B-
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccch--HH----HHHHHHHHHHhhhhccCCCHHHHHHhceEE
Confidence 3467888999999999999977 569999999987663222 22 2334455544444322 1222
Q ss_pred eeeeecc-CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh---c--cccccHHHHHHHHHHHHHHHHHHHhC
Q 018489 118 KFIGATM-GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN---R--RRKLAFKVVVQLALDLARGLSYLHSQ 191 (355)
Q Consensus 118 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~--~~~~~~~~~~~i~~qi~~al~~LH~~ 191 (355)
-.++... ......+....+.....-...+++|+-+ .++|.+++..- . ...+.....+.+..|+++.+++||..
T Consensus 86 ~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~ 164 (288)
T PF14531_consen 86 VPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY 164 (288)
T ss_dssp --SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc
Confidence 2222222 1122212111111100011236788887 56888876421 1 12345566677889999999999999
Q ss_pred CccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC--------CCCCCcchhHHHHHHHH
Q 018489 192 KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG--------NPYNRKCDVYSFGICLW 263 (355)
Q Consensus 192 ~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~ 263 (355)
|++|+||+|+|+|++.+|.++|+||+........... ...+..|.|||.... -.++.+.|.|+||+++|
T Consensus 165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred ceEecccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 9999999999999999999999999887654432221 234467899997643 24678999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q 018489 264 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316 (355)
Q Consensus 264 ~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 316 (355)
.|+++..||........... ....+..+|+.++.||..+|++||++|
T Consensus 242 ~lWC~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999999986543222211 112344679999999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=182.73 Aligned_cols=254 Identities=29% Similarity=0.534 Sum_probs=207.8
Q ss_pred ecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
++.+...+...|.+...|..|+|+|.|..++.|++........ ..+.|..|.-.|+-+.||||+++++.+..+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~r-------isrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTAR-------ISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchh-------hcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 4445666777899999999999999999999999965443322 234588899999999999999999988776
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEE
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENML 204 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~di~p~Nil 204 (355)
... .++..|++.|+|...+....+--.+..++.+++.+|+.+++|||+.. +.---|...+++
T Consensus 260 pnl----------------v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvm 323 (448)
T KOG0195|consen 260 PNL----------------VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVM 323 (448)
T ss_pred CCc----------------eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEE
Confidence 555 55999999999999998777777888999999999999999999974 444568889999
Q ss_pred EcCCCcEEEe--eccccccccCCCCCCCCCCCcccccCCcccCCCCC---CCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 205 LDKNRTVKIA--DFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY---NRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 205 i~~~~~v~L~--Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
|+++.++++. |--++.. .....-.+.|++||.+....- -.++|+|||++++++|.|...||.+.+.-+
T Consensus 324 idedltarismad~kfsfq-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme 396 (448)
T KOG0195|consen 324 IDEDLTARISMADTKFSFQ-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME 396 (448)
T ss_pred ecchhhhheecccceeeee-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence 9998876654 4333321 112234678999999987543 368999999999999999999999887766
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
---++-..+++..+|..++..+..|+.-|++.||.+||.++.|.-.|++..
T Consensus 397 cgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 397 CGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 666666778889999999999999999999999999999999988888753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=190.49 Aligned_cols=170 Identities=20% Similarity=0.201 Sum_probs=126.2
Q ss_pred cceecCCcceeecccccccceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce-e
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK-F 119 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~-~ 119 (355)
......++|.+.+.||+|+||.||+|.+ ++..+|||.......... .....+.+.+|++++++++|+|+++ +
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS----KPLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc----cHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 3455668999999999999999999965 467789998642110000 1123456889999999999999985 4
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC-
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV- 198 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di- 198 (355)
++. +. .++||||++|++|.. + .. .. ...++.+++++|.|||+.||+||||
T Consensus 88 ~~~----~~----------------~~LVmE~~~G~~L~~-~--~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~ 138 (365)
T PRK09188 88 LAT----GK----------------DGLVRGWTEGVPLHL-A--RP---HG---DPAWFRSAHRALRDLHRAGITHNDLA 138 (365)
T ss_pred EEc----CC----------------cEEEEEccCCCCHHH-h--Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCC
Confidence 331 11 267999999999963 2 11 11 1467899999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCCCC--------CCCCCcccccCCcccCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPNDM--------TGETGTLGYMAPEVLNG 246 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~--------~~~~~~~~y~aPE~~~~ 246 (355)
||+||+++.++.++|+|||++.......... ....++..|.+||.+..
T Consensus 139 KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 139 KPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999999999999999998654432111 23346777999998864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-25 Score=210.35 Aligned_cols=248 Identities=21% Similarity=0.241 Sum_probs=178.3
Q ss_pred cceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccc
Q 018489 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 130 (355)
+|...+.||.+.|=.|.+|+++...|+||+|-+..+.-.. ....+++ .|++ ...+++||.+++..........|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL----~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISL----RPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCc----hHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHH
Confidence 5778899999999999999998878999999765543222 2222222 2333 45569999999877655544443
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~ 210 (355)
+|-+|+ ..+|.|.+ ..+.-+...+.++|+.|++.||..+|..||+|||||.+||||+.-+.
T Consensus 98 ----------------lvRqyv-khnLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW 158 (1431)
T KOG1240|consen 98 ----------------LVRQYV-KHNLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW 158 (1431)
T ss_pred ----------------HHHHHH-hhhhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech
Confidence 477787 45888887 33455788899999999999999999999999999999999999999
Q ss_pred EEEeecccccc--cc-CCCCCCCCCC----CcccccCCcccCCC----------C-CCCcchhHHHHHHHHHHHh-CCCC
Q 018489 211 VKIADFGVARV--EA-SNPNDMTGET----GTLGYMAPEVLNGN----------P-YNRKCDVYSFGICLWEIYC-CDMP 271 (355)
Q Consensus 211 v~L~Dfg~a~~--~~-~~~~~~~~~~----~~~~y~aPE~~~~~----------~-~~~~~DvwslG~il~~llt-g~~p 271 (355)
+.|+||..-.- .+ +++.+..-+. .-.+|.|||.+... . .+++.||||+||+++||++ |.+|
T Consensus 159 ~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~Pl 238 (1431)
T KOG1240|consen 159 LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPL 238 (1431)
T ss_pred hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCc
Confidence 99999976541 11 1222222222 33489999998642 1 5689999999999999988 7888
Q ss_pred CCCCChhHHHHHHHhcC-CCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 272 YPDLSFSEVTSAVVRQN-LRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 272 ~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
|.-. ++....... ..+ .+..-.+..++++|..|++.||.+|.++++.|+.-.
T Consensus 239 F~LS----QL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 239 FTLS----QLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred ccHH----HHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 8421 111111110 000 011122458999999999999999999999998733
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-22 Score=181.44 Aligned_cols=251 Identities=28% Similarity=0.431 Sum_probs=197.4
Q ss_pred ceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCC-ccceeeeeccCCcccc
Q 018489 52 LVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP-NVTKFIGATMGSSELH 130 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~Iv~~~~~~~~~~~~~ 130 (355)
|.+.+.||.|+|+.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +|+++.+.+.....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-- 72 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS------KEVERFLREIQILASLNHPPNIVKLYDFFQDEGS-- 72 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch------hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE--
Confidence 788999999999999999877 8899999865443321 2345688899999999888 79999998854443
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
.+++++++.++++.+++..... ..++......++.|++.++.++|+.+++|+|+||+||+++..+
T Consensus 73 --------------~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~ 138 (384)
T COG0515 73 --------------LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG 138 (384)
T ss_pred --------------EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC
Confidence 3669999999999976643221 2699999999999999999999999999999999999999988
Q ss_pred -cEEEeeccccccccCCCC------CCCCCCCcccccCCcccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh--
Q 018489 210 -TVKIADFGVARVEASNPN------DMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF-- 277 (355)
Q Consensus 210 -~v~L~Dfg~a~~~~~~~~------~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~lltg~~p~~~~~~-- 277 (355)
.++++|||.+........ ......++..|++||.+.+ .......|+|++|++++++++|..||.....
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~ 218 (384)
T COG0515 139 RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS 218 (384)
T ss_pred CeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 799999999874443322 3456789999999999987 5788999999999999999999999877663
Q ss_pred --hHHHHHHHhcCCC---CCCCCCC----cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 278 --SEVTSAVVRQNLR---PEIPRCC----PSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 278 --~~~~~~~~~~~~~---~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
......+...... ....... ...+.+++..++..+|..|.+..+....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 219 ATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 3333333333221 1111211 2579999999999999999988877664
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-24 Score=183.94 Aligned_cols=214 Identities=21% Similarity=0.341 Sum_probs=158.4
Q ss_pred CCCccceeeeeccCCccccc--------cccc---ccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHH
Q 018489 112 DHPNVTKFIGATMGSSELHI--------QTEN---GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180 (355)
Q Consensus 112 ~h~~Iv~~~~~~~~~~~~~~--------~~~~---~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~q 180 (355)
+|||||.+...|.+.-...- .... .+..-...++|+||..+ ..+|..++.. +..+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHHH
Confidence 69999999998875432210 0000 00111235889999988 4599999953 45777888889999
Q ss_pred HHHHHHHHHhCCccccCCCCCcEEEc--CC--CcEEEeeccccccccC------CCCCCCCCCCcccccCCcccCCCCC-
Q 018489 181 LARGLSYLHSQKIVHRDVKTENMLLD--KN--RTVKIADFGVARVEAS------NPNDMTGETGTLGYMAPEVLNGNPY- 249 (355)
Q Consensus 181 i~~al~~LH~~~i~H~di~p~Nili~--~~--~~v~L~Dfg~a~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~- 249 (355)
+++|+.|||++||.|||+|.+||++. ++ -.+++.|||++--... .........|+...+|||+....+-
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 99999999999999999999999994 33 3588999998743222 1222333457888999999875321
Q ss_pred -----CCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 250 -----NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 250 -----~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
-.++|.|+.|.+.||+++...||...-+-........+...+.+++.+++.+++++..+|+.||.+|++.+=...
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 157999999999999999999997743322222334455667889999999999999999999999999887777
Q ss_pred HHHHh
Q 018489 325 MLEAI 329 (355)
Q Consensus 325 ~l~~~ 329 (355)
+|.-.
T Consensus 510 vl~Ls 514 (598)
T KOG4158|consen 510 VLNLS 514 (598)
T ss_pred HHHHH
Confidence 66543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=180.31 Aligned_cols=187 Identities=12% Similarity=0.105 Sum_probs=135.3
Q ss_pred cCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
...+|++.++||.|+||.||++..++..+|+|+++................+.+.+|++.+.++.|++|..+.+++....
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46899999999999999999987788899999996433221111111111334789999999999999999988866433
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
...+ ...+..+++|||++|.+|.++.. +++ ....+++.+|..+|+.|++|+|++|+||++++
T Consensus 109 ~~~~--------~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 109 RKTL--------RYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred cccc--------cccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence 2111 01234578999999999988741 233 24569999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l 265 (355)
+| ++|+|||........... ........+..++|+|+||+++..+
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CC-EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHH
Confidence 88 999999987633211110 0022233466789999999988764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=206.41 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=187.9
Q ss_pred eeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccc
Q 018489 53 VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 53 ~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 130 (355)
.....+|.|.+|.|+.+.. ..+.++.|.++.. .. ..+.+ ......+..|+-+-..+.|+|++.....+.......
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~-~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~ 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESE-RKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccH-HHHhhhhhhheeecccccCCchhhhHHHHhhcccch
Confidence 5677899999998887643 3455555555422 10 11111 111222677888888889999988877776655553
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~ 210 (355)
- .||||++ +|..++.. ...++...+-.++.|++.+|.|+|..|+.|+|+|++|+++...|.
T Consensus 398 ~----------------~mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~ 458 (601)
T KOG0590|consen 398 Q----------------SMEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI 458 (601)
T ss_pred h----------------hhhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc
Confidence 3 5999998 99998843 357889999999999999999999999999999999999999999
Q ss_pred EEEeeccccccccCCC----CCCCCCCCcccccCCcccCCCCCCC-cchhHHHHHHHHHHHhCCCCCCCCChhHHHH--H
Q 018489 211 VKIADFGVARVEASNP----NDMTGETGTLGYMAPEVLNGNPYNR-KCDVYSFGICLWEIYCCDMPYPDLSFSEVTS--A 283 (355)
Q Consensus 211 v~L~Dfg~a~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~~lltg~~p~~~~~~~~~~~--~ 283 (355)
++++|||.+....... ......+|+..|.|||++.+..|++ ..||||.|++++.|.+|+.||......+... .
T Consensus 459 lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~ 538 (601)
T KOG0590|consen 459 LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN 538 (601)
T ss_pred eEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh
Confidence 9999999987654332 2345577999999999999988875 5799999999999999999997654433321 1
Q ss_pred HHhcCC-----CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNL-----RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...... ...+...++...+.+|.+||+.+|.+|.|+++|++
T Consensus 539 ~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 539 NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111111 11123446788999999999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=170.13 Aligned_cols=148 Identities=16% Similarity=0.193 Sum_probs=109.3
Q ss_pred eecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHH-----------------HHHHHHHHHHHHHHHhhCCCCc
Q 018489 54 IKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAE-----------------IAALRSAFTQEVAVWHKLDHPN 115 (355)
Q Consensus 54 i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~~ 115 (355)
+.+.||+|++|.||+|.+ +|+.||+|+++........... .........+|+..+..+.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357899999999999965 6899999999765322111100 0111233456999999998777
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHH-HhCCcc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYL-HSQKIV 194 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L-H~~~i~ 194 (355)
+.....+.... .+|||||++|+++..... ...+++...++.++.|++.+|.++ |+.|++
T Consensus 81 v~~p~~~~~~~------------------~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~gii 140 (190)
T cd05147 81 IPCPEPILLKS------------------HVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCRLV 140 (190)
T ss_pred CCCCcEEEecC------------------CEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 64333221110 157999998877765432 245789999999999999999999 799999
Q ss_pred ccCCCCCcEEEcCCCcEEEeeccccccc
Q 018489 195 HRDVKTENMLLDKNRTVKIADFGVARVE 222 (355)
Q Consensus 195 H~di~p~Nili~~~~~v~L~Dfg~a~~~ 222 (355)
|+||||+||+++ ++.++|+|||++...
T Consensus 141 HrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 141 HADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred cCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 999999999998 588999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.2e-22 Score=192.69 Aligned_cols=250 Identities=20% Similarity=0.300 Sum_probs=182.2
Q ss_pred cccceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC---CCccc
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD---HPNVT 117 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv 117 (355)
..++++...+|.|.+.||+|+||.||+|.. +++.||||+-+-... . + |.--.+++.+|+ -+.|.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--W---E-------fYI~~q~~~RLk~~~~~~~~ 757 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--W---E-------FYICLQVMERLKPQMLPSIM 757 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--e---e-------eeehHHHHHhhchhhhcchH
Confidence 445788999999999999999999999954 689999999753321 1 1 111122333333 23344
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccC
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~d 197 (355)
.+...+... +..++|++|.+.|+|.+++. ..+.+++..+..+..||+..|.+||..+|||||
T Consensus 758 ~~~~a~~~~----------------~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgD 819 (974)
T KOG1166|consen 758 HISSAHVFQ----------------NASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGD 819 (974)
T ss_pred HHHHHHccC----------------CcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceeccc
Confidence 444444333 33467999999999999994 667899999999999999999999999999999
Q ss_pred CCCCcEEEcC-------CCcEEEeecccccccc--CCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhC
Q 018489 198 VKTENMLLDK-------NRTVKIADFGVARVEA--SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268 (355)
Q Consensus 198 i~p~Nili~~-------~~~v~L~Dfg~a~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg 268 (355)
|||+|++|.. .-.++|+|||.+.... .+.......+.|..+-.+|...|..|++.+|.|.|+.+++.||.|
T Consensus 820 iKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG 899 (974)
T KOG1166|consen 820 IKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFG 899 (974)
T ss_pred CCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHH
Confidence 9999999942 3458999999997533 233455667889999999999999999999999999999999999
Q ss_pred CCCC--CCCChhHHHHHHHhcCCCCCCCCCCc-HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 269 DMPY--PDLSFSEVTSAVVRQNLRPEIPRCCP-SSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 269 ~~p~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
+.-= ++.. +.....+++... +-+.+++..+|+.|-..=|...+|...|+....
T Consensus 900 ~y~q~~~g~~----------~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 900 KYMEVKNGSS----------WMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred HHHHhcCCcc----------eeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 7421 0000 000001222222 235678888888555555888888888887754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=161.56 Aligned_cols=149 Identities=17% Similarity=0.153 Sum_probs=111.2
Q ss_pred eecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHH-----------------HHHHHHHHHHHHHHHhhCCCCc
Q 018489 54 IKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAE-----------------IAALRSAFTQEVAVWHKLDHPN 115 (355)
Q Consensus 54 i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~-----------------~~~~~~~~~~E~~~l~~l~h~~ 115 (355)
+.+.||+|++|.||+|.+ +|+.||||+++........... .......+.+|...+.++.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 457899999999999976 5999999999865432111100 1112233567999999999888
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh-CCcc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIV 194 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~ 194 (355)
+.....+.... .++||||++|+++..... ....++......++.|++.++.++|+ .|++
T Consensus 81 i~~p~~~~~~~------------------~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~giv 140 (190)
T cd05145 81 VPVPEPILLKK------------------NVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAGLV 140 (190)
T ss_pred CCCceEEEecC------------------CEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 75433322211 157999998876544321 23467888999999999999999999 9999
Q ss_pred ccCCCCCcEEEcCCCcEEEeecccccccc
Q 018489 195 HRDVKTENMLLDKNRTVKIADFGVARVEA 223 (355)
Q Consensus 195 H~di~p~Nili~~~~~v~L~Dfg~a~~~~ 223 (355)
|+||||+||+++ ++.++|+|||.+....
T Consensus 141 HrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 141 HGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred cCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 999999999998 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-23 Score=188.38 Aligned_cols=226 Identities=27% Similarity=0.407 Sum_probs=186.7
Q ss_pred ccccccceEEEEE-----EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeeccCCcccc
Q 018489 57 VIARGTFGTVHRG-----LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSELH 130 (355)
Q Consensus 57 ~lg~G~~~~Vy~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~ 130 (355)
.+|+|+||.|+++ .+.+.-+++|+.++......... ....|-.++...+ ||.++++...+......+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-------~t~~er~il~~~~~~~f~v~lhyafqt~~kl~ 73 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-------HTKQERIILAFVHNTPFLVKLHYAFQTDGKLY 73 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-------ccccHHHHHhhccCCCceeeeeeeeccccchh
Confidence 3799999999976 35678899999876554433322 2445677777785 999999998888877775
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~ 210 (355)
+ ++++..|+.|...+ .....+.+.....+...++-++.++|+.+++|+|+|++||+++.+|.
T Consensus 74 l----------------~ld~~rgg~lft~l--~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh 135 (612)
T KOG0603|consen 74 L----------------ILDFLRGGDLFTRL--SKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH 135 (612)
T ss_pred H----------------hhhhcccchhhhcc--ccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc
Confidence 5 99999999998776 44567888999999999999999999999999999999999999999
Q ss_pred EEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC
Q 018489 211 VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 290 (355)
Q Consensus 211 v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~ 290 (355)
+++.|||.++........ +|+..|+|||++++ ...+.|.||+|+++++|++|-.||.. +....+....
T Consensus 136 i~~tdfglske~v~~~~~----cgt~eymApEI~~g--h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-- 203 (612)
T KOG0603|consen 136 IKLTDFGLSKEAVKEKIA----CGTYEYRAPEIING--HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-- 203 (612)
T ss_pred cccCCchhhhHhHhhhhc----ccchhhhhhHhhhc--cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc--
Confidence 999999999754433222 88999999999993 46889999999999999999999988 5555555533
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 018489 291 PEIPRCCPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 291 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
..++...+..+++++..++..+|.+|...
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 35888899999999999999999999754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=154.61 Aligned_cols=187 Identities=13% Similarity=0.061 Sum_probs=135.8
Q ss_pred eeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCccccc
Q 018489 53 VIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHI 131 (355)
Q Consensus 53 ~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~~ 131 (355)
-+...|++|+||+||++...+.+++.+.+.....- ........+.+|+++|+++ +++++++++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~-----~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----~~-- 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWW-----LRGVAWWLARREALALRQLDGLPRTPRLLHWD----GR-- 73 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhh-----hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----CE--
Confidence 35678999999999999888999998887533221 1112233578999999999 458898888751 11
Q ss_pred ccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCcEEEcCCCc
Q 018489 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV-KTENMLLDKNRT 210 (355)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di-~p~Nili~~~~~ 210 (355)
+++|+|+.|.+|...... ....++.|++.+|.++|+.||+|+|| ||+||+++.++.
T Consensus 74 --------------~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~ 130 (218)
T PRK12274 74 --------------HLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS 130 (218)
T ss_pred --------------EEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC
Confidence 569999999998654311 11357889999999999999999999 799999999999
Q ss_pred EEEeeccccccccCCCCC----CC---------CCCCcccccCCcccCC-CCCC-CcchhHHHHHHHHHHHhCCCCCC
Q 018489 211 VKIADFGVARVEASNPND----MT---------GETGTLGYMAPEVLNG-NPYN-RKCDVYSFGICLWEIYCCDMPYP 273 (355)
Q Consensus 211 v~L~Dfg~a~~~~~~~~~----~~---------~~~~~~~y~aPE~~~~-~~~~-~~~DvwslG~il~~lltg~~p~~ 273 (355)
++|+|||.+......... .. -...++.++.|+...- ...+ .+.+.++.|+.+|.++|+..++-
T Consensus 131 i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 131 PAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred EEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 999999999754432210 00 0113556666665432 1223 56788899999999999987753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-19 Score=150.54 Aligned_cols=141 Identities=24% Similarity=0.343 Sum_probs=111.6
Q ss_pred cccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccccc
Q 018489 56 SVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~ 135 (355)
+.||+|++|.||+|.+.+..+++|+........ ...........+.+|+.++..+.|++|.....++......
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~------ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRH-PELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF------ 74 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcC-hHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC------
Confidence 578999999999999999999999865322211 1112222345678899999999999887666554433333
Q ss_pred ccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEee
Q 018489 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (355)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~D 215 (355)
+++|||++|++|.+++... .. ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|
T Consensus 75 ----------~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liD 137 (211)
T PRK14879 75 ----------IIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLID 137 (211)
T ss_pred ----------EEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEE
Confidence 5799999999999988432 12 7889999999999999999999999999999999 88999999
Q ss_pred ccccc
Q 018489 216 FGVAR 220 (355)
Q Consensus 216 fg~a~ 220 (355)
||.+.
T Consensus 138 f~~a~ 142 (211)
T PRK14879 138 FGLAE 142 (211)
T ss_pred CCccc
Confidence 99886
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=153.54 Aligned_cols=150 Identities=21% Similarity=0.211 Sum_probs=112.7
Q ss_pred CCcceeecccccccceEEEEEE---ECCceeEEEEeecCCCCCccH---------------HHHHHHHHHHHHHHHHHhh
Q 018489 49 PSKLVIKSVIARGTFGTVHRGL---YDGHDVAVKLLDWGEEGHRTE---------------AEIAALRSAFTQEVAVWHK 110 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~---~~~~~vavK~~~~~~~~~~~~---------------~~~~~~~~~~~~E~~~l~~ 110 (355)
+..|.+.+.||+|++|.||+|. .+|..||+|+++......... .........+.+|+..+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458999999999999999997 378999999997554321110 0111233456789999999
Q ss_pred CCCCc--cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHH
Q 018489 111 LDHPN--VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYL 188 (355)
Q Consensus 111 l~h~~--Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 188 (355)
+.+.+ +.++++.. . .++||||++|.+|..... ....+....+..++.|++.++.+|
T Consensus 107 L~~~~i~~p~~~~~~----~----------------~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~L 164 (237)
T smart00090 107 LYEAGVPVPKPIAWR----R----------------NVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKL 164 (237)
T ss_pred HHhcCCCCCeeeEec----C----------------ceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHH
Confidence 96533 33333321 1 157999999988876542 234566777889999999999999
Q ss_pred HhCC-ccccCCCCCcEEEcCCCcEEEeecccccc
Q 018489 189 HSQK-IVHRDVKTENMLLDKNRTVKIADFGVARV 221 (355)
Q Consensus 189 H~~~-i~H~di~p~Nili~~~~~v~L~Dfg~a~~ 221 (355)
|+.| ++|+||+|+||+++ ++.++|+|||.+..
T Consensus 165 H~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 165 YKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred HhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 9999 99999999999999 88999999999863
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=148.85 Aligned_cols=139 Identities=17% Similarity=0.254 Sum_probs=102.7
Q ss_pred eecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-----CCCccceeeeeccCCcc
Q 018489 54 IKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-----DHPNVTKFIGATMGSSE 128 (355)
Q Consensus 54 i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~Iv~~~~~~~~~~~ 128 (355)
-.+.||+|+++.||....++.. +||+....... ..+.+.+|+.+++.+ .||||+++++++.+...
T Consensus 6 ~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~---------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 6 EQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG---------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred CcceecCCCceEEEECCCCcCe-EEEEEeccccc---------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 3467999999999974444444 69988643221 123478999999999 57999999999987642
Q ss_pred cccccccccccCCCCceEEEEEe--cCCCCHHHHHHhhccccccHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCcEEE
Q 018489 129 LHIQTENGQVAMPSNICCVVVEY--LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGL-SYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~--~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al-~~LH~~~i~H~di~p~Nili 205 (355)
... .+.+|+|| +.+++|.+++.. ..+++. ..++.+++.++ .|||+.+|+|+||||+||++
T Consensus 76 ~g~------------v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl 138 (210)
T PRK10345 76 TGY------------VYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILC 138 (210)
T ss_pred CeE------------EEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 100 11368999 557899999943 246665 35678888777 99999999999999999999
Q ss_pred cC----CCcEEEeecccc
Q 018489 206 DK----NRTVKIADFGVA 219 (355)
Q Consensus 206 ~~----~~~v~L~Dfg~a 219 (355)
+. .+.++|+||+-+
T Consensus 139 ~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 139 QRISESEVIPVVCDNIGE 156 (210)
T ss_pred eccCCCCCcEEEEECCCC
Confidence 74 347999995433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.9e-18 Score=161.26 Aligned_cols=144 Identities=21% Similarity=0.294 Sum_probs=112.5
Q ss_pred CcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
..|...+.||+|+||.||++.+.+..+++|+....... ..........+.+.+|++++..++|++++....+.......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYR-HPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEeccccc-chhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34566899999999999999988887777765322111 11112223345688999999999999988776555443332
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+||++ .++
T Consensus 412 ----------------~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~ 464 (535)
T PRK09605 412 ----------------TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDD 464 (535)
T ss_pred ----------------EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECC
Confidence 57999999999999874 346789999999999999999999999999999 678
Q ss_pred cEEEeecccccc
Q 018489 210 TVKIADFGVARV 221 (355)
Q Consensus 210 ~v~L~Dfg~a~~ 221 (355)
.++|+|||.+..
T Consensus 465 ~~~liDFGla~~ 476 (535)
T PRK09605 465 RLYLIDFGLGKY 476 (535)
T ss_pred cEEEEeCccccc
Confidence 999999999863
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-18 Score=144.87 Aligned_cols=138 Identities=22% Similarity=0.316 Sum_probs=105.8
Q ss_pred ccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccccccccc
Q 018489 57 VIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENG 136 (355)
Q Consensus 57 ~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~~ 136 (355)
.||+|++|.||++.+++..+++|+........ ...+.......+.+|++++..+.++++.....++...+.
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-------- 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRH-PELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN-------- 71 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcC-chHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC--------
Confidence 48999999999999999999999965332211 111222334567889999999988775544433333222
Q ss_pred cccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeec
Q 018489 137 QVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADF 216 (355)
Q Consensus 137 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Df 216 (355)
.+++|||++|++|.+++... . . .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++||
T Consensus 72 --------~~lv~e~~~g~~l~~~~~~~--~-~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDf 133 (199)
T TIGR03724 72 --------KTIVMEYIEGKPLKDVIEEG--N-D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDF 133 (199)
T ss_pred --------CEEEEEEECCccHHHHHhhc--H-H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEEC
Confidence 25799999999999887432 1 1 7899999999999999999999999999999 899999999
Q ss_pred ccccc
Q 018489 217 GVARV 221 (355)
Q Consensus 217 g~a~~ 221 (355)
|.+..
T Consensus 134 g~a~~ 138 (199)
T TIGR03724 134 GLGKY 138 (199)
T ss_pred CCCcC
Confidence 98863
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-19 Score=172.40 Aligned_cols=205 Identities=27% Similarity=0.414 Sum_probs=151.1
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|..+++|..|++|.||++++ +..++|+|+-+.. -++ +||..+-+.
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~---------------------lil-----Rnilt~a~n---- 131 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN---------------------LIL-----RNILTFAGN---- 131 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc---------------------hhh-----hccccccCC----
Confidence 47899999999999999999965 4888999764210 011 122222111
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
. +.| |+=...++ .-++++. +++.+++|||+.||+|+|+||+|.+|+
T Consensus 132 --p----------------fvv------gDc~tllk--~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT 177 (1205)
T KOG0606|consen 132 --P----------------FVV------GDCATLLK--NIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLIT 177 (1205)
T ss_pred --c----------------cee------chhhhhcc--cCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceee
Confidence 0 112 12122221 1123333 238899999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCC---------------CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 018489 207 KNRTVKIADFGVARVEASNPND---------------MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMP 271 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p 271 (355)
.-|++|++|||++......... ...-++|+.|.|||++....|...+|+|++|+++|+.+-|..|
T Consensus 178 ~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvp 257 (1205)
T KOG0606|consen 178 SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 257 (1205)
T ss_pred ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeee
Confidence 9999999999998743221110 1112689999999999999999999999999999999999999
Q ss_pred CCCCChhHHHHHHHhcCC-CCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 018489 272 YPDLSFSEVTSAVVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRP 317 (355)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rp 317 (355)
|.+.+.++....++.... .++-....+++++++|.++|+.+|..|.
T Consensus 258 ffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 258 FFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 999999988877766433 3333456789999999999999999995
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.7e-18 Score=142.64 Aligned_cols=144 Identities=24% Similarity=0.246 Sum_probs=107.9
Q ss_pred cceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccH-------------HHHHHHHHHHHHHHHHHhhCCCCc-
Q 018489 51 KLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTE-------------AEIAALRSAFTQEVAVWHKLDHPN- 115 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~- 115 (355)
.|.+.+.||+|++|.||++.. +++.||||+++......... .........+.+|..++..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 488899999999999999966 68999999986543211110 011122334678888898887764
Q ss_pred -cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcc
Q 018489 116 -VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIV 194 (355)
Q Consensus 116 -Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~ 194 (355)
+...++. ...+++|||++|++|..... ......++.+++.++.++|+.|++
T Consensus 96 ~v~~~~~~--------------------~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~ 147 (198)
T cd05144 96 PVPKPIDW--------------------NRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGII 147 (198)
T ss_pred CCCceeec--------------------CCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCC
Confidence 3333321 11267999999999876542 034567889999999999999999
Q ss_pred ccCCCCCcEEEcCCCcEEEeeccccccc
Q 018489 195 HRDVKTENMLLDKNRTVKIADFGVARVE 222 (355)
Q Consensus 195 H~di~p~Nili~~~~~v~L~Dfg~a~~~ 222 (355)
|+||+|+||+++.++.++|+|||.+...
T Consensus 148 H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 148 HGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred cCCCCcccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=158.71 Aligned_cols=208 Identities=33% Similarity=0.605 Sum_probs=164.1
Q ss_pred hhCCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHH
Q 018489 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYL 188 (355)
Q Consensus 109 ~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~L 188 (355)
+.+.|.|+.++++...++... ++|.+||..|+|.+.+.. ....+++.-...++++++.+|+|+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~----------------~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~yl 64 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEM----------------IVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYL 64 (484)
T ss_pred cccchhhhhhheeeEecCCce----------------EEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHH
Confidence 567899999999998877554 569999999999999864 466789999999999999999999
Q ss_pred HhCCc-cccCCCCCcEEEcCCCcEEEeeccccccccC--CCCCCCCCCCcccccCCcccCCC-------CCCCcchhHHH
Q 018489 189 HSQKI-VHRDVKTENMLLDKNRTVKIADFGVARVEAS--NPNDMTGETGTLGYMAPEVLNGN-------PYNRKCDVYSF 258 (355)
Q Consensus 189 H~~~i-~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Dvwsl 258 (355)
|.--+ +|+.+++.|.+++..-.+||+|||+...... .........-...|.|||.+.+. ..+.+.|+||+
T Consensus 65 h~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 65 HNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred hcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 98765 9999999999999999999999999876532 11112222345579999999863 14677999999
Q ss_pred HHHHHHHHhCCCCCCCCCh----hHHHHHHHhcC---CCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 259 GICLWEIYCCDMPYPDLSF----SEVTSAVVRQN---LRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 259 G~il~~lltg~~p~~~~~~----~~~~~~~~~~~---~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
|++++++++...||..... .+....+.... ..+.+. ...++++..++..||..+|.+||+++.+...++.+
T Consensus 145 ~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 145 GIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred HHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9999999999999976322 23444433312 233332 14566899999999999999999999999999988
Q ss_pred Hhhc
Q 018489 330 DTSK 333 (355)
Q Consensus 330 ~~~~ 333 (355)
....
T Consensus 225 ~~~~ 228 (484)
T KOG1023|consen 225 NKGG 228 (484)
T ss_pred cccc
Confidence 7654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-19 Score=163.41 Aligned_cols=170 Identities=22% Similarity=0.449 Sum_probs=131.5
Q ss_pred CCceEEEEEecCCCCHHHHHHh-hccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 142 SNICCVVVEYLPGGALKTYLIK-NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 142 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
..+.+|.|++|...+|.+|+.. ......+...++.|+.|+..++.| +|.+|+|++|.||++..+.+++|+|||+..
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 3456899999999999999963 334557888999999999999999 999999999999999999999999999987
Q ss_pred cccCCC------CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCC-C
Q 018489 221 VEASNP------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRP-E 292 (355)
Q Consensus 221 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~-~ 292 (355)
...... ...+.+.||..||+||.+.+..|+.++|||+||++++++++ -...+ ........++.+..+ .
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~----er~~t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF----ERIATLTDIRDGIIPPE 480 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH----HHHHhhhhhhcCCCChH
Confidence 544332 24566789999999999999999999999999999999986 22222 222222222222222 2
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 018489 293 IPRCCPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 293 ~~~~~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
+..+ .+.-..|+.++|.+.|.+||++
T Consensus 481 ~~~d-~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 481 FLQD-YPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred Hhhc-CcHHHHHHHHhcCCCcccCchH
Confidence 2222 3445689999999999999943
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-16 Score=136.03 Aligned_cols=146 Identities=17% Similarity=0.174 Sum_probs=104.4
Q ss_pred ccc-cccceEEEEEEECCceeEEEEeecCCCCCccHH----HHHHHHHHHHHHHHHHhhCCCCcc--ceeeeeccCCccc
Q 018489 57 VIA-RGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEA----EIAALRSAFTQEVAVWHKLDHPNV--TKFIGATMGSSEL 129 (355)
Q Consensus 57 ~lg-~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~I--v~~~~~~~~~~~~ 129 (355)
.|| .|+.|+||.+...+..++||.+.....-..... ........+.+|+.++..+.|++| +..+++.......
T Consensus 38 ~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~ 117 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGL 117 (239)
T ss_pred eeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCc
Confidence 466 788888888878899999999854321100000 001234557889999999988875 5566553322111
Q ss_pred ccccccccccCCCCceEEEEEecCC-CCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPG-GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
....++|||+++| .+|.+++.. ..+++.. +.+++.+|.+||+.||+|+||+|.|||++.+
T Consensus 118 ------------~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 118 ------------FYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPD 178 (239)
T ss_pred ------------ceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCC
Confidence 0112589999997 689888743 3455543 5789999999999999999999999999999
Q ss_pred CcEEEeecccccc
Q 018489 209 RTVKIADFGVARV 221 (355)
Q Consensus 209 ~~v~L~Dfg~a~~ 221 (355)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 9999999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-16 Score=131.28 Aligned_cols=144 Identities=24% Similarity=0.230 Sum_probs=95.6
Q ss_pred eecccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHH---------------HHHHHHHHHHHHHHhhCCCCc--
Q 018489 54 IKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEI---------------AALRSAFTQEVAVWHKLDHPN-- 115 (355)
Q Consensus 54 i~~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~---------------~~~~~~~~~E~~~l~~l~h~~-- 115 (355)
+.+.||+|+||.||+|.+. ++.||||+++............ .........|...+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 3568999999999999765 8999999986543221111100 000111234555555553332
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHH-HHhhccccccHHHHHHHHHHHHHHHHHHHh-CCc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY-LIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKI 193 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i 193 (355)
+.++++. ...+++|||++++++... +... ... ..+..++.+++.++.++|. .|+
T Consensus 81 ~~~~~~~--------------------~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~i 136 (187)
T cd05119 81 VPKPIDL--------------------NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAGL 136 (187)
T ss_pred CCceEec--------------------CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccCc
Confidence 2333321 112689999998543211 1110 011 6678899999999999999 999
Q ss_pred cccCCCCCcEEEcCCCcEEEeeccccccc
Q 018489 194 VHRDVKTENMLLDKNRTVKIADFGVARVE 222 (355)
Q Consensus 194 ~H~di~p~Nili~~~~~v~L~Dfg~a~~~ 222 (355)
+|+||+|+||+++ ++.++|+|||.+...
T Consensus 137 vH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 137 VHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 9999999999999 999999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-17 Score=160.54 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=189.6
Q ss_pred CcceeecccccccceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeeccC
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMG 125 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~ 125 (355)
..|.+.+.||+|.++.|-+... ....+++|.+......... .+....|..+-..+. |+|++.+++....
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~-------~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDS-------SEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccch-------hhhcCccccccccccccccccccCCccCC
Confidence 4566777799999999987643 3455666666443311111 122344666666675 9999999998887
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH-SQKIVHRDVKTENML 204 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~i~H~di~p~Nil 204 (355)
....+ +.++|..|+++.+.+........+......++.|+..++.|+| ..++.|+|++|+|.+
T Consensus 93 ~~~~~----------------~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 93 PRSYL----------------LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSL 156 (601)
T ss_pred Ccccc----------------cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccch
Confidence 77664 4999999999988873222325777788899999999999999 999999999999999
Q ss_pred EcCCC-cEEEeeccccccccC-CC--CCCCCCCC-cccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 205 LDKNR-TVKIADFGVARVEAS-NP--NDMTGETG-TLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 205 i~~~~-~v~L~Dfg~a~~~~~-~~--~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
++..+ .+++.|||+|..... .+ .......| +..|.|||...+. ......|+||.|+++..+++|..||......
T Consensus 157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 99999 999999999986554 22 22334567 9999999999884 4457899999999999999999999876544
Q ss_pred HHHHHHHh-c--CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 279 EVTSAVVR-Q--NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 279 ~~~~~~~~-~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
........ . .........++....+++.+++..+|..|.+.+++-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 237 DGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 43321111 1 1233455678899999999999999999999887754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=3e-15 Score=119.60 Aligned_cols=131 Identities=21% Similarity=0.243 Sum_probs=105.9
Q ss_pred eecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCC--CccceeeeeccCCccccc
Q 018489 54 IKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH--PNVTKFIGATMGSSELHI 131 (355)
Q Consensus 54 i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~~~~~~~~~~~~~~ 131 (355)
+.+.||.|.++.||++...+..+++|....... ...+.+|+.++..+.+ .++++++.+....+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~--- 67 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----------GADREREVAILQLLARKGLPVPKVLASGESDGW--- 67 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc-----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCc---
Confidence 457899999999999998889999999854321 2346788888888865 578888776654433
Q ss_pred ccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCcEEEcCC
Q 018489 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ---KIVHRDVKTENMLLDKN 208 (355)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~di~p~Nili~~~ 208 (355)
.+++|||+++.++..+ +......++.+++++++++|.. +++|+|++|+||+++..
T Consensus 68 -------------~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 68 -------------SYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred -------------cEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 3679999988777643 4456677889999999999985 79999999999999999
Q ss_pred CcEEEeeccccc
Q 018489 209 RTVKIADFGVAR 220 (355)
Q Consensus 209 ~~v~L~Dfg~a~ 220 (355)
+.++++||+.+.
T Consensus 126 ~~~~l~Df~~~~ 137 (155)
T cd05120 126 KILGIIDWEYAG 137 (155)
T ss_pred cEEEEEeccccc
Confidence 999999999885
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.3e-13 Score=113.52 Aligned_cols=146 Identities=14% Similarity=0.135 Sum_probs=100.4
Q ss_pred eecccccccceEEEEEEEC--------CceeEEEEeecCCCCCccH-----------------HHHHHHHHHHHHHHHHH
Q 018489 54 IKSVIARGTFGTVHRGLYD--------GHDVAVKLLDWGEEGHRTE-----------------AEIAALRSAFTQEVAVW 108 (355)
Q Consensus 54 i~~~lg~G~~~~Vy~~~~~--------~~~vavK~~~~~~~~~~~~-----------------~~~~~~~~~~~~E~~~l 108 (355)
+...||.|--+.||.|... +..+|||+++......... ......+....+|.+.|
T Consensus 1 ~~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L 80 (197)
T cd05146 1 INGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL 80 (197)
T ss_pred CCCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence 3568999999999999643 3789999996433221111 11222233344899999
Q ss_pred hhCCC--CccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHH
Q 018489 109 HKLDH--PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLS 186 (355)
Q Consensus 109 ~~l~h--~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 186 (355)
+++.. -++..++++.. .++||||+.++.+..-. .....++......+..+++.+|.
T Consensus 81 ~rl~~~Gv~vP~pi~~~~--------------------~~lvME~Ig~~~~~~~~--Lkd~~~~~~~~~~i~~~i~~~l~ 138 (197)
T cd05146 81 KRMQKAGIPCPEVVVLKK--------------------HVLVMSFIGDDQVPAPK--LKDAKLNDEEMKNAYYQVLSMMK 138 (197)
T ss_pred HHHHHcCCCCCeEEEecC--------------------CEEEEEEcCCCCccchh--hhccccCHHHHHHHHHHHHHHHH
Confidence 99843 34455554311 15799999765332211 11223556667788899999999
Q ss_pred HH-HhCCccccCCCCCcEEEcCCCcEEEeeccccccc
Q 018489 187 YL-HSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222 (355)
Q Consensus 187 ~L-H~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~ 222 (355)
.+ |+.|++||||++.||++. ++.++|+|||.+...
T Consensus 139 ~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 139 QLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 98 899999999999999996 578999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.7e-13 Score=107.16 Aligned_cols=138 Identities=24% Similarity=0.289 Sum_probs=105.3
Q ss_pred cccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccccc
Q 018489 56 SVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~ 135 (355)
..+++|+-+.+|.+.+-|.++++|. +....-...+-+....+++-.+|.+++.++.--+|.-.+=+..+++..
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~------ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG------ 74 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC------
Confidence 4688999999999988887877775 333333333444455566788999999999665665554444454444
Q ss_pred ccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEee
Q 018489 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (355)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~D 215 (355)
.|+|||++|..|.+.+... ...++..+-..+..||..||+||||.++||+++.++ +.++|
T Consensus 75 ----------~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~ID 134 (204)
T COG3642 75 ----------LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFID 134 (204)
T ss_pred ----------EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEE
Confidence 4599999999999888543 255777888888999999999999999999997665 99999
Q ss_pred ccccc
Q 018489 216 FGVAR 220 (355)
Q Consensus 216 fg~a~ 220 (355)
||++.
T Consensus 135 fGLg~ 139 (204)
T COG3642 135 FGLGE 139 (204)
T ss_pred CCccc
Confidence 99986
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=5e-13 Score=105.96 Aligned_cols=152 Identities=20% Similarity=0.296 Sum_probs=115.1
Q ss_pred eecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccccc
Q 018489 54 IKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (355)
Q Consensus 54 i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~ 133 (355)
....|.+|+-+.|+++.+.|+..+||- +....-.....+.+..+++..+|.++|.++.--+|.-..-++.+...-
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~-Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~---- 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKE-RFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG---- 85 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEee-cccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC----
Confidence 567889999999999999999999985 222222333455566777889999999988554554333333332222
Q ss_pred ccccccCCCCceEEEEEecCC-CCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---
Q 018489 134 ENGQVAMPSNICCVVVEYLPG-GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR--- 209 (355)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~--- 209 (355)
+|+|||++| .++.+++...............+++++-+.+..||..+++||||..+||++..++
T Consensus 86 ------------~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~ 153 (229)
T KOG3087|consen 86 ------------QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQI 153 (229)
T ss_pred ------------eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcC
Confidence 569999976 4888888776666666666688999999999999999999999999999996554
Q ss_pred cEEEeeccccccc
Q 018489 210 TVKIADFGVARVE 222 (355)
Q Consensus 210 ~v~L~Dfg~a~~~ 222 (355)
.+.|+|||++...
T Consensus 154 ~~~lIdfgls~~s 166 (229)
T KOG3087|consen 154 TPILIDFGLSSVS 166 (229)
T ss_pred ceEEEeecchhcc
Confidence 3589999998643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.2e-12 Score=122.06 Aligned_cols=160 Identities=17% Similarity=0.175 Sum_probs=101.6
Q ss_pred CcceeecccccccceEEEEEEE-C-CceeEEEEeecCCCC-------------------------CccHHHHHHHHHHHH
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY-D-GHDVAVKLLDWGEEG-------------------------HRTEAEIAALRSAFT 102 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~-~-~~~vavK~~~~~~~~-------------------------~~~~~~~~~~~~~~~ 102 (355)
..|.. +.||.|++|.||+|.. + |+.||||+.+..... ........+..+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 7899999999999965 3 899999999643210 001122234445555
Q ss_pred HHHHHHhhCCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccc----cccHHHHHHHH
Q 018489 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR----KLAFKVVVQLA 178 (355)
Q Consensus 103 ~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----~~~~~~~~~i~ 178 (355)
+|+.+.... .|+.++...|...+..++..-..+ -....++||||++|+++.++..-...+ .+.+..+..++
T Consensus 199 ~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d---~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREA--ANASQLRRNFEDSDMLYVPEVYWD---YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHH--HHHHHHHHHccCCCCeecceeecc---cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence 666655554 455555555544433322110000 023447899999999998753211111 34444555555
Q ss_pred HHHHHHHHHHHhCCccccCCCCCcEEEcCCC----cEEEeeccccccc
Q 018489 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNR----TVKIADFGVARVE 222 (355)
Q Consensus 179 ~qi~~al~~LH~~~i~H~di~p~Nili~~~~----~v~L~Dfg~a~~~ 222 (355)
.|++ ..|++|+|+||.||+++.+| .++++|||.+...
T Consensus 274 ~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 274 TQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 5554 58999999999999999888 9999999998644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.9e-12 Score=121.00 Aligned_cols=166 Identities=18% Similarity=0.264 Sum_probs=126.9
Q ss_pred EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccccccccccccCCCCceEEEE
Q 018489 70 LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV 149 (355)
Q Consensus 70 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 149 (355)
+.++.+|.|.+.+.... . ......+-++.++.++||||+++++.+...... |+|+
T Consensus 34 k~~~~~vsVF~~~~~~~-~--------~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~----------------ylvT 88 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-E--------VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTL----------------YLVT 88 (690)
T ss_pred eccCCceEEEEEeCCCc-h--------hhHHHHHHHHHhhhccCchhhhhhhhhcccCce----------------EEEe
Confidence 45788899988865443 1 112345677888999999999999998877665 5599
Q ss_pred EecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCC
Q 018489 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH-SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228 (355)
Q Consensus 150 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~ 228 (355)
|.+ .+|..+++. ++...+...+.||+.||.+|| +.+++|++|..+.|||+..|..+|++|.++......+..
T Consensus 89 ErV--~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~ 161 (690)
T KOG1243|consen 89 ERV--RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP 161 (690)
T ss_pred ecc--ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc
Confidence 988 488888754 336677778999999999997 568999999999999999999999999988654433322
Q ss_pred CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCC
Q 018489 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269 (355)
Q Consensus 229 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~ 269 (355)
.........|..|+.+.... -..|.|.||+++++++.|.
T Consensus 162 ~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 162 AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 22233444577777776654 4579999999999999993
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.5e-11 Score=114.86 Aligned_cols=147 Identities=23% Similarity=0.276 Sum_probs=92.6
Q ss_pred cccccccceEEEEEEE-CCceeEEEEeecCCCCCccHH--------------------------HHHHHHHH------HH
Q 018489 56 SVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEA--------------------------EIAALRSA------FT 102 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~--------------------------~~~~~~~~------~~ 102 (355)
+.||.|++|.||+|+. +|+.||||+.+..... .... -...+... +.
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~-~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEK-TIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHH-HHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999965 7999999998533211 0000 01111111 33
Q ss_pred HHHHHHhhC----CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHH
Q 018489 103 QEVAVWHKL----DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLA 178 (355)
Q Consensus 103 ~E~~~l~~l----~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~ 178 (355)
+|...+.++ ++.+-+.+-..+... ....+++|||++|.+|.++...... ... ...++
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~---------------~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia 262 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR---------------TSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALA 262 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh---------------cCCceEEEEeECCcccccHHHHHhc-CCC---HHHHH
Confidence 444444443 122212221111110 1123689999999999887643211 122 33455
Q ss_pred HHHHH-HHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccc
Q 018489 179 LDLAR-GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222 (355)
Q Consensus 179 ~qi~~-al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~ 222 (355)
..++. .+..+|..|++|+|++|.||+++.++.++++|||.+...
T Consensus 263 ~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 263 ENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 55555 478889999999999999999999999999999998643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=7.8e-14 Score=128.83 Aligned_cols=252 Identities=23% Similarity=0.222 Sum_probs=180.9
Q ss_pred eecCCcceeeccccc--ccceEEEEEE----ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccce
Q 018489 46 EIEPSKLVIKSVIAR--GTFGTVHRGL----YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTK 118 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~--G~~~~Vy~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~ 118 (355)
......+.+.+.+|. |.+|.||.+. .++..+|+|.-+..-..... ...-.+|......+ .|++.++
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-------~~~k~~~~~s~~~i~~~~~~v~ 182 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-------SKRKLREFLSHHKIDSHENPVR 182 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-------cccccchhhcccccCccccccc
Confidence 445567788899999 9999999764 46788898874322211110 11123455555555 6788888
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHH----HHHHHHhCCcc
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR----GLSYLHSQKIV 194 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~----al~~LH~~~i~ 194 (355)
.+..+...+.. ++-+|.+ +.+|..+... ....++...++.++.+... ||.++|..+++
T Consensus 183 ~~~~~e~~~~l----------------fiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~ 244 (524)
T KOG0601|consen 183 DSPAWEGSGIL----------------FIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIV 244 (524)
T ss_pred cCcccccCCcc----------------eeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCccc
Confidence 77766666655 4477887 5777777643 3445888999999999999 99999999999
Q ss_pred ccCCCCCcEEEcCC-CcEEEeeccccccccCCCCCCCC-----CCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhC
Q 018489 195 HRDVKTENMLLDKN-RTVKIADFGVARVEASNPNDMTG-----ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268 (355)
Q Consensus 195 H~di~p~Nili~~~-~~v~L~Dfg~a~~~~~~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg 268 (355)
|.|++|.||+...+ ...+++||++........-.... ..+...|++||..++- ++.+.|+++||.++.+..++
T Consensus 245 ~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~ 323 (524)
T KOG0601|consen 245 HDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILG 323 (524)
T ss_pred ccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhh
Confidence 99999999999998 88999999998765544322222 2678899999998875 67899999999999998887
Q ss_pred CCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 269 DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 269 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+....-...+. .+.......++....+.++...+..|++.+|..|++.+.+..
T Consensus 324 ~~~~~~g~~~~W~-~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 324 SHLPSVGKNSSWS-QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccccCCCCCCcc-ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 6554332111111 111112333455566778888999999999999999886654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.6e-12 Score=115.35 Aligned_cols=209 Identities=17% Similarity=0.332 Sum_probs=154.5
Q ss_pred EEEEEecCCC-CHHHHHH----hhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 146 CVVVEYLPGG-ALKTYLI----KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 146 ~lv~e~~~~~-sL~~~l~----~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.++|+.+.|. ...+++. .+.-....|.-.++.++.++.+.+.||..|.+-||+.++|+|+++++.|.|.|-..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 4588888664 3333331 1123457899999999999999999999999999999999999999999999876543
Q ss_pred cccCCCCCCCCCCCcccccCCcccC-----CCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCh-------hH--HHH---
Q 018489 221 VEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF-------SE--VTS--- 282 (355)
Q Consensus 221 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~lltg-~~p~~~~~~-------~~--~~~--- 282 (355)
. ...+....+.++...|.+||..+ +..-+...|.|.||+++++++.| ++||.+... -+ ...
T Consensus 166 i-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 166 I-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred e-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 2 25567778889999999999876 33456789999999999999886 999975421 11 000
Q ss_pred ---HHHhcCCCC---CCC-CCCcHHHHHHHHHhhhcC--CCCCCCHHHHHHHHHHhHhhc------CCCCCCCCCCCcce
Q 018489 283 ---AVVRQNLRP---EIP-RCCPSSLANVMKRCWDAN--PDKRPEMDEVVSMLEAIDTSK------GGGMIPGDQPQGCL 347 (355)
Q Consensus 283 ---~~~~~~~~~---~~~-~~~~~~l~~li~~~l~~~--p~~Rps~~ell~~l~~~~~~~------~~~~~~~~~~~~~~ 347 (355)
......+.+ ..+ .-+++++..+..+|+... +.-|||++-++..|..+.++. .+...+-....|.|
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~y~~hl~~CPw 324 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHVYPVHLTDCPW 324 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccccccCCCCCCch
Confidence 000011111 122 235889999999999654 457999999999999998654 55667888889999
Q ss_pred eeeccCCC
Q 018489 348 CFRKHRGP 355 (355)
Q Consensus 348 ~~~~~~~~ 355 (355)
|+.-.-|+
T Consensus 325 Ca~~~~g~ 332 (637)
T COG4248 325 CALDNQGV 332 (637)
T ss_pred hhhcccCc
Confidence 99865553
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.3e-13 Score=108.60 Aligned_cols=127 Identities=20% Similarity=0.160 Sum_probs=92.4
Q ss_pred ecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc-eeeeeccCCccccccc
Q 018489 55 KSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT-KFIGATMGSSELHIQT 133 (355)
Q Consensus 55 ~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv-~~~~~~~~~~~~~~~~ 133 (355)
.+.|+.|.++.||++...+..+++|+....... ...+..|..++..+.+.+++ +++.+.. .
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~----------~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~------ 64 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL----------LINRENEAENSKLAAEAGIGPKLYYFDP--E------ 64 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc----------ccCHHHHHHHHHHHHHhCCCCceEEEeC--C------
Confidence 356889999999999989999999997533210 11245688888887554443 3443321 1
Q ss_pred ccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCcEEEcCC
Q 018489 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKI-----VHRDVKTENMLLDKN 208 (355)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i-----~H~di~p~Nili~~~ 208 (355)
..++||||++|.++.... . ....++.+++.+|+.||+.++ +|+|++|.||+++ +
T Consensus 65 ----------~~~lv~e~i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~ 123 (170)
T cd05151 65 ----------TGVLITEFIEGSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D 123 (170)
T ss_pred ----------CCeEEEEecCCCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C
Confidence 125699999998876430 1 113456799999999999985 9999999999998 6
Q ss_pred CcEEEeeccccc
Q 018489 209 RTVKIADFGVAR 220 (355)
Q Consensus 209 ~~v~L~Dfg~a~ 220 (355)
+.++++||+.+.
T Consensus 124 ~~~~liDf~~a~ 135 (170)
T cd05151 124 GRLWLIDWEYAG 135 (170)
T ss_pred CeEEEEeccccc
Confidence 789999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.9e-12 Score=111.18 Aligned_cols=202 Identities=21% Similarity=0.344 Sum_probs=137.1
Q ss_pred HHhhCCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--cccccHHHHHHHHHHHHHH
Q 018489 107 VWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARG 184 (355)
Q Consensus 107 ~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~a 184 (355)
-|-++-|.||+++..++.+...- +..-..++.||+..|++..++++.. ...+....-.+|+.||+.|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~-----------e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsa 188 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYE-----------EKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSA 188 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccc-----------cccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 34455799999998887654431 1122356999999999999997543 4457888889999999999
Q ss_pred HHHHHhCC--ccccCCCCCcEEEcCCCcEEEeeccccccccCC----CCCCCCCCCcccccCCcccCCCCCCCcchhHHH
Q 018489 185 LSYLHSQK--IVHRDVKTENMLLDKNRTVKIADFGVARVEASN----PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258 (355)
Q Consensus 185 l~~LH~~~--i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 258 (355)
|.|||+.. ++|+++.-+.|++..+|-++++--........- ........+-++|.+||.=.....+-++|||++
T Consensus 189 l~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~f 268 (458)
T KOG1266|consen 189 LSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKF 268 (458)
T ss_pred hhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhh
Confidence 99999985 999999999999998888887643322211110 011122345678999997555556678999999
Q ss_pred HHHHHHHHhCCCC-CCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 259 GICLWEIYCCDMP-YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 259 G~il~~lltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
|++..+|..+..- -.+.+.......+..... ..-.+-=+++|.+|++..|..||++.+++-
T Consensus 269 gmcAlemailEiq~tnseS~~~~ee~ia~~i~-----~len~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 269 GMCALEMAILEIQSTNSESKVEVEENIANVII-----GLENGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred hHHHHHHHHheeccCCCcceeehhhhhhhhee-----eccCccccCcCcccccCCCCCCcchhhhhc
Confidence 9999999877532 222221111111111000 011222356799999999999999998764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.5e-10 Score=103.07 Aligned_cols=218 Identities=19% Similarity=0.267 Sum_probs=154.3
Q ss_pred ceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccccccccccccC
Q 018489 63 FGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAM 140 (355)
Q Consensus 63 ~~~Vy~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~ 140 (355)
-.+.|++ ..+|..|++|.++......... ...-+++++++.|+|+|++.++|.... |
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---------~t~lve~wkkl~h~NvV~frevf~t~t------------F 347 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK---------DTSLVEAWKKLCHTNVVPFREVFLTYT------------F 347 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCccc---------chHHHHHHHHhccCceeehhhhhhhhc------------c
Confidence 3567888 4589999999994333222211 224577889999999999999887322 3
Q ss_pred CCCceEEEEEecCC-CCHHHHHHhh-------------ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 141 PSNICCVVVEYLPG-GALKTYLIKN-------------RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 141 ~~~~~~lv~e~~~~-~sL~~~l~~~-------------~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.+..+++|++|.++ ++|.++...+ .+.+.++..+|.++.|+..||.++|+.|+..+-|.|.+|+++
T Consensus 348 ~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~ 427 (655)
T KOG3741|consen 348 GDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT 427 (655)
T ss_pred CcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee
Confidence 46677999999985 4677765321 134578899999999999999999999999999999999998
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.+-++++...|.......+.. +-+.+ -.+.|.=.||.+++.|.||..-=...+...... .
T Consensus 428 G~~RIriS~C~i~Dvl~~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--~- 487 (655)
T KOG3741|consen 428 GKMRIRISGCGIMDVLQEDPT--------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSH--L- 487 (655)
T ss_pred CcceEEEecccceeeecCCCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHH--H-
Confidence 888899988887765543321 11111 145789999999999999953211111111110 0
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
..+...++.+++++|..+...++++ -++.+++.++
T Consensus 488 ----~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 488 ----TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ----HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 0133456889999999999999887 5888887754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.6e-11 Score=97.21 Aligned_cols=133 Identities=26% Similarity=0.306 Sum_probs=84.4
Q ss_pred EEEEEEE-CCceeEEEEeecCCCCCc-----------------cHHHHHHHHHHHHHHHHHHhhCCCCc--cceeeeecc
Q 018489 65 TVHRGLY-DGHDVAVKLLDWGEEGHR-----------------TEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATM 124 (355)
Q Consensus 65 ~Vy~~~~-~~~~vavK~~~~~~~~~~-----------------~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~~ 124 (355)
.||.|.. ++..+|||+.+....... ........+....+|.+.|..+..-+ +.+++++..
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 4888865 688999999964322211 11223345566889999999996653 455554421
Q ss_pred CCcccccccccccccCCCCceEEEEEecC--CCCHHHHHHhhccccccHHHHHHHHHHHHHHHHH-HHhCCccccCCCCC
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLP--GGALKTYLIKNRRRKLAFKVVVQLALDLARGLSY-LHSQKIVHRDVKTE 201 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~-LH~~~i~H~di~p~ 201 (355)
. +|||||++ |.++..+... .++......++.+++..+.. +|+.|++|||+++.
T Consensus 81 ~--------------------~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~ 136 (188)
T PF01163_consen 81 N--------------------VIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEY 136 (188)
T ss_dssp T--------------------EEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STT
T ss_pred C--------------------EEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChh
Confidence 1 57999998 6666554421 12244556677788884444 68999999999999
Q ss_pred cEEEcCCCcEEEeeccccccc
Q 018489 202 NMLLDKNRTVKIADFGVARVE 222 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~ 222 (355)
||+++++ .+.++|||.+...
T Consensus 137 NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 137 NILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp SEEEETT-CEEE--GTTEEET
T ss_pred hEEeecc-eEEEEecCcceec
Confidence 9999877 9999999998643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.5e-11 Score=100.48 Aligned_cols=142 Identities=24% Similarity=0.250 Sum_probs=105.2
Q ss_pred ceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccH-------------HHHHHHHHHHHHHHHHHhhCCCC--c
Q 018489 52 LVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTE-------------AEIAALRSAFTQEVAVWHKLDHP--N 115 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~--~ 115 (355)
+.++..||.|--|.||.|.+ .|.+++||.-+......... ......+....+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 46788999999999999976 59999999875443322211 11123455678899999998554 5
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H 195 (355)
+.+.++ .+..++|||+++|-.|...- ++......++..|+..+..+=..|++|
T Consensus 173 VP~P~~--------------------~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVH 225 (304)
T COG0478 173 VPKPIA--------------------WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVH 225 (304)
T ss_pred CCCccc--------------------cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccc
Confidence 555554 33447899999997775432 234455566777777777777899999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccccc
Q 018489 196 RDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 196 ~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
||+++-||+++++|.++++||..+.
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred cCCchheEEEecCCCEEEEeCcccc
Confidence 9999999999999999999998875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.5e-12 Score=116.25 Aligned_cols=248 Identities=21% Similarity=0.168 Sum_probs=171.6
Q ss_pred cCCcceeecccccccceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeec
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGAT 123 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~ 123 (355)
...+|..+..||.|.|+.|+.+.. .+..|++|-....-.... .++ .-..|+.+...+ .|.+++..+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~--~di-----~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA--SDI-----FSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH--hhh-----cchhhhhHhhHhhcccccCCCCCCc
Confidence 347899999999999999998743 467788887754332211 111 123455555555 688888877776
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
......++ --||++++++...+ .-...+.+...+++..|++.++.++|++.++|+|++|+||
T Consensus 336 ~~~r~~~i----------------p~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni 397 (524)
T KOG0601|consen 336 SQLRQGYI----------------PLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNI 397 (524)
T ss_pred cccccccC----------------chhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccce
Confidence 66555543 77899888887665 3345688899999999999999999999999999999999
Q ss_pred EEcCC-CcEEEeeccccccccCCCCCCCCCCCccccc--CCcccCCCCCCCcchhHHHHHHHHHHHhCCC-CCCCCChhH
Q 018489 204 LLDKN-RTVKIADFGVARVEASNPNDMTGETGTLGYM--APEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSE 279 (355)
Q Consensus 204 li~~~-~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DvwslG~il~~lltg~~-p~~~~~~~~ 279 (355)
++..+ +.-+++||+......... ........+. ++.......+-.+.|+++||..+.+.+++.. ++.+..
T Consensus 398 ~i~~~~~~~~~~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--- 471 (524)
T KOG0601|consen 398 LISNDGFFSKLGDFGCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--- 471 (524)
T ss_pred eeccchhhhhccccccccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCccccc---
Confidence 99886 778899999886422111 1122233344 4444445667789999999999999998863 332211
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
...+..+..+ .......++..+.+.++..++..||.+.++.....-.
T Consensus 472 --~~~i~~~~~p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 472 --SLTIRSGDTP-NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred --ceeeeccccc-CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1111112222 2233347889999999999999999998876654433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.7e-12 Score=121.34 Aligned_cols=252 Identities=20% Similarity=0.285 Sum_probs=178.3
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
+....+.+.+.+-+-.|.++.++.+.. .+...+.|+......-.... .+....+-.++....+|-++...-.
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~------~~s~r~~s~~~i~p~~P~v~~~~~s 872 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTND------YESIRSKSNILITPRSPAVVRSFPS 872 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcccc------ccccCCccCccccCCCCceecccCC
Confidence 455667888888999999999998754 34445555443222111100 0001122222222233444444333
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...... +++++|+.+++|...+.. ....+.......+..+.+++++||...+.|+|++|.|
T Consensus 873 ~~~rsP~----------------~L~~~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~ 934 (1205)
T KOG0606|consen 873 FPCRSPL----------------PLVGHYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDS 934 (1205)
T ss_pred CCCCCCc----------------chhhHHhccCCchhhhhc--CCCcccccccchhHHHHhhhhccccchhhcccccccc
Confidence 3333333 569999999999988843 3457777777888899999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccc-cCC------------------------------CCCCCCCCCcccccCCcccCCCCCCC
Q 018489 203 MLLDKNRTVKIADFGVARVE-ASN------------------------------PNDMTGETGTLGYMAPEVLNGNPYNR 251 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~-~~~------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~ 251 (355)
.++..++...+.||+..... ..+ ........+++.|.+||...+.....
T Consensus 935 ~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs 1014 (1205)
T KOG0606|consen 935 LLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGS 1014 (1205)
T ss_pred hhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCC
Confidence 99999999999999832210 000 00112235889999999999998899
Q ss_pred cchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 018489 252 KCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP-EIPRCCPSSLANVMKRCWDANPDKRPEMD 320 (355)
Q Consensus 252 ~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 320 (355)
.+|+|+.|+++++.++|..||+..........+....... .-+...+.+.++++...|..+|.+|..+.
T Consensus 1015 ~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1015 AADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999999999999998888887776654433 33455789999999999999999997665
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.6e-10 Score=97.73 Aligned_cols=144 Identities=17% Similarity=0.110 Sum_probs=96.5
Q ss_pred cceEEEEEEECCceeEEEEeecCCCCCccHHHHHHH------HHHHHHHHHHHhhCCCCccc--eeeeeccCCccccccc
Q 018489 62 TFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAAL------RSAFTQEVAVWHKLDHPNVT--KFIGATMGSSELHIQT 133 (355)
Q Consensus 62 ~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~Iv--~~~~~~~~~~~~~~~~ 133 (355)
....|+++...|+.+.||........ .-...+ ...+.+|...+..+..-+|. .++.++......
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~~~----~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~---- 105 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTGWG----EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP---- 105 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCcHH----HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC----
Confidence 33446677788899999977322110 000000 01366788888777433332 333333211100
Q ss_pred ccccccCCCCceEEEEEecCCC-CHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC-----
Q 018489 134 ENGQVAMPSNICCVVVEYLPGG-ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK----- 207 (355)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~----- 207 (355)
.....++|+|++++. +|.+++........+......++.+++..++.||..|++|+|+++.|||++.
T Consensus 106 -------~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 106 -------ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred -------ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCC
Confidence 011236799999876 8999885433445667788899999999999999999999999999999975
Q ss_pred --CCcEEEeeccccc
Q 018489 208 --NRTVKIADFGVAR 220 (355)
Q Consensus 208 --~~~v~L~Dfg~a~ 220 (355)
+..+.|+||+.+.
T Consensus 179 ~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 179 EEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCceEEEEECCccc
Confidence 4689999999885
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.8e-10 Score=93.69 Aligned_cols=141 Identities=23% Similarity=0.229 Sum_probs=98.5
Q ss_pred cccccccceEEEEEEECC-ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc--cceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~~~~~~~~~~ 132 (355)
+.|+.|..+.||++...+ ..+++|+........ ....+..|..++..+.+.+ +.+++.+.....
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~--------~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~----- 70 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP--------SAHDVAREYRVLRALAGTGVPVPKVLALCEDPS----- 70 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCc--------ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-----
Confidence 568999999999997665 899999975433210 1223677889999886543 455665544321
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh----------------------
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS---------------------- 190 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~---------------------- 190 (355)
..+..+++|||++|.++.+.+. ...++......++.+++++|+.||+
T Consensus 71 --------~~~~~~~v~e~i~G~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~ 139 (223)
T cd05154 71 --------VLGTPFYVMERVDGRVLRDRLL---RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQV 139 (223)
T ss_pred --------ccCCceEEEEEeCCEecCCCCC---CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHH
Confidence 0123367999999988876541 1345666666677777777777763
Q ss_pred ----------------------------------CCccccCCCCCcEEEcC--CCcEEEeeccccc
Q 018489 191 ----------------------------------QKIVHRDVKTENMLLDK--NRTVKIADFGVAR 220 (355)
Q Consensus 191 ----------------------------------~~i~H~di~p~Nili~~--~~~v~L~Dfg~a~ 220 (355)
..++|+|++|.||+++. ++.+.++||+.+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 140 ARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 24699999999999998 6678999999885
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.7e-09 Score=88.28 Aligned_cols=146 Identities=16% Similarity=0.130 Sum_probs=101.9
Q ss_pred ccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc--cceeeeecc-CCccccccccc
Q 018489 59 ARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATM-GSSELHIQTEN 135 (355)
Q Consensus 59 g~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~~-~~~~~~~~~~~ 135 (355)
|+|+.|.|++....|..+-+|.....-...- -.+.-+..|.+|...+.++..-+ +.++. ++. .....
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~---r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~------ 96 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSV---RYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEG------ 96 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccc---cCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCC------
Confidence 5799999999988888888887631110000 00112345888999998884333 33333 221 11110
Q ss_pred ccccCCCCceEEEEEecCC-CCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCc--EE
Q 018489 136 GQVAMPSNICCVVVEYLPG-GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT--VK 212 (355)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~--v~ 212 (355)
.-..+||+|-++| .+|.+++....-.+.+......++.++..+++.||+.|+.|+|+.+.||+++.++. +.
T Consensus 97 ------~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~ 170 (216)
T PRK09902 97 ------EWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAG 170 (216)
T ss_pred ------ceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEE
Confidence 1123679997753 58988885544456788888899999999999999999999999999999986677 99
Q ss_pred Eeeccccc
Q 018489 213 IADFGVAR 220 (355)
Q Consensus 213 L~Dfg~a~ 220 (355)
++||.-++
T Consensus 171 lIDlEk~r 178 (216)
T PRK09902 171 FLDLEKSR 178 (216)
T ss_pred EEEhhccc
Confidence 99998776
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.99 E-value=1e-08 Score=85.09 Aligned_cols=152 Identities=18% Similarity=0.206 Sum_probs=93.8
Q ss_pred cCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHH--HHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAAL--RSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~--~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
...+|.+.+.+.......|.+-..++..+++|..+.... ......... -....+.+.....+...++..+.+.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~--r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y-- 104 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENR--RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY-- 104 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhh--hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce--
Confidence 457889999999999999998888999999999853221 111111111 01122333333333222222221111
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
++.+.....+ ....+++|||++|..|.+... +++ .+...+.+++..+|+.|++|||.+|.|+++
T Consensus 105 -----l~~ekk~~~~-~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv 168 (229)
T PF06176_consen 105 -----LAAEKKIFRY-TSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV 168 (229)
T ss_pred -----eeeeeeeccc-eeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE
Confidence 1111111111 233368999999998876541 222 244567788999999999999999999999
Q ss_pred cCCCcEEEeeccccc
Q 018489 206 DKNRTVKIADFGVAR 220 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~ 220 (355)
+++ .+.++||+...
T Consensus 169 ~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 169 SNN-GIRIIDTQGKR 182 (229)
T ss_pred ECC-cEEEEECcccc
Confidence 854 49999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3e-10 Score=106.93 Aligned_cols=141 Identities=23% Similarity=0.320 Sum_probs=104.9
Q ss_pred HHHHHHHhC-CccccCCCCCcEEEcCCCcEEEeeccccccccCCCC---------CCCCCCCcccccCCcccCCCCCCCc
Q 018489 183 RGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN---------DMTGETGTLGYMAPEVLNGNPYNRK 252 (355)
Q Consensus 183 ~al~~LH~~-~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~ 252 (355)
.++.++|.. ++||++|.|++|+++..+..||+.|+++........ ..........|.|||.+.+...+.+
T Consensus 110 dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~ 189 (700)
T KOG2137|consen 110 DGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPA 189 (700)
T ss_pred chhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccccc
Confidence 899999976 899999999999999999999999998764433111 1111224568999999999888999
Q ss_pred chhHHHHHHHHHHH-hCCCCCCCCChhHHHHH--HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 018489 253 CDVYSFGICLWEIY-CCDMPYPDLSFSEVTSA--VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323 (355)
Q Consensus 253 ~DvwslG~il~~ll-tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 323 (355)
+|++|+|+++|.+. .|+..+........... .........+..++|.++.+=+.+++..+..-||++.+++
T Consensus 190 sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 190 SDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 99999999999998 46655544422222211 1112222335577899999999999999999999776554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.9e-08 Score=84.68 Aligned_cols=109 Identities=22% Similarity=0.264 Sum_probs=80.3
Q ss_pred HHHHHHHHHHhhCCCCcc--ceeeeeccCCcccccccccccccCCCCceEEEEEecCCC-CHHHHHHhhccccccHHHHH
Q 018489 99 SAFTQEVAVWHKLDHPNV--TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG-ALKTYLIKNRRRKLAFKVVV 175 (355)
Q Consensus 99 ~~~~~E~~~l~~l~h~~I--v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~ 175 (355)
....+|...+..+..-+| .+++++....... ....++|+|++++. +|.+++.... ..+.....
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~------------~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~ 121 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGG------------GYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRR 121 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC------------ceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHH
Confidence 346677777777743333 3444443322111 02236899999874 7999885422 26777888
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC---cEEEeecccccc
Q 018489 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR---TVKIADFGVARV 221 (355)
Q Consensus 176 ~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~---~v~L~Dfg~a~~ 221 (355)
.++.++...++.||..|++|+|+++.|||+..++ .+.|+||+.+..
T Consensus 122 ~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 122 ELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.85 E-value=4e-08 Score=82.55 Aligned_cols=147 Identities=18% Similarity=0.143 Sum_probs=93.4
Q ss_pred eecccccccceEEEEEE-ECCceeEEEEeecCCCCCccH---------------HHHHHHHHHHHHHHHHHhhCCCC--c
Q 018489 54 IKSVIARGTFGTVHRGL-YDGHDVAVKLLDWGEEGHRTE---------------AEIAALRSAFTQEVAVWHKLDHP--N 115 (355)
Q Consensus 54 i~~~lg~G~~~~Vy~~~-~~~~~vavK~~~~~~~~~~~~---------------~~~~~~~~~~~~E~~~l~~l~h~--~ 115 (355)
+...|+.|--++||+|. .++..+|+|+++......... ............|+..|.++..- .
T Consensus 52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34477788889999985 468999999996433221110 00111122245566666666322 2
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh-CCcc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIV 194 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~ 194 (355)
+.+.+.+.. -.|||||+....+ -.-....-++.......+..++++.+.-|=. .|++
T Consensus 132 vP~Pi~~~~--------------------nVLvMEfIg~~g~--pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LV 189 (268)
T COG1718 132 VPEPIAFRN--------------------NVLVMEFIGDDGL--PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLV 189 (268)
T ss_pred CCCceeecC--------------------CeEEEEeccCCCC--CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcc
Confidence 333333322 1579999954311 0101112223333677788888888888866 8999
Q ss_pred ccCCCCCcEEEcCCCcEEEeecccccccc
Q 018489 195 HRDVKTENMLLDKNRTVKIADFGVARVEA 223 (355)
Q Consensus 195 H~di~p~Nili~~~~~v~L~Dfg~a~~~~ 223 (355)
|+||+.-|||+. ++.+.++||+.|....
T Consensus 190 HgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 190 HGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999998 8999999999997444
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.4e-08 Score=77.36 Aligned_cols=131 Identities=24% Similarity=0.274 Sum_probs=96.8
Q ss_pred ceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce-eeeeccCCcccc
Q 018489 52 LVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK-FIGATMGSSELH 130 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~-~~~~~~~~~~~~ 130 (355)
.++.+.|++|++|.||++.+.+..+|+|+-+.+.. +..+..|.++|..+.-.++.+ +|.+..+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~-----------r~~l~kEakiLeil~g~~~~p~vy~yg~~----- 87 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP-----------RRNLEKEAKILEILAGEGVTPEVYFYGED----- 87 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCceEEEEEecCCcc-----------hhhHHHHHHHHHHhhhcCCCceEEEechh-----
Confidence 35678999999999999999999999999764433 345778999998887766654 3333221
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCcEEEcCCC
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK-TENMLLDKNR 209 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~-p~Nili~~~~ 209 (355)
++.|||+.|.+|.++-... + .+-+..+++.-.-|-..||-|+.|+ |...++.+++
T Consensus 88 ---------------~i~me~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~ 143 (201)
T COG2112 88 ---------------FIRMEYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR 143 (201)
T ss_pred ---------------hhhhhhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC
Confidence 3479999998998765211 1 2335566677777888899999986 5566666677
Q ss_pred cEEEeeccccccc
Q 018489 210 TVKIADFGVARVE 222 (355)
Q Consensus 210 ~v~L~Dfg~a~~~ 222 (355)
.+.|+||..|+..
T Consensus 144 ~~~iIDFd~At~k 156 (201)
T COG2112 144 DVYIIDFDSATFK 156 (201)
T ss_pred cEEEEEccchhhc
Confidence 9999999998743
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=9.5e-06 Score=76.87 Aligned_cols=74 Identities=18% Similarity=0.279 Sum_probs=53.6
Q ss_pred EEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccc
Q 018489 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222 (355)
Q Consensus 146 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~ 222 (355)
.++|||++|-.+.+...... .+++.+.+...+.++. +..+=..|++|.|.+|.||++..+|.+.+.|||.....
T Consensus 242 VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 242 VLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred EEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 68999999999988753322 4455444444333322 22223489999999999999999999999999998633
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.3e-07 Score=75.46 Aligned_cols=135 Identities=13% Similarity=0.146 Sum_probs=76.2
Q ss_pred cccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc--cceeeeeccCCccccccc
Q 018489 56 SVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSSELHIQT 133 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~~~~~~~~~~~ 133 (355)
..||.|..+.||+. .+..+++|+..... .. ....+|.++++.+..-+ +.+++.+....+..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----~~-------~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~---- 69 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----DK-------ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRL---- 69 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----CH-------HHHHHHHHHHHHHHHcCCCCCceEEEEecCCee----
Confidence 46899999999984 36678899875321 11 12467888888774333 34555554433333
Q ss_pred ccccccCCCCceEEEEEecCCCC-HHHHH--------------Hh----hcc---ccccHHHHHHHHH-----------H
Q 018489 134 ENGQVAMPSNICCVVVEYLPGGA-LKTYL--------------IK----NRR---RKLAFKVVVQLAL-----------D 180 (355)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~s-L~~~l--------------~~----~~~---~~~~~~~~~~i~~-----------q 180 (355)
.++|++++|.+ +...+ -. -.. ..........-+. .
T Consensus 70 ------------glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~ 137 (226)
T TIGR02172 70 ------------GLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKD 137 (226)
T ss_pred ------------eeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHH
Confidence 45999998863 21111 00 000 0111111010000 0
Q ss_pred HHHH-HHHHH----hCCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 181 LARG-LSYLH----SQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 181 i~~a-l~~LH----~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
+... ..+|. ...++|||++|.||++++++ +.++||+.+.
T Consensus 138 ~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 138 YKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 1111 11221 12478999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.9e-06 Score=70.86 Aligned_cols=150 Identities=23% Similarity=0.347 Sum_probs=101.4
Q ss_pred Ccceeecccccccc-eEEEEEEECCceeEEEEeec---CCCCCc---------cHHHHHHHHHHHHHHHHHHhhC---CC
Q 018489 50 SKLVIKSVIARGTF-GTVHRGLYDGHDVAVKLLDW---GEEGHR---------TEAEIAALRSAFTQEVAVWHKL---DH 113 (355)
Q Consensus 50 ~~y~i~~~lg~G~~-~~Vy~~~~~~~~vavK~~~~---~~~~~~---------~~~~~~~~~~~~~~E~~~l~~l---~h 113 (355)
.+++.++.||.|.- |.||++...|..+|||+++. ...... ...........|..|.+...+| ++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78999999999999 99999999999999999432 111100 0111123455688888887777 45
Q ss_pred Ccc--ceeeeeccCCcccccc-c-ccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHH
Q 018489 114 PNV--TKFIGATMGSSELHIQ-T-ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH 189 (355)
Q Consensus 114 ~~I--v~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH 189 (355)
.++ ++++++..-....-+. . .++...-......||.||.+... .++... +.+|++-+..+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHHHH
Confidence 566 8999888544211110 0 01222334456689999886544 233333 456667778999
Q ss_pred hCCccccCCCCCcEEEcCCCcEEEeecccc
Q 018489 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVA 219 (355)
Q Consensus 190 ~~~i~H~di~p~Nili~~~~~v~L~Dfg~a 219 (355)
+.||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999987 3488999865
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.4e-06 Score=73.25 Aligned_cols=142 Identities=20% Similarity=0.232 Sum_probs=78.4
Q ss_pred ecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCC--ccceeeeeccCCcccccc
Q 018489 55 KSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP--NVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 55 ~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~Iv~~~~~~~~~~~~~~~ 132 (355)
++.|+.|..+.||++..++..+++|+.... .....+.+|..+++.+... .+..++........
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~-----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~---- 66 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP-----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEF---- 66 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH-----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEE----
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC-----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccc----
Confidence 356889999999999888889999997321 1123456788887777433 34455543221111
Q ss_pred cccccccCCCCceEEEEEecCCCCHHH----------------HHHh---h--ccccccHHH---------HHHH-----
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKT----------------YLIK---N--RRRKLAFKV---------VVQL----- 177 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~----------------~l~~---~--~~~~~~~~~---------~~~i----- 177 (355)
....+++|++++|.++.. .+.. . ....+.... ....
T Consensus 67 ---------~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (239)
T PF01636_consen 67 ---------NGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLR 137 (239)
T ss_dssp ---------TSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHH
T ss_pred ---------cccceEEEEEeccccccccccccccccccccchhhhhhccccccccccccccccccccccccccccccccc
Confidence 112478999999988877 1110 0 000011000 0000
Q ss_pred -------HHHHHH-HHHHHH-------hCCccccCCCCCcEEEc-CCCcEEEeeccccc
Q 018489 178 -------ALDLAR-GLSYLH-------SQKIVHRDVKTENMLLD-KNRTVKIADFGVAR 220 (355)
Q Consensus 178 -------~~qi~~-al~~LH-------~~~i~H~di~p~Nili~-~~~~v~L~Dfg~a~ 220 (355)
...+.. .+..++ ...++|+|+.|.||+++ .++.+-++||+.+.
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 138 ASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred chhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 011222 333333 24599999999999999 55666799998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.32 E-value=9.4e-06 Score=70.30 Aligned_cols=29 Identities=21% Similarity=0.343 Sum_probs=26.1
Q ss_pred CccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 192 KIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 192 ~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=9.1e-06 Score=76.82 Aligned_cols=76 Identities=14% Similarity=0.222 Sum_probs=53.4
Q ss_pred ceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc----CCCcEEEeecccc
Q 018489 144 ICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD----KNRTVKIADFGVA 219 (355)
Q Consensus 144 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~----~~~~v~L~Dfg~a 219 (355)
...++|||++|..+.+.- .-....++...+..-+.+...- -+=..|++|+|-+|.||++. .++.+.+.|||+.
T Consensus 276 ~RVLtME~~~G~~i~Dl~-~i~~~gi~~~~i~~~l~~~~~~--qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~ 352 (538)
T KOG1235|consen 276 KRVLTMEYVDGIKINDLD-AIDKRGISPHDILNKLVEAYLE--QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLY 352 (538)
T ss_pred ceEEEEEecCCccCCCHH-HHHHcCCCHHHHHHHHHHHHHH--HHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccc
Confidence 347899999998777653 2244557766555544443322 22246899999999999998 3678999999997
Q ss_pred ccc
Q 018489 220 RVE 222 (355)
Q Consensus 220 ~~~ 222 (355)
...
T Consensus 353 ~~i 355 (538)
T KOG1235|consen 353 AVI 355 (538)
T ss_pred ccc
Confidence 643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.7e-05 Score=62.91 Aligned_cols=102 Identities=22% Similarity=0.245 Sum_probs=78.0
Q ss_pred HHHHHHHhhCCC-CccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHh-hccccccHHHHHHHHH
Q 018489 102 TQEVAVWHKLDH-PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK-NRRRKLAFKVVVQLAL 179 (355)
Q Consensus 102 ~~E~~~l~~l~h-~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~i~~ 179 (355)
..|.-+++.+.+ +++.+++|++-. +++.||...+++...... ..-...+|..+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--------------------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~ 66 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--------------------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIAL 66 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--------------------EEEEEeecCccccccccccccccccCHHHHHHHHH
Confidence 357778888855 699999998743 458999976655321000 0112478999999999
Q ss_pred HHHHHHHHHHh---CCccccCCCCCcEEEcCCCcEEEeecccccccc
Q 018489 180 DLARGLSYLHS---QKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223 (355)
Q Consensus 180 qi~~al~~LH~---~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~ 223 (355)
++++.+.+|+. ..+.-.|++|+|+-++++|+++++|...+....
T Consensus 67 ~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 67 QLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred HHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 99999999987 347889999999999999999999998876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=2e-06 Score=75.07 Aligned_cols=142 Identities=23% Similarity=0.226 Sum_probs=98.3
Q ss_pred cceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHH-------------HHHHHHHHHHHHHHHHhhCCCC--
Q 018489 51 KLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEA-------------EIAALRSAFTQEVAVWHKLDHP-- 114 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~-- 114 (355)
-+.+++.||-|--|.||.+-+ .|++.++|+-+.......... .....+-...+|...++.|...
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 346788999999999999966 599999997654433222111 1112233456788888777332
Q ss_pred ccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcc
Q 018489 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIV 194 (355)
Q Consensus 115 ~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~ 194 (355)
.+.+.++ .+-.|+|||.+.|.+|...- ..-+ ...+...++..+-.|-..|+|
T Consensus 173 pVPkpiD--------------------~~RH~Vvmelv~g~Pl~~v~-----~v~d---~~~ly~~lm~~Iv~la~~GlI 224 (465)
T KOG2268|consen 173 PVPKPID--------------------HNRHCVVMELVDGYPLRQVR-----HVED---PPTLYDDLMGLIVRLANHGLI 224 (465)
T ss_pred CCCCccc--------------------ccceeeHHHhhcccceeeee-----ecCC---hHHHHHHHHHHHHHHHHcCce
Confidence 2334443 23347899999998886432 1112 234566677777888899999
Q ss_pred ccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 195 HRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 195 H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
|+|..-=||++.+++.++++||....
T Consensus 225 HgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 225 HGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred ecccchheeEEecCCCEEEeechHhh
Confidence 99999999999999999999998764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.7e-05 Score=67.95 Aligned_cols=134 Identities=18% Similarity=0.167 Sum_probs=75.6
Q ss_pred ccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc-eeeeeccCCccccccccc
Q 018489 57 VIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT-KFIGATMGSSELHIQTEN 135 (355)
Q Consensus 57 ~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv-~~~~~~~~~~~~~~~~~~ 135 (355)
.+..|-.+.+|+...++..+++|+.......... ...+|..+++.+...++. +++... .+
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~---------~r~~E~~~l~~l~~~g~~P~~i~~~--~~-------- 63 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGV---------DRQREYQILQALSALGLAPKPILVN--EH-------- 63 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccccccC---------cHHHHHHHHHHHHhcCCCCceEEEe--CC--------
Confidence 3566778889998888889999986432211101 134677888887543332 233221 11
Q ss_pred ccccCCCCceEEEEEecCCCCHHH-----------H---HHhhc-----cccccHH-HHHHHHHH---------HHHHHH
Q 018489 136 GQVAMPSNICCVVVEYLPGGALKT-----------Y---LIKNR-----RRKLAFK-VVVQLALD---------LARGLS 186 (355)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~sL~~-----------~---l~~~~-----~~~~~~~-~~~~i~~q---------i~~al~ 186 (355)
.+||+|++|.++.. + +.+-. ..+++.. .+..+..+ +...+.
T Consensus 64 ----------~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 133 (256)
T TIGR02721 64 ----------WLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYK 133 (256)
T ss_pred ----------EEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHH
Confidence 45999998876532 1 11100 1111211 11122111 111222
Q ss_pred HHHh--------CCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 187 YLHS--------QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 187 ~LH~--------~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.+-. ..++|+|+.|.||++++++ +.|+||..+.
T Consensus 134 ~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 134 QFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred HHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 2221 2589999999999998877 7899999886
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.3e-05 Score=66.49 Aligned_cols=30 Identities=27% Similarity=0.461 Sum_probs=25.5
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.+++|||+++.||+++.++..-++||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 358999999999999876556799999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.0001 Score=75.09 Aligned_cols=81 Identities=19% Similarity=0.149 Sum_probs=51.3
Q ss_pred ecccccccceEEEEEEECC----ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCcc--ceeeeeccCCc
Q 018489 55 KSVIARGTFGTVHRGLYDG----HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNV--TKFIGATMGSS 127 (355)
Q Consensus 55 ~~~lg~G~~~~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~I--v~~~~~~~~~~ 127 (355)
...++.|.+..+|+....+ ..+++|.......... ...+.+|.++++.+. |.++ .+++.++.+..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~--------~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~ 114 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS--------AHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS 114 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc--------HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC
Confidence 5677999999999886544 4678887643221111 123678999999984 6654 56665544322
Q ss_pred ccccccccccccCCCCceEEEEEecCCCC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGA 156 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~s 156 (355)
. .+..++||||++|..
T Consensus 115 v-------------~G~~flVME~v~G~~ 130 (822)
T PLN02876 115 V-------------IGTAFYIMEYLEGRI 130 (822)
T ss_pred c-------------CCCceEEEEecCCcc
Confidence 1 122367999998864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.96 E-value=9.5e-05 Score=63.57 Aligned_cols=29 Identities=24% Similarity=0.483 Sum_probs=26.4
Q ss_pred CccccCCCCCcEEEcC-CCcEEEeeccccc
Q 018489 192 KIVHRDVKTENMLLDK-NRTVKIADFGVAR 220 (355)
Q Consensus 192 ~i~H~di~p~Nili~~-~~~v~L~Dfg~a~ 220 (355)
+++|+|+.+.||+++. ++.+.|+||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 6999999999999997 5789999999885
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.95 E-value=5.8e-05 Score=67.36 Aligned_cols=144 Identities=19% Similarity=0.146 Sum_probs=80.3
Q ss_pred ecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc--cceeeeeccCCcccccc
Q 018489 55 KSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSSELHIQ 132 (355)
Q Consensus 55 ~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~~~~~~~~~~ 132 (355)
.+.|..|....+|+...++..+++|+.... . ......|+.++..+...+ +.+++... .+....
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~-----~-------~~~~~~e~~~l~~L~~~g~~vp~~i~~~--~g~~~~- 83 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV-----S-------AEELPFFLALLDHLAERGLPVPRPIADR--DGEYLS- 83 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC-----C-------hHhccHHHHHHHHHHHCCCCCCccccCC--CCcEee-
Confidence 556777888899998777778999987531 1 112445667666663332 33443321 111110
Q ss_pred cccccccCCCCceEEEEEecCCCCHHH----HH----------Hhhc-c--c------cccHHHH--H--------HHHH
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKT----YL----------IKNR-R--R------KLAFKVV--V--------QLAL 179 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~----~l----------~~~~-~--~------~~~~~~~--~--------~i~~ 179 (355)
...+..+++++|++|.++.. .. +... . . ...+... . ....
T Consensus 84 -------~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 156 (296)
T cd05153 84 -------ELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRA 156 (296)
T ss_pred -------eeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHH
Confidence 01234578999998876421 01 0000 0 0 0011000 0 0111
Q ss_pred HHHHHHHHHHh-------CCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 180 DLARGLSYLHS-------QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 180 qi~~al~~LH~-------~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.+..++.++.+ .+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 157 ~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 157 LLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 12233444443 479999999999999987777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.4e-05 Score=76.89 Aligned_cols=199 Identities=20% Similarity=0.238 Sum_probs=132.3
Q ss_pred HHHHHHHHhhCCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHH
Q 018489 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180 (355)
Q Consensus 101 ~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~q 180 (355)
...|+..+..+.|+|+..++.+........+ ...+..+++...++...+. .-...+..+.+.+..+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~------------~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~ 294 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGI------------VLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQK 294 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchH------------HHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHH
Confidence 3456777778899999999887765433221 0123667888888888773 3456888899999999
Q ss_pred HHHHHHHHHhCCccccCCCCC---cEEEcCCCcEEEe--eccccccccCCCCCCCCCCCcccccCCcccCCCCCC--Ccc
Q 018489 181 LARGLSYLHSQKIVHRDVKTE---NMLLDKNRTVKIA--DFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYN--RKC 253 (355)
Q Consensus 181 i~~al~~LH~~~i~H~di~p~---Nili~~~~~v~L~--Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~ 253 (355)
.++++.++|+..+.|.-+..+ +.-.+..+.+..+ ||+.+.......... ....+..+.++|....+..+ ...
T Consensus 295 ~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-~~~~~~~~~~~e~~~~~~~~~~r~~ 373 (1351)
T KOG1035|consen 295 LLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-SDLLAEIRNADEDLKENTAKKSRLT 373 (1351)
T ss_pred HhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccch-hhcCccccccccccccccchhhhhh
Confidence 999999999996655544444 3333445556655 888776554433222 23345566777777665544 447
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 254 DVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 254 DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
|+|++|.....+..|..+-.-. ..... .++......+.+...+|+..+.++|+++.+++..
T Consensus 374 dL~~lgll~~~~~~~~~i~~~~---~~~~~--------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 374 DLWCLGLLLLQLSQGEDISEKS---AVPVS--------LLDVLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHHHHHHHHhhhhhcCcccccc---cchhh--------hhccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 9999999999998876432110 00111 1122222378899999999999999999998874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00017 Score=64.75 Aligned_cols=149 Identities=19% Similarity=0.227 Sum_probs=81.3
Q ss_pred cceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc--cceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~~~~~~ 128 (355)
.......++.|....+|+...++..+++|+.+... ... .+..|.+++..|...+ +.+++... +.
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~----~~~-------~i~~e~~~l~~L~~~g~pvp~~i~t~---~g 88 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV----KAE-------ELPFFLALTTHLAARGLPVPKPVKSR---DG 88 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCCC----CHH-------HHHHHHHHHHHHHHCCCCCCccccCC---CC
Confidence 34456777888888999987666789999874321 111 1334566666663322 33333211 11
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHH-----H------HHHh--hccccc-----------cHHHHH---------
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALK-----T------YLIK--NRRRKL-----------AFKVVV--------- 175 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~-----~------~l~~--~~~~~~-----------~~~~~~--------- 175 (355)
..+ ....+..+++++|++|.++. . .+.. .....+ .+....
T Consensus 89 ~~~-------~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (307)
T TIGR00938 89 RQL-------STLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQ 161 (307)
T ss_pred Cee-------hhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccc
Confidence 111 01133457899999885431 1 1100 000001 000000
Q ss_pred ---HHHHHHHHHHHHHH-------hCCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 176 ---QLALDLARGLSYLH-------SQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 176 ---~i~~qi~~al~~LH-------~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.....+...+.++. ..+++|+|+++.||+++.++.+.++||+.+.
T Consensus 162 l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 162 LEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 00112233455553 2689999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00016 Score=65.25 Aligned_cols=30 Identities=27% Similarity=0.472 Sum_probs=25.9
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.+++|+|++|.||+++.+...-++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999866556899999875
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0003 Score=62.77 Aligned_cols=83 Identities=12% Similarity=0.040 Sum_probs=54.4
Q ss_pred cceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCC---CccceeeeeccCCc
Q 018489 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH---PNVTKFIGATMGSS 127 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~~Iv~~~~~~~~~~ 127 (355)
...-.+.||.|..+.||+....+..+++|+.+.... ...+..|...++.+.. -.+.++++++....
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~-----------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~ 83 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSFST-----------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ 83 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEeccccc-----------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence 344566899999999999877666788888643111 1236778888888732 35667776554321
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCH
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGAL 157 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL 157 (355)
. .+..++|||+++|.++
T Consensus 84 ~-------------~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 84 S-------------PGPDVLLLERLRGVSV 100 (297)
T ss_pred c-------------CCCeEEEEeccCCEec
Confidence 0 1223679999988754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00059 Score=56.71 Aligned_cols=140 Identities=20% Similarity=0.285 Sum_probs=87.4
Q ss_pred cccccccceEEEEEEECCceeEEEEeecCCCCCccHH-------HHHHHHHHHHHHHHHHhhCC------CCccceeeee
Q 018489 56 SVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEA-------EIAALRSAFTQEVAVWHKLD------HPNVTKFIGA 122 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~------h~~Iv~~~~~ 122 (355)
..||+|+.-.||..- .+...+||+............ ......+...+|+..+..+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 468999999999642 345578898865440000000 00001223445555555554 7889999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecC------CCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLP------GGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~------~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
..++...- +|+|.+. ..+|.+++. ...++. ... ..+-.-..+|-+.+|+.+
T Consensus 86 veT~~G~G----------------lv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~---~~L~~f~~~l~~~~Iv~~ 142 (199)
T PF10707_consen 86 VETNLGLG----------------LVVELIRDADGNISPTLEDYLK---EGGLTE-ELR---QALDEFKRYLLDHHIVIR 142 (199)
T ss_pred EecCCceE----------------EEEEEEECCCCCcCccHHHHHH---cCCccH-HHH---HHHHHHHHHHHHcCCeec
Confidence 88776664 4777653 237888883 334555 333 344455667888999999
Q ss_pred CCCCCcEEEcCCC----cEEEee-cccc
Q 018489 197 DVKTENMLLDKNR----TVKIAD-FGVA 219 (355)
Q Consensus 197 di~p~Nili~~~~----~v~L~D-fg~a 219 (355)
|++|.||++.... .++|+| ||..
T Consensus 143 dl~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 143 DLNPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred CCCcccEEEEecCCCceEEEEEeCCCCc
Confidence 9999999995322 577776 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00016 Score=64.56 Aligned_cols=147 Identities=17% Similarity=0.184 Sum_probs=95.1
Q ss_pred eeecccccccceEEEEEE-ECCceeEEEEeecCCCCCcc-----------------HHHHHHHHHHHHHHHHHHhhCCCC
Q 018489 53 VIKSVIARGTFGTVHRGL-YDGHDVAVKLLDWGEEGHRT-----------------EAEIAALRSAFTQEVAVWHKLDHP 114 (355)
Q Consensus 53 ~i~~~lg~G~~~~Vy~~~-~~~~~vavK~~~~~~~~~~~-----------------~~~~~~~~~~~~~E~~~l~~l~h~ 114 (355)
.|.++|..|--+.||.|. .+|..+|||+++.+-..... ......++-....|++-|.++..-
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 456678889999999995 47888999998432211110 011122233345677777777555
Q ss_pred ccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHH-hCCc
Q 018489 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH-SQKI 193 (355)
Q Consensus 115 ~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~i 193 (355)
+|.-.--... ....|||+|+....-.. -....-.++...+..+-.+++..+.-|- ..++
T Consensus 227 GIP~PePIlL------------------k~hVLVM~FlGrdgw~a--PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~L 286 (520)
T KOG2270|consen 227 GIPCPEPILL------------------KNHVLVMEFLGRDGWAA--PKLKDASLSTSKARELYQQCVRIMRRLYQKCRL 286 (520)
T ss_pred CCCCCCceee------------------ecceEeeeeccCCCCcC--cccccccCChHHHHHHHHHHHHHHHHHHHHhce
Confidence 4432111111 11257999995322111 1113445777788888888888888774 5699
Q ss_pred cccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 194 VHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 194 ~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
||.||+--|+|+ .+|.+.++|.+.+.
T Consensus 287 VHADLSEfN~Ly-hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 287 VHADLSEFNLLY-HDGKLYIIDVSQSV 312 (520)
T ss_pred eccchhhhhheE-ECCEEEEEEccccc
Confidence 999999999998 67899999999885
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=2.1e-05 Score=74.38 Aligned_cols=186 Identities=19% Similarity=0.178 Sum_probs=125.8
Q ss_pred CcceeecccccccceEEEEEEECCce-eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc-cceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYDGHD-VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN-VTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~ 127 (355)
.-|.....+++++.+.+++.+.+.+. ...+++... + ...-++++|.+++||| .+..++-+..
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~------------l--~~rl~~eLLdK~n~P~~~v~~~~d~~~-- 305 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------------L--SRRLAIELLDKVNNPNPVVRYLEDYDG-- 305 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc------------h--hhHHHHHHHHHccCCCCcccccccCCc--
Confidence 45677788899999999998765433 335554211 1 1334788999999999 4444433332
Q ss_pred ccccccccccccCCCCceEEEEEecCCC-CHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGG-ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.+..+.++++.++ +...-.. .....+..-....+.+.-+..++++|+.--+|+| ||+.+
T Consensus 306 --------------E~~~~i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s 366 (829)
T KOG0576|consen 306 --------------EDYLWIPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS 366 (829)
T ss_pred --------------ccccchhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc
Confidence 23335699999776 2221110 1122344555666777888999999988667877 66654
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCC
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~ 272 (355)
.+..+++||+...-..... ......+++.+++||....+.++...|+|++|.-..++.-|-.|-
T Consensus 367 -~~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 367 -EEEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred -ccccccccccCCcccCccc-ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4789999999876443322 334467889999999999999999999999998766766665554
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0019 Score=59.59 Aligned_cols=29 Identities=21% Similarity=0.390 Sum_probs=25.1
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
..++|||+++.|||+..+ .++++||.++.
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 468999999999999765 59999998775
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0014 Score=58.35 Aligned_cols=32 Identities=25% Similarity=0.517 Sum_probs=28.6
Q ss_pred CccccCCCCCcEEEcCCCcEEEeecccccccc
Q 018489 192 KIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223 (355)
Q Consensus 192 ~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~ 223 (355)
.++|||+++.|++|++.+.+=++||+.+...+
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 48999999999999999999999999987543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0018 Score=58.00 Aligned_cols=29 Identities=28% Similarity=0.458 Sum_probs=26.4
Q ss_pred CccccCCCCCcEEEcCC----CcEEEeeccccc
Q 018489 192 KIVHRDVKTENMLLDKN----RTVKIADFGVAR 220 (355)
Q Consensus 192 ~i~H~di~p~Nili~~~----~~v~L~Dfg~a~ 220 (355)
+++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999875 889999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0069 Score=55.86 Aligned_cols=81 Identities=9% Similarity=-0.059 Sum_probs=46.8
Q ss_pred eecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC---CCccceeeeeccCCcccc
Q 018489 54 IKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD---HPNVTKFIGATMGSSELH 130 (355)
Q Consensus 54 i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~~ 130 (355)
..+.||.|....||+....+..++||.-......... +...-..+...|...|+.+. -.++.+++.+..+.
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga--~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~---- 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGE--SWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM---- 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCc--cccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC----
Confidence 4667899999999999877778999976422111100 00000112233555555552 23566676655422
Q ss_pred cccccccccCCCCceEEEEEecCC
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPG 154 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~ 154 (355)
.+++||++++
T Consensus 110 --------------~vlvME~L~~ 119 (418)
T PLN02756 110 --------------ALIGMRYLEP 119 (418)
T ss_pred --------------CEEEEeecCC
Confidence 2568999966
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.33 E-value=3.6e-05 Score=79.51 Aligned_cols=213 Identities=13% Similarity=0.007 Sum_probs=136.0
Q ss_pred HHHHHHHHHHHHHhhCCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--cccccHHH
Q 018489 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKV 173 (355)
Q Consensus 96 ~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~ 173 (355)
.+++....|...++...|+++...+.-....... ..++.++|+.+|.+.+.+.+.. .......-
T Consensus 1271 Plkemll~e~de~~~~~h~~~~~~p~rI~ps~s~--------------ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~ 1336 (2724)
T KOG1826|consen 1271 PLKEMLLSERDELREAKHYLTEVDPLRIPPSEST--------------EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSP 1336 (2724)
T ss_pred HHHHhhhhhhhhhhhhhceeeecccccCCCCCCh--------------HHHHHHHHHHHhHHHHHHHhccccCCcchhch
Confidence 3445555566666677888887665544332221 2256899999999999986542 22344444
Q ss_pred HHHHHHHHHHHHHHHHhCC-----ccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCC
Q 018489 174 VVQLALDLARGLSYLHSQK-----IVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP 248 (355)
Q Consensus 174 ~~~i~~qi~~al~~LH~~~-----i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 248 (355)
+.....+.+....-+|+.. .+|.++++.|.+|.....++++++|+.+.......-.....+++.|+.|++.+.-.
T Consensus 1337 v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik 1416 (2724)
T KOG1826|consen 1337 VHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK 1416 (2724)
T ss_pred HHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh
Confidence 4444445466666666541 78999999999999999999999999984444333344456777889999988888
Q ss_pred CCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 018489 249 YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323 (355)
Q Consensus 249 ~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 323 (355)
++.++|+|..|+.+|....|..+|-..... ..+.+.+......++.-.|.+....+..+|-+.-..||.-...+
T Consensus 1417 ~t~rsdilr~s~~ly~rs~~n~~fi~flq~-~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isl 1490 (2724)
T KOG1826|consen 1417 FTKRSDILRRSLSLYLRSDGNAYFIFFLQP-ALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISL 1490 (2724)
T ss_pred hhhHHHHHHHHHHHHHHhcccHHHHHHHHH-HHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhc
Confidence 888899999999999988887766322111 11111122222233333344555555555555556666554433
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0047 Score=56.36 Aligned_cols=29 Identities=28% Similarity=0.594 Sum_probs=26.0
Q ss_pred CccccCCCCCcEEEcC-CCcEEEeeccccc
Q 018489 192 KIVHRDVKTENMLLDK-NRTVKIADFGVAR 220 (355)
Q Consensus 192 ~i~H~di~p~Nili~~-~~~v~L~Dfg~a~ 220 (355)
.++|+|+++.||++++ ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999986 4789999999885
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0027 Score=55.92 Aligned_cols=30 Identities=30% Similarity=0.576 Sum_probs=25.3
Q ss_pred CccccCCCCCcEEEcCCCcE-EEeecccccc
Q 018489 192 KIVHRDVKTENMLLDKNRTV-KIADFGVARV 221 (355)
Q Consensus 192 ~i~H~di~p~Nili~~~~~v-~L~Dfg~a~~ 221 (355)
.++|+|++|.||++++++.+ -|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 48999999999999875654 5999998863
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.096 Score=46.96 Aligned_cols=29 Identities=28% Similarity=0.469 Sum_probs=25.8
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.+++|||+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0041 Score=56.42 Aligned_cols=28 Identities=21% Similarity=0.469 Sum_probs=25.3
Q ss_pred ccccCCCCCcEEEcC-CCcEEEeeccccc
Q 018489 193 IVHRDVKTENMLLDK-NRTVKIADFGVAR 220 (355)
Q Consensus 193 i~H~di~p~Nili~~-~~~v~L~Dfg~a~ 220 (355)
++|+|+.+.||++++ ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 5789999999985
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0034 Score=56.40 Aligned_cols=29 Identities=24% Similarity=0.361 Sum_probs=27.3
Q ss_pred CccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 192 KIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 192 ~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
+++|+|+.++||+++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999999886
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0082 Score=54.07 Aligned_cols=28 Identities=32% Similarity=0.584 Sum_probs=25.8
Q ss_pred ccccCCCCCcEEEcCCCc-EEEeeccccc
Q 018489 193 IVHRDVKTENMLLDKNRT-VKIADFGVAR 220 (355)
Q Consensus 193 i~H~di~p~Nili~~~~~-v~L~Dfg~a~ 220 (355)
++|+|+.|+||+++.+.. +-++||+.+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998885 8899999885
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0079 Score=54.47 Aligned_cols=30 Identities=17% Similarity=0.373 Sum_probs=25.0
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeecccccc
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~ 221 (355)
..++|||+++.||++++++ ++++|+..+..
T Consensus 192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~ 221 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY 221 (370)
T ss_pred ceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence 3689999999999997654 77999987753
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.003 Score=58.98 Aligned_cols=154 Identities=21% Similarity=0.269 Sum_probs=91.8
Q ss_pred HHHHHHHHhhCCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHH
Q 018489 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180 (355)
Q Consensus 101 ~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~q 180 (355)
..-...+++.+.|+|.+.++++....... ..+|||++ +.+|++.+.... +-.....
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r---------------~IVV~e~~-~~Sled~~~~~~---l~~~s~~----- 84 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHER---------------VIVVMEHY-TMSLEDILKTGN---LKDESLL----- 84 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccce---------------EEEEehhh-ccchHHHHHhcc---cchhhhc-----
Confidence 34467788899999999998876544333 25799999 779999884332 1111110
Q ss_pred HHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHH
Q 018489 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260 (355)
Q Consensus 181 i~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 260 (355)
.|+-+ +-|++.. +| .++... | ....+++|||++|.
T Consensus 85 -------------~~~~~-~~~~~~~-------td-~~~t~~------------------~-----~~~~pKsdVwsl~~ 119 (725)
T KOG1093|consen 85 -------------AHGVL-HLNIIYI-------TD-HFLTKY------------------P-----SPIGPKSDVWSLGF 119 (725)
T ss_pred -------------ccccc-eehhhhc-------cc-cccccC------------------C-----CCCCcchhhhhHHH
Confidence 22211 1222221 22 011000 0 01124899999999
Q ss_pred HHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 018489 261 CLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE----------IPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323 (355)
Q Consensus 261 il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 323 (355)
++.++.-|..-|......+....+..-..... +...++.-+.++..+|+...|..||...++.
T Consensus 120 i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 120 IILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 99999988877766555555544443222211 1223456678889999999999888665544
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0066 Score=55.67 Aligned_cols=30 Identities=23% Similarity=0.413 Sum_probs=25.3
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeecccccc
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~ 221 (355)
..++|||++|.|||++++ .++++|..++..
T Consensus 227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFAfy 256 (409)
T PRK12396 227 QALIHGDLHTGSVFVKND-STKVIDPEFAFY 256 (409)
T ss_pred hhhccCcCCCCCEEecCC-ceEEEccccccc
Confidence 358999999999999875 589999888763
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.025 Score=58.99 Aligned_cols=30 Identities=30% Similarity=0.620 Sum_probs=26.1
Q ss_pred CCccccCCCCCcEEEcCCC--cEE-Eeeccccc
Q 018489 191 QKIVHRDVKTENMLLDKNR--TVK-IADFGVAR 220 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~--~v~-L~Dfg~a~ 220 (355)
.+++|+|+.+.||+++.++ ++. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999998775 566 99999886
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.037 Score=49.83 Aligned_cols=101 Identities=17% Similarity=0.263 Sum_probs=69.8
Q ss_pred ceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEEcCCCcEEEeeccccccc
Q 018489 144 ICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVE 222 (355)
Q Consensus 144 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~ 222 (355)
+.|++|++= |+++.- + ..-.++++..++++.+..+.-+..+ ..-|+|+.-.||+|+ .|+|.|+||-+++..
T Consensus 300 y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred EEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 345666664 555542 2 2245678888999988888877765 689999999999999 999999999999844
Q ss_pred cCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHH
Q 018489 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258 (355)
Q Consensus 223 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 258 (355)
...+.... ...--|..+.|.. +..-|||.+
T Consensus 372 ~~q~~isy-----~rldhp~lF~G~d-d~QFeIYrl 401 (488)
T COG5072 372 YSQGIISY-----NRLDHPDLFNGVD-DYQFEIYRL 401 (488)
T ss_pred cCCceeec-----cccCchhhhcCcc-ceeeeHHHH
Confidence 33322221 2334566666543 666777774
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.014 Score=51.62 Aligned_cols=76 Identities=20% Similarity=0.180 Sum_probs=43.1
Q ss_pred ceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC---CCCccceeeeeccCCcc
Q 018489 52 LVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIGATMGSSE 128 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~~~~ 128 (355)
.+-.+.++.|..+.+|+...++..+.||+-..... ..|..|..-|+.| .--.+.+++.+....+.
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~------------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~ 86 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGR------------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD 86 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGC------------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecChhhH------------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC
Confidence 34456788899999999998899999999862111 1255677766666 33456677776654433
Q ss_pred cccccccccccCCCCceEEEEEecCCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGG 155 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~ 155 (355)
. +++|||++.+
T Consensus 87 ~----------------fLlle~l~~~ 97 (288)
T PF03881_consen 87 A----------------FLLLEFLEMG 97 (288)
T ss_dssp C----------------EEEEE-----
T ss_pred c----------------eEEEEeecCC
Confidence 3 5699999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.14 Score=47.25 Aligned_cols=29 Identities=28% Similarity=0.290 Sum_probs=24.6
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
...+|+|+.+.||+.+ ++.++++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEec-CCCEEEEEecccc
Confidence 4689999999999875 4569999998885
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.16 Score=45.97 Aligned_cols=28 Identities=25% Similarity=0.318 Sum_probs=24.1
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.+++|+|+.+.||+++ + .+.++||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4689999999999995 4 57899999875
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.08 Score=47.08 Aligned_cols=28 Identities=36% Similarity=0.569 Sum_probs=24.0
Q ss_pred ccccCCCCCcEEEcCC--C---cEEEeeccccc
Q 018489 193 IVHRDVKTENMLLDKN--R---TVKIADFGVAR 220 (355)
Q Consensus 193 i~H~di~p~Nili~~~--~---~v~L~Dfg~a~ 220 (355)
++|||++..|||+..+ | .++++||-.++
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 8999999999999654 3 68999998775
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.029 Score=49.14 Aligned_cols=48 Identities=21% Similarity=0.299 Sum_probs=36.9
Q ss_pred HHHHHHHHHHHHHHHHHhC--CccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 173 VVVQLALDLARGLSYLHSQ--KIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 173 ~~~~i~~qi~~al~~LH~~--~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.+.+.+..+-.++.-++.. -++|+|+.|+|++.++.+.++|+||..|.
T Consensus 133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 3334445555555555544 58999999999999999999999999886
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.066 Score=46.35 Aligned_cols=75 Identities=21% Similarity=0.219 Sum_probs=50.2
Q ss_pred ecccccccceEEEEEE-ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHH---HHHhhCCCCccceeeeeccCCcccc
Q 018489 55 KSVIARGTFGTVHRGL-YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV---AVWHKLDHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 55 ~~~lg~G~~~~Vy~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~Iv~~~~~~~~~~~~~ 130 (355)
...+..|..+.|+.+. .+|++.++|+...... ...|. ..|+..+-.+.+++++.-....
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~--------------~~~E~~g~~~L~~w~G~GaVrll~~d~~~~--- 69 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE--------------AEHEARGEAALRWWNGRGAVRLLAADPERG--- 69 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCccc--------------chhhhhHHhHhheeCCCCceeeeccccccc---
Confidence 3556789999999994 5889999999842221 11233 5577778888899987653333
Q ss_pred cccccccccCCCCceEEEEEec-CCCCHHHHH
Q 018489 131 IQTENGQVAMPSNICCVVVEYL-PGGALKTYL 161 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~-~~~sL~~~l 161 (355)
.+++|.+ ++.+|.+..
T Consensus 70 ---------------AlLLErl~~g~~L~~~~ 86 (253)
T PF04655_consen 70 ---------------ALLLERLDPGRSLASLP 86 (253)
T ss_pred ---------------hhhhhhccCCCchhhcc
Confidence 3488888 445665543
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.28 Score=46.34 Aligned_cols=28 Identities=18% Similarity=0.453 Sum_probs=24.0
Q ss_pred CccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 192 KIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 192 ~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.++|+|+.+.||+.+.+ .++|+||..|.
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeecccc
Confidence 58999999999987654 49999999885
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 355 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-45 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-45 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-37 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-36 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-36 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-35 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-35 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-35 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-34 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-34 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-34 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-34 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-34 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-34 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-34 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-34 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-34 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-34 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-34 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-34 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-34 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-34 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-34 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-34 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-34 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-34 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-34 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-34 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-34 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-34 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-34 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-34 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-34 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-34 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-34 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-34 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-34 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-34 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-33 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-33 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-33 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-33 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-33 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-33 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-33 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-33 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-33 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-33 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-33 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-32 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-32 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-32 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-32 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-32 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-32 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-32 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-32 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-32 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-32 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-32 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-32 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-32 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-32 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-32 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-32 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-32 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-32 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-32 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-32 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-32 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-32 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-32 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-32 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-32 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-32 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-31 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-31 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-31 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-31 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-31 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-31 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-30 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-30 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-30 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-30 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-30 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-30 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-30 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-30 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-30 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-30 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-30 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-29 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-29 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-29 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-29 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-29 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-29 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-29 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-29 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-29 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-29 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-29 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-29 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-29 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-29 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-29 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-29 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-29 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-29 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-29 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-29 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-29 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-29 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-29 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-28 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-28 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-28 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-28 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-28 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-28 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-28 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-28 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-28 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-28 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-28 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-28 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-28 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-28 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-28 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-28 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-28 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-28 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-28 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-28 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-28 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-28 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-28 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-28 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-28 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-28 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-28 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-28 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-28 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-28 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-28 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-28 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-28 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-28 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-28 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-28 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-28 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-28 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-28 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-28 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-28 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-28 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-28 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-27 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-27 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-27 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-27 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-27 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-27 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-27 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-27 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-27 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-27 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-27 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-27 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-27 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-27 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-27 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-27 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-27 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-27 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-27 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-27 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-27 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-27 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-27 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-27 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-27 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-27 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-27 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-27 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-27 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-27 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-27 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-27 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-27 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-27 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-27 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-27 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-27 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-27 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-27 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-27 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-27 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-27 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-27 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-27 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-27 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-27 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-27 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-27 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-27 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-27 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-27 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-27 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-27 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-27 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-27 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-27 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-27 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-27 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-27 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-26 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-26 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-26 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-26 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-26 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-26 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-26 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-26 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-26 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-25 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-25 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-25 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-25 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-25 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-25 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-25 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-25 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-25 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-25 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-25 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-25 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-25 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-25 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-25 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-25 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-25 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-25 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-25 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-25 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-25 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-25 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-25 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-25 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-25 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-25 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-25 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-25 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-25 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-25 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-25 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-25 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-25 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-25 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-25 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-25 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-25 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-25 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-25 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-24 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-24 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-24 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-24 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-24 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-24 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-24 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-24 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-24 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-24 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-24 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-24 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-24 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-24 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-24 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-24 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-24 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-24 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-24 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-24 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-24 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-24 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-24 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-24 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-24 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-24 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-24 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-24 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-24 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-24 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-24 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-24 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-24 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-24 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-24 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-24 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-24 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-24 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-24 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-24 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-24 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-24 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-24 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-24 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-24 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-24 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-24 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-24 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-24 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-24 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-24 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-24 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-24 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-24 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-24 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-24 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-24 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-24 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-24 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-24 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-24 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-24 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-24 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-24 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-23 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-23 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-23 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-23 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-23 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-23 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-23 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-23 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-23 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-23 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-23 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-23 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-23 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-23 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-23 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-23 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-23 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-23 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-23 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-22 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-22 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-22 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-22 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-22 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-22 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-22 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-22 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-22 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-22 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-22 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-22 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-22 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-22 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-21 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-21 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-21 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-21 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-21 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-21 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-21 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-21 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-21 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-21 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-21 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-21 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-21 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-21 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-20 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-20 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-20 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-20 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-20 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-20 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-20 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-20 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-20 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-20 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-20 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-20 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-20 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-19 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-19 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-19 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-19 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-19 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-19 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-19 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-19 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-18 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-18 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-18 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-18 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-18 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-18 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-18 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-18 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-18 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-18 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-18 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-18 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-18 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-18 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-18 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-18 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-18 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-18 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-18 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-18 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-18 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-18 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-18 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-17 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-17 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-17 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-16 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-15 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-15 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-14 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-14 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-14 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-12 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 390 bits (1004), Expect = e-137
Identities = 107/293 (36%), Positives = 159/293 (54%), Gaps = 26/293 (8%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT 102
D +I L IK I G+FGTVHR + G DVAVK+L + A + F
Sbjct: 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKIL-------MEQDFHAERVNEFL 82
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+EVA+ +L HPN+ F+GA L +V EYL G+L L
Sbjct: 83 REVAIMKRLRHPNIVLFMGAVTQPPNL----------------SIVTEYLSRGSLYRLLH 126
Query: 163 KN-RRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDKNRTVKIADFGVA 219
K+ R +L + + +A D+A+G++YLH++ IVHR++K+ N+L+DK TVK+ DFG++
Sbjct: 127 KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
Query: 220 RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
R++AS GT +MAPEVL P N K DVYSFG+ LWE+ P+ +L+ ++
Sbjct: 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332
V +AV + R EIPR +A +++ CW P KRP ++ +L + S
Sbjct: 247 VVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 370 bits (951), Expect = e-129
Identities = 72/291 (24%), Positives = 132/291 (45%), Gaps = 31/291 (10%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
I+ +L + + G + +G + G+D+ VK+L + R + F +
Sbjct: 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRD-------FNE 56
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E HPNV +GA P+ ++ ++P G+L L +
Sbjct: 57 ECPRLRIFSHPNVLPVLGACQSP--------------PAPHPTLITHWMPYGSLYNVLHE 102
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ V+ ALD+ARG+++LH+ + I + + ++++D++ T +I+ V
Sbjct: 103 GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162
Query: 222 EASNPNDMTGETGTLGYMAPEVLNGNPYN---RKCDVYSFGICLWEIYCCDMPYPDLSFS 278
G ++APE L P + R D++SF + LWE+ ++P+ DLS
Sbjct: 163 F-----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM 217
Query: 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
E+ V + LRP IP ++ +MK C + +P KRP+ D +V +LE +
Sbjct: 218 EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-124
Identities = 83/296 (28%), Positives = 141/296 (47%), Gaps = 37/296 (12%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
EI+ ++L ++ +I G FG V+R + G +VAVK + +I+ QE
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHD-----PDEDISQTIENVRQE 56
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
++ L HPN+ G + L C+V+E+ GG L L
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNL----------------CLVMEFARGGPLNRVL--- 97
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQK---IVHRDVKTENMLLDK--------NRTVKI 213
+++ ++V A+ +ARG++YLH + I+HRD+K+ N+L+ + N+ +KI
Sbjct: 98 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157
Query: 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
DFG+AR G +MAPEV+ + +++ DV+S+G+ LWE+ ++P+
Sbjct: 158 TDFGLAREWHRT--TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215
Query: 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
+ V V L IP CP A +M+ CW+ +P RP ++ L I
Sbjct: 216 GIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-124
Identities = 85/302 (28%), Positives = 144/302 (47%), Gaps = 37/302 (12%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALR 98
+ + + +++ + I +G FG VH+G D VA+K L G+ E E+
Sbjct: 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS--EGETEMIEKF 67
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F +EV + L+HPN+ K G N +V+E++P G L
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMH------------------NPPRMVMEFVPCGDLY 109
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDK-----NRTV 211
L ++ + + V ++L LD+A G+ Y+ +Q IVHRD+++ N+ L
Sbjct: 110 HRL-LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168
Query: 212 KIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCD 269
K+ADFG+++ + ++G G +MAPE + Y K D YSF + L+ I +
Sbjct: 169 KVADFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
Query: 270 MPYPDLSFSEVT--SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
P+ + S+ ++ + + + LRP IP CP L NV++ CW +P KRP +V L
Sbjct: 226 GPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
Query: 328 AI 329
+
Sbjct: 286 EL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-124
Identities = 90/305 (29%), Positives = 144/305 (47%), Gaps = 38/305 (12%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
I+ ++ ++ V+ RG FG V + + DVA+K ++ E R AF E
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE-----------RKAFIVE 51
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+ +++HPN+ K GA + N C+V+EY GG+L L
Sbjct: 52 LRQLSRVNHPNIVKLYGACL------------------NPVCLVMEYAEGGSLYNVLHGA 93
Query: 165 RRR-KLAFKVVVQLALDLARGLSYLHSQK---IVHRDVKTENMLLDKNRTV-KIADFGVA 219
+ L ++G++YLHS + ++HRD+K N+LL TV KI DFG A
Sbjct: 94 EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
Query: 220 RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
++ MT G+ +MAPEV G+ Y+ KCDV+S+GI LWE+ P+ ++
Sbjct: 154 CDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA 210
Query: 280 VT-SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMI 338
V RP + + P + ++M RCW +P +RP M+E+V ++ + G
Sbjct: 211 FRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270
Query: 339 PGDQP 343
P P
Sbjct: 271 PLQYP 275
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-123
Identities = 68/317 (21%), Positives = 144/317 (45%), Gaps = 42/317 (13%)
Query: 28 ATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEG 87
A + ++ Q+W+I +L I +I +G FG V+ G + G +VA++L+D +
Sbjct: 11 ARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDN 69
Query: 88 HRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
F +EV + + H NV F+GA M L +
Sbjct: 70 EDQLKA-------FKREVMAYRQTRHENVVLFMGACMSPPHL----------------AI 106
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
+ G L + + ++ + L Q+A ++ +G+ YLH++ I+H+D+K++N+ D
Sbjct: 107 ITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD- 164
Query: 208 NRTVKIADFGVARVEA-----SNPNDMTGETGTLGYMAPEVL---------NGNPYNRKC 253
N V I DFG+ + + + + G L ++APE++ + P+++
Sbjct: 165 NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHS 224
Query: 254 DVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRC-CPSSLANVMKRCWDAN 312
DV++ G +E++ + P+ + + ++P + + +++++ CW
Sbjct: 225 DVFALGTIWYELHAREWPFKTQPAEAI-IWQMGTGMKPNLSQIGMGKEISDILLFCWAFE 283
Query: 313 PDKRPEMDEVVSMLEAI 329
++RP +++ MLE +
Sbjct: 284 QEERPTFTKLMDMLEKL 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 353 bits (908), Expect = e-122
Identities = 87/300 (29%), Positives = 150/300 (50%), Gaps = 35/300 (11%)
Query: 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALR 98
+ DWEI ++ + I G+FGTV++G + G DVAVK+L+ +
Sbjct: 13 RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQA----- 66
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F EV V K H N+ F+G + +V ++ G +L
Sbjct: 67 --FKNEVGVLRKTRHVNILLFMGYSTAPQ-----------------LAIVTQWCEGSSLY 107
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
+L K K ++ +A ARG+ YLH++ I+HRD+K+ N+ L ++ TVKI DFG+
Sbjct: 108 HHL-HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL 166
Query: 219 ARVEA--SNPNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYP 273
A ++ S + +G++ +MAPEV+ NPY+ + DVY+FGI L+E+ +PY
Sbjct: 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226
Query: 274 DLS-FSEVTSAVVRQNLRPEIPRC---CPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
+++ ++ V R +L P++ + CP + +M C D+RP +++ +E +
Sbjct: 227 NINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 337 bits (865), Expect = e-115
Identities = 89/318 (27%), Positives = 134/318 (42%), Gaps = 39/318 (12%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
PS L+ V+ +G FG + + + + + F
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMK-------ELIRFDEETQRTF 54
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+EV V L+HPNV KFIG L+ + EY+ GG L+ +
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNF----------------ITEYIKGGTLRGII 98
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
K+ + + V A D+A G++YLHS I+HRD+ + N L+ +N+ V +ADFG+AR+
Sbjct: 99 -KSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARL 157
Query: 222 EASNPND--------------MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
G +MAPE++NG Y+ K DV+SFGI L EI
Sbjct: 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217
Query: 268 CDMPYPDLSFSEVTSAV-VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326
PD + + VR L P CP S + RC D +P+KRP ++ L
Sbjct: 218 RVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277
Query: 327 EAIDTSKGGGMIPGDQPQ 344
E + G + G Q +
Sbjct: 278 ETLRMHLAGHLPLGPQLE 295
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 319 bits (818), Expect = e-108
Identities = 91/334 (27%), Positives = 139/334 (41%), Gaps = 67/334 (20%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
+V++ I +G FG V RG + G +VAVK+ EE ++ +
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE------------RSWFR 83
Query: 104 EVAVWH--KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E ++ L H N+ FI A + Q +V +Y G+L YL
Sbjct: 84 EAEIYQTVMLRHENILGFIAADNKDNGTWTQ------------LWLVSDYHEHGSLFDYL 131
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQ--------KIVHRDVKTENMLLDKNRTVKI 213
R + + +++LAL A GL++LH + I HRD+K++N+L+ KN T I
Sbjct: 132 ---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188
Query: 214 ADFGVARVEASNPND----MTGETGTLGYMAPEVLNGN------PYNRKCDVYSFGICLW 263
AD G+A S + GT YMAPEVL+ + ++ D+Y+ G+ W
Sbjct: 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248
Query: 264 EIYCC---------------DMPYPDLSFSEVTSAVVRQNLRPEIP---RCCP--SSLAN 303
EI D+ D S E+ V Q LRP IP + C +A
Sbjct: 249 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK 308
Query: 304 VMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGM 337
+M+ CW AN R + L + +G M
Sbjct: 309 IMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 342
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-108
Identities = 85/330 (25%), Positives = 134/330 (40%), Gaps = 67/330 (20%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
++ + I +G +G V G + G VAVK+ EE +++ +
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE------------ASWFR 78
Query: 104 EVAVWH--KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E ++ + H N+ FI A + + Q ++ +Y G+L YL
Sbjct: 79 ETEIYQTVLMRHENILGFIAADIKGTGSWTQ------------LYLITDYHENGSLYDYL 126
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQ--------KIVHRDVKTENMLLDKNRTVKI 213
+ L K +++LA GL +LH++ I HRD+K++N+L+ KN T I
Sbjct: 127 ---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183
Query: 214 ADFGVARVEASNPND----MTGETGTLGYMAPEVLNG------NPYNRKCDVYSFGICLW 263
AD G+A S+ N+ GT YM PEVL+ D+YSFG+ LW
Sbjct: 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243
Query: 264 EIYCC----------DMPYPDL-----SFSEVTSAVVRQNLRPEIPRC-----CPSSLAN 303
E+ +PY DL S+ ++ V + LRP P C +
Sbjct: 244 EVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGK 303
Query: 304 VMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333
+M CW NP R V L + S+
Sbjct: 304 LMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-107
Identities = 84/319 (26%), Positives = 135/319 (42%), Gaps = 67/319 (21%)
Query: 52 LVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH-- 109
+ + + +G +G V RG + G +VAVK+ +E ++ +E +++
Sbjct: 10 ITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE------------KSWFRETELYNTV 57
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
L H N+ FI + M S Q ++ Y G+L YL + L
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQ------------LWLITHYHEMGSLYDYL---QLTTL 102
Query: 170 AFKVVVQLALDLARGLSYLHSQ--------KIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+++ L +A GL++LH + I HRD+K++N+L+ KN IAD G+A +
Sbjct: 103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162
Query: 222 EASNPND----MTGETGTLGYMAPEVLNGNP------YNRKCDVYSFGICLWEIYCC--- 268
+ + N GT YMAPEVL+ ++ D+++FG+ LWE+
Sbjct: 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222
Query: 269 ------------DMPYPDLSFSEVTSAVVRQNLRPEIPR-----CCPSSLANVMKRCWDA 311
D+ D SF ++ V RP IP +SLA +MK CW
Sbjct: 223 NGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQ 282
Query: 312 NPDKRPEMDEVVSMLEAID 330
NP R + L ID
Sbjct: 283 NPSARLTALRIKKTLTKID 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 302 bits (774), Expect = e-102
Identities = 77/326 (23%), Positives = 129/326 (39%), Gaps = 65/326 (19%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEE-GHRTEAEIAALRSAF 101
++ + L + V ARG FG V + VAVK+ ++ + E E+ +L
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLP--- 73
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+ H N+ +FIGA + + + ++ + G+L +L
Sbjct: 74 --------GMKHENILQFIGAEKRGTSVDVD------------LWLITAFHEKGSLSDFL 113
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQ----------KIVHRDVKTENMLLDKNRTV 211
+ +++ + +A +ARGL+YLH I HRD+K++N+LL N T
Sbjct: 114 ---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170
Query: 212 KIADFGVARV--EASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWE 264
IADFG+A + D G+ GT YMAPEVL G + D+Y+ G+ LWE
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 265 IYCCDMPY----------------PDLSFSEVTSAVVRQNLRPEIPRCCPS-----SLAN 303
+ S ++ VV + RP + L
Sbjct: 231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 304 VMKRCWDANPDKRPEMDEVVSMLEAI 329
++ CWD + + R V + +
Sbjct: 291 TIEECWDHDAEARLSAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = e-100
Identities = 79/341 (23%), Positives = 136/341 (39%), Gaps = 78/341 (22%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT 102
+ ++ L + +I RG +G V++G D VAVK+ + F
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR------------QNFI 53
Query: 103 QEVAVWH--KLDHPNVTKFIGA-TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
E ++ ++H N+ +FI +++ ++ +V+EY P G+L
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRME------------YLLVMEYYPNGSLXK 101
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ---------KIVHRDVKTENMLLDKNRT 210
YL + +LA + RGL+YLH++ I HRD+ + N+L+ + T
Sbjct: 102 YL---SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158
Query: 211 VKIADFGVARVEASNP--------NDMTGETGTLGYMAPEVLNG-------NPYNRKCDV 255
I+DFG++ N N E GT+ YMAPEVL G ++ D+
Sbjct: 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM 218
Query: 256 YSFGICLWEIY--CCD-----------MPYPDL-----SFSEVTSAVVRQNLRPEIPRCC 297
Y+ G+ WEI+ C D M + +F ++ V R+ RP+ P
Sbjct: 219 YALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW 278
Query: 298 ------PSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332
SL ++ CWD + + R + +
Sbjct: 279 KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 1e-77
Identities = 87/293 (29%), Positives = 133/293 (45%), Gaps = 31/293 (10%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH--DVAVKLLDWGEEGHRTEAEIAALRS 99
+ W + LV+ I RG FG V G VAVK E L++
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC--------RETLPPDLKA 157
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F QE + + HPN+ + IG V +V+E + GG T
Sbjct: 158 KFLQEARILKQYSHPNIVRLIG----------------VCTQKQPIYIVMELVQGGDFLT 201
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+L + +L K ++Q+ D A G+ YL S+ +HRD+ N L+ + +KI+DFG++
Sbjct: 202 FL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
Query: 220 RVEASNPNDMTGETGTLGY--MAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLS 276
R EA +G + APE LN Y+ + DV+SFGI LWE + PYP+LS
Sbjct: 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320
Query: 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
+ V + R P CP ++ +M++CW P +RP + L++I
Sbjct: 321 NQQTREF-VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-73
Identities = 84/308 (27%), Positives = 133/308 (43%), Gaps = 35/308 (11%)
Query: 30 PIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGH 88
P + ++ WEI L ++ + G FG V Y+ H VAVK + G
Sbjct: 168 PCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS- 226
Query: 89 RTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVV 148
AF E V L H + K ++
Sbjct: 227 ---------VEAFLAEANVMKTLQHDKLVKLHAVVTKEP-----------------IYII 260
Query: 149 VEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
E++ G+L +L + K ++ + +A G++++ + +HRD++ N+L+ +
Sbjct: 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS 320
Query: 209 RTVKIADFGVARVEASNPNDMTGETGTLG---YMAPEVLNGNPYNRKCDVYSFGICLWEI 265
KIADFG+ARV N+ T G + APE +N + K DV+SFGI L EI
Sbjct: 321 LVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 378
Query: 266 Y-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
+PYP +S EV A + + R P CP L N+M RCW P++RP + + S
Sbjct: 379 VTYGRIPYPGMSNPEVIRA-LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437
Query: 325 MLEAIDTS 332
+L+ T+
Sbjct: 438 VLDDFYTA 445
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 4e-73
Identities = 80/307 (26%), Positives = 141/307 (45%), Gaps = 30/307 (9%)
Query: 35 SNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHR 89
S+ LK++ +D I + + ++ +G FG+V D VAVK+L +
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML---KADII 64
Query: 90 TEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV 149
++ F +E A + DHP+V K +G + + V++
Sbjct: 65 ASSD----IEEFLREAACMKEFDHPHVAKLVGVS---------LRSRAKGRLPIPM-VIL 110
Query: 150 EYLPGGALKTYLIKNR----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
++ G L +L+ +R L + +V+ +D+A G+ YL S+ +HRD+ N +L
Sbjct: 111 PFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML 170
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLW 263
++ TV +ADFG++R S G L ++A E L N Y DV++FG+ +W
Sbjct: 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMW 230
Query: 264 EIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
EI PY + +E+ + + R + P C + ++M +CW A+P +RP +
Sbjct: 231 EIMTRGQTPYAGIENAEIYNY-LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCL 289
Query: 323 VSMLEAI 329
LE I
Sbjct: 290 RMELENI 296
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 5e-73
Identities = 84/296 (28%), Positives = 133/296 (44%), Gaps = 39/296 (13%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
R W + +L + I +G FG V G Y G+ VAVK + A AF
Sbjct: 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----------ATAQAF 233
Query: 102 TQEVAVWHKLDHPNVTKFIGA-TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
E +V +L H N+ + +G L+I V EY+ G+L Y
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYI----------------VTEYMAKGSLVDY 277
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L R L +++ +LD+ + YL VHRD+ N+L+ ++ K++DFG+ +
Sbjct: 278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
Query: 221 VEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLS 276
+ + + + + APE L ++ K DV+SFGI LWEIY +PYP +
Sbjct: 338 EAS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391
Query: 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332
+V V + + + P CP ++ +VMK CW + RP ++ LE I T
Sbjct: 392 LKDVVPR-VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-72
Identities = 79/296 (26%), Positives = 140/296 (47%), Gaps = 31/296 (10%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH--DVAVKLLDWGEEGHRTEAEIAALR 98
WE+E + + +K + G +G V+ G++ + VAVK L +E E
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEE----- 262
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F +E AV ++ HPN+ + +G + T ++ E++ G L
Sbjct: 263 --FLKEAAVMKEIKHPNLVQLLG---------VCTREPPF-------YIITEFMTYGNLL 304
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
YL + R++++ V++ +A ++ + YL + +HR++ N L+ +N VK+ADFG+
Sbjct: 305 DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL 364
Query: 219 ARVEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLS 276
+R+ + + + APE L N ++ K DV++FG+ LWEI PYP +
Sbjct: 365 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424
Query: 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332
S+V + ++ R E P CP + +M+ CW NP RP E+ E +
Sbjct: 425 LSQVYEL-LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-72
Identities = 84/297 (28%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
R W + +L + I +G FG V G Y G+ VAVK + A A
Sbjct: 12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----------ATAQA 60
Query: 101 FTQEVAVWHKLDHPNVTKFIGA-TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F E +V +L H N+ + +G L+I V EY+ G+L
Sbjct: 61 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI----------------VTEYMAKGSLVD 104
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
YL R L +++ +LD+ + YL VHRD+ N+L+ ++ K++DFG+
Sbjct: 105 YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
Query: 220 RVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDL 275
+ + + + + + APE L ++ K DV+SFGI LWEIY +PYP +
Sbjct: 165 KEAS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218
Query: 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332
+V V + + + P CP ++ VMK CW + RP ++ LE I T
Sbjct: 219 PLKDVVPR-VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 5e-72
Identities = 79/309 (25%), Positives = 139/309 (44%), Gaps = 31/309 (10%)
Query: 33 KASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEG 87
+ S L+ + +D I+ + L++ ++ G FG+V G D VAVK + +
Sbjct: 17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM---KLD 73
Query: 88 HRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
+ ++ E F E A HPNV + +G E +P + V
Sbjct: 74 NSSQRE----IEEFLSEAACMKDFSHPNVIRLLGVC---------IEMSSQGIPKPM--V 118
Query: 148 VVEYLPGGALKTYLIKNR----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
++ ++ G L TYL+ +R + + + +++ +D+A G+ YL ++ +HRD+ N
Sbjct: 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNC 178
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGIC 261
+L + TV +ADFG+++ S G + ++A E L Y K DV++FG+
Sbjct: 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238
Query: 262 LWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD 320
+WEI PYP + E+ + R + P C L +M CW +P RP
Sbjct: 239 MWEIATRGMTPYPGVQNHEMYDY-LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFS 297
Query: 321 EVVSMLEAI 329
+ LE +
Sbjct: 298 VLRLQLEKL 306
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 7e-72
Identities = 90/307 (29%), Positives = 136/307 (44%), Gaps = 35/307 (11%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRS 99
+ WEI L ++ + +G FG V G ++G VA+K L G
Sbjct: 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------- 224
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
AF QE V KL H + + P I V EY+ G+L
Sbjct: 225 AFLQEAQVMKKLRHEKLVQLYAVVSEE--------------PIYI---VTEYMSKGSLLD 267
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+L + L +V +A +A G++Y+ VHRD++ N+L+ +N K+ADFG+A
Sbjct: 268 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327
Query: 220 RVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDL 275
R+ N+ T G + + APE + K DV+SFGI L E+ +PYP +
Sbjct: 328 RLIED--NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
Query: 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335
EV V + R P CP SL ++M +CW P++RP + + + LE TS
Sbjct: 386 VNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444
Query: 336 GMIPGDQ 342
PG+
Sbjct: 445 QYQPGEN 451
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 3e-71
Identities = 83/302 (27%), Positives = 132/302 (43%), Gaps = 45/302 (14%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRS 99
+WE+ L + + G FG V G Y+GH VAVK L G +
Sbjct: 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG----------SMSPD 53
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC-----CVVVEYLPG 154
AF E + +L H + + + ++ EY+
Sbjct: 54 AFLAEANLMKQLQHQRLVRLYA----------------------VVTQEPIYIITEYMEN 91
Query: 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
G+L +L KL ++ +A +A G++++ + +HRD++ N+L+ + KIA
Sbjct: 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 151
Query: 215 DFGVARVEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DM 270
DFG+AR+ N+ T G + APE +N + K DV+SFGI L EI +
Sbjct: 152 DFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209
Query: 271 PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330
PYP ++ EV + + R P CP L +M+ CW P+ RP D + S+LE
Sbjct: 210 PYPGMTNPEVIQN-LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
Query: 331 TS 332
T+
Sbjct: 269 TA 270
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 2e-70
Identities = 90/307 (29%), Positives = 135/307 (43%), Gaps = 35/307 (11%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRS 99
+ WEI L ++ + +G FG V G ++G VA+K L G
Sbjct: 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------- 307
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
AF QE V KL H + + P I V EY+ G+L
Sbjct: 308 AFLQEAQVMKKLRHEKLVQLYAVVSEE--------------PIYI---VTEYMSKGSLLD 350
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+L + L +V +A +A G++Y+ VHRD++ N+L+ +N K+ADFG+A
Sbjct: 351 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410
Query: 220 RVEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDL 275
R+ N+ T G + APE + K DV+SFGI L E+ +PYP +
Sbjct: 411 RLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468
Query: 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335
EV V + R P CP SL ++M +CW P++RP + + + LE TS
Sbjct: 469 VNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527
Query: 336 GMIPGDQ 342
PG+
Sbjct: 528 QYQPGEN 534
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 4e-70
Identities = 72/316 (22%), Positives = 134/316 (42%), Gaps = 50/316 (15%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEIAALR 98
+ E L + +G FG+V YD VAVK L E H +
Sbjct: 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD------- 57
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F +E+ + L H N+ K+ G + ++ +++EYLP G+L+
Sbjct: 58 --FEREIEILKSLQHDNIVKYKGVCYSAGRRNL--------------KLIMEYLPYGSLR 101
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
YL + + ++ ++Q + +G+ YL +++ +HRD+ T N+L++ VKI DFG+
Sbjct: 102 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160
Query: 219 ARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEI--YCCD---- 269
+V + + + + APE L + ++ DV+SFG+ L+E+ Y
Sbjct: 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220
Query: 270 ----------MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319
+ + ++ N R P CP + +M CW+ N ++RP
Sbjct: 221 PAEFMRMIGNDKQGQMIVFHLIEL-LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 279
Query: 320 DEVVSMLEAIDTSKGG 335
++ ++ I + G
Sbjct: 280 RDLALRVDQIRDNMAG 295
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 4e-70
Identities = 82/290 (28%), Positives = 136/290 (46%), Gaps = 35/290 (12%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
E++ ++ + + G FG V G + G +DVAVK++ G + F Q
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG----------SMSEDEFFQ 52
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E KL HP + KF G ++I V EY+ G L YL +
Sbjct: 53 EAQTMMKLSHPKLVKFYGVCSKEYPIYI----------------VTEYISNGCLLNYL-R 95
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ + L ++++ D+ G+++L S + +HRD+ N L+D++ VK++DFG+ R
Sbjct: 96 SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155
Query: 224 SNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSE 279
+ GT + APEV + Y+ K DV++FGI +WE++ MPY + SE
Sbjct: 156 D--DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
V V Q R P ++ +M CW P+KRP +++S +E +
Sbjct: 214 VVLK-VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-70
Identities = 77/301 (25%), Positives = 124/301 (41%), Gaps = 33/301 (10%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIA 95
Q I L + + G+FG V RG +D VAVK L + ++ E
Sbjct: 9 QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL---KPDVLSQPEA- 64
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
F +EV H LDH N+ + G + +V E P G
Sbjct: 65 --MDDFIREVNAMHSLDHRNLIRLYGVVLTPP-----------------MKMVTELAPLG 105
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
+L L + + + + A+ +A G+ YL S++ +HRD+ N+LL VKI D
Sbjct: 106 SLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 164
Query: 216 FGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMP 271
FG+ R N + + + APE L ++ D + FG+ LWE++ P
Sbjct: 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
Query: 272 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331
+ L+ S++ + ++ R P CP + NVM +CW P+ RP + L
Sbjct: 225 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284
Query: 332 S 332
+
Sbjct: 285 T 285
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 4e-70
Identities = 74/327 (22%), Positives = 136/327 (41%), Gaps = 50/327 (15%)
Query: 34 ASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEG 87
A + R + E L + +G FG+V YD VAVK L E
Sbjct: 25 AMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 84
Query: 88 HRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
H + F +E+ + L H N+ K+ G + ++ +
Sbjct: 85 HLRD---------FEREIEILKSLQHDNIVKYKGVCYSAGRRNL--------------KL 121
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
++EYLP G+L+ YL + + ++ ++Q + +G+ YL +++ +HRD+ T N+L++
Sbjct: 122 IMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN 180
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
VKI DFG+ +V + + + + APE L + ++ DV+SFG+ L+E
Sbjct: 181 ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 240
Query: 265 I--YCCD--------------MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRC 308
+ Y + + ++ N R P CP + +M C
Sbjct: 241 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL-LKNNGRLPRPDGCPDEIYMIMTEC 299
Query: 309 WDANPDKRPEMDEVVSMLEAIDTSKGG 335
W+ N ++RP ++ ++ I G
Sbjct: 300 WNNNVNQRPSFRDLALRVDQIRDQMAG 326
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 5e-70
Identities = 75/291 (25%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFT 102
WEI+P L + G FG V G + G DVA+K++ G + F
Sbjct: 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG----------SMSEDEFI 67
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+E V L H + + G V ++ EY+ G L YL
Sbjct: 68 EEAKVMMNLSHEKLVQLYG----------------VCTKQRPIFIITEYMANGCLLNYL- 110
Query: 163 KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
+ R + + ++++ D+ + YL S++ +HRD+ N L++ VK++DFG++R
Sbjct: 111 REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170
Query: 223 ASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFS 278
++ T G+ + PEVL + ++ K D+++FG+ +WEIY MPY + S
Sbjct: 171 LD--DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228
Query: 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
E + Q LR P + +M CW D+RP ++S + +
Sbjct: 229 ETAEH-IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 1e-69
Identities = 80/292 (27%), Positives = 138/292 (47%), Gaps = 35/292 (11%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGH--DVAVKLLDWGEEGHRTEAEIAALRSAF 101
WE+E + + +K + G +G V+ G++ + VAVK L F
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----------TMEVEEF 56
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+E AV ++ HPN+ + +G + T ++ E++ G L YL
Sbjct: 57 LKEAAVMKEIKHPNLVQLLG---------VCTREPPF-------YIITEFMTYGNLLDYL 100
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ R++++ V++ +A ++ + YL + +HRD+ N L+ +N VK+ADFG++R+
Sbjct: 101 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
Query: 222 EASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 277
+ T G + APE L N ++ K DV++FG+ LWEI PYP +
Sbjct: 161 MTG--DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218
Query: 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
S+V + ++ R E P CP + +M+ CW NP RP E+ E +
Sbjct: 219 SQVYEL-LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 1e-69
Identities = 95/304 (31%), Positives = 137/304 (45%), Gaps = 37/304 (12%)
Query: 38 LKKQRQDWEIEPSKLVIK--SVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRT 90
L + Q I PS L++ VI RG FG V+ G +D AVK L+
Sbjct: 11 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----D 66
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
E S F E + HPNV +G VV+
Sbjct: 67 IGE----VSQFLTEGIIMKDFSHPNVLSLLGI---------------CLRSEGSPLVVLP 107
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
Y+ G L+ ++ +N K ++ L +A+G+ YL S+K VHRD+ N +LD+ T
Sbjct: 108 YMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT 166
Query: 211 VKIADFGVAR-VEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
VK+ADFG+AR + + +TG +MA E L + K DV+SFG+ LWE+
Sbjct: 167 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226
Query: 267 C-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
PYPD++ ++T + Q R P CP L VM +CW + RP E+VS
Sbjct: 227 TRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285
Query: 326 LEAI 329
+ AI
Sbjct: 286 ISAI 289
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-69
Identities = 84/293 (28%), Positives = 139/293 (47%), Gaps = 35/293 (11%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
W I+PS+L I G FG VH G + VA+K + EG +E + F +
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEED-------FIE 52
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E V KL HP + + G + + + + V E++ G L YL +
Sbjct: 53 EAEVMMKLSHPKLVQLYGVCLEQAPICL----------------VTEFMEHGCLSDYL-R 95
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+R A + ++ + LD+ G++YL ++HRD+ N L+ +N+ +K++DFG+ R
Sbjct: 96 TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155
Query: 224 SNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSE 279
+ T TGT + +PEV + + Y+ K DV+SFG+ +WE++ +PY + S SE
Sbjct: 156 D--DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332
V + R PR + + +M CW P+ RP ++ L I S
Sbjct: 214 VVED-ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 4e-69
Identities = 90/304 (29%), Positives = 138/304 (45%), Gaps = 37/304 (12%)
Query: 38 LKKQRQDWEIEPSKLVIKS--VIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRT 90
L + +D I ++V S VI +G FG V+ G Y A+K L
Sbjct: 7 LLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL---SRITEM 63
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
+ AF +E + L+HPNV IG + P + V++
Sbjct: 64 QQ-----VEAFLREGLLMRGLNHPNVLALIGI---------------MLPPEGLPHVLLP 103
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
Y+ G L ++ ++ +R K ++ L +ARG+ YL QK VHRD+ N +LD++ T
Sbjct: 104 YMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT 162
Query: 211 VKIADFGVAR-VEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
VK+ADFG+AR + + + A E L + K DV+SFG+ LWE+
Sbjct: 163 VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
Query: 267 -CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
PY + ++T + Q R P CP SL VM++CW+A+P RP +V
Sbjct: 223 TRGAPPYRHIDPFDLTHF-LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281
Query: 326 LEAI 329
+E I
Sbjct: 282 VEQI 285
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 4e-69
Identities = 76/328 (23%), Positives = 132/328 (40%), Gaps = 50/328 (15%)
Query: 32 GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGE 85
G + L + G FG V YD + VAVK L +
Sbjct: 13 GALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL---K 69
Query: 86 EGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC 145
+ RS + QE+ + L H ++ K+ G + +
Sbjct: 70 ADAGPQH-----RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL-------------- 110
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
+V+EY+P G+L+ YL R + ++ A + G++YLH+Q +HRD+ N+LL
Sbjct: 111 QLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL 167
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICL 262
D +R VKI DFG+A+ + + APE L + DV+SFG+ L
Sbjct: 168 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227
Query: 263 WEI--YC-------------CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKR 307
+E+ +C + ++ +T + + R P CP+ + ++MK
Sbjct: 228 YELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL-LERGERLPRPDKCPAEVYHLMKN 286
Query: 308 CWDANPDKRPEMDEVVSMLEAIDTSKGG 335
CW+ RP + ++ +L+ + G
Sbjct: 287 CWETEASFRPTFENLIPILKTVHEKYQG 314
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 4e-69
Identities = 79/302 (26%), Positives = 126/302 (41%), Gaps = 48/302 (15%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAA 96
+ I +V+ ++ G FG V+ G+Y H VAVK ++ +
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC---KKDCTLDN---- 56
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC-----CVVVEY 151
+ F E + LDHP++ K IG I +++E
Sbjct: 57 -KEKFMSEAVIMKNLDHPHIVKLIG----------------------IIEEEPTWIIMEL 93
Query: 152 LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211
P G L YL + + L +V +L + + ++YL S VHRD+ N+L+ V
Sbjct: 94 YPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECV 152
Query: 212 KIADFGVARVEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIY-C 267
K+ DFG++R D + T +M+PE +N + DV+ F +C+WEI
Sbjct: 153 KLGDFGLSRYIED--EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSF 210
Query: 268 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
P+ L +V + + R P CP L +M RCWD +P RP E+V L
Sbjct: 211 GKQPFFWLENKDVIGV-LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269
Query: 328 AI 329
+
Sbjct: 270 DV 271
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 6e-69
Identities = 83/304 (27%), Positives = 138/304 (45%), Gaps = 43/304 (14%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAA 96
+WE+ K+ + + +G+FG V+ G+ G VA+K + E + E
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAA-SMRE--- 71
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
R F E +V + + +V + +G ++ V++E + G
Sbjct: 72 -RIEFLNEASVMKEFNCHHVVRLLGVV---------SQGQPT-------LVIMELMTRGD 114
Query: 157 LKTYLIKNR--------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
LK+YL R + ++Q+A ++A G++YL++ K VHRD+ N ++ ++
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174
Query: 209 RTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
TVKI DFG+ R G G L +M+PE L + DV+SFG+ LWEI
Sbjct: 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 267 -CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
+ PY LS +V V+ + P CP L +M+ CW NP RP E++S
Sbjct: 235 TLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
Query: 326 LEAI 329
++
Sbjct: 294 IKEE 297
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-68
Identities = 75/309 (24%), Positives = 133/309 (43%), Gaps = 48/309 (15%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEIAALR 98
E L + G FG V YD VAVK L +
Sbjct: 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KPESGGNH-----I 67
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
+ +E+ + L H N+ K+ G I TE+G + +++E+LP G+LK
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKG---------ICTEDGGNGI-----KLIMEFLPSGSLK 113
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
YL + K+ K ++ A+ + +G+ YL S++ VHRD+ N+L++ VKI DFG+
Sbjct: 114 EYL-PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172
Query: 219 ARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEI--YC------ 267
+ ++ T + + + APE L + + DV+SFG+ L E+ YC
Sbjct: 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232
Query: 268 -------CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD 320
+ ++ + + + +++ R P CP + +M++CW+ P R
Sbjct: 233 MALFLKMIGPTHGQMTVTRLVNT-LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQ 291
Query: 321 EVVSMLEAI 329
++ EA+
Sbjct: 292 NLIEGFEAL 300
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 5e-68
Identities = 78/306 (25%), Positives = 136/306 (44%), Gaps = 48/306 (15%)
Query: 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEA 92
+ +D+EI+ ++ + I G FG VH+G+Y + VA+K +
Sbjct: 3 MGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC---KNCTSDSV 59
Query: 93 EIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC-----CV 147
R F QE + DHP++ K IG + +
Sbjct: 60 -----REKFLQEALTMRQFDHPHIVKLIG----------------------VITENPVWI 92
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
++E G L+++L + R+ L ++ A L+ L+YL S++ VHRD+ N+L+
Sbjct: 93 IMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 151
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWE 264
N VK+ DFG++R + + +MAPE +N + DV+ FG+C+WE
Sbjct: 152 NDCVKLGDFGLSRYMED--STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 209
Query: 265 IYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
I P+ + ++V + R +P CP +L ++M +CW +P +RP E+
Sbjct: 210 ILMHGVKPFQGVKNNDVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 268
Query: 324 SMLEAI 329
+ L I
Sbjct: 269 AQLSTI 274
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 6e-68
Identities = 86/319 (26%), Positives = 132/319 (41%), Gaps = 50/319 (15%)
Query: 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRT 90
+ I+ +V+K + G FG V VAVK L ++ T
Sbjct: 3 MHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDP--T 57
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
A R F +E + L H ++ KF G + + +V E
Sbjct: 58 LAA----RKDFQREAELLTNLQHEHIVKFYGVC---------GDGDPL-------IMVFE 97
Query: 151 YLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196
Y+ G L +L + + +L ++ +A +A G+ YL SQ VHR
Sbjct: 98 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHR 157
Query: 197 DVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCD 254
D+ T N L+ N VKI DFG++R S G L +M PE + + + D
Sbjct: 158 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 217
Query: 255 VYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANP 313
V+SFG+ LWEI+ P+ LS +EV + Q E PR CP + +VM CW P
Sbjct: 218 VWSFGVILWEIFTYGKQPWFQLSNTEVIEC-ITQGRVLERPRVCPKEVYDVMLGCWQREP 276
Query: 314 DKRPEMDEVVSMLEAIDTS 332
+R + E+ +L A+ +
Sbjct: 277 QQRLNIKEIYKILHALGKA 295
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 7e-68
Identities = 80/298 (26%), Positives = 135/298 (45%), Gaps = 36/298 (12%)
Query: 41 QRQDWEIEPSKLVIKS-VIARGTFGTVHRGLYDGH----DVAVKLLDWGEEGHRTEAEIA 95
+ ++ ++ L ++ + G FGTV +G Y VAVK+L + EA
Sbjct: 7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-------KNEANDP 59
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
AL+ E V +LD+P + + IG + + +V+E G
Sbjct: 60 ALKDELLAEANVMQQLDNPYIVRMIG----------------ICEAESWM-LVMEMAELG 102
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
L YL +NR + K +++L ++ G+ YL VHRD+ N+LL KI+D
Sbjct: 103 PLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISD 160
Query: 216 FGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMP 271
FG+++ ++ N +T + + APE +N ++ K DV+SFG+ +WE + P
Sbjct: 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
Query: 272 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
Y + SEVT+ + + R P CP + ++M CW + + RP V L
Sbjct: 221 YRGMKGSEVTAM-LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-67
Identities = 84/298 (28%), Positives = 140/298 (46%), Gaps = 35/298 (11%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-----DVAVKLLDWGEEGHRTEAEIAALR 98
EIE S++ I+ +I G G V G VA+K L G TE + R
Sbjct: 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----TERQ----R 94
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F E ++ + DHPN+ + G V + +V EY+ G+L
Sbjct: 95 RDFLSEASIMGQFDHPNIIRLEG----------------VVTRGRLAMIVTEYMENGSLD 138
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
T+L + + +V + + G+ YL VHRD+ N+L+D N K++DFG+
Sbjct: 139 TFL-RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 219 ARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPD 274
+RV +P+ TG + + APE + ++ DV+SFG+ +WE+ + PY +
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332
++ +V S+ V + R P CP +L +M CW + +RP ++VS+L+A+ S
Sbjct: 258 MTNRDVISS-VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-67
Identities = 81/311 (26%), Positives = 125/311 (40%), Gaps = 55/311 (17%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAAL 97
I+ +V+K + G FG V VAVK L E R +
Sbjct: 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD------ 89
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
F +E + L H ++ +F G TE + +V EY+ G L
Sbjct: 90 ---FQREAELLTMLQHQHIVRFFGVC---------TEGRPL-------LMVFEYMRHGDL 130
Query: 158 KTYLIKNR-------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
+L + L ++ +A +A G+ YL VHRD+ T N L
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 190
Query: 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLG-----YMAPEVLNGNPYNRKCDVYSFG 259
+ + VKI DFG++R S D G +M PE + + + DV+SFG
Sbjct: 191 VGQGLVVKIGDFGMSRDIYS--TDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVWSFG 247
Query: 260 ICLWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 318
+ LWEI+ P+ LS +E + Q E PR CP + +M+ CW P +R
Sbjct: 248 VVLWEIFTYGKQPWYQLSNTEAIDC-ITQGRELERPRACPPEVYAIMRGCWQREPQQRHS 306
Query: 319 MDEVVSMLEAI 329
+ +V + L+A+
Sbjct: 307 IKDVHARLQAL 317
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 6e-67
Identities = 78/316 (24%), Positives = 137/316 (43%), Gaps = 49/316 (15%)
Query: 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTE 91
L + E L S + +G FG+V YD VAVK L + +
Sbjct: 11 LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSG-PD 66
Query: 92 AEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY 151
+ F +E+ + L + K+ G + G + +V+EY
Sbjct: 67 QQ-----RDFQREIQILKALHSDFIVKYRGVSYGPGRQSL--------------RLVMEY 107
Query: 152 LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211
LP G L+ +L ++R R L ++ + + +G+ YL S++ VHRD+ N+L++ V
Sbjct: 108 LPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHV 166
Query: 212 KIADFGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-C 267
KIADFG+A++ + + + + APE L+ N ++R+ DV+SFG+ L+E++
Sbjct: 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY 226
Query: 268 CDMPY--------------PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANP 313
CD + S + + + R P CP+ + +MK CW +P
Sbjct: 227 CDKSCSPSAEFLRMMGCERDVPALSRLLEL-LEEGQRLPAPPACPAEVHELMKLCWAPSP 285
Query: 314 DKRPEMDEVVSMLEAI 329
RP + L+ +
Sbjct: 286 QDRPSFSALGPQLDML 301
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 7e-67
Identities = 94/304 (30%), Positives = 138/304 (45%), Gaps = 37/304 (12%)
Query: 38 LKKQRQDWEIEPSKLVIK--SVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRT 90
L + Q I PS L++ VI RG FG V+ G +D AVK L+
Sbjct: 75 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----D 130
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
E S F E + HPNV +G VV+
Sbjct: 131 IGE----VSQFLTEGIIMKDFSHPNVLSLLGI---------------CLRSEGSPLVVLP 171
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
Y+ G L+ ++ +N K ++ L +A+G+ +L S+K VHRD+ N +LD+ T
Sbjct: 172 YMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT 230
Query: 211 VKIADFGVAR-VEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
VK+ADFG+AR + + + +TG +MA E L + K DV+SFG+ LWE+
Sbjct: 231 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
Query: 267 C-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
PYPD++ ++T + Q R P CP L VM +CW + RP E+VS
Sbjct: 291 TRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349
Query: 326 LEAI 329
+ AI
Sbjct: 350 ISAI 353
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 9e-67
Identities = 81/306 (26%), Positives = 121/306 (39%), Gaps = 49/306 (16%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAAL 97
E+ + + + G FG V+ G G VAVK L E +
Sbjct: 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQD----- 76
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
F E + K +H N+ + IG + ++ +++E + GG L
Sbjct: 77 ELDFLMEALIISKFNHQNIVRCIGVS---------LQSLPR-------FILMELMAGGDL 120
Query: 158 KTYLIKNR-----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK---NR 209
K++L + R LA ++ +A D+A G YL +HRD+ N LL R
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180
Query: 210 TVKIADFGVARVEASNPNDMTGETGTLGY-----MAPEVLNGNPYNRKCDVYSFGICLWE 264
KI DFG+AR G M PE + K D +SFG+ LWE
Sbjct: 181 VAKIGDFGMARDIYRA--SYY-RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 237
Query: 265 IY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
I+ MPYP S EV V R + P+ CP + +M +CW P+ RP ++
Sbjct: 238 IFSLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296
Query: 324 SMLEAI 329
+E
Sbjct: 297 ERIEYC 302
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 1e-66
Identities = 70/292 (23%), Positives = 139/292 (47%), Gaps = 36/292 (12%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEIAALRSA 100
++ ++ V+ G FGTV++GL+ VA+K L E +A
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKA-----NKE 63
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
E V +D+P+V + +G + S+ +Q ++ + +P G L Y
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTST---VQ--------------LITQLMPFGCLLDY 106
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
+ + + + + ++ + +A+G++YL +++VHRD+ N+L+ + VKI DFG+A+
Sbjct: 107 V-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 221 VEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLSF 277
+ + + E G + +MA E + Y + DV+S+G+ +WE+ PY +
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
Query: 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
SE++S + + R P C + +M++CW + D RP+ E++ +
Sbjct: 226 SEISSI-LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 2e-66
Identities = 83/304 (27%), Positives = 124/304 (40%), Gaps = 43/304 (14%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAA 96
E+ + + + G FG V+ G G VAVK L E +
Sbjct: 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQD---- 117
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
F E + K +H N+ + IG + ++ P +++E + GG
Sbjct: 118 -ELDFLMEALIISKFNHQNIVRCIGVS---------LQSL----P---RFILLELMAGGD 160
Query: 157 LKTYLIKNR-----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK---N 208
LK++L + R LA ++ +A D+A G YL +HRD+ N LL
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220
Query: 209 RTVKIADFGVARVEASNPNDMTGETGTLG--YMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
R KI DFG+AR G L +M PE + K D +SFG+ LWEI+
Sbjct: 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
Query: 267 -CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
MPYP S EV V R + P+ CP + +M +CW P+ RP ++
Sbjct: 281 SLGYMPYPSKSNQEVLEFV-TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339
Query: 326 LEAI 329
+E
Sbjct: 340 IEYC 343
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-66
Identities = 82/329 (24%), Positives = 132/329 (40%), Gaps = 57/329 (17%)
Query: 33 KASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGE 85
+ L + E + + I G FG V + G VAVK+L +
Sbjct: 30 RMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML---K 86
Query: 86 EGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC 145
E + ++ F +E A+ + D+PN+ K +G +
Sbjct: 87 EEA-SADM----QADFQREAALMAEFDNPNIVKLLGVC---------AVGKPM------- 125
Query: 146 CVVVEYLPGGALKTYLIKNR----------------------RRKLAFKVVVQLALDLAR 183
C++ EY+ G L +L L+ + +A +A
Sbjct: 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 185
Query: 184 GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAP 241
G++YL +K VHRD+ T N L+ +N VKIADFG++R S + +M P
Sbjct: 186 GMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 245
Query: 242 EVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSS 300
E + N Y + DV+++G+ LWEI+ PY ++ EV V N P CP
Sbjct: 246 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLE 304
Query: 301 LANVMKRCWDANPDKRPEMDEVVSMLEAI 329
L N+M+ CW P RP + +L+ +
Sbjct: 305 LYNLMRLCWSKLPADRPSFCSIHRILQRM 333
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-66
Identities = 79/298 (26%), Positives = 135/298 (45%), Gaps = 36/298 (12%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH------DVAVKLLDWGEEGHRTEAEIA 95
+ EI PS + + VI G FG V++G+ VA+K L
Sbjct: 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--------KAGYTE 87
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
R F E + + H N+ + G V ++ EY+ G
Sbjct: 88 KQRVDFLGEAGIMGQFSHHNIIRLEG----------------VISKYKPMMIITEYMENG 131
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
AL +L + + + + +V + +A G+ YL + VHRD+ N+L++ N K++D
Sbjct: 132 ALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSD 190
Query: 216 FGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMP 271
FG++RV +P +G + + APE ++ + DV+SFGI +WE+ + P
Sbjct: 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
Query: 272 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
Y +LS EV A + R P CPS++ +M +CW +RP+ ++VS+L+ +
Sbjct: 251 YWELSNHEVMKA-INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 3e-66
Identities = 71/298 (23%), Positives = 133/298 (44%), Gaps = 36/298 (12%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEI 94
+ + ++L V+ G FGTVH+G++ V +K++ E+ ++
Sbjct: 4 KVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI---EDKSGRQS-- 58
Query: 95 AALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG 154
A T + LDH ++ + +G GSS +V +YLP
Sbjct: 59 ---FQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-----------------LQLVTQYLPL 98
Query: 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
G+L ++ + R L ++++ + +A+G+ YL +VHR++ N+LL V++A
Sbjct: 99 GSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVA 157
Query: 215 DFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMP 271
DFGVA + + + +MA E ++ Y + DV+S+G+ +WE+ P
Sbjct: 158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
Query: 272 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
Y L +EV + + R P+ C + VM +CW + + RP E+ + +
Sbjct: 218 YAGLRLAEVPDL-LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 6e-66
Identities = 77/299 (25%), Positives = 133/299 (44%), Gaps = 36/299 (12%)
Query: 43 QDWEIEPSKLVI-KSVIARGTFGTVHRGLYDGH----DVAVKLLDWGEEGHRTEAEIAAL 97
+ ++ L+I + G FG+V +G+Y DVA+K+L ++G
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKAD----- 53
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
+E + H+LD+P + + IG V + +V+E GG L
Sbjct: 54 TEEMMREAQIMHQLDNPYIVRLIG----------------VCQAEALM-LVMEMAGGGPL 96
Query: 158 KTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
+L +R ++ V +L ++ G+ YL + VHRD+ N+LL KI+DFG
Sbjct: 97 HKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155
Query: 218 VARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYP 273
+++ ++ + T + L + APE +N ++ + DV+S+G+ +WE PY
Sbjct: 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215
Query: 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332
+ EV + + Q R E P CP L +M CW + RP+ V + A S
Sbjct: 216 KMKGPEVMAF-IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-65
Identities = 74/308 (24%), Positives = 121/308 (39%), Gaps = 49/308 (15%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAAL 97
EI S + + FG V++G G VA+K L ++
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKA-EGPL---- 55
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
R F E + +L HPNV +G T++ + ++ Y G L
Sbjct: 56 REEFRHEAMLRARLQHPNVVCLLGVV---------TKDQPL-------SMIFSYCSHGDL 99
Query: 158 KTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
+L+ + L V L +A G+ YL S +VH+D+ T N+
Sbjct: 100 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 159
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGIC 261
L+ VKI+D G+ R + L +MAPE + ++ D++S+G+
Sbjct: 160 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVV 219
Query: 262 LWEIY-CCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD 320
LWE++ PY S +V +R P CP+ + +M CW+ P +RP
Sbjct: 220 LWEVFSYGLQPYCGYSNQDVVEM-IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFK 278
Query: 321 EVVSMLEA 328
++ S L A
Sbjct: 279 DIHSRLRA 286
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-65
Identities = 80/294 (27%), Positives = 136/294 (46%), Gaps = 35/294 (11%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAALRS 99
E++ + + I V+ G FG V G VA+K L G TE + R
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TEKQ----RR 91
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F E ++ + DHPN+ + G V S +V EY+ G+L +
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEG----------------VVTKSKPVMIVTEYMENGSLDS 135
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+L + + +V + +A G+ YL VHRD+ N+L++ N K++DFG+
Sbjct: 136 FL-RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
Query: 220 RVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDL 275
RV +P G + + +PE + + DV+S+GI LWE+ + PY ++
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254
Query: 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
S +V A V + R P CP++L +M CW + + RP+ +++VS+L+ +
Sbjct: 255 SNQDVIKA-VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 217 bits (553), Expect = 4e-65
Identities = 77/295 (26%), Positives = 132/295 (44%), Gaps = 38/295 (12%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAALR 98
D+EI+ ++ + I G FG VH+G+Y + VA+K + R
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC---KNCTSDSV-----R 435
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F QE + DHP++ K IG + +++E G L+
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENP-----------------VWIIMELCTLGELR 478
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
++L + L ++ A L+ L+YL S++ VHRD+ N+L+ N VK+ DFG+
Sbjct: 479 SFLQVRKFS-LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 537
Query: 219 ARVEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPD 274
+R + + +MAPE +N + DV+ FG+C+WEI P+
Sbjct: 538 SRYMED--STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595
Query: 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
+ ++V + R +P CP +L ++M +CW +P +RP E+ + L I
Sbjct: 596 VKNNDVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 4e-65
Identities = 91/330 (27%), Positives = 139/330 (42%), Gaps = 48/330 (14%)
Query: 25 NATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VA 77
+ P+ + L WE +L + + RG FG V G D VA
Sbjct: 2 DPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVA 61
Query: 78 VKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSELHIQTENG 136
VK+L +EG T +E A E+ + + H NV +GA T+ G
Sbjct: 62 VKML---KEGA-THSE----HRALMSELKILIHIGHHLNVVNLLGAC---------TKPG 104
Query: 137 QVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLA 182
P V+VE+ G L TYL R + L + ++ + +A
Sbjct: 105 G---P---LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 158
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMA 240
+G+ +L S+K +HRD+ N+LL + VKI DFG+AR +P+ + L +MA
Sbjct: 159 KGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 218
Query: 241 PEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPS 299
PE + Y + DV+SFG+ LWEI+ PYP + E +++ R P
Sbjct: 219 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 278
Query: 300 SLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
+ M CW P +RP E+V L +
Sbjct: 279 EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 6e-65
Identities = 66/268 (24%), Positives = 114/268 (42%), Gaps = 22/268 (8%)
Query: 57 VIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
+I G FG V + DG +K + + E + E E+ AL KLDH
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE--KAEREVKALA-----------KLDHV 64
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N+ + G G + + + +E+ G L+ ++ K R KL +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
++L + +G+ Y+HS+K+++RD+K N+ L + VKI DFG+ N T G
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS-LKNDGKRTRSKG 183
Query: 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP 294
TL YM+PE ++ Y ++ D+Y+ G+ L E+ + TS I
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE------TSKFFTDLRDGIIS 237
Query: 295 RCCPSSLANVMKRCWDANPDKRPEMDEV 322
++++ P+ RP E+
Sbjct: 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 1e-64
Identities = 83/318 (26%), Positives = 139/318 (43%), Gaps = 57/318 (17%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAA 96
WE LV+ + G FG V + VAVK+L +E + +E
Sbjct: 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENA-SPSE--- 69
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
E V +++HP+V K GA +++G + ++VEY G+
Sbjct: 70 -LRDLLSEFNVLKQVNHPHVIKLYGAC---------SQDGPL-------LLIVEYAKYGS 112
Query: 157 LKTYLIKNR----------------------RRKLAFKVVVQLALDLARGLSYLHSQKIV 194
L+ +L ++R R L ++ A +++G+ YL K+V
Sbjct: 113 LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172
Query: 195 HRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRK 252
HRD+ N+L+ + R +KI+DFG++R + + G + +MA E L + Y +
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 253 CDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 311
DV+SFG+ LWEI PYP + + + ++ R E P C + +M +CW
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL-LKTGHRMERPDNCSEEMYRLMLQCWKQ 291
Query: 312 NPDKRPEMDEVVSMLEAI 329
PDKRP ++ LE +
Sbjct: 292 EPDKRPVFADISKDLEKM 309
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-64
Identities = 66/314 (21%), Positives = 119/314 (37%), Gaps = 66/314 (21%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDG---------HDVAVKLLDWGEEGHRTEAEIA 95
+I L+ + +GTF + +G+ +V +K+LD + HR +E
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KAHRNYSE-- 57
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
+F + ++ KL H ++ G V + + +V E++ G
Sbjct: 58 ----SFFEAASMMSKLSHKHLVLNYG----------------VCVCGDENILVQEFVKFG 97
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK-------- 207
+L TYL K + + +++A LA + +L ++H +V +N+LL +
Sbjct: 98 SLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN 156
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTLGY-------MAPEVL-NGNPYNRKCDVYSFG 259
+K++D G++ + PE + N N D +SFG
Sbjct: 157 PPFIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFG 205
Query: 260 ICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE 318
LWEI D P L + P+ LAN++ C D PD RP
Sbjct: 206 TTLWEICSGGDKPLSALDSQRKLQF-YEDRHQLPAPKAAE--LANLINNCMDYEPDHRPS 262
Query: 319 MDEVVSMLEAIDTS 332
++ L ++ T
Sbjct: 263 FRAIIRDLNSLFTP 276
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-64
Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 56/310 (18%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD----VAVKLLDWGEEGHRTEAEIAALRSA 100
++ + + + VI G FG V + A+K + +E ++ +
Sbjct: 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYA-SKDD----HRD 71
Query: 101 FTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F E+ V KL HPN+ +GA G + + +EY P G L
Sbjct: 72 FAGELEVLCKLGHHPNIINLLGAC---------EHRGYL-------YLAIEYAPHGNLLD 115
Query: 160 YLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
+L K+R L+ + ++ A D+ARG+ YL ++ +HRD+ N+L+
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLG-----YMAPEVLNGNPYNRKCDVYSFGI 260
+N KIADFG++R T+G +MA E LN + Y DV+S+G+
Sbjct: 176 GENYVAKIADFGLSR------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 229
Query: 261 CLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319
LWEI PY ++ +E+ + Q R E P C + ++M++CW P +RP
Sbjct: 230 LLWEIVSLGGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF 288
Query: 320 DEVVSMLEAI 329
+++ L +
Sbjct: 289 AQILVSLNRM 298
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-64
Identities = 95/323 (29%), Positives = 144/323 (44%), Gaps = 52/323 (16%)
Query: 34 ASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWG 84
S + + WE KL + + G FG V G D VAVK+L
Sbjct: 65 VSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--- 121
Query: 85 EEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSN 143
++ TE + S E+ + + H N+ +GA T++G +
Sbjct: 122 KDDA-TEKD----LSDLVSEMEMMKMIGKHKNIINLLGAC---------TQDGPL----- 162
Query: 144 ICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLH 189
V+VEY G L+ YL R ++ FK +V LARG+ YL
Sbjct: 163 --YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA 220
Query: 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGN 247
SQK +HRD+ N+L+ +N +KIADFG+AR + G L +MAPE L
Sbjct: 221 SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 280
Query: 248 PYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMK 306
Y + DV+SFG+ +WEI+ PYP + E+ +++ R + P C + L +M+
Sbjct: 281 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL-LKEGHRMDKPANCTNELYMMMR 339
Query: 307 RCWDANPDKRPEMDEVVSMLEAI 329
CW A P +RP ++V L+ I
Sbjct: 340 DCWHAVPSQRPTFKQLVEDLDRI 362
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 5e-64
Identities = 84/313 (26%), Positives = 134/313 (42%), Gaps = 51/313 (16%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAA 96
WE ++L + G FG V G VAVK+L + E
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSA-HLTE--- 69
Query: 97 LRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
R A E+ V L +H N+ +GA T G V+ EY G
Sbjct: 70 -REALMSELKVLSYLGNHMNIVNLLGAC---------TIGGPT-------LVITEYCCYG 112
Query: 156 ALKTYLIKNR----------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
L +L + R L + ++ + +A+G+++L S+ +HRD+
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172
Query: 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYS 257
N+LL R KI DFG+AR ++ N + L +MAPE + Y + DV+S
Sbjct: 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 232
Query: 258 FGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
+GI LWE++ PYP + ++++ R P P+ + ++MK CWDA+P KR
Sbjct: 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 317 PEMDEVVSMLEAI 329
P ++V ++E
Sbjct: 293 PTFKQIVQLIEKQ 305
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 5e-64
Identities = 96/334 (28%), Positives = 148/334 (44%), Gaps = 53/334 (15%)
Query: 24 ANATATP-IGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------- 75
+ + P + S + + WE KL + + G FG V G D
Sbjct: 8 HHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEA 67
Query: 76 --VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132
VAVK+L ++ TE + S E+ + + H N+ +GA
Sbjct: 68 VTVAVKML---KDDA-TEKD----LSDLVSEMEMMKMIGKHKNIINLLGAC--------- 110
Query: 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLA 178
T++G + V+VEY G L+ YL R ++ FK +V
Sbjct: 111 TQDGPL-------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL-- 236
LARG+ YL SQK +HRD+ N+L+ +N +KIADFG+AR + G L
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 237 GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPR 295
+MAPE L Y + DV+SFG+ +WEI+ PYP + E+ +++ R + P
Sbjct: 224 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL-LKEGHRMDKPA 282
Query: 296 CCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
C + L +M+ CW A P +RP ++V L+ I
Sbjct: 283 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-63
Identities = 69/292 (23%), Positives = 136/292 (46%), Gaps = 36/292 (12%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEIAALRSA 100
++ ++ V+ G FGTV++GL+ VA+K L E +A
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKA-----NKE 63
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
E V +D+P+V + +G + S+ ++ + +P G L Y
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTVQ-----------------LITQLMPFGCLLDY 106
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
+ + + + + ++ + +A+G++YL +++VHRD+ N+L+ + VKI DFG+A+
Sbjct: 107 V-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 221 VEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLSF 277
+ + + E G + +MA E + Y + DV+S+G+ +WE+ PY +
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
Query: 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
SE++S + + R P C + +M +CW + D RP+ E++ +
Sbjct: 226 SEISSI-LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 6e-63
Identities = 81/310 (26%), Positives = 127/310 (40%), Gaps = 49/310 (15%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAA 96
WE + L + G FG V G VAVK+L + E
Sbjct: 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTA-HADE--- 92
Query: 97 LRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
+ A E+ + L H N+ +GA T G V V+ EY G
Sbjct: 93 -KEALMSELKIMSHLGQHENIVNLLGAC---------THGGPV-------LVITEYCCYG 135
Query: 156 ALKTYLIKNRR------------RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
L +L + R + + ++ + +A+G+++L S+ +HRDV N+
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGIC 261
LL KI DFG+AR ++ N + L +MAPE + Y + DV+S+GI
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 262 LWEIYCC-DMPYP-DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319
LWEI+ PYP L S+ V+ + P P ++ ++M+ CW P RP
Sbjct: 256 LWEIFSLGLNPYPGILVNSKFYKL-VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF 314
Query: 320 DEVVSMLEAI 329
++ S L+
Sbjct: 315 QQICSFLQEQ 324
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 7e-63
Identities = 93/313 (29%), Positives = 142/313 (45%), Gaps = 52/313 (16%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTEAEI 94
WE+ +LV+ + G FG V G D VAVK+L + TE +
Sbjct: 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDA-TEKD- 117
Query: 95 AALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLP 153
S E+ + + H N+ +GA T++G + V+VEY
Sbjct: 118 ---LSDLISEMEMMKMIGKHKNIINLLGAC---------TQDGPL-------YVIVEYAS 158
Query: 154 GGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
G L+ YL R +L+ K +V A +ARG+ YL S+K +HRD+
Sbjct: 159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218
Query: 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYS 257
N+L+ ++ +KIADFG+AR G L +MAPE L Y + DV+S
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 278
Query: 258 FGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
FG+ LWEI+ PYP + E+ +++ R + P C + L +M+ CW A P +R
Sbjct: 279 FGVLLWEIFTLGGSPYPGVPVEELFKL-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 337
Query: 317 PEMDEVVSMLEAI 329
P ++V L+ I
Sbjct: 338 PTFKQLVEDLDRI 350
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 6e-62
Identities = 84/318 (26%), Positives = 127/318 (39%), Gaps = 56/318 (17%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAA 96
WE L V+ G FG V G VAVK+L +E +E
Sbjct: 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKA-DSSE--- 91
Query: 97 LRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
R A E+ + +L H N+ +GA T +G + ++ EY G
Sbjct: 92 -REALMSELKMMTQLGSHENIVNLLGAC---------TLSGPI-------YLIFEYCCYG 134
Query: 156 ALKTYLIKNR---------------------RRKLAFKVVVQLALDLARGLSYLHSQKIV 194
L YL R L F+ ++ A +A+G+ +L + V
Sbjct: 135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 194
Query: 195 HRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRK 252
HRD+ N+L+ + VKI DFG+AR S+ N + L +MAPE L Y K
Sbjct: 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 254
Query: 253 CDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA 311
DV+S+GI LWEI+ PYP + +++ + + P + +M+ CW
Sbjct: 255 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 314
Query: 312 NPDKRPEMDEVVSMLEAI 329
+ KRP + S L
Sbjct: 315 DSRKRPSFPNLTSFLGCQ 332
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 7e-61
Identities = 77/301 (25%), Positives = 133/301 (44%), Gaps = 36/301 (11%)
Query: 41 QRQDWEIEPSKLVI-KSVIARGTFGTVHRGLYDGH----DVAVKLLDWGEEGHRTEAEIA 95
+ + ++ L+I + G FG+V +G+Y DVA+K+L G E
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------K 377
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
A +E + H+LD+P + + IG + +V+E GG
Sbjct: 378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-----------------LMLVMEMAGGG 420
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
L +L +R ++ V +L ++ G+ YL + VHR++ N+LL KI+D
Sbjct: 421 PLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISD 479
Query: 216 FGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMP 271
FG+++ ++ + T + L + APE +N ++ + DV+S+G+ +WE P
Sbjct: 480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
Query: 272 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331
Y + EV + + Q R E P CP L +M CW + RP+ V + A
Sbjct: 540 YKKMKGPEVMAF-IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598
Query: 332 S 332
S
Sbjct: 599 S 599
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-58
Identities = 64/272 (23%), Positives = 119/272 (43%), Gaps = 26/272 (9%)
Query: 53 VIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V I G+FG DG +K ++ + E R +EVAV
Sbjct: 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS---RMSSKEREESR----REVAVLAN 79
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ HPN+ ++ + + L+I V++Y GG L + +
Sbjct: 80 MKHPNIVQYRESFEENGSLYI----------------VMDYCEGGDLFKRINAQKGVLFQ 123
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
++ + + L ++H +KI+HRD+K++N+ L K+ TV++ DFG+ARV S
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 290
GT Y++PE+ PYN K D+++ G L+E+ + S + ++ +
Sbjct: 184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243
Query: 291 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
P + L +++ + + NP RP ++ +
Sbjct: 244 P-VSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-56
Identities = 76/289 (26%), Positives = 126/289 (43%), Gaps = 34/289 (11%)
Query: 49 PSKL---VIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
PS+ + I G++G R DG + K LD+G TEAE L
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG---SMTEAEKQMLV----S 54
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
EV + +L HPN+ ++ + I N + +V+EY GG L + + K
Sbjct: 55 EVNLLRELKHPNIVRYY-------DRIIDRTNTTL-------YIVMEYCEGGDLASVITK 100
Query: 164 NRRRKLAF--KVVVQLALDLARGLSYLHSQK-----IVHRDVKTENMLLDKNRTVKIADF 216
+ + + V+++ L L H + ++HRD+K N+ LD + VK+ DF
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160
Query: 217 GVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
G+AR+ + + GT YM+PE +N YN K D++S G L+E+ P+ S
Sbjct: 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220
Query: 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
E+ + R IP L ++ R + RP ++E++
Sbjct: 221 QKELAGKIREGKFRR-IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 9e-56
Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 32/282 (11%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
+ RG FG V + D + A+K + R +EV KL+HP
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--------REKVMREVKALAKLEHP 63
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF--K 172
+ ++ A + + + + ++ LK + R
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSP----KVYLYIQMQLCRKENLKD-WMNGRCTIEERERS 118
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV----------- 221
V + + L +A + +LHS+ ++HRD+K N+ + VK+ DFG+
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 222 -EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280
TG+ GT YM+PE ++GN Y+ K D++S G+ L+E+ P+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235
Query: 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
T VR P + +++ +P +RPE +
Sbjct: 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-55
Identities = 68/291 (23%), Positives = 121/291 (41%), Gaps = 41/291 (14%)
Query: 54 IKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+V+ +G FG V R D A+K + TE +++ + EV + L
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTIL----SEVMLLASL 59
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---RK 168
+H V ++ A + + + + +EY G L + R
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVK---KKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV------- 221
+++ Q+ LSY+HSQ I+HRD+K N+ +D++R VKI DFG+A+
Sbjct: 117 EYWRLFRQILE----ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 222 -------EASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMPYP 273
+ +++T GT Y+A EVL+G YN K D+YS GI +E+
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFST 230
Query: 274 DLSFSEVTSAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
+ + + ++ P+ +++ D +P+KRP +
Sbjct: 231 GMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-55
Identities = 67/272 (24%), Positives = 120/272 (44%), Gaps = 28/272 (10%)
Query: 57 VIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I RG F V+R DG VA+K + A +E+ + +L+HP
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQI--FDLMDAKARADCI----KEIDLLKQLNHP 92
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK-- 172
NV K+ + + +EL+I V+E G L + +++K
Sbjct: 93 NVIKYYASFIEDNELNI----------------VLELADAGDLSRMIKHFKKQKRLIPER 136
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
V + + L L ++HS++++HRD+K N+ + VK+ D G+ R +S
Sbjct: 137 TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 196
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY--PDLSFSEVTSAVVRQNLR 290
GT YM+PE ++ N YN K D++S G L+E+ P+ ++ + + + +
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 256
Query: 291 PEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
P L ++ C + +P+KRP++ V
Sbjct: 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-54
Identities = 73/308 (23%), Positives = 114/308 (37%), Gaps = 40/308 (12%)
Query: 21 AASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAV 78
++ +P S +Q ++ S + G++G V + DG AV
Sbjct: 35 GEASETLQSPGYDPSRPESFFQQSFQRL-------SRLGHGSYGEVFKVRSKEDGRLYAV 87
Query: 79 KLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQ 137
K G + A EV K+ HP + A L++QTE
Sbjct: 88 KRSMSPFRGPKDRARK-------LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE--- 137
Query: 138 VAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197
L G +L + L V D L++LHSQ +VH D
Sbjct: 138 --------------LCGPSL-QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLD 182
Query: 198 VKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYS 257
VK N+ L K+ DFG+ E + G YMAPE+L G Y DV+S
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFS 240
Query: 258 FGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
G+ + E+ C+M P E + + L PE S L +V+ + +P R
Sbjct: 241 LGLTILEV-ACNMELP--HGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRA 297
Query: 318 EMDEVVSM 325
+ ++++
Sbjct: 298 TAEALLAL 305
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-54
Identities = 65/326 (19%), Positives = 128/326 (39%), Gaps = 40/326 (12%)
Query: 21 AASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAV 78
+S + G+ + + Q I+ + + G F V GL+DGH A+
Sbjct: 2 GSSHHHHHHSSGRENLYF--QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYAL 59
Query: 79 KLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQV 138
K + E+ R EA+ +E + +HPN+ + + + E G
Sbjct: 60 KRILCHEQQDREEAQ---------READMHRLFNHPNILRLVA--------YCLRERGA- 101
Query: 139 AMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF--KVVVQLALDLARGLSYLHSQKIVHR 196
+ +++ + G L + + + + ++ L L + RGL +H++ HR
Sbjct: 102 ---KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHR 158
Query: 197 DVKTENMLLDKNRTVKIADFGVARVEASNPN---------DMTGETGTLGYMAPEVLNGN 247
D+K N+LL + D G + D + T+ Y APE+ +
Sbjct: 159 DLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ 218
Query: 248 PY---NRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTSAVVRQNLRPEIPRCCPSSLAN 303
+ + + DV+S G L+ + + PY + + + V+ L S+L
Sbjct: 219 SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQ 278
Query: 304 VMKRCWDANPDKRPEMDEVVSMLEAI 329
++ +P +RP + ++S LEA+
Sbjct: 279 LLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-53
Identities = 67/318 (21%), Positives = 110/318 (34%), Gaps = 67/318 (21%)
Query: 30 PIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEG 87
+G S + ++ I G FG+V + + DG A+K G
Sbjct: 2 AMGMKSRYT----TEFHEL-------EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG 50
Query: 88 HRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICC 146
E +EV L H +V ++ A + IQ E
Sbjct: 51 SVDEQNA-------LREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE------------ 91
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFK--VVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
Y GG+L + +N R FK + L L + RGL Y+HS +VH D+K N+
Sbjct: 92 ----YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF 147
Query: 205 LDKN-------------------RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN 245
+ + KI D G + E G ++A EVL
Sbjct: 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQV-EEGDSRFLANEVLQ 203
Query: 246 GN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANV 304
N + K D+++ + + P P + + +RQ P IP+ +
Sbjct: 204 ENYTHLPKADIFALALTVVCA-AGAEPLPR-NGDQW--HEIRQGRLPRIPQVLSQEFTEL 259
Query: 305 MKRCWDANPDKRPEMDEV 322
+K +P++RP +
Sbjct: 260 LKVMIHPDPERRPSAMAL 277
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-52
Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 30/267 (11%)
Query: 57 VIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I RG+F TV++GL +VA L + T++E + +E + L HP
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQ---DRKLTKSERQRFK----EEAEMLKGLQHP 85
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N+ +F S + +V E + G LKTYL + + + KV+
Sbjct: 86 NIVRFYD-----SWESTVKGKKCI-------VLVTELMTSGTLKTYLKRFK--VMKIKVL 131
Query: 175 VQLALDLARGLSYLHSQK--IVHRDVKTENMLLD-KNRTVKIADFGVARVEASNPNDMTG 231
+ +GL +LH++ I+HRD+K +N+ + +VKI D G+A + +
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKA 189
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS-FSEVTSAVVRQNLR 290
GT +MAPE+ Y+ DVY+FG+C+ E+ + PY + +++ V
Sbjct: 190 VIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 248
Query: 291 PEIPRCCPSSLANVMKRCWDANPDKRP 317
+ + +++ C N D+R
Sbjct: 249 ASFDKVAIPEVKEIIEGCIRQNKDERY 275
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-51
Identities = 73/289 (25%), Positives = 135/289 (46%), Gaps = 38/289 (13%)
Query: 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAA 96
+ +++ E + + V+ +GT+G V+ G + +A+K + R
Sbjct: 11 ESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP-----ERDSRYSQP 65
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
L +E+A+ L H N+ +++G+ + + I +E +PGG+
Sbjct: 66 LH----EEIALHKHLKHKNIVQYLGSFSENGFIKI----------------FMEQVPGGS 105
Query: 157 LKTYLIKNRRRKLAFK--VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD-KNRTVKI 213
L L++++ L + + GL YLH +IVHRD+K +N+L++ + +KI
Sbjct: 106 LSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKI 164
Query: 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMP 271
+DFG ++ A TGTL YMAPE+++ P Y + D++S G + E+ P
Sbjct: 165 SDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
Query: 272 YPDLSFSEVTSA---VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
+ +L E +A V + PEIP + + +C++ +PDKR
Sbjct: 225 FYEL--GEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRA 271
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-49
Identities = 62/269 (23%), Positives = 98/269 (36%), Gaps = 41/269 (15%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ RG+FG VHR G AVK + L +E+ L P
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVR--------------LEVFRVEELVACAGLSSPR 111
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ GA ++I +E L GG+L + + L +
Sbjct: 112 IVPLYGAVREGPWVNI----------------FMELLEGGSLGQLI--KQMGCLPEDRAL 153
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKN-RTVKIADFGVARVEASNPNDMTGET- 233
GL YLH+++I+H DVK +N+LL + + DFG A + + T
Sbjct: 154 YYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 234 ----GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN- 288
GT +MAPEV+ G P + K D++S + + P+ + + +
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP 273
Query: 289 LRPEIPRCCPSSLANVMKRCWDANPDKRP 317
EIP C A ++ P R
Sbjct: 274 PIREIPPSCAPLTAQAIQEGLRKEPVHRA 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-48
Identities = 80/321 (24%), Positives = 126/321 (39%), Gaps = 78/321 (24%)
Query: 48 EPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDW-----GEEGHRTEAEIAALRSAFT 102
E V + + G FG V++G + VAVK L EE + + F
Sbjct: 29 ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ---Q-------FD 78
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV-------VVEYLPGG 155
QE+ V K H N+ + +G V Y+P G
Sbjct: 79 QEIKVMAKCQHENLVELLG-----------------------FSSDGDDLCLVYVYMPNG 115
Query: 156 ALKTYL-IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
+L L + L++ + ++A A G+++LH +HRD+K+ N+LLD+ T KI+
Sbjct: 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKIS 175
Query: 215 DFGVARVEASNPNDMTGET----GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC--- 267
DFG+AR T T GT YMAPE L G K D+YSFG+ L EI
Sbjct: 176 DFGLARASEK--FAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLP 232
Query: 268 -CDMPYPDLS--------FSEVTSAVVRQNLR----PEIPRCCPSSLANVMK---RCWDA 311
D E + + ++ +S+ + +C
Sbjct: 233 AVDEHREPQLLLDIKEEIEDE------EKTIEDYIDKKMNDADSTSVEAMYSVASQCLHE 286
Query: 312 NPDKRPEMDEVVSMLEAIDTS 332
+KRP++ +V +L+ + S
Sbjct: 287 KKNKRPDIKKVQQLLQEMTAS 307
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-47
Identities = 59/286 (20%), Positives = 109/286 (38%), Gaps = 44/286 (15%)
Query: 54 IKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
I I G V + L + A+K ++ EA+ L S + E+A +KL
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVN------LEEADNQTLDS-YRNEIAYLNKLQ 84
Query: 113 HPN--VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ + + + T+ I +V+E L ++L K ++ +
Sbjct: 85 QHSDKIIRLYD--------YEITDQ-------YIY-MVMEC-GNIDLNSWLKK--KKSID 125
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
++ + +H IVH D+K N L+ +K+ DFG+A + +
Sbjct: 126 PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVV 184
Query: 231 GET--GTLGYMAPEVLNGNP-----------YNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
++ GT+ YM PE + + K DV+S G L+ + P+ +
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244
Query: 278 S-EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
A++ N E P L +V+K C +P +R + E+
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-47
Identities = 80/305 (26%), Positives = 123/305 (40%), Gaps = 69/305 (22%)
Query: 55 KSVIARGTFGTVHRG-LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
K +I G FG V++G L DG VA+K E + E F E+ H
Sbjct: 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRT--PESSQGIEE-------FETEIETLSFCRH 94
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCV-------VVEYLPGGALKTYL--IKN 164
P++ IG C + +Y+ G LK +L
Sbjct: 95 PHLVSLIG-----------------------FCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
++++ +++ + ARGL YLH++ I+HRDVK+ N+LLD+N KI DFG+++
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK---K 188
Query: 225 NPNDMTGET-------GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC----DMPYP 273
+T GTLGY+ PE K DVYSFG+ L+E+ C P
Sbjct: 189 GTEL--DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 274 DLSFSEVT-----------SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
+ +V NL +I + +C + + RP M +V
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
Query: 323 VSMLE 327
+ LE
Sbjct: 307 LWKLE 311
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-47
Identities = 59/305 (19%), Positives = 114/305 (37%), Gaps = 51/305 (16%)
Query: 35 SNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAE 93
+ + + + + I I G V + L + A+K ++ EA+
Sbjct: 1 NECISVKGRIYSI-------LKQIGSGGSSKVFQVLNEKKQIYAIKYVN------LEEAD 47
Query: 94 IAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY 151
L S + E+A +KL + + + + T+ I +V+E
Sbjct: 48 NQTLDS-YRNEIAYLNKLQQHSDKIIRLYD--------YEITDQ-------YIY-MVMEC 90
Query: 152 LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211
L ++L K ++ + ++ + +H IVH D+K N L+ +
Sbjct: 91 -GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-L 146
Query: 212 KIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNP-----------YNRKCDVYSF 258
K+ DFG+A + + ++ GT+ YM PE + + K DV+S
Sbjct: 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206
Query: 259 GICLWEIYCCDMPYPDLSFS-EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
G L+ + P+ + A++ N E P L +V+K C +P +R
Sbjct: 207 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 266
Query: 318 EMDEV 322
+ E+
Sbjct: 267 SIPEL 271
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-46
Identities = 62/325 (19%), Positives = 115/325 (35%), Gaps = 73/325 (22%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
+ RG FG V + D + A+K + E +EV KL+HP
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK--------VMREVKALAKLEHP 64
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNIC----------------------------- 145
+ ++ A + + Q E ++ +
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 146 ------------CVVVEYLPGGALKTYLIKNRRRKLAF--KVVVQLALDLARGLSYLHSQ 191
+ ++ LK + R V + + + +A + +LHS+
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 192 KIVHRDVKTENMLLDKNRTVKIADFGVARV------------EASNPNDMTGETGTLGYM 239
++HRD+K N+ + VK+ DFG+ TG+ GT YM
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 240 APEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV--VRQNLRPEIPRCC 297
+PE ++GN Y+ K D++S G+ L+E + Y + E + VR P +
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFE-----LLYSFSTQMERVRIITDVRNLKFPLLFTQK 298
Query: 298 PSSLANVMKRCWDANPDKRPEMDEV 322
+++ +P +RPE ++
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDI 323
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-46
Identities = 85/308 (27%), Positives = 129/308 (41%), Gaps = 70/308 (22%)
Query: 55 KSVIARGTFGTVHRG-LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
K+++ RG FG V++G L DG VAVK L E E + F EV + H
Sbjct: 35 KNILGRGGFGKVYKGRLADGTLVAVKRLK-EERTQGGELQ-------FQTEVEMISMAVH 86
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCV-------VVEYLPGGALKTYL--IKN 164
N+ + G C+ V Y+ G++ + L
Sbjct: 87 RNLLRLRG-----------------------FCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQ---KIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ L + ++AL ARGL+YLH KI+HRDVK N+LLD+ + DFG+A++
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 222 EASNPNDMTGET----GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
T T GT+G++APE L+ + K DV+ +G+ L E+ + DL+
Sbjct: 184 ---MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF-DLAR 239
Query: 278 SEVTSA------------------VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319
+V +L+ L V C ++P +RP+M
Sbjct: 240 LANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM 299
Query: 320 DEVVSMLE 327
EVV MLE
Sbjct: 300 SEVVRMLE 307
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-46
Identities = 58/335 (17%), Positives = 118/335 (35%), Gaps = 51/335 (15%)
Query: 5 KKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFG 64
K+ + + + A+ + + + + I I G
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI-------LKQIGSGGSS 70
Query: 65 TVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIG 121
V + L + A+K ++ EA+ L S + E+A +KL + + +
Sbjct: 71 KVFQVLNEKKQIYAIKYVN------LEEADNQTLDS-YRNEIAYLNKLQQHSDKIIRLYD 123
Query: 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDL 181
+ +++ V+E L ++L K ++ + ++
Sbjct: 124 YEITDQYIYM----------------VMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNM 164
Query: 182 ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYM 239
+ +H IVH D+K N L+ +K+ DFG+A + + ++ G + YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 240 APEVLNGNP-----------YNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTSAVVRQ 287
PE + + K DV+S G L+ + P+ + A++
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283
Query: 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
N E P L +V+K C +P +R + E+
Sbjct: 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-45
Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 39/289 (13%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
Q W+ L I RG +G+V++ ++ G +AVK + + E E L
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EKEQKQLL-- 68
Query: 101 FTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
++ V + D P + +F GA + I +E + K
Sbjct: 69 --MDLDVVMRSSDCPYIVQFYGALFREGDCWI----------------CMELMSTSFDKF 110
Query: 160 YLIKNRRRKLAF--KVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADF 216
Y +++ ++ L + L++L KI+HRD+K N+LLD++ +K+ DF
Sbjct: 111 YKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170
Query: 217 GVARVEASNPNDMTGETGTLGYMAPEVLNGN----PYNRKCDVYSFGICLWEIYCCDMPY 272
G++ + + T + G YMAPE ++ + Y+ + DV+S GI L+E+ PY
Sbjct: 171 GISG-QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229
Query: 273 PDL-SFSEVTSAVVRQN---LRPEIPRCCPSSLANVMKRCWDANPDKRP 317
P S + + VV+ + L R S N + C + KRP
Sbjct: 230 PKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-45
Identities = 82/360 (22%), Positives = 127/360 (35%), Gaps = 68/360 (18%)
Query: 30 PIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLD 82
P+ + L WE +L + + RG FG V G D VAVK+L
Sbjct: 2 PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML- 60
Query: 83 WGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPN-------VTKFIGATM---------- 124
+EG T +E A E+ + + H N TK G M
Sbjct: 61 --KEGA-THSE----HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 113
Query: 125 -------------GSSELHIQTENGQ---------------VAMPSNICCVVVEYLPGGA 156
+ G+ S
Sbjct: 114 LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
Query: 157 LKT----YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212
+ L + ++ + +A+G+ +L S+K +HRD+ N+LL + VK
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233
Query: 213 IADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-D 269
I DFG+AR +P+ + L +MAPE + Y + DV+SFG+ LWEI+
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293
Query: 270 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
PYP + E +++ R P + M CW P +RP E+V L +
Sbjct: 294 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-44
Identities = 75/327 (22%), Positives = 128/327 (39%), Gaps = 43/327 (13%)
Query: 24 ANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLL 81
A + + Q E+ +L ++ V+A G F V+ + + G + A+K L
Sbjct: 2 AGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL 61
Query: 82 DWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAM 140
EE QEV KL HPN+ +F A E T +
Sbjct: 62 LSNEEEKNRAII---------QEVCFMKKLSGHPNIVQFCSAASIGKE-ESDTGQAEF-- 109
Query: 141 PSNICCVVVEYLPGGALKTYLIKNRRR-KLAFKVVVQLALDLARGLSYLHSQK--IVHRD 197
+++ L G L +L K R L+ V+++ R + ++H QK I+HRD
Sbjct: 110 ------LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRD 163
Query: 198 VKTENMLLDKNRTVKIADFGVARVEASNPN------------DMTGETGTLGYMAPEVLN 245
+K EN+LL T+K+ DFG A + P+ + T Y PE+++
Sbjct: 164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223
Query: 246 ---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLA 302
P K D+++ G L+ + P+ D +V +
Sbjct: 224 LYSNFPIGEKQDIWALGCILYLLCFRQHPFED----GAKLRIVNGKYSIPPHDTQYTVFH 279
Query: 303 NVMKRCWDANPDKRPEMDEVVSMLEAI 329
++++ NP++R + EVV L+ I
Sbjct: 280 SLIRAMLQVNPEERLSIAEVVHQLQEI 306
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 2e-43
Identities = 69/304 (22%), Positives = 126/304 (41%), Gaps = 36/304 (11%)
Query: 30 PIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEG 87
+ FL ++++ E++ S + G G V + + G +A KL+
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH----L 68
Query: 88 HRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
A + +E+ V H+ + P + F GA E+ I
Sbjct: 69 EIKPAIRNQII----RELQVLHECNSPYIVGFYGAFYSDGEISI---------------- 108
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLD 206
+E++ GG+L L K R + +++ ++++ + +GL+YL + KI+HRDVK N+L++
Sbjct: 109 CMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN 166
Query: 207 KNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+K+ DFGV+ ++ S N G T YM+PE L G Y+ + D++S G+ L E+
Sbjct: 167 SRGEIKLCDFGVSGQLIDSMANSFVG---TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
Query: 266 YCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
P P E+ + E R + + +
Sbjct: 224 AVGRYPIPPPDAKELELM---FGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL 280
Query: 326 LEAI 329
L+ I
Sbjct: 281 LDYI 284
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-43
Identities = 64/291 (21%), Positives = 112/291 (38%), Gaps = 45/291 (15%)
Query: 47 IEPSKLVIKSVIARGTFGT-VHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
+ K V+ G GT V+RG++D DVAVK + S +EV
Sbjct: 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL------------PECFSFADREV 68
Query: 106 AVWHKLD-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+ + D HPNV ++ +I +E L+ Y ++
Sbjct: 69 QLLRESDEHPNVIRYFCTEKDRQFQYI----------------AIELC-AATLQEY-VEQ 110
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL-----DKNRTVKIADFGVA 219
+ + L GL++LHS IVHRD+K N+L+ I+DFG+
Sbjct: 111 KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
Query: 220 RV---EASNPNDMTGETGTLGYMAPEVLNGNP---YNRKCDVYSFGICLWEIYCC-DMPY 272
+ + + +G GT G++APE+L+ + D++S G + + P+
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230
Query: 273 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 322
+ + +L P +A ++++ +P KRP V
Sbjct: 231 GKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-43
Identities = 65/297 (21%), Positives = 121/297 (40%), Gaps = 38/297 (12%)
Query: 32 GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHR 89
GK + +L Q ++ E + L + GT G V + + GH +AVK +
Sbjct: 7 GKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--- 63
Query: 90 TEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVV 148
+ E + ++ V K D P + + G + ++++ I
Sbjct: 64 -KEENKRIL----MDLDVVLKSHDCPYIVQCFGTFITNTDVFI----------------A 102
Query: 149 VEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDK 207
+E + A K + +++ ++ + + + L YL + ++HRDVK N+LLD+
Sbjct: 103 MELMGTCAEKLKKRMQGP--IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE 160
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVL-----NGNPYNRKCDVYSFGICL 262
+K+ DFG++ + G YMAPE + Y+ + DV+S GI L
Sbjct: 161 RGQIKLCDFGISG-RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219
Query: 263 WEIYCCDMPYPDL-SFSEVTSAVVRQNL-RPEIPRCCPSSLANVMKRCWDANPDKRP 317
E+ PY + + EV + V+++ + +K C + KRP
Sbjct: 220 VELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP 276
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 5e-42
Identities = 71/287 (24%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALR 98
+++ W +E I + +G FG V+ R +A+K+L + + E A +
Sbjct: 2 KKRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF------KAQLEKAGVE 53
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
+EV + L HPN+ + G + + +++EY P G +
Sbjct: 54 HQLRREVEIQSHLRHPNILRLYG--------YFHDAT-------RVY-LILEYAPLGTVY 97
Query: 159 TYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADF 216
L K + + + +LA LSY HS++++HRD+K EN+LL +KIADF
Sbjct: 98 RELQKLSKFDEQRTATYITELAN----ALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153
Query: 217 GVARVEASNPNDMTGET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
G + P+ + GTL Y+ PE++ G ++ K D++S G+ +E P+
Sbjct: 154 GWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210
Query: 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
++ E + R P +++ R NP +RP + EV
Sbjct: 211 TYQETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREV 255
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 68/273 (24%), Positives = 103/273 (37%), Gaps = 36/273 (13%)
Query: 32 GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHR 89
G++ + + WE+ K + G FG V R G VA+K
Sbjct: 3 GRSPSLPTQTCGPWEM-------KERLGTGGFGYVLRWIHQDTGEQVAIKQCR------- 48
Query: 90 TEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV 149
+ R + E+ + KL+HPNV + Q P+++ + +
Sbjct: 49 -QELSPKNRERWCLEIQIMKKLNHPNVVS----------AREVPDGLQKLAPNDLPLLAM 97
Query: 150 EYLPGGALKTYLIKNRRR-KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
EY GG L+ YL + L + L D++ L YLH +I+HRD+K EN++L
Sbjct: 98 EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG 157
Query: 209 R---TVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
KI D G A+ GTL Y+APE+L Y D +SFG +
Sbjct: 158 PQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAF 214
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRC 296
E P+ VR+ I
Sbjct: 215 ECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 63/283 (22%), Positives = 117/283 (41%), Gaps = 37/283 (13%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
E++ L + RG +G V + + G +AVK + E L
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN----SQEQKRLL----M 54
Query: 104 EVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY-L 161
++ + + D P F GA ++ I +E + K Y
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDVWI----------------CMELMDTSLDKFYKQ 98
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVAR 220
+ ++ + + ++ ++A+ + + L +LHS+ ++HRDVK N+L++ VK+ DFG++
Sbjct: 99 VIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG 158
Query: 221 VEASNPNDMTGETGTLGYMAPEV----LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL- 275
+ + G YMAPE LN Y+ K D++S GI + E+ PY
Sbjct: 159 -YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217
Query: 276 SFSEVTSAVVRQNLRPEIPR-CCPSSLANVMKRCWDANPDKRP 317
+ + VV + P++P + + +C N +RP
Sbjct: 218 TPFQQLKQVVEEPS-PQLPADKFSAEFVDFTSQCLKKNSKERP 259
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 147 bits (371), Expect = 3e-41
Identities = 44/333 (13%), Positives = 95/333 (28%), Gaps = 38/333 (11%)
Query: 17 TTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGH 74
A + AT P + Q KL + + G V +
Sbjct: 33 PAAMVEAVTATVWPQNAETTVDSLLSQ----GERKLKLVEPLRVGDRSVVFLVRDVERLE 88
Query: 75 DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTE 134
D A+K+ G E R+E E + +L + +
Sbjct: 89 DFALKVFTMGAENSRSELE------RLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142
Query: 135 NGQVAM---------PSNICCVVVEYLPGGALKTYL-----IKNRRRKLAFKVVVQLALD 180
Q + +++ L+ + R + L
Sbjct: 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQ 202
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
L R + L S+ +VH +N+ + + + + D + + + Y
Sbjct: 203 LIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS---SVPVTYAP 259
Query: 241 PEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP---- 294
E LN + + + + G+ ++ ++C +P+ ++ S P
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAF 319
Query: 295 RCC---PSSLANVMKRCWDANPDKRPEMDEVVS 324
C P + ++ R + + +R E +
Sbjct: 320 GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 54/322 (16%), Positives = 105/322 (32%), Gaps = 71/322 (22%)
Query: 53 VIKSVIARGTFGTVHRG--LYDGHDVAVKLLD---WGEEGHRTEAEIAALRSAFTQEVAV 107
++ ++ +G V RG G A+K+ + + E L+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK--------- 62
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-RR 166
KL+H N+ K + + +++E+ P G+L T L +
Sbjct: 63 --KLNHKNIVKLFAI--------EEETT------TRHKVLIMEFCPCGSLYTVLEEPSNA 106
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVE 222
L + + D+ G+++L IVHR++K N++ D K+ DFG AR
Sbjct: 107 YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGN--------PYNRKCDVYSFGICLWEIYCCDMPYPD 274
+ GT Y+ P++ Y D++S G+ + +P+
Sbjct: 167 EDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
Query: 275 LSFSEVTSAVVRQNLR---------------------------PEIPRCCPSSLANVMKR 307
V+ + + + R L V+
Sbjct: 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN 285
Query: 308 CWDANPDKRPEMDEVVSMLEAI 329
+A+ +K D+ + I
Sbjct: 286 ILEADQEKCWGFDQFFAETSDI 307
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-41
Identities = 54/325 (16%), Positives = 104/325 (32%), Gaps = 71/325 (21%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLD---WGEEGHRTEAEIAALRSAFTQEVAVW 108
+ ++ +G V RG G A+K+ + + E L+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK---------- 62
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-RRR 167
KL+H N+ K + + +++E+ P G+L T L +
Sbjct: 63 -KLNHKNIVKLFAI--------EEETT------TRHKVLIMEFCPCGSLYTVLEEPSNAY 107
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEA 223
L + + D+ G+++L IVHR++K N++ D K+ DFG AR
Sbjct: 108 GLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167
Query: 224 SNPNDMTGETGTLGYMAPEVLNGN--------PYNRKCDVYSFGICLWEIYCCDMPYPDL 275
+ GT Y+ P++ Y D++S G+ + +P+
Sbjct: 168 DD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 276 SFSEVTSAVVRQNLR---------------------------PEIPRCCPSSLANVMKRC 308
V+ + + + R L V+
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
Query: 309 WDANPDKRPEMDEVVSMLEAIDTSK 333
+A+ +K D+ + I
Sbjct: 287 LEADQEKCWGFDQFFAETSDILHRM 311
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 45/300 (15%), Positives = 96/300 (32%), Gaps = 37/300 (12%)
Query: 48 EPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAE--------IAAL 97
P LV +V+ + G V + + E + + L
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 98 RSAFTQEVAVWHK--------LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV 149
R Q+ A H + P K I + ++ + + P +
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR--FFLYPRMQSNL-- 191
Query: 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209
G L ++ ++ L +QL L + R L+ LH +VH ++ +++LD+
Sbjct: 192 -QTFGEVLLSHSSTHKS--LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 248
Query: 210 TVKIADFGVARVEASNPNDMTGET-GTLGYMAPEVLNGNP-----YNRKCDVYSFGICLW 263
V + F + ++ G A +L D ++ G+ ++
Sbjct: 249 GVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
I+C D+P D + + + R P + +++ + R + +
Sbjct: 309 WIWCADLPNTDDAALGGSEWIFRSCKNI------PQPVRALLEGFLRYPKEDRLLPLQAM 362
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 64/289 (22%), Positives = 125/289 (43%), Gaps = 38/289 (13%)
Query: 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAA 96
+ ++ + I+ I + +G FG V+ R + +A+K+L +++ E
Sbjct: 5 EMPKRKFTID--DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF------KSQLEKEG 56
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
+ +E+ + L HPN+ + + I +++E+ P G
Sbjct: 57 VEHQLRREIEIQSHLRHPNILRMYN--------YFHDR-------KRIY-LMLEFAPRGE 100
Query: 157 LKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
L L K+ R + + + +LA L Y H +K++HRD+K EN+L+ +KIA
Sbjct: 101 LYKELQKHGRFDEQRSATFMEELAD----ALHYCHERKVIHRDIKPENLLMGYKGELKIA 156
Query: 215 DFGVARVEASNPNDMTGET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
DFG + P+ GTL Y+ PE++ G ++ K D++ G+ +E P+
Sbjct: 157 DFGWS---VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213
Query: 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
S +E +V +L+ P +++ + +P +R + V
Sbjct: 214 SPSHTETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 66/306 (21%), Positives = 115/306 (37%), Gaps = 42/306 (13%)
Query: 32 GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLD----WGE 85
+++K+ + G +G V + A+K++
Sbjct: 21 INPGMYVRKKEGKIG---ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKG 77
Query: 86 EGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC 145
I E+++ LDHPN+ K ++
Sbjct: 78 RYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL-------------- 123
Query: 146 CVVVEYLPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
V E+ GG L +I + A ++ Q+ G+ YLH IVHRD+K EN+
Sbjct: 124 --VTEFYEGGELFEQIINRHKFDECDAANIMKQIL----SGICYLHKHNIVHRDIKPENI 177
Query: 204 LL---DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
LL + +KI DFG++ + + + GT Y+APEVL YN KCDV+S G+
Sbjct: 178 LLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGV 235
Query: 261 CLWEIYCCDMPYPDLSFSEVTSAVVRQNL---RPEIPRCCPSSLA-NVMKRCWDANPDKR 316
++ + C P+ + ++ V + + S A ++K + +KR
Sbjct: 236 IMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI--SDEAKELIKLMLTYDYNKR 293
Query: 317 PEMDEV 322
+E
Sbjct: 294 CTAEEA 299
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-40
Identities = 74/296 (25%), Positives = 117/296 (39%), Gaps = 47/296 (15%)
Query: 53 VIKSVIARGTFGTVH--RGLYDGHDVAVKLLD--------------WGEEGHRTEAEIAA 96
+K I +G++G V D A+K+L
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 97 LRSAFTQ---EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLP 153
R Q E+A+ KLDHPNV K + +E H+ +V E +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL--------------YMVFELVN 121
Query: 154 GGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212
G + A L G+ YLH QKI+HRD+K N+L+ ++ +K
Sbjct: 122 QGPVMEVPTLKPLSEDQARFYFQDLIK----GIEYLHYQKIIHRDIKPSNLLVGEDGHIK 177
Query: 213 IADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGN--PYN-RKCDVYSFGICLWEIYC 267
IADFGV+ +D GT +MAPE L+ ++ + DV++ G+ L+
Sbjct: 178 IADFGVSNE--FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
Query: 268 CDMPYPDLSFSEVTSAVVRQNLR-PEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
P+ D + S + Q L P+ P L +++ R D NP+ R + E+
Sbjct: 236 GQCPFMDERIMCLHSKIKSQALEFPDQPDIAE-DLKDLITRMLDKNPESRIVVPEI 290
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-40
Identities = 61/270 (22%), Positives = 115/270 (42%), Gaps = 37/270 (13%)
Query: 60 RGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
+G+F V+ ++ G +VA+K++D + A + EV + +L HP++
Sbjct: 21 KGSFAGVYRAESIHTGLEVAIKMID------KKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR---KLAFKVV 174
+ + + N + +V+E G + YL + A +
Sbjct: 75 ELYN--------YFEDSN-------YVY-LVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET- 233
Q+ G+ YLHS I+HRD+ N+LL +N +KIADFG+A + P++ T
Sbjct: 119 HQII----TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKH-YTL 172
Query: 234 -GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE 292
GT Y++PE+ + + + DV+S G + + P+ + + VV +
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE-- 230
Query: 293 IPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
+P +++ + NP R + V
Sbjct: 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 72/301 (23%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 33 KASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRT 90
F+ ++ + G +G V + A+K++ + +
Sbjct: 23 TPGMFITSKKGHLS---EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR---KTSVS 76
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
+ + L +EVAV LDHPN+ K ++ V+E
Sbjct: 77 TSSNSKLL----EEVAVLKLLDHPNIMKLYDFFEDKRNYYL----------------VME 116
Query: 151 YLPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--- 205
GG L +I + A ++ Q+ G++YLH IVHRD+K EN+LL
Sbjct: 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVL----SGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+K+ +KI DFG++ V + M GT Y+APEVL Y+ KCDV+S G+ L+ +
Sbjct: 173 EKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFIL 230
Query: 266 YCCDMPYPDLSFSEVTSAVVRQNL---RPEIPRCCPSSLA-NVMKRCWDANPDKRPEMDE 321
P+ + E+ V + PE S A +++K+ + +R +
Sbjct: 231 LAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV--SEGAKDLIKQMLQFDSQRRISAQQ 288
Query: 322 V 322
Sbjct: 289 A 289
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 54/323 (16%), Positives = 108/323 (33%), Gaps = 63/323 (19%)
Query: 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLD--------WGEEGHRT 90
+ +D I +++ + +G F + D A+K + + +
Sbjct: 22 YVKEKDKYINDYRII--RTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
+ I + F E+ + + + G I + ++ E
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEG--------IITN-------YDEVY-IIYE 123
Query: 151 YLPGGALKTYLIKNRR------RKLAFKVVVQLALDLARGLSYLHSQK-IVHRDVKTENM 203
Y+ ++ + + +V+ + + SY+H++K I HRDVK N+
Sbjct: 124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNP--YNRKCDVYSFG 259
L+DKN VK++DFG + + + GT +M PE + K D++S G
Sbjct: 184 LMDKNGRVKLSDFGES---EYMVDKKI-KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLG 239
Query: 260 ICLWE--------------------IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPS 299
ICL+ I ++ YP + +
Sbjct: 240 ICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP--LDRNHFLYPLTNKKSTCSNNFLSN 297
Query: 300 SLANVMKRCWDANPDKRPEMDEV 322
+ +K NP +R ++
Sbjct: 298 EDIDFLKLFLRKNPAERITSEDA 320
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-40
Identities = 72/299 (24%), Positives = 133/299 (44%), Gaps = 44/299 (14%)
Query: 35 SNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEA 92
F++ + + + V+ +G+FG V G + AVK++ + + +
Sbjct: 14 GMFVQHSTAIFS---DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKT 68
Query: 93 EIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYL 152
+ +L +EV + +LDHPN+ K ++ V E
Sbjct: 69 DKESLL----REVQLLKQLDHPNIMKLYEFFEDKGYFYL----------------VGEVY 108
Query: 153 PGGALKTYLIKNRRR--KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DK 207
GG L +I +R A +++ Q+ G++Y+H KIVHRD+K EN+LL K
Sbjct: 109 TGGELFDEIISRKRFSEVDAARIIRQVL----SGITYMHKNKIVHRDLKPENLLLESKSK 164
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+ ++I DFG++ ++ M + GT Y+APEVL+G Y+ KCDV+S G+ L+ +
Sbjct: 165 DANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLS 222
Query: 268 CDMPYPDLSFSEVTSAVVRQNL---RPEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 322
P+ + ++ V + P+ + S A +++++ P R +
Sbjct: 223 GCPPFNGANEYDILKKVEKGKYTFELPQWKKV--SESAKDLIRKMLTYVPSMRISARDA 279
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-40
Identities = 59/238 (24%), Positives = 91/238 (38%), Gaps = 28/238 (11%)
Query: 32 GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHR 89
G L D E + VI +G F V R G AVK++D +
Sbjct: 7 GGGGGILDMADDDVLFE-DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS 65
Query: 90 TEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV 149
L+ +E ++ H L HP++ + + L++ V
Sbjct: 66 PGLSTEDLK----REASICHMLKHPHIVELLETYSSDGMLYM----------------VF 105
Query: 150 EYLPGGALKTYLIKNRRRKLAF--KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL-- 205
E++ G L ++K + V + L Y H I+HRDVK +LL
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLAS 165
Query: 206 -DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
+ + VK+ FGVA + G GT +MAPEV+ PY + DV+ G+ L
Sbjct: 166 KENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-40
Identities = 74/297 (24%), Positives = 122/297 (41%), Gaps = 50/297 (16%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFT 102
W I ++ VI G V VA+K ++ + + + L
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDELL---- 61
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+E+ + HPN+ + + + EL + V++ L GG++ +I
Sbjct: 62 KEIQAMSQCHHPNIVSYYTSFVVKDELWL----------------VMKLLSGGSV-LDII 104
Query: 163 KNRRRKLAFKVVV----QLAL---DLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
K+ K K V +A ++ GL YLH +HRDVK N+LL ++ +V+IAD
Sbjct: 105 KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIAD 164
Query: 216 FGVARVEASNPNDMTGET-----GTLGYMAPEVL-NGNPYNRKCDVYSFGICLWEIYCCD 269
FGV+ A+ + + GT +MAPEV+ Y+ K D++SFGI E+
Sbjct: 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
Query: 270 MPYPDLSFSEVTSAVVRQNLRPEIPRCCPS---------SLANVMKRCWDANPDKRP 317
PY +V + QN P + S ++ C +P+KRP
Sbjct: 225 APYHKYPPMKVL-MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 39/300 (13%), Positives = 89/300 (29%), Gaps = 34/300 (11%)
Query: 48 EPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEG-----HRTEAEIAALRSA 100
P LV +V+ + G V + + E + + E+ LR
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL- 129
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
H + + + + L+T+
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 161 L-----IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
+ + L +QL L + R L+ LH +VH ++ +++LD+ V +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 216 FGVARVEASNPNDMTGETGTLGYMAPEVL-----------NGNPYNRKCDVYSFGICLWE 264
F + + + G+ PE+ D ++ G+ ++
Sbjct: 250 FEHLVRD----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 265 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
I+C D+P + + + R + P + +++ + R + +
Sbjct: 306 IWCADLPITKDAALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 81/294 (27%), Positives = 133/294 (45%), Gaps = 63/294 (21%)
Query: 43 QDWEIEPSKL-VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRS 99
Q+ + +P +L I +G+FG V +G+ VA+K++D EE +I
Sbjct: 14 QNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-EEAEDEIEDI----- 67
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
QE+ V + D P VTK+ G+ + ++L I ++EYL GG+
Sbjct: 68 --QQEITVLSQCDSPYVTKYYGSYLKDTKLWI----------------IMEYLGGGSALD 109
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
L++ L + + ++ +GL YLHS+K +HRD+K N+LL ++ VK+ADFGVA
Sbjct: 110 -LLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 166
Query: 220 RVEASNPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
+ GT +MAPEV+ + Y+ K D++S GI E+ + P+ +L
Sbjct: 167 ---GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223
Query: 277 FSEVTSAVVRQNLRP-----EIPRCCPSSLA--------NVMKRCWDANPDKRP 317
P IP+ P +L ++ C + P RP
Sbjct: 224 --------------PMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 263
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-39
Identities = 56/276 (20%), Positives = 110/276 (39%), Gaps = 42/276 (15%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ +G F A K++ ++ R + E+++ L H +
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVP------KSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK--LAFKV 173
V F G + + VV+E +L + + A
Sbjct: 77 VVGFHG--------FFED-------NDFVF-VVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE- 232
+ Q+ G YLH +++HRD+K N+ L+++ VKI DFG+ + + GE
Sbjct: 121 LRQIV----LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL-----ATKVEYDGER 171
Query: 233 --T--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288
GT Y+APEVL+ ++ + DV+S G ++ + P+ E + +
Sbjct: 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 231
Query: 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
IP+ A+++++ +P RP ++E+++
Sbjct: 232 YS--IPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-39
Identities = 48/254 (18%), Positives = 96/254 (37%), Gaps = 36/254 (14%)
Query: 35 SNFLKKQRQDWEIEPSKLVIKSVIARG--TFGTVHRGLY--DGHDVAVKLLDWGEEGHRT 90
N + + E + +VI +G TV+ Y G V V+ ++ +
Sbjct: 10 ENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC---S 66
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
+ L+ E+ V +HPN+ + + +EL + V
Sbjct: 67 NEMVTFLQ----GELHVSKLFNHPNIVPYRATFIADNELWV----------------VTS 106
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
++ G+ K + + + + + + + L Y+H VHR VK ++L+ +
Sbjct: 107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK 166
Query: 211 VKIADFGVA-------RVEASNPNDMTGETGTLGYMAPEVL--NGNPYNRKCDVYSFGIC 261
V ++ + + + L +++PEVL N Y+ K D+YS GI
Sbjct: 167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 226
Query: 262 LWEIYCCDMPYPDL 275
E+ +P+ D+
Sbjct: 227 ACELANGHVPFKDM 240
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 64/315 (20%), Positives = 122/315 (38%), Gaps = 41/315 (13%)
Query: 20 AAASANATATPIGKASNFLKKQRQDWEIEPSKL---VIKSVIARGTFGTVHRG--LYDGH 74
A A P A+ K+ + ++P V + +G F
Sbjct: 8 GKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKE 67
Query: 75 DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTE 134
A K++ ++ R + E+++ L H +V F G +
Sbjct: 68 VFAGKIVP------KSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG--------FFEDN 113
Query: 135 NGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIV 194
+ + VV+E +L RR+ L + G YLH +++
Sbjct: 114 D-------FVF-VVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRNRVI 163
Query: 195 HRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE---T--GTLGYMAPEVLNGNPY 249
HRD+K N+ L+++ VKI DFG+ + + GE GT Y+APEVL+ +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGL-----ATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 250 NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCW 309
+ + DV+S G ++ + P+ E + + IP+ A+++++
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--IPKHINPVAASLIQKML 276
Query: 310 DANPDKRPEMDEVVS 324
+P RP ++E+++
Sbjct: 277 QTDPTARPTINELLN 291
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 75/280 (26%), Positives = 126/280 (45%), Gaps = 42/280 (15%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I ++ +G+FG V + + AVK+++ + + + + +EV + KL
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTIL----REVELLKKL 78
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKL 169
DHPN+ K SS +I V E GG L +IK +R
Sbjct: 79 DHPNIMKLFEILEDSSSFYI----------------VGELYTGGELFDEIIKRKRFSEHD 122
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNP 226
A +++ Q+ G++Y+H IVHRD+K EN+LL +K+ +KI DFG++ N
Sbjct: 123 AARIIKQVF----SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
M GT Y+APEVL G Y+ KCDV+S G+ L+ + P+ + ++ V
Sbjct: 178 TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
Query: 287 QNL---RPEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 322
P+ S A +++++ +P R +
Sbjct: 237 GKYAFDLPQWRTI--SDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 44/316 (13%), Positives = 99/316 (31%), Gaps = 64/316 (20%)
Query: 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRTEA 92
K + ++++ + + ++ G F V+ + +K+ + E
Sbjct: 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK---PANPWEF 111
Query: 93 EIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYL 152
I TQ + KF A +NG +V E
Sbjct: 112 YI------GTQLMERLKPSMQHMFMKFYSA--------HLFQNG--------SVLVGELY 149
Query: 153 PGGALKTYLIKNRR---RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---- 205
G L + + + + +V+ A+ + + +H +I+H D+K +N +L
Sbjct: 150 SYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGF 209
Query: 206 -------DKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVY 256
D + + + D G + P T + T G+ E+L+ P+N + D +
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269
Query: 257 SFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ---------------NLRPEIPRCCPSS 300
++ + M + + R+ N+
Sbjct: 270 GVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDL 329
Query: 301 LANVMKRCWDANPDKR 316
L +K+ + + +
Sbjct: 330 LRQKLKKVFQQHYTNK 345
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-38
Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 54 IKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
I + G TV+ D VA+K + E F +EV +
Sbjct: 15 IVDKLGGGGMSTVYLA-EDTILNIKVAIKAI------FIPPREKEETLKRFEREVHNSSQ 67
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
L H N+ + E +V+EY+ G L Y+ L+
Sbjct: 68 LSHQNIVS----------MIDVDEEDDCYY------LVMEYIEGPTLSEYI--ESHGPLS 109
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ + G+ + H +IVHRD+K +N+L+D N+T+KI DFG+A+ + T
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169
Query: 231 GET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 289
GT+ Y +PE G + D+YS GI L+E+ + P+ E ++ +++
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN----GETAVSIAIKHI 225
Query: 290 RPEIPRC-------CPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331
+ +P P SL+NV+ R + + R + + M + + +
Sbjct: 226 QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK--TIQEMKDDLSS 272
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-38
Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 36/223 (16%)
Query: 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ G++G+V++ ++ G VA+K + + EI +E+++ + D P+
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEI-------IKEISIMQQCDSPH 85
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
V K+ G+ +++L I V+EY G++ + +I+ R + L +
Sbjct: 86 VVKYYGSYFKNTDLWI----------------VMEYCGAGSV-SDIIRLRNKTLTEDEIA 128
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET-- 233
+ +GL YLH + +HRD+K N+LL+ K+ADFGVA + M
Sbjct: 129 TILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDTMAKRNTV 185
Query: 234 -GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV+ YN D++S GI E+ PY D+
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-38
Identities = 65/284 (22%), Positives = 102/284 (35%), Gaps = 66/284 (23%)
Query: 54 IKSVIARGTFGTVHRGLYD---GHDVAVKLL--DWGEEGH-----RTEAEIAALRSAFTQ 103
++ ++ RG G V+ D VA+KL+ + + EA A
Sbjct: 38 LRRLVGRGGMGDVYEA-EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAG------- 89
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQ-TENGQ--VAMPSNICCVVVEYLPGGALKTY 160
+L P+V +H +GQ V M + G L
Sbjct: 90 ------RLQEPHVV----------PIHDFGEIDGQLYVDM---------RLINGVDLAAM 124
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L R+ LA V + + L H+ HRDVK EN+L+ + + DFG+A
Sbjct: 125 L--RRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS 182
Query: 221 VEASNPNDMTGET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
G T GTL YMAPE + + + D+Y+ L+E P +
Sbjct: 183 ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP-----YQG 237
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
+V+ ++ IPR PS++ P D V+
Sbjct: 238 DQLSVMGAHINQAIPR--PSTV----------RPGIPVAFDAVI 269
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-38
Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 51/278 (18%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I +G F V + G +VA+K++D + + ++ +EV + L+HPN
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL-------FREVRIMKILNHPN 75
Query: 116 VTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
+ K L I+T + +++EY GG + YL+ + R
Sbjct: 76 IVK----------LFEVIET-------EKTLY-LIMEYASGGEVFDYLVAHGR------- 110
Query: 174 VVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+ AR + Y H ++IVHRD+K EN+LLD + +KIADFG + +
Sbjct: 111 ---MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TV 166
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284
+ G Y APE+ G Y+ + DV+S G+ L+ + +P+ + E+ V
Sbjct: 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226
Query: 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
+R R IP + N++KR NP KR ++++
Sbjct: 227 LRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 70/319 (21%), Positives = 119/319 (37%), Gaps = 54/319 (16%)
Query: 20 AAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVA 77
+ + P + +D E ++ + ++ +G FGTV G L D VA
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA 60
Query: 78 VKLLD------WG--EEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129
+K++ W + E+A L V HP V + L
Sbjct: 61 IKVIPRNRVLGWSPLSDSVTCPLEVALLWK-------VGAGGGHPGVIR----------L 103
Query: 130 HIQTENGQV-AMPSNICCVVVEY-LPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGL 185
+V+E LP L Y+ + + Q+ +
Sbjct: 104 L------DWFETQEGFM-LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAI 152
Query: 186 SYLHSQKIVHRDVKTENMLLDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVL 244
+ HS+ +VHRD+K EN+L+D R K+ DFG + P GT Y PE +
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--DGTRVYSPPEWI 210
Query: 245 NGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLAN 303
+ + Y+ V+S GI L+++ C D+P+ E+ A + P
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFERD--QEILEAELH------FPAHVSPDCCA 262
Query: 304 VMKRCWDANPDKRPEMDEV 322
+++RC P RP ++E+
Sbjct: 263 LIRRCLAPKPSSRPSLEEI 281
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-37
Identities = 65/305 (21%), Positives = 122/305 (40%), Gaps = 64/305 (20%)
Query: 53 VIKSVIARGTFGTV-HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
V + ++ G+ GTV +G + G VAVK + +IA E+ + +
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRML------IDFCDIA------LMEIKLLTES 65
Query: 112 D-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-----R 165
D HPNV ++ + L+I +E L+ +
Sbjct: 66 DDHPNVIRYYCSETTDRFLYI----------------ALELC-NLNLQDLVESKNVSDEN 108
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD-------------KNRTVK 212
+ + L +A G+++LHS KI+HRD+K +N+L+ +N +
Sbjct: 109 LKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168
Query: 213 IADFGVARV----EASNPNDMTGETGTLGYMAPEVLNGN-------PYNRKCDVYSFGIC 261
I+DFG+ + ++S ++ +GT G+ APE+L + R D++S G
Sbjct: 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 262 LWEIYCC-DMPYPDLSFSE--VTSAVVRQNLRPEIPRCCPSSLA-NVMKRCWDANPDKRP 317
+ I P+ D E + + + + + A +++ + D +P KRP
Sbjct: 229 FYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288
Query: 318 EMDEV 322
+V
Sbjct: 289 TAMKV 293
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 67/276 (24%), Positives = 126/276 (45%), Gaps = 49/276 (17%)
Query: 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I +G GTV+ + G +VA++ ++ ++ + E I E+ V + +PN
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELII--------NEILVMRENKNPN 78
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ ++ + + EL + V+EYL GG+L + + + V
Sbjct: 79 IVNYLDSYLVGDELWV----------------VMEYLAGGSLTDVVTETCMDEGQIAAVC 122
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET-- 233
+ L + L +LHS +++HRD+K++N+LL + +VK+ DFG A + + +
Sbjct: 123 RECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSTM 176
Query: 234 -GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS-----FSEVTSAVVRQ 287
GT +MAPEV+ Y K D++S GI E+ + PY + + + ++
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIAT 230
Query: 288 NLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDE 321
N PE+ P + + + RC + + +KR E
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 71/300 (23%), Positives = 123/300 (41%), Gaps = 51/300 (17%)
Query: 54 IKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTE-AEIAALRSAFTQE---VA 106
+ ++ G VH D DVAVK+L R + A + F +E A
Sbjct: 16 LGEILGFGGMSEVHLA-RDLRDHRDVAVKVL-------RADLARDPSFYLRFRREAQNAA 67
Query: 107 VWHKLDHPNVTKF--IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
L+HP + G + E +P +V+EY+ G L+ + +
Sbjct: 68 ---ALNHPAIVAVYDTG----------EAETPAGPLPY----IVMEYVDGVTLRDIV--H 108
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ K +++ D + L++ H I+HRDVK N+++ VK+ DFG+AR A
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168
Query: 225 NPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281
+ N +T GT Y++PE G+ + + DVYS G L+E+ + P+ +
Sbjct: 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT----GDSP 224
Query: 282 SAVVRQNLRPEIPR------CCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335
+V Q++R + + L V+ + NP+ R + M + G
Sbjct: 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ--TAAEMRADLVRVHNG 282
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 66/305 (21%), Positives = 119/305 (39%), Gaps = 42/305 (13%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+K I +G++G V A+K+++ + ++ ++ EV + KL
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK----TEVRLMKKL 85
Query: 112 DHPNVTKFIGATMGSSELHIQTE----------------------NGQVAMPSNICCVVV 149
HPN+ + + + E V C
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--DK 207
++ K++ + + L YLH+Q I HRD+K EN L +K
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 208 NRTVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGIC 261
+ +K+ DFG+++ N MT + GT ++APEVLN Y KCD +S G+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 262 LWEIYCCDMPYPDLSFSEVTSAVVRQNLR---PEIPRCCPSSLA-NVMKRCWDANPDKRP 317
L + +P+P ++ ++ S V+ + L P S LA +++ + N D+R
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVL--SPLARDLLSNLLNRNVDERF 323
Query: 318 EMDEV 322
+
Sbjct: 324 DAMRA 328
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 63/279 (22%), Positives = 117/279 (41%), Gaps = 38/279 (13%)
Query: 53 VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
S + G FG V + +V VK + + E L T E+A+ +
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK-VTLEIAILSR 85
Query: 111 LDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-- 166
++H N+ K + + V+ ++ G L ++ ++ R
Sbjct: 86 VEHANIIK----------VLDIFEN-------QGFFQLVMEKHGSGLDLFAFIDRHPRLD 128
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP 226
LA + QL + YL + I+HRD+K EN+++ ++ T+K+ DFG A
Sbjct: 129 EPLASYIFRQLV----SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 227 NDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285
T GT+ Y APEVL GNPY + +++S G+ L+ + + P+ + E A +
Sbjct: 185 LFYT-FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE--LEETVEAAI 241
Query: 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
P L +++ P++R ++++V+
Sbjct: 242 H------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 71/284 (25%), Positives = 112/284 (39%), Gaps = 37/284 (13%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEI---EPSKL-VIKS 56
M + D +I T P G + LK +P KL
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLR 60
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I G+FG V+ + VA+K + + + + + +EV KL HP
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD------IIKEVRFLQKLRHP 114
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N ++ G + + V+EY G A L++ ++ L +
Sbjct: 115 NTIQYRGCYLREHTAWL----------------VMEYCLGSASD--LLEVHKKPLQEVEI 156
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ +GL+YLHS ++HRDVK N+LL + VK+ DFG A + N G
Sbjct: 157 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA-SIMAPANSF---VG 212
Query: 235 TLGYMAPEV---LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
T +MAPEV ++ Y+ K DV+S GI E+ P ++
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-37
Identities = 70/322 (21%), Positives = 116/322 (36%), Gaps = 56/322 (17%)
Query: 26 ATATPIGKASNFLKKQRQDWEIEPSKL----VIKSVIARGTFGTVHRGLY--DGHDVAVK 79
A + K F D + P L ++ + G G V VA++
Sbjct: 107 ALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR 166
Query: 80 LLD---WGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENG 136
++ + R + E+ + KL+HP + K E+
Sbjct: 167 IISKRKFAIGSAREADPALNVE----TEIEILKKLNHPCIIKIKNF--------FDAED- 213
Query: 137 QVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIV 194
+V+E + GG L ++ N+R Q+ L + YLH I+
Sbjct: 214 --------YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLHENGII 261
Query: 195 HRDVKTENMLL---DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN---P 248
HRD+K EN+LL +++ +KI DFG +++ + M GT Y+APEVL
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAG 320
Query: 249 YNRKCDVYSFG----ICLWEIYCCDMP--YPDLSFSEVTSAVVRQNLR-PEIPRCCPSSL 301
YNR D +S G ICL P + + + S
Sbjct: 321 YNRAVDCWSLGVILFICL-----SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 375
Query: 302 A-NVMKRCWDANPDKRPEMDEV 322
A +++K+ +P R +E
Sbjct: 376 ALDLVKKLLVVDPKARFTTEEA 397
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-37
Identities = 64/254 (25%), Positives = 116/254 (45%), Gaps = 44/254 (17%)
Query: 38 LKKQRQDWEIE----PSKL-VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRT 90
++K R+ + P+++ I + G FG V++ G A K+++ E
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE 61
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
+ + E+ + DHP + K +GA +L I ++E
Sbjct: 62 D---------YIVEIEILATCDHPYIVKLLGAYYHDGKLWI----------------MIE 96
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
+ PGGA+ ++ R L + + + L++LHS++I+HRD+K N+L+
Sbjct: 97 FCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD 155
Query: 211 VKIADFGVARVEASNPNDMTGET---GTLGYMAPEV-----LNGNPYNRKCDVYSFGICL 262
+++ADFGV+ A N + GT +MAPEV + PY+ K D++S GI L
Sbjct: 156 IRLADFGVS---AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212
Query: 263 WEIYCCDMPYPDLS 276
E+ + P+ +L+
Sbjct: 213 IEMAQIEPPHHELN 226
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-37
Identities = 68/278 (24%), Positives = 119/278 (42%), Gaps = 53/278 (19%)
Query: 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I G+ G V G VAVK++D ++ R EV + H N
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL---------LFNEVVIMRDYQHFN 103
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
V + + + EL + ++E+L GGAL + + R + V
Sbjct: 104 VVEMYKSYLVGEELWV----------------LMEFLQGGALTDIVSQVRLNEEQIATVC 147
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET-- 233
+ L + L+YLH+Q ++HRD+K++++LL + VK++DFG A D+
Sbjct: 148 EAVL---QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC---AQISKDVPKRKSL 201
Query: 234 -GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS-----FSEVTSAVVRQ 287
GT +MAPEV++ + Y + D++S GI + E+ + PY S +R
Sbjct: 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK------RLRD 255
Query: 288 NLRPEIPRCCPSSLANVMK----RCWDANPDKRPEMDE 321
+ P++ ++ V++ R +P +R E
Sbjct: 256 SPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQE 291
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-37
Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 36/224 (16%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
K ++ RG V R ++ + AVK++D G + E+ LR A +EV + K+
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 112 D-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RK 168
HPN+ + ++ + V + + G L YL + K
Sbjct: 81 SGHPNIIQLKDTYETNTFFFL----------------VFDLMKKGELFDYLTEKVTLSEK 124
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228
K++ L + LH IVHRD+K EN+LLD + +K+ DFG +
Sbjct: 125 ETRKIMRALL----EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EK 179
Query: 229 MTGETGTLGYMAPEVLNGN------PYNRKCDVYSFG----ICL 262
+ GT Y+APE++ + Y ++ D++S G L
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 223
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-37
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 38/216 (17%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
V+ G F V G A+K + + E E+AV K+
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---------NEIAVLKKI 63
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKL 169
H N+ ++ ++ V++ + GG L +++ K
Sbjct: 64 KHENIVTLEDIYESTTHYYL----------------VMQLVSGGELFDRILERGVYTEKD 107
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNP 226
A V+ Q+ + YLH IVHRD+K EN+L ++N + I DFG++++E
Sbjct: 108 ASLVIQQVL----SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QN 161
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
M+ GT GY+APEVL PY++ D +S G+
Sbjct: 162 GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-37
Identities = 59/246 (23%), Positives = 108/246 (43%), Gaps = 34/246 (13%)
Query: 22 ASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVK 79
++ +G+ S F+ + +K + +G F V R ++ G + A K
Sbjct: 4 MASMTGGQQMGRGSEFMMNASTKFS---DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 80 LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVA 139
+++ + + L +E + KL HPN+ + + S ++
Sbjct: 61 IIN---TKKLSARDFQKLE----REARICRKLQHPNIVRLHDSIQEESFHYL-------- 105
Query: 140 MPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
V + + GG L ++ R + + ++Y HS IVHR++K
Sbjct: 106 --------VFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLK 155
Query: 200 TENMLL---DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVY 256
EN+LL K VK+ADFG+A +E ++ G GT GY++PEVL +PY++ D++
Sbjct: 156 PENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW 214
Query: 257 SFGICL 262
+ G+ L
Sbjct: 215 ACGVIL 220
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-37
Identities = 69/283 (24%), Positives = 113/283 (39%), Gaps = 50/283 (17%)
Query: 57 VIARGTFGTVHRG--LYDGHDVAVKLLD------WGEEGHRTEAEIAALRSAFTQEVAVW 108
++ G++G V AVK+L + EI LR
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR---------- 61
Query: 109 HKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGA--LKTYLIKN 164
+L H NV + L + E + +V+EY G + + +
Sbjct: 62 -RLRHKNVIQ----------LVDVLYNEE-----KQKMY-MVMEYCVCGMQEMLDSVPEK 104
Query: 165 R-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
R A QL GL YLHSQ IVH+D+K N+LL T+KI+ GVA
Sbjct: 105 RFPVCQAHGYFCQLID----GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
Query: 224 SNPNDMTGET--GTLGYMAPEVLNGN-PYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
D T T G+ + PE+ NG ++ K D++S G+ L+ I P+ + +
Sbjct: 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
+ + + + IP C L++++K + P KR + ++
Sbjct: 221 LFENIGKGSYA--IPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-36
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+K + +G F V R + G + A K+++ + + L +E + KL
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIIN---TKKLSARDFQKLE----REARICRKL 62
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ + + S ++ V + + GG L ++ R +
Sbjct: 63 QHPNIVRLHDSIQEESFHYL----------------VFDLVTGGELFEDIVA--REFYSE 104
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNPND 228
+ ++Y HS IVHR++K EN+LL K VK+ADFG+A +
Sbjct: 105 ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EA 163
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFG----ICL 262
G GT GY++PEVL +PY++ D+++ G I L
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 49 PSKL-VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
P+ + + ++ GT+G V++G + G A+K++D + E EI QE+
Sbjct: 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIK-------QEI 71
Query: 106 AVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+ K H N+ + GA + + + + +V+E+ G++ +
Sbjct: 72 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQ----------LWLVMEFCGAGSVTDLIKNT 121
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ L + + + ++ RGLS+LH K++HRD+K +N+LL +N VK+ DFGV+
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
Query: 225 NPNDMTGETGTLGYMAPEVL-----NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
GT +MAPEV+ Y+ K D++S GI E+ P D+
Sbjct: 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMK----RCWDANPDKRPEMDE 321
+ R PR + + C N +RP ++
Sbjct: 242 ALFLIPRNP----APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQ 283
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-36
Identities = 68/282 (24%), Positives = 110/282 (39%), Gaps = 54/282 (19%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLD---WGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
+ G +G V VAVK++D + + EI + L+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----------LN 63
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
H NV KF G H + + + +EY GG L + +
Sbjct: 64 HENVVKFYG--------HRRE-------GNIQY-LFLEYCSGGELFDRIEPDIG------ 101
Query: 173 VVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ A+ G+ YLH I HRD+K EN+LLD+ +KI+DFG+A V
Sbjct: 102 ----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 225 NPNDMTGET--GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281
N + GTL Y+APE+L ++ DV+S GI L + ++P+ S S
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
Query: 282 SAVVRQNLRPEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 322
+ ++ P S ++ + NP R + ++
Sbjct: 218 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 259
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-36
Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 34/278 (12%)
Query: 53 VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ K + G FG VH G + +K ++ R++ + + E+ V
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTIN----KDRSQVPMEQIE----AEIEVLKS 76
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
LDHPN+ K ++I V+E GG L ++ + R A
Sbjct: 77 LDHPNIIKIFEVFEDYHNMYI----------------VMETCEGGELLERIVSAQARGKA 120
Query: 171 F--KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASN 225
V +L + L+Y HSQ +VH+D+K EN+L + +KI DFG+A + S+
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285
T GT YMAPEV + KCD++S G+ ++ + +P+ S EV
Sbjct: 181 -EHSTNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT 238
Query: 286 RQNLRPEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 322
+ + + A +++K+ +P++RP +V
Sbjct: 239 YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 68/282 (24%), Positives = 110/282 (39%), Gaps = 54/282 (19%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLD---WGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
+ G +G V VAVK++D + + EI + L+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----------LN 63
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
H NV KF G H + + + +EY GG L + +
Sbjct: 64 HENVVKFYG--------HRRE-------GNIQY-LFLEYCSGGELFDRIEPDIG------ 101
Query: 173 VVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ A+ G+ YLH I HRD+K EN+LLD+ +KI+DFG+A V
Sbjct: 102 ----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 225 NPNDMTGET--GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281
N + GTL Y+APE+L ++ DV+S GI L + ++P+ S S
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
Query: 282 SAVVRQNLRPEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 322
+ ++ P S ++ + NP R + ++
Sbjct: 218 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 259
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 62/284 (21%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ GTFG V G GH VAVK+L+ R + + +E+ HP+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN------RQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 116 VTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
+ K L+ I T P++ +V+EY+ GG L Y+ K+ R
Sbjct: 73 IIK----------LYQVIST-------PTDFF-MVMEYVSGGELFDYICKHGR------- 107
Query: 174 VVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+ AR + Y H +VHRD+K EN+LLD + KIADFG++
Sbjct: 108 ---VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------ 158
Query: 226 PNDMTG----ET--GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFS 278
N M+ T G+ Y APEV++G Y + D++S G+ L+ + C +P+ D
Sbjct: 159 -NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP 217
Query: 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
+ + IP S+A ++ +P KR + ++
Sbjct: 218 TLFKKIRGGVFY--IPEYLNRSVATLLMHMLQVDPLKRATIKDI 259
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 47/214 (21%), Positives = 87/214 (40%), Gaps = 30/214 (14%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ + +G F V R + G + A +++ + + L +E + L
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIIN---TKKLSARDHQKLE----REARICRLL 67
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ + + ++ + + + GG L ++ R +
Sbjct: 68 KHPNIVRLHDSISEEGHHYL----------------IFDLVTGGELFEDIVA--REYYSE 109
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNPND 228
+ + + H +VHR++K EN+LL K VK+ADFG+A
Sbjct: 110 ADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
G GT GY++PEVL +PY + D+++ G+ L
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 68/347 (19%), Positives = 127/347 (36%), Gaps = 77/347 (22%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
M S + ++ + A N + +++ P ++
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGP-------LLGS 53
Query: 61 GTFGTVHRG--LYDGHDVAVKLLD------WGEEGH--RTEAEIAALRSAFTQEVAVWHK 110
G FG+V+ G + D VA+K ++ WGE + R E+ L+ K
Sbjct: 54 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-----------K 102
Query: 111 LDH--PNVTKFIGATMGSSELHIQTENGQV-AMPSNICCVVVEY-LPGGALKTYLIKNRR 166
+ V + L P + +++E P L ++ +
Sbjct: 103 VSSGFSGVIR----------LL------DWFERPDSFV-LILERPEPVQDLFDFITERGA 145
Query: 167 --RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR-TVKIADFGVARVEA 223
+LA Q+ + + H+ ++HRD+K EN+L+D NR +K+ DFG
Sbjct: 146 LQEELARSFFWQVL----EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG---- 197
Query: 224 SNPNDMTGET-----GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSF 277
+ GT Y PE + + Y+ R V+S GI L+++ C D+P+
Sbjct: 198 ---ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-- 252
Query: 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
E+ V + S ++++ C P RP +E+ +
Sbjct: 253 EEIIRGQVF------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 62/296 (20%), Positives = 108/296 (36%), Gaps = 47/296 (15%)
Query: 54 IKSVIARGTFGTVHRGL---YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+K IA G G ++ L +G V +K L + A E +
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGL------VHSGDAEAQAM--AMAERQFLAE 135
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ HP++ + G + M EY+ G +LK +KL
Sbjct: 136 VVHPSIVQIF--NFVEHTDRHGDPVGYIVM---------EYVGGQSLKRSK----GQKLP 180
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ L++ LSYLHS +V+ D+K EN++L + + +K+ D G +
Sbjct: 181 VAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS-----RINSF 234
Query: 231 GET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 289
G GT G+ APE++ P D+Y+ G L + + +
Sbjct: 235 GYLYGTPGFQAPEIVRTGPTVA-TDIYTVGRTLAALTLDLPTRN----GRYVDGLPEDDP 289
Query: 290 RPEIPRCCPSSLANVMKRCWDANPDKRP----EM-DEVVSMLEAIDTSKGGGMIPG 340
+ S +++R D +P +R EM ++ +L + G PG
Sbjct: 290 VLKTYD----SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPG 341
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-35
Identities = 76/283 (26%), Positives = 123/283 (43%), Gaps = 48/283 (16%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I ++ +G+FG V + + AVK+++ + S +EV + KL
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-------KASAKNKDTSTILREVELLKKL 78
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKL 169
DHPN+ K SS +I V E GG L +IK +R
Sbjct: 79 DHPNIMKLFEILEDSSSFYI----------------VGELYTGGELFDEIIKRKRFSEHD 122
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNP 226
A +++ Q+ G++Y+H IVHRD+K EN+LL +K+ +KI DFG++ N
Sbjct: 123 AARIIKQVF----SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
M GT Y+APEVL G Y+ KCDV+S G+ L+ + P+ + ++ V
Sbjct: 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
Query: 287 QNLR------PEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 322
I S A +++++ +P R +
Sbjct: 237 GKYAFDLPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 48/213 (22%), Positives = 91/213 (42%), Gaps = 28/213 (13%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ + G F V + G + A K + + + + R +EV + ++
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIK---KRRLSSSRRGVSREEIEREVNILREI 65
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ +++ + ++E + GG L +L + + L
Sbjct: 66 RHPNIITLHDIFENKTDVVL----------------ILELVSGGELFDFLAE--KESLTE 107
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEASNPN 227
Q + G+ YLHS++I H D+K EN++L N +K+ DFG+A + N
Sbjct: 108 DEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-N 166
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+ GT ++APE++N P + D++S G+
Sbjct: 167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 62/267 (23%), Positives = 108/267 (40%), Gaps = 40/267 (14%)
Query: 3 KSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGT 62
S +N+ + ++ +A+A ++ + ++S + RG
Sbjct: 7 HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALS-DFFEVESELGRGA 65
Query: 63 FGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120
V+R A+K+L + +R E+ V +L HPN+ K
Sbjct: 66 TSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVR----TEIGVLLRLSHPNIIKLK 114
Query: 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKLAFKVVVQLA 178
+E+ + V+E + GG L +++ + A V Q+
Sbjct: 115 EIFETPTEISL----------------VLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158
Query: 179 LDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNPNDMTGETGT 235
++YLH IVHRD+K EN+L + +KIADFG++++ + M GT
Sbjct: 159 ----EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMKTVCGT 213
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICL 262
GY APE+L G Y + D++S GI
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 46/213 (21%), Positives = 86/213 (40%), Gaps = 36/213 (16%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+K I G++ R + AVK++D + E EI +
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI------------LLRYG 73
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ +++ V E + GG L +++ ++ +
Sbjct: 74 QHPNIITLKDVYDDGKYVYV----------------VTELMKGGELLDKILR--QKFFSE 115
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEASNPN 227
+ + + + + YLH+Q +VHRD+K N+L +++I DFG A+ +
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+ T ++APEVL Y+ CD++S G+
Sbjct: 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGV 208
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 43/226 (19%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLD---WGEEGHRTEAEIAALRSAFTQEVAVW 108
+ + G G V VA+K++ + R + E+ +
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE----TEIEIL 69
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-- 166
KL+HP + K E+ +V+E + GG L ++ N+R
Sbjct: 70 KKLNHPCIIKIKNF--------FDAED---------YYIVLELMEGGELFDKVVGNKRLK 112
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEA 223
Q+ L + YLH I+HRD+K EN+LL +++ +KI DFG +++
Sbjct: 113 EATCKLYFYQMLL----AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL- 167
Query: 224 SNPNDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFG----ICL 262
+ M GT Y+APEVL YNR D +S G ICL
Sbjct: 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 60/278 (21%), Positives = 114/278 (41%), Gaps = 40/278 (14%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+++ I RG++G V A K + ++ + QE+ + L
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIP-----KYFVEDVDRFK----QEIEIMKSL 63
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKL 169
DHPN+ + ++++++ V+E GG L ++ R
Sbjct: 64 DHPNIIRLYETFEDNTDIYL----------------VMELCTGGELFERVVHKRVFRESD 107
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNP 226
A +++ + ++Y H + HRD+K EN L + +K+ DFG+A
Sbjct: 108 AARIMKDVL----SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
M + GT Y++P+VL G Y +CD +S G+ ++ + C P+ + SEV +
Sbjct: 163 KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221
Query: 287 QNLR-PEIPRCCPSSLA-NVMKRCWDANPDKRPEMDEV 322
PE S A ++++R +P +R +
Sbjct: 222 GTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 46/213 (21%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G F V + G + A K + + + R +EV++ ++
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIK---KRQSRASRRGVCREEIEREVSILRQV 72
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ +++ + ++E + GG L +L + + L+
Sbjct: 73 LHPNIITLHDVYENRTDVVL----------------ILELVSGGELFDFLAQ--KESLSE 114
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEASNPN 227
+ + G++YLH++KI H D+K EN++L +K+ DFG+A
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-V 173
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+ GT ++APE++N P + D++S G+
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 39/225 (17%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
K VI RG V R ++ GH+ AVK+++ + ++ +R A +E + ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIME-VTAERLSPEQLEEVREATRRETHILRQV 156
Query: 112 -DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---R 167
HP++ I + SS + + V + + G L YL + +
Sbjct: 157 AGHPHIITLIDSYESSSFMFL----------------VFDLMRKGELFDYLTEKVALSEK 200
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
+ ++ L +S+LH+ IVHRD+K EN+LLD N ++++DFG +
Sbjct: 201 E-TRSIMRSLL----EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-E 254
Query: 228 DMTGETGTLGYMAPEVLNGN------PYNRKCDVYSFG----ICL 262
+ GT GY+APE+L + Y ++ D+++ G L
Sbjct: 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 46/213 (21%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G F V + G + A K + + + R +EV++ ++
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIK---KRQSRASRRGVSREEIEREVSILRQV 72
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
H NV +++ + ++E + GG L +L + + L+
Sbjct: 73 LHHNVITLHDVYENRTDVVL----------------ILELVSGGELFDFLAQ--KESLSE 114
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEASNPN 227
+ + G++YLH++KI H D+K EN++L +K+ DFG+A
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-V 173
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+ GT ++APE++N P + D++S G+
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 47/276 (17%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ G+FG V VA+K + R + + + +E++ L HP+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS------RQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 116 VTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
+ K L+ I T P++I +V+EY GG L Y+++ +R +
Sbjct: 71 IIK----------LYDVITT-------PTDIV-MVIEYA-GGELFDYIVEKKR--MTEDE 109
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG-- 231
+ + + Y H KIVHRD+K EN+LLD N VKIADFG++ N MT
Sbjct: 110 GRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS-------NIMTDGN 162
Query: 232 --ET--GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
+T G+ Y APEV+NG Y + DV+S GI L+ + +P+ D + V
Sbjct: 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS 222
Query: 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
+P ++++R A+P +R + E+
Sbjct: 223 CVYV--MPDFLSPGAQSLIRRMIVADPMQRITIQEI 256
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 62/284 (21%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ GTFG V G GH VAVK+L+ R + + +E+ HP+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN------RQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 116 VTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
+ K L+ I T PS+I +V+EY+ GG L Y+ KN R
Sbjct: 78 IIK----------LYQVIST-------PSDIF-MVMEYVSGGELFDYICKNGR------- 112
Query: 174 VVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
L +R G+ Y H +VHRD+K EN+LLD + KIADFG++
Sbjct: 113 ---LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------ 163
Query: 226 PNDMTG----ET--GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFS 278
N M+ T G+ Y APEV++G Y + D++S G+ L+ + C +P+ D
Sbjct: 164 -NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP 222
Query: 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
+ + P+ S+ +++K +P KR + ++
Sbjct: 223 TLFKKICDGIFY--TPQYLNPSVISLLKHMLQVDPMKRATIKDI 264
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 30/214 (14%)
Query: 53 VIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ + RG F V + + G + A K L + R + A + E+AV
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLK---KRRRGQDCRAEIL----HEIAVLEL 84
Query: 111 LDH-PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
P V +SE+ + ++EY GG + + + +
Sbjct: 85 AKSCPRVINLHEVYENTSEIIL----------------ILEYAAGGEIFSLCLPELAEMV 128
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNP 226
+ V++L + G+ YLH IVH D+K +N+LL +KI DFG++R
Sbjct: 129 SENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA- 187
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
++ GT Y+APE+LN +P D+++ GI
Sbjct: 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGI 221
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 36/214 (16%)
Query: 53 VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ + G+F + AVK++ + + +E+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS------------KRMEANTQKEITALKL 61
Query: 111 LD-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
+ HPN+ K + V+E L GG L + K ++
Sbjct: 62 CEGHPNIVKLHEVFHDQLHTFL----------------VMELLNGGELFERIKK--KKHF 103
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNP 226
+ + L +S++H +VHRD+K EN+L + N +KI DFG AR++ +
Sbjct: 104 SETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+ TL Y APE+LN N Y+ CD++S G+
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGV 197
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 74/291 (25%), Positives = 114/291 (39%), Gaps = 72/291 (24%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGE-EGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I G FG R VAVK ++ G + EI RS L HP
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRS-----------LRHP 76
Query: 115 NVTKFIGATMGSSELHIQTENGQV-AMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
N+ +F +V P+++ +++EY GG L + R
Sbjct: 77 NIVRFK----------------EVILTPTHLA-IIMEYASGGELYERICNAGR------- 112
Query: 174 VVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRT--VKIADFGVARVEA 223
+ D AR G+SY HS +I HRD+K EN LLD + +KI DFG +
Sbjct: 113 ---FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS---K 166
Query: 224 SNPNDMTGET--GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280
S+ ++ GT Y+APEVL Y+ + DV+S G+ L+ + P F +
Sbjct: 167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP-----FEDP 221
Query: 281 TSAVVRQNLRPEIPRC---CPSSL------ANVMKRCWDANPDKRPEMDEV 322
+ I P + +++ R + A+P R + E+
Sbjct: 222 EEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-33
Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ G F V + G A K + + + R +EV++ ++
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREVSILKEI 71
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPNV +++ + ++E + GG L +L + + L
Sbjct: 72 QHPNVITLHEVYENKTDVIL----------------ILELVAGGELFDFLAE--KESLTE 113
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEASNPN 227
+ + + G+ YLHS +I H D+K EN++L +KI DFG+A N
Sbjct: 114 EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-N 172
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+ GT ++APE++N P + D++S G+
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 205
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-33
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 40/217 (18%)
Query: 53 VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ K V+ G G V G A+KLL + + E+ W
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLY---DSPKARQEVDHH----------WQA 78
Query: 111 LDHPNVTKFIGA----TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR 166
P++ + G L I ++E + GG L + + +
Sbjct: 79 SGGPHIVCILDVYENMHHGKRCLLI----------------IMECMEGGELFSRIQERGD 122
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEA 223
+ + ++ D+ + +LHS I HRDVK EN+L +K+ +K+ DFG A+
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET- 181
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
N + T Y+APEVL Y++ CD++S G+
Sbjct: 182 -TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 52/263 (19%), Positives = 97/263 (36%), Gaps = 37/263 (14%)
Query: 2 EKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARG 61
K R D + + + + + D I + G
Sbjct: 9 HHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYD------YYDILEELGSG 62
Query: 62 TFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119
FG VHR + G K ++ + ++ E+++ ++L HP +
Sbjct: 63 AFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVK----NEISIMNQLHHPKLINL 113
Query: 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLAL 179
A E+ + ++E+L GG L + K++ V+
Sbjct: 114 HDAFEDKYEMVL----------------ILEFLSGGELFDRIAA-EDYKMSEAEVINYMR 156
Query: 180 DLARGLSYLHSQKIVHRDVKTENMLL--DKNRTVKIADFGVARVEASNPNDMTGETGTLG 237
GL ++H IVH D+K EN++ K +VKI DFG+A + + + T T
Sbjct: 157 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIVKVTTATAE 215
Query: 238 YMAPEVLNGNPYNRKCDVYSFGI 260
+ APE+++ P D+++ G+
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGV 238
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 55 KSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
++ G FG VH+ G +A K++ R + ++ E++V ++LD
Sbjct: 94 TEILGGGRFGQVHKCEETATGLKLAAKIIK-----TRGMKDKEEVK----NEISVMNQLD 144
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
H N+ + A +++ + V+EY+ GG L +I L
Sbjct: 145 HANLIQLYDAFESKNDIVL----------------VMEYVDGGELFDRIID-ESYNLTEL 187
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--DKNRTVKIADFGVARVEASNPNDMT 230
+ + G+ ++H I+H D+K EN+L + +KI DFG+AR +
Sbjct: 188 DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLK 246
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
GT ++APEV+N + + D++S G+
Sbjct: 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-32
Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 34/212 (16%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + RG FG VHR + K + + ++ +E+++ +
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVK------VKGTDQVLVK----KEISILNIA 58
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
H N+ + EL + + E++ G + + +L
Sbjct: 59 RHRNILHLHESFESMEELVM----------------IFEFISGLDIFERINT-SAFELNE 101
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--DKNRTVKIADFGVARVEASNPND- 228
+ +V + L +LHS I H D++ EN++ ++ T+KI +FG AR P D
Sbjct: 102 REIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDN 159
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
Y APEV + + D++S G
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGT 191
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 59/219 (26%), Positives = 88/219 (40%), Gaps = 43/219 (19%)
Query: 53 VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V V+ G G V + A+K+L R E E+ W
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVEL------------HWRA 111
Query: 111 LDHPNVTKFIGA----TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR 166
P++ + + G L I V+E L GG L + + R
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLI----------------VMECLDGGELFSRIQD--R 153
Query: 167 RKLAF--KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARV 221
AF + ++ + + YLHS I HRDVK EN+L N +K+ DFG A+
Sbjct: 154 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213
Query: 222 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
S+ N +T T Y+APEVL Y++ CD++S G+
Sbjct: 214 TTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 251
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 31/211 (14%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G FG VHR G++ A K + E++ +R +E+ L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKETVR----KEIQTMSVL 211
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HP + A +E+ + + E++ GG L + K++
Sbjct: 212 RHPTLVNLHDAFEDDNEMVM----------------IYEFMSGGELFEKVAD-EHNKMSE 254
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--DKNRTVKIADFGVARVEASNPNDM 229
V+ + +GL ++H VH D+K EN++ ++ +K+ DFG+ +
Sbjct: 255 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSV 313
Query: 230 TGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
TGT + APEV G P D++S G+
Sbjct: 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-30
Identities = 59/308 (19%), Positives = 110/308 (35%), Gaps = 50/308 (16%)
Query: 23 SANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKL 80
A P + + Q + P ++ G+F TV R L + A+K+
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI 62
Query: 81 LDWGEEGHRTEAEIAALRS-AFTQ-EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQV 138
L+ + I + E V +LDHP K Q +
Sbjct: 63 LE--------KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT--------FQDDEK-- 104
Query: 139 AMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHS 190
+ Y G L Y+ K R L YLH
Sbjct: 105 ------LYFGLSYAKNGELLKYIRKIGS----------FDETCTRFYTAEIVSALEYLHG 148
Query: 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNP 248
+ I+HRD+K EN+LL+++ ++I DFG A+V + + GT Y++PE+L
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208
Query: 249 YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRC 308
+ D+++ G ++++ P+ + + +++ P +++++
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--FPEKFFPKARDLVEKL 266
Query: 309 WDANPDKR 316
+ KR
Sbjct: 267 LVLDATKR 274
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 59/298 (19%), Positives = 108/298 (36%), Gaps = 69/298 (23%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I G++G V + G VA+K L + + ALR E+ + +L H
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV----IKKIALR-----EIRMLKQLKH 61
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
PN+ + LH+ V EY + + +R + +
Sbjct: 62 PNLVNLLEVFRRKRRLHL----------------VFEYCDHT-VLHE-LDRYQRGVPEHL 103
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
V + + +++ H +HRDVK EN+L+ K+ +K+ DFG AR+ + E
Sbjct: 104 VKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163
Query: 234 GTLGYMAPEVLNGNP-YNRKCDVYSFG------------------------IC------- 261
T Y +PE+L G+ Y DV++ G I
Sbjct: 164 ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI 223
Query: 262 --LWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
+++ + + + + + L + P +L ++K C +P +R
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPED---MEPLELKFPNISYPAL-GLLKGCLHMDPTERL 277
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 8/173 (4%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C V+EY GG L +L +R R + ++ L YLHS+ +V+RD+K EN++L
Sbjct: 81 CFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
DK+ +KI DFG+ + E + T GT Y+APEVL N Y R D + G+ ++
Sbjct: 139 DKDGHIKITDFGLCK-EGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 196
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
E+ C +P+ + + ++ + +R PR +++ +P +R
Sbjct: 197 EMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 57/173 (32%), Positives = 89/173 (51%), Gaps = 8/173 (4%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V+EYL GG L ++ K A ++ GL +LHS+ IV+RD+K +N+LL
Sbjct: 94 FFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
DK+ +KIADFG+ + E + T T GT Y+APE+L G YN D +SFG+ L+
Sbjct: 152 DKDGHIKIADFGMCK-ENMLGDAKTN-TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 209
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
E+ P+ E+ ++ N PR +++ + + P+KR
Sbjct: 210 EMLIGQSPFHGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKR 260
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 45/224 (20%)
Query: 55 KSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL- 111
+ V+ G V L + AVK+++ + I RS +EV + ++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIE------KQPGHI---RSRVFREVEMLYQCQ 68
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
H NV + I ++ V E + GG++ +++ K RR
Sbjct: 69 GHRNVLELIEFFEEEDRFYL----------------VFEKMRGGSILSHIHK--RRHFNE 110
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARV------- 221
+ D+A L +LH++ I HRD+K EN+L ++ VKI DF +
Sbjct: 111 LEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 222 EASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGI 260
+ ++ G+ YMAPEV+ + Y+++CD++S G+
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-29
Identities = 64/298 (21%), Positives = 115/298 (38%), Gaps = 69/298 (23%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
+ G++G V + G VA+K L ++ + A+R E+ + +L H
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM----VKKIAMR-----EIKLLKQLRH 83
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
N+ + ++ V E++ + L + L ++V
Sbjct: 84 ENLVNLLEVCKKKKRWYL----------------VFEFVDHT-ILDDL-ELFPNGLDYQV 125
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
V + + G+ + HS I+HRD+K EN+L+ ++ VK+ DFG AR A+ E
Sbjct: 126 VQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV 185
Query: 234 GTLGYMAPEVLNG-NPYNRKCDVYSFG------------------------IC------- 261
T Y APE+L G Y + DV++ G I
Sbjct: 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI 245
Query: 262 --LWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP 317
E++ + + + E+ R+ L P+ + ++ K+C +PDKRP
Sbjct: 246 PRHQELFNKNPVFAGVRLPEIKE---REPLERRYPKLSEVVI-DLAKKCLHIDPDKRP 299
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 9e-29
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 37/211 (17%)
Query: 61 GTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
GT+GTV + VA+K LD +EG +ALR E+ + +L H N+
Sbjct: 13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALR-----EICLLKELKHKNI 63
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQ 176
+ +L + V E+ LK Y + L ++V
Sbjct: 64 VRLHDVLHSDKKLTL----------------VFEFCDQD-LKKYF-DSCNGDLDPEIVKS 105
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL 236
L +GL + HS+ ++HRD+K +N+L+++N +K+A+FG+AR + E TL
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL 165
Query: 237 GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
Y P+VL G +YS I +W C
Sbjct: 166 WYRPPDVLFG------AKLYSTSIDMWSAGC 190
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 36/210 (17%)
Query: 61 GTFGTVHRGLY-DGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
GT+G V++ G VA+K LD +EG A+R E+++ +L HPN+
Sbjct: 32 GTYGVVYKAKDSQGRIVALKRIRLDAEDEG----IPSTAIR-----EISLLKELHHPNIV 82
Query: 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQL 177
I L + V E++ LK + + L +
Sbjct: 83 SLIDVIHSERCLTL----------------VFEFMEKD-LKKV-LDENKTGLQDSQIKIY 124
Query: 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLG 237
L RG+++ H +I+HRD+K +N+L++ + +K+ADFG+AR T E TL
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW 184
Query: 238 YMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
Y AP+VL G YS + +W I C
Sbjct: 185 YRAPDVLMG------SKKYSTSVDIWSIGC 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 36/210 (17%)
Query: 61 GTFGTVHRGLYD-GHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
GT+G V++ + G A+K L+ +EG +R E+++ +L H N+
Sbjct: 13 GTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPSTTIR-----EISILKELKHSNIV 63
Query: 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQL 177
K L + V E+L LK + L
Sbjct: 64 KLYDVIHTKKRLVL----------------VFEHLDQD-LKKL-LDVCEGGLESVTAKSF 105
Query: 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLG 237
L L G++Y H ++++HRD+K +N+L+++ +KIADFG+AR T E TL
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW 165
Query: 238 YMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
Y AP+VL G YS I +W + C
Sbjct: 166 YRAPDVLMG------SKKYSTTIDIWSVGC 189
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V+E++ GG L ++ + R+ A ++ L +LH + I++RD+K +N+LL
Sbjct: 100 FFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
D K+ADFG+ + E T T GT Y+APE+L Y D ++ G+ L+
Sbjct: 158 DHEGHCKLADFGMCK-EGICNGVTTA-TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
E+ C P+ + ++ A++ + P ++K NP R
Sbjct: 216 EMLCGHAPFEAENEDDLFEAILNDEVV--YPTWLHEDATGILKSFMTKNPTMR 266
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 70/209 (33%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-- 111
I G +GTV++ + GH VA+K + G G I+ +R EVA+ +L
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGG-GGGLPISTVR-----EVALLRRLEA 70
Query: 112 -DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+HPNV + + S +V + V E++ L+TYL K L
Sbjct: 71 FEHPNVVRLMDVCATSR----TDREIKVTL-------VFEHVDQD-LRTYLDKAPPPGLP 118
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ + L RGL +LH+ IVHRD+K EN+L+ TVK+ADFG+AR S +T
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALT 177
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFG 259
TL Y APEVL + Y D++S G
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVG 206
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 50/173 (28%), Positives = 87/173 (50%), Gaps = 8/173 (4%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V+EY+ GG L ++ + + V A ++A GL +L S+ I++RD+K +N++L
Sbjct: 97 YFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
D +KIADFG+ + E T T GT Y+APE++ PY + D ++FG+ L+
Sbjct: 155 DSEGHIKIADFGMCK-ENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 212
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
E+ P+ E+ +++ N+ P+ + K +P KR
Sbjct: 213 EMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKR 263
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 72/280 (25%), Positives = 123/280 (43%), Gaps = 54/280 (19%)
Query: 57 VIARGTFGTV----HRGLYDGHDVAVKLLDWG-----EEGHRTEAEIAALRSAFTQEVAV 107
VI RG++ V + A+K++ E+ + E + F Q
Sbjct: 16 VIGRGSYAKVLLVRLKK--TDRIYAMKVVKKELVNDDEDIDWVQTE----KHVFEQAS-- 67
Query: 108 WHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+HP F+ LH QT S + V+EY+ GG L ++ R
Sbjct: 68 ----NHP----FL------VGLHSCFQT-------ESRLF-FVIEYVNGGDLMFHM--QR 103
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+RKL + + +++ L+YLH + I++RD+K +N+LLD +K+ D+G+ + E
Sbjct: 104 QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLR 162
Query: 226 PNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
P D T T GT Y+APE+L G Y D ++ G+ ++E+ P+ + S+
Sbjct: 163 PGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221
Query: 284 VVRQNL-------RPEIPRCCPSSLANVMKRCWDANPDKR 316
L + IPR A+V+K + +P +R
Sbjct: 222 NTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 58 IARGTFGTVHRGL---YDGHDVAVK--LLDWGEEGHRTEA--EIAALRSAFTQEVAVWHK 110
I G +G V + G VA+K + GEEG E+A LR
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL--------ET 70
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+HPNV + S ++ + V E++ L TYL K +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDR----ETKLTL-------VFEHVDQD-LTTYLDKVPEPGVP 118
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ + + L RGL +LHS ++VHRD+K +N+L+ + +K+ADFG+AR+ S +T
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALT 177
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFG 259
TL Y APEVL + Y D++S G
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVG 206
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 71/280 (25%), Positives = 123/280 (43%), Gaps = 54/280 (19%)
Query: 57 VIARGTFGTV----HRGLYDGHDVAVKLLDWG-----EEGHRTEAEIAALRSAFTQEVAV 107
VI RG++ V + A++++ E+ + E + F Q
Sbjct: 59 VIGRGSYAKVLLVRLKK--TDRIYAMRVVKKELVNDDEDIDWVQTE----KHVFEQAS-- 110
Query: 108 WHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+HP F+ LH QT S + V+EY+ GG L ++ R
Sbjct: 111 ----NHP----FL------VGLHSCFQT-------ESRLF-FVIEYVNGGDLMFHM--QR 146
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+RKL + + +++ L+YLH + I++RD+K +N+LLD +K+ D+G+ + E
Sbjct: 147 QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLR 205
Query: 226 PNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
P D T T GT Y+APE+L G Y D ++ G+ ++E+ P+ + S+
Sbjct: 206 PGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
Query: 284 VVRQNL-------RPEIPRCCPSSLANVMKRCWDANPDKR 316
L + IPR A+V+K + +P +R
Sbjct: 265 NTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 76/350 (21%), Positives = 131/350 (37%), Gaps = 81/350 (23%)
Query: 3 KSKKQRNSDDNILVTTAAAASANATATPIGK--ASNFLKKQRQDWEIEPSKLVIK----- 55
++ + + D + A A+ P + S + + Q +E +
Sbjct: 131 VARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDF 190
Query: 56 SVIARGTFGTV----HRG---LYDGHDVAVKLL-------DWGEEGHRTEAEIAALRSAF 101
V+ RG FG V + LY A K L G +G E +I A
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLY-----ACKKLNKKRLKKRKGYQGAMVEKKILA----- 240
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKT 159
K+ + L +T+ C+V+ + GG ++
Sbjct: 241 --------KVHSRFIVS----------LAYAFETKTD--------LCLVMTIMNGGDIRY 274
Query: 160 YLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTV 211
++ F+ A GL +LH + I++RD+K EN+LLD + V
Sbjct: 275 HIYNVDEDNPGFQ------EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNV 328
Query: 212 KIADFGVARVEASNPNDMT-GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM 270
+I+D G+A VE T G GT G+MAPE+L G Y+ D ++ G+ L+E+
Sbjct: 329 RISDLGLA-VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
Query: 271 PYPD----LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
P+ + E+ V+ Q + P + + + +P+KR
Sbjct: 388 PFRARGEKVENKELKQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKR 435
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 56/179 (31%), Positives = 89/179 (49%), Gaps = 13/179 (7%)
Query: 145 CCVVVEYLPGGALKTYLIKNRRRKLAFK-VVVQL-ALDLARGLSYLHSQKIVHRDVKTEN 202
+VV+ L GG L+ +L +N FK V+L +L L YL +Q+I+HRD+K +N
Sbjct: 90 MFMVVDLLLGGDLRYHLQQNVH----FKEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145
Query: 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFG 259
+LLD++ V I DF +A +T GT YMAPE+ + G Y+ D +S G
Sbjct: 146 ILLDEHGHVHITDFNIAA-MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG 204
Query: 260 ICLWEIYCCDMPYPDLSFSEVTSAVVRQNL--RPEIPRCCPSSLANVMKRCWDANPDKR 316
+ +E+ PY S S + +V P + +++K+ + NPD+R
Sbjct: 205 VTAYELLRGRRPYHIRS-STSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 67/277 (24%), Positives = 121/277 (43%), Gaps = 56/277 (20%)
Query: 57 VIARGTFGTV----HRGLYDGHDV-AVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
V+ +G+FG V D + A+K+L R R + ++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD-------ILVEV 83
Query: 112 DHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
+HP FI +LH QTE +++++L GG L T L K
Sbjct: 84 NHP----FI------VKLHYAFQTEGK--------LYLILDFLRGGDLFTRLSKEVM--- 122
Query: 170 AFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
F + + L +LHS I++RD+K EN+LLD+ +K+ DFG+++
Sbjct: 123 -FT------EEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK- 174
Query: 222 EASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
E+ + + GT+ YMAPEV+N + + D +SFG+ ++E+ +P+ E
Sbjct: 175 ESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233
Query: 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
+ +++ L +P+ ++++ + NP R
Sbjct: 234 TMTMILKAKLG--MPQFLSPEAQSLLRMLFKRNPANR 268
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 53/174 (30%), Positives = 89/174 (51%), Gaps = 9/174 (5%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK-IVHRDVKTENML 204
C V+EY GG L +L +R R + ++ L YLHS+K +V+RD+K EN++
Sbjct: 224 CFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
Query: 205 LDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
LDK+ +KI DFG+ + E T GT Y+APEVL N Y R D + G+ +
Sbjct: 282 LDKDGHIKITDFGLCK-EGIKDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 339
Query: 263 WEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
+E+ C +P+ + ++ ++ + +R PR +++ +P +R
Sbjct: 340 YEMMCGRLPFYNQDHEKLFELILMEEIR--FPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 75/281 (26%), Positives = 119/281 (42%), Gaps = 65/281 (23%)
Query: 57 VIARGTFGTV----HRGLYDGHDVAVKLLDWG-----EEGHRTEAEIAALRSAFTQEVAV 107
VI +G+FG V H+ + AVK+L +E +E R+ + V
Sbjct: 45 VIGKGSFGKVLLARHKA--EEVFYAVKVLQKKAILKKKEEKHIMSE----RNVLLKNV-- 96
Query: 108 WHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
HP F+ LH QT + V++Y+ GG L +L + R
Sbjct: 97 ----KHP----FL------VGLHFSFQT-------ADKL-YFVLDYINGGELFYHLQRER 134
Query: 166 RRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
F AR L YLHS IV+RD+K EN+LLD + + DFG
Sbjct: 135 C----FL------EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184
Query: 218 VARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
+ + E N T T GT Y+APEVL+ PY+R D + G L+E+ P+
Sbjct: 185 LCK-ENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242
Query: 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
+ +E+ ++ + L+ + +S ++++ + KR
Sbjct: 243 NTAEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKR 281
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-27
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 42/215 (19%)
Query: 61 GTFGTVHRG--LYDGHDVAVK-----LLDWGEEG-HRTEAEIAALRSAFTQEVAVWHKLD 112
G F TV++ VA+K ++G +RT ALR E+ + +L
Sbjct: 21 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRT-----ALR-----EIKLLQELS 70
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
HPN+ + A S + + V +++ L+ IK+ L
Sbjct: 71 HPNIIGLLDAFGHKSNISL----------------VFDFMETD-LEVI-IKDNSLVLTPS 112
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+ L +GL YLH I+HRD+K N+LLD+N +K+ADFG+A+ S T +
Sbjct: 113 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 172
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
T Y APE+L G +Y G+ +W + C
Sbjct: 173 VVTRWYRAPELLFG------ARMYGVGVDMWAVGC 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 7/175 (4%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C+V+ + GG LK ++ + V A ++ GL LH ++IV+RD+K EN+LL
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
D + ++I+D G+A V + G GT+GYMAPEV+ Y D ++ G L+E+
Sbjct: 320 DDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378
Query: 266 YCCDMPYPD----LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
P+ + EV V ++ + +P +R
Sbjct: 379 IAGQSPFQQRKKKIKREEVERLVKEVPEE--YSERFSPQARSLCSQLLCKDPAER 431
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 50/173 (28%), Positives = 87/173 (50%), Gaps = 8/173 (4%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V+EY+ GG L ++ + + V A ++A GL +L S+ I++RD+K +N++L
Sbjct: 418 YFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
D +KIADFG+ + E T T GT Y+APE++ PY + D ++FG+ L+
Sbjct: 476 DSEGHIKIADFGMCK-ENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
E+ P+ E+ +++ N+ P+ + K +P KR
Sbjct: 534 EMLAGQAPFEGEDEDELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 66/284 (23%), Positives = 119/284 (41%), Gaps = 68/284 (23%)
Query: 57 VIARGTFGTV----HRGLYDGHDV-AVKLL-------DWGEEGHRTEAEIAALRSAFTQE 104
V+ +G +G V + + A+K+L + + H T+AE R+
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH-TKAE----RN----- 73
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+ ++ HP FI +L QT +++EYL GG L L
Sbjct: 74 --ILEEVKHP----FI------VDLIYAFQTGGK--------LYLILEYLSGGELFMQLE 113
Query: 163 KNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
+ F D A L +LH + I++RD+K EN++L+ VK+
Sbjct: 114 REGI----FM------EDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLT 163
Query: 215 DFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
DFG+ + E+ + +T T GT+ YMAPE+L + +NR D +S G ++++ P+
Sbjct: 164 DFGLCK-ESIHDGTVTH-TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221
Query: 273 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
+ + +++ L +P +++K+ N R
Sbjct: 222 TGENRKKTIDKILKCKLN--LPPYLTQEARDLLKKLLKRNAASR 263
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 38/214 (17%)
Query: 58 IARGTFGTVHRGLYD--GHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
+ GT+ TV++G + VA+K L+ EEG A A+R EV++ L H
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLE-HEEG----APCTAIR-----EVSLLKDLKH 59
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
N+ L + V EYL LK YL + +
Sbjct: 60 ANIVTLHDIIHTEKSLTL----------------VFEYLDKD-LKQYL-DDCGNIINMHN 101
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
V L RGL+Y H QK++HRD+K +N+L+++ +K+ADFG+AR ++ E
Sbjct: 102 VKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV 161
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
TL Y P++L G YS I +W + C
Sbjct: 162 VTLWYRPPDILLG------STDYSTQIDMWGVGC 189
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 61 GTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
GT+ TV++G G VA+K LD EEG A+R E+++ +L H N+
Sbjct: 16 GTYATVYKGLNKTTGVYVALKEVKLD-SEEG----TPSTAIR-----EISLMKELKHENI 65
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL----IKNRRRKLAFK 172
+ ++L + V E++ LK Y+ + N R L
Sbjct: 66 VRLYDVIHTENKLTL----------------VFEFMDND-LKKYMDSRTVGNTPRGLELN 108
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+V L +GL++ H KI+HRD+K +N+L++K +K+ DFG+AR N + E
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
TL Y AP+VL G YS I +W C
Sbjct: 169 VVTLWYRAPDVLMG------SRTYSTSIDIWSCGC 197
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 68/283 (24%), Positives = 112/283 (39%), Gaps = 52/283 (18%)
Query: 31 IGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGH 88
+ A F K +Q + I VI RG FG V + A+K+L+
Sbjct: 56 LEWAKPFTSKVKQM-RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN------ 108
Query: 89 RTEAEIAALR-SAFTQ-EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICC 146
+ E+ +A + E V D +T A Q +N+
Sbjct: 109 --KWEMLKRAETACFREERDVLVNGDSKWITTLHYA--------FQD-------DNNL-Y 150
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRDV 198
+V++Y GG L T L K R L ++AR + +H VHRD+
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDR---------LPEEMARFYLAEMVIAIDSVHQLHYVHRDI 201
Query: 199 KTENMLLDKNRTVKIADFGVARVEASNPNDMTGET-GTLGYMAPEVLNGNP-----YNRK 252
K +N+L+D N +++ADFG + + GT Y++PE+L Y +
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPE 261
Query: 253 CDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPR 295
CD +S G+C++E+ + P+ S E ++ R + P
Sbjct: 262 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 59/256 (23%)
Query: 35 SNFLKKQR------QDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEE 86
++FL+ ++ ++ I VI RG F V + G A+K+++ +
Sbjct: 40 ADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM 99
Query: 87 GHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNI 144
R E F +E V D +T+ LH Q + +
Sbjct: 100 LKRGEVS------CFREERDVLVNGDRRWITQ----------LHFAFQD-------ENYL 136
Query: 145 CCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHR 196
+V+EY GG L T L K R + ++AR + +H VHR
Sbjct: 137 -YLVMEYYVGGDLLTLLSKFGER---------IPAEMARFYLAEIVMAIDSVHRLGYVHR 186
Query: 197 DVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET-GTLGYMAPEVLNG-------NP 248
D+K +N+LLD+ +++ADFG ++ + GT Y++PE+L
Sbjct: 187 DIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS 246
Query: 249 YNRKCDVYSFGICLWE 264
Y +CD ++ G+ +E
Sbjct: 247 YGPECDWWALGVFAYE 262
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 65/218 (29%), Positives = 93/218 (42%), Gaps = 33/218 (15%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I +GTFG V + G VA+K L++ +EG I ALR E+ + L H
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP----ITALR-----EIKILQLLKH 75
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
NV I + G + + V ++ L L N K
Sbjct: 76 ENVVNLIEI-CRTKASPYNRCKGSIYL-------VFDFCEHD-LAGLL-SNVLVKFTLSE 125
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV----EASNPNDM 229
+ ++ L GL Y+H KI+HRD+K N+L+ ++ +K+ADFG+AR + S PN
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 230 TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
T TL Y PE+L G Y I LW C
Sbjct: 186 TNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGC 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 65/245 (26%), Positives = 101/245 (41%), Gaps = 42/245 (17%)
Query: 35 SNFLKKQR------QDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEE 86
NFL + + +D ++ + VI RG FG V R A+KLL E
Sbjct: 48 DNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM 107
Query: 87 GHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNI 144
R+++ F +E + + P ++ +L Q +
Sbjct: 108 IKRSDSA------FFWEERDIMAFANSP----WV------VQLFYAFQD-------DRYL 144
Query: 145 CCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
+V+EY+PGG L + + K ++ L +HS +HRDVK +NML
Sbjct: 145 -YMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 200
Query: 205 LDKNRTVKIADFGVARVEASNPNDMTGET-GTLGYMAPEVLNGNP----YNRKCDVYSFG 259
LDK+ +K+ADFG GT Y++PEVL Y R+CD +S G
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 260 ICLWE 264
+ L+E
Sbjct: 261 VFLYE 265
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 43/216 (19%)
Query: 61 GTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
GT+G V++ VA+K L+ EEG A+R EV++ +L H N+
Sbjct: 45 GTYGEVYKAIDTVTNETVAIKRIRLEHEEEG----VPGTAIR-----EVSLLKELQHRNI 95
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQ 176
+ + LH+ + EY LK Y+ ++ ++ +V+
Sbjct: 96 IELKSVIHHNHRLHL----------------IFEYAEND-LKKYM--DKNPDVSMRVIKS 136
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT-----VKIADFGVARVEASNPNDMTG 231
L G+++ HS++ +HRD+K +N+LL + +KI DFG+AR T
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
E TL Y PE+L G YS + +W I C
Sbjct: 197 EIITLWYRPPEILLG------SRHYSTSVDIWSIAC 226
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 77/279 (27%), Positives = 127/279 (45%), Gaps = 59/279 (21%)
Query: 54 IKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ------EV 105
I + G+FG VH R ++G A+K+L + + L+ Q E
Sbjct: 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK--------KEIVVRLK----QVEHTNDER 57
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ + HP + + G Q I ++++Y+ GG L + L K++
Sbjct: 58 LMLSIVTHPFIIRMWGTF--------QD-------AQQIF-MIMDYIEGGELFSLLRKSQ 101
Query: 166 RRKLAFKVVV------QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
R F V ++ L L YLHS+ I++RD+K EN+LLDKN +KI DFG A
Sbjct: 102 R----FPNPVAKFYAAEVCL----ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
Query: 220 RVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
+ D+T T GT Y+APEV++ PYN+ D +SFGI ++E+ P+ D +
Sbjct: 154 KYV----PDVTY-TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208
Query: 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
+ ++ LR P + +++ R + +R
Sbjct: 209 MKTYEKILNAELR--FPPFFNEDVKDLLSRLITRDLSQR 245
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 60/289 (20%), Positives = 118/289 (40%), Gaps = 63/289 (21%)
Query: 46 EIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
+ + + G+FG V + G+ A+K+LD + ++ L+ Q
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD--------KQKVVKLK----Q 84
Query: 104 ------EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
E + ++ P + K + + SN+ +V+EY+ GG +
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSF--------KD-------NSNLY-MVMEYVAGGEM 128
Query: 158 KTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNR 209
++L + R + AR YLHS +++RD+K EN+L+D+
Sbjct: 129 FSHLRRIGR----------FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG 178
Query: 210 TVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+++ DFG A+ T T GT +APE++ YN+ D ++ G+ ++E+
Sbjct: 179 YIQVTDFGFAKRV----KGRTW-TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 268 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
P+ ++ +V +R P S L ++++ + KR
Sbjct: 234 GYPPFFADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 44/187 (23%), Positives = 90/187 (48%), Gaps = 29/187 (15%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRD 197
++++Y+ GG L T+L + R F + L +LH I++RD
Sbjct: 135 HLILDYINGGELFTHLSQRER----FT------EHEVQIYVGEIVLALEHLHKLGIIYRD 184
Query: 198 VKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNP--YNRKC 253
+K EN+LLD N V + DFG+++ ++ + GT+ YMAP+++ G +++
Sbjct: 185 IKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAV 243
Query: 254 DVYSFGICLWEIYCCDMPY----PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCW 309
D +S G+ ++E+ P+ S +E++ +++ P+ + ++++R
Sbjct: 244 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQRLL 301
Query: 310 DANPDKR 316
+P KR
Sbjct: 302 MKDPKKR 308
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 42/176 (23%), Positives = 83/176 (47%), Gaps = 12/176 (6%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
+++ + GG L +L ++ + + A ++ GL ++H++ +V+RD+K N+LL
Sbjct: 268 SFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
Query: 206 DKNRTVKIADFGVARVEASNPNDMT-GETGTLGYMAPEVLN-GNPYNRKCDVYSFGICLW 263
D++ V+I+D G+A GT GYMAPEVL G Y+ D +S G L+
Sbjct: 326 DEHGHVRISDLGLAC---DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382
Query: 264 EIYCCDMPY---PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
++ P+ E+ + + +P L ++++ + ++R
Sbjct: 383 KLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPDSFSPELRSLLEGLLQRDVNRR 436
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 47/219 (21%), Positives = 74/219 (33%), Gaps = 60/219 (27%)
Query: 53 VIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V V+ G G V + A+K+L R E E+ W
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVEL------------HWRA 67
Query: 111 LDHPNVTKFIGA----TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR 166
P++ + + G L I V+E L GG L + +
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLI----------------VMECLDGGELFSRIQDRGD 111
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEA 223
+ + ++ + + YLHS I HRDVK EN+L N +K+ DFG
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG------ 165
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
A E Y++ CD++S G+ +
Sbjct: 166 ---------------FAKETTGEK-YDKSCDMWSLGVIM 188
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 61/253 (24%), Positives = 101/253 (39%), Gaps = 37/253 (14%)
Query: 17 TTAAAASANATATPIGKASNFLKKQRQDWEI---EPSKLVIKSVIARGTFGTVHRG-LYD 72
T + A P+ + +K D + VI G+FG V + L +
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63
Query: 73 GHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130
+VA+K L D + R E+ +R + HPNV
Sbjct: 64 SDEVAIKKVLQDKRFKN-R---ELQIMR-----------IVKHPNVVDL---------KA 99
Query: 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF-KVVVQLAL-DLARGLSYL 188
NG + +V+EY+P + + K ++++L + L R L+Y+
Sbjct: 100 FFYSNGDKKDEVFLN-LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 189 HSQKIVHRDVKTENMLLDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN 247
HS I HRD+K +N+LLD +K+ DFG A++ + + Y APE++ G
Sbjct: 158 HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYICSRYYRAPELIFGA 216
Query: 248 P-YNRKCDVYSFG 259
Y D++S G
Sbjct: 217 TNYTTNIDIWSTG 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-23
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 30/229 (13%)
Query: 53 VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRT-EAEIAALRSAFTQEVAVWH 109
++ + G F TV + + VA+K++ + E EI L+ +
Sbjct: 22 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 110 KLDHPNVTKFIGATM--GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
+ ++ K + G + +H+ +V E L G L + K R
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHV--------------VMVFEVL-GENLLALIKKYEHR 126
Query: 168 KLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLD------KNRTVKIADFGVAR 220
+ V Q++ L GL Y+H + I+H D+K EN+L++ +KIAD G A
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 221 VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269
T T Y +PEVL G P+ D++S ++E+ D
Sbjct: 187 WY---DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 5e-23
Identities = 34/287 (11%), Positives = 77/287 (26%), Gaps = 71/287 (24%)
Query: 54 IKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ + D VA+ +D +G + + S T ++ +
Sbjct: 35 LLIFHGGVPPLQFWQA-LDTALDRQVALTFVD--PQGVLPDDVLQETLSR-TLRLS---R 87
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+D P V + + VV E++ GG+L+ +
Sbjct: 88 IDKPGVAR----------VLDVVHTR------AGGLVVAEWIRGGSLQEVA----DTSPS 127
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
++ LA H + + + + V +A
Sbjct: 128 PVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ--- 287
M N + D+ G L+ + P P+ + R
Sbjct: 175 -------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAG 220
Query: 288 ------NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328
++ +IP ++ V R + R ++++++
Sbjct: 221 QPIEPADIDRDIPF----QISAVAARSVQGDGGIRSA-STLLNLMQQ 262
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 7e-22
Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 57 VIARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
VI G+FG V++ G VA+K L D E+ +R KLD
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMR-----------KLD 105
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF- 171
H N+ + + +G+ + +V++Y+P + R K
Sbjct: 106 HCNIVRL---------RYFFYSSGEKKDEVYLN-LVLDYVPE-TVYRVARHYSRAKQTLP 154
Query: 172 KVVVQLAL-DLARGLSYLHSQKIVHRDVKTENMLLDKNR-TVKIADFGVARVEASNPNDM 229
+ V+L + L R L+Y+HS I HRD+K +N+LLD + +K+ DFG A+
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PN 213
Query: 230 TGETGTLGYMAPEVLNGNP-YNRKCDVYSFG 259
+ Y APE++ G Y DV+S G
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAG 244
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 42/222 (18%), Positives = 82/222 (36%), Gaps = 36/222 (16%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRS 99
+W + + RG + V + + V VK+L + + + EI L
Sbjct: 29 VVEWGN-QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-PVKKKKIKREIKILE- 85
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
+ PN+ I + S +V E++ K
Sbjct: 86 ---------NLRGGPNIITL---------ADIVKDP-----VSRTPALVFEHVNNTDFKQ 122
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD-KNRTVKIADFGV 218
+ L + ++ + L Y HS I+HRDVK N+++D ++R +++ D+G+
Sbjct: 123 LY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 219 ARVEASNPNDMTGETGTLGYMAPEVL-NGNPYNRKCDVYSFG 259
A + + + PE+L + Y+ D++S G
Sbjct: 178 AEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 6e-21
Identities = 63/236 (26%), Positives = 90/236 (38%), Gaps = 56/236 (23%)
Query: 53 VIKSVIARGTFGTVHRG----LYDGHDVAVKLLDWGEEGHRTEA--EIAALRSAFTQEVA 106
+ RGT+G V++ D D A+K + G A EIA LR
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRE------- 74
Query: 107 VWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR 166
L HPNV ++ + + +V + + +Y L IK R
Sbjct: 75 ----LKHPNVISLQ-------KVFLSHADRKVWL-------LFDYAEHD-LWHI-IKFHR 114
Query: 167 RKLAFKVVVQLALD--------LARGLSYLHSQKIVHRDVKTENMLLDKNR----TVKIA 214
A K VQL + G+ YLH+ ++HRD+K N+L+ VKIA
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174
Query: 215 DFGVARVEASNPNDMTGETG---TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
D G AR+ S + T Y APE+L G Y+ I +W I C
Sbjct: 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGC 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-21
Identities = 60/320 (18%), Positives = 120/320 (37%), Gaps = 63/320 (19%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVK----LLDWGEEGHRTEAEIAAL 97
+ + S ++ I+ G++G V G+ +G VA+K + G +
Sbjct: 16 ELHAM-QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 98 RSAFTQEVAVWHKLDHPNVTK----FIGATMGS-SELHIQTENGQVAMPSNICCVVVEYL 152
R +E+ + + HPN+ F+ + +L++ TE M +++ V
Sbjct: 75 RV--LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE----LMRTDLAQV----- 123
Query: 153 PGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212
I ++R ++ + + + GL LH +VHRD+ N+LL N +
Sbjct: 124 ---------IHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174
Query: 213 IADFGVARVEASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEIYCCD-- 269
I DF +AR + ++ N T Y APE+ + + + D++S G + E++
Sbjct: 175 ICDFNLAREDTADAN-KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233
Query: 270 ----------------MPYPDLSF-SEVTSAVVRQNLRPEIPRCCPSSLANV-------- 304
+ P + +S R LR + + V
Sbjct: 234 FRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVA 293
Query: 305 ---MKRCWDANPDKRPEMDE 321
+ + + NP +R ++
Sbjct: 294 LDLIAKMLEFNPQRRISTEQ 313
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-20
Identities = 52/246 (21%), Positives = 90/246 (36%), Gaps = 51/246 (20%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAF 101
E K + + G+FG V + G A+K L D E+ ++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMK--- 55
Query: 102 TQEVAVWHKLDHPNVTK----FIGATMGSSELHIQTENGQVAMPSNICC----------- 146
LDH N+ K F + ++ N
Sbjct: 56 --------VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNP 107
Query: 147 -------VVVEYLPG---GALKTYLIKNRRRKLAFKVVVQLAL-DLARGLSYLHSQKIVH 195
V++EY+P LK+++ R + + + + L R + ++HS I H
Sbjct: 108 SQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNL---ISIYIYQLFRAVGFIHSLGICH 164
Query: 196 RDVKTENMLLDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEV-LNGNPYNRKC 253
RD+K +N+L++ T+K+ DFG A+ + + Y APE+ L Y
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSI 223
Query: 254 DVYSFG 259
D++S G
Sbjct: 224 DLWSIG 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 61/333 (18%), Positives = 115/333 (34%), Gaps = 88/333 (26%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLL----DWGEEGHRTEAEIA 95
+ + + I G G V +VA+K L R E+
Sbjct: 55 DSTFTV-LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 113
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFI------GATMGSSELHIQTENGQVAMPSNICCVVV 149
++ ++H N+ + ++++ E M +N+C V
Sbjct: 114 LMK-----------CVNHKNIISLLNVFTPQKTLEEFQDVYLVME----LMDANLCQV-- 156
Query: 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209
++ L R L ++++ G+ +LHS I+HRD+K N+++ +
Sbjct: 157 -------IQMELDHERMSYLLYQML--------CGIKHLHSAGIIHRDLKPSNIVVKSDC 201
Query: 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI---- 265
T+KI DFG+AR ++ MT T Y APEV+ G Y D++S G + E+
Sbjct: 202 TLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
Query: 266 ------------------------------------YCCDMP-YPDLSFSEVTSAVVRQN 288
Y + P Y L+F ++ +
Sbjct: 261 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA 320
Query: 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE 321
+ +++ + +P KR +D+
Sbjct: 321 DSEHNKLKASQAR-DLLSKMLVIDPAKRISVDD 352
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 63/333 (18%), Positives = 115/333 (34%), Gaps = 88/333 (26%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLL----DWGEEGHRTEAEIA 95
+ + + I G G V +VA+K L R E+
Sbjct: 18 DSTFTV-LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV 76
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFI------GATMGSSELHIQTENGQVAMPSNICCVVV 149
++ ++H N+ + + +++I E M +N+C V
Sbjct: 77 LMKC-----------VNHKNIIGLLNVFTPQKSLEEFQDVYIVME----LMDANLCQV-- 119
Query: 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209
++ L R L ++++ G+ +LHS I+HRD+K N+++ +
Sbjct: 120 -------IQMELDHERMSYLLYQML--------CGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI---- 265
T+KI DFG+AR ++ MT T Y APEV+ G Y D++S G + E+
Sbjct: 165 TLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
Query: 266 ------------------------------------YCCDMP-YPDLSFSEVTSAVVRQN 288
Y + P Y SF ++ V+
Sbjct: 224 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA 283
Query: 289 LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE 321
+ +++ + + KR +DE
Sbjct: 284 DSEHNKLKASQAR-DLLSKMLVIDASKRISVDE 315
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-19
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 32/228 (14%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVK-LLDWGEEGHRTEAEIAAL 97
+ + V + + +GTFGTV G G VA+K ++ +R + L
Sbjct: 15 DERSRKEMDRFQVER-MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDL 73
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
L HPN+ + G+ VV+EY+P L
Sbjct: 74 A-----------VLHHPNIVQL---------QSYFYTLGERDRRDIYLNVVMEYVPD-TL 112
Query: 158 KTYLIKNRRRKLAFKVV-VQLAL-DLARGLSYLH--SQKIVHRDVKTENMLLDK-NRTVK 212
RR++A + +++ L L R + LH S + HRD+K N+L+++ + T+K
Sbjct: 113 HRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172
Query: 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFG 259
+ DFG A+ + + + Y APE++ GN Y D++S G
Sbjct: 173 LCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG 219
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 37/233 (15%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLL----DWGEEGHRTEAEI 94
+ WE+ P V + + G +G+V + G VA+K L R E+
Sbjct: 16 NKTAWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL 74
Query: 95 AALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG 154
L+ + H NV L + T + + +V+ ++
Sbjct: 75 LLLKH-----------MQHENVIGL---------LDVFTPASSLRNFYDFY-LVMPFMQ- 112
Query: 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
T L K K + + + L + +GL Y+HS +VHRD+K N+ ++++ +KI
Sbjct: 113 ----TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168
Query: 215 DFGVARVEASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEIY 266
DFG+AR +MTG T Y APEV L+ YN+ D++S G + E+
Sbjct: 169 DFGLARHAD---AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 35/84 (41%), Positives = 53/84 (63%), Gaps = 4/84 (4%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPE 242
RGL Y+HS I+HRD+K N+ ++++ +KI DFG+AR ++MTG T Y APE
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPE 199
Query: 243 V-LNGNPYNRKCDVYSFGICLWEI 265
+ LN YN+ D++S G + E+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAEL 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 9e-18
Identities = 52/236 (22%), Positives = 97/236 (41%), Gaps = 33/236 (13%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGH--RTEAEIAAL 97
+++ S+ + + G G V + VA+K + + EI +
Sbjct: 4 IHGFDL-GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKII 62
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLP---G 154
R +LDH N+ K + T++ N +V EY+
Sbjct: 63 R-----------RLDHDNIVKVF--EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA 109
Query: 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD-KNRTVKI 213
L+ + +L + QL RGL Y+HS ++HRD+K N+ ++ ++ +KI
Sbjct: 110 NVLEQGPLLEEHARL---FMYQLL----RGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162
Query: 214 ADFGVARV---EASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEI 265
DFG+AR+ S+ ++ T Y +P + L+ N Y + D+++ G E+
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 33/85 (38%), Positives = 52/85 (61%), Gaps = 4/85 (4%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPE 242
+GL Y+H+ I+HRD+K N+ ++++ +KI DFG+AR ++MTG T Y APE
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPE 195
Query: 243 V-LNGNPYNRKCDVYSFGICLWEIY 266
V LN Y + D++S G + E+
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMI 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 50/241 (20%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEA-----EI 94
Q +++ + S I G +G V + VA+K + E H+T EI
Sbjct: 20 GQVFDV-GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREI 76
Query: 95 AALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS-----ELHIQTENGQVAMPSNICCVVV 149
L + H N+ + +++I + M +++ +
Sbjct: 77 KILL-----------RFRHENIIGINDIIRAPTIEQMKDVYIVQD----LMETDLYKL-- 119
Query: 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209
LKT + N + Q+ RGL Y+HS ++HRD+K N+LL+
Sbjct: 120 -------LKTQHLSNDHICY---FLYQIL----RGLKYIHSANVLHRDLKPSNLLLNTTC 165
Query: 210 TVKIADFGVARV---EASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEI 265
+KI DFG+ARV + + +T T Y APE+ LN Y + D++S G L E+
Sbjct: 166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
Query: 266 Y 266
Sbjct: 226 L 226
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 44/181 (24%), Positives = 72/181 (39%), Gaps = 43/181 (23%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYM--- 239
R + LH ++HRD+K N+L++ N +K+ DFG+AR+ + D + TG M
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 240 -------APEV-LNGNPYNRKCDVYSFGICLWEIY--------------------CCDMP 271
APEV L Y+R DV+S G L E++ P
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 272 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANV-----------MKRCWDANPDKRPEMD 320
+ D + S R+ ++ +P + L + ++R +P KR
Sbjct: 243 HSDNDLRCIESPRAREYIK-SLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 321 E 321
E
Sbjct: 302 E 302
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 42/224 (18%)
Query: 54 IKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ VI +G+FG V + YD VA+K++ +E+ +
Sbjct: 101 VLKVIGKGSFGQVVKA-YDHKVHQHVALKMV----------RNEKRFHRQAAEEIRILEH 149
Query: 111 L---DHPNVTKFIGATMGSS---ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
L D N I M + HI C+ E L L + KN
Sbjct: 150 LRKQDKDNTMNVI--HMLENFTFRNHI--------------CMTFELL-SMNLYELIKKN 192
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL-DKNRT-VKIADFGVARVE 222
+ + + +V + A + + L LH +I+H D+K EN+LL + R+ +K+ DFG + E
Sbjct: 193 KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+ + Y APEV+ G Y D++S G L E+
Sbjct: 253 ---HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 67/307 (21%), Positives = 109/307 (35%), Gaps = 88/307 (28%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
+ +Q NS V+ + K + + + DW+I P + I+ +I
Sbjct: 5 EAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI-PDRYEIRHLIGT 63
Query: 61 GTFGTVHRGL--YDGHDVAVK--LLDWGEEGH--RTEAEIAALRSAFTQEVAVWHKLDHP 114
G++G V + VA+K L + + R EIA L +L+H
Sbjct: 64 GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN-----------RLNHD 112
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICC-----VVVEYLP---------GGALKTY 160
+V K + + +P ++ VV+E L
Sbjct: 113 HVVKVL----------------DIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL 156
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
IK ++ L G+ Y+HS I+HRD+K N L++++ +VK+ DFG+AR
Sbjct: 157 HIKT--------LLYNLL----VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204
Query: 221 VEASNPND---------------------------MTGETGTLGYMAPEV-LNGNPYNRK 252
N +TG T Y APE+ L Y
Sbjct: 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA 264
Query: 253 CDVYSFG 259
DV+S G
Sbjct: 265 IDVWSIG 271
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 37/125 (29%), Positives = 59/125 (47%), Gaps = 8/125 (6%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENM 203
C+V E L L L R ++ + + A + L +L + + I+H D+K EN+
Sbjct: 132 CLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 190
Query: 204 LL--DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGIC 261
LL K +KI DFG + + + Y +PEVL G PY+ D++S G
Sbjct: 191 LLCNPKRSAIKIVDFGSSCQLG---QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCI 247
Query: 262 LWEIY 266
L E++
Sbjct: 248 LVEMH 252
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 29/99 (29%), Positives = 45/99 (45%), Gaps = 22/99 (22%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND-------------- 228
+ + YLHS ++HRD+K N+LL+ VK+ADFG++R +
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 229 -------MTGETGTLGYMAPEV-LNGNPYNRKCDVYSFG 259
+T T Y APE+ L Y + D++S G
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 23/100 (23%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND-------------- 228
G +++H I+HRD+K N LL+++ +VK+ DFG+AR S +
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 229 --------MTGETGTLGYMAPEV-LNGNPYNRKCDVYSFG 259
+T T Y APE+ L Y + D++S G
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 42/233 (18%), Positives = 84/233 (36%), Gaps = 46/233 (19%)
Query: 58 IARGTFGTVHRG----------LYDGHDVAVKLLDWGEEGH-RTEAEIAAL-RSAFTQEV 105
R G ++ ++KL + R E R+A +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL----DAKDGRLFNEQNFFQRAAKPLQV 105
Query: 106 AVW---HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
W + + +G G + +V+ L G +L++ L
Sbjct: 106 NKWKKLYSTPLLAIPTCMGF--GVHQ-------------DKYRFLVLPSL-GRSLQSALD 149
Query: 163 KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--DKNRTVKIADFGVAR 220
+ + L+ + V+Q+A L L +LH + VH +V EN+ + + V +A +G A
Sbjct: 150 VSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
Query: 221 VEASN-------PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+ + G L +++ ++ G +R+ D+ S G C+ +
Sbjct: 210 RYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM--LK 260
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 46/225 (20%), Positives = 82/225 (36%), Gaps = 33/225 (14%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGH---RTEAEI--AALRSAFTQEVAVWHK 110
I G FG ++ A ++ + + +E + + ++ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
LD+ + F G S L M V+E L G L+ +
Sbjct: 105 LDYLGIPLFYG-----SGLTEFKGRSYRFM-------VMERL-GIDLQKIS--GQNGTFK 149
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD--KNRTVKIADFGVARVEASN--- 225
V+QL + + L Y+H + VH D+K N+LL V +AD+G++ N
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 226 ----PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
N G GT+ + + + G +R+ DV G C+ +
Sbjct: 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCM--LR 252
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 42/171 (24%), Positives = 65/171 (38%), Gaps = 54/171 (31%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENML 204
C+V E L G L ++IK+ + L V ++ + +GL YLH++ +I+H D+K EN+L
Sbjct: 121 CMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179
Query: 205 L-------------------------------------------------DKNRTVKIAD 215
L + VKIAD
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
G A T + T Y + EVL G+ YN D++S +E+
Sbjct: 240 LGNACWV---HKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 1e-12
Identities = 49/310 (15%), Positives = 94/310 (30%), Gaps = 59/310 (19%)
Query: 39 KKQRQDWE--IEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLL-----DWGEEGHRTE 91
+K + + KL I G FG V + + D VA+K++ D H+
Sbjct: 7 QKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKT 66
Query: 92 AEIAALRSAFTQEVAVWHKL---DHPNVTKFIGA---------TMGSSELHIQTENGQ-- 137
E ++E+++ + + H + G
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 138 ---VAMPSNICCVVVEYLPGGA-LKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKI 193
+ +V+E+ GG L+ K A ++ QL LA + L
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR---F 183
Query: 194 VHRDVKTENMLLDKNRTVKIADFG-------------VARVEASNPNDMTGET--GTLGY 238
HRD+ N+LL K K+ V+ ++ +
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243
Query: 239 MAPEVLNGNPYNRKCDVYSFGI---------------CLWEIYCCDMPYPDLSFSEVTSA 283
M ++ G+ + + D+Y LW Y D ++F +
Sbjct: 244 MDEDLFTGD-GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNT 302
Query: 284 VVRQNLRPEI 293
+ ++ +I
Sbjct: 303 PAMKQIKRKI 312
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 46/247 (18%), Positives = 85/247 (34%), Gaps = 66/247 (26%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ + GTFG V + + AVK++ + + A+I E + K+
Sbjct: 39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKKYTRSAKI---------EADILKKI 88
Query: 112 --DHPNVTKFIGATMGSSEL--------HIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
D N + + H+ C++ E L G +L +
Sbjct: 89 QNDDINNNNIV-------KYHGKFMYYDHM--------------CLIFEPL-GPSLYEII 126
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+N + + +++ + L+YL + H D+K EN+LLD K
Sbjct: 127 TRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186
Query: 222 EASNPNDMTGETGTL-----G-----------------YMAPEVLNGNPYNRKCDVYSFG 259
+ ++ + G Y APEV+ ++ D++SFG
Sbjct: 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246
Query: 260 ICLWEIY 266
L E+Y
Sbjct: 247 CVLAELY 253
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 38/147 (25%), Positives = 58/147 (39%), Gaps = 37/147 (25%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C+ E L G +L +N + V +A L L +LH ++ H D+K EN+L
Sbjct: 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156
Query: 206 -------------------DKNRTVKIADFGVARVEASNPNDMTGETGTLG-------YM 239
KN ++++ADFG A T + Y
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----------TFDHEHHTTIVATRHYR 206
Query: 240 APEVLNGNPYNRKCDVYSFGICLWEIY 266
PEV+ + + CDV+S G L+E Y
Sbjct: 207 PPEVILELGWAQPCDVWSIGCILFEYY 233
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 37/147 (25%), Positives = 61/147 (41%), Gaps = 37/147 (25%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C+V E L G + ++ +N + ++A + + +++LHS K+ H D+K EN+L
Sbjct: 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF 151
Query: 206 D-------------------KNRTVKIADFGVARVEASNPNDMTGETGTLG-------YM 239
N +K+ DFG A T + Y
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA----------TYDDEHHSTLVSTRHYR 201
Query: 240 APEVLNGNPYNRKCDVYSFGICLWEIY 266
APEV+ +++ CDV+S G L E Y
Sbjct: 202 APEVILALGWSQPCDVWSIGCILIEYY 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 41/171 (23%), Positives = 68/171 (39%), Gaps = 37/171 (21%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH-P 114
I G FG + G LY VA+KL E ++ E + +L
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL-----EPMKSR------APQLHLEYRFYKQLGSGD 65
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
+ + G + N +V+E L G +L L R + K V
Sbjct: 66 GIPQVYYF--GPCGKY------------NA--MVLELL-GPSL-EDLFDLCDRTFSLKTV 107
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLL-----DKNRTVKIADFGVAR 220
+ +A+ L + Y+HS+ +++RDVK EN L+ + + I DF +A+
Sbjct: 108 LMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 34/227 (14%)
Query: 58 IARGTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRTEAEI--AALRSAFTQEVAVW 108
I +G FG ++ + VK+ TE + A + Q+
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK 168
KL + V K+ G S LH + M +++ G L+ N + +
Sbjct: 103 RKLKYLGVPKYWG-----SGLHDKNGKSYRFM-------IMDRF-GSDLQKIYEANAK-R 148
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD--KNRTVKIADFGVARV----- 221
+ K V+QL+L + L Y+H + VH D+K N+LL+ V + D+G+A
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 222 --EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+A + GT+ + + + NG +R+ D+ G C+ I
Sbjct: 209 VHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCM--IQ 253
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 65/297 (21%), Positives = 113/297 (38%), Gaps = 50/297 (16%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH-P 114
I G+FG ++ G + G +VA+KL E +T+ E ++ +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-----ECVKTK------HPQLHIESKIYKMMQGGV 65
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
+ G+ + N+ V+E L G +L+ L RK + K V
Sbjct: 66 GIPTIRWC--GAEGDY------------NVM--VMELL-GPSLE-DLFNFCSRKFSLKTV 107
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNPNDMT- 230
+ LA + + Y+HS+ +HRDVK +N L+ K V I DFG+A+ + +
Sbjct: 108 LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK-KYRDARTHQH 166
Query: 231 -------GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
TGT Y + G +R+ D+ S G L +P+ L +
Sbjct: 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226
Query: 284 VVR-----QNLRPE-IPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334
R + E + + PS A + C D +P+ + + + +G
Sbjct: 227 YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 47/229 (20%), Positives = 85/229 (37%), Gaps = 48/229 (20%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ I G+FG + G L + VA+K E R++ E + L
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSD------APQLRDEYRTYKLL 62
Query: 112 DH-PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ G LH N+ +V++ L G +L+ L+ RK +
Sbjct: 63 AGCTGIPNVYYF--GQEGLH------------NV--LVIDLL-GPSLE-DLLDLCGRKFS 104
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL-----DKNRTVKIADFGVARVEASN 225
K V A + + +H + +V+RD+K +N L+ + + DFG+ + +
Sbjct: 105 VKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK-FYRD 163
Query: 226 PNDMT--------GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
P +GT YM+ G +R+ D+ + G +Y
Sbjct: 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF--MY 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 44/222 (19%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHP 114
I G+FG ++ G + +VA+KL E +T+ E ++ L
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTK------HPQLLYESKIYRILQGGT 63
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
+ G + N+ +V++ L G +L+ L RKL+ K V
Sbjct: 64 GIPNVRWF--GVEGDY------------NV--LVMDLL-GPSLE-DLFNFCSRKLSLKTV 105
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT---VKIADFGVA---RVEASN--- 225
+ LA + + ++HS+ +HRD+K +N L+ R V I DFG+A R +++
Sbjct: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
Query: 226 -PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+ TGT Y + G +R+ D+ S G L +Y
Sbjct: 166 PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVL--MY 205
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 355 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.37 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.37 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.25 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.19 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.79 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.58 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.48 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.45 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.26 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.21 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.2 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.18 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.08 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.99 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.27 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.05 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.94 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.65 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.85 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 83.12 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=409.40 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=217.8
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++++.||+|+||.||+|.+ +++.||||++.+... ......+.+.+|+++++.++||||++++++|.+.
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~------~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 104 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI------IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 104 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 46899999999999999999976 688999999963221 1111235688999999999999999999999876
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.+ ||||||++||+|.+++.+ .+.+++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 105 ~~~----------------yivmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~ 166 (311)
T 4aw0_A 105 EKL----------------YFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 166 (311)
T ss_dssp SEE----------------EEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CEE----------------EEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc
Confidence 655 569999999999999954 46799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
.++.+||+|||+|....... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 167 ~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 246 (311)
T 4aw0_A 167 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI 246 (311)
T ss_dssp TTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998654322 2334568999999999999999999999999999999999999999999988888888
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 323 (355)
..... .++..+++++.+||.+||+.||.+|||++|++
T Consensus 247 ~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 247 IKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 77654 57788999999999999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=415.62 Aligned_cols=252 Identities=25% Similarity=0.456 Sum_probs=215.5
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++++.||+|+||.||+|.+ +++.||||++...... .. ..+.+.+|+.++++++|||||++++++.+.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~----~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 95 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS---SK----EREESRREVAVLANMKHPNIVQYRESFEEN 95 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC---HH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC---HH----HHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 46999999999999999999976 5899999999765432 11 245688999999999999999999999876
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ||||||++||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 96 ~~~----------------yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 159 (350)
T 4b9d_A 96 GSL----------------YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT 159 (350)
T ss_dssp TEE----------------EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC
T ss_pred CEE----------------EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC
Confidence 655 6699999999999999776667789999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.+|.+||+|||+|+............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 160 ~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 239 (350)
T 4b9d_A 160 KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239 (350)
T ss_dssp TTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence 99999999999998654322223345799999999999999999999999999999999999999999998888888877
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... +..+..+|+++.+||.+||+.||.+|||++|+++
T Consensus 240 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 240 GSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 654 3566778999999999999999999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-56 Score=397.84 Aligned_cols=266 Identities=32% Similarity=0.593 Sum_probs=219.3
Q ss_pred cccceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
...|++..+++++.+.||+|+||.||+|.+.+ .||||+++..... . ...+.|.+|+.++++++|||||++++
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~---~----~~~~~f~~E~~il~~l~HpNIV~l~g 99 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPT---P----EQFQAFRNEVAVLRKTRHVNILLFMG 99 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCC---H----HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCC---H----HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34689999999999999999999999998765 5999998643321 1 12456889999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++..+ . ++|||||+++|+|.+++... ...+++..+..|+.|++.||+|||+++|+||||||+
T Consensus 100 ~~~~~-~----------------~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~ 161 (307)
T 3omv_A 100 YMTKD-N----------------LAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSN 161 (307)
T ss_dssp EECSS-S----------------CEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSS
T ss_pred EEECC-e----------------EEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHH
Confidence 86532 2 26799999999999999643 456999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCC--CCCCCCCCCcccccCCcccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 018489 202 NMLLDKNRTVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~lltg~~p~~~~~ 276 (355)
|||++.++.+||+|||+|+..... ........||+.|+|||++.+ +.++.++||||||+++|+|+||+.||.+.+
T Consensus 162 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 162 NIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp SEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred HEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999764432 222344679999999999864 458999999999999999999999999877
Q ss_pred hhHHHHHHHhcCCC-C---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 277 FSEVTSAVVRQNLR-P---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 277 ~~~~~~~~~~~~~~-~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
........+..... + ..+..+|+++.+||.+||+.||.+|||+.+|++.|+.++.+.
T Consensus 242 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 242 NRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 66655555544332 2 345678999999999999999999999999999999987653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-57 Score=404.91 Aligned_cols=247 Identities=27% Similarity=0.407 Sum_probs=216.8
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+|++++.||+|+||.||+|.+ +|+.||||++....... .+.+.+|+.+++.++|||||++++++.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---------GGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---------HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5699999999999999999976 58999999997554332 234778999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.+ ||||||++||+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 145 ~~----------------~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 205 (346)
T 4fih_A 145 EL----------------WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 205 (346)
T ss_dssp EE----------------EEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EE----------------EEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC
Confidence 55 669999999999998853 46999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+|.+||+|||+|.............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 206 ~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 285 (346)
T 4fih_A 206 DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 285 (346)
T ss_dssp TCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred CCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 99999999999987665555556678999999999999999999999999999999999999999998888877776654
Q ss_pred CC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.. ....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 286 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 286 LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22 22334568999999999999999999999999886
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-57 Score=403.00 Aligned_cols=263 Identities=24% Similarity=0.329 Sum_probs=222.8
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
+....+.|++.+.||+|+||.||+|.+ +|+.||||+++.... ..+|+.+++.++|||||+++++
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------------~~~E~~il~~l~HpnIV~l~~~ 118 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------------RVEELVACAGLSSPRIVPLYGA 118 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------------CTHHHHTTTTCCCTTBCCEEEE
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------------HHHHHHHHHhCCCCCCCcEEEE
Confidence 334557899999999999999999976 588999999975332 2369999999999999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+.+.+.. +|||||++||+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 119 ~~~~~~~----------------~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 180 (336)
T 4g3f_A 119 VREGPWV----------------NIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADN 180 (336)
T ss_dssp EEETTEE----------------EEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGG
T ss_pred EEECCEE----------------EEEEeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHH
Confidence 8876555 669999999999999954 4579999999999999999999999999999999999
Q ss_pred EEEcCCC-cEEEeeccccccccCCCC-----CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 018489 203 MLLDKNR-TVKIADFGVARVEASNPN-----DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (355)
Q Consensus 203 ili~~~~-~v~L~Dfg~a~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~ 276 (355)
||++.+| .+||+|||+|+....... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 181 ILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp EEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred EEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 9999887 699999999986543221 1223479999999999999999999999999999999999999999887
Q ss_pred hhHHHHHHHhcCCC-CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCCCC
Q 018489 277 FSEVTSAVVRQNLR-PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIP 339 (355)
Q Consensus 277 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~~~ 339 (355)
.......+...... ..++..+++++.++|.+||+.||.+|||+.||++.|..+....++...|
T Consensus 261 ~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP 324 (336)
T 4g3f_A 261 RGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324 (336)
T ss_dssp CSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred HHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence 77777776665432 2467789999999999999999999999999999999988776654444
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-56 Score=397.29 Aligned_cols=263 Identities=30% Similarity=0.523 Sum_probs=220.2
Q ss_pred ceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
..+..++|.+.+.||+|+||.||+|.+ ++..||||+++... . ..++.|.+|++++++++|||||
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-----~----~~~~~f~~E~~il~~l~HpnIV 106 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-----E----SARQDFQREAELLTMLQHQHIV 106 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-----H----HHHHHHHHHHHHHTTCCCTTBC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-----H----HHHHHHHHHHHHHHhCCCCCCC
Confidence 456678999999999999999999975 36789999996321 1 2245688999999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-------------cccccHHHHHHHHHHHHHH
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-------------RRKLAFKVVVQLALDLARG 184 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~~~~~~~~i~~qi~~a 184 (355)
++++++.+.... +|||||+++|+|.+++.... ..++++..++.|+.|++.|
T Consensus 107 ~l~g~~~~~~~~----------------~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 170 (329)
T 4aoj_A 107 RFFGVCTEGRPL----------------LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAG 170 (329)
T ss_dssp CEEEEECSSSSE----------------EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHH
T ss_pred cEEEEEEECCEE----------------EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHH
Confidence 999998876555 66999999999999996532 2469999999999999999
Q ss_pred HHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHH
Q 018489 185 LSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262 (355)
Q Consensus 185 l~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il 262 (355)
|.|||+++|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++
T Consensus 171 l~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl 250 (329)
T 4aoj_A 171 MVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250 (329)
T ss_dssp HHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred HHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHH
Confidence 999999999999999999999999999999999998543322 222345789999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 263 WEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 263 ~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
|||+| |+.||.+.+..+....+... .....+..+++++.+|+.+||+.||++|||+.||++.|+.+....
T Consensus 251 ~Ellt~G~~Pf~~~~~~~~~~~i~~g-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 251 WEIFTYGKQPWYQLSNTEAIDCITQG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHHHTTSCCTTCSSCHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 99999 89999998888877766553 456778889999999999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=395.14 Aligned_cols=264 Identities=30% Similarity=0.513 Sum_probs=224.0
Q ss_pred eecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
++..++|.+.+.||+|+||.||+|.+ ++..||||+++... . ...+.|.+|+.++++++|||||+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-----~----~~~~~f~~E~~il~~l~HpnIV~ 79 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-----D----NARKDFHREAELLTNLQHEHIVK 79 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-----H----HHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-----h----HHHHHHHHHHHHHHhCCCCCCcc
Confidence 45567899999999999999999975 36789999996321 1 12456889999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-----------cccccHHHHHHHHHHHHHHHHH
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-----------RRKLAFKVVVQLALDLARGLSY 187 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~al~~ 187 (355)
+++++.+.+.. +|||||+++|+|.+++.... ...+++..++.|+.|++.||.|
T Consensus 80 l~g~~~~~~~~----------------~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y 143 (299)
T 4asz_A 80 FYGVCVEGDPL----------------IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVY 143 (299)
T ss_dssp EEEEECSSSSE----------------EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeeCCEE----------------EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 99999876655 66999999999999996532 3469999999999999999999
Q ss_pred HHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHH
Q 018489 188 LHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265 (355)
Q Consensus 188 LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l 265 (355)
||+++|+||||||+|||++.++.+||+|||+|+....... ......||+.|+|||.+.+..++.++||||||+++|||
T Consensus 144 LH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~El 223 (299)
T 4asz_A 144 LASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 223 (299)
T ss_dssp HHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999999999999975433222 12234588999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCC
Q 018489 266 YC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335 (355)
Q Consensus 266 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 335 (355)
+| |+.||.+.+..+....+... .....+..+|+++.+|+.+||+.||.+|||+.+|.+.|+++....+.
T Consensus 224 lt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~ 293 (299)
T 4asz_A 224 FTYGKQPWYQLSNNEVIECITQG-RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV 293 (299)
T ss_dssp HTTTCCTTTTSCHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred HcCCCCCCCCCCHHHHHHHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence 98 89999999888877776654 44567888999999999999999999999999999999999876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=388.11 Aligned_cols=247 Identities=28% Similarity=0.526 Sum_probs=201.0
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||||+++...... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK------SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD 86 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC------HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 5899999999999999999975 68999999997543221 122355889999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+ +|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 87 ~~----------------~ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~ 147 (275)
T 3hyh_A 87 EI----------------IMVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDE 147 (275)
T ss_dssp EE----------------EEEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT
T ss_pred EE----------------EEEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECC
Confidence 55 6699999 6799999854 467999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
++.+||+|||+|...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 148 ~~~vkl~DFGla~~~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~ 226 (275)
T 3hyh_A 148 HLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN 226 (275)
T ss_dssp TCCEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCEEEeecCCCeecCCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 999999999999754432 23345689999999999998876 5899999999999999999999999888887777766
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.. ..++..+|+++.+||.+||+.||.+|||++|+++
T Consensus 227 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 227 GV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp TC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 54 3467789999999999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-57 Score=400.01 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=211.2
Q ss_pred ecCCcceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
+++++|++++.||+|+||.||+|++ +++.||||+++........ ...+.+|+.++++++||||+++++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-------~~~~~~E~~il~~l~HpnIv~l~~ 93 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-------RVRTKMERDILVEVNHPFIVKLHY 93 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-------CC------CCCCCCCCTTEECEEE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-------HHHHHHHHHHHHHCCCCCCCeEEE
Confidence 4568999999999999999999965 4678999999654322111 123678999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++.+.+.. ++||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+
T Consensus 94 ~~~~~~~~----------------~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~ 155 (304)
T 3ubd_A 94 AFQTEGKL----------------YLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPE 155 (304)
T ss_dssp EEEETTEE----------------EEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGG
T ss_pred EEEECCEE----------------EEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHH
Confidence 99876655 669999999999999954 467999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
|||++.+|.+||+|||+|+............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 156 NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 235 (304)
T 3ubd_A 156 NILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235 (304)
T ss_dssp GEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred HeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH
Confidence 99999999999999999986554445555678999999999999999999999999999999999999999999988888
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM-----DEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell~ 324 (355)
..+..... .++..+|+++.+||.+||+.||.+|||+ +|+++
T Consensus 236 ~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 236 TMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 88877543 5678899999999999999999999984 66664
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-56 Score=406.67 Aligned_cols=247 Identities=27% Similarity=0.407 Sum_probs=217.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++++.||+|+||.||+|.+ +|+.||||++....... ++.+.+|+.+++.++|||||+++++|.+.+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---------GGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---------HHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 5699999999999999999976 58999999997654432 234778999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.+ |||||||+||+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 222 ~~----------------~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~ 282 (423)
T 4fie_A 222 EL----------------WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 282 (423)
T ss_dssp EE----------------EEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT
T ss_pred EE----------------EEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC
Confidence 55 669999999999999843 46999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+|.+||+|||+|.............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 283 ~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 362 (423)
T 4fie_A 283 DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 362 (423)
T ss_dssp TCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred CCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 99999999999987665555556678999999999999999999999999999999999999999998888877776654
Q ss_pred CC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.. ....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 363 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 363 LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 32 23345678999999999999999999999999986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=390.89 Aligned_cols=260 Identities=28% Similarity=0.507 Sum_probs=221.7
Q ss_pred ceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
.++..+++++.+.||+|+||.||+|.+ +++.||||+++..... ..++.|.+|+.++++++|||||
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--------~~~~~f~~E~~il~~l~HpNIV 92 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--------PLREEFRHEAMLRARLQHPNVV 92 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---------CHHHHHHHHHHHHHCCCTTBC
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--------HHHHHHHHHHHHHHhCCCCCCC
Confidence 356667899999999999999999975 4578999998643321 1134588999999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHHHHHHHHHH
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLAR 183 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~ 183 (355)
++++++...+.. +|||||+++|+|.+++.... ...+++..++.|+.||+.
T Consensus 93 ~l~g~~~~~~~~----------------~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 156 (308)
T 4gt4_A 93 CLLGVVTKDQPL----------------SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA 156 (308)
T ss_dssp CEEEEECSSSSC----------------EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHH
T ss_pred CcceEEEECCEE----------------EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHH
Confidence 999998876655 66999999999999996432 345899999999999999
Q ss_pred HHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCC--CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHH
Q 018489 184 GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGIC 261 (355)
Q Consensus 184 al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~i 261 (355)
||.|||+++|+||||||+|||++.++.+||+|||+++..... ........||+.|+|||.+.+..++.++||||||++
T Consensus 157 gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvv 236 (308)
T 4gt4_A 157 GMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVV 236 (308)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHH
Confidence 999999999999999999999999999999999999754332 222344678999999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 262 LWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 262 l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
+|||+| |..||.+.+..+....+.. ....+.+..+|+++.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 237 l~El~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 237 LWEVFSYGLQPYCGYSNQDVVEMIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTTTCCTTTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999998 8999999988877766654 445567888999999999999999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-55 Score=397.10 Aligned_cols=277 Identities=30% Similarity=0.541 Sum_probs=233.0
Q ss_pred cchhhcccccceecCCcceeecccccccceEEEEEEECC-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHH
Q 018489 35 SNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107 (355)
Q Consensus 35 ~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 107 (355)
...++.+..+|++..++|++.+.||+|+||.||+|.+.+ +.||||.++.... .. ..+.+.+|+.+
T Consensus 49 ~~~lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~----~~----~~~~~~~E~~i 120 (353)
T 4ase_A 49 CERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----HS----EHRALMSELKI 120 (353)
T ss_dssp GGGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC----HH----HHHHHHHHHHH
T ss_pred hhcCCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC----hH----HHHHHHHHHHH
Confidence 334556667899999999999999999999999997643 5699999864321 11 13558899999
Q ss_pred HhhCCC-CccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHH
Q 018489 108 WHKLDH-PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFK 172 (355)
Q Consensus 108 l~~l~h-~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~ 172 (355)
+.++.| ||||++++++...+. .++||||||++|+|.+++.... ...+++.
T Consensus 121 l~~l~hhpnIV~l~g~~~~~~~---------------~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~ 185 (353)
T 4ase_A 121 LIHIGHHLNVVNLLGACTKPGG---------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 185 (353)
T ss_dssp HHHHCCCTTBCCEEEEECCTTS---------------CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHH
T ss_pred HHHcCCCCcEEEEEEEEEecCC---------------EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHH
Confidence 999965 899999998765322 2367999999999999997543 2348999
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCC
Q 018489 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYN 250 (355)
Q Consensus 173 ~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 250 (355)
.+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....... ......||+.|+|||.+.+..++
T Consensus 186 ~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~ 265 (353)
T 4ase_A 186 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 265 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC
Confidence 9999999999999999999999999999999999999999999999985543322 22334688999999999999999
Q ss_pred CcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 251 RKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 251 ~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
.++||||||+++|||+| |+.||.+.+..+.....+........+..+++++.+++.+||+.||.+|||+.+|++.|+++
T Consensus 266 ~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 266 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 99999999999999998 99999987766666666666777788889999999999999999999999999999999998
Q ss_pred HhhcC
Q 018489 330 DTSKG 334 (355)
Q Consensus 330 ~~~~~ 334 (355)
.++..
T Consensus 346 lq~~~ 350 (353)
T 4ase_A 346 LQANA 350 (353)
T ss_dssp HHHTC
T ss_pred HHHhh
Confidence 76643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-55 Score=385.37 Aligned_cols=249 Identities=27% Similarity=0.488 Sum_probs=205.2
Q ss_pred ceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
|++.+.||+|+||.||+|.+ ++..||+|++...... . ...+.+.+|+.++++++|||||++++++.....
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~- 99 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---K----SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK- 99 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---H----HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET-
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC---H----HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC-
Confidence 37888999999999999976 5788999999644321 1 124568899999999999999999998864211
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEc-
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLD- 206 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~di~p~Nili~- 206 (355)
..+.++|||||++||+|.+++.+ ...+++..++.|+.||+.||.|||++| |+||||||+|||++
T Consensus 100 -----------~~~~~~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~ 166 (290)
T 3fpq_A 100 -----------GKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 166 (290)
T ss_dssp -----------TEEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS
T ss_pred -----------CCcEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC
Confidence 12234789999999999999954 467999999999999999999999998 99999999999997
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.+|.+||+|||+|+.... ......+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+.+....+...+.
T Consensus 167 ~~g~vKl~DFGla~~~~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~ 243 (290)
T 3fpq_A 167 PTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 243 (290)
T ss_dssp TTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred CCCCEEEEeCcCCEeCCC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH
Confidence 479999999999975432 23344689999999999976 599999999999999999999999987655444444333
Q ss_pred -cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 -QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
......++...++++.+||.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33334456678899999999999999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-53 Score=387.19 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=211.4
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++++.||+|+||.||+|.+ +|+.||||+++..... . ...+.+.+|+.+|+.++|||||++++++...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~---~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV---V----TNAKRTLRELKILKHFKHDNIIAIKDILRPT 125 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS---H----HHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc---h----HHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence 36899999999999999999976 6899999999643321 1 1134577899999999999999999987654
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
..+ .+.+.+||||||++ |+|.+++. ..+.+++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 126 ~~~----------~~~~~~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~ 192 (398)
T 4b99_A 126 VPY----------GEFKSVYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN 192 (398)
T ss_dssp SCT----------TTCCCEEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred ccc----------ccCCEEEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC
Confidence 322 12456689999995 67999884 456899999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCC----CCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 207 KNRTVKIADFGVARVEASN----PNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
.+|.+||+|||+|+..... .......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l 272 (398)
T 4b99_A 193 ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL 272 (398)
T ss_dssp TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999999999999754332 2233456899999999998875 5799999999999999999999999999888888
Q ss_pred HHHHhcCCCCC-----------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRPE-----------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+......+. +...+++++.+||.+||.+||.+|||+.|+|+
T Consensus 273 ~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 273 QLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 77765332221 11346889999999999999999999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=373.38 Aligned_cols=260 Identities=24% Similarity=0.408 Sum_probs=191.7
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++++.||+|+||.||+|.+ +++.||||+++.... . ...+.+.+|+.++++++|||||++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~----~----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 76 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR----E----LAREKVMREVKALAKLEHPGIVRYFNAWLEKN 76 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS----H----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC----H----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence 4799999999999999999976 588999999975431 1 12356889999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
..... ....+..++++||||++||+|.+++..... ...++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 77 ~~~~~----~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~ 152 (299)
T 4g31_A 77 TTEKL----QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT 152 (299)
T ss_dssp --------------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred ccccc----cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC
Confidence 32211 111233456899999999999999964322 2355677899999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCC------------CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 018489 207 KNRTVKIADFGVARVEASNPN------------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~ 274 (355)
.++.+||+|||+|+....... .....+||+.|+|||++.+..|+.++|||||||++|+|++ ||..
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 999999999999986543221 1233579999999999999999999999999999999996 7765
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
................+......++.+.+||.+||+.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 230 QMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 32221111112222212222334567889999999999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=373.08 Aligned_cols=260 Identities=33% Similarity=0.494 Sum_probs=203.3
Q ss_pred CcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
.+|.+.+.||+|+||.||+|.++|+.||||+++... .. ......|+..+.+++||||+++++++...+..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~-----~~-----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~ 72 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ER-----SWFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG-----HH-----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-----hh-----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence 578999999999999999999999999999985321 11 11233566677788999999999998754421
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ--------KIVHRDVKTE 201 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--------~i~H~di~p~ 201 (355)
...++|||||+++|+|.+++.. .++++..+.+++.|++.||+|||++ +|+||||||+
T Consensus 73 ------------~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~ 137 (303)
T 3hmm_A 73 ------------WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp ------------SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGG
T ss_pred ------------ceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcc
Confidence 1124789999999999999953 4699999999999999999999987 9999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCC----CCCCCCcccccCCcccCCC------CCCCcchhHHHHHHHHHHHhCCCC
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNGN------PYNRKCDVYSFGICLWEIYCCDMP 271 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~~lltg~~p 271 (355)
|||++.++.+||+|||+|+........ .....||+.|+|||++.+. .++.++||||||+++|||+||..|
T Consensus 138 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~ 217 (303)
T 3hmm_A 138 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217 (303)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCB
T ss_pred cEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCC
Confidence 999999999999999999865443221 2235799999999999764 356789999999999999999766
Q ss_pred CCCC---------------ChhHHHHHHHhcCCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 272 YPDL---------------SFSEVTSAVVRQNLRPEIPRC-----CPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 272 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
|... ........+......+.++.. .+..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 218 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 5321 123334444445555555543 23578999999999999999999999999999976
Q ss_pred hcC
Q 018489 332 SKG 334 (355)
Q Consensus 332 ~~~ 334 (355)
..+
T Consensus 298 ~~~ 300 (303)
T 3hmm_A 298 QEG 300 (303)
T ss_dssp C--
T ss_pred HcC
Confidence 543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=362.42 Aligned_cols=244 Identities=22% Similarity=0.311 Sum_probs=195.2
Q ss_pred CCcceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeee
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGA 122 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~ 122 (355)
.++|++.+.||+|+||.||+|.+ +++.||+|.+..... ...+.+|+++++.+ +||||++++++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----------~~~~~~E~~~l~~~~~h~nIv~l~~~ 88 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----------PIRIAAELQCLTVAGGQDNVMGVKYC 88 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----------HHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----------HHHHHHHHHHHHHhcCCCCCceEEEE
Confidence 37899999999999999999965 367899999854321 12367899999998 79999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...+.. ++||||++|++|.+++ +.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 89 ~~~~~~~----------------~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeN 147 (361)
T 4f9c_A 89 FRKNDHV----------------VIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSN 147 (361)
T ss_dssp EEETTEE----------------EEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEECCEE----------------EEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHH
Confidence 8876555 6699999999999988 248999999999999999999999999999999999
Q ss_pred EEEcCC-CcEEEeeccccccccCCC----------------------------CCCCCCCCcccccCCcccCCC-CCCCc
Q 018489 203 MLLDKN-RTVKIADFGVARVEASNP----------------------------NDMTGETGTLGYMAPEVLNGN-PYNRK 252 (355)
Q Consensus 203 ili~~~-~~v~L~Dfg~a~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~ 252 (355)
||++.+ +.+||+|||+|+...... ......+||+.|+|||++.+. .++.+
T Consensus 148 iLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~ 227 (361)
T 4f9c_A 148 FLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTA 227 (361)
T ss_dssp EEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTH
T ss_pred eEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCc
Confidence 999876 899999999997443211 112335799999999999875 58999
Q ss_pred chhHHHHHHHHHHHhCCCCCCCC-ChhHHHHHHHhc--------------------------------------------
Q 018489 253 CDVYSFGICLWEIYCCDMPYPDL-SFSEVTSAVVRQ-------------------------------------------- 287 (355)
Q Consensus 253 ~DvwslG~il~~lltg~~p~~~~-~~~~~~~~~~~~-------------------------------------------- 287 (355)
+||||+||++|+|++|+.||... +..+.+..+...
T Consensus 228 ~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~ 307 (361)
T 4f9c_A 228 IDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPK 307 (361)
T ss_dssp HHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------
T ss_pred cchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccc
Confidence 99999999999999999999544 333333322210
Q ss_pred --------CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 --------NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.........+++++.+||++||++||.+|||++|+|+
T Consensus 308 ~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 308 LTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp --------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0001123457899999999999999999999999985
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=355.18 Aligned_cols=272 Identities=39% Similarity=0.644 Sum_probs=222.7
Q ss_pred hcccccceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
......+++..++|++.+.||+|+||.||+|.+++..||+|++...... .. ..+.+.+|+.++++++||||++
T Consensus 26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~---~~----~~~~~~~E~~~l~~l~hp~iv~ 98 (309)
T 3p86_A 26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFH---AE----RVNEFLREVAIMKRLRHPNIVL 98 (309)
T ss_dssp ------CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCS---HH----HHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCC---HH----HHHHHHHHHHHHHhCCCCCEee
Confidence 4556678888999999999999999999999999999999998654321 11 1345788999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHhCC--ccc
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQK--IVH 195 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H 195 (355)
+++++...... ++||||+++++|.+++.... ...+++..++.++.|++.||.|||++| ++|
T Consensus 99 ~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH 162 (309)
T 3p86_A 99 FMGAVTQPPNL----------------SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162 (309)
T ss_dssp EEEEECSTTCC----------------EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCC
T ss_pred EEEEEEECCce----------------EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEC
Confidence 99998766554 66999999999999996432 234999999999999999999999999 999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 196 ~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
|||||+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 163 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp TTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred CCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999976554444445567899999999999999999999999999999999999999998
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
+..+....+........++..+++++.++|.+||+.||.+|||+.++++.|+.+..+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 243 NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 8888877777677777888899999999999999999999999999999999997653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=382.02 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=207.7
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
.+..++|++++.||+|+||.||+|++ +|+.||||++.+........ ........+++.+++.++|||||+++++|
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~---~~~~~~E~~~l~ll~~~~HP~IV~l~~~f 261 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCPFIVCMSYAF 261 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC---HHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhh---HHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence 45568999999999999999999976 68999999996432111111 11112234457778888999999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.+.+.+ |+||||++||+|.+++.+ .+.+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 262 ~~~~~l----------------ylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNI 323 (689)
T 3v5w_A 262 HTPDKL----------------SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323 (689)
T ss_dssp ECSSEE----------------EEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred EECCEE----------------EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHe
Confidence 877665 569999999999999954 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh---hH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF---SE 279 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~---~~ 279 (355)
||+.+|.+||+|||+|...... .....+||+.|+|||++.+ ..|+.++|+|||||++|+|++|..||.+.+. ..
T Consensus 324 Lld~~G~vKL~DFGlA~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~ 401 (689)
T 3v5w_A 324 LLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401 (689)
T ss_dssp EECTTSCEEECCCTTCEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH
T ss_pred EEeCCCCEEecccceeeecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9999999999999999865432 2344689999999999964 5799999999999999999999999976432 23
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 018489 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVS 324 (355)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 324 (355)
....+.. ....++..+|+++.+||.+||+.||.+|++ ++||++
T Consensus 402 i~~~i~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 402 IDRMTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHhhcC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 3333333 344577889999999999999999999998 677765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=380.71 Aligned_cols=248 Identities=22% Similarity=0.366 Sum_probs=215.2
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++++.||+|+||.||+|.+ +|+.||+|++..... . ..+.+.+|+.+|+.++||||++++++|.+..
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-----~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----S----DKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----H----HHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-----h----hHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 6899999999999999999976 689999999865321 1 1345778999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.+ +|||||++||+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 228 ~~----------------~iv~E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~ 290 (573)
T 3uto_A 228 EM----------------VMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290 (573)
T ss_dssp EE----------------EEEEECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EE----------------EEEEeecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC
Confidence 55 669999999999998853 3456999999999999999999999999999999999999985
Q ss_pred C--CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 208 N--RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 208 ~--~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
+ +.+||+|||++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 291 ~~~~~vKl~DFG~a~~~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~ 369 (573)
T 3uto_A 291 KRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369 (573)
T ss_dssp SSCCCEEECCCSSCEECCTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEeeccceeEccCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 4 89999999999865432 23344579999999999999999999999999999999999999999999988888887
Q ss_pred hcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...... .....+++++.+||.+||+.||.+|||+.|+++
T Consensus 370 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 370 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 765443 334568999999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=335.89 Aligned_cols=262 Identities=26% Similarity=0.481 Sum_probs=226.7
Q ss_pred cceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
.+++..++|++.+.||+|+||.||+|.+++..||+|++...... .. ..+.+.+|+.++++++||||+++++++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~---~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~ 76 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWS---TR----KSRDFNEECPRLRIFSHPNVLPVLGAC 76 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCC---HH----HHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccC---HH----HHHHHHHHHHHHHhcCCCchhheEEEE
Confidence 45677889999999999999999999999999999999754322 11 134588999999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCC
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTE 201 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~di~p~ 201 (355)
..... +..+++|||+++++|.+++.......+++..++.++.|++.||.|||++| ++|+||+|+
T Consensus 77 ~~~~~--------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~ 142 (271)
T 3kmu_A 77 QSPPA--------------PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSR 142 (271)
T ss_dssp CTTTS--------------SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGG
T ss_pred ccCCC--------------CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccc
Confidence 76522 23377999999999999997655556999999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCC---cchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNR---KCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
||+++.++.++++||+++.... .....+++.|+|||.+.+..++. ++||||||+++|+|++|..||...+..
T Consensus 143 Nil~~~~~~~~l~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 217 (271)
T 3kmu_A 143 SVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM 217 (271)
T ss_dssp GEEECTTSCEEEEGGGSCCTTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH
T ss_pred eEEEcCCcceeEEeccceeeec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH
Confidence 9999999999999998875322 22346789999999998765444 799999999999999999999999888
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
............+..+..+++++.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 218 EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 88888888888888888999999999999999999999999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=347.36 Aligned_cols=268 Identities=34% Similarity=0.585 Sum_probs=224.8
Q ss_pred ccccceecCCcceeecccccccceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 111 (355)
....+++..++|++.+.||+|+||.||+|.+. +..||+|+++... .. ...+.+.+|+.+++.+
T Consensus 72 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l 143 (370)
T 2psq_A 72 EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TE----KDLSDLVSEMEMMKMI 143 (370)
T ss_dssp CCTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC----BH----HHHHHHHHHHHHHHHS
T ss_pred ccccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc----CH----HHHHHHHHHHHHHHHh
Confidence 34457778899999999999999999999752 3469999986432 11 1234578999999999
Q ss_pred -CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHHH
Q 018489 112 -DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQ 176 (355)
Q Consensus 112 -~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~ 176 (355)
+||||+++++++...+.. ++||||+++++|.+++.... ...+++..++.
T Consensus 144 ~~hpnIv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (370)
T 2psq_A 144 GKHKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207 (370)
T ss_dssp CCCTTBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHH
T ss_pred cCCCCEeeEEEEEccCCCE----------------EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHH
Confidence 899999999998766554 66999999999999997543 23589999999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcch
Q 018489 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCD 254 (355)
Q Consensus 177 i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~D 254 (355)
++.||+.||.|||++|++||||||+|||++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|
T Consensus 208 i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 287 (370)
T 2psq_A 208 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 287 (370)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHH
T ss_pred HHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHH
Confidence 99999999999999999999999999999999999999999997544322 1223345678899999999999999999
Q ss_pred hHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 255 VYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 255 vwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
|||||+++|+|++ |..||.+.+..+....+.. ......+..+++++.++|.+||+.||.+||++.++++.|+++.+..
T Consensus 288 vwslG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 288 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 9999999999999 9999998887776655443 4455677889999999999999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=333.78 Aligned_cols=263 Identities=31% Similarity=0.641 Sum_probs=223.6
Q ss_pred cccceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
...|.+..++|++.+.||+|+||.||+|.+ ++..||+|++...... .+.+.+|+.++++++||||++++
T Consensus 2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~ 71 (269)
T 4hcu_A 2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLY 71 (269)
T ss_dssp ---CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----------HHHHHHHHHHHHhCCCCCEeeEE
Confidence 356889999999999999999999999987 6788999999654321 13478899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++...... ++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||||
T Consensus 72 ~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp 134 (269)
T 4hcu_A 72 GVCLEQAPI----------------CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA 134 (269)
T ss_dssp EEECSSSSE----------------EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEEecCCce----------------EEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcch
Confidence 998765544 6699999999999998643 45699999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChh
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~ 278 (355)
+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus 135 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~ 214 (269)
T 4hcu_A 135 RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 214 (269)
T ss_dssp GGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred heEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 99999999999999999997543221 12233456778999999998889999999999999999999 99999988877
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
+....+... .....+..+++++.++|.+||+.||.+||++.++++.|+.+..+
T Consensus 215 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 215 EVVEDISTG-FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhcC-ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 766665443 44556677899999999999999999999999999999998765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=339.03 Aligned_cols=249 Identities=24% Similarity=0.446 Sum_probs=215.0
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
...+|++.+.||+|+||.||+|.+ +++.||+|++....... .+.+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---------KELIINEILVMRENKNPNIVNYLDSYLV 88 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---------HHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence 347899999999999999999965 68899999986543322 2347789999999999999999999886
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. ++||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 89 ~~~~----------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~ 149 (297)
T 3fxz_A 89 GDEL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (297)
T ss_dssp TTEE----------------EEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCEE----------------EEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE
Confidence 6554 669999999999999853 469999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
+.++.++|+|||.+..............++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 229 (297)
T 3fxz_A 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229 (297)
T ss_dssp CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999998866555555556789999999999999999999999999999999999999998887766665554
Q ss_pred hcC-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQN-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... .....+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 230 TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 433 233456678999999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=334.76 Aligned_cols=259 Identities=32% Similarity=0.667 Sum_probs=214.6
Q ss_pred ceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
+++..++|++.+.||+|+||.||+|.+++..||+|+++..... ......+.+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (271)
T 3dtc_A 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDE-----DISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76 (271)
T ss_dssp CBCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC---------------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcc-----cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 4567789999999999999999999999999999998643321 11222355788999999999999999999987
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCC
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK---IVHRDVKTE 201 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~di~p~ 201 (355)
..... ++||||+++++|.+++ ....+++..++.++.|++.||.|||++| ++|+||||+
T Consensus 77 ~~~~~----------------~lv~e~~~~~~L~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~ 137 (271)
T 3dtc_A 77 KEPNL----------------CLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137 (271)
T ss_dssp CC--C----------------EEEEECCTTEEHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGG
T ss_pred cCCce----------------EEEEEcCCCCCHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchH
Confidence 65554 6699999999999988 3457999999999999999999999999 899999999
Q ss_pred cEEEcC--------CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 018489 202 NMLLDK--------NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (355)
Q Consensus 202 Nili~~--------~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~ 273 (355)
||+++. ++.++|+|||.+....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.
T Consensus 138 Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 215 (271)
T 3dtc_A 138 NILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215 (271)
T ss_dssp GEEESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred HEEEecccccccccCcceEEccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999986 7789999999997544322 224578999999999998889999999999999999999999999
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
+.+.................+..+++++.++|.+||+.||.+|||+.++++.|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 216 GIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 98888888777777777778888999999999999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=342.03 Aligned_cols=252 Identities=27% Similarity=0.444 Sum_probs=216.8
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
+..++|++.+.||+|+||.||+|.+ +++.||+|+++.... ........+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 75 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh------hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence 4457999999999999999999976 588999999963211 01112345778999999999999999999988
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..+.. ++||||++|++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 76 ~~~~~----------------~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 137 (337)
T 1o6l_A 76 THDRL----------------CFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp CSSEE----------------EEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred eCCEE----------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEE
Confidence 76554 669999999999999854 457999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
++.+|.++|+|||++..............||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+
T Consensus 138 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 217 (337)
T 1o6l_A 138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217 (337)
T ss_dssp ECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999999999976444444455567999999999999999999999999999999999999999988888777777
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
..... .++..+++++.++|.+||+.||.+|| ++.++++
T Consensus 218 ~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 218 LMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HcCCC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 66543 46778899999999999999999999 8999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=341.51 Aligned_cols=266 Identities=31% Similarity=0.570 Sum_probs=221.3
Q ss_pred ceecCCcceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
.++..++|++.+.||+|+||.||+|.+ .+..||||+++... .. ...+.+.+|+.+++.++||||+++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l~h~~iv~~ 115 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----TE----RQRRDFLSEASIMGQFDHPNIIRL 115 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC----CH----HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC----CH----HHHHHHHHHHHHHHhCCCCCCCcE
Confidence 467789999999999999999999976 24459999996332 11 123568899999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++...... ++||||+++++|.+++... ...+++..++.|+.|++.||.|||+.||+|+|||
T Consensus 116 ~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk 178 (325)
T 3kul_A 116 EGVVTRGRLA----------------MIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178 (325)
T ss_dssp EEEECGGGCC----------------EEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred EEEEEeCCcc----------------EEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence 9998765544 6699999999999998543 4569999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~ 275 (355)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 179 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 179 ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp GGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999986543322 1222345678999999998889999999999999999999 99999988
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCC
Q 018489 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGG 336 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~ 336 (355)
........+... .....+..+++++.++|..||+.||.+|||+.+|++.|+.+..+....
T Consensus 259 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 259 TNRDVISSVEEG-YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp CHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred CHHHHHHHHHcC-CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 887776665543 455667789999999999999999999999999999999998765543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=342.13 Aligned_cols=248 Identities=27% Similarity=0.502 Sum_probs=215.1
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||||++...... . ...+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 86 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN---P----TSLQKLFREVRIMKILNHPNIVKLFEVIETE 86 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---H----HHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC---H----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 46899999999999999999976 7899999999654321 1 1234577899999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 87 ~~~----------------~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~ 148 (328)
T 3fe3_A 87 KTL----------------YLIMEYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD 148 (328)
T ss_dssp SEE----------------EEEECCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CEE----------------EEEEECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc
Confidence 554 669999999999999954 35699999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCC-CcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
.++.++|+|||++...... .......|++.|+|||.+.+..++ .++||||||+++|+|++|+.||.+.+.......+.
T Consensus 149 ~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 227 (328)
T 3fe3_A 149 ADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 227 (328)
T ss_dssp TTSCEEECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCEEEeeccCceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999999754432 334456799999999999887765 78999999999999999999999998888888777
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.... .++..+++++.++|++||+.||.+|||+.++++
T Consensus 228 ~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 228 RGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred hCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 7654 466678999999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=346.07 Aligned_cols=276 Identities=30% Similarity=0.535 Sum_probs=231.5
Q ss_pred cchhhcccccceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHH
Q 018489 35 SNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107 (355)
Q Consensus 35 ~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 107 (355)
...+......|++..++|++.+.||+|+||.||+|.+ +++.||||+++.... .. ..+.+.+|+.+
T Consensus 7 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~----~~~~~~~E~~~ 78 (359)
T 3vhe_A 7 CERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----HS----EHRALMSELKI 78 (359)
T ss_dssp GGGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----HH----HHHHHHHHHHH
T ss_pred hhhCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC----HH----HHHHHHHHHHH
Confidence 3445666778899999999999999999999999974 347899999964321 11 13457899999
Q ss_pred HhhC-CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc--------------------
Q 018489 108 WHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-------------------- 166 (355)
Q Consensus 108 l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------------- 166 (355)
+.++ +||||+++++++...+. ..++||||+++++|.+++.....
T Consensus 79 l~~l~~hpniv~~~~~~~~~~~---------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (359)
T 3vhe_A 79 LIHIGHHLNVVNLLGACTKPGG---------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143 (359)
T ss_dssp HHHHCCCTTBCCEEEEECSTTS---------------CCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------
T ss_pred HHhhcCCcceeeeeeeeecCCC---------------ceEEEEEecCCCcHHHHHHhccccccccccccchhhccccccc
Confidence 9999 88999999998876443 23679999999999999965432
Q ss_pred --------------------------------------------ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 167 --------------------------------------------RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 167 --------------------------------------------~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
..+++..++.++.||+.||.|||++|++|+||||+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~N 223 (359)
T 3vhe_A 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 223 (359)
T ss_dssp ----------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhh
Confidence 128999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~ 279 (355)
|+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....
T Consensus 224 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 303 (359)
T 3vhe_A 224 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303 (359)
T ss_dssp EEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred EEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH
Confidence 9999999999999999975433222 2233557888999999998889999999999999999998 999999887777
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
..............+..+++++.++|.+||+.||.+|||+.++++.|+.+..+.
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 304 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 776777777777788889999999999999999999999999999999987653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=331.11 Aligned_cols=269 Identities=30% Similarity=0.573 Sum_probs=225.0
Q ss_pred cccceecCCcceeecccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
..+|++..++|++.+.||+|+||.||+|.+. +..||+|++...... .+.+.+|+.+++.++||||++++
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~ 74 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----------PDAFLAEANLMKQLQHQRLVRLY 74 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----------HHHHHHHHHHHHhCCCcCcceEE
Confidence 4578999999999999999999999999775 468999998643321 23478899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++.... .++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|
T Consensus 75 ~~~~~~~-----------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp 137 (279)
T 1qpc_A 75 AVVTQEP-----------------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA 137 (279)
T ss_dssp EEECSSS-----------------CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEcCCC-----------------cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 9875322 36799999999999999655445799999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChh
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~ 278 (355)
+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus 138 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 217 (279)
T 1qpc_A 138 ANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217 (279)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred hhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH
Confidence 999999999999999999976543321 2233456778999999988888999999999999999999 99999988877
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCCC
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMI 338 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~~ 338 (355)
+....+.. ......+..+++++.++|.+||+.||.+|||+.++++.|+.+.....+...
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 276 (279)
T 1qpc_A 218 EVIQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276 (279)
T ss_dssp HHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-----
T ss_pred HHHHHHhc-ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCC
Confidence 66655544 344556678899999999999999999999999999999999887665443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=334.38 Aligned_cols=266 Identities=26% Similarity=0.508 Sum_probs=214.0
Q ss_pred ceecCCcceeecccccccceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
.++..++|++.+.||+|+||.||+|.+ +++.||+|++.... . ...+.+.+|+.+++.++||||++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----~----~~~~~~~~E~~~l~~l~h~~iv~ 75 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-----E----EHLRDFEREIEILKSLQHDNIVK 75 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-----H----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-----H----HHHHHHHHHHHHHHhCCCCCEee
Confidence 456778999999999999999999974 57899999986321 1 12345789999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++...+.. ..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||
T Consensus 76 ~~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Di 140 (295)
T 3ugc_A 76 YKGVCYSAGRR--------------NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 140 (295)
T ss_dssp EEEEECHHHHT--------------SCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEecCCCC--------------ceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCC
Confidence 99987644322 237899999999999999654 345999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCC---CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNP---NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
||+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 141 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 141 ATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp SGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred CHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 9999999999999999999997654322 1222345677899999999888999999999999999999999998643
Q ss_pred Chh---------------HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 276 SFS---------------EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 276 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
... ...............+..+++++.++|.+||+.||.+|||+.++++.|+.+....+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 221 PAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred hHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 211 12223334455556778899999999999999999999999999999999987654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=335.40 Aligned_cols=270 Identities=29% Similarity=0.546 Sum_probs=229.5
Q ss_pred cccceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CC
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DH 113 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 113 (355)
...|++..++|++.+.||+|+||.||+|.+ ++..||+|+++.... . ...+.+.+|+.+++++ +|
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~l~~h 86 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----L----TEREALMSELKVLSYLGNH 86 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----H----HHHHHHHHHHHHHHHHCCC
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh----H----HHHHHHHHHHHHHhhcccC
Confidence 455788889999999999999999999974 457899999964321 1 1235688999999999 99
Q ss_pred CccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc----------------ccccHHHHHHH
Q 018489 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR----------------RKLAFKVVVQL 177 (355)
Q Consensus 114 ~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----------------~~~~~~~~~~i 177 (355)
|||+++++++...+.. ++||||+++++|.+++..... ..+++..++.+
T Consensus 87 ~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (313)
T 1t46_A 87 MNIVNLLGACTIGGPT----------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150 (313)
T ss_dssp TTBCCEEEEECSSSSC----------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHH
T ss_pred CCeeeEEEEEecCCCc----------------EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHH
Confidence 9999999998766554 669999999999999975432 24899999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchh
Q 018489 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDV 255 (355)
Q Consensus 178 ~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv 255 (355)
+.|++.||.|||++|++|+||||+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++||
T Consensus 151 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 230 (313)
T 1t46_A 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230 (313)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHH
Confidence 999999999999999999999999999999999999999999755433221 223446778999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 256 YSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 256 wslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
||||+++|+|++ |..||.....................+..+++++.++|.+||+.||.+|||+.++++.|+++.....
T Consensus 231 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 999999999998 9999988877666666666666666778899999999999999999999999999999999987755
Q ss_pred C
Q 018489 335 G 335 (355)
Q Consensus 335 ~ 335 (355)
.
T Consensus 311 ~ 311 (313)
T 1t46_A 311 N 311 (313)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=346.72 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=209.3
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHH-HhhCCCCccceeeee
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV-WHKLDHPNVTKFIGA 122 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~Iv~~~~~ 122 (355)
.+..++|++.+.||+|+||.||+|.+ ++..||+|+++......... ...+.+|..+ ++.++||||++++++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~------~~~~~~e~~~ll~~~~hp~Iv~l~~~ 107 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE------EKHIMSERNVLLKNVKHPFLVGLHFS 107 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------------CCBCCCCCTTBCCEEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHH------HHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence 34568999999999999999999976 57889999997544321111 1234456665 466799999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...+.. ++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 108 ~~~~~~~----------------~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 169 (373)
T 2r5t_A 108 FQTADKL----------------YFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPEN 169 (373)
T ss_dssp EECSSEE----------------EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred EEeCCEE----------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHH
Confidence 8876555 669999999999999854 4569999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
|+++.+|.++|+|||++..............||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+...
T Consensus 170 Ill~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~ 249 (373)
T 2r5t_A 170 ILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249 (373)
T ss_dssp EEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH
T ss_pred EEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 99999999999999999865444445556789999999999999999999999999999999999999999988888888
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
.+..... .++..++.++.++|.+||+.||.+||++.+.+..+
T Consensus 250 ~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 250 NILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp HHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred HHHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 7776543 46677899999999999999999999985444433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=340.62 Aligned_cols=269 Identities=29% Similarity=0.510 Sum_probs=223.7
Q ss_pred ccceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCC
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHP 114 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 114 (355)
.+|++..++|++.+.||+|+||.||+|.+ ++..||+|++..... ....+.+.+|+.++.++ +||
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~hp 109 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--------SSEREALMSELKMMTQLGSHE 109 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCCT
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--------HHHHHHHHHHHHHHHhhcCCC
Confidence 45888899999999999999999999976 346799999964321 11234588999999999 999
Q ss_pred ccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc---------------------ccccHHH
Q 018489 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---------------------RKLAFKV 173 (355)
Q Consensus 115 ~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------------~~~~~~~ 173 (355)
||+++++++...+.. ++||||+++++|.+++..... ..+++..
T Consensus 110 ~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 173 (344)
T 1rjb_A 110 NIVNLLGACTLSGPI----------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173 (344)
T ss_dssp TBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHH
T ss_pred CeeeEEEEEeeCCcc----------------EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHH
Confidence 999999998766554 669999999999999965432 2479999
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCC
Q 018489 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNR 251 (355)
Q Consensus 174 ~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~ 251 (355)
++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.
T Consensus 174 ~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 253 (344)
T 1rjb_A 174 LLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 253 (344)
T ss_dssp HHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCCh
Confidence 999999999999999999999999999999999999999999999975543322 122344677899999998888999
Q ss_pred cchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 252 KCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 252 ~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
++||||||+++|+|++ |..||.+...................+..+++++.++|.+||+.||.+|||+.++++.|+.+.
T Consensus 254 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 254 KSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp HHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred hHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 9999999999999998 999999887777777777777777778889999999999999999999999999999999987
Q ss_pred hhcCC
Q 018489 331 TSKGG 335 (355)
Q Consensus 331 ~~~~~ 335 (355)
....+
T Consensus 334 ~~~~~ 338 (344)
T 1rjb_A 334 ADAEE 338 (344)
T ss_dssp -----
T ss_pred HHHHH
Confidence 65443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=344.10 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=210.3
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeec
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGAT 123 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~ 123 (355)
+..++|++.+.||+|+||.||+|.+ +++.||||+++... .......+.+.+|..++..+ +||||+++++++
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~------~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV------ILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH------HHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH------hcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 4557999999999999999999976 57899999996321 11112234567899999988 799999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...+.. ++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 94 ~~~~~~----------------~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 155 (353)
T 3txo_A 94 QTPDRL----------------FFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV 155 (353)
T ss_dssp ECSSEE----------------EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred EeCCEE----------------EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHE
Confidence 876654 669999999999999954 46799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
|++.++.++|+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....
T Consensus 156 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~ 235 (353)
T 3txo_A 156 LLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 235 (353)
T ss_dssp EECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999997554444445556899999999999988899999999999999999999999999998888888
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH------HHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM------DEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~ell~ 324 (355)
+..... .++..+++++.++|++||+.||.+||++ .+|++
T Consensus 236 i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 236 ILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 877544 4667789999999999999999999998 67765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=334.10 Aligned_cols=261 Identities=27% Similarity=0.398 Sum_probs=210.1
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccH-----------------HHHHHHHHHHHHHHHH
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTE-----------------AEIAALRSAFTQEVAV 107 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~-----------------~~~~~~~~~~~~E~~~ 107 (355)
+..++|++.+.||+|+||.||+|.+ +++.||||++.......... .......+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3447999999999999999999976 68899999997544221100 0001123457899999
Q ss_pred HhhCCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHH
Q 018489 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSY 187 (355)
Q Consensus 108 l~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 187 (355)
++.++||||+++++++..... ...++||||+++++|.+++ ....+++..++.++.|++.||.|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~--------------~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~ 152 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNE--------------DHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEY 152 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSS--------------SEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEcCCC--------------CEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHH
Confidence 999999999999998875332 2337899999999998764 34579999999999999999999
Q ss_pred HHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCC---CCCcchhHHHHHHHHH
Q 018489 188 LHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP---YNRKCDVYSFGICLWE 264 (355)
Q Consensus 188 LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~~ 264 (355)
||++|++|+||||+||+++.++.++|+|||.+..............++..|+|||.+.+.. ++.++||||||+++|+
T Consensus 153 lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 153 LHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp HHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred HHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence 9999999999999999999999999999999986554444445567999999999998764 3678999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 265 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 265 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
|++|..||...+.......+............+++++.++|.+||+.||.+||++.++++
T Consensus 233 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 233 FVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 999999999887777766666655554455678999999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=351.14 Aligned_cols=261 Identities=31% Similarity=0.620 Sum_probs=225.5
Q ss_pred cccceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
...|++..++|++.+.||+|+||.||+|.+++..||||+++.... .+.+.+|+.++++++||||+++++
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~ 253 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLG 253 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT-----------SHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH-----------HHHHHHHHHHHHhccCCCEEEEEE
Confidence 567899999999999999999999999999999999999964321 234788999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++..... ..++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+
T Consensus 254 ~~~~~~~---------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~ 318 (450)
T 1k9a_A 254 VIVEEKG---------------GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 318 (450)
T ss_dssp EEECTTS---------------CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEcCCC---------------ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence 8765431 2367999999999999997665555899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~ 280 (355)
|||++.++.++|+|||++...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.
T Consensus 319 Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~ 395 (450)
T 1k9a_A 319 NVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 395 (450)
T ss_dssp GEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH
T ss_pred hEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999999744322 122356788999999999999999999999999999998 9999998877776
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
...+.. ......+..+++++.++|.+||+.||.+|||+.+|++.|+.+...
T Consensus 396 ~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 396 VPRVEK-GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHc-CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 665543 455667788999999999999999999999999999999999765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=331.84 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=215.6
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|+||.||+|.+ ++..||+|++....... ....+.+.+|+.++.+++||||+++++++..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK------EETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCC------HHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcccc------HHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence 357999999999999999999976 57899999986544322 1224568899999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. ++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 83 ~~~~----------------~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~ 144 (294)
T 4eqm_A 83 DDCY----------------YLVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI 144 (294)
T ss_dssp SSEE----------------EEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CCeE----------------EEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 5544 669999999999999954 3579999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.++.++|+|||.+....... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+........
T Consensus 145 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~ 224 (294)
T 4eqm_A 145 DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224 (294)
T ss_dssp CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH
T ss_pred CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 999999999999997544322 2223356899999999999998999999999999999999999999988876666555
Q ss_pred HhcCCCC---CCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHhHhhc
Q 018489 285 VRQNLRP---EIPRCCPSSLANVMKRCWDANPDKRP-EMDEVVSMLEAIDTSK 333 (355)
Q Consensus 285 ~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~ell~~l~~~~~~~ 333 (355)
....... .....+++.+.++|.+||+.||.+|| +++++++.|..+....
T Consensus 225 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 225 IQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred hhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 4443322 24566899999999999999999998 9999999999876543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=330.93 Aligned_cols=265 Identities=31% Similarity=0.605 Sum_probs=217.8
Q ss_pred hcccccceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
......|.+..++|++.+.||+|+||.||++.++++.||+|+++... ..+.+.+|+.+++.++||||++
T Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~ 78 (278)
T 1byg_A 10 EFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQ 78 (278)
T ss_dssp -----CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------------HHHHHTHHHHTTCCCTTBCC
T ss_pred hhhhccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----------HHHHHHHHHHHHHhCCCCCEee
Confidence 34455678888999999999999999999999999999999986432 1245788999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++.... +..++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||
T Consensus 79 ~~~~~~~~~---------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 143 (278)
T 1byg_A 79 LLGVIVEEK---------------GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 143 (278)
T ss_dssp EEEEECCC-----------------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEEcCC---------------CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Confidence 999865432 12367999999999999997655555899999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus 144 kp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 220 (278)
T 1byg_A 144 AARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220 (278)
T ss_dssp SGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred CcceEEEeCCCcEEEeecccccccccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998754322 222356788999999988889999999999999999998 9999998877
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
......+.. ......+..+++.+.++|.+||+.||.+||++.++++.|+.+....
T Consensus 221 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 221 KDVVPRVEK-GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp GGHHHHHTT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHhc-CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 766655433 3455677788999999999999999999999999999999998653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=348.76 Aligned_cols=251 Identities=21% Similarity=0.360 Sum_probs=215.7
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ ++..+|+|++...... . ...+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~---~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS---A----RDHQKLEREARICRLLKHPNIVRLHDSISEE 82 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH---H----HHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC---H----HHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence 37899999999999999999976 6899999999754321 1 1134578999999999999999999998766
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++||||++|++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 83 ~~~----------------~lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~ 144 (444)
T 3soa_A 83 GHH----------------YLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLA 144 (444)
T ss_dssp SEE----------------EEEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEES
T ss_pred CEE----------------EEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence 555 569999999999999854 46699999999999999999999999999999999999998
Q ss_pred ---CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 207 ---KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 207 ---~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
.++.++|+|||.+..............|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......
T Consensus 145 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~ 224 (444)
T 3soa_A 145 SKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ 224 (444)
T ss_dssp BSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 46889999999998666555555567899999999999998999999999999999999999999999888888888
Q ss_pred HHhcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+......... ...+++++.++|.+||+.||.+|||+.++++
T Consensus 225 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 225 IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 7776554333 3468999999999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=341.95 Aligned_cols=271 Identities=28% Similarity=0.450 Sum_probs=215.4
Q ss_pred hhcccccceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 38 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
.+....++.+..++|++.+.||+|+||.||+|.+.++.||||++.... .. .....+|+.++..++||||+
T Consensus 12 ~~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~----~~~~~~E~~~l~~l~hpniv 81 (322)
T 3soc_A 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD------KQ----SWQNEYEVYSLPGMKHENIL 81 (322)
T ss_dssp --CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG------HH----HHHHHHHHHTSTTCCCTTBC
T ss_pred cccCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc------hH----HHHHHHHHHHHhcCCCCCch
Confidence 345566788999999999999999999999999999999999995321 11 22345688999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC------
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ------ 191 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~------ 191 (355)
++++++...... ....++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.
T Consensus 82 ~~~~~~~~~~~~------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~ 146 (322)
T 3soc_A 82 QFIGAEKRGTSV------------DVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKD 146 (322)
T ss_dssp CEEEEEEEECSS------------SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETT
T ss_pred hhcceeccCCCC------------CceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhcccccc
Confidence 999998764421 2234789999999999999953 4599999999999999999999999
Q ss_pred ----CccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCC-----CCCCcchhHHHHH
Q 018489 192 ----KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGN-----PYNRKCDVYSFGI 260 (355)
Q Consensus 192 ----~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~ 260 (355)
|++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++||||||+
T Consensus 147 ~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 226 (322)
T 3soc_A 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226 (322)
T ss_dssp EEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred ccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHH
Confidence 999999999999999999999999999976543322 23335789999999999873 4556789999999
Q ss_pred HHHHHHhCCCCCCCCC----------------hhHHHHHHHhcCCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCH
Q 018489 261 CLWEIYCCDMPYPDLS----------------FSEVTSAVVRQNLRPEIPRC-----CPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 261 il~~lltg~~p~~~~~----------------~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
++|+|++|+.||.+.. ..............+.+... .++++.++|.+||+.||.+|||+
T Consensus 227 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (322)
T 3soc_A 227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306 (322)
T ss_dssp HHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH
Confidence 9999999999996532 12222233333333333321 24569999999999999999999
Q ss_pred HHHHHHHHHhHhhc
Q 018489 320 DEVVSMLEAIDTSK 333 (355)
Q Consensus 320 ~ell~~l~~~~~~~ 333 (355)
.++++.|+.+....
T Consensus 307 ~ell~~L~~l~~~~ 320 (322)
T 3soc_A 307 GCVGERITQMQRLT 320 (322)
T ss_dssp HHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHh
Confidence 99999999997653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=340.30 Aligned_cols=274 Identities=32% Similarity=0.558 Sum_probs=229.2
Q ss_pred cccccceecCCcceeecccccccceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhh
Q 018489 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110 (355)
Q Consensus 40 ~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 110 (355)
.....|++..++|++.+.||+|+||.||+|.+. +..||+|+++.... . ...+.+.+|+.+++.
T Consensus 59 ~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~ 130 (382)
T 3tt0_A 59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT----E----KDLSDLISEMEMMKM 130 (382)
T ss_dssp CCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC----H----HHHHHHHHHHHHHHH
T ss_pred ccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC----H----HHHHHHHHHHHHHHH
Confidence 344567888899999999999999999999753 25699999864321 1 123457889999999
Q ss_pred C-CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHH
Q 018489 111 L-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVV 175 (355)
Q Consensus 111 l-~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~ 175 (355)
+ +||||+++++++...+.. ++||||+++++|.+++.... ...+++..++
T Consensus 131 l~~hpnIv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 194 (382)
T 3tt0_A 131 IGKHKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194 (382)
T ss_dssp HCCCTTBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHH
T ss_pred hcCCchhhhheeeeccCCce----------------EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHH
Confidence 9 999999999998766554 66999999999999997643 2459999999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcc
Q 018489 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKC 253 (355)
Q Consensus 176 ~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~ 253 (355)
.|+.|++.||.|||++|++|+||||+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++
T Consensus 195 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 274 (382)
T 3tt0_A 195 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 274 (382)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHH
T ss_pred HHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchh
Confidence 999999999999999999999999999999999999999999997554322 223334567889999999999999999
Q ss_pred hhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 254 DVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 254 DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
||||||+++|+|++ |..||...+..+....+. .......+..+++++.++|.+||+.||.+|||+.++++.|+++...
T Consensus 275 DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 275 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 99999999999999 999999887776665544 4445566778999999999999999999999999999999999877
Q ss_pred cCCCCC
Q 018489 333 KGGGMI 338 (355)
Q Consensus 333 ~~~~~~ 338 (355)
......
T Consensus 354 ~~~~~~ 359 (382)
T 3tt0_A 354 TSNQEM 359 (382)
T ss_dssp SCSCC-
T ss_pred HhcCCC
Confidence 654443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=331.91 Aligned_cols=265 Identities=30% Similarity=0.602 Sum_probs=227.4
Q ss_pred ccccceecCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
..+.|++..++|++.+.||+|+||.||+|.+. +..||+|++..... . .+.+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~------~~~~~~E~~~l~~l~h~~i~~ 73 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----E------VEEFLKEAAVMKEIKHPNLVQ 73 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----H------HHHHHHHHHHHHHCCCTTBCC
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----H------HHHHHHHHHHHHhCCCCCEee
Confidence 44688999999999999999999999999774 78899999864321 1 245778999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++...... ++||||+++++|.+++.......+++..++.++.|++.+|.|||+.|++|+||
T Consensus 74 ~~~~~~~~~~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~di 137 (288)
T 3kfa_A 74 LLGVCTREPPF----------------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137 (288)
T ss_dssp EEEEECSSSSE----------------EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCC
T ss_pred EEEEEccCCCE----------------EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCC
Confidence 99988765544 66999999999999997766677999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 276 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~ 276 (355)
+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+
T Consensus 138 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp SGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999976543322 2223345678999999998889999999999999999999 999999887
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
.......+. .......+..+++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 218 LSQVYELLE-KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp GGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 776655544 3455567778899999999999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=326.59 Aligned_cols=261 Identities=30% Similarity=0.577 Sum_probs=221.1
Q ss_pred cceecCCcceeecccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
.+++..++|++.+.||+|+||.||+|.+. +..||+|+++..... .+.+.+|+.++..++||||++++++
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~ 71 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----------EDEFFQEAQTMMKLSHPKLVKFYGV 71 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 57788899999999999999999999775 457999999654321 1347789999999999999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...... ++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||||+|
T Consensus 72 ~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 134 (268)
T 3sxs_A 72 CSKEYPI----------------YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARN 134 (268)
T ss_dssp ECSSSSE----------------EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGG
T ss_pred EccCCce----------------EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcce
Confidence 8765544 6699999999999999653 4569999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~ 280 (355)
|+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+....
T Consensus 135 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 214 (268)
T 3sxs_A 135 CLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV 214 (268)
T ss_dssp EEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH
Confidence 9999999999999999975543322 2233445678999999998888999999999999999999 9999998887776
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
...+.. ......+..+++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 215 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 215 VLKVSQ-GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHT-TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHc-CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 665544 334455667899999999999999999999999999999988643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=328.75 Aligned_cols=263 Identities=27% Similarity=0.569 Sum_probs=220.7
Q ss_pred cccceecCCcceeecccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
...|++..++|++.+.||+|+||.||++.+. +..||+|++...... .+.+.+|+.++..++||||++++
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~ 85 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----------EDEFIEEAKVMMNLSHEKLVQLY 85 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----------HHHHHHHHHHHhcCCCCCEeeEE
Confidence 3677888999999999999999999999775 457999999644321 13477899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++...... ++||||+++++|.+++... ...+++..++.++.|++.+|.|||++|++|+||||
T Consensus 86 ~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp 148 (283)
T 3gen_A 86 GVCTKQRPI----------------FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 148 (283)
T ss_dssp EEECSSSSE----------------EEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSG
T ss_pred EEEecCCCe----------------EEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCcc
Confidence 998765544 6699999999999998643 45699999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChh
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~ 278 (355)
+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..
T Consensus 149 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~ 228 (283)
T 3gen_A 149 RNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228 (283)
T ss_dssp GGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh
Confidence 99999999999999999997543221 12233456778999999998889999999999999999998 99999988877
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
.....+.. ......+..+++.+.++|.+||+.||.+|||+.++++.|+++...
T Consensus 229 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 229 ETAEHIAQ-GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhc-ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 76665544 344556677899999999999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=339.92 Aligned_cols=270 Identities=30% Similarity=0.516 Sum_probs=224.1
Q ss_pred ccccceecCCcceeecccccccceEEEEEEECC-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCC
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 113 (355)
....+++..++|++.+.||+|+||.||+|.+.+ ..||+|+++.... ....+.+.+|+.+++.++|
T Consensus 38 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h 109 (343)
T 1luf_A 38 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------ADMQADFQREAALMAEFDN 109 (343)
T ss_dssp HHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--------HHHHHHHHHHHHHHHTCCC
T ss_pred ccceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--------HHHHHHHHHHHHHHHhCCC
Confidence 344577888999999999999999999997653 7899999864321 1224568899999999999
Q ss_pred CccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc----------------------cccccH
Q 018489 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----------------------RRKLAF 171 (355)
Q Consensus 114 ~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------------~~~~~~ 171 (355)
|||+++++++...+.. ++||||+++++|.+++.... ...+++
T Consensus 110 p~iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 173 (343)
T 1luf_A 110 PNIVKLLGVCAVGKPM----------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173 (343)
T ss_dssp TTBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCH
T ss_pred CCEEEEEEEEccCCce----------------EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCH
Confidence 9999999998765544 66999999999999997542 256999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCC
Q 018489 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPY 249 (355)
Q Consensus 172 ~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 249 (355)
..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+....... .......++..|+|||.+.+..+
T Consensus 174 ~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 253 (343)
T 1luf_A 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 253 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc
Confidence 9999999999999999999999999999999999999999999999987543221 22233567889999999998889
Q ss_pred CCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 250 NRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 250 ~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
+.++||||||+++|+|++ |..||.+.+..+....+... .....+..+++++.++|.+||+.||.+||++.++++.|++
T Consensus 254 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~ 332 (343)
T 1luf_A 254 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332 (343)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHH
Confidence 999999999999999999 99999988877766665543 3345677889999999999999999999999999999999
Q ss_pred hHhhcCC
Q 018489 329 IDTSKGG 335 (355)
Q Consensus 329 ~~~~~~~ 335 (355)
+.....+
T Consensus 333 ~~~~~~~ 339 (343)
T 1luf_A 333 MCERAEG 339 (343)
T ss_dssp TTC----
T ss_pred HHhhhhh
Confidence 9765543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=343.36 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=206.4
Q ss_pred cceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFI 120 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~ 120 (355)
...+..++|++.+.||+|+||.||+|++ +++.||+|+++........ ..+.+.+|..++.++ +||||++++
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~------~~~~~~~E~~il~~~~~hp~Iv~l~ 119 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE------DIDWVQTEKHVFEQASNHPFLVGLH 119 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----------CCHHHHHHHHHHHHTTCTTBCCEE
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHH------HHHHHHHHHHHHHhcCCCCCcCeeE
Confidence 3456678999999999999999999976 5788999999754322111 123366788888877 899999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++...... ++||||++|++|..++.. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 120 ~~~~~~~~~----------------~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp 181 (396)
T 4dc2_A 120 SCFQTESRL----------------FFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 181 (396)
T ss_dssp EEEECSSEE----------------EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred EEEEECCEE----------------EEEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCH
Confidence 998876655 669999999999999854 46799999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC----
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS---- 276 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~---- 276 (355)
+|||++.+|.++|+|||++..............||+.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 182 ~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~ 261 (396)
T 4dc2_A 182 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261 (396)
T ss_dssp GGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---
T ss_pred HHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccc
Confidence 9999999999999999999864444455566789999999999999999999999999999999999999996431
Q ss_pred -----hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 018489 277 -----FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 277 -----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
.......+... ...++..+++++.+||++||+.||.+||++
T Consensus 262 ~~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 262 PDQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---CCHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cchhhHHHHHHHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 22233344433 345778899999999999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=336.37 Aligned_cols=265 Identities=32% Similarity=0.535 Sum_probs=217.1
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
..+..++|++.+.||+|+||.||+|.+ ++..||+|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---------~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 75 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---------EETQRTFLKEVKVMRCLEHPNVLKFIGV 75 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---------HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---------HHHHHHHHHHHHHHHhCCCcCcccEEEE
Confidence 456789999999999999999999976 48899999884321 1224568899999999999999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...... ++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 76 ~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~N 138 (310)
T 3s95_A 76 LYKDKRL----------------NFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHN 138 (310)
T ss_dssp EEETTEE----------------EEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTS
T ss_pred EecCCee----------------EEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCe
Confidence 8765544 6699999999999999653 4569999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCC--------------CCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhC
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDM--------------TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg 268 (355)
|+++.++.++|+|||.+.......... ....|++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus 139 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g 218 (310)
T 3s95_A 139 CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218 (310)
T ss_dssp EEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHT
T ss_pred EEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcC
Confidence 999999999999999997554322211 145789999999999999999999999999999999999
Q ss_pred CCCCCCCChhH-----HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCCCC
Q 018489 269 DMPYPDLSFSE-----VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIP 339 (355)
Q Consensus 269 ~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~~~ 339 (355)
..||....... ........ ..+..+++++.++|.+||+.||++|||+.++++.|+.+.....+..+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~~~ 290 (310)
T 3s95_A 219 VNADPDYLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290 (310)
T ss_dssp CCSSTTTSCBCTTSSBCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCCCC
T ss_pred CCCCcchhhhHHHHhhhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcccC
Confidence 99986532211 11111111 245677889999999999999999999999999999998776554433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=336.72 Aligned_cols=253 Identities=20% Similarity=0.363 Sum_probs=214.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ ++..||+|++.......... ....+.+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR---GVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc---hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 7899999999999999999976 58899999997654332110 001234778999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||++|++|.+++. ....+++..++.++.||+.||.|||+.|++|+||||+||+++.
T Consensus 89 ~~----------------~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~ 150 (361)
T 2yab_A 89 DV----------------VLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150 (361)
T ss_dssp EE----------------EEEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred EE----------------EEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeC
Confidence 54 66999999999999994 3567999999999999999999999999999999999999987
Q ss_pred CC----cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 208 NR----TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 208 ~~----~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
++ .++|+|||.+...... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....
T Consensus 151 ~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~ 229 (361)
T 2yab_A 151 KNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229 (361)
T ss_dssp TTSSSCCEEECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred CCCCccCEEEEecCCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 77 7999999999765432 233456799999999999998999999999999999999999999999888888777
Q ss_pred HHhcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+........ ....+++++.++|.+||..||.+|||+.++++
T Consensus 230 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 230 ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 766544322 23567999999999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=324.70 Aligned_cols=261 Identities=31% Similarity=0.649 Sum_probs=222.4
Q ss_pred cceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
+|.+..++|++.+.||+|+||.||++.+ ++..||+|++...... .+.+.+|+.+++.++||||++++++
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~ 71 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYGV 71 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 5788999999999999999999999977 5778999999654321 1347789999999999999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...+.. +++|||+++++|.+++... ...+++..++.++.|++.||.+||++|++|+||+|+|
T Consensus 72 ~~~~~~~----------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N 134 (267)
T 3t9t_A 72 CLEQAPI----------------CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 134 (267)
T ss_dssp ECSSSSC----------------EEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred EccCCCe----------------EEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchhe
Confidence 8765544 6699999999999998653 4568999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~ 280 (355)
|+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+.
T Consensus 135 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 214 (267)
T 3t9t_A 135 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 214 (267)
T ss_dssp EEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH
Confidence 999999999999999987543221 12233456778999999998889999999999999999999 8999998887776
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
...+.. ......+..+++.+.++|.+||+.||.+||++.++++.|+.+..+
T Consensus 215 ~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 215 VEDIST-GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhc-CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 665544 344456677899999999999999999999999999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=338.36 Aligned_cols=257 Identities=24% Similarity=0.352 Sum_probs=214.0
Q ss_pred cccceecCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccce
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTK 118 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~ 118 (355)
...-.+..++|++.+.||+|+||.||+|.+. ++.||+|+++.... ......+.+..|..++..+ +||+|++
T Consensus 12 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~------~~~~~~~~~~~E~~~l~~~~~hp~iv~ 85 (353)
T 2i0e_A 12 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV------IQDDDVECTMVEKRVLALPGKPPFLTQ 85 (353)
T ss_dssp -------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH------HHTTCHHHHHHHHHHHTCTTCCTTBCC
T ss_pred CCcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hcchHHHHHHHHHHHHHhcCCCCEEee
Confidence 3344566789999999999999999999874 67899999964211 0111234567899999888 8999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++...+.. ++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||
T Consensus 86 l~~~~~~~~~~----------------~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDl 147 (353)
T 2i0e_A 86 LHSCFQTMDRL----------------YFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147 (353)
T ss_dssp EEEEEECSSEE----------------EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred EEEEEEcCCEE----------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccC
Confidence 99998766554 669999999999999954 356999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
||+||+++.+|.++|+|||++..............||+.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..
T Consensus 148 kp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 227 (353)
T 2i0e_A 148 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227 (353)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH
Confidence 99999999999999999999975444444455568999999999999999999999999999999999999999998888
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVS 324 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 324 (355)
+....+..... .++..+++++.++|.+||+.||.+||+ +.+|++
T Consensus 228 ~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 228 ELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 88887777543 467789999999999999999999995 466654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=331.19 Aligned_cols=267 Identities=30% Similarity=0.553 Sum_probs=224.5
Q ss_pred ccccceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCC
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 113 (355)
....|++..++|++.+.||+|+||.||+|.+ ++..||+|++.... .. ...+.+.+|+.+++.++|
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l~h 85 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----SP----SELRDLLSEFNVLKQVNH 85 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC----CH----HHHHHHHHHHHHHTTCCC
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC----CH----HHHHHHHHHHHHHhhCCC
Confidence 3456788889999999999999999999965 34789999986332 11 123457889999999999
Q ss_pred CccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc----------------------ccccH
Q 018489 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR----------------------RKLAF 171 (355)
Q Consensus 114 ~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----------------------~~~~~ 171 (355)
|||+++++++...+.. ++||||+++++|.+++..... ..+++
T Consensus 86 p~iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (314)
T 2ivs_A 86 PHVIKLYGACSQDGPL----------------LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149 (314)
T ss_dssp TTBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECH
T ss_pred CceeeEEEEEecCCce----------------EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCH
Confidence 9999999998765554 669999999999999975432 34899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCC
Q 018489 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPY 249 (355)
Q Consensus 172 ~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 249 (355)
..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..+
T Consensus 150 ~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 229 (314)
T 2ivs_A 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY 229 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc
Confidence 99999999999999999999999999999999999999999999999975543222 2233456788999999998889
Q ss_pred CCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 250 NRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 250 ~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
+.++||||||+++|+|++ |..||.+.........+.. ......+..+++++.++|.+||+.||.+||++.++++.|++
T Consensus 230 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 230 TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT-GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhc-CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 999999999999999999 9999998877766655443 44556777899999999999999999999999999999999
Q ss_pred hHhh
Q 018489 329 IDTS 332 (355)
Q Consensus 329 ~~~~ 332 (355)
+...
T Consensus 309 ~~~~ 312 (314)
T 2ivs_A 309 MMVK 312 (314)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 8754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=349.36 Aligned_cols=267 Identities=31% Similarity=0.577 Sum_probs=227.6
Q ss_pred ccccceecCCcceeecccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
....|++..++|++.+.||+|+||.||+|.+. +..||||+++..... .+.+.+|+.+++.++||||+++
T Consensus 179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~iv~l 248 (454)
T 1qcf_A 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----------VEAFLAEANVMKTLQHDKLVKL 248 (454)
T ss_dssp CTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHTTCCCTTBCCE
T ss_pred cccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc----------HHHHHHHHHHHhhCCCCCEeeE
Confidence 35678999999999999999999999999874 678999999653321 2458899999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++.. .. .++||||+++++|.+++.......+++..++.++.||+.||.|||++|++|||||
T Consensus 249 ~~~~~~-~~----------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk 311 (454)
T 1qcf_A 249 HAVVTK-EP----------------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311 (454)
T ss_dssp EEEECS-SS----------------CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCS
T ss_pred EEEEeC-Cc----------------cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence 998752 22 2679999999999999976555678999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
|+|||++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 312 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~ 391 (454)
T 1qcf_A 312 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391 (454)
T ss_dssp GGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred HHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997543221 11223346778999999998889999999999999999999 9999999888
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCC
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 335 (355)
.+....+.. ......+..+++++.++|.+||+.||.+|||+.+|++.|+.+......
T Consensus 392 ~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 392 PEVIRALER-GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp HHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred HHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 777766554 345566778999999999999999999999999999999999776543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=334.41 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=206.6
Q ss_pred eecCCcceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
.+..++|++.+.||+|+||.||++.+ ++..||+|+++....... ......+.+|+.+++.++||||++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~ 87 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN-----AKDTAHTKAERNILEEVKHPFIVDLI 87 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-------------------HHHHHHHCCCTTBCCEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh-----hhHHHHHHHHHHHHHhCCCCCcccee
Confidence 35568999999999999999999975 688999999965432111 11133467899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++...+.. ++||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||
T Consensus 88 ~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp 149 (327)
T 3a62_A 88 YAFQTGGKL----------------YLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKP 149 (327)
T ss_dssp EEEECSSCE----------------EEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCT
T ss_pred EEEEcCCEE----------------EEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCH
Confidence 998765544 669999999999999854 45689999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
+||+++.++.++|+|||.+..............|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.+....
T Consensus 150 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 229 (327)
T 3a62_A 150 ENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229 (327)
T ss_dssp TTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred HHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 99999999999999999987544443444456789999999999998899999999999999999999999999888887
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
...+..... .++..+++++.++|.+||+.||.+|| ++.++++
T Consensus 230 ~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 230 IDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 777766543 46677899999999999999999999 7778776
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=338.85 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=212.9
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIG 121 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~ 121 (355)
..+..++|++.+.||+|+||.||+|.+ +++.||||+++.... ......+.+..|..++..+ +||||+++++
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~il~~~~~hp~iv~l~~ 85 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV------LMDDDVECTMVEKRVLSLAWEHPFLTHMFC 85 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh------hhhhhHHHHHHHHHHHHhcCCCCCCCcEEE
Confidence 456678999999999999999999976 578999999964211 0011123466788888876 9999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++...+.. ++||||++|++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+
T Consensus 86 ~~~~~~~~----------------~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 147 (345)
T 1xjd_A 86 TFQTKENL----------------FFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 147 (345)
T ss_dssp EEECSSEE----------------EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred EEEeCCEE----------------EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChh
Confidence 98876554 669999999999999954 356999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
||+++.+|.++|+|||++..............||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+..
T Consensus 148 NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 227 (345)
T 1xjd_A 148 NILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227 (345)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred hEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999999975443334445568999999999999999999999999999999999999999998888877
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD-EVV 323 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-ell 323 (355)
..+.... ..++..+++++.++|.+||+.||.+||++. +|+
T Consensus 228 ~~i~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 228 HSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 7776654 346777899999999999999999999987 665
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=334.50 Aligned_cols=247 Identities=23% Similarity=0.389 Sum_probs=207.0
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeec
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGAT 123 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~ 123 (355)
+..++|++.+.||+|+||.||+|.+ +++.||+|++........ ...+.+.+|..++.++ +||||+++++++
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD------EDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSH------HHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcch------HHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 4557999999999999999999976 578999999975433211 1234467899999988 899999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...... ++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 80 ~~~~~~----------------~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 141 (345)
T 3a8x_A 80 QTESRL----------------FFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 141 (345)
T ss_dssp ECSSEE----------------EEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred EeCCEE----------------EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 765554 669999999999999854 35799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC--------
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL-------- 275 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~-------- 275 (355)
+++.++.++|+|||++..............||+.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 142 ll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 221 (345)
T 3a8x_A 142 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221 (345)
T ss_dssp EECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------
T ss_pred EECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc
Confidence 999999999999999975444444455568999999999999999999999999999999999999999652
Q ss_pred -ChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 018489 276 -SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319 (355)
Q Consensus 276 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 319 (355)
........+... ...++..++.++.++|.+||+.||.+||++
T Consensus 222 ~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 222 NTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -CHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ccHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 222333344433 345677899999999999999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=331.57 Aligned_cols=248 Identities=27% Similarity=0.438 Sum_probs=213.8
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|+||.||+|.+ +++.||+|+++.... ......+.+.+|..+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV------VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 457899999999999999999976 588999999953211 111123457789999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.... ++||||++|++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||++
T Consensus 78 ~~~~----------------~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll 139 (318)
T 1fot_A 78 AQQI----------------FMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 139 (318)
T ss_dssp SSEE----------------EEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred CCEE----------------EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE
Confidence 5554 669999999999999954 4569999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
+.+|.++|+|||.+..... ......||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+.
T Consensus 140 ~~~g~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 216 (318)
T 1fot_A 140 DKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216 (318)
T ss_dssp CTTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCCCCEEEeecCcceecCC---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999999975443 2234578999999999999999999999999999999999999999988888777777
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
.... .++..+++++.++|.+||+.||.+|| +++++++
T Consensus 217 ~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 217 NAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred hCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 6543 46678899999999999999999999 8888885
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=326.72 Aligned_cols=265 Identities=29% Similarity=0.589 Sum_probs=211.2
Q ss_pred ccccceecCCcceeecccccccceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 115 (355)
...++++..++|++.+.||+|+||.||+|.+. +..||+|++.... . ....+.+.+|+.+++.++|||
T Consensus 6 s~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~----~----~~~~~~~~~e~~~l~~l~h~~ 77 (281)
T 1mp8_A 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----S----DSVREKFLQEALTMRQFDHPH 77 (281)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT----S----HHHHHHHHHHHHHHHTCCCTT
T ss_pred cccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC----C----HHHHHHHHHHHHHHHhCCCCc
Confidence 34568888999999999999999999999763 3469999885321 1 123456889999999999999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H 195 (355)
|+++++++.. + ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|
T Consensus 78 iv~~~~~~~~-~----------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 139 (281)
T 1mp8_A 78 IVKLIGVITE-N----------------PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVH 139 (281)
T ss_dssp BCCEEEEECS-S----------------SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred cceEEEEEcc-C----------------ccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 9999998742 2 236799999999999998643 446999999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 018489 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYP 273 (355)
Q Consensus 196 ~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~ 273 (355)
+||||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 140 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~ 219 (281)
T 1mp8_A 140 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219 (281)
T ss_dssp SCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999999975543221 1223456778999999998889999999999999999996 999999
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
+.+..+....+... .....+..+++++.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 220 ~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 220 GVKNNDVIGRIENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 88877776665543 34456778999999999999999999999999999999998654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=325.61 Aligned_cols=260 Identities=32% Similarity=0.653 Sum_probs=217.0
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
.+..++|++.+.||+|+||.||+|.+ +++.||+|++......... ......+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET--EMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCH--HHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccch--hHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 45678999999999999999999977 6889999998655433221 1111224578999999999999999999987
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCC
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTE 201 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~di~p~ 201 (355)
.... ++||||+++++|.+++.. ....+++..++.++.|++.||.|||++| ++|+||||+
T Consensus 93 ~~~~------------------~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~ 153 (287)
T 4f0f_A 93 HNPP------------------RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSP 153 (287)
T ss_dssp TTTT------------------EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGG
T ss_pred cCCC------------------eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcc
Confidence 6543 469999999999988854 3457999999999999999999999999 999999999
Q ss_pred cEEEcCCCc-----EEEeeccccccccCCCCCCCCCCCcccccCCcccC--CCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 018489 202 NMLLDKNRT-----VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN--GNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (355)
Q Consensus 202 Nili~~~~~-----v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~~lltg~~p~~~ 274 (355)
||+++.++. ++|+|||.+..... ......++..|+|||.+. ...++.++||||||+++|+|++|..||..
T Consensus 154 Nil~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 230 (287)
T 4f0f_A 154 NIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230 (287)
T ss_dssp GEEESCCCTTCSCCEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eEEEeccCCCCceeEEeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 999988776 99999999874332 334467899999999994 45578899999999999999999999987
Q ss_pred CChhHH--HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 275 LSFSEV--TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 275 ~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
.+.... ............++..+++++.++|.+||+.||.+|||+.++++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 231 YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 654433 4555666677778888999999999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=341.13 Aligned_cols=266 Identities=32% Similarity=0.587 Sum_probs=223.6
Q ss_pred ccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
....|++..++|++.+.||+|+||.||+|.+ ++..||||+++... . ....+.+.+|+.+++.++||||++
T Consensus 105 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~----~~~~~~~~~E~~~l~~l~hpniv~ 176 (377)
T 3cbl_A 105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL----P----PDLKAKFLQEARILKQYSHPNIVR 176 (377)
T ss_dssp CCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS----C----HHHHTTTTHHHHHHTTCCCTTBCC
T ss_pred cccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC----C----HHHHHHHHHHHHHHHhCCCCCEEE
Confidence 3457889999999999999999999999987 58899999986321 1 122345788999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++...+.. ++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||
T Consensus 177 ~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDl 239 (377)
T 3cbl_A 177 LIGVCTQKQPI----------------YIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239 (377)
T ss_dssp EEEEECSSSSC----------------EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EEEEEecCCCc----------------EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCccc
Confidence 99998765544 6699999999999999643 456999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCCCC--CCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPNDM--TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~ 275 (355)
||+||+++.++.++|+|||++.......... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 240 kp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 240 AARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp SGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred CHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997543221111 11234667999999998889999999999999999998 99999988
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
+..+....+. .......+..+++++.++|.+||+.||.+|||+.+|++.|+++...
T Consensus 320 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 320 SNQQTREFVE-KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 7766655443 4455567778999999999999999999999999999999998653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=326.65 Aligned_cols=261 Identities=33% Similarity=0.631 Sum_probs=211.6
Q ss_pred eecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
.++.++|++.+.||+|+||.||++.+.++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 72 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES-----------ERKAFIVELRQLSRVNHPNIVKLYGACLN 72 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT-----------HHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh-----------HHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3566899999999999999999999999999999985321 13457889999999999999999997753
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCCC
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFKVVVQLALDLARGLSYLHS---QKIVHRDVKTE 201 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~di~p~ 201 (355)
. .++||||+++++|.+++..... ..+++..++.++.|++.||.|||+ +|++|+||||+
T Consensus 73 ~------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~ 134 (307)
T 2eva_A 73 P------------------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 134 (307)
T ss_dssp T------------------TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGG
T ss_pred C------------------cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChh
Confidence 2 2679999999999999964322 247899999999999999999999 89999999999
Q ss_pred cEEEcCCCc-EEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 202 NMLLDKNRT-VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 202 Nili~~~~~-v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
||+++.++. ++|+|||.+...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus 135 NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 211 (307)
T 2eva_A 135 NLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211 (307)
T ss_dssp GEEEETTTTEEEECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH
T ss_pred HEEEeCCCCEEEEcccccccccccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH
Confidence 999998886 799999998754322 2234689999999999999999999999999999999999999986543222
Q ss_pred -HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCCC
Q 018489 281 -TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMI 338 (355)
Q Consensus 281 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~~ 338 (355)
.............+..+++.+.++|.+||+.||.+|||+.++++.|+.+.....+...
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 212 RIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp HHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred HHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 2222334445566778899999999999999999999999999999999876655433
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=330.14 Aligned_cols=283 Identities=27% Similarity=0.480 Sum_probs=219.5
Q ss_pred cccchhhcccccceecCCcceeecccccccceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHH
Q 018489 33 KASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107 (355)
Q Consensus 33 ~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 107 (355)
....-+.....++.+..++|++.+.||+|+||.||+|.+. +..||+|+++..... . ...+.+.+|+.+
T Consensus 17 ~~~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~---~----~~~~~~~~e~~~ 89 (313)
T 3brb_A 17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS---Q----REIEEFLSEAAC 89 (313)
T ss_dssp -------CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC---H----HHHHHHHHHHHH
T ss_pred CchHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc---h----hHHHHHHHHHHH
Confidence 4444467778889999999999999999999999999652 347999998644321 1 113457889999
Q ss_pred HhhCCCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh----ccccccHHHHHHHHHHHHH
Q 018489 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN----RRRKLAFKVVVQLALDLAR 183 (355)
Q Consensus 108 l~~l~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~~i~~qi~~ 183 (355)
++.++||||+++++++....... ....+++|||+++++|.+++... ....+++..++.++.|++.
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~-----------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~ 158 (313)
T 3brb_A 90 MKDFSHPNVIRLLGVCIEMSSQG-----------IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158 (313)
T ss_dssp HHTCCCTTBCCCCEEEEC------------------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHH
T ss_pred HhcCCCCCeeeeeEEEeeccccC-----------CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHH
Confidence 99999999999999887654321 12347899999999999998542 2356999999999999999
Q ss_pred HHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHH
Q 018489 184 GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGIC 261 (355)
Q Consensus 184 al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~i 261 (355)
||.|||++|++|+||||+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||++
T Consensus 159 aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 238 (313)
T 3brb_A 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238 (313)
T ss_dssp HHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHH
T ss_pred HHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHH
Confidence 9999999999999999999999999999999999987543322 12223456778999999999899999999999999
Q ss_pred HHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 262 LWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 262 l~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
+|+|++ |..||...........+... .....+..+++++.++|.+||+.||.+||++.++++.|+++.....
T Consensus 239 l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 239 MWEIATRGMTPYPGVQNHEMYDYLLHG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHhcCCCCCccCCHHHHHHHHHcC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 999999 89999988877776665543 3456677889999999999999999999999999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=336.84 Aligned_cols=249 Identities=24% Similarity=0.400 Sum_probs=212.3
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ ++..||+|++...... .. ..+.+.+|+.+++.++||||+++++++...+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---AR----DFQKLEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---HH----HHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC---HH----HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 6899999999999999999976 5889999999754332 11 1345789999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++. ....+++..++.++.||+.||.|||++||+|+||||+||+++.
T Consensus 102 ~~----------------~lv~e~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 163 (362)
T 2bdw_A 102 FH----------------YLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 163 (362)
T ss_dssp EE----------------EEEECCCCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESC
T ss_pred EE----------------EEEEecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 54 66999999999999884 3467999999999999999999999999999999999999976
Q ss_pred C---CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 208 N---RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 208 ~---~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+ +.++|+|||.+...... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+
T Consensus 164 ~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i 242 (362)
T 2bdw_A 164 KAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242 (362)
T ss_dssp SSTTCCEEECCCTTCBCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCCCEEEeecCcceEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 5 45999999999755432 3334567999999999999989999999999999999999999999998888777777
Q ss_pred HhcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
......... ...+++++.++|.+||+.||.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 243 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 665544332 2457999999999999999999999999886
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=332.67 Aligned_cols=279 Identities=28% Similarity=0.493 Sum_probs=211.4
Q ss_pred hcccccceecCCcceeecccccccceEEEEEEECC--c---eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCC
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG--H---DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~--~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 113 (355)
.....++.+..++|++.+.||+|+||.||+|.+.. . .||+|+++...... ...+.+.+|+.+++.++|
T Consensus 12 ~~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h 84 (323)
T 3qup_A 12 KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-------SDIEEFLREAACMKEFDH 84 (323)
T ss_dssp ----CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-------HHHHHHHHHHHHHTTCCC
T ss_pred HHHhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-------HHHHHHHHHHHHHHHCCC
Confidence 34456677888999999999999999999997643 2 79999986432211 113558899999999999
Q ss_pred CccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc----ccccHHHHHHHHHHHHHHHHHHH
Q 018489 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR----RKLAFKVVVQLALDLARGLSYLH 189 (355)
Q Consensus 114 ~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH 189 (355)
|||+++++++........ ....+++|||+++++|.+++..... ..+++..++.++.|++.||.|||
T Consensus 85 ~~iv~~~~~~~~~~~~~~----------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH 154 (323)
T 3qup_A 85 PHVAKLVGVSLRSRAKGR----------LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS 154 (323)
T ss_dssp TTBCCCCEEEECC-----------------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CceehhhceeeccccccC----------CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 999999998876543311 1223679999999999999865432 25999999999999999999999
Q ss_pred hCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh
Q 018489 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 190 ~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt 267 (355)
++|++|+||||+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 155 ~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 234 (323)
T 3qup_A 155 SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234 (323)
T ss_dssp HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHh
Confidence 9999999999999999999999999999997543322 12223446778999999999889999999999999999999
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCC
Q 018489 268 -CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335 (355)
Q Consensus 268 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 335 (355)
|..||.+.+..+....+... .....+..+++++.++|.+||+.||.+|||+.++++.|+++.....-
T Consensus 235 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 235 RGQTPYAGIENAEIYNYLIGG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp TSCCTTTTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred CCCCCccccChHHHHHHHhcC-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 99999998887777666554 34456677899999999999999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=346.67 Aligned_cols=269 Identities=32% Similarity=0.555 Sum_probs=223.9
Q ss_pred ccccceecCCcceeecccccccceEEEEEEECC-ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
....|++..++|++.+.||+|+||.||+|.+.+ ..||||+++..... .+.+.+|+.++++++||||+++
T Consensus 175 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hp~iv~~ 244 (452)
T 1fmk_A 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQEAQVMKKLRHEKLVQL 244 (452)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred CccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----------HHHHHHHHHHHHhCCCCCEeeE
Confidence 356789999999999999999999999998764 67999999654321 2347889999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++.. .. .++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|||||
T Consensus 245 ~~~~~~-~~----------------~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk 307 (452)
T 1fmk_A 245 YAVVSE-EP----------------IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 307 (452)
T ss_dssp EEEECS-SS----------------CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEcC-Cc----------------eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 998754 22 2679999999999999976555679999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
|+|||++.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus 308 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 387 (452)
T 1fmk_A 308 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387 (452)
T ss_dssp GGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred hhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997554321 12223446778999999998889999999999999999999 9999998887
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGM 337 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~ 337 (355)
.+....+.. ......+..+++.+.++|.+||+.||.+|||+.+|++.|+.+..+.....
T Consensus 388 ~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 388 REVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp HHHHHHHHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred HHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 776665543 44556677899999999999999999999999999999999987655443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=332.87 Aligned_cols=269 Identities=28% Similarity=0.513 Sum_probs=216.4
Q ss_pred ecCCcceeecccccccceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
++.++|++.+.||+|+||.||+|.+ ++..||+|++.... . ...+.+.+|+.++++++||||++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----~----~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-----P----DQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-----H----HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-----H----HHHHHHHHHHHHHHhcCCCceeEEE
Confidence 5678999999999999999999973 57889999986432 1 1234578999999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++...+. +..++||||+++++|.+++... ...+++..++.|+.|++.||.|||++|++|+||||
T Consensus 91 ~~~~~~~~--------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp 155 (327)
T 3lxl_A 91 GVSYGPGR--------------QSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAA 155 (327)
T ss_dssp EEEECSSS--------------CEEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEecCCC--------------ceEEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCh
Confidence 98764332 2337899999999999999653 34699999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~ 277 (355)
+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 156 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 156 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp GGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred hhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 999999999999999999986543322 22334577889999999988889999999999999999999999854332
Q ss_pred h--------------HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCCCC
Q 018489 278 S--------------EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIP 339 (355)
Q Consensus 278 ~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~~~ 339 (355)
. ...............+..+++++.++|.+||+.||.+|||+.++++.|+.+.....+...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 311 (327)
T 3lxl_A 236 EFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH 311 (327)
T ss_dssp HHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----------
T ss_pred hhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccc
Confidence 1 2333444455566677889999999999999999999999999999999998776655543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=328.73 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=206.3
Q ss_pred ecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
...++|++.+.||+|+||.||+|.+ +++.||+|++...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-------EGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-------chhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 3448999999999999999999987 6789999999643221 1223457789999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.... ++||||+++ +|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 91 ~~~~----------------~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~ 152 (311)
T 3niz_A 91 ERCL----------------TLVFEFMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152 (311)
T ss_dssp SSCE----------------EEEEECCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCEE----------------EEEEcCCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE
Confidence 5544 679999975 88887754 34569999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.++.++|+|||.+..............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+
T Consensus 153 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 232 (311)
T 3niz_A 153 NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232 (311)
T ss_dssp CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH
T ss_pred CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99999999999999866555455555678999999999876 56899999999999999999999999887776666555
Q ss_pred HhcCCCCC----------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRPE----------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
......+. ....+++++.+||.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 44211110 12346789999999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=325.32 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=205.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||+|++......... .+.+.+|+.++++++||||+++++++....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-------PSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH-------HHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCc-------chHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 6899999999999999999977 5789999999765433221 234678999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 75 ~~----------------~lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~ 136 (292)
T 3o0g_A 75 KL----------------TLVFEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136 (292)
T ss_dssp EE----------------EEEEECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EE----------------EEEEecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 44 669999975 66655543 3467999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCC-CCCcchhHHHHHHHHHHHhCCCC-CCCCChhHHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMP-YPDLSFSEVTSAVV 285 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~lltg~~p-~~~~~~~~~~~~~~ 285 (355)
++.++|+|||.+..............++..|+|||.+.+.. ++.++||||||+++|+|++|..| |.+.+.......+.
T Consensus 137 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~ 216 (292)
T 3o0g_A 137 NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp TSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred CCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 99999999999987665555556678899999999998765 79999999999999999988877 55556555555554
Q ss_pred hcCCCC---------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRP---------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.....+ .....+++++.++|.+||+.||.+|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 321111 122347899999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=350.68 Aligned_cols=264 Identities=29% Similarity=0.598 Sum_probs=227.1
Q ss_pred ccccceecCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
....|++..++|++.+.||+|+||.||+|.+. +..||||+++..... .+.+.+|+.++++++||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~ 280 (495)
T 1opk_A 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----------VEEFLKEAAVMKEIKHPNLVQ 280 (495)
T ss_dssp SSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----------HHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----------hHHHHHHHHHHHhcCCCCEee
Confidence 45678999999999999999999999999775 789999998643321 244788999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++...... ++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||
T Consensus 281 l~~~~~~~~~~----------------~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDl 344 (495)
T 1opk_A 281 LLGVCTREPPF----------------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344 (495)
T ss_dssp EEEEECSSSSC----------------EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EEEEEecCCcE----------------EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 99998766554 66999999999999997666677999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 276 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~ 276 (355)
||+|||++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+
T Consensus 345 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 345 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp SGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999986543221 2223445678999999998889999999999999999999 999999888
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
..+....+ ........+..+++++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 425 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 425 LSQVYELL-EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp GGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 77666544 4455566778899999999999999999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=330.15 Aligned_cols=265 Identities=23% Similarity=0.380 Sum_probs=212.7
Q ss_pred cccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCcc
Q 018489 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNV 116 (355)
Q Consensus 40 ~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~I 116 (355)
.....+....++|++.+.||+|+||.||+|.+ +++.||+|++...... .+.+.+|+.+++.+ +||||
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~~h~~i 83 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----------EEEIKQEINMLKKYSHHRNI 83 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----------THHHHHHHHHHHHHCCSTTB
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----------HHHHHHHHHHHHhccCCCCe
Confidence 34455566678999999999999999999987 7899999999754321 13467899999998 89999
Q ss_pred ceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
+++++++....... .....++||||+++++|.+++.......+++..++.++.||+.||.|||++|++|+
T Consensus 84 ~~~~~~~~~~~~~~----------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 153 (326)
T 2x7f_A 84 ATYYGAFIKKNPPG----------MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR 153 (326)
T ss_dssp CCEEEEEEECC--C----------CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred eeeeeEEeeccCcc----------ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999887543110 13345789999999999999977666789999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC-----CCCCCCcchhHHHHHHHHHHHhCCCC
Q 018489 197 DVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMP 271 (355)
Q Consensus 197 di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~lltg~~p 271 (355)
||+|+||+++.++.++|+|||.+..............++..|+|||.+. +..++.++||||||+++|+|++|..|
T Consensus 154 dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 233 (326)
T 2x7f_A 154 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233 (326)
T ss_dssp CCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred CCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999876544333344457899999999987 45688999999999999999999999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 272 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
|...+.......+............++..+.++|.+||+.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 234 LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp TTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 98887777666666555544456678999999999999999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=326.43 Aligned_cols=265 Identities=32% Similarity=0.636 Sum_probs=205.4
Q ss_pred cccccceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 40 ~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
.....+++..++|++.+.||+|+||.||+|.+.+ .+|+|+++..... . ...+.+.+|+.++++++||||+++
T Consensus 14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~---~----~~~~~~~~E~~~l~~l~h~~iv~~ 85 (289)
T 3og7_A 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPT---P----QQLQAFKNEVGVLRKTRHVNILLF 85 (289)
T ss_dssp ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCC---H----HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCC---H----HHHHHHHHHHHHHHhCCCCcEEEE
Confidence 3445578889999999999999999999998765 5999999654322 1 123557899999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
+++... . ..++||||+++++|.+++.. ....+++..++.++.|++.+|.|||+.|++|+|||
T Consensus 86 ~~~~~~-~----------------~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlk 147 (289)
T 3og7_A 86 MGYSTA-P----------------QLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147 (289)
T ss_dssp EEEECS-S----------------SCEEEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred EeeccC-C----------------ccEEEEEecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCc
Confidence 986532 2 23679999999999998854 34569999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCC--CCCCCCCCCcccccCCcccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~--~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~lltg~~p~~~ 274 (355)
|+||+++.++.++|+|||.+...... ........++..|+|||.+. +..++.++||||||+++|+|++|..||..
T Consensus 148 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 227 (289)
T 3og7_A 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227 (289)
T ss_dssp GGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence 99999999999999999998754321 22223456899999999987 56788899999999999999999999988
Q ss_pred CChhHHHHHHHhc-CCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 275 LSFSEVTSAVVRQ-NLRPE---IPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 275 ~~~~~~~~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
............. ..... ....+++++.++|.+||+.||.+|||+.++++.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 228 INNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 6655555444433 33222 34568899999999999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=331.87 Aligned_cols=274 Identities=30% Similarity=0.542 Sum_probs=227.5
Q ss_pred hhcccccceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhh
Q 018489 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110 (355)
Q Consensus 38 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 110 (355)
++.....|++..++|++.+.||+|+||.||+|.+ +++.||+|++..... . ...+.+.+|+.++..
T Consensus 15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~ 86 (316)
T 2xir_A 15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----H----SEHRALMSELKILIH 86 (316)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----H----HHHHHHHHHHHHHHH
T ss_pred ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC----c----HHHHHHHHHHHHHHh
Confidence 3455567888899999999999999999999974 357899999964321 1 123457889999999
Q ss_pred C-CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc--------------ccccHHHHH
Q 018489 111 L-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--------------RKLAFKVVV 175 (355)
Q Consensus 111 l-~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~ 175 (355)
+ +||||+++++++...+. ..+++|||+++++|.+++..... ..+++..++
T Consensus 87 l~~hp~iv~~~~~~~~~~~---------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (316)
T 2xir_A 87 IGHHLNVVNLLGACTKPGG---------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151 (316)
T ss_dssp HCCCTTBCCEEEEECCTTS---------------CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHH
T ss_pred cccCCCeeeEEEEEecCCC---------------ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHH
Confidence 9 78999999998765432 23679999999999999965432 128999999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcc
Q 018489 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKC 253 (355)
Q Consensus 176 ~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~ 253 (355)
.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++
T Consensus 152 ~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 231 (316)
T 2xir_A 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 231 (316)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchh
Confidence 9999999999999999999999999999999999999999999975443222 12234567789999999988899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 254 DVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 254 DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
||||||+++|+|++ |..||.+...................+..+++++.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 232 Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 232 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 99999999999998 99999887766656555555566667778899999999999999999999999999999999876
Q ss_pred cC
Q 018489 333 KG 334 (355)
Q Consensus 333 ~~ 334 (355)
..
T Consensus 312 ~~ 313 (316)
T 2xir_A 312 NA 313 (316)
T ss_dssp HC
T ss_pred hc
Confidence 54
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=334.26 Aligned_cols=250 Identities=21% Similarity=0.333 Sum_probs=215.2
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
.+..++|++.+.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 110 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV------VKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh------ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 35568999999999999999999976 588999999853211 1111234577899999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...... ++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 111 ~~~~~~----------------~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 172 (350)
T 1rdq_E 111 KDNSNL----------------YMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172 (350)
T ss_dssp ECSSEE----------------EEEEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EcCCEE----------------EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceE
Confidence 765554 669999999999999954 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
+++.+|.++|+|||.+...... .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....
T Consensus 173 ll~~~g~~kL~DFg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~ 249 (350)
T 1rdq_E 173 LIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK 249 (350)
T ss_dssp EECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EECCCCCEEEcccccceeccCC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH
Confidence 9999999999999999755432 2345789999999999999999999999999999999999999999888888877
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 324 (355)
+..... .++..+++++.++|.+||+.||.+||+ +++|++
T Consensus 250 i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 250 IVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 776543 467788999999999999999999998 787775
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=332.09 Aligned_cols=267 Identities=27% Similarity=0.521 Sum_probs=225.9
Q ss_pred cccceecCCcceeecccccccceEEEEEEECC-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CC
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DH 113 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 113 (355)
...+++..++|++.+.||+|+||.||+|.+.+ ..||+|++..... . ...+.+.+|+.+++.+ +|
T Consensus 38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~l~~h 109 (333)
T 2i1m_A 38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH----A----DEKEALMSELKIMSHLGQH 109 (333)
T ss_dssp CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC----H----HHHHHHHHHHHHHHHHCCC
T ss_pred cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC----h----HHHHHHHHHHHHHHhhcCC
Confidence 34688889999999999999999999997642 3799999864321 1 1235578999999999 89
Q ss_pred CccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc------------cccccHHHHHHHHHHH
Q 018489 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------RRKLAFKVVVQLALDL 181 (355)
Q Consensus 114 ~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~~~i~~qi 181 (355)
|||+++++++...+.. ++||||+++++|.+++.... ...+++..++.++.|+
T Consensus 110 ~~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi 173 (333)
T 2i1m_A 110 ENIVNLLGACTHGGPV----------------LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173 (333)
T ss_dssp TTBCCEEEEECSSSSC----------------EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHH
T ss_pred CCeeeEEEEEecCCce----------------EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHH
Confidence 9999999998766554 66999999999999996543 3458999999999999
Q ss_pred HHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHH
Q 018489 182 ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFG 259 (355)
Q Consensus 182 ~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 259 (355)
+.||.|||++|++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||
T Consensus 174 ~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 253 (333)
T 2i1m_A 174 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 253 (333)
T ss_dssp HHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHH
Confidence 9999999999999999999999999999999999999975433222 12234467789999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 260 ICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 260 ~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
+++|+|++ |..||.+...................+..+++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 254 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 254 ILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 99999998 99999988777767677776666677778899999999999999999999999999999988654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=326.21 Aligned_cols=266 Identities=26% Similarity=0.445 Sum_probs=206.2
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ ++..||+|++....... ....+.+.+|+.+++.++||||+++++++...
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 104 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD------AKARADCIKEIDLLKQLNHPNVIKYYASFIED 104 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 36899999999999999999975 68999999996533221 12245578899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
+.. +++|||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||+|+||+
T Consensus 105 ~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl 168 (310)
T 2wqm_A 105 NEL----------------NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 168 (310)
T ss_dssp TEE----------------EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CcE----------------EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEE
Confidence 544 6699999999999998643 2456899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--hhHHHH
Q 018489 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS--FSEVTS 282 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~--~~~~~~ 282 (355)
++.++.++|+|||.+..............++..|+|||.+.+..++.++||||||+++|+|++|..||.+.. ......
T Consensus 169 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 248 (310)
T 2wqm_A 169 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248 (310)
T ss_dssp ECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHH
T ss_pred EcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHH
Confidence 999999999999998765544444445578899999999999999999999999999999999999997643 233334
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCC
Q 018489 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGG 336 (355)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~ 336 (355)
.+............+++++.++|.+||+.||.+|||+.++++.|+++.......
T Consensus 249 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 249 KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp HHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 444444433344678999999999999999999999999999999998776543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=330.33 Aligned_cols=274 Identities=33% Similarity=0.574 Sum_probs=226.4
Q ss_pred chhhcccccceecCCcceeecccccccceEEEEEEE---------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHH
Q 018489 36 NFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY---------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVA 106 (355)
Q Consensus 36 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~ 106 (355)
.+--.+...|++..++|++.+.||+|+||.||+|.+ ++..||+|++.... .. ...+.+.+|+.
T Consensus 21 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~ 92 (334)
T 2pvf_A 21 EYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TE----KDLSDLVSEME 92 (334)
T ss_dssp --CCCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC----CH----HHHHHHHHHHH
T ss_pred cccCCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC----cH----HHHHHHHHHHH
Confidence 333446677899999999999999999999999975 35679999986432 11 12345788999
Q ss_pred HHhhC-CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc--------------ccccH
Q 018489 107 VWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--------------RKLAF 171 (355)
Q Consensus 107 ~l~~l-~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~ 171 (355)
+++.+ +||||+++++++...+.. ++||||+++++|.+++..... ..+++
T Consensus 93 ~l~~l~~hp~iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 156 (334)
T 2pvf_A 93 MMKMIGKHKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156 (334)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSCC----------------EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCH
T ss_pred HHHHhhcCCCEeeEEEEEccCCce----------------EEEEECCCCCcHHHHHHHhccccccccccccccccccCCH
Confidence 99999 999999999998765544 669999999999999965431 34899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCC
Q 018489 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPY 249 (355)
Q Consensus 172 ~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 249 (355)
..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..+
T Consensus 157 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 236 (334)
T 2pvf_A 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 236 (334)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc
Confidence 99999999999999999999999999999999999999999999999975543221 1233456788999999988888
Q ss_pred CCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 250 NRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 250 ~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
+.++||||||+++|+|++ |..||.+.+..+....+... .....+..++.++.++|.+||+.||.+||++.++++.|++
T Consensus 237 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 315 (334)
T 2pvf_A 237 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315 (334)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 999999999999999999 99999988877766555443 4455677889999999999999999999999999999999
Q ss_pred hHhhcC
Q 018489 329 IDTSKG 334 (355)
Q Consensus 329 ~~~~~~ 334 (355)
+.....
T Consensus 316 l~~~~~ 321 (334)
T 2pvf_A 316 ILTLTT 321 (334)
T ss_dssp HHHHHC
T ss_pred HHhccc
Confidence 976644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=330.68 Aligned_cols=267 Identities=27% Similarity=0.486 Sum_probs=216.5
Q ss_pred eecCCcc-eeecccccccceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 46 EIEPSKL-VIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 46 ~~~~~~y-~i~~~lg~G~~~~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
.+...+| ++.+.||+|+||.||++.+ +++.||||+++.... ....+.+.+|+.+++.++||||++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~ 97 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--------PQHRSGWKQEIDILRTLYHEHIIK 97 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC--------hHHHHHHHHHHHHHHhCCCcchhh
Confidence 3344555 9999999999999988754 678899999964321 122455889999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++...+.. ..++||||+++++|.+++.. ..+++..++.++.|++.+|.+||+.|++|+||
T Consensus 98 ~~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Di 160 (318)
T 3lxp_A 98 YKGCCEDAGAA--------------SLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDL 160 (318)
T ss_dssp EEEEEEETTTT--------------EEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EEEEEecCCCc--------------eEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 99998764322 23789999999999999843 45999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 161 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 161 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp SGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred chheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 99999999999999999999986544322 223345778899999999888899999999999999999999999653
Q ss_pred Chh--------------HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 018489 276 SFS--------------EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGM 337 (355)
Q Consensus 276 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~ 337 (355)
... ...............+..+++++.++|++||+.||.+|||+.++++.|+.+.....+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 241 PTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred chhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 221 12233344555666778899999999999999999999999999999999987665443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=338.34 Aligned_cols=273 Identities=19% Similarity=0.261 Sum_probs=210.4
Q ss_pred ecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHH----HHHHHHHHHHhhCCCCc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALR----SAFTQEVAVWHKLDHPN 115 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~~ 115 (355)
+..++|++.+.||+|+||.||+|.+. +..||||++...... ...+...+. ..+..|+..+..++|||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP--LFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH--HHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh--HHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 55679999999999999999999763 478999998654321 111111111 23445677788889999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H 195 (355)
|+++++++...... ..+.++||||+ +++|.+++.. ....+++..++.|+.||+.||.|||++||+|
T Consensus 110 iv~~~~~~~~~~~~------------~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiH 175 (364)
T 3op5_A 110 VPKYWGSGLHDKNG------------KSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHEYVH 175 (364)
T ss_dssp SCCEEEEEEEEETT------------EEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCeEEeeeeeccCC------------cceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEE
Confidence 99999988754220 12347899999 9999999865 3467999999999999999999999999999
Q ss_pred cCCCCCcEEEc--CCCcEEEeeccccccccCCCC-------CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHH
Q 018489 196 RDVKTENMLLD--KNRTVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266 (355)
Q Consensus 196 ~di~p~Nili~--~~~~v~L~Dfg~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll 266 (355)
|||||+|||++ .++.++|+|||++........ ......||..|+|||.+.+..++.++||||||+++|+|+
T Consensus 176 rDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 255 (364)
T 3op5_A 176 GDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255 (364)
T ss_dssp CCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999 889999999999975432211 113345999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhHHHHHHHhcCCCCC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCC
Q 018489 267 CCDMPYPDLSFSEVTSAVVRQNLRPE---------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335 (355)
Q Consensus 267 tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 335 (355)
+|+.||.+.................. ....+++++.+++..||+.||.+||++.+|++.|+.+....+.
T Consensus 256 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 256 TGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp HSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 99999986432222211111100000 1256789999999999999999999999999999999876543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=336.79 Aligned_cols=264 Identities=30% Similarity=0.514 Sum_probs=219.5
Q ss_pred ceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
.++..++|++.+.||+|+||.||+|.+ ++..||||+++... .... ...+.+|+.+++.++||||+
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~----~~~~~~E~~~l~~l~hpnIv 137 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQD----ELDFLMEALIISKFNHQNIV 137 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC----CHHH----HHHHHHHHHHHHHCCCTTBC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc----Chhh----HHHHHHHHHHHHhCCCCCCC
Confidence 456678999999999999999999974 35679999985321 1111 23477899999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc-----ccccHHHHHHHHHHHHHHHHHHHhCC
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-----RKLAFKVVVQLALDLARGLSYLHSQK 192 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~ 192 (355)
++++++...... ++||||+++++|.+++..... ..+++..++.++.||+.||.|||++|
T Consensus 138 ~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 201 (367)
T 3l9p_A 138 RCIGVSLQSLPR----------------FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 201 (367)
T ss_dssp CEEEEECSSSSC----------------EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEecCCCC----------------EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 999998765554 569999999999999976432 35899999999999999999999999
Q ss_pred ccccCCCCCcEEEcCCC---cEEEeeccccccccCC--CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh
Q 018489 193 IVHRDVKTENMLLDKNR---TVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 193 i~H~di~p~Nili~~~~---~v~L~Dfg~a~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt 267 (355)
|+||||||+|||++.++ .++|+|||.+...... ........++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 202 ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 281 (367)
T 3l9p_A 202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281 (367)
T ss_dssp CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999998555 5999999999743221 122233457889999999988889999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 268 -CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 268 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
|..||...+..+....+... .....+..++..+.++|.+||+.||.+||++.+|++.|+.+....
T Consensus 282 ~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 282 LGYMPYPSKSNQEVLEFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp TSCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCCCCHHHHHHHHHcC-CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 99999998877776665543 345567788999999999999999999999999999999997654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=324.86 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=202.8
Q ss_pred CcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
++|++.+.||+|+||.||+|.+ +++.||+|++......... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI-------PSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC-------CHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccccc-------chhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 6899999999999999999977 4889999999654332211 2346789999999999999999999876554
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++||||+++ +|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++.+
T Consensus 75 ~----------------~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 136 (288)
T 1ob3_A 75 L----------------VLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE 136 (288)
T ss_dssp E----------------EEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred E----------------EEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC
Confidence 4 669999965 898888543 4569999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+.++|+|||.+..............++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+...
T Consensus 137 ~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 216 (288)
T 1ob3_A 137 GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216 (288)
T ss_dssp SCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999999765544344445678999999999976 45899999999999999999999999988877666655432
Q ss_pred CCCC---------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRP---------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+ .....+++++.++|.+||+.||.+|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1100 112457899999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=348.23 Aligned_cols=255 Identities=25% Similarity=0.430 Sum_probs=208.9
Q ss_pred cceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
...+..++|++.+.||+|+||.||+|.+ ++..||||++...... .......+.+|+.+++.++||||+++++
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 215 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV------AKDEVAHTLTENRVLQNSRHPFLTALKY 215 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------------CCCCCSCTTSCCEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh------hhHHHHHHHHHHHHHHhCCCCeEeeEEE
Confidence 3445668999999999999999999976 5889999999632111 1111234678999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKT 200 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~di~p 200 (355)
++...+.. ++||||+++++|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||
T Consensus 216 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp 277 (446)
T 4ejn_A 216 SFQTHDRL----------------CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 277 (446)
T ss_dssp EEEETTEE----------------EEEECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCG
T ss_pred EEeeCCEE----------------EEEEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCH
Confidence 98766554 669999999999999854 4579999999999999999999998 9999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
+|||++.++.++|+|||++..............||+.|+|||.+.+..++.++||||||+++|+|++|..||...+....
T Consensus 278 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 357 (446)
T 4ejn_A 278 ENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357 (446)
T ss_dssp GGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH
Confidence 99999999999999999997655444455567899999999999999999999999999999999999999999888888
Q ss_pred HHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 281 TSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
...+..... .++..+++++.++|.+||+.||.+|| ++.++++
T Consensus 358 ~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 358 FELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHhCCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 777766544 46778899999999999999999999 9999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=322.57 Aligned_cols=271 Identities=28% Similarity=0.523 Sum_probs=225.4
Q ss_pred ccceecCCcceeec-ccccccceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 43 QDWEIEPSKLVIKS-VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 43 ~~~~~~~~~y~i~~-~lg~G~~~~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
+.+.+..++|.+.+ .||+|+||.||+|.+ ++..||+|+++... .. ...+.+.+|+.+++.++||||+
T Consensus 2 ~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l~h~~i~ 73 (287)
T 1u59_A 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT----EK----ADTEEMMREAQIMHQLDNPYIV 73 (287)
T ss_dssp CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC----CH----HHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc----ch----hHHHHHHHHHHHHHhCCCCCEe
Confidence 35677788999988 999999999999964 57789999996432 11 2234578899999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccC
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~d 197 (355)
++++++.. +. .++||||+++++|.+++.. ....+++..++.++.|++.||.+||+.|++|+|
T Consensus 74 ~~~~~~~~-~~----------------~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 135 (287)
T 1u59_A 74 RLIGVCQA-EA----------------LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135 (287)
T ss_dssp CEEEEEES-SS----------------EEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEEEEecC-CC----------------cEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCC
Confidence 99998732 22 3679999999999999853 345699999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 018489 198 VKTENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYP 273 (355)
Q Consensus 198 i~p~Nili~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~ 273 (355)
|+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 136 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 215 (287)
T 1u59_A 136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215 (287)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999999976543222 1223346788999999988888999999999999999998 999999
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCCCCC
Q 018489 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMIPG 340 (355)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~~~~ 340 (355)
..+..+....+.. ......+..+++++.++|.+||+.||.+||++.++++.|+.+..+.++.....
T Consensus 216 ~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~ 281 (287)
T 1u59_A 216 KMKGPEVMAFIEQ-GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281 (287)
T ss_dssp TCCTHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred cCCHHHHHHHHhc-CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence 8877666655444 44456778899999999999999999999999999999999987765555443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=335.90 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=208.1
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||||++.......... ...+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPG----LSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSS----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccccc----chHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 36899999999999999999976 58999999985321100000 0124578999999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
+.. ++||||+++++|.+.+.... ...+++..++.++.||+.||.|||++|++|+||||+||+
T Consensus 99 ~~~----------------~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl 162 (351)
T 3c0i_A 99 GML----------------YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162 (351)
T ss_dssp TEE----------------EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CEE----------------EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeE
Confidence 544 66999999999998886432 335899999999999999999999999999999999999
Q ss_pred EcCCCc---EEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 205 LDKNRT---VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 205 i~~~~~---v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
++.++. ++|+|||.+..............+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.. ....
T Consensus 163 ~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~ 241 (351)
T 3c0i_A 163 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLF 241 (351)
T ss_dssp ECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHH
T ss_pred EecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHH
Confidence 986654 999999999866554444455679999999999999889999999999999999999999998753 3444
Q ss_pred HHHHhcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+........ ....+++++.++|.+||+.||.+|||+.++++
T Consensus 242 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 242 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 44444433221 12467999999999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=327.17 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=212.9
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ ++..||+|++.......... ....+.+.+|+.+++.++||||+++++++....
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR---GVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 6799999999999999999976 58899999997654322110 001244778999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++. ....+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 88 ~~----------------~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 149 (326)
T 2y0a_A 88 DV----------------ILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149 (326)
T ss_dssp EE----------------EEEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred EE----------------EEEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEec
Confidence 44 66999999999999994 3467999999999999999999999999999999999999988
Q ss_pred CC----cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 208 NR----TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 208 ~~----~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
++ .++|+|||.+...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....
T Consensus 150 ~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 228 (326)
T 2y0a_A 150 RNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 228 (326)
T ss_dssp SSSSSCCEEECCCTTCEECCTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred CCCCCCCEEEEECCCCeECCCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH
Confidence 77 8999999999765432 233446789999999999998999999999999999999999999998887777766
Q ss_pred HHhcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+........ ....+++.+.++|.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 229 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 665443321 23567899999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=336.74 Aligned_cols=263 Identities=30% Similarity=0.595 Sum_probs=210.1
Q ss_pred ceecCCcceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
.++..++|.+.+.||+|+||.||+|.+ ++..||||+++... .. ...+.+.+|+.++.+++||||+++
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~----~~~~~~~~E~~~l~~l~h~niv~~ 111 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TE----KQRRDFLGEASIMGQFDHPNIIRL 111 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC----CH----HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc----CH----HHHHHHHHHHHHHHhCCCCCCCeE
Confidence 356678999999999999999999965 36779999986432 11 224568899999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++...... ++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|||||
T Consensus 112 ~~~~~~~~~~----------------~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 174 (373)
T 2qol_A 112 EGVVTKSKPV----------------MIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 174 (373)
T ss_dssp EEEECSSSSC----------------EEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred EEEEeeCCce----------------EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence 9998765544 6699999999999999643 4569999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCCC---CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~ 275 (355)
|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus 175 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 175 ARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp GGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred cceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999765433221 112234678999999998889999999999999999998 99999988
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
+..+....+.. ......+..++.++.++|.+||+.||.+||++.++++.|+.+....
T Consensus 255 ~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 255 SNQDVIKAVDE-GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp CHHHHHHHHHT-TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CHHHHHHHHHc-CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 87776655543 3344556678999999999999999999999999999999997654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=339.07 Aligned_cols=267 Identities=21% Similarity=0.360 Sum_probs=212.7
Q ss_pred ccccceecCCcceeecccccc--cceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcc
Q 018489 41 QRQDWEIEPSKLVIKSVIARG--TFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G--~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I 116 (355)
....+....++|++.+.||+| +||.||+|.+ +++.||||++...... ....+.+.+|+.+++.++||||
T Consensus 16 ~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~ni 88 (389)
T 3gni_B 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-------NEMVTFLQGELHVSKLFNHPNI 88 (389)
T ss_dssp --CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHHHCCCTTB
T ss_pred hhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-------hHHHHHHHHHHHHHHhCCCCCC
Confidence 445566778999999999999 9999999987 5899999999654321 1234567889999999999999
Q ss_pred ceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
+++++++...+.. ++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||
T Consensus 89 v~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr 152 (389)
T 3gni_B 89 VPYRATFIADNEL----------------WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHR 152 (389)
T ss_dssp CCEEEEEEETTEE----------------EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred CcEeEEEEECCEE----------------EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 9999998866554 669999999999999977666779999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeeccccccccCCC-------CCCCCCCCcccccCCcccCC--CCCCCcchhHHHHHHHHHHHh
Q 018489 197 DVKTENMLLDKNRTVKIADFGVARVEASNP-------NDMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 197 di~p~Nili~~~~~v~L~Dfg~a~~~~~~~-------~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~llt 267 (355)
||||+|||++.++.++|+|||.+....... .......++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 153 Dlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~ 232 (389)
T 3gni_B 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232 (389)
T ss_dssp CCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHH
Confidence 999999999999999999999876432211 11223468889999999987 578999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHhcCC--------------------------------------------CCCCCCCCcHHHHH
Q 018489 268 CDMPYPDLSFSEVTSAVVRQNL--------------------------------------------RPEIPRCCPSSLAN 303 (355)
Q Consensus 268 g~~p~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~l~~ 303 (355)
|+.||.+.+............. ....+..+++++.+
T Consensus 233 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 312 (389)
T 3gni_B 233 GHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312 (389)
T ss_dssp SSCTTTTCCSTTHHHHC--------------------------------------------------------CCHHHHH
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHH
Confidence 9999987665554433322111 01134557889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH--HHHHhH
Q 018489 304 VMKRCWDANPDKRPEMDEVVS--MLEAID 330 (355)
Q Consensus 304 li~~~l~~~p~~Rps~~ell~--~l~~~~ 330 (355)
||.+||+.||.+|||+.++++ .++.+.
T Consensus 313 li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 313 FVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred HHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 999999999999999999986 244443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=333.27 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=195.5
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
.....++|++.+.||+|+||.||+|.+ +++.||||+++.... .+.+.+|+.+++.++||||++++++
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~ 116 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----------KKIVRTEIGVLLRLSHPNIIKLKEI 116 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------------CHHHHHCCCTTBCCEEEE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----------HHHHHHHHHHHHhCCCCCCcceeee
Confidence 344457899999999999999999987 467899999964321 2347789999999999999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...... ++||||+++++|.+++. ....+++..++.++.|++.||.|||+.|++|+||||+|
T Consensus 117 ~~~~~~~----------------~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 178 (349)
T 2w4o_A 117 FETPTEI----------------SLVLELVTGGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPEN 178 (349)
T ss_dssp EECSSEE----------------EEEECCCCSCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred EecCCeE----------------EEEEEeCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCccc
Confidence 8765544 66999999999999984 34569999999999999999999999999999999999
Q ss_pred EEEcC---CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 203 MLLDK---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 203 ili~~---~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
|+++. ++.++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 179 Ill~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 257 (349)
T 2w4o_A 179 LLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ 257 (349)
T ss_dssp EEESSSSTTCCEEECCCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH
T ss_pred EEEecCCCCCCEEEccCccccccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH
Confidence 99975 889999999998754332 22234568999999999999899999999999999999999999998765544
Q ss_pred -HHHHHHhcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 280 -VTSAVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 280 -~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....+....... .....++.++.++|.+||+.||.+|||+.++++
T Consensus 258 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 258 FMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 444444433322 233568999999999999999999999999886
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=326.56 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=195.5
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ ++..||+|+++........ +.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--------~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP--------STAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSC--------HHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccH--------HHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 46899999999999999999965 5889999999765432221 2366899999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc----cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+.. ++||||++ ++|.+++.... ...+++..++.++.||+.||.|||++|++|+||||+|
T Consensus 76 ~~~----------------~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~N 138 (317)
T 2pmi_A 76 NKL----------------TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQN 138 (317)
T ss_dssp TEE----------------EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CeE----------------EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHH
Confidence 544 67999997 59999886542 2458999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
|+++.++.++|+|||.+..............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+..
T Consensus 139 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 218 (317)
T 2pmi_A 139 LLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL 218 (317)
T ss_dssp EEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred eEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999999866544444555678999999999976 46899999999999999999999999988877776
Q ss_pred HHHHhcCCC--------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLR--------------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~--------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+...... ......++.++.++|.+||+.||.+|||+.++++
T Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 219 KLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 665442110 0112356889999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=327.11 Aligned_cols=269 Identities=29% Similarity=0.510 Sum_probs=219.4
Q ss_pred ccccceecCCcceeec-ccccccceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc
Q 018489 41 QRQDWEIEPSKLVIKS-VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~-~lg~G~~~~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 115 (355)
...++.+..++|++.+ .||+|+||.||+|.+ ++..||+|+++..... ....+.+.+|+.+++.++|||
T Consensus 7 ~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~ 79 (291)
T 1xbb_A 7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-------PALKDELLAEANVMQQLDNPY 79 (291)
T ss_dssp ----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTT
T ss_pred CcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-------HHHHHHHHHHHHHHHhCCCCC
Confidence 3456677889999999 999999999999954 3578999999643221 223456889999999999999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H 195 (355)
|+++++++. .+. .++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|
T Consensus 80 i~~~~~~~~-~~~----------------~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H 140 (291)
T 1xbb_A 80 IVRMIGICE-AES----------------WMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVH 140 (291)
T ss_dssp BCCEEEEEE-SSS----------------EEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEEEEEEEC-CCC----------------cEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEc
Confidence 999999873 222 3679999999999999954 456999999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccccccccCCCCC---CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCC
Q 018489 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMP 271 (355)
Q Consensus 196 ~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p 271 (355)
+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 141 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p 220 (291)
T 1xbb_A 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220 (291)
T ss_dssp SCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCC
Confidence 999999999999999999999999765433221 122345678999999988888999999999999999999 9999
Q ss_pred CCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCC
Q 018489 272 YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGG 336 (355)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~ 336 (355)
|...+..+....+.. ......+..+++++.++|.+||+.||.+||++.++++.|+++.....+.
T Consensus 221 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 221 YRGMKGSEVTAMLEK-GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp STTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 998877766555444 4445667789999999999999999999999999999999998765443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=331.49 Aligned_cols=248 Identities=19% Similarity=0.301 Sum_probs=212.4
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ ++..+|+|++.... .. ...+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~------~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TD----QVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HH----HHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc------cc----HHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 47899999999999999999976 57899999986321 11 23477899999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++||||++|++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 74 ~~~----------------~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~ 136 (321)
T 1tki_A 74 EEL----------------VMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp TEE----------------EEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred CEE----------------EEEEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence 554 669999999999999843 234699999999999999999999999999999999999998
Q ss_pred C--CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 207 K--NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 207 ~--~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
. ++.++|+|||.+...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+
T Consensus 137 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 215 (321)
T 1tki_A 137 TRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215 (321)
T ss_dssp SSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cCCCCCEEEEECCCCeECCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence 7 789999999999765432 2233456899999999999988899999999999999999999999998888888777
Q ss_pred HhcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
........ ....+++++.++|.+||..||.+|||+.++++
T Consensus 216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 77654432 22467999999999999999999999999988
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=324.96 Aligned_cols=262 Identities=27% Similarity=0.484 Sum_probs=213.3
Q ss_pred eecCCcceeecccccccceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
.+...+|++.+.||+|+||.||+|.+ +++.||+|++....... ..+.+.+|+.+++.++||||+++
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~ 88 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--------HIADLKKEIEILRNLYHENIVKY 88 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--------CHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--------hHHHHHHHHHHHHhCCCCCeeee
Confidence 34567799999999999999999973 67899999996433211 12457889999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++...... ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+|||
T Consensus 89 ~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik 153 (302)
T 4e5w_A 89 KGICTEDGGN--------------GIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA 153 (302)
T ss_dssp EEEEEC---C--------------CEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eeEEecCCCc--------------eEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCc
Confidence 9988765322 237799999999999998653 3569999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC-
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL- 275 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~- 275 (355)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++|..|+...
T Consensus 154 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 233 (302)
T 4e5w_A 154 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233 (302)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred hheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh
Confidence 9999999999999999999976544332 233456788899999999888899999999999999999999876321
Q ss_pred -------------ChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 276 -------------SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 276 -------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
..................+..+++++.++|.+||+.||.+|||+.++++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 234 ALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2223333444455566677889999999999999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=319.72 Aligned_cols=264 Identities=29% Similarity=0.551 Sum_probs=217.8
Q ss_pred cccceecCCcceeecccccccceEEEEEEECC-----ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcc
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-----HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I 116 (355)
...+.+..++|++.+.||+|+||.||+|.+.+ ..||+|++..... . ...+.+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~l~h~~i 75 (281)
T 3cc6_A 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT----L----DNKEKFMSEAVIMKNLDHPHI 75 (281)
T ss_dssp CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC----H----HHHHHHHHHHHHHHHHCCTTB
T ss_pred CccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC----c----hHHHHHHHHHHHHHhCCCCCc
Confidence 34678888999999999999999999997532 3599999864321 1 123558899999999999999
Q ss_pred ceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
+++++++.... .+++|||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+
T Consensus 76 ~~~~~~~~~~~-----------------~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 137 (281)
T 3cc6_A 76 VKLIGIIEEEP-----------------TWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHR 137 (281)
T ss_dssp CCEEEEECSSS-----------------CEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred ceEEEEEcCCC-----------------CEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 99999875322 25799999999999999653 4569999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 018489 197 DVKTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPD 274 (355)
Q Consensus 197 di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~ 274 (355)
||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||..
T Consensus 138 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 138 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp CCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999999975443221 2233456778999999988889999999999999999998 9999988
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
.........+... .....+..+++.+.++|.+||+.||.+||++.++++.|+.+...
T Consensus 218 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 218 LENKDVIGVLEKG-DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp SCGGGHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CChHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 7777666555443 34456677899999999999999999999999999999998654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=330.38 Aligned_cols=258 Identities=21% Similarity=0.311 Sum_probs=211.9
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeec
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGAT 123 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~ 123 (355)
+..++|++.+.||+|+||.||+|.+ +++.||||++...... +.+.+|+.+++.+ +||||+++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~E~~~l~~l~~h~~i~~~~~~~ 74 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----------PQLHLEYRFYKQLGSGDGIPQVYYFG 74 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----------CCHHHHHHHHHHHCSCTTSCCEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----------HHHHHHHHHHHHhhCCCCCCEEEEEE
Confidence 4458999999999999999999974 6899999998754332 1267899999999 999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...... ++||||+ +++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||
T Consensus 75 ~~~~~~----------------~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Ni 136 (330)
T 2izr_A 75 PCGKYN----------------AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENF 136 (330)
T ss_dssp EETTEE----------------EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred ecCCcc----------------EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHe
Confidence 765544 6799999 99999999653 46799999999999999999999999999999999999
Q ss_pred EEcCCCc-----EEEeeccccccccCCCC-------CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 018489 204 LLDKNRT-----VKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMP 271 (355)
Q Consensus 204 li~~~~~-----v~L~Dfg~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p 271 (355)
+++.++. ++|+|||.+........ ......||..|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 137 ll~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~P 216 (330)
T 2izr_A 137 LIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216 (330)
T ss_dssp EECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCC
Confidence 9998887 99999999986543322 12456799999999999999999999999999999999999999
Q ss_pred CCCCChh---HHHHHHHhcCCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 272 YPDLSFS---EVTSAVVRQNLRP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 272 ~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
|.+.+.. +....+....... .....+| ++.++|..||+.||.+||++++|++.|+++....+
T Consensus 217 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 217 WQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp TTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 9875433 2233322211111 1223355 99999999999999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=334.27 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=209.2
Q ss_pred cceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
...+..++|++.+.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 82 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC------VERNEVRNVFKELQIMQGLEHPFLVNLWY 82 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc------ccHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3456678999999999999999999976 578899999853211 11112345778999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++...... ++||||+.|++|.+++. ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 83 ~~~~~~~~----------------~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~ 144 (384)
T 4fr4_A 83 SFQDEEDM----------------FMVVDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPD 144 (384)
T ss_dssp EEECSSEE----------------EEEECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred EEEeCCEE----------------EEEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHH
Confidence 98876655 66999999999999985 3467999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh-
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF- 277 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~lltg~~p~~~~~~- 277 (355)
||+++.+|.++|+|||++...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 145 NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~ 223 (384)
T 4fr4_A 145 NILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST 223 (384)
T ss_dssp GEEECTTSCEEECCCTTCEECCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS
T ss_pred HeEECCCCCEEEeccceeeeccCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc
Confidence 999999999999999999755432 33455689999999999974 4588999999999999999999999975433
Q ss_pred --hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 018489 278 --SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-MDEVVS 324 (355)
Q Consensus 278 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~ell~ 324 (355)
......+.. ....++..+++++.++|.+||+.||.+||+ ++++++
T Consensus 224 ~~~~~~~~~~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 224 SSKEIVHTFET--TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cHHHHHHHHhh--cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 333333333 334567788999999999999999999998 777664
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=330.63 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=215.6
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||++.+ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 113 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 113 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 47899999999999999999976 47889999986443221 12245578899999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++||||+++++|.+++.. ...+++..++.++.|++.+|.|||++|++|+||+|+||+++
T Consensus 114 ~~~----------------~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 175 (335)
T 2owb_A 114 DFV----------------FVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175 (335)
T ss_dssp SEE----------------EEEECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred CeE----------------EEEEecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc
Confidence 544 679999999999998854 45799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+..............++..|+|||.+.+..++.++||||||+++|+|++|..||......+....+..
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 255 (335)
T 2owb_A 176 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 255 (335)
T ss_dssp TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred CCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc
Confidence 99999999999998665444445556789999999999998899999999999999999999999998877776666655
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... .++..+++++.++|.+||+.||.+||++.++++
T Consensus 256 ~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 256 NEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCC--CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 433 466778999999999999999999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=321.22 Aligned_cols=251 Identities=28% Similarity=0.464 Sum_probs=211.4
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
....++|++.+.||+|+||.||+|.+ ++..||+|++... ..........+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA------QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH------HHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecc------ccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence 34457999999999999999999976 4678999998531 112222345688999999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...... ++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 79 ~~~~~~----------------~lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Ni 140 (279)
T 3fdn_A 79 HDATRV----------------YLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 140 (279)
T ss_dssp ECSSEE----------------EEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGE
T ss_pred ecCCEE----------------EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhE
Confidence 765554 669999999999999854 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
+++.++.++|+|||.+..... .......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......
T Consensus 141 li~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 218 (279)
T 3fdn_A 141 LLGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 218 (279)
T ss_dssp EECTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred EEcCCCCEEEEeccccccCCc--ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence 999999999999998864332 223345789999999999999899999999999999999999999998888777776
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+.... ..++..+++++.++|.+||+.||.+||++.++++
T Consensus 219 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 219 ISRVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHHTC--CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHhCC--CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 65543 3466778999999999999999999999999997
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=327.44 Aligned_cols=256 Identities=32% Similarity=0.573 Sum_probs=202.1
Q ss_pred ecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhh--CCCCccceeeeecc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK--LDHPNVTKFIGATM 124 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~~~~~~~ 124 (355)
+..++|++.+.||+|+||.||+|.++++.||||++.... ...+.+|.+++.. ++||||+++++++.
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------------EKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------------HHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------------chhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 345899999999999999999999999999999985321 1224456666665 79999999999865
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHH--------hCCcccc
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH--------SQKIVHR 196 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH--------~~~i~H~ 196 (355)
.... .....++||||+++++|.+++. ...+++..++.++.|++.||.||| +.|++|+
T Consensus 73 ~~~~------------~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 137 (301)
T 3q4u_A 73 TSRH------------SSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR 137 (301)
T ss_dssp EEET------------TEEEEEEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECS
T ss_pred cccC------------CCceeEEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecC
Confidence 4321 1233478999999999999993 457999999999999999999999 9999999
Q ss_pred CCCCCcEEEcCCCcEEEeeccccccccCCCCC----CCCCCCcccccCCcccCCC------CCCCcchhHHHHHHHHHHH
Q 018489 197 DVKTENMLLDKNRTVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNGN------PYNRKCDVYSFGICLWEIY 266 (355)
Q Consensus 197 di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~~ll 266 (355)
||||+||+++.++.++|+|||.+......... .....++..|+|||.+.+. .++.++||||||+++|+|+
T Consensus 138 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~ 217 (301)
T 3q4u_A 138 DLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217 (301)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999754433222 2334789999999999876 3457899999999999999
Q ss_pred hC----------CCCCCCCC-----hhHHHHHHHhcCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 267 CC----------DMPYPDLS-----FSEVTSAVVRQNLRPEIPR-----CCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 267 tg----------~~p~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
+| ..||.... ..............+..+. .+++++.++|.+||+.||.+|||+.++++.|
T Consensus 218 tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 218 RRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred hhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 99 88885532 1222222222233333332 2457899999999999999999999999999
Q ss_pred HHh
Q 018489 327 EAI 329 (355)
Q Consensus 327 ~~~ 329 (355)
+++
T Consensus 298 ~~i 300 (301)
T 3q4u_A 298 TKI 300 (301)
T ss_dssp HHH
T ss_pred hcc
Confidence 986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=325.10 Aligned_cols=246 Identities=26% Similarity=0.406 Sum_probs=210.4
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
.|...+.||+|+||.||+|.+ +|+.||||++....... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEE 116 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---------HHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence 477888999999999999976 58999999997544321 2347789999999999999999999876655
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. ++||||+++++|.+++. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 117 ~----------------~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 117 L----------------WVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp E----------------EEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred E----------------EEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 4 66999999999999884 3569999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcC
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~ 288 (355)
+.++|+|||.+..............|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+....
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 257 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP 257 (321)
T ss_dssp CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred CcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 99999999998766544444455689999999999999999999999999999999999999999887777666655543
Q ss_pred CCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 289 LRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 289 ~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... .....+++++.++|.+||+.||.+|||+.++++
T Consensus 258 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 258 PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 221 223457899999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=321.88 Aligned_cols=261 Identities=18% Similarity=0.285 Sum_probs=214.9
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeee
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGA 122 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~ 122 (355)
.+..++|++.+.||+|+||.||+|.+ +++.||+|++....... .+.+|+.++..+ +|+|+++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~e~~~~~~l~~~~~i~~~~~~ 74 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----------QLRDEYRTYKLLAGCTGIPNVYYF 74 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC-----------CHHHHHHHHHHTTTCTTCCCEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccH-----------HHHHHHHHHHHHhcCCCCCeEEee
Confidence 45678999999999999999999974 78999999986543221 266799999999 89999999988
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...... ++||||+ +++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 75 ~~~~~~~----------------~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N 136 (298)
T 1csn_A 75 GQEGLHN----------------VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDN 136 (298)
T ss_dssp EEETTEE----------------EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred cCCCcee----------------EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 7655444 6799999 99999999653 4569999999999999999999999999999999999
Q ss_pred EEEcCCCc-----EEEeeccccccccCCCC-------CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCC
Q 018489 203 MLLDKNRT-----VKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM 270 (355)
Q Consensus 203 ili~~~~~-----v~L~Dfg~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~ 270 (355)
|+++.++. ++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.
T Consensus 137 Il~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (298)
T 1csn_A 137 FLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 216 (298)
T ss_dssp EEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCC
Confidence 99987776 99999999986544322 2344568999999999999999999999999999999999999
Q ss_pred CCCCCC---hhHHHHHHHhcC---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCC
Q 018489 271 PYPDLS---FSEVTSAVVRQN---LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335 (355)
Q Consensus 271 p~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 335 (355)
||...+ .......+.... ........+++++.++|.+||+.||.+||++.+|++.|+++....+.
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 217 PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp TTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 998743 333333332221 11223456899999999999999999999999999999999876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=336.33 Aligned_cols=248 Identities=27% Similarity=0.491 Sum_probs=205.5
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||+|++.... .........+.+|+.+++.++||||+++++++...
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 81 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQL------LKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP 81 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHH------ccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 36899999999999999999986 78899999985311 11111234578999999999999999999998876
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ++||||+ +|+|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++
T Consensus 82 ~~~----------------~lv~E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~ 142 (336)
T 3h4j_B 82 TDI----------------VMVIEYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD 142 (336)
T ss_dssp SEE----------------EEEECCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC
T ss_pred CEE----------------EEEEECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc
Confidence 554 6699999 7799988854 45799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
.++.++|+|||++...... .......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||.+.........+.
T Consensus 143 ~~~~~kl~DFG~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~ 221 (336)
T 3h4j_B 143 DNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN 221 (336)
T ss_dssp TTCCEEECCSSCTBTTTTS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC
T ss_pred CCCCEEEEEeccceeccCC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 9999999999999754432 33345679999999999998765 689999999999999999999998754433322221
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.....++..+++++.++|++||+.||.+|||+.++++
T Consensus 222 --~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 --SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1223456778999999999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=327.51 Aligned_cols=265 Identities=29% Similarity=0.532 Sum_probs=221.3
Q ss_pred ccccceecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCC
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 113 (355)
....|++..++|++.+.||+|+||.||+|.+. +..||+|++..... . .....+.+|+.+++.++|
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~----~----~~~~~~~~E~~~l~~l~h 87 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS----M----RERIEFLNEASVMKEFNC 87 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC----H----HHHHHHHHHHHHGGGCCC
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC----H----HHHHHHHHHHHHHHhcCC
Confidence 34567888899999999999999999999653 57899999863221 1 113457889999999999
Q ss_pred CccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc--------ccccHHHHHHHHHHHHHHH
Q 018489 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--------RKLAFKVVVQLALDLARGL 185 (355)
Q Consensus 114 ~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~i~~qi~~al 185 (355)
|||+++++++...+.. ++||||+++++|.+++..... ..+++..++.++.|++.||
T Consensus 88 ~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 151 (322)
T 1p4o_A 88 HHVVRLLGVVSQGQPT----------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151 (322)
T ss_dssp TTBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHH
T ss_pred CCEeeeEEEEccCCcc----------------EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHH
Confidence 9999999998765544 669999999999999965432 4578999999999999999
Q ss_pred HHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHH
Q 018489 186 SYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263 (355)
Q Consensus 186 ~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ 263 (355)
.|||++|++|+||||+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|
T Consensus 152 ~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 231 (322)
T 1p4o_A 152 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 231 (322)
T ss_dssp HHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHH
Confidence 99999999999999999999999999999999987543221 1122335678899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 264 EIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 264 ~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
+|++ |..||...+.......+.... ....+..+++.+.++|.+||+.||.+|||+.++++.|+++.
T Consensus 232 el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 232 EIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHhcCCCccccCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 9999 899999888777666655443 34566778999999999999999999999999999998874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=319.12 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=213.0
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ ++..||+|++...... .. ..+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---AR----DFQKLEREARICRKLQHPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC---HH----HHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC---HH----HHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence 47899999999999999999976 5789999999654321 11 134577899999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... +++|||+++++|.+.+.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++
T Consensus 78 ~~~----------------~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~ 139 (284)
T 3kk8_A 78 SFH----------------YLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 139 (284)
T ss_dssp SEE----------------EEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred CEE----------------EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEe
Confidence 544 669999999999998854 46699999999999999999999999999999999999997
Q ss_pred CCCc---EEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 207 KNRT---VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 207 ~~~~---v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
.++. ++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......
T Consensus 140 ~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 218 (284)
T 3kk8_A 140 SKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 218 (284)
T ss_dssp SSSTTCCEEECCCTTCEECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cCCCCCcEEEeeceeeEEcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH
Confidence 6655 999999999755432 333446789999999999999999999999999999999999999999888877777
Q ss_pred HHhcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+......... ...+++++.++|.+||+.||.+|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 219 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 7665544333 2468999999999999999999999999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=331.82 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=197.8
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
....++|++.+.||+|+||.||++.+ +++.||+|++....... +.+.+|+.+++.++||||+++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~E~~~l~~l~hpniv~~~~~~ 85 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----------ENVQREIINHRSLRHPNIVRFKEVI 85 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----------HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----------HHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 44568999999999999999999976 68899999997543221 2367899999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...... ++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||
T Consensus 86 ~~~~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Ni 147 (361)
T 3uc3_A 86 LTPTHL----------------AIIMEYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENT 147 (361)
T ss_dssp ECSSEE----------------EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGE
T ss_pred eeCCEE----------------EEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 866554 669999999999999854 45699999999999999999999999999999999999
Q ss_pred EEcCCCc--EEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCc-chhHHHHHHHHHHHhCCCCCCCCCh---
Q 018489 204 LLDKNRT--VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRK-CDVYSFGICLWEIYCCDMPYPDLSF--- 277 (355)
Q Consensus 204 li~~~~~--v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~lltg~~p~~~~~~--- 277 (355)
+++.++. ++|+|||.+...... .......|++.|+|||.+.+..++.+ +||||||+++|+|++|+.||.+...
T Consensus 148 ll~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 226 (361)
T 3uc3_A 148 LLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226 (361)
T ss_dssp EECSSSSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC
T ss_pred EEcCCCCceEEEeecCcccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH
Confidence 9987765 999999998743222 22334578999999999988777655 8999999999999999999987544
Q ss_pred -hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 278 -SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 278 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
......+............+++++.+||.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 227 YRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 33334444444443444467999999999999999999999999987
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=331.77 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=205.0
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||+|++....... ..+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 77 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--------CPENIKKEICINKMLNHENVVKFYGHRREG 77 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--------hHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 47899999999999999999976 58899999986433211 124477899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++||||+++++|.+++. ....+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 78 ~~~----------------~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~ 139 (323)
T 3tki_A 78 NIQ----------------YLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139 (323)
T ss_dssp SEE----------------EEEEECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CeE----------------EEEEEcCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe
Confidence 554 66999999999999883 445699999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCChhHHH-H
Q 018489 207 KNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT-S 282 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~lltg~~p~~~~~~~~~~-~ 282 (355)
.++.++|+|||.+....... .......|+..|+|||.+.+..+ +.++||||||+++|+|++|..||......... .
T Consensus 140 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 219 (323)
T 3tki_A 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219 (323)
T ss_dssp TTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH
T ss_pred CCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 99999999999997543221 22334678999999999987765 77899999999999999999999876654333 3
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..............+++++.+||.+||+.||.+|||+.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 220 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 333333333334568999999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=350.08 Aligned_cols=269 Identities=32% Similarity=0.555 Sum_probs=227.8
Q ss_pred ccccceecCCcceeecccccccceEEEEEEECC-ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
....|++..++|++.+.||+|+||.||+|.+.+ ..||||+++..... .+.+.+|+.++++++||||+++
T Consensus 258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~ 327 (535)
T 2h8h_A 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQEAQVMKKLRHEKLVQL 327 (535)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred CccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----------HHHHHHHHHHHHhCCCCCEeeE
Confidence 356789999999999999999999999998864 67999999754321 2347899999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++.. .. .++||||+++++|.+++.......+++..++.|+.||+.||.|||++||+|||||
T Consensus 328 ~~~~~~-~~----------------~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk 390 (535)
T 2h8h_A 328 YAVVSE-EP----------------IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 390 (535)
T ss_dssp EEEECS-SS----------------CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEee-cc----------------ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 998754 22 2679999999999999976555679999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
|+|||++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus 391 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~ 470 (535)
T 2h8h_A 391 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470 (535)
T ss_dssp GGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH
T ss_pred HhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997543211 11223346778999999998889999999999999999999 9999998887
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGM 337 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~ 337 (355)
.+....+.. ......+..+++++.+||.+||+.||++|||+.+|++.|+.+..+....-
T Consensus 471 ~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~ 529 (535)
T 2h8h_A 471 REVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529 (535)
T ss_dssp HHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred HHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence 777665543 44556677899999999999999999999999999999999987655443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=334.19 Aligned_cols=273 Identities=18% Similarity=0.236 Sum_probs=214.1
Q ss_pred cCCcceeecccccccceEEEEEEEC----------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD----------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
..++|++.+.||+|+||.||+|.+. +..||+|++... +.+.+|+.+++.++||||+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------------~~~~~E~~~l~~l~h~niv 105 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------------GRLFNEQNFFQRAAKPLQV 105 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------------STHHHHHHHHHHHCCHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------------chHHHHHHHHHHhcccchh
Confidence 3589999999999999999999763 688999998643 1367899999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccC
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~d 197 (355)
++++.+.......+....+.........++||||+ +++|.+++.......+++..++.++.||+.||.|||++|++|+|
T Consensus 106 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~D 184 (352)
T 2jii_A 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGN 184 (352)
T ss_dssp HHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSC
T ss_pred hhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 97665544332222111111112345678999999 99999999765567899999999999999999999999999999
Q ss_pred CCCCcEEEcCCC--cEEEeeccccccccCCCC-------CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhC
Q 018489 198 VKTENMLLDKNR--TVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268 (355)
Q Consensus 198 i~p~Nili~~~~--~v~L~Dfg~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg 268 (355)
|||+||+++.++ .++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 264 (352)
T 2jii_A 185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG 264 (352)
T ss_dssp CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999988 999999999975432211 12334789999999999998999999999999999999999
Q ss_pred CCCCCCCC--hhHHHHHHHh-cCCCCCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCC
Q 018489 269 DMPYPDLS--FSEVTSAVVR-QNLRPEIP------RCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335 (355)
Q Consensus 269 ~~p~~~~~--~~~~~~~~~~-~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 335 (355)
+.||.... .......... ......+. ..+++++.++|.+||+.||.+||++.++++.|+.+....+.
T Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 265 FLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp CCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 99998753 2222222111 11111111 24689999999999999999999999999999999887653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=331.14 Aligned_cols=267 Identities=29% Similarity=0.450 Sum_probs=212.3
Q ss_pred cccceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
..++....++|++.+.||+|+||.||+|.+ ++..||+|++...... ..+.+.+|+.+++.++||||++++
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~ 101 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---------GIEEFETEIETLSFCRHPHLVSLI 101 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS---------HHHHHHHHHHGGGSCCCTTBCCEE
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH---------HHHHHHHHHHHHHhCCCCCEeeEE
Confidence 344555678999999999999999999976 4789999988643221 134578899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--cccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++...+.. ++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||
T Consensus 102 ~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dl 165 (321)
T 2qkw_B 102 GFCDERNEM----------------ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDV 165 (321)
T ss_dssp EECCCTTCC----------------EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EEEcCCCeE----------------EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCC
Confidence 998765544 66999999999999885432 235899999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~ 276 (355)
||+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 166 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 166 KSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp CSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred CHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 9999999999999999999997543221 22233458899999999988889999999999999999999999997543
Q ss_pred hhHHH------HHHHh-cC--------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 277 FSEVT------SAVVR-QN--------LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 277 ~~~~~------~~~~~-~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
..+.. ..... .. .........+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 22111 11111 11 111122334677999999999999999999999999999887543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=326.74 Aligned_cols=262 Identities=21% Similarity=0.328 Sum_probs=208.9
Q ss_pred ecCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
+..++|++.+.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--------VDVQMREFEVLKKLNHKNIVKLFAIEE 77 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--------HHHHHHHHHHHHhcCCCCcceEEEEee
Confidence 45689999999999999999999774 88999999964332111 234678999999999999999999887
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
..... ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 78 ~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 143 (319)
T 4euu_A 78 ETTTR--------------HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143 (319)
T ss_dssp CTTTC--------------CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred cCCCc--------------eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 55432 33789999999999999965432 2399999999999999999999999999999999999
Q ss_pred EE----cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC--------CCCCCCcchhHHHHHHHHHHHhCCCC
Q 018489 204 LL----DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN--------GNPYNRKCDVYSFGICLWEIYCCDMP 271 (355)
Q Consensus 204 li----~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~il~~lltg~~p 271 (355)
++ +..+.++|+|||.+...... .......++..|+|||.+. +..++.++||||||+++|+|++|+.|
T Consensus 144 ll~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~p 222 (319)
T 4euu_A 144 MRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222 (319)
T ss_dssp EEEECTTSCEEEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred EEeccCCCCceEEEccCCCceecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99 77788999999999765433 2334467899999999985 56788999999999999999999999
Q ss_pred CCCCCh----hHHHHHHHhcCCCC-----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 272 YPDLSF----SEVTSAVVRQNLRP-----------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 272 ~~~~~~----~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
|..... .+....+....... .+...+++.+.++|++||+.||++|||++|+++
T Consensus 223 f~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp EECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 975432 33333333322110 122234678999999999999999999999999
Q ss_pred HHHHhHh
Q 018489 325 MLEAIDT 331 (355)
Q Consensus 325 ~l~~~~~ 331 (355)
...+...
T Consensus 303 h~~d~~~ 309 (319)
T 4euu_A 303 ETSDILH 309 (319)
T ss_dssp HHHHHTC
T ss_pred ccHHHhh
Confidence 8776543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=326.12 Aligned_cols=268 Identities=25% Similarity=0.393 Sum_probs=212.2
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
...++|++.+.||+|+||.||+|.+ +++.||||+++...... ......+.+|+.++..++||||+++++++.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 82 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD------PSFYLRFRREAQNAAALNHPAIVAVYDTGE 82 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS------HHHHHHHHHHHTTCCCCCCTTBCCEEEEEE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC------HHHHHHHHHHHHHHHcCCCCCcceEEEeee
Confidence 3458999999999999999999975 68899999996543221 123455889999999999999999999876
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..... ....++||||+++++|.+++.. ...+++..++.++.|++.+|.|||++|++|+||||+||+
T Consensus 83 ~~~~~------------~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 148 (311)
T 3ork_A 83 AETPA------------GPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 148 (311)
T ss_dssp EEETT------------EEEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred ccCCC------------CcccEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEE
Confidence 54432 1233679999999999999954 457999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 205 LDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
++.++.++|+|||.+........ ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.....
T Consensus 149 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~ 228 (311)
T 3ork_A 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228 (311)
T ss_dssp EETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999975443221 223346899999999999999999999999999999999999999988887777
Q ss_pred HHHHhcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHhHhhcC
Q 018489 282 SAVVRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRP-EMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 282 ~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp-s~~ell~~l~~~~~~~~ 334 (355)
.........+. ....+++++.++|.+||+.||.+|| +++++.+.+..+.....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~ 284 (311)
T 3ork_A 229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP 284 (311)
T ss_dssp HHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred HHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence 66666544332 2355899999999999999999999 45556667766654433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=342.04 Aligned_cols=252 Identities=27% Similarity=0.513 Sum_probs=214.7
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
.+..++|.+.+.||+|+||.||+|.+ +++.||||++.... .........+.+|+.+++.++||||+++++++
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~------~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK------IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH------HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh------ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34457999999999999999999976 58999999995321 11112235688999999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...+.. ++||||+++++|.+++. ....+++..++.++.||+.||.|||++|++||||||+||
T Consensus 86 ~~~~~~----------------~lv~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NI 147 (476)
T 2y94_A 86 STPSDI----------------FMVMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENV 147 (476)
T ss_dssp ECSSEE----------------EEEEECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGE
T ss_pred EECCEE----------------EEEEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHE
Confidence 766554 66999999999999984 456799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
+++.++.++|+|||.+...... .......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||.+.+......
T Consensus 148 ll~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 226 (476)
T 2y94_A 148 LLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK 226 (476)
T ss_dssp EECTTCCEEECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH
T ss_pred EEecCCCeEEEeccchhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 9999999999999999765432 23344679999999999998765 689999999999999999999999888777777
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+..... ..+..+++++.++|.+||+.||.+|||+.++++
T Consensus 227 ~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 227 KICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 6665433 456678999999999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=330.84 Aligned_cols=263 Identities=22% Similarity=0.372 Sum_probs=208.2
Q ss_pred cccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
...+++ .++|++.+.||+|+||.||+|.+ +++.||||++...... ....+.+.+|+.+++.++||||+++
T Consensus 18 ~~~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~l 89 (367)
T 1cm8_A 18 KTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-------ELFAKRAYRELRLLKHMRHENVIGL 89 (367)
T ss_dssp SSEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-------HHHHHHHHHHHHHHHHCCBTTBCCC
T ss_pred Cceeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-------HHHHHHHHHHHHHHHhCCCcCCCCc
Confidence 344555 47899999999999999999976 6889999998543221 1224557899999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++....... .....++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.|++|||||
T Consensus 90 ~~~~~~~~~~~----------~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk 155 (367)
T 1cm8_A 90 LDVFTPDETLD----------DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK 155 (367)
T ss_dssp SEEECSCSSTT----------TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred eeeEecCCccc----------cCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcC
Confidence 99987654321 123347899999 8899999853 569999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
|+||+++.++.++|+|||.+..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 156 p~NIll~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 232 (367)
T 1cm8_A 156 PGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 232 (367)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HHHEEEcCCCCEEEEeeeccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999999986543 2344678999999999877 67899999999999999999999999988877
Q ss_pred HHHHHHHhcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q 018489 279 EVTSAVVRQNLRP-----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLE 327 (355)
Q Consensus 279 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~ 327 (355)
+.+..+......+ .+....++++.+||.+||+.||.+|||+.++++ .++
T Consensus 233 ~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~ 312 (367)
T 1cm8_A 233 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312 (367)
T ss_dssp HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence 6666554321111 123456899999999999999999999999988 454
Q ss_pred Hh
Q 018489 328 AI 329 (355)
Q Consensus 328 ~~ 329 (355)
.+
T Consensus 313 ~~ 314 (367)
T 1cm8_A 313 SL 314 (367)
T ss_dssp TT
T ss_pred hh
Confidence 44
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=342.51 Aligned_cols=257 Identities=27% Similarity=0.371 Sum_probs=214.8
Q ss_pred ccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
.++.+..++|++.+.||+|+||.||+|.+ ++..||+|+++.... ......+.+.+|..++..++||||++++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~------~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 135 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM------IKRSDSAFFWEERDIMAFANSPWVVQLF 135 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH------HHTCCCSTHHHHHHHHHHCCCTTBCCEE
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh------hhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45677789999999999999999999976 578999999853110 0000112367899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++.+.... ++||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 136 ~~~~~~~~~----------------~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp 196 (410)
T 3v8s_A 136 YAFQDDRYL----------------YMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 196 (410)
T ss_dssp EEEECSSEE----------------EEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred EEEEECCEE----------------EEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCH
Confidence 998866554 669999999999998843 4699999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCC----CCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNP----YNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
+|||++.+|.++|+|||++........ ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.
T Consensus 197 ~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 197 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred HHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 999999999999999999975543322 233567999999999998654 788999999999999999999999998
Q ss_pred ChhHHHHHHHhcC--CCCCCCCCCcHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 018489 276 SFSEVTSAVVRQN--LRPEIPRCCPSSLANVMKRCWDANPDK--RPEMDEVVS 324 (355)
Q Consensus 276 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~ell~ 324 (355)
+.......+.... ........+++++.+||.+||+.+|.+ ||++++|++
T Consensus 277 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 277 SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp SHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 8888888776643 222333468999999999999999988 999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=324.03 Aligned_cols=264 Identities=31% Similarity=0.581 Sum_probs=215.2
Q ss_pred ceecCCcceeecccccccceEEEEEEECC------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDG------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
.++..++|++.+.||+|+||.||+|.+.. ..||+|+++... .. .....+.+|+.+++.++||||++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l~h~~iv~ 110 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TE----KQRVDFLGEAGIMGQFSHHNIIR 110 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CH----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----CH----HHHHHHHHHHHHHHhCCCCCCCc
Confidence 46778999999999999999999996532 359999986432 11 12345788999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++...+.. ++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||
T Consensus 111 ~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 173 (333)
T 1mqb_A 111 LEGVISKYKPM----------------MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDL 173 (333)
T ss_dssp EEEEECSSSSE----------------EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEecCCCc----------------EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 99998765544 6799999999999998643 456999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPD 274 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~ 274 (355)
||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 174 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 174 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp CGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999976543221 1122345678999999998889999999999999999999 9999998
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
.+..+....+... .....+..++..+.++|.+||+.||.+||++.++++.|+.+.....
T Consensus 254 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 254 LSNHEVMKAINDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CCHHHHHHHHHTT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CCHHHHHHHHHCC-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 8877766655443 3445667789999999999999999999999999999999875543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=331.19 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=213.8
Q ss_pred ccchhhcccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC
Q 018489 34 ASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111 (355)
Q Consensus 34 ~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 111 (355)
+........+...+..++|++.+.||+|+||.||+|.+ +++.||||+++.. . ...+.+..|+.+++.+
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~----~~~~~~~~e~~~l~~l 88 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI------K----KYTRSAKIEADILKKI 88 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------H----HHHHHHHHHHHHHHHT
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc------h----hhhhhhHHHHHHHHHh
Confidence 33445667777778889999999999999999999987 6889999998521 1 1233466789999988
Q ss_pred C-----CCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHH
Q 018489 112 D-----HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLS 186 (355)
Q Consensus 112 ~-----h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~ 186 (355)
. ||||+++++++...+.. ++||||+ +++|.+++.......+++..++.++.||+.||.
T Consensus 89 ~~~~~~h~~iv~~~~~~~~~~~~----------------~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 151 (360)
T 3llt_A 89 QNDDINNNNIVKYHGKFMYYDHM----------------CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151 (360)
T ss_dssp CCCSTTGGGBCCEEEEEEETTEE----------------EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred cccCCCCCCeecccceeeECCee----------------EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 6 99999999988765544 6799999 999999998766667999999999999999999
Q ss_pred HHHhCCccccCCCCCcEEEcC-------------------------CCcEEEeeccccccccCCCCCCCCCCCcccccCC
Q 018489 187 YLHSQKIVHRDVKTENMLLDK-------------------------NRTVKIADFGVARVEASNPNDMTGETGTLGYMAP 241 (355)
Q Consensus 187 ~LH~~~i~H~di~p~Nili~~-------------------------~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aP 241 (355)
|||++||+|+||||+|||++. ++.++|+|||.+..... ......++..|+||
T Consensus 152 ~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aP 228 (360)
T 3llt_A 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAP 228 (360)
T ss_dssp HHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCH
T ss_pred HHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCc
Confidence 999999999999999999975 78999999999975443 22345789999999
Q ss_pred cccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCC------------------------CC---
Q 018489 242 EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPE------------------------IP--- 294 (355)
Q Consensus 242 E~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~------------------------~~--- 294 (355)
|.+.+..++.++||||||+++|+|++|+.||...+..+....+........ .+
T Consensus 229 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 308 (360)
T 3llt_A 229 EVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENA 308 (360)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTC
T ss_pred HHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccc
Confidence 999999999999999999999999999999988777666554433211100 00
Q ss_pred -----------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 295 -----------------RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 295 -----------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...++.+.+||.+||+.||.+|||+.|+++
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 309 SSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp SCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 112377889999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=316.60 Aligned_cols=264 Identities=33% Similarity=0.526 Sum_probs=214.8
Q ss_pred CCcceeecccccccceEEEEEEE--CC---ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DG---HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
.-.|.+.+.||+|+||.||+|.+ ++ ..+|+|++..... . ...+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~----~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 91 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE----M----QQVEAFLREGLLMRGLNHPNVLALIGIM 91 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS----H----HHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc----H----HHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34567789999999999999965 32 2699999853221 1 1235578899999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...+.. .+++|||+.+++|.+++.. ....+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 92 ~~~~~~---------------~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Ni 155 (298)
T 3pls_A 92 LPPEGL---------------PHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNC 155 (298)
T ss_dssp CCSSSC---------------CEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCC---------------cEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 754433 2569999999999999854 356789999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCC----CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCC-CCCCCCChh
Q 018489 204 LLDKNRTVKIADFGVARVEASN----PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFS 278 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~-~p~~~~~~~ 278 (355)
+++.++.++|+|||.+...... ........++..|+|||.+.+..++.++||||||+++|+|++|. .||...+..
T Consensus 156 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~ 235 (298)
T 3pls_A 156 MLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235 (298)
T ss_dssp EECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG
T ss_pred EEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH
Confidence 9999999999999999744321 22233456788999999999999999999999999999999955 455555555
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGM 337 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~ 337 (355)
..... .........+..+++++.++|.+||+.||.+|||+.++++.|+.+.....+..
T Consensus 236 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 236 DLTHF-LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp GHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred HHHHH-hhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 54444 44444556677789999999999999999999999999999999988765544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=327.89 Aligned_cols=259 Identities=27% Similarity=0.534 Sum_probs=211.5
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCce----eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHD----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
.+..++|++.+.||+|+||.||+|.+ ++.. |++|++........ .+.+.+|+.++..++||||+++
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~ 80 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--------FQAVTDHMLAIGSLDHAHIVRL 80 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC--------BCSCCHHHHHHHTCCCTTBCCE
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH--------HHHHHHHHHHHhcCCCCCcCeE
Confidence 34568999999999999999999976 3444 77777743322111 1225679999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++... ..++||||+++++|.+++... ...+++..++.|+.|++.||.|||++|++|||||
T Consensus 81 ~~~~~~~-----------------~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik 142 (325)
T 3kex_A 81 LGLCPGS-----------------SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA 142 (325)
T ss_dssp EEEECBS-----------------SEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEcCC-----------------ccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9987532 236799999999999998643 4579999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 276 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~ 276 (355)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 143 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 143 ARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp STTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred hheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 9999999999999999999986543322 2233457779999999998889999999999999999999 999999877
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
.......+.. ......+..++.++.++|.+||+.||.+||++.++++.|+.+..
T Consensus 223 ~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 223 LAEVPDLLEK-GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTHHHHHHHT-TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHc-CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 6666555443 34455667788999999999999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=320.47 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=215.5
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|+||.||++.+ +++.+|+|++....... ....+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 86 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQHVVGFHGFFED 86 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC------HHHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 347899999999999999999977 47889999986543221 1224557889999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. +++|||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||++
T Consensus 87 ~~~~----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 148 (294)
T 2rku_A 87 NDFV----------------FVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL 148 (294)
T ss_dssp SSEE----------------EEEEECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCEE----------------EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE
Confidence 5544 669999999999998854 4579999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
+.++.++|+|||.+..............++..|+|||.+.+..++.++||||||+++|+|++|..||......+....+.
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 228 (294)
T 2rku_A 149 NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 228 (294)
T ss_dssp CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 99999999999999866544444555678999999999999889999999999999999999999999887777666555
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... ..++..+++.+.++|.+||+.||.+|||+.++++
T Consensus 229 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 229 KNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp TTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 433 3466788999999999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=333.63 Aligned_cols=269 Identities=21% Similarity=0.332 Sum_probs=203.3
Q ss_pred eecCCcceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHH----HHHHHHHHHHHhhCCCCcc
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAAL----RSAFTQEVAVWHKLDHPNV 116 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~I 116 (355)
.+..++|++.+.||+|+||.||+|.+ ++..+|+|++...... ...+...+ ...+.+|+..+..++||||
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP--LFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CH--HHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcc--hHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 45568999999999999999999987 5678999998754321 11222211 2346788999999999999
Q ss_pred ceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
+++++++..... .....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++|++|+
T Consensus 111 ~~~~~~~~~~~~------------~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 175 (345)
T 2v62_A 111 PLFYGSGLTEFK------------GRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHENEYVHG 175 (345)
T ss_dssp CCEEEEEEEESS------------SCEEEEEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred ceeecccccccC------------CCcEEEEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 999998875210 123447899999 9999999854 3479999999999999999999999999999
Q ss_pred CCCCCcEEEcCCC--cEEEeeccccccccCCC-------CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh
Q 018489 197 DVKTENMLLDKNR--TVKIADFGVARVEASNP-------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 197 di~p~Nili~~~~--~v~L~Dfg~a~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt 267 (355)
||||+||+++.++ .++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 176 Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 255 (345)
T 2v62_A 176 DIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLC 255 (345)
T ss_dssp CCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 9999999998877 99999999997543221 11234578999999999999999999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 268 CDMPYPDLSFSEVTSAVVRQNLRPEIP---------RCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 268 g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
|+.||....................++ ..+++++.++|..||+.||.+||++.+|++.|+.+..
T Consensus 256 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 256 GKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp SSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred CCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 999996532211111111111111111 2678999999999999999999999999999988654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=321.21 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=187.2
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|+||.||+|.+ ++..||+|++.... .......+.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA------MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED 82 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh------hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc
Confidence 346899999999999999999976 68899999985321 1111223568899999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.... +++|||+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||+|+||++
T Consensus 83 ~~~~----------------~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili 145 (278)
T 3cok_A 83 SNYV----------------YLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL 145 (278)
T ss_dssp SSEE----------------EEEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE
T ss_pred CCeE----------------EEEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 5544 679999999999999864 34579999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
+.++.++|+|||.+..............++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.........
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 225 (278)
T 3cok_A 146 TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV 225 (278)
T ss_dssp CTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC
T ss_pred cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh
Confidence 99999999999999865544333444678999999999999889999999999999999999999998766555444332
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.. ....+..++.++.++|.+||+.||.+||++.++++
T Consensus 226 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 22 22456678999999999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=338.52 Aligned_cols=265 Identities=25% Similarity=0.376 Sum_probs=190.8
Q ss_pred ccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
..+.+ .++|++.+.||+|+||.||+|.+ +++.||||++...... . ...+.+.+|+.+++.++||||++++
T Consensus 47 ~~~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~----~~~~~~~~E~~~l~~l~h~niv~l~ 118 (458)
T 3rp9_A 47 SDWQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED---L----IDCKRILREIAILNRLNHDHVVKVL 118 (458)
T ss_dssp SSCCS-CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS---H----HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcCcc-CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC---H----HHHHHHHHHHHHHHhCCCCCCCceE
Confidence 34444 37899999999999999999965 6889999998543221 1 1234578899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++...... ....+++||||+ +++|.+++. ....+++..++.++.||+.||.|||+.||+||||||
T Consensus 119 ~~~~~~~~~-----------~~~~~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp 184 (458)
T 3rp9_A 119 DIVIPKDVE-----------KFDELYVVLEIA-DSDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKP 184 (458)
T ss_dssp EECCCSCTT-----------TCCCEEEEECCC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred EEEecCCcc-----------cCceEEEEEecc-ccchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCCh
Confidence 988644311 123458899998 578999884 446799999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCC---------------------------CCCCCCCCcccccCCccc-CCCCCCCc
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNP---------------------------NDMTGETGTLGYMAPEVL-NGNPYNRK 252 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~ 252 (355)
+|||++.++.++|+|||++....... ......++|..|+|||++ .+..++.+
T Consensus 185 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 264 (458)
T 3rp9_A 185 ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA 264 (458)
T ss_dssp GGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTH
T ss_pred hhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcH
Confidence 99999999999999999997643221 122345679999999986 55679999
Q ss_pred chhHHHHHHHHHHHh-----------CCCCCCCCCh--------------------hHHHHHHHhcCCC-----------
Q 018489 253 CDVYSFGICLWEIYC-----------CDMPYPDLSF--------------------SEVTSAVVRQNLR----------- 290 (355)
Q Consensus 253 ~DvwslG~il~~llt-----------g~~p~~~~~~--------------------~~~~~~~~~~~~~----------- 290 (355)
+|||||||++|+|++ |+.+|.+.+. ...+..+......
T Consensus 265 ~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 344 (458)
T 3rp9_A 265 IDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344 (458)
T ss_dssp HHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSC
T ss_pred hHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCC
Confidence 999999999999998 6666655431 1112211110000
Q ss_pred ------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHh
Q 018489 291 ------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAI 329 (355)
Q Consensus 291 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~ 329 (355)
.......++++.+||.+||..||.+|||++|+++ .++.+
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 0112345899999999999999999999999998 44444
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=320.73 Aligned_cols=264 Identities=29% Similarity=0.534 Sum_probs=213.1
Q ss_pred ceecCCcceeecccccccceEEEEEEEC---Cc--eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD---GH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
..+..++|++.+.||+|+||.||+|.+. +. .||+|+++...... ....+.+.+|+.+++.++||||+++
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~ 86 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ------PEAMDDFIREVNAMHSLDHRNLIRL 86 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC------HHHHHHHHHHHHHHHhCCCCCcccE
Confidence 4556789999999999999999999752 22 58999986432211 1234568899999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++.... .+++|||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||+
T Consensus 87 ~~~~~~~~-----------------~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik 148 (291)
T 1u46_A 87 YGVVLTPP-----------------MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA 148 (291)
T ss_dssp EEEECSSS-----------------CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred EEEEccCC-----------------ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCc
Confidence 99887543 25799999999999998653 4569999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~ 275 (355)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 149 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 9999999999999999999876543322 1223456778999999988888999999999999999999 99999999
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
+..+....+.........+..++.++.++|.+||+.||.+|||+.++++.|+++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 229 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 888888877777666677788999999999999999999999999999999988643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=321.16 Aligned_cols=257 Identities=27% Similarity=0.469 Sum_probs=212.0
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|+||.||++.+ +++.||+|++...... . ...+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---E----AEKQMLVSEVNLLRELKHPNIVRYYDRIID 76 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC---H----HHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC---H----HHHHHHHHHHHHHHhcCCCCCCeEEEEEec
Confidence 347899999999999999999976 5889999999754322 1 124568899999999999999999997754
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--cccccHHHHHHHHHHHHHHHHHHHhCC-----ccccCC
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQK-----IVHRDV 198 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~-----i~H~di 198 (355)
... ...++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.| ++|+||
T Consensus 77 ~~~--------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl 142 (279)
T 2w5a_A 77 RTN--------------TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142 (279)
T ss_dssp GGG--------------TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCC
T ss_pred CCC--------------ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEecc
Confidence 322 23378999999999999996543 234999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
+|+||+++.++.++|+|||.+..............++..|+|||.+.+..++.++||||||+++|+|++|..||...+..
T Consensus 143 ~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 222 (279)
T 2w5a_A 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 222 (279)
T ss_dssp SGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred chhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH
Confidence 99999999999999999999876543322222345788999999999988999999999999999999999999988877
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSML 326 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l 326 (355)
.....+.... ...++..++.++.++|.+||+.||.+||++.++++.+
T Consensus 223 ~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 223 ELAGKIREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHHHHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HHHHHHhhcc-cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 6666555543 3456778899999999999999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=322.84 Aligned_cols=262 Identities=22% Similarity=0.327 Sum_probs=204.8
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|+||.||+|.+ +++.||+|++...... .....+.+.+|+.+++.++||||+++++++..
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS------DPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc------CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 347899999999999999999976 5889999998643221 12334568899999999999999999998876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. +++|||+++++|.+++.. ...+++..++.++.|++.+|.|||++|++|+||+|+||++
T Consensus 106 ~~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~ 167 (309)
T 2h34_A 106 DGQL----------------YVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV 167 (309)
T ss_dssp TTEE----------------EEEEECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CCeE----------------EEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE
Confidence 5544 669999999999999964 3569999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~- 246 (309)
T 2h34_A 168 SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH- 246 (309)
T ss_dssp CTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH-
T ss_pred cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH-
Confidence 999999999999987544322 222345688999999999998899999999999999999999999988665533333
Q ss_pred HhcCCC--CCCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHhHhhcC
Q 018489 285 VRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRP-EMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 285 ~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~ell~~l~~~~~~~~ 334 (355)
...... ...+..+++++.++|.+||+.||.+|| +++++++.|+.+.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 247 INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred hccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 332221 134567899999999999999999999 99999999998865543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=329.40 Aligned_cols=245 Identities=22% Similarity=0.411 Sum_probs=204.9
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 125 (355)
.++|++.+.||+|+||.||+|.+ +++.||+|++...... ..+|++++.++ +||||+++++++.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------------~~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------------PTEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------------CHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------------hHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 37899999999999999999976 5889999999754422 23577777777 89999999999876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.... ++||||++|++|.+++. ....+++..++.++.||+.||.|||++|++||||||+||++
T Consensus 88 ~~~~----------------~lv~E~~~gg~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~ 149 (342)
T 2qr7_A 88 GKYV----------------YVVTELMKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149 (342)
T ss_dssp SSEE----------------EEEECCCCSCBHHHHHH--TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CCEE----------------EEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEE
Confidence 5544 66999999999999985 34679999999999999999999999999999999999998
Q ss_pred cCC----CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC---Chh
Q 018489 206 DKN----RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL---SFS 278 (355)
Q Consensus 206 ~~~----~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~---~~~ 278 (355)
... +.++|+|||.+..............+++.|+|||.+.+..++.++||||||+++|+|++|..||... +..
T Consensus 150 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 229 (342)
T 2qr7_A 150 VDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE 229 (342)
T ss_dssp SSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH
T ss_pred ecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH
Confidence 543 3599999999986655444455567899999999998877889999999999999999999999763 445
Q ss_pred HHHHHHHhcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 279 EVTSAVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 279 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+....+....... ..+..+++++.++|.+||+.||.+||++.++++
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 230 EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 5555555544432 234568999999999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=327.36 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=197.2
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||||+++...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-------GVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-------ccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 36899999999999999999965 68899999996543221 1234467899999999999999999998766
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ++||||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++
T Consensus 106 ~~~----------------~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~ 166 (329)
T 3gbz_A 106 HRL----------------HLIFEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLS 166 (329)
T ss_dssp TEE----------------EEEEECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred CEE----------------EEEEecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEe
Confidence 554 66999997 499999854 45699999999999999999999999999999999999994
Q ss_pred -----CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 207 -----KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 207 -----~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
..+.++|+|||.+..............++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 246 (329)
T 3gbz_A 167 VSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ 246 (329)
T ss_dssp C-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH
Confidence 45569999999998665444445556789999999999874 589999999999999999999999998887777
Q ss_pred HHHHHhcCCCCC----------------C------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 281 TSAVVRQNLRPE----------------I------------PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~~~~~~----------------~------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+......+. + ...+++++.+||.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 247 LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 766654321111 0 0116789999999999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=323.51 Aligned_cols=261 Identities=29% Similarity=0.362 Sum_probs=205.3
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC---CCCccceeee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIG 121 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~ 121 (355)
+..++|++.+.||+|+||.||+|.+ +++.||+|++........... ....+.+|+.+++.+ +||||+++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGG----LPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSC----CCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccc----cchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 4468999999999999999999974 688999999964332111100 011244566666555 5999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++...... .....+++|||+. ++|.+++.......+++..++.++.|++.||.|||++|++|+||||+
T Consensus 82 ~~~~~~~~-----------~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~ 149 (308)
T 3g33_A 82 VCATSRTD-----------REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 149 (308)
T ss_dssp EEEECCSS-----------SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred eeeccCCC-----------CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 88654321 0113478999996 59999997665566999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
||+++.++.++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.....
T Consensus 150 Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 228 (308)
T 3g33_A 150 NILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 228 (308)
T ss_dssp TEEECTTSCEEECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH
T ss_pred HEEEcCCCCEEEeeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999999754432 2334457899999999999988999999999999999999999999998887777
Q ss_pred HHHHhcCCCCC-------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRPE-------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+......+. ....+++++.++|.+||+.||.+|||+.++++
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 66654221111 11356889999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=323.23 Aligned_cols=260 Identities=26% Similarity=0.556 Sum_probs=210.2
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCcee----EEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDV----AVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~v----avK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
.+..++|++.+.||+|+||.||+|.+ +++.+ ++|.+....... . .+.+.+|+.+++.++||||+++
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~-~-------~~~~~~E~~~l~~l~hp~iv~~ 82 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-A-------NKEILDEAYVMASVDNPHVCRL 82 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC-C-------HHHHHHHHHHHTTCCBTTBCCC
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH-H-------HHHHHHHHHHHHhCCCCCeeEE
Confidence 35678999999999999999999976 45554 666664322211 1 2447789999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++.... .+++++|+.+++|.+++... ...+++..++.|+.|++.||.|||++|++|+|||
T Consensus 83 ~~~~~~~~-----------------~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 144 (327)
T 3lzb_A 83 LGICLTST-----------------VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144 (327)
T ss_dssp CEEEESSS-----------------EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred EEEEecCC-----------------ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCC
Confidence 99887543 25699999999999998653 4569999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 276 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~ 276 (355)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 145 p~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 145 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp GGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred HHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 9999999999999999999976543222 2223456778999999999999999999999999999999 999999887
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
.......+.. ......+..++.++.++|.+||+.||.+||++.++++.|+.+...
T Consensus 225 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 225 ASEISSILEK-GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp GGGHHHHHHT-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHc-CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 7776655443 445566777899999999999999999999999999999998743
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=322.30 Aligned_cols=257 Identities=25% Similarity=0.441 Sum_probs=207.4
Q ss_pred eecCCcceeecccccccceEEEEEEEC--C-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcc
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLYD--G-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~~--~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I 116 (355)
++..++|++.+.||+|+||.||+|.+. + ..||+|++..... ...+.+.+|+.++++++||||
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i 74 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---------NYSESFFEAASMMSKLSHKHL 74 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---------GGHHHHHHHHHHHHTSCCTTB
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---------HHHHHHHHHHHHHHhCCCCCE
Confidence 456789999999999999999999653 3 4699999854221 113457889999999999999
Q ss_pred ceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
+++++++...+.. ++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+
T Consensus 75 v~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~ 137 (289)
T 4fvq_A 75 VLNYGVCVCGDEN----------------ILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHG 137 (289)
T ss_dssp CCEEEEECCTTCC----------------EEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred eEEEEEEEeCCCC----------------EEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECC
Confidence 9999998866554 5699999999999999653 3459999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCc--------EEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHh
Q 018489 197 DVKTENMLLDKNRT--------VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 197 di~p~Nili~~~~~--------v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~llt 267 (355)
||||+||+++.++. ++|+|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 138 Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 213 (289)
T 4fvq_A 138 NVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213 (289)
T ss_dssp CCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHT
T ss_pred CcCcceEEEecCCcccccccceeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHc
Confidence 99999999998887 999999998643221 12346778999999987 678999999999999999999
Q ss_pred C-CCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCC
Q 018489 268 C-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335 (355)
Q Consensus 268 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 335 (355)
| ..||............ . ....++...++++.++|.+||+.||.+|||+.++++.|+++.+..+.
T Consensus 214 g~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 214 GGDKPLSALDSQRKLQFY-E--DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp TTCCTTTTSCHHHHHHHH-H--TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred CCCCCccccchHHHHHHh-h--ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 5 5555555544433332 2 23345666788999999999999999999999999999999876443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=340.38 Aligned_cols=256 Identities=25% Similarity=0.433 Sum_probs=210.5
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCc----cHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHR----TEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
.++|++.+.||+|+||.||+|.+ ++..||+|++........ .........+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 37899999999999999999976 578899999975432211 001112234568899999999999999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...... ++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 115 ~~~~~~~----------------~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N 176 (504)
T 3q5i_A 115 FEDKKYF----------------YLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPEN 176 (504)
T ss_dssp EECSSEE----------------EEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEcCCEE----------------EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHH
Confidence 8765544 669999999999999854 4669999999999999999999999999999999999
Q ss_pred EEEcCCC---cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 203 MLLDKNR---TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 203 ili~~~~---~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
|+++.++ .++|+|||.+...... .......|++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+
T Consensus 177 il~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 254 (504)
T 3q5i_A 177 ILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254 (504)
T ss_dssp EEESSTTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9998776 6999999999755432 33345679999999999875 58999999999999999999999999999888
Q ss_pred HHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 280 VTSAVVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 280 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....+......... ...+++++.++|++||+.||.+|||+.++++
T Consensus 255 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 255 IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 88888776554332 2568999999999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=323.60 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=201.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||+|++...... ....+.+.+|+.++++++||||+++++++....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-------PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc-------hHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence 6899999999999999999976 4889999998644321 223455778999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++. ....+++..++.++.|++.||.|||++|++|+||+|+||+++.
T Consensus 76 ~~----------------~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~ 137 (311)
T 4agu_A 76 RL----------------HLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK 137 (311)
T ss_dssp EE----------------EEEEECCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred eE----------------EEEEEeCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcC
Confidence 44 66999999999998874 3466999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
++.++|+|||.+..............++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 138 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 217 (311)
T 4agu_A 138 HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRK 217 (311)
T ss_dssp TSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999866544444455678999999999876 5689999999999999999999999998877666554433
Q ss_pred cCC-------------------CCCC----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNL-------------------RPEI----------PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~-------------------~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... .... ...++.++.++|.+||+.||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 218 TLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred HhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 110 0000 1357888999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=324.79 Aligned_cols=258 Identities=26% Similarity=0.560 Sum_probs=210.4
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCce----eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHD----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
+..++|++.+.||+|+||.||+|.+ +++. ||+|.+..... ....+.+.+|+.++++++||||++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~ 83 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--------PKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------------CHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--------HHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 4568999999999999999999976 4444 57777642211 12234588899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++.... . +++++|+.+++|.+++... ...+++..++.|+.|++.||.|||++|++||||||
T Consensus 84 ~~~~~~~-~----------------~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp 145 (327)
T 3poz_A 84 GICLTST-V----------------QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145 (327)
T ss_dssp EEEESSS-E----------------EEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEEecCC-e----------------EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCh
Confidence 9887543 2 5699999999999998653 45699999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 146 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp GGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred heEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 9999999999999999999865433222 223456778999999999999999999999999999999 9999998877
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
......+. .......+..++.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 226 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 226 SEISSILE-KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp GGHHHHHH-TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 76655444 344555677789999999999999999999999999999998864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=326.89 Aligned_cols=255 Identities=21% Similarity=0.350 Sum_probs=206.8
Q ss_pred ccceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCC--Ccccee
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH--PNVTKF 119 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~~ 119 (355)
..+.+..++|++.+.||+|+||.||++.+ ++..||||++...... . ...+.+.+|+.++..+.| +||+++
T Consensus 2 e~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~----~~~~~~~~E~~~l~~l~~~~~~iv~~ 74 (343)
T 3dbq_A 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD---N----QTLDSYRNEIAYLNKLQQHSDKIIRL 74 (343)
T ss_dssp CCEESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCC---H----HHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred ceeeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccc---h----HHHHHHHHHHHHHHhhhhcCCceEEE
Confidence 34678889999999999999999999965 5788999999754322 1 123457889999999976 999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++...... ++|||+ .+++|.+++.. ...+++..++.++.|++.||.|||++||+|||||
T Consensus 75 ~~~~~~~~~~----------------~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDik 135 (343)
T 3dbq_A 75 YDYEITDQYI----------------YMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 135 (343)
T ss_dssp EEEEECSSEE----------------EEEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred eeeEeeCCEE----------------EEEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9998765544 669995 48899999954 4679999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCC-----------CCCCCcchhHHHHHHHHHHH
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNG-----------NPYNRKCDVYSFGICLWEIY 266 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~ll 266 (355)
|+|||++ ++.++|+|||.+........ ......|++.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 136 p~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell 214 (343)
T 3dbq_A 136 PANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 214 (343)
T ss_dssp GGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHH
T ss_pred cceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHH
Confidence 9999996 68899999999975543322 2234578999999999854 56889999999999999999
Q ss_pred hCCCCCCCCCh-hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 267 CCDMPYPDLSF-SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 267 tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+|+.||..... ...............++...+.++.++|.+||+.||.+|||+.++++
T Consensus 215 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 215 YGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 99999987543 34445555555666777888899999999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=320.37 Aligned_cols=254 Identities=20% Similarity=0.353 Sum_probs=213.2
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ ++..||+|++.......... ....+.+.+|+.+++.++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR---GVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc---chhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 36899999999999999999976 58899999997654332110 00124478899999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus 88 ~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~ 149 (321)
T 2a2a_A 88 TDV----------------VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149 (321)
T ss_dssp SEE----------------EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred CEE----------------EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe
Confidence 544 669999999999999953 46799999999999999999999999999999999999999
Q ss_pred CCC----cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 207 KNR----TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 207 ~~~----~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
.++ .++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+...
T Consensus 150 ~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 228 (321)
T 2a2a_A 150 DKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228 (321)
T ss_dssp CTTSSSCCEEECCCTTCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred cCCCCcCCEEEccCccceecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 887 7999999999755432 23344578999999999999999999999999999999999999999888777776
Q ss_pred HHHhcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+....... .....+++.+.++|.+||+.||.+|||+.++++
T Consensus 229 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 229 NITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 665543322 122567899999999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=337.37 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=212.8
Q ss_pred cccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
..++.+..++|++.+.||+|+||.||+|.+ +++.||+|+++... .......+.+.+|..++..++||||+++
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~------~~~~~~~~~~~~E~~il~~~~hp~Iv~l 126 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD------MLKRGEVSCFREERDVLVNGDRRWITQL 126 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHHGGGCCHHHHHHHHHHSCTTTBCCE
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH------hhhHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 345667789999999999999999999976 58999999995311 1111122347789999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++.+.+.. ++||||++|++|.+++... +..+++..++.++.||+.||.|||++||+|||||
T Consensus 127 ~~~~~~~~~~----------------~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLK 189 (412)
T 2vd5_A 127 HFAFQDENYL----------------YLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIK 189 (412)
T ss_dssp EEEEECSSEE----------------EEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred EEEEeeCCEE----------------EEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccC
Confidence 9998876554 6699999999999999643 3479999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccC-------CCCCCCcchhHHHHHHHHHHHhCCCC
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLN-------GNPYNRKCDVYSFGICLWEIYCCDMP 271 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~il~~lltg~~p 271 (355)
|+|||++.++.++|+|||++........ ......||+.|+|||++. +..++.++|+||||+++|+|++|+.|
T Consensus 190 p~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P 269 (412)
T 2vd5_A 190 PDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269 (412)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred HHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCC
Confidence 9999999999999999999976544322 223457999999999987 35688999999999999999999999
Q ss_pred CCCCChhHHHHHHHhcCC---CCCCCCCCcHHHHHHHHHhhhcCCCCC---CCHHHHHH
Q 018489 272 YPDLSFSEVTSAVVRQNL---RPEIPRCCPSSLANVMKRCWDANPDKR---PEMDEVVS 324 (355)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~ell~ 324 (355)
|.+.+..+....+..... .+..+..+++++.++|++||. +|.+| |++++|++
T Consensus 270 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 270 FYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp TCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 999888887777765322 222346789999999999999 99998 58888876
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=316.93 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=213.3
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
.+..++|++.+.||+|+||.||+|.+ ++..||+|++.... .......+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 83 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ------LEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc------cchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 34457999999999999999999977 46789999985321 11112235588999999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...+.. +++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||
T Consensus 84 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 145 (284)
T 2vgo_A 84 HDRKRI----------------YLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENL 145 (284)
T ss_dssp ECSSEE----------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred EcCCEE----------------EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 765544 6699999999999999543 5699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
+++.++.++|+|||.+...... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......
T Consensus 146 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 223 (284)
T 2vgo_A 146 LMGYKGELKIADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR 223 (284)
T ss_dssp EECTTCCEEECCCTTCEECSSS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred EEcCCCCEEEecccccccCccc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH
Confidence 9999999999999998654332 22345789999999999998899999999999999999999999998887776666
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+.... ..++..++.++.++|.+||+.||.+||++.++++
T Consensus 224 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 224 IVNVD--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHTTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Hhccc--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 65533 3466778999999999999999999999999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=329.37 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=207.6
Q ss_pred Cccee--ecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 50 SKLVI--KSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 50 ~~y~i--~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
+.|.+ .+.||+|+||.||+|.+ ++..||+|+++.... ...+.+.+|+.++++++||||+++++++..
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 157 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---------KDKEEVKNEISVMNQLDHANLIQLYDAFES 157 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 34554 67899999999999976 588999999964321 113457899999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. ++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.||+|+||||+|||+
T Consensus 158 ~~~~----------------~lv~E~~~~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 220 (373)
T 2x4f_A 158 KNDI----------------VLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC 220 (373)
T ss_dssp SSEE----------------EEEEECCTTCEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCEE----------------EEEEeCCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE
Confidence 5544 679999999999998864 34569999999999999999999999999999999999999
Q ss_pred --cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 206 --DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 206 --~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
+.++.++|+|||.+...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....
T Consensus 221 ~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 299 (373)
T 2x4f_A 221 VNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN 299 (373)
T ss_dssp EETTTTEEEECCCSSCEECCTT-CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred ecCCCCcEEEEeCCCceecCCc-cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 56789999999999865433 223345789999999999998899999999999999999999999999888888877
Q ss_pred HHhcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHh
Q 018489 284 VVRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAI 329 (355)
Q Consensus 284 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~ 329 (355)
+........ ....+++++.++|.+||+.||.+||++.++++ .+...
T Consensus 300 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 300 ILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 777554332 23568999999999999999999999999998 55544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=333.44 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=194.3
Q ss_pred CCcceee-cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHh-hCCCCccceeeeecc
Q 018489 49 PSKLVIK-SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH-KLDHPNVTKFIGATM 124 (355)
Q Consensus 49 ~~~y~i~-~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~Iv~~~~~~~ 124 (355)
.++|.+. +.||+|+||.||++.+ +++.||||++... ..+.+|+.++. ..+||||+++++++.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------~~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------------hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 3677776 7899999999999976 5889999998521 12556787764 458999999999875
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
... .+..+.++||||++|++|.+++.......+++..++.|+.||+.||.|||+.||+||||||+|||
T Consensus 126 ~~~------------~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nil 193 (400)
T 1nxk_A 126 NLY------------AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193 (400)
T ss_dssp EEE------------TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred ecc------------cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEE
Confidence 311 01234478999999999999997654567999999999999999999999999999999999999
Q ss_pred EcC---CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh---
Q 018489 205 LDK---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS--- 278 (355)
Q Consensus 205 i~~---~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~--- 278 (355)
++. ++.++|+|||++...... .......+|..|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 194 l~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 272 (400)
T 1nxk_A 194 YTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 272 (400)
T ss_dssp ESSSSTTCCEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC
T ss_pred EecCCCCccEEEEecccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc
Confidence 987 789999999999754432 2234467899999999999999999999999999999999999999765432
Q ss_pred -HHHHHHHhcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 279 -EVTSAVVRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 279 -~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.....+........ ....+++++.+||++||+.||.+|||+.++++
T Consensus 273 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 273 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 23334443333222 22568999999999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=316.14 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=219.6
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeecc
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATM 124 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~ 124 (355)
..++|++.+.||+|+||.||+|.+ +++.||||++...........+....++.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 457999999999999999999977 57899999997665444455566667788999999999995 999999999887
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..... ++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+
T Consensus 95 ~~~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 156 (298)
T 1phk_A 95 TNTFF----------------FLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 156 (298)
T ss_dssp CSSEE----------------EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cCCeE----------------EEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence 65444 679999999999999954 457999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC------CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN------GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
++.++.++|+|||.+...... .......++..|+|||.+. ...++.++||||||+++|+|++|..||...+..
T Consensus 157 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 235 (298)
T 1phk_A 157 LDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235 (298)
T ss_dssp ECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EcCCCcEEEecccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH
Confidence 999999999999999754432 2334457899999999984 456789999999999999999999999988887
Q ss_pred HHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 279 EVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.....+.........+ ..++..+.++|.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 236 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 7777776655443332 457899999999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=352.24 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=215.3
Q ss_pred cccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccce
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTK 118 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~ 118 (355)
.....+..++|++++.||+|+||.||+|.+ +++.||||+++.... ......+.+..|..++..+ +||+|+.
T Consensus 333 ~~~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~~~~E~~~l~~~~~~~~i~~ 406 (674)
T 3pfq_A 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV------IQDDDVECTMVEKRVLALPGKPPFLTQ 406 (674)
T ss_dssp -------CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH------HHTTTTHHHHHHHHHHTCTTCCTTBCC
T ss_pred CccccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc------ccHHHHHHHHHHHHHHHhccCCCeEEE
Confidence 334556678999999999999999999976 577899999963211 0111123467789999888 7999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++...+.. ++||||++|++|.+++.. ...+++..++.|+.||+.||.|||++||+||||
T Consensus 407 l~~~~~~~~~~----------------~lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDL 468 (674)
T 3pfq_A 407 LHSCFQTMDRL----------------YFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468 (674)
T ss_dssp EEEECBCSSEE----------------EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCC
T ss_pred EEEEEEeCCEE----------------EEEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccC
Confidence 99998876655 569999999999999954 357999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
||+|||++.++.++|+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..
T Consensus 469 Kp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~ 548 (674)
T 3pfq_A 469 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 548 (674)
T ss_dssp CSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH
Confidence 99999999999999999999986544444555678999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM-----DEVVS 324 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell~ 324 (355)
+....+..... .++..+++++.+||++||+.||.+||++ ++|++
T Consensus 549 ~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 549 ELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 88888776543 5778899999999999999999999987 66654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=340.98 Aligned_cols=260 Identities=24% Similarity=0.391 Sum_probs=215.3
Q ss_pred cccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
..++.+..++|++.+.||+|+||.||+|.+ +++.||+|+++.... ........+.+|..++..++||||+++
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~~E~~il~~~~hp~Iv~l 139 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM------LKRAETACFREERDVLVNGDSKWITTL 139 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH------HHTTTTCCHHHHHHHHHHSCTTTBCCE
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh------hhHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 345667789999999999999999999976 468899999953110 000111237789999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++.+.... ++||||++||+|.+++... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 140 ~~~~~~~~~~----------------~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLK 202 (437)
T 4aw2_A 140 HYAFQDDNNL----------------YLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIK 202 (437)
T ss_dssp EEEEECSSEE----------------EEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred EEEEeeCCEE----------------EEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccC
Confidence 9998876655 6699999999999999642 4579999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~lltg~~p~~ 273 (355)
|+|||++.++.++|+|||++........ ......||+.|+|||++. ...++.++||||||+++|+|++|+.||.
T Consensus 203 p~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 282 (437)
T 4aw2_A 203 PDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282 (437)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred HHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999975543322 233467999999999986 4568999999999999999999999999
Q ss_pred CCChhHHHHHHHhcCCCCCCC---CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 018489 274 DLSFSEVTSAVVRQNLRPEIP---RCCPSSLANVMKRCWDANPDK--RPEMDEVVS 324 (355)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~--Rps~~ell~ 324 (355)
+.+..+....+........++ ..+++++.+||++||..+|.+ |++++++++
T Consensus 283 ~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 283 AESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 988888887776543222233 458999999999999888888 999999887
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=331.97 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=196.0
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~ 125 (355)
.++|++.+.||+|+||.||+|.+ +++.||||++...... . ...+.+.+|+.++..+. ||||+++++++..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~---~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN---S----TDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC---H----HHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC---h----HHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 37899999999999999999976 5889999998533211 1 11344678999999996 9999999999875
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. .+++||||++ ++|..++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 81 ~~~~--------------~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 142 (388)
T 3oz6_A 81 DNDR--------------DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142 (388)
T ss_dssp TTSS--------------CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCC--------------EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE
Confidence 4422 3378999996 589888843 479999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCC---------------------CCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASN---------------------PNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLW 263 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~ 263 (355)
+.++.++|+|||+++..... ........+|..|+|||++.+ ..++.++|||||||++|
T Consensus 143 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 222 (388)
T 3oz6_A 143 NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222 (388)
T ss_dssp CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHH
Confidence 99999999999999754321 112234579999999999987 67899999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHHHHhcCCCCC---------------------------------------------CCCCCc
Q 018489 264 EIYCCDMPYPDLSFSEVTSAVVRQNLRPE---------------------------------------------IPRCCP 298 (355)
Q Consensus 264 ~lltg~~p~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~ 298 (355)
+|++|+.||.+.+....+..+......+. ....++
T Consensus 223 ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (388)
T 3oz6_A 223 EILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302 (388)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCC
Confidence 99999999998887776666543211110 112578
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 299 SSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 299 ~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
+++.+||.+||+.||.+|||+.|+++-
T Consensus 303 ~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 303 EEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 899999999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=333.09 Aligned_cols=267 Identities=30% Similarity=0.439 Sum_probs=211.5
Q ss_pred hcccccceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
.....++.+..++|++.+.||+|+||.||+|.+ +++.||+|++......... ..+.+|+.+++.++||||+
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv 90 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE--------LQFQTEVEMISMAVHRNLL 90 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CC--------CHHHHHHHGGGTCCCTTBC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHH--------HHHHHHHHHHHhccCCCcc
Confidence 445567788889999999999999999999965 5889999998654322111 1377899999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--cccccHHHHHHHHHHHHHHHHHHHhC---C
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQ---K 192 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~---~ 192 (355)
++++++...... ++||||+++++|.+++.... ...+++..++.++.|++.||.|||++ |
T Consensus 91 ~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ 154 (326)
T 3uim_A 91 RLRGFCMTPTER----------------LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154 (326)
T ss_dssp CCCEEECCSSCC----------------EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred ceEEEEecCCce----------------EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 999998766554 56999999999999996543 23499999999999999999999999 9
Q ss_pred ccccCCCCCcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 018489 193 IVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMP 271 (355)
Q Consensus 193 i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p 271 (355)
++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 155 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 234 (326)
T 3uim_A 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234 (326)
T ss_dssp EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCS
T ss_pred eEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCc
Confidence 99999999999999999999999999986543322 23334589999999999888899999999999999999999999
Q ss_pred CCCC----ChhHHHHHHHhcC-------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 272 YPDL----SFSEVTSAVVRQN-------------LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 272 ~~~~----~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
|... ............. .....+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 235 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 235 FDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp BCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred ccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 9521 1111111111110 11111222347899999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=314.29 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=212.0
Q ss_pred CcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+. +..+|+|++....... .+.+.+|+.+++.++||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---------VDRFKQEIEIMKSLDHPNIIRLYETFEDNT 79 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---------HHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---------HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 68999999999999999999774 5689999986543221 234788999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE--
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL-- 205 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili-- 205 (355)
.. ++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||++
T Consensus 80 ~~----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~ 141 (277)
T 3f3z_A 80 DI----------------YLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLT 141 (277)
T ss_dssp EE----------------EEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred eE----------------EEEEeccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEec
Confidence 44 669999999999998854 4569999999999999999999999999999999999999
Q ss_pred -cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 206 -DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 -~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.++.++|+|||.+...... .......++..|+|||.+.+. ++.++||||||+++|+|++|..||...+..+....+
T Consensus 142 ~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 219 (277)
T 3f3z_A 142 DSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI 219 (277)
T ss_dssp SSTTCCEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCCcEEEEecccceeccCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 78899999999999754432 333445789999999998775 889999999999999999999999998888777777
Q ss_pred HhcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHhH
Q 018489 285 VRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAID 330 (355)
Q Consensus 285 ~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~~ 330 (355)
......... ...+++++.++|.+||+.||.+||++.++++ .+++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 220 REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 665443221 1267899999999999999999999999986 444443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=317.71 Aligned_cols=266 Identities=24% Similarity=0.404 Sum_probs=211.6
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
..+|++.+.||+|+||.||+|.+ +++.||+|++.... +.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------------EKAEREVKALAKLDHVNIVHYNGCWDGF 76 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------------GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------------HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence 36899999999999999999987 48999999996543 1256799999999999999999987542
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
...................++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156 (284)
T ss_dssp EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc
Confidence 21110000011111234568899999999999999876667899999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|..|+... ......+..
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~ 233 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD 233 (284)
T ss_dssp ETTEEEECCCTTCEESSCC-SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT
T ss_pred CCCCEEECcchhheecccc-ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc
Confidence 9999999999998765433 2234457899999999999988999999999999999999999887421 112222211
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
..++..++..+.++|.+||+.||.+||++.++++.|..+..+..
T Consensus 234 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 234 ----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 23556789999999999999999999999999999999876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=345.15 Aligned_cols=269 Identities=28% Similarity=0.527 Sum_probs=219.9
Q ss_pred ccceecCCcceeec-ccccccceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 43 QDWEIEPSKLVIKS-VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 43 ~~~~~~~~~y~i~~-~lg~G~~~~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
..+.+..+++.+.+ .||+|+||.||+|.+ ++..||||+++...... . .+.+.+|+.++++++||||+
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-~-------~~~~~~E~~il~~l~hpniv 399 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-D-------TEEMMREAQIMHQLDNPYIV 399 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST-T-------HHHHHHHHHHHTTCCCTTBC
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH-H-------HHHHHHHHHHHHhCCCCCEe
Confidence 34566677777777 899999999999965 35679999997543211 1 24578899999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccC
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~d 197 (355)
++++++... . .++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+|||
T Consensus 400 ~l~~~~~~~-~----------------~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrD 461 (613)
T 2ozo_A 400 RLIGVCQAE-A----------------LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461 (613)
T ss_dssp CEEEEEESS-S----------------EEEEEECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred eEEEEeccC-C----------------eEEEEEeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCc
Confidence 999987642 2 3679999999999999854 345699999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccccCCCCC---CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 018489 198 VKTENMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYP 273 (355)
Q Consensus 198 i~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~ 273 (355)
|||+|||++.++.++|+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 462 lkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 541 (613)
T 2ozo_A 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541 (613)
T ss_dssp CSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999755332211 122335678999999998889999999999999999998 999999
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCCC
Q 018489 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMI 338 (355)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~~ 338 (355)
+.+..+....+.. ......+..+++++.++|.+||+.||.+||++.+|++.|+.+..+.+....
T Consensus 542 ~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~ 605 (613)
T 2ozo_A 542 KMKGPEVMAFIEQ-GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605 (613)
T ss_dssp TCCSHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred CCCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence 8887776665544 445567788999999999999999999999999999999999877655443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=316.04 Aligned_cols=266 Identities=33% Similarity=0.542 Sum_probs=214.0
Q ss_pred eecCCcceeecccccccceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
.-...+|++.+.||+|+||.||+|.+. ...+|+|.+..... . ...+.+.+|+.++++++||||++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~----~----~~~~~~~~E~~~l~~l~h~~iv~~~ 92 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD----I----GEVSQFLTEGIIMKDFSHPNVLSLL 92 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS----H----HHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC----H----HHHHHHHHHHHHHHhCCCCCEeeee
Confidence 334567999999999999999999753 23588998853221 1 1234578899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++...+ +..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||
T Consensus 93 ~~~~~~~---------------~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp 156 (298)
T 3f66_A 93 GICLRSE---------------GSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAA 156 (298)
T ss_dssp EEECCSS---------------SCCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred eEEEcCC---------------CceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCch
Confidence 9855432 223679999999999999954 345689999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCC----CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNP----NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~ 275 (355)
+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 157 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 157 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp GGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred heEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 99999999999999999997543321 22233456778999999998889999999999999999999 66777776
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCC
Q 018489 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGG 336 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~ 336 (355)
+..+....... ......+..+++.+.++|.+||+.||.+|||+.++++.|+++.....+.
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 237 NTFDITVYLLQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp CTTTHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred CHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 66665555444 3444556778999999999999999999999999999999998765543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=331.68 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=211.2
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ ++..||+|++.... ... ...+.+|+.+++.++||||+++++++...
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLD----KYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHH----HHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----hhh----HHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 36899999999999999999976 57899999986432 111 23578899999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ++||||+++++|.+++.. ....+++..++.++.||+.||.|||++|++|+||||+||+++
T Consensus 121 ~~~----------------~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~ 183 (387)
T 1kob_A 121 YEM----------------VLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 183 (387)
T ss_dssp SEE----------------EEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred CEE----------------EEEEEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEe
Confidence 544 669999999999998853 234699999999999999999999999999999999999997
Q ss_pred C--CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 207 K--NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 207 ~--~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
. .+.++|+|||.+...... .......+|..|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+
T Consensus 184 ~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i 262 (387)
T 1kob_A 184 TKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262 (387)
T ss_dssp STTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred cCCCCceEEEecccceecCCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4 578999999999765432 2223346899999999999999999999999999999999999999998887777777
Q ss_pred HhcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....... .....+++++.++|.+||+.||.+|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 263 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 6654432 334568999999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=327.31 Aligned_cols=272 Identities=25% Similarity=0.487 Sum_probs=217.3
Q ss_pred hcccccceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
....+.|++..++|++.+.||+|+||.||+|.+.+ .+|+|+++........ .+.+.+|+.+++.++||||++
T Consensus 22 ~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~ 93 (319)
T 2y4i_B 22 SIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ-------LKAFKREVMAYRQTRHENVVL 93 (319)
T ss_dssp CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC-------CCCCCTTGGGGTTCCCTTBCC
T ss_pred ccccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH-------HHHHHHHHHHHhcCCCCCEeE
Confidence 44667788889999999999999999999998866 5999998754332211 123667999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++...... +++|||+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||
T Consensus 94 ~~~~~~~~~~~----------------~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl 156 (319)
T 2y4i_B 94 FMGACMSPPHL----------------AIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL 156 (319)
T ss_dssp CCEEEECSSCE----------------EEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred EEEEEecCCce----------------EEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Confidence 99998765544 669999999999999854 2346999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccC-----CCCCCCCCCCcccccCCcccCC---------CCCCCcchhHHHHHHHHH
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEAS-----NPNDMTGETGTLGYMAPEVLNG---------NPYNRKCDVYSFGICLWE 264 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~-----~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwslG~il~~ 264 (355)
+|+||+++ ++.++|+|||.+..... .........++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 157 kp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~e 235 (319)
T 2y4i_B 157 KSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE 235 (319)
T ss_dssp CSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHH
T ss_pred ChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHH
Confidence 99999998 68999999999764321 1122333468899999999874 347889999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCC
Q 018489 265 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGG 336 (355)
Q Consensus 265 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~ 336 (355)
|++|..||...+.......+............++.++.++|.+||+.||.+|||+.++++.|+.+.......
T Consensus 236 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 236 LHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp HHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred HHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 999999999888877776665554444444568899999999999999999999999999999998765444
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=316.13 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=211.4
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||++.+ ++..||+|++..... .......+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL-----RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHH-----HHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccc-----cccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 37899999999999999999976 578999999853211 01112345688999999999999999999987533
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+. +..++||||++++ |.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++
T Consensus 79 ~~--------------~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~ 143 (305)
T 2wtk_C 79 EK--------------QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143 (305)
T ss_dssp -----------------CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CC--------------CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc
Confidence 22 2347899999765 88888766667899999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCC--CCCCCCCCCcccccCCcccCCCC--CCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 207 KNRTVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
.++.++|+|||.+...... ........++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+......
T Consensus 144 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 223 (305)
T 2wtk_C 144 TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE 223 (305)
T ss_dssp TTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Confidence 9999999999999755422 12223456899999999998753 3679999999999999999999999888777776
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHh
Q 018489 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAI 329 (355)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~ 329 (355)
.+.... ..++..+++.+.++|.+||+.||.+|||+.++++ .++..
T Consensus 224 ~i~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 224 NIGKGS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHCC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred HHhcCC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 665543 3466788999999999999999999999999996 44443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=324.33 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=209.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+|++.+.||+|+||.||+|.+ +++.||||++....... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS------NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCH------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccc------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 5699999999999999999975 68899999996543221 122355788999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+. |+|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 128 ~~----------------~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 189 (348)
T 1u5q_A 128 TA----------------WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 189 (348)
T ss_dssp EE----------------EEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred eE----------------EEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence 44 66999996 5888877543 457999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
++.++|+|||.+..... .....+++.|+|||.+. +..++.++||||||+++|+|++|+.||...+.......+
T Consensus 190 ~~~~kL~DfG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 265 (348)
T 1u5q_A 190 PGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 265 (348)
T ss_dssp TTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CCCEEEeeccCceecCC----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99999999999975432 23357899999999984 567889999999999999999999999988877777666
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
............+++.+.++|.+||+.||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 266 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 6665555556678999999999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=323.77 Aligned_cols=265 Identities=26% Similarity=0.508 Sum_probs=214.7
Q ss_pred ceecCCcceeecccccccceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
..+..++|++.+.||+|+||.||++.+ +++.||+|++..... ...+.+.+|+.+++.++||||++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~ 106 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---------EHLRDFEREIEILKSLQHDNIVK 106 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS---------HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH---------HHHHHHHHHHHHHHhCCCCCeee
Confidence 355678999999999999999999974 578999999864321 11345789999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++...+.. ..++||||+++++|.+++... ...+++..++.++.|++.||.+||+.|++|+||
T Consensus 107 ~~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~di 171 (326)
T 2w1i_A 107 YKGVCYSAGRR--------------NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 171 (326)
T ss_dssp EEEEECC------------------CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EEEEEEecCCC--------------ceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCC
Confidence 99987654322 237899999999999999653 346999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCCC---CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
||+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 172 kp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 172 ATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp CGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred CcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999865433221 22345677899999998888899999999999999999999988642
Q ss_pred Chh---------------HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 276 SFS---------------EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 276 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
... ......+........+..+++++.++|.+||+.||.+|||+.++++.|+.+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 252 PAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 110 1122333344455667789999999999999999999999999999999997653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=313.94 Aligned_cols=249 Identities=27% Similarity=0.475 Sum_probs=204.2
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||++.+ ++..+|+|++........ .+.+.+|+.+++.++||||+++++++....
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 93 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--------MEQIEAEIEVLKSLDHPNIIKIFEVFEDYH 93 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--------HHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--------HHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence 7899999999999999999976 578999999975442211 244778999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.. ++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||+|+||++
T Consensus 94 ~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~ 157 (285)
T 3is5_A 94 NM----------------YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILF 157 (285)
T ss_dssp EE----------------EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred eE----------------EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEE
Confidence 44 6699999999999988643 24679999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 206 ---DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 206 ---~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
+.++.++|+|||.+...... .......++..|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+...
T Consensus 158 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~ 235 (285)
T 3is5_A 158 QDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235 (285)
T ss_dssp SSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ecCCCCCCEEEEeeecceecCCc-ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh
Confidence 45688999999999754432 22344578999999999864 57899999999999999999999999988777766
Q ss_pred HHHhcCCCCCC-CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNLRPEI-PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
........... ...+++++.++|.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 236 KATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred hhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 66554433322 2447899999999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=339.09 Aligned_cols=248 Identities=29% Similarity=0.518 Sum_probs=210.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ ++..||||++......... ...+.+|+.++++++||||+++++++....
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 94 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-------TSTILREVELLKKLDHPNIMKLFEILEDSS 94 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchH-------HHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence 6899999999999999999976 5889999998543221111 244778999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD- 206 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~- 206 (355)
.. ++||||+++++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 95 ~~----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 156 (486)
T 3mwu_A 95 SF----------------YIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (486)
T ss_dssp EE----------------EEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESS
T ss_pred EE----------------EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 54 669999999999998854 35799999999999999999999999999999999999995
Q ss_pred --CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 207 --KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 207 --~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
.++.++|+|||.+...... .......|++.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+....+
T Consensus 157 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 234 (486)
T 3mwu_A 157 KEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234 (486)
T ss_dssp SSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCCCEEEEECCcCeECCCC-CccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5567999999999755432 333446799999999999874 899999999999999999999999999888888888
Q ss_pred HhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.........+ ..+++++.++|.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 235 ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 7766554433 467999999999999999999999999997
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=325.44 Aligned_cols=245 Identities=23% Similarity=0.417 Sum_probs=181.6
Q ss_pred Ccceee---cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeec
Q 018489 50 SKLVIK---SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGAT 123 (355)
Q Consensus 50 ~~y~i~---~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~ 123 (355)
.+|.+. +.||+|+||.||+|.+ +++.||||++.... ...+.+|+.++..+. ||||+++++++
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~l~~l~~h~niv~~~~~~ 75 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------------EANTQKEITALKLCEGHPNIVKLHEVF 75 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------------HHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------------hhhHHHHHHHHHHhcCCCCeeEEEEEE
Confidence 345554 7899999999999976 57899999985321 234668999999996 99999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.+.... ++||||+++++|.+++.. ...+++..++.++.|++.+|.|||++|++|+||||+||
T Consensus 76 ~~~~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 137 (325)
T 3kn6_A 76 HDQLHT----------------FLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 137 (325)
T ss_dssp ECSSEE----------------EEEECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred EcCCEE----------------EEEEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHE
Confidence 765554 669999999999999954 46799999999999999999999999999999999999
Q ss_pred EEcCCC---cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh---
Q 018489 204 LLDKNR---TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF--- 277 (355)
Q Consensus 204 li~~~~---~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~--- 277 (355)
+++.++ .++|+|||.+..............++..|+|||.+.+..++.++||||||+++|+|++|..||...+.
T Consensus 138 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 217 (325)
T 3kn6_A 138 LFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT 217 (325)
T ss_dssp EEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------
T ss_pred EEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc
Confidence 998766 89999999998665554555556789999999999999999999999999999999999999976433
Q ss_pred ----hHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 278 ----SEVTSAVVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 278 ----~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+....+......... ...+++++.++|.+||+.||.+|||+.++++
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 218 CTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 3334444333322111 1357899999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=328.45 Aligned_cols=264 Identities=27% Similarity=0.396 Sum_probs=211.3
Q ss_pred ccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
+...+.-..++|++.+.||+|+||.||+|.+ ++..||+|++........ .....+.+.+|+.+++.++||||++
T Consensus 17 q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~ 92 (345)
T 3hko_A 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI----NPKDVERIKTEVRLMKKLHHPNIAR 92 (345)
T ss_dssp CCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC-------CHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhccc----CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3344444458999999999999999999976 577899999853211000 1122456889999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh----------------------------------
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN---------------------------------- 164 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---------------------------------- 164 (355)
+++++...... ++||||+++++|.+++...
T Consensus 93 ~~~~~~~~~~~----------------~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (345)
T 3hko_A 93 LYEVYEDEQYI----------------CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156 (345)
T ss_dssp EEEEEECSSEE----------------EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--
T ss_pred eehhhccCCeE----------------EEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccc
Confidence 99998765544 6799999999999988411
Q ss_pred ----ccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC--cEEEeeccccccccCCCC----CCCCCCC
Q 018489 165 ----RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR--TVKIADFGVARVEASNPN----DMTGETG 234 (355)
Q Consensus 165 ----~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~--~v~L~Dfg~a~~~~~~~~----~~~~~~~ 234 (355)
....+++..++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||.+........ ......+
T Consensus 157 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g 236 (345)
T 3hko_A 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236 (345)
T ss_dssp CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CC
T ss_pred ccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCC
Confidence 022357888999999999999999999999999999999998766 899999999975432211 2344578
Q ss_pred cccccCCcccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhh
Q 018489 235 TLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWD 310 (355)
Q Consensus 235 ~~~y~aPE~~~~--~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~ 310 (355)
++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.........+ ..+++++.++|.+||+
T Consensus 237 t~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 316 (345)
T 3hko_A 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLN 316 (345)
T ss_dssp CGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSC
T ss_pred CccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcC
Confidence 999999999975 678899999999999999999999999998888888877765544333 2478999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 018489 311 ANPDKRPEMDEVVS 324 (355)
Q Consensus 311 ~~p~~Rps~~ell~ 324 (355)
.||.+||++.++++
T Consensus 317 ~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 317 RNVDERFDAMRALQ 330 (345)
T ss_dssp SCTTTSCCHHHHHH
T ss_pred CChhHCCCHHHHhc
Confidence 99999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=319.66 Aligned_cols=260 Identities=29% Similarity=0.475 Sum_probs=206.6
Q ss_pred cceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccc
Q 018489 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 130 (355)
.|...+.||+|+||.||+|.+++..||+|++......... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~- 105 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE-----ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL- 105 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTT-----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC-
T ss_pred ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchH-----HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce-
Confidence 3455689999999999999999999999998654322111 1245588999999999999999999998765554
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCC
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~ 209 (355)
+++|||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++
T Consensus 106 ---------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~ 170 (307)
T 2nru_A 106 ---------------CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF 170 (307)
T ss_dssp ---------------EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred ---------------EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC
Confidence 66999999999999986433 34699999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH----
Q 018489 210 TVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA---- 283 (355)
Q Consensus 210 ~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~---- 283 (355)
.++|+|||.+........ ......++..|+|||.+.+. ++.++||||||+++|+|++|..||...........
T Consensus 171 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (307)
T 2nru_A 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249 (307)
T ss_dssp CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHH
T ss_pred cEEEeecccccccccccccccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHH
Confidence 999999999875543222 12335689999999998764 78999999999999999999999976543221111
Q ss_pred HHhc---------CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 284 VVRQ---------NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 284 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
.... ......+...+..+.++|.+||+.||.+|||+.++++.|+.+.++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 250 IEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp HHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred hhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 1110 011122233467899999999999999999999999999998653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=321.49 Aligned_cols=275 Identities=27% Similarity=0.386 Sum_probs=202.8
Q ss_pred hcccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCc
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPN 115 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ 115 (355)
....+.+++...+|++.+.||+|+||.||+|.+ +++.||+|++.... . ...+.+.+|+.++.++. |||
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~----~~~~~~~~e~~~l~~l~~h~~ 87 (337)
T 3ll6_A 17 DFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-----E----EKNRAIIQEVCFMKKLSGHPN 87 (337)
T ss_dssp SSTTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-----H----HHHHHHHHHHHHHHHHTTSTT
T ss_pred HhhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-----h----HHHHHHHHHHHHHHHhccCCC
Confidence 334577889999999999999999999999987 78899999985332 1 12345778999999995 999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh-ccccccHHHHHHHHHHHHHHHHHHHhCC--
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-RRRKLAFKVVVQLALDLARGLSYLHSQK-- 192 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~-- 192 (355)
|+++++++....... .......+++|||+. ++|.+++... ....+++..++.++.|++.||.|||+.|
T Consensus 88 iv~~~~~~~~~~~~~--------~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ 158 (337)
T 3ll6_A 88 IVQFCSAASIGKEES--------DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPP 158 (337)
T ss_dssp BCCEEEEEEECTTTS--------TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred hhhcccccccccccc--------ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 999999885332211 112345688999995 6898888643 3456999999999999999999999999
Q ss_pred ccccCCCCCcEEEcCCCcEEEeeccccccccCCCCC------------CCCCCCcccccCCccc---CCCCCCCcchhHH
Q 018489 193 IVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND------------MTGETGTLGYMAPEVL---NGNPYNRKCDVYS 257 (355)
Q Consensus 193 i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~------------~~~~~~~~~y~aPE~~---~~~~~~~~~Dvws 257 (355)
++|+||||+||+++.++.++|+|||.+......... .....++..|+|||.+ .+..++.++||||
T Consensus 159 ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~s 238 (337)
T 3ll6_A 159 IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWA 238 (337)
T ss_dssp CBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHH
T ss_pred EEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHH
Confidence 999999999999999999999999999765432211 1134588999999998 5567889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCC
Q 018489 258 FGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335 (355)
Q Consensus 258 lG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 335 (355)
||+++|+|++|..||........ .............+..+.++|.+||+.||.+||++.++++.|+.+......
T Consensus 239 lG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 239 LGCILYLLCFRQHPFEDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp HHHHHHHHHHSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHhCCCCCcchhHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 99999999999999976544332 222333344566788999999999999999999999999999999876543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=313.03 Aligned_cols=252 Identities=27% Similarity=0.491 Sum_probs=204.6
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
.+..++|++.+.||+|+||.||+|.+ +++.||+|++.... .......+.+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK------IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc------ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 34557999999999999999999976 58899999985321 11112245678999999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...+.. ++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||
T Consensus 81 ~~~~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 142 (276)
T 2h6d_A 81 STPTDF----------------FMVMEYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENV 142 (276)
T ss_dssp ECSSEE----------------EEEEECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGE
T ss_pred ecCCeE----------------EEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhE
Confidence 765544 669999999999999954 35699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
+++.++.++|+|||.+...... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||...+......
T Consensus 143 l~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 221 (276)
T 2h6d_A 143 LLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK 221 (276)
T ss_dssp EECTTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EECCCCCEEEeecccccccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 9999999999999998754432 22234568899999999988765 589999999999999999999999887777666
Q ss_pred HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+.... ..++..++.++.++|.+||+.||.+|||+.++++
T Consensus 222 ~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 222 KIRGGV--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhhcCc--ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 655543 3456778999999999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=328.89 Aligned_cols=255 Identities=21% Similarity=0.346 Sum_probs=207.4
Q ss_pred ccceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC--CCcccee
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD--HPNVTKF 119 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~ 119 (355)
..+.+...+|++.+.||+|+||.||++.+ ++..||||++...... . ...+.+.+|+.++..+. ||||+++
T Consensus 49 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~---~----~~~~~~~~Ei~~l~~l~~~~~~iv~~ 121 (390)
T 2zmd_A 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD---N----QTLDSYRNEIAYLNKLQQHSDKIIRL 121 (390)
T ss_dssp CCEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC---H----HHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred ccccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc---H----HHHHHHHHHHHHHHHcccCCCeEEEE
Confidence 44677778899999999999999999965 4788999999754321 1 12345789999999996 5999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++...+.. ++|||+ .+++|.+++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~~~~~~----------------~lv~E~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlk 182 (390)
T 2zmd_A 122 YDYEITDQYI----------------YMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182 (390)
T ss_dssp EEEEECSSEE----------------EEEEEC-CSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCC
T ss_pred EEEEecCCEE----------------EEEEec-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 9988765544 679994 58899999964 3578999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCC-----------CCCCCcchhHHHHHHHHHHH
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNG-----------NPYNRKCDVYSFGICLWEIY 266 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~ll 266 (355)
|+|||++ ++.++|+|||++........ ......|++.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 183 p~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell 261 (390)
T 2zmd_A 183 PANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261 (390)
T ss_dssp GGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHH
T ss_pred HHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHH
Confidence 9999995 68999999999975543221 2234579999999999865 36889999999999999999
Q ss_pred hCCCCCCCCCh-hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 267 CCDMPYPDLSF-SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 267 tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+|+.||..... ......+........++...+.++.++|.+||+.||.+||++.++++
T Consensus 262 ~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 262 YGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 99999987543 34555555555566677778899999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=323.12 Aligned_cols=263 Identities=30% Similarity=0.543 Sum_probs=215.4
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCce--eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHD--VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIG 121 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~ 121 (355)
+..++|++.+.||+|+||.||+|.+ ++.. +++|.+...... ...+.+.+|+.+++.+ +||||+++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~~E~~~l~~l~~hp~iv~~~~ 93 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--------DDHRDFAGELEVLCKLGHHPNIINLLG 93 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch--------HHHHHHHHHHHHHHhccCCCchhhhce
Confidence 4557899999999999999999965 5554 499988642211 1134478899999999 9999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHHHHHHHHHHHHHH
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSY 187 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~ 187 (355)
++...+.. ++||||+++++|.+++.... ...+++..++.++.|++.||.|
T Consensus 94 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 157 (327)
T 1fvr_A 94 ACEHRGYL----------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 157 (327)
T ss_dssp EEEETTEE----------------EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHH
T ss_pred eeeeCCce----------------EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 98765544 67999999999999996532 2469999999999999999999
Q ss_pred HHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh
Q 018489 188 LHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 188 LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt 267 (355)
||++|++|+||||+||+++.++.++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 158 LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 236 (327)
T 1fvr_A 158 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236 (327)
T ss_dssp HHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred HHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHc
Confidence 99999999999999999999999999999998733221 12233456778999999988888999999999999999998
Q ss_pred -CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCC
Q 018489 268 -CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335 (355)
Q Consensus 268 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 335 (355)
|..||.+.+..+....+.. ......+..+++++.++|.+||+.||.+|||+.++++.|+.+......
T Consensus 237 ~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 237 LGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp TSCCTTTTCCHHHHHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred CCCCCCCCCcHHHHHHHhhc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 9999998887766655443 344556677899999999999999999999999999999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.18 Aligned_cols=256 Identities=26% Similarity=0.469 Sum_probs=208.2
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
.......|++.+.||+|+||.||+|.+ ++..||+|++...... . ...+.+.+|+.+++.++||||++++++
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~---~----~~~~~~~~e~~~l~~l~h~~iv~~~~~ 93 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---K----SERQRFKEEAEMLKGLQHPNIVRFYDS 93 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---H----HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC---H----HHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 444566799999999999999999976 5678999998643321 1 124568899999999999999999998
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCC
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKT 200 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~di~p 200 (355)
+..... .....++||||+++++|.+++.. ...+++..++.|+.|++.||.|||+.| ++|+||+|
T Consensus 94 ~~~~~~------------~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp 159 (290)
T 1t4h_A 94 WESTVK------------GKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159 (290)
T ss_dssp EEEESS------------SCEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCG
T ss_pred eccccC------------CCceEEEEEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCH
Confidence 754211 12345789999999999999954 366999999999999999999999999 99999999
Q ss_pred CcEEEc-CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 201 ENMLLD-KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 201 ~Nili~-~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
+||+++ .++.++|+|||.+...... ......++..|+|||.+.+. ++.++||||||+++|+|++|..||.......
T Consensus 160 ~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 236 (290)
T 1t4h_A 160 DNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAA 236 (290)
T ss_dssp GGEEESSTTSCEEECCTTGGGGCCTT--SBEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred HHEEEECCCCCEEEeeCCCccccccc--ccccccCCcCcCCHHHHhcc-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHH
Confidence 999997 7899999999999744332 22345689999999998754 8999999999999999999999998865544
Q ss_pred HHHHHHh-cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 280 VTSAVVR-QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 280 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....... ......++...++++.++|.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 237 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 4444333 33333455667899999999999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=316.29 Aligned_cols=248 Identities=30% Similarity=0.501 Sum_probs=213.7
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ ++..||+|++........ .+.+.+|+.+++.++||||+++++++....
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--------IEDIQQEITVLSQCDSPYVTKYYGSYLKDT 93 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT--------HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH--------HHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 6799999999999999999976 588999999975543211 345788999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.
T Consensus 94 ~~----------------~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 154 (303)
T 3a7i_A 94 KL----------------WIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 154 (303)
T ss_dssp EE----------------EEEEECCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred eE----------------EEEEEeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECC
Confidence 44 67999999999999984 357999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.++|+|||.+..............++..|+|||.+.+..++.++||||||+++|+|++|..||...........+..
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~- 233 (303)
T 3a7i_A 155 HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK- 233 (303)
T ss_dssp TSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-
T ss_pred CCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-
Confidence 9999999999997655444444556789999999999998899999999999999999999999988777666555444
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 325 (355)
.....++..++..+.++|.+||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 234 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 34455677889999999999999999999999999873
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=324.33 Aligned_cols=271 Identities=28% Similarity=0.504 Sum_probs=201.7
Q ss_pred cceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHH--HHHHHhhCCCCccceeee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ--EVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~--E~~~l~~l~h~~Iv~~~~ 121 (355)
...+..++|++.+.||+|+||.||+|.++++.||||++.... ...+.. |+..+..++||||+++++
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~~~h~~i~~~~~ 74 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------------RQNFINEKNIYRVPLMEHDNIARFIV 74 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------------HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------------hhhHHHHHHHHHHHhccCcchhhhee
Confidence 445677899999999999999999999999999999995321 111233 444445579999999987
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC---------C
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ---------K 192 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---------~ 192 (355)
.+..... ......++||||+++++|.+++.. ...++..++.++.|++.||.|||+. |
T Consensus 75 ~~~~~~~-----------~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ 140 (336)
T 3g2f_A 75 GDERVTA-----------DGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA 140 (336)
T ss_dssp EEEEECT-----------TSCEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC
T ss_pred ccccccc-----------CCCceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccc
Confidence 5432110 012234789999999999999943 3468999999999999999999999 9
Q ss_pred ccccCCCCCcEEEcCCCcEEEeeccccccccCC--------CCCCCCCCCcccccCCcccCC-------CCCCCcchhHH
Q 018489 193 IVHRDVKTENMLLDKNRTVKIADFGVARVEASN--------PNDMTGETGTLGYMAPEVLNG-------NPYNRKCDVYS 257 (355)
Q Consensus 193 i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~--------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dvws 257 (355)
++|+||||+|||++.++.++|+|||.+...... ........|+..|+|||.+.+ ..++.++||||
T Consensus 141 ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diws 220 (336)
T 3g2f_A 141 ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA 220 (336)
T ss_dssp EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHH
T ss_pred eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHH
Confidence 999999999999999999999999999754422 112234568999999999987 34567899999
Q ss_pred HHHHHHHHHhCCCCCCCCC------------------hhHHHHHHHhcCCCCCCCCC------CcHHHHHHHHHhhhcCC
Q 018489 258 FGICLWEIYCCDMPYPDLS------------------FSEVTSAVVRQNLRPEIPRC------CPSSLANVMKRCWDANP 313 (355)
Q Consensus 258 lG~il~~lltg~~p~~~~~------------------~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~~p 313 (355)
||+++|+|++|..||.... ..............+.++.. +++++.++|.+||+.||
T Consensus 221 lG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 300 (336)
T 3g2f_A 221 LGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300 (336)
T ss_dssp HHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSG
T ss_pred HHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCCh
Confidence 9999999999977653211 11222222233334444443 34589999999999999
Q ss_pred CCCCCHHHHHHHHHHhHhhcCCCCCCC
Q 018489 314 DKRPEMDEVVSMLEAIDTSKGGGMIPG 340 (355)
Q Consensus 314 ~~Rps~~ell~~l~~~~~~~~~~~~~~ 340 (355)
.+|||+.++++.|+.+...-..-....
T Consensus 301 ~~Rps~~e~l~~L~~ll~~~~~~~~~~ 327 (336)
T 3g2f_A 301 EARLTAQXAEERMAELMMIWERNKSVS 327 (336)
T ss_dssp GGSCCHHHHHHHHHHHHHCCCC-----
T ss_pred hhCcchHHHHHHHHHHHHHHHhcccCC
Confidence 999999999999999986654444333
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=340.05 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=213.0
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
..+..++|++.+.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|..++..++||||++++++
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 253 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL------KKRKGYQGAMVEKKILAKVHSRFIVSLAYA 253 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh------hhhHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 346678999999999999999999976 589999999953211 111123457789999999999999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+...... ++||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||
T Consensus 254 ~~~~~~l----------------~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP 317 (543)
T 3c4z_A 254 FETKTDL----------------CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP 317 (543)
T ss_dssp EECSSEE----------------EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred EeeCCEE----------------EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCCh
Confidence 8766554 66999999999999986543 45699999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC----
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS---- 276 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~---- 276 (355)
+||+++.+|.++|+|||++..............||+.|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 318 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~ 397 (543)
T 3c4z_A 318 ENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397 (543)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC
T ss_pred HHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh
Confidence 9999999999999999999865544444444689999999999999999999999999999999999999998753
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 018489 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM-----DEVVS 324 (355)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell~ 324 (355)
.......+... ...++..+++++.++|.+||+.||.+||++ ++|++
T Consensus 398 ~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 398 NKELKQRVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHHHHHHHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 33444444443 335677899999999999999999999965 56654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=323.97 Aligned_cols=278 Identities=21% Similarity=0.329 Sum_probs=215.9
Q ss_pred hhcccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc
Q 018489 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115 (355)
Q Consensus 38 ~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 115 (355)
...+.+.+.+..++|++.+.||+|+||.||++.+ +++.||+|++.... . ...+.+.+|+.+++.++|||
T Consensus 17 ~~~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~----~~~~~~~~E~~~l~~l~h~~ 87 (317)
T 2buj_A 17 LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-----Q----QDREEAQREADMHRLFNHPN 87 (317)
T ss_dssp CSEEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-----H----HHHHHHHHHHHHHHTCCCTT
T ss_pred eeecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-----H----HHHHHHHHHHHHHhhcCCCC
Confidence 3455667888899999999999999999999975 68999999985422 1 12345788999999999999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCCc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKI 193 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~i 193 (355)
|+++++++..... .....++||||+++++|.+++... ....+++..++.++.|++.||.|||++|+
T Consensus 88 iv~~~~~~~~~~~------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i 155 (317)
T 2buj_A 88 ILRLVAYCLRERG------------AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGY 155 (317)
T ss_dssp BCCCCEEEEEEET------------TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eeeEEEEEEeccC------------CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 9999998863211 122347899999999999998653 34679999999999999999999999999
Q ss_pred cccCCCCCcEEEcCCCcEEEeeccccccccCCCCC---------CCCCCCcccccCCcccCCCC---CCCcchhHHHHHH
Q 018489 194 VHRDVKTENMLLDKNRTVKIADFGVARVEASNPND---------MTGETGTLGYMAPEVLNGNP---YNRKCDVYSFGIC 261 (355)
Q Consensus 194 ~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~i 261 (355)
+|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+.+.. ++.++||||||++
T Consensus 156 vH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i 235 (317)
T 2buj_A 156 AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235 (317)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHH
T ss_pred ccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHH
Confidence 99999999999999999999999988643211110 01224688999999998654 6889999999999
Q ss_pred HHHHHhCCCCCCCCChh-HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCC
Q 018489 262 LWEIYCCDMPYPDLSFS-EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGG 336 (355)
Q Consensus 262 l~~lltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~ 336 (355)
+|+|++|..||...... ..................++.++.++|.+||+.||.+||++.++++.|+.+.....+.
T Consensus 236 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 236 LYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp HHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred HHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 99999999999542111 1112222233334445678999999999999999999999999999999987654443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=316.89 Aligned_cols=247 Identities=24% Similarity=0.412 Sum_probs=209.2
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||++.+ +++.||+|++....... .+.+.+|+.+++.++||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---------DSSLENEIAVLKKIKHENIVTLEDIYEST 78 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---------hHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence 36899999999999999999976 58999999997543211 23477899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE-
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL- 205 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili- 205 (355)
... +++|||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||++
T Consensus 79 ~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~ 140 (304)
T 2jam_A 79 THY----------------YLVMQLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYL 140 (304)
T ss_dssp SEE----------------EEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEES
T ss_pred CEE----------------EEEEEcCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence 544 669999999999999854 3569999999999999999999999999999999999999
Q ss_pred --cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 206 --DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 206 --~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
+.++.++|+|||.+..... .......++..|+|||.+.+..++.++||||||+++|+|++|..||...+.......
T Consensus 141 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 218 (304)
T 2jam_A 141 TPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK 218 (304)
T ss_dssp SSSTTCCEEBCSCSTTCCCCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred cCCCCCCEEEccCCcceecCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 7889999999999864332 122234588999999999999999999999999999999999999998888777777
Q ss_pred HHhcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+....... .....+++++.++|.+||+.||.+||++.++++
T Consensus 219 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 219 IKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 66654332 344678999999999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=336.58 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=209.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ ++..||+|++......... ...+.+|+.+++.++||||+++++++....
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 109 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-------NSKLLEEVAVLKLLDHPNIMKLYDFFEDKR 109 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-------THHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-------HHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 6899999999999999999977 5788999999754432221 234778999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 110 ~~----------------~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 171 (494)
T 3lij_A 110 NY----------------YLVMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLES 171 (494)
T ss_dssp EE----------------EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred EE----------------EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeC
Confidence 54 669999999999998854 466999999999999999999999999999999999999976
Q ss_pred ---CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 208 ---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 208 ---~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
++.++|+|||++...... .......|++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+
T Consensus 172 ~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 249 (494)
T 3lij_A 172 KEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249 (494)
T ss_dssp SSTTCCEEECCCTTCEECBTT-BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCCcEEEEECCCCeECCCC-ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 455999999999765432 33344679999999999875 5899999999999999999999999999988888888
Q ss_pred HhcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHh
Q 018489 285 VRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAI 329 (355)
Q Consensus 285 ~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~ 329 (355)
......... ...+++++.++|++||+.||.+|||+.++++ .++..
T Consensus 250 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 250 EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 776554433 2568999999999999999999999999986 45544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=320.77 Aligned_cols=263 Identities=30% Similarity=0.526 Sum_probs=214.2
Q ss_pred eecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
++..++|++.+.||+|+||.||+|.+ ++..||+|++.... ... ....+.+|+.+++.++||||++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~----~~~~~~~E~~~l~~l~h~~iv~ 97 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQ----DELDFLMEALIISKFNHQNIVR 97 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC----CHH----HHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc----chh----hHHHHHHHHHHHhhCCCCCCCe
Confidence 46678999999999999999999973 45689999985321 111 1235778999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc-----ccccHHHHHHHHHHHHHHHHHHHhCCc
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-----RKLAFKVVVQLALDLARGLSYLHSQKI 193 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~i 193 (355)
+++++...... ++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|+
T Consensus 98 ~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i 161 (327)
T 2yfx_A 98 CIGVSLQSLPR----------------FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF 161 (327)
T ss_dssp EEEEECSSSSC----------------EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEEEcCCCCc----------------EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCe
Confidence 99998765554 569999999999999976432 458999999999999999999999999
Q ss_pred cccCCCCCcEEEcC---CCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-
Q 018489 194 VHRDVKTENMLLDK---NRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC- 267 (355)
Q Consensus 194 ~H~di~p~Nili~~---~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt- 267 (355)
+|+||+|+||+++. +..++|+|||.+....... .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 162 ~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 241 (327)
T 2yfx_A 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241 (327)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999984 4469999999987443222 12233457889999999988889999999999999999998
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 268 CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 268 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
|..||...........+.. ......+..++..+.++|.+||+.||.+||++.++++.|+.+....
T Consensus 242 g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 242 GYMPYPSKSNQEVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp SCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCcCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 9999998877766655544 3445567788999999999999999999999999999999887543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=324.29 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=203.3
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|+||.||+|.+ +++.||+|++........ .....+.+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA----KDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh----hhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 457899999999999999999976 588999999864332111 11123357789999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.... ++||||+++ +|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 84 ~~~~----------------~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 145 (346)
T 1ua2_A 84 KSNI----------------SLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL 145 (346)
T ss_dssp TTCC----------------EEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CCce----------------EEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE
Confidence 5544 669999975 88888753 34568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.++.++|+|||.+..............++..|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..+....+
T Consensus 146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i 225 (346)
T 1ua2_A 146 DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 225 (346)
T ss_dssp CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999999999998665555555567889999999999764 5889999999999999999999999998887777666
Q ss_pred HhcCCCCC--------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRPE--------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
......+. +...+++++.++|.+||+.||.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 55321110 01445789999999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=340.43 Aligned_cols=251 Identities=27% Similarity=0.488 Sum_probs=214.9
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|+||.||+|.+ +++.||||++.......... .+.+.+|+.++++++||||+++++++..
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~ 97 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD------KESLLREVQLLKQLDHPNIMKLYEFFED 97 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC------HHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH------HHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 347899999999999999999976 68899999997654332222 2457889999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.... ++||||+.+++|.+.+. ....+++..++.++.||+.||.|||++|++||||||+||++
T Consensus 98 ~~~~----------------~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 159 (484)
T 3nyv_A 98 KGYF----------------YLVGEVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159 (484)
T ss_dssp SSEE----------------EEEECCCCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CCEE----------------EEEEecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence 5544 66999999999999885 34679999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 206 ---DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 206 ---~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
+.++.++|+|||.+...... .......|++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+...
T Consensus 160 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 237 (484)
T 3nyv_A 160 ESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK 237 (484)
T ss_dssp SSSSTTCCEEECCTTHHHHBCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ecCCCCCcEEEEeeeeeEEcccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 56789999999999755433 22334568999999999977 58999999999999999999999999999888888
Q ss_pred HHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+.........+ ..+++++.++|.+||+.||.+|||+.++++
T Consensus 238 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 238 KVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 887766554433 468999999999999999999999999997
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=322.63 Aligned_cols=255 Identities=25% Similarity=0.439 Sum_probs=215.5
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCC
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGS 126 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~ 126 (355)
++|++.+.||.|++|.||+|.+ +|+.||||++...... ..........+.+.+|+.++..+ +||||+++++++...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAER-LSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSC-CCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-cCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 6899999999999999999976 5899999999765432 23344556677789999999999 899999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++
T Consensus 173 ~~~----------------~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 173 SFM----------------FLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234 (365)
T ss_dssp SEE----------------EEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CEE----------------EEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 544 679999999999999954 45799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC------CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG------NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
.++.++|+|||.+...... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+....
T Consensus 235 ~~~~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 313 (365)
T 2y7j_A 235 DNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313 (365)
T ss_dssp TTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCCEEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9999999999998755432 23344678999999999853 3578899999999999999999999998877777
Q ss_pred HHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 281 TSAVVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+......... ...++..+.++|.+||+.||.+||++.++++
T Consensus 314 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 314 LRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 7666665443322 2467889999999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=324.52 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=198.8
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||+|++........ ...+.+|+.+++.++||||+++++++....
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA--------PCTAIREVSLLKDLKHANIVTLHDIIHTEK 73 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc--------chhHHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence 6899999999999999999976 588999999864332111 112446999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||++ ++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 74 ~~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 135 (324)
T 3mtl_A 74 SL----------------TLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE 135 (324)
T ss_dssp CE----------------EEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT
T ss_pred EE----------------EEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC
Confidence 44 67999996 5888888643 456999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
++.++|+|||.+..............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+..
T Consensus 136 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 215 (324)
T 3mtl_A 136 RGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215 (324)
T ss_dssp TCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999765544444555678999999999876 5689999999999999999999999999888777766654
Q ss_pred cCCCCC----------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPE----------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....+. ....+++++.+||.+||+.||.+|||+.|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 216 ILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 221110 11246789999999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=314.98 Aligned_cols=261 Identities=22% Similarity=0.380 Sum_probs=200.8
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
+++..++|++.+.||+|+||.||+|.+ +++.||+|+++.... . ....+.+.++...++.++||||++++++
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~---~~~~~~~~~~~~~~~~~~h~~iv~~~~~ 74 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN----S---QEQKRLLMDLDISMRTVDCPFTVTFYGA 74 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C----H---HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC----c---HHHHHHHHHHHHHHHhCCCCeEEEEeee
Confidence 567789999999999999999999987 789999999854321 1 1223345556666888899999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhC-CccccCCC
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVK 199 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~di~ 199 (355)
+...... ++||||++ ++|.+++... ....+++..++.++.|++.||.|||++ |++|+|||
T Consensus 75 ~~~~~~~----------------~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlk 137 (290)
T 3fme_A 75 LFREGDV----------------WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK 137 (290)
T ss_dssp EECSSSE----------------EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCS
T ss_pred eeccCCE----------------EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC
Confidence 8765544 66999996 4888877542 356799999999999999999999998 99999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCccc----CCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVL----NGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
|+||+++.++.++|+|||.+...... .......++..|+|||.+ .+..++.++||||||+++|+|++|..||...
T Consensus 138 p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 138 PSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp GGGCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred HHHEEECCCCCEEEeecCCccccccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 99999999999999999999754432 222334688999999996 4567889999999999999999999999864
Q ss_pred -ChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHhH
Q 018489 276 -SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAID 330 (355)
Q Consensus 276 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~~ 330 (355)
.....................+++++.++|.+||+.||.+|||+.++++ .+....
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 217 GTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp SCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 3444444555544444445678999999999999999999999999988 555443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=342.64 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=212.7
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
..+..++|++.+.||+|+||.||+|.+ +++.||+|++..... ........+.+|+.++..++||||++++++
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 252 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI------KKRKGEAMALNEKQILEKVNSRFVVSLAYA 252 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh------hhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence 347778999999999999999999976 689999999953211 111123447789999999999999999999
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...+.. ++||||++|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|
T Consensus 253 ~~~~~~l----------------~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeN 316 (576)
T 2acx_A 253 YETKDAL----------------CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPEN 316 (576)
T ss_dssp EECSSEE----------------EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred EeeCCEE----------------EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchhe
Confidence 8765554 669999999999999976555569999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh----h
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF----S 278 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~----~ 278 (355)
||++.+|.++|+|||++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .
T Consensus 317 ILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~ 395 (576)
T 2acx_A 317 ILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395 (576)
T ss_dssp EEECTTSCEEECCCTTCEECCTT-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH
T ss_pred EEEeCCCCeEEEecccceecccC-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH
Confidence 99999999999999999765432 223345899999999999998899999999999999999999999987532 3
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
.....+.. ....++..+++++.+||.+||+.||.+|| ++.++++
T Consensus 396 ~i~~~i~~--~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 396 EVERLVKE--VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHHHhhc--ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 33333333 33456778899999999999999999999 7888875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=313.85 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=210.8
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||+|++...... +.+.+|+.+++.+.|++++..+..+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----------PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----------CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----------hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 57899999999999999999974 6899999998654432 1367899999999998877766554322
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE-
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL- 205 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili- 205 (355)
....+++|||+ +++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 77 ---------------~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~ 139 (296)
T 3uzp_A 77 ---------------GDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp ---------------TTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred ---------------CCceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEe
Confidence 23347899999 89999999643 4579999999999999999999999999999999999999
Q ss_pred --cCCCcEEEeeccccccccCCCC-------CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 018489 206 --DKNRTVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (355)
Q Consensus 206 --~~~~~v~L~Dfg~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~ 276 (355)
+.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 140 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 140 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 4889999999999986544322 1244578999999999999999999999999999999999999998643
Q ss_pred h---hHHHHHHHhcCCC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCC
Q 018489 277 F---SEVTSAVVRQNLR---PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGG 336 (355)
Q Consensus 277 ~---~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~ 336 (355)
. ......+...... ..+...+++++.++|.+||+.||.+|||+.++++.|+.+....+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 220 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp CSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred chhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 2 2223222221111 1233667999999999999999999999999999999998886543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=334.05 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=200.1
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||||++..... . ....+.+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~---~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---N----QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 133 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG---S----HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc---C----hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence 47899999999999999999966 588999999964321 1 12234577899999999999999999998755
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.... .....++||||+++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 134 ~~~~----------~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~ 198 (464)
T 3ttj_A 134 KTLE----------EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198 (464)
T ss_dssp CSTT----------TCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred Cccc----------cCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe
Confidence 4321 12345889999965 5666652 3499999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||++...... .......+|..|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+.+..+..
T Consensus 199 ~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~ 277 (464)
T 3ttj_A 199 SDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277 (464)
T ss_dssp TTSCEEECCCCCC-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEEEEEeeeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999755432 233456789999999999999999999999999999999999999999887777666554
Q ss_pred cCCCCC--------------------C---------CCC-----------CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPE--------------------I---------PRC-----------CPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~--------------------~---------~~~-----------~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....+. . +.. .++++.+||.+||+.||.+|||+.|+++
T Consensus 278 ~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 211110 0 000 1567999999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=325.03 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=202.8
Q ss_pred cCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|+||.||+|.+. ++.||+|++...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-------KMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-------hHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 4578999999999999999999774 889999998654321 1223457789999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.... ++||||+++++|.+++. ....+++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 96 ~~~~----------------~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~ 157 (331)
T 4aaa_A 96 KKRW----------------YLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV 157 (331)
T ss_dssp TTEE----------------EEEEECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CCEE----------------EEEEecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE
Confidence 5544 66999999988888763 34569999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.++.++|+|||.+..............++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 237 (331)
T 4aaa_A 158 SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHI 237 (331)
T ss_dssp CTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 999999999999997655544445556789999999999875 7899999999999999999999999988776655544
Q ss_pred HhcCCC--------------------CC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLR--------------------PE---------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~--------------------~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...... +. ....+++++.++|.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 238 MMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 321110 00 01356899999999999999999999999886
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=344.43 Aligned_cols=262 Identities=30% Similarity=0.531 Sum_probs=213.4
Q ss_pred cceecCCcceeec-ccccccceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 44 DWEIEPSKLVIKS-VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 44 ~~~~~~~~y~i~~-~lg~G~~~~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
.+.+....+.+.. .||+|+||.||+|.+ .+..||||+++...... ...+.+.+|+.++.+++||||++
T Consensus 362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~~~E~~il~~l~hpnIv~ 434 (635)
T 4fl3_A 362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-------ALKDELLAEANVMQQLDNPYIVR 434 (635)
T ss_dssp SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG-------GGHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCEee
Confidence 3455555555544 899999999999954 35789999996433221 12345889999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++.... .++||||+++++|.+++. ....+++..++.|+.||+.||.|||++||+||||
T Consensus 435 l~~~~~~~~-----------------~~lv~E~~~~g~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDL 495 (635)
T 4fl3_A 435 MIGICEAES-----------------WMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 495 (635)
T ss_dssp EEEEEESSS-----------------EEEEEECCTTEEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEecCC-----------------EEEEEEccCCCCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCC
Confidence 999875322 267999999999999995 3467999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPD 274 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~ 274 (355)
||+|||++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+
T Consensus 496 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 575 (635)
T 4fl3_A 496 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 575 (635)
T ss_dssp SGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999975543221 1222346678999999999899999999999999999998 9999999
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
.+..+....+.. ......+..+++++.++|..||+.||++||++.+|++.|+++...
T Consensus 576 ~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 576 MKGSEVTAMLEK-GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 888776665544 445567788999999999999999999999999999999998653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=311.39 Aligned_cols=263 Identities=21% Similarity=0.392 Sum_probs=214.4
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||+|++.......... ....+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR---GVSREEIEREVNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc---chHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence 36799999999999999999977 48899999997654332110 00124578899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++
T Consensus 81 ~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 142 (283)
T 3bhy_A 81 TDV----------------VLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL 142 (283)
T ss_dssp SEE----------------EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred CeE----------------EEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEe
Confidence 544 669999999999999954 45799999999999999999999999999999999999998
Q ss_pred CCC----cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 207 KNR----TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 207 ~~~----~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
.++ .++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||...+..+...
T Consensus 143 ~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 221 (283)
T 3bhy_A 143 DKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 221 (283)
T ss_dssp CSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred cCCCCCCceEEEecccceeccCC-CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHH
Confidence 877 8999999999755432 22334568999999999999899999999999999999999999999888777766
Q ss_pred HHHhcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHhHhhc
Q 018489 283 AVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAIDTSK 333 (355)
Q Consensus 283 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~~~~~ 333 (355)
.+....... .....+++.+.++|.+||+.||.+||++.++++ .++.+....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 222 NISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred HhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 665443322 123567899999999999999999999999998 666665443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=314.00 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=206.7
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||+|++...... +.+.+|+.++..++|++++..+..+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----------PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----------CCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----------hHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence 47899999999999999999974 6889999987644322 1266799999999988877776655322
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE-
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL- 205 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili- 205 (355)
....+++|||+ +++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 77 ---------------~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 139 (296)
T 4hgt_A 77 ---------------GDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp ---------------TTEEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred ---------------CCceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeee
Confidence 23347899999 99999998643 4569999999999999999999999999999999999999
Q ss_pred --cCCCcEEEeeccccccccCCCC-------CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 018489 206 --DKNRTVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (355)
Q Consensus 206 --~~~~~v~L~Dfg~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~ 276 (355)
+.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 140 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 140 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 7899999999999986543322 2234578999999999999999999999999999999999999997643
Q ss_pred hh---HHHHHHHhcCCC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCC
Q 018489 277 FS---EVTSAVVRQNLR---PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGG 336 (355)
Q Consensus 277 ~~---~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~ 336 (355)
.. .....+...... ......+++++.++|..||+.||.+|||+.++++.|+++....+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 220 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp CSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 22 222222221111 1233567899999999999999999999999999999998876643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=320.52 Aligned_cols=258 Identities=32% Similarity=0.570 Sum_probs=203.4
Q ss_pred CcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC--CCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL--DHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.++++.||||++.... ...+.+|.+++..+ +||||+++++++....
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 689999999999999999999999999999985321 11233455555554 9999999999877553
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC--------CccccCCC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ--------KIVHRDVK 199 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--------~i~H~di~ 199 (355)
.. ....++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ |++|+|||
T Consensus 105 ~~------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dik 169 (337)
T 3mdy_A 105 GS------------WTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169 (337)
T ss_dssp GG------------GCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCC
T ss_pred CC------------CCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccc
Confidence 21 1334789999999999999943 4699999999999999999999999 99999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCCC----CCCCCCcccccCCcccCCCCCCCc------chhHHHHHHHHHHHhC-
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNGNPYNRK------CDVYSFGICLWEIYCC- 268 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~------~DvwslG~il~~lltg- 268 (355)
|+||+++.++.++|+|||.+......... .....|+..|+|||.+.+...+.. +||||||+++|+|++|
T Consensus 170 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred hHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 99999999999999999999754432221 124578999999999988766554 9999999999999999
Q ss_pred ---------CCCCCCCC-----hhHHHHHHHhcCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 269 ---------DMPYPDLS-----FSEVTSAVVRQNLRPEIPR-----CCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 269 ---------~~p~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
..||.... ..............+.++. .+++++.++|.+||+.||.+|||+.++++.|+.+
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 250 VSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 77775432 1222233333333444443 4567899999999999999999999999999999
Q ss_pred HhhcC
Q 018489 330 DTSKG 334 (355)
Q Consensus 330 ~~~~~ 334 (355)
..+..
T Consensus 330 ~~~~~ 334 (337)
T 3mdy_A 330 SESQD 334 (337)
T ss_dssp HHTTT
T ss_pred Hhhcc
Confidence 87754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=324.38 Aligned_cols=258 Identities=25% Similarity=0.447 Sum_probs=210.6
Q ss_pred hcccccceecCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcc
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I 116 (355)
.......++..++|++.+.||+|+||.||++.+. +..||+|++..... ....+.+.+|+.+++.++||||
T Consensus 22 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i 93 (360)
T 3eqc_A 22 TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYI 93 (360)
T ss_dssp HHHHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC--------HHHHHHHHHHHGGGGGCCCTTB
T ss_pred hhhhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC--------HHHHHHHHHHHHHHHHCCCCCE
Confidence 3334445677899999999999999999999874 88999999965321 1224568899999999999999
Q ss_pred ceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC-Cccc
Q 018489 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVH 195 (355)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H 195 (355)
+++++++...+.. ++||||+++++|.+++.. ...+++..++.++.|++.+|.|||++ |++|
T Consensus 94 v~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H 155 (360)
T 3eqc_A 94 VGFYGAFYSDGEI----------------SICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMH 155 (360)
T ss_dssp CCEEEEEEETTEE----------------EEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred EEEeEEEEECCEE----------------EEEEECCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence 9999988765544 669999999999999954 35699999999999999999999996 9999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 196 ~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
+||||+||+++.++.++|+|||.+...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp SCCSGGGEEECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred CCccHHHEEECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998644321 223357899999999999999999999999999999999999999876
Q ss_pred ChhHHHH------------------------------------------HHHhcCCCCCCCCCCcHHHHHHHHHhhhcCC
Q 018489 276 SFSEVTS------------------------------------------AVVRQNLRPEIPRCCPSSLANVMKRCWDANP 313 (355)
Q Consensus 276 ~~~~~~~------------------------------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 313 (355)
+...... .+............++.++.++|.+||+.||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 313 (360)
T 3eqc_A 234 DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 313 (360)
T ss_dssp CHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSST
T ss_pred CHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcCh
Confidence 5543321 2222222222334578999999999999999
Q ss_pred CCCCCHHHHHH
Q 018489 314 DKRPEMDEVVS 324 (355)
Q Consensus 314 ~~Rps~~ell~ 324 (355)
.+|||+.++++
T Consensus 314 ~~Rpt~~ell~ 324 (360)
T 3eqc_A 314 AERADLKQLMV 324 (360)
T ss_dssp TTSCCHHHHHT
T ss_pred hhCCCHHHHhh
Confidence 99999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=326.70 Aligned_cols=265 Identities=32% Similarity=0.542 Sum_probs=207.4
Q ss_pred cCCcceeecccccccceEEEEEEEC--C---ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD--G---HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
...+|++.+.||+|+||.||+|.+. + ..||+|.++.... . ...+.+.+|+.++++++||||++++++
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~~E~~il~~l~hpnIv~~~~~ 158 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD---I-----GEVSQFLTEGIIMKDFSHPNVLSLLGI 158 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC---S-----HHHHHHHHHHTTSTTCCCTTBCCCCEE
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC---H-----HHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 3456889999999999999999652 2 3589998854221 1 113457889999999999999999998
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...+ +..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++||||||+|
T Consensus 159 ~~~~~---------------~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 222 (373)
T 3c1x_A 159 CLRSE---------------GSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 222 (373)
T ss_dssp ECCCS---------------SCCEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred EEcCC---------------CCeEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchhe
Confidence 65432 223679999999999999954 34568999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCC----CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPN----DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
|+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus 223 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp EEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred EEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 9999999999999999975432211 1223456778999999998889999999999999999999 7888887766
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGM 337 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~ 337 (355)
.+....+.. ......+..+++.+.++|.+||+.||.+||++.++++.|+.+.....+..
T Consensus 303 ~~~~~~~~~-~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 303 FDITVYLLQ-GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp SCHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred HHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 665555444 33445667789999999999999999999999999999999987765443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=325.12 Aligned_cols=272 Identities=22% Similarity=0.346 Sum_probs=209.2
Q ss_pred ceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
++...++|++.+.||+|+||.||+|.+ +++.||||++...... ..+|+.+++.++||||++++++
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------------~~~E~~il~~l~hpnIv~l~~~ 68 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------------KNRELDIMKVLDHVNIIKLVDY 68 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------------CCHHHHHHTTCCCTTBCCEEEE
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------------HHHHHHHHHHcCCCCccchhhe
Confidence 345678999999999999999999976 6899999998654322 2369999999999999999998
Q ss_pred ccCCcccccccc------------c----------ccccCCCCceEEEEEecCCCCHHHHHHh--hccccccHHHHHHHH
Q 018489 123 TMGSSELHIQTE------------N----------GQVAMPSNICCVVVEYLPGGALKTYLIK--NRRRKLAFKVVVQLA 178 (355)
Q Consensus 123 ~~~~~~~~~~~~------------~----------~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~ 178 (355)
+........... . -.......+.++||||++ ++|.+.+.. .....+++..++.++
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~ 147 (383)
T 3eb0_A 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYI 147 (383)
T ss_dssp EEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHH
T ss_pred eeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHH
Confidence 865432100000 0 000023456789999997 588877754 345679999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCcEEEc-CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhH
Q 018489 179 LDLARGLSYLHSQKIVHRDVKTENMLLD-KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVY 256 (355)
Q Consensus 179 ~qi~~al~~LH~~~i~H~di~p~Nili~-~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvw 256 (355)
.||+.||.|||++||+||||||+||+++ .++.++|+|||.+...... .......++..|+|||.+.+. .++.++|||
T Consensus 148 ~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 148 YQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 9999999999999999999999999997 6899999999999754332 333446789999999998875 489999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC---------------------------CCCCCCcHHHHHHHHHhh
Q 018489 257 SFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP---------------------------EIPRCCPSSLANVMKRCW 309 (355)
Q Consensus 257 slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l 309 (355)
|+|+++|+|++|+.||.+.+..+....+......+ .++..+++++.+||.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999999999999988777776665421111 134567899999999999
Q ss_pred hcCCCCCCCHHHHHH--HHHHhHh
Q 018489 310 DANPDKRPEMDEVVS--MLEAIDT 331 (355)
Q Consensus 310 ~~~p~~Rps~~ell~--~l~~~~~ 331 (355)
+.||.+|||+.|+++ .++.+..
T Consensus 307 ~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred cCChhhCCCHHHHhcCHHHHHHHh
Confidence 999999999999996 5555544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=321.87 Aligned_cols=258 Identities=25% Similarity=0.417 Sum_probs=212.2
Q ss_pred ccceecCCcceee-cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccce
Q 018489 43 QDWEIEPSKLVIK-SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTK 118 (355)
Q Consensus 43 ~~~~~~~~~y~i~-~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~ 118 (355)
+..+...++|.+. +.||+|+||.||+|.+ +++.||+|++......... ...+.+|+.++..+ .||||++
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~~iv~ 93 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-------RAEILHEIAVLELAKSCPRVIN 93 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC-------HHHHHHHHHHHHHTTTCTTBCC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH-------HHHHHHHHHHHHhccCCCCEEE
Confidence 3334445788888 8999999999999976 4899999999754433222 23477899999999 5699999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++...... ++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||
T Consensus 94 ~~~~~~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Di 157 (327)
T 3lm5_A 94 LHEVYENTSEI----------------ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDL 157 (327)
T ss_dssp EEEEEECSSEE----------------EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EEEEEEeCCeE----------------EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcC
Confidence 99998765554 66999999999999886555577999999999999999999999999999999
Q ss_pred CCCcEEEcC---CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 199 KTENMLLDK---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 199 ~p~Nili~~---~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
||+||+++. ++.++|+|||.+...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 158 kp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp CGGGEEESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ChHHEEEecCCCCCcEEEeeCccccccCCc-cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999987 789999999999755432 2233457899999999999999999999999999999999999999998
Q ss_pred ChhHHHHHHHhcCCC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 276 SFSEVTSAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+..+....+...... ......+++.+.++|.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 237 DNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp SHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 887777666654433 2344568999999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=325.76 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=194.6
Q ss_pred cccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 40 ~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
.....|++. ++|++.+.||+|+||.||+|.+ +++.||||++...... . ...+.+.+|+.+++.++||||+
T Consensus 20 ~~~~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~----~~~~~~~~E~~~l~~l~hpnIv 91 (367)
T 2fst_X 20 LNKTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS---I----IHAKRTYRELRLLKHMKHENVI 91 (367)
T ss_dssp ETTEEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS---H----HHHHHHHHHHHHHHHCCCTTBC
T ss_pred ecCcccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC---H----HHHHHHHHHHHHHHhCCCCCCC
Confidence 344556665 8899999999999999999975 6889999998643211 1 1234577899999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccC
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~d 197 (355)
++++++....... .....+++|+++ +++|.+++.. ..+++..++.++.||+.||.|||+.|++|||
T Consensus 92 ~~~~~~~~~~~~~----------~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~D 157 (367)
T 2fst_X 92 GLLDVFTPARSLE----------EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRD 157 (367)
T ss_dssp CCSEEECSCSSGG----------GCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred cEEEEEecCCccc----------cCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCC
Confidence 9999886543221 123457899999 7899998843 5799999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 018489 198 VKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (355)
Q Consensus 198 i~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~ 276 (355)
|||+||+++.++.++|+|||.+..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 158 lkp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 158 LKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp CCGGGEEECTTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCHhhEEECCCCCEEEeeccccccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999975432 2334578999999999887 678999999999999999999999999888
Q ss_pred hhHHHHHHHhcCCCC---------------------C--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 277 FSEVTSAVVRQNLRP---------------------E--------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 277 ~~~~~~~~~~~~~~~---------------------~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....+..+......+ . .....++++.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 235 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 776666554421111 0 11346789999999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=314.92 Aligned_cols=249 Identities=24% Similarity=0.434 Sum_probs=205.6
Q ss_pred cCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|+||.||+|.+. +..||+|++..... .+.+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----------LQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----------CHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----------HHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 4578999999999999999999764 88999999975432 1347789999999999999999998876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.... ++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 96 ~~~~----------------~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~ 158 (314)
T 3com_A 96 NTDL----------------WIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL 158 (314)
T ss_dssp TTEE----------------EEEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCEE----------------EEEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE
Confidence 5544 679999999999999863 34679999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
+.++.++|+|||.+..............++..|+|||.+.+..++.++||||||+++|+|++|..||...+.........
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 238 (314)
T 3com_A 159 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP 238 (314)
T ss_dssp CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 99999999999999765544444455678999999999999889999999999999999999999998877665554443
Q ss_pred hcCC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNL-RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.... ....+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 239 TNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 3322 12234557899999999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=320.97 Aligned_cols=264 Identities=23% Similarity=0.391 Sum_probs=199.7
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||||+++...... ..+.+.+|+.++++++||||+++++++....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--------AREKVMREVKALAKLEHPGIVRYFNAWLETP 77 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTT--------HHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchh--------HHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence 5799999999999999999976 58899999997543211 1345789999999999999999999886544
Q ss_pred ccccccc-----------------------------------------cccccCCCCceEEEEEecCCCCHHHHHHhhcc
Q 018489 128 ELHIQTE-----------------------------------------NGQVAMPSNICCVVVEYLPGGALKTYLIKNRR 166 (355)
Q Consensus 128 ~~~~~~~-----------------------------------------~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~ 166 (355)
......+ .........+.+++|||+++++|.+++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 3110000 00011223457999999999999999965432
Q ss_pred -ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC------------CCCCCCC
Q 018489 167 -RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP------------NDMTGET 233 (355)
Q Consensus 167 -~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~------------~~~~~~~ 233 (355)
...++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+....... .......
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 345667799999999999999999999999999999999999999999999998654432 2223457
Q ss_pred CcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCC
Q 018489 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANP 313 (355)
Q Consensus 234 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 313 (355)
+++.|+|||.+.+..++.++||||||+++|+|++|..|+.. .............+......++++.++|.+||+.||
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCC
Confidence 89999999999999999999999999999999998766421 111111122222112223346788999999999999
Q ss_pred CCCCCHHHHHH
Q 018489 314 DKRPEMDEVVS 324 (355)
Q Consensus 314 ~~Rps~~ell~ 324 (355)
.+|||+.++++
T Consensus 315 ~~Rps~~~~l~ 325 (332)
T 3qd2_B 315 TERPEATDIIE 325 (332)
T ss_dssp GGSCCHHHHHH
T ss_pred CcCCCHHHHhh
Confidence 99999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=312.84 Aligned_cols=260 Identities=26% Similarity=0.463 Sum_probs=209.0
Q ss_pred cccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 40 ~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
.+...+....++|.....||+|+||.||+|.+ ++..||+|.+...... ..+.+.+|+.+++.++||||+
T Consensus 12 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv 82 (295)
T 2clq_A 12 SDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---------YSQPLHEEIALHKHLKHKNIV 82 (295)
T ss_dssp --CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------------HHHHHHHHHHHTCCCTTBC
T ss_pred hccccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH---------HHHHHHHHHHHHHhCCCCCEe
Confidence 34455566667777788999999999999976 5788999998654321 124578899999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
++++++...+.. ++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+
T Consensus 83 ~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 146 (295)
T 2clq_A 83 QYLGSFSENGFI----------------KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146 (295)
T ss_dssp CEEEEEEETTEE----------------EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred eEeeEEEeCCcE----------------EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEcc
Confidence 999988765544 66999999999999996542 2356799999999999999999999999999
Q ss_pred CCCCCcEEEcC-CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC--CCCCcchhHHHHHHHHHHHhCCCCCC
Q 018489 197 DVKTENMLLDK-NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYP 273 (355)
Q Consensus 197 di~p~Nili~~-~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~lltg~~p~~ 273 (355)
||+|+||+++. ++.++|+|||.+..............++..|+|||.+.+. .++.++||||||+++|+|++|+.||.
T Consensus 147 dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp CCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred CCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 99999999987 8999999999997655443334456789999999998764 37899999999999999999999997
Q ss_pred CCChhH-HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 274 DLSFSE-VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 274 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...... ...........+.++..+++++.++|.+||+.||.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 227 ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp GGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 643322 222333334555677889999999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=314.34 Aligned_cols=245 Identities=18% Similarity=0.301 Sum_probs=198.0
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeecc
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATM 124 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~ 124 (355)
..++|++.+.||+|+||.||+|.+ +++.||+|++.... .+.+.+|+.+++.+. ||||+++++++.
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------------KKKIKREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------------hHHHHHHHHHHHHcCCCCCEEEeeeeec
Confidence 458999999999999999999965 68899999985322 234778999999996 999999999887
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
.... ...+++|||+++++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+
T Consensus 102 ~~~~--------------~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil 162 (330)
T 3nsz_A 102 DPVS--------------RTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 162 (330)
T ss_dssp CTTT--------------CCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cCCC--------------CceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence 6432 23378999999999998872 4899999999999999999999999999999999999
Q ss_pred EcCCC-cEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCC-hhHHH
Q 018489 205 LDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLS-FSEVT 281 (355)
Q Consensus 205 i~~~~-~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~-~~~~~ 281 (355)
++.++ .++|+|||.+...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.... ..+..
T Consensus 163 ~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l 241 (330)
T 3nsz_A 163 IDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241 (330)
T ss_dssp EETTTTEEEECCCTTCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred EcCCCCEEEEEeCCCceEcCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH
Confidence 99776 8999999999755433 23344678899999999987 678999999999999999999999995432 22222
Q ss_pred HHHHh-------------cC----------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVR-------------QN----------------------LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~-------------~~----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+.. .. ........+++++.+||.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 242 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111 00 001112236899999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=311.06 Aligned_cols=249 Identities=27% Similarity=0.378 Sum_probs=204.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||+|++...... ...+.+.+|+.+++.++||||+++++++....
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--------THHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--------hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence 6899999999999999999976 5889999998643321 11345788999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++++|.+++. ....+++..++.++.|++.||.|||++|++|+||+|+||+++.
T Consensus 79 ~~----------------~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 140 (276)
T 2yex_A 79 IQ----------------YLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 140 (276)
T ss_dssp EE----------------EEEEECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred EE----------------EEEEEecCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc
Confidence 44 66999999999999883 3457999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCChhHH-HHH
Q 018489 208 NRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEV-TSA 283 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~lltg~~p~~~~~~~~~-~~~ 283 (355)
++.++|+|||.+....... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||........ ...
T Consensus 141 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 220 (276)
T 2yex_A 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220 (276)
T ss_dssp TCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH
T ss_pred CCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence 9999999999987543221 22334578999999999988664 6789999999999999999999987655432 333
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.............+++.+.++|.+||+.||.+|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 33322222233467999999999999999999999999876
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=315.47 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=196.8
Q ss_pred CCcceee-cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeecc
Q 018489 49 PSKLVIK-SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (355)
Q Consensus 49 ~~~y~i~-~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 124 (355)
.++|++. +.||+|+||.||+|.+ +++.||||++....... .+.+.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---------RSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---------HHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---------HHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3678885 7899999999999965 68999999997543211 23477899999885 8999999999987
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..+.. ++||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+
T Consensus 82 ~~~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 143 (316)
T 2ac3_A 82 EEDRF----------------YLVFEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL 143 (316)
T ss_dssp ETTEE----------------EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred eCCEE----------------EEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEE
Confidence 65544 669999999999999954 356999999999999999999999999999999999999
Q ss_pred EcCCCc---EEEeeccccccccCCC-------CCCCCCCCcccccCCcccCC-----CCCCCcchhHHHHHHHHHHHhCC
Q 018489 205 LDKNRT---VKIADFGVARVEASNP-------NDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCD 269 (355)
Q Consensus 205 i~~~~~---v~L~Dfg~a~~~~~~~-------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~lltg~ 269 (355)
++.++. ++|+|||.+....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 144 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~ 223 (316)
T 2ac3_A 144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY 223 (316)
T ss_dssp ESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSS
T ss_pred EccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCC
Confidence 988776 9999999987543211 11223458999999999875 45788999999999999999999
Q ss_pred CCCCCCCh---------------hHHHHHHHhcCCCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 270 MPYPDLSF---------------SEVTSAVVRQNLRPEI--PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 270 ~p~~~~~~---------------~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.||.+... ......+......... ...+++++.++|.+||+.||.+|||+.++++
T Consensus 224 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 99976542 2233333333322111 1457899999999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=326.74 Aligned_cols=258 Identities=24% Similarity=0.316 Sum_probs=204.4
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
...+|++.+.||+|+||.||+|.+ +++.||||.+...... ..+|+.+++.++||||+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------------~~~E~~il~~l~hpniv~l~~~~~~ 118 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------------KNRELQIMRKLDHCNIVRLRYFFYS 118 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------------CCHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------------HHHHHHHHHHcCCCCccceeeEEec
Confidence 345799999999999999999977 5899999998643321 2369999999999999999988754
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHh--hccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK--NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.... .+..++++||||+++ +|.+.+.. .....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 119 ~~~~----------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 187 (420)
T 1j1b_A 119 SGEK----------KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 187 (420)
T ss_dssp EETT----------TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGE
T ss_pred cCCC----------CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhE
Confidence 2211 012234789999965 67666643 2356799999999999999999999999999999999999
Q ss_pred EEcCC-CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 204 LLDKN-RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~~-~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
|++.+ +.+||+|||++...... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 188 Ll~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l 266 (420)
T 1j1b_A 188 LLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266 (420)
T ss_dssp EEETTTTEEEECCCTTCEECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEeCCCCeEEeccchhhhhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99965 67899999999854432 223446789999999998764 7899999999999999999999999988876666
Q ss_pred HHHHhcCCC---------------CC------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHhH
Q 018489 282 SAVVRQNLR---------------PE------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAID 330 (355)
Q Consensus 282 ~~~~~~~~~---------------~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~~ 330 (355)
..+...... .. +...+++++.+||.+||+.||.+||++.|+++ .++.+.
T Consensus 267 ~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 267 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 555442110 00 23456899999999999999999999999986 455443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=315.03 Aligned_cols=250 Identities=26% Similarity=0.468 Sum_probs=204.7
Q ss_pred CCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+. +..||+|++...... ..+.+.+|+.++..++||||+++++++...
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---------ELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---------CHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---------HHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 478999999999999999999874 789999998643221 124577899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus 89 ~~~----------------~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 151 (302)
T 2j7t_A 89 GKL----------------WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT 151 (302)
T ss_dssp -CE----------------EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC
T ss_pred CeE----------------EEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC
Confidence 544 6799999999999988643 45699999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCccc-----CCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVL-----NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
.++.++|+|||.+..............++..|+|||.+ .+..++.++||||||+++|+|++|..||...+.....
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 231 (302)
T 2j7t_A 152 LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231 (302)
T ss_dssp TTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH
Confidence 99999999999875432222222335688999999998 4667889999999999999999999999988877766
Q ss_pred HHHHhcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+....... ..+..++.++.++|.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 232 LKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 6665544322 234567899999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=329.76 Aligned_cols=263 Identities=21% Similarity=0.329 Sum_probs=209.4
Q ss_pred ecCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
+..++|++.+.||+|+||.||+|.+. ++.||||++........ .+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~~~~~~~ 77 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--------VDVQMREFEVLKKLNHKNIVKLFAIEE 77 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch--------HHHHHHHHHHHHhcCCCCCCeEEEeec
Confidence 45689999999999999999999774 88999999964322111 234678999999999999999999887
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
..... ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 78 ~~~~~--------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 143 (396)
T 4eut_A 78 ETTTR--------------HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143 (396)
T ss_dssp CTTTC--------------CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cCCCC--------------eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHE
Confidence 55422 33789999999999999864332 2399999999999999999999999999999999999
Q ss_pred EE----cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC--------CCCCCcchhHHHHHHHHHHHhCCCC
Q 018489 204 LL----DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG--------NPYNRKCDVYSFGICLWEIYCCDMP 271 (355)
Q Consensus 204 li----~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~lltg~~p 271 (355)
++ +.++.++|+|||.+...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.|
T Consensus 144 ll~~~~~~~~~~kL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~P 222 (396)
T 4eut_A 144 MRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222 (396)
T ss_dssp EEEECTTSCEEEEECCGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred EEeecCCCceeEEEecCCCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99 77788999999999755432 23344678999999999864 4567899999999999999999999
Q ss_pred CCCCC----hhHHHHHHHhcCCCC-----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 272 YPDLS----FSEVTSAVVRQNLRP-----------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 272 ~~~~~----~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
|.... ..+....+....... .+...++..+.++|.+||+.||++||++.++++
T Consensus 223 f~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp EECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 96432 334444444332110 111234678999999999999999999999999
Q ss_pred HHHHhHhh
Q 018489 325 MLEAIDTS 332 (355)
Q Consensus 325 ~l~~~~~~ 332 (355)
.++++...
T Consensus 303 ~l~~il~~ 310 (396)
T 4eut_A 303 ETSDILHR 310 (396)
T ss_dssp HHHHHHTC
T ss_pred HHHHHhhc
Confidence 99988654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=319.61 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=205.4
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ ++..||||++.... . ....+.+.+|+.++..++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE----H----QTYCQRTLREIKILLRFRHENIIGINDIIRAP 97 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT----C----HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc----C----cHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence 47899999999999999999976 57889999986322 1 12235578899999999999999999988654
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... .....++||||+. ++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 98 ~~~-----------~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~ 162 (364)
T 3qyz_A 98 TIE-----------QMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 162 (364)
T ss_dssp STT-----------TCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred Ccc-----------ccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC
Confidence 321 1234578999996 589988843 4699999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
.++.++|+|||.+........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+...
T Consensus 163 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 242 (364)
T 3qyz_A 163 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242 (364)
T ss_dssp TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH
T ss_pred CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH
Confidence 999999999999975543221 1234578999999998654 558999999999999999999999999887776666
Q ss_pred HHHhcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNLRP-----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+......+ .....+++++.+||.+||+.||.+|||+.++++
T Consensus 243 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 554311111 012456889999999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=328.38 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=195.3
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||+|++........... .......+.+|+.++++++||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAR-EADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC---------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccc-cchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 47899999999999999999976 578999999975432211111 111223477899999999999999999987432
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
. .++||||+++++|.+++. ....+++..++.++.|++.||.|||++|++|+||||+|||++
T Consensus 213 ~-----------------~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~ 273 (419)
T 3i6u_A 213 D-----------------YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 273 (419)
T ss_dssp E-----------------EEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred c-----------------eEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEe
Confidence 2 267999999999998873 456799999999999999999999999999999999999997
Q ss_pred CCC---cEEEeeccccccccCCCCCCCCCCCcccccCCcccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 207 KNR---TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 207 ~~~---~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
..+ .++|+|||.+...... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||........
T Consensus 274 ~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~ 352 (419)
T 3i6u_A 274 SQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 352 (419)
T ss_dssp SSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC
T ss_pred cCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH
Confidence 544 5999999999755432 22334678999999999864 5678899999999999999999999987654433
Q ss_pred HHHHHhcCCCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 281 TSAVVRQNLRP---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
........... .....+++.+.++|.+||+.||.+||++.++++
T Consensus 353 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 353 LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 33333322221 122467899999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=328.57 Aligned_cols=255 Identities=23% Similarity=0.385 Sum_probs=203.7
Q ss_pred ceecCCcceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccce
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTK 118 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~ 118 (355)
..+..++|++.+.||+|+||.||++.+ +++.||||+++......... ..+.+.+|+.++..+ +||||++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv~ 123 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK-----TTEHTRTERQVLEHIRQSPFLVT 123 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES-----SGGGCCCHHHHHHHHHTCTTBCC
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhh-----HHHHHHHHHHHHHHccCCCceeE
Confidence 344568999999999999999999976 68999999986432110000 012255788999999 7999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++...... ++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||
T Consensus 124 ~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dl 185 (355)
T 1vzo_A 124 LHYAFQTETKL----------------HLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDI 185 (355)
T ss_dssp EEEEEEETTEE----------------EEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred EEEEEeeCceE----------------EEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 99988765544 669999999999999954 356999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCC-CCCCCCCCCcccccCCcccCC--CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASN-PNDMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
||+|||++.++.++|+|||++...... ........++..|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 186 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 186 KLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp CGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred CHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 999999999999999999998754322 122233568999999999986 34789999999999999999999999754
Q ss_pred Ch----hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 276 SF----SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 276 ~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
.. ......+.. ..+.++..++..+.++|.+||+.||.+|| ++.++++
T Consensus 266 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 266 GEKNSQAEISRRILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp TSCCCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CccchHHHHHHHHhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 32 222223322 33456778899999999999999999999 9999887
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=308.78 Aligned_cols=249 Identities=29% Similarity=0.510 Sum_probs=209.8
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||+|++......... .+.+.+|+.++++++||||+++++++...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-------TSTILREVELLKKLDHPNIMKLFEILEDS 93 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC-------HHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH-------HHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence 36899999999999999999977 5889999999654433222 23477899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... +++|||+++++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++
T Consensus 94 ~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~ 155 (287)
T 2wei_A 94 SSF----------------YIVGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155 (287)
T ss_dssp SEE----------------EEEECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred CeE----------------EEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEe
Confidence 544 669999999999998854 35699999999999999999999999999999999999996
Q ss_pred CC---CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 207 KN---RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 207 ~~---~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
.+ +.++|+|||.+...... .......++..|+|||.+.+. ++.++||||||+++|+|++|..||...+.......
T Consensus 156 ~~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (287)
T 2wei_A 156 SKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR 233 (287)
T ss_dssp CSSTTCCEEECSTTGGGTBCCC-SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cCCCcccEEEeccCcceeecCC-CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 54 47999999998754432 222334578899999998875 88999999999999999999999999888877777
Q ss_pred HHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+.........+ ..+++++.++|.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 76665544333 568999999999999999999999999997
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=319.60 Aligned_cols=259 Identities=34% Similarity=0.577 Sum_probs=209.3
Q ss_pred CCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhh--CCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK--LDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.++++.||||++.... ...+.+|.+++.. ++||||+++++++...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------------ERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG------------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh------------HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3689999999999999999999999999999985321 1335678888877 6999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHH--------hCCccccCC
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH--------SQKIVHRDV 198 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH--------~~~i~H~di 198 (355)
... ....++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.|++|+||
T Consensus 109 ~~~------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl 173 (342)
T 1b6c_B 109 NGT------------WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173 (342)
T ss_dssp CSS------------CCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred CCc------------cceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCC
Confidence 421 1234789999999999999953 46999999999999999999999 899999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCC----CCCCCCCcccccCCcccCCCC------CCCcchhHHHHHHHHHHHhC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPN----DMTGETGTLGYMAPEVLNGNP------YNRKCDVYSFGICLWEIYCC 268 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~~lltg 268 (355)
||+||+++.++.++|+|||.+........ ......++..|+|||.+.+.. ++.++||||||+++|+|++|
T Consensus 174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 99999999999999999999976544322 224457899999999998752 33689999999999999999
Q ss_pred ----------CCCCCCCC-----hhHHHHHHHhcCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 018489 269 ----------DMPYPDLS-----FSEVTSAVVRQNLRPEIPR-----CCPSSLANVMKRCWDANPDKRPEMDEVVSMLEA 328 (355)
Q Consensus 269 ----------~~p~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~ 328 (355)
..||.... .......+......+.++. .+++.+.++|.+||+.||.+|||+.++++.|+.
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 78886542 2333333434444444443 235689999999999999999999999999999
Q ss_pred hHhhcC
Q 018489 329 IDTSKG 334 (355)
Q Consensus 329 ~~~~~~ 334 (355)
+....+
T Consensus 334 i~~~~~ 339 (342)
T 1b6c_B 334 LSQQEG 339 (342)
T ss_dssp HHHTTC
T ss_pred HHHHhc
Confidence 987654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=308.56 Aligned_cols=244 Identities=25% Similarity=0.363 Sum_probs=200.8
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCC
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGS 126 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~ 126 (355)
++|++.+.||+|+||.||+|.+ +++.||+|++......... ...+.+|+..+..+ +||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-------EQNALREVYAHAVLGQHSHVVRYFSAWAED 83 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH-------HHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH-------HHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 6899999999999999999977 5899999999754332211 23466889999999 999999999998765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc--ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
+.. ++||||+++++|.+++..... ..+++..++.++.||+.||.|||++|++|+||||+||+
T Consensus 84 ~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl 147 (289)
T 1x8b_A 84 DHM----------------LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF 147 (289)
T ss_dssp TEE----------------EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CeE----------------EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEE
Confidence 544 669999999999999965432 56899999999999999999999999999999999999
Q ss_pred EcCC-------------------CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHH
Q 018489 205 LDKN-------------------RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWE 264 (355)
Q Consensus 205 i~~~-------------------~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ 264 (355)
++.+ ..++|+|||.+...... ....++..|+|||.+.+. .++.++||||||+++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 223 (289)
T 1x8b_A 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223 (289)
T ss_dssp EC--------------------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHH
T ss_pred EcCCCCCcccccccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHH
Confidence 9844 47999999998765432 224589999999999876 56689999999999999
Q ss_pred HHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 265 IYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 265 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
|++|..++.... .... ......+.++..+++++.++|.+||+.||.+|||+.++++
T Consensus 224 l~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 224 AAGAEPLPRNGD---QWHE-IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HTTCCCCCSSSH---HHHH-HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhcCCCCCcchh---HHHH-HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 999987764432 2222 3334445677789999999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=319.74 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=201.8
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||||++............ ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIE-DPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEE-ETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccc-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 7899999999999999999965 6889999999765432110000 000123567999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEEecCCC-CHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGG-ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.. ++||||+.++ +|.+++. ....+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 103 ~~----------------~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 164 (335)
T 3dls_A 103 FF----------------QLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA 164 (335)
T ss_dssp EE----------------EEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred EE----------------EEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc
Confidence 54 5699998766 9999884 345699999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
.++.++|+|||.+...... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||......
T Consensus 165 ~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------- 236 (335)
T 3dls_A 165 EDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------- 236 (335)
T ss_dssp TTSCEEECCCTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------
T ss_pred CCCcEEEeecccceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------
Confidence 9999999999999765433 22334568999999999988776 78999999999999999999999763221
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.......+..+++++.++|.+||+.||.+|||+.++++
T Consensus 237 -~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 237 -VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp -TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11223345568999999999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=316.17 Aligned_cols=257 Identities=26% Similarity=0.450 Sum_probs=193.3
Q ss_pred cceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
.+.+..++|++.+.||+|+||.||+|.+ +++.||||++..... ....+.+.+|+.+++.++||||+++++
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 80 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--------QTSMDELLKEIQAMSQCHHPNIVSYYT 80 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------------CCCCCCCTTBCCEEE
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--------chhHHHHHHHHHHHhhcCCCCEeeEEE
Confidence 3678889999999999999999999965 689999999854321 112345778999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh------ccccccHHHHHHHHHHHHHHHHHHHhCCccc
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN------RRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H 195 (355)
++...+.. ++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++|
T Consensus 81 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 144 (303)
T 2vwi_A 81 SFVVKDEL----------------WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIH 144 (303)
T ss_dssp EEESSSCE----------------EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEeecCCc----------------EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 98766554 6699999999999998642 2456999999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccccccccCCC-----CCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCC
Q 018489 196 RDVKTENMLLDKNRTVKIADFGVARVEASNP-----NDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCD 269 (355)
Q Consensus 196 ~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~-----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~ 269 (355)
+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 145 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 224 (303)
T 2vwi_A 145 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224 (303)
T ss_dssp CCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999987543221 11233468899999999875 56889999999999999999999
Q ss_pred CCCCCCChhHHHHHHHhcCCC--------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 270 MPYPDLSFSEVTSAVVRQNLR--------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 270 ~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.||.................. ......++.++.++|.+||+.||.+||++.++++
T Consensus 225 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 225 APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 999887776655544433221 1233567899999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=317.41 Aligned_cols=259 Identities=24% Similarity=0.322 Sum_probs=205.5
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||+|++.......... ..+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-------ITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSC-------HHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccch-------HHHHHHHHHHHhccCCCcccHhheeecc
Confidence 47999999999999999999976 68899999986554433222 2366899999999999999999988764
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
...+. ...+..++||||+++ +|.+.+.. ....+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 89 ~~~~~--------~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 158 (351)
T 3mi9_A 89 ASPYN--------RCKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT 158 (351)
T ss_dssp ----------------CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred ccccc--------cCCceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc
Confidence 43211 113456889999965 77777643 345699999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccC----CCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 207 KNRTVKIADFGVARVEAS----NPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~----~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
.++.++|+|||.+..... .........++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.....
T Consensus 159 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 238 (351)
T 3mi9_A 159 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238 (351)
T ss_dssp TTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred CCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999999975432 1223344578999999999876 45899999999999999999999999998877766
Q ss_pred HHHHhcCC--CCCCCCC----------------------------CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNL--RPEIPRC----------------------------CPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~--~~~~~~~----------------------------~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+..... ....... .++++.+||.+||+.||.+|||+.|+++
T Consensus 239 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 66544221 1111111 2677999999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=322.56 Aligned_cols=261 Identities=22% Similarity=0.390 Sum_probs=210.6
Q ss_pred eecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHH--------HHHHHHHHHHHHHHHHhhCCCCccc
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEA--------EIAALRSAFTQEVAVWHKLDHPNVT 117 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~Iv 117 (355)
.+..++|++.+.||+|+||.||+|.+++..||+|++........... ......+.+.+|+.+++.++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 34457999999999999999999999999999999964322111000 0000114578999999999999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHH------HHhhccccccHHHHHHHHHHHHHHHHHHHh-
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY------LIKNRRRKLAFKVVVQLALDLARGLSYLHS- 190 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~~~~~~~~~~~~~i~~qi~~al~~LH~- 190 (355)
++++++...+.. ++||||+++++|.++ +.......+++..++.++.|++.||.|||+
T Consensus 107 ~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 170 (348)
T 2pml_X 107 TCEGIITNYDEV----------------YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170 (348)
T ss_dssp CCSEEEESSSEE----------------EEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEeeCCeE----------------EEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc
Confidence 999998766544 669999999999998 644336789999999999999999999999
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCC-cchhHHHHHHHHHHHhC
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNR-KCDVYSFGICLWEIYCC 268 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslG~il~~lltg 268 (355)
.|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+. .++. ++||||||+++|+|++|
T Consensus 171 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp SCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred CCEeecCCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999765432 33446789999999999887 5655 99999999999999999
Q ss_pred CCCCCCCCh-hHHHHHHHhcCCCCCC-----------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 269 DMPYPDLSF-SEVTSAVVRQNLRPEI-----------------PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 269 ~~p~~~~~~-~~~~~~~~~~~~~~~~-----------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..||...+. .+....+......... ...+++++.++|.+||+.||.+||++.++++
T Consensus 249 ~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 249 VVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999988766 4555444443322111 1568999999999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=323.60 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=202.8
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC------CCCcccee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL------DHPNVTKF 119 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~Iv~~ 119 (355)
...+|++.+.||+|+||.||+|.+ +++.||||+++... ...+.+.+|+.+++.+ +|+||+++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----------RFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----------chHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 347899999999999999999976 47899999995321 1123455677777666 67799999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++...... ++||||+. ++|.+++.......+++..++.|+.||+.||.|||++||+|||||
T Consensus 165 ~~~~~~~~~~----------------~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlK 227 (429)
T 3kvw_A 165 LENFTFRNHI----------------CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLK 227 (429)
T ss_dssp EEEEEETTEE----------------EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCS
T ss_pred EeecccCCeE----------------EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 9988765544 67999995 699999977666679999999999999999999999999999999
Q ss_pred CCcEEEcCCCc--EEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 018489 200 TENMLLDKNRT--VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (355)
Q Consensus 200 p~Nili~~~~~--v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~ 277 (355)
|+|||++.++. ++|+|||.+..... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.+.+.
T Consensus 228 p~NILl~~~~~~~vkL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 228 PENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp GGGEEESSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHeEEccCCCcceEEeecccceecCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999887 99999999975432 23345789999999999998999999999999999999999999998887
Q ss_pred hHHHHHHHhcCCCC---------------------------------------------------------CCCCCCcHH
Q 018489 278 SEVTSAVVRQNLRP---------------------------------------------------------EIPRCCPSS 300 (355)
Q Consensus 278 ~~~~~~~~~~~~~~---------------------------------------------------------~~~~~~~~~ 300 (355)
.+.+..+......+ .+....+++
T Consensus 305 ~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 384 (429)
T 3kvw_A 305 GDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384 (429)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHH
T ss_pred HHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHH
Confidence 76665554321100 012234788
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 301 LANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 301 l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+.+||.+||++||.+|||+.|+++
T Consensus 385 ~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 385 FLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHCCCChhhCCCHHHHhC
Confidence 999999999999999999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=312.57 Aligned_cols=246 Identities=26% Similarity=0.309 Sum_probs=193.9
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 125 (355)
.++|++.+.||+|+||.||+|.+ +++.||||++...... ... ......|+..+..+ +||||+++++++..
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~----~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG---PKD----RARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS---HHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC---hHH----HHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 36899999999999999999977 5889999998543321 111 12233444444444 99999999999876
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.... ++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.||+|+||||+||++
T Consensus 129 ~~~~----------------~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll 190 (311)
T 3p1a_A 129 GGIL----------------YLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL 190 (311)
T ss_dssp TTEE----------------EEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCEE----------------EEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE
Confidence 5544 6799999 77999888654 4569999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
+.++.++|+|||.+...... .......|+..|+|||.+.+ .++.++||||||+++|+|++|..|+... .....+.
T Consensus 191 ~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~ 265 (311)
T 3p1a_A 191 GPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---EGWQQLR 265 (311)
T ss_dssp CGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHT
T ss_pred CCCCCEEEccceeeeecccC-CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHh
Confidence 99999999999998755432 23344568999999999987 6899999999999999999997665432 2233333
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.......++..+++++.++|.+||+.||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 266 QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 333333445678999999999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=313.57 Aligned_cols=258 Identities=26% Similarity=0.349 Sum_probs=206.1
Q ss_pred ecCCcceeecccccccceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC---CCCccceee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFI 120 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~ 120 (355)
...++|++.+.||+|+||.||+|.+ +++.||+|++.......... ..+.+|+.+++.+ +||||++++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~-------~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-------LSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB-------CTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC-------chhhHHHHHHHhhhccCCCCeEeee
Confidence 3458899999999999999999976 46889999986543221111 1134566665555 899999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++..... ......++||||++ ++|.+++.......+++..++.++.|++.||.|||++|++|+||+|
T Consensus 81 ~~~~~~~~-----------~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp 148 (326)
T 1blx_A 81 DVCTVSRT-----------DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 148 (326)
T ss_dssp EEEEEEEC-----------SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred eeeeeccc-----------CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCH
Confidence 98762110 01233478999997 5999999776666799999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
+||+++.++.++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+....
T Consensus 149 ~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (326)
T 1blx_A 149 QNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 227 (326)
T ss_dssp GGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred HHeEEcCCCCEEEecCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 9999999999999999998754322 223345788999999999998899999999999999999999999998887777
Q ss_pred HHHHHhcCCC-------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 281 TSAVVRQNLR-------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+...... ..+...++..+.++|.+||+.||.+||++.++++
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 6666532110 0123567899999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=325.28 Aligned_cols=266 Identities=23% Similarity=0.346 Sum_probs=200.7
Q ss_pred ccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
+.+.+ .++|++.+.||+|+||.||+|.+ +++.||||++...... ....+.+.+|+.+++.++||||++++
T Consensus 20 ~~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~nIv~l~ 91 (432)
T 3n9x_A 20 KNVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED-------LIDCKRILREITILNRLKSDYIIRLY 91 (432)
T ss_dssp GGCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS-------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred Cccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC-------hHHHHHHHHHHHHHHHcCCCCcceEE
Confidence 34444 47999999999999999999976 5788999999643211 11234578999999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++...... .....++||||++ ++|.+++. ....+++..++.++.||+.||.|||+.||+||||||
T Consensus 92 ~~~~~~~~~-----------~~~~~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp 157 (432)
T 3n9x_A 92 DLIIPDDLL-----------KFDELYIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKP 157 (432)
T ss_dssp EECCCSCTT-----------TCCCEEEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred EEEecCCCC-----------cCCeEEEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 988755321 1234588999995 59999984 446799999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCC----------------------CCCCCCCcccccCCccc-CCCCCCCcchhHH
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPN----------------------DMTGETGTLGYMAPEVL-NGNPYNRKCDVYS 257 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~----------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~Dvws 257 (355)
+|||++.++.++|+|||++........ ......+|..|+|||++ .+..++.++||||
T Consensus 158 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwS 237 (432)
T 3n9x_A 158 ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237 (432)
T ss_dssp GGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHH
T ss_pred HHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccch
Confidence 999999999999999999986543221 12456789999999986 5567999999999
Q ss_pred HHHHHHHHHhCCCC-----------CCCCC-----------------hhHHHHHHHhc----------------------
Q 018489 258 FGICLWEIYCCDMP-----------YPDLS-----------------FSEVTSAVVRQ---------------------- 287 (355)
Q Consensus 258 lG~il~~lltg~~p-----------~~~~~-----------------~~~~~~~~~~~---------------------- 287 (355)
|||++|+|++|..| |.+.+ ....+..+...
T Consensus 238 lG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 317 (432)
T 3n9x_A 238 TGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317 (432)
T ss_dssp HHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHH
T ss_pred HHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHH
Confidence 99999999985443 33322 11111111110
Q ss_pred --CCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHhH
Q 018489 288 --NLRPE-----IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAID 330 (355)
Q Consensus 288 --~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~~ 330 (355)
..... ....+++++.+||.+||+.||.+|||++|+++ .++.+.
T Consensus 318 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 318 LFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp TSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred hCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 00000 11457899999999999999999999999987 455543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=316.39 Aligned_cols=257 Identities=23% Similarity=0.309 Sum_probs=198.5
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||||++...... . ...+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN---Q----THAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 96 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS---H----HHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC---h----HHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence 47899999999999999999976 5889999999753321 1 1234577899999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.... .....++||||+++ +|.+.+. ..+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 97 ~~~~----------~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~ 161 (371)
T 2xrw_A 97 KSLE----------EFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 161 (371)
T ss_dssp CSTT----------TCCEEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cccc----------cccceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 4221 12345889999964 7887773 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+..
T Consensus 162 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 240 (371)
T 2xrw_A 162 SDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240 (371)
T ss_dssp TTSCEEECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC
T ss_pred CCCCEEEEEeecccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999754332 223345789999999999999999999999999999999999999998887766665544
Q ss_pred cCCCC--------------------CC--------------CC------CCcHHHHHHHHHhhhcCCCCCCCHHHHHH--
Q 018489 287 QNLRP--------------------EI--------------PR------CCPSSLANVMKRCWDANPDKRPEMDEVVS-- 324 (355)
Q Consensus 287 ~~~~~--------------------~~--------------~~------~~~~~l~~li~~~l~~~p~~Rps~~ell~-- 324 (355)
....+ .+ +. ..+.++.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 241 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp -CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 21111 00 00 01567999999999999999999999997
Q ss_pred HHHH
Q 018489 325 MLEA 328 (355)
Q Consensus 325 ~l~~ 328 (355)
.++.
T Consensus 321 ~~~~ 324 (371)
T 2xrw_A 321 YINV 324 (371)
T ss_dssp HHHT
T ss_pred chhh
Confidence 4443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=320.99 Aligned_cols=266 Identities=21% Similarity=0.334 Sum_probs=207.1
Q ss_pred ccccceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
....-+....+|++.+.||+|+||.||+|.+ .+..+|+|.+...... ..+|+.+++.++||||+++
T Consensus 31 ~~~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------------~~~E~~il~~l~h~niv~l 97 (394)
T 4e7w_A 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------------KNRELQIMRIVKHPNVVDL 97 (394)
T ss_dssp ESSSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------------CCHHHHHHHTCCCTTBCCE
T ss_pred CCCCCCcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------------HHHHHHHHHhCCCCCcceE
Confidence 3333444557899999999999999999977 4556888887543321 2369999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHh-hccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK-NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
++++...... .+..+.++||||++++.+...... .....+++..++.++.||+.||.|||++||+||||
T Consensus 98 ~~~~~~~~~~----------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 167 (394)
T 4e7w_A 98 KAFFYSNGDK----------KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDI 167 (394)
T ss_dssp EEEEEEESSS----------SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EEEEEecCCC----------CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCC
Confidence 9988643321 123345789999976444333321 23567999999999999999999999999999999
Q ss_pred CCCcEEEc-CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 018489 199 KTENMLLD-KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (355)
Q Consensus 199 ~p~Nili~-~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~ 276 (355)
||+||+++ .++.++|+|||.+...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+
T Consensus 168 kp~Nill~~~~~~~kL~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 168 KPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHHEEEcCCCCcEEEeeCCCcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999 7999999999999765332 233446789999999998764 58999999999999999999999999988
Q ss_pred hhHHHHHHHhcCCCC---------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q 018489 277 FSEVTSAVVRQNLRP---------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLE 327 (355)
Q Consensus 277 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~ 327 (355)
..+....+......+ .++..+++++.+||.+||+.||.+|||+.++++ .++
T Consensus 247 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 247 GIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 777666555421110 123447899999999999999999999999987 344
Q ss_pred HhH
Q 018489 328 AID 330 (355)
Q Consensus 328 ~~~ 330 (355)
.+.
T Consensus 327 ~~~ 329 (394)
T 4e7w_A 327 ELR 329 (394)
T ss_dssp TTT
T ss_pred hhc
Confidence 443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=318.22 Aligned_cols=257 Identities=14% Similarity=0.205 Sum_probs=208.9
Q ss_pred cccceecCCcceeecccccccceEEEEEE-------ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC--
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGL-------YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-- 112 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-- 112 (355)
...+++..++|++.+.||+|+||.||+|. .++..||+|+++... ...+.+|..++..+.
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~l~~~ 124 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------------PWEFYIGTQLMERLKPS 124 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------------HHHHHHHHHHHHHSCGG
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------------hhHHHHHHHHHHHhhhh
Confidence 35678888999999999999999999993 368899999986422 123566777777775
Q ss_pred -CCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh---ccccccHHHHHHHHHHHHHHHHHH
Q 018489 113 -HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN---RRRKLAFKVVVQLALDLARGLSYL 188 (355)
Q Consensus 113 -h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~L 188 (355)
|+||+.+++++...+.. ++||||+++++|.+++... ....+++..++.|+.||+.||.||
T Consensus 125 ~~~~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~l 188 (365)
T 3e7e_A 125 MQHMFMKFYSAHLFQNGS----------------VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188 (365)
T ss_dssp GGGGBCCEEEEEECSSCE----------------EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhheeeecCCCc----------------EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence 89999999998766555 5699999999999999653 345699999999999999999999
Q ss_pred HhCCccccCCCCCcEEEcC-----------CCcEEEeecccccccc--CCCCCCCCCCCcccccCCcccCCCCCCCcchh
Q 018489 189 HSQKIVHRDVKTENMLLDK-----------NRTVKIADFGVARVEA--SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDV 255 (355)
Q Consensus 189 H~~~i~H~di~p~Nili~~-----------~~~v~L~Dfg~a~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 255 (355)
|++||+||||||+|||++. ++.++|+|||.+.... ..........||..|+|||.+.+..++.++||
T Consensus 189 H~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 268 (365)
T 3e7e_A 189 HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268 (365)
T ss_dssp HTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHH
T ss_pred hhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccH
Confidence 9999999999999999988 8999999999997433 22333455679999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHhHhhc
Q 018489 256 YSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIP-RCCPSSLANVMKRCWDANPDKR-PEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 256 wslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~R-ps~~ell~~l~~~~~~~ 333 (355)
||||+++|+|++|+.||........ .....+. ...++.+.+++..||+.+|.+| |++.++.+.|+++....
T Consensus 269 wslG~il~elltg~~pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 269 FGVAATVYCMLFGTYMKVKNEGGEC-------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp HHHHHHHHHHHHSSCCCEEEETTEE-------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCccccCCCCce-------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 9999999999999999954322110 0001111 1247789999999999999999 68999999999887654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=337.09 Aligned_cols=265 Identities=29% Similarity=0.591 Sum_probs=219.2
Q ss_pred ccccceecCCcceeecccccccceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 115 (355)
....+++..++|++.+.||+|+||.||+|.+. +..||+|.++... . ....+.+.+|+.+++.++|||
T Consensus 381 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~----~----~~~~~~~~~E~~~l~~l~Hpn 452 (656)
T 2j0j_A 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT----S----DSVREKFLQEALTMRQFDHPH 452 (656)
T ss_dssp CGGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT----C----HHHHHHHHHHHHHHHHCCCTT
T ss_pred cccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC----C----HHHHHHHHHHHHHHHhCCCCC
Confidence 34567888899999999999999999999763 3569999875322 1 123456889999999999999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H 195 (355)
|+++++++.. +. .++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++|
T Consensus 453 Iv~l~~~~~~-~~----------------~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH 514 (656)
T 2j0j_A 453 IVKLIGVITE-NP----------------VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVH 514 (656)
T ss_dssp BCCEEEEECS-SS----------------CEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CCeEEEEEec-Cc----------------eEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 9999998743 22 26799999999999998643 446999999999999999999999999999
Q ss_pred cCCCCCcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 018489 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYP 273 (355)
Q Consensus 196 ~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~ 273 (355)
|||||+|||++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 515 rDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 594 (656)
T 2j0j_A 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594 (656)
T ss_dssp SCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999975543221 1223456778999999998889999999999999999997 999999
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
+.+..+....+... .....+..+++.+.++|.+||+.||.+||++.++++.|+.+...
T Consensus 595 ~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 595 GVKNNDVIGRIENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp TCCHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHcC-CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 98887777666554 34457778999999999999999999999999999999998653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=310.28 Aligned_cols=261 Identities=21% Similarity=0.333 Sum_probs=206.9
Q ss_pred hhhcccccceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC--C
Q 018489 37 FLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD--H 113 (355)
Q Consensus 37 ~~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h 113 (355)
.-....+.+.+..++|++.+.||+|+||.||++.+ ++..||+|++...... . ...+.+.+|+.++..+. |
T Consensus 15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~----~~~~~~~~E~~~l~~l~~~~ 87 (313)
T 3cek_A 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD---N----QTLDSYRNEIAYLNKLQQHS 87 (313)
T ss_dssp -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC---H----HHHHHHHHHHHHHHHHGGGC
T ss_pred CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc---c----cchHHHHHHHHHHHhccccC
Confidence 34556677889999999999999999999999976 4788999999654322 1 12345788999999996 5
Q ss_pred CccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCc
Q 018489 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKI 193 (355)
Q Consensus 114 ~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i 193 (355)
+||+++++++...+.. +++||+ .+++|.+++.. ...+++..++.++.|++.||.|||++|+
T Consensus 88 ~~iv~~~~~~~~~~~~----------------~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~i 148 (313)
T 3cek_A 88 DKIIRLYDYEITDQYI----------------YMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGI 148 (313)
T ss_dssp TTBCCEEEEEECSSEE----------------EEEECC-CSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CceEEEEEEeecCCEE----------------EEEEec-CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999988765544 669994 58899999964 4578999999999999999999999999
Q ss_pred cccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCC-----------CCCCCcchhHHHHH
Q 018489 194 VHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNG-----------NPYNRKCDVYSFGI 260 (355)
Q Consensus 194 ~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~ 260 (355)
+|+||+|+||+++ ++.++|+|||.+........ ......++..|+|||.+.+ ..++.++||||||+
T Consensus 149 vH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~ 227 (313)
T 3cek_A 149 VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227 (313)
T ss_dssp CCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHH
T ss_pred eecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHH
Confidence 9999999999996 58999999999975443221 1233568999999999875 46788999999999
Q ss_pred HHHHHHhCCCCCCCCCh-hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 261 CLWEIYCCDMPYPDLSF-SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 261 il~~lltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
++|+|++|..||..... ...............++...+.++.++|.+||+.||.+||++.++++
T Consensus 228 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 228 ILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 99999999999987543 34444555555555677778999999999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=316.99 Aligned_cols=260 Identities=22% Similarity=0.394 Sum_probs=207.3
Q ss_pred hcccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcc
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I 116 (355)
......|++. ++|++.+.||+|+||.||+|.+ +++.||||++...... ....+.+.+|+.+++.++||||
T Consensus 32 ~~~~~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~ni 103 (371)
T 4exu_A 32 DVNKTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-------EIFAKRAYRELLLLKHMQHENV 103 (371)
T ss_dssp EETTEEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-------HHHHHHHHHHHHHHHHCCCTTB
T ss_pred eeccceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-------hhHHHHHHHHHHHHHhcCCCCc
Confidence 3344456665 7999999999999999999976 5889999999643321 1234557789999999999999
Q ss_pred ceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
+++++++...+.... ....++||||+. ++|.+++ ...+++..++.++.|++.||.|||++|++|+
T Consensus 104 v~~~~~~~~~~~~~~----------~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 168 (371)
T 4exu_A 104 IGLLDVFTPASSLRN----------FYDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHR 168 (371)
T ss_dssp CCCSEEECSCSSSTT----------CCCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred hhhhhheeccCCccc----------ceeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence 999999876554311 112378999996 5887766 3459999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 197 DVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 197 di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
||||+||+++.++.++|+|||.+..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.
T Consensus 169 Dikp~NIll~~~~~~kL~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 169 DLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp CCCGGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CcCHHHeEECCCCCEEEEecCccccccc---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999975432 2334578999999999987 67899999999999999999999999988
Q ss_pred ChhHHHHHHHhcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 276 SFSEVTSAVVRQNLRP-----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+..+....+......+ .....+++++.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 246 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 7766665554321111 012356899999999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=318.38 Aligned_cols=268 Identities=20% Similarity=0.314 Sum_probs=205.3
Q ss_pred ccceecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCcc--HHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRT--EAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
..+....++|++.+.||+|+||.||+|.+ ++..||||++......... ........+.+.+|+.++++++||||+++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 34555678999999999999999999965 5889999998644332211 11122334568899999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++...+.. .....++||||++ ++|.+++.. ....+++..++.++.|++.||.|||++|++|+|||
T Consensus 95 ~~~~~~~~~~-----------~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 161 (362)
T 3pg1_A 95 RDIFVHFEEP-----------AMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLH 161 (362)
T ss_dssp SEEEEECCTT-----------TCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred eeeEEeccCC-----------CcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCC
Confidence 9988543211 1234588999996 588887753 34569999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
|+||+++.++.++|+|||.+...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp GGGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred hHHEEEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999743322 23344578899999999887 67899999999999999999999999988776
Q ss_pred HHHHHHHhcCCCC------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 279 EVTSAVVRQNLRP------------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 279 ~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+....+......+ ......++.+.++|.+||+.||.+|||+.++++
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 6666554321111 012345888999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=323.61 Aligned_cols=258 Identities=22% Similarity=0.341 Sum_probs=206.7
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccc-eeeeecc
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT-KFIGATM 124 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv-~~~~~~~ 124 (355)
..++|++.+.||+|+||.||+|.+ +++.||||++....... .+.+|+.+++.+.|++++ .+..++.
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-----------~~~~E~~il~~L~~~~~i~~i~~~~~ 73 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----------QLLYESKIYRILQGGTGIPNVRWFGV 73 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-----------CHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-----------HHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 358999999999999999999975 58999999987544322 256799999999775444 4444333
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
.. ...++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+|+||||+|||
T Consensus 74 ~~----------------~~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NIL 135 (483)
T 3sv0_A 74 EG----------------DYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (483)
T ss_dssp ET----------------TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred eC----------------CEEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEE
Confidence 32 2347799999 99999999643 457999999999999999999999999999999999999
Q ss_pred E---cCCCcEEEeeccccccccCCCC-------CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 018489 205 L---DKNRTVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (355)
Q Consensus 205 i---~~~~~v~L~Dfg~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~ 274 (355)
| +.++.++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+
T Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~ 215 (483)
T 3sv0_A 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (483)
T ss_dssp ECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred EecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 9 6889999999999986544322 12246789999999999999999999999999999999999999987
Q ss_pred CCh---hHHHHHHHhcC---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 275 LSF---SEVTSAVVRQN---LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 275 ~~~---~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
... ...+..+.... ....+...+++++.++|..||+.+|.+||++.+|++.|+.+....+
T Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 216 LKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp CCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 543 22222222211 1112335679999999999999999999999999999999976543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=328.86 Aligned_cols=269 Identities=15% Similarity=0.191 Sum_probs=197.4
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHH---HHHhhCCCCccceee
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV---AVWHKLDHPNVTKFI 120 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~Iv~~~ 120 (355)
....++|++.+.||+|+||.||+|.+ +++.||||++.......... .+.+.+|+ .+++.++||||++++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~------~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA------IKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTH------HHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHH------HHHHHHHHHHHHhccccCCHHHHHHH
Confidence 33458899999999999999999974 58999999997543322221 34577899 555556899999998
Q ss_pred eeccCCccccccccc--cc-ccCCC-----CceEEEEEecCCCCHHHHHHhhc-----cccccHHHHHHHHHHHHHHHHH
Q 018489 121 GATMGSSELHIQTEN--GQ-VAMPS-----NICCVVVEYLPGGALKTYLIKNR-----RRKLAFKVVVQLALDLARGLSY 187 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~--~~-~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~ 187 (355)
+.+.......-.... -. ...+. ...+++|||+ +|+|.+++.... ...+++..++.|+.||+.||.|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 544322211000000 00 00000 1357999999 679999996532 1234458889999999999999
Q ss_pred HHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-----------CCCCcchhH
Q 018489 188 LHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-----------PYNRKCDVY 256 (355)
Q Consensus 188 LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dvw 256 (355)
||++||+||||||+|||++.++.++|+|||++..... ......| ..|+|||.+.+. .++.++|||
T Consensus 222 LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 222 LHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp HHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred HHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 9999999999999999999999999999999975332 2334456 899999999877 799999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHhHh
Q 018489 257 SFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAIDT 331 (355)
Q Consensus 257 slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~~~ 331 (355)
|||+++|+|++|+.||...+.......+. .....+++++.++|.+||+.||.+||++.++++ .++.+..
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 99999999999999997654433222221 123567999999999999999999999999996 5555543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=310.13 Aligned_cols=263 Identities=23% Similarity=0.448 Sum_probs=196.6
Q ss_pred cchhhcccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC
Q 018489 35 SNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112 (355)
Q Consensus 35 ~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 112 (355)
......+.+.+.+..++|++.+.||+|+||.||+|.+ +++.||||++..... . ....+.+.++..+++.++
T Consensus 10 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~---~~~~~~~~~~~~~~~~~~ 82 (318)
T 2dyl_A 10 TGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN----K---EENKRILMDLDVVLKSHD 82 (318)
T ss_dssp CCSEEESSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC----H---HHHHHHHHHHHHHHHTTT
T ss_pred CceEEecchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc----c---hHHHHHHHHHHHHHHhcC
Confidence 3456667888999999999999999999999999977 588999999965432 1 112334555666788889
Q ss_pred CCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC-
Q 018489 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ- 191 (355)
Q Consensus 113 h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~- 191 (355)
||||+++++++...+.. ++||||+ ++.+..+.. .....+++..++.++.|++.||.|||++
T Consensus 83 h~~i~~~~~~~~~~~~~----------------~lv~e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 144 (318)
T 2dyl_A 83 CPYIVQCFGTFITNTDV----------------FIAMELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKH 144 (318)
T ss_dssp CTTBCCEEEEEECSSEE----------------EEEECCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCceeeEEEEEecCCcE----------------EEEEecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 99999999998866544 6699999 556655543 3356799999999999999999999996
Q ss_pred CccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC-----CCCCCCcchhHHHHHHHHHHH
Q 018489 192 KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIY 266 (355)
Q Consensus 192 ~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll 266 (355)
|++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+. +..++.++||||||+++|+|+
T Consensus 145 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 223 (318)
T 2dyl_A 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223 (318)
T ss_dssp CCCCCCCCGGGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHH
T ss_pred CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHH
Confidence 9999999999999999999999999998654332 2233456889999999995 456889999999999999999
Q ss_pred hCCCCCCCCC-hhHHHHHHHhcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 267 CCDMPYPDLS-FSEVTSAVVRQNLRPEIP--RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 267 tg~~p~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+|..||.... .......+.... ....+ ..+++++.++|.+||+.||.+||++.++++
T Consensus 224 ~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 224 TGQFPYKNCKTDFEVLTKVLQEE-PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HSSCTTTTCCSHHHHHHHHHHSC-CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred hCCCCCCCCCccHHHHHHHhccC-CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 9999998743 344444444432 22222 457999999999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=311.52 Aligned_cols=254 Identities=23% Similarity=0.379 Sum_probs=197.2
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||||++.......... ........+.+|+.+++.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSA-READPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhccc-ccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 6899999999999999999976 57899999996543211111 11122334778999999999999999999875433
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.++||||+++++|.+++. ....+++..++.++.||+.||.|||++|++|+||+|+||+++.
T Consensus 89 -----------------~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 149 (322)
T 2ycf_A 89 -----------------YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 149 (322)
T ss_dssp -----------------EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred -----------------eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEec
Confidence 267999999999999884 4567999999999999999999999999999999999999987
Q ss_pred CCc---EEEeeccccccccCCCCCCCCCCCcccccCCcccC---CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 208 NRT---VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 208 ~~~---v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
++. ++|+|||.+...... .......++..|+|||.+. ...++.++||||||+++|+|++|..||.........
T Consensus 150 ~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 228 (322)
T 2ycf_A 150 QEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228 (322)
T ss_dssp SSSSCCEEECCCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH
T ss_pred CCCCCeEEEccCccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH
Confidence 664 999999999754322 1112245788999999973 567889999999999999999999999765443222
Q ss_pred -HHHHhcCCC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 -SAVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 -~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+...... +.....+++++.++|.+||+.||.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 229 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 333332221 1223567899999999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=311.65 Aligned_cols=256 Identities=23% Similarity=0.396 Sum_probs=204.4
Q ss_pred ccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
..|++ .++|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+.+|+.+++.++||||++++
T Consensus 18 ~~~~l-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~ 89 (353)
T 3coi_A 18 TAWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-------EIFAKRAYRELLLLKHMQHENVIGLL 89 (353)
T ss_dssp EEEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred ccccc-CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-------hHHHHHHHHHHHHHHhcCCCCcccHh
Confidence 34554 37899999999999999999976 5889999999643221 12245578899999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++........ ....+++|||+. ++|.+++ ...+++..++.++.||+.||.|||++|++|+||+|
T Consensus 90 ~~~~~~~~~~~----------~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp 154 (353)
T 3coi_A 90 DVFTPASSLRN----------FYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKP 154 (353)
T ss_dssp EEECSCSSGGG----------CCCCEEEEECCS-EEGGGTT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCG
T ss_pred heEeccccccc----------ceeEEEEecccc-CCHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 99876554311 123378999996 5887766 23599999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
+||+++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+
T Consensus 155 ~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 231 (353)
T 3coi_A 155 GNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231 (353)
T ss_dssp GGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH
T ss_pred HHEeECCCCcEEEeecccccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999999754322 234578899999999887 678999999999999999999999999887666
Q ss_pred HHHHHHhcC-----------------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 280 VTSAVVRQN-----------------------------LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 280 ~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....+.... ........+++++.++|.+||+.||.+|||+.++++
T Consensus 232 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 232 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 555443311 011233467899999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=311.57 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=205.6
Q ss_pred CCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+. ++.||||++.... . ......+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD----K----PLFALRTLREIKILKHFKHENIITIFNIQRPD 81 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS----S----HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc----c----chHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence 489999999999999999999774 8899999985322 1 11234567899999999999999999987643
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... .....+++|||+. ++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 82 ~~~-----------~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~ 146 (353)
T 2b9h_A 82 SFE-----------NFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146 (353)
T ss_dssp CST-----------TCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred ccC-----------ccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc
Confidence 211 1245588999996 589988843 5699999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCC----------CCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 018489 207 KNRTVKIADFGVARVEASNPN----------DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~ 275 (355)
.++.++|+|||.+........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.
T Consensus 147 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp TTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999975543211 1223468999999998754 67899999999999999999999999988
Q ss_pred ChhHHHHHHHhcCCCC------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH-
Q 018489 276 SFSEVTSAVVRQNLRP------------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS- 324 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~- 324 (355)
+.......+......+ .....+++++.++|.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 227 DYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp SHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 7665554443211110 012357899999999999999999999999987
Q ss_pred -HHHHhHh
Q 018489 325 -MLEAIDT 331 (355)
Q Consensus 325 -~l~~~~~ 331 (355)
.++....
T Consensus 307 p~~~~~~~ 314 (353)
T 2b9h_A 307 PYLQTYHD 314 (353)
T ss_dssp GGGTTTCC
T ss_pred ccccccCC
Confidence 4554433
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=312.53 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=202.3
Q ss_pred eecCCcceeecccccccceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCC------cc
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP------NV 116 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~I 116 (355)
++..++|++.+.||+|+||.||+|.+ ++..||+|+++.. . ...+.+.+|+.+++.++|+ ++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~----~~~~~~~~e~~~l~~l~~~~~~~~~~i 79 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------D----RYCEAARSEIQVLEHLNTTDPNSTFRC 79 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------H----HHHHHHHHHHHHHHHHHHHCTTCTTCB
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------C----chhHHHHHHHHHHHHhhhcCCCCceee
Confidence 34568999999999999999999976 5789999998521 1 1234567888888888655 48
Q ss_pred ceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcccc
Q 018489 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (355)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~ 196 (355)
+++++++...+.. ++||||+ +++|.+++.......+++..++.++.|++.||.|||++|++|+
T Consensus 80 ~~~~~~~~~~~~~----------------~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 142 (339)
T 1z57_A 80 VQMLEWFEHHGHI----------------CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHT 142 (339)
T ss_dssp CCEEEEEEETTEE----------------EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EeeecccccCCcE----------------EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence 9999888765544 6799999 8899999976655679999999999999999999999999999
Q ss_pred CCCCCcEEEcC-------------------CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHH
Q 018489 197 DVKTENMLLDK-------------------NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYS 257 (355)
Q Consensus 197 di~p~Nili~~-------------------~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 257 (355)
||||+||+++. ++.++|+|||.+..... ......++..|+|||.+.+..++.++||||
T Consensus 143 Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 219 (339)
T 1z57_A 143 DLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWS 219 (339)
T ss_dssp CCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHH
T ss_pred CCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHH
Confidence 99999999987 66899999999975432 233457899999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC------------------------------------------CCCCC
Q 018489 258 FGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR------------------------------------------PEIPR 295 (355)
Q Consensus 258 lG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~ 295 (355)
||+++|+|++|..||...+..+....+...... .....
T Consensus 220 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (339)
T 1z57_A 220 IGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299 (339)
T ss_dssp HHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCS
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccch
Confidence 999999999999999987766555443221110 00112
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 296 CCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 296 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..++++.++|.+||+.||.+|||+.|+++
T Consensus 300 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 300 VEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 23678999999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=312.26 Aligned_cols=278 Identities=22% Similarity=0.273 Sum_probs=203.6
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|+||.||+|.+ ++..||||++........ .+.+++..+..++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN----------RELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCC----------HHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccH----------HHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 347899999999999999999976 488999999865433221 24567778888899999999998864
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHh--hccccccHHHHHHHHHHHHHHHHHHH--hCCccccCCCCC
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK--NRRRKLAFKVVVQLALDLARGLSYLH--SQKIVHRDVKTE 201 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~LH--~~~i~H~di~p~ 201 (355)
.... .....+.++||||+++ +|...+.. .....+++..++.++.|++.||.||| +.|++|+||||+
T Consensus 91 ~~~~---------~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~ 160 (360)
T 3e3p_A 91 LGER---------DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPH 160 (360)
T ss_dssp ECSS---------CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGG
T ss_pred cccc---------cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHH
Confidence 3321 0112345789999976 55554432 24567899999999999999999999 999999999999
Q ss_pred cEEEcC-CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 202 NMLLDK-NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 202 Nili~~-~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
||+++. ++.++|+|||.+...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+...
T Consensus 161 NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 239 (360)
T 3e3p_A 161 NVLVNEADGTLKLCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG 239 (360)
T ss_dssp GEEEETTTTEEEECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HEEEeCCCCcEEEeeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH
Confidence 999996 899999999999755432 233445789999999998765 48999999999999999999999999988777
Q ss_pred HHHHHHhcCCC------------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q 018489 280 VTSAVVRQNLR------------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLE 327 (355)
Q Consensus 280 ~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~ 327 (355)
....+...... .......++++.+||.+||+.||.+|||+.++++ .++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 319 (360)
T 3e3p_A 240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319 (360)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGG
T ss_pred HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccc
Confidence 66665542111 1122335789999999999999999999999997 566
Q ss_pred HhHhhcCCCCCCCCCCCcc
Q 018489 328 AIDTSKGGGMIPGDQPQGC 346 (355)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~ 346 (355)
.+.............|..+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~ 338 (360)
T 3e3p_A 320 ELHDPATKLPNNKDLPEDL 338 (360)
T ss_dssp GGGCTTCCCTTSCCCCGGG
T ss_pred ccCCccccCCCCCCCCcHH
Confidence 6655544444444444433
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=305.93 Aligned_cols=261 Identities=21% Similarity=0.291 Sum_probs=200.1
Q ss_pred CCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+. ++.||+|++.... . ...+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-----P----QSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-----H----HHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-----h----HHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 489999999999999999999774 8899999986432 1 1234577899999999999999999988654
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
..... .........+..++||||++ ++|.+++. ...+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 81 ~~~~~--~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 81 GSQLT--DDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN 154 (320)
T ss_dssp SCBCC--C----CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred ccccc--cccccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 32211 00111223456789999997 59999883 35699999999999999999999999999999999999997
Q ss_pred -CCCcEEEeeccccccccCC---CCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 207 -KNRTVKIADFGVARVEASN---PNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 207 -~~~~v~L~Dfg~a~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
.++.++|+|||.+...... ........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+..
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5679999999999754322 112233456889999998865 67899999999999999999999999988776665
Q ss_pred HHHHhcCCCC----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRP----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+....... .....++.++.++|.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 5544321110 122457899999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=320.31 Aligned_cols=270 Identities=14% Similarity=0.154 Sum_probs=187.2
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHH---HHHhhCCCCccceeeee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV---AVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~Iv~~~~~ 122 (355)
...+|++.+.||+|+||.||+|.+ +++.||||++....... ....+.+.+|+ ..++. +||||++++..
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~ 132 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS------RSELERLHEATFAAARLLG-ESPEEARDRRR 132 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTH------HHHHHHHHHHHHHHHHHHC-----------C
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccc------ccHHHHHHHHHHHHHHhcc-cChhhhhhcee
Confidence 345699999999999999999975 58899999997654321 12234466774 45555 79999886654
Q ss_pred ccCCccccccccc--------ccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHH------HHHHHHHHHHHHHH
Q 018489 123 TMGSSELHIQTEN--------GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV------VQLALDLARGLSYL 188 (355)
Q Consensus 123 ~~~~~~~~~~~~~--------~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~------~~i~~qi~~al~~L 188 (355)
+..+......... ..........++||||++ ++|.+++... +..+.+..+ +.++.||+.||+||
T Consensus 133 ~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp BCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 4322111110000 000001144689999997 8999999754 334555555 77889999999999
Q ss_pred HhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC--CCCCCcchhHHHHHHHHHHH
Q 018489 189 HSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIY 266 (355)
Q Consensus 189 H~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll 266 (355)
|++||+||||||+|||++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 211 H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 211 QSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp HHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred HHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 9999999999999999999999999999999855322 113456699999999987 67899999999999999999
Q ss_pred hCCCCCCCCChhHHH--HH---HH--hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHh
Q 018489 267 CCDMPYPDLSFSEVT--SA---VV--RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAI 329 (355)
Q Consensus 267 tg~~p~~~~~~~~~~--~~---~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~ 329 (355)
+|+.||......... .. .. ...........+++.+.++|.+||+.||.+|||+.++++ .++.+
T Consensus 288 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp HSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred hCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 999999776332110 00 00 011122223478999999999999999999999999975 44444
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=318.47 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=197.7
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC--------CCccc
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD--------HPNVT 117 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~Iv 117 (355)
..++|++.+.||+|+||.||+|.+ +++.||||++... . ...+.+.+|+.+++.+. |+||+
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------E----HYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------H----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------C----cchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 358999999999999999999965 5789999999532 1 12345778999998885 78899
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC-Ccccc
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHR 196 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~ 196 (355)
++++++..... .....++||||+ +++|.+.+.......+++..++.++.||+.||.|||++ ||+||
T Consensus 105 ~~~~~~~~~~~------------~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHr 171 (397)
T 1wak_A 105 QLLDDFKISGV------------NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHT 171 (397)
T ss_dssp CEEEEEEEEET------------TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECC
T ss_pred eeecceeecCC------------CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 99998763210 122347899999 66777777655556799999999999999999999999 99999
Q ss_pred CCCCCcEEEcCCC-------------------------------------------------cEEEeeccccccccCCCC
Q 018489 197 DVKTENMLLDKNR-------------------------------------------------TVKIADFGVARVEASNPN 227 (355)
Q Consensus 197 di~p~Nili~~~~-------------------------------------------------~v~L~Dfg~a~~~~~~~~ 227 (355)
||||+|||++.++ .++|+|||.+......
T Consensus 172 Dikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-- 249 (397)
T 1wak_A 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-- 249 (397)
T ss_dssp CCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--
T ss_pred CCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--
Confidence 9999999998775 7999999999765432
Q ss_pred CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh------hHHHHHHHhcCCC-----------
Q 018489 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF------SEVTSAVVRQNLR----------- 290 (355)
Q Consensus 228 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~------~~~~~~~~~~~~~----------- 290 (355)
.....+|..|+|||.+.+..++.++||||||+++|+|++|..||...+. ......+......
T Consensus 250 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 328 (397)
T 1wak_A 250 -FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328 (397)
T ss_dssp -SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTT
T ss_pred -CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccc
Confidence 3445789999999999998899999999999999999999999976542 2222222110000
Q ss_pred -----------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 291 -----------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 291 -----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+...++++.+||.+||+.||.+|||+.++++
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp GGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0112234567899999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=311.11 Aligned_cols=248 Identities=21% Similarity=0.373 Sum_probs=174.4
Q ss_pred Ccceeec-ccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 50 SKLVIKS-VIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 50 ~~y~i~~-~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
++|++.+ .||+|+||.||+|.+. ++.||||++... .. ...+....++.++||||+++++++...
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PK-------ARQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HH-------HHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HH-------HHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 6899855 6999999999999774 899999998532 11 112233345667999999999988642
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.. .....++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 95 ~~------------~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~ 162 (336)
T 3fhr_A 95 HH------------GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 162 (336)
T ss_dssp ET------------TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred cC------------CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE
Confidence 21 122347899999999999999766556799999999999999999999999999999999999997
Q ss_pred C---CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 207 K---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 207 ~---~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
. ++.++|+|||.+..... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus 163 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 240 (336)
T 3fhr_A 163 SKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG 240 (336)
T ss_dssp CSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ecCCCceEEEeccccceeccc--cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh
Confidence 6 45599999999975442 222345678999999999888889999999999999999999999976654433211
Q ss_pred ----HHhc--CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 ----VVRQ--NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ----~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+... .........+++++.++|.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 241 MKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111 1122233568999999999999999999999999997
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=318.66 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=181.8
Q ss_pred Cccee-ecccccccceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 50 SKLVI-KSVIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 50 ~~y~i-~~~lg~G~~~~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
+.|.+ .+.||+|+||.||+|.+ ++..||||++...... ..+.+|+.+++.++||||+++++++.
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----------MSACREIALLRELKHPNVISLQKVFL 88 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----------HHHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----------HHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 56777 45899999999999975 3678999998643221 23668999999999999999999885
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-------cccccHHHHHHHHHHHHHHHHHHHhCCccccC
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~d 197 (355)
.... ...++||||+. ++|.+++.... ...+++..++.|+.||+.||.|||++||+|||
T Consensus 89 ~~~~--------------~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~D 153 (405)
T 3rgf_A 89 SHAD--------------RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 153 (405)
T ss_dssp ETTT--------------TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCC--------------CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCC
Confidence 4322 23378999995 58888775332 12499999999999999999999999999999
Q ss_pred CCCCcEEE----cCCCcEEEeeccccccccCCC---CCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCC
Q 018489 198 VKTENMLL----DKNRTVKIADFGVARVEASNP---NDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCD 269 (355)
Q Consensus 198 i~p~Nili----~~~~~v~L~Dfg~a~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~ 269 (355)
|||+|||+ +.++.++|+|||.+....... .......+|..|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 154 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 233 (405)
T 3rgf_A 154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233 (405)
T ss_dssp CCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCC
Confidence 99999999 677899999999997654321 223345789999999999874 5899999999999999999999
Q ss_pred CCCCCCChh---------HHHHHHHhcCCCCC------------------------------------CCCCCcHHHHHH
Q 018489 270 MPYPDLSFS---------EVTSAVVRQNLRPE------------------------------------IPRCCPSSLANV 304 (355)
Q Consensus 270 ~p~~~~~~~---------~~~~~~~~~~~~~~------------------------------------~~~~~~~~l~~l 304 (355)
.||.+.... +.+..+......+. .....++.+.+|
T Consensus 234 ~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 313 (405)
T 3rgf_A 234 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313 (405)
T ss_dssp CTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHH
T ss_pred CCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHH
Confidence 999765431 23333222111000 011226789999
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 018489 305 MKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 305 i~~~l~~~p~~Rps~~ell~ 324 (355)
|.+||+.||.+|||+.|+++
T Consensus 314 l~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 314 LQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHccCCcccCCCHHHHhc
Confidence 99999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=300.95 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=196.9
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||+|++... . ...+.+.+|+.+++.++||||+++++++....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT------E----EKLSTILSEVMLLASLNHQYVVRYYAAWLERR 75 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE------H----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc------H----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence 6899999999999999999976 6889999998531 1 12355788999999999999999999886543
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
..... ..........++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++|+||+|+||+++.
T Consensus 76 ~~~~~---~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 76 NFVKP---MTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCCC---------CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred chhhh---hcccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC
Confidence 22110 0111224566899999999999999965 3456889999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCC--------------CCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCC
Q 018489 208 NRTVKIADFGVARVEASN--------------PNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPY 272 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~ 272 (355)
++.++|+|||.+...... ........++..|+|||.+.+. .++.++||||||+++|+|++ ||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 999999999998754321 1122345688999999999864 68999999999999999998 55
Q ss_pred CCCCh-hHHHHHHHhc--CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 273 PDLSF-SEVTSAVVRQ--NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 273 ~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..... ......+... .....++...++.+.++|.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 229 STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp SSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 43322 2222332222 2233455667888999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=310.15 Aligned_cols=257 Identities=26% Similarity=0.481 Sum_probs=183.4
Q ss_pred ccccceecCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHH-HHhhCCCCccc
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVA-VWHKLDHPNVT 117 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv 117 (355)
..+.|.+..++|++.+.||+|+||.||+|.+. ++.||||++..... ... ...+..|+. +++.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~----~~~~~~e~~~~~~~~~h~niv 84 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EKE----QKQLLMDLDVVMRSSDCPYIV 84 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC----HHH----HHHHHHHHHHHHSSCCCTTBC
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC----chH----HHHHHHHHHHHHHcCCCCcEe
Confidence 45668888899999999999999999999774 89999999964321 111 122334444 77778999999
Q ss_pred eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh---ccccccHHHHHHHHHHHHHHHHHHHhC-Cc
Q 018489 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN---RRRKLAFKVVVQLALDLARGLSYLHSQ-KI 193 (355)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~-~i 193 (355)
++++++...+.. ++||||+++ +|.+++... ....+++..++.++.|++.||.|||+. |+
T Consensus 85 ~~~~~~~~~~~~----------------~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~i 147 (327)
T 3aln_A 85 QFYGALFREGDC----------------WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147 (327)
T ss_dssp CEEEEEECSSEE----------------EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSC
T ss_pred eeeeEEEeCCce----------------EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCE
Confidence 999998765544 669999975 888877532 256799999999999999999999999 99
Q ss_pred cccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCccc----CCCCCCCcchhHHHHHHHHHHHhCC
Q 018489 194 VHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVL----NGNPYNRKCDVYSFGICLWEIYCCD 269 (355)
Q Consensus 194 ~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~il~~lltg~ 269 (355)
+|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+ .+..++.++||||||+++|+|++|.
T Consensus 148 vH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (327)
T 3aln_A 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226 (327)
T ss_dssp CCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSC
T ss_pred eECCCCHHHEEEcCCCCEEEccCCCceecccc-cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999754432 222334688999999998 4566889999999999999999999
Q ss_pred CCCCCCChh-HHHHHHHhcCCCCC----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 270 MPYPDLSFS-EVTSAVVRQNLRPE----IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 270 ~p~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.||...... +...... ....+. ....+++++.++|.+||+.||.+||++.++++
T Consensus 227 ~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 227 FPYPKWNSVFDQLTQVV-KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSSCC-------CCCC-CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCcchHHHHHHHHh-cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 999765432 1111111 111111 22457999999999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=306.53 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=194.2
Q ss_pred ccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC----CCCcc
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL----DHPNV 116 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~~I 116 (355)
...+...++|++.+.||+|+||.||+|.+ ++..||+|++.......... ......+.+|+.++.++ +||||
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~h~~i 100 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP---LSDSVTCPLEVALLWKVGAGGGHPGV 100 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-----------CCCCHHHHHHHHHHSSCCCSSB
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccccc---chhhHHHHHHHHHHHhhcccCCCCCe
Confidence 34555568999999999999999999976 67899999996544321110 11122355688888888 89999
Q ss_pred ceeeeeccCCcccccccccccccCCCCceEEEEEe-cCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccc
Q 018489 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY-LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (355)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H 195 (355)
+++++++...+.. +++||+ +.+++|.+++.. ...+++..++.++.|++.||.|||++|++|
T Consensus 101 ~~~~~~~~~~~~~----------------~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 162 (312)
T 2iwi_A 101 IRLLDWFETQEGF----------------MLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSRGVVH 162 (312)
T ss_dssp CCEEEEC-----C----------------EEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHHTEEC
T ss_pred eeEEEEEecCCeE----------------EEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 9999988765544 569999 789999999964 456999999999999999999999999999
Q ss_pred cCCCCCcEEEc-CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCC-CCcchhHHHHHHHHHHHhCCCCCC
Q 018489 196 RDVKTENMLLD-KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYP 273 (355)
Q Consensus 196 ~di~p~Nili~-~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~lltg~~p~~ 273 (355)
+||+|+||+++ .++.++|+|||.+...... ......++..|+|||.+.+..+ +.++||||||+++|+|++|+.||.
T Consensus 163 ~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 163 RDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp CCCSGGGEEEETTTTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCChhhEEEeCCCCeEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence 99999999999 8899999999998765432 2344568999999999876655 458999999999999999999996
Q ss_pred CCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... .+.. ....++..++.++.++|.+||+.||.+||++.++++
T Consensus 241 ~~~------~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 241 RDQ------EILE--AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp SHH------HHHH--TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ChH------HHhh--hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 532 1222 223466778999999999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=306.46 Aligned_cols=247 Identities=25% Similarity=0.350 Sum_probs=197.8
Q ss_pred cCCcceeecccccccceEEEEEEEC--C-ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc------cce
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD--G-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN------VTK 118 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~--~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------Iv~ 118 (355)
..++|++.+.||+|+||.||+|.+. + ..||+|+++.. . ...+.+.+|+.+++.+.|++ ++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------G----KYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------H----HHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------c----cchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 3589999999999999999999763 3 68999998531 1 12345677888888886655 778
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++...... ++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+|+||
T Consensus 87 ~~~~~~~~~~~----------------~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dl 149 (355)
T 2eu9_A 87 MSDWFNFHGHM----------------CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDL 149 (355)
T ss_dssp EEEEEEETTEE----------------EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred eeeeeeeCCeE----------------EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 77776654443 6799999 667777776655567999999999999999999999999999999
Q ss_pred CCCcEEE-------------------cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHH
Q 018489 199 KTENMLL-------------------DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFG 259 (355)
Q Consensus 199 ~p~Nili-------------------~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 259 (355)
||+||++ +.++.++|+|||.+..... ......++..|+|||.+.+..++.++||||||
T Consensus 150 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 226 (355)
T 2eu9_A 150 KPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIG 226 (355)
T ss_dssp CGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHH
T ss_pred CHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCccchHHHH
Confidence 9999999 5678999999999975433 22345789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHHHHhcCCCC------------------------------------------CCCCCC
Q 018489 260 ICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP------------------------------------------EIPRCC 297 (355)
Q Consensus 260 ~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~ 297 (355)
+++|+|++|..||...+..+....+....... ......
T Consensus 227 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (355)
T 2eu9_A 227 CILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306 (355)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHH
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchh
Confidence 99999999999999877665544333211100 001112
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 298 PSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 298 ~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+.++.+||.+||+.||.+|||+.++++
T Consensus 307 ~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 307 HVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 468999999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=312.96 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=198.8
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-----------
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD----------- 112 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----------- 112 (355)
.+..++|++.+.||+|+||.||+|.+ +++.||||++.... ...+.+.+|+.+++++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~~~~ 84 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----------VYTEAAEDEIKLLQRVNDADNTKEDSMG 84 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----------cchhhhhHHHHHHHHhhcccccchhccc
Confidence 45678999999999999999999975 68899999985311 11344677888888875
Q ss_pred CCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC-
Q 018489 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ- 191 (355)
Q Consensus 113 h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~- 191 (355)
|+||+++++++...... ....+++|||+ +++|.+++.......+++..++.++.||+.||.|||++
T Consensus 85 ~~~i~~~~~~~~~~~~~------------~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ 151 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGPN------------GVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC 151 (373)
T ss_dssp HTTBCCCCEEEEEEETT------------EEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cchHHHHHHHhhccCCC------------CceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 89999999988754311 12347899999 89999999876667799999999999999999999998
Q ss_pred CccccCCCCCcEEEc------CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHH
Q 018489 192 KIVHRDVKTENMLLD------KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265 (355)
Q Consensus 192 ~i~H~di~p~Nili~------~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l 265 (355)
|++|+||||+||+++ ..+.++|+|||.+...... .....++..|+|||.+.+..++.++||||||+++|+|
T Consensus 152 ~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 228 (373)
T 1q8y_A 152 GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 228 (373)
T ss_dssp CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHH
T ss_pred CEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHH
Confidence 999999999999995 3448999999999755432 3345789999999999999899999999999999999
Q ss_pred HhCCCCCCCCCh------hHHHHHHHhcC----------------------------------------CCCCCCCCCcH
Q 018489 266 YCCDMPYPDLSF------SEVTSAVVRQN----------------------------------------LRPEIPRCCPS 299 (355)
Q Consensus 266 ltg~~p~~~~~~------~~~~~~~~~~~----------------------------------------~~~~~~~~~~~ 299 (355)
++|..||...+. ......+.... ....++..+++
T Consensus 229 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (373)
T 1q8y_A 229 ITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 308 (373)
T ss_dssp HHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHH
T ss_pred HhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHH
Confidence 999999976542 22222221100 00112334567
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 300 SLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 300 ~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
++.+||.+||+.||.+|||+.++++
T Consensus 309 ~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 309 EISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHHHHHhccCccccCCHHHHhh
Confidence 8999999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=307.30 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=198.7
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CC-----ccce
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HP-----NVTK 118 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~Iv~ 118 (355)
...++|++.+.||+|+||.||+|.+ +++.||||+++.. . .....+.+|+.++..+. |+ +|+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------K----AFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------H----HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------H----HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 3458999999999999999999976 5788999999531 1 11234567888887774 55 4888
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHH--hCCcccc
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH--SQKIVHR 196 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~i~H~ 196 (355)
+++++...+.. ++||||++ ++|.+++.......+++..++.++.|++.||.||| +.||+||
T Consensus 121 ~~~~~~~~~~~----------------~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHr 183 (382)
T 2vx3_A 121 LKRHFMFRNHL----------------CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHC 183 (382)
T ss_dssp EEEEEEETTEE----------------EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECC
T ss_pred eeeeeccCCce----------------EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcC
Confidence 88887765444 67999995 59999997665567999999999999999999999 5799999
Q ss_pred CCCCCcEEEc--CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 018489 197 DVKTENMLLD--KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (355)
Q Consensus 197 di~p~Nili~--~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~ 274 (355)
||||+|||++ .++.++|+|||.+..... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.+
T Consensus 184 Dlkp~NIll~~~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 184 DLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CCSGGGEEESSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcccEEEecCCCCcEEEEeccCceeccc---ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999995 478899999999976543 23346789999999999999999999999999999999999999998
Q ss_pred CChhHHHHHHHhcCCCCC----------------CCC-------------------------------------------
Q 018489 275 LSFSEVTSAVVRQNLRPE----------------IPR------------------------------------------- 295 (355)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~----------------~~~------------------------------------------- 295 (355)
.+..+....+......+. ++.
T Consensus 261 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 340 (382)
T 2vx3_A 261 ANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESG 340 (382)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTT
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCcccccccc
Confidence 887776665544211100 000
Q ss_pred ---CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 296 ---CCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 296 ---~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..++++.+||.+||+.||.+|||+.++++
T Consensus 341 ~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~ 372 (382)
T 2vx3_A 341 HTVADYLKFKDLILRMLDYDPKTRIQPYYALQ 372 (382)
T ss_dssp CCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccchhhHHHHHHHHHhcCCChhhCCCHHHHhc
Confidence 00147899999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=302.75 Aligned_cols=250 Identities=22% Similarity=0.393 Sum_probs=200.9
Q ss_pred cceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC--CCcccee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD--HPNVTKF 119 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~ 119 (355)
..+...++|++.+.||+|+||.||+|.+ ++..||||++........... ...+.+.+|+.+++.+. |+||+++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL---PNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC---TTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh---hhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3444568999999999999999999976 688999999975433211000 00122557889999985 5999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCC-CCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG-GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
++++...+.. +++||++.+ ++|.+++.. ...+++..++.++.|++.||.|||++|++|+||
T Consensus 114 ~~~~~~~~~~----------------~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl 175 (320)
T 3a99_A 114 LDWFERPDSF----------------VLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDI 175 (320)
T ss_dssp EEEEECSSEE----------------EEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred EEEEecCCcE----------------EEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCC
Confidence 9998866554 569999976 899999854 467999999999999999999999999999999
Q ss_pred CCCcEEEc-CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCC
Q 018489 199 KTENMLLD-KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLS 276 (355)
Q Consensus 199 ~p~Nili~-~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~lltg~~p~~~~~ 276 (355)
+|+||+++ .++.++|+|||.+...... ......++..|+|||.+.+..+ +.++||||||+++|+|++|+.||....
T Consensus 176 kp~NIll~~~~~~~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 253 (320)
T 3a99_A 176 KDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253 (320)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred CHHHEEEeCCCCCEEEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh
Confidence 99999999 7899999999999765432 2334578999999999877655 688999999999999999999996532
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..... ...++..+++++.++|.+||+.||.+||++.++++
T Consensus 254 ------~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 ------EIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------HHHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------hhhcc--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12222 23456678999999999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.19 Aligned_cols=234 Identities=13% Similarity=0.132 Sum_probs=186.3
Q ss_pred ecCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
+..++|++.+.||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.++..++||||+++++++.
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP------DDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC------HHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 45588999999999999999999874 8999999996543321 122455788999999999999999999987
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..+.. ++||||++|++|.+++.. + .....+..|+.|++.||.|||++|++|+||||+||+
T Consensus 102 ~~~~~----------------~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIl 161 (286)
T 3uqc_A 102 TRAGG----------------LVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVR 161 (286)
T ss_dssp ETTEE----------------EEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred ECCcE----------------EEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEE
Confidence 65544 679999999999999832 2 455678899999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH--
Q 018489 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS-- 282 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~-- 282 (355)
++.+|.++|++++.. + .++.++||||||+++|+|++|+.||.+.+......
T Consensus 162 l~~~g~~kl~~~~~~--------------------~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~ 214 (286)
T 3uqc_A 162 VSIDGDVVLAYPATM--------------------P-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA 214 (286)
T ss_dssp EETTSCEEECSCCCC--------------------T-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC
T ss_pred EcCCCCEEEEecccc--------------------C-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH
Confidence 999999999855432 2 26789999999999999999999998765432110
Q ss_pred -HHHhcCCC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 283 -AVVRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 283 -~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
........ ......+++++.++|.+||+.||.+| |+.++++.|+.+.....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 215 ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 00010000 01235679999999999999999999 99999999999876543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.10 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=190.4
Q ss_pred cccceecCCcceeecccccccceE-EEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCcccee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGT-VHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKF 119 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~ 119 (355)
...+.+...+|.+.+.||+|+||. ||++..+++.||||++...... .+.+|+.+++.+ +||||+++
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------------~~~~E~~~l~~l~~HpnIv~l 83 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------------FADREVQLLRESDEHPNVIRY 83 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------------ECHHHHHHHHHSCCCTTBCCE
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------------HHHHHHHHHHhccCCCCcCeE
Confidence 345777888999999999999998 4566788999999998543221 145799999999 89999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++...... ++||||+. ++|.+++... ...+.+..++.++.||+.||.|||++||+|||||
T Consensus 84 ~~~~~~~~~~----------------~lv~E~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlK 145 (432)
T 3p23_A 84 FCTEKDRQFQ----------------YIAIELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLK 145 (432)
T ss_dssp EEEEEETTEE----------------EEEEECCS-EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred EEEEecCCEE----------------EEEEECCC-CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCC
Confidence 9988765544 67999995 5999998643 3345556678999999999999999999999999
Q ss_pred CCcEEEcC-----CCcEEEeeccccccccCCC---CCCCCCCCcccccCCcccCC---CCCCCcchhHHHHHHHHHHHh-
Q 018489 200 TENMLLDK-----NRTVKIADFGVARVEASNP---NDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYC- 267 (355)
Q Consensus 200 p~Nili~~-----~~~v~L~Dfg~a~~~~~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~llt- 267 (355)
|+||+++. ...++|+|||++....... .......||+.|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 146 p~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~ 225 (432)
T 3p23_A 146 PHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225 (432)
T ss_dssp TTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTT
T ss_pred HHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcC
Confidence 99999953 2358899999997554322 22334578999999999984 567889999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHhcCCCCC-CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 268 CDMPYPDLSFSEVTSAVVRQNLRPE-IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 268 g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
|..||.................... .....+..+.+||.+||+.||.+|||+.++++
T Consensus 226 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 226 GSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp SCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 9999976544433222111111111 11223567899999999999999999999983
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=306.01 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=183.4
Q ss_pred CCcceeecccccccceEEEEE-EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRG-LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~ 126 (355)
.+.|.+.+.||+|+||+||.+ ..+++.||||++.... .+.+.+|+.++.++ +||||+++++++...
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------------CDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------------HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------------HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 356677899999999999754 6689999999985321 12356899999876 899999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcccc-----ccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK-----LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
... ++||||++ ++|.+++....... .++..++.++.||+.||.|||++||+||||||+
T Consensus 82 ~~~----------------~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~ 144 (434)
T 2rio_A 82 RFL----------------YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144 (434)
T ss_dssp SEE----------------EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred CeE----------------EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChH
Confidence 444 67999995 69999996432211 133346789999999999999999999999999
Q ss_pred cEEEcCC-------------CcEEEeeccccccccCCCC----CCCCCCCcccccCCcccCC-------CCCCCcchhHH
Q 018489 202 NMLLDKN-------------RTVKIADFGVARVEASNPN----DMTGETGTLGYMAPEVLNG-------NPYNRKCDVYS 257 (355)
Q Consensus 202 Nili~~~-------------~~v~L~Dfg~a~~~~~~~~----~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dvws 257 (355)
||+++.+ +.++|+|||.+........ ......||+.|+|||.+.+ ..++.++||||
T Consensus 145 NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwS 224 (434)
T 2rio_A 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224 (434)
T ss_dssp GEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHH
T ss_pred hEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHh
Confidence 9999754 4899999999986543322 1233578999999999976 56889999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 258 FGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEI-----PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 258 lG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
||+++|+|++ |..||....... ..+......... ...+++++.++|.+||+.||.+|||+.++++
T Consensus 225 lG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 225 MGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 9999999999 999997654433 223332222111 1124688999999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=290.34 Aligned_cols=227 Identities=21% Similarity=0.387 Sum_probs=178.6
Q ss_pred Ccceee-cccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHH-hhCCCCccceeeeeccC
Q 018489 50 SKLVIK-SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW-HKLDHPNVTKFIGATMG 125 (355)
Q Consensus 50 ~~y~i~-~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~~~~~~~~ 125 (355)
++|.+. +.||+|+||.||++.+ +++.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 667777 7899999999999976 6889999998531 1255788877 55699999999998764
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.. ......++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 83 ~~------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 150 (299)
T 3m2w_A 83 LY------------AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 150 (299)
T ss_dssp EE------------TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred hc------------CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 11 012334789999999999999977656679999999999999999999999999999999999999
Q ss_pred cC---CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 206 DK---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 206 ~~---~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
+. ++.++|+|||.+.... +..++.++||||||+++|+|++|..||..........
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 208 (299)
T 3m2w_A 151 TSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 208 (299)
T ss_dssp SSSSTTCCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C
T ss_pred ecCCCCCcEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH
Confidence 98 7899999999986332 2346789999999999999999999997654433221
Q ss_pred HHHhcCCC--CCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNLR--PEIP----RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~~--~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
........ ...+ ..+++++.++|.+||+.||.+|||+.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 209 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11111111 1112 457899999999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.83 Aligned_cols=263 Identities=26% Similarity=0.353 Sum_probs=199.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ ++..||||+++... .. ...+.+.+|+.+++.++||||+++++++....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~----~~----~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL----SP----KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC----CH----HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC----CH----HHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 7899999999999999999965 68899999985421 11 22455888999999999999999999876522
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc-cccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
.. .+.+..++||||++|++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus 86 ~~----------~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~ 155 (676)
T 3qa8_A 86 KL----------APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ 155 (676)
T ss_dssp CC----------CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEE
T ss_pred cc----------cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEee
Confidence 11 12344578999999999999996532 23689999999999999999999999999999999999999
Q ss_pred CCCc---EEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 207 KNRT---VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 207 ~~~~---v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
.++. ++|+|||.+...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||.+......+..
T Consensus 156 ~~g~~~~vKL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~ 234 (676)
T 3qa8_A 156 PGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG 234 (676)
T ss_dssp CCSSSCEEEECSCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST
T ss_pred cCCCceeEEEcccccccccccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh
Confidence 7765 999999999865433 233446789999999999999999999999999999999999999976432211100
Q ss_pred H---------H-hcC------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH-----HHHHHHHhHh
Q 018489 284 V---------V-RQN------------LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDE-----VVSMLEAIDT 331 (355)
Q Consensus 284 ~---------~-~~~------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e-----ll~~l~~~~~ 331 (355)
. . ... ....+...+++.+.++|..||+.||.+|||+.+ +.+.++.+..
T Consensus 235 ~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp TCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0 0 000 000122335789999999999999999999988 4455555554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=302.51 Aligned_cols=263 Identities=16% Similarity=0.199 Sum_probs=189.0
Q ss_pred ceecCCcceeecccccccceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCC-Cccceeee
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH-PNVTKFIG 121 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~ 121 (355)
+......|.+.+.||+|+||.||+|.+. ++.||||++........ ...+.+.+|+.++..+.| +|...+..
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~------~~~~~~~~E~~~~~~l~~~~~~~~~~~ 146 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS------NAIKQMKEEVLRLRLLRGIKNQKQAKV 146 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----------CCHHHHHHHHGGGGSTTCCSHHHHHH
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH------HHHHHHHHHHHHHHhhccCCCHHHHHH
Confidence 3344566899999999999999999874 89999999874333221 113447889999999976 33322221
Q ss_pred e---------ccCCccccc-ccccccccCCCCceEEEEEecCCCCHHHHHHh-----hccccccHHHHHHHHHHHHHHHH
Q 018489 122 A---------TMGSSELHI-QTENGQVAMPSNICCVVVEYLPGGALKTYLIK-----NRRRKLAFKVVVQLALDLARGLS 186 (355)
Q Consensus 122 ~---------~~~~~~~~~-~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~~~i~~qi~~al~ 186 (355)
+ ........+ ..............+++|+++ +++|.+++.. .....+++..++.++.||+.||.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 225 (413)
T 3dzo_A 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 225 (413)
T ss_dssp HTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHH
T ss_pred hcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHH
Confidence 1 110000000 000000000112346777776 6799998852 23556889999999999999999
Q ss_pred HHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCccc----------CCCCCCCcchhH
Q 018489 187 YLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVL----------NGNPYNRKCDVY 256 (355)
Q Consensus 187 ~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Dvw 256 (355)
|||++||+||||||+|||++.++.++|+|||++...... .....| ..|+|||.+ .+..++.++|||
T Consensus 226 ~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 226 SLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp HHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred HHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 999999999999999999999999999999998754432 334466 999999999 555688899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 257 SFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 257 slG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
|||+++|+|++|+.||...+.......+.. ....+|+++.+||.+||+.||.+||++.++++
T Consensus 302 SlGvil~elltg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHHCCCCCCCcchhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999999999987654443322211 22457899999999999999999999776643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=312.44 Aligned_cols=247 Identities=23% Similarity=0.305 Sum_probs=193.8
Q ss_pred eecCCcceeecccccccceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
++..++|++.+.||+|+||.||+|.+ +++.||||++.... .. ...+.+.+|+.++.+++||||++++++
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~----~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~ 147 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG----DA----EAQAMAMAERQFLAEVVHPSIVQIFNF 147 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC----CH----HHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC----CH----HHHHHHHHHHHHHHhcCCCCcCeEeee
Confidence 34568999999999999999999976 47899999985321 11 223457889999999999999999998
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...+.. .....++||||++|++|.+++. ..+++..++.|+.||+.+|.|||++||+|+||||+|
T Consensus 148 ~~~~~~~-----------~~~~~~lv~E~~~g~~L~~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~N 212 (681)
T 2pzi_A 148 VEHTDRH-----------GDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPEN 212 (681)
T ss_dssp EEEECTT-----------SCEEEEEEEECCCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred EeecCCC-----------CCceeEEEEEeCCCCcHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHH
Confidence 8765431 0122478999999999998763 269999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
|+++.+ .++|+|||.+...... ....||+.|+|||.+.+. ++.++||||||+++|+|++|..||.+.....
T Consensus 213 Ill~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--- 283 (681)
T 2pzi_A 213 IMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--- 283 (681)
T ss_dssp EEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---
T ss_pred eEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc---
Confidence 999875 8999999999765432 345789999999998765 4889999999999999999998886521110
Q ss_pred HHHhcCCCCC-CCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHhH
Q 018489 283 AVVRQNLRPE-IPRCCPSSLANVMKRCWDANPDKRP-EMDEVVSMLEAID 330 (355)
Q Consensus 283 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp-s~~ell~~l~~~~ 330 (355)
.... .....++.+.++|.+||+.||.+|| +++++.+.|..+.
T Consensus 284 ------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 ------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000 0011357899999999999999999 6777777776653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=291.45 Aligned_cols=262 Identities=15% Similarity=0.194 Sum_probs=185.4
Q ss_pred ecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC---------CCccc
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD---------HPNVT 117 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------h~~Iv 117 (355)
+..++|++.+.||+|+||.||+|.++++.||||++.......... ......+.+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNG-SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTT-BCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCcccccc-ccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 345789999999999999999999999999999997654321000 00001234667888777775 66666
Q ss_pred eeeeeccCCc--cccccccccc------------ccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHH
Q 018489 118 KFIGATMGSS--ELHIQTENGQ------------VAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR 183 (355)
Q Consensus 118 ~~~~~~~~~~--~~~~~~~~~~------------~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~ 183 (355)
++.+.+.... +..++...+. -..+.+..++||||+++|++.+.+. ...+++..++.|+.||+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHHHH
Confidence 6655432110 0000000000 0112456789999999997666552 356899999999999999
Q ss_pred HHHHHH-hCCccccCCCCCcEEEcCCC--------------------cEEEeeccccccccCCCCCCCCCCCcccccCCc
Q 018489 184 GLSYLH-SQKIVHRDVKTENMLLDKNR--------------------TVKIADFGVARVEASNPNDMTGETGTLGYMAPE 242 (355)
Q Consensus 184 al~~LH-~~~i~H~di~p~Nili~~~~--------------------~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE 242 (355)
||.||| ++||+||||||+|||++.++ .++|+|||+++..... ...||..|+|||
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 999999 99999999999999999887 8999999999865432 237899999999
Q ss_pred ccCCCCCCCcchhHHHHHH-HHHHHhCCCCCCCCCh-hHHHHHHHhc-CCCCC----CCCCCcHHHHHHHHHhhhcCCCC
Q 018489 243 VLNGNPYNRKCDVYSFGIC-LWEIYCCDMPYPDLSF-SEVTSAVVRQ-NLRPE----IPRCCPSSLANVMKRCWDANPDK 315 (355)
Q Consensus 243 ~~~~~~~~~~~DvwslG~i-l~~lltg~~p~~~~~~-~~~~~~~~~~-~~~~~----~~~~~~~~l~~li~~~l~~~p~~ 315 (355)
++.+.. +.++||||++++ .+++++|..||..... ......+... ..... .+..+++++.+||.+||++|
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 999876 899999998776 7778889999844211 1122222221 11111 12246789999999999976
Q ss_pred CCCHHHHH
Q 018489 316 RPEMDEVV 323 (355)
Q Consensus 316 Rps~~ell 323 (355)
|+.|++
T Consensus 324 --sa~e~l 329 (336)
T 2vuw_A 324 --SATDLL 329 (336)
T ss_dssp --SHHHHH
T ss_pred --CHHHHH
Confidence 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=254.44 Aligned_cols=191 Identities=17% Similarity=0.143 Sum_probs=133.3
Q ss_pred ccccccceEEEEE--EECCceeEEEEeecCCCCC-ccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCcccccc
Q 018489 57 VIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGH-RTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 57 ~lg~G~~~~Vy~~--~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
.++.|+++.+..+ ...|+.+++|++....... ........-.+.|.+|+++|+++ .|+||+++++++.+....
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~--- 317 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG--- 317 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE---
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE---
Confidence 3456666665554 3478999999997654332 33344455567799999999999 799999999999887766
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
||||||++|++|.+++.. ..++++. +|+.||+.||.|+|++||+||||||+|||++.+|.+|
T Consensus 318 -------------yLVMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vK 379 (569)
T 4azs_A 318 -------------WLVMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHAR 379 (569)
T ss_dssp -------------EEEEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEE
T ss_pred -------------EEEEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEE
Confidence 559999999999999954 4567664 5889999999999999999999999999999999999
Q ss_pred EeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCC
Q 018489 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~ 269 (355)
|+|||+|+............+||+.|+|||++.+. +..++|+|++|++++.+.++.
T Consensus 380 L~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 380 LIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred EeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 99999998665555555556799999999999875 567899999999988765553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-28 Score=231.77 Aligned_cols=191 Identities=16% Similarity=0.211 Sum_probs=143.5
Q ss_pred eeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcccccc
Q 018489 53 VIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQ 132 (355)
Q Consensus 53 ~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~~ 132 (355)
...+.||+|+||.||++...+..+++|........ ..........+.+.+|++++++++||||+++..+....+..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~--- 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYR-DERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK--- 414 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTS-CHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT---
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEeccccc-chhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc---
Confidence 45679999999999999889999999987543221 22223334466789999999999999999544443333333
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEE
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~ 212 (355)
++||||+++++|.+++.. ++.++.|++.+|.|||++||+||||||+|||++. .++
T Consensus 415 -------------~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~k 469 (540)
T 3en9_A 415 -------------RIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLY 469 (540)
T ss_dssp -------------EEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEE
T ss_pred -------------EEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEE
Confidence 679999999999999843 5689999999999999999999999999999998 999
Q ss_pred EeeccccccccCCCCC-------CCCCCCcccccCCcccCC--CCCCCcchhHHHHHHHHHHHhCCCCC
Q 018489 213 IADFGVARVEASNPND-------MTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPY 272 (355)
Q Consensus 213 L~Dfg~a~~~~~~~~~-------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~lltg~~p~ 272 (355)
|+|||+++........ .....||+.|+|||++.. ..|+...|+|+..+-..+.+.++.+|
T Consensus 470 L~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 470 IIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp ECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9999999865432111 123468999999999987 56777889999888888877776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-24 Score=189.94 Aligned_cols=154 Identities=15% Similarity=0.077 Sum_probs=113.2
Q ss_pred CCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccH---------HHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTE---------AEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
...|.+.+.||+|+||.||+|.+ +++.||+|+++......... ......+..+.+|+.+++.++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 34455669999999999999987 58899999996433211100 011123556889999999998 4 55
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+.+++.. +..++||||++|++|.+ +. . .....++.|++.+|.+||+.|++|+||
T Consensus 166 v~~~~~~-----------------~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDl 219 (282)
T 1zar_A 166 VPKVYAW-----------------EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDL 219 (282)
T ss_dssp SCCEEEE-----------------ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCeEEec-----------------cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCC
Confidence 5554321 12367999999999987 41 1 234579999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN 245 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~ 245 (355)
||+||+++ ++.++|+|||.+... ..+.|||.+.
T Consensus 220 kp~NILl~-~~~vkl~DFG~a~~~-------------~~~~a~e~l~ 252 (282)
T 1zar_A 220 SQYNVLVS-EEGIWIIDFPQSVEV-------------GEEGWREILE 252 (282)
T ss_dssp STTSEEEE-TTEEEECCCTTCEET-------------TSTTHHHHHH
T ss_pred CHHHEEEE-CCcEEEEECCCCeEC-------------CCCCHHHHHH
Confidence 99999999 999999999999632 2356777764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.9e-20 Score=162.63 Aligned_cols=146 Identities=17% Similarity=0.124 Sum_probs=106.7
Q ss_pred CcceeecccccccceEEEEEEE--CCce--eEEEEeecCCCCCccH---------------HHHHHHHHHHHHHHHHHhh
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHD--VAVKLLDWGEEGHRTE---------------AEIAALRSAFTQEVAVWHK 110 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~--vavK~~~~~~~~~~~~---------------~~~~~~~~~~~~E~~~l~~ 110 (355)
.-|.+.+.||+|+||.||+|.+ +|+. ||||+++......... .........+.+|+.++..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3478999999999999999976 8888 9999985432111100 0012233457889999999
Q ss_pred CCCCcc--ceeeeeccCCcccccccccccccCCCCceEEEEEecCC-C----CHHHHHHhhccccccHHHHHHHHHHHHH
Q 018489 111 LDHPNV--TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG-G----ALKTYLIKNRRRKLAFKVVVQLALDLAR 183 (355)
Q Consensus 111 l~h~~I--v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~~~~~~~i~~qi~~ 183 (355)
+.|+++ ..+++. . ..++||||+.+ | +|.++... .++..+..++.|++.
T Consensus 127 l~~~~i~~p~~~~~----~----------------~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~ 181 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----M----------------KNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVE 181 (258)
T ss_dssp HHHTTCCCCCEEEE----E----------------TTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHH
T ss_pred HHhCCCCCCeEEEc----C----------------CCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHH
Confidence 987764 333321 1 12679999942 3 67665421 345567889999999
Q ss_pred HHHHHH-hCCccccCCCCCcEEEcCCCcEEEeeccccccc
Q 018489 184 GLSYLH-SQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222 (355)
Q Consensus 184 al~~LH-~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~ 222 (355)
+|.+|| +.|++|+||||+|||++. .++|+|||.|...
T Consensus 182 ~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 182 NVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999 999999999999999988 9999999999643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.8e-18 Score=156.45 Aligned_cols=143 Identities=18% Similarity=0.155 Sum_probs=99.3
Q ss_pred cceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCc-------------cHHHHHHHHHHHHHHHHHHhhCCCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHR-------------TEAEIAALRSAFTQEVAVWHKLDHPNV 116 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~-------------~~~~~~~~~~~~~~E~~~l~~l~h~~I 116 (355)
-|++.+.||.|++|.||+|.+ +|+.||||+++....... ........+-...+|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 489999999999999999975 689999999864321110 011111222223456666666644333
Q ss_pred c--eeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCcc
Q 018489 117 T--KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIV 194 (355)
Q Consensus 117 v--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~ 194 (355)
. ..++. ...+|||||++|.+|..+. .......++.|++.+|.+||+.|++
T Consensus 176 ~vp~p~~~--------------------~~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIV 227 (397)
T 4gyi_A 176 PVPEPIAQ--------------------SRHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLI 227 (397)
T ss_dssp SCCCEEEE--------------------ETTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred CCCeeeec--------------------cCceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCc
Confidence 2 11111 1126799999998886543 1123457889999999999999999
Q ss_pred ccCCCCCcEEEcCCC----------cEEEeecccccc
Q 018489 195 HRDVKTENMLLDKNR----------TVKIADFGVARV 221 (355)
Q Consensus 195 H~di~p~Nili~~~~----------~v~L~Dfg~a~~ 221 (355)
||||||.|||+++++ .++++||+.+..
T Consensus 228 HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 228 HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 999999999998776 389999998863
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=8e-13 Score=114.66 Aligned_cols=139 Identities=13% Similarity=0.070 Sum_probs=104.6
Q ss_pred CcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeeccCCcc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSE 128 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~ 128 (355)
..|++...++.|+.+.||++...+..+++|+......... ..+.+|..+++.+ .+..+.+++++....+.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~---------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT---------YDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTST---------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCH---------HHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 3688999999999999999987889999999864211111 1266788888888 45667778777654333
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh------------------
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS------------------ 190 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~------------------ 190 (355)
.++||||++|.+|.+... +......++.++..+|+.||+
T Consensus 85 ----------------~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~ 141 (263)
T 3tm0_A 85 ----------------SNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE 141 (263)
T ss_dssp ----------------EEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHH
T ss_pred ----------------eEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHH
Confidence 367999999999976531 112234678899999999998
Q ss_pred -----------------------------------------CCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 191 -----------------------------------------QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 191 -----------------------------------------~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
..++|||++|.||++++++.+.|+||+.+.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999875556699999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=1e-10 Score=100.95 Aligned_cols=132 Identities=17% Similarity=0.123 Sum_probs=89.9
Q ss_pred cceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc--cceeeeeccCCc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSS 127 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~~~~~ 127 (355)
.|.+....+.|..+.||++.. +|..+++|+...... ..+.+|+.+++.+.+.+ +.+++.+....+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~------------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~ 88 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------------NELQDEAARLSWLATTGVPCAAVLDVVTEAG 88 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcccc------------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence 455554445667799999865 467899999754311 12567888888884434 445676654433
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC---------------
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--------------- 192 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--------------- 192 (355)
. .++||||++|.+|. . .. .+ ...++.++..+|+.||+..
T Consensus 89 ~----------------~~~v~e~i~G~~l~--~--~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~ 142 (264)
T 1nd4_A 89 R----------------DWLLLGEVPGQDLL--S--SH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIE 142 (264)
T ss_dssp C----------------EEEEEECCSSEETT--T--SC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHH
T ss_pred C----------------CEEEEEecCCcccC--c--Cc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence 2 36799999998884 2 11 11 1245667777777777643
Q ss_pred -------------------------------------------ccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 193 -------------------------------------------IVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 193 -------------------------------------------i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
++|+|++|.||++++++.+.|+||+.+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 143 RARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876656799999986
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=2e-10 Score=104.23 Aligned_cols=144 Identities=14% Similarity=0.176 Sum_probs=103.5
Q ss_pred eeecccccccceEEEEEEECCceeEEEEee--cCCCCCccHHHHHHHHHHHHHHHHHHhhCCC--CccceeeeeccCCcc
Q 018489 53 VIKSVIARGTFGTVHRGLYDGHDVAVKLLD--WGEEGHRTEAEIAALRSAFTQEVAVWHKLDH--PNVTKFIGATMGSSE 128 (355)
Q Consensus 53 ~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~~~~~~~~~~~ 128 (355)
.-.+.|+.|.++.||++...+..+++|+.. ..... .....+.+|..+++.+.. ..+.+++.++.+...
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~--------~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~ 112 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL--------PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV 112 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC------------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC--------CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc
Confidence 345678999999999998888899999874 22110 012346779999988864 446677766554321
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh------------------
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS------------------ 190 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~------------------ 190 (355)
.+..++||||++|.++.+.. -..++......++.++..+|+.||+
T Consensus 113 -------------~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3dxp_A 113 -------------IGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYF 175 (359)
T ss_dssp -------------TSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHH
T ss_pred -------------cCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCch
Confidence 12346799999998875421 2346788888999999999999997
Q ss_pred ----------------------------------------CCccccCCCCCcEEEcCCCc--EEEeecccccc
Q 018489 191 ----------------------------------------QKIVHRDVKTENMLLDKNRT--VKIADFGVARV 221 (355)
Q Consensus 191 ----------------------------------------~~i~H~di~p~Nili~~~~~--v~L~Dfg~a~~ 221 (355)
.+++|||++|.||+++.++. +.|+||+.+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 176 QRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987754 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.99 E-value=5.3e-10 Score=98.98 Aligned_cols=185 Identities=21% Similarity=0.237 Sum_probs=116.6
Q ss_pred cccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCc--cceeeeeccCCcccccc
Q 018489 56 SVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN--VTKFIGATMGSSELHIQ 132 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~--Iv~~~~~~~~~~~~~~~ 132 (355)
+.++.|..+.||++. ..+++|+... . .....+.+|..+++.+ .+.. +..++.........
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~-------~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~--- 88 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH-------S----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY--- 88 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS-------H----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC---
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC-------c----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC---
Confidence 458999999999864 6799998631 1 1234577899999887 3333 23333332221110
Q ss_pred cccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh----------------------
Q 018489 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS---------------------- 190 (355)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~---------------------- 190 (355)
...++||++++|.+|.+... ..++......++.++...++.||+
T Consensus 89 ----------~~~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~ 154 (304)
T 3sg8_A 89 ----------QMSFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDN 154 (304)
T ss_dssp ----------SCSCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHH
T ss_pred ----------CcceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHH
Confidence 12367999999998876432 346777777888888888888885
Q ss_pred ------------------------------------CCccccCCCCCcEEEcC--CCcEEEeeccccccccCCCCCCCCC
Q 018489 191 ------------------------------------QKIVHRDVKTENMLLDK--NRTVKIADFGVARVEASNPNDMTGE 232 (355)
Q Consensus 191 ------------------------------------~~i~H~di~p~Nili~~--~~~v~L~Dfg~a~~~~~~~~~~~~~ 232 (355)
..++|+|++|.||+++. .+.+.++||+.+...... .+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~ 233 (304)
T 3sg8_A 155 KKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISL 233 (304)
T ss_dssp HHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTT
T ss_pred HHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHH
Confidence 13799999999999988 456789999998754321 111000
Q ss_pred CCcccccCCcccCC-----CCC---------CCcchhHHHHHHHHHHHhCCCCC
Q 018489 233 TGTLGYMAPEVLNG-----NPY---------NRKCDVYSFGICLWEIYCCDMPY 272 (355)
Q Consensus 233 ~~~~~y~aPE~~~~-----~~~---------~~~~DvwslG~il~~lltg~~p~ 272 (355)
.....-..|+.... +.. ....+.|+++.+++.+.+|..+|
T Consensus 234 ~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 234 MEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00000012222110 000 12368999999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=9.4e-07 Score=78.05 Aligned_cols=134 Identities=17% Similarity=0.171 Sum_probs=85.8
Q ss_pred ecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCC---ccceeeeeccCCccccc
Q 018489 55 KSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP---NVTKFIGATMGSSELHI 131 (355)
Q Consensus 55 ~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~Iv~~~~~~~~~~~~~~ 131 (355)
.+.++.|....||+. +..+++|+... . .....+.+|..+++.+.+. .+..++.+...
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~-------~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~------ 83 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS-------Q----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR------ 83 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS-------H----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC------
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC-------c----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc------
Confidence 345788888899987 78899998521 1 1234578899999998542 23444443321
Q ss_pred ccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh---------------------
Q 018489 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS--------------------- 190 (355)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~--------------------- 190 (355)
..+..+++|+|++|.++.+... ..++......++.++...|+.||+
T Consensus 84 ---------~~g~~~~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~ 150 (306)
T 3tdw_A 84 ---------SDGNPFVGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKIL 150 (306)
T ss_dssp ---------TTSCEEEEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHH
T ss_pred ---------CCCceEEEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHH
Confidence 1223468999999988876321 112333344444444444444443
Q ss_pred ---------------------------------------CCccccCCCCCcEEEcC---CCcE-EEeecccccc
Q 018489 191 ---------------------------------------QKIVHRDVKTENMLLDK---NRTV-KIADFGVARV 221 (355)
Q Consensus 191 ---------------------------------------~~i~H~di~p~Nili~~---~~~v-~L~Dfg~a~~ 221 (355)
..++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 151 LLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 24699999999999987 4554 7999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.3e-06 Score=75.62 Aligned_cols=129 Identities=18% Similarity=0.170 Sum_probs=85.7
Q ss_pred ccccce-EEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeeccCCcccccccc
Q 018489 59 ARGTFG-TVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSELHIQTE 134 (355)
Q Consensus 59 g~G~~~-~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~~~~~ 134 (355)
..|..+ .||+... .+..+++|+.... . ...+.+|...|+.+. +-.+.+++.+..+.+..
T Consensus 33 ~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~----- 95 (272)
T 4gkh_A 33 NVGQSGATIYRLYGKPNAPELFLKHGKGS------V------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA----- 95 (272)
T ss_dssp ECSSSSCEEEEEECCTTCCCEEEEEEETH------H------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE-----
T ss_pred cCCCcCCeEEEEEecCCCeEEEEEECCCC------C------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE-----
Confidence 344443 6887644 4568999987421 1 223667888888773 22355666655544333
Q ss_pred cccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh------------------------
Q 018489 135 NGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS------------------------ 190 (355)
Q Consensus 135 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~------------------------ 190 (355)
++||++++|.++.+..... ......+..++...|+.||.
T Consensus 96 -----------~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (272)
T 4gkh_A 96 -----------WLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMN 158 (272)
T ss_dssp -----------EEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHH
T ss_pred -----------EEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHH
Confidence 6799999999888765321 11223456667777777774
Q ss_pred ----------------------------------CCccccCCCCCcEEEcCCCcEEEeecccccc
Q 018489 191 ----------------------------------QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (355)
Q Consensus 191 ----------------------------------~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~ 221 (355)
..++|||+++.||+++.++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 159 NGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1278999999999998877777999998863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=2.9e-06 Score=76.55 Aligned_cols=31 Identities=16% Similarity=0.318 Sum_probs=26.1
Q ss_pred hCCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 190 ~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 3469999999999999864457899999886
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.19 E-value=3.4e-05 Score=63.26 Aligned_cols=140 Identities=11% Similarity=0.096 Sum_probs=96.1
Q ss_pred CHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCC
Q 018489 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234 (355)
Q Consensus 156 sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~ 234 (355)
+|.+++.. .+.++++.++|.++.|.+.+|..+-. +.-...=+.|..|++..+|.|.+.+ ..+. ..
T Consensus 34 SL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~ 99 (229)
T 2yle_A 34 SLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG 99 (229)
T ss_dssp EHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred cHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence 79998864 57789999999999999999887721 2222344567999999999998874 2111 11
Q ss_pred cccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhc---
Q 018489 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDA--- 311 (355)
Q Consensus 235 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--- 311 (355)
...+.|||... ...+.+.=|||||+++|..+--.+| ...+..+|+.|.+||..|..-
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~~~d 159 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANTVEA 159 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTCCC-
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhcccc
Confidence 23466888764 3346788999999999988654433 234566899999999999765
Q ss_pred ----------------------CCCCCCCHHHHHHHHHHh
Q 018489 312 ----------------------NPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 312 ----------------------~p~~Rps~~ell~~l~~~ 329 (355)
.+..|.++++|++.-..-
T Consensus 160 ~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~h 199 (229)
T 2yle_A 160 DGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAH 199 (229)
T ss_dssp -------------------CCSCCCCCCSHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCcCCHHHHHHHHHhh
Confidence 245788999988766543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=5.8e-05 Score=67.30 Aligned_cols=30 Identities=27% Similarity=0.450 Sum_probs=27.5
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.+++|||+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=8.2e-05 Score=68.00 Aligned_cols=31 Identities=19% Similarity=0.360 Sum_probs=26.1
Q ss_pred hCCccccCCCCCcEEEcCCCcEEEeecccccc
Q 018489 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (355)
Q Consensus 190 ~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~ 221 (355)
...++|||++|.||+++.+ .+.++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 3579999999999999765 489999987763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=9.3e-05 Score=65.21 Aligned_cols=77 Identities=19% Similarity=0.116 Sum_probs=53.8
Q ss_pred eeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC---CCccceeeeeccCCccc
Q 018489 53 VIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD---HPNVTKFIGATMGSSEL 129 (355)
Q Consensus 53 ~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~ 129 (355)
.-.+.|+.|....+|+...++..+++|+.... . ...+..|...|+.+. ...+.+++.+....+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g-- 104 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERS------Y------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQG-- 104 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGG------G------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS--
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCcc------c------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC--
Confidence 34567899999999999878889999997521 1 234677888887772 245666766554332
Q ss_pred ccccccccccCCCCceEEEEEecCCCCH
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGAL 157 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL 157 (355)
..++||||++|.++
T Consensus 105 --------------~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 105 --------------HSFLLLEALNKSKN 118 (312)
T ss_dssp --------------EEEEEEECCCCCCC
T ss_pred --------------ceEEEEEeccCCCC
Confidence 23679999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.79 E-value=8.9e-05 Score=65.04 Aligned_cols=29 Identities=28% Similarity=0.365 Sum_probs=25.1
Q ss_pred CccccCCCCCcEEEcCCCcEEEeecccccc
Q 018489 192 KIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (355)
Q Consensus 192 ~i~H~di~p~Nili~~~~~v~L~Dfg~a~~ 221 (355)
.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5677889999998863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00012 Score=63.86 Aligned_cols=55 Identities=16% Similarity=0.027 Sum_probs=39.4
Q ss_pred CCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 112 (355)
+.+..-.+.+|.|..+.||+... +|+.|++|+......... ..+..|...|+.+.
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~---------~~~~~Ea~~L~~L~ 69 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALD---------GLFRAEALGLDWLG 69 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCT---------THHHHHHHHHHHHT
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchh---------hHHHHHHHHHHHHH
Confidence 45566778899999999999964 689999998754332211 12567888888773
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.0007 Score=62.28 Aligned_cols=33 Identities=15% Similarity=0.348 Sum_probs=28.5
Q ss_pred HhCCccccCCCCCcEEEcCCCcEEEeeccccccc
Q 018489 189 HSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222 (355)
Q Consensus 189 H~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~ 222 (355)
+...++|||++|.||+++.++ +.++||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 456799999999999998776 999999988643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00079 Score=59.40 Aligned_cols=147 Identities=16% Similarity=0.169 Sum_probs=75.7
Q ss_pred eeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc--cceeeeeccCCcccc
Q 018489 53 VIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSSELH 130 (355)
Q Consensus 53 ~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~~~~~~~~ 130 (355)
.-.+.|+.|....+|+...++..+++|+...... . ..+..|+.++..+...+ +.+++... ++. ..
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~--~---------~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~-~~ 91 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE--K---------NDLPFFLGLMQHLAAKGLSCPLPLPRK-DGE-LL 91 (322)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC-----C---------CHHHHHHHHHHHHHHTTCCCCCBCCBT-TCC-SC
T ss_pred eEeeccCCCcccceEEEEeCCccEEEEEeCCCCC--H---------HHHHHHHHHHHHHHHCCCCCCcccCCC-CCC-EE
Confidence 3455677888899999977667899999854211 0 12345666666663222 22333211 111 10
Q ss_pred cccccccccCCCCceEEEEEecCCCCHHH-----------H---HHhh-cc--cc----c---cHHHHHH----------
Q 018489 131 IQTENGQVAMPSNICCVVVEYLPGGALKT-----------Y---LIKN-RR--RK----L---AFKVVVQ---------- 176 (355)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~sL~~-----------~---l~~~-~~--~~----~---~~~~~~~---------- 176 (355)
.. ..+..+++|+|++|.++.. . ++.. .. .. . .+...+.
T Consensus 92 ~~--------~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 92 GE--------LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp EE--------ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred EE--------ECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 00 0123477999998865311 0 1110 00 00 0 1111000
Q ss_pred --HHHHHHHHHHHHHh-------CCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 177 --LALDLARGLSYLHS-------QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 177 --i~~qi~~al~~LH~-------~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
+...+...+.++.. .+++|+|+++.||+++.++.+.++||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00113344455542 369999999999999877656799999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00093 Score=59.32 Aligned_cols=32 Identities=31% Similarity=0.459 Sum_probs=27.6
Q ss_pred CCccccCCCCCcEEEcCC----CcEEEeeccccccc
Q 018489 191 QKIVHRDVKTENMLLDKN----RTVKIADFGVARVE 222 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~----~~v~L~Dfg~a~~~ 222 (355)
..++|||+++.||+++.+ +.+.++||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 67999999988744
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00057 Score=61.69 Aligned_cols=28 Identities=18% Similarity=0.433 Sum_probs=24.1
Q ss_pred CccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 192 KIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 192 ~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
+++|+|+++.||+++.++ +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 589999999999997654 8999998876
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0029 Score=56.40 Aligned_cols=32 Identities=19% Similarity=0.412 Sum_probs=28.0
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeeccccccc
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~ 222 (355)
..++|+|+.+.||+++.++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998888999999887643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.005 Score=54.34 Aligned_cols=29 Identities=24% Similarity=0.266 Sum_probs=25.3
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeecccccc
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~ 221 (355)
..++|||+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4589999999999998 4 899999988763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0032 Score=58.46 Aligned_cols=59 Identities=12% Similarity=-0.000 Sum_probs=35.5
Q ss_pred ecccccccceEEEEEEECC--ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcc-ceeeeec
Q 018489 55 KSVIARGTFGTVHRGLYDG--HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV-TKFIGAT 123 (355)
Q Consensus 55 ~~~lg~G~~~~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~~~~~~ 123 (355)
.+.|+.|-...+|++...+ ..+++|+........ .+ -.+|..++..+...++ .++++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-id---------R~~E~~vl~~L~~~gl~P~ll~~~ 174 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-IN---------REREKKISCILYNKNIAKKIYVFF 174 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SC---------HHHHHHHHHHHTTSSSBCCEEEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cC---------HHHHHHHHHHHHhcCCCCCEEEEe
Confidence 4567788889999998765 889999874322111 11 1368888888855444 3455544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0021 Score=59.22 Aligned_cols=59 Identities=19% Similarity=0.160 Sum_probs=35.8
Q ss_pred eecccccccceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcc-ceeeeec
Q 018489 54 IKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV-TKFIGAT 123 (355)
Q Consensus 54 i~~~lg~G~~~~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~~~~~~ 123 (355)
-.+.|+.|....+|++... +..+++|+.... ... ..+.+|..++..+...++ .++++.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~-------~~li~E~~~l~~L~~~g~~P~l~~~~ 145 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETE-------SHLVAESVIFTLLSERHLGPKLYGIF 145 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCH-------HHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcH-------HHHHHHHHHHHHHHhCCCCCcEEEEe
Confidence 3456788888999998653 478999998321 110 113357777777733333 4455443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0026 Score=57.48 Aligned_cols=140 Identities=16% Similarity=0.254 Sum_probs=77.3
Q ss_pred CcceeecccccccceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcc-cee
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV-TKF 119 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~~ 119 (355)
+...+ +.|..|-...+|++... +..+++|+.-. .. .. .....+|..+++.+...++ .++
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~-~~-------~~~~~rE~~vl~~L~~~gv~P~l 119 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--IL-QG-------VDSLVLESVMFAILAERSLGPQL 119 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CC-------HHHHHHHHHHHHHHHHTTSSCCE
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--cc-ch-------HHHHHHHHHHHHHHHhcCCCCeE
Confidence 34443 45677888889988653 47899998621 10 01 1224478888877732222 445
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHH-----------H---HHhhc------cccc--cHHHHHHH
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT-----------Y---LIKNR------RRKL--AFKVVVQL 177 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~-----------~---l~~~~------~~~~--~~~~~~~i 177 (355)
++.+.. .+||||++|.+|.. + +.+-. .+.. -+..+.+|
T Consensus 120 l~~~~~--------------------g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w 179 (379)
T 3feg_A 120 YGVFPE--------------------GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERY 179 (379)
T ss_dssp EEEETT--------------------EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHH
T ss_pred EEEcCC--------------------ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHH
Confidence 554432 13899998755421 1 11000 1111 24555556
Q ss_pred HHHHHH-------------------HHHHHH----h----CCccccCCCCCcEEEcCC----CcEEEeeccccc
Q 018489 178 ALDLAR-------------------GLSYLH----S----QKIVHRDVKTENMLLDKN----RTVKIADFGVAR 220 (355)
Q Consensus 178 ~~qi~~-------------------al~~LH----~----~~i~H~di~p~Nili~~~----~~v~L~Dfg~a~ 220 (355)
..++-. .+.+|. . ..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 180 LKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 554422 223332 2 258999999999999876 789999999886
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.0027 Score=57.95 Aligned_cols=29 Identities=24% Similarity=0.495 Sum_probs=25.0
Q ss_pred ccccCCCCCcEEE------cCCCcEEEeecccccc
Q 018489 193 IVHRDVKTENMLL------DKNRTVKIADFGVARV 221 (355)
Q Consensus 193 i~H~di~p~Nili------~~~~~v~L~Dfg~a~~ 221 (355)
++|+|+.+.||++ +.+..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3467799999998863
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.05 E-value=0.059 Score=49.32 Aligned_cols=28 Identities=18% Similarity=0.519 Sum_probs=25.7
Q ss_pred CccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 192 KIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 192 ~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.++|+|+.+.||+ +.++.+.++||..+.
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCC
Confidence 4899999999999 788899999999886
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.65 E-value=1.1 Score=36.50 Aligned_cols=82 Identities=6% Similarity=0.057 Sum_probs=59.2
Q ss_pred ccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC
Q 018489 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG 246 (355)
Q Consensus 167 ~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~ 246 (355)
..++....++++.+|+....+++ .-+|--|+|+|++++.++.+++.-.|.-... +|.
T Consensus 76 k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~~~p~i~~RGik~~l-----------------~P~---- 132 (215)
T 4ann_A 76 KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRDGLPIAKTRGLQNVV-----------------DPL---- 132 (215)
T ss_dssp GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTTSCEEESCCEETTTB-----------------SCC----
T ss_pred HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCCCCEEEEEccCccCC-----------------CCC----
Confidence 45888999999999988774443 3467789999999999999999977764322 121
Q ss_pred CCCCCcchhHHHHHHHHHHHhCCCCC
Q 018489 247 NPYNRKCDVYSFGICLWEIYCCDMPY 272 (355)
Q Consensus 247 ~~~~~~~DvwslG~il~~lltg~~p~ 272 (355)
..+...=+-.+=+++..+++++..|
T Consensus 133 -~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 133 -PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp -CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred -CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 1222233445778899999998876
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.85 E-value=2.5 Score=34.53 Aligned_cols=82 Identities=12% Similarity=0.152 Sum_probs=57.7
Q ss_pred ccccHHHHHHHHHHHHHHHH-HHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC
Q 018489 167 RKLAFKVVVQLALDLARGLS-YLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN 245 (355)
Q Consensus 167 ~~~~~~~~~~i~~qi~~al~-~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~ 245 (355)
..++....++++.+|+.... ++ ..-+|--|+|+|++++.++.+++.-.|.-... +|..
T Consensus 80 ~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~l-----------------pP~e-- 138 (219)
T 4ano_A 80 RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRALEPFFLHVGVKESL-----------------PPDE-- 138 (219)
T ss_dssp HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTCCEEESCCEETTTB-----------------SSCS--
T ss_pred HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCCcEEEEEcCCcccC-----------------CCCC--
Confidence 35788899999999887666 44 34467788999999999999999988764322 2221
Q ss_pred CCCCCCcchhHHHHHHHHHHHhCCCCC
Q 018489 246 GNPYNRKCDVYSFGICLWEIYCCDMPY 272 (355)
Q Consensus 246 ~~~~~~~~DvwslG~il~~lltg~~p~ 272 (355)
.+...=+-++=+++..++.++..|
T Consensus 139 ---~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 139 ---WDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp ---CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred ---CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 122222334778888888888765
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=83.12 E-value=32 Score=32.73 Aligned_cols=45 Identities=24% Similarity=0.320 Sum_probs=31.8
Q ss_pred HHHHHHHHHHH--HHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 172 KVVVQLALDLA--RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 172 ~~~~~i~~qi~--~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.....++..++ +.+.|+= |+ ||=+++||||+.+|++.=+|||...
T Consensus 455 ~a~~nF~~S~A~ySvv~YIL--Gi--gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 455 EVMDTYVKSCAGYCVITYIL--GV--GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp HHHHHHHHHHHHHHHHHHHH--TC--CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred HHHHHHHHHHHHHhHhheee--ec--cCCCCcceeEcCCCCEeeeehHHhh
Confidence 34444444433 4444442 32 6999999999999999999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 355 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-80 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-79 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-75 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-71 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-70 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-69 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-69 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-67 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-67 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-66 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-65 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-65 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-64 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-63 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-63 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-62 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-62 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-58 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-57 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-57 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-56 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-54 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-54 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-54 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-50 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-50 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-49 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 1e-80
Identities = 86/298 (28%), Positives = 147/298 (49%), Gaps = 35/298 (11%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
DWEI ++ + I G+FGTV++G + G DVAVK+L A AF
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML-------NVTAPTPQQLQAFKN 53
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
EV V K H N+ F+G + +V ++ G +L +L
Sbjct: 54 EVGVLRKTRHVNILLFMGYSTA-----------------PQLAIVTQWCEGSSLYHHL-H 95
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV-- 221
K ++ +A A+G+ YLH++ I+HRD+K+ N+ L ++ TVKI DFG+A V
Sbjct: 96 IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155
Query: 222 EASNPNDMTGETGTLGYMAPEVL---NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278
S + +G++ +MAPEV+ + NPY+ + DVY+FGI L+E+ +PY +++
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215
Query: 279 EVTSAVVRQNLR----PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332
+ +V + ++ CP ++ +M C D+RP ++++ +E + S
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 8e-79
Identities = 78/290 (26%), Positives = 127/290 (43%), Gaps = 31/290 (10%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
W + +L + I +G FG V G Y G+ VAVK + AE + +
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMT------ 55
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+L H N+ + +G + +V EY+ G+L YL
Sbjct: 56 -----QLRHSNLVQLLGVIV---------------EEKGGLYIVTEYMAKGSLVDYLRSR 95
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
R L +++ +LD+ + YL VHRD+ N+L+ ++ K++DFG+ +
Sbjct: 96 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---E 152
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSA 283
+ + + APE L ++ K DV+SFGI LWEIY +PYP + +V
Sbjct: 153 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 212
Query: 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333
V + + + P CP ++ VMK CW + RP ++ LE I T +
Sbjct: 213 -VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 9e-75
Identities = 82/294 (27%), Positives = 130/294 (44%), Gaps = 31/294 (10%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
+WE+ L + + G FG V G Y VAVK L G A
Sbjct: 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD----------A 54
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
F E + +L H + + + T+ ++ EY+ G+L +
Sbjct: 55 FLAEANLMKQLQHQRLVRLYA---------VVTQEP--------IYIITEYMENGSLVDF 97
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L KL ++ +A +A G++++ + +HRD++ N+L+ + KIADFG+AR
Sbjct: 98 LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 221 -VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFS 278
+E + G + + APE +N + K DV+SFGI L EI +PYP ++
Sbjct: 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332
EV + R R P CP L +M+ CW P+ RP D + S+LE T+
Sbjct: 218 EVIQNLER-GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 1e-71
Identities = 87/303 (28%), Positives = 132/303 (43%), Gaps = 31/303 (10%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
+ WEI L ++ + +G FG V G + VA+K L G A
Sbjct: 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------A 58
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
F QE V KL H + + +V EY+ G+L +
Sbjct: 59 FLQEAQVMKKLRHEKLVQLYAVVSEEP-----------------IYIVTEYMSKGSLLDF 101
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L + L +V +A +A G++Y+ VHRD++ N+L+ +N K+ADFG+AR
Sbjct: 102 LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 161
Query: 221 -VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFS 278
+E + G + + APE + K DV+SFGI L E+ +PYP +
Sbjct: 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221
Query: 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMI 338
EV V R R P CP SL ++M +CW P++RP + + + LE TS
Sbjct: 222 EVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
Query: 339 PGD 341
PG+
Sbjct: 281 PGE 283
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 2e-70
Identities = 80/316 (25%), Positives = 125/316 (39%), Gaps = 56/316 (17%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRTEAEIAAL 97
WE L V+ G FG V VAVK+L E ++
Sbjct: 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK--------EKADSSE 83
Query: 98 RSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
R A E+ + +L H N+ +GA S +++ + EY G
Sbjct: 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYL----------------IFEYCCYGD 127
Query: 157 LKTYLIKNRRR---------------------KLAFKVVVQLALDLARGLSYLHSQKIVH 195
L YL R + L F+ ++ A +A+G+ +L + VH
Sbjct: 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187
Query: 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKC 253
RD+ N+L+ + VKI DFG+AR S+ N + + +MAPE L Y K
Sbjct: 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS 247
Query: 254 DVYSFGICLWEIYCCD-MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDAN 312
DV+S+GI LWEI+ PYP + +++ + + P + +M+ CW +
Sbjct: 248 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD 307
Query: 313 PDKRPEMDEVVSMLEA 328
KRP + S L
Sbjct: 308 SRKRPSFPNLTSFLGC 323
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 3e-69
Identities = 77/296 (26%), Positives = 133/296 (44%), Gaps = 36/296 (12%)
Query: 43 QDWEIEPSKLVIKSV-IARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAAL 97
+ ++ L+I + + G FG+V +G+Y DVA+K+L G E A
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------KAD 52
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
+E + H+LD+P + + IG + +V+E GG L
Sbjct: 53 TEEMMREAQIMHQLDNPYIVRLIGVCQAEA-----------------LMLVMEMAGGGPL 95
Query: 158 KTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
+L+ +R ++ V +L ++ G+ YL + VHRD+ N+LL KI+DFG
Sbjct: 96 HKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 154
Query: 218 VARVEASNPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYP 273
+++ ++ + T + L + APE +N ++ + DV+S+G+ +WE PY
Sbjct: 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214
Query: 274 DLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
+ EV + + Q R E P CP L +M CW + RP+ V + A
Sbjct: 215 KMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (551), Expect = 3e-69
Identities = 77/292 (26%), Positives = 131/292 (44%), Gaps = 29/292 (9%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALR 98
WE+E + + +K + G +G V+ G++ VAVK L E
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----------EDTMEV 57
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F +E AV ++ HPN+ + +G +I TE ++ G L
Sbjct: 58 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE----------------FMTYGNLL 101
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
YL + R++++ V++ +A ++ + YL + +HRD+ N L+ +N VK+ADFG+
Sbjct: 102 DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 161
Query: 219 AR-VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
+R + G + + APE L N ++ K DV++FG+ LWEI M
Sbjct: 162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221
Query: 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
++ ++ R E P CP + +M+ CW NP RP E+ E +
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 5e-68
Identities = 64/279 (22%), Positives = 116/279 (41%), Gaps = 31/279 (11%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ I G++G + DG + K L + A + EV + +L
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKEL-------DYGSMTEAEKQMLVSEVNLLREL 60
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ ++ + + + +V+EY GG L + + K + +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTL--------------YIVMEYCEGGDLASVITKGTKERQYL 106
Query: 172 --KVVVQLALDLARGLSYLHSQ-----KIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ V+++ L L H + ++HRD+K N+ LD + VK+ DFG+AR+
Sbjct: 107 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284
+ + GT YM+PE +N YN K D++S G L+E+ P+ S E+ +
Sbjct: 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 226
Query: 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVV 323
IP L ++ R + RP ++E++
Sbjct: 227 REGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-67
Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 31/286 (10%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
I+P L + G FG V G + +DVA+K++ G F +E
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----------FIEEA 50
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
V L H + + G + I + EY+ G L YL
Sbjct: 51 KVMMNLSHEKLVQLYGVCTKQRPIFI----------------ITEYMANGCLLNYLR-EM 93
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VEAS 224
R + + ++++ D+ + YL S++ +HRD+ N L++ VK++DFG++R V
Sbjct: 94 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVTSA 283
G + + PEVL + ++ K D+++FG+ +WEIY MPY + SE
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213
Query: 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
+ Q LR P + +M CW D+RP ++S + +
Sbjct: 214 IA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-67
Identities = 82/290 (28%), Positives = 132/290 (45%), Gaps = 36/290 (12%)
Query: 47 IEPSKLVIKS-VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
++ L ++ + G FGTV +G Y VAVK+L + EA AL+
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-------KNEANDPALKDEL 55
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E V +LD+P + + IG S +V+E G L YL
Sbjct: 56 LAEANVMQQLDNPYIVRMIGICEAES-----------------WMLVMEMAELGPLNKYL 98
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+NR + K +++L ++ G+ YL VHRD+ N+LL KI+DFG+++
Sbjct: 99 QQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 156
Query: 222 EASNPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 277
++ N +T + + APE +N ++ K DV+SFG+ +WE + PY +
Sbjct: 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216
Query: 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
SEVT A++ + R P CP + ++M CW + + RP V L
Sbjct: 217 SEVT-AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 3e-67
Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 29/285 (10%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
I+PS+L I G FG VH G + + VA+K + G F +E
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----------FIEEA 51
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
V KL HP + + G + + + + V E++ G L YL R
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQAPICL----------------VFEFMEHGCLSDYLRTQR 95
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
A + ++ + LD+ G++YL ++HRD+ N L+ +N+ +K++DFG+ R +
Sbjct: 96 GLFAA-ETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154
Query: 226 PNDMT-GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284
+ G + + +PEV + + Y+ K DV+SFG+ +WE++ + +
Sbjct: 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214
Query: 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
+ R PR + + +M CW P+ RP ++ L I
Sbjct: 215 ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-66
Identities = 78/292 (26%), Positives = 134/292 (45%), Gaps = 32/292 (10%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALR 98
D+EI+ ++ + I G FG VH+G+Y VA+K ++R
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--------NCTSDSVR 52
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F QE + DHP++ K IG + N +++E G L+
Sbjct: 53 EKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGELR 95
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
++ ++ R+ L ++ A L+ L+YL S++ VHRD+ N+L+ N VK+ DFG+
Sbjct: 96 SF-LQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154
Query: 219 AR-VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
+R +E S + + +MAPE +N + DV+ FG+C+WEI +
Sbjct: 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214
Query: 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
+ + R +P CP +L ++M +CW +P +RP E+ + L I
Sbjct: 215 NNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 4e-66
Identities = 70/282 (24%), Positives = 125/282 (44%), Gaps = 32/282 (11%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFT 102
W +E I + +G FG V+ +A+K+L + + E A +
Sbjct: 3 WALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQLR 54
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+EV + L HPN+ + G ++ +++ ++EY P G + L
Sbjct: 55 REVEIQSHLRHPNILRLYGYFHDATRVYL----------------ILEYAPLGTVYREL- 97
Query: 163 KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
+ K + +LA LSY HS++++HRD+K EN+LL +KIADFG +
Sbjct: 98 -QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-- 154
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
+ + T GTL Y+ PE++ G ++ K D++S G+ +E P+ ++ E
Sbjct: 155 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 214
Query: 283 AVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
+ R + P +++ R NP +RP + EV+
Sbjct: 215 RISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-65
Identities = 95/304 (31%), Positives = 140/304 (46%), Gaps = 37/304 (12%)
Query: 38 LKKQRQDWEIEPSKLVI--KSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRT 90
L + Q I PS L++ VI RG FG V+ G +D AVK L+
Sbjct: 13 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-------- 64
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
S F E + HPNV +G + VV+
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---------------RSEGSPLVVLP 109
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
Y+ G L+ + I+N K ++ L +A+G+ +L S+K VHRD+ N +LD+ T
Sbjct: 110 YMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT 168
Query: 211 VKIADFGVARV----EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
VK+ADFG+AR E + ++ TG + +MA E L + K DV+SFG+ LWE+
Sbjct: 169 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 228
Query: 267 C-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
PYPD++ ++T ++ Q R P CP L VM +CW + RP E+VS
Sbjct: 229 TRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
Query: 326 LEAI 329
+ AI
Sbjct: 288 ISAI 291
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (528), Expect = 1e-65
Identities = 82/324 (25%), Positives = 132/324 (40%), Gaps = 57/324 (17%)
Query: 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRT 90
L + E + + I G FG V + VAVK+L
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-------- 52
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
E A +++ F +E A+ + D+PN+ K +G + C++ E
Sbjct: 53 EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM----------------CLLFE 96
Query: 151 YLPGGALKTYLIKNRRR----------------------KLAFKVVVQLALDLARGLSYL 188
Y+ G L +L L+ + +A +A G++YL
Sbjct: 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156
Query: 189 HSQKIVHRDVKTENMLLDKNRTVKIADFGVARV--EASNPNDMTGETGTLGYMAPEVLNG 246
+K VHRD+ T N L+ +N VKIADFG++R A + + +M PE +
Sbjct: 157 SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216
Query: 247 NPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVM 305
N Y + DV+++G+ LWEI+ + PY ++ EV V N P CP L N+M
Sbjct: 217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPENCPLELYNLM 275
Query: 306 KRCWDANPDKRPEMDEVVSMLEAI 329
+ CW P RP + +L+ +
Sbjct: 276 RLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 4e-65
Identities = 76/292 (26%), Positives = 121/292 (41%), Gaps = 33/292 (11%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAALRSAF 101
I L + + G+FG V RG +D VAVK L + F
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD------DF 58
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+EV H LDH N+ + G + + +V E P G+L L
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVL-----------------TPPMKMVTELAPLGSLLDRL 101
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
K++ + + A+ +A G+ YL S++ +HRD+ N+LL VKI DFG+ R
Sbjct: 102 RKHQGH-FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160
Query: 222 EASNPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 277
N + + + APE L ++ D + FG+ LWE++ P+ L+
Sbjct: 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220
Query: 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
S++ + ++ R P CP + NVM +CW P+ RP + L
Sbjct: 221 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 8e-65
Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 34/277 (12%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G FG V++ A K++D E + + E+ +
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED---------YMVEIDILASC 66
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
DHPN+ K + A + L I ++E+ GGA+ +++ R L
Sbjct: 67 DHPNIVKLLDAFYYENNLWI----------------LIEFCAGGAVDAVMLE-LERPLTE 109
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
+ + L+YLH KI+HRD+K N+L + +K+ADFGV+
Sbjct: 110 SQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
Query: 232 ETGTLGYMAPEVL-----NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
GT +MAPEV+ PY+ K DV+S GI L E+ + P+ +L+ V + +
Sbjct: 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229
Query: 287 QN-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
P S+ + +K+C + N D R ++
Sbjct: 230 SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (520), Expect = 2e-64
Identities = 80/297 (26%), Positives = 136/297 (45%), Gaps = 37/297 (12%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALR 98
EI+ S + I+ VI G FG V G VA+K L R
Sbjct: 20 AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK--------SGYTEKQR 71
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F E ++ + DHPNV G S+ + I + E++ G+L
Sbjct: 72 RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI----------------ITEFMENGSLD 115
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
++L +N + +V + +A G+ YL VHRD+ N+L++ N K++DFG+
Sbjct: 116 SFLRQNDGQF-TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 219 ARVEASNPNDMT-----GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPY 272
+R + +D T G + + APE + + DV+S+GI +WE+ + PY
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234
Query: 273 PDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
D++ +V +A+ Q+ R P CPS+L +M CW + + RP+ ++V+ L+ +
Sbjct: 235 WDMTNQDVINAI-EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 7e-64
Identities = 80/314 (25%), Positives = 131/314 (41%), Gaps = 51/314 (16%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIA 95
WE ++L + G FG V VAVK+L H TE
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTE---- 69
Query: 96 ALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG 154
R A E+ V L +H N+ +GA + + EY
Sbjct: 70 --REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV----------------ITEYCCY 111
Query: 155 GALKTYLIKNR----------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198
G L +L + R L + ++ + +A+G+++L S+ +HRD+
Sbjct: 112 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171
Query: 199 KTENMLLDKNRTVKIADFGVARVEASNPNDM--TGETGTLGYMAPEVLNGNPYNRKCDVY 256
N+LL R KI DFG+AR ++ N + + +MAPE + Y + DV+
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 257 SFGICLWEIYCCDMP-YPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDK 315
S+GI LWE++ YP + ++++ R P P+ + ++MK CWDA+P K
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291
Query: 316 RPEMDEVVSMLEAI 329
RP ++V ++E
Sbjct: 292 RPTFKQIVQLIEKQ 305
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 8e-64
Identities = 69/294 (23%), Positives = 123/294 (41%), Gaps = 34/294 (11%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEIAALR 98
EI PS + + VI G FG V++G+ VA+K L R
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK--------AGYTEKQR 53
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F E + + H N+ + G + I + EY+ G
Sbjct: 54 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI----------------ITEYMENG-AL 96
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
++ + + + +V + +A G+ YL + VHRD+ N+L++ N K++DFG+
Sbjct: 97 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156
Query: 219 ARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
+RV +P +G + + APE ++ + DV+SFGI +WE+
Sbjct: 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216
Query: 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
+ + R P CPS++ +M +CW +RP+ ++VS+L+ +
Sbjct: 217 LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (514), Expect = 2e-63
Identities = 66/286 (23%), Positives = 110/286 (38%), Gaps = 34/286 (11%)
Query: 45 WEIEPSKL-VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
++ +P KL I G+FG V+ + + VA+K + + +
Sbjct: 9 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM------SYSGKQSNEKWQDI 62
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+EV KL HPN ++ G + + V+EY G A
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWL----------------VMEYCLGSASDLLE 106
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ ++ L + + +GL+YLHS ++HRDVK N+LL + VK+ DFG A +
Sbjct: 107 V--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 222 EASNPNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278
GT +MAPEV+ Y+ K DV+S GI E+ P +++
Sbjct: 165 M----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
Query: 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
+ + N + C P RP + ++
Sbjct: 221 SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 5e-63
Identities = 79/302 (26%), Positives = 134/302 (44%), Gaps = 43/302 (14%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAA 96
+WE+ K+ + + +G+FG V+ G+ VA+K ++ EA
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 65
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
R F E +V + + +V + +G + ++E + G
Sbjct: 66 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV----------------IMELMTRGD 109
Query: 157 LKTYLIKNRRR--------KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
LK+YL R + ++Q+A ++A G++YL++ K VHRD+ N ++ ++
Sbjct: 110 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169
Query: 209 RTVKIADFGVARV--EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
TVKI DFG+ R E + +M+PE L + DV+SFG+ LWEI
Sbjct: 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 267 CC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSM 325
+ PY LS +V V+ + P CP L +M+ CW NP RP E++S
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
Query: 326 LE 327
++
Sbjct: 289 IK 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 4e-62
Identities = 87/313 (27%), Positives = 135/313 (43%), Gaps = 52/313 (16%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTEAEI 94
WE+ +LV+ + G FG V G D VAVK+L
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--------SDAT 58
Query: 95 AALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLP 153
S E+ + + H N+ +GA L++ +VEY
Sbjct: 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV----------------IVEYAS 102
Query: 154 GGALKTYL--------------IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
G L+ YL N +L+ K +V A +ARG+ YL S+K +HRD+
Sbjct: 103 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162
Query: 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYS 257
N+L+ ++ +KIADFG+AR + +MAPE L Y + DV+S
Sbjct: 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222
Query: 258 FGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKR 316
FG+ LWEI+ PYP + E+ ++++ R + P C + L +M+ CW A P +R
Sbjct: 223 FGVLLWEIFTLGGSPYPGVPVEELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281
Query: 317 PEMDEVVSMLEAI 329
P ++V L+ I
Sbjct: 282 PTFKQLVEDLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 4e-62
Identities = 82/310 (26%), Positives = 127/310 (40%), Gaps = 46/310 (14%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRTEAEIAA 96
WE +L + + RG FG V VAVK+L + A +
Sbjct: 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-------KEGATHSE 59
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
R+ ++ + H H NV +GA P V+VE+ G
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGA---------------CTKPGGPLMVIVEFCKFGN 104
Query: 157 LKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202
L TYL R + L + ++ + +A+G+ +L S+K +HRD+ N
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164
Query: 203 MLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+LL + VKI DFG+AR +P+ + L +MAPE + Y + DV+SFG+
Sbjct: 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224
Query: 261 CLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEM 319
LWEI+ PYP + E +++ R P + M CW P +RP
Sbjct: 225 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 284
Query: 320 DEVVSMLEAI 329
E+V L +
Sbjct: 285 SELVEHLGNL 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-62
Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 42/302 (13%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
++ + + + VI G FG V + DG + + E + + F
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR------DFAG 59
Query: 104 EVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
E+ V KL HPN+ +GA L++ +EY P G L +L
Sbjct: 60 ELEVLCKLGHHPNIINLLGACEHRGYLYL----------------AIEYAPHGNLLDFLR 103
Query: 163 KN--------------RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
K+ L+ + ++ A D+ARG+ YL ++ +HRD+ N+L+ +N
Sbjct: 104 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163
Query: 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268
KIADFG++R + G + +MA E LN + Y DV+S+G+ LWEI
Sbjct: 164 YVAKIADFGLSRGQEVYVKKTMG-RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222
Query: 269 DM-PYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
PY ++ +E+ + Q R E P C + ++M++CW P +RP +++ L
Sbjct: 223 GGTPYCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
Query: 328 AI 329
+
Sbjct: 282 RM 283
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 7e-62
Identities = 92/323 (28%), Positives = 135/323 (41%), Gaps = 65/323 (20%)
Query: 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGH-RTEAEIAALRSAFTQEVAVWH 109
+V++ I +G FG V RG + G +VAVK+ EE EAEI
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTV----------- 52
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
L H N+ FI A + Q +V +Y G+L YL R +
Sbjct: 53 MLRHENILGFIAADNKDNGTWTQ------------LWLVSDYHEHGSLFDYL---NRYTV 97
Query: 170 AFKVVVQLALDLARGLSYLHSQ--------KIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ +++LAL A GL++LH + I HRD+K++N+L+ KN T IAD G+A
Sbjct: 98 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157
Query: 222 EASNPNDM----TGETGTLGYMAPEVLNGN------PYNRKCDVYSFGICLWEIYC---- 267
S + + GT YMAPEVL+ + ++ D+Y+ G+ WEI
Sbjct: 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217
Query: 268 -----------CDMPYPDLSFSEVTSAVVRQNLRPEIPRC-----CPSSLANVMKRCWDA 311
D+ D S E+ V Q LRP IP +A +M+ CW A
Sbjct: 218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277
Query: 312 NPDKRPEMDEVVSMLEAIDTSKG 334
N R + L + +G
Sbjct: 278 NGAARLTALRIKKTLSQLSQQEG 300
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 8e-62
Identities = 68/277 (24%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I RG+F TV++GL +VA L + + R F +E + L
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCEL-------QDRKLTKSERQRFKEEAEMLKGL 65
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ +F + + + +V E + G LKTYL R + +
Sbjct: 66 QHPNIVRFYDSWESTVK------------GKKCIVLVTELMTSGTLKTYL--KRFKVMKI 111
Query: 172 KVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLL-DKNRTVKIADFGVARVEASNPND 228
KV+ + +GL +LH++ I+HRD+K +N+ + +VKI D G+A + +
Sbjct: 112 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASF 169
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288
GT +MAPE+ Y+ DVY+FG+C+ E+ + PY + + V
Sbjct: 170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 228
Query: 289 LRP-EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
++P + + +++ C N D+R + ++++
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-61
Identities = 61/275 (22%), Positives = 119/275 (43%), Gaps = 31/275 (11%)
Query: 51 KLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108
K I +G GTV+ + G +VA++ ++ ++ + E+ V
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---------IINEILVM 71
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK 168
+ +PN+ ++ + + EL + V+EYL GG+L + + +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWV----------------VMEYLAGGSLTDVVTETCMDE 115
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228
+ + + + L +LHS +++HRD+K++N+LL + +VK+ DFG +
Sbjct: 116 ---GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288
+ GT +MAPEV+ Y K D++S GI E+ + PY + + +
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232
Query: 289 -LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
+ P + + + RC D + +KR E+
Sbjct: 233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-59
Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 32/277 (11%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ + G +G V VAVK++D E +E+ + L
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKML 60
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
+H NV KF G + ++ +EY GG L + + +
Sbjct: 61 NHENVVKFYGHRREGNIQYL----------------FLEYCSGGELFDRIEPDIG--MPE 102
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--M 229
+ L G+ YLH I HRD+K EN+LLD+ +KI+DFG+A V N + +
Sbjct: 103 PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162
Query: 230 TGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288
GTL Y+APE+L ++ DV+S GI L + ++P+ S S + ++
Sbjct: 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 222
Query: 289 -LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324
+ S+ ++ + NP R + ++
Sbjct: 223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 7e-59
Identities = 68/292 (23%), Positives = 135/292 (46%), Gaps = 36/292 (12%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEIAALRSA 100
++ ++ V+ G FGTV++GL+ VA+K L EA
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--------EATSPKANKE 57
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
E V +D+P+V + +G + S+ ++ + +P G L Y
Sbjct: 58 ILDEAYVMASVDNPHVCRLLGICLTSTV-----------------QLITQLMPFGCLLDY 100
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
+ +++ + ++ + +A+G++YL +++VHRD+ N+L+ + VKI DFG+A+
Sbjct: 101 VREHKDNI-GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159
Query: 221 VEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 277
+ + + G + +MA E + Y + DV+S+G+ +WE+ PY +
Sbjct: 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219
Query: 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
SE+ S+++ + R P C + +M +CW + D RP+ E++ +
Sbjct: 220 SEI-SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-58
Identities = 57/289 (19%), Positives = 110/289 (38%), Gaps = 30/289 (10%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
Q + P ++ G+F TV L + A+K+L+ +
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP------Y 54
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
T+E V +LDHP K +L+ + Y G L Y
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYF----------------GLSYAKNGELLKY 98
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
+ K ++ L YLH + I+HRD+K EN+LL+++ ++I DFG A+
Sbjct: 99 IRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK 156
Query: 221 VEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278
V + GT Y++PE+L + D+++ G ++++ P+ +
Sbjct: 157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 216
Query: 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327
+ ++ L + P +++++ + KR +E+
Sbjct: 217 LIFQKII--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 189 bits (480), Expect = 9e-58
Identities = 57/296 (19%), Positives = 109/296 (36%), Gaps = 37/296 (12%)
Query: 37 FLKKQRQDWEIEPSKL----VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRT 90
+ + Q EI+ + I + G FG VHR G++ A K + E +
Sbjct: 9 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK- 67
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
+E+ L HP + A +E+ + + E
Sbjct: 68 --------ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM----------------IYE 103
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--DKN 208
++ GG L + K++ V+ + +GL ++H VH D+K EN++ ++
Sbjct: 104 FMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS 162
Query: 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268
+K+ DFG+ + TGT + APEV G P D++S G+ + +
Sbjct: 163 NELKLIDFGLTA-HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
Query: 269 DMPYPDLSFSEVTSAVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
P+ + E V + + +++ A+P+ R + +
Sbjct: 222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 188 bits (479), Expect = 1e-57
Identities = 56/275 (20%), Positives = 103/275 (37%), Gaps = 33/275 (12%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G FG VHR + G K ++ + E+++ ++L
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---------VKNEISIMNQL 83
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HP + A E+ + ++E+L GG L I K++
Sbjct: 84 HHPKLINLHDAFEDKYEMVL----------------ILEFLSGGELFDR-IAAEDYKMSE 126
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR--TVKIADFGVARVEASNPNDM 229
V+ GL ++H IVH D+K EN++ + + +VKI DFG+A + +
Sbjct: 127 AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIV 185
Query: 230 TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNL 289
T T + APE+++ P D+++ G+ + + P+ E V R +
Sbjct: 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 245
Query: 290 RP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
+ + +K P KR + +
Sbjct: 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 186 bits (473), Expect = 1e-57
Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 30/280 (10%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
K ++ RG V R + AVK++D G + E+ LR A +EV + K+
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 112 -DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
HPN+ + ++ + V + + G L YL + L+
Sbjct: 67 SGHPNIIQLKDTYETNTFFFL----------------VFDLMKKGELFDYL--TEKVTLS 108
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
K ++ L + LH IVHRD+K EN+LLD + +K+ DFG + + +
Sbjct: 109 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLR 167
Query: 231 GETGTLGYMAPEVLNGNP------YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284
GT Y+APE++ + Y ++ D++S G+ ++ + P+ + +
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
Query: 285 VRQNLRPEIPRC--CPSSLANVMKRCWDANPDKRPEMDEV 322
+ N + P ++ +++ R P KR +E
Sbjct: 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-57
Identities = 65/322 (20%), Positives = 127/322 (39%), Gaps = 73/322 (22%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
E++ S + G G V + + G +A KL+ + A+R+ +
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--------PAIRNQIIR 53
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E+ V H+ + P + F GA E+ I +E++ GG+L L
Sbjct: 54 ELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGGSLDQVL-- 95
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
+ ++ +++ ++++ + +GL+YL + KI+HRDVK N+L++ +K+ DFGV+
Sbjct: 96 KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-- 153
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY---------- 272
+ GT YM+PE L G Y+ + D++S G+ L E+ P
Sbjct: 154 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213
Query: 273 --------------------------------PDLSFSEVTSAVVRQNLRPEIPRCCPSS 300
P ++ E+ +V +
Sbjct: 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 273
Query: 301 LANVMKRCWDANPDKRPEMDEV 322
+ + +C NP +R ++ ++
Sbjct: 274 FQDFVNKCLIKNPAERADLKQL 295
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 185 bits (470), Expect = 3e-57
Identities = 71/293 (24%), Positives = 121/293 (41%), Gaps = 32/293 (10%)
Query: 49 PSKL----VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT 102
PS L + ++ G VH L DVAVK+L A + F
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL------RADLARDPSFYLRFR 55
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+E L+HP + + + +V+EY+ G L+ +
Sbjct: 56 REAQNAAALNHPAIVAVYDTGEAETPAG------------PLPYIVMEYVDGVTLRDIV- 102
Query: 163 KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
+ + K +++ D + L++ H I+HRDVK N+++ VK+ DFG+AR
Sbjct: 103 -HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161
Query: 223 ASNPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
A + N +T GT Y++PE G+ + + DVYS G L+E+ + P+ S
Sbjct: 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
Query: 280 VTSAVVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPE-MDEVVSMLEAI 329
V VR++ P + L V+ + NP+ R + E+ + L +
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-56
Identities = 66/267 (24%), Positives = 110/267 (41%), Gaps = 27/267 (10%)
Query: 53 VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
++ ++ +G+FG V + A+K L + E ++ +
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE-----CTMVEKRVLSLA 59
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+HP +T L E YL GG L ++ K
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVME----------------YLNGGDLMYHI--QSCHKFD 101
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
A ++ GL +LHS+ IV+RD+K +N+LLDK+ +KIADFG+ +
Sbjct: 102 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 161
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 290
GT Y+APE+L G YN D +SFG+ L+E+ P+ E+ ++ N
Sbjct: 162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-- 219
Query: 291 PEIPRCCPSSLANVMKRCWDANPDKRP 317
P PR +++ + + P+KR
Sbjct: 220 PFYPRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (456), Expect = 1e-54
Identities = 60/276 (21%), Positives = 120/276 (43%), Gaps = 34/276 (12%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ V+ G F V VA+K + + + + E+AV HK+
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIA--------KKALEGKEGSMENEIAVLHKI 64
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ L++ +++ + GG L +++
Sbjct: 65 KHPNIVALDDIYESGGHLYL----------------IMQLVSGGELFDRIVEKGF--YTE 106
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNPND 228
+ +L + + YLH IVHRD+K EN+L D++ + I+DFG++++E +
Sbjct: 107 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SV 165
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQN 288
++ GT GY+APEVL PY++ D +S G+ + + C P+ D + +++ +++
Sbjct: 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 225
Query: 289 LRPEIPRC--CPSSLANVMKRCWDANPDKRPEMDEV 322
+ P S + ++ + +P+KR ++
Sbjct: 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-54
Identities = 55/281 (19%), Positives = 103/281 (36%), Gaps = 37/281 (13%)
Query: 53 VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V V+ G G V + A+K+L + + E+ A
Sbjct: 15 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRA---------- 61
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
P++ + + +V+E L GG L + + +
Sbjct: 62 SQCPHIVRIVDVYENLYAGR------------KCLLIVMECLDGGELFSRIQDRGDQAFT 109
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK---NRTVKIADFGVARVEASNPN 227
+ ++ + + YLHS I HRDVK EN+L N +K+ DFG A+ S+ +
Sbjct: 110 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
T T Y+APEVL Y++ CD++S G+ ++ + C P+ ++ + +
Sbjct: 170 LTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228
Query: 288 NLRPEI------PRCCPSSLANVMKRCWDANPDKRPEMDEV 322
+ + +++ P +R + E
Sbjct: 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-54
Identities = 49/278 (17%), Positives = 96/278 (34%), Gaps = 34/278 (12%)
Query: 51 KLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108
K +I + RG FG VHR K + +E+++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----------LVKKEISIL 55
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK 168
+ H N+ + EL + + E++ G + I +
Sbjct: 56 NIARHRNILHLHESFESMEELVM----------------IFEFISGLDIFER-INTSAFE 98
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD--KNRTVKIADFGVARVEASNP 226
L + +V + L +LHS I H D++ EN++ ++ T+KI +FG AR +
Sbjct: 99 LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPG 157
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
++ Y APEV + + D++S G ++ + P+ + ++ ++
Sbjct: 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
Query: 287 QNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
E + + + R R E
Sbjct: 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-52
Identities = 56/277 (20%), Positives = 107/277 (38%), Gaps = 30/277 (10%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ G F V + G A K + + + R +EV++ ++
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREVSILKEI 70
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPNV +++ + ++E + GG L + + L
Sbjct: 71 QHPNVITLHEVYENKTDVIL----------------ILELVAGGELFDF--LAEKESLTE 112
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN----RTVKIADFGVARVEASNPN 227
+ + + G+ YLHS +I H D+K EN++L +KI DFG+A + N
Sbjct: 113 EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGN 171
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
+ GT ++APE++N P + D++S G+ + + P+ + E + V
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231
Query: 288 N--LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
N E + + ++R +P KR + +
Sbjct: 232 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 170 bits (432), Expect = 4e-51
Identities = 67/266 (25%), Positives = 118/266 (44%), Gaps = 31/266 (11%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G+FG VH ++G A+K+L + E + +
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVL------KKEIVVRLKQVEHTNDERLMLSIV 61
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HP + + G + ++ ++++Y+ GG L + L K++R
Sbjct: 62 THPFIIRMWGTFQDAQQI----------------FMIMDYIEGGELFSLLRKSQRFP--N 103
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
V A ++ L YLHS+ I++RD+K EN+LLDKN +KI DFG A+ P+
Sbjct: 104 PVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYT 160
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 291
GT Y+APEV++ PYN+ D +SFGI ++E+ P+ D + + ++
Sbjct: 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--EL 218
Query: 292 EIPRCCPSSLANVMKRCWDANPDKRP 317
P + +++ R + +R
Sbjct: 219 RFPPFFNEDVKDLLSRLITRDLSQRL 244
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 170 bits (432), Expect = 1e-50
Identities = 60/268 (22%), Positives = 111/268 (41%), Gaps = 27/268 (10%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ +I RG FG V+ G A+K LD + + E AL +++
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLD-KKRIKMKQGETLALN--ERIMLSLVSTG 64
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
D P + A +L +++ + GG L +L ++
Sbjct: 65 DCPFIVCMSYAFHTPDKLSF----------------ILDLMNGGDLHYHLSQHGVFSE-- 106
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
+ A ++ GL ++H++ +V+RD+K N+LLD++ V+I+D G+A +
Sbjct: 107 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD--FSKKKPHA 164
Query: 232 ETGTLGYMAPEVL-NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR-QNL 289
GT GYMAPEVL G Y+ D +S G L+++ P+ + +
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
Query: 290 RPEIPRCCPSSLANVMKRCWDANPDKRP 317
E+P L ++++ + ++R
Sbjct: 225 AVELPDSFSPELRSLLEGLLQRDVNRRL 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 2e-50
Identities = 59/299 (19%), Positives = 103/299 (34%), Gaps = 46/299 (15%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ I G+FG ++ G + G +VA+KL + + E + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYK-----------MM 59
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
I + ++ +V+E L L RK +
Sbjct: 60 QGGVGIPTIRWCGAEGDYNV---------------MVMELLGPSLE--DLFNFCSRKFSL 102
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENML---LDKNRTVKIADFGVARVEASNPND 228
K V+ LA + + Y+HS+ +HRDVK +N L K V I DFG+A+
Sbjct: 103 KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162
Query: 229 -------MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281
TGT Y + G +R+ D+ S G L +P+ L +
Sbjct: 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222
Query: 282 SAVVRQNLR------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334
R + + + + PS A + C D +P+ + + + +G
Sbjct: 223 QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 9e-50
Identities = 56/279 (20%), Positives = 110/279 (39%), Gaps = 36/279 (12%)
Query: 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
S+ + ++ G FG+V+ G+ D VA+K ++ + ++ + EV +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEVVL 60
Query: 108 WHKLD--HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
K+ V + + + +++E I
Sbjct: 61 LKKVSSGFSGVIRLLD----------------WFERPDSFVLILERPEPVQDLFDFIT-E 103
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR-TVKIADFGVARVEAS 224
R L ++ + + + H+ ++HRD+K EN+L+D NR +K+ DFG +
Sbjct: 104 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--L 161
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
T GT Y PE + + Y R V+S GI L+++ C D+P+
Sbjct: 162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEE 215
Query: 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
++R + + S ++++ C P RP +E+
Sbjct: 216 IIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-49
Identities = 66/266 (24%), Positives = 107/266 (40%), Gaps = 28/266 (10%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
++ +GTFG V G A+K+L + E E V
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA------HTVTESRVLQNT 62
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HP +T A L E Y GG L +L +R R
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVME----------------YANGGELFFHL--SRERVFTE 104
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
+ ++ L YLHS+ +V+RD+K EN++LDK+ +KI DFG+ + S+ M
Sbjct: 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 291
GT Y+APEVL N Y R D + G+ ++E+ C +P+ + + ++ +
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EI 222
Query: 292 EIPRCCPSSLANVMKRCWDANPDKRP 317
PR +++ +P +R
Sbjct: 223 RFPRTLSPEAKSLLAGLLKKDPKQRL 248
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 163 bits (414), Expect = 9e-49
Identities = 47/296 (15%), Positives = 93/296 (31%), Gaps = 48/296 (16%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ I G+FG + G L + VA+K + + E + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEY--------RTYKLLAGC 60
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
+ G +V++ L G L+ RK +
Sbjct: 61 TGIPNVYYFGQE------------------GLHNVLVIDLL--GPSLEDLLDLCGRKFSV 100
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK-----NRTVKIADFGVARV----- 221
K V A + + +H + +V+RD+K +N L+ + + + DFG+ +
Sbjct: 101 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160
Query: 222 --EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
+ + +GT YM+ G +R+ D+ + G +P+ L +
Sbjct: 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220
Query: 280 VTSAVVR------QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329
R E+ P M + D P+ D + + +
Sbjct: 221 NKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-45
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 51/295 (17%)
Query: 57 VIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
+ G F TV++ VA+K + GHR+EA+ R+ +E+ + +L HP
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRT-ALREIKLLQELSHP 60
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N+ + A S + + V +++ +IK+ L +
Sbjct: 61 NIIGLLDAFGHKSNISL----------------VFDFMETDLE--VIIKDNSLVLTPSHI 102
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
L +GL YLH I+HRD+K N+LLD+N +K+ADFG+A+ S T +
Sbjct: 103 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 162
Query: 235 TLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP-- 291
T Y APE+L G Y D+++ G L E+ P S + + + P
Sbjct: 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 222
Query: 292 ------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
I L ++++ + NP R +
Sbjct: 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-45
Identities = 68/300 (22%), Positives = 113/300 (37%), Gaps = 51/300 (17%)
Query: 54 IKSVIARGTFGTVHRG---LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ I G +G V + G VA+K + R + + + +EVAV
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVAVLRH 63
Query: 111 L---DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
L +HPNV + S +V E++ TYL K
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRE-----------TKLTLVFEHVDQDLT-TYLDKVPEP 111
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
+ + + + L RGL +LHS ++VHRD+K +N+L+ + +K+ADFG+AR+ S
Sbjct: 112 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQM 170
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
+T TL Y APEVL + Y D++S G E++ + S + ++
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230
Query: 288 NLRP-------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
P + +++ +C NP KR
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-44
Identities = 62/315 (19%), Positives = 115/315 (36%), Gaps = 59/315 (18%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
Q +++ P + S I G +G V + VA+K + E
Sbjct: 2 QVFDVGP-RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS--------PFEHQTYCQR 52
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
+E+ + + H N+ + ++ +V +L G L
Sbjct: 53 TLREIKILLRFRHENIIGINDIIRAPTIEQMK------------DVYLVTHLMGADLYKL 100
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L + + L+ + + RGL Y+HS ++HRD+K N+LL+ +KI DFG+AR
Sbjct: 101 L---KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157
Query: 221 VEASNPNDMTGET---GTLGYMAPEVL-NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
V + + T T Y APE++ N Y + D++S G L E+ +P
Sbjct: 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217
Query: 277 FSEVTSAVVRQNLRP-----------------------------EIPRCCPSSLANVMKR 307
+ + + ++ P + S +++ +
Sbjct: 218 YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 277
Query: 308 CWDANPDKRPEMDEV 322
NP KR E+++
Sbjct: 278 MLTFNPHKRIEVEQA 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-44
Identities = 62/299 (20%), Positives = 116/299 (38%), Gaps = 54/299 (18%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I GT+G V++ G VA+K + R + E + S +E+++ +L
Sbjct: 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKEL 58
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
+HPN+ K + ++L++ V LK ++ + +
Sbjct: 59 NHPNIVKLLDVIHTENKLYL-----------------VFEFLHQDLKKFMDASALTGIPL 101
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
++ L +GL++ HS +++HRD+K +N+L++ +K+ADFG+AR T
Sbjct: 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 232 ETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 290
E TL Y APE+L G Y D++S G E+ +P S + + R
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 291 P---------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
P ++ +++ + +P+KR
Sbjct: 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (377), Expect = 2e-43
Identities = 64/298 (21%), Positives = 113/298 (37%), Gaps = 54/298 (18%)
Query: 54 IKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
I GT+G V++ G A+K + R E E + S +E+++ +L
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIREISILKELK 58
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
H N+ K L +V E+L L+ L
Sbjct: 59 HSNIVKLYDVIHTKKRL----------------VLVFEHLDQDLK--KLLDVCEGGLESV 100
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
L L G++Y H ++++HRD+K +N+L+++ +KIADFG+AR T E
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 233 TGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 291
TL Y AP+VL G+ Y+ D++S G E+ +P +S ++ + R P
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP 220
Query: 292 ---------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
+ S +++ + +P++R +
Sbjct: 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (380), Expect = 4e-43
Identities = 62/310 (20%), Positives = 120/310 (38%), Gaps = 45/310 (14%)
Query: 24 ANATATPIGKASN----FLKKQRQD----WEIEPSKLV------IKSVIARGTFGTVHRG 69
NA A G FL K ++D WE + G+FG V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 70 LY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127
+ G+ A+K+LD + + E E + ++ P + K +
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIE------HTLNEKRILQAVNFPFLVKLEFSFK--- 111
Query: 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSY 187
++ +V+EY+ GG + ++L R + + A + Y
Sbjct: 112 -------------DNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEY 156
Query: 188 LHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN 247
LHS +++RD+K EN+L+D+ +++ DFG A+ + G +APE++
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP---EALAPEIILSK 213
Query: 248 PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKR 307
YN+ D ++ G+ ++E+ P+ ++ +V + P S L ++++
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRN 271
Query: 308 CWDANPDKRP 317
+ KR
Sbjct: 272 LLQVDLTKRF 281
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-42
Identities = 61/310 (19%), Positives = 113/310 (36%), Gaps = 54/310 (17%)
Query: 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
SK + I +GTFG V + + G VA+K + E E +E+ +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-------LMENEKEGFPITALREIKI 62
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
L H NV I + + + + +V ++ N
Sbjct: 63 LQLLKHENVVNLIEICRTKASPYNRCKGS--------IYLVFDFCEHDLAGLLS--NVLV 112
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV----EA 223
K + ++ L GL Y+H KI+HRD+K N+L+ ++ +K+ADFG+AR +
Sbjct: 113 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 172
Query: 224 SNPNDMTGETGTLGYMAPEVL-NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
S PN T TL Y PE+L Y D++ G + E++ + +
Sbjct: 173 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232
Query: 283 AVVR-----------------------------QNLRPEIPRCCPSSLA-NVMKRCWDAN 312
+ + + ++ + A +++ + +
Sbjct: 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292
Query: 313 PDKRPEMDEV 322
P +R + D+
Sbjct: 293 PAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-40
Identities = 60/314 (19%), Positives = 113/314 (35%), Gaps = 57/314 (18%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALR 98
+ WE+ + + G +G V G VA+K L +
Sbjct: 10 TKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-------YRPFQSELFA 61
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
+E+ + + H NV + L T+ +V+ ++ G
Sbjct: 62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD----------FYLVMPFM--GTDL 109
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
L+K+ + L + L + +GL Y+H+ I+HRD+K N+ ++++ +KI DFG+
Sbjct: 110 GKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167
Query: 219 ARVEASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
AR ++MTG T Y APEV LN Y + D++S G + E+ +
Sbjct: 168 AR---QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224
Query: 278 SEVTSAVVRQNLRP-----------------------------EIPRCCPSSLANVMKRC 308
+ +++ P I N++++
Sbjct: 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284
Query: 309 WDANPDKRPEMDEV 322
+ ++R E
Sbjct: 285 LVLDAEQRVTAGEA 298
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-40
Identities = 57/297 (19%), Positives = 97/297 (32%), Gaps = 54/297 (18%)
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
VI G+FG V++ G VA+K + + +E+ + KLDH
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------------FKNRELQIMRKLDHC 73
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL-IKNRRRKLAFKV 173
N+ + S E +V++Y+P + ++ L
Sbjct: 74 NIVRLRYFFYSSGEK----------KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN-RTVKIADFGVARVEASNPNDMTGE 232
V L R L+Y+HS I HRD+K +N+LLD + +K+ DFG A+ +++
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR------ 286
+ Y DV+S G L E+ +P S + +++
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 287 ---------------------QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
P + R + P R E
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 6e-40
Identities = 61/275 (22%), Positives = 117/275 (42%), Gaps = 34/275 (12%)
Query: 54 IKSVIARGTFGTVHRGL-----YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108
+ V+ G +G V G A+K+L T + A E V
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-----KATIVQKAKTTEHTRTERQVL 82
Query: 109 HKLDH-PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
+ P + A ++LH+ ++Y+ GG L T+L ++R
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLI----------------LDYINGGELFTHL--SQRE 124
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
+ V ++ L +LH I++RD+K EN+LLD N V + DFG+++ ++
Sbjct: 125 RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
Query: 228 DMT-GETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284
+ GT+ YMAP+++ G +++ D +S G+ ++E+ P+ + +
Sbjct: 185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244
Query: 285 VRQNLR--PEIPRCCPSSLANVMKRCWDANPDKRP 317
R+ L+ P P+ + ++++R +P KR
Sbjct: 245 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRL 279
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-37
Identities = 58/300 (19%), Positives = 110/300 (36%), Gaps = 56/300 (18%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I GT+GTV + VA+K + R + + + S+ +E+ + +L
Sbjct: 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICLLKEL 58
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
H N+ + +L + E + L
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS------------------CNGDLDP 100
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
++V L +GL + HS+ ++HRD+K +N+L+++N +K+A+FG+AR +
Sbjct: 101 EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
Query: 232 ETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMP-YPDLSFSEVTSAVVRQNL 289
E TL Y P+VL G Y+ D++S G E+ P +P + + R
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 290 RP---------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
P + ++ ++++ NP +R +E
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-35
Identities = 67/313 (21%), Positives = 115/313 (36%), Gaps = 57/313 (18%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRS 99
+ WE+ P + S + G +G+V G VAVK L +
Sbjct: 11 KTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQSIIHAK 62
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
+E+ + + H NV + + L +V +L G L
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN-----------DVYLVTHLMGADLNN 111
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+ +KL V L + RGL Y+HS I+HRD+K N+ ++++ +KI DFG+A
Sbjct: 112 I---VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168
Query: 220 RVEASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278
R ++MTG T Y APE+ LN YN+ D++S G + E+ +P
Sbjct: 169 R---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
Query: 279 EVTSAVVRQNLRP-----------------------------EIPRCCPSSLANVMKRCW 309
+ ++R P + +++++
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285
Query: 310 DANPDKRPEMDEV 322
+ DKR +
Sbjct: 286 VLDSDKRITAAQA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (313), Expect = 1e-33
Identities = 49/333 (14%), Positives = 100/333 (30%), Gaps = 81/333 (24%)
Query: 39 KKQRQDWEIEPSKL--------VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGH 88
+ R+ W+ E + + + RG + V + + V VK+L
Sbjct: 16 HRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK------ 69
Query: 89 RTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
+ +E+ + L PN+ +
Sbjct: 70 ------PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP--------------AL 109
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD- 206
V E++ K + L + ++ + L Y HS I+HRDVK N+++D
Sbjct: 110 VFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 164
Query: 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
++R +++ D+G+A + + + PE+L Y+ D++S G L +
Sbjct: 165 EHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 223
Query: 266 YCCDMPYP--------------------------------DLSFSEVTSAVVRQNLR--- 290
P+ D F+++ R+
Sbjct: 224 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283
Query: 291 -PEIPRCCPSSLANVMKRCWDANPDKRPEMDEV 322
E + + + + R E
Sbjct: 284 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 9e-32
Identities = 57/311 (18%), Positives = 108/311 (34%), Gaps = 65/311 (20%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I G G V +VA+K L + +E+ + +
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCV 73
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
+H N+ + L + +V+E + + ++ ++++
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQD----------VYLVMELMDANLCQVIQMELDHERMSY 123
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
L + G+ +LHS I+HRD+K N+++ + T+KI DFG+AR MT
Sbjct: 124 -----LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTP 177
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLRP 291
T Y APEV+ G Y D++S G + E+ + +P + + + V+ Q P
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 292 ----------------------------------------EIPRCCPSSLANVMKRCWDA 311
E + S +++ +
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 312 NPDKRPEMDEV 322
+P KR +D+
Sbjct: 298 DPAKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (276), Expect = 4e-28
Identities = 58/268 (21%), Positives = 107/268 (39%), Gaps = 24/268 (8%)
Query: 50 SKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
++ ++ + G F TV + + VA+K++ + A E+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----------VYTEAAEDEIKL 62
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
+++ + TK MG++ + ++ P+ + V+V + G L + K R
Sbjct: 63 LQRVNDADNTKEDS--MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 120
Query: 168 KLAFKVVVQLALDLARGLSYLH-SQKIVHRDVKTENMLLDKNRT------VKIADFGVAR 220
+ V Q++ L GL Y+H I+H D+K EN+L++ + +KIAD G A
Sbjct: 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180
Query: 221 VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280
+ + T Y +PEVL G P+ D++S ++E+ D +
Sbjct: 181 WYDEHYTNSIQ---TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237
Query: 281 TSAVVRQNLRPEIPRCCPSSLANVMKRC 308
T E+ PS L K
Sbjct: 238 TKDDDHIAQIIELLGELPSYLLRNGKYT 265
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.4 bits (200), Expect = 6e-19
Identities = 28/212 (13%), Positives = 59/212 (27%), Gaps = 37/212 (17%)
Query: 53 VIKSVIARGTFGTVHRG-LYDGHDVAVKLLDWGEEGHRTEAEIAALRSA-FTQEVAVWHK 110
I ++ G V + VK G + E F+ +
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ + K G + V + L + ++
Sbjct: 63 NEFRALQKLQGL--------------------AVPKVY-AWEGNAVLMELIDAKELYRVR 101
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ ++ + ++ + + IVH D+ N+L+ + + I DF + VE
Sbjct: 102 VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS-VEVGEEGWRE 159
Query: 231 GETGTLGYMAPEVLN-----GNPYNRKCDVYS 257
+ +V N Y + D+ S
Sbjct: 160 -------ILERDVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 355 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.73 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.68 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.56 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.31 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.85 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-56 Score=390.52 Aligned_cols=266 Identities=28% Similarity=0.539 Sum_probs=228.0
Q ss_pred ccccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
+-.+|++..++|++.+.||+|+||.||+|.+ +++.||||+++..... .+.+.+|+.++++++||||++
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----------~~~~~~E~~il~~l~HpnIv~ 77 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----------VEEFLKEAAVMKEIKHPNLVQ 77 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----------HHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----------HHHHHHHHHHHHhCCCCCEec
Confidence 4456999999999999999999999999976 5788999998643321 234789999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++.+.+.. +++|||+++|+|.+++.......+++..++.|+.||+.||.|||++||+||||
T Consensus 78 ~~~~~~~~~~~----------------~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 141 (287)
T d1opja_ 78 LLGVCTREPPF----------------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 141 (287)
T ss_dssp EEEEECSSSSC----------------EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred CCccEeeCCee----------------EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCcc
Confidence 99999876655 56999999999999997766778999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~ 277 (355)
||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 142 Kp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~ 221 (287)
T d1opja_ 142 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221 (287)
T ss_dssp SGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch
Confidence 99999999999999999999986544322 22334578899999999999999999999999999999997766654444
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
.......+.....+..+..+++++.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus 222 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 4445555666677788889999999999999999999999999999999987543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=385.92 Aligned_cols=265 Identities=32% Similarity=0.613 Sum_probs=218.1
Q ss_pred ccceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 122 (355)
.+|++..++|++.+.||+|+||.||+|+..+ .||||+++........ .+.|.+|+.++++++||||++++++
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~~~~~ 72 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ-------LQAFKNEVGVLRKTRHVNILLFMGY 72 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTH-------HHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHH-------HHHHHHHHHHHHhCCCCCEeeeeEE
Confidence 3689999999999999999999999998665 5999999654433211 3458899999999999999999997
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
...+ . .++||||+++|+|.+++... ...+++..+..|+.|++.||+|||++||+||||||+|
T Consensus 73 ~~~~-~----------------~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~N 134 (276)
T d1uwha_ 73 STAP-Q----------------LAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNN 134 (276)
T ss_dssp ECSS-S----------------CEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred Eecc-E----------------EEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHH
Confidence 6432 2 36799999999999998643 4569999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 018489 203 MLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~lltg~~p~~~~~~ 277 (355)
||++.++.+||+|||+|....... .......||+.|+|||++.+ ..++.++||||||+++|+|+||+.||.+.+.
T Consensus 135 iLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 135 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp EEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 999999999999999997654322 22344578999999999865 3578999999999999999999999998776
Q ss_pred hHHHHHHHhcCCC-C---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 278 SEVTSAVVRQNLR-P---EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 278 ~~~~~~~~~~~~~-~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
............. + ..+..+|+++.+||.+||+.||.+|||+.+|++.|+.+..+.
T Consensus 215 ~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 215 RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp HHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 6555555444332 2 345678999999999999999999999999999999998653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-56 Score=386.37 Aligned_cols=254 Identities=28% Similarity=0.498 Sum_probs=206.4
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +|+.||+|++...... ... .+.+.+|++++++++||||+++++++.+.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 75 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDR 75 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC---HHH----HHHHHHHHHHTTSCCCTTBCCEEEEEEC-
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC---HHH----HHHHHHHHHHHHHCCCCCEeeEEEEEEeC
Confidence 36899999999999999999976 5889999999754432 111 35578999999999999999999988653
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--ccccccHHHHHHHHHHHHHHHHHHHhCC-----ccccCCC
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQK-----IVHRDVK 199 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~LH~~~-----i~H~di~ 199 (355)
.. +.+++||||+++|+|.+++.+. ....+++..++.++.||+.||.|||++| |+|||||
T Consensus 76 ~~--------------~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiK 141 (269)
T d2java1 76 TN--------------TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 141 (269)
T ss_dssp -----------------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CC
T ss_pred CC--------------CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCc
Confidence 32 2237799999999999998653 3457999999999999999999999976 9999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
|+|||++.++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+
T Consensus 142 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~ 221 (269)
T d2java1 142 PANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 221 (269)
T ss_dssp GGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred hhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH
Confidence 99999999999999999999876554444455789999999999999999999999999999999999999999988888
Q ss_pred HHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 280 VTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....+..... ..++..+|+++.+||.+||+.||.+|||+.||++
T Consensus 222 ~~~~i~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 222 LAGKIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 7777666544 3567789999999999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=382.61 Aligned_cols=247 Identities=28% Similarity=0.473 Sum_probs=215.5
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||+|++.... .......+.+.+|+.+++.++||||+++++++.+.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ------LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH------ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence 6899999999999999999976 57899999985321 111223456889999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~----------------~ivmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~ 141 (263)
T d2j4za1 80 RV----------------YLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS 141 (263)
T ss_dssp EE----------------EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred EE----------------EEEEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecC
Confidence 55 569999999999999954 457999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.+||+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 142 ~~~~kl~DFG~a~~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 219 (263)
T d2j4za1 142 AGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219 (263)
T ss_dssp TSCEEECCCCSCSCCCCC--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred CCCEeecccceeeecCCC--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999999999999754432 233467999999999999999999999999999999999999999998888877777664
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
. ..++..+|+++.+||.+||+.||.+|||++|+++
T Consensus 220 ~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 E--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 4 3567789999999999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=387.45 Aligned_cols=247 Identities=25% Similarity=0.453 Sum_probs=216.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+|++.+.||+|+||.||+|.+ +|+.||||+++...... .+.+.+|+.++++++||||+++++++...+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---------KELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---------HHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 5799999999999999999975 58999999997544321 245789999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 91 ~~----------------~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 151 (293)
T d1yhwa1 91 EL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151 (293)
T ss_dssp EE----------------EEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EE----------------EEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC
Confidence 55 569999999999998743 46999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+...
T Consensus 152 ~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 231 (293)
T d1yhwa1 152 DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231 (293)
T ss_dssp TCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH
T ss_pred CCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Confidence 99999999999987655555556678999999999999999999999999999999999999999988877766666554
Q ss_pred C-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 N-LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
. .....+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3 334556778999999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=383.75 Aligned_cols=265 Identities=30% Similarity=0.576 Sum_probs=225.2
Q ss_pred ccccceecCCcceeecccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
..++|++..++|++.+.||+|+||.||+|.+. +..||||+++..... .+.+.+|+.++++++||||+++
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----------~~~~~~E~~~l~~l~HpnIv~~ 73 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----------PDAFLAEANLMKQLQHQRLVRL 73 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----------HHHHHHHHHHHHhCCCCCEeEE
Confidence 45679999999999999999999999999875 578999999643321 2348899999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++... . .++||||+++|+|.+++.......+++..++.|+.||+.||.|||++||+|||||
T Consensus 74 ~g~~~~~-~----------------~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiK 136 (272)
T d1qpca_ 74 YAVVTQE-P----------------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136 (272)
T ss_dssp EEEECSS-S----------------CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred EeeeccC-C----------------eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccc
Confidence 9987532 2 2679999999999998866666679999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCC-CCCCCCCh
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSF 277 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~-~p~~~~~~ 277 (355)
|+|||++.++.+||+|||+|+...... .......++..|+|||.+.+..++.++||||||+++|+|+||. .||...+.
T Consensus 137 p~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~ 216 (272)
T d1qpca_ 137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (272)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred hhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998654432 2233456889999999999888999999999999999999965 55555555
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
.+....+ .....+..+..+++++.+||.+||+.||++|||+++|++.|+.+.++.
T Consensus 217 ~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 217 PEVIQNL-ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp HHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHH-HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 5555444 445666778889999999999999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=375.90 Aligned_cols=258 Identities=31% Similarity=0.640 Sum_probs=211.9
Q ss_pred ecCCcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
+++++|++.+.||+|+||.||+|.+ +++.||||+++..... .+.+.+|+.++++++||||+++++++..
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----------~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYGVCLE 71 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----------HHHHHHHHHHHHhcCCCCcccccceecc
Confidence 5678999999999999999999987 4678999998643321 2347899999999999999999999887
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. ++||||+++|+|.+++.. ....+++..++.|+.|++.||.|||+++|+||||||+||++
T Consensus 72 ~~~~----------------~lv~E~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill 134 (263)
T d1sm2a_ 72 QAPI----------------CLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 134 (263)
T ss_dssp SSSC----------------EEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE
T ss_pred CCce----------------EEEEEecCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee
Confidence 6655 569999999999998864 34568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCC-CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~ 283 (355)
+.++.+||+|||+++....... ......||..|+|||.+.+..++.++||||||+++|+|+| |..||...+..+....
T Consensus 135 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~ 214 (263)
T d1sm2a_ 135 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214 (263)
T ss_dssp CGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH
T ss_pred cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 9999999999999976543322 2233568899999999999999999999999999999999 5666766666666655
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
+.. ......+..+++++.++|.+||+.||.+|||+++|++.|+++..+
T Consensus 215 i~~-~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 215 IST-GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHh-cCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 444 555667788899999999999999999999999999999999776
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-55 Score=379.81 Aligned_cols=249 Identities=26% Similarity=0.377 Sum_probs=206.5
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||||+++..... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--------hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence 6899999999999999999976 5889999999654321 11245789999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++|+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 77 ~~----------------~ivmEy~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~ 138 (271)
T d1nvra_ 77 IQ----------------YLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 138 (271)
T ss_dssp EE----------------EEEEECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred ee----------------EEEEeccCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECC
Confidence 55 66999999999999984 4567999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH-
Q 018489 208 NRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA- 283 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~- 283 (355)
++.+||+|||+|....... .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........
T Consensus 139 ~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~ 218 (271)
T d1nvra_ 139 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 218 (271)
T ss_dssp TCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH
T ss_pred CCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 9999999999998654322 22345679999999999988765 5789999999999999999999987655443333
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.............+++++.+||.+||+.||.+|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 219 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 33333333334568999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=380.66 Aligned_cols=249 Identities=27% Similarity=0.441 Sum_probs=212.9
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
+.|++++.||+|+||.||+|.+ ++..||+|+++...... .+.+.+|++++++++||||+++++++.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---------LEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG---------GGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH---------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 4689999999999999999976 57899999997543321 234778999999999999999999988765
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 83 ~~----------------~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~ 145 (288)
T d2jfla1 83 NL----------------WILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 145 (288)
T ss_dssp EE----------------EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred eE----------------EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC
Confidence 54 6699999999999987543 456999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccC-----CCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
++.+||+|||+|..............||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 146 ~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~ 225 (288)
T d2jfla1 146 DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL 225 (288)
T ss_dssp TSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH
T ss_pred CCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 99999999999975443323334567999999999984 4567899999999999999999999999988888887
Q ss_pred HHHhcCCC-CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNLR-PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+...... ...+..+++++.+||.+||+.||.+|||+.|+++
T Consensus 226 ~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 226 KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 77765432 3345678999999999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-55 Score=382.12 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=213.8
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
.+++|++++.||+|+||.||+|.+ +++.||||++..... ......+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 79 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI------IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc------cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE
Confidence 347899999999999999999976 588999999853211 111223558899999999999999999999887
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. ++||||++||+|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 80 ~~~~----------------~ivmEy~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll 141 (288)
T d1uu3a_ 80 DEKL----------------YFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 141 (288)
T ss_dssp SSEE----------------EEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCEE----------------EEEEEccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc
Confidence 6555 669999999999998854 4679999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
+.++.++|+|||+|....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 142 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~ 221 (288)
T d1uu3a_ 142 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK 221 (288)
T ss_dssp CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH
Confidence 999999999999998654322 223445799999999999999999999999999999999999999999888888877
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+.... ..++..+++++.+||.+||+.||.+|||++|+++
T Consensus 222 i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 222 IIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 76654 3577889999999999999999999999999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-54 Score=375.36 Aligned_cols=270 Identities=31% Similarity=0.529 Sum_probs=221.5
Q ss_pred ccccceecCCcceeecccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 41 ~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
.+++|++..++|++.+.||+|+||.||+|.+. +..||||+++..... .+.|.+|+.++++++||||+++
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----------~~~~~~E~~~l~~l~h~nIv~~ 77 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQEAQVMKKLRHEKLVQL 77 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----------HHHHHHHHHHHHhcccCCEeEE
Confidence 45678888899999999999999999999874 467999999654321 2348899999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++.+. .. ++||||+++|+|..++.......+++..++.++.||+.||+|||+.||+|||||
T Consensus 78 ~g~~~~~-~~----------------~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlK 140 (285)
T d1fmka3 78 YAVVSEE-PI----------------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 140 (285)
T ss_dssp EEEECSS-SC----------------EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecC-Ce----------------EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheeccccc
Confidence 9987542 23 569999999999999876666779999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCC-CCCCCh
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMP-YPDLSF 277 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p-~~~~~~ 277 (355)
|+||||+.++.+||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..| +.....
T Consensus 141 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~ 220 (285)
T d1fmka3 141 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 220 (285)
T ss_dssp GGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997553322 233345689999999999999999999999999999999996555 455555
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCCCCC
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGGGMI 338 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~~ 338 (355)
.+....+ ......+.+..+++++.++|.+||+.||++||++++|+++|+...++......
T Consensus 221 ~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~ 280 (285)
T d1fmka3 221 REVLDQV-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280 (285)
T ss_dssp HHHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred HHHHHHH-HhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCC
Confidence 5555444 44566678889999999999999999999999999999999998877554333
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=370.70 Aligned_cols=258 Identities=31% Similarity=0.617 Sum_probs=219.6
Q ss_pred ceecCCcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeecc
Q 018489 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (355)
Q Consensus 45 ~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 124 (355)
|++..++|++.+.||+|+||.||+|.++|+.||||+++.... .+.+.+|++++++++||||+++++++.
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~-----------~~~~~~E~~~l~~l~HpnIv~~~g~~~ 70 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLGVIV 70 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH-----------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 788999999999999999999999999999999999964321 244789999999999999999999876
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
+... ..++||||+++|+|.+++.......+++..+++|+.||+.||.|||+++++||||+|+||+
T Consensus 71 ~~~~---------------~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil 135 (262)
T d1byga_ 71 EEKG---------------GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 135 (262)
T ss_dssp CC-----------------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCC---------------cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhe
Confidence 4322 1267999999999999997665567999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018489 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283 (355)
Q Consensus 205 i~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~ 283 (355)
++.++.++|+|||.+...... .....++..|+|||.+.+..++.++||||||+++|+|+| |+.||...+..+....
T Consensus 136 ~~~~~~~kl~dfg~s~~~~~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~ 212 (262)
T d1byga_ 136 VSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 212 (262)
T ss_dssp ECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH
T ss_pred ecCCCCEeecccccceecCCC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 999999999999999754322 233467889999999998899999999999999999998 7899988877777666
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
+. ....++++..+++++.+||.+||+.||.+|||+.++++.|+.+++.
T Consensus 213 i~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 213 VE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HT-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH-cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 54 4566778888999999999999999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-54 Score=383.21 Aligned_cols=260 Identities=31% Similarity=0.545 Sum_probs=221.6
Q ss_pred cceecCCcceeecccccccceEEEEEEECC-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCc
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 115 (355)
.|++..++|++.+.||+|+||.||+|.+.+ ..||+|.+...... .....+.+|+.++.++ +|||
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~~Hpn 102 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--------SEREALMSELKMMTQLGSHEN 102 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCCTT
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--------HHHHHHHHHHHHHHHhcCCCc
Confidence 478888999999999999999999997632 25899988543221 1234578899999998 8999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc---------------------ccccHHHH
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---------------------RKLAFKVV 174 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------------~~~~~~~~ 174 (355)
|+++++++...+.. ++||||+++|+|.+++..... ..+++..+
T Consensus 103 Iv~l~~~~~~~~~~----------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 166 (325)
T d1rjba_ 103 IVNLLGACTLSGPI----------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 166 (325)
T ss_dssp BCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHH
T ss_pred EeEEEEEEeeCCeE----------------EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHH
Confidence 99999999876655 569999999999999965432 35899999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCc
Q 018489 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRK 252 (355)
Q Consensus 175 ~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~ 252 (355)
+.++.|++.||+|||++||+||||||+||+++.++.+||+|||+|+........ .....+|+.|+|||.+.+..++.+
T Consensus 167 ~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 246 (325)
T d1rjba_ 167 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246 (325)
T ss_dssp HHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc
Confidence 999999999999999999999999999999999999999999999765443322 233457899999999999999999
Q ss_pred chhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 018489 253 CDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLE 327 (355)
Q Consensus 253 ~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~ 327 (355)
+||||||+++|+|+| |..||.+.+.......++........+..+|+++.+||.+||+.||++|||++||++.|.
T Consensus 247 ~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred eeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 999999999999997 899999888777778888888888888999999999999999999999999999999885
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=366.64 Aligned_cols=255 Identities=27% Similarity=0.567 Sum_probs=220.9
Q ss_pred ecCCcceeecccccccceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
+++++|++.+.||+|+||.||+|++. +..||||+++..... .+.+.+|+.++++++||||+++++++.+
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~ 70 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----------EDEFIEEAKVMMNLSHEKLVQLYGVCTK 70 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----------HHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----------HHHHHHHHHHHHhcCCCceeeEEEEEee
Confidence 46789999999999999999999874 568999999754432 2347899999999999999999999886
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. ++||||+++|+|..++.. ....+++..+++|+.|+++||.|||++||+||||||+||++
T Consensus 71 ~~~~----------------~iv~Ey~~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill 133 (258)
T d1k2pa_ 71 QRPI----------------FIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 133 (258)
T ss_dssp SSSE----------------EEEEECCTTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE
T ss_pred CCce----------------EEEEEccCCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE
Confidence 6555 569999999999998754 34568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCC-CCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASN-PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~ 283 (355)
+.++.+||+|||++...... ........++..|+|||.+.+..++.++||||||+++|+|+| |+.||.+.+..+....
T Consensus 134 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~ 213 (258)
T d1k2pa_ 134 NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213 (258)
T ss_dssp CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH
T ss_pred cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH
Confidence 99999999999999754433 223334678899999999999999999999999999999998 8999999988877766
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
+.. ......+..+++++.+||.+||+.||++|||+++|++.|.++
T Consensus 214 i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 214 IAQ-GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHh-CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 654 456677888999999999999999999999999999988653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=379.44 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=219.2
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++++.||+|+||.||+|.+ +++.||||++++... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc------cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 347899999999999999999975 689999999963211 011123457789999999999999999999987
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.+ ++||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 77 ~~~~----------------~iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl 138 (337)
T d1o6la_ 77 HDRL----------------CFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138 (337)
T ss_dssp SSEE----------------EEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred cccc----------------ccceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe
Confidence 6665 569999999999999854 4679999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
+.+|.++|+|||+|.............+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+.
T Consensus 139 ~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~ 218 (337)
T d1o6la_ 139 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218 (337)
T ss_dssp CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh
Confidence 99999999999999866555555566789999999999999999999999999999999999999999999888887777
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 324 (355)
... ..++..+++++.+||.+||++||.+|++ ++++++
T Consensus 219 ~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 219 MEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 654 4578889999999999999999999994 788876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-53 Score=373.34 Aligned_cols=261 Identities=30% Similarity=0.584 Sum_probs=211.3
Q ss_pred eecCCcceeecccccccceEEEEEEEC--C---ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceee
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLYD--G---HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 120 (355)
++..++|++.+.||+|+||.||+|.+. + ..||||.+.... .. ...+.|.+|+.++++++||||++++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l~HpnIv~l~ 93 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY----TE----KQRRDFLSEASIMGQFDHPNVIHLE 93 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC----CH----HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc----CH----HHHHHHHHHHHHHHhCCCCCCccEE
Confidence 456689999999999999999999763 3 247888774322 11 1245688999999999999999999
Q ss_pred eeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 018489 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (355)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p 200 (355)
+++...+.. ++||||+++|+|.+++.. ....+++..++.|+.||+.||.|||++|++||||||
T Consensus 94 g~~~~~~~~----------------~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp 156 (299)
T d1jpaa_ 94 GVVTKSTPV----------------MIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAA 156 (299)
T ss_dssp EEECSSSSC----------------EEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEEeeCCEE----------------EEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCcccc
Confidence 998876655 569999999999998864 345699999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEeeccccccccCCCC-----CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 018489 201 ENMLLDKNRTVKIADFGVARVEASNPN-----DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPD 274 (355)
Q Consensus 201 ~Nili~~~~~v~L~Dfg~a~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~ 274 (355)
+|||++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|+|+| |..||.+
T Consensus 157 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 157 RNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp GGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 999999999999999999986543221 1122457889999999999999999999999999999998 8999999
Q ss_pred CChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 275 LSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
.+..+....+.. ......+..+++++.+||.+||+.||.+|||+.+|++.|+++..+
T Consensus 237 ~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 237 MTNQDVINAIEQ-DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 888777666544 455667788999999999999999999999999999999998765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-53 Score=377.42 Aligned_cols=248 Identities=23% Similarity=0.421 Sum_probs=200.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++.+.||+|+||.||+|.+ +++.||||++....... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--------KEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 6799999999999999999976 58899999997543221 1244778999999999999999999988765
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD- 206 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~- 206 (355)
.. ++||||++|++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||++.
T Consensus 81 ~~----------------~lvmE~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~ 142 (307)
T d1a06a_ 81 HL----------------YLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 142 (307)
T ss_dssp EE----------------EEEECCCCSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred EE----------------EEEEeccCCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecc
Confidence 55 66999999999999995 456799999999999999999999999999999999999995
Q ss_pred --CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 207 --KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 207 --~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
.++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 143 ~~~~~~vkl~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i 221 (307)
T d1a06a_ 143 LDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI 221 (307)
T ss_dssp SSTTCCEEECCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCceEEEeccceeEEccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5789999999999755432 2334467999999999999999999999999999999999999999998888888777
Q ss_pred HhcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....... .....+|+++.+||.+||+.||.+|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 222 LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 7765543 344678999999999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-53 Score=377.52 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=213.0
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+|++++.||+|+||.||+|.+ +++.||||+++...... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS------NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC------HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence 3599999999999999999975 57889999997544321 122455889999999999999999999988765
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+.+|+|..++. ...++++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 89 ~~----------------~iv~E~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 150 (309)
T d1u5ra_ 89 TA----------------WLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 150 (309)
T ss_dssp EE----------------EEEEECCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred EE----------------EEEEEecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECC
Confidence 55 66999999999876663 3467999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC---CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
++.+||+|||.+..... .....||+.|+|||++.+ +.++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 151 ~~~~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i 226 (309)
T d1u5ra_ 151 PGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226 (309)
T ss_dssp TTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CCCEEEeecccccccCC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999999999975432 234579999999999864 45889999999999999999999999998888888777
Q ss_pred HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 285 VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 285 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.........+..+|+++.+||.+||+.||.+|||++++++
T Consensus 227 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 7766665566678999999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=367.54 Aligned_cols=249 Identities=27% Similarity=0.495 Sum_probs=204.3
Q ss_pred ceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
|++.+.||+|+||+||+|.+ ++..||+|.+...... .. ..+.+.+|++++++++||||+++++++.....
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~---~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~- 82 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---KS----ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK- 82 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---HH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS-
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC---HH----HHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc-
Confidence 47888999999999999977 4778999998654321 11 14568899999999999999999998764211
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEEc-
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLD- 206 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~di~p~Nili~- 206 (355)
..+..++||||+++|+|.+++.+ ...+++..++.|+.||+.||.|||++| |+||||||+|||++
T Consensus 83 -----------~~~~~~ivmE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~ 149 (270)
T d1t4ha_ 83 -----------GKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 149 (270)
T ss_dssp -----------SCEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS
T ss_pred -----------cCCEEEEEEeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC
Confidence 12334789999999999999954 467999999999999999999999998 99999999999996
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH-HHHH
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT-SAVV 285 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~-~~~~ 285 (355)
.++.+||+|||++..... .......||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+....... ..+.
T Consensus 150 ~~~~~Kl~DFGla~~~~~--~~~~~~~GT~~Y~aPE~~~~~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~ 226 (270)
T d1t4ha_ 150 PTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 226 (270)
T ss_dssp TTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred CCCCEEEeecCcceeccC--CccCCcccCccccCHHHhCCC-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH
Confidence 578999999999975433 223346799999999999764 899999999999999999999999876554444 4444
Q ss_pred hcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.......++...++++.+||.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 333334556678999999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=381.13 Aligned_cols=258 Identities=26% Similarity=0.482 Sum_probs=210.0
Q ss_pred eecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeec
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 123 (355)
++..++|++.+.||+|+||+||+|.+ +++.||+|+++..... ..++.+.+|+.++++++||||+++++++
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 73 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--------AIRNQIIRELQVLHECNSPYIVGFYGAF 73 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--------THHHHHHHHGGGGGGCCCTTBCCEEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--------HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 56778999999999999999999976 5889999999754321 1134578999999999999999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCc
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTEN 202 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~di~p~N 202 (355)
.+.+.. ++||||++||+|.+++.+ ...+++..++.++.|++.||.|||++ ||+||||||+|
T Consensus 74 ~~~~~~----------------~iVmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~N 135 (322)
T d1s9ja_ 74 YSDGEI----------------SICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 135 (322)
T ss_dssp ECSSEE----------------EEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred EECCEE----------------EEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHH
Confidence 876655 669999999999999954 45699999999999999999999975 99999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
||++.++.+||+|||+|...... .....+||..|+|||++.+..++.++||||+||++|+|++|+.||.+.+......
T Consensus 136 ILl~~~~~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~ 213 (322)
T d1s9ja_ 136 ILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213 (322)
T ss_dssp EEECTTCCEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHH
T ss_pred eeECCCCCEEEeeCCCccccCCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99999999999999999854322 2234689999999999999999999999999999999999999997654322111
Q ss_pred H-----------------------------------------HHhcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHH
Q 018489 283 A-----------------------------------------VVRQNLRPEIP-RCCPSSLANVMKRCWDANPDKRPEMD 320 (355)
Q Consensus 283 ~-----------------------------------------~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~ 320 (355)
. .......+..+ ..++.++.++|.+||+.||.+|||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ 293 (322)
T d1s9ja_ 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293 (322)
T ss_dssp HC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 0 00111111222 23688999999999999999999999
Q ss_pred HHHH--HHHHhHh
Q 018489 321 EVVS--MLEAIDT 331 (355)
Q Consensus 321 ell~--~l~~~~~ 331 (355)
|+++ .+++...
T Consensus 294 e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 294 QLMVHAFIKRSDA 306 (322)
T ss_dssp HHHTSHHHHHHHH
T ss_pred HHhhCHhhCcCCc
Confidence 9998 5665443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=368.80 Aligned_cols=262 Identities=29% Similarity=0.556 Sum_probs=219.7
Q ss_pred ceecCCcceeecc-cccccceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 45 WEIEPSKLVIKSV-IARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 45 ~~~~~~~y~i~~~-lg~G~~~~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
+-+..++|.+.+. ||+|+||.||+|.+ ++..||||+++.... . ...+.+.+|+.++++++||||+++
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~----~----~~~~~~~~E~~il~~l~HpnIv~l 74 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----K----ADTEEMMREAQIMHQLDNPYIVRL 74 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC----H----HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC----H----HHHHHHHHHHHHHHhCCCCCEeeE
Confidence 4456678888885 99999999999965 345799999864321 1 123568899999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++..+ . .++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++||+|||||
T Consensus 75 ~g~~~~~-~----------------~~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlK 136 (285)
T d1u59a_ 75 IGVCQAE-A----------------LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 136 (285)
T ss_dssp EEEEESS-S----------------EEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred eeeeccC-e----------------EEEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCc
Confidence 9987542 2 2679999999999998743 34579999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~ 275 (355)
|+||+++.++.+||+|||+++....... ......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.+.
T Consensus 137 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 137 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp GGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999986543322 2233467889999999998889999999999999999998 89999988
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhc
Q 018489 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSK 333 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 333 (355)
+..+....+. ....+..+..+|+++.+||.+||+.||++|||+.+|++.|+.+..+.
T Consensus 217 ~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 217 KGPEVMAFIE-QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CTHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 8776665544 45566788889999999999999999999999999999999887654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-52 Score=365.62 Aligned_cols=257 Identities=24% Similarity=0.387 Sum_probs=225.2
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeeccC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMG 125 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~ 125 (355)
.++|++.+.||+|+||+||+|++ +++.||||+++...............++.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 37899999999999999999976 68999999998877666666677778888999999999996 9999999999987
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. +|||||+++|+|.+++.. ...+++..++.++.||+.||+|||++|++||||||+||++
T Consensus 82 ~~~~----------------~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill 143 (277)
T d1phka_ 82 NTFF----------------FLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL 143 (277)
T ss_dssp SSEE----------------EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred Ccce----------------EEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE
Confidence 6655 569999999999999964 4579999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC------CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG------NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~ 279 (355)
+.++.+||+|||.+...... .......||..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+...
T Consensus 144 ~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~ 222 (277)
T d1phka_ 144 DDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222 (277)
T ss_dssp CTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cCCCCeEEccchheeEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence 99999999999999865443 33455689999999999853 356889999999999999999999999998888
Q ss_pred HHHHHHhcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 280 VTSAVVRQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 280 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....+........ ....+|+++.+||.+||+.||.+|||++|+++
T Consensus 223 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 8888777655433 33468999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=365.00 Aligned_cols=261 Identities=30% Similarity=0.582 Sum_probs=212.2
Q ss_pred eecCCcceeecccccccceEEEEEEECC------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 46 EIEPSKLVIKSVIARGTFGTVHRGLYDG------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 46 ~~~~~~y~i~~~lg~G~~~~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
++.++.|++.++||+|+||.||+|.+.+ ..||||.++.... .. ....|.+|+.++++++||||+++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~----~~----~~~~~~~E~~il~~l~H~nIv~~ 74 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT----EK----QRVDFLGEAGIMGQFSHHNIIRL 74 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC----HH----HHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC----hH----HHHHHHHHHHHHHhcCCCCEeee
Confidence 5778899999999999999999997532 3699999853221 11 13458899999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++...+.. +++|||+.++++.+++.. ....+++..++.++.|++.||.|||+++|+|||||
T Consensus 75 ~g~~~~~~~~----------------~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlK 137 (283)
T d1mqba_ 75 EGVISKYKPM----------------MIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137 (283)
T ss_dssp EEEECSSSSE----------------EEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred eEEEecCCce----------------EEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccccccCccc
Confidence 9998876655 569999999999988754 34579999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCC---CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCC-CCCC
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMP-YPDL 275 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p-~~~~ 275 (355)
|+|||++.++.+||+|||+++....... ......||..|+|||.+.+..++.++||||||+++|+|+++..| +...
T Consensus 138 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~ 217 (283)
T d1mqba_ 138 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217 (283)
T ss_dssp GGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC
Confidence 9999999999999999999986543221 22334678999999999999999999999999999999996555 4555
Q ss_pred ChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 276 SFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
+..+.. ..+.....+..+..++.++.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 218 ~~~~~~-~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 218 SNHEVM-KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CHHHHH-HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CHHHHH-HHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 555444 44555667778888999999999999999999999999999999988764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-52 Score=366.33 Aligned_cols=262 Identities=24% Similarity=0.393 Sum_probs=215.5
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++.+.||+|+||.||+|.+ +++.||||+++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD------PSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 79 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC------HHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence 47899999999999999999976 58999999997543321 12245688999999999999999999988754
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ....++||||++|++|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+||+++
T Consensus 80 ~~~------------~~~~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~ 145 (277)
T d1o6ya_ 80 TPA------------GPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 145 (277)
T ss_dssp CSS------------SEEEEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred cCC------------CceEEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC
Confidence 431 1234789999999999998854 46799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCC---CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 207 KNRTVKIADFGVARVEASNP---NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
.++.++++|||.+....... .......||+.|+|||++.+..++.++||||||+++|+|+||+.||.+.+..+....
T Consensus 146 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~ 225 (277)
T d1o6ya_ 146 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 225 (277)
T ss_dssp TTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHH
Confidence 99999999999886443222 233445789999999999999999999999999999999999999999888888777
Q ss_pred HHhcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHhH
Q 018489 284 VVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRP-EMDEVVSMLEAID 330 (355)
Q Consensus 284 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~ell~~l~~~~ 330 (355)
.......+ .....+|+++.++|.+||+.||.+|| |++++++.|.++.
T Consensus 226 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 226 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 77665443 23467899999999999999999999 8999999998875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=363.79 Aligned_cols=262 Identities=30% Similarity=0.604 Sum_probs=212.1
Q ss_pred cceecCCcceeecccccccceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccce
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 118 (355)
+|++..++|++.+.||+|+||.||+|.+. +..||||.++... . ...++.+.+|+.++++++||||++
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~----~----~~~~~~~~~E~~~l~~l~HpnIv~ 72 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT----S----DSVREKFLQEALTMRQFDHPHIVK 72 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT----S----HHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc----C----HHHHHHHHHHHHHHHhCCCCCEee
Confidence 58888899999999999999999999763 2457888774322 1 122456889999999999999999
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di 198 (355)
+++++.. +. .++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++|++||||
T Consensus 73 l~~~~~~-~~----------------~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDl 134 (273)
T d1mp8a_ 73 LIGVITE-NP----------------VWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 134 (273)
T ss_dssp EEEEECS-SS----------------CEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEec-Ce----------------EEEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccCeecccc
Confidence 9998753 22 2679999999999998754 3457999999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEeeccccccccCCC-CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 018489 199 KTENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 276 (355)
Q Consensus 199 ~p~Nili~~~~~v~L~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~ 276 (355)
||+||+++.++.+||+|||++....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+
T Consensus 135 Kp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 135 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp SGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred chhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999997644322 22334567889999999999999999999999999999998 899999988
Q ss_pred hhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 277 FSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
..+....+.. ......+..+|+++.+||.+||+.||.+|||+.+|++.|+++...
T Consensus 215 ~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 215 NNDVIGRIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp GGGHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 8887776654 445567888999999999999999999999999999999988543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=369.09 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=216.0
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++++.||+|+||.||+|.+ +|+.||||+++......... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR---GVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh---hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 6899999999999999999976 58899999997554322211 011345789999999999999999999988766
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 87 ~~----------------~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~ 148 (293)
T d1jksa_ 87 DV----------------ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148 (293)
T ss_dssp EE----------------EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred EE----------------EEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEec
Confidence 55 669999999999999954 357999999999999999999999999999999999999987
Q ss_pred CC----cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 208 NR----TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 208 ~~----~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
++ .++|+|||++...... .......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||.+.+..+....
T Consensus 149 ~~~~~~~vkl~DfG~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~ 227 (293)
T d1jksa_ 149 RNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 227 (293)
T ss_dssp SSSSSCCEEECCCTTCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCcccceEecchhhhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 76 5999999999765433 334456789999999999999999999999999999999999999999888888877
Q ss_pred HHhcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 284 VVRQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 284 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+....... ..+..+|+++.+||++||+.||.+|||++|+++
T Consensus 228 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 228 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 76654432 233678999999999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-52 Score=370.01 Aligned_cols=246 Identities=27% Similarity=0.445 Sum_probs=214.7
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++++.||+|+||.||+|.+ +|+.||||+++.... ......+.+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV------VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc------cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence 6899999999999999999976 589999999853211 11122356889999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||++|++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 78 ~~----------------~ivmE~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~ 139 (316)
T d1fota_ 78 QI----------------FMIMDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK 139 (316)
T ss_dssp EE----------------EEEECCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT
T ss_pred ee----------------eeEeeecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcC
Confidence 55 56999999999999884 4567899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+|.+||+|||.|...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 140 ~g~vkL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~ 216 (316)
T d1fota_ 140 NGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 216 (316)
T ss_dssp TSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC
T ss_pred CCCEEEecCccceEeccc---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC
Confidence 999999999999865432 23467999999999999999999999999999999999999999999888888887775
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
.. .++..+++++.++|.+||..||.+|+ |+++|++
T Consensus 217 ~~--~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 217 EL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CC--CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 43 46778899999999999999999996 8999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=369.21 Aligned_cols=271 Identities=30% Similarity=0.539 Sum_probs=217.9
Q ss_pred hcccccceecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC
Q 018489 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111 (355)
Q Consensus 39 ~~~~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 111 (355)
+.+...|++..++|++.+.||+|+||.||+|.+. ++.||||+++.... . ...+.+.+|...+.++
T Consensus 2 p~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~----~----~~~~~~~~e~~~l~~~ 73 (299)
T d1ywna1 2 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----H----SEHRALMSELKILIHI 73 (299)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C----H----HHHHHHHHHHHHHHHH
T ss_pred CCCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC----c----HHHHHHHHHHHHHHhh
Confidence 3456778998899999999999999999999752 35799999853221 1 1123466677777776
Q ss_pred -CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHHH
Q 018489 112 -DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQ 176 (355)
Q Consensus 112 -~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~ 176 (355)
+|+||+.+++++...+. .+++||||+++|+|.+++.... ...+++..++.
T Consensus 74 ~~h~~iv~~~~~~~~~~~---------------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 138 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGG---------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138 (299)
T ss_dssp CCCTTBCCEEEEECSTTS---------------CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHH
T ss_pred cCCCeEEEeeeeeccCCC---------------eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHH
Confidence 78999999987765432 2367999999999999996543 23589999999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcch
Q 018489 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCD 254 (355)
Q Consensus 177 i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~D 254 (355)
++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....... ......||+.|+|||.+.+..++.++|
T Consensus 139 ~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD 218 (299)
T d1ywna1 139 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 218 (299)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccc
Confidence 999999999999999999999999999999999999999999975443322 233457899999999999999999999
Q ss_pred hHHHHHHHHHHHhC-CCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 255 VYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 255 vwslG~il~~lltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
|||+|+++|+|++| ..||.+.+..+.....+.....+..+..+++++.++|.+||+.||.+|||+.+|++.|+++.++
T Consensus 219 iwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 219 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred eeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 99999999999986 5688887776777677777777788889999999999999999999999999999999998655
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-52 Score=377.79 Aligned_cols=248 Identities=22% Similarity=0.369 Sum_probs=213.8
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++++.||+|+||.||+|.+ +|+.||||++.... .. -.+.+.+|+.++++++||||+++++++.+.+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-----~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ES----DKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-----HH----HHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-----hh----hHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5899999999999999999976 58899999986432 11 1345789999999999999999999988765
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||++||+|.+++.. ....+++..++.|+.||+.||.|||++|++||||||+|||++.
T Consensus 97 ~~----------------~ivmE~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~ 159 (350)
T d1koaa2 97 EM----------------VMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 159 (350)
T ss_dssp EE----------------EEEECCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EE----------------EEEEEcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc
Confidence 54 669999999999998853 2456999999999999999999999999999999999999964
Q ss_pred --CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 208 --NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 208 --~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 160 ~~~~~vkL~DFG~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 238 (350)
T d1koaa2 160 KRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238 (350)
T ss_dssp TTSCCEEECCCTTCEECCTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCeEEEeecchheecccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 678999999999765432 33344678999999999999999999999999999999999999999998888888887
Q ss_pred hcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....... ....+++++.+||.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 7655433 23468999999999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-52 Score=377.23 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=214.7
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++++.||+|+||.||+|.+ +|+.||||+++... ..+ .+.+.+|+.++++++||||+++++++.+.+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLD----KYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHH----HHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----hhH----HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5799999999999999999976 58999999986432 111 345778999999999999999999988765
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc-
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD- 206 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~- 206 (355)
.. ++||||++||+|.+++.. ...++++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 100 ~~----------------~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~ 162 (352)
T d1koba_ 100 EM----------------VLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 162 (352)
T ss_dssp EE----------------EEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EE----------------EEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc
Confidence 55 569999999999987743 345699999999999999999999999999999999999997
Q ss_pred -CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 207 -KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 207 -~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
.++.++|+|||+|...... .......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 163 ~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 241 (352)
T d1koba_ 163 KKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241 (352)
T ss_dssp TTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred cCCCeEEEeecccceecCCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 6789999999999865433 23344578999999999999999999999999999999999999999999888888887
Q ss_pred hcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRP--EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...... .....+++++.+||.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 765543 344678999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=364.06 Aligned_cols=259 Identities=29% Similarity=0.543 Sum_probs=213.4
Q ss_pred ecCCcceeecccccccceEEEEEEECC-----ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLYDG-----HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
++.++|++.+.||+|+||.||+|...+ ..||||++....... ....+.+.+|+.++++++||||+++++
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ------PEAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC------HHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 567899999999999999999997532 368999885433221 122356889999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++.+. .. ++||||++++++.+.+... ...+++..++.++.|++.||.|||++||+||||||+
T Consensus 79 ~~~~~-~~----------------~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~ 140 (273)
T d1u46a_ 79 VVLTP-PM----------------KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR 140 (273)
T ss_dssp EECSS-SC----------------EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEeec-ch----------------heeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHH
Confidence 88653 22 5699999999999987653 456999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCC---CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCh
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~ 277 (355)
||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|+| |..||.+.+.
T Consensus 141 NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~ 220 (273)
T d1u46a_ 141 NLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220 (273)
T ss_dssp GEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred HhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH
Confidence 999999999999999999865433221 223357789999999999999999999999999999998 8999999999
Q ss_pred hHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 018489 278 SEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAI 329 (355)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~ 329 (355)
.+....+......++.+..+|+++.+||.+||+.||.+|||+.+|++.|+++
T Consensus 221 ~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 221 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 9999888888888888889999999999999999999999999999998875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-52 Score=363.16 Aligned_cols=248 Identities=31% Similarity=0.554 Sum_probs=207.2
Q ss_pred cccccccceEEEEEEEC----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccc
Q 018489 56 SVIARGTFGTVHRGLYD----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131 (355)
Q Consensus 56 ~~lg~G~~~~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~ 131 (355)
+.||+|+||.||+|.+. ++.||||+++..... ...++.+.+|+.++++++||||+++++++... ..
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-------~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~-- 82 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-------PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SW-- 82 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SE--
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-------HHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CE--
Confidence 46999999999999652 367999998543221 22345688999999999999999999987532 22
Q ss_pred ccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcE
Q 018489 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211 (355)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v 211 (355)
++||||+++|+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||+++.++.+
T Consensus 83 --------------~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~ 146 (277)
T d1xbba_ 83 --------------MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA 146 (277)
T ss_dssp --------------EEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred --------------EEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcc
Confidence 579999999999999853 4679999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCC---CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhc
Q 018489 212 KIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 212 ~L~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~~~~~~~~~~ 287 (355)
+|+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+. .
T Consensus 147 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~ 225 (277)
T d1xbba_ 147 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-K 225 (277)
T ss_dssp EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-T
T ss_pred cccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-c
Confidence 9999999976543322 1223468899999999998889999999999999999998 899999988776665554 4
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 288 NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
...+..+..+|+++.+||.+||+.||.+|||+.+|++.|+...
T Consensus 226 ~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 5566778889999999999999999999999999999998865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-51 Score=371.21 Aligned_cols=247 Identities=21% Similarity=0.339 Sum_probs=214.6
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++++.||+|+||.||+|.+ +|+.||||++.... .......+.+.+|+.+++.++||||+++++++...
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~------~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 113 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK------VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH------ccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc
Confidence 37899999999999999999976 58999999985321 11112234578999999999999999999998876
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
... ++||||+.+|+|..++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++
T Consensus 114 ~~~----------------~~v~e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~ 175 (350)
T d1rdqe_ 114 SNL----------------YMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175 (350)
T ss_dssp SEE----------------EEEEECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred ccc----------------ccccccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC
Confidence 655 569999999999999854 45799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.+|.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 176 ~~g~ikL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 252 (350)
T d1rdqe_ 176 QQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252 (350)
T ss_dssp TTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEeeeceeeeecccc---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc
Confidence 9999999999999865432 2346799999999999999999999999999999999999999999888888877776
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
... ..+..+++++.++|++||+.||.+|+ |+++|++
T Consensus 253 ~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 253 GKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 543 46678999999999999999999994 8999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=367.07 Aligned_cols=249 Identities=27% Similarity=0.448 Sum_probs=213.3
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHh-hCCCCccceeeeeccCC
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH-KLDHPNVTKFIGATMGS 126 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~Iv~~~~~~~~~ 126 (355)
++|++++.||+|+||+||+|.+ +++.||||++++... ......+.+..|..++. .++||||+++++++.+.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~------~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV------LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc------cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence 6899999999999999999977 689999999963211 00111233455666554 68999999999999877
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+.. ++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++
T Consensus 76 ~~~----------------yivmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~ 137 (320)
T d1xjda_ 76 ENL----------------FFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 137 (320)
T ss_dssp SEE----------------EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred Cce----------------eEEEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec
Confidence 665 569999999999999954 46799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
.++.++|+|||.+..............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 138 ~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 217 (320)
T d1xjda_ 138 KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 217 (320)
T ss_dssp TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 99999999999998665555555667899999999999999999999999999999999999999999988888877766
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 018489 287 QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMD-EVVS 324 (355)
Q Consensus 287 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-ell~ 324 (355)
.. +.++..+|+++.+||.+||+.||.+||++. ++++
T Consensus 218 ~~--~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 218 DN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC--CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 43 467788999999999999999999999985 6754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=360.65 Aligned_cols=266 Identities=33% Similarity=0.599 Sum_probs=219.5
Q ss_pred cccceecCCcceeecccccccceEEEEEEECC---------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG---------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL- 111 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 111 (355)
..+|++..++|++++.||+|+||.||+|...+ ..||||+++.... ... ...+.+|...+.++
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~----~~~----~~~~~~e~~~l~~~~ 76 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT----EKD----LSDLISEMEMMKMIG 76 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC----HHH----HHHHHHHHHHHHHHC
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC----hHH----HHHHHHHHHHHHHhc
Confidence 44599999999999999999999999996532 4699999864321 111 23467788888887
Q ss_pred CCCccceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc--------------cccccHHHHHHH
Q 018489 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQL 177 (355)
Q Consensus 112 ~h~~Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i 177 (355)
+||||+++++++.+.+.. ++||||+++|+|.+++.... ...+++..++.+
T Consensus 77 ~HpnIv~~~~~~~~~~~~----------------~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 140 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140 (299)
T ss_dssp CCTTBCCEEEEECSSSSC----------------EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHH
T ss_pred CCCeEEecccccccCCeE----------------EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHH
Confidence 899999999999876554 56999999999999996543 245899999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCCcchh
Q 018489 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDV 255 (355)
Q Consensus 178 ~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 255 (355)
+.||+.||+|||++|++||||||+|||++.++.+||+|||.+....... .......+++.|+|||.+.++.++.++||
T Consensus 141 ~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~Di 220 (299)
T d1fgka_ 141 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 220 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhh
Confidence 9999999999999999999999999999999999999999998654332 22334568889999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 256 YSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 256 wslG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
||||+++|+|++ |..||.+.+.......+ .....+..+..+++++.+||.+||+.||.+|||+.||++.|+++..-
T Consensus 221 wS~Gvvl~ell~~g~~p~~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 221 WSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhHHHHHHhccCCCCCCCCCCHHHHHHHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 999999999998 78999888877665544 45667788888999999999999999999999999999999998653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-51 Score=360.37 Aligned_cols=263 Identities=30% Similarity=0.513 Sum_probs=221.0
Q ss_pred ccceecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCc
Q 018489 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115 (355)
Q Consensus 43 ~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 115 (355)
..+++--++|++.+.||+|+||.||+|++. ++.||||+++.... . ...+.+.+|+.++++++|||
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~----~----~~~~~~~~E~~il~~l~h~n 77 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS----A----DMQADFQREAALMAEFDNPN 77 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC----H----HHHHHHHHHHHHHHTCCCTT
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC----h----HHHHHHHHHHHHHHhcCCCC
Confidence 446666678999999999999999999764 36799999853221 1 22456889999999999999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc----------------------cccccHHH
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----------------------RRKLAFKV 173 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------------~~~~~~~~ 173 (355)
|+++++++...... +++|||+++++|.+++.... ...+++..
T Consensus 78 iv~~~~~~~~~~~~----------------~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 141 (301)
T d1lufa_ 78 IVKLLGVCAVGKPM----------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 141 (301)
T ss_dssp BCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHH
T ss_pred cccceeeeccCCce----------------EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHH
Confidence 99999998876655 56999999999999985432 23488999
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCC--CCCCCCCCcccccCCcccCCCCCCC
Q 018489 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNR 251 (355)
Q Consensus 174 ~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~ 251 (355)
++.|+.|++.||+|||++|++||||||+|||++.++.+||+|||++....... .......+++.|+|||.+.+..++.
T Consensus 142 ~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ 221 (301)
T d1lufa_ 142 QLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT 221 (301)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh
Confidence 99999999999999999999999999999999999999999999997543322 2223456888999999999999999
Q ss_pred cchhHHHHHHHHHHHhCC-CCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 252 KCDVYSFGICLWEIYCCD-MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 252 ~~DvwslG~il~~lltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
++||||||+++|+|++|. .||.+.+..+....+... ..+..+..+++++.+||.+||+.||.+|||+.+|++.|+++.
T Consensus 222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 999999999999999985 688888888877766554 456778889999999999999999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-50 Score=366.89 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=206.5
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccC
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 125 (355)
..++|++.+.||+|+||.||+|.+ +|+.||||++...... ............+|+.+++.++||||+++++++..
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~---~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~ 78 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK---MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 78 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcc---hhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE
Confidence 357899999999999999999976 5899999998532110 00011112223456778888899999999999887
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
.+.. ++||||++||+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||+
T Consensus 79 ~~~~----------------~ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl 140 (364)
T d1omwa3 79 PDKL----------------SFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 140 (364)
T ss_dssp SSEE----------------EEEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCEE----------------EEEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE
Confidence 6655 569999999999999954 4678999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHH
Q 018489 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (355)
Q Consensus 206 ~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~ 284 (355)
+.+|.+||+|||+|...... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+........
T Consensus 141 ~~~g~iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 218 (364)
T d1omwa3 141 DEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218 (364)
T ss_dssp CSSSCEEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH
T ss_pred cCCCcEEEeeeceeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999855432 2334579999999999875 56899999999999999999999999876554433322
Q ss_pred -HhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 018489 285 -VRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPE-----MDEVVS 324 (355)
Q Consensus 285 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 324 (355)
........++..+++++.+||.+||+.||.+||| ++++++
T Consensus 219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 2233445567789999999999999999999998 688875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=360.16 Aligned_cols=257 Identities=26% Similarity=0.541 Sum_probs=212.2
Q ss_pred cCCcceeecccccccceEEEEEEEC--Cc----eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLYD--GH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
..++|++++.||+|+||.||+|.+. |+ +||+|.++..... ...+.+.+|+.++++++||||+++++
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~g 78 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--------KANKEILDEAYVMASVDNPHVCRLLG 78 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------------CTHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--------HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 4568999999999999999999763 33 5888887532211 12345889999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++.+... +++++|+.+++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+
T Consensus 79 ~~~~~~~-----------------~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~ 140 (317)
T d1xkka_ 79 ICLTSTV-----------------QLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 140 (317)
T ss_dssp EEESSSE-----------------EEEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEecCCe-----------------eEEEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhh
Confidence 9875432 468899999999998764 3567999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCC--CCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh-CCCCCCCCChh
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt-g~~p~~~~~~~ 278 (355)
||+++.++.+||+|||++......... .....||..|+|||.+.+..++.++||||||+++|+|+| |..||.+.+..
T Consensus 141 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp GEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred cceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence 999999999999999999865443222 223467899999999999999999999999999999998 89999988777
Q ss_pred HHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 279 EVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
+....+. .+..+..+..+++++.+||.+||+.||.+|||+.+|++.|..+..
T Consensus 221 ~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 221 EISSILE-KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp GHHHHHH-HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHH-cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 7665544 455567778899999999999999999999999999999988753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-51 Score=365.40 Aligned_cols=248 Identities=23% Similarity=0.396 Sum_probs=199.5
Q ss_pred Ccceeec-ccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhh-CCCCccceeeeeccC
Q 018489 50 SKLVIKS-VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK-LDHPNVTKFIGATMG 125 (355)
Q Consensus 50 ~~y~i~~-~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~ 125 (355)
++|++.+ .||+|+||.||+|.+ +++.||||+++.. ..+.+|+.++.+ .+||||++++++|.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 6899875 599999999999975 5889999998531 235678888655 489999999998864
Q ss_pred CcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q 018489 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (355)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili 205 (355)
... .++++|+|||||+||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+|||+
T Consensus 77 ~~~------------~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll 144 (335)
T d2ozaa1 77 LYA------------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 144 (335)
T ss_dssp EET------------TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred ccc------------CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccc
Confidence 211 12344889999999999999976555679999999999999999999999999999999999999
Q ss_pred cC---CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 206 DK---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 206 ~~---~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
+. .+.++|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+......
T Consensus 145 ~~~~~~~~~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~ 223 (335)
T d2ozaa1 145 TSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 223 (335)
T ss_dssp SCSSTTCCEEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----
T ss_pred ccccccccccccccceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH
Confidence 75 567999999999765443 33445689999999999999999999999999999999999999998766555444
Q ss_pred HHHhcCCCC--CCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNLRP--EIP----RCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~~~--~~~----~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+....... .++ ..+|+++.+||.+||+.||.+|||+.|+++
T Consensus 224 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 224 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 433322211 222 247899999999999999999999999987
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=363.98 Aligned_cols=247 Identities=19% Similarity=0.306 Sum_probs=212.4
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++++.||+|+||.||+|.+ +++.||+|+++.... . ...+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~------~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT------D----QVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH------H----HHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc------c----HHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 7899999999999999999976 588999999964321 1 234678999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.+ ++||||++|++|.+++.. .+..+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 75 ~~----------------~lvmE~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~ 137 (321)
T d1tkia_ 75 EL----------------VMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp EE----------------EEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EE----------------EEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC
Confidence 55 669999999999999853 2346999999999999999999999999999999999999985
Q ss_pred --CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 208 --NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 208 --~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
.+.++|+|||.+...... .......+++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+.
T Consensus 138 ~~~~~ikl~DFG~~~~~~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~ 216 (321)
T d1tkia_ 138 RRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp SSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CCceEEEEcccchhhccccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 458999999999755332 22334568899999999999999999999999999999999999999999888888887
Q ss_pred hcCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNLRPE--IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....... ....+++++.+||.+||..||.+|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 7655432 22468999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=357.61 Aligned_cols=265 Identities=30% Similarity=0.556 Sum_probs=226.9
Q ss_pred cceecCCcceeecccccccceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCc
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 115 (355)
.|++..++|++.+.||+|+||.||+|.+ ++..||||+++.... .. ....+.+|+.+++.+ +|||
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~----~~----~~~~~~~E~~~~~~l~~Hpn 88 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----LT----EREALMSELKVLSYLGNHMN 88 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----HH----HHHHHHHHHHHHHHHCCCTT
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC----HH----HHHHHHHHHHHHHhccCCCC
Confidence 6788889999999999999999999965 346799999964321 11 134578899999999 7999
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhc----------------cccccHHHHHHHHH
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----------------RRKLAFKVVVQLAL 179 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~~~~~~~~i~~ 179 (355)
|+++++++...+.. +++|||+++|+|.+++.... ...+++..++.++.
T Consensus 89 Iv~~~g~~~~~~~~----------------~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 152 (311)
T d1t46a_ 89 IVNLLGACTIGGPT----------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152 (311)
T ss_dssp BCCEEEEECSSSSC----------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHH
T ss_pred EEEEEEEEeeCCEE----------------EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHH
Confidence 99999999876655 56999999999999986542 23589999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHH
Q 018489 180 DLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYS 257 (355)
Q Consensus 180 qi~~al~~LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 257 (355)
||+.||+|||++|++||||||+||+++.++.++++|||.+........ ......+++.|+|||.+.+..++.++||||
T Consensus 153 qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS 232 (311)
T d1t46a_ 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 232 (311)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccc
Confidence 999999999999999999999999999999999999999986544322 223356889999999999989999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhh
Q 018489 258 FGICLWEIYC-CDMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTS 332 (355)
Q Consensus 258 lG~il~~llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 332 (355)
||+++|+|+| |..||...+..+....++.....+..+..+++++.+||.+||+.||.+|||+.+|+++|+++.+.
T Consensus 233 ~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 9999999998 66777777777777788888888888888999999999999999999999999999999986544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=356.29 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=208.0
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++++.||+|+||.||+|.+ +++.||||+++...... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-------GVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh-------HHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 6899999999999999999976 58899999996443221 12345788999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. ++||||+.+ .+..++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 75 ~~----------------~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~ 137 (298)
T d1gz8a_ 75 KL----------------YLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137 (298)
T ss_dssp EE----------------EEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred ce----------------eEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecc
Confidence 55 669999965 5555665556677999999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCC-CCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHh
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~ 286 (355)
++.++|+|||.|..............+++.|+|||.+.... ++.++||||+|+++|+|++|+.||.+.+..+....+..
T Consensus 138 ~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~ 217 (298)
T d1gz8a_ 138 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217 (298)
T ss_dssp TSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence 99999999999987766556666678999999999877654 57899999999999999999999998887776666544
Q ss_pred cCCCCC---------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 287 QNLRPE---------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 287 ~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
....+. ....+++++.+||++||+.||.+|||++||++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 211110 01245788999999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=359.03 Aligned_cols=249 Identities=24% Similarity=0.329 Sum_probs=202.9
Q ss_pred eecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccccc
Q 018489 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131 (355)
Q Consensus 54 i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~~ 131 (355)
.++.||+|+||+||+|.+ +|+.||||+++....... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~-- 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA----KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI-- 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC--
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh----hHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce--
Confidence 467899999999999975 588999999865433211 112234578899999999999999999999876655
Q ss_pred ccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCCCcE
Q 018489 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211 (355)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~~~v 211 (355)
++||||+.++++..+. .....+++..++.++.||+.||.|||++|++||||||+|||++.++.+
T Consensus 76 --------------~ivmE~~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~ 139 (299)
T d1ua2a_ 76 --------------SLVFDFMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVL 139 (299)
T ss_dssp --------------EEEEECCSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred --------------eehhhhhcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCcc
Confidence 6699999887776655 345679999999999999999999999999999999999999999999
Q ss_pred EEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhcCCC
Q 018489 212 KIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQNLR 290 (355)
Q Consensus 212 ~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~~~~ 290 (355)
||+|||.+..............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 140 KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~ 219 (299)
T d1ua2a_ 140 KLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 219 (299)
T ss_dssp EECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCC
Confidence 99999999866655555556789999999999875 46799999999999999999999999998888877766542111
Q ss_pred CC--------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 291 PE--------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 291 ~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
+. ....+++++.+||.+||+.||.+|||++|+|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 10 01346789999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=356.69 Aligned_cols=262 Identities=30% Similarity=0.547 Sum_probs=216.1
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCc--eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeee
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIG 121 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~ 121 (355)
++.++|++.+.||+|+||.||+|.+ ++. .||||.++..... ...+.+.+|+++++++ +||||+++++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~~HpnIv~~~~ 78 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--------DDHRDFAGELEVLCKLGHHPNIINLLG 78 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh--------HHHHHHHHHHHHHHhccCCCCEeeEEE
Confidence 4568999999999999999999966 444 4677776432211 1134588999999999 7999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhh--------------ccccccHHHHHHHHHHHHHHHHH
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--------------RRRKLAFKVVVQLALDLARGLSY 187 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~al~~ 187 (355)
++...+.. ++||||+++|+|.+++... ....+++..++.++.||+.||.|
T Consensus 79 ~~~~~~~~----------------~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~ 142 (309)
T d1fvra_ 79 ACEHRGYL----------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 142 (309)
T ss_dssp EEEETTEE----------------EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHH
T ss_pred EEecCCee----------------EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHh
Confidence 99876655 5699999999999998643 23679999999999999999999
Q ss_pred HHhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh
Q 018489 188 LHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 188 LH~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt 267 (355)
||++|++||||||+|||++.++.+||+|||++...... .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 143 lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~ 221 (309)
T d1fvra_ 143 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221 (309)
T ss_dssp HHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred hhcCCccccccccceEEEcCCCceEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHh
Confidence 99999999999999999999999999999999754322 22234568899999999999999999999999999999999
Q ss_pred CC-CCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 268 CD-MPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 268 g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
|. .||.+.+..+....+.. ...+..+..+++++.+||.+||+.||++|||+.+|++.|+++.....
T Consensus 222 ~~~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 222 LGGTPYCGMTCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp TSCCTTTTCCHHHHHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred cCCCCCCCCCHHHHHHHHHh-cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 65 57888777776666544 45667788899999999999999999999999999999999876543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=353.17 Aligned_cols=262 Identities=29% Similarity=0.531 Sum_probs=222.9
Q ss_pred cceecCCcceeecccccccceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcc
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I 116 (355)
+|++..++|++.+.||+|+||.||+|.+. ++.||||+++... ... ....+.+|+.++++++||||
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~----~~~----~~~~~~~E~~il~~l~h~nI 85 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMR----ERIEFLNEASVMKEFNCHHV 85 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHH----HHHHHHHHHHHGGGCCCTTB
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc----ChH----HHHHHHHHHHHHHHcCCCCE
Confidence 58999999999999999999999999753 4689999985322 111 13457899999999999999
Q ss_pred ceeeeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhcc--------ccccHHHHHHHHHHHHHHHHHH
Q 018489 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--------RKLAFKVVVQLALDLARGLSYL 188 (355)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~L 188 (355)
+++++++...... ++||||+++|+|.+++..... ..+++..+..++.|+++||.||
T Consensus 86 v~~~~~~~~~~~~----------------~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L 149 (308)
T d1p4oa_ 86 VRLLGVVSQGQPT----------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 149 (308)
T ss_dssp CCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred eeeeeEEecCCce----------------eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999998766655 569999999999999864321 3468899999999999999999
Q ss_pred HhCCccccCCCCCcEEEcCCCcEEEeeccccccccCCCC--CCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHH
Q 018489 189 HSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266 (355)
Q Consensus 189 H~~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll 266 (355)
|+++|+||||||+|||++.++++||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 150 H~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~ 229 (308)
T d1p4oa_ 150 NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229 (308)
T ss_dssp HHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred hhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHH
Confidence 999999999999999999999999999999975543322 223346889999999999999999999999999999999
Q ss_pred hC-CCCCCCCChhHHHHHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhH
Q 018489 267 CC-DMPYPDLSFSEVTSAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAID 330 (355)
Q Consensus 267 tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~ 330 (355)
|| ..||.+.+..+....+.+. .....+..+++.+.++|.+||+.||.+|||+.+|++.|++..
T Consensus 230 t~~~~p~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 230 TLAEQPYQGLSNEQVLRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred hCCCCCCCCCCHHHHHHHHHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 98 5889888888888776654 446677889999999999999999999999999999988764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-49 Score=349.70 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=203.8
Q ss_pred CcceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
++|++++.||+|+||+||+|.+ +++.||||+++........ .+.+.+|+.++++++||||+++++.+...+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~-------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI-------PSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC-------CHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHH-------HHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence 6899999999999999999976 5789999999654432211 2347889999999999999999999987666
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcCC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~~ 208 (355)
. +++|+|+.++.+..+. ...+.+++..++.++.||+.||+|||+.||+||||||+|||++.+
T Consensus 75 ~----------------~i~~e~~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~ 136 (286)
T d1ob3a_ 75 L----------------VLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE 136 (286)
T ss_dssp E----------------EEEEECCSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred e----------------eEEEEeehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC
Confidence 5 5699999776666554 345779999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 209 ~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
+.++|+|||.+..............+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 137 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~ 216 (286)
T d1ob3a_ 137 GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216 (286)
T ss_dssp SCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 999999999998765554545556789999999998764 5789999999999999999999999988877766655431
Q ss_pred CCC---------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLR---------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
... ......+++++.++|++||+.||++|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 0123456889999999999999999999999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=345.00 Aligned_cols=259 Identities=32% Similarity=0.501 Sum_probs=208.4
Q ss_pred eeecccccccceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 53 VIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 53 ~i~~~lg~G~~~~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
.+.++||+|+||+||+|.+. ...||||.++... .. ...+.+.+|++++++++||||+++++++...+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~----~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 101 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DI----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 101 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC----CH----HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc----CH----HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC
Confidence 34678999999999999763 2358999985322 11 11356889999999999999999999875432
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+|+||||||+|||++.
T Consensus 102 ---------------~~~~lv~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~ 165 (311)
T d1r0pa_ 102 ---------------GSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 165 (311)
T ss_dssp ---------------TEEEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred ---------------CceEEEEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC
Confidence 223679999999999998854 4456888999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCC----CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHH
Q 018489 208 NRTVKIADFGVARVEASNP----NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~ 283 (355)
++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus 166 ~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~ 245 (311)
T d1r0pa_ 166 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245 (311)
T ss_dssp TCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH
T ss_pred CCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 9999999999998544322 122234688999999999988999999999999999999998877765443333333
Q ss_pred HHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcCC
Q 018489 284 VVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKGG 335 (355)
Q Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~ 335 (355)
.+..+..+..+..+++++.+||.+||+.||++||++.||++.|+++.....+
T Consensus 246 ~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 246 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 3444566677888999999999999999999999999999999999876443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=348.71 Aligned_cols=256 Identities=25% Similarity=0.320 Sum_probs=203.8
Q ss_pred CCcceeecccccccceEEEEEEEC---CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC---CCCccceeeee
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIGA 122 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~ 122 (355)
.++|++++.||+|+||+||+|.+. ++.||||+++......... ..+.+|+.+++.+ +||||++++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~-------~~~~~E~~~l~~l~~~~HpnIv~~~~~ 78 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-------LSTIREVAVLRHLETFEHPNVVRLFDV 78 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB-------CTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH-------HHHHHHHHHHHHHhhcCCCCcceeeee
Confidence 479999999999999999999863 5679999986543322111 1134566665554 89999999998
Q ss_pred ccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 018489 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (355)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~N 202 (355)
+...... .....+++|||++++.+... .......+++..++.++.|++.||+|||++||+||||||+|
T Consensus 79 ~~~~~~~-----------~~~~~~~~~e~~~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N 146 (305)
T d1blxa_ 79 CTVSRTD-----------RETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146 (305)
T ss_dssp EEEEECS-----------SEEEEEEEEECCSCBHHHHH-HHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred ecccccc-----------cCceEEEEEEeccCCchhhh-hhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccE
Confidence 8543211 12344789999987666543 33456779999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 018489 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (355)
Q Consensus 203 ili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~ 282 (355)
||++..+.++|+|||.+...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 147 ILi~~~~~~kl~dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 225 (305)
T d1blxa_ 147 ILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 225 (305)
T ss_dssp EEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EEEcCCCCeeecchhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99999999999999998744322 33455689999999999999999999999999999999999999999988877776
Q ss_pred HHHhcCCC-------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 283 AVVRQNLR-------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 283 ~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+...... ..+...+++.+.+||.+||++||.+|||+.|+++
T Consensus 226 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 226 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 66542111 0123457899999999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-50 Score=349.34 Aligned_cols=245 Identities=22% Similarity=0.400 Sum_probs=199.2
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC--CCccceeeeecc
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD--HPNVTKFIGATM 124 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~ 124 (355)
.++|++.+.||+|+||.||+|.+ +++.||||++............ ....+.+|+.++++++ ||||+++++++.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~---~~~~~~~E~~il~~l~~~h~nIv~~~~~~~ 79 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP---NGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 79 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECT---TCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhh---HHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence 36899999999999999999976 5889999998754322111000 0112457999999885 899999999998
Q ss_pred CCcccccccccccccCCCCceEEEEEecCC-CCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPG-GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
..+.. ++||||+.+ +++.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 80 ~~~~~----------------~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI 141 (273)
T d1xwsa_ 80 RPDSF----------------VLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 141 (273)
T ss_dssp CSSEE----------------EEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred eCCeE----------------EEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccce
Confidence 76655 569999976 578777743 46799999999999999999999999999999999999
Q ss_pred EEcC-CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCC-CCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 204 LLDK-NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 204 li~~-~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
|++. ++.++|+|||.+..... .......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+
T Consensus 142 ll~~~~~~vkl~DFG~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----- 214 (273)
T d1xwsa_ 142 LIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 214 (273)
T ss_dssp EEETTTTEEEECCCTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred EEecCCCeEEECccccceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----
Confidence 9985 57999999999975443 23345679999999999987654 577999999999999999999997532
Q ss_pred HHHHhcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.+... ...++..+|+++.+||.+||+.||.+|||++|+++
T Consensus 215 -~i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 -EIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -HHHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHhhc--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 22332 23466789999999999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=348.47 Aligned_cols=262 Identities=23% Similarity=0.362 Sum_probs=207.1
Q ss_pred cceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
.|++ .++|++++.||+|+||+||+|.+ +|+.||||+++..... . ...+.+.+|+.++++++||||+++++
T Consensus 13 ~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~----~~~~~~~~Ei~il~~l~hpniv~l~~ 84 (346)
T d1cm8a_ 13 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS---E----LFAKRAYRELRLLKHMRHENVIGLLD 84 (346)
T ss_dssp EECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS---H----HHHHHHHHHHHHHHHCCBTTBCCCSE
T ss_pred eeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC---h----HHHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 3555 48999999999999999999976 5899999999643221 1 12345788999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++...+.... ...+++||||+ +.+|..++. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 85 ~~~~~~~~~~----------~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~ 150 (346)
T d1cm8a_ 85 VFTPDETLDD----------FTDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPG 150 (346)
T ss_dssp EECSCSSTTT----------CCCCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred EeccCccccc----------cceEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcc
Confidence 9887654322 33458899999 667877763 357999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
|||++.++.++++|||.+..... ......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+....
T Consensus 151 NIL~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~ 227 (346)
T d1cm8a_ 151 NLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227 (346)
T ss_dssp GEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred hhhcccccccccccccceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH
Confidence 99999999999999999975543 3345679999999999876 4578999999999999999999999998876665
Q ss_pred HHHHHhcCCC-----------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHh
Q 018489 281 TSAVVRQNLR-----------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAI 329 (355)
Q Consensus 281 ~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~ 329 (355)
.......... ......+++++.+||.+||..||.+|||+.|+|+ .++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 5444331111 1123456899999999999999999999999997 35555
Q ss_pred H
Q 018489 330 D 330 (355)
Q Consensus 330 ~ 330 (355)
.
T Consensus 308 ~ 308 (346)
T d1cm8a_ 308 H 308 (346)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=344.43 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=201.2
Q ss_pred cceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 44 ~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
.|++. ++|++++.||+|+||+||+|.+ +++.||||+++.... ....+.+.+|+.++++++||||+++++
T Consensus 3 ~~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~Ei~il~~l~hp~iv~~~~ 73 (345)
T d1pmea_ 3 VFDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--------QTYCQRTLREIKILLRFRHENIIGIND 73 (345)
T ss_dssp CCCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC--------HHHHHHHHHHHHHHHHCCCTTBCCCCE
T ss_pred ccCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC--------hHHHHHHHHHHHHHHHcCCCCCCcEEE
Confidence 34444 5799999999999999999976 589999999864321 122345788999999999999999999
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
++....... ....+ +++|+.+++|.+++.. +++++..++.++.||+.||.|||++||+||||||+
T Consensus 74 ~~~~~~~~~-----------~~~~~-l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~ 138 (345)
T d1pmea_ 74 IIRAPTIEQ-----------MKDVY-LVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 138 (345)
T ss_dssp EECCSSTTT-----------CCCEE-EEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred EEeeccccc-----------cceEE-EEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcc
Confidence 886554321 12224 4556669999999843 46999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCC---CCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCh
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNP---NDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~ 277 (355)
|||++.++.++|+|||.+....... .......+++.|+|||.+.. ..++.++||||+|+++|+|++|+.||...+.
T Consensus 139 NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 139 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp GEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 9999999999999999997543321 22344578999999999854 5678999999999999999999999988776
Q ss_pred hHHHHHHHhcCCCC-----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 278 SEVTSAVVRQNLRP-----------------------------EIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 278 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.............+ .....+++++.+||.+||+.||.+|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 55554443211111 012356789999999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=343.22 Aligned_cols=260 Identities=33% Similarity=0.484 Sum_probs=203.3
Q ss_pred CcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCccc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 129 (355)
.+|.+.+.||+|+||.||+|+++|..||||+++... . . ......|+..+.+++||||+++++++...+..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-----~--~---~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----E--R---SWFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-----H--H---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-----h--h---HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCc
Confidence 578899999999999999999999999999985321 1 1 11123456666678999999999998754421
Q ss_pred ccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCC
Q 018489 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS--------QKIVHRDVKTE 201 (355)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~--------~~i~H~di~p~ 201 (355)
....++||||+++|+|.+++.+ ..+++..++.++.|++.+|.|+|+ +||+||||||+
T Consensus 73 ------------~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~ 137 (303)
T d1vjya_ 73 ------------WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp ------------SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGG
T ss_pred ------------ceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCcc
Confidence 1234789999999999999954 469999999999999999999996 59999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCC----CCCCCCCcccccCCcccCCCC------CCCcchhHHHHHHHHHHHhCCCC
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPN----DMTGETGTLGYMAPEVLNGNP------YNRKCDVYSFGICLWEIYCCDMP 271 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~~lltg~~p 271 (355)
||||+.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++||||||+++|+|+||..|
T Consensus 138 NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~ 217 (303)
T d1vjya_ 138 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217 (303)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCB
T ss_pred ceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCC
Confidence 99999999999999999986544322 233467999999999987642 56789999999999999999877
Q ss_pred CCCC---------------ChhHHHHHHHhcCCCCCCCCCC-----cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHh
Q 018489 272 YPDL---------------SFSEVTSAVVRQNLRPEIPRCC-----PSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDT 331 (355)
Q Consensus 272 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 331 (355)
|... ...............+.++... +..+.+|+.+||+.||.+|||+.||++.|+++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 6421 2233333444445545554332 3459999999999999999999999999999986
Q ss_pred hcC
Q 018489 332 SKG 334 (355)
Q Consensus 332 ~~~ 334 (355)
..+
T Consensus 298 ~~~ 300 (303)
T d1vjya_ 298 QEG 300 (303)
T ss_dssp HHC
T ss_pred hcC
Confidence 644
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=334.36 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=207.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++++.||+|+||+||+|++ +++.||||+++....... ....+.+|+.+++.++||||+++++++....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~-------~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-------VPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT-------HHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH-------HHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence 5899999999999999999976 578899999976543222 1345788999999999999999999998776
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
.. +++++++.+++|..++. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 75 ~~----------------~iv~~~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~ 136 (292)
T d1unla_ 75 KL----------------TLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136 (292)
T ss_dssp EE----------------EEEEECCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred ce----------------eEEeeeccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccccc
Confidence 65 55999999988888773 4567899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCC-CCCChhHHHHHHH
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPY-PDLSFSEVTSAVV 285 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~-~~~~~~~~~~~~~ 285 (355)
++.++|+|||.+..............++..|.|||.+.+. .++.++|||||||++|+|++|+.|| .+.+..+....+.
T Consensus 137 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~ 216 (292)
T d1unla_ 137 NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp TCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred CCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999998776655555666788899999998765 4689999999999999999999986 4445555554443
Q ss_pred hcCC---------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 286 RQNL---------------------------RPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 286 ~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
.... .......+++++.+||.+||+.||.+|||++|+|+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3111 11123456789999999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=344.13 Aligned_cols=257 Identities=24% Similarity=0.315 Sum_probs=203.5
Q ss_pred cceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCcc
Q 018489 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (355)
Q Consensus 51 ~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 128 (355)
+|+..++||+|+||+||+|++ +++.||||++...... ..+|+.++++++||||+++++++.....
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------------~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------------KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------------CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------------HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 699999999999999999987 5889999999754422 2369999999999999999998854322
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHh-hccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK-NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
. .+..++++||||++++.+..+... .....+++..++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 88 ~----------~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~ 157 (350)
T d1q5ka_ 88 K----------KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 157 (350)
T ss_dssp C----------CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT
T ss_pred c----------CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec
Confidence 1 013345889999976544443321 24557999999999999999999999999999999999999987
Q ss_pred CC-cEEEeeccccccccCCCCCCCCCCCcccccCCcccCC-CCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHH
Q 018489 208 NR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (355)
Q Consensus 208 ~~-~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~ 285 (355)
++ .+||+|||++...... .......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+..+.+..+.
T Consensus 158 ~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~ 236 (350)
T d1q5ka_ 158 DTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236 (350)
T ss_dssp TTCCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred CCCceeEecccchhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH
Confidence 65 8999999999755432 33444689999999998875 578999999999999999999999999888777666554
Q ss_pred hcCCC---------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHhHh
Q 018489 286 RQNLR---------------------------PEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLEAIDT 331 (355)
Q Consensus 286 ~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~~~~~ 331 (355)
..... .......++++.+||.+||++||.+|||+.|+++ .++.+..
T Consensus 237 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 31100 0112346889999999999999999999999986 4555543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=337.33 Aligned_cols=259 Identities=23% Similarity=0.289 Sum_probs=200.2
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCC
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 126 (355)
.++|++++.||+|+||+||+|.+ +|+.||||++......... .+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-------~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-------PITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSS-------CHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHH-------HHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence 47999999999999999999976 5889999998655433222 23467899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
...+. ...+..+++|||+.++.+.... .....+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 82 ~~~~~--------~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~ 151 (318)
T d3blha1 82 ASPYN--------RCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT 151 (318)
T ss_dssp -----------------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred ccccc--------ccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec
Confidence 43322 1234568999999776665433 4456799999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccccCCC----CCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHH
Q 018489 207 KNRTVKIADFGVARVEASNP----NDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (355)
Q Consensus 207 ~~~~v~L~Dfg~a~~~~~~~----~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~ 281 (355)
.++.++|+|||++....... .......+|+.|+|||.+.+. .++.++||||+|+++|+|++|+.||.+.+.....
T Consensus 152 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~ 231 (318)
T d3blha1 152 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 231 (318)
T ss_dssp TTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred CCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH
Confidence 99999999999997543221 222335689999999998764 6899999999999999999999999988777766
Q ss_pred HHHHhcCCCC--CCCC----------------------------CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVRQNLRP--EIPR----------------------------CCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~~~~~~--~~~~----------------------------~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+....... .... ..++++.+||.+||++||++|||++|+++
T Consensus 232 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 6554422111 1100 12567889999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-47 Score=334.87 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=200.5
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeee-ccCC
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA-TMGS 126 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~-~~~~ 126 (355)
++|++.+.||+|+||.||+|.+ +++.||||++....... .+.+|+++++.++|++++..+.. +...
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-----------~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----------QLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC-----------CHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH-----------HHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 6799999999999999999976 48899999987544321 25679999999987776655443 3333
Q ss_pred cccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEc
Q 018489 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (355)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~ 206 (355)
+ ..++||||+ +++|...+.. ....+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 76 ~----------------~~~ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~ 137 (299)
T d1ckia_ 76 D----------------YNVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 137 (299)
T ss_dssp T----------------EEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred C----------------EEEEEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccc
Confidence 3 336799999 5677766543 456799999999999999999999999999999999999985
Q ss_pred ---CCCcEEEeeccccccccCCC-------CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 018489 207 ---KNRTVKIADFGVARVEASNP-------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (355)
Q Consensus 207 ---~~~~v~L~Dfg~a~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~ 276 (355)
.+..++|+|||+|....... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 138 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 138 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp CGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 45579999999998654322 12234579999999999999999999999999999999999999998765
Q ss_pred hhHHHHHHH---h---cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 277 FSEVTSAVV---R---QNLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 277 ~~~~~~~~~---~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
......... . ..........+|+++.++|..||+.+|.+||++.+|.+.|+++....+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 218 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp -------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 433322211 1 111122456789999999999999999999999999999999876543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=343.00 Aligned_cols=263 Identities=25% Similarity=0.370 Sum_probs=208.2
Q ss_pred cccceecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcccee
Q 018489 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (355)
Q Consensus 42 ~~~~~~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~ 119 (355)
...|++ +++|++++.||+|+||+||+|.+ +|+.||||+++..... .. ..+.+.+|+.++++++||||+++
T Consensus 11 ~~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~----~~~~~~~Ei~il~~l~h~~iv~~ 82 (348)
T d2gfsa1 11 KTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS---II----HAKRTYRELRLLKHMKHENVIGL 82 (348)
T ss_dssp SSEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS---HH----HHHHHHHHHHHHHHCCCTTBCCC
T ss_pred CccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC---hH----HHHHHHHHHHHHHhcCCCCeeeE
Confidence 445666 58999999999999999999976 5899999999654321 11 12447789999999999999999
Q ss_pred eeeccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 018489 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (355)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~ 199 (355)
++++...... .+...+++|+|+.+++|.+++. .+.+++..++.++.||+.||.|||++||+|||||
T Consensus 83 ~~~~~~~~~~-----------~~~~~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiK 148 (348)
T d2gfsa1 83 LDVFTPARSL-----------EEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 148 (348)
T ss_dssp SEEECSCSST-----------TTCCCCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred EEEEeecccc-----------ccCceEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhCCCcccccC
Confidence 9988654332 1122244667778999999883 3569999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChh
Q 018489 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (355)
Q Consensus 200 p~Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~ 278 (355)
|+|||++.++.++++|||.+.... .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..
T Consensus 149 p~NILi~~~~~~kl~dfg~a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~ 225 (348)
T d2gfsa1 149 PSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225 (348)
T ss_dssp GGGEEECTTCCEEECCC----CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CccccccccccccccccchhcccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999987543 333446789999999987765 5689999999999999999999999988877
Q ss_pred HHHHHHHhcCCCCC-----------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q 018489 279 EVTSAVVRQNLRPE-----------------------------IPRCCPSSLANVMKRCWDANPDKRPEMDEVVS--MLE 327 (355)
Q Consensus 279 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~l~ 327 (355)
.....+........ ....+++++.+||.+||+.||.+|||+.|+|+ .++
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp HHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 66665544322111 12356889999999999999999999999997 455
Q ss_pred Hh
Q 018489 328 AI 329 (355)
Q Consensus 328 ~~ 329 (355)
.+
T Consensus 306 ~~ 307 (348)
T d2gfsa1 306 QY 307 (348)
T ss_dssp TT
T ss_pred CC
Confidence 44
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3e-46 Score=329.56 Aligned_cols=259 Identities=18% Similarity=0.286 Sum_probs=209.4
Q ss_pred ecCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCC-Cccceeeeec
Q 018489 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH-PNVTKFIGAT 123 (355)
Q Consensus 47 ~~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~ 123 (355)
|-+++|++.+.||+|+||.||+|++ +++.||||++....... .+.+|++.+..+.| +|++.+++++
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-----------~~~~e~~~~~~l~~~~~i~~~~~~~ 70 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----------QLRDEYRTYKLLAGCTGIPNVYYFG 70 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC-----------CHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcH-----------HHHHHHHHHHHhcCCCCCCEEEEEe
Confidence 3468999999999999999999976 58899999986543321 25678888888855 8999999887
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
...... ++||||+ +++|.+++.. ....++...+..++.|++.+|.|||++||+||||||+||
T Consensus 71 ~~~~~~----------------~~vme~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Ni 132 (293)
T d1csna_ 71 QEGLHN----------------VLVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132 (293)
T ss_dssp EETTEE----------------EEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred ecCCcc----------------EEEEEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccce
Confidence 765544 6699999 7899998754 455799999999999999999999999999999999999
Q ss_pred EEcC-----CCcEEEeeccccccccCCC-------CCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 018489 204 LLDK-----NRTVKIADFGVARVEASNP-------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMP 271 (355)
Q Consensus 204 li~~-----~~~v~L~Dfg~a~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p 271 (355)
+++. ++.++|+|||+|+...... .......||+.|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 133 li~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~P 212 (293)
T d1csna_ 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 212 (293)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCc
Confidence 9964 6789999999998654321 123345799999999999999999999999999999999999999
Q ss_pred CCCCChh---HHHHHHHhc---CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhHhhcC
Q 018489 272 YPDLSFS---EVTSAVVRQ---NLRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVSMLEAIDTSKG 334 (355)
Q Consensus 272 ~~~~~~~---~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 334 (355)
|.+.... .....+... .....+...+|+++.+++..|+..+|++||+++.+.+.|+++....+
T Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 213 WQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp TSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 9765432 222222221 11223446689999999999999999999999999999999876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-46 Score=336.01 Aligned_cols=245 Identities=18% Similarity=0.302 Sum_probs=196.5
Q ss_pred cCCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhC-CCCccceeeeecc
Q 018489 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (355)
Q Consensus 48 ~~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 124 (355)
+.++|++++.||+|+||+||+|++ +++.||||+++... .+.+.+|+.+++.+ .||||+++++++.
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------------~~~~~~Ei~il~~l~~hpnIv~~~~~~~ 100 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------------KKKIKREIKILENLRGGPNIITLADIVK 100 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------------HHHHHHHHHHHHhccCCCCCcEEEEEEE
Confidence 347899999999999999999976 58999999985322 23477899999999 5999999999887
Q ss_pred CCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 018489 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (355)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nil 204 (355)
..... +.++||||+.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~--------------~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NIL 161 (328)
T d3bqca1 101 DPVSR--------------TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161 (328)
T ss_dssp CTTTC--------------SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred ecCCC--------------ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceE
Confidence 54332 337899999999987643 46999999999999999999999999999999999999
Q ss_pred EcCCC-cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCC-CCCCcchhHHHHHHHHHHHhCCCCCCCCChh-HHH
Q 018489 205 LDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVT 281 (355)
Q Consensus 205 i~~~~-~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~lltg~~p~~~~~~~-~~~ 281 (355)
++.++ .++|+|||.|...... .......+|..|+|||.+.+. .++.++|+||+|+++|+|++|..||...... ...
T Consensus 162 i~~~~~~vkl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~ 240 (328)
T d3bqca1 162 IDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240 (328)
T ss_dssp EETTTTEEEECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred EcCCCCeeeecccccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHH
Confidence 98655 6899999999755433 334456789999999998765 5799999999999999999999999765432 221
Q ss_pred HHHHh-------------cC----------------------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 282 SAVVR-------------QN----------------------LRPEIPRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 282 ~~~~~-------------~~----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
..+.. .. ........+++++.+||++||++||.+|||++|+|+
T Consensus 241 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 241 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 00 001112346889999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=341.06 Aligned_cols=252 Identities=23% Similarity=0.386 Sum_probs=203.7
Q ss_pred CcceeecccccccceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCC-Cccceeeeec
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH-PNVTKFIGAT 123 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~ 123 (355)
++|++++.||+|+||.||+|.+ +|+.||||+++......... ..+.+.+|+.++++++| |||+++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~-----~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK-----TTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES-----SGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchH-----HHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 7899999999999999999965 47889999985432111100 01236789999999966 8999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 018489 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (355)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Ni 203 (355)
.+.... +++|||+.+++|.+++.. .+.+++..++.++.||+.||.|+|++|++||||||+||
T Consensus 99 ~~~~~~----------------~~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Ni 160 (322)
T d1vzoa_ 99 QTETKL----------------HLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 160 (322)
T ss_dssp EETTEE----------------EEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred ccCCce----------------eeeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccce
Confidence 876655 569999999999999854 45688999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeccccccccCC-CCCCCCCCCcccccCCcccCCC--CCCCcchhHHHHHHHHHHHhCCCCCCCCChhHH
Q 018489 204 LLDKNRTVKIADFGVARVEASN-PNDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (355)
Q Consensus 204 li~~~~~v~L~Dfg~a~~~~~~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~ 280 (355)
+++.++.++|+|||.+...... ........+++.|++||.+.+. .++.++|||||||++|+|++|+.||.+.+....
T Consensus 161 ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~ 240 (322)
T d1vzoa_ 161 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240 (322)
T ss_dssp EECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred eecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999754332 2233446789999999999764 467899999999999999999999987655444
Q ss_pred HHHHHhc--CCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 018489 281 TSAVVRQ--NLRPEIPRCCPSSLANVMKRCWDANPDKRP-----EMDEVVS 324 (355)
Q Consensus 281 ~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 324 (355)
...+... ...+.++..+++++.++|.+||++||.+|| |++|+++
T Consensus 241 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 241 QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 3333321 234456778999999999999999999999 4888876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=338.79 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=193.6
Q ss_pred CcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCccceeeeeccCCc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 127 (355)
++|++++.||+|+||+||+|.+ +|+.||||+++..... . ...+.+.+|+.++++++||||+++++++....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~---~----~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN---Q----THAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS---H----HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC---H----HHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence 6799999999999999999987 5899999999754321 1 12345789999999999999999999987543
Q ss_pred ccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEcC
Q 018489 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (355)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~Nili~~ 207 (355)
... ..+++|+||||+.++.+ +.+ ...+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 90 ~~~----------~~~~~~iv~Ey~~~~l~-~~~----~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~ 154 (355)
T d2b1pa1 90 TLE----------EFQDVYLVMELMDANLC-QVI----QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154 (355)
T ss_dssp STT----------TCCEEEEEEECCSEEHH-HHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred ccc----------cCceeEEEEeccchHHH-Hhh----hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccc
Confidence 321 14566899999966544 444 245899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHhCCCCCCCCChhHHHHHHHhc
Q 018489 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (355)
Q Consensus 208 ~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~lltg~~p~~~~~~~~~~~~~~~~ 287 (355)
++.++++|||.+..... ........+|..|+|||.+.+..++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 155 ~~~~kl~df~~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~ 233 (355)
T d2b1pa1 155 DCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233 (355)
T ss_dssp TCCEEECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ccceeeechhhhhcccc-ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999999874433 23344557899999999999999999999999999999999999999888766655544321
Q ss_pred CCCC--------------------C--------------C------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 018489 288 NLRP--------------------E--------------I------PRCCPSSLANVMKRCWDANPDKRPEMDEVVS 324 (355)
Q Consensus 288 ~~~~--------------------~--------------~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 324 (355)
...+ . . ....++++.+||++||.+||++|||++|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1110 0 0 0113567899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.8e-40 Score=299.54 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=187.0
Q ss_pred CCcceeecccccccceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-----------CCc
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-----------HPN 115 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~ 115 (355)
.+||++++.||+|+||+||+|++ +|+.||||+++... ...+.+.+|+.+++.+. |+|
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----------VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----------cchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 46799999999999999999976 68999999996321 11234567888777764 578
Q ss_pred cceeeeeccCCcccccccccccccCCCCceEEEEEecCCC-CHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh-CCc
Q 018489 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG-ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKI 193 (355)
Q Consensus 116 Iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i 193 (355)
|+++++++......+. +++|.++..+ .............+++..++.++.||+.||.|||+ .||
T Consensus 82 iv~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~I 147 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGV--------------HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGI 147 (362)
T ss_dssp BCCCCEEEEEEETTEE--------------EEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred eEEEEEEeeeccccce--------------eeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCc
Confidence 8888887754332222 4455555443 44444445566789999999999999999999998 899
Q ss_pred cccCCCCCcEEEcCCC------cEEEeeccccccccCCCCCCCCCCCcccccCCcccCCCCCCCcchhHHHHHHHHHHHh
Q 018489 194 VHRDVKTENMLLDKNR------TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (355)
Q Consensus 194 ~H~di~p~Nili~~~~------~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~llt 267 (355)
+||||||+|||++.++ .++++|||.+..... ......+++.|+|||.+.+..++.++|+||+|+++++|++
T Consensus 148 vHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 224 (362)
T d1q8ya_ 148 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224 (362)
T ss_dssp ECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccCChhHeeeeccCcccccceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHH
Confidence 9999999999998655 499999999875443 2344679999999999999999999999999999999999
Q ss_pred CCCCCCCCChh------HHHHHHHhc--------------------------CC--------------CCCCCCCCcHHH
Q 018489 268 CDMPYPDLSFS------EVTSAVVRQ--------------------------NL--------------RPEIPRCCPSSL 301 (355)
Q Consensus 268 g~~p~~~~~~~------~~~~~~~~~--------------------------~~--------------~~~~~~~~~~~l 301 (355)
|+.||...+.. ......... .. ........++++
T Consensus 225 g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (362)
T d1q8ya_ 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304 (362)
T ss_dssp SSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHH
T ss_pred CCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHH
Confidence 99999754321 111111000 00 001122346789
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH--HHHHh
Q 018489 302 ANVMKRCWDANPDKRPEMDEVVS--MLEAI 329 (355)
Q Consensus 302 ~~li~~~l~~~p~~Rps~~ell~--~l~~~ 329 (355)
.+||.+||++||.+|||++|+|+ .+++.
T Consensus 305 ~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 305 SDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999987 35433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.1e-24 Score=178.76 Aligned_cols=172 Identities=15% Similarity=0.115 Sum_probs=119.5
Q ss_pred ceeecccccccceEEEEEEE-CCceeEEEEeecCCCCCc---------cHHHHHHHHHHHHHHHHHHhhCCCCccceeee
Q 018489 52 LVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHR---------TEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (355)
Q Consensus 52 y~i~~~lg~G~~~~Vy~~~~-~~~~vavK~~~~~~~~~~---------~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~ 121 (355)
+.+.+.||+|+||.||+|.+ +|+.||||+++....... ..............|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46789999999999999975 689999999864322100 00111222344567889999999999988776
Q ss_pred eccCCcccccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 018489 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (355)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~di~p~ 201 (355)
+.. .+++|||+++..+. .++......++.|++.+|.+||++|++|+||||+
T Consensus 82 ~~~--------------------~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~ 132 (191)
T d1zara2 82 WEG--------------------NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQY 132 (191)
T ss_dssp EET--------------------TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTT
T ss_pred ecC--------------------CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChh
Confidence 432 15799999875543 2445556789999999999999999999999999
Q ss_pred cEEEcCCCcEEEeeccccccccCCCCCCCCCCCcccccCC------cccCCCCCCCcchhHHHHHHH
Q 018489 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAP------EVLNGNPYNRKCDVYSFGICL 262 (355)
Q Consensus 202 Nili~~~~~v~L~Dfg~a~~~~~~~~~~~~~~~~~~y~aP------E~~~~~~~~~~~DvwslG~il 262 (355)
|||++++ .++|+|||.|.....+... .|... +.+ ...|+.++|+||+.--+
T Consensus 133 NILv~~~-~~~liDFG~a~~~~~~~~~--------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 133 NVLVSEE-GIWIIDFPQSVEVGEEGWR--------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp SEEEETT-EEEECCCTTCEETTSTTHH--------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred heeeeCC-CEEEEECCCcccCCCCCcH--------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999864 5899999998644322110 11110 111 24567889999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.73 E-value=1.8e-08 Score=84.88 Aligned_cols=139 Identities=13% Similarity=0.084 Sum_probs=88.7
Q ss_pred CcceeecccccccceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCC-CCccceeeeeccCCcc
Q 018489 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSE 128 (355)
Q Consensus 50 ~~y~i~~~lg~G~~~~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~ 128 (355)
..|++.+..+-++.+.||+...++..+++|+.......... .+.+|...+..+. +=.+.+++.+....+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~---------~~~~E~~~l~~l~~~vpvP~vl~~~~~~~- 83 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTY---------DVEREKDMMLWLEGKLPVPKVLHFERHDG- 83 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTT---------CHHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchh---------hHHHHHHHHHHHhccCCCCcEEEEEecCC-
Confidence 46677776666666889999888888999988644332221 1456777776662 222345555443333
Q ss_pred cccccccccccCCCCceEEEEEecCCCCHHHHHHhhccccccHHHHHHHHHHHHHHHHHHHh------------------
Q 018489 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS------------------ 190 (355)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~------------------ 190 (355)
..++||++++|.++.+.... ......++.++...++.||+
T Consensus 84 ---------------~~~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~ 141 (263)
T d1j7la_ 84 ---------------WSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE 141 (263)
T ss_dssp ---------------EEEEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHH
T ss_pred ---------------ceEEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhh
Confidence 23679999999887654311 01122234444555555553
Q ss_pred -----------------------------------------CCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 191 -----------------------------------------QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 191 -----------------------------------------~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 137999999999999876666799999886
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=2.7e-06 Score=70.70 Aligned_cols=28 Identities=21% Similarity=0.359 Sum_probs=25.1
Q ss_pred ccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 193 IVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 193 i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
++|+|+.|.||+++++..+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999887667799999886
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.68 E-value=7.3e-05 Score=66.07 Aligned_cols=30 Identities=20% Similarity=0.338 Sum_probs=25.7
Q ss_pred CccccCCCCCcEEEcCCCcEEEeeccccccc
Q 018489 192 KIVHRDVKTENMLLDKNRTVKIADFGVARVE 222 (355)
Q Consensus 192 ~i~H~di~p~Nili~~~~~v~L~Dfg~a~~~ 222 (355)
.++|||++|.|||+++++ ++++||..+...
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G 253 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 253 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence 589999999999998765 899999988643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.56 E-value=0.00018 Score=61.73 Aligned_cols=29 Identities=24% Similarity=0.248 Sum_probs=23.8
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeecccccc
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~~ 221 (355)
.+++|+|+++.||++++ + ..++||+.+..
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 36899999999999964 3 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.31 E-value=0.0012 Score=56.06 Aligned_cols=30 Identities=20% Similarity=0.331 Sum_probs=27.1
Q ss_pred CCccccCCCCCcEEEcCCCcEEEeeccccc
Q 018489 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (355)
Q Consensus 191 ~~i~H~di~p~Nili~~~~~v~L~Dfg~a~ 220 (355)
.|++|+|+.++||+++.+...-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999986
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.85 E-value=0.0021 Score=56.38 Aligned_cols=77 Identities=23% Similarity=0.286 Sum_probs=45.2
Q ss_pred CCcceeecccccccceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHhhCCCCcc-ce
Q 018489 49 PSKLVIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV-TK 118 (355)
Q Consensus 49 ~~~y~i~~~lg~G~~~~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-v~ 118 (355)
.+.+++ +.|+.|-.-.+|++... ...|++++.-... ... ...+|..+++.+.-.++ .+
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~i-------dr~~E~~i~~~ls~~gl~Pk 109 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TES-------HLVAESVIFTLLSERHLGPK 109 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHH-------HHHHHHHHHHHHHHTTSSSC
T ss_pred ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hhh-------HHHHHHHHHHHHHhCCCCCe
Confidence 345555 46788888899998643 3457888763211 111 13357777777733344 35
Q ss_pred eeeeccCCcccccccccccccCCCCceEEEEEecCCCCH
Q 018489 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157 (355)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~sL 157 (355)
+++++.. .+|++|++|.++
T Consensus 110 ll~~~~~--------------------g~I~efi~g~~l 128 (395)
T d1nw1a_ 110 LYGIFSG--------------------GRLEEYIPSRPL 128 (395)
T ss_dssp EEEEETT--------------------EEEECCCCEEEC
T ss_pred EEEEcCC--------------------ceEEEEeccccC
Confidence 5655432 348899876543
|